Psyllid ID: psy1684
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 189 | 2.2.26 [Sep-21-2011] | |||||||
| Q9V9J3 | 517 | Tyrosine-protein kinase S | yes | N/A | 0.338 | 0.123 | 0.797 | 1e-28 | |
| P42686 | 505 | Tyrosine-protein kinase i | N/A | N/A | 0.343 | 0.128 | 0.557 | 4e-20 | |
| P42688 | 362 | Tyrosine-protein kinase S | N/A | N/A | 0.328 | 0.171 | 0.567 | 8e-20 | |
| P42690 | 506 | Tyrosine-protein kinase i | N/A | N/A | 0.328 | 0.122 | 0.582 | 6e-19 | |
| P13116 | 532 | Tyrosine-protein kinase S | N/A | N/A | 0.285 | 0.101 | 0.625 | 2e-18 | |
| P13115 | 532 | Tyrosine-protein kinase S | N/A | N/A | 0.285 | 0.101 | 0.625 | 2e-18 | |
| P00523 | 533 | Proto-oncogene tyrosine-p | yes | N/A | 0.285 | 0.101 | 0.625 | 7e-18 | |
| P14084 | 568 | Tyrosine-protein kinase t | N/A | N/A | 0.248 | 0.082 | 0.684 | 1e-17 | |
| P15054 | 587 | Tyrosine-protein kinase t | N/A | N/A | 0.248 | 0.080 | 0.684 | 2e-17 | |
| P27446 | 537 | Tyrosine-protein kinase F | N/A | N/A | 0.275 | 0.096 | 0.609 | 2e-17 |
| >sp|Q9V9J3|SRC42_DROME Tyrosine-protein kinase Src42A OS=Drosophila melanogaster GN=Src42A PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 125 bits (315), Expect = 1e-28, Method: Compositional matrix adjust.
Identities = 55/69 (79%), Positives = 60/69 (86%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180
GMTNAEVL QVEHGYRMP PP C PRLY+IMLECW KDP++RPTFETLQWKLEDF+T +
Sbjct: 449 GMTNAEVLTQVEHGYRMPQPPNCEPRLYEIMLECWHKDPMRRPTFETLQWKLEDFYTSDQ 508
Query: 181 SDYKEASGY 189
SDYKEA Y
Sbjct: 509 SDYKEAQAY 517
|
Essential for correct eye morphogenesis (ommatidial R7 neuron formation), this requires the Ras1/MAPK signal transduction pathway. May be involved in the regulation of cytoskeleton organization and cell-cell contacts in developing ommatidia. Drosophila melanogaster (taxid: 7227) EC: 2EC: .EC: 7EC: .EC: 1EC: 0EC: .EC: 2 |
| >sp|P42686|SRK1_SPOLA Tyrosine-protein kinase isoform SRK1 OS=Spongilla lacustris GN=SRK1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 97.8 bits (242), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 39/70 (55%), Positives = 51/70 (72%)
Query: 111 VVSAVDFGSGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170
+++ F GMTN EVL +++ YRMPCP CP + +DIML+CW +DP RPTFETLQW
Sbjct: 428 IITYGRFPYPGMTNPEVLEKIQQNYRMPCPANCPKQFHDIMLDCWREDPASRPTFETLQW 487
Query: 171 KLEDFFTMEG 180
+LE+FF EG
Sbjct: 488 QLEEFFNSEG 497
|
Spongilla lacustris (taxid: 6055) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|P42688|SRK2_SPOLA Tyrosine-protein kinase SRK2 (Fragment) OS=Spongilla lacustris GN=SRK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 96.7 bits (239), Expect = 8e-20, Method: Compositional matrix adjust.
Identities = 38/67 (56%), Positives = 49/67 (73%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180
GM+NAEVL ++ GYRMPCP P LY IML+CW ++P RPTFE LQW+LEDFF ++
Sbjct: 293 GMSNAEVLQNLDKGYRMPCPVTTPESLYQIMLDCWKRNPADRPTFEALQWRLEDFFVLDA 352
Query: 181 SDYKEAS 187
Y+ A+
Sbjct: 353 GQYQHAA 359
|
Spongilla lacustris (taxid: 6055) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|P42690|SRK4_SPOLA Tyrosine-protein kinase isoform SRK4 OS=Spongilla lacustris GN=SRK1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 94.0 bits (232), Expect = 6e-19, Method: Compositional matrix adjust.
Identities = 39/67 (58%), Positives = 50/67 (74%)
Query: 111 VVSAVDFGSGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170
V++ F GMTNA+VL Q++ YRMP P GCP +LY IM++CW +DP RPTFETL W
Sbjct: 428 VITYGRFPYPGMTNAQVLEQIQQSYRMPRPMGCPEKLYAIMMDCWREDPASRPTFETLSW 487
Query: 171 KLEDFFT 177
+LE+FFT
Sbjct: 488 QLEEFFT 494
|
Spongilla lacustris (taxid: 6055) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|P13116|SRC2_XENLA Tyrosine-protein kinase Src-2 OS=Xenopus laevis GN=src-b PE=2 SV=3 | Back alignment and function description |
|---|
Score = 92.0 bits (227), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 40/64 (62%), Positives = 46/64 (71%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180
GM N EVL QVE GYRMPCPP CP L+D+M +CW KDP +RPTFE LQ LED+FT
Sbjct: 464 GMVNREVLDQVERGYRMPCPPDCPESLHDLMFQCWRKDPEERPTFEYLQAFLEDYFTATE 523
Query: 181 SDYK 184
Y+
Sbjct: 524 PQYQ 527
|
Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|P13115|SRC1_XENLA Tyrosine-protein kinase Src-1 OS=Xenopus laevis GN=src-a PE=2 SV=4 | Back alignment and function description |
|---|
Score = 91.7 bits (226), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 40/64 (62%), Positives = 46/64 (71%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180
GM N EVL QVE GYRMPCPP CP L+D+M +CW KDP +RPTFE LQ LED+FT
Sbjct: 464 GMVNREVLDQVERGYRMPCPPDCPESLHDLMFQCWRKDPEERPTFEYLQAFLEDYFTATE 523
Query: 181 SDYK 184
Y+
Sbjct: 524 PQYQ 527
|
Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|P00523|SRC_CHICK Proto-oncogene tyrosine-protein kinase Src OS=Gallus gallus GN=SRC PE=1 SV=4 | Back alignment and function description |
|---|
Score = 90.1 bits (222), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 40/64 (62%), Positives = 46/64 (71%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180
GM N EVL QVE GYRMPCPP CP L+D+M +CW KDP +RPTFE LQ LED+FT
Sbjct: 465 GMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTE 524
Query: 181 SDYK 184
Y+
Sbjct: 525 PQYQ 528
|
Non-receptor protein tyrosine kinase which is activated following engagement of many different classes of cellular receptors including immune response receptors, integrins and other adhesion receptors, receptor protein tyrosine kinases, G protein-coupled receptors as well as cytokine receptors. Participates in signaling pathways that control a diverse spectrum of biological activities including gene transcription, immune response, cell adhesion, cell cycle progression, apoptosis, migration, and transformation. Due to functional redundancy between members of the SRC kinase family, identification of the specific role of each SRC kinase is very difficult. SRC appears to be one of the primary kinases activated following engagement of receptors and plays a role in the activation of other protein tyrosine kinase (PTK) families. Receptor clustering or dimerization leads to recruitment of SRC to the receptor complexes where it phosphorylates the tyrosine residues within the receptor cytoplasmic domains. Plays an important role in the regulation of cytoskeletal organization through phosphorylation of specific substrates involved in this process. When cells adhere via focal adhesions to the extra-cellular matrix, signals are transmitted by integrins into the cell and result in tyrosine phosphorylation of a number of focal adhesion proteins, including PTK2/FAK1 and paxillin (PXN). Also active at the sites of cell-cell contact adherens junctions and at gap junctions. Implicated in the regulation of pre-mRNA-processing. Might be involved not only in mediating the transduction of mitogenic signals at the level of the plasma membrane but also in controlling progression through the cell cycle via interaction with regulatory proteins in the nucleus. Gallus gallus (taxid: 9031) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|P14084|SRC_AVISS Tyrosine-protein kinase transforming protein Src OS=Avian sarcoma virus (strain S1) GN=V-SRC PE=3 SV=3 | Back alignment and function description |
|---|
Score = 89.7 bits (221), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 39/57 (68%), Positives = 44/57 (77%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFT 177
GM N EVL QVE GYRMPCPP CP L+D+M +CW KDP +RPTFE LQ LED+FT
Sbjct: 465 GMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFT 521
|
This phosphoprotein, required for both the initiation and the maintenance of neoplastic transformation, is a protein kinase that catalyzes the phosphorylation of tyrosine residues in vitro. Galliformes (taxid: 8976) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|P15054|SRC_AVIS2 Tyrosine-protein kinase transforming protein Src OS=Avian sarcoma virus (strain PR2257) GN=V-SRC PE=3 SV=3 | Back alignment and function description |
|---|
Score = 89.0 bits (219), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 39/57 (68%), Positives = 44/57 (77%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFT 177
GM N EVL QVE GYRMPCPP CP L+D+M +CW KDP +RPTFE LQ LED+FT
Sbjct: 465 GMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFT 521
|
This phosphoprotein, required for both the initiation and the maintenance of neoplastic transformation, is a protein kinase that catalyzes the phosphorylation of tyrosine residues in vitro. Galliformes (taxid: 8976) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|P27446|FYN_XIPHE Tyrosine-protein kinase Fyn OS=Xiphophorus helleri GN=fyn PE=2 SV=3 | Back alignment and function description |
|---|
Score = 88.6 bits (218), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 39/64 (60%), Positives = 46/64 (71%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180
GM N EVL QVE GYRMPCP CP L+++ML+CW KDP +RPTFE LQ LED+FT
Sbjct: 469 GMNNREVLEQVERGYRMPCPQDCPASLHELMLQCWKKDPEERPTFEYLQAFLEDYFTATE 528
Query: 181 SDYK 184
Y+
Sbjct: 529 PQYQ 532
|
Tyrosine-protein kinase implicated in the control of cell growth. Plays a role in the regulation of intracellular calcium levels. Required in brain development and mature brain function with important roles in the regulation of axon growth, axon guidance, and neurite extension. Xiphophorus helleri (taxid: 8084) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 189 | ||||||
| 340716501 | 527 | PREDICTED: tyrosine-protein kinase Src42 | 0.338 | 0.121 | 0.913 | 1e-32 | |
| 350404530 | 518 | PREDICTED: tyrosine-protein kinase Src42 | 0.338 | 0.123 | 0.913 | 1e-32 | |
| 383860313 | 505 | PREDICTED: tyrosine-protein kinase Src42 | 0.338 | 0.126 | 0.913 | 1e-32 | |
| 328788805 | 505 | PREDICTED: tyrosine-protein kinase Src42 | 0.338 | 0.126 | 0.913 | 1e-32 | |
| 307212546 | 505 | Tyrosine-protein kinase Src42A [Harpegna | 0.338 | 0.126 | 0.913 | 1e-32 | |
| 270010401 | 422 | hypothetical protein TcasGA2_TC009792 [T | 0.338 | 0.151 | 0.884 | 4e-31 | |
| 332020426 | 505 | Tyrosine-protein kinase Src42A [Acromyrm | 0.338 | 0.126 | 0.884 | 4e-31 | |
| 91086687 | 507 | PREDICTED: similar to AGAP006270-PA [Tri | 0.338 | 0.126 | 0.884 | 4e-31 | |
| 427789247 | 538 | Putative protein kinase [Rhipicephalus p | 0.328 | 0.115 | 0.895 | 5e-31 | |
| 241999648 | 447 | src tyrosine kinase, putative [Ixodes sc | 0.328 | 0.138 | 0.895 | 7e-31 |
| >gi|340716501|ref|XP_003396736.1| PREDICTED: tyrosine-protein kinase Src42A-like isoform 1 [Bombus terrestris] | Back alignment and taxonomy information |
|---|
Score = 145 bits (365), Expect = 1e-32, Method: Compositional matrix adjust.
Identities = 63/69 (91%), Positives = 65/69 (94%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180
GMTNAEVLHQVEHGYRMPCPPGCP LYDIMLECW KDP+KRPTFETLQWKLEDFFTMEG
Sbjct: 459 GMTNAEVLHQVEHGYRMPCPPGCPTALYDIMLECWNKDPMKRPTFETLQWKLEDFFTMEG 518
Query: 181 SDYKEASGY 189
S+YKEAS Y
Sbjct: 519 SEYKEASAY 527
|
Source: Bombus terrestris Species: Bombus terrestris Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|350404530|ref|XP_003487134.1| PREDICTED: tyrosine-protein kinase Src42A-like isoform 3 [Bombus impatiens] | Back alignment and taxonomy information |
|---|
Score = 145 bits (365), Expect = 1e-32, Method: Compositional matrix adjust.
Identities = 63/69 (91%), Positives = 65/69 (94%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180
GMTNAEVLHQVEHGYRMPCPPGCP LYDIMLECW KDP+KRPTFETLQWKLEDFFTMEG
Sbjct: 450 GMTNAEVLHQVEHGYRMPCPPGCPTALYDIMLECWNKDPMKRPTFETLQWKLEDFFTMEG 509
Query: 181 SDYKEASGY 189
S+YKEAS Y
Sbjct: 510 SEYKEASAY 518
|
Source: Bombus impatiens Species: Bombus impatiens Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|383860313|ref|XP_003705635.1| PREDICTED: tyrosine-protein kinase Src42A-like [Megachile rotundata] | Back alignment and taxonomy information |
|---|
Score = 145 bits (365), Expect = 1e-32, Method: Compositional matrix adjust.
Identities = 63/69 (91%), Positives = 65/69 (94%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180
GMTNAEVLHQVEHGYRMPCPPGCP LYDIMLECW KDP+KRPTFETLQWKLEDFFTMEG
Sbjct: 437 GMTNAEVLHQVEHGYRMPCPPGCPTALYDIMLECWNKDPMKRPTFETLQWKLEDFFTMEG 496
Query: 181 SDYKEASGY 189
S+YKEAS Y
Sbjct: 497 SEYKEASAY 505
|
Source: Megachile rotundata Species: Megachile rotundata Genus: Megachile Family: Megachilidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|328788805|ref|XP_396043.3| PREDICTED: tyrosine-protein kinase Src42A-like isoform 1 [Apis mellifera] gi|340716503|ref|XP_003396737.1| PREDICTED: tyrosine-protein kinase Src42A-like isoform 2 [Bombus terrestris] gi|340716505|ref|XP_003396738.1| PREDICTED: tyrosine-protein kinase Src42A-like isoform 3 [Bombus terrestris] gi|350404526|ref|XP_003487132.1| PREDICTED: tyrosine-protein kinase Src42A-like isoform 1 [Bombus impatiens] gi|350404528|ref|XP_003487133.1| PREDICTED: tyrosine-protein kinase Src42A-like isoform 2 [Bombus impatiens] gi|380027727|ref|XP_003697570.1| PREDICTED: tyrosine-protein kinase Src42A-like [Apis florea] | Back alignment and taxonomy information |
|---|
Score = 145 bits (365), Expect = 1e-32, Method: Compositional matrix adjust.
Identities = 63/69 (91%), Positives = 65/69 (94%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180
GMTNAEVLHQVEHGYRMPCPPGCP LYDIMLECW KDP+KRPTFETLQWKLEDFFTMEG
Sbjct: 437 GMTNAEVLHQVEHGYRMPCPPGCPTALYDIMLECWNKDPMKRPTFETLQWKLEDFFTMEG 496
Query: 181 SDYKEASGY 189
S+YKEAS Y
Sbjct: 497 SEYKEASAY 505
|
Source: Apis mellifera Species: Apis mellifera Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|307212546|gb|EFN88269.1| Tyrosine-protein kinase Src42A [Harpegnathos saltator] | Back alignment and taxonomy information |
|---|
Score = 144 bits (364), Expect = 1e-32, Method: Compositional matrix adjust.
Identities = 63/69 (91%), Positives = 65/69 (94%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180
GMTNAEVLHQVEHGYRMPCPPGCP LYDIMLECW KDP+KRPTFETLQWKLEDFFTMEG
Sbjct: 437 GMTNAEVLHQVEHGYRMPCPPGCPSTLYDIMLECWNKDPMKRPTFETLQWKLEDFFTMEG 496
Query: 181 SDYKEASGY 189
S+YKEAS Y
Sbjct: 497 SEYKEASAY 505
|
Source: Harpegnathos saltator Species: Harpegnathos saltator Genus: Harpegnathos Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|270010401|gb|EFA06849.1| hypothetical protein TcasGA2_TC009792 [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 139 bits (351), Expect = 4e-31, Method: Compositional matrix adjust.
Identities = 61/69 (88%), Positives = 64/69 (92%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180
GMTNAEVLHQVEHGYRMP PPGCP LYDIMLECW +DP+KRPTFETLQWKLEDFFTMEG
Sbjct: 354 GMTNAEVLHQVEHGYRMPSPPGCPAPLYDIMLECWNRDPMKRPTFETLQWKLEDFFTMEG 413
Query: 181 SDYKEASGY 189
S+YKEAS Y
Sbjct: 414 SEYKEASAY 422
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|332020426|gb|EGI60846.1| Tyrosine-protein kinase Src42A [Acromyrmex echinatior] | Back alignment and taxonomy information |
|---|
Score = 139 bits (351), Expect = 4e-31, Method: Compositional matrix adjust.
Identities = 61/69 (88%), Positives = 64/69 (92%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180
GMTNAEVLHQVEHGYRMP PPGCP LY+IMLECW KDP+KRPTFETLQWKLEDFFTMEG
Sbjct: 437 GMTNAEVLHQVEHGYRMPSPPGCPDTLYNIMLECWNKDPMKRPTFETLQWKLEDFFTMEG 496
Query: 181 SDYKEASGY 189
S+YKEAS Y
Sbjct: 497 SEYKEASAY 505
|
Source: Acromyrmex echinatior Species: Acromyrmex echinatior Genus: Acromyrmex Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|91086687|ref|XP_969129.1| PREDICTED: similar to AGAP006270-PA [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 139 bits (351), Expect = 4e-31, Method: Compositional matrix adjust.
Identities = 61/69 (88%), Positives = 64/69 (92%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180
GMTNAEVLHQVEHGYRMP PPGCP LYDIMLECW +DP+KRPTFETLQWKLEDFFTMEG
Sbjct: 439 GMTNAEVLHQVEHGYRMPSPPGCPAPLYDIMLECWNRDPMKRPTFETLQWKLEDFFTMEG 498
Query: 181 SDYKEASGY 189
S+YKEAS Y
Sbjct: 499 SEYKEASAY 507
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|427789247|gb|JAA60075.1| Putative protein kinase [Rhipicephalus pulchellus] | Back alignment and taxonomy information |
|---|
Score = 139 bits (350), Expect = 5e-31, Method: Compositional matrix adjust.
Identities = 60/67 (89%), Positives = 64/67 (95%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180
GMTNAEVLHQVEHGYRMPCPPGCPP LY+IMLE W KDP+KRPTFETLQWKLEDFFTMEG
Sbjct: 469 GMTNAEVLHQVEHGYRMPCPPGCPPALYEIMLETWHKDPMKRPTFETLQWKLEDFFTMEG 528
Query: 181 SDYKEAS 187
S+YKEA+
Sbjct: 529 SEYKEAA 535
|
Source: Rhipicephalus pulchellus Species: Rhipicephalus pulchellus Genus: Rhipicephalus Family: Ixodidae Order: Ixodida Class: Arachnida Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|241999648|ref|XP_002434467.1| src tyrosine kinase, putative [Ixodes scapularis] gi|215497797|gb|EEC07291.1| src tyrosine kinase, putative [Ixodes scapularis] | Back alignment and taxonomy information |
|---|
Score = 139 bits (349), Expect = 7e-31, Method: Compositional matrix adjust.
Identities = 60/67 (89%), Positives = 64/67 (95%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180
GMTNAEVLHQVEHGYRMPCPPGCPP LY+IMLE W KDP+KRPTFETLQWKLEDFFTMEG
Sbjct: 378 GMTNAEVLHQVEHGYRMPCPPGCPPALYEIMLETWHKDPMKRPTFETLQWKLEDFFTMEG 437
Query: 181 SDYKEAS 187
S+YKEA+
Sbjct: 438 SEYKEAA 444
|
Source: Ixodes scapularis Species: Ixodes scapularis Genus: Ixodes Family: Ixodidae Order: Ixodida Class: Arachnida Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 189 | ||||||
| FB|FBgn0264959 | 517 | Src42A "Src oncogene at 42A" [ | 0.365 | 0.133 | 0.797 | 2e-56 | |
| WB|WBGene00005078 | 507 | src-2 [Caenorhabditis elegans | 0.417 | 0.155 | 0.650 | 1.1e-45 | |
| UNIPROTKB|F1RZK6 | 511 | FRK "Uncharacterized protein" | 0.544 | 0.201 | 0.454 | 2.8e-36 | |
| RGD|621423 | 506 | Frk "fyn-related kinase" [Ratt | 0.359 | 0.134 | 0.492 | 1.6e-34 | |
| UNIPROTKB|Q62662 | 506 | Frk "Tyrosine-protein kinase F | 0.359 | 0.134 | 0.492 | 1.6e-34 | |
| UNIPROTKB|E1BPI3 | 514 | FRK "Uncharacterized protein" | 0.492 | 0.180 | 0.448 | 1.6e-34 | |
| UNIPROTKB|P42685 | 505 | FRK "Tyrosine-protein kinase F | 0.359 | 0.134 | 0.507 | 3.9e-34 | |
| MGI|MGI:103265 | 512 | Frk "fyn-related kinase" [Mus | 0.492 | 0.181 | 0.438 | 9.4e-34 | |
| UNIPROTKB|J9NY14 | 505 | FRK "Uncharacterized protein" | 0.492 | 0.184 | 0.459 | 2.8e-33 | |
| UNIPROTKB|F1PR52 | 509 | FRK "Uncharacterized protein" | 0.492 | 0.182 | 0.459 | 2.9e-33 |
| FB|FBgn0264959 Src42A "Src oncogene at 42A" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 313 (115.2 bits), Expect = 2.0e-56, Sum P(2) = 2.0e-56
Identities = 55/69 (79%), Positives = 60/69 (86%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180
GMTNAEVL QVEHGYRMP PP C PRLY+IMLECW KDP++RPTFETLQWKLEDF+T +
Sbjct: 449 GMTNAEVLTQVEHGYRMPQPPNCEPRLYEIMLECWHKDPMRRPTFETLQWKLEDFYTSDQ 508
Query: 181 SDYKEASGY 189
SDYKEA Y
Sbjct: 509 SDYKEAQAY 517
|
|
| WB|WBGene00005078 src-2 [Caenorhabditis elegans (taxid:6239)] | Back alignment and assigned GO terms |
|---|
Score = 286 (105.7 bits), Expect = 1.1e-45, Sum P(2) = 1.1e-45
Identities = 54/83 (65%), Positives = 63/83 (75%)
Query: 109 GVVVSA-VDFGS---GGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPT 164
G++++ V FG GMTNAEVL QV+ GYRMPCP GCP LYDIM +CW DP KRPT
Sbjct: 422 GILLTEIVTFGRLPYPGMTNAEVLQQVDAGYRMPCPAGCPVTLYDIMQQCWRSDPDKRPT 481
Query: 165 FETLQWKLEDFFTMEGSDYKEAS 187
FETLQWKLED F ++ S+YKEAS
Sbjct: 482 FETLQWKLEDLFNLDSSEYKEAS 504
|
|
| UNIPROTKB|F1RZK6 FRK "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 222 (83.2 bits), Expect = 2.8e-36, Sum P(2) = 2.8e-36
Identities = 50/110 (45%), Positives = 68/110 (61%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRS---SFCLKMTTGRSL 57
W+FG IKR +AEK+LL PEN GAFLIR+SES+K D+SLS + ++
Sbjct: 125 WFFGAIKRADAEKQLLYPENQEGAFLIRESESQKGDFSLSVLHEGIVKHYRIRRLDEGGF 184
Query: 58 FETQKAGRTTIHYPELVEHYSKDADGLCVNLRKPC--VQVSCRIYLVHGT 105
F T++ +T++ E V HYS+ +DGLCV L KPC +QV I L + T
Sbjct: 185 FLTRRRTFSTLN--EFVSHYSRTSDGLCVKLGKPCLKIQVPATIDLSYKT 232
|
|
| RGD|621423 Frk "fyn-related kinase" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 205 (77.2 bits), Expect = 1.6e-34, Sum P(2) = 1.6e-34
Identities = 34/69 (49%), Positives = 47/69 (68%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180
GMT A+V+H + YR+P P CP + Y IM+ECW +P +RPTFETL WKLED+F +
Sbjct: 437 GMTGAQVIHMLGQNYRLPQPSNCPEQFYSIMMECWNVEPKQRPTFETLHWKLEDYFEPDS 496
Query: 181 SDYKEASGY 189
S Y + + +
Sbjct: 497 S-YSDTNNF 504
|
|
| UNIPROTKB|Q62662 Frk "Tyrosine-protein kinase FRK" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 205 (77.2 bits), Expect = 1.6e-34, Sum P(2) = 1.6e-34
Identities = 34/69 (49%), Positives = 47/69 (68%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180
GMT A+V+H + YR+P P CP + Y IM+ECW +P +RPTFETL WKLED+F +
Sbjct: 437 GMTGAQVIHMLGQNYRLPQPSNCPEQFYSIMMECWNVEPKQRPTFETLHWKLEDYFEPDS 496
Query: 181 SDYKEASGY 189
S Y + + +
Sbjct: 497 S-YSDTNNF 504
|
|
| UNIPROTKB|E1BPI3 FRK "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 208 (78.3 bits), Expect = 1.6e-34, Sum P(2) = 1.6e-34
Identities = 44/98 (44%), Positives = 64/98 (65%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS---EYKRSSFCLKMTTGRSL 57
W+FG IKR +AEK+LL EN GAFLIR+SES+K D++LS E + ++
Sbjct: 126 WFFGAIKRTDAEKQLLYSENQTGAFLIRESESQKGDFALSVLDEGVVKHYRIRRLDEGGF 185
Query: 58 FETQKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQV 95
F T++ +T++ E V HY+K +DGLCV L KPC+++
Sbjct: 186 FLTRRRTFSTLN--EFVSHYTKTSDGLCVKLGKPCLKI 221
|
|
| UNIPROTKB|P42685 FRK "Tyrosine-protein kinase FRK" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 208 (78.3 bits), Expect = 3.9e-34, Sum P(2) = 3.9e-34
Identities = 35/69 (50%), Positives = 49/69 (71%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180
GMT A+V+ + YR+P P CP + Y+IMLECW +P +RPTFETL+WKLED+F +
Sbjct: 436 GMTGAQVIQMLAQNYRLPQPSNCPQQFYNIMLECWNAEPKERPTFETLRWKLEDYFETDS 495
Query: 181 SDYKEASGY 189
S Y +A+ +
Sbjct: 496 S-YSDANNF 503
|
|
| MGI|MGI:103265 Frk "fyn-related kinase" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 200 (75.5 bits), Expect = 9.4e-34, Sum P(2) = 9.4e-34
Identities = 43/98 (43%), Positives = 63/98 (64%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS---EYKRSSFCLKMTTGRSL 57
W+FG IKR +AEK+LL EN GAFLIR+SES+K D+SLS E + ++
Sbjct: 123 WFFGAIKRADAEKQLLYSENQTGAFLIRESESQKGDFSLSVLDEGVVKHYRIRRLDEGGF 182
Query: 58 FETQKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQV 95
F T++ +T++ E V +Y+ +DGLCV L KPC+++
Sbjct: 183 FLTRRKVFSTLN--EFVNYYTTTSDGLCVKLEKPCLKI 218
|
|
| UNIPROTKB|J9NY14 FRK "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 206 (77.6 bits), Expect = 2.8e-33, Sum P(2) = 2.8e-33
Identities = 45/98 (45%), Positives = 62/98 (63%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS---EYKRSSFCLKMTTGRSL 57
W+FG IKR EAEK+LL N GAFLIR+SES+K D++LS E + ++
Sbjct: 120 WFFGAIKRTEAEKQLLYSGNQTGAFLIRESESQKGDFALSVLDERVVKHYRIRRMDEGEF 179
Query: 58 FETQKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQV 95
F +QK T++ E V HY+K +DGLCV L KPC+++
Sbjct: 180 FLSQKRTFPTLN--EFVSHYTKTSDGLCVQLGKPCLKI 215
|
|
| UNIPROTKB|F1PR52 FRK "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 206 (77.6 bits), Expect = 2.9e-33, Sum P(2) = 2.9e-33
Identities = 45/98 (45%), Positives = 62/98 (63%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS---EYKRSSFCLKMTTGRSL 57
W+FG IKR EAEK+LL N GAFLIR+SES+K D++LS E + ++
Sbjct: 120 WFFGAIKRTEAEKQLLYSGNQTGAFLIRESESQKGDFALSVLDERVVKHYRIRRMDEGEF 179
Query: 58 FETQKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQV 95
F +QK T++ E V HY+K +DGLCV L KPC+++
Sbjct: 180 FLSQKRTFPTLN--EFVSHYTKTSDGLCVQLGKPCLKI 215
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 189 | |||
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-35 | |
| cd10370 | 96 | cd10370, SH2_Src_Src42, Src homology 2 (SH2) domai | 1e-34 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-32 | |
| cd09933 | 101 | cd09933, SH2_Src_family, Src homology 2 (SH2) doma | 2e-29 | |
| cd10369 | 96 | cd10369, SH2_Src_Frk, Src homology 2 (SH2) domain | 2e-23 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-23 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-23 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-22 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-21 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-20 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-20 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-20 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-19 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-19 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-19 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-18 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-16 | |
| cd10367 | 101 | cd10367, SH2_Src_Fgr, Src homology 2 (SH2) domain | 5e-16 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-15 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-15 | |
| cd10362 | 101 | cd10362, SH2_Src_Lck, Src homology 2 (SH2) domain | 3e-15 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-15 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-15 | |
| pfam00017 | 77 | pfam00017, SH2, SH2 domain | 6e-15 | |
| cd10363 | 104 | cd10363, SH2_Src_HCK, Src homology 2 (SH2) domain | 1e-14 | |
| cd10371 | 100 | cd10371, SH2_Src_Blk, Src homology 2 (SH2) domain | 3e-14 | |
| smart00252 | 84 | smart00252, SH2, Src homology 2 domains | 3e-14 | |
| cd10419 | 101 | cd10419, SH2_Src_Fyn_isoform_b_like, Src homology | 6e-14 | |
| cd10364 | 101 | cd10364, SH2_Src_Lyn, Src homology 2 (SH2) domain | 1e-13 | |
| cd10366 | 101 | cd10366, SH2_Src_Yes, Src homology 2 (SH2) domain | 2e-13 | |
| cd10368 | 101 | cd10368, SH2_Src_Fyn, Src homology 2 (SH2) domain | 2e-13 | |
| cd10365 | 101 | cd10365, SH2_Src_Src, Src homology 2 (SH2) domain | 2e-13 | |
| cd09937 | 98 | cd09937, SH2_csk_like, Src homology 2 (SH2) domain | 3e-13 | |
| cd10418 | 101 | cd10418, SH2_Src_Fyn_isoform_a_like, Src homology | 9e-13 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-12 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-12 | |
| cd10360 | 79 | cd10360, SH2_Srm, Src homology 2 (SH2) domain foun | 3e-12 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-12 | |
| cd10344 | 104 | cd10344, SH2_SLAP, Src homology 2 domain found in | 3e-12 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-12 | |
| cd09938 | 104 | cd09938, SH2_N-SH2_Zap70_Syk_like, N-terminal Src | 1e-11 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-11 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-11 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-11 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-11 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 9e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 9e-11 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-10 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-10 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-10 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-10 | |
| cd00173 | 79 | cd00173, SH2, Src homology 2 (SH2) domain | 3e-10 | |
| cd09935 | 94 | cd09935, SH2_ABL, Src homology 2 (SH2) domain foun | 4e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-10 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-10 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-10 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 9e-10 | |
| cd09945 | 98 | cd09945, SH2_SHB_SHD_SHE_SHF_like, Src homology 2 | 9e-10 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-09 | |
| cd09941 | 95 | cd09941, SH2_Grb2_like, Src homology 2 domain foun | 2e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-09 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-09 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-09 | |
| cd09943 | 93 | cd09943, SH2_Nck_family, Src homology 2 (SH2) doma | 5e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 6e-09 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 9e-09 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-08 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-08 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-08 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-08 | |
| cd10408 | 97 | cd10408, SH2_Nck1, Src homology 2 (SH2) domain fou | 5e-08 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 8e-08 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-07 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-07 | |
| cd09931 | 99 | cd09931, SH2_C-SH2_SHP_like, C-terminal Src homolo | 3e-07 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-07 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-07 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-07 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-07 | |
| cd09934 | 104 | cd09934, SH2_Tec_family, Src homology 2 (SH2) doma | 8e-07 | |
| cd10397 | 106 | cd10397, SH2_Tec_Btk, Src homology 2 (SH2) domain | 1e-06 | |
| cd10402 | 105 | cd10402, SH2_C-SH2_Zap70, C-terminal Src homology | 1e-06 | |
| cd09926 | 106 | cd09926, SH2_CRK_like, Src homology 2 domain found | 2e-06 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-06 | |
| cd10401 | 99 | cd10401, SH2_C-SH2_Syk_like, C-terminal Src homolo | 2e-06 | |
| cd10392 | 98 | cd10392, SH2_SHF, Src homology 2 domain found in S | 2e-06 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-06 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 7e-06 | |
| cd10347 | 81 | cd10347, SH2_Nterm_shark_like, N-terminal Src homo | 9e-06 | |
| cd10398 | 106 | cd10398, SH2_Tec_Txk, Src homology 2 (SH2) domain | 1e-05 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-05 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-05 | |
| cd10354 | 77 | cd10354, SH2_Cterm_RasGAP, C-terminal Src homology | 2e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-05 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-05 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-05 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-05 | |
| cd10409 | 98 | cd10409, SH2_Nck2, Src homology 2 (SH2) domain fou | 4e-05 | |
| cd10391 | 98 | cd10391, SH2_SHE, Src homology 2 domain found in S | 4e-05 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-05 | |
| cd10340 | 99 | cd10340, SH2_N-SH2_SHP_like, N-terminal Src homolo | 5e-05 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-05 | |
| cd10341 | 99 | cd10341, SH2_N-SH2_PLC_gamma_like, N-terminal Src | 6e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-05 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-05 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 8e-05 | |
| cd10358 | 100 | cd10358, SH2_PTK6_Brk, Src homology 2 domain found | 8e-05 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-04 | |
| cd09944 | 108 | cd09944, SH2_Grb7_family, Src homology 2 (SH2) dom | 1e-04 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-04 | |
| cd10348 | 86 | cd10348, SH2_Cterm_shark_like, C-terminal Src homo | 2e-04 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-04 | |
| cd10343 | 103 | cd10343, SH2_SHIP, Src homology 2 (SH2) domain fou | 2e-04 | |
| cd10387 | 100 | cd10387, SH2_SOCS6, Src homology 2 (SH2) domain fo | 2e-04 | |
| cd09942 | 110 | cd09942, SH2_nSH2_p85_like, N-terminal Src homolog | 3e-04 | |
| cd10388 | 101 | cd10388, SH2_SOCS7, Src homology 2 (SH2) domain fo | 3e-04 | |
| cd10412 | 97 | cd10412, SH2_SH2B3, Src homology 2 (SH2) domain fo | 4e-04 | |
| cd10396 | 108 | cd10396, SH2_Tec_Itk, Src homology 2 (SH2) domain | 5e-04 | |
| cd09923 | 81 | cd09923, SH2_SOCS_family, Src homology 2 (SH2) dom | 8e-04 | |
| cd10337 | 136 | cd10337, SH2_BCAR3, Src homology 2 (SH2) domain in | 0.001 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 0.001 | |
| cd10389 | 97 | cd10389, SH2_SHB, Src homology 2 domain found in S | 0.001 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.001 | |
| cd10346 | 97 | cd10346, SH2_SH2B_family, Src homology 2 (SH2) dom | 0.001 | |
| cd10352 | 91 | cd10352, SH2_a2chimerin_b2chimerin, Src homology 2 | 0.002 | |
| cd09932 | 104 | cd09932, SH2_C-SH2_PLC_gamma_like, C-terminal Src | 0.003 | |
| cd10390 | 98 | cd10390, SH2_SHD, Src homology 2 domain found in S | 0.003 | |
| cd10410 | 97 | cd10410, SH2_SH2B1, Src homology 2 (SH2) domain fo | 0.004 | |
| cd10349 | 77 | cd10349, SH2_SH2D2A_SH2D7, Src homology 2 domain f | 0.004 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 2e-35
Identities = 45/55 (81%), Positives = 48/55 (87%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDF 175
GMTNAEVL QV+ GYRMPCPPGCP LYDIML+CW +DP RPTFETLQWKLEDF
Sbjct: 207 GMTNAEVLQQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|198233 cd10370, SH2_Src_Src42, Src homology 2 (SH2) domain found in the Src oncogene at 42A (Src42) | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 1e-34
Identities = 63/96 (65%), Positives = 69/96 (71%), Gaps = 9/96 (9%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSL--- 57
WYFGKIKRIEAEKKLLLPEN+HGAFLIRDSESR NDYSLS R +K R L
Sbjct: 5 WYFGKIKRIEAEKKLLLPENEHGAFLIRDSESRHNDYSLS--VRDGDTVKHYRIRQLDEG 62
Query: 58 --FETQKAGRTTIHYPELVEHYSKDADGLCVNLRKP 91
F ++ T+ ELVEHYSKD+DGLCVNLRKP
Sbjct: 63 GFFIARRTTFRTLQ--ELVEHYSKDSDGLCVNLRKP 96
|
Src42 is a member of the Src non-receptor type tyrosine kinase family of proteins. The integration of receptor tyrosine kinase-induced RAS and Src42 signals by Connector eNhancer of KSR (CNK) as a two-component input is essential for RAF activation in Drosophila. Src42 is present in a wide variety of organisms including: California sea hare, pea aphid, yellow fever mosquito, honey bee, Panamanian leafcutter ant, and sea urchin. Src42 has a unique N-terminal domain, an SH3 domain, an SH2 domain, a kinase domain and a regulatory tail, as do the other members of the family. Like the other members of the Src family the SH2 domain in addition to binding the target, also plays an autoinhibitory role by binding to its C-terminal tail. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. Length = 96 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 4e-32
Identities = 39/55 (70%), Positives = 43/55 (78%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDF 175
GMTN EVL QVE GYRMP PP CP LYD+ML+CW KDP +RPTFE LQ LED+
Sbjct: 207 GMTNREVLEQVERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY 261
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|199827 cd09933, SH2_Src_family, Src homology 2 (SH2) domain found in the Src family of non-receptor tyrosine kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-29
Identities = 46/99 (46%), Positives = 55/99 (55%), Gaps = 10/99 (10%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS---EYKRSSFCLKMTTGRSL 57
W+FGKIKR +AEK LL P N G FLIR+SE+ YSLS +K R L
Sbjct: 5 WFFGKIKRKDAEKLLLAPGNPRGTFLIRESETTPGAYSLSVRDGDDARGDTVKHYRIRKL 64
Query: 58 -----FETQKAGRTTIHYPELVEHYSKDADGLCVNLRKP 91
+ T +A T+ ELV+HYSKDADGLC L P
Sbjct: 65 DNGGYYITTRATFPTLQ--ELVQHYSKDADGLCCRLTVP 101
|
The Src family kinases are nonreceptor tyrosine kinases that have been implicated in pathways regulating proliferation, angiogenesis, invasion and metastasis, and bone metabolism. It is thought that transforming ability of Src is linked to its ability to activate key signaling molecules in these pathways, rather than through direct activity. As such blocking Src activation has been a target for drug companies. Src family members can be divided into 3 groups based on their expression pattern: 1) Src, Fyn, and Yes; 2) Blk, Fgr, Hck, Lck, and Lyn; and 3) Frk-related kinases Frk/Rak and Iyk/Bsk Of these, cellular c-Src is the best studied and most frequently implicated in oncogenesis. The c-Src contains five distinct regions: a unique N-terminal domain, an SH3 domain, an SH2 domain, a kinase domain and a regulatory tail, as do the other members of the family. Src exists in both active and inactive conformations. Negative regulation occurs through phosphorylation of Tyr, resulting in an intramolecular association between phosphorylated Tyr and the SH2 domain of SRC, which locks the protein in a closed conformation. Further stabilization of the inactive state occurs through interactions between the SH3 domain and a proline-rich stretch of residues within the kinase domain. Conversely, dephosphorylation of Tyr allows SRC to assume an open conformation. Full activity requires additional autophosphorylation of a Tyr residue within the catalytic domain. Loss of the negative-regulatory C-terminal segment has been shown to result in increased activity and transforming potential. Phosphorylation of the C-terminal Tyr residue by C-terminal Src kinase (Csk) and Csk homology kinase results in increased intramolecular interactions and consequent Src inactivation. Specific phosphatases, protein tyrosine phosphatase a (PTPa) and the SH-containing phosphatases SHP1/SHP2, have also been shown to take a part in Src activation. Src is also activated by direct binding of focal adhesion kinase (Fak) and Crk-associated substrate (Cas) to the SH2 domain. SRC activity can also be regulated by numerous receptor tyrosine kinases (RTKs), such as Her2, epidermal growth factor receptor (EGFR), fibroblast growth factor receptor, platelet-derived growth factor receptor (PDGFR), and vascular endothelial growth factor receptor (VEGFR). In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. Length = 101 |
| >gnl|CDD|199831 cd10369, SH2_Src_Frk, Src homology 2 (SH2) domain found in the Fyn-related kinase (Frk) | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 2e-23
Identities = 40/94 (42%), Positives = 58/94 (61%), Gaps = 5/94 (5%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSS---FCLKMTTGRSL 57
W+FG IKR +AEK+LL EN GAFLIR+SES+K ++SLS + ++
Sbjct: 5 WFFGAIKRADAEKQLLYSENQTGAFLIRESESQKGEFSLSVLDGGVVKHYRIRRLDEGGF 64
Query: 58 FETQKAGRTTIHYPELVEHYSKDADGLCVNLRKP 91
F T++ +T++ E V +Y+ +DGLCV L KP
Sbjct: 65 FLTRRKTFSTLN--EFVNYYTTTSDGLCVKLGKP 96
|
Frk is a member of the Src non-receptor type tyrosine kinase family of proteins. The Frk subfamily is composed of Frk/Rak and Iyk/Bsk/Gst. It is expressed primarily epithelial cells. Frk is a nuclear protein and may function during G1 and S phase of the cell cycle and suppress growth. Unlike the other Src members it lacks a glycine at position 2 of SH4 which is important for addition of a myristic acid moiety that is involved in targeting Src PTKs to cellular membranes. FRK and SHB exert similar effects when overexpressed in rat phaeochromocytoma (PC12) and beta-cells, where both induce PC12 cell differentiation and beta-cell proliferation. Under conditions that cause beta-cell degeneration these proteins augment beta-cell apoptosis. The FRK-SHB responses involve FAK and insulin receptor substrates (IRS) -1 and -2. Frk has been demonstrated to interact with retinoblastoma protein. Frk regulates PTEN protein stability by phosphorylating PTEN, which in turn prevents PTEN degradation. Frk also plays a role in regulation of embryonal pancreatic beta cell formation. Frk has a unique N-terminal domain, an SH3 domain, an SH2 domain, a kinase domain and a regulatory tail, as do the other members of the family. Like the other members of the Src family the SH2 domain in addition to binding the target, also plays an autoinhibitory role by binding to its activation loop. The tryosine involved is at the same site as the tyrosine involved in the autophosphorylation of Src. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. Length = 96 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 7e-23
Identities = 36/55 (65%), Positives = 42/55 (76%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDF 175
GM N EVL QVE GYRMPCP CP L+++ML+CW KDP +RPTFE LQ LED+
Sbjct: 206 GMNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLEDY 260
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 91.4 bits (228), Expect = 8e-23
Identities = 28/52 (53%), Positives = 34/52 (65%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKL 172
GM+N EVL +E GYR+P P CP LY++ML+CW DP RPTF L L
Sbjct: 207 GMSNEEVLELLEDGYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 1e-22
Identities = 38/57 (66%), Positives = 44/57 (77%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFT 177
GM N EVL QVE GYRMPCPP CP L+D+M +CW K+P +RPTFE LQ LED+FT
Sbjct: 206 GMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 262
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 3e-21
Identities = 31/55 (56%), Positives = 38/55 (69%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDF 175
GMTN EV+ +E GYRMP P CP LY++M CW + P +RPTFE L+ LEDF
Sbjct: 206 GMTNPEVIQNLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 2e-20
Identities = 28/55 (50%), Positives = 37/55 (67%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDF 175
GM N EV Q+ GYRMPCP CP +Y IMLECW +P RP+F+ L+ +L++
Sbjct: 207 GMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 84.1 bits (209), Expect = 5e-20
Identities = 30/53 (56%), Positives = 38/53 (71%)
Query: 120 GGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKL 172
GM+N EVL +++GYR+P PP CPP LYD+ML+CW +DP RPTF L L
Sbjct: 205 PGMSNEEVLEYLKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 7e-20
Identities = 35/55 (63%), Positives = 41/55 (74%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDF 175
GM N EVL QVE GYRMPCP GCP L+++M CW KDP +RPTFE +Q LED+
Sbjct: 206 GMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLEDY 260
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 2e-19
Identities = 30/52 (57%), Positives = 37/52 (71%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKL 172
GM+NAEVL ++ GYR+P PP CPP LY +ML+CW +DP RPTF L L
Sbjct: 207 GMSNAEVLEYLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (201), Expect = 6e-19
Identities = 27/54 (50%), Positives = 34/54 (62%)
Query: 120 GGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLE 173
G++N EVL + GYR+P P CP LY++ML CW DP RPTF L +LE
Sbjct: 209 PGLSNEEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 6e-19
Identities = 24/49 (48%), Positives = 28/49 (57%)
Query: 120 GGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETL 168
G M AEV+ +E G R+P P CP +Y IML CW P RPTF L
Sbjct: 200 GEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSEL 248
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-18
Identities = 30/55 (54%), Positives = 38/55 (69%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDF 175
GM+N EV+ +E GYRMP P CP LY+IM+ CW P +RPTFE +Q L+DF
Sbjct: 206 GMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 3e-17
Identities = 25/51 (49%), Positives = 33/51 (64%)
Query: 125 AEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDF 175
+V+ VE GYRM P GCPP +Y +M +CW DP KRPTF+ L+ +L
Sbjct: 206 KDVVPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-16
Identities = 27/59 (45%), Positives = 38/59 (64%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTME 179
G+ N +V+ ++E+G R+P PP CPP LY +M +CW DP KRP F L+ +L D E
Sbjct: 211 GVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|198230 cd10367, SH2_Src_Fgr, Src homology 2 (SH2) domain found in Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog, Fgr | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 5e-16
Identities = 43/100 (43%), Positives = 57/100 (57%), Gaps = 12/100 (12%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS---------EYKRSSFCLKM 51
WYFGKI R +AE++LL P N GAFLIR+SE+ K YSLS ++ + K+
Sbjct: 5 WYFGKIGRKDAERQLLSPGNPRGAFLIRESETTKGAYSLSIRDWDQNRGDHVKHYKIRKL 64
Query: 52 TTGRSLFETQKAGRTTIHYPELVEHYSKDADGLCVNLRKP 91
TG + T +A T+ ELV+HY + DGLC L P
Sbjct: 65 DTG-GYYITTRAQFDTVQ--ELVQHYMEVNDGLCYLLTAP 101
|
Fgr is a member of the Src non-receptor type tyrosine kinase family of proteins. The protein contains N-terminal sites for myristoylation and palmitoylation, a PTK domain, and SH2 and SH3 domains which are involved in mediating protein-protein interactions with phosphotyrosine-containing and proline-rich motifs, respectively. Fgr is expressed in B-cells and myeloid cells, localizes to plasma membrane ruffles, and functions as a negative regulator of cell migration and adhesion triggered by the beta-2 integrin signal transduction pathway. Multiple alternatively spliced variants, encoding the same protein, have been identified Fgr has been shown to interact with Wiskott-Aldrich syndrome protein. Fgr has a unique N-terminal domain, an SH3 domain, an SH2 domain, a kinase domain and a regulatory tail, as do the other members of the family. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. Length = 101 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-15
Identities = 27/55 (49%), Positives = 37/55 (67%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDF 175
GM+N++V+ ++ GYRMP CP LYDIM CW + +RPTF+ LQ L+DF
Sbjct: 207 GMSNSDVMSALQRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-15
Identities = 23/49 (46%), Positives = 33/49 (67%)
Query: 126 EVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLED 174
+V+ +VE GY+M P GCPP +YD+M +CW D RP+F L+ +LE
Sbjct: 207 DVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|198225 cd10362, SH2_Src_Lck, Src homology 2 (SH2) domain in lymphocyte cell kinase (Lck) | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 3e-15
Identities = 34/100 (34%), Positives = 52/100 (52%), Gaps = 12/100 (12%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS---------EYKRSSFCLKM 51
W+F + R +AE++LL P N HG+FLIR+SE+ +SLS E + +
Sbjct: 5 WFFKNLSRNDAERQLLAPGNTHGSFLIRESETTAGSFSLSVRDFDQNQGEVVKHYKIRNL 64
Query: 52 TTGRSLFETQKAGRTTIHYPELVEHYSKDADGLCVNLRKP 91
G + + + +H ELV HY+ +DGLC L +P
Sbjct: 65 DNG-GFYISPRITFPGLH--ELVRHYTNASDGLCTRLSRP 101
|
Lck is a member of the Src non-receptor type tyrosine kinase family of proteins. It is expressed in the brain, T-cells, and NK cells. The unique domain of Lck mediates its interaction with two T-cell surface molecules, CD4 and CD8. It associates with their cytoplasmic tails on CD4 T helper cells and CD8 cytotoxic T cells to assist signaling from the T cell receptor (TCR) complex. When the T cell receptor is engaged by the specific antigen presented by MHC, Lck phosphorylase the intracellular chains of the CD3 and zeta-chains of the TCR complex, allowing ZAP-70 to bind them. Lck then phosphorylates and activates ZAP-70, which in turn phosphorylates Linker of Activated T cells (LAT), a transmembrane protein that serves as a docking site for proteins including: Shc-Grb2-SOS, PI3K, and phospholipase C (PLC). The tyrosine phosphorylation cascade culminates in the intracellular mobilization of a calcium ions and activation of important signaling cascades within the lymphocyte, including the Ras-MEK-ERK pathway, which goes on to activate certain transcription factors such as NFAT, NF-kappaB, and AP-1. These transcription factors regulate the production cytokines such as Interleukin-2 that promote long-term proliferation and differentiation of the activated lymphocytes. The N-terminal tail of Lck is myristoylated and palmitoylated and it tethers the protein to the plasma membrane of the cell. Lck also contains a SH3 domain, a SH2 domain, and a C-terminal tyrosine kinase domain. Lck has 2 phosphorylation sites, the first an autophosphorylation site that is linked to activation of the protein and the second which is phosphorylated by Csk, which inhibits it. Lck is also inhibited by SHP-1 dephosphorylation and by Cbl ubiquitin ligase, which is part of the ubiquitin-mediated pathway. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. Length = 101 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 4e-15
Identities = 24/60 (40%), Positives = 35/60 (58%), Gaps = 3/60 (5%)
Query: 117 FGSG---GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLE 173
G GM+N + ++E GYRMP P CP +Y +ML+CW DP RP+F + +L+
Sbjct: 191 LGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 4e-15
Identities = 25/54 (46%), Positives = 34/54 (62%)
Query: 120 GGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLE 173
M+N +V+ VE GYR+P P CP LY +ML+CW KD +RPTF + L+
Sbjct: 210 WDMSNQDVIKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLD 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|215658 pfam00017, SH2, SH2 domain | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 6e-15
Identities = 32/79 (40%), Positives = 39/79 (49%), Gaps = 4/79 (5%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSF--CLKMTTGRSLF 58
WY GKI R EAE+ LLL G FL+R+SES+ DY+LS + +
Sbjct: 1 WYHGKISREEAER-LLLNPKPDGTFLVRESESKPGDYTLSVRDDGRVKHYRIQSLDNGGY 59
Query: 59 ETQKAGRTTIHYPELVEHY 77
G T PELVEHY
Sbjct: 60 -YISGGVTFNSLPELVEHY 77
|
Length = 77 |
| >gnl|CDD|198226 cd10363, SH2_Src_HCK, Src homology 2 (SH2) domain found in HCK | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-14
Identities = 40/101 (39%), Positives = 59/101 (58%), Gaps = 10/101 (9%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS--EYK-RSSFCLKMTTGRSL 57
W+F I R +AE++LL P N G+F+IRDSE+ K YSLS +Y + +K R+L
Sbjct: 5 WFFKGISRKDAERQLLAPGNMLGSFMIRDSETTKGSYSLSVRDYDPQHGDTVKHYKIRTL 64
Query: 58 -----FETQKAGRTTIHYPELVEHYSKDADGLCVNLRKPCV 93
+ + ++ +T+ ELV+HY K DGLC L PC+
Sbjct: 65 DNGGFYISPRSTFSTLQ--ELVDHYKKGNDGLCQKLSVPCM 103
|
HCK is a member of the Src non-receptor type tyrosine kinase family of proteins and is expressed in hemopoietic cells. HCK is proposed to couple the Fc receptor to the activation of the respiratory burst. It may also play a role in neutrophil migration and in the degranulation of neutrophils. It has two different translational starts that have different subcellular localization. HCK has been shown to interact with BCR gene, ELMO1 Cbl gene, RAS p21 protein activator 1, RASA3, Granulocyte colony-stimulating factor receptor, ADAM15 and RAPGEF1. Like the other members of the Src family the SH2 domain in addition to binding the target, also plays an autoinhibitory role by binding to its C-terminal tail. In general SH2 domains are involved in signal transduction. HCK has a unique N-terminal domain, an SH3 domain, an SH2 domain, a kinase domain and a regulatory tail, as do the other members of the family. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. Length = 104 |
| >gnl|CDD|198234 cd10371, SH2_Src_Blk, Src homology 2 (SH2) domain found in B lymphoid kinase (Blk) | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-14
Identities = 40/96 (41%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS--EYKRSSFCLKMTTGRSLF 58
W+F I R +AE++LL P N G+FLIR+SES K +SLS + +K RSL
Sbjct: 5 WFFRTISRKDAERQLLAPMNKAGSFLIRESESNKGAFSLSVKDVTTQGEVVKHYKIRSLD 64
Query: 59 ETQKAGRTTIHYPE---LVEHYSKDADGLCVNLRKP 91
I +P LV+HYSK DGLC L P
Sbjct: 65 NGGYYISPRITFPTLQALVQHYSKKGDGLCQKLTLP 100
|
Blk is a member of the Src non-receptor type tyrosine kinase family of proteins. Blk is expressed in the B-cells. Unlike most other Src members Blk lacks cysteine residues in the SH4 domain that undergo palmitylation. Blk is required for the development of IL-17-producing gamma-delta T cells. Furthermore, Blk is expressed in lymphoid precursors and, in this capacity, plays a role in regulating thymus cellularity during ontogeny. Blk has a unique N-terminal domain, an SH3 domain, an SH2 domain, a kinase domain and a regulatory tail, as do the other members of the family. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. Length = 100 |
| >gnl|CDD|214585 smart00252, SH2, Src homology 2 domains | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 3e-14
Identities = 34/96 (35%), Positives = 40/96 (41%), Gaps = 27/96 (28%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS-------------EYKRSSF 47
WY G I R EAEK L G FL+RDSES DY LS + F
Sbjct: 3 WYHGFISREEAEKLLK--NEGDGDFLVRDSESSPGDYVLSVRVKGKVKHYRIRRNEDGKF 60
Query: 48 CLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83
L G F ++ ELVEHY K++ G
Sbjct: 61 YL---EGGRKFP-------SL--VELVEHYQKNSLG 84
|
Src homology 2 domains bind phosphotyrosine-containing polypeptides via 2 surface pockets. Specificity is provided via interaction with residues that are distinct from the phosphotyrosine. Only a single occurrence of a SH2 domain has been found in S. cerevisiae. Length = 84 |
| >gnl|CDD|198282 cd10419, SH2_Src_Fyn_isoform_b_like, Src homology 2 (SH2) domain found in Fyn isoform b like proteins | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 6e-14
Identities = 40/97 (41%), Positives = 56/97 (57%), Gaps = 12/97 (12%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS---------EYKRSSFCLKM 51
WYFGK+ R +AE++LL N G FLIR+SE+ K YSLS ++ + K+
Sbjct: 5 WYFGKLGRKDAERQLLSFGNPRGTFLIRESETTKGAYSLSIRDWDDMKGDHVKHYKIRKL 64
Query: 52 TTGRSLFETQKAGRTTIHYPELVEHYSKDADGLCVNL 88
G + T +A T+ +LV+HYS+ ADGLC NL
Sbjct: 65 DNG-GYYITTRAQFETLQ--QLVQHYSEKADGLCFNL 98
|
Fyn is a member of the Src non-receptor type tyrosine kinase family of proteins. This cd contains the SH2 domain found in Fyn isoform b type proteins. Fyn is involved in the control of cell growth and is required in the following pathways: T and B cell receptor signaling, integrin-mediated signaling, growth factor and cytokine receptor signaling, platelet activation, ion channel function, cell adhesion, axon guidance, fertilization, entry into mitosis, and differentiation of natural killer cells, oligodendrocytes and keratinocytes. The protein associates with the p85 subunit of phosphatidylinositol 3-kinase and interacts with the Fyn-binding protein. Alternatively spliced transcript variants encoding distinct isoforms exist. Fyn is primarily localized to the cytoplasmic leaflet of the plasma membrane. Tyrosine phosphorylation of target proteins by Fyn serves to either regulate target protein activity, and/or to generate a binding site on the target protein that recruits other signaling molecules. FYN has been shown to interact with a number of proteins including: BCAR1, Cbl, Janus kinase, nephrin, Sky, tyrosine kinase, Wiskott-Aldrich syndrome protein, and Zap-70. Fyn has a unique N-terminal domain, an SH3 domain, an SH2 domain, a kinase domain and a regulatory tail, as do the other members of the family. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. Length = 101 |
| >gnl|CDD|198227 cd10364, SH2_Src_Lyn, Src homology 2 (SH2) domain found in Lyn | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-13
Identities = 38/97 (39%), Positives = 52/97 (53%), Gaps = 6/97 (6%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS---EYKRSSFCLKMTTGRSL 57
W+F I R +AE++LL P N GAFLIR+SE+ K YSLS + +K RSL
Sbjct: 5 WFFKDITRKDAERQLLAPGNSAGAFLIRESETLKGSYSLSVRDYDPQHGDVIKHYKIRSL 64
Query: 58 FETQKAGRTTIHYP---ELVEHYSKDADGLCVNLRKP 91
I +P ++++HY K +DGLC L K
Sbjct: 65 DNGGYYISPRITFPCISDMIKHYQKQSDGLCRRLEKA 101
|
Lyn is a member of the Src non-receptor type tyrosine kinase family of proteins and is expressed in the hematopoietic cells, in neural tissues, liver, and adipose tissue. There are two alternatively spliced forms of Lyn. Lyn plays an inhibitory role in myeloid lineage proliferation. Following engagement of the B cell receptors, Lyn undergoes rapid phosphorylation and activation, triggering a cascade of signaling events mediated by Lyn phosphorylation of tyrosine residues within the immunoreceptor tyrosine-based activation motifs (ITAM) of the receptor proteins, and subsequent recruitment and activation of other kinases including Syk, phospholipase C2 (PLC2) and phosphatidyl inositol-3 kinase. These kinases play critical roles in proliferation, Ca2+ mobilization and cell differentiation. Lyn plays an essential role in the transmission of inhibitory signals through phosphorylation of tyrosine residues within the immunoreceptor tyrosine-based inhibitory motifs (ITIM) in regulatory proteins such as CD22, PIR-B and FC RIIb1. Their ITIM phosphorylation subsequently leads to recruitment and activation of phosphatases such as SHIP-1 and SHP-1 which further down modulate signaling pathways, attenuate cell activation and can mediate tolerance. Lyn also plays a role in the insulin signaling pathway. Activated Lyn phosphorylates insulin receptor substrate 1 (IRS1) leading to an increase in translocation of Glut-4 to the cell membrane and increased glucose utilization. It is the primary Src family member involved in signaling downstream of the B cell receptor. Lyn plays an unusual, 2-fold role in B cell receptor signaling; it is essential for initiation of signaling but is also later involved in negative regulation of the signal. Lyn has a unique N-terminal domain, an SH3 domain, an SH2 domain, a kinase domain and a regulatory tail, as do the other members of the family. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. Length = 101 |
| >gnl|CDD|198229 cd10366, SH2_Src_Yes, Src homology 2 (SH2) domain found in Yes | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-13
Identities = 37/96 (38%), Positives = 55/96 (57%), Gaps = 10/96 (10%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS-----EYKRSS---FCLKMT 52
WYFGK+ R +AE+ LL P N G FL+R+SE+ K YSLS E + + + ++
Sbjct: 5 WYFGKMGRKDAERLLLNPGNQRGIFLVRESETTKGAYSLSIRDWDEVRGDNVKHYKIRKL 64
Query: 53 TGRSLFETQKAGRTTIHYPELVEHYSKDADGLCVNL 88
+ T +A T+ +LV+HY++ ADGLC L
Sbjct: 65 DNGGYYITTRAQFDTLQ--KLVKHYTEHADGLCHKL 98
|
Yes is a member of the Src non-receptor type tyrosine kinase family of proteins. Yes is the cellular homolog of the Yamaguchi sarcoma virus oncogene. In humans it is encoded by the YES1 gene which maps to chromosome 18 and is in close proximity to thymidylate synthase. A corresponding Yes pseudogene has been found on chromosome 22. YES1 has been shown to interact with Janus kinase 2, CTNND1,RPL10, and Occludin. Yes1 has a unique N-terminal domain, an SH3 domain, an SH2 domain, a kinase domain and a regulatory tail, as do the other members of the family. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. Length = 101 |
| >gnl|CDD|198231 cd10368, SH2_Src_Fyn, Src homology 2 (SH2) domain found in Fyn | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-13
Identities = 38/100 (38%), Positives = 55/100 (55%), Gaps = 12/100 (12%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS---------EYKRSSFCLKM 51
WYFGK+ R +AE++LL N G FLIR+SE+ K YSLS ++ + K+
Sbjct: 5 WYFGKLGRKDAERQLLSFGNPRGTFLIRESETTKGAYSLSIRDWDDMKGDHVKHYKIRKL 64
Query: 52 TTGRSLFETQKAGRTTIHYPELVEHYSKDADGLCVNLRKP 91
G + T +A T+ +LV+HYS+ A+GLC L
Sbjct: 65 DNG-GYYITTRAQFETLQ--QLVQHYSETANGLCKVLIVT 101
|
Fyn is a member of the Src non-receptor type tyrosine kinase family of proteins. Fyn is involved in the control of cell growth and is required in the following pathways: T and B cell receptor signaling, integrin-mediated signaling, growth factor and cytokine receptor signaling, platelet activation, ion channel function, cell adhesion, axon guidance, fertilization, entry into mitosis, and differentiation of natural killer cells, oligodendrocytes and keratinocytes. The protein associates with the p85 subunit of phosphatidylinositol 3-kinase and interacts with the Fyn-binding protein. Alternatively spliced transcript variants encoding distinct isoforms exist. Fyn is primarily localized to the cytoplasmic leaflet of the plasma membrane. Tyrosine phosphorylation of target proteins by Fyn serves to either regulate target protein activity, and/or to generate a binding site on the target protein that recruits other signaling molecules. FYN has been shown to interact with a number of proteins including: BCAR1, Cbl, Janus kinase, nephrin, Sky, tyrosine kinase, Wiskott-Aldrich syndrome protein, and Zap-70. Fyn has a unique N-terminal domain, an SH3 domain, an SH2 domain, a kinase domain and a regulatory tail, as do the other members of the family. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. Length = 101 |
| >gnl|CDD|198228 cd10365, SH2_Src_Src, Src homology 2 (SH2) domain found in tyrosine kinase sarcoma (Src) | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-13
Identities = 35/96 (36%), Positives = 53/96 (55%), Gaps = 10/96 (10%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDY--SLSEYKRSS------FCLKMT 52
WYFGKI R E+E+ LL EN G FL+R+SE+ K Y S+S++ + + ++
Sbjct: 5 WYFGKITRRESERLLLNAENPRGTFLVRESETTKGAYCLSVSDFDNAKGLNVKHYKIRKL 64
Query: 53 TGRSLFETQKAGRTTIHYPELVEHYSKDADGLCVNL 88
+ T + ++ +LV +YSK ADGLC L
Sbjct: 65 DSGGFYITSRTQFNSLQ--QLVAYYSKHADGLCHRL 98
|
Src is a member of the Src non-receptor type tyrosine kinase family of proteins. Src is thought to play a role in the regulation of embryonic development and cell growth. Members here include v-Src and c-Src. v-Src lacks the C-terminal inhibitory phosphorylation site and is therefore constitutively active as opposed to normal cellular src (c-Src) which is only activated under certain circumstances where it is required (e.g. growth factor signaling). v-Src is an oncogene whereas c-Src is a proto-oncogene. c-Src consists of three domains, an N-terminal SH3 domain, a central SH2 domain and a tyrosine kinase domain. The SH2 and SH3 domains work together in the auto-inhibition of the kinase domain. The phosphorylation of an inhibitory tyrosine near the c-terminus of the protein produces a binding site for the SH2 domain which then facilitates binding of the SH3 domain to a polyproline site within the linker between the SH2 domain and the kinase domain. Binding of the SH3 domain inactivates the enzyme. This allows for multiple mechanisms for c-Src activation: dephosphorylation of the C-terminal tyrosine by a protein tyrosine phosphatase, binding of the SH2 domain by a competitive phospho-tyrosine residue, or competitive binding of a polyproline binding site to the SH3 domain. Unlike most other Src members Src lacks cysteine residues in the SH4 domain that undergo palmitylation. Serine and threonine phosphorylation sites have also been identified in the unique domains of Src and are believed to modulate protein-protein interactions or regulate catalytic activity. Alternatively spliced forms of Src, which contain 6- or 11-amino acid insertions in the SH3 domain, are expressed in CNS neurons. c-Src has a unique N-terminal domain, an SH3 domain, an SH2 domain, a kinase domain and a regulatory tail, as do the other members of the family. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. Length = 101 |
| >gnl|CDD|198190 cd09937, SH2_csk_like, Src homology 2 (SH2) domain found in Carboxyl-Terminal Src Kinase (Csk) | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 3e-13
Identities = 42/98 (42%), Positives = 54/98 (55%), Gaps = 16/98 (16%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET 60
W+ GKI R EAE+ L PE+ G FL+R+S + DY+L SF K+ R +
Sbjct: 5 WFHGKISREEAERLLQPPED--GLFLVRESTNYPGDYTLC----VSFEGKVEHYRVI--- 55
Query: 61 QKAGRTTIHYPE-------LVEHYSKDADGLCVNLRKP 91
+ G+ TI E LVEHY+KDADGLC L KP
Sbjct: 56 YRNGKLTIDEEEYFENLIQLVEHYTKDADGLCTRLVKP 93
|
Both the C-terminal Src kinase (CSK) and CSK-homologous kinase (CHK) are members of the CSK-family of protein tyrosine kinases. These proteins suppress activity of Src-family kinases (SFK) by selectively phosphorylating the conserved C-terminal tail regulatory tyrosine by a similar mechanism. CHK is also capable of inhibiting SFKs by a non-catalytic mechanism that involves binding of CHK to SFKs to form stable protein complexes. The unphosphorylated form of SFKs is inhibited by CSK and CHK by a two-step mechanism. The first step involves the formation of a complex of SFKs with CSK/CHK with the SFKs in the complex are inactive. The second step, involves the phosphorylation of the C-terminal tail tyrosine of SFKs, which then dissociates and adopt an inactive conformation. The structural basis of how the phosphorylated SFKs dissociate from CSK/CHK to adopt the inactive conformation is not known. The inactive conformation of SFKs is stabilized by two intramolecular inhibitory interactions: (a) the pYT:SH2 interaction in which the phosphorylated C-terminal tail tyrosine (YT) binds to the SH2 domain, and (b) the linker:SH3 interaction of which the SH2-kinase domain linker binds to the SH3 domain. SFKs are activated by multiple mechanisms including binding of the ligands to the SH2 and SH3 domains to displace the two inhibitory intramolecular interactions, autophosphorylation, and dephosphorylation of YT. By selective phosphorylation and the non-catalytic inhibitory mechanism CSK and CHK are able to inhibit the active forms of SFKs. CSK and CHK are regulated by phosphorylation and inter-domain interactions. They both contain SH3, SH2, and kinase domains separated by the SH3-SH2 connector and SH2 kinase linker, intervening segments separating the three domains. They lack a conserved tyrosine phosphorylation site in the kinase domain and the C-terminal tail regulatory tyrosine phosphorylation site. The CSK SH2 domain is crucial for stabilizing the kinase domain in the active conformation. A disulfide bond here regulates CSK kinase activity. The subcellular localization and activity of CSK are regulated by its SH2 domain. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. Length = 98 |
| >gnl|CDD|198281 cd10418, SH2_Src_Fyn_isoform_a_like, Src homology 2 (SH2) domain found in Fyn isoform a like proteins | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 9e-13
Identities = 39/100 (39%), Positives = 55/100 (55%), Gaps = 12/100 (12%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS---------EYKRSSFCLKM 51
WYFGK+ R +AE++LL N G FLIR+SE+ K YSLS ++ + K+
Sbjct: 5 WYFGKLGRKDAERQLLSFGNPRGTFLIRESETTKGAYSLSIRDWDDMKGDHVKHYKIRKL 64
Query: 52 TTGRSLFETQKAGRTTIHYPELVEHYSKDADGLCVNLRKP 91
G + T +A T+ +LV+HYS+ A GLC L P
Sbjct: 65 DNG-GYYITTRAQFETLQ--QLVQHYSERAAGLCCRLVVP 101
|
Fyn is a member of the Src non-receptor type tyrosine kinase family of proteins. This cd contains the SH2 domain found in Fyn isoform a type proteins. Fyn is involved in the control of cell growth and is required in the following pathways: T and B cell receptor signaling, integrin-mediated signaling, growth factor and cytokine receptor signaling, platelet activation, ion channel function, cell adhesion, axon guidance, fertilization, entry into mitosis, and differentiation of natural killer cells, oligodendrocytes and keratinocytes. The protein associates with the p85 subunit of phosphatidylinositol 3-kinase and interacts with the Fyn-binding protein. Alternatively spliced transcript variants encoding distinct isoforms exist. Fyn is primarily localized to the cytoplasmic leaflet of the plasma membrane. Tyrosine phosphorylation of target proteins by Fyn serves to either regulate target protein activity, and/or to generate a binding site on the target protein that recruits other signaling molecules. FYN has been shown to interact with a number of proteins including: BCAR1, Cbl, Janus kinase, nephrin, Sky, tyrosine kinase, Wiskott-Aldrich syndrome protein, and Zap-70. Fyn has a unique N-terminal domain, an SH3 domain, an SH2 domain, a kinase domain and a regulatory tail, as do the other members of the family. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. Length = 101 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 1e-12
Identities = 26/52 (50%), Positives = 32/52 (61%)
Query: 122 MTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLE 173
M+ EV VE GYRM P GCP +Y +M CW +P KRP+F L+ KLE
Sbjct: 201 MSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-12
Identities = 22/56 (39%), Positives = 33/56 (58%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFF 176
G+ ++V +E GYRM P GCPP++Y++M CW +P RP+F + E F
Sbjct: 208 GIDLSQVYELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF 263
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-12
Identities = 22/56 (39%), Positives = 32/56 (57%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFF 176
GM EV +E G RM CP CPP +YD+M CW +RP F ++ +L +++
Sbjct: 201 GMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNYY 256
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|198223 cd10360, SH2_Srm, Src homology 2 (SH2) domain found in Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristoylation sites (srm) | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-12
Identities = 27/61 (44%), Positives = 35/61 (57%), Gaps = 3/61 (4%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS---EYKRSSFCLKMTTGRSL 57
WYF I R +A++ LL P N+ GAFLIR SES YSLS + K + + M SL
Sbjct: 2 WYFSGISRTQAQQLLLSPPNEPGAFLIRPSESSLGGYSLSVRAQAKVCHYRICMAPSGSL 61
Query: 58 F 58
+
Sbjct: 62 Y 62
|
Srm is a nonreceptor protein kinase that has two SH2 domains, a SH3 domain, and a kinase domain with a tyrosine residue for autophosphorylation. However it lacks an N-terminal glycine for myristoylation and a C-terminal tyrosine which suppresses kinase activity when phosphorylated. Srm is most similar to members of the Tec family who other members include: Tec, Btk/Emb, and Itk/Tsk/Emt. However Srm differs in its N-terminal unique domain it being much smaller than in the Tec family and is closer to Src. Srm is thought to be a new family of nonreceptor tyrosine kinases that may be redundant in function. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. Length = 79 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 3e-12
Identities = 26/52 (50%), Positives = 30/52 (57%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKL 172
GMTN + QVE GYRM CP CP +Y +M CW P RP F LQ +L
Sbjct: 197 GMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|198207 cd10344, SH2_SLAP, Src homology 2 domain found in Src-like adaptor proteins | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 3e-12
Identities = 35/91 (38%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET 60
W F + R +AE+ L+LP N G+FLIR+SE+R+ YSLS R S +F
Sbjct: 12 WLFEGLSREKAEELLMLPGNQVGSFLIRESETRRGCYSLSVRHRGSQSRDSVKHYRIFRL 71
Query: 61 QKAG-----RTTIH-YPELVEHYSKDADGLC 85
R T ++V HYS+ ADGLC
Sbjct: 72 DNGWFYISPRLTFQCLEDMVNHYSESADGLC 102
|
SLAP belongs to the subfamily of adapter proteins that negatively regulate cellular signaling initiated by tyrosine kinases. It has a myristylated N-terminus, SH3 and SH2 domains with high homology to Src family tyrosine kinases, and a unique C-terminal tail, which is important for c-Cbl binding. SLAP negatively regulates platelet-derived growth factor (PDGF)-induced mitogenesis in fibroblasts and regulates F-actin assembly for dorsal ruffles formation. c-Cbl mediated SLAP inhibition towards actin remodeling. Moreover, SLAP enhanced PDGF-induced c-Cbl phosphorylation by SFK. In contrast, SLAP mitogenic inhibition was not mediated by c-Cbl, but it rather involved a competitive mechanism with SFK for PDGF-receptor (PDGFR) association and mitogenic signaling. Accordingly, phosphorylation of the Src mitogenic substrates Stat3 and Shc were reduced by SLAP. Thus, we concluded that SLAP regulates PDGFR signaling by two independent mechanisms: a competitive mechanism for PDGF-induced Src mitogenic signaling and a non-competitive mechanism for dorsal ruffles formation mediated by c-Cbl. SLAP is a hematopoietic adaptor containing Src homology (SH)3 and SH2 motifs and a unique carboxy terminus. Unlike c-Src, SLAP lacks a tyrosine kinase domain. Unlike c-Src, SLAP does not impact resorptive function of mature osteoclasts but induces their early apoptosis. SLAP negatively regulates differentiation of osteoclasts and proliferation of their precursors. Conversely, SLAP decreases osteoclast death by inhibiting activation of caspase 3. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. Length = 104 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 7e-12
Identities = 22/47 (46%), Positives = 32/47 (68%)
Query: 122 MTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETL 168
M+N +V+ +E GYR+P P CP L+ +ML+CW KD +RP FE +
Sbjct: 213 MSNQDVIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQI 259
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|198191 cd09938, SH2_N-SH2_Zap70_Syk_like, N-terminal Src homology 2 (SH2) domain found in Zeta-chain-associated protein kinase 70 (ZAP-70) and Spleen tyrosine kinase (Syk) proteins | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 1e-11
Identities = 35/94 (37%), Positives = 43/94 (45%), Gaps = 3/94 (3%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET 60
+++G I R EAE+ L L G FL+R S Y LS F T R L T
Sbjct: 3 FFYGSITREEAEEYLKLAGMSDGLFLLRQSLRSLGGYVLSVCHGRKF-HHYTIERQLNGT 61
Query: 61 QK--AGRTTIHYPELVEHYSKDADGLCVNLRKPC 92
G+ EL E++S D DGL LRKPC
Sbjct: 62 YAIAGGKAHCGPAELCEYHSTDLDGLVCLLRKPC 95
|
ZAP-70 and Syk comprise a family of hematopoietic cell specific protein tyrosine kinases (PTKs) that are required for antigen and antibody receptor function. ZAP-70 is expressed in T and natural killer (NK) cells and Syk is expressed in B cells, mast cells, polymorphonuclear leukocytes, platelets, macrophages, and immature T cells. They are required for the proper development of T and B cells, immune receptors, and activating NK cells. They consist of two N-terminal Src homology 2 (SH2) domains and a C-terminal kinase domain separated from the SH2 domains by a linker or hinge region. Phosphorylation of both tyrosine residues within the Immunoreceptor Tyrosine-based Activation Motifs (ITAM; consensus sequence Yxx[LI]x(7,8)Yxx[LI]) by the Src-family PTKs is required for efficient interaction of ZAP-70 and Syk with the receptor subunits and for receptor function. ZAP-70 forms two phosphotyrosine binding pockets, one of which is shared by both SH2 domains. In Syk the two SH2 domains do not form such a phosphotyrosine-binding site. The SH2 domains here are believed to function independently. In addition, the two SH2 domains of Syk display flexibility in their relative orientation, allowing Syk to accommodate a greater variety of spacing sequences between the ITAM phosphotyrosines and singly phosphorylated non-classical ITAM ligands. This model contains the N-terminus SH2 domains of both Syk and Zap70. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. Length = 104 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-11
Identities = 22/53 (41%), Positives = 32/53 (60%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLE 173
+ N EVL V G R+ P CP ++Y +M CW +DP +RPTF+ +Q L+
Sbjct: 216 ALNNQEVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-11
Identities = 20/47 (42%), Positives = 30/47 (63%)
Query: 122 MTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETL 168
M+N +V++ +E YR+P P CP L+ +ML+CW KD RP F +
Sbjct: 215 MSNQDVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQI 261
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 2e-11
Identities = 19/44 (43%), Positives = 29/44 (65%)
Query: 122 MTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTF 165
M+ +V+ VE G+R+P P CP L+ +ML+CW K+ +RP F
Sbjct: 212 MSGQDVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRF 255
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 4e-11
Identities = 19/49 (38%), Positives = 26/49 (53%)
Query: 120 GGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETL 168
+N+EV+ V GYR+ P P +Y IM CW + P RP F+ L
Sbjct: 203 ERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKL 251
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 6e-11
Identities = 18/55 (32%), Positives = 31/55 (56%)
Query: 122 MTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFF 176
M EV+ +E G R+ CP CPP +Y +M +CW+ RP F ++ ++ ++
Sbjct: 202 MKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYY 256
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 7e-11
Identities = 21/53 (39%), Positives = 31/53 (58%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLE 173
GM + EV++ V G + CP CP LY++M CW K P RP+F ++ L+
Sbjct: 235 GMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 9e-11
Identities = 21/52 (40%), Positives = 31/52 (59%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKL 172
G +N EV+ V +PC CPPR+Y +M ECW + P +RP F+ + +L
Sbjct: 229 GFSNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 9e-11
Identities = 20/52 (38%), Positives = 28/52 (53%)
Query: 126 EVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFT 177
E+ ++ GYR+ P CP L+ +M CW DP +RP+F L L DF
Sbjct: 227 EMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-10
Identities = 23/52 (44%), Positives = 31/52 (59%), Gaps = 3/52 (5%)
Query: 127 VLHQVE---HGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDF 175
V H +E + R+P PPGCP +Y IM ECW DP +RP+F L ++E
Sbjct: 232 VYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-10
Identities = 19/44 (43%), Positives = 29/44 (65%)
Query: 122 MTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTF 165
M+N EV+ + G+R+P P CP +Y +ML+CW +D +RP F
Sbjct: 214 MSNHEVMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRF 257
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 1e-10
Identities = 20/54 (37%), Positives = 31/54 (57%), Gaps = 7/54 (12%)
Query: 122 MTNAEVLHQVEHGYR-------MPCPPGCPPRLYDIMLECWLKDPVKRPTFETL 168
+T+ +V+ H +R +P PP CP +Y++MLECW +D RPTF +
Sbjct: 237 LTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 2e-10
Identities = 19/53 (35%), Positives = 34/53 (64%), Gaps = 1/53 (1%)
Query: 121 GMTNAEVLHQVE-HGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKL 172
G++ +++L +++ G R+ P CP +Y++ML+CW +P RPTF L+ L
Sbjct: 203 GLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|198173 cd00173, SH2, Src homology 2 (SH2) domain | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 3e-10
Identities = 31/90 (34%), Positives = 39/90 (43%), Gaps = 25/90 (27%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS-------------EYKRSSF 47
W+ G I R EAE+ LL G FL+R+S S DY LS E +
Sbjct: 2 WFHGSISREEAER--LLRGKPDGTFLVRESSSEPGDYVLSVRSGDGKVKHYLIERNEGGY 59
Query: 48 CLKMTTGRSLFETQKAGRTTIHYPELVEHY 77
L +GR+ F + PELVEHY
Sbjct: 60 YLLGGSGRT-FPS---------LPELVEHY 79
|
In general, SH2 domains are involved in signal transduction; they bind pTyr-containing polypeptide ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. They are present in a wide array of proteins including: adaptor proteins (Nck1, Crk, Grb2), scaffolds (Slp76, Shc, Dapp1), kinases (Src, Syk, Fps, Tec), phosphatases (Shp-1, Shp-2), transcription factors (STAT1), Ras signaling molecules (Ras-Gap), ubiquitination factors (c-Cbl), cytoskeleton regulators (Tensin), signal regulators (SAP), and phospholipid second messengers (PLCgamma), amongst others. Length = 79 |
| >gnl|CDD|198189 cd09935, SH2_ABL, Src homology 2 (SH2) domain found in Abelson murine lymphosarcoma virus (ABL) proteins | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 4e-10
Identities = 36/94 (38%), Positives = 51/94 (54%), Gaps = 7/94 (7%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS-EYKRSSFCLKMTTGRS--L 57
WY G I R AE LL +G+FL+R+SES YS+S Y + +++ +
Sbjct: 5 WYHGPISRNAAE--YLLSSGINGSFLVRESESSPGQYSISLRYDGRVYHYRISEDSDGKV 62
Query: 58 FETQKAGRTTIHYPELVEHYSKDADGLCVNLRKP 91
+ TQ+ T+ ELV H+SK+ADGL LR P
Sbjct: 63 YVTQEHRFNTL--AELVHHHSKNADGLITTLRYP 94
|
ABL-family proteins are highly conserved tyrosine kinases. Each ABL protein contains an SH3-SH2-TK (Src homology 3-Src homology 2-tyrosine kinase) domain cassette, which confers autoregulated kinase activity and is common among nonreceptor tyrosine kinases. Several types of posttranslational modifications control ABL catalytic activity, subcellular localization, and stability, with consequences for both cytoplasmic and nuclear ABL functions. Binding partners provide additional regulation of ABL catalytic activity, substrate specificity, and downstream signaling. By combining this cassette with actin-binding and -bundling domain, ABL proteins are capable of connecting phosphoregulation with actin-filament reorganization. Vertebrate paralogs, ABL1 and ABL2, have evolved to perform specialized functions. ABL1 includes nuclear localization signals and a DNA binding domain which is used to mediate DNA damage-repair functions, while ABL2 has additional binding capacity for actin and for microtubules to enhance its cytoskeletal remodeling functions. SH2 is involved in several autoinhibitory mechanism that constrain the enzymatic activity of the ABL-family kinases. In one mechanism SH2 and SH3 cradle the kinase domain while a cap sequence stabilizes the inactive conformation resulting in a locked inactive state. Another involves phosphatidylinositol 4,5-bisphosphate (PIP2) which binds the SH2 domain through residues normally required for phosphotyrosine binding in the linker segment between the SH2 and kinase domains. The SH2 domain contributes to ABL catalytic activity and target site specificity. It is thought that the ABL catalytic site and SH2 pocket have coevolved to recognize the same sequences. Recent work now supports a hierarchical processivity model in which the substrate target site most compatible with ABL kinase domain preferences is phosphorylated with greatest efficiency. If this site is compatible with the ABL SH2 domain specificity, it will then reposition and dock in the SH2 pocket. This mechanism also explains how ABL kinases phosphorylates poor targets on the same substrate if they are properly positioned and how relatively poor substrate proteins might be recruited to ABL through a complex with strong substrates that can also dock with the SH2 pocket. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. Length = 94 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 4e-10
Identities = 23/54 (42%), Positives = 30/54 (55%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLED 174
G+ N E+ + HG R+ P C LYD+M CW DP RPTF L+ LE+
Sbjct: 218 GVENHEIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN 271
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 5e-10
Identities = 20/52 (38%), Positives = 32/52 (61%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKL 172
G +N EV+ + +PCP CP R+Y +M+ECW + P +RP F+ + +L
Sbjct: 229 GFSNQEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 5e-10
Identities = 20/54 (37%), Positives = 30/54 (55%)
Query: 120 GGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLE 173
G M +L ++ G R+P PP CP +YD+M CW +P RP+F L ++
Sbjct: 228 GQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVD 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 9e-10
Identities = 22/54 (40%), Positives = 30/54 (55%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLED 174
G TN EV+ V G R+ P GCP +Y IM +CW P RP F T+ +++
Sbjct: 224 GRTNQEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|198198 cd09945, SH2_SHB_SHD_SHE_SHF_like, Src homology 2 domain found in SH2 domain-containing adapter proteins B, D, E, and F (SHB, SHD, SHE, SHF) | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 9e-10
Identities = 31/82 (37%), Positives = 43/82 (52%), Gaps = 8/82 (9%)
Query: 1 WYFGKIKRIEAEKKL-LLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFE 59
WY G I RIEAE L E G++L+R+SES K DYSLS K + + M R+
Sbjct: 3 WYHGAITRIEAESLLRPCKE---GSYLVRNSESTKQDYSLS-LKSAKGFMHMRIQRNETG 58
Query: 60 TQKAGRTTIHY---PELVEHYS 78
G+ + + PE++ HY
Sbjct: 59 QYILGQFSRPFETIPEMIRHYC 80
|
SHB, SHD, SHE, and SHF are SH2 domain-containing proteins that play various roles throughout the cell. SHB functions in generating signaling compounds in response to tyrosine kinase activation. SHB contains proline-rich motifs, a phosphotyrosine binding (PTB) domain, tyrosine phosphorylation sites, and a SH2 domain. SHB mediates certain aspects of platelet-derived growth factor (PDGF) receptor-, fibroblast growth factor (FGF) receptor-, neural growth factor (NGF) receptor TRKA-, T cell receptor-, interleukin-2 (IL-2) receptor- and focal adhesion kinase- (FAK) signaling. SRC-like FYN-Related Kinase FRK/RAK (also named BSK/IYK or GTK) and SHB regulate apoptosis, proliferation and differentiation. SHB promotes apoptosis and is also required for proper mitogenicity, spreading and tubular morphogenesis in endothelial cells. SHB also plays a role in preventing early cavitation of embryoid bodies and reduces differentiation to cells expressing albumin, amylase, insulin and glucagon. SHB is a multifunctional protein that has difference responses in different cells under various conditions. SHE is expressed in heart, lung, brain, and skeletal muscle, while expression of SHD is restricted to the brain. SHF is mainly expressed in skeletal muscle, brain, liver, prostate, testis, ovary, small intestine, and colon. SHD may be a physiological substrate of c-Abl and may function as an adapter protein in the central nervous system. It is also thought to be involved in apoptotic regulation. SHD contains five YXXP motifs, a substrate sequence preferred by Abl tyrosine kinases, in addition to a poly-proline rich region and a C-terminal SH2 domain. SHE contains two pTry protein binding domains, protein interaction domain (PID) and a SH2 domain, followed by a glycine-proline rich region, all of which are N-terminal to the phosphotyrosine binding (PTB) domain. SHF contains four putative tyrosine phosphorylation sites and an SH2 domain. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. Length = 98 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-09
Identities = 20/51 (39%), Positives = 31/51 (60%)
Query: 122 MTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKL 172
++N + +E G R+PCP CP +Y +M CW DP +RP+F T+ +L
Sbjct: 200 LSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|199828 cd09941, SH2_Grb2_like, Src homology 2 domain found in Growth factor receptor-bound protein 2 (Grb2) and similar proteins | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 2e-09
Identities = 22/40 (55%), Positives = 29/40 (72%), Gaps = 1/40 (2%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS 40
W+ GKI R EAE+ +L+ + GAFLIR+SES D+SLS
Sbjct: 5 WFHGKISRAEAEE-ILMNQRPDGAFLIRESESSPGDFSLS 43
|
The adaptor proteins here include homologs Grb2 in humans, Sex muscle abnormal protein 5 (Sem-5) in Caenorhabditis elegans, and Downstream of receptor kinase (drk) in Drosophila melanogaster. They are composed of one SH2 and two SH3 domains. Grb2/Sem-5/drk regulates the Ras pathway by linking the tyrosine kinases to the Ras guanine nucleotide releasing protein Sos, which converts Ras to the active GTP-bound state. The SH2 domain of Grb2/Sem-5/drk binds class II phosphotyrosyl peptides while its SH3 domain binds to Sos and Sos-derived, proline-rich peptides. Besides it function in Ras signaling, Grb2 is also thought to play a role in apoptosis. Unlike most SH2 structures in which the peptide binds in an extended conformation (such that the +3 peptide residue occupies a hydrophobic pocket in the protein, conferring a modest degree of selectivity), Grb2 forms several hydrogen bonds via main chain atoms with the side chain of +2 Asn. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. Length = 95 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-09
Identities = 19/53 (35%), Positives = 34/53 (64%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLE 173
G+ N+E+ + + G R+ PP C +Y++M +CW +P RP+F+ L+ +LE
Sbjct: 218 GVENSEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLE 270
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-09
Identities = 21/49 (42%), Positives = 29/49 (59%)
Query: 120 GGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETL 168
G MT ++ +E G R+P PP CP +Y +M +CW P KR TF+ L
Sbjct: 228 GQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 3e-09
Identities = 21/54 (38%), Positives = 30/54 (55%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLED 174
G++N EVL V G + P CP +L ++M CW +P RPTF + L+D
Sbjct: 224 GLSNEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|198196 cd09943, SH2_Nck_family, Src homology 2 (SH2) domain found in the Nck family | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 5e-09
Identities = 35/86 (40%), Positives = 41/86 (47%), Gaps = 16/86 (18%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET 60
WY+G+I R +AE LL G FLIRDSES DYS+S LK F+
Sbjct: 3 WYYGRITRHQAET-LLNEHGHEGDFLIRDSESNPGDYSVS--------LKAPGRNKHFKV 53
Query: 61 Q------KAGRTTIH-YPELVEHYSK 79
Q G+ H ELVEHY K
Sbjct: 54 QVVDNVYCIGQRKFHTMDELVEHYKK 79
|
Nck proteins are adaptors that modulate actin cytoskeleton dynamics by linking proline-rich effector molecules to tyrosine kinases or phosphorylated signaling intermediates. There are two members known in this family: Nck1 (Nckalpha) and Nck2 (Nckbeta and Growth factor receptor-bound protein 4 (Grb4)). They are characterized by having 3 SH3 domains and a C-terminal SH2 domain. Nck1 and Nck2 have overlapping functions as determined by gene knockouts. Both bind receptor tyrosine kinases and other tyrosine-phosphorylated proteins through their SH2 domains. In addition they also bind distinct targets. Neuronal signaling proteins: EphrinB1, EphrinB2, and Disabled-1 (Dab-1) all bind to Nck-2 exclusively. And in the case of PDGFR, Tyr(P)751 binds to Nck1 while Tyr(P)1009 binds to Nck2. Nck1 and Nck2 have a role in the infection process of enteropathogenic Escherichia coli (EPEC). Their SH3 domains are involved in recruiting and activating the N-WASP/Arp2/3 complex inducing actin polymerization resulting in the production of pedestals, dynamic bacteria-presenting protrusions of the plasma membrane. A similar thing occurs in the vaccinia virus where motile plasma membrane projections are formed beneath the virus. Recently it has been shown that the SH2 domains of both Nck1 and Nck2 bind the G-protein coupled receptor kinase-interacting protein 1 (GIT1) in a phosphorylation-dependent manner. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. Length = 93 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 6e-09
Identities = 20/43 (46%), Positives = 27/43 (62%)
Query: 131 VEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLE 173
++ GYRM P P +YDIM CW DP+KRPTF+ + +E
Sbjct: 330 IKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 9e-09
Identities = 19/53 (35%), Positives = 31/53 (58%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLE 173
G++N EV+ + G + P CP +YDIML CW +DP +R + + +L+
Sbjct: 227 GLSNEEVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-08
Identities = 21/57 (36%), Positives = 31/57 (54%)
Query: 119 SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDF 175
G MT ++ +E G R+PCP CP +Y +M CW + RPTF +L L++
Sbjct: 225 QGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 1e-08
Identities = 17/35 (48%), Positives = 22/35 (62%)
Query: 134 GYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETL 168
GYRM P C LY +M +CW + P +RPTF+ L
Sbjct: 250 GYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQL 284
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-08
Identities = 22/56 (39%), Positives = 34/56 (60%), Gaps = 1/56 (1%)
Query: 120 GGMTNAEVLHQVEHG-YRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLED 174
G+++ EVL++++ G +P P GCP RLY +M CW +P RP+F L L +
Sbjct: 220 YGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-08
Identities = 22/67 (32%), Positives = 32/67 (47%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180
G+ E+ + G+RM P C LY +M ECW P +RPTF+ L L+
Sbjct: 239 GIPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVS 298
Query: 181 SDYKEAS 187
+Y + S
Sbjct: 299 EEYLDLS 305
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 5e-08
Identities = 23/53 (43%), Positives = 33/53 (62%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLE 173
G+ N+E+ + G R+ PP C LY +M CWL +P RP+FETL+ +LE
Sbjct: 217 GVENSEIYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELE 269
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|198271 cd10408, SH2_Nck1, Src homology 2 (SH2) domain found in Nck | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-08
Identities = 34/88 (38%), Positives = 45/88 (51%), Gaps = 20/88 (22%)
Query: 1 WYFGKIKRIEAEKKLLLPENDH-GAFLIRDSESRKNDYSLS-----EYKRSSFCLKMTT- 53
WY+GK+ R +AE + L E + G FLIRDSES ND+S+S + K LK
Sbjct: 3 WYYGKVTRHQAE--MALNERGNEGDFLIRDSESSPNDFSVSLKAQGKNKHFKVQLKECVY 60
Query: 54 --GRSLFETQKAGRTTIHYPELVEHYSK 79
G+ F + + ELVEHY K
Sbjct: 61 CIGQRKFSSME---------ELVEHYKK 79
|
Nck proteins are adaptors that modulate actin cytoskeleton dynamics by linking proline-rich effector molecules to tyrosine kinases or phosphorylated signaling intermediates. There are two members known in this family: Nck1 (Nckalpha) and Nck2 (Nckbeta and Growth factor receptor-bound protein 4 (Grb4)). They are characterized by having 3 SH3 domains and a C-terminal SH2 domain. Nck1 and Nck2 have overlapping functions as determined by gene knockouts. Both bind receptor tyrosine kinases and other tyrosine-phosphorylated proteins through their SH2 domains. In addition they also bind distinct targets. Neuronal signaling proteins: EphrinB1, EphrinB2, and Disabled-1 (Dab-1) all bind to Nck-2 exclusively. And in the case of PDGFR, Tyr(P)751 binds to Nck1 while Tyr(P)1009 binds to Nck2. Nck1 and Nck2 have a role in the infection process of enteropathogenic Escherichia coli (EPEC). Their SH3 domains are involved in recruiting and activating the N-WASP/Arp2/3 complex inducing actin polymerization resulting in the production of pedestals, dynamic bacteria-presenting protrusions of the plasma membrane. A similar thing occurs in the vaccinia virus where motile plasma membrane projections are formed beneath the virus. Recently it has been shown that the SH2 domains of both Nck1 and Nck2 bind the G-protein coupled receptor kinase-interacting protein 1 (GIT1) in a phosphorylation-dependent manner. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. Length = 97 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 8e-08
Identities = 19/51 (37%), Positives = 27/51 (52%)
Query: 126 EVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFF 176
++ + G R+ P CP LY++ML CW P RPTF L ++E F
Sbjct: 210 DITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-07
Identities = 19/52 (36%), Positives = 32/52 (61%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKL 172
G +N +V+ + + +PCP CP +Y +MLECW + P +RP F+ + +L
Sbjct: 229 GYSNQDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-07
Identities = 20/52 (38%), Positives = 31/52 (59%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKL 172
GMT AE+ ++ GYR+ P C +YD+M +CW + P +RP+F + L
Sbjct: 214 GMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 265
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-07
Identities = 20/52 (38%), Positives = 30/52 (57%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKL 172
GMT AE+ ++ GYRM P C +Y++M +CW P +RP F + +L
Sbjct: 221 GMTCAELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQL 272
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|198185 cd09931, SH2_C-SH2_SHP_like, C-terminal Src homology 2 (C-SH2) domain found in SH2 domain Phosphatases (SHP) proteins | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 3e-07
Identities = 30/111 (27%), Positives = 48/111 (43%), Gaps = 34/111 (30%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS---------------EYKRS 45
W+ G + EAEK LLL + G+FL+R+S+S+ D+ LS + +
Sbjct: 2 WFHGHLSGKEAEK-LLLEKGKPGSFLVRESQSKPGDFVLSVRTDDDKVTHIMIRCQGGKY 60
Query: 46 SFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSK----DADGLCVNLRKPC 92
G F++ +LVEHY K + G V+L++P
Sbjct: 61 DVG-----GGEEFDSLT---------DLVEHYKKNPMVETSGTVVHLKQPL 97
|
The SH2 domain phosphatases (SHP-1, SHP-2/Syp, Drosophila corkscrew (csw), and Caenorhabditis elegans Protein Tyrosine Phosphatase (Ptp-2)) are cytoplasmic signaling enzymes. They are both targeted and regulated by interactions of their SH2 domains with phosphotyrosine docking sites. These proteins contain two SH2 domains (N-SH2, C-SH2) followed by a tyrosine phosphatase (PTP) domain, and a C-terminal extension. Shp1 and Shp2 have two tyrosyl phosphorylation sites in their C-tails, which are phosphorylated differentially by receptor and nonreceptor PTKs. Csw retains the proximal tyrosine and Ptp-2 lacks both sites. Shp-binding proteins include receptors, scaffolding adapters, and inhibitory receptors. Some of these bind both Shp1 and Shp2 while others bind only one. Most proteins that bind a Shp SH2 domain contain one or more immuno-receptor tyrosine-based inhibitory motifs (ITIMs): [SIVL]xpYxx[IVL]. Shp1 N-SH2 domain blocks the catalytic domain and keeps the enzyme in the inactive conformation, and is thus believed to regulate the phosphatase activity of SHP-1. Its C-SH2 domain is thought to be involved in searching for phosphotyrosine activators. The SHP2 N-SH2 domain is a conformational switch; it either binds and inhibits the phosphatase, or it binds phosphoproteins and activates the enzyme. The C-SH2 domain contributes binding energy and specificity, but it does not have a direct role in activation. Csw SH2 domain function is essential, but either SH2 domain can fulfill this requirement. The role of the csw SH2 domains during Sevenless receptor tyrosine kinase (SEV) signaling is to bind Daughter of Sevenless rather than activated SEV. Ptp-2 acts in oocytes downstream of sheath/oocyte gap junctions to promote major sperm protein (MSP)-induced MAP Kinase (MPK-1) phosphorylation. Ptp-2 functions in the oocyte cytoplasm, not at the cell surface to inhibit multiple RasGAPs, resulting in sustained Ras activation. It is thought that MSP triggers PTP-2/Ras activation and ROS production to stimulate MPK-1 activity essential for oocyte maturation and that secreted MSP domains and Cu/Zn superoxide dismutases function antagonistically to control ROS and MAPK signaling. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. Length = 99 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-07
Identities = 19/48 (39%), Positives = 30/48 (62%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETL 168
GMT AE+ ++ GYR+ P C +YD+M +CW + P +RP+F +
Sbjct: 226 GMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI 273
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 4e-07
Identities = 19/47 (40%), Positives = 27/47 (57%)
Query: 120 GGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFE 166
G + N++ V+ GY+M P PP +Y IM CW +P +RPTF
Sbjct: 317 GILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFS 363
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 5e-07
Identities = 20/55 (36%), Positives = 30/55 (54%)
Query: 120 GGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLED 174
G +++ ++ GYRM P P +YDIM CW DP+KRPTF+ + +
Sbjct: 246 GMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-07
Identities = 19/59 (32%), Positives = 32/59 (54%)
Query: 120 GGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTM 178
G + ++ ++++ GYRM P +YDIM++CW +P KRP+F L +E
Sbjct: 342 GMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLPS 400
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 6e-07
Identities = 23/62 (37%), Positives = 33/62 (53%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180
G+ E+ ++ G+RM P C LY IM ECW P +RPTF+ L L+ T+
Sbjct: 239 GIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298
Query: 181 SD 182
+D
Sbjct: 299 TD 300
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 6e-07
Identities = 25/64 (39%), Positives = 35/64 (54%), Gaps = 4/64 (6%)
Query: 109 GVVV-SAVDFGS---GGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPT 164
GV V + FGS G+ +E+ +E G R+P PP C +Y IM++CW+ D RP
Sbjct: 198 GVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPK 257
Query: 165 FETL 168
F L
Sbjct: 258 FREL 261
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 7e-07
Identities = 19/40 (47%), Positives = 26/40 (65%)
Query: 134 GYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLE 173
GYRM P C +Y++ML CW ++P KRPTF + +LE
Sbjct: 245 GYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|198188 cd09934, SH2_Tec_family, Src homology 2 (SH2) domain found in Tec-like proteins | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 8e-07
Identities = 28/98 (28%), Positives = 47/98 (47%), Gaps = 11/98 (11%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSS-------FCLKMTT 53
WY G + R AE LL E+ G F++R+S S K Y++S + + + +K
Sbjct: 8 WYVGDMSRQRAES-LLKQEDKEGCFVVRNS-STKGLYTVSLFTKVPGSPHVKHYHIKQNA 65
Query: 54 GRSLFETQKAGRTTIHYPELVEHYSKDADGLCVNLRKP 91
+ +K TI PEL+ ++ ++ GL L+ P
Sbjct: 66 RSEFYLAEKHCFETI--PELINYHQHNSGGLATRLKYP 101
|
The Tec protein tyrosine kinase is the founding member of a family that includes Btk, Itk, Bmx, and Txk. The members have a PH domain, a zinc-binding motif, a SH3 domain, a SH2 domain, and a protein kinase catalytic domain. Btk is involved in B-cell receptor signaling with mutations in Btk responsible for X-linked agammaglobulinemia (XLA) in humans and X-linked immunodeficiency (xid) in mice. Itk is involved in T-cell receptor signaling. Tec is expressed in both T and B cells, and is thought to function in activated and effector T lymphocytes to induce the expression of genes regulated by NFAT transcription factors. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. Length = 104 |
| >gnl|CDD|198260 cd10397, SH2_Tec_Btk, Src homology 2 (SH2) domain found in Tec protein, Bruton's tyrosine kinase (Btk) | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-06
Identities = 31/106 (29%), Positives = 52/106 (49%), Gaps = 16/106 (15%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSS---------FCLKM 51
WY + R +AE+ LL E G F++RDS S+ Y++S + +S+ + +
Sbjct: 8 WYSKNMTRSQAEQ-LLKQEGKEGGFIVRDS-SKAGKYTVSVFAKSAGDPQGVIRHYVVCS 65
Query: 52 TTGRSLFETQKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQVSC 97
T + +K +TI PEL+ ++ +A GL L+ P VS
Sbjct: 66 TPQSQYYLAEKHLFSTI--PELINYHQHNAAGLISRLKYP---VSS 106
|
A member of the Tec protein tyrosine kinase Btk is expressed in bone marrow, spleen, all hematopoietic cells except T lymphocytes and plasma cells where it plays a crucial role in B cell maturation and mast cell activation. Btk has been shown to interact with GNAQ, PLCG2, protein kinase D1, B-cell linker, SH3BP5, caveolin 1, ARID3A, and GTF2I. Most of the Tec family members have a PH domain (Txk and the short (type 1) splice variant of Drosophila Btk29A are exceptions), a Tec homology (TH) domain, a SH3 domain, a SH2 domain, and a protein kinase catalytic domain. Btk is implicated in the primary immunodeficiency disease X-linked agammaglobulinemia (Bruton's agammaglobulinemia). The TH domain consists of a Zn2+-binding Btk motif and a proline-rich region. The Btk motif is found in Tec kinases, Ras GAP, and IGBP. It is crucial for the function of Tec PH domains and it's lack of presence in Txk is not surprising since it lacks a PH domain. The type 1 splice form of the Drosophila homolog also lacks both the PH domain and the Btk motif. The proline-rich regions are highly conserved for the most part with the exception of Bmx whose residues surrounding the PXXP motif are not conserved (TH-like) and Btk29A which is entirely unique with large numbers of glycine residues (TH-extended). Tec family members all lack a C-terminal tyrosine having an autoinhibitory function in its phosphorylated state. Two tyrosine phosphorylation (pY) sites have been identified in Btk: one located in the activation loop of the catalytic domain which regulates the transition between open (active) and closed (inactive) states and the other in its SH3 domain. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. Length = 106 |
| >gnl|CDD|198265 cd10402, SH2_C-SH2_Zap70, C-terminal Src homology 2 (SH2) domain found in Zeta-chain-associated protein kinase 70 (ZAP-70) | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-06
Identities = 29/106 (27%), Positives = 48/106 (45%), Gaps = 26/106 (24%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET 60
WY G I R EAE++L G FL+R+ + + ++ L + G++++
Sbjct: 12 WYHGSIARDEAERRLYSGAQPDGKFLLRERK-----------ESGTYALSLVYGKTVYHY 60
Query: 61 Q----KAGRTTIHYPE---------LVEHYSKDADGLCVNLRKPCV 93
+ K+G+ +I PE LVE+ DGL LR+ C
Sbjct: 61 RIDQDKSGKYSI--PEGTKFDTLWQLVEYLKLKPDGLIFVLRESCP 104
|
ZAP-70 and Syk comprise a family of hematopoietic cell specific protein tyrosine kinases (PTKs) that are required for antigen and antibody receptor function. ZAP-70 is expressed in T and natural killer (NK) cells and Syk is expressed in B cells, mast cells, polymorphonuclear leukocytes, platelets, macrophages, and immature T cells. They are required for the proper development of T and B cells, immune receptors, and activating NK cells. They consist of two N-terminal Src homology 2 (SH2) domains and a C-terminal kinase domain separated from the SH2 domains by a linker or hinge region. Phosphorylation of both tyrosine residues within the Immunoreceptor Tyrosine-based Activation Motifs (ITAM; consensus sequence Yxx[LI]x(7,8)Yxx[LI]) by the Src-family PTKs is required for efficient interaction of ZAP-70 and Syk with the receptor subunits and for receptor function. ZAP-70 forms two phosphotyrosine binding pockets, one of which is shared by both SH2 domains. In Syk the two SH2 domains do not form such a phosphotyrosine-binding site. The SH2 domains here are believed to function independently. In addition, the two SH2 domains of Syk display flexibility in their relative orientation, allowing Syk to accommodate a greater variety of spacing sequences between the ITAM phosphotyrosines and singly phosphorylated non-classical ITAM ligands. This model contains the C-terminus SH2 domains of Zap70. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. Length = 105 |
| >gnl|CDD|198180 cd09926, SH2_CRK_like, Src homology 2 domain found in cancer-related signaling adaptor protein CRK | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-06
Identities = 21/48 (43%), Positives = 27/48 (56%), Gaps = 2/48 (4%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFC 48
WYFG + R EA++ LL HG FL+RDS + DY LS + S
Sbjct: 9 WYFGPMSRQEAQE--LLQGQRHGVFLVRDSSTIPGDYVLSVSENSRVS 54
|
SH2 domain in the CRK proteins. CRKI (SH2-SH3) and CRKII (SH2-SH3-SH3) are splicing isoforms of the oncoprotein CRK. CRKs regulate transcription and cytoskeletal reorganization for cell growth and motility by linking tyrosine kinases to small G proteins. The SH2 domain of CRK associates with tyrosine-phosphorylated receptors or components of focal adhesions, such as p130Cas and paxillin. CRK transmits signals to small G proteins through effectors that bind its SH3 domain, such as C3G, the guanine-nucleotide exchange factor (GEF) for Rap1 and R-Ras, and DOCK180, the GEF for Rac6. The binding of p130Cas to the CRK-C3G complex activates Rap1, leading to regulation of cell adhesion, and activates R-Ras, leading to JNK-mediated activation of cell proliferation, whereas the binding of CRK DOCK180 induces Rac1-mediated activation of cellular migration. The activity of the different splicing isoforms varies greatly with CRKI displaying substantial transforming activity, CRKII less so, and phosphorylated CRKII with no biological activity whatsoever. CRKII has a linker region with a phosphorylated Tyr and an additional C-terminal SH3 domain. The phosphorylated Tyr creates a binding site for its SH2 domain which disrupts the association between CRK and its SH2 target proteins. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. Length = 106 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 2e-06
Identities = 18/48 (37%), Positives = 29/48 (60%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETL 168
G+ E+ +E G R+P PP C +Y ++++CW+ D RPTF+ L
Sbjct: 214 GIPAVEIPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKEL 261
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|198264 cd10401, SH2_C-SH2_Syk_like, C-terminal Src homology 2 (SH2) domain found in Spleen tyrosine kinase (Syk) proteins | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-06
Identities = 36/104 (34%), Positives = 52/104 (50%), Gaps = 24/104 (23%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSL--- 57
W+ GKI R E+E+ LL+ +G FLIR+ ++ Y+L CL + G+ L
Sbjct: 5 WFHGKISREESEQILLIGSKTNGKFLIRERDNN-GSYAL--------CL-LHDGKVLHYR 54
Query: 58 FETQKAGRTTIHYPE---------LVEHYSKDADGLCVNLRKPC 92
+ K G+ +I P+ LVEHYS DGL L +PC
Sbjct: 55 IDKDKTGKLSI--PDGKKFDTLWQLVEHYSYKPDGLLRVLTEPC 96
|
ZAP-70 and Syk comprise a family of hematopoietic cell specific protein tyrosine kinases (PTKs) that are required for antigen and antibody receptor function. ZAP-70 is expressed in T and natural killer (NK) cells and Syk is expressed in B cells, mast cells, polymorphonuclear leukocytes, platelets, macrophages, and immature T cells. They are required for the proper development of T and B cells, immune receptors, and activating NK cells. They consist of two N-terminal Src homology 2 (SH2) domains and a C-terminal kinase domain separated from the SH2 domains by a linker or hinge region. Phosphorylation of both tyrosine residues within the Immunoreceptor Tyrosine-based Activation Motifs (ITAM; consensus sequence Yxx[LI]x(7,8)Yxx[LI]) by the Src-family PTKs is required for efficient interaction of ZAP-70 and Syk with the receptor subunits and for receptor function. ZAP-70 forms two phosphotyrosine binding pockets, one of which is shared by both SH2 domains. In Syk the two SH2 domains do not form such a phosphotyrosine-binding site. The SH2 domains here are believed to function independently. In addition, the two SH2 domains of Syk display flexibility in their relative orientation, allowing Syk to accommodate a greater variety of spacing sequences between the ITAM phosphotyrosines and singly phosphorylated non-classical ITAM ligands. This model contains the C-terminus SH2 domains of Syk. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. Length = 99 |
| >gnl|CDD|198255 cd10392, SH2_SHF, Src homology 2 domain found in SH2 domain-containing adapter protein F (SHF) | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-06
Identities = 28/81 (34%), Positives = 44/81 (54%), Gaps = 6/81 (7%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET 60
WY G I R +AE L L + ++L+R+SE+ KND+SLS K S + M R+
Sbjct: 3 WYHGAISRTDAENLLRLCK--EASYLVRNSETSKNDFSLS-LKSSQGFMHMKLSRTKEHK 59
Query: 61 QKAGRTTIHY---PELVEHYS 78
G+ + + PE++ HY+
Sbjct: 60 YVLGQNSPPFSSVPEIIHHYA 80
|
SHF is thought to play a role in PDGF-receptor signaling and regulation of apoptosis. SHF is mainly expressed in skeletal muscle, brain, liver, prostate, testis, ovary, small intestine, and colon. SHF contains four putative tyrosine phosphorylation sites and an SH2 domain. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. Length = 98 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-06
Identities = 19/45 (42%), Positives = 26/45 (57%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTF 165
G++N +VL V G + P CP R+ D+M CW +P RPTF
Sbjct: 224 GLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTF 268
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 3e-06
Identities = 20/51 (39%), Positives = 27/51 (52%)
Query: 124 NAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLED 174
+ E +++ G RM P P +Y IML+CW +P RPTF L L D
Sbjct: 282 DEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGD 332
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 6e-06
Identities = 21/49 (42%), Positives = 26/49 (53%)
Query: 120 GGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETL 168
G N E +++ G RM P P +Y IML CW DP +RPTF L
Sbjct: 279 GVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSAL 327
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 7e-06
Identities = 21/58 (36%), Positives = 32/58 (55%), Gaps = 3/58 (5%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTM 178
G+ E+ +E G R+P PP C +Y IM++CW+ D RP F L +++F M
Sbjct: 214 GIPAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFREL---VDEFSRM 268
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|198210 cd10347, SH2_Nterm_shark_like, N-terminal Src homology 2 (SH2) domain found in SH2 domains, ANK, and kinase domain (shark) proteins | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 9e-06
Identities = 20/40 (50%), Positives = 22/40 (55%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS 40
WY GKI R AE LL G FL+R+S S DY LS
Sbjct: 3 WYHGKISREVAEALLLREGGRDGLFLVRESTSAPGDYVLS 42
|
These non-receptor protein-tyrosine kinases contain two SH2 domains, five ankyrin (ANK)-like repeats, and a potential tyrosine phosphorylation site in the carboxyl-terminal tail which resembles the phosphorylation site in members of the src family. Like, mammalian non-receptor protein-tyrosine kinases, ZAP-70 and syk proteins, they do not have SH3 domains. However, the presence of ANK makes these unique among protein-tyrosine kinases. Both tyrosine kinases and ANK repeats have been shown to transduce developmental signals, and SH2 domains are known to participate intimately in tyrosine kinase signaling. These tyrosine kinases are believed to be involved in epithelial cell polarity. The members of this family include the shark (SH2 domains, ANK, and kinase domain) gene in Drosophila and yellow fever mosquitos, as well as the hydra protein HTK16. Drosophila Shark is proposed to transduce intracellularly the Crumbs, a protein necessary for proper organization of ectodermal epithelia, intercellular signal. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. Length = 81 |
| >gnl|CDD|198261 cd10398, SH2_Tec_Txk, Src homology 2 (SH2) domain found in Tec protein, Txk | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 1e-05
Identities = 29/100 (29%), Positives = 49/100 (49%), Gaps = 13/100 (13%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSS---------FCLKM 51
WY I R +AE+ LL E+ GAF++RDS Y++S + R+ + +K
Sbjct: 8 WYHKNITRNQAER-LLRQESKEGAFIVRDS-RHLGSYTISVFTRARRSTEASIKHYQIKK 65
Query: 52 TTGRSLFETQKAGRTTIHYPELVEHYSKDADGLCVNLRKP 91
+ ++ +I PEL++++ +A GL LR P
Sbjct: 66 NDSGQWYVAERHLFQSI--PELIQYHQHNAAGLMSRLRYP 103
|
A member of the Tec protein tyrosine kinase Txk is expressed in thymus, spleen, lymph node, T lymphocytes, NK cells, mast cell lines, and myeloid cell line. Txk plays a role in TCR signal transduction, T cell development, and selection which is analogous to the function of Itk. Txk has been shown to interact with IFN-gamma. Unlike most of the Tec family members Txk lacks a PH domain. Instead Txk has a unique region containing a palmitoylated cysteine string which has a similar membrane tethering function as the PH domain. Txk also has a zinc-binding motif, a SH3 domain, a SH2 domain, and a protein kinase catalytic domain. The TH domain consists of a Zn2+-binding Btk motif and a proline-rich region. The Btk motif is found in Tec kinases, Ras GAP, and IGBP and crucial to the function of the PH domain. It is not present in Txk which is not surprising since it lacks a PH domain. The type 1 splice form of the Drosophila homolog also lacks both the PH domain and the Btk motif. The proline-rich regions are highly conserved for the most part with the exception of Bmx whose residues surrounding the PXXP motif are not conserved (TH-like) and Btk29A which is entirely unique with large numbers of glycine residues (TH-extended). Tec family members all lack a C-terminal tyrosine having an autoinhibitory function in its phosphorylated state. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. Length = 106 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-05
Identities = 18/48 (37%), Positives = 28/48 (58%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETL 168
G+ E+ +E G R+P PP C +Y +M++CW+ D RP F+ L
Sbjct: 214 GIPTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-05
Identities = 14/36 (38%), Positives = 22/36 (61%)
Query: 137 MPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKL 172
+P P CP LY +ML CW ++ +RP+F+ + L
Sbjct: 259 LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|198217 cd10354, SH2_Cterm_RasGAP, C-terminal Src homology 2 (SH2) domain found in Ras GTPase-activating protein 1 (GAP) | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 2e-05
Identities = 18/40 (45%), Positives = 26/40 (65%), Gaps = 1/40 (2%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS 40
W+ GKI R EA +L+ G+FL+R+S++ DYSLS
Sbjct: 2 WFHGKISREEAYN-MLVKVGGPGSFLVRESDNTPGDYSLS 40
|
RasGAP is part of the GAP1 family of GTPase-activating proteins. The protein is located in the cytoplasm and stimulates the GTPase activity of normal RAS p21, but not its oncogenic counterpart. Acting as a suppressor of RAS function, the protein enhances the weak intrinsic GTPase activity of RAS proteins resulting in RAS inactivation, thereby allowing control of cellular proliferation and differentiation. Mutations leading to changes in the binding sites of either protein are associated with basal cell carcinomas. Alternative splicing results in two isoforms. The shorter isoform which lacks the N-terminal hydrophobic region, has the same activity, and is expressed in placental tissues. In general longer isoform contains 2 SH2 domains, a SH3 domain, a pleckstrin homology (PH) domain, and a calcium-dependent phospholipid-binding C2 domain. The C-terminus contains the catalytic domain of RasGap which catalyzes the activation of Ras by hydrolyzing GTP-bound active Ras into an inactive GDP-bound form of Ras. This model contains the C-terminal SH2 domain. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. Length = 77 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-05
Identities = 18/53 (33%), Positives = 27/53 (50%)
Query: 124 NAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFF 176
+ E +++ G RM P P +Y ML+CW +P +RPTF L L +
Sbjct: 288 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-05
Identities = 16/50 (32%), Positives = 28/50 (56%)
Query: 123 TNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKL 172
+N+EV+ + G+R+ P +Y++M CW + P RP+F L +L
Sbjct: 206 SNSEVVETINAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-05
Identities = 18/45 (40%), Positives = 26/45 (57%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTF 165
GM+N +VL V G + P CP L+++M CW +P RP+F
Sbjct: 224 GMSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSF 268
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-05
Identities = 20/58 (34%), Positives = 30/58 (51%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTM 178
G+ E+ ++ G+RM P C LY +M +CW P RPTF+ L L+ T+
Sbjct: 242 GIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|198272 cd10409, SH2_Nck2, Src homology 2 (SH2) domain found in Nck | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 4e-05
Identities = 32/89 (35%), Positives = 42/89 (47%), Gaps = 22/89 (24%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGA---FLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSL 57
WY+G + R +AE L N+ G FLIRDSES +D+S+S LK
Sbjct: 3 WYYGNVTRHQAECAL----NERGVEGDFLIRDSESSPSDFSVS--------LKAVGKNKH 50
Query: 58 FETQKA------GRTTIH-YPELVEHYSK 79
F+ Q G+ + ELVEHY K
Sbjct: 51 FKVQLVDNVYCIGQRRFNSMDELVEHYKK 79
|
Nck proteins are adaptors that modulate actin cytoskeleton dynamics by linking proline-rich effector molecules to tyrosine kinases or phosphorylated signaling intermediates. There are two members known in this family: Nck1 (Nckalpha) and Nck2 (Nckbeta and Growth factor receptor-bound protein 4 (Grb4)). They are characterized by having 3 SH3 domains and a C-terminal SH2 domain. Nck1 and Nck2 have overlapping functions as determined by gene knockouts. Both bind receptor tyrosine kinases and other tyrosine-phosphorylated proteins through their SH2 domains. In addition they also bind distinct targets. Neuronal signaling proteins: EphrinB1, EphrinB2, and Disabled-1 (Dab-1) all bind to Nck-2 exclusively. And in the case of PDGFR, Tyr(P)751 binds to Nck1 while Tyr(P)1009 binds to Nck2. Nck1 and Nck2 have a role in the infection process of enteropathogenic Escherichia coli (EPEC). Their SH3 domains are involved in recruiting and activating the N-WASP/Arp2/3 complex inducing actin polymerization resulting in the production of pedestals, dynamic bacteria-presenting protrusions of the plasma membrane. A similar thing occurs in the vaccinia virus where motile plasma membrane projections are formed beneath the virus. Recently it has been shown that the SH2 domains of both Nck1 and Nck2 bind the G-protein coupled receptor kinase-interacting protein 1 (GIT1) in a phosphorylation-dependent manner. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. Length = 98 |
| >gnl|CDD|198254 cd10391, SH2_SHE, Src homology 2 domain found in SH2 domain-containing adapter protein E (SHE) | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 4e-05
Identities = 25/81 (30%), Positives = 40/81 (49%), Gaps = 6/81 (7%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKM---TTGRSL 57
WY G I R EAE +L ++L+R+SES + YS++ K S C+ + T +
Sbjct: 3 WYHGSISRAEAESRL--QPCKEASYLVRNSESGNSKYSIA-LKTSQGCVHIIVAQTKDNK 59
Query: 58 FETQKAGRTTIHYPELVEHYS 78
+ + PE+V +YS
Sbjct: 60 YTLNQTSAVFDSIPEVVHYYS 80
|
SHE is expressed in heart, lung, brain, and skeletal muscle. SHE contains two pTry protein binding domains, protein interaction domain (PID) and a SH2 domain, followed by a glycine-proline rich region, all of which are N-terminal to the phosphotyrosine binding (PTB) domain. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. Length = 98 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-05
Identities = 11/30 (36%), Positives = 17/30 (56%)
Query: 140 PPGCPPRLYDIMLECWLKDPVKRPTFETLQ 169
P CP ++ +M+ CW +D RPTF +
Sbjct: 261 TPLCPSPVFKLMMRCWSRDIKDRPTFNKIH 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|198203 cd10340, SH2_N-SH2_SHP_like, N-terminal Src homology 2 (N-SH2) domain found in SH2 domain Phosphatases (SHP) proteins | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 5e-05
Identities = 26/98 (26%), Positives = 43/98 (43%), Gaps = 9/98 (9%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFC-LKMTTGRSLFE 59
W+ I IEAE LL G+FL R S+S D++LS + +K+ ++
Sbjct: 2 WFHPVISGIEAEN-LLKTRGVDGSFLARPSKSNPGDFTLSVRRGDEVTHIKIQNTGDYYD 60
Query: 60 TQKAGRTTIHYPELVEHYS------KDADGLCVNLRKP 91
G ELV++Y ++ +G + L+ P
Sbjct: 61 LY-GGEKFATLSELVQYYMEQHGQLREKNGDVIELKYP 97
|
The SH2 domain phosphatases (SHP-1, SHP-2/Syp, Drosophila corkscrew (csw), and Caenorhabditis elegans Protein Tyrosine Phosphatase (Ptp-2)) are cytoplasmic signaling enzymes. They are both targeted and regulated by interactions of their SH2 domains with phosphotyrosine docking sites. These proteins contain two SH2 domains (N-SH2, C-SH2) followed by a tyrosine phosphatase (PTP) domain, and a C-terminal extension. Shp1 and Shp2 have two tyrosyl phosphorylation sites in their C-tails, which are phosphorylated differentially by receptor and nonreceptor PTKs. Csw retains the proximal tyrosine and Ptp-2 lacks both sites. Shp-binding proteins include receptors, scaffolding adapters, and inhibitory receptors. Some of these bind both Shp1 and Shp2 while others bind only one. Most proteins that bind a Shp SH2 domain contain one or more immuno-receptor tyrosine-based inhibitory motifs (ITIMs): [IVL]xpYxx[IVL]. Shp1 N-SH2 domain blocks the catalytic domain and keeps the enzyme in the inactive conformation, and is thus believed to regulate the phosphatase activity of SHP-1. Its C-SH2 domain is thought to be involved in searching for phosphotyrosine activators. The SHP2 N-SH2 domain is a conformational switch; it either binds and inhibits the phosphatase, or it binds phosphoproteins and activates the enzyme. The C-SH2 domain contributes binding energy and specificity, but it does not have a direct role in activation. Csw SH2 domain function is essential, but either SH2 domain can fulfill this requirement. The role of the csw SH2 domains during Sevenless receptor tyrosine kinase (SEV) signaling is to bind Daughter of Sevenless rather than activated SEV. Ptp-2 acts in oocytes downstream of sheath/oocyte gap junctions to promote major sperm protein (MSP)-induced MAP Kinase (MPK-1) phosphorylation. Ptp-2 functions in the oocyte cytoplasm, not at the cell surface to inhibit multiple RasGAPs, resulting in sustained Ras activation. It is thought that MSP triggers PTP-2/Ras activation and ROS production to stimulate MPK-1 activity essential for oocyte maturation and that secreted MSP domains and Cu/Zn superoxide dismutases function antagonistically to control ROS and MAPK signaling. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. Length = 99 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 6e-05
Identities = 22/65 (33%), Positives = 33/65 (50%), Gaps = 6/65 (9%)
Query: 109 GVVVSAVDFGSGGM-----TNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRP 163
GV++ V F G M +N EV+ + G+R+ P +Y++M CW + P RP
Sbjct: 188 GVLMWEV-FTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRP 246
Query: 164 TFETL 168
TF L
Sbjct: 247 TFAEL 251
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|199829 cd10341, SH2_N-SH2_PLC_gamma_like, N-terminal Src homology 2 (N-SH2) domain in Phospholipase C gamma | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 6e-05
Identities = 21/43 (48%), Positives = 27/43 (62%), Gaps = 3/43 (6%)
Query: 1 WYFGKIK--RIEAEKKLL-LPENDHGAFLIRDSESRKNDYSLS 40
W+ GK+ R EAEK LL E G FL+R+SE+ DY+LS
Sbjct: 6 WFHGKLGDGRDEAEKLLLEYCEGGDGTFLVRESETFVGDYTLS 48
|
Phospholipase C gamma is a signaling molecule that is recruited to the C-terminal tail of the receptor upon autophosphorylation of a highly conserved tyrosine. PLCgamma is composed of a Pleckstrin homology (PH) domain followed by an elongation factor (EF) domain, 2 catalytic regions of PLC domains that flank 2 tandem SH2 domains (N-SH2, C-SH2), and ending with a SH3 domain and C2 domain. N-SH2 SH2 domain-mediated interactions represent a crucial step in transmembrane signaling by receptor tyrosine kinases. SH2 domains recognize phosphotyrosine (pY) in the context of particular sequence motifs in receptor phosphorylation sites. Both N-SH2 and C-SH2 have a very similar binding affinity to pY. But in growth factor stimulated cells these domains bind to different target proteins. N-SH2 binds to pY containing sites in the C-terminal tails of tyrosine kinases and other receptors. Recently it has been shown that this interaction is mediated by phosphorylation-independent interactions between a secondary binding site found exclusively on the N-SH2 domain and a region of the FGFR1 tyrosine kinase domain. This secondary site on the SH2 cooperates with the canonical pY site to regulate selectivity in mediating a specific cellular process. C-SH2 binds to an intramolecular site on PLCgamma itself which allows it to hydrolyze phosphatidylinositol-4,5-bisphosphate into diacylglycerol and inositol triphosphate. These then activate protein kinase C and release calcium. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. Length = 99 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 7e-05
Identities = 14/30 (46%), Positives = 21/30 (70%)
Query: 140 PPGCPPRLYDIMLECWLKDPVKRPTFETLQ 169
PP CP LY++ML+CW +D +RP+F +
Sbjct: 270 PPPCPQGLYELMLQCWSRDCRERPSFSDIH 299
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 7e-05
Identities = 19/58 (32%), Positives = 30/58 (51%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTM 178
G+ E+ ++ G+RM P C LY +M +CW P +RPTF+ L L+ +
Sbjct: 245 GVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 8e-05
Identities = 16/47 (34%), Positives = 25/47 (53%)
Query: 122 MTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETL 168
N+E + +V G R+ P ++Y IM CW + +RPTF+ L
Sbjct: 205 FNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQL 251
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|198221 cd10358, SH2_PTK6_Brk, Src homology 2 domain found in protein-tyrosine kinase-6 (PTK6) which is also known as breast tumor kinase (Brk) | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 8e-05
Identities = 21/40 (52%), Positives = 24/40 (60%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS 40
W+FG I R EA ++L N GAFLIR SE DY LS
Sbjct: 4 WFFGCISRSEAVRRLQAEGNATGAFLIRVSEKPSADYVLS 43
|
Human protein-tyrosine kinase-6 (PTK6, also known as breast tumor kinase (Brk)) is a member of the non-receptor protein-tyrosine kinase family and is expressed in two-thirds of all breast tumors. PTK6 (9). PTK6 contains a SH3 domain, a SH2 domain, and catalytic domains. For the case of the non-receptor protein-tyrosine kinases, the SH2 domain is typically involved in negative regulation of kinase activity by binding to a phosphorylated tyrosine residue near to the C terminus. The C-terminal sequence of PTK6 (PTSpYENPT where pY is phosphotyrosine) is thought to be a self-ligand for the SH2 domain. The structure of the SH2 domain resembles other SH2 domains except for a centrally located four-stranded antiparallel beta-sheet (strands betaA, betaB, betaC, and betaD). There are also differences in the loop length which might be responsible for PTK6 ligand specificity. There are two possible means of regulation of PTK6: autoinhibitory with the phosphorylation of Tyr playing a role in its negative regulation and autophosphorylation at this site, though it has been shown that PTK6 might phosphorylate signal transduction-associated proteins Sam68 and signal transducing adaptor family member 2 (STAP/BKS) in vivo. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. Length = 100 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 1e-04
Identities = 19/48 (39%), Positives = 27/48 (56%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETL 168
GM EV +E G R+ P C +Y +M++CW+ D RPTF+ L
Sbjct: 214 GMRPHEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|198197 cd09944, SH2_Grb7_family, Src homology 2 (SH2) domain found in the growth factor receptor bound, subclass 7 (Grb7) proteins | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 1e-04
Identities = 26/100 (26%), Positives = 39/100 (39%), Gaps = 5/100 (5%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS-----EYKRSSFCLKMTTGR 55
W+ G I R EA + + G FL+R+S+S + LS + K G+
Sbjct: 7 WFHGGISRDEAARLIRQQGLVDGVFLVRESQSNPGAFVLSLKHGQKIKHYQIIPIEDEGQ 66
Query: 56 SLFETQKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQV 95
F +LVE Y +A L L+ C +V
Sbjct: 67 WYFTLDDGVTKFYDLLQLVEFYQLNAGSLPTRLKHYCTRV 106
|
The Grb family binds to the epidermal growth factor receptor (EGFR, erbB1) via their SH2 domains. There are 3 members of the Grb7 family of proteins: Grb7, Grb10, and Grb14. They are composed of an N-terminal Proline-rich domain, a Ras Associating-like (RA) domain, a Pleckstrin Homology (PH) domain, a phosphotyrosine interaction region (PIR, BPS) and a C-terminal SH2 domain. The SH2 domains of Grb7, Grb10 and Grb14 preferentially bind to a different RTK. Grb7 binds strongly to the erbB2 receptor, unlike Grb10 and Grb14 which bind weakly to it. Grb14 binds to Fibroblast Growth Factor Receptor (FGFR). Grb10 has been shown to interact with many different proteins, including the insulin and IGF1 receptors, platelet-derived growth factor (PDGF) receptor-beta, Ret, Kit, Raf1 and MEK1, and Nedd4. Grb7 family proteins are phosphorylated on serine/threonine as well as tyrosine residues. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. Length = 108 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 1e-04
Identities = 15/52 (28%), Positives = 28/52 (53%)
Query: 122 MTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLE 173
++N E + + G + P CPP +Y IM CW ++P +R + + +L+
Sbjct: 228 LSNTEAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|198211 cd10348, SH2_Cterm_shark_like, C-terminal Src homology 2 (SH2) domain found in SH2 domains, ANK, and kinase domain (shark) proteins | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 2e-04
Identities = 25/94 (26%), Positives = 36/94 (38%), Gaps = 19/94 (20%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS----------EYKRSSFCLK 50
W G + R EA + L + G+FL+R S R Y L+ E +
Sbjct: 2 WLHGALDRNEAVEILKQKADADGSFLVRYSRRRPGGYVLTLVYENHVYHFEIQNRDDKWF 61
Query: 51 MTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84
FE+ L+EHY++ ADGL
Sbjct: 62 YIDDGPYFES---------LEHLIEHYTQFADGL 86
|
These non-receptor protein-tyrosine kinases contain two SH2 domains, five ankyrin (ANK)-like repeats, and a potential tyrosine phosphorylation site in its carboxyl-terminal tail which resembles the phosphorylation site in members of the src family. Like, mammalian non-receptor protein-tyrosine kinases, ZAP-70 and syk proteins, they do not have SH3 domains. However, the presence of ANK makes these unique among protein-tyrosine kinases. Both tyrosine kinases and ANK repeats have been shown to transduce developmental signals, and SH2 domains are known to participate intimately in tyrosine kinase signaling. These tyrosine kinases are believed to be involved in epithelial cell polarity. The members of this family include the shark (SH2 domains, ANK, and kinase domain) gene in Drosophila and yellow fever mosquitos, as well as the hydra protein HTK16. Drosophila Shark is proposed to transduce intracellularly the Crumbs, a protein necessary for proper organization of ectodermal epithelia, intercellular signal. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. Length = 86 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 2e-04
Identities = 16/48 (33%), Positives = 27/48 (56%)
Query: 122 MTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQ 169
++N EV+ + G + P CP +YDIML CW ++P +R + +
Sbjct: 229 LSNTEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIY 276
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|198206 cd10343, SH2_SHIP, Src homology 2 (SH2) domain found in SH2-containing inositol-5'-phosphatase (SHIP) and SLAM-associated protein (SAP) | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 2e-04
Identities = 31/97 (31%), Positives = 45/97 (46%), Gaps = 7/97 (7%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSE-YKRSSFCLK-MTTGRSLF 58
WY G I R +AE+ LL G+FL+RDSES Y+L Y+ + +
Sbjct: 5 WYHGNITRSKAEE-LLSKAGKDGSFLVRDSESVSGAYALCVLYQNCVHTYRILPNAEDKL 63
Query: 59 ETQKAGRTTIHY----PELVEHYSKDADGLCVNLRKP 91
Q + + + PEL+E Y K+ GL +L P
Sbjct: 64 SVQASEGVPVRFFTTLPELIEFYQKENMGLVTHLLYP 100
|
The SH2-containing inositol-5'-phosphatase, SHIP (also called SHIP1/SHIP1a), is a hematopoietic-restricted phosphatidylinositide phosphatase that translocates to the plasma membrane after extracellular stimulation and hydrolyzes the phosphatidylinositol-3-kinase (PI3K)-generated second messenger PI-3,4,5-P3 (PIP3) to PI-3,4-P2. As a result, SHIP dampens down PIP3 mediated signaling and represses the proliferation, differentiation, survival, activation, and migration of hematopoietic cells. PIP3 recruits lipid-binding pleckstrin homology(PH) domain-containing proteins to the inner wall of the plasma membrane and activates them. PH domain-containing downstream effectors include the survival/proliferation enhancing serine/threonine kinase, Akt (protein kinase B), the tyrosine kinase, Btk, the regulator of protein translation, S6K, and the Rac and cdc42 guanine nucleotide exchange factor, Vav. SHIP is believed to act as a tumor suppressor during leukemogenesis and lymphomagenesis, and may play a role in activating the immune system to combat cancer. SHIP contains an N-terminal SH2 domain, a centrally located phosphatase domain that specifically hydrolyzes the 5'-phosphate from PIP3, PI-4,5-P2 and inositol-1,3,4,5- tetrakisphosphate (IP4), a C2 domain, that is an allosteric activating site when bound by SHIP's enzymatic product, PI-3,4-P2; 2 NPXY motifs that bind proteins with a phosphotyrosine binding (Shc, Dok 1, Dok 2) or an SH2 (p85a, SHIP2) domain; and a proline-rich domain consisting of four PxxP motifs that bind a subset of SH3-containing proteins including Grb2, Src, Lyn, Hck, Abl, PLCg1, and PIAS1. The SH2 domain of SHIP binds to the tyrosine phosphorylated forms of Shc, SHP-2, Doks, Gabs, CD150, platelet-endothelial cell adhesion molecule, Cas, c-Cbl, immunoreceptor tyrosine-based inhibitory motifs (ITIMs), and immunoreceptor tyrosine-based activation motifs (ITAMs). The X-linked lymphoproliferative syndrome (XLP) gene encodes SAP (also called SH2D1A/DSHP) a protein that consists of a 5 residue N-terminus, a single SH2 domain, and a short 25 residue C-terminal tail. XLP is characterized by an extreme sensitivity to Epstein-Barr virus. Both T and natural killer (NK) cell dysfunctions have been seen in XLP patients. SAP binds the cytoplasmic tail of Signaling lymphocytic activation molecule (SLAM), 2B4, Ly-9, and CD84. SAP is believed to function as a signaling inhibitor, by blocking or regulating binding of other signaling proteins. SAP and the SAP-like protein EAT-2 recognize the sequence motif TIpYXX(V/I), which is found in the cytoplasmic domains of a restricted number of T, B, and NK cell surface receptors and are proposed to be natural inhibitors or regulators of the physiological role of a small family of receptors on the surface of these cells. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. Length = 103 |
| >gnl|CDD|198250 cd10387, SH2_SOCS6, Src homology 2 (SH2) domain found in suppressor of cytokine signaling (SOCS) proteins | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 2e-04
Identities = 20/41 (48%), Positives = 26/41 (63%), Gaps = 4/41 (9%)
Query: 1 WYFGKIKRIEAEKKLL-LPENDHGAFLIRDSESRKNDYSLS 40
WY+G I R EAE KL +P+ G+FL+RDS + SLS
Sbjct: 12 WYWGPITRWEAEGKLANVPD---GSFLVRDSSDDRYLLSLS 49
|
SH2 domain found in SOCS proteins. SOCS was first recognized as a group of cytokine-inducible SH2 (CIS) domain proteins comprising eight family members in human (CIS and SOCS1-SOCS7). In addition to the SH2 domain, SOCS proteins have a variable N-terminal domain and a conserved SOCS box in the C-terminal domain. SOCS proteins bind to a substrate via their SH2 domain. The prototypical members, CIS and SOCS1-SOCS3, have been shown to regulate growth hormone signaling in vitro and in a classic negative feedback response compete for binding at phosphotyrosine sites in JAK kinase and receptor pathways to displace effector proteins and target bound receptors for proteasomal degradation. Loss of SOCS activity results in excessive cytokine signaling associated with a variety of hematopoietic, autoimmune, and inflammatory diseases and certain cancers. Members (SOCS4-SOCS7) were identified by their conserved SOCS box, an adapter motif of 3 helices that associates substrate binding domains, such as the SOCS SH2 domain, ankryin, and WD40 with ubiquitin ligase components. These show limited cytokine induction. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. Length = 100 |
| >gnl|CDD|198195 cd09942, SH2_nSH2_p85_like, N-terminal Src homology 2 (nSH2) domain found in p85 | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 3e-04
Identities = 16/40 (40%), Positives = 25/40 (62%), Gaps = 2/40 (5%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS 40
WY+G I R E +K+ + G FL+RD+ + K DY+L+
Sbjct: 9 WYWGDISREEVNEKMRDTPD--GTFLVRDASTMKGDYTLT 46
|
Phosphoinositide 3-kinases (PI3Ks) are essential for cell growth, migration, and survival. p110, the catalytic subunit, is composed of an adaptor-binding domain, a Ras-binding domain, a C2 domain, a helical domain, and a kinase domain. The regulatory unit is called p85 and is composed of an SH3 domain, a RhoGap domain, a N-terminal SH2 (nSH2) domain, an internal SH2 (iSH2) domain, and C-terminal (cSH2) domain. There are 2 inhibitory interactions between p110alpha and p85 of P13K: (1) p85 nSH2 domain with the C2, helical, and kinase domains of p110alpha and (2) p85 iSH2 domain with C2 domain of p110alpha. There are 3 inhibitory interactions between p110beta and p85 of P13K: (1) p85 nSH2 domain with the C2, helical, and kinase domains of p110beta, (2) p85 iSH2 domain with C2 domain of p110alpha, and (3) p85 cSH2 domain with the kinase domain of p110alpha. It is interesting to note that p110beta is oncogenic as a wild type protein while p110alpha lacks this ability. One explanation is the idea that the regulation of p110beta by p85 is unique because of the addition of inhibitory contacts from the cSH2 domain and the loss of contacts in the iSH2 domain. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. Length = 110 |
| >gnl|CDD|198251 cd10388, SH2_SOCS7, Src homology 2 (SH2) domain found in suppressor of cytokine signaling (SOCS) proteins | Back alignment and domain information |
|---|
Score = 38.1 bits (89), Expect = 3e-04
Identities = 19/61 (31%), Positives = 29/61 (47%), Gaps = 14/61 (22%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS------------EYKRSSFC 48
WY+G + +AEK L + G+FL+RDS + +SLS E + +F
Sbjct: 12 WYWGPMSWEDAEKVLSNKPD--GSFLVRDSSDDRYIFSLSFRSQGSVHHTRIEQYQGTFS 69
Query: 49 L 49
L
Sbjct: 70 L 70
|
SH2 domain found in SOCS proteins. SOCS was first recognized as a group of cytokine-inducible SH2 (CIS) domain proteins comprising eight family members in human (CIS and SOCS1-SOCS7). In addition to the SH2 domain, SOCS proteins have a variable N-terminal domain and a conserved SOCS box in the C-terminal domain. SOCS proteins bind to a substrate via their SH2 domain. The prototypical members, CIS and SOCS1-SOCS3, have been shown to regulate growth hormone signaling in vitro and in a classic negative feedback response compete for binding at phosphotyrosine sites in JAK kinase and receptor pathways to displace effector proteins and target bound receptors for proteasomal degradation. Loss of SOCS activity results in excessive cytokine signaling associated with a variety of hematopoietic, autoimmune, and inflammatory diseases and certain cancers. Members (SOCS4-SOCS7) were identified by their conserved SOCS box, an adapter motif of 3 helices that associates substrate binding domains, such as the SOCS SH2 domain, ankryin, and WD40 with ubiquitin ligase components. These show limited cytokine induction. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. Length = 101 |
| >gnl|CDD|198275 cd10412, SH2_SH2B3, Src homology 2 (SH2) domain found in SH2B adapter proteins (SH2B1, SH2B2, SH2B3) | Back alignment and domain information |
|---|
Score = 38.0 bits (88), Expect = 4e-04
Identities = 17/41 (41%), Positives = 27/41 (65%), Gaps = 1/41 (2%)
Query: 1 WYFGKIKRIEAEKKLLLPEND-HGAFLIRDSESRKNDYSLS 40
W+ G I R++A + + L D HG FL+R SE+R+ +Y L+
Sbjct: 10 WFHGPISRVKAAQLVQLQGPDAHGVFLVRQSETRRGEYVLT 50
|
SH2B3 (Lnk), like other members of the SH2B adapter protein family, contains a pleckstrin homology domain, at least one dimerization domain, and a C-terminal SH2 domain which binds to phosphorylated tyrosines in a variety of tyrosine kinases. SH2B3 negatively regulates lymphopoiesis and early hematopoiesis. The lnk-deficiency results in enhanced production of B cells, and expansion as well as enhanced function of hematopoietic stem cells (HSCs), demonstrating negative regulatory functions of Sh2b3/Lnk in cytokine signaling. Sh2b3/Lnk also functions in responses controlled by cell adhesion and in crosstalk between integrin- and cytokine-mediated signaling. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. Length = 97 |
| >gnl|CDD|198259 cd10396, SH2_Tec_Itk, Src homology 2 (SH2) domain found in Tec protein, IL2-inducible T-cell kinase (Itk) | Back alignment and domain information |
|---|
Score = 37.8 bits (88), Expect = 5e-04
Identities = 32/102 (31%), Positives = 52/102 (50%), Gaps = 15/102 (14%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRS----SFCLK------ 50
WY I R +AEK LL E G F++RDS S+ Y++S Y ++ + C++
Sbjct: 8 WYNKNINRSKAEK-LLRDEGKEGGFMVRDS-SQPGLYTVSLYTKAGGEGNPCIRHYHIKE 65
Query: 51 -MTTGRSLFETQKAGRTTIHYPELVEHYSKDADGLCVNLRKP 91
+ + + +K +I PEL+E++ +A GL LR P
Sbjct: 66 TNDSPKKYYLAEKHVFNSI--PELIEYHKHNAAGLVTRLRYP 105
|
A member of the Tec protein tyrosine kinase Itk is expressed thymus, spleen, lymph node, T lymphocytes, NK and mast cells. It plays a role in T-cell proliferation and differentiation, analogous to Tec family kinases Txk. Itk has been shown to interact with Fyn, Wiskott-Aldrich syndrome protein, KHDRBS1, PLCG1, Lymphocyte cytosolic protein 2, Linker of activated T cells, Karyopherin alpha 2, Grb2, and Peptidylprolyl isomerase A. Most of the Tec family members have a PH domain (Txk and the short (type 1) splice variant of Drosophila Btk29A are exceptions), a Tec homology (TH) domain, a SH3 domain, a SH2 domain, and a protein kinase catalytic domain. The TH domain consists of a Zn2+-binding Btk motif and a proline-rich region. The Btk motif is found in Tec kinases, Ras GAP, and IGBP. It is crucial for the function of Tec PH domains and it's lack of presence in Txk is not surprising since it lacks a PH domain. The type 1 splice form of the Drosophila homolog also lacks both the PH domain and the Btk motif. The proline-rich regions are highly conserved for the most part with the exception of Bmx whose residues surrounding the PXXP motif are not conserved (TH-like) and Btk29A which is entirely unique with large numbers of glycine residues (TH-extended). Tec family members all lack a C-terminal tyrosine having an autoinhibitory function in its phosphorylated state. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. Length = 108 |
| >gnl|CDD|198178 cd09923, SH2_SOCS_family, Src homology 2 (SH2) domain found in suppressor of cytokine signaling (SOCS) family | Back alignment and domain information |
|---|
Score = 36.4 bits (85), Expect = 8e-04
Identities = 26/91 (28%), Positives = 35/91 (38%), Gaps = 24/91 (26%)
Query: 1 WYFGKIKRIEAEKKLLLPENDH-GAFLIRDSESRKNDYSLS------------EYKRSSF 47
WY+G I R EAE+ L G FL+RDS + +S+S EY F
Sbjct: 2 WYWGGITRYEAEELL---AGKPEGTFLVRDSSDSRYLFSVSFRTYGRTLHARIEYSNGRF 58
Query: 48 CLKMTTGRSLFETQKAGRTTIHYPELVEHYS 78
S + + EL+EHY
Sbjct: 59 --------SFDSSDPSVPRFPCVVELIEHYV 81
|
SH2 domain found in SOCS proteins. SOCS was first recognized as a group of cytokine-inducible SH2 (CIS) domain proteins comprising eight family members in human (CIS and SOCS1-SOCS7). In addition to the SH2 domain, SOCS proteins have a variable N-terminal domain and a conserved SOCS box in the C-terminal domain. SOCS proteins bind to a substrate via their SH2 domain. The prototypical members, CIS and SOCS1-SOCS3, have been shown to regulate growth hormone signaling in vitro and in a classic negative feedback response compete for binding at phosphotyrosine sites in JAK kinase and receptor pathways to displace effector proteins and target bound receptors for proteasomal degradation. Loss of SOCS activity results in excessive cytokine signaling associated with a variety of hematopoietic, autoimmune, and inflammatory diseases and certain cancers. Members (SOCS4-SOCS7) were identified by their conserved SOCS box, an adapter motif of 3 helices that associates substrate binding domains, such as the SOCS SH2 domain, ankryin, and WD40 with ubiquitin ligase components. These show limited cytokine induction. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. Length = 81 |
| >gnl|CDD|198200 cd10337, SH2_BCAR3, Src homology 2 (SH2) domain in the Breast Cancer Anti-estrogen Resistance protein 3 | Back alignment and domain information |
|---|
Score = 37.3 bits (87), Expect = 0.001
Identities = 18/40 (45%), Positives = 22/40 (55%), Gaps = 4/40 (10%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS 40
WY G+I R AE L+ G FL+RDS S DY L+
Sbjct: 8 WYHGRIPRQVAES--LVQRE--GDFLVRDSLSSPGDYVLT 43
|
BCAR3 is part of a growing family of guanine nucleotide exchange factors is responsible for activation of Ras-family GTPases, including Sos1 and 2, GRF1 and 2, CalDAG-GEF/GRP1-4, C3G, cAMP-GEF/Epac 1 and 2, PDZ-GEFs, MR-GEF, RalGDS family members, RalGPS, RasGEF, Smg GDS, and phospholipase C(epsilon). 12102558 21262352 BCAR3 binds to the carboxy-terminus of BCAR1/p130Cas, a focal adhesion adapter protein. Over expression of BCAR1 (p130Cas) and BCAR3 induces estrogen independent growth in normally estrogen-dependent cell lines. They have been linked to resistance to anti-estrogens in breast cancer, Rac activation, and cell motility, though the BCAR3/p130Cas complex is not required for this activity in BCAR3. Many BCAR3-mediated signaling events in epithelial and mesenchymal cells are independent of p130Cas association. Structurally these proteins contain a single SH2 domain upstream of their RasGEF domain, which is responsible for the ability of BCAR3 to enhance p130Cas over-expression-induced migration. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. Length = 136 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.001
Identities = 16/54 (29%), Positives = 29/54 (53%)
Query: 122 MTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDF 175
++N EV+ + G + P CP +YD+ML CW ++P R + + L++
Sbjct: 226 LSNNEVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|198252 cd10389, SH2_SHB, Src homology 2 domain found in SH2 domain-containing adapter protein B (SHB) | Back alignment and domain information |
|---|
Score = 36.6 bits (84), Expect = 0.001
Identities = 23/79 (29%), Positives = 41/79 (51%), Gaps = 3/79 (3%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFC-LKMTTGRSLFE 59
WY G I R +AE L L + ++L+R+S++ K+DYSLS F +K+ + +
Sbjct: 3 WYHGAISRGDAENLLRLCK--ECSYLVRNSQTSKHDYSLSLKSNQGFMHMKLAKTKEKYV 60
Query: 60 TQKAGRTTIHYPELVEHYS 78
+ PE++ +Y+
Sbjct: 61 LGQNSPPFDSVPEVIHYYT 79
|
SHB functions in generating signaling compounds in response to tyrosine kinase activation. SHB contains proline-rich motifs, a phosphotyrosine binding (PTB) domain, tyrosine phosphorylation sites, and a SH2 domain. SHB mediates certain aspects of platelet-derived growth factor (PDGF) receptor-, fibroblast growth factor (FGF) receptor-, neural growth factor (NGF) receptor TRKA-, T cell receptor-, interleukin-2 (IL-2) receptor- and focal adhesion kinase- (FAK) signaling. SRC-like FYN-Related Kinase FRK/RAK (also named BSK/IYK or GTK) and SHB regulate apoptosis, proliferation and differentiation. SHB promotes apoptosis and is also required for proper mitogenicity, spreading and tubular morphogenesis in endothelial cells. SHB also plays a role in preventing early cavitation of embryoid bodies and reduces differentiation to cells expressing albumin, amylase, insulin and glucagon. SHB is a multifunctional protein that has difference responses in different cells under various conditions. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. Length = 97 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.001
Identities = 17/54 (31%), Positives = 26/54 (48%)
Query: 124 NAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFT 177
N + + ++ GYRM P +Y+IM +CW + RP F L + D T
Sbjct: 348 NEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLLT 401
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|198209 cd10346, SH2_SH2B_family, Src homology 2 (SH2) domain found in SH2B adapter protein family | Back alignment and domain information |
|---|
Score = 36.2 bits (84), Expect = 0.001
Identities = 15/41 (36%), Positives = 26/41 (63%), Gaps = 1/41 (2%)
Query: 1 WYFGKIKRIEAEKKLLLPEND-HGAFLIRDSESRKNDYSLS 40
W+ G + R +A + +L D HG FL+R SE+R+ ++ L+
Sbjct: 10 WFHGTLSRSDAAQLVLHSGADGHGVFLVRQSETRRGEFVLT 50
|
The SH2B adapter protein family has 3 members: SH2B1 (SH2-B, PSM), SH2B2 (APS), and SH2B3 (Lnk). SH2B family members contain a pleckstrin homology domain, at least one dimerization domain, and a C-terminal SH2 domain which binds to phosphorylated tyrosines in a variety of tyrosine kinases. SH2B1 and SH2B2 function in signaling pathways found downstream of growth hormone receptor and receptor tyrosine kinases, including the insulin, insulin-like growth factor-I (IGF-I), platelet-derived growth factor (PDGF), nerve growth factor, hepatocyte growth factor, and fibroblast growth factor receptors. SH2B2beta, a new isoform of SH2B2, is an endogenous inhibitor of SH2B1 and/or SH2B2 (SH2B2alpha), negatively regulating insulin signaling and/or JAK2-mediated cellular responses. SH2B3 negatively regulates lymphopoiesis and early hematopoiesis. The lnk-deficiency results in enhanced production of B cells, and expansion as well as enhanced function of hematopoietic stem cells (HSCs), demonstrating negative regulatory functions of Sh2b3/Lnk in cytokine signaling. Sh2b3/Lnk also functions in responses controlled by cell adhesion and in crosstalk between integrin- and cytokine-mediated signaling. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. Length = 97 |
| >gnl|CDD|198215 cd10352, SH2_a2chimerin_b2chimerin, Src homology 2 (SH2) domain found in alpha2-chimerin and beta2-chimerin proteins | Back alignment and domain information |
|---|
Score = 35.8 bits (83), Expect = 0.002
Identities = 17/39 (43%), Positives = 22/39 (56%), Gaps = 2/39 (5%)
Query: 2 YFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS 40
Y G I R EAE+ LL G++LIR+S Y+LS
Sbjct: 9 YHGLISREEAEQ--LLSGASDGSYLIRESSRDDGYYTLS 45
|
Chimerins are a family of phorbol ester- and diacylglycerol-responsive GTPase-activating proteins. Alpha1-chimerin (formerly known as n-chimerin) and alpha2-chimerin are alternatively spliced products of a single gene, as are beta1- and beta2-chimerin. alpha1- and beta1-chimerin have a relatively short N-terminal region that does not encode any recognizable domains, whereas alpha2- and beta2-chimerin both include a functional SH2 domain that can bind to phosphotyrosine motifs within receptors. All of the isoforms contain a GAP domain with specificity in vitro for Rac1 and a diacylglycerol (DAG)-binding C1 domain which allows them to translocate to membranes in response to DAG signaling and anchors them in close proximity to activated Rac. Other C1 domain-containing diacylglycerol receptors including: PKC, Munc-13 proteins, phorbol ester binding scaffolding proteins involved in Ca2+-stimulated exocytosis, and RasGRPs, diacylglycerol-activated guanine-nucleotide exchange factors (GEFs) for Ras and Rap1. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. Length = 91 |
| >gnl|CDD|198186 cd09932, SH2_C-SH2_PLC_gamma_like, C-terminal Src homology 2 (C-SH2) domain in Phospholipase C gamma | Back alignment and domain information |
|---|
Score = 35.3 bits (82), Expect = 0.003
Identities = 15/41 (36%), Positives = 26/41 (63%), Gaps = 3/41 (7%)
Query: 1 WYFGKIKRIEAEKKL-LLPENDHGAFLIRDSESRKNDYSLS 40
W+ + R +AE+ L +P + GAFL+R SE+ N +++S
Sbjct: 6 WFHANLTREQAEEMLMRVPRD--GAFLVRPSETDPNSFAIS 44
|
Phospholipase C gamma is a signaling molecule that is recruited to the C-terminal tail of the receptor upon autophosphorylation of a highly conserved tyrosine. PLCgamma is composed of a Pleckstrin homology (PH) domain followed by an elongation factor (EF) domain, 2 catalytic regions of PLC domains that flank 2 tandem SH2 domains (N-SH2, C-SH2), and ending with a SH3 domain and C2 domain. N-SH2 SH2 domain-mediated interactions represent a crucial step in transmembrane signaling by receptor tyrosine kinases. SH2 domains recognize phosphotyrosine (pY) in the context of particular sequence motifs in receptor phosphorylation sites. Both N-SH2 and C-SH2 have a very similar binding affinity to pY. But in growth factor stimulated cells these domains bind to different target proteins. N-SH2 binds to pY containing sites in the C-terminal tails of tyrosine kinases and other receptors. Recently it has been shown that this interaction is mediated by phosphorylation-independent interactions between a secondary binding site found exclusively on the N-SH2 domain and a region of the FGFR1 tyrosine kinase domain. This secondary site on the SH2 cooperates with the canonical pY site to regulate selectivity in mediating a specific cellular process. C-SH2 binds to an intramolecular site on PLCgamma itself which allows it to hydrolyze phosphatidylinositol-4,5-bisphosphate into diacylglycerol and inositol triphosphate. These then activate protein kinase C and release calcium. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. Length = 104 |
| >gnl|CDD|198253 cd10390, SH2_SHD, Src homology 2 domain found in SH2 domain-containing adapter proteins D (SHD) | Back alignment and domain information |
|---|
Score = 35.4 bits (81), Expect = 0.003
Identities = 28/81 (34%), Positives = 41/81 (50%), Gaps = 6/81 (7%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET 60
W+ G + R +AE L L + G++L+R SE+R D SLS F L + R+
Sbjct: 3 WFHGPLSRADAENLLSLCK--EGSYLVRLSETRPQDCSLSLRSSQGF-LHLKFARTRENQ 59
Query: 61 QKAGRTTIHY---PELVEHYS 78
G+ + + PELV HYS
Sbjct: 60 VVLGQHSGPFPSVPELVLHYS 80
|
The expression of SHD is restricted to the brain. SHD may be a physiological substrate of c-Abl and may function as an adapter protein in the central nervous system. It is also thought to be involved in apoptotic regulation. SHD contains five YXXP motifs, a substrate sequence preferred by Abl tyrosine kinases, in addition to a poly-proline rich region and a C-terminal SH2 domain. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. Length = 98 |
| >gnl|CDD|198273 cd10410, SH2_SH2B1, Src homology 2 (SH2) domain found in SH2B adapter proteins (SH2B1, SH2B2, SH2B3) | Back alignment and domain information |
|---|
Score = 35.0 bits (80), Expect = 0.004
Identities = 15/41 (36%), Positives = 26/41 (63%), Gaps = 1/41 (2%)
Query: 1 WYFGKIKRIEAEKKLLLP-ENDHGAFLIRDSESRKNDYSLS 40
W+ G + R++A + +L HG FL+R SE+R+ +Y L+
Sbjct: 10 WFHGMLSRLKAAQLVLEGGTGSHGVFLVRQSETRRGEYVLT 50
|
SH2B1 (SH2-B, PSM), like other members of the SH2B adapter protein family, contains a pleckstrin homology domain, at least one dimerization domain, and a C-terminal SH2 domain which binds to phosphorylated tyrosines in a variety of tyrosine kinases. SH2B1 and SH2B2 function in signaling pathways found downstream of growth hormone receptor and receptor tyrosine kinases, including the insulin, insulin-like growth factor-I (IGF-I), platelet-derived growth factor (PDGF), nerve growth factor, hepatocyte growth factor, and fibroblast growth factor receptors. SH2B2beta, a new isoform of SH2B2, is an endogenous inhibitor of SH2B1 and/or SH2B2 (SH2B2alpha), negatively regulating insulin signaling and/or JAK2-mediated cellular responses. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. Length = 97 |
| >gnl|CDD|199830 cd10349, SH2_SH2D2A_SH2D7, Src homology 2 domain found in the SH2 domain containing protein 2A and 7 (SH2D2A and SH2D7) | Back alignment and domain information |
|---|
Score = 34.4 bits (79), Expect = 0.004
Identities = 23/82 (28%), Positives = 38/82 (46%), Gaps = 11/82 (13%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCL-----KMTTGR 55
W+ G I R EAE+ LL G +L+R SE + LS Y+ + C ++ GR
Sbjct: 2 WFHGFITRREAER--LLEPKPQGCYLVRFSE-SAVTFVLS-YRSRTCCRHFLLAQLRDGR 57
Query: 56 SLFETQKAGRTTIHYPELVEHY 77
+ + + + +L+ HY
Sbjct: 58 HVVLGEDSAHARLQ--DLLLHY 77
|
SH2D2A and SH7 both contain a single SH2 domain. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. Length = 77 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 189 | |||
| KOG4278|consensus | 1157 | 100.0 | ||
| KOG0197|consensus | 468 | 100.0 | ||
| KOG1026|consensus | 774 | 99.97 | ||
| KOG1095|consensus | 1025 | 99.95 | ||
| KOG0196|consensus | 996 | 99.95 | ||
| KOG0194|consensus | 474 | 99.94 | ||
| KOG4257|consensus | 974 | 99.94 | ||
| KOG0192|consensus | 362 | 99.93 | ||
| KOG0200|consensus | 609 | 99.92 | ||
| KOG4721|consensus | 904 | 99.9 | ||
| KOG0199|consensus | 1039 | 99.88 | ||
| KOG1025|consensus | 1177 | 99.87 | ||
| KOG0193|consensus | 678 | 99.86 | ||
| KOG1094|consensus | 807 | 99.84 | ||
| KOG1024|consensus | 563 | 99.84 | ||
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.79 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.78 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.77 | |
| KOG0581|consensus | 364 | 99.73 | ||
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.72 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.7 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.7 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.7 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.69 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.68 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.68 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.68 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.68 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.68 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.67 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.67 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.67 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.67 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.66 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.66 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.66 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.66 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.65 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.65 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.65 | |
| KOG0578|consensus | 550 | 99.65 | ||
| cd00173 | 94 | SH2 Src homology 2 domains; Signal transduction, i | 99.65 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.64 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.64 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.64 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.64 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.64 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.64 | |
| PF00017 | 77 | SH2: SH2 domain; InterPro: IPR000980 The Src homol | 99.64 | |
| KOG0661|consensus | 538 | 99.64 | ||
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.63 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.63 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.63 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.63 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.62 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.62 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.62 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.62 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.62 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.62 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.62 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.62 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.62 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.62 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.62 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.62 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.62 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.62 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.62 | |
| KOG0575|consensus | 592 | 99.62 | ||
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.61 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.61 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.61 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.6 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.6 | |
| smart00252 | 84 | SH2 Src homology 2 domains. Src homology 2 domains | 99.6 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.6 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.59 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.59 | |
| KOG0588|consensus | 786 | 99.59 | ||
| KOG0198|consensus | 313 | 99.59 | ||
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.59 | |
| KOG1187|consensus | 361 | 99.58 | ||
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.58 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.58 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.58 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.58 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.58 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.58 | |
| KOG4279|consensus | 1226 | 99.57 | ||
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.57 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.57 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.57 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.57 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.57 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.56 | |
| KOG0591|consensus | 375 | 99.56 | ||
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.56 | |
| KOG0584|consensus | 632 | 99.55 | ||
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.55 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.55 | |
| KOG0195|consensus | 448 | 99.55 | ||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.55 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.54 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.54 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.54 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.54 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.54 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.53 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.53 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.53 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.52 | |
| KOG0582|consensus | 516 | 99.52 | ||
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.52 | |
| KOG0579|consensus | 1187 | 99.52 | ||
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.52 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.52 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.51 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.51 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.51 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.51 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.51 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.51 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.5 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.5 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.5 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.5 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.49 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.49 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.49 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.49 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.48 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.48 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.48 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.48 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.48 | |
| KOG0589|consensus | 426 | 99.47 | ||
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.47 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.47 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.47 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.46 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.46 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.46 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.45 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.45 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.45 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.44 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.44 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.44 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.44 | |
| KOG0593|consensus | 396 | 99.43 | ||
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.43 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.43 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.43 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.43 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.43 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.42 | |
| KOG0615|consensus | 475 | 99.42 | ||
| KOG0580|consensus | 281 | 99.42 | ||
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.41 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.41 | |
| KOG0583|consensus | 370 | 99.41 | ||
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.41 | |
| KOG0577|consensus | 948 | 99.41 | ||
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.41 | |
| KOG0201|consensus | 467 | 99.4 | ||
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.4 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.4 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.4 | |
| KOG0033|consensus | 355 | 99.4 | ||
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.4 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.39 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.39 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.39 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.39 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.39 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.39 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.38 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.38 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.38 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.38 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.38 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.38 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.38 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.37 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.37 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.37 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.37 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.37 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.37 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.37 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.37 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.36 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.36 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.35 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.35 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.35 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.35 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.35 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.35 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.34 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.34 | |
| KOG2052|consensus | 513 | 99.34 | ||
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.34 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.34 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.34 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.34 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.34 | |
| KOG0595|consensus | 429 | 99.33 | ||
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.33 | |
| KOG4645|consensus | 1509 | 99.33 | ||
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.33 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.32 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.32 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.32 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.32 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.32 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.32 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.31 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.31 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.31 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.3 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.3 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.3 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.3 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.29 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.29 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.29 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.29 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.29 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.29 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.28 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.28 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.27 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.27 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.27 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.27 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.27 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.26 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.26 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.26 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.26 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.25 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.25 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.25 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.25 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.24 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.24 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.24 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.24 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.24 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.24 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.23 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.23 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.23 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.23 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.22 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.21 | |
| KOG0790|consensus | 600 | 99.21 | ||
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.21 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.21 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.21 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.21 | |
| KOG2345|consensus | 302 | 99.21 | ||
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.2 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.2 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.2 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.2 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.2 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.2 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.19 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.19 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.19 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.19 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.19 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.19 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.19 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.18 | |
| KOG0592|consensus | 604 | 99.18 | ||
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.18 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.18 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.17 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.17 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.16 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.16 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.16 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.16 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.16 | |
| KOG1989|consensus | 738 | 99.16 | ||
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.16 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.15 | |
| KOG4717|consensus | 864 | 99.15 | ||
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.15 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.15 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.15 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.14 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.14 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.13 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.13 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.13 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.12 | |
| KOG4226|consensus | 379 | 99.12 | ||
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.12 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.11 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.11 | |
| KOG4637|consensus | 464 | 99.11 | ||
| KOG0659|consensus | 318 | 99.11 | ||
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.11 | |
| KOG0576|consensus | 829 | 99.11 | ||
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.11 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.11 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.1 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.1 | |
| KOG0599|consensus | 411 | 99.1 | ||
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.1 | |
| KOG4792|consensus | 293 | 99.1 | ||
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.09 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.09 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.09 | |
| KOG0598|consensus | 357 | 99.09 | ||
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.09 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.09 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.08 | |
| KOG0585|consensus | 576 | 99.07 | ||
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.07 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.07 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.06 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.06 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.06 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.05 | |
| KOG0603|consensus | 612 | 99.05 | ||
| KOG0574|consensus | 502 | 99.05 | ||
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.05 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.04 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.04 | |
| KOG4637|consensus | 464 | 99.04 | ||
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.04 | |
| KOG1264|consensus | 1267 | 99.02 | ||
| KOG1023|consensus | 484 | 99.02 | ||
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.02 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.01 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.01 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 98.99 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 98.99 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 98.99 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 98.99 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 98.99 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 98.98 | |
| KOG0600|consensus | 560 | 98.97 | ||
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 98.95 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 98.95 | |
| KOG0694|consensus | 694 | 98.95 | ||
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 98.93 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 98.93 | |
| KOG3653|consensus | 534 | 98.92 | ||
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 98.92 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 98.91 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 98.91 | |
| KOG0586|consensus | 596 | 98.91 | ||
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 98.89 | |
| KOG0611|consensus | 668 | 98.89 | ||
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 98.88 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 98.87 | |
| KOG0587|consensus | 953 | 98.87 | ||
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 98.86 | |
| KOG0032|consensus | 382 | 98.85 | ||
| KOG0596|consensus | 677 | 98.83 | ||
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 98.81 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 98.79 | |
| KOG0658|consensus | 364 | 98.78 | ||
| KOG0197|consensus | 468 | 98.78 | ||
| KOG2996|consensus | 865 | 98.78 | ||
| KOG0607|consensus | 463 | 98.76 | ||
| KOG0597|consensus | 808 | 98.75 | ||
| PTZ00284 | 467 | protein kinase; Provisional | 98.74 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 98.71 | |
| KOG0983|consensus | 391 | 98.69 | ||
| KOG0616|consensus | 355 | 98.69 | ||
| KOG1264|consensus | 1267 | 98.68 | ||
| KOG0594|consensus | 323 | 98.65 | ||
| KOG1006|consensus | 361 | 98.62 | ||
| KOG1035|consensus | 1351 | 98.59 | ||
| KOG0663|consensus | 419 | 98.59 | ||
| KOG1930|consensus | 483 | 98.57 | ||
| KOG0660|consensus | 359 | 98.57 | ||
| KOG4250|consensus | 732 | 98.54 | ||
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 98.51 | |
| KOG0194|consensus | 474 | 98.47 | ||
| KOG0604|consensus | 400 | 98.44 | ||
| KOG0605|consensus | 550 | 98.42 | ||
| KOG0790|consensus | 600 | 98.31 | ||
| KOG1027|consensus | 903 | 98.3 | ||
| KOG3601|consensus | 222 | 98.28 | ||
| KOG4278|consensus | 1157 | 98.26 | ||
| KOG0610|consensus | 459 | 98.18 | ||
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 98.11 | |
| KOG0667|consensus | 586 | 98.1 | ||
| KOG0671|consensus | 415 | 98.07 | ||
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 98.07 | |
| KOG1151|consensus | 775 | 98.01 | ||
| KOG0669|consensus | 376 | 98.0 | ||
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 97.98 | |
| KOG0696|consensus | 683 | 97.97 | ||
| KOG0614|consensus | 732 | 97.85 | ||
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 97.77 | |
| KOG0666|consensus | 438 | 97.58 | ||
| KOG0986|consensus | 591 | 97.55 | ||
| KOG1167|consensus | 418 | 97.45 | ||
| KOG0690|consensus | 516 | 97.28 | ||
| KOG0662|consensus | 292 | 97.16 | ||
| KOG0590|consensus | 601 | 97.09 | ||
| KOG3751|consensus | 622 | 97.03 | ||
| KOG0668|consensus | 338 | 96.94 | ||
| KOG0612|consensus | 1317 | 96.92 | ||
| KOG0665|consensus | 369 | 96.9 | ||
| KOG0664|consensus | 449 | 96.9 | ||
| KOG1152|consensus | 772 | 96.84 | ||
| PF14633 | 220 | SH2_2: SH2 domain; PDB: 3GXX_A 3GXW_B 3PJP_B 2XP1_ | 96.73 | |
| KOG0695|consensus | 593 | 96.62 | ||
| KOG4236|consensus | 888 | 96.44 | ||
| KOG4158|consensus | 598 | 96.12 | ||
| KOG0670|consensus | 752 | 95.94 | ||
| KOG0984|consensus | 282 | 95.63 | ||
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 95.45 | |
| KOG3697|consensus | 345 | 94.61 | ||
| KOG1345|consensus | 378 | 94.54 | ||
| KOG1266|consensus | 458 | 94.27 | ||
| KOG1240|consensus | 1431 | 93.88 | ||
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 93.7 | |
| KOG1290|consensus | 590 | 93.05 | ||
| KOG0606|consensus | 1205 | 90.2 | ||
| KOG1033|consensus | 516 | 89.87 | ||
| KOG1164|consensus | 322 | 88.56 | ||
| KOG0608|consensus | 1034 | 87.48 | ||
| KOG4566|consensus | 258 | 82.84 | ||
| KOG1163|consensus | 341 | 82.56 |
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=237.93 Aligned_cols=175 Identities=30% Similarity=0.502 Sum_probs=161.6
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC--ccCCCCCcC-HhHHHHHh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET--QKAGRTTIH-YPELVEHY 77 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g--yl~~~~~~~-l~~li~~~ 77 (189)
||||+++|..++.+|+.-. .|.|||||+.+.+|.|++|+++ .+.|.||+|.....| |+.....|. +.+|+.|+
T Consensus 154 WYHGpvSRsaaEy~LsSgI--nGSFLVRESEsSpgQ~sISlRy--eGRVyHYRINt~~dgK~yvt~EsrF~TLaELVHHH 229 (1157)
T KOG4278|consen 154 WYHGPVSRSAAEYILSSGI--NGSFLVRESESSPGQYSISLRY--EGRVYHYRINTDNDGKMYVTQESRFRTLAELVHHH 229 (1157)
T ss_pred cccCccccchhhhhhhcCc--ccceEEeeccCCCcceeEEEEe--cceEEEEEeeccCCccEEEeehhhhhHHHHHHhhc
Confidence 9999999999999997654 4999999999999999999999 999999999999888 999999999 99999999
Q ss_pred hhccCCceeeccCCcccccccc--cccccC--------------------------------------------------
Q psy1684 78 SKDADGLCVNLRKPCVQVSCRI--YLVHGT-------------------------------------------------- 105 (189)
Q Consensus 78 ~~~a~gl~~~~~~~~~~~~~p~--~l~~~~-------------------------------------------------- 105 (189)
..+|+||.+.+..|..+++.|. ++++..
T Consensus 230 StvADGLittLhYPApK~nKptvygvSPn~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveE 309 (1157)
T KOG4278|consen 230 STVADGLITTLHYPAPKKNKPTVYGVSPNADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE 309 (1157)
T ss_pred cccccceeEeeeccCccCCCCceeeecCCcchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHH
Confidence 9999999999999988888776 343322
Q ss_pred --------------------------------------------------------------------------------
Q psy1684 106 -------------------------------------------------------------------------------- 105 (189)
Q Consensus 106 -------------------------------------------------------------------------------- 105 (189)
T Consensus 310 FLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHR 389 (1157)
T KOG4278|consen 310 FLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHR 389 (1157)
T ss_pred HHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhh
Confidence
Q ss_pred -------------------------------------------------CCCCccc-e-EEEec-------------CCC
Q psy1684 106 -------------------------------------------------NLSGVVV-S-AVDFG-------------SGG 121 (189)
Q Consensus 106 -------------------------------------------------~~~~~~~-s-VwsfG-------------~~~ 121 (189)
..+.|+. | ||+|| |+|
T Consensus 390 DLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG 469 (1157)
T KOG4278|consen 390 DLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG 469 (1157)
T ss_pred hhhhhhccccccceEEeeccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC
Confidence 5678899 9 99999 999
Q ss_pred CChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q psy1684 122 MTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTME 179 (189)
Q Consensus 122 ~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~ 179 (189)
++..+|+..+.+|+||..|..||+.+|+||..||+++|++||+|+||...|+.|+++.
T Consensus 470 idlSqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s 527 (1157)
T KOG4278|consen 470 IDLSQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS 527 (1157)
T ss_pred ccHHHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence 9999999999999999999999999999999999999999999999999999999854
|
|
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=229.09 Aligned_cols=181 Identities=47% Similarity=0.771 Sum_probs=157.5
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEec----CCCeeeEEEEEeccCC--c--cCCCCCcC-Hh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKR----SSFCLKMTTGRSLFET--Q--KAGRTTIH-YP 71 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~----~~~~v~h~~i~~~~~g--y--l~~~~~~~-l~ 71 (189)
||+|+|+|.++++.|.......|+||||++.+..|+|+++++.. ....++|++|...++| + +.....|. +.
T Consensus 83 Wf~~~isR~~ae~~ll~p~~~~G~flvR~se~~~g~yslsv~~~~~~~~~~~v~hyri~~~~~~~~~~~~~~~~~F~~l~ 162 (468)
T KOG0197|consen 83 WFFGKISREEAERQLLAPENKEGAFLVRESESDKGDYSLSVREGDSGGLGAKVKHYRIRQLDGGGLYPYIDERELFSSLQ 162 (468)
T ss_pred chhccccHHHHHHhhcCCCCCccceeeecccCCcCCeeEEEEeccccCCccceeeeeeeEcCCCCeecCCCHHHhhhhHH
Confidence 99999999999988877777889999999998899999999984 1239999999998888 4 77778888 99
Q ss_pred HHHHHhhhccCCceeeccCCcccc--cccc--cccccC------------------------------------------
Q psy1684 72 ELVEHYSKDADGLCVNLRKPCVQV--SCRI--YLVHGT------------------------------------------ 105 (189)
Q Consensus 72 ~li~~~~~~a~gl~~~~~~~~~~~--~~p~--~l~~~~------------------------------------------ 105 (189)
++++|+...+.|++..+..|+... .+|. +++++.
T Consensus 163 ~lv~~~~~~~~gl~~~l~~p~~~~~~~~p~~~~~~~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~ 242 (468)
T KOG0197|consen 163 QLVNYYSKNADGLCTRLRDPCSKQGHTKPQTPDLARDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS 242 (468)
T ss_pred HHHhhhhccCcchhhcccCchhccCCCCCCCCccccCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc
Confidence 999999999999999998887642 1232 222222
Q ss_pred --------------------------------------------------------------------------------
Q psy1684 106 -------------------------------------------------------------------------------- 105 (189)
Q Consensus 106 -------------------------------------------------------------------------------- 105 (189)
T Consensus 243 m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~ 322 (468)
T KOG0197|consen 243 MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK 322 (468)
T ss_pred cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC
Confidence
Q ss_pred ------------------------------------------------------CCCCccc-e-EEEec-----------
Q psy1684 106 ------------------------------------------------------NLSGVVV-S-AVDFG----------- 118 (189)
Q Consensus 106 ------------------------------------------------------~~~~~~~-s-VwsfG----------- 118 (189)
..++||. | |||||
T Consensus 323 ~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~ 402 (468)
T KOG0197|consen 323 NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGR 402 (468)
T ss_pred CccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCC
Confidence 7888999 9 99999
Q ss_pred --CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcCC
Q psy1684 119 --SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEGS 181 (189)
Q Consensus 119 --~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~~~ 181 (189)
|+++++.+++..|.+|+|+|.|+.||+++|+||..||+.+|++||||+.+...|+.+.....+
T Consensus 403 ~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~~~ 467 (468)
T KOG0197|consen 403 VPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTSTEG 467 (468)
T ss_pred CCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcccC
Confidence 899999999999999999999999999999999999999999999999999999999886554
|
|
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-32 Score=216.60 Aligned_cols=168 Identities=19% Similarity=0.325 Sum_probs=137.7
Q ss_pred CCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC-ccCCCCCcCHhHHHHHhhhcc
Q psy1684 3 FGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET-QKAGRTTIHYPELVEHYSKDA 81 (189)
Q Consensus 3 ~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g-yl~~~~~~~l~~li~~~~~~a 81 (189)
.+.++|+|||++||+|...++.++|.|||.. ||+.-.++.. .....+ ..+| - ........+++..+.|+|
T Consensus 543 la~l~H~nIVrLlGVC~~~~P~~MvFEYm~~-GDL~eFLra~-sP~a~~-----~~~g~~--~~~~L~~~q~L~iA~QIA 613 (774)
T KOG1026|consen 543 LAELQHPNIVRLLGVCREGDPLCMVFEYMDH-GDLHEFLRAR-SPKADK-----LASGQD--TPPPLSTSQFLHIATQIA 613 (774)
T ss_pred HHhccCCCeEEEEEEEccCCeeEEEEEeccc-ccHHHHHHhh-CCcccc-----ccCCCC--CCCCCCHHHHHHHHHHHH
Confidence 4578999999999999999999999999998 6553333331 111100 1111 1 022244788999999999
Q ss_pred CCceeeccCCcccccccc----------------cccccC------------------------CCCCccc-e-EEEec-
Q psy1684 82 DGLCVNLRKPCVQVSCRI----------------YLVHGT------------------------NLSGVVV-S-AVDFG- 118 (189)
Q Consensus 82 ~gl~~~~~~~~~~~~~p~----------------~l~~~~------------------------~~~~~~~-s-VwsfG- 118 (189)
.||.|+.+...+|||+.. ||+++. ..++||+ | |||||
T Consensus 614 aGM~YLs~~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GV 693 (774)
T KOG1026|consen 614 AGMEYLSSHHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGV 693 (774)
T ss_pred HHHHHHHhCcccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhh
Confidence 999999999999999766 555555 7899999 9 99999
Q ss_pred ------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q psy1684 119 ------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTME 179 (189)
Q Consensus 119 ------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~ 179 (189)
|.+++++||++.|+.|.-++.|.+||.++|+||..||+.+|++||+|+||...|+.+.+.+
T Consensus 694 vLWEIFsyG~QPy~glSn~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 694 VLWEIFSYGKQPYYGLSNQEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred hhhhhhccccCcccccchHHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 8899999999999999999999999999999999999999999999999999999887643
|
|
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-29 Score=207.66 Aligned_cols=162 Identities=20% Similarity=0.241 Sum_probs=134.2
Q ss_pred CCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccC
Q psy1684 3 FGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDAD 82 (189)
Q Consensus 3 ~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~ 82 (189)
+++..|+|+++++|.|-.....+||.|+|.+ |++.-.++.. +. . -.....+.+.+|+.+..++|.
T Consensus 749 m~~f~HpNiv~liGv~l~~~~~~i~leyM~g-GDL~sflr~~---r~---------~--~~~~~~L~~~dLl~~a~dvA~ 813 (1025)
T KOG1095|consen 749 MSKFDHPNIVSLIGVCLDSGPPLILLEYMEG-GDLLSFLRES---RP---------A--PFQPSNLSMRDLLAFALDVAK 813 (1025)
T ss_pred HhcCCCcceeeEEEeecCCCCcEEEehhccc-CcHHHHHHhc---cc---------c--cCCCCCCCHHHHHHHHHHHhh
Confidence 4678999999999999988889999999998 4332222220 00 0 000223348999999999999
Q ss_pred CceeeccCCcccccccc----------------cccccC------------------------CCCCccc-e-EEEec--
Q psy1684 83 GLCVNLRKPCVQVSCRI----------------YLVHGT------------------------NLSGVVV-S-AVDFG-- 118 (189)
Q Consensus 83 gl~~~~~~~~~~~~~p~----------------~l~~~~------------------------~~~~~~~-s-VwsfG-- 118 (189)
|+.|+.+++.||||+.. |||++. ..+.||. | |||||
T Consensus 814 G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVl 893 (1025)
T KOG1095|consen 814 GMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVL 893 (1025)
T ss_pred hhHHHHhCCCcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHH
Confidence 99999999999999766 666644 5688999 9 99999
Q ss_pred -----------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q psy1684 119 -----------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTME 179 (189)
Q Consensus 119 -----------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~ 179 (189)
|++.++.+|+..+.+|-|++.|..||..+|+||.+||+.+|++||+|..|++.+..+.+..
T Consensus 894 lWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 894 LWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred HHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 9999999999988777799999999999999999999999999999999999999888754
|
|
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-29 Score=202.15 Aligned_cols=171 Identities=20% Similarity=0.347 Sum_probs=121.5
Q ss_pred CCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEe----ccCC--ccCCCCCcC--HhH--
Q psy1684 3 FGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRS----LFET--QKAGRTTIH--YPE-- 72 (189)
Q Consensus 3 ~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~----~~~g--yl~~~~~~~--l~~-- 72 (189)
+|..+|||+++|-|+..+..+.+||.|+|.+ |.+--.++. +++++.-.++.. ++.| ||.+-..+| |++
T Consensus 684 MGQFdHPNIIrLEGVVTks~PvMIiTEyMEN-GsLDsFLR~-~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARN 761 (996)
T KOG0196|consen 684 MGQFDHPNIIRLEGVVTKSKPVMIITEYMEN-GSLDSFLRQ-NDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARN 761 (996)
T ss_pred cccCCCCcEEEEEEEEecCceeEEEhhhhhC-CcHHHHHhh-cCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhh
Confidence 6889999999999999999999999999999 533333333 133333222221 2222 554433333 211
Q ss_pred -HHH--HhhhccC-CceeeccC------------CcccccccccccccCCCCCccc-e-EEEec-------------CCC
Q psy1684 73 -LVE--HYSKDAD-GLCVNLRK------------PCVQVSCRIYLVHGTNLSGVVV-S-AVDFG-------------SGG 121 (189)
Q Consensus 73 -li~--~~~~~a~-gl~~~~~~------------~~~~~~~p~~l~~~~~~~~~~~-s-VwsfG-------------~~~ 121 (189)
|++ ...++++ |++..+.. -.|+|.+||-+ ...+||. | ||||| |-+
T Consensus 762 ILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAI----a~RKFTsASDVWSyGIVmWEVmSyGERPYWd 837 (996)
T KOG0196|consen 762 ILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAI----AYRKFTSASDVWSYGIVMWEVMSYGERPYWD 837 (996)
T ss_pred eeeccceEEEeccccceeecccCCCccccccCCccceeecChhHh----hhcccCchhhccccceEEEEecccCCCcccc
Confidence 111 1123333 44433311 12344444444 7889999 9 99999 888
Q ss_pred CChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q psy1684 122 MTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTME 179 (189)
Q Consensus 122 ~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~ 179 (189)
|++.+|+..|..|+|+|.|.+||..+++||..||++|-..||.|.+|+..|+.+++.+
T Consensus 838 mSNQdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 838 MSNQDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred cchHHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 9999999999999999999999999999999999999999999999999999988753
|
|
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-28 Score=189.55 Aligned_cols=156 Identities=25% Similarity=0.361 Sum_probs=137.6
Q ss_pred CCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCC-CcCHhHHHHHhhhcc
Q psy1684 3 FGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRT-TIHYPELVEHYSKDA 81 (189)
Q Consensus 3 ~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~-~~~l~~li~~~~~~a 81 (189)
+..++|+|+++++|++..+++.+||+|.+++ | ++.. ||.+.. .+++.+.+.+..+.|
T Consensus 215 Mr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~g-G----sL~~-----------------~L~k~~~~v~~~ek~~~~~~AA 272 (474)
T KOG0194|consen 215 MRQLNHPNVVRFYGVAVLEEPLMLVMELCNG-G----SLDD-----------------YLKKNKKSLPTLEKLRFCYDAA 272 (474)
T ss_pred HHhCCCCCEEEEEEEEcCCCccEEEEEecCC-C----cHHH-----------------HHHhCCCCCCHHHHHHHHHHHH
Confidence 4578999999999999999999999999998 4 3444 666555 366899999999999
Q ss_pred CCceeeccCCcccccccc-------------------------------------cccccC-CCCCccc-e-EEEec---
Q psy1684 82 DGLCVNLRKPCVQVSCRI-------------------------------------YLVHGT-NLSGVVV-S-AVDFG--- 118 (189)
Q Consensus 82 ~gl~~~~~~~~~~~~~p~-------------------------------------~l~~~~-~~~~~~~-s-VwsfG--- 118 (189)
.|+.|+|.+.|+|||+.+ |||||. ..+.||. + |||||
T Consensus 273 ~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~ 352 (474)
T KOG0194|consen 273 RGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLL 352 (474)
T ss_pred hHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeE
Confidence 999999999999999766 666665 4567999 9 99999
Q ss_pred ----------CCCCChHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcC
Q psy1684 119 ----------SGGMTNAEVLHQV-EHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180 (189)
Q Consensus 119 ----------~~~~~~~~~~~~v-~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~~ 180 (189)
|+++++.++...| .+|+|++.|..+|.++..++.+||..||++||||.++.+.|+.+.....
T Consensus 353 ~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 353 WEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred EeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 8999999999999 7899999999999999999999999999999999999999998887544
|
|
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-28 Score=193.71 Aligned_cols=153 Identities=22% Similarity=0.417 Sum_probs=132.3
Q ss_pred CCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCC-CcCHhHHHHHhhhcc
Q psy1684 3 FGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRT-TIHYPELVEHYSKDA 81 (189)
Q Consensus 3 ~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~-~~~l~~li~~~~~~a 81 (189)
+.+..|+++++|+|.|. +.+.+||+|..+.|. ++. ||..++ .+.+..|+-|+.+.+
T Consensus 445 MrnfdHphIikLIGv~~-e~P~WivmEL~~~GE-----Lr~-----------------yLq~nk~sL~l~tL~ly~~Qi~ 501 (974)
T KOG4257|consen 445 MRNFDHPHIIKLIGVCV-EQPMWIVMELAPLGE-----LRE-----------------YLQQNKDSLPLRTLTLYCYQIC 501 (974)
T ss_pred HHhCCCcchhheeeeee-ccceeEEEecccchh-----HHH-----------------HHHhccccchHHHHHHHHHHHH
Confidence 46789999999999996 568999999988732 222 555433 344888999999999
Q ss_pred CCceeeccCCcccccccc--------------------------------------cccccC-CCCCccc-e-EEEec--
Q psy1684 82 DGLCVNLRKPCVQVSCRI--------------------------------------YLVHGT-NLSGVVV-S-AVDFG-- 118 (189)
Q Consensus 82 ~gl~~~~~~~~~~~~~p~--------------------------------------~l~~~~-~~~~~~~-s-VwsfG-- 118 (189)
++++|++++.++|||+.. |||+|. ....||. | ||-||
T Consensus 502 talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVC 581 (974)
T KOG4257|consen 502 TALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVC 581 (974)
T ss_pred HHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHH
Confidence 999999999999999765 666655 5677999 9 99999
Q ss_pred -----------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q psy1684 119 -----------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTM 178 (189)
Q Consensus 119 -----------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~ 178 (189)
|.|+.+.+|+-.+++|.|+|.|+.||+.+|.||.+||+.+|.+||+|++|...|+.+++.
T Consensus 582 mWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe 652 (974)
T KOG4257|consen 582 MWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE 652 (974)
T ss_pred HHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999999999999999999999999999999884
|
|
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.4e-27 Score=178.22 Aligned_cols=154 Identities=18% Similarity=0.249 Sum_probs=128.6
Q ss_pred CCCChHHHHHHhcCCCCCC-CcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC--CCCcCHhHHHHHhhhc
Q psy1684 4 GKIKRIEAEKKLLLPENDH-GAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG--RTTIHYPELVEHYSKD 80 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~-g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~--~~~~~l~~li~~~~~~ 80 (189)
..++|+|+++++|.|..+. +..||+|+++++. +.. +++. +..+++...+.+..++
T Consensus 94 ~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~Gs-----L~~-----------------~l~~~~~~~l~~~~~l~~aldi 151 (362)
T KOG0192|consen 94 SRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGS-----LSV-----------------LLHKKRKRKLPLKVRLRIALDI 151 (362)
T ss_pred HhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCc-----HHH-----------------HHhhcccCCCCHHHHHHHHHHH
Confidence 3589999999999998877 6899999999843 333 3333 3456678888889999
Q ss_pred cCCceeeccCC-cccccc-cc-------------------------------------cccccCC---CCCccc-e-EEE
Q psy1684 81 ADGLCVNLRKP-CVQVSC-RI-------------------------------------YLVHGTN---LSGVVV-S-AVD 116 (189)
Q Consensus 81 a~gl~~~~~~~-~~~~~~-p~-------------------------------------~l~~~~~---~~~~~~-s-Vws 116 (189)
|.|+.|+|... +||||+ |+ |||||.. ..+|+. + |||
T Consensus 152 ArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvyS 231 (362)
T KOG0192|consen 152 ARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYS 231 (362)
T ss_pred HHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhh
Confidence 99999999998 899986 43 5555553 346999 9 999
Q ss_pred ec------------CCCCChHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q psy1684 117 FG------------SGGMTNAEVLHQV-EHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTME 179 (189)
Q Consensus 117 fG------------~~~~~~~~~~~~v-~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~ 179 (189)
|| |.++++.++...+ ..+.|+++|..||+.+..||.+||+.||+.||+|.+|+..|+.+.+..
T Consensus 232 FgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 232 FGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI 307 (362)
T ss_pred HHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence 99 9999998888887 588999999999999999999999999999999999999999887743
|
|
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.1e-26 Score=184.97 Aligned_cols=165 Identities=22% Similarity=0.271 Sum_probs=129.2
Q ss_pred CChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCC--CCcCHhHHHHHhhhccCC
Q psy1684 6 IKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGR--TTIHYPELVEHYSKDADG 83 (189)
Q Consensus 6 l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~--~~~~l~~li~~~~~~a~g 83 (189)
..|+|++.+||.|.+....++|.|+... |++.-.++. .. . ............ ..+...+|+.+..|+|.|
T Consensus 359 g~H~niv~llG~~t~~~~~~~v~Ey~~~-G~L~~~Lr~--~r---~--~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~G 430 (609)
T KOG0200|consen 359 GKHPNIVNLLGACTQDGPLYVIVEYAEH-GDLLEFLRK--KR---V--TESIDGSGVFPNERDALTTKDLLSFAYQIANG 430 (609)
T ss_pred cCCcchhhheeeeccCCceEEEEEeccC-CcHHHHHHh--cc---c--cccccccCCCccccCCcCHHHHHHHHHHHHHH
Confidence 4699999999999887889999999998 433222332 11 0 000000011111 125589999999999999
Q ss_pred ceeeccCCcccccccc----------------cccccC-------------------------CCCCccc-e-EEEec--
Q psy1684 84 LCVNLRKPCVQVSCRI----------------YLVHGT-------------------------NLSGVVV-S-AVDFG-- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~p~----------------~l~~~~-------------------------~~~~~~~-s-VwsfG-- 118 (189)
+.++...+|+|||++. |||++. ....|+. | |||||
T Consensus 431 Me~L~~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~ 510 (609)
T KOG0200|consen 431 MEYLASVPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGIL 510 (609)
T ss_pred HHHHhhCCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHH
Confidence 9999999999999766 555432 3467999 9 99999
Q ss_pred -----------CCCCC-hHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q psy1684 119 -----------SGGMT-NAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTM 178 (189)
Q Consensus 119 -----------~~~~~-~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~ 178 (189)
|+++. ..++.+.+.+|.|++.|..|+.++|+||..||+.+|++||+|+++.+.|+..+..
T Consensus 511 L~EifsLG~~PYp~~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~~ 582 (609)
T KOG0200|consen 511 LWEIFTLGGTPYPGIPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQD 582 (609)
T ss_pred HHHHhhCCCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHHH
Confidence 99987 7888888999999999999999999999999999999999999999999997653
|
|
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-25 Score=173.07 Aligned_cols=149 Identities=15% Similarity=0.226 Sum_probs=126.6
Q ss_pred CCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccC
Q psy1684 3 FGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDAD 82 (189)
Q Consensus 3 ~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~ 82 (189)
.++|.|+|++.++|+|.+....+||+|++..+. +.- .|.....+.-.-|++|...+|.
T Consensus 166 LRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq-L~~---------------------VLka~~~itp~llv~Wsk~IA~ 223 (904)
T KOG4721|consen 166 LRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ-LYE---------------------VLKAGRPITPSLLVDWSKGIAG 223 (904)
T ss_pred HHhccCcceeeEeeeecCCceeEEeeecccccc-HHH---------------------HHhccCccCHHHHHHHHHHhhh
Confidence 357899999999999999999999999999833 211 1222444555668899999999
Q ss_pred CceeeccCCcccccccc------------------------------------cccccC-CCCCccc-e-EEEec-----
Q psy1684 83 GLCVNLRKPCVQVSCRI------------------------------------YLVHGT-NLSGVVV-S-AVDFG----- 118 (189)
Q Consensus 83 gl~~~~~~~~~~~~~p~------------------------------------~l~~~~-~~~~~~~-s-VwsfG----- 118 (189)
|+.|+|...|||||+.. |||+|+ +..+.++ . |||||
T Consensus 224 GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWE 303 (904)
T KOG4721|consen 224 GMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWE 303 (904)
T ss_pred hhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHH
Confidence 99999999999999644 777777 6677999 9 99999
Q ss_pred -------CCCCChHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q psy1684 119 -------SGGMTNAEVLHQVE-HGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLE 173 (189)
Q Consensus 119 -------~~~~~~~~~~~~v~-~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~ 173 (189)
|.+++...|+..|. +-..+|.|..||..++-||++||+..|..||+|.+|+..|+
T Consensus 304 mLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 304 MLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred HHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence 89998888888884 45789999999999999999999999999999999999985
|
|
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.2e-24 Score=170.39 Aligned_cols=145 Identities=19% Similarity=0.300 Sum_probs=118.4
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC--CCCcCHhHHHHHhhhccC
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG--RTTIHYPELVEHYSKDAD 82 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~--~~~~~l~~li~~~~~~a~ 82 (189)
+|.|+++++|+|+... ...++|.|..+. | |+.. -|++ +..|-+.-|.+|+.++|.
T Consensus 167 ~L~H~hliRLyGvVl~-qp~mMV~ELapl-G----SLld-----------------rLrka~~~~llv~~Lcdya~QiA~ 223 (1039)
T KOG0199|consen 167 KLQHPHLIRLYGVVLD-QPAMMVFELAPL-G----SLLD-----------------RLRKAKKAILLVSRLCDYAMQIAK 223 (1039)
T ss_pred hccCcceeEEeeeecc-chhhHHhhhccc-c----hHHH-----------------HHhhccccceeHHHHHHHHHHHHH
Confidence 6789999999987764 678889998887 4 2333 1111 222336778889999999
Q ss_pred CceeeccCCcccccccc----------------cccccC-------------------------CCCCccc-e-EEEec-
Q psy1684 83 GLCVNLRKPCVQVSCRI----------------YLVHGT-------------------------NLSGVVV-S-AVDFG- 118 (189)
Q Consensus 83 gl~~~~~~~~~~~~~p~----------------~l~~~~-------------------------~~~~~~~-s-VwsfG- 118 (189)
|+.|+-.+.+||||+.. ||.+-. +..+||. | ||+||
T Consensus 224 aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGV 303 (1039)
T KOG0199|consen 224 AMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGV 303 (1039)
T ss_pred HHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhh
Confidence 99999999999999755 222211 7889999 9 99999
Q ss_pred ------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q psy1684 119 ------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKL 172 (189)
Q Consensus 119 ------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l 172 (189)
|.|.+..+|++.|..|.|++.|+.||++||++|.+||+.+|.+||||..|...+
T Consensus 304 TiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 304 TIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred hHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 888999999999999999999999999999999999999999999999998554
|
|
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-23 Score=168.53 Aligned_cols=153 Identities=20% Similarity=0.265 Sum_probs=129.2
Q ss_pred CCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC-CCCcCHhHHHHHhhhcc
Q psy1684 3 FGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG-RTTIHYPELVEHYSKDA 81 (189)
Q Consensus 3 ~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~-~~~~~l~~li~~~~~~a 81 (189)
++.+.|+|+++||++|..+. ..||+++++.+. +.+ |+.. +..+...+++++..|+|
T Consensus 752 masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~-----LlD-----------------yvr~hr~~igsq~lLnw~~QIA 808 (1177)
T KOG1025|consen 752 MASLDHPNLLRLLGVCMLST-LQLVTQLMPLGC-----LLD-----------------YVREHRDNIGSQDLLNWCYQIA 808 (1177)
T ss_pred HhcCCCchHHHHhhhcccch-HHHHHHhcccch-----HHH-----------------HHHHhhccccHHHHHHHHHHHH
Confidence 46899999999999998766 788999999733 333 2322 22344889999999999
Q ss_pred CCceeeccCCcccccccc----------------cccc-----------------------cC-CCCCccc-e-EEEec-
Q psy1684 82 DGLCVNLRKPCVQVSCRI----------------YLVH-----------------------GT-NLSGVVV-S-AVDFG- 118 (189)
Q Consensus 82 ~gl~~~~~~~~~~~~~p~----------------~l~~-----------------------~~-~~~~~~~-s-VwsfG- 118 (189)
+||.|++....+|||+.. ++++ +. ....|+. | |||||
T Consensus 809 kgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGV 888 (1177)
T KOG1025|consen 809 KGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGV 888 (1177)
T ss_pred HHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhh
Confidence 999999999999998755 2222 11 6678999 9 99999
Q ss_pred ------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q psy1684 119 ------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTM 178 (189)
Q Consensus 119 ------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~ 178 (189)
|.+++..+|-..++.|.|++.|+.|+.++|.+|.+||..|+..||+|+++...+.++.+.
T Consensus 889 tiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 889 TIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred hHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 899999999999999999999999999999999999999999999999999999998874
|
|
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.1e-23 Score=161.08 Aligned_cols=153 Identities=18% Similarity=0.244 Sum_probs=120.8
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
++-.|.|++=++|.|.+ ++..||+..+.+...| . |..+. ..+|.+..+++.++++++|
T Consensus 443 kkTRH~NIlLFMG~~~~-p~~AIiTqwCeGsSLY-----~-------hlHv~---------etkfdm~~~idIAqQiaqG 500 (678)
T KOG0193|consen 443 KKTRHENILLFMGACMN-PPLAIITQWCEGSSLY-----T-------HLHVQ---------ETKFDMNTTIDIAQQIAQG 500 (678)
T ss_pred hhcchhhheeeehhhcC-CceeeeehhccCchhh-----h-------hccch---------hhhhhHHHHHHHHHHHHHh
Confidence 35568888888887764 4457777776652211 1 21121 2357789999999999999
Q ss_pred ceeeccCCcccccccc---------------------------------------cccccC----CCCCccc-e-EEEec
Q psy1684 84 LCVNLRKPCVQVSCRI---------------------------------------YLVHGT----NLSGVVV-S-AVDFG 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~p~---------------------------------------~l~~~~----~~~~~~~-s-VwsfG 118 (189)
+.|+|.+.|||||+.. |||+|+ ...+||. | |||||
T Consensus 501 M~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFG 580 (678)
T KOG0193|consen 501 MDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFG 580 (678)
T ss_pred hhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhh
Confidence 9999999999999766 555555 6788999 9 99999
Q ss_pred ------------CCCCChHHHHHHHHcCCCCCCC----CCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q psy1684 119 ------------SGGMTNAEVLHQVEHGYRMPCP----PGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTM 178 (189)
Q Consensus 119 ------------~~~~~~~~~~~~v~~g~~~~~p----~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~ 178 (189)
|..-..++|+..|.+|+-++.+ .+||.++++|+..||..++++||.|.+|+..|+.++.+
T Consensus 581 iV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 581 IVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred HHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 8866778999999999765543 57999999999999999999999999999999888763
|
|
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.3e-23 Score=160.67 Aligned_cols=151 Identities=21% Similarity=0.333 Sum_probs=116.0
Q ss_pred CCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCC--CCcCHhHHHHHhhhc
Q psy1684 3 FGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGR--TTIHYPELVEHYSKD 80 (189)
Q Consensus 3 ~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~--~~~~l~~li~~~~~~ 80 (189)
++.++|||+++|+|+|..+++..+|+|++.+ |++ +. |+... ....-...+..+.++
T Consensus 589 LsqLkhPNIveLvGVC~~DePicmI~EYmEn-GDL----nq-----------------Fl~aheapt~~t~~~vsi~tqi 646 (807)
T KOG1094|consen 589 LSRLKHPNIVELLGVCVQDDPLCMITEYMEN-GDL----NQ-----------------FLSAHELPTAETAPGVSICTQI 646 (807)
T ss_pred HhccCCCCeeEEEeeeecCCchHHHHHHHhc-CcH----HH-----------------HHHhccCcccccchhHHHHHHH
Confidence 3578999999999999999999999999999 532 22 22111 011123344567777
Q ss_pred cCCceeeccCCcccccccc----------------cccccC------------------------CCCCccc-e-EEEec
Q psy1684 81 ADGLCVNLRKPCVQVSCRI----------------YLVHGT------------------------NLSGVVV-S-AVDFG 118 (189)
Q Consensus 81 a~gl~~~~~~~~~~~~~p~----------------~l~~~~------------------------~~~~~~~-s-VwsfG 118 (189)
+.|++|+.+-.++|||+.. ||++.. ..++||+ | ||+||
T Consensus 647 asgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafg 726 (807)
T KOG1094|consen 647 ASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFG 726 (807)
T ss_pred HHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhH
Confidence 8888888888888888644 455433 6789999 9 99999
Q ss_pred --------------CCCCChHHHHHHHHc----C---CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q psy1684 119 --------------SGGMTNAEVLHQVEH----G---YRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDF 175 (189)
Q Consensus 119 --------------~~~~~~~~~~~~v~~----g---~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~ 175 (189)
|..++.+++.+.... + .-++.|.-||.+++++|.+||..|..+||+|++|...|.+.
T Consensus 727 vTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 727 VTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred HHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 899999888876532 1 23678999999999999999999999999999999888653
|
|
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.7e-22 Score=150.52 Aligned_cols=160 Identities=21% Similarity=0.247 Sum_probs=116.8
Q ss_pred CCCChHHHHHHhcCCCCC-CCcEEEecCCCCCCceEEEEEecCCCeeeEEE-EEeccCCccCCCCCcCHhHHHHHhhhcc
Q psy1684 4 GKIKRIEAEKKLLLPEND-HGAFLIRDSESRKNDYSLSEYKRSSFCLKMTT-GRSLFETQKAGRTTIHYPELVEHYSKDA 81 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~-~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~-i~~~~~gyl~~~~~~~l~~li~~~~~~a 81 (189)
..++|+|+..+++++... +-.|++...+.- |. .+.|. +.+.++ -.....+.-.+++....|.+
T Consensus 342 y~~sH~nll~V~~V~ie~~~~P~V~y~~~~~-gN------------LK~FL~~Cr~~~--~~~aqtvtt~qlV~masQla 406 (563)
T KOG1024|consen 342 YGASHPNLLSVLGVSIEDYATPFVLYPATGV-GN------------LKSFLQICRGDD--PSYAQTVTTIQLVLMASQLA 406 (563)
T ss_pred hcCcCCCccceeEEEeeccCcceEEEeccCc-ch------------HHHHHHHhccCC--CccccchhHHHHHHHHHHHH
Confidence 356788888888877543 223555555443 21 11111 111000 00112233456777888888
Q ss_pred CCceeeccCCcccccccc---------------------------------------cccccC-CCCCccc-e-EEEec-
Q psy1684 82 DGLCVNLRKPCVQVSCRI---------------------------------------YLVHGT-NLSGVVV-S-AVDFG- 118 (189)
Q Consensus 82 ~gl~~~~~~~~~~~~~p~---------------------------------------~l~~~~-~~~~~~~-s-VwsfG- 118 (189)
-++.++|...++|.|+.. ||+.|. ....||. | |||||
T Consensus 407 ~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGV 486 (563)
T KOG1024|consen 407 MAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGV 486 (563)
T ss_pred HHHHHHHhcCcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHH
Confidence 899999999999988655 333332 5677999 9 99999
Q ss_pred ------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q psy1684 119 ------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTM 178 (189)
Q Consensus 119 ------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~ 178 (189)
|.++++.++...+++|+|+..|.+||.+++.+|..||+..|++||+|+|++.-|.++..+
T Consensus 487 llWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 487 LLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred HHHHHHhcCCCCccccCHHHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999999999999999999999999999887653
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.3e-22 Score=147.09 Aligned_cols=146 Identities=21% Similarity=0.361 Sum_probs=107.9
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCC--CCcCHhHHHHHhhhccC
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGR--TTIHYPELVEHYSKDAD 82 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~--~~~~l~~li~~~~~~a~ 82 (189)
.++|+|+++++|.+......++|.|+++. | ++.. +|... ..++...+..+..+++.
T Consensus 57 ~l~h~ni~~~~g~~~~~~~~~lv~e~~~~-g----~L~~-----------------~L~~~~~~~~~~~~~~~i~~~i~~ 114 (259)
T PF07714_consen 57 KLRHPNIVKLYGFCIENEPLFLVMEYCPG-G----SLDD-----------------YLKSKNKEPLSEQQRLSIAIQIAE 114 (259)
T ss_dssp THSBTTBE-EEEEEESSSSEEEEEE--TT-E----BHHH-----------------HHHHTCTTTSBHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccc-c----cccc-----------------cccccccccccccccccccccccc
Confidence 46889999999888766667888888776 3 1222 33333 34456777888888999
Q ss_pred CceeeccCCcccccccc---------------------------------------cccccC-CCCCccc-e-EEEec--
Q psy1684 83 GLCVNLRKPCVQVSCRI---------------------------------------YLVHGT-NLSGVVV-S-AVDFG-- 118 (189)
Q Consensus 83 gl~~~~~~~~~~~~~p~---------------------------------------~l~~~~-~~~~~~~-s-VwsfG-- 118 (189)
|+.++|...++|+++.. |+++|. ....++. + |||||
T Consensus 115 ~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~ 194 (259)
T PF07714_consen 115 ALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGML 194 (259)
T ss_dssp HHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999987532 222222 3445788 9 99999
Q ss_pred -----------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q psy1684 119 -----------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKL 172 (189)
Q Consensus 119 -----------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l 172 (189)
|.+.+..++...+.++.+++.|..||..+++||.+||+.||.+||||.+|++.|
T Consensus 195 l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 195 LYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cccccccccccccccccccccccccccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 777788888999999999999999999999999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.4e-20 Score=138.53 Aligned_cols=152 Identities=14% Similarity=0.141 Sum_probs=103.9
Q ss_pred CCCChHHHHHHhcCCCC----CCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhh
Q psy1684 4 GKIKRIEAEKKLLLPEN----DHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSK 79 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~----~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~ 79 (189)
..+.|+|++++++.+.. ....+||+|+++++. +.. ++.....+.....+.+..+
T Consensus 73 ~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~-----L~~-----------------~l~~~~~~~~~~~~~i~~~ 130 (283)
T PHA02988 73 RRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGY-----LRE-----------------VLDKEKDLSFKTKLDMAID 130 (283)
T ss_pred HhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCc-----HHH-----------------HHhhCCCCChhHHHHHHHH
Confidence 35677777777765432 123467777766522 111 2332333344445556666
Q ss_pred ccCCceeeccC-Ccccccc-cc---------------c------------------ccccCC---CCCccc-e-EEEec-
Q psy1684 80 DADGLCVNLRK-PCVQVSC-RI---------------Y------------------LVHGTN---LSGVVV-S-AVDFG- 118 (189)
Q Consensus 80 ~a~gl~~~~~~-~~~~~~~-p~---------------~------------------l~~~~~---~~~~~~-s-VwsfG- 118 (189)
.+.|+.++|.. .++|+|+ |+ | +++|.. .+.|+. + |||||
T Consensus 131 i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGv 210 (283)
T PHA02988 131 CCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGV 210 (283)
T ss_pred HHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccccccccCcccccCHHHhhhccccccchhhhhHHHH
Confidence 67777777763 6667775 33 1 222222 257899 9 99999
Q ss_pred -----------CCCCChHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q psy1684 119 -----------SGGMTNAEVLHQV-EHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFT 177 (189)
Q Consensus 119 -----------~~~~~~~~~~~~v-~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~ 177 (189)
|.+.+..++...+ ..+.+++.|..||+++.+||.+||+.||++||||++|++.|+.+..
T Consensus 211 il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 211 VLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred HHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 7777777877776 4566777888899999999999999999999999999999987643
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.5e-20 Score=136.70 Aligned_cols=149 Identities=19% Similarity=0.295 Sum_probs=109.7
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC-CCCcCHhHHHHHhhhccCC
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG-RTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~-~~~~~l~~li~~~~~~a~g 83 (189)
.+.|+|++++++.+......+||+|+++.+. +.. ++.. ...+...++..+..+.+.|
T Consensus 62 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~-----L~~-----------------~l~~~~~~l~~~~~~~~~~~i~~a 119 (266)
T cd05064 62 QFDHSNIVRLEGVITRGNTMMIVTEYMSNGA-----LDS-----------------FLRKHEGQLVAGQLMGMLPGLASG 119 (266)
T ss_pred cCCCCCcCeEEEEEecCCCcEEEEEeCCCCc-----HHH-----------------HHHhCCCCCCHHHHHHHHHHHHHH
Confidence 4678888887776666666788888777622 111 2221 1234456667777788888
Q ss_pred ceeeccCCcccccc-cc-------------------------------------cccccC-CCCCccc-e-EEEec----
Q psy1684 84 LCVNLRKPCVQVSC-RI-------------------------------------YLVHGT-NLSGVVV-S-AVDFG---- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~-------------------------------------~l~~~~-~~~~~~~-s-VwsfG---- 118 (189)
+.++|..+++|+|+ |. ++++|. ..+.++. + |||||
T Consensus 120 l~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 199 (266)
T cd05064 120 MKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMW 199 (266)
T ss_pred HHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHH
Confidence 88888888888885 33 111221 3456788 9 99999
Q ss_pred ---------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q psy1684 119 ---------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDF 175 (189)
Q Consensus 119 ---------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~ 175 (189)
|.+.+..+++..+.++.+++.|..+|..+.+++.+||+.+|++||++.+|.+.|+.+
T Consensus 200 ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 200 EVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 445666778888888888888999999999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.8e-18 Score=128.86 Aligned_cols=106 Identities=20% Similarity=0.207 Sum_probs=84.9
Q ss_pred CCcCHhHHHHHhhhccCCceeecc-CCcccccc-cc----------------------------------cccccC-CCC
Q psy1684 66 TTIHYPELVEHYSKDADGLCVNLR-KPCVQVSC-RI----------------------------------YLVHGT-NLS 108 (189)
Q Consensus 66 ~~~~l~~li~~~~~~a~gl~~~~~-~~~~~~~~-p~----------------------------------~l~~~~-~~~ 108 (189)
..+.-..|-....++.+||.|+|. ..|+|||+ |+ .||+|- .++
T Consensus 173 g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS~a~tfvGT~~YMsPERi~g~ 252 (364)
T KOG0581|consen 173 GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNSIANTFVGTSAYMSPERISGE 252 (364)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhhhcccccccccccChhhhcCC
Confidence 345545566667788899999995 89999996 65 233332 567
Q ss_pred Cccc-e-EEEec------------CCC-----CChHHHHHHHHcCCCCCCCCC-CCHHHHHHHHHhcccCCCCCCCHHHH
Q psy1684 109 GVVV-S-AVDFG------------SGG-----MTNAEVLHQVEHGYRMPCPPG-CPPRLYDIMLECWLKDPVKRPTFETL 168 (189)
Q Consensus 109 ~~~~-s-VwsfG------------~~~-----~~~~~~~~~v~~g~~~~~p~~-~p~~~~~l~~~C~~~~p~~RP~~~~i 168 (189)
.|+. + ||||| |+. .+..+++..|..+..|..|.. +++++..++..|+++||++||+.+|+
T Consensus 253 ~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qL 332 (364)
T KOG0581|consen 253 SYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQL 332 (364)
T ss_pred cCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHH
Confidence 8999 9 99999 333 346788888999988888987 99999999999999999999999999
Q ss_pred HHH
Q psy1684 169 QWK 171 (189)
Q Consensus 169 ~~~ 171 (189)
+..
T Consensus 333 l~H 335 (364)
T KOG0581|consen 333 LQH 335 (364)
T ss_pred hcC
Confidence 864
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.4e-18 Score=126.79 Aligned_cols=150 Identities=22% Similarity=0.386 Sum_probs=109.0
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC--CCCcCHhHHHHHhhhccC
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG--RTTIHYPELVEHYSKDAD 82 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~--~~~~~l~~li~~~~~~a~ 82 (189)
.++|+|++++++.+......++|+|+++++. +.. ++.. ...+....+..+..+.+.
T Consensus 58 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~-----L~~-----------------~~~~~~~~~l~~~~~~~~~~ql~~ 115 (263)
T cd05052 58 EIKHPNLVQLLGVCTREPPFYIITEFMTYGN-----LLD-----------------YLRECNRQEVNAVVLLYMATQISS 115 (263)
T ss_pred hCCCCChhheEEEEcCCCCcEEEEEeCCCCc-----HHH-----------------HHHhCCCCCCCHHHHHHHHHHHHH
Confidence 5678888888887777777788888877632 111 1111 112334455566677777
Q ss_pred CceeeccCCcccccc-cc---------------c----------------------ccccC-CCCCccc-e-EEEec---
Q psy1684 83 GLCVNLRKPCVQVSC-RI---------------Y----------------------LVHGT-NLSGVVV-S-AVDFG--- 118 (189)
Q Consensus 83 gl~~~~~~~~~~~~~-p~---------------~----------------------l~~~~-~~~~~~~-s-VwsfG--- 118 (189)
|+.++|..+++|+|+ |. + +++|. ....++. + |||||
T Consensus 116 ~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il 195 (263)
T cd05052 116 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLL 195 (263)
T ss_pred HHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHH
Confidence 888888888888875 33 1 11221 3455788 9 99999
Q ss_pred ----------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q psy1684 119 ----------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFF 176 (189)
Q Consensus 119 ----------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~ 176 (189)
|++.+..++...+..+.+++.|..+|.++.+++.+||..||++|||+.++.+.|++++
T Consensus 196 ~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 263 (263)
T cd05052 196 WEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF 263 (263)
T ss_pred HHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhhC
Confidence 4555667777778888888889999999999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.70 E-value=6.8e-18 Score=126.30 Aligned_cols=156 Identities=19% Similarity=0.276 Sum_probs=108.4
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC-CCCcCHhHHHHHhhhccC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG-RTTIHYPELVEHYSKDAD 82 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~-~~~~~l~~li~~~~~~a~ 82 (189)
..+.|+|++++++.+. ....++|.++.+++. +.. ++.. ...+....+..+..+.+.
T Consensus 64 ~~l~h~~iv~~~~~~~-~~~~~~i~e~~~~gs-----L~~-----------------~l~~~~~~~~~~~~~~i~~qi~~ 120 (279)
T cd05111 64 GSLDHAYIVRLLGICP-GASLQLVTQLSPLGS-----LLD-----------------HVRQHRDSLDPQRLLNWCVQIAK 120 (279)
T ss_pred hcCCCCCcceEEEEEC-CCccEEEEEeCCCCc-----HHH-----------------HHHhcccCCCHHHHHHHHHHHHH
Confidence 3456677777666543 233455566555421 111 2322 223445666777778888
Q ss_pred CceeeccCCcccccc-cc---------------cccc-----------------------cC-CCCCccc-e-EEEec--
Q psy1684 83 GLCVNLRKPCVQVSC-RI---------------YLVH-----------------------GT-NLSGVVV-S-AVDFG-- 118 (189)
Q Consensus 83 gl~~~~~~~~~~~~~-p~---------------~l~~-----------------------~~-~~~~~~~-s-VwsfG-- 118 (189)
|+.++|..+++|+|+ |. ++++ |. ..+.++. + |||||
T Consensus 121 ~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~i 200 (279)
T cd05111 121 GMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVT 200 (279)
T ss_pred HHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHH
Confidence 889999888888885 43 2221 11 3356888 9 99999
Q ss_pred -----------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcCCCC
Q psy1684 119 -----------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEGSDY 183 (189)
Q Consensus 119 -----------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~~~~~ 183 (189)
|.+.+..++...+.++.+++.|..|+.++..++.+||..||++|||+.++++.|..+.+.+ |.|
T Consensus 201 l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~-~~~ 275 (279)
T cd05111 201 VWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP-PRY 275 (279)
T ss_pred HHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC-cce
Confidence 4455566666677888888888899999999999999999999999999999999988744 555
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.70 E-value=5.8e-18 Score=126.70 Aligned_cols=164 Identities=17% Similarity=0.278 Sum_probs=109.8
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.++|+|++++++.+......++++|+..++. +.-.+.. ...... .. ..++-......+....+..+..+.+.++
T Consensus 64 ~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~-L~~~l~~--~~~~~~--~~-~~~~~~~~~~~l~~~~~~~~~~~l~~al 137 (283)
T cd05048 64 DLQHPNIVCLLGVCTKEQPTCMLFEYLAHGD-LHEFLVR--NSPHSD--VG-AESGDETVKSSLDCSDFLHIAIQIAAGM 137 (283)
T ss_pred hcCCcccceEEEEEcCCCceEEEEecCCCCc-HHHHHHh--cCCCcc--cc-cccccccccCCCCHHHHHHHHHHHHHHH
Confidence 4678888888877666666788888877632 1100000 000000 00 0000000012333566667777888889
Q ss_pred eeeccCCcccccc-cc---------------ccc-----------------------ccC-CCCCccc-e-EEEec----
Q psy1684 85 CVNLRKPCVQVSC-RI---------------YLV-----------------------HGT-NLSGVVV-S-AVDFG---- 118 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~---------------~l~-----------------------~~~-~~~~~~~-s-VwsfG---- 118 (189)
.++|..+++|+|+ |+ +++ +|. ..+.++. + |||||
T Consensus 138 ~~lH~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~ 217 (283)
T cd05048 138 EYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLW 217 (283)
T ss_pred HHHHhCCeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHH
Confidence 9999988888885 44 222 111 3356788 9 99999
Q ss_pred ---------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q psy1684 119 ---------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLED 174 (189)
Q Consensus 119 ---------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~ 174 (189)
|.+.+..++...+.++..++.|..+|.++.+|+.+||+.||++||++++|++.|+.
T Consensus 218 el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 218 EIFSYGLQPYYGFSNQEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 44556678888888888888899999999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.70 E-value=8.5e-18 Score=129.05 Aligned_cols=110 Identities=27% Similarity=0.449 Sum_probs=86.9
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cccc-----------------------cC-CC
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVH-----------------------GT-NL 107 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~-----------------------~~-~~ 107 (189)
+...+++.+..+.+.|+.++|..+++|+|+ |+ |+++ |. ..
T Consensus 171 l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 250 (338)
T cd05102 171 LTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFD 250 (338)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhc
Confidence 446677888889999999999999999996 44 3332 11 23
Q ss_pred CCccc-e-EEEec-------------CCCCCh-HHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 108 SGVVV-S-AVDFG-------------SGGMTN-AEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 108 ~~~~~-s-VwsfG-------------~~~~~~-~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
..++. + ||||| |++... ..+...+..+.++..|..+|+++.+|+.+||+.||++|||+.+|++.
T Consensus 251 ~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~ 330 (338)
T cd05102 251 KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEI 330 (338)
T ss_pred CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 45788 9 99999 333332 34555567777777888999999999999999999999999999999
Q ss_pred HHHHHh
Q psy1684 172 LEDFFT 177 (189)
Q Consensus 172 l~~~~~ 177 (189)
|+.+++
T Consensus 331 l~~~~~ 336 (338)
T cd05102 331 LGDLLQ 336 (338)
T ss_pred HHHHHh
Confidence 999876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.8e-17 Score=124.70 Aligned_cols=174 Identities=15% Similarity=0.190 Sum_probs=119.2
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..++|+|++++++.+...+..++|+|+.+++. +.-.+.. ....... +.. ..-......++....+....+.+.+
T Consensus 62 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~-L~~~i~~-~~~~~~~--~~~--~~~~~~~~~~~~~~~~~i~~~i~~a 135 (291)
T cd05094 62 TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGD-LNKFLRA-HGPDAMI--LVD--GQPRQAKGELGLSQMLHIASQIASG 135 (291)
T ss_pred hcCCCCCcceEEEEEccCCceEEEEecCCCCc-HHHHHHh-cCccccc--ccc--cccccCcCCCCHHHHHHHHHHHHHH
Confidence 45789999999888877778899999888632 2100000 0000000 000 0000011234466677777888888
Q ss_pred ceeeccCCcccccc-cc---------------ccc-----------------------ccC-CCCCccc-e-EEEec---
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YLV-----------------------HGT-NLSGVVV-S-AVDFG--- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l~-----------------------~~~-~~~~~~~-s-VwsfG--- 118 (189)
+.++|..+++|+|+ |. +++ +|. ....++. + |||||
T Consensus 136 l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 215 (291)
T cd05094 136 MVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVIL 215 (291)
T ss_pred HHHHHhCCeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHH
Confidence 99999999999886 44 222 111 3355788 9 99999
Q ss_pred ----------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcCCCCC
Q psy1684 119 ----------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEGSDYK 184 (189)
Q Consensus 119 ----------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~~~~~~ 184 (189)
|...+..++...+..+..+..+..+|.++.+++.+||+.||++|||+.+|++.|+.+.. +.|.|.
T Consensus 216 ~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~-~~~~~~ 290 (291)
T cd05094 216 WEIFTYGKQPWFQLSNTEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK-ATPIYL 290 (291)
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh-hcCccc
Confidence 44455667777777887777788899999999999999999999999999999999876 456664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.5e-17 Score=124.69 Aligned_cols=167 Identities=21% Similarity=0.265 Sum_probs=116.5
Q ss_pred ChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEe-cCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCce
Q psy1684 7 KRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYK-RSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGLC 85 (189)
Q Consensus 7 ~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~-~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl~ 85 (189)
.|+|++++++.+......+||+|+... +.+.-.+.. ...+....+.+. ......+.+..++.+..+.+.|+.
T Consensus 79 ~h~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~qi~~al~ 151 (304)
T cd05101 79 KHKNIINLLGACTQDGPLYVIVEYASK-GNLREYLRARRPPGMEYSYDIA------RVPDEQMTFKDLVSCTYQVARGME 151 (304)
T ss_pred cCCCchheeEEEecCCceEEEEecCCC-CcHHHHHHhcCCcccccccccc------cCCcccccHHHHHHHHHHHHHHHH
Confidence 688999988877767778899998876 322100000 000000000000 001223446677778888899999
Q ss_pred eeccCCcccccc-cc---------------ccc-----------------------ccC-CCCCccc-e-EEEec-----
Q psy1684 86 VNLRKPCVQVSC-RI---------------YLV-----------------------HGT-NLSGVVV-S-AVDFG----- 118 (189)
Q Consensus 86 ~~~~~~~~~~~~-p~---------------~l~-----------------------~~~-~~~~~~~-s-VwsfG----- 118 (189)
++|..+++|+|+ |. +++ +|. ....++. + |||||
T Consensus 152 ~LH~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~e 231 (304)
T cd05101 152 YLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE 231 (304)
T ss_pred HHHHCCeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHH
Confidence 999999999986 44 111 111 2345788 9 99999
Q ss_pred --------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcC
Q psy1684 119 --------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180 (189)
Q Consensus 119 --------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~~ 180 (189)
|.+.+..++...+..+.++..|..+|.++.+|+.+||+.+|++|||+.+|++.|+.++....
T Consensus 232 l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~ 301 (304)
T cd05101 232 IFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT 301 (304)
T ss_pred HHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence 44456778888888888888888999999999999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.6e-17 Score=121.84 Aligned_cols=108 Identities=26% Similarity=0.420 Sum_probs=82.7
Q ss_pred HhHHHHHhhhccCCceeeccCCcccccc-cc---------------ccc-------------------------ccC-CC
Q psy1684 70 YPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLV-------------------------HGT-NL 107 (189)
Q Consensus 70 l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~-------------------------~~~-~~ 107 (189)
..+++.+..+.+.|+.++|..+++|+|+ |. +++ +|. ..
T Consensus 97 ~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 176 (262)
T cd05058 97 VKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT 176 (262)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhcc
Confidence 4555666667777888888888888775 33 222 111 23
Q ss_pred CCccc-e-EEEec-------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q psy1684 108 SGVVV-S-AVDFG-------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKL 172 (189)
Q Consensus 108 ~~~~~-s-VwsfG-------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l 172 (189)
..++. + ||||| |.+.+..++...+..+..++.|..+|..+.+++.+||+.+|++||++.+|++.|
T Consensus 177 ~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l 256 (262)
T cd05058 177 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRI 256 (262)
T ss_pred CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 55788 8 99999 444556667777777877777888999999999999999999999999999999
Q ss_pred HHHHh
Q psy1684 173 EDFFT 177 (189)
Q Consensus 173 ~~~~~ 177 (189)
++++.
T Consensus 257 ~~~~~ 261 (262)
T cd05058 257 EQIFS 261 (262)
T ss_pred HHHhc
Confidence 98864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.2e-17 Score=123.36 Aligned_cols=109 Identities=27% Similarity=0.469 Sum_probs=82.3
Q ss_pred CcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------c------------------------ccccC-
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------Y------------------------LVHGT- 105 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~------------------------l~~~~- 105 (189)
.++...+..+..+.+.++.++|...++|+|+ |. + +++|.
T Consensus 91 ~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 170 (257)
T cd05116 91 HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM 170 (257)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHh
Confidence 3444555556666677777777777777765 33 1 11111
Q ss_pred CCCCccc-e-EEEec-------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 106 NLSGVVV-S-AVDFG-------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 106 ~~~~~~~-s-VwsfG-------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
....++. + ||||| |.+.+..++...+.++.+++.|..+|+++.+||.+||+.||++||+|.+|..
T Consensus 171 ~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 171 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred ccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 2345778 8 99999 5556667788888888888889999999999999999999999999999999
Q ss_pred HHHHH
Q psy1684 171 KLEDF 175 (189)
Q Consensus 171 ~l~~~ 175 (189)
.|++.
T Consensus 251 ~l~~~ 255 (257)
T cd05116 251 RLRNY 255 (257)
T ss_pred HHhcc
Confidence 99765
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.3e-17 Score=124.91 Aligned_cols=165 Identities=19% Similarity=0.319 Sum_probs=111.3
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..++|+|++++++.+...+..+++.++...+....+.... ..+..+..... .......+....+..+..+.+.|
T Consensus 63 ~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~-----~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ql~~a 136 (283)
T cd05091 63 SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMR-----SPHSDVGSTDD-DKTVKSTLEPADFVHIVTQIAAG 136 (283)
T ss_pred hcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhc-----CCCcccccccc-ccccccccCHHHHHHHHHHHHHH
Confidence 4577888888887776666778888877653211000000 00000000000 00112234456667777888889
Q ss_pred ceeeccCCcccccc-cc---------------cccccC------------------------CCCCccc-e-EEEec---
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YLVHGT------------------------NLSGVVV-S-AVDFG--- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l~~~~------------------------~~~~~~~-s-VwsfG--- 118 (189)
+.++|..+++|+|+ |. ++++.. ..+.++. + |||||
T Consensus 137 L~~lH~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l 216 (283)
T cd05091 137 MEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVL 216 (283)
T ss_pred HHHHHHcCccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHH
Confidence 99999999999986 44 222111 2355788 8 99999
Q ss_pred ----------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q psy1684 119 ----------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLED 174 (189)
Q Consensus 119 ----------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~ 174 (189)
|.+....++...+..+...+.|..+|.++.+|+.+||+.+|++||+|++|+..|++
T Consensus 217 ~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 217 WEVFSYGLQPYCGYSNQDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 44556678888888888788889999999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.7e-17 Score=125.16 Aligned_cols=151 Identities=20% Similarity=0.241 Sum_probs=106.2
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCC-CCcCHhHHHHHhhhccCC
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGR-TTIHYPELVEHYSKDADG 83 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~-~~~~l~~li~~~~~~a~g 83 (189)
.++|+|++++++.+.. +..++|.+++..+. +.. ++... ..+....+..+..+++.|
T Consensus 65 ~l~h~niv~~~g~~~~-~~~~~v~e~~~~g~-----l~~-----------------~l~~~~~~~~~~~~~~~~~qi~~~ 121 (316)
T cd05108 65 SVDNPHVCRLLGICLT-STVQLITQLMPFGC-----LLD-----------------YVREHKDNIGSQYLLNWCVQIAKG 121 (316)
T ss_pred hCCCCCCCeEEEEEcC-CCceeeeecCCCCC-----HHH-----------------HHHhccccCCHHHHHHHHHHHHHH
Confidence 4567777777765543 34456666655422 111 22221 123355566777788889
Q ss_pred ceeeccCCcccccc-cc---------------cccc-----------------------cC-CCCCccc-e-EEEec---
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YLVH-----------------------GT-NLSGVVV-S-AVDFG--- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l~~-----------------------~~-~~~~~~~-s-VwsfG--- 118 (189)
+.++|..+++|+|+ |+ |+++ |. ....++. + |||||
T Consensus 122 L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l 201 (316)
T cd05108 122 MNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 201 (316)
T ss_pred HHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHH
Confidence 99999999999985 44 2221 11 3355788 9 99999
Q ss_pred ----------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q psy1684 119 ----------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTM 178 (189)
Q Consensus 119 ----------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~ 178 (189)
|.+....++...+..+.+++.|..|+.++.+++.+||..||++||+|.+|+..|..+...
T Consensus 202 ~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 202 WELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred HHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 445556666666678888888899999999999999999999999999999999888763
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.4e-17 Score=128.43 Aligned_cols=107 Identities=28% Similarity=0.488 Sum_probs=83.0
Q ss_pred CHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cccc-----------------------cC-CCC
Q psy1684 69 HYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVH-----------------------GT-NLS 108 (189)
Q Consensus 69 ~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~-----------------------~~-~~~ 108 (189)
....+..+..+++.|+.++|..+++|+|+ |. |++. |. ...
T Consensus 212 ~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 291 (375)
T cd05104 212 DTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNC 291 (375)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCC
Confidence 35567778888999999999999999986 44 2221 11 234
Q ss_pred Cccc-e-EEEec-------------CCCCCh-HHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q psy1684 109 GVVV-S-AVDFG-------------SGGMTN-AEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKL 172 (189)
Q Consensus 109 ~~~~-s-VwsfG-------------~~~~~~-~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l 172 (189)
.++. + ||||| |.+... ..+...+..+.++..|..+|.++++|+.+||+.||++||||++|++.|
T Consensus 292 ~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l 371 (375)
T cd05104 292 VYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLI 371 (375)
T ss_pred CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHH
Confidence 5788 9 99999 334433 345555677877778888999999999999999999999999999999
Q ss_pred HHH
Q psy1684 173 EDF 175 (189)
Q Consensus 173 ~~~ 175 (189)
+..
T Consensus 372 ~~~ 374 (375)
T cd05104 372 EQQ 374 (375)
T ss_pred Hhh
Confidence 864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.67 E-value=9.2e-17 Score=120.83 Aligned_cols=163 Identities=21% Similarity=0.296 Sum_probs=110.3
Q ss_pred ChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC-ccCCCCCcCHhHHHHHhhhccCCce
Q psy1684 7 KRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET-QKAGRTTIHYPELVEHYSKDADGLC 85 (189)
Q Consensus 7 ~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g-yl~~~~~~~l~~li~~~~~~a~gl~ 85 (189)
+|+|++++++.+......++|+|+.+.+..... +.. . ..... ..... .......+....++.+..+.+.|+.
T Consensus 74 ~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~-l~~--~-~~~~~---~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~ 146 (293)
T cd05053 74 KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDF-LRA--R-RPPGE---YASPDDPRPPEETLTQKDLVSFAYQVARGME 146 (293)
T ss_pred CCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHH-HHh--c-CCCcc---ccccccccccccccCHHHHHHHHHHHHHHHH
Confidence 577777777766666667788887776321110 000 0 00000 00000 1111233446667777788888999
Q ss_pred eeccCCcccccc-cc---------------cc-----------------------cccC-CCCCccc-e-EEEec-----
Q psy1684 86 VNLRKPCVQVSC-RI---------------YL-----------------------VHGT-NLSGVVV-S-AVDFG----- 118 (189)
Q Consensus 86 ~~~~~~~~~~~~-p~---------------~l-----------------------~~~~-~~~~~~~-s-VwsfG----- 118 (189)
++|..+++|+|+ |. ++ ++|. ....++. + |||||
T Consensus 147 ~LH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 226 (293)
T cd05053 147 FLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWE 226 (293)
T ss_pred HHHHCCccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHH
Confidence 999999999875 44 21 1221 3345788 9 99999
Q ss_pred --------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q psy1684 119 --------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFF 176 (189)
Q Consensus 119 --------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~ 176 (189)
|.+.+..++...+..+.+++.|..++.++.+|+.+||..||++|||+.++++.|+.++
T Consensus 227 l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 227 IFTLGGSPYPGIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HhcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 4455667777778888888888899999999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.1e-17 Score=122.27 Aligned_cols=149 Identities=22% Similarity=0.395 Sum_probs=103.4
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC-CCCcCHhHHHHHhhhccCC
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG-RTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~-~~~~~l~~li~~~~~~a~g 83 (189)
.+.|+|++++++.+. .+..++|+|+.+. +. +.. ++.. ...+....+..+..+.+.|
T Consensus 51 ~l~h~~ii~~~~~~~-~~~~~lv~e~~~~-~~----L~~-----------------~l~~~~~~~~~~~~~~~~~~i~~~ 107 (257)
T cd05115 51 QLDNPYIVRMIGVCE-AEALMLVMEMASG-GP----LNK-----------------FLSGKKDEITVSNVVELMHQVSMG 107 (257)
T ss_pred hcCCCCeEEEEEEEc-CCCeEEEEEeCCC-CC----HHH-----------------HHHhCCCCCCHHHHHHHHHHHHHH
Confidence 456666666666543 3345666666554 21 111 2221 2234455666666777778
Q ss_pred ceeeccCCcccccc-cc---------------ccc------------------------ccC-CCCCccc-e-EEEec--
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YLV------------------------HGT-NLSGVVV-S-AVDFG-- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l~------------------------~~~-~~~~~~~-s-VwsfG-- 118 (189)
+.++|..+++|+|+ |. +++ +|. ....++. + |||||
T Consensus 108 l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~ 187 (257)
T cd05115 108 MKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGIT 187 (257)
T ss_pred HHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHH
Confidence 88888888888875 33 111 111 2345788 9 99999
Q ss_pred -----------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q psy1684 119 -----------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFF 176 (189)
Q Consensus 119 -----------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~ 176 (189)
|.+.+..++...+..|.+++.|..+++++.++|.+||..||++||+|.+|.+.|+.++
T Consensus 188 l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 188 MWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYY 256 (257)
T ss_pred HHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence 4556677788888888888899999999999999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.67 E-value=5e-17 Score=120.22 Aligned_cols=150 Identities=23% Similarity=0.458 Sum_probs=106.1
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC--CCCcCHhHHHHHhhhcc
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG--RTTIHYPELVEHYSKDA 81 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~--~~~~~l~~li~~~~~~a 81 (189)
..++|+|++++++.+......++|+|+...+. +.. ++.. ...+....+..+..+..
T Consensus 57 ~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~-----L~~-----------------~~~~~~~~~~~~~~~~~~~~~i~ 114 (261)
T cd05148 57 KRLRHKHLISLFAVCSVGEPVYIITELMEKGS-----LLA-----------------FLRSPEGQVLPVASLIDMACQVA 114 (261)
T ss_pred hcCCCcchhheeeeEecCCCeEEEEeecccCC-----HHH-----------------HHhcCCCCCCCHHHHHHHHHHHH
Confidence 35678888888776666666778888776532 111 1111 11233455555666667
Q ss_pred CCceeeccCCcccccc-cc---------------c---------------------ccccC-CCCCccc-e-EEEec---
Q psy1684 82 DGLCVNLRKPCVQVSC-RI---------------Y---------------------LVHGT-NLSGVVV-S-AVDFG--- 118 (189)
Q Consensus 82 ~gl~~~~~~~~~~~~~-p~---------------~---------------------l~~~~-~~~~~~~-s-VwsfG--- 118 (189)
.++.++|..+++|+|+ |. + +++|. ..+.++. + |||||
T Consensus 115 ~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l 194 (261)
T cd05148 115 EGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILL 194 (261)
T ss_pred HHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHH
Confidence 7777778777777775 33 1 11221 3356788 9 99999
Q ss_pred ----------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q psy1684 119 ----------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDF 175 (189)
Q Consensus 119 ----------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~ 175 (189)
|.+.+..++...+..+.+++.|..+|+++.++|.+||+.||++|||+++|.+.|+.+
T Consensus 195 ~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 195 YEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 455666778888888888888899999999999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.66 E-value=9.7e-17 Score=121.10 Aligned_cols=165 Identities=22% Similarity=0.296 Sum_probs=114.3
Q ss_pred ChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccC---CCCCcCHhHHHHHhhhccCC
Q psy1684 7 KRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKA---GRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 7 ~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~---~~~~~~l~~li~~~~~~a~g 83 (189)
.|+|++++++.+......++|+|+.+.+....+.... ... ........ ....+....+..+..+.+.|
T Consensus 61 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~------~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a 131 (297)
T cd05089 61 HHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKS---RVL------ETDPAFAKEHGTASTLTSQQLLQFASDVATG 131 (297)
T ss_pred CCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhc---ccc------ccccccccccCccCCCCHHHHHHHHHHHHHH
Confidence 5889998888776666688999987763211110000 000 00000000 01123466677778888899
Q ss_pred ceeeccCCcccccc-cc---------------ccc--------------------ccC-CCCCccc-e-EEEec------
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YLV--------------------HGT-NLSGVVV-S-AVDFG------ 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l~--------------------~~~-~~~~~~~-s-VwsfG------ 118 (189)
+.++|..+++|+|+ |+ |++ +|. ....++. + |||||
T Consensus 132 l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el 211 (297)
T cd05089 132 MQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEI 211 (297)
T ss_pred HHHHHHCCcccCcCCcceEEECCCCeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHH
Confidence 99999999999986 44 222 111 2345788 9 99999
Q ss_pred -------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcC
Q psy1684 119 -------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180 (189)
Q Consensus 119 -------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~~ 180 (189)
|.+.+..++...+..+.+++.|..++.++.+|+.+||..||.+|||+.+|++.|+.+++..+
T Consensus 212 ~t~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 212 VSLGGTPYCGMTCAELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred HcCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 44556677777788888888888999999999999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.4e-17 Score=123.08 Aligned_cols=173 Identities=18% Similarity=0.239 Sum_probs=117.7
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC--ccCC--CCCcCHhHHHHHhhh
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET--QKAG--RTTIHYPELVEHYSK 79 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g--yl~~--~~~~~l~~li~~~~~ 79 (189)
..++|+|++++++.+...+..++|+|+..++. +.-.+... ......+........ +... ...+....+..+..+
T Consensus 58 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~-L~~~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ 135 (290)
T cd05045 58 KQVNHPHVIKLYGACSQDGPLLLIVEYAKYGS-LRSFLRES-RKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQ 135 (290)
T ss_pred hhCCCCCEeeEEEEEecCCCcEEEEEecCCCC-HHHHHHhc-CCccccccccccccccccccCccccccCHHHHHHHHHH
Confidence 45789999999888777778899999887632 21000000 000000000000000 1111 123446667777888
Q ss_pred ccCCceeeccCCcccccc-cc---------------ccccc-----------------------C-CCCCccc-e-EEEe
Q psy1684 80 DADGLCVNLRKPCVQVSC-RI---------------YLVHG-----------------------T-NLSGVVV-S-AVDF 117 (189)
Q Consensus 80 ~a~gl~~~~~~~~~~~~~-p~---------------~l~~~-----------------------~-~~~~~~~-s-Vwsf 117 (189)
.+.|+.++|..+++|+|+ |. ++++. . ....++. + ||||
T Consensus 136 i~~~l~~LH~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~sl 215 (290)
T cd05045 136 ISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSF 215 (290)
T ss_pred HHHHHHHHHHCCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHH
Confidence 889999999999999986 44 22211 0 2344688 8 9999
Q ss_pred c-------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q psy1684 118 G-------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTM 178 (189)
Q Consensus 118 G-------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~ 178 (189)
| |++..+.++...+..+.+++.|..++.++.+++.+||+.||++||++++|++.|++++..
T Consensus 216 G~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 216 GVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred HHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 9 445567778777888888888899999999999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.66 E-value=5.6e-17 Score=120.40 Aligned_cols=149 Identities=24% Similarity=0.349 Sum_probs=103.2
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC-CCCcCHhHHHHHhhhccCC
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG-RTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~-~~~~~l~~li~~~~~~a~g 83 (189)
.++|+|++++++........++|+|+..++. +.. ++.. ...+....+..+..+.+.|
T Consensus 61 ~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~-----L~~-----------------~~~~~~~~~~~~~~~~~~~~l~~~ 118 (266)
T cd05033 61 QFDHPNIIRLEGVVTKSRPVMIITEYMENGS-----LDK-----------------FLRENDGKFTVGQLVGMLRGIASG 118 (266)
T ss_pred hCCCCCcceEeEEEecCCceEEEEEcCCCCC-----HHH-----------------HHHhccCCCCHHHHHHHHHHHHHH
Confidence 4556666666655444445566666655421 111 2221 1234455666666777788
Q ss_pred ceeeccCCcccccc-cc---------------cc-----------------------cccC-CCCCccc-e-EEEec---
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YL-----------------------VHGT-NLSGVVV-S-AVDFG--- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l-----------------------~~~~-~~~~~~~-s-VwsfG--- 118 (189)
+.++|..+++|+|+ |. ++ ++|. ....++. + |||||
T Consensus 119 l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l 198 (266)
T cd05033 119 MKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVM 198 (266)
T ss_pred HHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHH
Confidence 88888888888875 33 11 1111 2355788 8 99999
Q ss_pred ----------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q psy1684 119 ----------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDF 175 (189)
Q Consensus 119 ----------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~ 175 (189)
|.+.+..++...+..+.+++.|..+|..+.+|+.+||+.+|++||++.+|++.|+.+
T Consensus 199 ~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 199 WEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 445666778888888888888889999999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.66 E-value=9.7e-17 Score=122.04 Aligned_cols=172 Identities=21% Similarity=0.271 Sum_probs=116.2
Q ss_pred ChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEec-CCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCce
Q psy1684 7 KRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKR-SSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGLC 85 (189)
Q Consensus 7 ~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~-~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl~ 85 (189)
.|+|++++++.+......++|+|+++.+. +.-.+... ......++.+ .......+...+++.+..+.+.++.
T Consensus 76 ~h~~iv~~~~~~~~~~~~~lv~e~~~~g~-L~~~i~~~~~~~~~~~~~~------~~~~~~~l~~~~~~~~~~qi~~aL~ 148 (314)
T cd05099 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGN-LREFLRARRPPGPDYTFDI------TKVPEEQLSFKDLVSCAYQVARGME 148 (314)
T ss_pred CCCCeeeEEEEEccCCceEEEEecCCCCc-HHHHHHhcCCCcccccccc------cCCcccccCHHHHHHHHHHHHHHHH
Confidence 47788887776665556788888877632 10000000 0000000000 0011123446667777788888999
Q ss_pred eeccCCcccccc-cc---------------cccc-----------------------cC-CCCCccc-e-EEEec-----
Q psy1684 86 VNLRKPCVQVSC-RI---------------YLVH-----------------------GT-NLSGVVV-S-AVDFG----- 118 (189)
Q Consensus 86 ~~~~~~~~~~~~-p~---------------~l~~-----------------------~~-~~~~~~~-s-VwsfG----- 118 (189)
++|..+++|+|+ |+ ++++ |. ..+.++. + |||||
T Consensus 149 ~lH~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~e 228 (314)
T cd05099 149 YLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWE 228 (314)
T ss_pred HHHHCCeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHH
Confidence 999999999886 44 2221 11 2345788 9 99999
Q ss_pred --------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcCCCCCC
Q psy1684 119 --------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEGSDYKE 185 (189)
Q Consensus 119 --------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~ 185 (189)
|.+.+..++...+..+.++..|..+|.++.+|+.+||..||++|||+.++++.|+.+......+|.+
T Consensus 229 l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~ 303 (314)
T cd05099 229 IFTLGGSPYPGIPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSEEYLD 303 (314)
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcCCcee
Confidence 4455567777778788777888899999999999999999999999999999999998877666653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.65 E-value=6.8e-17 Score=121.41 Aligned_cols=167 Identities=14% Similarity=0.190 Sum_probs=114.5
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC---CCCcCHhHHHHHhhhc
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG---RTTIHYPELVEHYSKD 80 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~---~~~~~l~~li~~~~~~ 80 (189)
..+.|+|++++++.+...+..++|.|+..++. +.-.+.. .+.... ++.. ...+.......+..+.
T Consensus 62 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~-L~~~i~~--~~~~~~---------~~~~~~~~~~l~~~~~~~~~~ql 129 (288)
T cd05093 62 TNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGD-LNKFLRA--HGPDAV---------LMAEGNRPAELTQSQMLHIAQQI 129 (288)
T ss_pred HhCCCCCcceEEEEEecCCccEEEEEcCCCCC-HHHHHHH--cCCccc---------cccccCCCCCCCHHHHHHHHHHH
Confidence 35678888888887776777888888877632 2100000 000000 1111 1123455666677788
Q ss_pred cCCceeeccCCcccccc-cc---------------cc-----------------------cccC-CCCCccc-e-EEEec
Q psy1684 81 ADGLCVNLRKPCVQVSC-RI---------------YL-----------------------VHGT-NLSGVVV-S-AVDFG 118 (189)
Q Consensus 81 a~gl~~~~~~~~~~~~~-p~---------------~l-----------------------~~~~-~~~~~~~-s-VwsfG 118 (189)
+.++.++|..+++|+|+ |. ++ ++|. ....++. + |||||
T Consensus 130 ~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG 209 (288)
T cd05093 130 AAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLG 209 (288)
T ss_pred HHHHHHHHhCCeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHH
Confidence 88888888888888885 43 11 2221 3345788 9 99999
Q ss_pred -------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcCCCC
Q psy1684 119 -------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEGSDY 183 (189)
Q Consensus 119 -------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~~~~~ 183 (189)
|.+.+..++...+..+..++.|..+|.++.+|+.+||+.||.+|||+.++...|+.+.+. .+.|
T Consensus 210 ~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~-~~~~ 286 (288)
T cd05093 210 VVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA-SPVY 286 (288)
T ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh-cccc
Confidence 444556777788888877777888999999999999999999999999999999998864 3444
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.65 E-value=8.2e-17 Score=118.87 Aligned_cols=147 Identities=17% Similarity=0.258 Sum_probs=101.5
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC-CCCcCHhHHHHHhhhccC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG-RTTIHYPELVEHYSKDAD 82 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~-~~~~~l~~li~~~~~~a~ 82 (189)
..+.|+|++++++.+......++|+|+.+++. + .. ++.. ...+....+..+..+.+.
T Consensus 54 ~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~-L----~~-----------------~~~~~~~~~~~~~~~~~~~~i~~ 111 (256)
T cd05114 54 MKLSHPKLVQLYGVCTQQKPLYIVTEFMENGC-L----LN-----------------YLRQRQGKLSKDMLLSMCQDVCE 111 (256)
T ss_pred HHCCCCCceeEEEEEccCCCEEEEEEcCCCCc-H----HH-----------------HHHhCccCCCHHHHHHHHHHHHH
Confidence 34667777777776666666777777776522 1 11 1211 112334455566667777
Q ss_pred CceeeccCCcccccc-cc---------------ccc----------------------ccC-CCCCccc-e-EEEec---
Q psy1684 83 GLCVNLRKPCVQVSC-RI---------------YLV----------------------HGT-NLSGVVV-S-AVDFG--- 118 (189)
Q Consensus 83 gl~~~~~~~~~~~~~-p~---------------~l~----------------------~~~-~~~~~~~-s-VwsfG--- 118 (189)
++.++|..+++|+|+ |. +++ +|. ....++. + |||||
T Consensus 112 ~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l 191 (256)
T cd05114 112 GMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLM 191 (256)
T ss_pred HHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHH
Confidence 788888888888775 33 111 111 2345788 9 99999
Q ss_pred ----------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q psy1684 119 ----------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKL 172 (189)
Q Consensus 119 ----------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l 172 (189)
|.+.+..++...+.++.++..|...+.++.+|+.+||+.||++||++++|++.|
T Consensus 192 ~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 192 WEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 334455677788888888888888999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.65 E-value=5e-17 Score=122.03 Aligned_cols=166 Identities=19% Similarity=0.218 Sum_probs=110.9
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC---ccCCCCCcCHhHHHHHhhhcc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET---QKAGRTTIHYPELVEHYSKDA 81 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g---yl~~~~~~~l~~li~~~~~~a 81 (189)
.+.|+|++++++.+...+..++|+|+.+.+. +.-.+.. ............... +......+...++..+..+.+
T Consensus 64 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~-L~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~ 140 (288)
T cd05050 64 EFDHPNIVKLLGVCAVGKPMCLLFEYMAYGD-LNEFLRH--RSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVA 140 (288)
T ss_pred hcCCCchheEEEEEcCCCccEEEEecCCCCC-HHHHHHH--cCccccccccccccccccccccccccCHHHHHHHHHHHH
Confidence 5678999998888777778899999888732 2100110 000000000000000 111122334555667777788
Q ss_pred CCceeeccCCcccccc-cc---------------ccc-----------------------ccC-CCCCccc-e-EEEec-
Q psy1684 82 DGLCVNLRKPCVQVSC-RI---------------YLV-----------------------HGT-NLSGVVV-S-AVDFG- 118 (189)
Q Consensus 82 ~gl~~~~~~~~~~~~~-p~---------------~l~-----------------------~~~-~~~~~~~-s-VwsfG- 118 (189)
.++.++|...++|+|+ |. +++ +|. ....++. + |||||
T Consensus 141 ~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~ 220 (288)
T cd05050 141 AGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGV 220 (288)
T ss_pred HHHHHHHhCCeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHH
Confidence 8888888888888875 33 211 111 3356788 9 99999
Q ss_pred ------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q psy1684 119 ------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLE 173 (189)
Q Consensus 119 ------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~ 173 (189)
|.+.+..++...+..+..++.|..+|.++.+|+.+||+.+|++|||+.||++.|+
T Consensus 221 il~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 221 VLWEIFSYGMQPYYGMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 3455667788888888777788899999999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=99.65 E-value=2e-16 Score=123.46 Aligned_cols=145 Identities=10% Similarity=0.083 Sum_probs=108.0
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
....|+|+|.+|......+..|+|+|++.. |.++ + .+.++ .+...++...+.....|
T Consensus 325 ~~~~H~NiVnfl~Sylv~deLWVVMEym~g-gsLT----D----vVt~~--------------~~~E~qIA~Icre~l~a 381 (550)
T KOG0578|consen 325 RDLHHPNIVNFLDSYLVGDELWVVMEYMEG-GSLT----D----VVTKT--------------RMTEGQIAAICREILQG 381 (550)
T ss_pred HhccchHHHHHHHHhcccceeEEEEeecCC-Cchh----h----hhhcc--------------cccHHHHHHHHHHHHHH
Confidence 456899999999866666779999999998 5221 1 22222 12233344444556678
Q ss_pred ceeeccCCcccccccc-------------------------------------cccccC-CCCCccc-e-EEEec-----
Q psy1684 84 LCVNLRKPCVQVSCRI-------------------------------------YLVHGT-NLSGVVV-S-AVDFG----- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~p~-------------------------------------~l~~~~-~~~~~~~-s-VwsfG----- 118 (189)
|.++|..+|+|||+.. |||+|+ ....|.. . |||+|
T Consensus 382 L~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIE 461 (550)
T KOG0578|consen 382 LKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIE 461 (550)
T ss_pred HHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHH
Confidence 8888888888887655 788777 4556999 9 99999
Q ss_pred -------CCCCChHHHHHHHHc-C-CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 119 -------SGGMTNAEVLHQVEH-G-YRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 119 -------~~~~~~~~~~~~v~~-g-~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
|-..++.+.+..+.. | ..+..|...++++++++.+|+..|+.+||+++|+++.
T Consensus 462 MveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 462 MVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred HhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 666677788888854 4 2345678899999999999999999999999999874
|
|
| >cd00173 SH2 Src homology 2 domains; Signal transduction, involved in recognition of phosphorylated tyrosine (pTyr) | Back alignment and domain information |
|---|
Probab=99.65 E-value=2.9e-15 Score=94.15 Aligned_cols=87 Identities=43% Similarity=0.590 Sum_probs=74.1
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC-ccCC-CCCcC-HhHHHHHh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET-QKAG-RTTIH-YPELVEHY 77 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g-yl~~-~~~~~-l~~li~~~ 77 (189)
||||.|++..|+++|.. ..+|+||||.+.+..+.|+||++. .+.+.|++|....++ ++.. ...|. +.+|++++
T Consensus 2 w~~g~i~r~~Ae~~L~~--~~~G~FLiR~s~~~~~~~~Lsv~~--~~~v~H~~I~~~~~~~~~~~~~~~f~sl~eLv~~y 77 (94)
T cd00173 2 WYHGPISREEAEELLKK--KPDGTFLVRDSESSPGDYVLSVRV--KGKVKHYRIERTDDGYYLLGEGRSFPSLPELIEHY 77 (94)
T ss_pred ccccCCCHHHHHHHHhc--CCCceEEEEecCCCCCCEEEEEEE--CCEEEEEEEEECCCCeEEecCCCccCCHHHHHHHH
Confidence 99999999999999965 578999999999777999999999 899999999999888 4443 66788 99999999
Q ss_pred hhcc--CCceeeccCC
Q psy1684 78 SKDA--DGLCVNLRKP 91 (189)
Q Consensus 78 ~~~a--~gl~~~~~~~ 91 (189)
.... .++...+..|
T Consensus 78 ~~~~~~~~~~~~L~~p 93 (94)
T cd00173 78 QKNPLSDGLGVKLRYP 93 (94)
T ss_pred hhCccCCCcccEeCCc
Confidence 9887 5655555444
|
SH2 domains typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.64 E-value=3.8e-17 Score=123.66 Aligned_cols=165 Identities=19% Similarity=0.266 Sum_probs=106.0
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC--ccCCCCCcCHhHHHHHhhhcc
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET--QKAGRTTIHYPELVEHYSKDA 81 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g--yl~~~~~~~l~~li~~~~~~a 81 (189)
..++|+|++++++.+...+..+||+|++.++....+ +.. . .. .........+ .......+....+..+..+.+
T Consensus 74 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~-l~~--~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~ 148 (304)
T cd05096 74 SRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQF-LSS--H-HL-DDKEENGNDAVPPAHCLPAISYSSLLHVALQIA 148 (304)
T ss_pred hhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHH-HHh--c-cc-cccccccccccccccccccccHHHHHHHHHHHH
Confidence 457899999988887777778999999876331110 000 0 00 0000000000 011112233566777788888
Q ss_pred CCceeeccCCcccccc-cc---------------cccc-----------------------cC-CCCCccc-e-EEEec-
Q psy1684 82 DGLCVNLRKPCVQVSC-RI---------------YLVH-----------------------GT-NLSGVVV-S-AVDFG- 118 (189)
Q Consensus 82 ~gl~~~~~~~~~~~~~-p~---------------~l~~-----------------------~~-~~~~~~~-s-VwsfG- 118 (189)
.|+.++|..+++|+|+ |+ |++. |. ..+.++. + |||||
T Consensus 149 ~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~ 228 (304)
T cd05096 149 SGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGV 228 (304)
T ss_pred HHHHHHHHCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHH
Confidence 9999999999999986 44 3222 11 2356788 9 99999
Q ss_pred -------------CCCCChHHHHHHHHc-------CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q psy1684 119 -------------SGGMTNAEVLHQVEH-------GYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLE 173 (189)
Q Consensus 119 -------------~~~~~~~~~~~~v~~-------g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~ 173 (189)
|.+.+..+++..+.. ...+..|+.||..+.+||.+||+.||++|||+.+|.+.|+
T Consensus 229 ~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 229 TLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred HHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 444555555544321 1123456789999999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.64 E-value=9.3e-17 Score=118.82 Aligned_cols=148 Identities=26% Similarity=0.482 Sum_probs=100.6
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC--CCCcCHhHHHHHhhhccC
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG--RTTIHYPELVEHYSKDAD 82 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~--~~~~~l~~li~~~~~~a~ 82 (189)
.++|+|++++++........+||+|++.++. +.. ++.. ...+.+.....+..+.+.
T Consensus 57 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~-----L~~-----------------~l~~~~~~~~~~~~~~~~~~~l~~ 114 (261)
T cd05072 57 TLQHDKLVRLYAVVTKEEPIYIITEYMAKGS-----LLD-----------------FLKSDEGGKVLLPKLIDFSAQIAE 114 (261)
T ss_pred hCCCCCeeeEEEEEcCCCCcEEEEecCCCCc-----HHH-----------------HHHHhcCCCCCHHHHHHHHHHHHH
Confidence 4556666666555544455566666665422 111 2211 122335555666667777
Q ss_pred CceeeccCCcccccc-cc---------------cc----------------------cccC-CCCCccc-e-EEEec---
Q psy1684 83 GLCVNLRKPCVQVSC-RI---------------YL----------------------VHGT-NLSGVVV-S-AVDFG--- 118 (189)
Q Consensus 83 gl~~~~~~~~~~~~~-p~---------------~l----------------------~~~~-~~~~~~~-s-VwsfG--- 118 (189)
|+.++|..+++|+|+ |. ++ ++|. ..+.++. + |||||
T Consensus 115 ~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l 194 (261)
T cd05072 115 GMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILL 194 (261)
T ss_pred HHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHH
Confidence 888888888888775 43 11 1111 3355788 8 99999
Q ss_pred ----------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q psy1684 119 ----------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLED 174 (189)
Q Consensus 119 ----------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~ 174 (189)
|.+.+..++...+..+.+.+.+..+|.++.+++.+||..||++||++++|.+.|++
T Consensus 195 ~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 195 YEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred HHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 44555677777888888777778899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.64 E-value=6.7e-17 Score=120.24 Aligned_cols=108 Identities=30% Similarity=0.476 Sum_probs=85.0
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cccccC------------------------CC
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVHGT------------------------NL 107 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~~~------------------------~~ 107 (189)
+....+..+..+.+.|+.++|..+++|+|+ |+ |++... ..
T Consensus 109 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 188 (272)
T cd05075 109 LPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLAD 188 (272)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccC
Confidence 335556667778888999999999999886 44 222110 23
Q ss_pred CCccc-e-EEEec-------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q psy1684 108 SGVVV-S-AVDFG-------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKL 172 (189)
Q Consensus 108 ~~~~~-s-VwsfG-------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l 172 (189)
..++. + ||||| |.+....++...+.++.+++.+..++..+.+++.+||+.||++|||+.+|++.|
T Consensus 189 ~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 268 (272)
T cd05075 189 RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCEL 268 (272)
T ss_pred CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 44678 8 99999 455667778888888887778889999999999999999999999999999999
Q ss_pred HHH
Q psy1684 173 EDF 175 (189)
Q Consensus 173 ~~~ 175 (189)
+++
T Consensus 269 ~~~ 271 (272)
T cd05075 269 EKA 271 (272)
T ss_pred Hhh
Confidence 875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.2e-16 Score=118.78 Aligned_cols=150 Identities=20% Similarity=0.288 Sum_probs=102.8
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC-CCCcCHhHHHHHhhhccC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG-RTTIHYPELVEHYSKDAD 82 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~-~~~~~l~~li~~~~~~a~ 82 (189)
..+.|+|++++++.+......++|+|+... +.+ .. ++.. ...+...++..+..+.+.
T Consensus 60 ~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~-~~L----~~-----------------~l~~~~~~~~~~~~~~i~~~l~~ 117 (269)
T cd05065 60 GQFDHPNIIHLEGVVTKSRPVMIITEFMEN-GAL----DS-----------------FLRQNDGQFTVIQLVGMLRGIAA 117 (269)
T ss_pred HhCCCcCcceEEEEECCCCceEEEEecCCC-CcH----HH-----------------HHhhCCCCCCHHHHHHHHHHHHH
Confidence 356788888877766666667888887765 311 11 1111 122334555555566666
Q ss_pred CceeeccCCcccccc-cc---------------c--------------------------ccccC-CCCCccc-e-EEEe
Q psy1684 83 GLCVNLRKPCVQVSC-RI---------------Y--------------------------LVHGT-NLSGVVV-S-AVDF 117 (189)
Q Consensus 83 gl~~~~~~~~~~~~~-p~---------------~--------------------------l~~~~-~~~~~~~-s-Vwsf 117 (189)
++.++|..+++|+|+ |. + +++|. ....++. + ||||
T Consensus 118 al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dvwsl 197 (269)
T cd05065 118 GMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSY 197 (269)
T ss_pred HHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhh
Confidence 777777777777664 32 1 11111 2355788 8 9999
Q ss_pred c-------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q psy1684 118 G-------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDF 175 (189)
Q Consensus 118 G-------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~ 175 (189)
| |.+.+..++...+..+.+.+.|..+|..+.+++.+||..+|++||++.+|+..|+.+
T Consensus 198 G~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 198 GIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 9 334456677777777777888889999999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.64 E-value=5.5e-17 Score=126.34 Aligned_cols=109 Identities=26% Similarity=0.461 Sum_probs=83.2
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------ccccc-----------------------C-CC
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVHG-----------------------T-NL 107 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~~-----------------------~-~~ 107 (189)
+....+..+..+++.|+.++|..+++|||+ |+ |++.. . ..
T Consensus 209 l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 288 (374)
T cd05106 209 LDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFD 288 (374)
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcC
Confidence 335667778889999999999999999996 44 22221 1 23
Q ss_pred CCccc-e-EEEec-------------CCCCChH-HHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 108 SGVVV-S-AVDFG-------------SGGMTNA-EVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 108 ~~~~~-s-VwsfG-------------~~~~~~~-~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
+.++. + ||||| |++.... .+...+..+.++..|...|+++.+++.+||+.||++|||+.+|++.
T Consensus 289 ~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~ 368 (374)
T cd05106 289 CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQL 368 (374)
T ss_pred CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 45788 9 99999 3333332 3334456667777788889999999999999999999999999999
Q ss_pred HHHHH
Q psy1684 172 LEDFF 176 (189)
Q Consensus 172 l~~~~ 176 (189)
|+.++
T Consensus 369 l~~~~ 373 (374)
T cd05106 369 IQRQL 373 (374)
T ss_pred HHHHh
Confidence 98875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.64 E-value=7.1e-17 Score=119.32 Aligned_cols=148 Identities=19% Similarity=0.258 Sum_probs=104.9
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC-CCCcCHhHHHHHhhhccC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG-RTTIHYPELVEHYSKDAD 82 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~-~~~~~l~~li~~~~~~a~ 82 (189)
..+.|+|++++++.+...+..++|+|+...+. +.. ++.. ...+....+..+..+.+.
T Consensus 54 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~-----l~~-----------------~i~~~~~~~~~~~~~~~~~~i~~ 111 (256)
T cd05113 54 MKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGC-----LLN-----------------YLREHGKRFQPSQLLEMCKDVCE 111 (256)
T ss_pred hcCCCCCeeeEEEEEccCCCcEEEEEcCCCCc-----HHH-----------------HHHhcCCCCCHHHHHHHHHHHHH
Confidence 45678888888877766667788888766521 111 1211 112345666777778888
Q ss_pred CceeeccCCcccccc-cc---------------ccc----------------------ccC-CCCCccc-e-EEEec---
Q psy1684 83 GLCVNLRKPCVQVSC-RI---------------YLV----------------------HGT-NLSGVVV-S-AVDFG--- 118 (189)
Q Consensus 83 gl~~~~~~~~~~~~~-p~---------------~l~----------------------~~~-~~~~~~~-s-VwsfG--- 118 (189)
|+.++|..+++|+|+ |. +++ +|. ....++. + |||||
T Consensus 112 ~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l 191 (256)
T cd05113 112 GMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLM 191 (256)
T ss_pred HHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHH
Confidence 888888888888875 33 111 111 2345788 9 99999
Q ss_pred ----------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q psy1684 119 ----------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLE 173 (189)
Q Consensus 119 ----------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~ 173 (189)
|...+..++...+..+.+.+.|...+..+++++.+||+.||++||++.+|++.|+
T Consensus 192 ~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 192 WEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 3334556677778888888788888999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PF00017 SH2: SH2 domain; InterPro: IPR000980 The Src homology 2 (SH2) domain is a protein domain of about 100 amino-acid residues first identified as a conserved sequence region between the oncoproteins Src and Fps [] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.5e-15 Score=91.93 Aligned_cols=74 Identities=31% Similarity=0.411 Sum_probs=67.4
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC--ccCCCCCcC-HhHHHHHh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET--QKAGRTTIH-YPELVEHY 77 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g--yl~~~~~~~-l~~li~~~ 77 (189)
||||.|++.+|+++|.. ..++|+||||.+.+.++.|+|+++. .+.+.|++|.+..++ ++.....|. +.+|++||
T Consensus 1 W~~g~isr~~Ae~~L~~-~~~~G~FLvR~s~~~~~~~~Lsv~~--~~~v~h~~I~~~~~~~~~~~~~~~F~sl~~LV~~y 77 (77)
T PF00017_consen 1 WFHGFISRQEAERLLMQ-GKPDGTFLVRPSSSKPGKYVLSVRF--DGKVKHFRINRTENGGYFLSDGKKFPSLSDLVEHY 77 (77)
T ss_dssp TBEESSHHHHHHHHHHT-TSSTTEEEEEEESSSTTSEEEEEEE--TTEEEEEEEEEETTSEEESSTSSEBSSHHHHHHHH
T ss_pred CcCCCCCHHHHHHHHHh-cCCCCeEEEEecccccccccccccc--ccccEEEEEEecCCceEEccCCCcCCCHHHHHHhC
Confidence 99999999999999976 5689999999999888999999999 999999999999888 676667788 99999886
|
Similar sequences were later found in many other intracellular signal-transducing proteins []. SH2 domains function as regulatory modules of intracellular signalling cascades by interacting with high affinity to phosphotyrosine-containing target peptides in a sequence-specific, SH2 domains recognise between 3-6 residues C-terminal to the phosphorylated tyrosine in a fashion that differs from one SH2 domain to another, and strictly phosphorylation-dependent manner [, , , ]. They are found in a wide variety of protein contexts e.g., in association with catalytic domains of phospholipase Cy (PLCy) and the non-receptor protein tyrosine kinases; within structural proteins such as fodrin and tensin; and in a group of small adaptor molecules, i.e Crk and Nck. The domains are frequently found as repeats in a single protein sequence and will then often bind both mono- and di-phosphorylated substrates. The structure of the SH2 domain belongs to the alpha+beta class, its overall shape forming a compact flattened hemisphere. The core structural elements comprise a central hydrophobic anti-parallel beta-sheet, flanked by 2 short alpha-helices. The loop between strands 2 and 3 provides many of the binding interactions with the phosphate group of its phosphopeptide ligand, and is hence designated the phosphate binding loop, the phosphorylated ligand binds perpendicular to the beta-sheet and typically interacts with the phosphate binding loop and a hydrophobic binding pocket that interacts with a pY+3 side chain. The N- and C-termini of the domain are close together in space and on the opposite face from the phosphopeptide binding surface and it has been speculated that this has facilitated their integration into surface-exposed regions of host proteins [].; GO: 0005515 protein binding; PDB: 1M27_A 1KA6_A 1D4W_B 1D4T_A 1D1Z_B 1KA7_A 1UUR_A 1UUS_A 1BLJ_A 1BLK_A .... |
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=99.64 E-value=5.3e-17 Score=124.58 Aligned_cols=146 Identities=13% Similarity=0.097 Sum_probs=110.8
Q ss_pred CCCC-hHHHHHHhcCCCCCC-CcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhcc
Q psy1684 4 GKIK-RIEAEKKLLLPENDH-GAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDA 81 (189)
Q Consensus 4 g~l~-~~n~~~lL~~~~~~~-g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a 81 (189)
.+|+ |+|++++..+-.+.+ ..|+|+|+|.. +.|-| .++ .+..|+..++.++..|+.
T Consensus 63 ~kln~hpniikL~Evi~d~~~~L~fVfE~Md~-NLYqL-mK~--------------------R~r~fse~~irnim~Qil 120 (538)
T KOG0661|consen 63 RKLNPHPNIIKLKEVIRDNDRILYFVFEFMDC-NLYQL-MKD--------------------RNRLFSESDIRNIMYQIL 120 (538)
T ss_pred HhcCCCCcchhhHHHhhccCceEeeeHHhhhh-hHHHH-Hhh--------------------cCCcCCHHHHHHHHHHHH
Confidence 4677 999999888776666 78999999987 53322 111 134566788888999999
Q ss_pred CCceeeccCCcccccc-cc---------------cccccC----------------------CCCCccc-e-EEEec---
Q psy1684 82 DGLCVNLRKPCVQVSC-RI---------------YLVHGT----------------------NLSGVVV-S-AVDFG--- 118 (189)
Q Consensus 82 ~gl~~~~~~~~~~~~~-p~---------------~l~~~~----------------------~~~~~~~-s-VwsfG--- 118 (189)
+||+++|..+..|||+ || |||++. +.+-||. . +||+|
T Consensus 121 qGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~ 200 (538)
T KOG0661|consen 121 QGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIM 200 (538)
T ss_pred HHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHH
Confidence 9999999999999995 77 778877 6778999 8 99999
Q ss_pred ---------CCCCChHHHHHHHHc--------------------CCCCCC-C--------CCCCHHHHHHHHHhcccCCC
Q psy1684 119 ---------SGGMTNAEVLHQVEH--------------------GYRMPC-P--------PGCPPRLYDIMLECWLKDPV 160 (189)
Q Consensus 119 ---------~~~~~~~~~~~~v~~--------------------g~~~~~-p--------~~~p~~~~~l~~~C~~~~p~ 160 (189)
|+|.+..+-+.+|.. +.+.|. + +.++.+..+||.+|+++||+
T Consensus 201 aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~ 280 (538)
T KOG0661|consen 201 AELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPD 280 (538)
T ss_pred HHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCc
Confidence 888775443333311 112221 1 24888999999999999999
Q ss_pred CCCCHHHHHHH
Q psy1684 161 KRPTFETLQWK 171 (189)
Q Consensus 161 ~RP~~~~i~~~ 171 (189)
+|||+++.++.
T Consensus 281 kRpTA~~al~~ 291 (538)
T KOG0661|consen 281 KRPTASQALQH 291 (538)
T ss_pred cCccHHHHhcC
Confidence 99999998864
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.2e-16 Score=119.05 Aligned_cols=162 Identities=21% Similarity=0.298 Sum_probs=107.9
Q ss_pred ChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCcc---CCCCCcCHhHHHHHhhhccCC
Q psy1684 7 KRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQK---AGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 7 ~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl---~~~~~~~l~~li~~~~~~a~g 83 (189)
.|+|++++++.+....-.++|+|+.+++....+.... .. ......+. .....+....+..+..+.+.+
T Consensus 54 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~----~~-----~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~a 124 (270)
T cd05047 54 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKS----RV-----LETDPAFAIANSTASTLSSQQLLHFAADVARG 124 (270)
T ss_pred cCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhc----cc-----cccccccccccCCcCCCCHHHHHHHHHHHHHH
Confidence 5777777776665555567788877653211100000 00 00000000 011234466677777888889
Q ss_pred ceeeccCCcccccc-cc---------------cccc--------------------cC-CCCCccc-e-EEEec------
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YLVH--------------------GT-NLSGVVV-S-AVDFG------ 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l~~--------------------~~-~~~~~~~-s-VwsfG------ 118 (189)
+.++|..+++|+|+ |. +++. |. ....++. + |||||
T Consensus 125 l~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el 204 (270)
T cd05047 125 MDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 204 (270)
T ss_pred HHHHHHCCEeecccccceEEEcCCCeEEECCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHH
Confidence 99999999999986 44 2221 11 2345788 8 99999
Q ss_pred -------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q psy1684 119 -------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFT 177 (189)
Q Consensus 119 -------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~ 177 (189)
|.+.+..++...+..+.+++.|..++.++.+|+.+||..||.+|||+.+++..|+.+++
T Consensus 205 ~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~~ 270 (270)
T cd05047 205 VSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 270 (270)
T ss_pred HcCCCCCccccCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhhC
Confidence 44445566777777777788888899999999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.3e-16 Score=118.60 Aligned_cols=108 Identities=28% Similarity=0.441 Sum_probs=86.0
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cccc-----------------------cC-CC
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVH-----------------------GT-NL 107 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~-----------------------~~-~~ 107 (189)
+....+..+..+.+.|+.++|..+++|+|+ |+ ++++ +. ..
T Consensus 110 ~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 189 (273)
T cd05035 110 LPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD 189 (273)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhccc
Confidence 345666667778888999999999999886 44 2221 11 23
Q ss_pred CCccc-e-EEEec-------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q psy1684 108 SGVVV-S-AVDFG-------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKL 172 (189)
Q Consensus 108 ~~~~~-s-VwsfG-------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l 172 (189)
..++. + ||||| |.+.+..++...+..+..++.|..++.++.+++.+||+.||++|||+.++++.|
T Consensus 190 ~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l 269 (273)
T cd05035 190 RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVL 269 (273)
T ss_pred CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 45778 9 99999 556667788888888888888899999999999999999999999999999999
Q ss_pred HHH
Q psy1684 173 EDF 175 (189)
Q Consensus 173 ~~~ 175 (189)
+++
T Consensus 270 ~~~ 272 (273)
T cd05035 270 ENI 272 (273)
T ss_pred Hhh
Confidence 875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.9e-16 Score=120.47 Aligned_cols=161 Identities=23% Similarity=0.308 Sum_probs=114.0
Q ss_pred ChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC--cc-----CCCCCcCHhHHHHHhhh
Q psy1684 7 KRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET--QK-----AGRTTIHYPELVEHYSK 79 (189)
Q Consensus 7 ~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g--yl-----~~~~~~~l~~li~~~~~ 79 (189)
.|+|++++.+.+......++|.|+.+++. +... +.. ....+ +. .....+.+..++.+..+
T Consensus 76 ~h~~iv~~~~~~~~~~~~~lv~e~~~~g~-----L~~~----l~~----~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~q 142 (334)
T cd05100 76 KHKNIINLLGACTQDGPLYVLVEYASKGN-----LREY----LRA----RRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQ 142 (334)
T ss_pred CCCCeeeeeEEEccCCceEEEEecCCCCc-----HHHH----HHh----cCCcccccccccccCccccCCHHHHHHHHHH
Confidence 58888888877766666788888877632 1110 000 00000 00 01123446667777888
Q ss_pred ccCCceeeccCCcccccc-cc---------------cccc-----------------------cC-CCCCccc-e-EEEe
Q psy1684 80 DADGLCVNLRKPCVQVSC-RI---------------YLVH-----------------------GT-NLSGVVV-S-AVDF 117 (189)
Q Consensus 80 ~a~gl~~~~~~~~~~~~~-p~---------------~l~~-----------------------~~-~~~~~~~-s-Vwsf 117 (189)
.+.|+.++|..+++|+|+ |. ++++ |. ....++. + ||||
T Consensus 143 i~~al~~LH~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 222 (334)
T cd05100 143 VARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 222 (334)
T ss_pred HHHHHHHHHHCCeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHH
Confidence 889999999999999985 44 2221 11 2345788 9 9999
Q ss_pred c-------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcC
Q psy1684 118 G-------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180 (189)
Q Consensus 118 G-------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~~ 180 (189)
| |.+.+..++...+..+.+++.|..++.++.+|+.+||+.+|++||++.+|++.|+.+.....
T Consensus 223 G~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 223 GVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred HHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 9 45556677777788888888888999999999999999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.6e-16 Score=118.80 Aligned_cols=116 Identities=23% Similarity=0.374 Sum_probs=89.2
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------c-----------------------ccccC-CC
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------Y-----------------------LVHGT-NL 107 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~-----------------------l~~~~-~~ 107 (189)
+....+..+..+.+.|+.++|..+++|+|+ |. + +++|. ..
T Consensus 106 ~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~ 185 (279)
T cd05057 106 IGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH 185 (279)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhc
Confidence 345566667777888888888888888875 33 1 11221 23
Q ss_pred CCccc-e-EEEec-------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q psy1684 108 SGVVV-S-AVDFG-------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKL 172 (189)
Q Consensus 108 ~~~~~-s-VwsfG-------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l 172 (189)
..++. + ||||| |.+.+..++...+..+...+.|..++.++.+++.+||..||++||++.++++.|
T Consensus 186 ~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l 265 (279)
T cd05057 186 RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEF 265 (279)
T ss_pred CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 56788 8 99999 455566778888888888888889999999999999999999999999999999
Q ss_pred HHHHhhcCCCCC
Q psy1684 173 EDFFTMEGSDYK 184 (189)
Q Consensus 173 ~~~~~~~~~~~~ 184 (189)
+++.+ ..+.|.
T Consensus 266 ~~~~~-~~~~~~ 276 (279)
T cd05057 266 SKMAR-DPQRYL 276 (279)
T ss_pred HHHHh-CCcceE
Confidence 99876 444443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.4e-16 Score=117.87 Aligned_cols=107 Identities=49% Similarity=0.891 Sum_probs=82.7
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cc----------------------cccC-CCC
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YL----------------------VHGT-NLS 108 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l----------------------~~~~-~~~ 108 (189)
+....+..+..+.+.|+.++|..+++|+|+ |. ++ ++|. ...
T Consensus 100 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 179 (261)
T cd05068 100 LKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYN 179 (261)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCCCcCceeccCccccccC
Confidence 445666666777778888888888888875 44 11 1221 234
Q ss_pred Cccc-e-EEEec-------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q psy1684 109 GVVV-S-AVDFG-------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLE 173 (189)
Q Consensus 109 ~~~~-s-VwsfG-------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~ 173 (189)
.++. + ||||| |.+.+..++...+..+.+++.|..+|..+.+++.+||+.+|++||++.+|.+.|+
T Consensus 180 ~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~ 259 (261)
T cd05068 180 RFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLE 259 (261)
T ss_pred CCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHh
Confidence 5688 9 99999 4566677777788777777788899999999999999999999999999999997
Q ss_pred H
Q psy1684 174 D 174 (189)
Q Consensus 174 ~ 174 (189)
+
T Consensus 260 ~ 260 (261)
T cd05068 260 D 260 (261)
T ss_pred c
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.62 E-value=5.6e-17 Score=121.13 Aligned_cols=145 Identities=13% Similarity=0.088 Sum_probs=98.1
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC-CCCcCHhHHHHHhhhccC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG-RTTIHYPELVEHYSKDAD 82 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~-~~~~~l~~li~~~~~~a~ 82 (189)
..++|+|++++++.+......+||+|++++ |.+ .. ++.. ...++....+.+..+.+.
T Consensus 71 ~~l~h~niv~~~~~~~~~~~~~lv~ey~~~-g~L----~~-----------------~l~~~~~~~~~~~~~~i~~qi~~ 128 (274)
T cd05076 71 SQVSHIHLAFVHGVCVRGSENIMVEEFVEH-GPL----DV-----------------CLRKEKGRVPVAWKITVAQQLAS 128 (274)
T ss_pred hcCCCCCeeeEEEEEEeCCceEEEEecCCC-CcH----HH-----------------HHHhcCCCCCHHHHHHHHHHHHH
Confidence 467899999999888777778899998887 321 11 1111 223445556677778888
Q ss_pred CceeeccCCcccccc-ccc---------------------------------------ccccC-C-CCCccc-e-EEEec
Q psy1684 83 GLCVNLRKPCVQVSC-RIY---------------------------------------LVHGT-N-LSGVVV-S-AVDFG 118 (189)
Q Consensus 83 gl~~~~~~~~~~~~~-p~~---------------------------------------l~~~~-~-~~~~~~-s-VwsfG 118 (189)
|+.++|..+++|+|+ |.. ++++. . ...++. + |||||
T Consensus 129 ~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG 208 (274)
T cd05076 129 ALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFG 208 (274)
T ss_pred HHHHHHcCCccCCCCCcccEEEeccCcccCccceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHHHHHHH
Confidence 889999988888885 431 11111 1 234788 8 99999
Q ss_pred -------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q psy1684 119 -------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKL 172 (189)
Q Consensus 119 -------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l 172 (189)
|.+.+..+....+.... ..|...++++.++|.+||+.+|++||||++|++.|
T Consensus 209 ~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 209 TTLLEICFDGEVPLKERTPSEKERFYEKKH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHHHHhCCCCCccccChHHHHHHHHhcc--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 33333344433333333 33444567899999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.5e-16 Score=117.47 Aligned_cols=116 Identities=30% Similarity=0.429 Sum_probs=87.1
Q ss_pred ccCCCCCcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------c------------------------
Q psy1684 61 QKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------Y------------------------ 100 (189)
Q Consensus 61 yl~~~~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~------------------------ 100 (189)
++.....++......+..+.+.++.++|..+++|+|+ |+ +
T Consensus 85 ~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y 164 (257)
T cd05060 85 YLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKW 164 (257)
T ss_pred HHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccc
Confidence 4443334445566667777788888888888888885 44 1
Q ss_pred ccccC-CCCCccc-e-EEEec-------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q psy1684 101 LVHGT-NLSGVVV-S-AVDFG-------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPT 164 (189)
Q Consensus 101 l~~~~-~~~~~~~-s-VwsfG-------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~ 164 (189)
+++|. ....++. + ||||| |...+..++...+..+.+++.|..+|..+++|+.+||..||++||+
T Consensus 165 ~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~ 244 (257)
T cd05060 165 YAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPT 244 (257)
T ss_pred cCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcC
Confidence 11111 2345788 9 99999 4455666777778788788889999999999999999999999999
Q ss_pred HHHHHHHHHHHH
Q psy1684 165 FETLQWKLEDFF 176 (189)
Q Consensus 165 ~~~i~~~l~~~~ 176 (189)
+.+|++.|+.+.
T Consensus 245 ~~~l~~~l~~~~ 256 (257)
T cd05060 245 FSELESTFRRDP 256 (257)
T ss_pred HHHHHHHHHhcc
Confidence 999999997653
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.62 E-value=1e-16 Score=125.73 Aligned_cols=109 Identities=26% Similarity=0.414 Sum_probs=83.9
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cccccC------------------------CC
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVHGT------------------------NL 107 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~~~------------------------~~ 107 (189)
+.+..++.+..+.+.|+.++|..+++|+|+ |. ++++.. ..
T Consensus 236 l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 315 (401)
T cd05107 236 LSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN 315 (401)
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC
Confidence 335667778888899999999999999986 44 222210 22
Q ss_pred CCccc-e-EEEec-------------CCCCChHH-HHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 108 SGVVV-S-AVDFG-------------SGGMTNAE-VLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 108 ~~~~~-s-VwsfG-------------~~~~~~~~-~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
..++. + ||||| |......+ ....+..+.+++.|..++.++.+|+.+||..+|.+||+|++|++.
T Consensus 316 ~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 316 NLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 34678 8 99999 33333333 334456788888888999999999999999999999999999999
Q ss_pred HHHHH
Q psy1684 172 LEDFF 176 (189)
Q Consensus 172 l~~~~ 176 (189)
|+.++
T Consensus 396 L~~~~ 400 (401)
T cd05107 396 VGDLL 400 (401)
T ss_pred HHHHh
Confidence 99876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.8e-16 Score=119.01 Aligned_cols=166 Identities=21% Similarity=0.282 Sum_probs=110.3
Q ss_pred ChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCcee
Q psy1684 7 KRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGLCV 86 (189)
Q Consensus 7 ~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl~~ 86 (189)
+|+|++++++.+......++|+|+.+++....+............+.+ .......+....+..+..+.+.|+.+
T Consensus 66 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~------~~~~~~~l~~~~~~~~~~qi~~al~~ 139 (303)
T cd05088 66 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI------ANSTASTLSSQQLLHFAADVARGMDY 139 (303)
T ss_pred CCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccc------cccccCcCCHHHHHHHHHHHHHHHHH
Confidence 688888888777666678888888776321110000000000000000 00112234466677778888889999
Q ss_pred eccCCcccccc-cc---------------cccc--------------------cC-CCCCccc-e-EEEec---------
Q psy1684 87 NLRKPCVQVSC-RI---------------YLVH--------------------GT-NLSGVVV-S-AVDFG--------- 118 (189)
Q Consensus 87 ~~~~~~~~~~~-p~---------------~l~~--------------------~~-~~~~~~~-s-VwsfG--------- 118 (189)
+|..+++|+|+ |+ |+++ |. ....++. + |||||
T Consensus 140 LH~~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~ 219 (303)
T cd05088 140 LSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL 219 (303)
T ss_pred HHhCCccccccchheEEecCCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhc
Confidence 99999999986 44 2221 11 2234678 8 99999
Q ss_pred ----CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q psy1684 119 ----SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTM 178 (189)
Q Consensus 119 ----~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~ 178 (189)
|.+.+..++...+..+.+++.|..++.++.+|+.+||+.+|++||++.+++..|+.++..
T Consensus 220 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 220 GGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred CCCCcccCChHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 334455666666777777777888999999999999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.7e-16 Score=120.27 Aligned_cols=167 Identities=21% Similarity=0.311 Sum_probs=109.7
Q ss_pred ChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCcee
Q psy1684 7 KRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGLCV 86 (189)
Q Consensus 7 ~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl~~ 86 (189)
+|+|++++++.+...+..|+|+|+... +++.-.+..........+ .+........+....++.+..+.+.|+.+
T Consensus 82 ~h~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~i~~~~~~~~~~~-----~~~~~~~~~~l~~~~~~~~~~qi~~aL~~ 155 (307)
T cd05098 82 KHKNIINLLGACTQDGPLYVIVEYASK-GNLREYLRARRPPGMEYC-----YNPTQVPEEQLSFKDLVSCAYQVARGMEY 155 (307)
T ss_pred CCCCEeeEEEEEecCCceEEEEecCCC-CcHHHHHHhcCCcccccc-----cccccCccccCCHHHHHHHHHHHHHHHHH
Confidence 577777777766666677888887765 322100000000000000 00000111223456677777788888888
Q ss_pred eccCCcccccc-cc---------------ccc-----------------------ccC-CCCCccc-e-EEEec------
Q psy1684 87 NLRKPCVQVSC-RI---------------YLV-----------------------HGT-NLSGVVV-S-AVDFG------ 118 (189)
Q Consensus 87 ~~~~~~~~~~~-p~---------------~l~-----------------------~~~-~~~~~~~-s-VwsfG------ 118 (189)
+|..+++|+|+ |+ +++ +|. ....++. + |||||
T Consensus 156 lH~~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el 235 (307)
T cd05098 156 LASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 235 (307)
T ss_pred HHHCCcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHH
Confidence 88888888875 43 111 111 2345788 9 99999
Q ss_pred -------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q psy1684 119 -------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTME 179 (189)
Q Consensus 119 -------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~ 179 (189)
|.+.+..++...+..+.+++.|..++.++.+|+.+||..+|++|||+.+|++.|+.++...
T Consensus 236 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 236 FTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred HcCCCCCCCcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 3444556777777778778888899999999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.2e-16 Score=118.04 Aligned_cols=159 Identities=19% Similarity=0.272 Sum_probs=106.4
Q ss_pred CCChHHHHHHhcCCCC-CCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 5 KIKRIEAEKKLLLPEN-DHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~-~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
.++|+|++++++.+.. ....+++.++.+. +.+.-.+.. + ..+-......+....+..+..+.+.|
T Consensus 64 ~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~-~~L~~~l~~-------~------~~~~~~~~~~l~~~~~~~i~~~i~~~ 129 (280)
T cd05043 64 GLSHQNILPILHVCIEDGEPPFVLYPYMNW-GNLKLFLQQ-------C------RLGEANNPQALSTQQLVHMAIQIACG 129 (280)
T ss_pred hCCCCCCCeEEEEEecCCCCCEEEEEcCCC-CcHHHHHHh-------c------cccccccccCCCHHHHHHHHHHHHHH
Confidence 4678888887775443 3456677776664 321000000 0 00000001234455666677788888
Q ss_pred ceeeccCCcccccc-cc---------------cccc-----------------------cC-CCCCccc-e-EEEec---
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YLVH-----------------------GT-NLSGVVV-S-AVDFG--- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l~~-----------------------~~-~~~~~~~-s-VwsfG--- 118 (189)
+.++|...++|+|+ |. ++++ |. ....++. + |||||
T Consensus 130 l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l 209 (280)
T cd05043 130 MSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLL 209 (280)
T ss_pred HHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHH
Confidence 88898888888875 43 2221 11 2345788 9 99999
Q ss_pred ----------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q psy1684 119 ----------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFT 177 (189)
Q Consensus 119 ----------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~ 177 (189)
|.+.++.++...+..+.+++.+..+|+++.+++.+||..||++|||+.+++..|+.+.+
T Consensus 210 ~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 210 WELMTLGQTPYVEIDPFEMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred HHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 33455667777777888887888899999999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.5e-16 Score=117.43 Aligned_cols=149 Identities=23% Similarity=0.373 Sum_probs=104.4
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCC--CcCHhHHHHHhhhccC
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRT--TIHYPELVEHYSKDAD 82 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~--~~~l~~li~~~~~~a~ 82 (189)
.++|+|++++++.+...+..++|+|++.++. +.. ++.... .+....+..+..+.+.
T Consensus 56 ~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~-----L~~-----------------~~~~~~~~~~~~~~~~~~~~qi~~ 113 (256)
T cd05039 56 TLRHPNLVQLLGVVLQGNPLYIVTEYMAKGS-----LVD-----------------YLRSRGRAVITLAQQLGFALDVCE 113 (256)
T ss_pred hcCCcceeeeEEEEcCCCCeEEEEEecCCCc-----HHH-----------------HHHhcCCCCCCHHHHHHHHHHHHH
Confidence 4567777777766655666777777666421 111 222111 2335666666677788
Q ss_pred CceeeccCCcccccc-cc---------------c------------------ccccC-CCCCccc-e-EEEec-------
Q psy1684 83 GLCVNLRKPCVQVSC-RI---------------Y------------------LVHGT-NLSGVVV-S-AVDFG------- 118 (189)
Q Consensus 83 gl~~~~~~~~~~~~~-p~---------------~------------------l~~~~-~~~~~~~-s-VwsfG------- 118 (189)
++.++|..+++|+|+ |. + +++|. ..+.++. + |||||
T Consensus 114 ~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~ 193 (256)
T cd05039 114 GMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIY 193 (256)
T ss_pred HHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHH
Confidence 888888888888875 44 1 11221 3456788 9 99999
Q ss_pred ------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q psy1684 119 ------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDF 175 (189)
Q Consensus 119 ------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~ 175 (189)
|...+..++...+..+.++..|..+|+++.+++.+||..+|++||++.++++.|+++
T Consensus 194 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 194 SFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred hcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 334555677777777777778888999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.7e-16 Score=117.91 Aligned_cols=149 Identities=20% Similarity=0.298 Sum_probs=100.9
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCC-CCcCHhHHHHHhhhccCC
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGR-TTIHYPELVEHYSKDADG 83 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~-~~~~l~~li~~~~~~a~g 83 (189)
.+.|+|++++.+.+...+..+||+|+.++ +. +.. ++... ..+...++..+..+.+.+
T Consensus 61 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~~----L~~-----------------~~~~~~~~~~~~~~~~i~~~i~~~ 118 (267)
T cd05066 61 QFDHPNIIHLEGVVTKSKPVMIVTEYMEN-GS----LDA-----------------FLRKHDGQFTVIQLVGMLRGIASG 118 (267)
T ss_pred hCCCCCcceEEEEEecCCccEEEEEcCCC-CC----HHH-----------------HHHhcCCCCCHHHHHHHHHHHHHH
Confidence 35677777776665555566777776665 21 111 22111 123345555566666677
Q ss_pred ceeeccCCcccccc-cc---------------c------------------------ccccC-CCCCccc-e-EEEec--
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------Y------------------------LVHGT-NLSGVVV-S-AVDFG-- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~------------------------l~~~~-~~~~~~~-s-VwsfG-- 118 (189)
+.++|..+++|+|+ |. + +++|. ..+.++. + |||||
T Consensus 119 l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~ 198 (267)
T cd05066 119 MKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIV 198 (267)
T ss_pred HHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHH
Confidence 77777777777764 33 1 11111 2356788 8 99999
Q ss_pred -----------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q psy1684 119 -----------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDF 175 (189)
Q Consensus 119 -----------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~ 175 (189)
|.+.+..+....+.++.+++.+..+|+.+.+++.+||+.+|.+||+|.+|++.|+.+
T Consensus 199 l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 199 MWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 334445667777788888888889999999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.4e-16 Score=118.37 Aligned_cols=149 Identities=21% Similarity=0.306 Sum_probs=99.8
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC-CCCcCHhHHHHHhhhccCC
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG-RTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~-~~~~~l~~li~~~~~~a~g 83 (189)
.++|+|++++.+.+...+..+||+|+..+ +. +.. ++.. ...+....+..+..+.+.+
T Consensus 62 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~~----L~~-----------------~~~~~~~~~~~~~~~~~~~~l~~a 119 (268)
T cd05063 62 QFSHHNIIRLEGVVTKFKPAMIITEYMEN-GA----LDK-----------------YLRDHDGEFSSYQLVGMLRGIAAG 119 (268)
T ss_pred cCCCCCeeEEEEEEccCCCcEEEEEcCCC-CC----HHH-----------------HHHhcCCCCCHHHHHHHHHHHHHH
Confidence 45566666666655555556666666554 21 111 2211 1223344555566666677
Q ss_pred ceeeccCCcccccc-cc---------------c------------------------ccccC-CCCCccc-e-EEEec--
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------Y------------------------LVHGT-NLSGVVV-S-AVDFG-- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~------------------------l~~~~-~~~~~~~-s-VwsfG-- 118 (189)
+.++|..+++|+|+ |+ + +++|. ..+.++. + |||||
T Consensus 120 l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~i 199 (268)
T cd05063 120 MKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIV 199 (268)
T ss_pred HHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHH
Confidence 77777777777764 33 1 11221 2345788 8 99999
Q ss_pred -----------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q psy1684 119 -----------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDF 175 (189)
Q Consensus 119 -----------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~ 175 (189)
|...+..++...+..+.+.+.+..+|.++.+++.+||+.+|++||++.+|++.|+.+
T Consensus 200 l~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 200 MWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 334455677777777777788888999999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.62 E-value=7.1e-17 Score=126.62 Aligned_cols=108 Identities=27% Similarity=0.433 Sum_probs=83.4
Q ss_pred HhHHHHHhhhccCCceeeccCCcccccc-cc---------------ccc-----------------------ccC-CCCC
Q psy1684 70 YPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLV-----------------------HGT-NLSG 109 (189)
Q Consensus 70 l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~-----------------------~~~-~~~~ 109 (189)
..+++.+..+.+.|+.++|...++|+|+ |. |++ +|. ....
T Consensus 236 ~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 315 (400)
T cd05105 236 TLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNL 315 (400)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCC
Confidence 4556667788889999999999999986 43 222 111 2345
Q ss_pred ccc-e-EEEec-------------CCCCCh-HHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q psy1684 110 VVV-S-AVDFG-------------SGGMTN-AEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLE 173 (189)
Q Consensus 110 ~~~-s-VwsfG-------------~~~~~~-~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~ 173 (189)
++. + ||||| |++... ..+...+..+.+++.|..+|.++.++|.+||+.||++||+|.+|.+.|+
T Consensus 316 ~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~ 395 (400)
T cd05105 316 YTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVE 395 (400)
T ss_pred CCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHH
Confidence 788 9 99999 233322 3445566778888888899999999999999999999999999999999
Q ss_pred HHHh
Q psy1684 174 DFFT 177 (189)
Q Consensus 174 ~~~~ 177 (189)
+++.
T Consensus 396 ~l~~ 399 (400)
T cd05105 396 SLLP 399 (400)
T ss_pred HHcC
Confidence 8764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.8e-16 Score=118.55 Aligned_cols=113 Identities=24% Similarity=0.363 Sum_probs=89.5
Q ss_pred CcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cccc-----------------------cC-C
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVH-----------------------GT-N 106 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~-----------------------~~-~ 106 (189)
.++....+.+..+.+.|+.++|..+++|+|+ |+ |+++ |. .
T Consensus 105 ~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~ 184 (279)
T cd05109 105 RIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184 (279)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhc
Confidence 4556777778888999999999999999986 44 2221 11 3
Q ss_pred CCCccc-e-EEEec-------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 107 LSGVVV-S-AVDFG-------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 107 ~~~~~~-s-VwsfG-------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
...++. + ||||| |.+....++...+..+.+++.|..++.++.+++.+||..||++||++.++++.
T Consensus 185 ~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~ 264 (279)
T cd05109 185 HRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDE 264 (279)
T ss_pred cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 455788 9 99999 33445566767777788888888999999999999999999999999999999
Q ss_pred HHHHHhhc
Q psy1684 172 LEDFFTME 179 (189)
Q Consensus 172 l~~~~~~~ 179 (189)
|+.+.+.+
T Consensus 265 l~~~~~~~ 272 (279)
T cd05109 265 FSRMARDP 272 (279)
T ss_pred HHHhhcCC
Confidence 98886644
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.3e-16 Score=116.18 Aligned_cols=148 Identities=20% Similarity=0.389 Sum_probs=101.6
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCC-CCcCHhHHHHHhhhccC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGR-TTIHYPELVEHYSKDAD 82 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~-~~~~l~~li~~~~~~a~ 82 (189)
..++|+|++++++.+......+||.|+..++. +.. ++... ..+.......+..+.+.
T Consensus 48 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~-----L~~-----------------~~~~~~~~~~~~~~~~~~~qi~~ 105 (252)
T cd05084 48 KQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD-----FLT-----------------FLRTEGPRLKVKELIQMVENAAA 105 (252)
T ss_pred HhCCCCCcceEEEEEcCCCCeEEEEeeccCCc-----HHH-----------------HHHhCCCCCCHHHHHHHHHHHHH
Confidence 35678888887777766666778887766522 111 12111 12334555556666777
Q ss_pred CceeeccCCcccccc-cc---------------cc-----------------------cccC-CCCCccc-e-EEEec--
Q psy1684 83 GLCVNLRKPCVQVSC-RI---------------YL-----------------------VHGT-NLSGVVV-S-AVDFG-- 118 (189)
Q Consensus 83 gl~~~~~~~~~~~~~-p~---------------~l-----------------------~~~~-~~~~~~~-s-VwsfG-- 118 (189)
|+.++|..+++|+|+ |. ++ ++|. ..+.++. + |||||
T Consensus 106 ~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i 185 (252)
T cd05084 106 GMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGIL 185 (252)
T ss_pred HHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHH
Confidence 777777777777764 33 11 1221 3345788 8 99999
Q ss_pred -----------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q psy1684 119 -----------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLE 173 (189)
Q Consensus 119 -----------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~ 173 (189)
|...+..+....+..+.+++.|..+|.++.+|+.+||+.||++|||+.++.+.|+
T Consensus 186 l~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 186 LWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 3344556666777777777888899999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.3e-16 Score=119.24 Aligned_cols=154 Identities=19% Similarity=0.271 Sum_probs=102.9
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.++|+|++++++.+......++|+|++.++. +... +.. ... .......+.+.+.+.+..+.+.|+
T Consensus 65 ~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~-----L~~~----i~~-----~~~-~~~~~~~~~~~~~~~~~~qi~~~l 129 (277)
T cd05036 65 KFNHQNIVRLIGVSFERLPRFILLELMAGGD-----LKSF----LRE-----NRP-RPERPSSLTMKDLLFCARDVAKGC 129 (277)
T ss_pred hCCCCCEeeEEEEEccCCCcEEEEecCCCCC-----HHHH----HHH-----hCC-CCCCCCCCCHHHHHHHHHHHHHHH
Confidence 4567777777765555556677777666522 1110 000 000 000011244666777777888888
Q ss_pred eeeccCCcccccc-cc------------------cccc-----------------------cC-CCCCccc-e-EEEec-
Q psy1684 85 CVNLRKPCVQVSC-RI------------------YLVH-----------------------GT-NLSGVVV-S-AVDFG- 118 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~------------------~l~~-----------------------~~-~~~~~~~-s-VwsfG- 118 (189)
.++|...++|+|+ |+ |+++ |. ....++. + |||||
T Consensus 130 ~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~ 209 (277)
T cd05036 130 KYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGV 209 (277)
T ss_pred HHHHHCCEeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHH
Confidence 8888888888875 43 1111 11 2355888 9 99999
Q ss_pred ------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q psy1684 119 ------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLE 173 (189)
Q Consensus 119 ------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~ 173 (189)
|.+.+..++...+..+.+++.|..+|.++.+++.+||+.||++|||+.+|++.|+
T Consensus 210 il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 210 LLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 4555666777777777777788899999999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.8e-16 Score=118.77 Aligned_cols=166 Identities=17% Similarity=0.297 Sum_probs=109.9
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..+.|+|++++++.....+..++|+|+...+....+.... . .+..........-.....+...+++....+.+.+
T Consensus 62 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~-~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~a 136 (283)
T cd05090 62 AELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMR----S-PHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAG 136 (283)
T ss_pred hhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhc----C-CCCccccccccccccccccCHHHHHHHHHHHHHH
Confidence 4677889888888766667788999988763211000000 0 0000000000000001223355566677778888
Q ss_pred ceeeccCCcccccc-cc---------------cccc-----------------------cC-CCCCccc-e-EEEec---
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YLVH-----------------------GT-NLSGVVV-S-AVDFG--- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l~~-----------------------~~-~~~~~~~-s-VwsfG--- 118 (189)
+.++|..+++|+|+ |. +++. |. ..+.++. + |||||
T Consensus 137 l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il 216 (283)
T cd05090 137 MEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVL 216 (283)
T ss_pred HHHHHhcCeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHH
Confidence 99999999999986 44 2221 11 2345788 8 99999
Q ss_pred ----------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q psy1684 119 ----------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLED 174 (189)
Q Consensus 119 ----------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~ 174 (189)
|.+.+..++...+..+..++.|..+|.++.+++.+||+.||++||++.+|.+.|..
T Consensus 217 ~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 217 WEIFSFGLQPYYGFSNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 33455667888888887788889999999999999999999999999999988853
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=99.62 E-value=8.8e-17 Score=126.44 Aligned_cols=146 Identities=14% Similarity=0.168 Sum_probs=107.8
Q ss_pred CCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccC
Q psy1684 3 FGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDAD 82 (189)
Q Consensus 3 ~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~ 82 (189)
|..|+|+|+|++.++....+..|||.|.+.++. +.. ++...+.+.-.+..-|..|+..
T Consensus 72 Hr~L~HpnIV~f~~~FEDs~nVYivLELC~~~s-----L~e-----------------l~Krrk~ltEpEary~l~QIv~ 129 (592)
T KOG0575|consen 72 HRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGS-----LME-----------------LLKRRKPLTEPEARYFLRQIVE 129 (592)
T ss_pred HHhcCCCcEEeeeeEeecCCceEEEEEecCCcc-----HHH-----------------HHHhcCCCCcHHHHHHHHHHHH
Confidence 788999999999999988899999999998832 211 1221233444455556666667
Q ss_pred CceeeccCCcccccccc-------------------------------------cccccC-CCCCccc-e-EEEec----
Q psy1684 83 GLCVNLRKPCVQVSCRI-------------------------------------YLVHGT-NLSGVVV-S-AVDFG---- 118 (189)
Q Consensus 83 gl~~~~~~~~~~~~~p~-------------------------------------~l~~~~-~~~~~~~-s-VwsfG---- 118 (189)
|+.|+|...|+|||+.= .+|+|+ .....+. + |||.|
T Consensus 130 GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmY 209 (592)
T KOG0575|consen 130 GLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMY 209 (592)
T ss_pred HHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHH
Confidence 77777777777776543 444444 3445788 9 99999
Q ss_pred --------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 119 --------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 119 --------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
|+.-+..+.+.+|+... -.+|.....+..+||.+.++.||++|||..+|+..
T Consensus 210 tLL~G~PPFetk~vkety~~Ik~~~-Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 210 TLLVGRPPFETKTVKETYNKIKLNE-YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred hhhhCCCCcccchHHHHHHHHHhcC-cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 66666778888886542 34577999999999999999999999999999864
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.6e-16 Score=118.24 Aligned_cols=169 Identities=21% Similarity=0.269 Sum_probs=113.4
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..+.|+|++++++.+......++|+|+++++. +.-.+.. .... .. ............+..+..+.+.|
T Consensus 64 ~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~-L~~~l~~--~~~~----~~-----~~~~~~~~~~~~~~~~~~~l~~~ 131 (288)
T cd05061 64 KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGD-LKSYLRS--LRPE----AE-----NNPGRPPPTLQEMIQMAAEIADG 131 (288)
T ss_pred HhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCC-HHHHHHH--hccc----cc-----cCCCCCCCCHHHHHHHHHHHHHH
Confidence 35678888888876666667788888877632 2100100 0000 00 00001122255666677778888
Q ss_pred ceeeccCCcccccc-cc---------------cccc-----------------------cC-CCCCccc-e-EEEec---
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YLVH-----------------------GT-NLSGVVV-S-AVDFG--- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l~~-----------------------~~-~~~~~~~-s-VwsfG--- 118 (189)
+.++|..+++|+|+ |+ ++++ |. ..+.++. + |||||
T Consensus 132 l~~lH~~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l 211 (288)
T cd05061 132 MAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVL 211 (288)
T ss_pred HHHHHhCCCcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHH
Confidence 88888888888885 44 2221 11 2355788 9 99999
Q ss_pred ----------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcCCCCCCCC
Q psy1684 119 ----------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEGSDYKEAS 187 (189)
Q Consensus 119 ----------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~ 187 (189)
|.+.+..++...+..+..++.|..+|+++.+++.+||+.||++|||+.++++.|...+. |-|.+++
T Consensus 212 ~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~---~~~~~~~ 287 (288)
T cd05061 212 WEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH---PSFPEVS 287 (288)
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC---CCCCCCC
Confidence 44556677777777777777788999999999999999999999999999998877654 6666554
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.61 E-value=6.2e-16 Score=115.04 Aligned_cols=151 Identities=23% Similarity=0.429 Sum_probs=105.0
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC-CCCcCHhHHHHHhhhccC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG-RTTIHYPELVEHYSKDAD 82 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~-~~~~~l~~li~~~~~~a~ 82 (189)
..+.|+|++++++.+. .+..++|.|+.+. ++ +.. ++.. ...+....+..+..+.+.
T Consensus 62 ~~~~h~~i~~~~~~~~-~~~~~lv~e~~~~-~~----L~~-----------------~l~~~~~~~~~~~~~~~~~~l~~ 118 (270)
T cd05056 62 RQFDHPHIVKLIGVIT-ENPVWIVMELAPL-GE----LRS-----------------YLQVNKYSLDLASLILYSYQLST 118 (270)
T ss_pred HhCCCCchhceeEEEc-CCCcEEEEEcCCC-Cc----HHH-----------------HHHhCCCCCCHHHHHHHHHHHHH
Confidence 3567888888877654 3456777777665 31 211 2221 112334555555666677
Q ss_pred CceeeccCCcccccc-cc-------------------------------------cccccC-CCCCccc-e-EEEec---
Q psy1684 83 GLCVNLRKPCVQVSC-RI-------------------------------------YLVHGT-NLSGVVV-S-AVDFG--- 118 (189)
Q Consensus 83 gl~~~~~~~~~~~~~-p~-------------------------------------~l~~~~-~~~~~~~-s-VwsfG--- 118 (189)
|+.++|..+++|+|+ |. ++++|. ....++. + |||||
T Consensus 119 ~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 198 (270)
T cd05056 119 ALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCM 198 (270)
T ss_pred HHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHH
Confidence 777777777777764 33 112222 2345788 9 99999
Q ss_pred ----------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q psy1684 119 ----------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFT 177 (189)
Q Consensus 119 ----------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~ 177 (189)
|.+.+..+....+..+.+++.|..+|.++.++|.+||..+|++|||+.+++..|+.+..
T Consensus 199 ~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 199 WEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred HHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 44555667777788888888899999999999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.61 E-value=4e-16 Score=115.01 Aligned_cols=148 Identities=26% Similarity=0.413 Sum_probs=109.1
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC---------CCCcCHhHHH
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG---------RTTIHYPELV 74 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~---------~~~~~l~~li 74 (189)
..++|+|++++++.+......+||+|+.+.+. +.. ++.. ...++..++.
T Consensus 51 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~-----L~~-----------------~l~~~~~~~~~~~~~~~~~~~~~ 108 (262)
T cd00192 51 KKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGD-----LLD-----------------YLRKSRPVFPSPEKSTLSLKDLL 108 (262)
T ss_pred hhcCCCChheeeeeecCCCceEEEEEeccCCc-----HHH-----------------HHhhccccccccccccCCHHHHH
Confidence 34667888887777666666788888776522 111 1111 1334466777
Q ss_pred HHhhhccCCceeeccCCcccccc-cc---------------c-----------------------ccccC-CCCCccc-e
Q psy1684 75 EHYSKDADGLCVNLRKPCVQVSC-RI---------------Y-----------------------LVHGT-NLSGVVV-S 113 (189)
Q Consensus 75 ~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~-----------------------l~~~~-~~~~~~~-s 113 (189)
.+..+.+.++.++|..+++|+|+ |. + +++|. ....++. +
T Consensus 109 ~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 188 (262)
T cd00192 109 SFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKS 188 (262)
T ss_pred HHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhh
Confidence 77788888999999999999986 43 1 11111 2346788 9
Q ss_pred -EEEec-------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q psy1684 114 -AVDFG-------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLE 173 (189)
Q Consensus 114 -VwsfG-------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~ 173 (189)
|||+| |.+.+..++...+..+.+++.|..+|.++.+++.+||..||++|||+.++++.|+
T Consensus 189 Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 189 DVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 99999 5566677888888888888899999999999999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.4e-16 Score=114.96 Aligned_cols=107 Identities=27% Similarity=0.446 Sum_probs=83.4
Q ss_pred CHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cccc------------------cC-CCCCccc-
Q psy1684 69 HYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVH------------------GT-NLSGVVV- 112 (189)
Q Consensus 69 ~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~------------------~~-~~~~~~~- 112 (189)
....+..+..+.+.|+.++|..+++|+|+ |. ++++ |. ....++.
T Consensus 100 ~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 179 (256)
T cd05082 100 GGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTK 179 (256)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccCCCCccceeecCHHHHccCCCCch
Confidence 35666777778888999999999999986 44 2111 11 3345788
Q ss_pred e-EEEec-------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q psy1684 113 S-AVDFG-------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDF 175 (189)
Q Consensus 113 s-VwsfG-------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~ 175 (189)
+ ||||| |...+..++...+..+..+..+..+|+.+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 180 ~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 180 SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred hhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 9 99999 334455677777777877778889999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.5e-16 Score=116.83 Aligned_cols=161 Identities=17% Similarity=0.239 Sum_probs=106.2
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.+.|+|++++.+.+......++|+|++.+ +.+.-.+.. .+......... ......+....+..+..+.+.|+
T Consensus 64 ~l~~~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~i~~--~~~~~~~~~~~-----~~~~~~l~~~~~~~~~~~i~~~l 135 (280)
T cd05049 64 NFQHENIVKFYGVCTEGDPPIMVFEYMEH-GDLNKFLRS--HGPDAAFLKSP-----DSPMGELTLSQLLQIAVQIASGM 135 (280)
T ss_pred hcCCCCchheeeEEecCCCeEEEEecCCC-CCHHHHHHh--cCCchhhhccc-----ccccccccHHHHHHHHHHHHHHH
Confidence 56788888888877666778888888876 322111111 00000000000 00112233555566667777788
Q ss_pred eeeccCCcccccc-cc---------------cc-----------------------cccC-CCCCccc-e-EEEec----
Q psy1684 85 CVNLRKPCVQVSC-RI---------------YL-----------------------VHGT-NLSGVVV-S-AVDFG---- 118 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~---------------~l-----------------------~~~~-~~~~~~~-s-VwsfG---- 118 (189)
.++|..+++|+|+ |. ++ |+|. ..+.++. + |||||
T Consensus 136 ~~lH~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 215 (280)
T cd05049 136 VYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLW 215 (280)
T ss_pred HHHhhCCeeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHH
Confidence 8888888888774 33 11 2221 3456788 9 99999
Q ss_pred ---------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q psy1684 119 ---------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLE 173 (189)
Q Consensus 119 ---------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~ 173 (189)
|.+.+..++...+..|...+.|..+|.++.+++.+||+.||++||++.||++.|+
T Consensus 216 e~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 216 EIFTYGKQPWYGLSNEEVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHhcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 3455567777777888777777889999999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >smart00252 SH2 Src homology 2 domains | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.3e-14 Score=89.23 Aligned_cols=77 Identities=42% Similarity=0.495 Sum_probs=67.7
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC--ccCCCCCcC-HhHHHHHh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET--QKAGRTTIH-YPELVEHY 77 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g--yl~~~~~~~-l~~li~~~ 77 (189)
||||.|++.+|+++|..+ ++|+||||.+....+.|+||++. .+.++|+.|....+| ++.+...|. +.+||+++
T Consensus 3 w~~g~i~r~~Ae~lL~~~--~~G~FLvR~s~~~~~~~~Lsv~~--~~~~~h~~I~~~~~~~~~l~~~~~F~sl~eLI~~y 78 (84)
T smart00252 3 WYHGFISREEAEKLLKNE--GDGDFLVRDSESEPGDYVLSVRV--KGKVKHYRIRRNEDGKFYLDGGRKFPSLVELVEHY 78 (84)
T ss_pred eecccCCHHHHHHHHhcC--CCcEEEEEcCCCCCCCEEEEEEE--CCEEEEEEEEECCCCcEEECCCCccCCHHHHHHHH
Confidence 999999999999999654 48999999999877999999999 899999999988855 676667888 99999999
Q ss_pred hhcc
Q psy1684 78 SKDA 81 (189)
Q Consensus 78 ~~~a 81 (189)
....
T Consensus 79 ~~~~ 82 (84)
T smart00252 79 QKNS 82 (84)
T ss_pred hhCC
Confidence 8654
|
Src homology 2 domains bind phosphotyrosine-containing polypeptides via 2 surface pockets. Specificity is provided via interaction with residues that are distinct from the phosphotyrosine. Only a single occurrence of a SH2 domain has been found in S. cerevisiae. |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.8e-16 Score=116.04 Aligned_cols=105 Identities=26% Similarity=0.407 Sum_probs=80.5
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------ccc----------------------ccC-CCC
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLV----------------------HGT-NLS 108 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~----------------------~~~-~~~ 108 (189)
+..........+.+.|+.++|..+++|+|+ |+ +++ +|. ...
T Consensus 97 ~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~ 176 (256)
T cd05059 97 LGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYS 176 (256)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccccCCCCCCccccCHHHhccC
Confidence 335556666677778888888888888875 33 111 111 235
Q ss_pred Cccc-e-EEEec-------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q psy1684 109 GVVV-S-AVDFG-------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKL 172 (189)
Q Consensus 109 ~~~~-s-VwsfG-------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l 172 (189)
.++. + ||||| |.+.+..+....+..+.+++.|..+|.++.+|+.+||..+|++|||+.++++.|
T Consensus 177 ~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 177 RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 6788 9 99999 334556777778888888888889999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.59 E-value=3.8e-16 Score=118.22 Aligned_cols=151 Identities=19% Similarity=0.258 Sum_probs=103.0
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCC-CCcCHhHHHHHhhhccCC
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGR-TTIHYPELVEHYSKDADG 83 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~-~~~~l~~li~~~~~~a~g 83 (189)
.++|+|++++++.+.. ...++|.++.+.+. +.. ++... ..+....+..+..+.+.|
T Consensus 65 ~l~h~niv~~~~~~~~-~~~~~v~e~~~~g~-----l~~-----------------~~~~~~~~~~~~~~~~~~~qi~~~ 121 (303)
T cd05110 65 SMDHPHLVRLLGVCLS-PTIQLVTQLMPHGC-----LLD-----------------YVHEHKDNIGSQLLLNWCVQIAKG 121 (303)
T ss_pred hCCCCCcccEEEEEcC-CCceeeehhcCCCC-----HHH-----------------HHHhcccCCCHHHHHHHHHHHHHH
Confidence 4567777777765543 23455666655422 111 22211 123345556667777888
Q ss_pred ceeeccCCcccccc-cc---------------cccc-----------------------cC-CCCCccc-e-EEEec---
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YLVH-----------------------GT-NLSGVVV-S-AVDFG--- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l~~-----------------------~~-~~~~~~~-s-VwsfG--- 118 (189)
+.++|..+++|+|+ |. |++. +. ....++. + |||||
T Consensus 122 L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l 201 (303)
T cd05110 122 MMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTI 201 (303)
T ss_pred HHHHhhcCeeccccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHH
Confidence 88888888888875 44 2111 11 2355788 8 99999
Q ss_pred ----------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q psy1684 119 ----------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTM 178 (189)
Q Consensus 119 ----------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~ 178 (189)
|.+....++...+..+.+++.|..++..+.+++.+||..+|++||+++++++.|+.+.+.
T Consensus 202 ~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 202 WELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 344555666666777888888888999999999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.59 E-value=4e-16 Score=116.34 Aligned_cols=156 Identities=21% Similarity=0.297 Sum_probs=105.1
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC-ccCCCCCcCHhHHHHHhhhccCC
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET-QKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g-yl~~~~~~~l~~li~~~~~~a~g 83 (189)
.++|+|++++++.+......++|+|+.+. +.+.-.+.. . .... .......+....+..+..+.+.|
T Consensus 65 ~~~~~~i~~~~~~~~~~~~~~~v~e~~~~-~~L~~~l~~--~----------~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 131 (277)
T cd05032 65 EFNCHHVVRLLGVVSTGQPTLVVMELMAK-GDLKSYLRS--R----------RPEAENNPGLGPPTLQKFIQMAAEIADG 131 (277)
T ss_pred hCCCCceeEEEEEEcCCCCcEEEEecCCC-CCHHHHHHh--c----------ccchhhccCCCCCCHHHHHHHHHHHHHH
Confidence 45677788777766666667888887765 321000000 0 0000 00011123355566667777888
Q ss_pred ceeeccCCcccccc-cc---------------ccc-----------------------ccC-CCCCccc-e-EEEec---
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YLV-----------------------HGT-NLSGVVV-S-AVDFG--- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l~-----------------------~~~-~~~~~~~-s-VwsfG--- 118 (189)
+.++|..+++|+|+ |. +++ +|. ..+.++. + |||||
T Consensus 132 l~~lH~~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 211 (277)
T cd05032 132 MAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVL 211 (277)
T ss_pred HHHHHhCCccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHH
Confidence 88888888888875 33 211 111 3355788 9 99999
Q ss_pred ----------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q psy1684 119 ----------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLE 173 (189)
Q Consensus 119 ----------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~ 173 (189)
|.+.+..++...+..+..++.|..+|.++.+++.+||+.+|++|||+.+|+..|+
T Consensus 212 ~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 212 WEMATLAEQPYQGLSNEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HHhhccCCCCCccCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 4455667777777777778888999999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=99.59 E-value=7.1e-16 Score=122.66 Aligned_cols=146 Identities=13% Similarity=0.060 Sum_probs=117.1
Q ss_pred CCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccC
Q psy1684 3 FGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDAD 82 (189)
Q Consensus 3 ~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~ 82 (189)
+.-|.|+|+++|+.+-.+....|||.|++++|..|. |+..++.+.-.+.+.|+.|+..
T Consensus 66 MkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFd----------------------ylv~kG~l~e~eaa~ff~QIi~ 123 (786)
T KOG0588|consen 66 MKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFD----------------------YLVRKGPLPEREAAHFFRQILD 123 (786)
T ss_pred HHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHH----------------------HHHhhCCCCCHHHHHHHHHHHH
Confidence 345778888888887777777888888888754221 4444556666788889999999
Q ss_pred CceeeccCCcccccc-cc---------------cccc--------------------cC-CCCCccc--e-EEEec----
Q psy1684 83 GLCVNLRKPCVQVSC-RI---------------YLVH--------------------GT-NLSGVVV--S-AVDFG---- 118 (189)
Q Consensus 83 gl~~~~~~~~~~~~~-p~---------------~l~~--------------------~~-~~~~~~~--s-VwsfG---- 118 (189)
|+.|+|...+.|||+ |+ |||- |. .+.+|.- + |||.|
T Consensus 124 gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILf 203 (786)
T KOG0588|consen 124 GVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILF 203 (786)
T ss_pred HHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHH
Confidence 999999999999995 77 2221 11 6777886 7 99999
Q ss_pred --------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 119 --------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 119 --------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
|.+-+...++.+|.+|. ..+|...|.+.++|+.+++..||+.|-|++||++.
T Consensus 204 ALLtG~LPFdDdNir~LLlKV~~G~-f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 204 ALLTGKLPFDDDNIRVLLLKVQRGV-FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred HHHhCCCCCCCccHHHHHHHHHcCc-ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 88888889999999995 55679999999999999999999999999999885
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=99.59 E-value=7.1e-16 Score=115.69 Aligned_cols=146 Identities=16% Similarity=0.141 Sum_probs=95.9
Q ss_pred CCChHHHHHHhcCCCCCC--CcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCC-CcCHhHHHHHhhhcc
Q psy1684 5 KIKRIEAEKKLLLPENDH--GAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRT-TIHYPELVEHYSKDA 81 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~--g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~-~~~l~~li~~~~~~a 81 (189)
+++|+|+|+.+|.-...+ -.+|++|+.+.+. +.. ++.... .++...+..|.+++.
T Consensus 70 ~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~Gs-----L~~-----------------~~~~~g~~l~E~~v~~ytr~iL 127 (313)
T KOG0198|consen 70 RLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGS-----LSD-----------------LIKRYGGKLPEPLVRRYTRQIL 127 (313)
T ss_pred hCCCCCEEeeCCccccccCeeeEeeeeccCCCc-----HHH-----------------HHHHcCCCCCHHHHHHHHHHHH
Confidence 455777777776533333 2566666666532 222 222222 455555667778888
Q ss_pred CCceeeccCCccccccc-c----------------------------------------cccccCCC-CCcc-c-e-EEE
Q psy1684 82 DGLCVNLRKPCVQVSCR-I----------------------------------------YLVHGTNL-SGVV-V-S-AVD 116 (189)
Q Consensus 82 ~gl~~~~~~~~~~~~~p-~----------------------------------------~l~~~~~~-~~~~-~-s-Vws 116 (189)
.|+.|+|+++++|+|+. + |+|||.-. +... . + |||
T Consensus 128 ~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWS 207 (313)
T KOG0198|consen 128 EGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWS 207 (313)
T ss_pred HHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhh
Confidence 88888888888888853 3 33333322 4334 4 7 999
Q ss_pred ec------CCCC-------ChHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q psy1684 117 FG------SGGM-------TNAEVLHQV-EHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKL 172 (189)
Q Consensus 117 fG------~~~~-------~~~~~~~~v-~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l 172 (189)
+| +.+. ...+.+..+ .++..|++|..++.+..+++..|+..||++|||+++++...
T Consensus 208 lGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 208 LGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred cCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 99 4432 222333333 45556788999999999999999999999999999998764
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.59 E-value=3.2e-16 Score=117.30 Aligned_cols=163 Identities=14% Similarity=0.199 Sum_probs=104.7
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..++|+|++++++.+...+..++|+|+..++....+ +.. .....+. ...+-......+....+..+..+.+.+
T Consensus 62 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~-i~~--~~~~~~~----~~~~~~~~~~~l~~~~~~~~~~qi~~a 134 (280)
T cd05092 62 TVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRF-LRS--HGPDAKI----LAGGEDVAPGQLTLGQMLAIASQIASG 134 (280)
T ss_pred hcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHH-HHh--cCcchhh----hcccccCCccccCHHHHHHHHHHHHHH
Confidence 356788888887776666677888888776321111 111 0000000 000000001123345556666677778
Q ss_pred ceeeccCCcccccc-cc---------------ccc-----------------------ccC-CCCCccc-e-EEEec---
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YLV-----------------------HGT-NLSGVVV-S-AVDFG--- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l~-----------------------~~~-~~~~~~~-s-VwsfG--- 118 (189)
+.++|..+++|+|+ |+ +++ +|. ....++. + |||||
T Consensus 135 l~~LH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 214 (280)
T cd05092 135 MVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVL 214 (280)
T ss_pred HHHHHHCCeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHH
Confidence 88888888888875 33 221 221 3355788 9 99999
Q ss_pred ----------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q psy1684 119 ----------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLE 173 (189)
Q Consensus 119 ----------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~ 173 (189)
|.+.+..+....+..+..++.|..+|+++.+|+.+||+.||.+||++.+|.+.|+
T Consensus 215 ~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 215 WEIFTYGKQPWYQLSNTEAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHHcCCCCCCccCCHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 3344556667777777777788899999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=99.58 E-value=2.6e-16 Score=121.40 Aligned_cols=153 Identities=17% Similarity=0.241 Sum_probs=100.4
Q ss_pred CCCCChHHHHHHhcCCCCCCC-cEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCC--CcCHhHHHHHhhh
Q psy1684 3 FGKIKRIEAEKKLLLPENDHG-AFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRT--TIHYPELVEHYSK 79 (189)
Q Consensus 3 ~g~l~~~n~~~lL~~~~~~~g-~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~--~~~l~~li~~~~~ 79 (189)
.+.++|+|+++|+|+|....+ .+||.|++++ | ++.+ .|++.. ..++...+..+..
T Consensus 125 ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~n-G----sL~d-----------------~L~~~~~~~L~W~~R~kIa~g 182 (361)
T KOG1187|consen 125 LSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPN-G----SLED-----------------HLHGKKGEPLDWETRLKIALG 182 (361)
T ss_pred HhcCCCcCcccEEEEEecCCceEEEEEEccCC-C----CHHH-----------------HhCCCCCCCCCHHHHHHHHHH
Confidence 467899999999999988775 8999999999 4 2333 122221 3347778888888
Q ss_pred ccCCceeeccC---Ccccccccc----------------cccc---c---------C-----------CCCCccc-e-EE
Q psy1684 80 DADGLCVNLRK---PCVQVSCRI----------------YLVH---G---------T-----------NLSGVVV-S-AV 115 (189)
Q Consensus 80 ~a~gl~~~~~~---~~~~~~~p~----------------~l~~---~---------~-----------~~~~~~~-s-Vw 115 (189)
+|.|+.|+|.. +++|||+.. |||+ + . ..+..|. + ||
T Consensus 183 ~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVy 262 (361)
T KOG1187|consen 183 AARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVY 262 (361)
T ss_pred HHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccc
Confidence 88899999884 488988644 3322 1 1 3456788 9 99
Q ss_pred Eec---------CCCCC------hHHHH----HHHHcCCCCC-----CC-CCCC-----HHHHHHHHHhcccCCCCCCCH
Q psy1684 116 DFG---------SGGMT------NAEVL----HQVEHGYRMP-----CP-PGCP-----PRLYDIMLECWLKDPVKRPTF 165 (189)
Q Consensus 116 sfG---------~~~~~------~~~~~----~~v~~g~~~~-----~p-~~~p-----~~~~~l~~~C~~~~p~~RP~~ 165 (189)
||| -+.++ ...+. ..+.++.... .. ...+ ..+..+..+|.+.+|.+||+|
T Consensus 263 SFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m 342 (361)
T KOG1187|consen 263 SFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTM 342 (361)
T ss_pred cchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCH
Confidence 999 01111 11111 2233332111 11 1222 235577789999999999999
Q ss_pred HHHHHHHHHHHh
Q psy1684 166 ETLQWKLEDFFT 177 (189)
Q Consensus 166 ~~i~~~l~~~~~ 177 (189)
.+|++.|+.+..
T Consensus 343 ~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 343 SQVVKELEGILS 354 (361)
T ss_pred HHHHHHHHhhcc
Confidence 999999976654
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.58 E-value=2.8e-16 Score=116.63 Aligned_cols=146 Identities=14% Similarity=0.096 Sum_probs=92.7
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC-CCCcCHhHHHHHhhhccC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG-RTTIHYPELVEHYSKDAD 82 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~-~~~~~l~~li~~~~~~a~ 82 (189)
..+.|+|++++++.+......++|.|++..+. +. . ++.. ...+....+..+..+.+.
T Consensus 59 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~-l~----~-----------------~~~~~~~~~~~~~~~~i~~qi~~ 116 (262)
T cd05077 59 RQVSHKHIVLLYGVCVRDVENIMVEEFVEFGP-LD----L-----------------FMHRKSDVLTTPWKFKVAKQLAS 116 (262)
T ss_pred HhCCCCCEeeEEEEEecCCCCEEEEecccCCC-HH----H-----------------HHHhcCCCCCHHHHHHHHHHHHH
Confidence 35678888888877666666778888776522 11 0 1211 123445556667778888
Q ss_pred CceeeccCCcccccc-cc---------------------------------------cccccC-C-CCCccc-e-EEEec
Q psy1684 83 GLCVNLRKPCVQVSC-RI---------------------------------------YLVHGT-N-LSGVVV-S-AVDFG 118 (189)
Q Consensus 83 gl~~~~~~~~~~~~~-p~---------------------------------------~l~~~~-~-~~~~~~-s-VwsfG 118 (189)
|+.++|..+++|+|+ |. ++++|. . ...++. + |||||
T Consensus 117 ~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG 196 (262)
T cd05077 117 ALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFG 196 (262)
T ss_pred HHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCcccccccccccChhhhcCCCCCCchhHHHHHH
Confidence 888888888888875 43 112221 1 345788 9 99999
Q ss_pred -------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q psy1684 119 -------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLE 173 (189)
Q Consensus 119 -------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~ 173 (189)
+.+....+... ...+. ...+...+.++.+||.+||+.||.+||+|++|++.|+
T Consensus 197 ~~l~el~~~~~~p~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 197 TTLWEICYNGEIPLKDKTLAEKER-FYEGQ-CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred HHHHHHHhCCCCCCCCcchhHHHH-HHhcC-ccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 22222222222 22222 2223345689999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.4e-15 Score=117.11 Aligned_cols=111 Identities=25% Similarity=0.446 Sum_probs=86.2
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cccc-----------------------cC-CC
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVH-----------------------GT-NL 107 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~-----------------------~~-~~ 107 (189)
+.+..++.+..+.+.|+.++|..+++|+|+ |. +++. |. ..
T Consensus 176 ~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 255 (343)
T cd05103 176 LTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 255 (343)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcC
Confidence 346667778889999999999999999996 44 2221 11 23
Q ss_pred CCccc-e-EEEec-------------CCCCC-hHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 108 SGVVV-S-AVDFG-------------SGGMT-NAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 108 ~~~~~-s-VwsfG-------------~~~~~-~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
..++. + ||||| |++.. ..++...+..+.+++.|..+++++.+++.+||+.||++|||+.+|++.
T Consensus 256 ~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 256 RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 45788 9 99999 33322 234555567788888888889999999999999999999999999999
Q ss_pred HHHHHhh
Q psy1684 172 LEDFFTM 178 (189)
Q Consensus 172 l~~~~~~ 178 (189)
|+.+++.
T Consensus 336 l~~~~~~ 342 (343)
T cd05103 336 LGNLLQA 342 (343)
T ss_pred HHHHHhc
Confidence 9999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.58 E-value=5.3e-16 Score=115.87 Aligned_cols=157 Identities=18% Similarity=0.256 Sum_probs=103.3
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.++|+|++++++.+......++|+|+.+.+. +.-.+.. . .-... .......+....++.+..+.+.++
T Consensus 65 ~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~-L~~~~~~--~----~~~~~-----~~~~~~~~~~~~~~~~~~~l~~~l 132 (277)
T cd05062 65 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGD-LKSYLRS--L----RPEME-----NNPVQAPPSLKKMIQMAGEIADGM 132 (277)
T ss_pred hCCCCCeeeEEEEEcCCCCeEEEEecCCCCC-HHHHHHH--c----Ccccc-----ccccccCCCHHHHHHHHHHHHHHH
Confidence 4667778777776655556777888776522 1100000 0 00000 000011122555666677778888
Q ss_pred eeeccCCcccccc-cc---------------cccc-----------------------cC-CCCCccc-e-EEEec----
Q psy1684 85 CVNLRKPCVQVSC-RI---------------YLVH-----------------------GT-NLSGVVV-S-AVDFG---- 118 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~---------------~l~~-----------------------~~-~~~~~~~-s-VwsfG---- 118 (189)
.++|..+++|+|+ |. +++. |. ..+.++. + |||||
T Consensus 133 ~~lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 212 (277)
T cd05062 133 AYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLW 212 (277)
T ss_pred HHHHHCCcccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHH
Confidence 8888888888875 44 2221 11 2345788 9 99999
Q ss_pred ---------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q psy1684 119 ---------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLE 173 (189)
Q Consensus 119 ---------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~ 173 (189)
|.+.+..++...+..+..++.|..+|..+.+++.+||+.||++|||+.++++.|+
T Consensus 213 el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 213 EIATLAEQPYQGMSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 4566667777777776666778889999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.2e-16 Score=128.07 Aligned_cols=149 Identities=15% Similarity=0.084 Sum_probs=105.6
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..++|+|++++++.+...+..|||+|+++++. + .. .+.. .+.....+...+...+..+++.|
T Consensus 120 ~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~-L----~~----~l~~---------~~~~~~~l~~~~~~~i~~qi~~a 181 (478)
T PTZ00267 120 AACDHFGIVKHFDDFKSDDKLLLIMEYGSGGD-L----NK----QIKQ---------RLKEHLPFQEYEVGLLFYQIVLA 181 (478)
T ss_pred HhCCCCCEeEEEEEEEECCEEEEEEECCCCCC-H----HH----HHHH---------HHhccCCCCHHHHHHHHHHHHHH
Confidence 46788899988887776777888999887632 1 11 0000 01112223344455556677788
Q ss_pred ceeeccCCcccccc-cc---------------ccc-----------------------ccC-CCCCccc-e-EEEec---
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YLV-----------------------HGT-NLSGVVV-S-AVDFG--- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l~-----------------------~~~-~~~~~~~-s-VwsfG--- 118 (189)
+.++|..+++|+|+ |+ +++ +|. ....++. + |||||
T Consensus 182 L~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l 261 (478)
T PTZ00267 182 LDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVIL 261 (478)
T ss_pred HHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHH
Confidence 88888888888886 44 222 111 3455888 9 99999
Q ss_pred ---------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 119 ---------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 119 ---------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
|.+.+..+++..+..+...+.|..++.++.+||.+||..||++||++.+++.
T Consensus 262 ~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 262 YELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 5566677788888778777788889999999999999999999999999864
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.58 E-value=7e-16 Score=114.11 Aligned_cols=145 Identities=12% Similarity=0.058 Sum_probs=94.7
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCC-CCcCHhHHHHHhhhccCC
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGR-TTIHYPELVEHYSKDADG 83 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~-~~~~l~~li~~~~~~a~g 83 (189)
.++|+|++++++.+...+..++|+|+++. |. +.. ++... ..+.....+.+..+.+.|
T Consensus 55 ~~~h~~iv~~~~~~~~~~~~~lv~e~~~~-g~----L~~-----------------~l~~~~~~~~~~~~~~~~~qi~~~ 112 (258)
T cd05078 55 QLSHKHLVLNYGVCVCGDESIMVQEYVKF-GS----LDT-----------------YLKKNKNLINISWKLEVAKQLAWA 112 (258)
T ss_pred hCCCCChhheeeEEEeCCCcEEEEecCCC-Cc----HHH-----------------HHhcCCCCCCHHHHHHHHHHHHHH
Confidence 56788888877766655667777777765 31 111 22222 123455566677788888
Q ss_pred ceeeccCCcccccc-ccc----------------------------------------ccccC-CC-CCccc-e-EEEec
Q psy1684 84 LCVNLRKPCVQVSC-RIY----------------------------------------LVHGT-NL-SGVVV-S-AVDFG 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~~----------------------------------------l~~~~-~~-~~~~~-s-VwsfG 118 (189)
+.++|..+++|+|+ |.. +++|. .. ..++. + |||||
T Consensus 113 l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG 192 (258)
T cd05078 113 LHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECIENPQNLSLAADKWSFG 192 (258)
T ss_pred HHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccCCchhccccCCccCchhccCCCCCCchhhHHHHH
Confidence 88999999999885 431 11221 11 34788 9 99999
Q ss_pred ------C-------CCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q psy1684 119 ------S-------GGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLE 173 (189)
Q Consensus 119 ------~-------~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~ 173 (189)
+ ...+........ ..+...|...+.++.+|+.+||+.||++|||+++|++.|+
T Consensus 193 ~~l~~l~~g~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 193 TTLWEIFSGGDKPLSALDSQKKLQFY--EDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred HHHHHHHcCCCCChhhccHHHHHHHH--HccccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 1 222222222222 2244566677789999999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.58 E-value=1e-15 Score=112.51 Aligned_cols=147 Identities=24% Similarity=0.408 Sum_probs=98.7
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC-CCCcCHhHHHHHhhhccCC
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG-RTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~-~~~~~l~~li~~~~~~a~g 83 (189)
.+.|+|++++++.+......++|+|+.+.+. +.. ++.. ...+....+..+..+.+.+
T Consensus 48 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~-----L~~-----------------~~~~~~~~~~~~~~~~~~~~i~~~ 105 (250)
T cd05085 48 QYDHPNIVKLIGVCTQRQPIYIVMELVPGGD-----FLS-----------------FLRKKKDELKTKQLVKFALDAAAG 105 (250)
T ss_pred hCCCCCcCeEEEEEecCCccEEEEECCCCCc-----HHH-----------------HHHhcCCCCCHHHHHHHHHHHHHH
Confidence 4567777777766666666777777766522 111 1111 1122244445555566666
Q ss_pred ceeeccCCcccccc-cc---------------c----------------------ccccC-CCCCccc-e-EEEec----
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------Y----------------------LVHGT-NLSGVVV-S-AVDFG---- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~----------------------l~~~~-~~~~~~~-s-VwsfG---- 118 (189)
+.++|...++|+|+ |+ + +++|. ..+.++. + |||||
T Consensus 106 l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~ 185 (250)
T cd05085 106 MAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLW 185 (250)
T ss_pred HHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHH
Confidence 66777767777664 33 1 11221 3355788 8 99999
Q ss_pred ---------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q psy1684 119 ---------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLE 173 (189)
Q Consensus 119 ---------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~ 173 (189)
|.+....++...+..+.++..|..+|.++.+++.+||+.+|++||++.++.+.|.
T Consensus 186 ~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 186 ETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 4455566777777888888888899999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=99.57 E-value=7.1e-16 Score=123.72 Aligned_cols=148 Identities=15% Similarity=0.163 Sum_probs=102.4
Q ss_pred CCCCCChHHHHHHhcCCCCCCCcEEE-ecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcC-HhHHHHH-hh
Q psy1684 2 YFGKIKRIEAEKKLLLPENDHGAFLI-RDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIH-YPELVEH-YS 78 (189)
Q Consensus 2 ~~g~l~~~n~~~lL~~~~~~~g~fLv-re~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~-l~~li~~-~~ 78 (189)
.|..+.|+|+|++||++. ++|.|.| +|-.++ |+++-.++.. .| .+. -...+.| .+
T Consensus 625 LH~~LrHkNIVrYLGs~s-enGf~kIFMEqVPG-GSLSsLLrsk-WG-------------------PlKDNEstm~fYtk 682 (1226)
T KOG4279|consen 625 LHSTLRHKNIVRYLGSVS-ENGFFKIFMEQVPG-GSLSSLLRSK-WG-------------------PLKDNESTMNFYTK 682 (1226)
T ss_pred HHHHHhhHhHHHHhhccC-CCCeEEEEeecCCC-CcHHHHHHhc-cC-------------------CCccchhHHHHHHH
Confidence 477899999999999876 4565554 566665 5332222220 00 111 1223443 45
Q ss_pred hccCCceeeccCCcccccccc--------------------------------------cccccC---CCCCccc-e-EE
Q psy1684 79 KDADGLCVNLRKPCVQVSCRI--------------------------------------YLVHGT---NLSGVVV-S-AV 115 (189)
Q Consensus 79 ~~a~gl~~~~~~~~~~~~~p~--------------------------------------~l~~~~---~~~~~~~-s-Vw 115 (189)
++..|+.|+|...|+|||+.- .||+|. -...|.. + ||
T Consensus 683 QILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIW 762 (1226)
T KOG4279|consen 683 QILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIW 762 (1226)
T ss_pred HHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhh
Confidence 667899999999999998765 333333 2234889 9 99
Q ss_pred Eec------------CCC-CChHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 116 DFG------------SGG-MTNAEVLHQVE-HGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 116 sfG------------~~~-~~~~~~~~~v~-~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
||| |-. -++...+.+|. -...||+|...+.+.+.+|.+|+..||.+||++++++..
T Consensus 763 S~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 763 SFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred hccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 999 322 34566677773 456799999999999999999999999999999998763
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.7e-15 Score=112.38 Aligned_cols=108 Identities=44% Similarity=0.730 Sum_probs=82.8
Q ss_pred CHhHHHHHhhhccCCceeeccCCcccccc-cc---------------c----------------------ccccC-CCCC
Q psy1684 69 HYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------Y----------------------LVHGT-NLSG 109 (189)
Q Consensus 69 ~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~----------------------l~~~~-~~~~ 109 (189)
.+..+.....+.+.++.++|..+++|+|+ |. + +++|. ....
T Consensus 100 ~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~ 179 (262)
T cd05071 100 RLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 179 (262)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccccccCCcccceecCHhHhccCC
Confidence 35556666777778888888888888875 43 1 11111 2345
Q ss_pred ccc-e-EEEec-------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q psy1684 110 VVV-S-AVDFG-------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLED 174 (189)
Q Consensus 110 ~~~-s-VwsfG-------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~ 174 (189)
++. + ||||| |.+....++...+..+..++.+..+|..+.+|+.+||+.||++||++++++..|+.
T Consensus 180 ~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 180 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred CCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 788 8 99999 44555677777777777777778899999999999999999999999999999987
Q ss_pred HH
Q psy1684 175 FF 176 (189)
Q Consensus 175 ~~ 176 (189)
.+
T Consensus 260 ~~ 261 (262)
T cd05071 260 YF 261 (262)
T ss_pred hc
Confidence 65
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.57 E-value=6.8e-16 Score=115.62 Aligned_cols=109 Identities=24% Similarity=0.449 Sum_probs=78.5
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------ccc------------------------ccC-C
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLV------------------------HGT-N 106 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~------------------------~~~-~ 106 (189)
++..+...+..+.+.|+.++|..+++|+|+ |. +++ +|. .
T Consensus 104 l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~ 183 (283)
T cd05080 104 LNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183 (283)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhc
Confidence 456666777778888888888888888885 43 111 111 2
Q ss_pred CCCccc-e-EEEec------CCC---------------------CChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccc
Q psy1684 107 LSGVVV-S-AVDFG------SGG---------------------MTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLK 157 (189)
Q Consensus 107 ~~~~~~-s-VwsfG------~~~---------------------~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~ 157 (189)
...++. + ||||| +.+ .....+...+..+.+++.|..+|.++.+++.+||+.
T Consensus 184 ~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~ 263 (283)
T cd05080 184 ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWET 263 (283)
T ss_pred ccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhcc
Confidence 345788 9 99999 111 111223333445666677888999999999999999
Q ss_pred CCCCCCCHHHHHHHHHHHH
Q psy1684 158 DPVKRPTFETLQWKLEDFF 176 (189)
Q Consensus 158 ~p~~RP~~~~i~~~l~~~~ 176 (189)
||++|||+++|+..|+.+.
T Consensus 264 ~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 264 EAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred ChhhCCCHHHHHHHHHHhh
Confidence 9999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.1e-15 Score=112.54 Aligned_cols=146 Identities=12% Similarity=0.064 Sum_probs=100.6
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCC--CCcCHhHHHHHhhhcc
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGR--TTIHYPELVEHYSKDA 81 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~--~~~~l~~li~~~~~~a 81 (189)
..++|+|++++++.+......++|+|+.+++. +.. ++... ..+....+.....+.+
T Consensus 54 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~-----L~~-----------------~l~~~~~~~~~~~~~~~i~~~l~ 111 (256)
T cd08529 54 AKLDSSYIIRYYESFLDKGKLNIVMEYAENGD-----LHK-----------------LLKMQRGRPLPEDQVWRFFIQIL 111 (256)
T ss_pred HhcCCCCeehheeeeccCCEEEEEEEeCCCCc-----HHH-----------------HHHHhcCCCCCHHHHHHHHHHHH
Confidence 35678888888877766666788888776522 111 12111 1233444455556667
Q ss_pred CCceeeccCCcccccc-cc------------------------------------cccccC-CCCCccc-e-EEEec---
Q psy1684 82 DGLCVNLRKPCVQVSC-RI------------------------------------YLVHGT-NLSGVVV-S-AVDFG--- 118 (189)
Q Consensus 82 ~gl~~~~~~~~~~~~~-p~------------------------------------~l~~~~-~~~~~~~-s-VwsfG--- 118 (189)
.++.++|..+++|+|+ |. ++++|. ....++. + |||||
T Consensus 112 ~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 191 (256)
T cd08529 112 LGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVL 191 (256)
T ss_pred HHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHH
Confidence 7777888877777775 33 111221 3345788 9 99999
Q ss_pred ---------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 119 ---------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 119 ---------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
|...+..++...+..+..++.+...+.++.+++.+||+.+|++||++.+|++.
T Consensus 192 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 192 YECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 55556667777777787777888899999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.57 E-value=6.6e-16 Score=114.58 Aligned_cols=106 Identities=13% Similarity=0.180 Sum_probs=74.6
Q ss_pred HhHHHHHhhhccCCceeeccCCccccccc-c------------------------------------cccccC-CCCCcc
Q psy1684 70 YPELVEHYSKDADGLCVNLRKPCVQVSCR-I------------------------------------YLVHGT-NLSGVV 111 (189)
Q Consensus 70 l~~li~~~~~~a~gl~~~~~~~~~~~~~p-~------------------------------------~l~~~~-~~~~~~ 111 (189)
...+..+..+.+.|+.++|..+++|+|+. . ++++|. ....++
T Consensus 105 ~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 184 (267)
T cd08228 105 ERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYN 184 (267)
T ss_pred HHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhHHHhcCCCCccccChhhhccCCCC
Confidence 44555666677778888888888887753 3 122222 335578
Q ss_pred c-e-EEEec------------CCCC--ChHHHHHHHHcCCCCCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q psy1684 112 V-S-AVDFG------------SGGM--TNAEVLHQVEHGYRMPCP-PGCPPRLYDIMLECWLKDPVKRPTFETLQWKLED 174 (189)
Q Consensus 112 ~-s-VwsfG------------~~~~--~~~~~~~~v~~g~~~~~p-~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~ 174 (189)
. + ||||| |.+. +..++...+..+..++.| ...+..+.++|.+||..+|++||+|.+|++.|++
T Consensus 185 ~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~ 264 (267)
T cd08228 185 FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQ 264 (267)
T ss_pred chhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHH
Confidence 8 8 99999 2111 234566666555545444 4688999999999999999999999999999987
Q ss_pred H
Q psy1684 175 F 175 (189)
Q Consensus 175 ~ 175 (189)
+
T Consensus 265 ~ 265 (267)
T cd08228 265 M 265 (267)
T ss_pred h
Confidence 5
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.3e-15 Score=113.09 Aligned_cols=155 Identities=22% Similarity=0.323 Sum_probs=101.3
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..+.|+|++++++.+......++|+|+.++ +.+.-.+.. . . ... .....+.+.++.....+.+.|
T Consensus 54 ~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~-~~L~~~l~~--~-----~-~~~------~~~~~~~~~~~~~~~~~l~~~ 118 (269)
T cd05044 54 SNFNHPNIVKLLGVCLLNEPQYIIMELMEG-GDLLSYLRD--A-----R-VER------FGPPLLTLKELLDICLDVAKG 118 (269)
T ss_pred HhcCCCCeeeEeeeecCCCCeEEEEeccCC-CcHHHHHHH--h-----h-hcc------cCCccccHHHHHHHHHHHHHH
Confidence 356778888877776666667778877765 311000000 0 0 000 001123355556666666777
Q ss_pred ceeeccCCcccccc-ccc-------------------------------------------ccccC-CCCCccc-e-EEE
Q psy1684 84 LCVNLRKPCVQVSC-RIY-------------------------------------------LVHGT-NLSGVVV-S-AVD 116 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~~-------------------------------------------l~~~~-~~~~~~~-s-Vws 116 (189)
+.++|...++|+|+ |.. +++|. ..+.++. + |||
T Consensus 119 l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s 198 (269)
T cd05044 119 CVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWS 198 (269)
T ss_pred HHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHH
Confidence 77777777777764 331 11111 3355788 8 999
Q ss_pred ec-------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q psy1684 117 FG-------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLE 173 (189)
Q Consensus 117 fG-------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~ 173 (189)
|| |+..+..++...+..+.++..|..+|..+.+++.+||..+|.+||++.+|++.|+
T Consensus 199 lG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 199 FGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred HHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 99 3444566777777777777888899999999999999999999999999998885
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.7e-15 Score=111.69 Aligned_cols=106 Identities=32% Similarity=0.486 Sum_probs=81.9
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cc------------------cccC-CCCCccc
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YL------------------VHGT-NLSGVVV 112 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l------------------~~~~-~~~~~~~ 112 (189)
+.......+..+.+.++.++|..+++|+|+ |. ++ ++|. ..+.++.
T Consensus 97 ~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~ 176 (254)
T cd05083 97 VSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTAPEALKHKKFSS 176 (254)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccCCCCCCCceecCHHHhccCCcCc
Confidence 335556666777788888888888888885 44 11 1111 3356888
Q ss_pred -e-EEEec-------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q psy1684 113 -S-AVDFG-------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLE 173 (189)
Q Consensus 113 -s-VwsfG-------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~ 173 (189)
+ ||||| |.+.+..++...+.++.+++.+..+|.++.+++.+||+.+|++||++++|+..|+
T Consensus 177 ~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 177 KSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred hhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 9 99999 4455666777778888888878889999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.4e-16 Score=114.18 Aligned_cols=152 Identities=14% Similarity=0.114 Sum_probs=104.3
Q ss_pred CCCChHHHHHHhc-C-CCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhcc
Q psy1684 4 GKIKRIEAEKKLL-L-PENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDA 81 (189)
Q Consensus 4 g~l~~~n~~~lL~-~-~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a 81 (189)
..++|+|++++++ . ..+.+-.+||+|++.. |+++- .++||+-. +..|+-..+-.+..+..
T Consensus 73 kQL~HpNIVqYy~~~f~~~~evlnivmE~c~~-GDLsq--------mIk~~K~q---------kr~ipE~~Vwk~f~QL~ 134 (375)
T KOG0591|consen 73 KQLNHPNIVQYYAHSFIEDNEVLNIVMELCDA-GDLSQ--------MIKHFKKQ---------KRLIPEKTVWKYFVQLC 134 (375)
T ss_pred HhcCCchHHHHHHHhhhccchhhHHHHHhhcc-cCHHH--------HHHHHHhc---------cccCchHHHHHHHHHHH
Confidence 5789999999997 2 2233347999999988 54422 33443221 22333333333444444
Q ss_pred CCceeecc--C--Ccccccc-cc---------------cccccC----------------------CCCCccc-e-EEEe
Q psy1684 82 DGLCVNLR--K--PCVQVSC-RI---------------YLVHGT----------------------NLSGVVV-S-AVDF 117 (189)
Q Consensus 82 ~gl~~~~~--~--~~~~~~~-p~---------------~l~~~~----------------------~~~~~~~-s-Vwsf 117 (189)
.++..+|. . .++|||+ |. ||++-. ..++|+. | |||.
T Consensus 135 ~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWsl 214 (375)
T KOG0591|consen 135 RALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSL 214 (375)
T ss_pred HHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHH
Confidence 45555555 2 3778885 54 222211 7788999 9 9999
Q ss_pred c------------CCCCChHHHHHHHHcCCCCCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q psy1684 118 G------------SGGMTNAEVLHQVEHGYRMPCP-PGCPPRLYDIMLECWLKDPVKRPTFETLQWKLE 173 (189)
Q Consensus 118 G------------~~~~~~~~~~~~v~~g~~~~~p-~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~ 173 (189)
| |.|-+..++..+|..|.-+|.| ...+.++..|+..|+..||+.||+...++..+.
T Consensus 215 GCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 215 GCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred HHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 9 7777888999999999888888 678899999999999999999998544544443
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.5e-15 Score=112.62 Aligned_cols=150 Identities=21% Similarity=0.292 Sum_probs=95.6
Q ss_pred CCChHHHHHHhcCCCCC--CCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCC-CCcCHhHHHHHhhhcc
Q psy1684 5 KIKRIEAEKKLLLPEND--HGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGR-TTIHYPELVEHYSKDA 81 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~--~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~-~~~~l~~li~~~~~~a 81 (189)
.+.|+|++++.+.+... .+.++|+|+.+++. +.. ++... ..+.......+..+.+
T Consensus 62 ~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~-----L~~-----------------~l~~~~~~~~~~~~~~i~~~i~ 119 (284)
T cd05079 62 NLYHENIVKYKGICTEDGGNGIKLIMEFLPSGS-----LKE-----------------YLPRNKNKINLKQQLKYAVQIC 119 (284)
T ss_pred hCCCCCeeeeeeEEecCCCCceEEEEEccCCCC-----HHH-----------------HHHhccCCCCHHHHHHHHHHHH
Confidence 45666666666544332 34567777665421 111 22211 1233555566667777
Q ss_pred CCceeeccCCcccccc-cc---------------ccc------------------------ccC-CCCCccc-e-EEEec
Q psy1684 82 DGLCVNLRKPCVQVSC-RI---------------YLV------------------------HGT-NLSGVVV-S-AVDFG 118 (189)
Q Consensus 82 ~gl~~~~~~~~~~~~~-p~---------------~l~------------------------~~~-~~~~~~~-s-VwsfG 118 (189)
.++.++|..+++|+|+ |. +++ +|. ....++. + |||||
T Consensus 120 ~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG 199 (284)
T cd05079 120 KGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFG 199 (284)
T ss_pred HHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhh
Confidence 7888888888888875 33 111 111 3345788 9 99999
Q ss_pred ---CC-------CCC-----------------hHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 119 ---SG-------GMT-----------------NAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 119 ---~~-------~~~-----------------~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
|. +.. .......+..+.+.+.+..++.++.+|+.+||+.||++|||++++++.
T Consensus 200 ~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 200 VTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred hhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 11 111 122233345566677788899999999999999999999999999999
Q ss_pred HHHHH
Q psy1684 172 LEDFF 176 (189)
Q Consensus 172 l~~~~ 176 (189)
|+.++
T Consensus 280 l~~~~ 284 (284)
T cd05079 280 FEAIL 284 (284)
T ss_pred HHhhC
Confidence 98763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=99.55 E-value=8.1e-16 Score=121.46 Aligned_cols=110 Identities=11% Similarity=0.170 Sum_probs=88.8
Q ss_pred ccCCCCCcCHhHHHHHhhhccCCceeeccC--Ccccccccc------------------------------------ccc
Q psy1684 61 QKAGRTTIHYPELVEHYSKDADGLCVNLRK--PCVQVSCRI------------------------------------YLV 102 (189)
Q Consensus 61 yl~~~~~~~l~~li~~~~~~a~gl~~~~~~--~~~~~~~p~------------------------------------~l~ 102 (189)
|+.....+.++.+..|++++..||.|+|+. ||+|||+.- .||
T Consensus 133 Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~aksvIGTPEFMA 212 (632)
T KOG0584|consen 133 YRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHAKSVIGTPEFMA 212 (632)
T ss_pred HHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccccceeccCccccC
Confidence 666566667888999999999999999986 789998644 556
Q ss_pred ccCCCCCccc-e-EEEec------------CCCC-ChHHHHHHHHcCCCCCC-CCCCCHHHHHHHHHhcccCCCCCCCHH
Q psy1684 103 HGTNLSGVVV-S-AVDFG------------SGGM-TNAEVLHQVEHGYRMPC-PPGCPPRLYDIMLECWLKDPVKRPTFE 166 (189)
Q Consensus 103 ~~~~~~~~~~-s-VwsfG------------~~~~-~~~~~~~~v~~g~~~~~-p~~~p~~~~~l~~~C~~~~p~~RP~~~ 166 (189)
+|.....|++ . ||||| |... ++.+|+++|..|..|.. ..--.++++++|.+|+.. .++|||+.
T Consensus 213 PEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~ 291 (632)
T KOG0584|consen 213 PEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAK 291 (632)
T ss_pred hHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHH
Confidence 6657788999 9 99999 4443 57899999999976532 233458999999999998 99999999
Q ss_pred HHHHH
Q psy1684 167 TLQWK 171 (189)
Q Consensus 167 ~i~~~ 171 (189)
|+++.
T Consensus 292 eLL~d 296 (632)
T KOG0584|consen 292 ELLKD 296 (632)
T ss_pred HHhhC
Confidence 99864
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.55 E-value=2e-15 Score=111.77 Aligned_cols=107 Identities=43% Similarity=0.717 Sum_probs=81.8
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cccc----------------------cC-CCC
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVH----------------------GT-NLS 108 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~----------------------~~-~~~ 108 (189)
++......+..+.+.++.++|..+++|+|+ |. +++. |. ..+
T Consensus 99 ~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~ 178 (260)
T cd05069 99 LKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 178 (260)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccC
Confidence 335666667777788888888888888885 43 1111 10 234
Q ss_pred Cccc-e-EEEec-------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q psy1684 109 GVVV-S-AVDFG-------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLE 173 (189)
Q Consensus 109 ~~~~-s-VwsfG-------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~ 173 (189)
.++. + ||||| |.+.+..+....+..+..++.|...|..+.+++.+||..||++||++++|.+.|+
T Consensus 179 ~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 258 (260)
T cd05069 179 RFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLE 258 (260)
T ss_pred CcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHh
Confidence 5788 8 99999 4455566777777777777778889999999999999999999999999999886
Q ss_pred H
Q psy1684 174 D 174 (189)
Q Consensus 174 ~ 174 (189)
.
T Consensus 259 ~ 259 (260)
T cd05069 259 D 259 (260)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.8e-15 Score=113.87 Aligned_cols=158 Identities=21% Similarity=0.332 Sum_probs=97.3
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.++|+|++++++.+...+..++|.|+... +.+.-.+.. . .... .........+....+.....+.+.|+
T Consensus 75 ~l~~~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~--~-~~~~-------~~~~~~~~~~~~~~~~~~~~~i~~al 143 (296)
T cd05051 75 RLSDPNIARLLGVCTVDPPLCMIMEYMEN-GDLNQFLQK--H-VAET-------SGLACNSKSLSFSTLLYMATQIASGM 143 (296)
T ss_pred hcCCCCEeEEEEEEecCCCcEEEEecCCC-CCHHHHHHh--c-cccc-------ccccccCCCCCHHHHHHHHHHHHHHH
Confidence 45667777766665555566777776654 211000000 0 0000 00001122344566667777888889
Q ss_pred eeeccCCcccccc-cc---------------cccc-----------------------cC-CCCCccc-e-EEEec----
Q psy1684 85 CVNLRKPCVQVSC-RI---------------YLVH-----------------------GT-NLSGVVV-S-AVDFG---- 118 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~---------------~l~~-----------------------~~-~~~~~~~-s-VwsfG---- 118 (189)
.++|..+++|+|+ |+ ++++ |. ..+.++. + |||||
T Consensus 144 ~~LH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ 223 (296)
T cd05051 144 RYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLW 223 (296)
T ss_pred HHHHHcCccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHH
Confidence 9999999999885 44 2221 11 2346788 9 99999
Q ss_pred ----------CCCCChHHHHHHHHcC-------CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q psy1684 119 ----------SGGMTNAEVLHQVEHG-------YRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLE 173 (189)
Q Consensus 119 ----------~~~~~~~~~~~~v~~g-------~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~ 173 (189)
|...+..+++..+... ...+.|..+|.++.+|+.+||+.||++|||+.+|++.|+
T Consensus 224 el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 224 EILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 2334455555554332 123456678999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.4e-15 Score=110.03 Aligned_cols=152 Identities=16% Similarity=0.178 Sum_probs=108.7
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
-.+|+|+..+||.|..++..-+|..+++.+..|.+..-. .+. .+...+.+.|..+++.|+
T Consensus 243 ifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~--t~v------------------vvd~sqav~faldiargm 302 (448)
T KOG0195|consen 243 IFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQ--TSV------------------VVDHSQAVRFALDIARGM 302 (448)
T ss_pred eecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcC--ccE------------------EEecchHHHHHHHHHhhH
Confidence 357999999999998888888889999985544222111 000 011344455555555555
Q ss_pred eeeccC---------------------------------Cccccc-ccccccccCCCC---Cccc--e-EEEec------
Q psy1684 85 CVNLRK---------------------------------PCVQVS-CRIYLVHGTNLS---GVVV--S-AVDFG------ 118 (189)
Q Consensus 85 ~~~~~~---------------------------------~~~~~~-~p~~l~~~~~~~---~~~~--s-VwsfG------ 118 (189)
+++|+. .++.|. .|.|+++|.... ..+. + .|||+
T Consensus 303 aflhslep~ipr~~lns~hvmidedltarismad~kfsfqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel 382 (448)
T KOG0195|consen 303 AFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWEL 382 (448)
T ss_pred HHHhhcchhhhhhhcccceEEecchhhhheecccceeeeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHh
Confidence 555542 122222 355777776322 2344 6 99999
Q ss_pred ------CCCCChHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q psy1684 119 ------SGGMTNAEVLHQV-EHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFF 176 (189)
Q Consensus 119 ------~~~~~~~~~~~~v-~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~ 176 (189)
|.++++.+.--+| .+|.|..+|+...+.+.+||.-|...||.+||.|..|+-.|+.|.
T Consensus 383 ~trevpfadlspmecgmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 383 NTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred hccccccccCCchhhhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 8999998887777 799999999999999999999999999999999999999998763
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.55 E-value=5.9e-16 Score=133.53 Aligned_cols=151 Identities=18% Similarity=0.176 Sum_probs=95.1
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
+.++|+|++++++.+...+..|||+|+++++. +.. ++. .+.......+..+++.|
T Consensus 738 ~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~-----L~~-----------------~l~---~l~~~~~~~i~~~ia~~ 792 (968)
T PLN00113 738 GKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKN-----LSE-----------------VLR---NLSWERRRKIAIGIAKA 792 (968)
T ss_pred hhCCCCCcceEEEEEEcCCCCEEEEeCCCCCc-----HHH-----------------HHh---cCCHHHHHHHHHHHHHH
Confidence 56889999999999988888999999998732 211 111 12234444555666667
Q ss_pred ceeec---cCCcccccc-cc-------------------------------cccccC-CCCCccc-e-EEEec------C
Q psy1684 84 LCVNL---RKPCVQVSC-RI-------------------------------YLVHGT-NLSGVVV-S-AVDFG------S 119 (189)
Q Consensus 84 l~~~~---~~~~~~~~~-p~-------------------------------~l~~~~-~~~~~~~-s-VwsfG------~ 119 (189)
+.|+| ..+++|+|+ |. ++|+|. ....|+. + ||||| .
T Consensus 793 L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~ 872 (968)
T PLN00113 793 LRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELL 872 (968)
T ss_pred HHHhccCCCCCeecCCCCHHhEEECCCCceEEEeccccccccCCCccccccccCcccccCCCCCcccchhhHHHHHHHHH
Confidence 77777 446667664 32 344544 3456899 9 99999 1
Q ss_pred CCCC--------hHHHHHHHHc----C-----CCC------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q psy1684 120 GGMT--------NAEVLHQVEH----G-----YRM------PCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFF 176 (189)
Q Consensus 120 ~~~~--------~~~~~~~v~~----g-----~~~------~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~ 176 (189)
.+.. ...+...... . ..+ +.+...+.++.+++.+||+.||++||||++|++.|+.+.
T Consensus 873 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 873 TGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred hCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 1110 0111111110 0 000 111123346778999999999999999999999999987
Q ss_pred hhc
Q psy1684 177 TME 179 (189)
Q Consensus 177 ~~~ 179 (189)
+..
T Consensus 953 ~~~ 955 (968)
T PLN00113 953 RSS 955 (968)
T ss_pred ccc
Confidence 743
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.8e-15 Score=111.91 Aligned_cols=107 Identities=43% Similarity=0.712 Sum_probs=83.1
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cc----------------------cccC-CCC
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YL----------------------VHGT-NLS 108 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l----------------------~~~~-~~~ 108 (189)
+....+..+..+.+.++.++|..+++|+|+ |. ++ ++|. ...
T Consensus 99 ~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 178 (260)
T cd05070 99 LKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 178 (260)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcC
Confidence 445666677777788888888888888885 44 11 1111 234
Q ss_pred Cccc-e-EEEec-------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q psy1684 109 GVVV-S-AVDFG-------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLE 173 (189)
Q Consensus 109 ~~~~-s-VwsfG-------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~ 173 (189)
.++. + ||||| |.+.+..++...+..+.+++.|..+|.++.+|+.+||..||++|||+.++.+.|+
T Consensus 179 ~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 258 (260)
T cd05070 179 RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLE 258 (260)
T ss_pred CCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence 5778 8 99999 4556667777778778788888899999999999999999999999999998886
Q ss_pred H
Q psy1684 174 D 174 (189)
Q Consensus 174 ~ 174 (189)
.
T Consensus 259 ~ 259 (260)
T cd05070 259 D 259 (260)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.9e-15 Score=114.40 Aligned_cols=147 Identities=21% Similarity=0.308 Sum_probs=98.2
Q ss_pred ChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCC--CcCHhHHHHHhhhccCCc
Q psy1684 7 KRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRT--TIHYPELVEHYSKDADGL 84 (189)
Q Consensus 7 ~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~--~~~l~~li~~~~~~a~gl 84 (189)
+|+|++++++.+......++|.|+.+.+. +.. ++.... .+...++..+..+.+.|+
T Consensus 97 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~-----L~~-----------------~i~~~~~~~l~~~~~~~i~~~i~~~l 154 (302)
T cd05055 97 NHENIVNLLGACTIGGPILVITEYCCYGD-----LLN-----------------FLRRKRESFLTLEDLLSFSYQVAKGM 154 (302)
T ss_pred CCCCcceEEEEEecCCceEEEEEcCCCCc-----HHH-----------------HHHhCCCCCCCHHHHHHHHHHHHHHH
Confidence 57777777766655566677777766522 111 222111 134566666667777788
Q ss_pred eeeccCCcccccc-cc---------------cc-----------------------cccC-CCCCccc-e-EEEec----
Q psy1684 85 CVNLRKPCVQVSC-RI---------------YL-----------------------VHGT-NLSGVVV-S-AVDFG---- 118 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~---------------~l-----------------------~~~~-~~~~~~~-s-VwsfG---- 118 (189)
.++|...++|+|+ |. ++ ++|. ....++. + |||||
T Consensus 155 ~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~ 234 (302)
T cd05055 155 AFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLW 234 (302)
T ss_pred HHHHHCCeehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHH
Confidence 8888888888775 33 11 1221 2345688 9 99999
Q ss_pred ---------CCCCCh-HHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q psy1684 119 ---------SGGMTN-AEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDF 175 (189)
Q Consensus 119 ---------~~~~~~-~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~ 175 (189)
|.+... ......+..+.++..|...++++.+++.+||..+|++|||+.+|++.|+++
T Consensus 235 el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 235 EIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 222332 234444566777777778899999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.54 E-value=3.5e-15 Score=110.35 Aligned_cols=107 Identities=46% Similarity=0.762 Sum_probs=82.0
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cc----------------------cccC-CCC
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YL----------------------VHGT-NLS 108 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l----------------------~~~~-~~~ 108 (189)
++...+..+..+.+.++.++|..+++|+|+ |. ++ ++|. ...
T Consensus 100 ~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~ 179 (261)
T cd05034 100 LRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYG 179 (261)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccC
Confidence 445556666677777888888888888875 33 11 1111 234
Q ss_pred Cccc-e-EEEec-------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q psy1684 109 GVVV-S-AVDFG-------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLE 173 (189)
Q Consensus 109 ~~~~-s-VwsfG-------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~ 173 (189)
.++. + ||||| |.+.+...+...+..+.+.+.|..+|.++.+++.+||..||.+||+++++...|+
T Consensus 180 ~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~ 259 (261)
T cd05034 180 RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLE 259 (261)
T ss_pred CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHh
Confidence 5788 8 99999 4455667788888888888888899999999999999999999999999998886
Q ss_pred H
Q psy1684 174 D 174 (189)
Q Consensus 174 ~ 174 (189)
.
T Consensus 260 ~ 260 (261)
T cd05034 260 D 260 (261)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.54 E-value=2.1e-15 Score=111.20 Aligned_cols=103 Identities=14% Similarity=0.151 Sum_probs=76.7
Q ss_pred CHhHHHHHhhhccCCceeeccCCcccccc-cc------------------------------------cccccC-CCCCc
Q psy1684 69 HYPELVEHYSKDADGLCVNLRKPCVQVSC-RI------------------------------------YLVHGT-NLSGV 110 (189)
Q Consensus 69 ~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~------------------------------------~l~~~~-~~~~~ 110 (189)
....+..+..+.+.|+.++|..+++|+|+ |. ++++|. ....+
T Consensus 98 ~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~ 177 (255)
T cd08219 98 PEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPY 177 (255)
T ss_pred CHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccccccCCccccCHHHHccCCc
Confidence 34455566677777888888888888875 33 111121 23447
Q ss_pred cc-e-EEEec------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 111 VV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 111 ~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
+. + ||||| |.+.+.......+..+...+.|..++.++.+|+.+||+.||++|||+.+|+..
T Consensus 178 ~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 178 NNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 78 8 99999 44555566667777787777888899999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.9e-15 Score=112.05 Aligned_cols=109 Identities=17% Similarity=0.198 Sum_probs=77.9
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc------------------------------------cccccC-CCCC
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI------------------------------------YLVHGT-NLSG 109 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~------------------------------------~l~~~~-~~~~ 109 (189)
+....+..+..+.+.|+.++|..+++|+|+ |+ ++++|. ....
T Consensus 103 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~ 182 (267)
T cd08224 103 IPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG 182 (267)
T ss_pred cCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCcccceecCCccccCHHHhccCC
Confidence 334455556666777788888888878775 33 111221 3455
Q ss_pred ccc-e-EEEec------------C--CCCChHHHHHHHHcCCCCCCCC-CCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q psy1684 110 VVV-S-AVDFG------------S--GGMTNAEVLHQVEHGYRMPCPP-GCPPRLYDIMLECWLKDPVKRPTFETLQWKL 172 (189)
Q Consensus 110 ~~~-s-VwsfG------------~--~~~~~~~~~~~v~~g~~~~~p~-~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l 172 (189)
++. + ||||| | ...+..++...+..+..++.|. ..+.++.+++.+||..+|++|||+.+|++.|
T Consensus 183 ~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~ 262 (267)
T cd08224 183 YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVA 262 (267)
T ss_pred CCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 888 9 99999 2 1223345666666777777776 7889999999999999999999999999999
Q ss_pred HHHH
Q psy1684 173 EDFF 176 (189)
Q Consensus 173 ~~~~ 176 (189)
+++.
T Consensus 263 ~~~~ 266 (267)
T cd08224 263 KEMH 266 (267)
T ss_pred HHhc
Confidence 8764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.53 E-value=4.6e-15 Score=109.73 Aligned_cols=107 Identities=37% Similarity=0.667 Sum_probs=81.3
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------ccc----------------------ccC-CCC
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLV----------------------HGT-NLS 108 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~----------------------~~~-~~~ 108 (189)
+....+.....+.+.++.++|..+++|+|+ |. +++ +|. ...
T Consensus 99 ~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~ 178 (260)
T cd05067 99 LTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 178 (260)
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhccC
Confidence 335555666667777888888888888875 33 111 111 234
Q ss_pred Cccc-e-EEEec-------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q psy1684 109 GVVV-S-AVDFG-------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLE 173 (189)
Q Consensus 109 ~~~~-s-VwsfG-------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~ 173 (189)
.++. + ||||| |.+.+..++...+..+.+++.|..+|.++.+++.+||..||++||++++|...|+
T Consensus 179 ~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 258 (260)
T cd05067 179 TFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLE 258 (260)
T ss_pred CcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhh
Confidence 4678 8 99999 4455666777778888888888899999999999999999999999999999886
Q ss_pred H
Q psy1684 174 D 174 (189)
Q Consensus 174 ~ 174 (189)
.
T Consensus 259 ~ 259 (260)
T cd05067 259 D 259 (260)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.53 E-value=6.1e-15 Score=113.35 Aligned_cols=110 Identities=26% Similarity=0.443 Sum_probs=85.0
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cccccC------------------------CC
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVHGT------------------------NL 107 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~~~------------------------~~ 107 (189)
+....+..+..+++.|+.++|..+++|+|+ |+ |++... ..
T Consensus 170 l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 249 (337)
T cd05054 170 LTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFD 249 (337)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcC
Confidence 335567778888899999999999999996 44 222211 23
Q ss_pred CCccc-e-EEEec-------------CCCCCh-HHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 108 SGVVV-S-AVDFG-------------SGGMTN-AEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 108 ~~~~~-s-VwsfG-------------~~~~~~-~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
..++. + ||||| |.+... ......+..+.++..|..+++++.+|+.+||+.+|++||++.+|++.
T Consensus 250 ~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 250 KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 45788 9 99999 333222 23444556777777888899999999999999999999999999999
Q ss_pred HHHHHh
Q psy1684 172 LEDFFT 177 (189)
Q Consensus 172 l~~~~~ 177 (189)
|+.+++
T Consensus 330 l~~~~~ 335 (337)
T cd05054 330 LGDLLQ 335 (337)
T ss_pred HHHHHh
Confidence 999886
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.53 E-value=3.1e-15 Score=110.00 Aligned_cols=105 Identities=30% Similarity=0.564 Sum_probs=78.5
Q ss_pred CHhHHHHHhhhccCCceeeccCCcccccc-cc---------------c-----------------------ccccC-CCC
Q psy1684 69 HYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------Y-----------------------LVHGT-NLS 108 (189)
Q Consensus 69 ~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~-----------------------l~~~~-~~~ 108 (189)
....+.....+.+.++.++|...++|+|+ |. + +++|. ..+
T Consensus 91 ~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~ 170 (251)
T cd05041 91 TVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYG 170 (251)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccC
Confidence 35555556666677788888888888875 33 1 11111 335
Q ss_pred Cccc-e-EEEec-------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q psy1684 109 GVVV-S-AVDFG-------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLE 173 (189)
Q Consensus 109 ~~~~-s-VwsfG-------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~ 173 (189)
.++. + ||||| |.+.+.......+..+.+++.|..+|.++.+++.+||..+|.+|||+.++++.|+
T Consensus 171 ~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 171 RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 5788 9 99999 4455556666677777777788899999999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.52 E-value=4.1e-15 Score=112.15 Aligned_cols=158 Identities=20% Similarity=0.288 Sum_probs=96.3
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.++|+|++++++.+...+..++|.|+...+. +.-.+.. .. .. ... .......+....+..+..+.+.++
T Consensus 75 ~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~-L~~~l~~--~~-~~-----~~~--~~~~~~~~~~~~~~~~~~~i~~al 143 (296)
T cd05095 75 RLKDPNIIRLLAVCITSDPLCMITEYMENGD-LNQFLSR--HE-PQ-----EAA--EKADVVTISYSTLIFMATQIASGM 143 (296)
T ss_pred hCCCCCcceEEEEEecCCccEEEEEeCCCCc-HHHHHHh--cC-cc-----ccc--ccccccccCHHHHHHHHHHHHHHH
Confidence 4567777777666555566677777766522 1000000 00 00 000 000011233555666777778888
Q ss_pred eeeccCCcccccc-cc---------------cccccC------------------------CCCCccc-e-EEEec----
Q psy1684 85 CVNLRKPCVQVSC-RI---------------YLVHGT------------------------NLSGVVV-S-AVDFG---- 118 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~---------------~l~~~~------------------------~~~~~~~-s-VwsfG---- 118 (189)
.++|..+++|+|+ |+ |++... ..+.++. + |||||
T Consensus 144 ~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~ 223 (296)
T cd05095 144 KYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLW 223 (296)
T ss_pred HHHHHCCeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHH
Confidence 8888888888885 44 222210 2345788 9 99999
Q ss_pred ----------CCCCChHHHHHHHH-------cCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q psy1684 119 ----------SGGMTNAEVLHQVE-------HGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLE 173 (189)
Q Consensus 119 ----------~~~~~~~~~~~~v~-------~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~ 173 (189)
|...+..+++..+. .....+.|..||..+.+||.+||+.||++||++.+|.+.|+
T Consensus 224 el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 224 EILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 33334444443331 12234566789999999999999999999999999998885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.1e-15 Score=116.70 Aligned_cols=147 Identities=14% Similarity=0.120 Sum_probs=97.8
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
.-++|||++.+.-+.......|+|+.+|..|..+.| +++ |...+ +.-..+....+.+.+|
T Consensus 79 sl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldI---------ik~---------~~~~G--l~E~~Ia~iLre~Lka 138 (516)
T KOG0582|consen 79 SLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDI---------IKT---------YYPDG--LEEASIATILREVLKA 138 (516)
T ss_pred hhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHH---------HHH---------Hcccc--ccHHHHHHHHHHHHHH
Confidence 357899999977666667778999999988442211 111 01101 1111122233455567
Q ss_pred ceeeccCCcccccccc-----------------------------------------cccccC---CCCCccc-e-EEEe
Q psy1684 84 LCVNLRKPCVQVSCRI-----------------------------------------YLVHGT---NLSGVVV-S-AVDF 117 (189)
Q Consensus 84 l~~~~~~~~~~~~~p~-----------------------------------------~l~~~~---~~~~~~~-s-Vwsf 117 (189)
|.|+|..+.||||+.+ |||+|. ....|+. + ||||
T Consensus 139 L~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSf 218 (516)
T KOG0582|consen 139 LDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSF 218 (516)
T ss_pred HHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhh
Confidence 8888888888887644 677776 3455999 9 9999
Q ss_pred c------------CCCCChHHHHHHHHcCCCCCCC----------CCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 118 G------------SGGMTNAEVLHQVEHGYRMPCP----------PGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 118 G------------~~~~~~~~~~~~v~~g~~~~~p----------~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
| |..+.+.+++-.-.+|. +|.| ...+..+++++..|+..||++|||++++++.
T Consensus 219 GITA~ELA~G~aPf~k~pPmkvLl~tLqn~-pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 219 GITACELAHGHAPFSKYPPMKVLLLTLQND-PPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred hHHHHHHhcCCCCcccCChHHHHHHHhcCC-CCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 9 88888877765444443 2211 1345678899999999999999999999864
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.52 E-value=5.5e-15 Score=110.17 Aligned_cols=156 Identities=24% Similarity=0.365 Sum_probs=102.9
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC-ccCCCCCcCHhHHHHHhhhccC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET-QKAGRTTIHYPELVEHYSKDAD 82 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g-yl~~~~~~~l~~li~~~~~~a~ 82 (189)
..++|+|++++++.+...+..++|+|+.+. +. +.. .+.. ...+ -......+.......+..+.+.
T Consensus 63 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~~----L~~----~i~~-----~~~~~~~~~~~~l~~~~~~~~~~~l~~ 128 (275)
T cd05046 63 RKLSHKNVVRLLGLCREAEPHYMILEYTDL-GD----LKQ----FLRA-----TKSKDEKLKPPPLSTKQKVALCTQIAL 128 (275)
T ss_pred HhcCCcceeeeEEEECCCCcceEEEEecCC-Cc----HHH----HHHh-----cccccccccccCCCHHHHHHHHHHHHH
Confidence 456788888888777666677888887765 31 111 0000 0000 0000113446667777788888
Q ss_pred CceeeccCCcccccc-cc---------------ccc----------------------ccC-CCCCccc-e-EEEec---
Q psy1684 83 GLCVNLRKPCVQVSC-RI---------------YLV----------------------HGT-NLSGVVV-S-AVDFG--- 118 (189)
Q Consensus 83 gl~~~~~~~~~~~~~-p~---------------~l~----------------------~~~-~~~~~~~-s-VwsfG--- 118 (189)
++.++|...++|+|+ |+ +++ +|. ....++. + |||||
T Consensus 129 ~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l 208 (275)
T cd05046 129 GMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLM 208 (275)
T ss_pred HHHHhhhcCcccCcCccceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHH
Confidence 999999999999986 44 111 111 2334677 8 99999
Q ss_pred ----------CCCCChHHHHHHHHcCC-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q psy1684 119 ----------SGGMTNAEVLHQVEHGY-RMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLE 173 (189)
Q Consensus 119 ----------~~~~~~~~~~~~v~~g~-~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~ 173 (189)
|.+.+..++...+..+. ..+.+..+|..+.+++.+||+.||++||++.+++..|+
T Consensus 209 ~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 209 WEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHHHhCCCCCccccchHHHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 33444566666665443 34456789999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.1e-14 Score=116.14 Aligned_cols=146 Identities=10% Similarity=0.047 Sum_probs=102.3
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
....||++++||+.-..+...+|+.|++.+|- +-. . .+.-...+.-.++--.+.++.++
T Consensus 84 a~CdHP~ivkLl~ayy~enkLwiliEFC~GGA-----VDa--------i--------mlEL~r~LtE~QIqvvc~q~ldA 142 (1187)
T KOG0579|consen 84 AECDHPVIVKLLSAYYFENKLWILIEFCGGGA-----VDA--------I--------MLELGRVLTEDQIQVVCYQVLDA 142 (1187)
T ss_pred hcCCChHHHHHHHHHhccCceEEEEeecCCch-----HhH--------H--------HHHhccccchHHHHHHHHHHHHH
Confidence 34579999999986666677888888887632 100 0 11111222212222223344566
Q ss_pred ceeeccCCcccccccc-------------------------------------cccccC------CCCCccc-e-EEEec
Q psy1684 84 LCVNLRKPCVQVSCRI-------------------------------------YLVHGT------NLSGVVV-S-AVDFG 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~p~-------------------------------------~l~~~~------~~~~~~~-s-VwsfG 118 (189)
|.++|+..|||||+.. |||+++ ...+|+. + |||||
T Consensus 143 Ln~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlG 222 (1187)
T KOG0579|consen 143 LNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLG 222 (1187)
T ss_pred HHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhh
Confidence 7777777777776544 777776 6788999 9 99999
Q ss_pred ------------CCCCChHHHHHHHHcCCCC--CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 119 ------------SGGMTNAEVLHQVEHGYRM--PCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 119 ------------~~~~~~~~~~~~v~~g~~~--~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
...+++..|+-+|.+...| -.|..+...+.+++.+|+..||..||+.++|++
T Consensus 223 ITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 223 ITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred hHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 6677888888888665433 358899999999999999999999999999986
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.52 E-value=9.8e-15 Score=108.04 Aligned_cols=105 Identities=36% Similarity=0.719 Sum_probs=80.7
Q ss_pred HhHHHHHhhhccCCceeeccCCcccccc-cc---------------cc----------------------cccC-CCCCc
Q psy1684 70 YPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YL----------------------VHGT-NLSGV 110 (189)
Q Consensus 70 l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l----------------------~~~~-~~~~~ 110 (189)
...+..+..+.+.++.++|..+++|+|+ |. ++ ++|. ..+.+
T Consensus 101 ~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~ 180 (260)
T cd05073 101 LPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF 180 (260)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCc
Confidence 5556666677778888888888888875 43 11 1111 23456
Q ss_pred cc-e-EEEec-------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q psy1684 111 VV-S-AVDFG-------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLED 174 (189)
Q Consensus 111 ~~-s-VwsfG-------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~ 174 (189)
+. + ||||| |++.+..++...+..+..++.+...|.++.+++.+||+.||++||++.++.+.|+.
T Consensus 181 ~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 181 TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 88 8 99999 44555667777777887778888899999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.52 E-value=6.4e-15 Score=109.61 Aligned_cols=147 Identities=16% Similarity=0.116 Sum_probs=93.0
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC----CCCcCHhHHHHHhhh
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG----RTTIHYPELVEHYSK 79 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~----~~~~~l~~li~~~~~ 79 (189)
..++|+|++++++.+......|+|+|+++. +++ .. ++.. ........+..+..+
T Consensus 50 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~~L----~~-----------------~l~~~~~~~~~~~~~~~~~~~~~ 107 (268)
T cd05086 50 RILQHPNILQCLGQCVEAIPYLLVFEYCEL-GDL----KS-----------------YLSQEQWHRRNSQLLLLQRMACE 107 (268)
T ss_pred hccCCcchhheEEEecCCCccEEEEecCCC-CcH----HH-----------------HHHhhhcccccccHHHHHHHHHH
Confidence 357899999999988777788999999876 422 11 1100 001113333444555
Q ss_pred ccCCceeeccCCcccccc-cc---------------c-----------------------ccccCC--------CCCccc
Q psy1684 80 DADGLCVNLRKPCVQVSC-RI---------------Y-----------------------LVHGTN--------LSGVVV 112 (189)
Q Consensus 80 ~a~gl~~~~~~~~~~~~~-p~---------------~-----------------------l~~~~~--------~~~~~~ 112 (189)
.+.|+.++|...++|+|+ |. + +++|.. ...++.
T Consensus 108 i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~ 187 (268)
T cd05086 108 IAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTK 187 (268)
T ss_pred HHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCC
Confidence 666777777777777764 33 1 122211 123577
Q ss_pred -e-EEEec-------------CCCCChHHHHHHHHcCC-----CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q psy1684 113 -S-AVDFG-------------SGGMTNAEVLHQVEHGY-----RMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKL 172 (189)
Q Consensus 113 -s-VwsfG-------------~~~~~~~~~~~~v~~g~-----~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l 172 (189)
+ ||||| |.+.+..+++..+..+. ++..+...++.+++++..|| .+|++||++++|++.|
T Consensus 188 ~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 188 PSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred cchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 8 99999 44445556665553321 23334456789999999999 6899999999999887
Q ss_pred H
Q psy1684 173 E 173 (189)
Q Consensus 173 ~ 173 (189)
.
T Consensus 267 ~ 267 (268)
T cd05086 267 T 267 (268)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.51 E-value=6.4e-15 Score=108.53 Aligned_cols=144 Identities=12% Similarity=0.080 Sum_probs=91.2
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCC--CCcCHhHHHHHhhhccC
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGR--TTIHYPELVEHYSKDAD 82 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~--~~~~l~~li~~~~~~a~ 82 (189)
.++|+|++++++........++|+|+.+.+. +.. ++... ..+....+..+..+.+.
T Consensus 55 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~-----L~~-----------------~~~~~~~~~~~~~~~~~~~~~i~~ 112 (256)
T cd08220 55 LLSHPNIIEYYENFLEDKALMIVMEYAPGGT-----LAE-----------------YIQKRCNSLLDEDTILHFFVQILL 112 (256)
T ss_pred hCCCCchhheeeeEecCCEEEEEEecCCCCC-----HHH-----------------HHHHhcccCCCHHHHHHHHHHHHH
Confidence 4567777776655444455666776665421 111 12111 11233444445556666
Q ss_pred CceeeccCCcccccc-cc------------------------------------cccccC-CCCCccc-e-EEEec----
Q psy1684 83 GLCVNLRKPCVQVSC-RI------------------------------------YLVHGT-NLSGVVV-S-AVDFG---- 118 (189)
Q Consensus 83 gl~~~~~~~~~~~~~-p~------------------------------------~l~~~~-~~~~~~~-s-VwsfG---- 118 (189)
++.++|..+++|+|+ |. ++++|. ....++. + |||||
T Consensus 113 ~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ 192 (256)
T cd08220 113 ALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLY 192 (256)
T ss_pred HHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccccccccCCcccCchhccCCCCCcccchHHHHHHHH
Confidence 667777766666654 22 222222 2344678 8 99999
Q ss_pred --------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 119 --------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 119 --------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
|.+.+.......+..+...+.|..++.++.+++.+||+.||++|||+.+++.
T Consensus 193 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 193 ELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred HHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 5555555555566666666778889999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.51 E-value=5.1e-15 Score=110.88 Aligned_cols=46 Identities=43% Similarity=1.044 Sum_probs=40.0
Q ss_pred HHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q psy1684 130 QVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDF 175 (189)
Q Consensus 130 ~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~ 175 (189)
.+..+.+++.+..+|.++.+|+.+||+.+|++|||+.+|++.|+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 238 LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 3455666777888999999999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.51 E-value=6.3e-15 Score=108.69 Aligned_cols=66 Identities=30% Similarity=0.609 Sum_probs=55.0
Q ss_pred CCCccc-e-EEEec-------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 107 LSGVVV-S-AVDFG-------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 107 ~~~~~~-s-VwsfG-------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
.+.++. + ||||| |.+....++...+..+.++..|...+.++++|+.+||+.+|++|||+.++++.
T Consensus 175 ~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 175 FSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred cCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 356788 9 99999 33344566777777787777788899999999999999999999999999987
Q ss_pred H
Q psy1684 172 L 172 (189)
Q Consensus 172 l 172 (189)
|
T Consensus 255 l 255 (256)
T cd05112 255 L 255 (256)
T ss_pred h
Confidence 6
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.51 E-value=6.5e-15 Score=111.99 Aligned_cols=141 Identities=9% Similarity=-0.005 Sum_probs=94.9
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.++|+|+++++..+...+..+||+|++.+ |+ +.. ++.....+.......+..+.+.|+
T Consensus 49 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-g~----L~~-----------------~l~~~~~~~~~~~~~~~~qi~~~l 106 (312)
T cd05585 49 QVNCPFIVPLKFSFQSPEKLYLVLAFING-GE----LFH-----------------HLQREGRFDLSRARFYTAELLCAL 106 (312)
T ss_pred hCCCCcEeceeeEEecCCeEEEEEcCCCC-Cc----HHH-----------------HHHhcCCCCHHHHHHHHHHHHHHH
Confidence 45677777766665555667777777665 31 111 232233444455555666778889
Q ss_pred eeeccCCcccccc-cc---------------cccc---------------------cC-CCCCccc-e-EEEec------
Q psy1684 85 CVNLRKPCVQVSC-RI---------------YLVH---------------------GT-NLSGVVV-S-AVDFG------ 118 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~---------------~l~~---------------------~~-~~~~~~~-s-VwsfG------ 118 (189)
.++|..+++|+|+ |+ |++. |. ....++. + |||||
T Consensus 107 ~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el 186 (312)
T cd05585 107 ENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEM 186 (312)
T ss_pred HHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHH
Confidence 9999999999986 44 2221 11 3445788 9 99999
Q ss_pred ------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy1684 119 ------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETL 168 (189)
Q Consensus 119 ------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i 168 (189)
|.+.+..++...+..+ .+..|..+++++.+++.+||+.||++||++.++
T Consensus 187 ~tg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~ 241 (312)
T cd05585 187 LTGLPPFYDENVNEMYRKILQE-PLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGA 241 (312)
T ss_pred HhCCCCcCCCCHHHHHHHHHcC-CCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCH
Confidence 5555666666666554 355678899999999999999999999875433
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.51 E-value=6.5e-15 Score=108.59 Aligned_cols=101 Identities=11% Similarity=0.123 Sum_probs=74.9
Q ss_pred HhHHHHHhhhccCCceeeccCCcccccc-cc------------------------------------cccccC-CCCCcc
Q psy1684 70 YPELVEHYSKDADGLCVNLRKPCVQVSC-RI------------------------------------YLVHGT-NLSGVV 111 (189)
Q Consensus 70 l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~------------------------------------~l~~~~-~~~~~~ 111 (189)
...+..+..+.+.|+.++|...++|+|+ |. ++++|. ..+.++
T Consensus 100 ~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~ 179 (256)
T cd08218 100 EDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYN 179 (256)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhhccCCccccCHHHhCCCCCC
Confidence 4455566667777777788777777764 22 112222 345577
Q ss_pred c-e-EEEec------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 112 V-S-AVDFG------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 112 ~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
. + ||||| |...+..+....+..+..++.|..++.++++++.+||+.+|++||++.+|++
T Consensus 180 ~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 180 NKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 8 8 99999 4444556666677778777788899999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.51 E-value=5.2e-15 Score=113.33 Aligned_cols=144 Identities=8% Similarity=-0.041 Sum_probs=97.8
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.++|+|++++++.....+..++|+|++.++. +.. ++.....+.......+..+.+.|+
T Consensus 74 ~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~-----L~~-----------------~l~~~~~~~~~~~~~~~~qi~~aL 131 (329)
T PTZ00263 74 ELSHPFIVNMMCSFQDENRVYFLLEFVVGGE-----LFT-----------------HLRKAGRFPNDVAKFYHAELVLAF 131 (329)
T ss_pred hCCCCCCCcEEEEEEcCCEEEEEEcCCCCCh-----HHH-----------------HHHHcCCCCHHHHHHHHHHHHHHH
Confidence 4567777777766655566677777766522 111 222222333333444556777888
Q ss_pred eeeccCCcccccc-cc---------------cc------------------cccC-CCCCccc-e-EEEec---------
Q psy1684 85 CVNLRKPCVQVSC-RI---------------YL------------------VHGT-NLSGVVV-S-AVDFG--------- 118 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~---------------~l------------------~~~~-~~~~~~~-s-VwsfG--------- 118 (189)
.++|..+++|+|+ |+ |+ |+|. ....++. + |||||
T Consensus 132 ~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg 211 (329)
T PTZ00263 132 EYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211 (329)
T ss_pred HHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcC
Confidence 9999999999886 44 22 2222 3445788 9 99999
Q ss_pred ---CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q psy1684 119 ---SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPT-----FETLQWK 171 (189)
Q Consensus 119 ---~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~-----~~~i~~~ 171 (189)
|.+.+..++...+..+ +++.|..++.++.+|+.+||+.||++||+ +++|+..
T Consensus 212 ~~pf~~~~~~~~~~~i~~~-~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 212 YPPFFDDTPFRIYEKILAG-RLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred CCCCCCCCHHHHHHHHhcC-CcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 5566667777777766 46678889999999999999999999997 6777643
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.50 E-value=9.7e-15 Score=107.74 Aligned_cols=147 Identities=19% Similarity=0.338 Sum_probs=97.7
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCC--CCcCHhHHHHHhhhcc
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGR--TTIHYPELVEHYSKDA 81 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~--~~~~l~~li~~~~~~a 81 (189)
..+.|+|++++.+.... ...++|+|+... +. +.. ++... ..+.......+..+.+
T Consensus 51 ~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~-~~----L~~-----------------~l~~~~~~~~~~~~~~~~~~qi~ 107 (257)
T cd05040 51 HSLDHENLIRLYGVVLT-HPLMMVTELAPL-GS----LLD-----------------RLRKDALGHFLISTLCDYAVQIA 107 (257)
T ss_pred hhcCCCCccceeEEEcC-CeEEEEEEecCC-Cc----HHH-----------------HHHhcccccCcHHHHHHHHHHHH
Confidence 34566777766655443 455666666554 21 111 22211 1233566666677778
Q ss_pred CCceeeccCCcccccc-cc---------------cc------------------------cccC-CCCCccc-e-EEEec
Q psy1684 82 DGLCVNLRKPCVQVSC-RI---------------YL------------------------VHGT-NLSGVVV-S-AVDFG 118 (189)
Q Consensus 82 ~gl~~~~~~~~~~~~~-p~---------------~l------------------------~~~~-~~~~~~~-s-VwsfG 118 (189)
.|+.++|..+++|+|+ |+ ++ ++|. ....++. + |||||
T Consensus 108 ~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG 187 (257)
T cd05040 108 NGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFG 187 (257)
T ss_pred HHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHH
Confidence 8888888888888875 44 11 1111 2346788 9 99999
Q ss_pred -------------CCCCChHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q psy1684 119 -------------SGGMTNAEVLHQVE-HGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLE 173 (189)
Q Consensus 119 -------------~~~~~~~~~~~~v~-~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~ 173 (189)
|.+.+..++...+. .+..++.|..+|.++.+++.+||+.+|++|||+.+|+..|.
T Consensus 188 ~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 188 VTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 33445566666664 56667778889999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.50 E-value=9.4e-15 Score=108.73 Aligned_cols=106 Identities=26% Similarity=0.428 Sum_probs=82.0
Q ss_pred HhHHHHHhhhccCCceeeccCCcccccc-cc---------------cccccC------------------------CCCC
Q psy1684 70 YPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVHGT------------------------NLSG 109 (189)
Q Consensus 70 l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~~~------------------------~~~~ 109 (189)
...+..+..+.+.|+.++|..+++|+|+ |. +++... ....
T Consensus 112 ~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~ 191 (273)
T cd05074 112 LQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNV 191 (273)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCc
Confidence 5566777788888999999999999986 44 221110 2234
Q ss_pred ccc-e-EEEec-------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q psy1684 110 VVV-S-AVDFG-------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLED 174 (189)
Q Consensus 110 ~~~-s-VwsfG-------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~ 174 (189)
++. + ||||| |.+.+..++...+..+..++.+..++..+.+++.+||+.+|++|||+.+++..|+.
T Consensus 192 ~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~ 271 (273)
T cd05074 192 YTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL 271 (273)
T ss_pred cchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 577 8 99999 33445566666677777777778899999999999999999999999999999986
Q ss_pred H
Q psy1684 175 F 175 (189)
Q Consensus 175 ~ 175 (189)
+
T Consensus 272 ~ 272 (273)
T cd05074 272 I 272 (273)
T ss_pred h
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.50 E-value=5.4e-15 Score=111.46 Aligned_cols=160 Identities=17% Similarity=0.239 Sum_probs=98.4
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..++|+|++++++.+......++|+|++.++. +.-.+.. ......+. .......+....+.....+.+.|
T Consensus 72 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~-L~~~l~~--~~~~~~~~-------~~~~~~~~~~~~~~~i~~~i~~a 141 (295)
T cd05097 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGD-LNQFLSQ--REIESTFT-------HANNIPSVSIANLLYMAVQIASG 141 (295)
T ss_pred HhCCCCCcCeEEEEEcCCCccEEEEecCCCCc-HHHHHHh--cccccccc-------ccccCCcccHHHHHHHHHHHHHH
Confidence 35778888888877766677788888877632 1000000 00000000 00001122355556666777778
Q ss_pred ceeeccCCcccccc-cc---------------ccc-----------------------ccC-CCCCccc-e-EEEec---
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YLV-----------------------HGT-NLSGVVV-S-AVDFG--- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l~-----------------------~~~-~~~~~~~-s-VwsfG--- 118 (189)
+.++|..+++|+|+ |. +++ +|. ..+.++. + |||||
T Consensus 142 l~~lH~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l 221 (295)
T cd05097 142 MKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTL 221 (295)
T ss_pred HHHHHhcCeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHH
Confidence 88888888888875 43 111 111 2345788 9 99999
Q ss_pred -----------CCCCChHHHHHHHHc-----C--CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q psy1684 119 -----------SGGMTNAEVLHQVEH-----G--YRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLE 173 (189)
Q Consensus 119 -----------~~~~~~~~~~~~v~~-----g--~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~ 173 (189)
|...+..+++..+.. + .....++.+|+.+.+|+.+||+.||++|||+.+|++.|+
T Consensus 222 ~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 222 WEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 334445555544321 1 123446678999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.50 E-value=8.7e-15 Score=111.55 Aligned_cols=141 Identities=12% Similarity=0.059 Sum_probs=96.7
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..++|+|++++++........|||+|++.++. +.. ++.....+...++..+..+.+.|
T Consensus 53 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~-----L~~-----------------~l~~~~~l~~~~~~~~~~qi~~~ 110 (318)
T cd05582 53 AEVNHPFIVKLHYAFQTEGKLYLILDFLRGGD-----LFT-----------------RLSKEVMFTEEDVKFYLAELALA 110 (318)
T ss_pred HhCCCCCcccEEEEEEcCCEEEEEEcCCCCCc-----HHH-----------------HHHHcCCCCHHHHHHHHHHHHHH
Confidence 35677888877766655666777777776522 111 22223334455666677788888
Q ss_pred ceeeccCCcccccc-cc---------------cccc---------------------cC-CCCCccc-e-EEEec-----
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YLVH---------------------GT-NLSGVVV-S-AVDFG----- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l~~---------------------~~-~~~~~~~-s-VwsfG----- 118 (189)
+.++|...++|+|+ |. |++. |. ....++. + |||||
T Consensus 111 l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~e 190 (318)
T cd05582 111 LDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFE 190 (318)
T ss_pred HHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeee
Confidence 99999999999886 43 2221 11 2345788 8 99999
Q ss_pred -------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q psy1684 119 -------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFET 167 (189)
Q Consensus 119 -------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~ 167 (189)
|.+.+..++...+.++ ....|..+++++.+|+.+||+.||++||++.+
T Consensus 191 l~tg~~p~~~~~~~~~~~~i~~~-~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 191 MLTGSLPFQGKDRKETMTMILKA-KLGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred eccCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 5555666666666554 34567889999999999999999999999554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.49 E-value=8.7e-15 Score=108.58 Aligned_cols=64 Identities=16% Similarity=0.164 Sum_probs=51.6
Q ss_pred CCCccc-e-EEEec------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 107 LSGVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 107 ~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
...++. + ||||| |.+.+..+.+..+..+.++..|..+|.++.+++.+||+.||++||++.+|++
T Consensus 186 ~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 186 QTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred cCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 345778 8 99999 5455555555556666677788899999999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.49 E-value=8.5e-15 Score=108.05 Aligned_cols=145 Identities=14% Similarity=0.194 Sum_probs=93.5
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCC-CcCHhHHHHHhhhccC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRT-TIHYPELVEHYSKDAD 82 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~-~~~l~~li~~~~~~a~ 82 (189)
..++|+|++++++.+.. ...++|.|+++. +.+ .. ++.... .+.....+.+..+.+.
T Consensus 56 ~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~-~~L----~~-----------------~l~~~~~~~~~~~~~~~~~~i~~ 112 (259)
T cd05037 56 SQLSHKHLVKLYGVCVR-DENIMVEEYVKF-GPL----DV-----------------FLHREKNNVSLHWKLDVAKQLAS 112 (259)
T ss_pred HcCCCcchhheeeEEec-CCcEEEEEcCCC-CcH----HH-----------------HHHhhccCCCHHHHHHHHHHHHH
Confidence 45788999988887765 667888888776 311 11 222122 3345556666777788
Q ss_pred CceeeccCCcccccc-ccc---------------------------------------ccccC-CC--CCccc-e-EEEe
Q psy1684 83 GLCVNLRKPCVQVSC-RIY---------------------------------------LVHGT-NL--SGVVV-S-AVDF 117 (189)
Q Consensus 83 gl~~~~~~~~~~~~~-p~~---------------------------------------l~~~~-~~--~~~~~-s-Vwsf 117 (189)
|+.++|..+++|+|+ |.. +++|. .. ..++. + ||||
T Consensus 113 ~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~sl 192 (259)
T cd05037 113 ALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIPWIAPECIRNGQASLTIAADKWSF 192 (259)
T ss_pred HHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcccccccccccccCCCccChhhhcCCCCCcchhhHHHHH
Confidence 888888888888875 441 11111 12 25788 8 9999
Q ss_pred c-------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q psy1684 118 G-------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLE 173 (189)
Q Consensus 118 G-------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~ 173 (189)
| +...+..+...........+.|. ...+.+++.+||..+|++|||+.+|++.|+
T Consensus 193 G~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 193 GTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMPD--CAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred HHHHHHHHhCCCCCcccCCchhHHHHHhcCCCCCCCC--chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 9 22222223333333333333333 389999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.49 E-value=5.7e-15 Score=108.91 Aligned_cols=104 Identities=11% Similarity=0.062 Sum_probs=77.1
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------c---------------------ccccC-CCCC
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------Y---------------------LVHGT-NLSG 109 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~---------------------l~~~~-~~~~ 109 (189)
+....+..+..+.+.|+.++|...++|+|+ |. + ++++. .+..
T Consensus 98 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~ 177 (256)
T cd08221 98 FEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVK 177 (256)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccccccccCCCccccCHhhcCCCC
Confidence 335556666677778888888888888875 33 1 11111 2234
Q ss_pred ccc-e-EEEec------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 110 VVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 110 ~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
++. + ||||| |.+.+..+....+..+...+.+..++.++.+++.+||..+|++||+++++++.
T Consensus 178 ~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 178 YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 678 8 99999 55555666777777777677777899999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.49 E-value=2e-14 Score=107.47 Aligned_cols=108 Identities=24% Similarity=0.403 Sum_probs=75.3
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------c------------------------ccccC-C
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------Y------------------------LVHGT-N 106 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~------------------------l~~~~-~ 106 (189)
+....+..+..+.+.++.++|...++|+|+ |. + ++++. .
T Consensus 106 ~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~ 185 (284)
T cd05038 106 INLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR 185 (284)
T ss_pred cCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHc
Confidence 335555666667777788888888888775 33 1 11111 2
Q ss_pred CCCccc-e-EEEec------CCC------C---------------ChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhccc
Q psy1684 107 LSGVVV-S-AVDFG------SGG------M---------------TNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLK 157 (189)
Q Consensus 107 ~~~~~~-s-VwsfG------~~~------~---------------~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~ 157 (189)
...++. + ||||| +.+ . ....+...+..+.+.+.|..||.++.+|+.+||+.
T Consensus 186 ~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~ 265 (284)
T cd05038 186 TSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEA 265 (284)
T ss_pred cCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhcc
Confidence 345788 8 99999 111 0 01223344456667777888999999999999999
Q ss_pred CCCCCCCHHHHHHHHHHH
Q psy1684 158 DPVKRPTFETLQWKLEDF 175 (189)
Q Consensus 158 ~p~~RP~~~~i~~~l~~~ 175 (189)
||++|||+.+|++.|+.+
T Consensus 266 ~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 266 EPQDRPSFADLILIVDRL 283 (284)
T ss_pred ChhhCCCHHHHHHHHhhc
Confidence 999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.48 E-value=6.2e-15 Score=109.64 Aligned_cols=147 Identities=16% Similarity=0.118 Sum_probs=90.5
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC-----CCCcCHhHHHHHhh
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG-----RTTIHYPELVEHYS 78 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~-----~~~~~l~~li~~~~ 78 (189)
..++|+|++++++.+......++|+|+++++. +.. ++.. ........+..+..
T Consensus 50 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~-----L~~-----------------~l~~~~~~~~~~~~~~~~~~~~~ 107 (269)
T cd05087 50 RSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD-----LKG-----------------YLRSCRKAELMTPDPTTLQRMAC 107 (269)
T ss_pred HhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc-----HHH-----------------HHHHhhhcccccccHHHHHHHHH
Confidence 45778999998887776777889999887632 211 1100 00111233344555
Q ss_pred hccCCceeeccCCcccccc-cc---------------c-----------------------ccccCCC--------CCcc
Q psy1684 79 KDADGLCVNLRKPCVQVSC-RI---------------Y-----------------------LVHGTNL--------SGVV 111 (189)
Q Consensus 79 ~~a~gl~~~~~~~~~~~~~-p~---------------~-----------------------l~~~~~~--------~~~~ 111 (189)
+.+.++.++|..+++|+|+ |. + +++|... ..++
T Consensus 108 qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~ 187 (269)
T cd05087 108 EIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQT 187 (269)
T ss_pred HHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCC
Confidence 6666777777777777764 22 1 1222111 1357
Q ss_pred c-e-EEEec-------------CCCCChHHHHHHHHcCC--CCCCC---CCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 112 V-S-AVDFG-------------SGGMTNAEVLHQVEHGY--RMPCP---PGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 112 ~-s-VwsfG-------------~~~~~~~~~~~~v~~g~--~~~~p---~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
. + ||||| |+..++.+.......+. +.+.| ..++..+.+||..|| .+|++|||+++|+..
T Consensus 188 ~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~ 266 (269)
T cd05087 188 KESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLL 266 (269)
T ss_pred ccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHH
Confidence 7 8 99999 44445555544433332 22222 256789999999999 589999999999988
Q ss_pred HH
Q psy1684 172 LE 173 (189)
Q Consensus 172 l~ 173 (189)
|+
T Consensus 267 l~ 268 (269)
T cd05087 267 LS 268 (269)
T ss_pred hc
Confidence 74
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.48 E-value=3e-14 Score=106.40 Aligned_cols=145 Identities=10% Similarity=0.043 Sum_probs=95.8
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..+.|+|++++++.+......|||+|+++++. + .. ++. ...+....+.....+.+.|
T Consensus 57 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~-L----~~-----------------~~~-~~~~~~~~~~~~~~~i~~~ 113 (277)
T cd06642 57 SQCDSPYITRYYGSYLKGTKLWIIMEYLGGGS-A----LD-----------------LLK-PGPLEETYIATILREILKG 113 (277)
T ss_pred HcCCCCccHhhhcccccCCceEEEEEccCCCc-H----HH-----------------Hhh-cCCCCHHHHHHHHHHHHHH
Confidence 46789999999988877777899999988632 1 11 111 1112223333344455566
Q ss_pred ceeeccCCcccccc-cc------------------------------------cccccC-CCCCccc-e-EEEec-----
Q psy1684 84 LCVNLRKPCVQVSC-RI------------------------------------YLVHGT-NLSGVVV-S-AVDFG----- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~------------------------------------~l~~~~-~~~~~~~-s-VwsfG----- 118 (189)
+.++|..+++|+|+ |+ ++++|. ....++. + |||||
T Consensus 114 l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e 193 (277)
T cd06642 114 LDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIE 193 (277)
T ss_pred HHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHH
Confidence 66677666666654 33 122222 3345788 9 99999
Q ss_pred -------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 119 -------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 119 -------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
+.+..+..+...+..+..+..+..++.++.+++.+||+.+|++||++.+|++.
T Consensus 194 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 194 LAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred HHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 33344445555555555555667789999999999999999999999999873
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.6e-14 Score=108.76 Aligned_cols=145 Identities=8% Similarity=-0.039 Sum_probs=103.3
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..++|+|++++++........++|+|++.++. +.. ++.....+.......+..+.+.|
T Consensus 56 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~-----L~~-----------------~~~~~~~~~~~~~~~~~~qi~~~ 113 (291)
T cd05612 56 KEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGE-----LFS-----------------YLRNSGRFSNSTGLFYASEIVCA 113 (291)
T ss_pred HhCCCCcHhhhHhhhccCCeEEEEEeCCCCCC-----HHH-----------------HHHHcCCCCHHHHHHHHHHHHHH
Confidence 46789999999887766677888999887632 111 22223334444455566777888
Q ss_pred ceeeccCCcccccc-cc---------------cc------------------cccC-CCCCccc-e-EEEec--------
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YL------------------VHGT-NLSGVVV-S-AVDFG-------- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l------------------~~~~-~~~~~~~-s-VwsfG-------- 118 (189)
+.++|..+++|+|+ |+ |+ |+|. ....++. + |||||
T Consensus 114 l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~ 193 (291)
T cd05612 114 LEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLV 193 (291)
T ss_pred HHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHh
Confidence 89999999999886 44 22 1221 3345788 9 99999
Q ss_pred ----CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q psy1684 119 ----SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPT-----FETLQWK 171 (189)
Q Consensus 119 ----~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~-----~~~i~~~ 171 (189)
|.+.+..++...+..+ .+..|...+..+.+|+.+||+.||.+||+ +.++++.
T Consensus 194 g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 194 GYPPFFDDNPFGIYEKILAG-KLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CCCCCCCCCHHHHHHHHHhC-CcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 6666677777777665 35677788999999999999999999995 7777654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.3e-14 Score=107.61 Aligned_cols=154 Identities=14% Similarity=0.107 Sum_probs=96.2
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.+.|+|++++++.+......++|+++...+. +.. .... .......+....+..+..+.+.|+
T Consensus 58 ~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~-----L~~----~~~~---------~~~~~~~~~~~~~~~~~~~i~~~l 119 (267)
T cd08229 58 QLNHPNVIKYYASFIEDNELNIVLELADAGD-----LSR----MIKH---------FKKQKRLIPEKTVWKYFVQLCSAL 119 (267)
T ss_pred HccCCchhhhhheeEeCCeEEEEEEecCCCC-----HHH----HHHH---------hhccCCCCCHHHHHHHHHHHHHHH
Confidence 4678888888876665566777887766522 111 0000 000012233445555666677777
Q ss_pred eeeccCCcccccc-cc------------------------------------cccccC-CCCCccc-e-EEEec------
Q psy1684 85 CVNLRKPCVQVSC-RI------------------------------------YLVHGT-NLSGVVV-S-AVDFG------ 118 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~------------------------------------~l~~~~-~~~~~~~-s-VwsfG------ 118 (189)
.++|..+++|+|+ |. ++++|. ....++. + |||||
T Consensus 120 ~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l 199 (267)
T cd08229 120 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199 (267)
T ss_pred HHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHH
Confidence 7777777777775 33 112221 3456788 9 99999
Q ss_pred ------CCCCC--hHHHHHHHHcCCCCCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q psy1684 119 ------SGGMT--NAEVLHQVEHGYRMPCP-PGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFF 176 (189)
Q Consensus 119 ------~~~~~--~~~~~~~v~~g~~~~~p-~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~ 176 (189)
|.+.. ..++...+..+..++.| ..++.++.+++.+||..||.+|||+.+|++.+.++.
T Consensus 200 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 200 AALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred HhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 32222 23444555544434433 468899999999999999999999999999987763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.7e-14 Score=106.24 Aligned_cols=146 Identities=25% Similarity=0.421 Sum_probs=98.4
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCC--cCHhHHHHHhhhccC
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTT--IHYPELVEHYSKDAD 82 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~--~~l~~li~~~~~~a~ 82 (189)
.+.|+|+++++..+......++|+++.+.+. +.. ++..... +....+..+..+...
T Consensus 57 ~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~-----l~~-----------------~~~~~~~~~~~~~~~~~~~~ql~~ 114 (258)
T smart00219 57 KLDHPNIVKLLGVCTEEEPLMIVMEYMEGGD-----LLD-----------------YLRKNRPKELSLSDLLSFALQIAR 114 (258)
T ss_pred hcCCCchheEEEEEcCCCeeEEEEeccCCCC-----HHH-----------------HHHhhhhccCCHHHHHHHHHHHHH
Confidence 3456666666655554455566666555421 111 1211111 445556666677777
Q ss_pred CceeeccCCcccccc-cc---------------c----------------------ccccC-CCCCccc-e-EEEec---
Q psy1684 83 GLCVNLRKPCVQVSC-RI---------------Y----------------------LVHGT-NLSGVVV-S-AVDFG--- 118 (189)
Q Consensus 83 gl~~~~~~~~~~~~~-p~---------------~----------------------l~~~~-~~~~~~~-s-VwsfG--- 118 (189)
++.++|..+++|+|+ |. + +++|. ....++. + |||+|
T Consensus 115 ~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~ 194 (258)
T smart00219 115 GMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLL 194 (258)
T ss_pred HHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHH
Confidence 888888888888875 33 1 11111 2345778 8 99999
Q ss_pred ----------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q psy1684 119 ----------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKL 172 (189)
Q Consensus 119 ----------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l 172 (189)
|.+.+..++...+..+.+++.|..+|.++.+++.+||..||++|||+.++++.|
T Consensus 195 ~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 195 WEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 444566778888888888888889999999999999999999999999998754
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=99.47 E-value=1e-14 Score=112.62 Aligned_cols=148 Identities=11% Similarity=0.044 Sum_probs=112.5
Q ss_pred CCCChHHHHHHhcCCCCCCC-cEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccC
Q psy1684 4 GKIKRIEAEKKLLLPENDHG-AFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDAD 82 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g-~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~ 82 (189)
.++.|||||.+.......+. .+||++|+.++...-+..+. . +.-|.-..+..+..+...
T Consensus 58 s~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~--------------k------~~~f~E~~i~~~~~Q~~~ 117 (426)
T KOG0589|consen 58 SKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQ--------------K------GVLFPEERILKWFVQILL 117 (426)
T ss_pred HhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHH--------------h------hccccHHHHHHHHHHHHH
Confidence 35778888888876665556 78888888873311111100 0 112335567778888888
Q ss_pred CceeeccCCcccccccc----------------cccccC----------------------CCCCccc-e-EEEec----
Q psy1684 83 GLCVNLRKPCVQVSCRI----------------YLVHGT----------------------NLSGVVV-S-AVDFG---- 118 (189)
Q Consensus 83 gl~~~~~~~~~~~~~p~----------------~l~~~~----------------------~~~~~~~-s-VwsfG---- 118 (189)
++.|+|...|+|||+.. |+|+.. .+.+|+. + +||+|
T Consensus 118 av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~y 197 (426)
T KOG0589|consen 118 AVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLY 197 (426)
T ss_pred HHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHH
Confidence 99999999999998654 332222 6778999 9 99999
Q ss_pred --------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 119 --------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 119 --------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
|.+-+...++.++.++...|.|.....++..||..|+..+|..||+..+++..
T Consensus 198 Em~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 198 EMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 78878888888898888888999999999999999999999999999999986
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.5e-14 Score=110.47 Aligned_cols=143 Identities=7% Similarity=-0.070 Sum_probs=93.9
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.+.|+|++++.......+..+||+|++.++. +.. ++.....+....+..+..+.+.|+
T Consensus 51 ~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~-----L~~-----------------~l~~~~~~~~~~~~~~~~qi~~~L 108 (323)
T cd05571 51 NTRHPFLTALKYSFQTHDRLCFVMEYANGGE-----LFF-----------------HLSRERVFSEDRARFYGAEIVSAL 108 (323)
T ss_pred hCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc-----HHH-----------------HHHHcCCCCHHHHHHHHHHHHHHH
Confidence 3455565555544444445566666655421 111 233233444455555667788889
Q ss_pred eeeccCCcccccc-cc---------------ccc---------------------ccC-CCCCccc-e-EEEec------
Q psy1684 85 CVNLRKPCVQVSC-RI---------------YLV---------------------HGT-NLSGVVV-S-AVDFG------ 118 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~---------------~l~---------------------~~~-~~~~~~~-s-VwsfG------ 118 (189)
.++|..+++|+|+ |+ |++ +|. ....++. + |||+|
T Consensus 109 ~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 188 (323)
T cd05571 109 GYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 188 (323)
T ss_pred HHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhh
Confidence 9999999999986 44 222 222 3455888 9 99999
Q ss_pred ------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q psy1684 119 ------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRP-----TFETLQW 170 (189)
Q Consensus 119 ------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP-----~~~~i~~ 170 (189)
|.+.+..++...+..+ ....|...++++.+|+.+||+.||++|| +..++++
T Consensus 189 ltg~~Pf~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 189 MCGRLPFYNQDHEKLFELILME-EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred hcCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 4455555666655544 3567788999999999999999999999 7888865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.47 E-value=2.3e-14 Score=109.54 Aligned_cols=143 Identities=12% Similarity=0.009 Sum_probs=99.8
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..++|+|++++++........+||+|++.+ +++ .. ++. ...+.......+..+.+.|
T Consensus 57 ~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~-~~L----~~-----------------~~~-~~~l~~~~~~~~~~qi~~a 113 (324)
T cd05589 57 NSERHPFLVNLFACFQTEDHVCFVMEYAAG-GDL----MM-----------------HIH-TDVFSEPRAVFYAACVVLG 113 (324)
T ss_pred cccCCCChhceeeEEEcCCEEEEEEcCCCC-CcH----HH-----------------Hhh-cCCCCHHHHHHHHHHHHHH
Confidence 456789999988877666778889988876 321 11 111 1234455556666777778
Q ss_pred ceeeccCCcccccc-cc---------------cc---------------------cccC-CCCCccc-e-EEEec-----
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YL---------------------VHGT-NLSGVVV-S-AVDFG----- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l---------------------~~~~-~~~~~~~-s-VwsfG----- 118 (189)
+.++|..+++|+|+ |+ |+ ++|. ....++. + |||||
T Consensus 114 l~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~e 193 (324)
T cd05589 114 LQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYE 193 (324)
T ss_pred HHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHH
Confidence 88888888888875 33 22 2222 3456788 9 99999
Q ss_pred -------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q psy1684 119 -------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPT-----FETLQW 170 (189)
Q Consensus 119 -------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~-----~~~i~~ 170 (189)
|.+.+..++...+..+. +..|..+|+++.+++.+||+.||++||+ +.++++
T Consensus 194 l~~G~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 194 MLVGESPFPGDDEEEVFDSIVNDE-VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred HHhCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 66666677777776553 4467789999999999999999999994 555554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.47 E-value=8.9e-15 Score=108.69 Aligned_cols=150 Identities=10% Similarity=0.063 Sum_probs=91.7
Q ss_pred CChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCce
Q psy1684 6 IKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGLC 85 (189)
Q Consensus 6 l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl~ 85 (189)
+.|+|++++++.+......+||+|+..++. +.. .+.. .......+....+.....+.+.|+.
T Consensus 66 ~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~-----l~~----~l~~---------~~~~~~~~~~~~~~~~~~~l~~~l~ 127 (269)
T cd08528 66 LRHPNIVRYYKTFLENDRLYIVMDLIEGAP-----LGE----HFNS---------LKEKKQRFTEERIWNIFVQMVLALR 127 (269)
T ss_pred CCCCCeeeEEeeEccCCeEEEEEecCCCCc-----HHH----HHHH---------HHhccCCCCHHHHHHHHHHHHHHHH
Confidence 566777777666655566677777666522 111 0000 0001122334445555566677777
Q ss_pred eecc-CCccccccc-c-----------------------------------cccccC-CCCCccc-e-EEEec-------
Q psy1684 86 VNLR-KPCVQVSCR-I-----------------------------------YLVHGT-NLSGVVV-S-AVDFG------- 118 (189)
Q Consensus 86 ~~~~-~~~~~~~~p-~-----------------------------------~l~~~~-~~~~~~~-s-VwsfG------- 118 (189)
++|. .+++|+|+. . +++++. ..+.++. + |||||
T Consensus 128 ~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~ 207 (269)
T cd08528 128 YLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMC 207 (269)
T ss_pred HhccCCceeecCCCHHHEEECCCCcEEEecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHH
Confidence 7774 557777652 2 111221 3355788 9 99999
Q ss_pred -----CCCCChHHHHHHHHcCCCCCCCC-CCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q psy1684 119 -----SGGMTNAEVLHQVEHGYRMPCPP-GCPPRLYDIMLECWLKDPVKRPTFETLQWKLE 173 (189)
Q Consensus 119 -----~~~~~~~~~~~~v~~g~~~~~p~-~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~ 173 (189)
|.......+...+..+...+.+. .+++++.++|.+||+.||++||++.++...+.
T Consensus 208 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 208 TLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred hCCCcccccCHHHHHHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 33334445555565555444444 67899999999999999999999999998774
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.46 E-value=3.8e-14 Score=108.29 Aligned_cols=144 Identities=13% Similarity=0.044 Sum_probs=96.1
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..++|+|++++++.+......|+|+|+..++. + .. ++.....+.......+..+.+.|
T Consensus 55 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~-L----~~-----------------~~~~~~~~~~~~~~~~~~qi~~~ 112 (323)
T cd05584 55 EAVKHPFIVDLIYAFQTGGKLYLILEYLSGGE-L----FM-----------------HLEREGIFMEDTACFYLSEISLA 112 (323)
T ss_pred HhCCCCchhceeeEEecCCeEEEEEeCCCCch-H----HH-----------------HHHHcCCCCHHHHHHHHHHHHHH
Confidence 35678888887776655566778888776522 1 11 12212223333334455566778
Q ss_pred ceeeccCCcccccc-cc---------------ccc---------------------ccC-CCCCccc-e-EEEec-----
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YLV---------------------HGT-NLSGVVV-S-AVDFG----- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l~---------------------~~~-~~~~~~~-s-VwsfG----- 118 (189)
+.++|..+++|+|+ |+ |++ +|. ....++. + |||||
T Consensus 113 l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 192 (323)
T cd05584 113 LEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYD 192 (323)
T ss_pred HHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHH
Confidence 88888888888875 33 222 222 2344678 8 99999
Q ss_pred -------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q psy1684 119 -------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRP-----TFETLQW 170 (189)
Q Consensus 119 -------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP-----~~~~i~~ 170 (189)
|.+.+..+....+..+ ..+.|..+++++.+++.+||+.||++|| +..+++.
T Consensus 193 ll~G~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 193 MLTGAPPFTAENRKKTIDKILKG-KLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred HhcCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 5556666666777665 3567888999999999999999999999 7777765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.46 E-value=3.1e-14 Score=108.47 Aligned_cols=103 Identities=14% Similarity=0.055 Sum_probs=77.2
Q ss_pred CCcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cccc---------------------cC-CC
Q psy1684 66 TTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVH---------------------GT-NL 107 (189)
Q Consensus 66 ~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~---------------------~~-~~ 107 (189)
..+.......+..+.+.|+.++|..+++|+|+ |+ |++. |. ..
T Consensus 91 ~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~ 170 (316)
T cd05592 91 GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKG 170 (316)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCccccCHHHHcC
Confidence 34555555666778888999999999999986 44 2222 11 34
Q ss_pred CCccc-e-EEEec------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH-HHH
Q psy1684 108 SGVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFE-TLQ 169 (189)
Q Consensus 108 ~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~-~i~ 169 (189)
..++. + ||||| |.+.+..++...+... ++..|..++.++.+++.+||+.||++||++. +++
T Consensus 171 ~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 171 QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND-RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 55888 9 99999 6677777777666543 5667888999999999999999999999976 453
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.46 E-value=4.7e-14 Score=109.04 Aligned_cols=142 Identities=11% Similarity=0.052 Sum_probs=89.4
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..+.|+|++++++........++|+|++.+ +. +.. ........+..+..+++.|
T Consensus 127 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~~----L~~---------------------~~~~~~~~~~~i~~qi~~a 180 (353)
T PLN00034 127 RDVNHPNVVKCHDMFDHNGEIQVLLEFMDG-GS----LEG---------------------THIADEQFLADVARQILSG 180 (353)
T ss_pred HhCCCCCcceeeeEeccCCeEEEEEecCCC-Cc----ccc---------------------cccCCHHHHHHHHHHHHHH
Confidence 356788888888776666667788888776 31 111 0011122233444556666
Q ss_pred ceeeccCCcccccc-cc------------------------------------cccccC-----CCCCc-cc-e-EEEec
Q psy1684 84 LCVNLRKPCVQVSC-RI------------------------------------YLVHGT-----NLSGV-VV-S-AVDFG 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~------------------------------------~l~~~~-----~~~~~-~~-s-VwsfG 118 (189)
+.++|..+++|+|+ |. ++++|. ..+.+ +. + |||||
T Consensus 181 L~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG 260 (353)
T PLN00034 181 IAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLG 260 (353)
T ss_pred HHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHH
Confidence 77777777777764 32 122222 12233 45 8 99999
Q ss_pred ------------CCCCC---hHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 119 ------------SGGMT---NAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 119 ------------~~~~~---~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
|.... ...+...+..+..+..+..++.++.+||.+||+.||++|||+.||++.
T Consensus 261 vil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 261 VSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 32211 123334444555666778899999999999999999999999999875
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.45 E-value=2.6e-14 Score=105.68 Aligned_cols=149 Identities=15% Similarity=0.119 Sum_probs=97.2
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..++|+|++++++........++|+|+++.+. +...+.. +......+.......+..+.+.|
T Consensus 57 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~-l~~~~~~-----------------~~~~~~~~~~~~~~~~~~~l~~~ 118 (260)
T cd08222 57 SKLDHPAIVKFHASFLERDAFCIITEYCEGRD-LDCKLEE-----------------LKHTGKTLSENQVCEWFIQLLLG 118 (260)
T ss_pred HhCCCCcHHHHHHHHhcCCceEEEEEeCCCCC-HHHHHHH-----------------HhhcccccCHHHHHHHHHHHHHH
Confidence 35689999999987777777889999887632 1100000 00011223344444555556666
Q ss_pred ceeeccCCcccccc-cc-----------------------------------cccccC-CCCCccc-e-EEEec------
Q psy1684 84 LCVNLRKPCVQVSC-RI-----------------------------------YLVHGT-NLSGVVV-S-AVDFG------ 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~-----------------------------------~l~~~~-~~~~~~~-s-VwsfG------ 118 (189)
+.++|..+++|+++ |. ++++|. ....++. + |||||
T Consensus 119 l~~lH~~~i~h~~l~~~nili~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l 198 (260)
T cd08222 119 VHYMHQRRILHRDLKAKNIFLKNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198 (260)
T ss_pred HHHHHHcCccccCCChhheEeecCCEeecccCceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHH
Confidence 66666666666653 22 112221 2345778 8 99999
Q ss_pred ------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 119 ------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 119 ------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
+.+.+..++...+..+..+..|..+|.++.++|.+||..||++||++.++++
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 199 CCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred HhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 4444445555666667777778889999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.45 E-value=4.5e-14 Score=104.07 Aligned_cols=146 Identities=12% Similarity=0.165 Sum_probs=93.0
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC--CCCcCHhHHHHHhhhcc
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG--RTTIHYPELVEHYSKDA 81 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~--~~~~~l~~li~~~~~~a 81 (189)
..++|+|++++++.+......+||.|+.+.+. + .. ++.. ...+....+..+..+.+
T Consensus 54 ~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~-L----~~-----------------~~~~~~~~~~~~~~~~~~~~~l~ 111 (257)
T cd08225 54 AKMKHPNIVTFFASFQENGRLFIVMEYCDGGD-L----MK-----------------RINRQRGVLFSEDQILSWFVQIS 111 (257)
T ss_pred HhCCCCChhhhhheeccCCeEEEEEecCCCCc-H----HH-----------------HHHhccCCCCCHHHHHHHHHHHH
Confidence 35678999999887777777888998877522 1 11 0100 01122333444444555
Q ss_pred CCceeeccCCcccccc-cc-------------------------------------cccccC-CCCCccc-e-EEEec--
Q psy1684 82 DGLCVNLRKPCVQVSC-RI-------------------------------------YLVHGT-NLSGVVV-S-AVDFG-- 118 (189)
Q Consensus 82 ~gl~~~~~~~~~~~~~-p~-------------------------------------~l~~~~-~~~~~~~-s-VwsfG-- 118 (189)
.++.++|...++|+|+ |. ++++|. ....++. + |||||
T Consensus 112 ~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~i 191 (257)
T cd08225 112 LGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCV 191 (257)
T ss_pred HHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHH
Confidence 5555555555555553 22 122222 3456788 9 99999
Q ss_pred ----------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 119 ----------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 119 ----------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
|...+..+....+..+...+.++..+.++.+++.+||..+|++|||+.+|++.
T Consensus 192 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 192 LYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred HHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 44444555555555565566677889999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.9e-14 Score=106.97 Aligned_cols=151 Identities=18% Similarity=0.112 Sum_probs=93.3
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..+.|+|++++++.+......+||+|+++. |++.-.+.. .. . .....+....+..+..+.+.|
T Consensus 50 ~~l~h~nii~~~~~~~~~~~~~lv~e~~~~-g~L~~~l~~--~~-~-------------~~~~~~~~~~~~~~~~qi~~~ 112 (269)
T cd05042 50 RELNHPNVLQCLGQCIESIPYLLVLEFCPL-GDLKNYLRS--NR-G-------------MVAQMAQKDVLQRMACEVASG 112 (269)
T ss_pred HhCCCCCcceEEEEECCCCceEEEEEeCCC-CcHHHHHHh--cc-c-------------cccccccHHHHHHHHHHHHHH
Confidence 346788888888877777778888888876 322100000 00 0 000011133344556666777
Q ss_pred ceeeccCCcccccc-cc---------------ccc-----------------------ccC--------CCCCccc-e-E
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YLV-----------------------HGT--------NLSGVVV-S-A 114 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l~-----------------------~~~--------~~~~~~~-s-V 114 (189)
+.++|..+++|+|+ |. +++ +|. ....++. + |
T Consensus 113 l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Di 192 (269)
T cd05042 113 LLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNI 192 (269)
T ss_pred HHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHH
Confidence 77777777777775 33 222 111 1234677 8 9
Q ss_pred EEec-------------CCCCChHHHHHHHHcCCC--CC---CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q psy1684 115 VDFG-------------SGGMTNAEVLHQVEHGYR--MP---CPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKL 172 (189)
Q Consensus 115 wsfG-------------~~~~~~~~~~~~v~~g~~--~~---~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l 172 (189)
|||| |.+..+.+++..+..... ++ .+..++..+.+++..|| .||++|||+++|++.|
T Consensus 193 wslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 193 WSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred HHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 9999 445555565555433322 22 33468899999999999 5999999999999877
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.5e-14 Score=115.20 Aligned_cols=104 Identities=17% Similarity=0.172 Sum_probs=83.4
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cccc-----------------------cC-CC
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVH-----------------------GT-NL 107 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~-----------------------~~-~~ 107 (189)
+....+..+..+.+.|+.++|..+++|+|+ |+ |+++ |. ..
T Consensus 140 l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~ 219 (496)
T PTZ00283 140 FREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR 219 (496)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCC
Confidence 444556667778889999999999999996 44 3322 11 33
Q ss_pred CCccc-e-EEEec------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 108 SGVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 108 ~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
..++. + ||||| |.+.+..+++..+..+...+.|..+|+++.+|+.+||+.||++||++.+++..
T Consensus 220 ~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 220 KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 45888 9 99999 66667778888888887778889999999999999999999999999999763
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.6e-14 Score=109.22 Aligned_cols=143 Identities=7% Similarity=-0.054 Sum_probs=95.2
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.+.|+|++++++.....+..+||+|++.++. + .. ++.....+.......+..+.+.|+
T Consensus 51 ~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~-L----~~-----------------~l~~~~~~~~~~~~~~~~qi~~aL 108 (323)
T cd05595 51 NTRHPFLTALKYAFQTHDRLCFVMEYANGGE-L----FF-----------------HLSRERVFTEERARFYGAEIVSAL 108 (323)
T ss_pred hCCCCCCcceeeEEecCCEEEEEEeCCCCCc-H----HH-----------------HHHHcCCCCHHHHHHHHHHHHHHH
Confidence 4567777776665555556677777776522 1 11 222223344445555666777888
Q ss_pred eeeccCCcccccc-cc---------------c---------------------ccccC-CCCCccc-e-EEEec------
Q psy1684 85 CVNLRKPCVQVSC-RI---------------Y---------------------LVHGT-NLSGVVV-S-AVDFG------ 118 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~---------------~---------------------l~~~~-~~~~~~~-s-VwsfG------ 118 (189)
.++|..+++|+|+ |+ | +|+|. ..+.++. + |||||
T Consensus 109 ~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~el 188 (323)
T cd05595 109 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 188 (323)
T ss_pred HHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHH
Confidence 8888888888875 43 2 22222 3456888 9 99999
Q ss_pred ------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q psy1684 119 ------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRP-----TFETLQW 170 (189)
Q Consensus 119 ------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP-----~~~~i~~ 170 (189)
|.+.+..++...+..+ ....|..+++++.+++.+||..||++|| +..++++
T Consensus 189 l~g~~Pf~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 189 MCGRLPFYNQDHERLFELILME-EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred HhCCCCCCCCCHHHHHHHHhcC-CCCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 5555556666665443 2456778999999999999999999998 7888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.8e-14 Score=106.82 Aligned_cols=104 Identities=12% Similarity=0.090 Sum_probs=71.5
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------c---------------------ccccC-----
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------Y---------------------LVHGT----- 105 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~---------------------l~~~~----- 105 (189)
+....+..+..+.+.|+.++|..+++|+|+ |. + +++|.
T Consensus 100 l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 179 (282)
T cd06643 100 LTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCET 179 (282)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccccccccccccccCHhhccccC
Confidence 334555566667777888888888888875 33 1 12221
Q ss_pred -CCCCccc-e-EEEec------------CCCCChHHHHHHHHcCC--CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy1684 106 -NLSGVVV-S-AVDFG------------SGGMTNAEVLHQVEHGY--RMPCPPGCPPRLYDIMLECWLKDPVKRPTFETL 168 (189)
Q Consensus 106 -~~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~--~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i 168 (189)
....++. + ||||| |.+.+..+....+..+. .++.|..+|.++.+++.+||+.||.+||++.++
T Consensus 180 ~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 259 (282)
T cd06643 180 SKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQL 259 (282)
T ss_pred CCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHH
Confidence 1234788 9 99999 44445555544444332 334567789999999999999999999999998
Q ss_pred HHH
Q psy1684 169 QWK 171 (189)
Q Consensus 169 ~~~ 171 (189)
++.
T Consensus 260 l~~ 262 (282)
T cd06643 260 LQH 262 (282)
T ss_pred hcC
Confidence 753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.44 E-value=3.4e-14 Score=105.10 Aligned_cols=64 Identities=14% Similarity=0.243 Sum_probs=48.3
Q ss_pred CCccc-e-EEEec------------CCCCChHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 108 SGVVV-S-AVDFG------------SGGMTNAEVLHQV-EHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 108 ~~~~~-s-VwsfG------------~~~~~~~~~~~~v-~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
..++. + |||+| |.+.+..+....+ .....+..|..++.++.+++.+||..+|.+|||+.++++.
T Consensus 182 ~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 182 EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 44778 9 99999 3343333333333 3445566788899999999999999999999999998763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=99.43 E-value=3.2e-14 Score=104.22 Aligned_cols=145 Identities=12% Similarity=0.118 Sum_probs=101.5
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..+.|+|+|.|+.++......+||.|++.. . +.+ - +.+..+| +.-.-+..+..+..+|
T Consensus 56 KqLkH~NLVnLiEVFrrkrklhLVFE~~dh-T-----vL~--------e-Le~~p~G-------~~~~~vk~~l~Q~l~a 113 (396)
T KOG0593|consen 56 KQLKHENLVNLIEVFRRKRKLHLVFEYCDH-T-----VLH--------E-LERYPNG-------VPSELVKKYLYQLLKA 113 (396)
T ss_pred HhcccchHHHHHHHHHhcceeEEEeeecch-H-----HHH--------H-HHhccCC-------CCHHHHHHHHHHHHHH
Confidence 568899999999988888889999999886 2 222 0 1111121 1122234566788889
Q ss_pred ceeeccCCcccccc-cc---------------cccccC-----------------------CCCCccc-e-EEEec----
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YLVHGT-----------------------NLSGVVV-S-AVDFG---- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l~~~~-----------------------~~~~~~~-s-VwsfG---- 118 (189)
+.++|+..|+|||+ || |+|+.. -...|.. . |||.|
T Consensus 114 i~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~a 193 (396)
T KOG0593|consen 114 IHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFA 193 (396)
T ss_pred hhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHH
Confidence 99999999999996 77 444333 2356888 8 99999
Q ss_pred --------CCCCChHHHHHHHHc--------------------CCCCCCCCC----------CCHHHHHHHHHhcccCCC
Q psy1684 119 --------SGGMTNAEVLHQVEH--------------------GYRMPCPPG----------CPPRLYDIMLECWLKDPV 160 (189)
Q Consensus 119 --------~~~~~~~~~~~~v~~--------------------g~~~~~p~~----------~p~~~~~l~~~C~~~~p~ 160 (189)
|+|.+.-+-+..|.. |.++|.|++ ...-+.++|..|++.||+
T Consensus 194 El~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~ 273 (396)
T KOG0593|consen 194 ELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPD 273 (396)
T ss_pred HHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCcc
Confidence 888776544433322 445555532 334567999999999999
Q ss_pred CCCCHHHHHH
Q psy1684 161 KRPTFETLQW 170 (189)
Q Consensus 161 ~RP~~~~i~~ 170 (189)
+|++-++++.
T Consensus 274 ~R~sc~qll~ 283 (396)
T KOG0593|consen 274 DRLSCEQLLH 283 (396)
T ss_pred ccccHHHHhc
Confidence 9999999875
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.2e-14 Score=108.58 Aligned_cols=146 Identities=11% Similarity=0.071 Sum_probs=94.8
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC-CCCcCHhHHHHHhhhccC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG-RTTIHYPELVEHYSKDAD 82 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~-~~~~~l~~li~~~~~~a~ 82 (189)
..++|+|++++++.+......|||+|+.+.+. + .. ++.. ...+....+..+..+.+.
T Consensus 57 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~-L----~~-----------------~~~~~~~~l~~~~~~~~~~ql~~ 114 (280)
T cd06611 57 SECKHPNIVGLYEAYFYENKLWILIEFCDGGA-L----DS-----------------IMLELERGLTEPQIRYVCRQMLE 114 (280)
T ss_pred HhCCCCceeEEEEEEecCCeEEEEeeccCCCc-H----HH-----------------HHHHhcCCCCHHHHHHHHHHHHH
Confidence 34566666666665555555666666665521 1 11 1211 123445556666677777
Q ss_pred CceeeccCCcccccc-cc------------------------------------cccccC------CCCCccc-e-EEEe
Q psy1684 83 GLCVNLRKPCVQVSC-RI------------------------------------YLVHGT------NLSGVVV-S-AVDF 117 (189)
Q Consensus 83 gl~~~~~~~~~~~~~-p~------------------------------------~l~~~~------~~~~~~~-s-Vwsf 117 (189)
|+.++|...++|+|+ |. ++++|. ....++. + ||||
T Consensus 115 ~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~sl 194 (280)
T cd06611 115 ALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSL 194 (280)
T ss_pred HHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHH
Confidence 888888888888875 33 111111 1244788 9 9999
Q ss_pred c------------CCCCChHHHHHHHHcCCCC--CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 118 G------------SGGMTNAEVLHQVEHGYRM--PCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 118 G------------~~~~~~~~~~~~v~~g~~~--~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
| |.+.+..+.+..+..+..+ ..|..++.++.+++.+||+.+|.+||++.++++.
T Consensus 195 G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 195 GITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 9 5555556666666666433 3466789999999999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.43 E-value=3.7e-14 Score=108.08 Aligned_cols=140 Identities=11% Similarity=0.049 Sum_probs=93.5
Q ss_pred ChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCcee
Q psy1684 7 KRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGLCV 86 (189)
Q Consensus 7 ~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl~~ 86 (189)
.|+|++++++.....+..|||+|++++ |++ .. ++.....+.......+..+.+.|+.+
T Consensus 54 ~hp~iv~~~~~~~~~~~~~lv~ey~~~-g~L----~~-----------------~l~~~~~~~~~~~~~~~~qi~~al~~ 111 (316)
T cd05619 54 EHPFLTHLYCTFQTKENLFFVMEYLNG-GDL----MF-----------------HIQSCHKFDLPRATFYAAEIICGLQF 111 (316)
T ss_pred CCCcCcceEEEEEeCCEEEEEEeCCCC-CcH----HH-----------------HHHHcCCCCHHHHHHHHHHHHHHHHH
Confidence 566666665555445556666666554 211 11 22222334455556666777888888
Q ss_pred eccCCcccccc-cc---------------ccc---------------------ccC-CCCCccc-e-EEEec--------
Q psy1684 87 NLRKPCVQVSC-RI---------------YLV---------------------HGT-NLSGVVV-S-AVDFG-------- 118 (189)
Q Consensus 87 ~~~~~~~~~~~-p~---------------~l~---------------------~~~-~~~~~~~-s-VwsfG-------- 118 (189)
+|..+++|+|+ |+ |++ +|. ....++. + |||||
T Consensus 112 LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~ 191 (316)
T cd05619 112 LHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLI 191 (316)
T ss_pred HHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHh
Confidence 88888888885 33 222 221 3456888 9 99999
Q ss_pred ----CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH-HHH
Q psy1684 119 ----SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFE-TLQ 169 (189)
Q Consensus 119 ----~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~-~i~ 169 (189)
|.+.+..++...+..+. +..|..++.++.+++.+||+.||++||++. ++.
T Consensus 192 G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 192 GQSPFHGHDEEELFQSIRMDN-PCYPRWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred CCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 66666777777775543 456778899999999999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.43 E-value=5.7e-14 Score=107.59 Aligned_cols=144 Identities=7% Similarity=-0.067 Sum_probs=94.1
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.+.|+|++++.......+..+||+|+++++. + .. ++.....+...+...+..+.+.|+
T Consensus 51 ~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~-L----~~-----------------~l~~~~~l~~~~~~~~~~qi~~aL 108 (328)
T cd05593 51 NTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE-L----FF-----------------HLSRERVFSEDRTRFYGAEIVSAL 108 (328)
T ss_pred hCCCCCCcceEEEEEcCCEEEEEEeCCCCCC-H----HH-----------------HHHhcCCCCHHHHHHHHHHHHHHH
Confidence 3455666555544444445566666655421 1 01 222233344555566667778888
Q ss_pred eeeccCCcccccc-cc---------------ccc---------------------ccC-CCCCccc-e-EEEec------
Q psy1684 85 CVNLRKPCVQVSC-RI---------------YLV---------------------HGT-NLSGVVV-S-AVDFG------ 118 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~---------------~l~---------------------~~~-~~~~~~~-s-VwsfG------ 118 (189)
.++|..+++|+|+ |+ |++ +|. ....++. + |||||
T Consensus 109 ~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el 188 (328)
T cd05593 109 DYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 188 (328)
T ss_pred HHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHH
Confidence 8999988889886 44 222 221 3456788 9 99999
Q ss_pred ------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q psy1684 119 ------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRP-----TFETLQWK 171 (189)
Q Consensus 119 ------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP-----~~~~i~~~ 171 (189)
|.+.+..++...+..+ ....|..+++++.+++.+||..||++|| ++.+|++.
T Consensus 189 ltG~~Pf~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 189 MCGRLPFYNQDHEKLFELILME-DIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred hhCCCCCCCCCHHHHHHHhccC-CccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 5555556666655443 3456788999999999999999999997 88888754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.43 E-value=5.1e-14 Score=107.37 Aligned_cols=141 Identities=11% Similarity=0.001 Sum_probs=93.7
Q ss_pred ChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCcee
Q psy1684 7 KRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGLCV 86 (189)
Q Consensus 7 ~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl~~ 86 (189)
.|+|++++++.....+..++|+|++.+ +.+ .. ++.....+...+...+..+.+.|+.+
T Consensus 54 ~h~~i~~~~~~~~~~~~~~lv~e~~~~-~~L----~~-----------------~~~~~~~l~~~~~~~~~~qi~~~l~~ 111 (318)
T cd05570 54 KHPFLTQLHSCFQTKDRLFFVMEYVNG-GDL----MF-----------------HIQRSGRFDEPRARFYAAEIVLGLQF 111 (318)
T ss_pred CCCCccceeeEEEcCCEEEEEEcCCCC-CCH----HH-----------------HHHHcCCCCHHHHHHHHHHHHHHHHH
Confidence 466666665554444455666666554 211 01 22223344455556666777788888
Q ss_pred eccCCcccccc-cc---------------ccc---------------------ccC-CCCCccc-e-EEEec--------
Q psy1684 87 NLRKPCVQVSC-RI---------------YLV---------------------HGT-NLSGVVV-S-AVDFG-------- 118 (189)
Q Consensus 87 ~~~~~~~~~~~-p~---------------~l~---------------------~~~-~~~~~~~-s-VwsfG-------- 118 (189)
+|..+++|+|+ |+ |++ +|. ....++. + |||||
T Consensus 112 LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~ 191 (318)
T cd05570 112 LHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLA 191 (318)
T ss_pred HHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhh
Confidence 88888888875 43 222 111 3456888 9 99999
Q ss_pred ----CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q psy1684 119 ----SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTF-----ETLQW 170 (189)
Q Consensus 119 ----~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~-----~~i~~ 170 (189)
|.+.+..++...+..+ .+..|..++.++.+||.+||..||++||++ .++++
T Consensus 192 G~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 192 GQSPFEGDDEDELFQSILED-EVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCCCCCCCCHHHHHHHHHcC-CCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 6666667776666554 345677899999999999999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.43 E-value=5.2e-14 Score=103.78 Aligned_cols=103 Identities=17% Similarity=0.201 Sum_probs=76.8
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc------------------------------------cccccC-CCCC
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI------------------------------------YLVHGT-NLSG 109 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~------------------------------------~l~~~~-~~~~ 109 (189)
+...++..+..+.+.|+.++|...++|+|+ |+ ++++|. ....
T Consensus 99 l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 178 (257)
T cd08223 99 LPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKP 178 (257)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCccccccCCcCccChhHhcCCC
Confidence 345566667777778888888888888875 44 111222 2344
Q ss_pred ccc-e-EEEec------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 110 VVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 110 ~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
++. + ||||| |.+.+..++...+..+..++.|...++++.+++.+||+.||.+||++.++++
T Consensus 179 ~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 179 YNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred CCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 678 8 99999 4555556666667777666677889999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.42 E-value=8.8e-14 Score=106.19 Aligned_cols=136 Identities=8% Similarity=-0.062 Sum_probs=93.2
Q ss_pred ChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCcee
Q psy1684 7 KRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGLCV 86 (189)
Q Consensus 7 ~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl~~ 86 (189)
.|+|+++++......+..|||+|++.+ +++ .. ++.....+.......+..+.+.|+.+
T Consensus 54 ~h~~iv~~~~~~~~~~~~~iv~Ey~~~-g~L----~~-----------------~i~~~~~l~~~~~~~~~~ql~~~L~~ 111 (320)
T cd05590 54 NHPFLTQLYCCFQTPDRLFFVMEFVNG-GDL----MF-----------------HIQKSRRFDEARARFYAAEITSALMF 111 (320)
T ss_pred CCCchhceeeEEEcCCEEEEEEcCCCC-chH----HH-----------------HHHHcCCCCHHHHHHHHHHHHHHHHH
Confidence 577777766655555566777777665 311 11 22223334444455566777788888
Q ss_pred eccCCcccccc-cc---------------cccc---------------------cC-CCCCccc-e-EEEec--------
Q psy1684 87 NLRKPCVQVSC-RI---------------YLVH---------------------GT-NLSGVVV-S-AVDFG-------- 118 (189)
Q Consensus 87 ~~~~~~~~~~~-p~---------------~l~~---------------------~~-~~~~~~~-s-VwsfG-------- 118 (189)
+|..+++|+|+ |+ |++. |. ....++. + |||||
T Consensus 112 lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~ 191 (320)
T cd05590 112 LHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLC 191 (320)
T ss_pred HHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhh
Confidence 88888888886 44 2222 11 3455788 9 99999
Q ss_pred ----CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH
Q psy1684 119 ----SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTF 165 (189)
Q Consensus 119 ----~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~ 165 (189)
|.+.+..++...+..+. ...|..++.++.+++.+|++.||++||+.
T Consensus 192 g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 192 GHAPFEAENEDDLFEAILNDE-VVYPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 66667777777776553 45677899999999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=99.42 E-value=3e-14 Score=107.99 Aligned_cols=145 Identities=8% Similarity=-0.020 Sum_probs=97.4
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
.+++|||+|++......++-.|+|.|++.+|..|.-.+.. +++... .. -.+..|...+
T Consensus 231 kkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~n----------------k~l~ed----~~--K~~f~Qll~a 288 (475)
T KOG0615|consen 231 KKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVAN----------------KYLRED----LG--KLLFKQLLTA 288 (475)
T ss_pred HhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhc----------------cccccc----hh--HHHHHHHHHH
Confidence 4789999999998888888889999999984322111111 111110 11 1234455678
Q ss_pred ceeeccCCcccccc-cc------------------cccc--------------------cC---CCCC-ccc-e-EEEec
Q psy1684 84 LCVNLRKPCVQVSC-RI------------------YLVH--------------------GT---NLSG-VVV-S-AVDFG 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~------------------~l~~--------------------~~---~~~~-~~~-s-VwsfG 118 (189)
+.|+|..+|+|||+ |+ |||+ |. .+-. +.. . +||.|
T Consensus 289 vkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlG 368 (475)
T KOG0615|consen 289 VKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLG 368 (475)
T ss_pred HHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeecc
Confidence 88999999999996 66 3333 22 2222 344 6 99999
Q ss_pred ------------CCCCCh-HHHHHHHHcCCCCCCC---CCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 119 ------------SGGMTN-AEVLHQVEHGYRMPCP---PGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 119 ------------~~~~~~-~~~~~~v~~g~~~~~p---~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
|.+-.. ..+.++|.+|.-..-| .....+..+||.+.+..||+.|||..|.++
T Consensus 369 cvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 369 CVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred ceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 333222 2377788888544333 357889999999999999999999999876
|
|
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.3e-13 Score=97.79 Aligned_cols=147 Identities=11% Similarity=0.072 Sum_probs=108.8
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..+.|||+.++++....+.-.||+.|+.+.+..|.. +.. . ....|.-..-..|..+.|.+
T Consensus 77 s~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~-L~~--------------~-----~~~~f~e~~~a~Yi~q~A~A 136 (281)
T KOG0580|consen 77 SHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKD-LQE--------------G-----RMKRFDEQRAATYIKQLANA 136 (281)
T ss_pred cccCCccHHhhhhheeccceeEEEEEecCCchHHHH-HHh--------------c-----ccccccccchhHHHHHHHHH
Confidence 578999999999998888899999999988442211 000 0 11233322234466677889
Q ss_pred ceeeccCCcccccc-ccccc----------------------------------ccC-CCCCccc-e-EEEec-------
Q psy1684 84 LCVNLRKPCVQVSC-RIYLV----------------------------------HGT-NLSGVVV-S-AVDFG------- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~~l~----------------------------------~~~-~~~~~~~-s-VwsfG------- 118 (189)
+.|+|.+.++|||+ |+.+- +|. .+..++. . +|+.|
T Consensus 137 l~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yefl 216 (281)
T KOG0580|consen 137 LLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFL 216 (281)
T ss_pred HHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHH
Confidence 99999999999996 66221 111 5666888 8 99999
Q ss_pred -----CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 119 -----SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 119 -----~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
|+..+..+..+.|.+- +...|+..+.+..++|.+|+..+|.+|.+-.|++..
T Consensus 217 vg~ppFes~~~~etYkrI~k~-~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 217 VGLPPFESQSHSETYKRIRKV-DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred hcCCchhhhhhHHHHHHHHHc-cccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 6666667777777543 466789999999999999999999999999998764
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.41 E-value=3.6e-14 Score=108.78 Aligned_cols=30 Identities=20% Similarity=0.474 Sum_probs=27.6
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 142 GCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 142 ~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
..++++.+||.+||..||++|||+.+|++.
T Consensus 272 ~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 272 VFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 467899999999999999999999999875
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.41 E-value=6.6e-14 Score=107.76 Aligned_cols=144 Identities=8% Similarity=-0.146 Sum_probs=99.1
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.+.|+|++++++.+......|||+|++..+. +.. ++.....+.......+..+.+.|+
T Consensus 87 ~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~-----L~~-----------------~i~~~~~~~~~~~~~~~~qi~~aL 144 (340)
T PTZ00426 87 YINHPFCVNLYGSFKDESYLYLVLEFVIGGE-----FFT-----------------FLRRNKRFPNDVGCFYAAQIVLIF 144 (340)
T ss_pred hCCCCCCcceEEEEEeCCEEEEEEeCCCCCc-----HHH-----------------HHHHcCCCCHHHHHHHHHHHHHHH
Confidence 4667888887776655556677888776522 111 232233444444555667777888
Q ss_pred eeeccCCcccccc-cc---------------cc------------------cccC-CCCCccc-e-EEEec---------
Q psy1684 85 CVNLRKPCVQVSC-RI---------------YL------------------VHGT-NLSGVVV-S-AVDFG--------- 118 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~---------------~l------------------~~~~-~~~~~~~-s-VwsfG--------- 118 (189)
.++|..+++|+|+ |+ |+ |+|. ....++. + |||||
T Consensus 145 ~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G 224 (340)
T PTZ00426 145 EYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224 (340)
T ss_pred HHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcC
Confidence 8899989999886 44 22 2222 3345788 9 99999
Q ss_pred ---CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q psy1684 119 ---SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRP-----TFETLQWK 171 (189)
Q Consensus 119 ---~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP-----~~~~i~~~ 171 (189)
|.+.+...+...+..+. ...|...++++.++|.+|++.||++|+ +++++++.
T Consensus 225 ~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 225 CPPFYANEPLLIYQKILEGI-IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 55666666677776664 446778899999999999999999995 88888764
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=99.41 E-value=4.3e-14 Score=109.44 Aligned_cols=148 Identities=11% Similarity=0.147 Sum_probs=104.5
Q ss_pred CCC-hHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 5 KIK-RIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 5 ~l~-~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
.+. |+|+++++.+.......|+|+|+..+ |++ .. |+.....+.-.+...++.|..+|
T Consensus 75 ~~~~HpnI~~l~ev~~t~~~~~ivmEy~~g-GdL----~~-----------------~i~~~g~l~E~~ar~~F~Qlisa 132 (370)
T KOG0583|consen 75 RLRSHPNIIRLLEVFATPTKIYIVMEYCSG-GDL----FD-----------------YIVNKGRLKEDEARKYFRQLISA 132 (370)
T ss_pred HhccCCCEeEEEEEEecCCeEEEEEEecCC-ccH----HH-----------------HHHHcCCCChHHHHHHHHHHHHH
Confidence 344 67777766665556667777777665 311 11 33333344445566678888999
Q ss_pred ceeeccCCcccccc-cc----------------cccc---------------------cC-CCCC-ccc--e-EEEec--
Q psy1684 84 LCVNLRKPCVQVSC-RI----------------YLVH---------------------GT-NLSG-VVV--S-AVDFG-- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~----------------~l~~---------------------~~-~~~~-~~~--s-VwsfG-- 118 (189)
+.|+|..+|+|||+ |+ |++. |. .... |+. + |||+|
T Consensus 133 v~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GVi 212 (370)
T KOG0583|consen 133 VAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVI 212 (370)
T ss_pred HHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHH
Confidence 99999999999995 66 2221 11 4445 875 7 99999
Q ss_pred ----------CCCCChHHHHHHHHcCCCCCCCCCC-CHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q psy1684 119 ----------SGGMTNAEVLHQVEHGYRMPCPPGC-PPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFT 177 (189)
Q Consensus 119 ----------~~~~~~~~~~~~v~~g~~~~~p~~~-p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~ 177 (189)
|.+.+...+...+.+| +..+|..+ ++++..|+.+|+..||.+|+|..+|+ ....++
T Consensus 213 Ly~ml~G~~PF~d~~~~~l~~ki~~~-~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~--~h~w~~ 279 (370)
T KOG0583|consen 213 LYVLLCGRLPFDDSNVPNLYRKIRKG-EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL--EHPWFQ 279 (370)
T ss_pred HHHHHhCCCCCCCccHHHHHHHHhcC-CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh--hChhhc
Confidence 6776666777777666 46678888 99999999999999999999999998 334444
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.41 E-value=3e-14 Score=106.46 Aligned_cols=101 Identities=15% Similarity=0.139 Sum_probs=71.9
Q ss_pred hHHHHHhhhccCCceeeccCCcccccc-cc------------------------------------cccccC-CCCCccc
Q psy1684 71 PELVEHYSKDADGLCVNLRKPCVQVSC-RI------------------------------------YLVHGT-NLSGVVV 112 (189)
Q Consensus 71 ~~li~~~~~~a~gl~~~~~~~~~~~~~-p~------------------------------------~l~~~~-~~~~~~~ 112 (189)
.++..+..+.+.++.++|..+++|+|+ |. ++++|. ....++.
T Consensus 101 ~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~ 180 (277)
T cd06640 101 FQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDS 180 (277)
T ss_pred HHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccccccccCcccccCHhHhccCCCcc
Confidence 334444555666777777777777764 32 122222 3455788
Q ss_pred -e-EEEec------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 113 -S-AVDFG------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 113 -s-VwsfG------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
+ ||||| +.+.++..+...+..+..+..+..+|.++.+++.+||..+|++||++.+++..
T Consensus 181 ~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 181 KADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 9 99999 55556666666666666666677899999999999999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.3e-14 Score=114.75 Aligned_cols=148 Identities=12% Similarity=0.105 Sum_probs=109.4
Q ss_pred CCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhcc
Q psy1684 2 YFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDA 81 (189)
Q Consensus 2 ~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a 81 (189)
|...+.|||.+.+-||-..+.-.|||+||+-+.- .+ .+ -++ ++.+.-.++........
T Consensus 79 FL~~l~HPntieYkgCyLre~TaWLVMEYClGSA------sD----ll-----------eVh-kKplqEvEIAAi~~gaL 136 (948)
T KOG0577|consen 79 FLRQLRHPNTIEYKGCYLREHTAWLVMEYCLGSA------SD----LL-----------EVH-KKPLQEVEIAAITHGAL 136 (948)
T ss_pred HHHhccCCCcccccceeeccchHHHHHHHHhccH------HH----HH-----------HHH-hccchHHHHHHHHHHHH
Confidence 4567899999999888888888999999887521 11 00 011 11222233444455666
Q ss_pred CCceeeccCCcccccccc---------------------------------cccccC----CCCCccc-e-EEEec----
Q psy1684 82 DGLCVNLRKPCVQVSCRI---------------------------------YLVHGT----NLSGVVV-S-AVDFG---- 118 (189)
Q Consensus 82 ~gl~~~~~~~~~~~~~p~---------------------------------~l~~~~----~~~~~~~-s-VwsfG---- 118 (189)
+|++|+|+..-||||+.. |||+++ ..+.|+- + |||+|
T Consensus 137 ~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCI 216 (948)
T KOG0577|consen 137 QGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 216 (948)
T ss_pred HHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCchhcccCCccccchhHheeccccccCCccceeeccchhh
Confidence 788888888888887655 777776 6788999 9 99999
Q ss_pred --------CCCCChHHHHHHHHcCCCCCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 119 --------SGGMTNAEVLHQVEHGYRMPCP-PGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 119 --------~~~~~~~~~~~~v~~g~~~~~p-~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
+.+++....+.-|.....|..+ ++++..+..++..|++.-|.+|||..++++.
T Consensus 217 ELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 217 ELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred hhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 6778888888888766666554 4688899999999999999999999988764
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.4e-13 Score=105.12 Aligned_cols=103 Identities=11% Similarity=-0.021 Sum_probs=76.1
Q ss_pred CcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------ccc---------------------ccC-CCC
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLV---------------------HGT-NLS 108 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~---------------------~~~-~~~ 108 (189)
.+.......+..+.+.|+.++|..+++|+|+ |+ |++ +|. ...
T Consensus 92 ~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 171 (321)
T cd05591 92 KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQEL 171 (321)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccCccccCHHHHcCC
Confidence 3444555556677788899999999999986 44 222 111 345
Q ss_pred Cccc-e-EEEec------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-------CHHH
Q psy1684 109 GVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRP-------TFET 167 (189)
Q Consensus 109 ~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP-------~~~~ 167 (189)
.++. + ||||| |.+.+..++...+..+. ...|..++.++.+|+.+|++.||++|| +..+
T Consensus 172 ~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~ 250 (321)
T cd05591 172 EYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD-VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDA 250 (321)
T ss_pred CCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHH
Confidence 6888 9 99999 66667777777776654 446678899999999999999999999 6666
Q ss_pred HHH
Q psy1684 168 LQW 170 (189)
Q Consensus 168 i~~ 170 (189)
+++
T Consensus 251 ~~~ 253 (321)
T cd05591 251 IKQ 253 (321)
T ss_pred Hhc
Confidence 654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.2e-14 Score=110.65 Aligned_cols=166 Identities=13% Similarity=0.090 Sum_probs=102.4
Q ss_pred CChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEec-CCCeeeEEEEEeccCC--ccCCCCCcC--HhHH---HH--
Q psy1684 6 IKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKR-SSFCLKMTTGRSLFET--QKAGRTTIH--YPEL---VE-- 75 (189)
Q Consensus 6 l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~-~~~~v~h~~i~~~~~g--yl~~~~~~~--l~~l---i~-- 75 (189)
..++|+-++++.-....-.+|++|++..+....+.-... .....-++.+.....| |+|..+.+| +... +.
T Consensus 68 ~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~ 147 (467)
T KOG0201|consen 68 CDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSES 147 (467)
T ss_pred cCcchHHhhhhheeecccHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEecc
Confidence 445677777776655566778899988743222211110 0122233333334444 777776665 3221 10
Q ss_pred HhhhccC-CceeeccCCccccc----ccccccccC-CCCCccc-e-EEEec------------CCCCChHHHHHHHHcCC
Q psy1684 76 HYSKDAD-GLCVNLRKPCVQVS----CRIYLVHGT-NLSGVVV-S-AVDFG------------SGGMTNAEVLHQVEHGY 135 (189)
Q Consensus 76 ~~~~~a~-gl~~~~~~~~~~~~----~p~~l~~~~-~~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~ 135 (189)
...+.++ |.+..+......|+ .|.|||+|+ ....|+. + |||+| +.++++..++..|-+..
T Consensus 148 g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~ 227 (467)
T KOG0201|consen 148 GDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSA 227 (467)
T ss_pred CcEEEEecceeeeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCC
Confidence 1111222 44444433333332 355888888 4447999 9 99999 77788877776665554
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 136 RMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 136 ~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
.|.....+.+.++++|..|+..||+.||+++++++.
T Consensus 228 PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 228 PPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred CCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 444445788999999999999999999999999874
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.40 E-value=7.8e-14 Score=106.58 Aligned_cols=100 Identities=12% Similarity=-0.064 Sum_probs=72.3
Q ss_pred CCcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------ccc---------------------ccC-CC
Q psy1684 66 TTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLV---------------------HGT-NL 107 (189)
Q Consensus 66 ~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~---------------------~~~-~~ 107 (189)
..+.......+..+.+.|+.++|..+++|+|+ |. |++ +|. ..
T Consensus 91 ~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 170 (323)
T cd05575 91 RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRK 170 (323)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCChhhcChhhhcC
Confidence 34444445556677888899999999999886 43 222 221 34
Q ss_pred CCccc-e-EEEec------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH
Q psy1684 108 SGVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFE 166 (189)
Q Consensus 108 ~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~ 166 (189)
..++. + ||||| |.+.+..++...+..+. ...++..+.++.+++.+|++.||++||+..
T Consensus 171 ~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 171 QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP-LRLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 56888 9 99999 55556667777765553 345667899999999999999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.40 E-value=5.2e-14 Score=105.72 Aligned_cols=103 Identities=15% Similarity=0.085 Sum_probs=72.3
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------ccc--------------------ccC-CCCCc
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLV--------------------HGT-NLSGV 110 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~--------------------~~~-~~~~~ 110 (189)
+....+..+..+.+.|+.++|..+++|+|+ |+ |++ +|. ....+
T Consensus 107 ~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 186 (290)
T cd07862 107 VPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSY 186 (290)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEeccCCcccccccccccccChHHHhCCCC
Confidence 345566677788889999999999999986 44 221 111 24567
Q ss_pred cc-e-EEEec------------CCCCChHHHHHHHHcCCCCCCC--------------------------CCCCHHHHHH
Q psy1684 111 VV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMPCP--------------------------PGCPPRLYDI 150 (189)
Q Consensus 111 ~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~~p--------------------------~~~p~~~~~l 150 (189)
+. + ||||| |.+.+..+.+..+.++...+.| +.++..+.+|
T Consensus 187 ~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 266 (290)
T cd07862 187 ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDL 266 (290)
T ss_pred CCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHH
Confidence 88 9 99999 5555555555555332211111 2467788999
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q psy1684 151 MLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 151 ~~~C~~~~p~~RP~~~~i~~ 170 (189)
+.+|++.||++|||+.++++
T Consensus 267 i~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 267 LLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred HHHHhccCchhcCCHHHHhc
Confidence 99999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.40 E-value=9.6e-14 Score=105.81 Aligned_cols=103 Identities=13% Similarity=0.036 Sum_probs=76.3
Q ss_pred CCcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cccc---------------------cC-CC
Q psy1684 66 TTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVH---------------------GT-NL 107 (189)
Q Consensus 66 ~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~---------------------~~-~~ 107 (189)
..+.......+..+.+.|+.++|..+++|+|+ |+ |++. |. ..
T Consensus 91 ~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 170 (316)
T cd05620 91 GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQG 170 (316)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcC
Confidence 34445556666778888999999999999986 44 2222 11 34
Q ss_pred CCccc-e-EEEec------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH-HHH
Q psy1684 108 SGVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFE-TLQ 169 (189)
Q Consensus 108 ~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~-~i~ 169 (189)
..++. + |||+| |.+.+..++...+..+ .+..|..++.++.+++.+||+.||++||++. ++.
T Consensus 171 ~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 171 LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD-TPHYPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 56888 9 99999 5566666777666544 3556778999999999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.6e-14 Score=102.00 Aligned_cols=97 Identities=14% Similarity=0.093 Sum_probs=76.5
Q ss_pred HHHhhhccCCceeeccCCcccccc-cc------------------cccccC---------------------CCCCccc-
Q psy1684 74 VEHYSKDADGLCVNLRKPCVQVSC-RI------------------YLVHGT---------------------NLSGVVV- 112 (189)
Q Consensus 74 i~~~~~~a~gl~~~~~~~~~~~~~-p~------------------~l~~~~---------------------~~~~~~~- 112 (189)
..+.+|+.+++.|+|..+|+|||. |+ |+|.+. +..+|+.
T Consensus 113 SH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kp 192 (355)
T KOG0033|consen 113 SHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKP 192 (355)
T ss_pred HHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccccccccCCCcccCHHHhhcCCCCCc
Confidence 335566778899999999999995 66 333332 6678999
Q ss_pred e-EEEec------------CCCCChHHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 113 S-AVDFG------------SGGMTNAEVLHQVEHG-YRMPCP--PGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 113 s-VwsfG------------~~~~~~~~~~~~v~~g-~~~~~p--~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
+ ||+.| |-|.+...+.+.|..| +-.+.| ++..++.++|+.+++..||++|-|..|.++
T Consensus 193 vDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 193 VDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred chhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 9 99999 6666778899999776 444443 467899999999999999999999998765
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.4e-13 Score=101.41 Aligned_cols=144 Identities=14% Similarity=0.116 Sum_probs=92.3
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.+.|+|++++.+.+......++|+|+.++ +. +.. ++.....+.......+..+.+.|+
T Consensus 58 ~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~~----L~~-----------------~~~~~~~~~~~~~~~~~~~i~~~l 115 (258)
T cd06632 58 KLQHPNIVQYLGTEREEDNLYIFLELVPG-GS----LAK-----------------LLKKYGSFPEPVIRLYTRQILLGL 115 (258)
T ss_pred hcCCCCchheeeeEecCCeEEEEEEecCC-Cc----HHH-----------------HHHhcCCCCHHHHHHHHHHHHHHH
Confidence 45677777777666555666777776654 21 111 222222334445555666777788
Q ss_pred eeeccCCcccccc-cc---------------c--------------------ccccC-CCCC-ccc-e-EEEec------
Q psy1684 85 CVNLRKPCVQVSC-RI---------------Y--------------------LVHGT-NLSG-VVV-S-AVDFG------ 118 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~---------------~--------------------l~~~~-~~~~-~~~-s-VwsfG------ 118 (189)
.++|..+++|+|+ |. + ++++. .... ++. + |||||
T Consensus 116 ~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l 195 (258)
T cd06632 116 EYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEM 195 (258)
T ss_pred HHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHH
Confidence 8888888888775 33 1 11111 2223 788 8 99999
Q ss_pred ------CCCCChHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 119 ------SGGMTNAEVLHQVEH-GYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 119 ------~~~~~~~~~~~~v~~-g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
|......+....+.. +..+..|..+++++.+++.+||+.||++||++.+++.
T Consensus 196 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 196 ATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred HhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 333443343334433 4556677889999999999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.6e-13 Score=105.27 Aligned_cols=144 Identities=10% Similarity=-0.028 Sum_probs=91.1
Q ss_pred CChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCce
Q psy1684 6 IKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGLC 85 (189)
Q Consensus 6 l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl~ 85 (189)
+.|+|++++++.+...+..|||+|++.++. +.. ++.....+.......+..+.+.|+.
T Consensus 58 ~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~-----L~~-----------------~l~~~~~l~~~~~~~~~~qi~~~l~ 115 (333)
T cd05600 58 TKSEWLVKLLYAFQDDEYLYLAMEYVPGGD-----FRT-----------------LLNNLGVLSEDHARFYMAEMFEAVD 115 (333)
T ss_pred CCCCCCccEEEEEEcCCEEEEEEeCCCCCC-----HHH-----------------HHHHcCCCCHHHHHHHHHHHHHHHH
Confidence 446666666555544455566666655421 111 2322333444445555667777888
Q ss_pred eeccCCcccccc-cc---------------cc------------------cccC-CCCCccc-e-EEEec----------
Q psy1684 86 VNLRKPCVQVSC-RI---------------YL------------------VHGT-NLSGVVV-S-AVDFG---------- 118 (189)
Q Consensus 86 ~~~~~~~~~~~~-p~---------------~l------------------~~~~-~~~~~~~-s-VwsfG---------- 118 (189)
++|...++|+|+ |+ |+ ++|. ....++. + |||||
T Consensus 116 ~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~ 195 (333)
T cd05600 116 ALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGF 195 (333)
T ss_pred HHHHCCccccCCCHHHEEECCCCCEEEEeCcCCcccccccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCC
Confidence 888888888885 44 22 2222 3456888 9 99999
Q ss_pred --CCCCChHHHHHHHHcCC-CCCCCC------CCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 119 --SGGMTNAEVLHQVEHGY-RMPCPP------GCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 119 --~~~~~~~~~~~~v~~g~-~~~~p~------~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
|.+.+..++...+.... .+..|. .++.++.+|+.+||..+|.+||++.++++.
T Consensus 196 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 196 PPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 55556666666654321 122222 468999999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.39 E-value=8.3e-14 Score=104.47 Aligned_cols=145 Identities=12% Similarity=0.009 Sum_probs=91.4
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..+.|+|++++++.+...+..+||+|++.. +.+.. +......+....+..+..+.+.|
T Consensus 55 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~~l~~---------------------~~~~~~~~~~~~~~~~~~qi~~~ 112 (287)
T cd07848 55 RTLKQENIVELKEAFRRRGKLYLVFEYVEK-NMLEL---------------------LEEMPNGVPPEKVRSYIYQLIKA 112 (287)
T ss_pred HhCCCccccchhhhEecCCEEEEEEecCCC-CHHHH---------------------HHhcCCCCCHHHHHHHHHHHHHH
Confidence 457789999988877777778899998875 32110 00001123344455566677778
Q ss_pred ceeeccCCcccccc-cc---------------cc----------------------cccC-CCCCccc-e-EEEec----
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YL----------------------VHGT-NLSGVVV-S-AVDFG---- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l----------------------~~~~-~~~~~~~-s-VwsfG---- 118 (189)
+.++|..+++|+|+ |+ |+ ++|. ....++. + |||||
T Consensus 113 L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~ 192 (287)
T cd07848 113 IHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILG 192 (287)
T ss_pred HHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHH
Confidence 88888888888775 33 22 2221 3456888 9 99999
Q ss_pred --------CCCCChHHHHHHHHc--C------------------CCCCC-----------CCCCCHHHHHHHHHhcccCC
Q psy1684 119 --------SGGMTNAEVLHQVEH--G------------------YRMPC-----------PPGCPPRLYDIMLECWLKDP 159 (189)
Q Consensus 119 --------~~~~~~~~~~~~v~~--g------------------~~~~~-----------p~~~p~~~~~l~~~C~~~~p 159 (189)
|++.+..+....+.. | ...+. ...++.++.+|+.+|++.||
T Consensus 193 el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P 272 (287)
T cd07848 193 ELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNP 272 (287)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCc
Confidence 555544333322211 0 00000 11367889999999999999
Q ss_pred CCCCCHHHHHH
Q psy1684 160 VKRPTFETLQW 170 (189)
Q Consensus 160 ~~RP~~~~i~~ 170 (189)
++|||++++++
T Consensus 273 ~~R~s~~~~l~ 283 (287)
T cd07848 273 TDRYLTEQCLN 283 (287)
T ss_pred ccCCCHHHHhc
Confidence 99999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.39 E-value=4.6e-14 Score=107.98 Aligned_cols=28 Identities=25% Similarity=0.488 Sum_probs=25.8
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 143 CPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 143 ~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
+++++.+++.+||+.||++|||++++++
T Consensus 279 ~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 279 FSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred cCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 4678999999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.2e-13 Score=105.56 Aligned_cols=105 Identities=10% Similarity=-0.033 Sum_probs=76.5
Q ss_pred CCcCHhHHHHHhhhccCCceeecc-CCcccccc-cc---------------cccc---------------------cC-C
Q psy1684 66 TTIHYPELVEHYSKDADGLCVNLR-KPCVQVSC-RI---------------YLVH---------------------GT-N 106 (189)
Q Consensus 66 ~~~~l~~li~~~~~~a~gl~~~~~-~~~~~~~~-p~---------------~l~~---------------------~~-~ 106 (189)
..+.......+..+.+.|+.++|. .+++|+|+ |+ |++. |. .
T Consensus 90 ~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 169 (325)
T cd05594 90 RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLE 169 (325)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHc
Confidence 344455566667788889999997 78999986 54 2222 11 3
Q ss_pred CCCccc-e-EEEec------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHH
Q psy1684 107 LSGVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRP-----TFET 167 (189)
Q Consensus 107 ~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP-----~~~~ 167 (189)
...++. + ||||| |.+.+..++...+..+ ....|...++++.+|+.+||+.||++|+ ++++
T Consensus 170 ~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ 248 (325)
T cd05594 170 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-EIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKE 248 (325)
T ss_pred cCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC-CCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHH
Confidence 456888 9 99999 4555556666655443 3556788999999999999999999996 8888
Q ss_pred HHHH
Q psy1684 168 LQWK 171 (189)
Q Consensus 168 i~~~ 171 (189)
+++.
T Consensus 249 il~h 252 (325)
T cd05594 249 IMQH 252 (325)
T ss_pred HhcC
Confidence 8753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.39 E-value=1e-13 Score=103.26 Aligned_cols=102 Identities=15% Similarity=0.114 Sum_probs=71.6
Q ss_pred CHhHHHHHhhhccCCceeeccCCcccccc-cc------------------------------------cccccC-CCCCc
Q psy1684 69 HYPELVEHYSKDADGLCVNLRKPCVQVSC-RI------------------------------------YLVHGT-NLSGV 110 (189)
Q Consensus 69 ~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~------------------------------------~l~~~~-~~~~~ 110 (189)
....+.....+.+.++.++|...++|+|+ |. ++++|. ....+
T Consensus 96 ~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~ 175 (274)
T cd06609 96 DETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGY 175 (274)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccccccccCCccccChhhhccCCC
Confidence 34445555566666777777777777764 22 122222 33447
Q ss_pred cc-e-EEEec------------CCCCChHHHHHHHHcCCCCCCCCC-CCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 111 VV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMPCPPG-CPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 111 ~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~~p~~-~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
+. + ||||| |.+.++.++...+..+..+..+.. +|.++.+++.+||..||++|||++++++
T Consensus 176 ~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 176 DEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 88 9 99999 445555566666666665555555 8999999999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.5e-13 Score=100.31 Aligned_cols=143 Identities=12% Similarity=0.069 Sum_probs=92.3
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..++|+|++++..........|+|+++..+ +. +.. ++.....+....+..+..+.+.|
T Consensus 55 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~~----L~~-----------------~l~~~~~l~~~~~~~~~~~i~~~ 112 (258)
T cd05578 55 QELNHPFLVNLWYSFQDEENMYLVVDLLLG-GD----LRY-----------------HLSQKVKFSEEQVKFWICEIVLA 112 (258)
T ss_pred HhCCCCChHHHHHhhcCCCeEEEEEeCCCC-CC----HHH-----------------HHHhcCCcCHHHHHHHHHHHHHH
Confidence 357899999988877777778999998776 31 111 12112123334444555566667
Q ss_pred ceeeccCCccccccc-c-----------------------------------cccccC-CCCCccc-e-EEEec------
Q psy1684 84 LCVNLRKPCVQVSCR-I-----------------------------------YLVHGT-NLSGVVV-S-AVDFG------ 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~p-~-----------------------------------~l~~~~-~~~~~~~-s-VwsfG------ 118 (189)
+.++|..+++|+|+. . ++++|. ....++. + |||||
T Consensus 113 l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l 192 (258)
T cd05578 113 LEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYEC 192 (258)
T ss_pred HHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHH
Confidence 777777777777643 2 122222 3344688 9 99999
Q ss_pred ------CCCCC---hHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH--HHHH
Q psy1684 119 ------SGGMT---NAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTF--ETLQ 169 (189)
Q Consensus 119 ------~~~~~---~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~--~~i~ 169 (189)
|...+ ..++... ....+...|..+|.++.+++.+||..||.+||++ ++++
T Consensus 193 ~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 193 LRGKRPYRGHSRTIRDQIRAK-QETADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred HhCCCCCCCCCccHHHHHHHH-hccccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 44433 2333332 2224566778899999999999999999999999 5544
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.38 E-value=9.5e-14 Score=106.58 Aligned_cols=29 Identities=21% Similarity=0.474 Sum_probs=26.3
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 143 CPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 143 ~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
.+.++.+|+.+||+.||++|||+.+++..
T Consensus 271 ~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 271 FGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred cCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 56889999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.38 E-value=1e-13 Score=102.38 Aligned_cols=103 Identities=15% Similarity=0.067 Sum_probs=76.6
Q ss_pred cCHhHHHHHhhhccCCceeec-----cCCcccccc-cc---------------c---------------------ccccC
Q psy1684 68 IHYPELVEHYSKDADGLCVNL-----RKPCVQVSC-RI---------------Y---------------------LVHGT 105 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~-----~~~~~~~~~-p~---------------~---------------------l~~~~ 105 (189)
++......+..+.+.|+.++| ...++|+|+ |. + +++|.
T Consensus 102 l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~ 181 (265)
T cd08217 102 IEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQ 181 (265)
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCCcccccccccCCCccChhh
Confidence 345556666677777888888 777888775 33 1 11111
Q ss_pred -CCCCccc-e-EEEec------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 106 -NLSGVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 106 -~~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
....++. + ||||| |.+.+..++...+..+..+..|...+.++.+++.+||+.+|++||++.+|++
T Consensus 182 ~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 182 LNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred hcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 2344678 8 99999 5555566777777777777788889999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.38 E-value=3.1e-13 Score=100.09 Aligned_cols=145 Identities=17% Similarity=0.078 Sum_probs=92.5
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCC-CCcCHhHHHHHhhhccCC
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGR-TTIHYPELVEHYSKDADG 83 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~-~~~~l~~li~~~~~~a~g 83 (189)
.+.|+|++++++.+......+||+++..... +.. ++... ..+....+.....+.+.+
T Consensus 55 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~-----L~~-----------------~~~~~~~~~~~~~~~~~~~~l~~~ 112 (265)
T cd06605 55 KCNSPYIVGFYGAFYNNGDISICMEYMDGGS-----LDK-----------------ILKEVQGRIPERILGKIAVAVLKG 112 (265)
T ss_pred HCCCCchhhhheeeecCCEEEEEEEecCCCc-----HHH-----------------HHHHccCCCCHHHHHHHHHHHHHH
Confidence 4568888888877666667778888776421 111 11111 223334444455566677
Q ss_pred ceeecc-CCcccccc-cc----------------------------------cccccC-CCCCccc-e-EEEec------
Q psy1684 84 LCVNLR-KPCVQVSC-RI----------------------------------YLVHGT-NLSGVVV-S-AVDFG------ 118 (189)
Q Consensus 84 l~~~~~-~~~~~~~~-p~----------------------------------~l~~~~-~~~~~~~-s-VwsfG------ 118 (189)
+.++|. .+++|+|+ |. ++++|. ....++. + |||||
T Consensus 113 l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l 192 (265)
T cd06605 113 LTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIEL 192 (265)
T ss_pred HHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHH
Confidence 777777 77777765 22 122222 3456888 9 99999
Q ss_pred ------CCCC-----ChHHHHHHHHcCCCCCCCCC-CCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 119 ------SGGM-----TNAEVLHQVEHGYRMPCPPG-CPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 119 ------~~~~-----~~~~~~~~v~~g~~~~~p~~-~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
|... ...+....+..+..+..|.. ++.++.++|.+||..||++|||+.+++..
T Consensus 193 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 193 ATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred HhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 2222 22344444555555555655 88999999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.38 E-value=4.5e-14 Score=107.06 Aligned_cols=103 Identities=13% Similarity=0.084 Sum_probs=70.7
Q ss_pred CHhHHHHHhhhccCCceeeccCCcccccc-cc--------------------------------cccccC----CCCCcc
Q psy1684 69 HYPELVEHYSKDADGLCVNLRKPCVQVSC-RI--------------------------------YLVHGT----NLSGVV 111 (189)
Q Consensus 69 ~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~--------------------------------~l~~~~----~~~~~~ 111 (189)
....+..+..+.+.|+.++|...++|+|+ |. ++++|. ..+.++
T Consensus 113 ~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 192 (307)
T cd06607 113 QEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFVGTPYWMAPEVILAMDEGQYD 192 (307)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCCCCccCCccccCceeeeccCCCCCC
Confidence 34555566667777888888888888875 33 233332 135588
Q ss_pred c-e-EEEec------------CCCCChHHHHHHHHcCCCCCC-CCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 112 V-S-AVDFG------------SGGMTNAEVLHQVEHGYRMPC-PPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 112 ~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~~-p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
. + ||||| |.+.+.......+..+..+.. +..++.++.+++.+||+.||++||++.+|+..
T Consensus 193 ~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 193 GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred cccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 8 9 99999 334444444444444433333 34688999999999999999999999999873
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.3e-13 Score=102.53 Aligned_cols=145 Identities=6% Similarity=-0.061 Sum_probs=97.5
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..++|+|++++++.+...+..|+|+|+++++. +.. ++. ...+...+...+..+...|
T Consensus 74 ~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~-----L~~-----------------~~~-~~~l~~~~~~~~~~qi~~~ 130 (292)
T cd06658 74 RDYHHENVVDMYNSYLVGDELWVVMEFLEGGA-----LTD-----------------IVT-HTRMNEEQIATVCLSVLRA 130 (292)
T ss_pred HhCCCCcHHHHHHheecCCeEEEEEeCCCCCc-----HHH-----------------HHh-cCCCCHHHHHHHHHHHHHH
Confidence 45789999999988777778899999887622 111 111 1123345556666777778
Q ss_pred ceeeccCCcccccc-cc---------------cc---------------------cccC-CCCCccc-e-EEEec-----
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YL---------------------VHGT-NLSGVVV-S-AVDFG----- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l---------------------~~~~-~~~~~~~-s-VwsfG----- 118 (189)
+.++|..+++|+|+ |. ++ ++|. ....++. + |||||
T Consensus 131 l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~e 210 (292)
T cd06658 131 LSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIE 210 (292)
T ss_pred HHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHH
Confidence 88888888888875 33 11 1111 2235788 8 99999
Q ss_pred -------CCCCChHHHHHHHHcCCCCC--CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 119 -------SGGMTNAEVLHQVEHGYRMP--CPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 119 -------~~~~~~~~~~~~v~~g~~~~--~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
|.+.+..+....+....... .+...+..+.+++.+||..||++|||++++++.
T Consensus 211 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 211 MIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 44555555555554443222 223578899999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.8e-13 Score=100.26 Aligned_cols=144 Identities=8% Similarity=-0.018 Sum_probs=88.3
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.++|+|++++++........++|+|+..+ +. +.. ++.....+....+..+..+.+.|+
T Consensus 49 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~~----L~~-----------------~l~~~~~l~~~~~~~~~~~i~~~l 106 (262)
T cd05572 49 ECNHPFIVKLYRTFKDKKYIYMLMEYCLG-GE----LWT-----------------ILRDRGLFDEYTARFYIACVVLAF 106 (262)
T ss_pred hCCCCCEeeeeeeEEcCCccEEEEecCCC-Cc----HHH-----------------HHhhcCCCCHHHHHHHHHHHHHHH
Confidence 45677777766655555556677776654 21 111 222222233333444445556666
Q ss_pred eeeccCCcccccc-cc-----------------------------------cccccC-CCCCccc-e-EEEec-------
Q psy1684 85 CVNLRKPCVQVSC-RI-----------------------------------YLVHGT-NLSGVVV-S-AVDFG------- 118 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~-----------------------------------~l~~~~-~~~~~~~-s-VwsfG------- 118 (189)
.++|...++|+|+ |. ++++|. ....++. + |||||
T Consensus 107 ~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~ 186 (262)
T cd05572 107 EYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELL 186 (262)
T ss_pred HHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHH
Confidence 6666666666654 22 122222 3345788 9 99999
Q ss_pred -----CCCCC--hHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q psy1684 119 -----SGGMT--NAEVLHQVEH-GYRMPCPPGCPPRLYDIMLECWLKDPVKRPT-----FETLQW 170 (189)
Q Consensus 119 -----~~~~~--~~~~~~~v~~-g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~-----~~~i~~ 170 (189)
|.+.. ..++...+.. ...++.|..++.++.++|.+||+.||++||+ ++|+++
T Consensus 187 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 187 TGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred hCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 33333 4555666554 4566778888999999999999999999999 676665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.38 E-value=3.3e-13 Score=99.82 Aligned_cols=145 Identities=16% Similarity=0.148 Sum_probs=89.6
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..+.|+|++++++.+...+..++|+|+...+. +.. ++.....+.......+..+.+.|
T Consensus 54 ~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~-----L~~-----------------~~~~~~~~~~~~~~~i~~~i~~~ 111 (264)
T cd06626 54 ELLKHPNLVKYYGVEVHREKVYIFMEYCSGGT-----LEE-----------------LLEHGRILDEHVIRVYTLQLLEG 111 (264)
T ss_pred HhCCCCChhheeeeEecCCEEEEEEecCCCCc-----HHH-----------------HHhhcCCCChHHHHHHHHHHHHH
Confidence 35678888888877666667788888776522 111 11111122233334444555666
Q ss_pred ceeeccCCccccccc-c----------------------------------------cccccC-CCC---Cccc-e-EEE
Q psy1684 84 LCVNLRKPCVQVSCR-I----------------------------------------YLVHGT-NLS---GVVV-S-AVD 116 (189)
Q Consensus 84 l~~~~~~~~~~~~~p-~----------------------------------------~l~~~~-~~~---~~~~-s-Vws 116 (189)
+.++|...++|+|+. . ++++|. ... .++. + |||
T Consensus 112 l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s 191 (264)
T cd06626 112 LAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWS 191 (264)
T ss_pred HHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHH
Confidence 666666666666542 2 122222 112 2677 8 999
Q ss_pred ec------------CCCC-ChHHHHHHHHcCCCCCCCCCC--CHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 117 FG------------SGGM-TNAEVLHQVEHGYRMPCPPGC--PPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 117 fG------------~~~~-~~~~~~~~v~~g~~~~~p~~~--p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
|| |.+. +...+...+..+..+..|... ++.+.+++.+||+.+|.+|||+.+|+.
T Consensus 192 ~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 192 LGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred HHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 99 4443 233444445556556666554 999999999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.37 E-value=5.4e-13 Score=100.01 Aligned_cols=145 Identities=17% Similarity=0.107 Sum_probs=93.7
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC---CCCcCHhHHHHHhhhcc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG---RTTIHYPELVEHYSKDA 81 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~---~~~~~l~~li~~~~~~a 81 (189)
.+.|+|++++++.+......++|+|+++.+. + .. ++.. ...+....+..+..+.+
T Consensus 55 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~-l----~~-----------------~~~~~~~~~~~~~~~~~~~~~~i~ 112 (286)
T cd06622 55 KAVSPYIVDFYGAFFIEGAVYMCMEYMDAGS-L----DK-----------------LYAGGVATEGIPEDVLRRITYAVV 112 (286)
T ss_pred hcCCCcHHhhhhheecCCeEEEEEeecCCCC-H----HH-----------------HHHhccccCCCCHHHHHHHHHHHH
Confidence 4678999999987776777889999887632 1 11 1111 11233444555555666
Q ss_pred CCceeecc-CCcccccc-cc----------------------------------cccccCC-------CCCccc-e-EEE
Q psy1684 82 DGLCVNLR-KPCVQVSC-RI----------------------------------YLVHGTN-------LSGVVV-S-AVD 116 (189)
Q Consensus 82 ~gl~~~~~-~~~~~~~~-p~----------------------------------~l~~~~~-------~~~~~~-s-Vws 116 (189)
.++.++|. .+++|+|+ |+ ++++|.. ...++. + |||
T Consensus 113 ~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Diws 192 (286)
T cd06622 113 KGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWS 192 (286)
T ss_pred HHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCccccCCCccCccCcchhcCCCCCccCCCCcccchHh
Confidence 66777764 36667664 32 1222221 123578 8 999
Q ss_pred ec------------CCCCChHHHH---HHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 117 FG------------SGGMTNAEVL---HQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 117 fG------------~~~~~~~~~~---~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
|| |...+...+. ..+..+..+..|..++.++.++|.+||..+|++||++.+++..
T Consensus 193 lG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 193 LGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred HHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 99 3333333333 3344566666778899999999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.4e-13 Score=102.27 Aligned_cols=145 Identities=12% Similarity=0.084 Sum_probs=87.9
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCC-CCc--CHhHHHHHhhhc
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGR-TTI--HYPELVEHYSKD 80 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~-~~~--~l~~li~~~~~~ 80 (189)
..++|+|++++++.+...+..++|.|+.+++. + .. ++... ..+ ....+..+..+.
T Consensus 60 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~-L----~~-----------------~l~~~~~~~~~~~~~~~~~~~qi 117 (268)
T cd06624 60 SYLKHRNIVQYLGSDSENGFFKIFMEQVPGGS-L----SA-----------------LLRSKWGPLKDNEQTIIFYTKQI 117 (268)
T ss_pred HhcCCCCeeeeeeeeccCCEEEEEEecCCCCC-H----HH-----------------HHHHhcccCCCcHHHHHHHHHHH
Confidence 35678888888877766667788888776522 1 11 11100 011 123333444556
Q ss_pred cCCceeeccCCcccccc-cc-------------------------------------cccccC-CC--CCccc-e-EEEe
Q psy1684 81 ADGLCVNLRKPCVQVSC-RI-------------------------------------YLVHGT-NL--SGVVV-S-AVDF 117 (189)
Q Consensus 81 a~gl~~~~~~~~~~~~~-p~-------------------------------------~l~~~~-~~--~~~~~-s-Vwsf 117 (189)
+.|+.++|..+++|+|+ |. ++++|. .. ..++. + ||||
T Consensus 118 ~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~sl 197 (268)
T cd06624 118 LEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSL 197 (268)
T ss_pred HHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHH
Confidence 66666777666666664 22 122222 12 23778 9 9999
Q ss_pred c------------CCCCC-hHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 118 G------------SGGMT-NAEVLHQV-EHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 118 G------------~~~~~-~~~~~~~v-~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
| |.... ........ .....+..|..+++++.+++.+||+.+|++|||+.+|+.
T Consensus 198 Gvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 198 GCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred HHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 9 22222 12222222 223445678889999999999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.8e-13 Score=104.61 Aligned_cols=142 Identities=11% Similarity=-0.059 Sum_probs=90.4
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.+.|+|+++++......+..++|+|++.++. + .. ++.....+.......+..+...|+
T Consensus 52 ~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~-L----~~-----------------~~~~~~~~~~~~~~~~~~qi~~~L 109 (325)
T cd05602 52 NVKHPFLVGLHFSFQTADKLYFVLDYINGGE-L----FY-----------------HLQRERCFLEPRARFYAAEIASAL 109 (325)
T ss_pred hCCCCCCCceeEEEEcCCeEEEEEeCCCCCc-H----HH-----------------HHHhcCCCCHHHHHHHHHHHHHHH
Confidence 3455666655554444445566666655421 1 11 222223333333444566777888
Q ss_pred eeeccCCcccccc-cc---------------cccc---------------------cC-CCCCccc-e-EEEec------
Q psy1684 85 CVNLRKPCVQVSC-RI---------------YLVH---------------------GT-NLSGVVV-S-AVDFG------ 118 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~---------------~l~~---------------------~~-~~~~~~~-s-VwsfG------ 118 (189)
.++|..+++|+|+ |+ |++. |. ....++. + |||+|
T Consensus 110 ~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 189 (325)
T cd05602 110 GYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEM 189 (325)
T ss_pred HHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHH
Confidence 8888888888885 44 3222 11 3456888 9 99999
Q ss_pred ------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q psy1684 119 ------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQ 169 (189)
Q Consensus 119 ------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~ 169 (189)
|.+.+..+....+..+. ...++.++.++.+++.+|++.||++||+..+.+
T Consensus 190 ~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 190 LYGLPPFYSRNTAEMYDNILNKP-LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred hcCCCCCCCCCHHHHHHHHHhCC-cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 55566667666665442 345568899999999999999999999987543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.7e-13 Score=102.30 Aligned_cols=104 Identities=13% Similarity=0.126 Sum_probs=73.9
Q ss_pred cCHhHHHHHhhhccCCceeeccCCccccccc-c---------------c---------------------ccccC-CCCC
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSCR-I---------------Y---------------------LVHGT-NLSG 109 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~p-~---------------~---------------------l~~~~-~~~~ 109 (189)
+....+.....+.+.++.++|..+++|+|+. . + +++|. ....
T Consensus 98 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~ 177 (277)
T cd06641 98 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA 177 (277)
T ss_pred CCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhccccCCccccChhhhccCC
Confidence 3345555566666677777777777777642 2 1 22222 3345
Q ss_pred ccc-e-EEEec------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 110 VVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 110 ~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
++. + ||||| +.+.+.......+..+..+..+..+|.++.+++.+||..+|.+||++.++++.
T Consensus 178 ~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 178 YDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 788 8 99999 44455555666666666666777899999999999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.37 E-value=7.3e-14 Score=102.86 Aligned_cols=144 Identities=12% Similarity=0.101 Sum_probs=88.4
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC-CCCcCHhHHHHHhhhccCC
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG-RTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~-~~~~~l~~li~~~~~~a~g 83 (189)
.++|+|++++++.+......++|+|+..... +.. ++.. ...+.......+..+.+.|
T Consensus 54 ~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~-----L~~-----------------~l~~~~~~l~~~~~~~~~~~l~~~ 111 (256)
T cd06612 54 QCDSPYIVKYYGSYFKNTDLWIVMEYCGAGS-----VSD-----------------IMKITNKTLTEEEIAAILYQTLKG 111 (256)
T ss_pred hCCCCcEeeeeeeeecCCcEEEEEecCCCCc-----HHH-----------------HHHhCccCCCHHHHHHHHHHHHHH
Confidence 4567777777766655555667777665421 111 1111 1223344555566666777
Q ss_pred ceeeccCCcccccc-cc------------------------------------cccccC-CCCCccc-e-EEEec-----
Q psy1684 84 LCVNLRKPCVQVSC-RI------------------------------------YLVHGT-NLSGVVV-S-AVDFG----- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~------------------------------------~l~~~~-~~~~~~~-s-VwsfG----- 118 (189)
+.++|..+++|+|+ |. ++++|. ....++. + |||||
T Consensus 112 l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~ 191 (256)
T cd06612 112 LEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIE 191 (256)
T ss_pred HHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHH
Confidence 77888777777775 33 111211 3346788 9 99999
Q ss_pred -------CCCCChHHHHHHHHcCC--CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 119 -------SGGMTNAEVLHQVEHGY--RMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 119 -------~~~~~~~~~~~~v~~g~--~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
|...++.+....+.... ....|...+.++.+++.+||+.||++|||+.+|+.
T Consensus 192 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 192 MAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred HHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 34444444333332221 22344567889999999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.6e-13 Score=103.21 Aligned_cols=63 Identities=16% Similarity=0.161 Sum_probs=46.3
Q ss_pred CCccc-e-EEEec------------CCCCChHHHHHHHHcCCCC--CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 108 SGVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRM--PCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 108 ~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~--~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
..++. + ||||| |.+.+..+....+..+..+ ..|..++.++.+++.+||..||++||++.+|++
T Consensus 190 ~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 190 TPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred CCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 34788 8 99999 3334444444444444322 345678899999999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.37 E-value=3.2e-14 Score=105.56 Aligned_cols=105 Identities=15% Similarity=0.143 Sum_probs=64.6
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc------------------------------------cccccC----C
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI------------------------------------YLVHGT----N 106 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~------------------------------------~l~~~~----~ 106 (189)
+.......+..+.+.|+.++|..+++|+|+ |. ++++|. .
T Consensus 103 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~ 182 (267)
T cd06646 103 LSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEK 182 (267)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccccCccccCccccCHhHccccc
Confidence 344455555666677777777777777764 33 122221 1
Q ss_pred CCCccc-e-EEEec------------CCCCChHHHHHHHH-cCCCCCCC---CCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy1684 107 LSGVVV-S-AVDFG------------SGGMTNAEVLHQVE-HGYRMPCP---PGCPPRLYDIMLECWLKDPVKRPTFETL 168 (189)
Q Consensus 107 ~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~-~g~~~~~p---~~~p~~~~~l~~~C~~~~p~~RP~~~~i 168 (189)
...++. + ||||| |.+.++.+....+. ....++.+ ...+.++.+++.+||+.||++|||+++|
T Consensus 183 ~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~i 262 (267)
T cd06646 183 NGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERL 262 (267)
T ss_pred CCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHH
Confidence 334778 8 99999 22222222222221 22222222 3467899999999999999999999999
Q ss_pred HHHH
Q psy1684 169 QWKL 172 (189)
Q Consensus 169 ~~~l 172 (189)
++.|
T Consensus 263 l~~l 266 (267)
T cd06646 263 LTHL 266 (267)
T ss_pred hcCC
Confidence 8643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.37 E-value=3.2e-13 Score=99.37 Aligned_cols=145 Identities=12% Similarity=0.066 Sum_probs=98.1
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC----CCCcCHhHHHHHhhh
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG----RTTIHYPELVEHYSK 79 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~----~~~~~l~~li~~~~~ 79 (189)
..++|+|++++.+........++|+++.+... +.. ++.. ...+....+..+..+
T Consensus 54 ~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~-----L~~-----------------~~~~~~~~~~~~~~~~~~~~~~~ 111 (256)
T cd08530 54 ASVNHPNIISYKEAFLDGNKLCIVMEYAPFGD-----LSK-----------------AISKRKKKRKLIPEQEIWRIFIQ 111 (256)
T ss_pred HhCCCCCchhhhhhhccCCEEEEEehhcCCCC-----HHH-----------------HHHHHHhhcCCCCHHHHHHHHHH
Confidence 45677888887766655566777887765522 111 1110 122334445555666
Q ss_pred ccCCceeeccCCcccccc-ccc----------------------------------ccccC-CCCCccc-e-EEEec---
Q psy1684 80 DADGLCVNLRKPCVQVSC-RIY----------------------------------LVHGT-NLSGVVV-S-AVDFG--- 118 (189)
Q Consensus 80 ~a~gl~~~~~~~~~~~~~-p~~----------------------------------l~~~~-~~~~~~~-s-VwsfG--- 118 (189)
.+.|+.++|..+++|+|+ |.. +++|. ....++. + |||+|
T Consensus 112 l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~ 191 (256)
T cd08530 112 LLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLL 191 (256)
T ss_pred HHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccCCcccccCCccccCHHHHCCCCCCchhhHHHHHHHH
Confidence 677777888888778765 331 11111 3445788 8 99999
Q ss_pred ---------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 119 ---------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 119 ---------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
|...+..++...+..+..++.+...+.++.+++.+||+.+|++||++.+++.
T Consensus 192 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 192 YEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 5555666777777777777777889999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.2e-13 Score=103.41 Aligned_cols=64 Identities=20% Similarity=0.254 Sum_probs=45.3
Q ss_pred CCccc-e-EEEec------------CCCCChHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 108 SGVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYR--MPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 108 ~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~--~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
..++. + ||||| |.+.+..+.+..+..+.. ...|..++.++.+||.+||+.||++|||+.+|++.
T Consensus 204 ~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 204 STYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred ccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 34788 9 99999 333333333333333322 22456678899999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.36 E-value=2.6e-13 Score=103.76 Aligned_cols=140 Identities=13% Similarity=-0.019 Sum_probs=92.5
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.+.|+|+++++......+..+||+|++.++. + .. ++.....+.......+..+.+.|+
T Consensus 52 ~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~-L----~~-----------------~l~~~~~~~~~~~~~~~~qi~~al 109 (325)
T cd05604 52 NVKHPFLVGLHYSFQTTEKLYFVLDFVNGGE-L----FF-----------------HLQRERSFPEPRARFYAAEIASAL 109 (325)
T ss_pred hCCCCCCccEEEEEecCCEEEEEEcCCCCCC-H----HH-----------------HHHHcCCCCHHHHHHHHHHHHHHH
Confidence 3556666665554444455666666655421 1 01 222233444555566677888899
Q ss_pred eeeccCCcccccc-cc---------------cccc---------------------cC-CCCCccc-e-EEEec------
Q psy1684 85 CVNLRKPCVQVSC-RI---------------YLVH---------------------GT-NLSGVVV-S-AVDFG------ 118 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~---------------~l~~---------------------~~-~~~~~~~-s-VwsfG------ 118 (189)
.++|..+++|+|+ |+ |+++ |. ....++. + |||||
T Consensus 110 ~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el 189 (325)
T cd05604 110 GYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEM 189 (325)
T ss_pred HHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhh
Confidence 9999999999986 43 2222 11 3456788 9 99999
Q ss_pred ------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q psy1684 119 ------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFET 167 (189)
Q Consensus 119 ------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~ 167 (189)
|.+.+..++...+..+. +..++..+.++.+++.+|+..||.+||++.+
T Consensus 190 ~~G~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 190 LYGLPPFYCRDVAEMYDNILHKP-LVLRPGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred hcCCCCCCCCCHHHHHHHHHcCC-ccCCCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 55556667777766553 3445578899999999999999999998864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.35 E-value=4e-13 Score=102.96 Aligned_cols=137 Identities=9% Similarity=-0.061 Sum_probs=85.7
Q ss_pred ChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCcee
Q psy1684 7 KRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGLCV 86 (189)
Q Consensus 7 ~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl~~ 86 (189)
.|+|++++++........|||+|++++ +++ .. ++.....+.......+..+.+.|+.+
T Consensus 54 ~hp~iv~~~~~~~~~~~~~lv~E~~~~-~~L----~~-----------------~~~~~~~l~~~~~~~i~~qi~~~l~~ 111 (329)
T cd05618 54 NHPFLVGLHSCFQTESRLFFVIEYVNG-GDL----MF-----------------HMQRQRKLPEEHARFYSAEISLALNY 111 (329)
T ss_pred CCCcCCceeeEEEeCCEEEEEEeCCCC-CCH----HH-----------------HHHHcCCCCHHHHHHHHHHHHHHHHH
Confidence 566676666655555556677776665 311 11 22222334445555566777888888
Q ss_pred eccCCcccccc-cc---------------cccc---------------------cC-CCCCccc-e-EEEec--------
Q psy1684 87 NLRKPCVQVSC-RI---------------YLVH---------------------GT-NLSGVVV-S-AVDFG-------- 118 (189)
Q Consensus 87 ~~~~~~~~~~~-p~---------------~l~~---------------------~~-~~~~~~~-s-VwsfG-------- 118 (189)
+|...++|+|+ |+ |+++ |. ....++. + |||||
T Consensus 112 lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~ 191 (329)
T cd05618 112 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 191 (329)
T ss_pred HHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhh
Confidence 99888889886 44 2222 11 3455788 9 99999
Q ss_pred ----CCC--------CChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH
Q psy1684 119 ----SGG--------MTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTF 165 (189)
Q Consensus 119 ----~~~--------~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~ 165 (189)
|.. ....+.+...........|..++.++.+|+.+||+.||++||+.
T Consensus 192 g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 192 GRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 211 01112222222233456788899999999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.9e-13 Score=100.55 Aligned_cols=104 Identities=15% Similarity=0.171 Sum_probs=78.0
Q ss_pred CcCHhHHHHHhhhccCCceeeccCCcccccc-cc------------------------------------cccccC-CCC
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI------------------------------------YLVHGT-NLS 108 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~------------------------------------~l~~~~-~~~ 108 (189)
.+....+..+..+.+.|+.++|..+++|+|+ |. +++++. ...
T Consensus 99 ~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~ 178 (258)
T cd08215 99 PFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNK 178 (258)
T ss_pred CcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcceecceeeeecccChhHhccC
Confidence 3446667777777888888888888888875 33 111111 234
Q ss_pred Cccc-e-EEEec------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 109 GVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 109 ~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
.++. + |||+| |...+..++...+..+...+.|..++.++.+++.+||..+|++|||+.++++
T Consensus 179 ~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 179 PYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 5778 8 99999 4455566677776666667778899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.3e-13 Score=105.07 Aligned_cols=103 Identities=14% Similarity=0.083 Sum_probs=71.0
Q ss_pred HhHHHHHhhhccCCceeeccCCcccccc-cc--------------------------------cccccC----CCCCccc
Q psy1684 70 YPELVEHYSKDADGLCVNLRKPCVQVSC-RI--------------------------------YLVHGT----NLSGVVV 112 (189)
Q Consensus 70 l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~--------------------------------~l~~~~----~~~~~~~ 112 (189)
..++..+..+.+.|+.++|...++|+|+ |. ++++|. ..+.++.
T Consensus 124 ~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 203 (317)
T cd06635 124 EVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGTPYWMAPEVILAMDEGQYDG 203 (317)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCcccccCCccccChhhhhcCCCCCCCc
Confidence 4445555666777788888888888775 33 222332 2345788
Q ss_pred -e-EEEec------------CCCCChHHHHHHHHcCCC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q psy1684 113 -S-AVDFG------------SGGMTNAEVLHQVEHGYR-MPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKL 172 (189)
Q Consensus 113 -s-VwsfG------------~~~~~~~~~~~~v~~g~~-~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l 172 (189)
+ ||||| |.+.........+..+.. ...+..+++.+.+|+.+||+.+|.+||++.+|++.+
T Consensus 204 ~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 204 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred cccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 8 99999 334444555555544433 333456889999999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.35 E-value=2.2e-13 Score=100.70 Aligned_cols=144 Identities=12% Similarity=0.100 Sum_probs=85.2
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCC-CCcCHhHHHHHhhhccCC
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGR-TTIHYPELVEHYSKDADG 83 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~-~~~~l~~li~~~~~~a~g 83 (189)
.++|+|++++++........++++|+...+. +.. ++... ..+....+.....+.+.|
T Consensus 56 ~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~-----l~~-----------------~~~~~~~~l~~~~~~~~~~ql~~~ 113 (262)
T cd06613 56 ECRHPNIVAYFGSYLRRDKLWIVMEYCGGGS-----LQD-----------------IYQVTRGPLSELQIAYVCRETLKG 113 (262)
T ss_pred hCCCCChhceEEEEEeCCEEEEEEeCCCCCc-----HHH-----------------HHHhhccCCCHHHHHHHHHHHHHH
Confidence 5677777777765555556677777665421 111 11111 223334444455555666
Q ss_pred ceeeccCCcccccc-cc------------------------------------cccccC-CCC---Cccc-e-EEEec--
Q psy1684 84 LCVNLRKPCVQVSC-RI------------------------------------YLVHGT-NLS---GVVV-S-AVDFG-- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~------------------------------------~l~~~~-~~~---~~~~-s-VwsfG-- 118 (189)
+.++|...++|+|+ |. ++++|. ... .++. + |||||
T Consensus 114 l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~ 193 (262)
T cd06613 114 LAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGIT 193 (262)
T ss_pred HHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHH
Confidence 66666666666664 22 222332 223 6888 9 99999
Q ss_pred ----------CCCCChHHHHHHHHcC-CCCC---CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 119 ----------SGGMTNAEVLHQVEHG-YRMP---CPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 119 ----------~~~~~~~~~~~~v~~g-~~~~---~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
|.+.+..+....+... ..++ .+...|.++.+++.+||..||.+|||+.+|+.
T Consensus 194 l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 194 AIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 4444544444444322 2222 23345788999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.35 E-value=2.2e-13 Score=103.43 Aligned_cols=104 Identities=13% Similarity=0.093 Sum_probs=70.3
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc--------------------------------cccccC----CCCCc
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI--------------------------------YLVHGT----NLSGV 110 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~--------------------------------~l~~~~----~~~~~ 110 (189)
+....+..+..+.+.|+.++|..+++|+|+ |. ++++|. ..+.+
T Consensus 112 l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 191 (308)
T cd06634 112 LQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMDEGQY 191 (308)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCcccccCCccccCHHHHhhcccCCC
Confidence 334445555566677788888888888775 33 122221 12457
Q ss_pred cc-e-EEEec------------CCCCChHHHHHHHHcCCCCCC-CCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 111 VV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMPC-PPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 111 ~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~~-p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
+. + ||||| |.+.+..+....+..+..+.. +..++..+.+||.+||+.+|.+||++.++++.
T Consensus 192 ~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred CcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 88 8 99999 334444445555555544433 45688999999999999999999999998865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.6e-13 Score=102.86 Aligned_cols=104 Identities=17% Similarity=0.200 Sum_probs=71.5
Q ss_pred CcCHhHHHHHhhhccCCceeeccCCcccccc-cc------------------------------------cccccC-CCC
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI------------------------------------YLVHGT-NLS 108 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~------------------------------------~l~~~~-~~~ 108 (189)
.+...++..+..+.+.|+.++|..+++|.|+ |. ++++|. ...
T Consensus 112 ~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~ 191 (286)
T cd06614 112 RMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRK 191 (286)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhccccCCcccCCHhHhcCC
Confidence 4445566667777788888888888888875 33 111221 234
Q ss_pred Cccc-e-EEEec------------CCCCChHHHHHHHHcCCCCC--CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 109 GVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMP--CPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 109 ~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~--~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
.++. + ||||| |.+.++......+..+..++ .+..+|.++.+++.+||+.+|.+||++.+|+.
T Consensus 192 ~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 192 DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred CCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 5788 9 99999 44444444444443333332 23348999999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.34 E-value=2.4e-13 Score=102.70 Aligned_cols=143 Identities=10% Similarity=0.036 Sum_probs=86.2
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.++|+|++.+++.+...+..++|+|+... +.+ .. ++. ...++..++.....+.+.++
T Consensus 72 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~~L----~~-----------------~~~-~~~l~~~~~~~i~~~l~~al 128 (296)
T cd06655 72 ELKNPNIVNFLDSFLVGDELFVVMEYLAG-GSL----TD-----------------VVT-ETCMDEAQIAAVCRECLQAL 128 (296)
T ss_pred hcCCCceeeeeeeEecCceEEEEEEecCC-CcH----HH-----------------HHH-hcCCCHHHHHHHHHHHHHHH
Confidence 45666666666655545556666666554 211 10 111 11233444444455555666
Q ss_pred eeeccCCcccccc-cc------------------------------------cccccC-CCCCccc-e-EEEec------
Q psy1684 85 CVNLRKPCVQVSC-RI------------------------------------YLVHGT-NLSGVVV-S-AVDFG------ 118 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~------------------------------------~l~~~~-~~~~~~~-s-VwsfG------ 118 (189)
.++|..+++|+|+ |. ++++|. ....++. + |||||
T Consensus 129 ~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~l 208 (296)
T cd06655 129 EFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEM 208 (296)
T ss_pred HHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHH
Confidence 7777777777664 33 122222 3345788 9 99999
Q ss_pred ------CCCCChHHHHHHHHcCC--CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 119 ------SGGMTNAEVLHQVEHGY--RMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 119 ------~~~~~~~~~~~~v~~g~--~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
|.+.+..+....+..+. .+..|..+++.+.++|.+||..||.+||++.+|+.
T Consensus 209 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 209 VEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred HhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 44444444444443332 23356778999999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.34 E-value=2.7e-13 Score=100.51 Aligned_cols=64 Identities=20% Similarity=0.250 Sum_probs=47.2
Q ss_pred CCCccc-e-EEEec------------CCCCChHHHHHHHHc--CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 107 LSGVVV-S-AVDFG------------SGGMTNAEVLHQVEH--GYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 107 ~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~--g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
...++. + ||||| |...+.......+.. +..++.|..++.++.+++.+||+.+|++||++.+++.
T Consensus 182 ~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 182 ESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 344678 8 99999 444443333333322 4445677889999999999999999999999998874
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=99.34 E-value=2.9e-13 Score=103.55 Aligned_cols=151 Identities=17% Similarity=0.225 Sum_probs=97.9
Q ss_pred CCChHHHHHHhcCCCCCCCc----EEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhc
Q psy1684 5 KIKRIEAEKKLLLPENDHGA----FLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKD 80 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~----fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~ 80 (189)
.|+|+|+..+++...+..|+ +||.+|.+.+. +.+ ||.. ..+.....+......
T Consensus 261 mLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GS-----L~D-----------------yL~r-~tv~~~~ml~LalS~ 317 (513)
T KOG2052|consen 261 MLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGS-----LYD-----------------YLNR-NTVTTEGMLKLALSI 317 (513)
T ss_pred HhccchhhhhhhccccCCCceEEEEEeeecccCCc-----HHH-----------------HHhh-ccCCHHHHHHHHHHH
Confidence 47899999999866665554 78999888843 222 3331 233344445444555
Q ss_pred cCCceeecc-------C-Ccccccccc-----------------------------------------cccccC-----C
Q psy1684 81 ADGLCVNLR-------K-PCVQVSCRI-----------------------------------------YLVHGT-----N 106 (189)
Q Consensus 81 a~gl~~~~~-------~-~~~~~~~p~-----------------------------------------~l~~~~-----~ 106 (189)
|.||+.+|. + .+.|||+.. .||||. .
T Consensus 318 AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin 397 (513)
T KOG2052|consen 318 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETIN 397 (513)
T ss_pred hhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcC
Confidence 556555553 1 245555443 444444 3
Q ss_pred CCCccc---e-EEEec----------------------CCCC-----ChHHHHHHH-HcCCCCCCCCC-----CCHHHHH
Q psy1684 107 LSGVVV---S-AVDFG----------------------SGGM-----TNAEVLHQV-EHGYRMPCPPG-----CPPRLYD 149 (189)
Q Consensus 107 ~~~~~~---s-VwsfG----------------------~~~~-----~~~~~~~~v-~~g~~~~~p~~-----~p~~~~~ 149 (189)
...|.. + ||||| |-++ +.+++.+.| .+..||++|.. +-..+.+
T Consensus 398 ~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~k 477 (513)
T KOG2052|consen 398 MKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAK 477 (513)
T ss_pred hhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHH
Confidence 334543 6 99999 3332 234454444 57788888863 2357789
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q psy1684 150 IMLECWLKDPVKRPTFETLQWKLEDFFTM 178 (189)
Q Consensus 150 l~~~C~~~~p~~RP~~~~i~~~l~~~~~~ 178 (189)
||+.||..||+.|-|+--|.+.|..+.++
T Consensus 478 lMkeCW~~Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 478 LMKECWYANPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred HHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence 99999999999999999999999988764
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.34 E-value=7.7e-13 Score=101.35 Aligned_cols=106 Identities=8% Similarity=-0.143 Sum_probs=73.8
Q ss_pred CCCcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------ccc---------------------ccC-C
Q psy1684 65 RTTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLV---------------------HGT-N 106 (189)
Q Consensus 65 ~~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~---------------------~~~-~ 106 (189)
...+....+..+..+.+.|+.++|..+++|+|+ |+ |++ +|. .
T Consensus 90 ~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~ 169 (330)
T cd05586 90 EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLL 169 (330)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHc
Confidence 344555666667778888999999999999986 44 222 221 1
Q ss_pred C-CCccc-e-EEEec------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC----HHH
Q psy1684 107 L-SGVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPT----FET 167 (189)
Q Consensus 107 ~-~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~----~~~ 167 (189)
. ..++. + |||+| |.+.+..++...+..+.........+.++.+++.+||..||++||+ +.+
T Consensus 170 ~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 249 (330)
T cd05586 170 DEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVE 249 (330)
T ss_pred CCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHH
Confidence 2 23788 9 99999 4445556677777665432223457899999999999999999995 555
Q ss_pred HHH
Q psy1684 168 LQW 170 (189)
Q Consensus 168 i~~ 170 (189)
+++
T Consensus 250 ll~ 252 (330)
T cd05586 250 LKE 252 (330)
T ss_pred Hhc
Confidence 544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.34 E-value=2.3e-13 Score=102.20 Aligned_cols=102 Identities=10% Similarity=0.060 Sum_probs=69.6
Q ss_pred CHhHHHHHhhhccCCceeeccCCcccccc-cc------------------------------------cccccC-CCCCc
Q psy1684 69 HYPELVEHYSKDADGLCVNLRKPCVQVSC-RI------------------------------------YLVHGT-NLSGV 110 (189)
Q Consensus 69 ~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~------------------------------------~l~~~~-~~~~~ 110 (189)
...++..+..+.+.++.++|...++|+|+ |. ++++|. ....+
T Consensus 113 ~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 192 (285)
T cd06648 113 NEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPY 192 (285)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccccCCccccCHHHhcCCCC
Confidence 34445556667777788888888888875 33 111111 23457
Q ss_pred cc-e-EEEec------------CCCCChHHHHHHHHcCCCCC--CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 111 VV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMP--CPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 111 ~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~--~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
+. + ||||| |.+.++.+....+..+..+. .+..+|..+.++|.+||+.||++|||+.++++
T Consensus 193 ~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 193 GTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 88 9 99999 34444555556665553222 23348899999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.34 E-value=4.2e-13 Score=100.74 Aligned_cols=143 Identities=13% Similarity=-0.046 Sum_probs=88.2
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccC--CCCCcCHhHHHHHhhhccC
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKA--GRTTIHYPELVEHYSKDAD 82 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~--~~~~~~l~~li~~~~~~a~ 82 (189)
.++|+|++.+++.+...+..++|+|++..+. + .. ++. ....+....+..+..+.+.
T Consensus 56 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~-L----~~-----------------~~~~~~~~~~~~~~~~~~~~qi~~ 113 (285)
T cd05605 56 KVNSRFVVSLAYAYETKDALCLVLTLMNGGD-L----KF-----------------HIYNMGNPGFDEERAVFYAAEITC 113 (285)
T ss_pred hcCCCCEeeeeeeecCCCeEEEEEeccCCCc-H----HH-----------------HHHhcCcCCCCHHHHHHHHHHHHH
Confidence 3456666666555555555666666665422 1 11 111 1123445556666677778
Q ss_pred CceeeccCCcccccc-cc---------------cc--------------------cccC-CCCCccc-e-EEEec-----
Q psy1684 83 GLCVNLRKPCVQVSC-RI---------------YL--------------------VHGT-NLSGVVV-S-AVDFG----- 118 (189)
Q Consensus 83 gl~~~~~~~~~~~~~-p~---------------~l--------------------~~~~-~~~~~~~-s-VwsfG----- 118 (189)
|+.++|...++|+|+ |. ++ ++|. ....++. + |||||
T Consensus 114 ~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~e 193 (285)
T cd05605 114 GLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYE 193 (285)
T ss_pred HHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHH
Confidence 888888888888875 33 11 1111 3355788 9 99999
Q ss_pred -------CCCCChHH----HHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q psy1684 119 -------SGGMTNAE----VLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRP-----TFETLQW 170 (189)
Q Consensus 119 -------~~~~~~~~----~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP-----~~~~i~~ 170 (189)
|.+.+... +...+.. .....|...+..+++|+.+||..||++|| +++++++
T Consensus 194 l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 194 MIEGKSPFRQRKEKVKREEVERRVKE-DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred HHHCCCCCCCCchhhHHHHHHHHhhh-cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 54443322 2233332 33455677899999999999999999999 7778754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.34 E-value=6.5e-13 Score=98.08 Aligned_cols=145 Identities=12% Similarity=0.055 Sum_probs=94.8
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.++|+|++++++........|+|++++.. +. +.. ++.....+.......+..+.+.|+
T Consensus 49 ~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~~----L~~-----------------~l~~~~~~~~~~~~~i~~qi~~~L 106 (265)
T cd05579 49 QAQSPYVVKLYYSFQGKKNLYLVMEYLPG-GD----LAS-----------------LLENVGSLDEDVARIYIAEIVLAL 106 (265)
T ss_pred hCCCcchhHHHHheecCcEEEEEEecCCC-Cc----HHH-----------------HHHHcCCCCHHHHHHHHHHHHHHH
Confidence 46789999988777666677888888775 31 111 121112233444555556666777
Q ss_pred eeeccCCccccccc-c--------------------------------------------cccccC-CCCCccc-e-EEE
Q psy1684 85 CVNLRKPCVQVSCR-I--------------------------------------------YLVHGT-NLSGVVV-S-AVD 116 (189)
Q Consensus 85 ~~~~~~~~~~~~~p-~--------------------------------------------~l~~~~-~~~~~~~-s-Vws 116 (189)
.++|...++|+|+. . +++++. ....++. + |||
T Consensus 107 ~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~s 186 (265)
T cd05579 107 EYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWS 186 (265)
T ss_pred HHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHH
Confidence 77777777777652 2 111111 2334677 8 999
Q ss_pred ec------------CCCCChHHHHHHHHcCCCCCCCCCC--CHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q psy1684 117 FG------------SGGMTNAEVLHQVEHGYRMPCPPGC--PPRLYDIMLECWLKDPVKRPTFETLQWKL 172 (189)
Q Consensus 117 fG------------~~~~~~~~~~~~v~~g~~~~~p~~~--p~~~~~l~~~C~~~~p~~RP~~~~i~~~l 172 (189)
|| |...+..++...+..+. .+.|..+ +.++.+++.+||+.+|++|||++++.+.|
T Consensus 187 lG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 187 LGCILYEFLVGIPPFHGETPEEIFQNILNGK-IEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-cCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 99 55556667766665543 4455555 99999999999999999999996655544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.34 E-value=4.9e-13 Score=99.50 Aligned_cols=144 Identities=12% Similarity=0.114 Sum_probs=83.9
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.++|+|++++++.+...+..++|.|+.+++. +.. ++.....+.......+..+.+.++
T Consensus 64 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~-----L~~-----------------~l~~~~~l~~~~~~~~~~qi~~~l 121 (272)
T cd06629 64 DLDHLNIVQYLGFETTEEYLSIFLEYVPGGS-----IGS-----------------CLRTYGRFEEQLVRFFTEQVLEGL 121 (272)
T ss_pred hcCCCCcceEEEEeccCCceEEEEecCCCCc-----HHH-----------------HHhhccCCCHHHHHHHHHHHHHHH
Confidence 4567777777766655566677777666522 111 122222233233333445566667
Q ss_pred eeeccCCcccccc-cc--------------------------------------cccccC-CC--CCccc-e-EEEec--
Q psy1684 85 CVNLRKPCVQVSC-RI--------------------------------------YLVHGT-NL--SGVVV-S-AVDFG-- 118 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~--------------------------------------~l~~~~-~~--~~~~~-s-VwsfG-- 118 (189)
.++|...++|+|+ |+ ++++|. .. ..++. + |||||
T Consensus 122 ~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~ 201 (272)
T cd06629 122 AYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCV 201 (272)
T ss_pred HHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHH
Confidence 7777777777664 22 122222 11 23788 8 99999
Q ss_pred ----------CCCCChHHHHHHH-HcCCCCCCCC----CCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 119 ----------SGGMTNAEVLHQV-EHGYRMPCPP----GCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 119 ----------~~~~~~~~~~~~v-~~g~~~~~p~----~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
|...+..+....+ ....+++.|. .++.++.+++.+||..+|++|||+.+|++
T Consensus 202 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 202 VLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred HHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 3333333323233 2233344443 46889999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=99.33 E-value=7.3e-14 Score=105.68 Aligned_cols=148 Identities=15% Similarity=0.113 Sum_probs=109.9
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhc
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKD 80 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~ 80 (189)
|....|+|+|+|.++.++...+..|||+|++.. |++.- |+.....++-.-...|..|.
T Consensus 61 ~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~g-GDLs~---------------------yi~~~~~l~e~t~r~Fm~QL 118 (429)
T KOG0595|consen 61 KILKELKHPNIVRLLDCIEDDDFIYLVMEYCNG-GDLSD---------------------YIRRRGRLPEATARHFMQQL 118 (429)
T ss_pred HHHHhcCCcceeeEEEEEecCCeEEEEEEeCCC-CCHHH---------------------HHHHcCCCCHHHHHHHHHHH
Confidence 345689999999999988888889999999997 43221 44444444433334466788
Q ss_pred cCCceeeccCCcccccc-cc-----------------------------------------cccccC-CCCCccc-e-EE
Q psy1684 81 ADGLCVNLRKPCVQVSC-RI-----------------------------------------YLVHGT-NLSGVVV-S-AV 115 (189)
Q Consensus 81 a~gl~~~~~~~~~~~~~-p~-----------------------------------------~l~~~~-~~~~~~~-s-Vw 115 (189)
|.|+.++|.+.|+|||+ |. .||+|+ ..++|+. + .|
T Consensus 119 A~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLW 198 (429)
T KOG0595|consen 119 ASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLW 198 (429)
T ss_pred HHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHH
Confidence 88999999999999985 54 222222 5788999 9 99
Q ss_pred Eec------------CCCCChHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 116 DFG------------SGGMTNAEVLHQVEHGYR--MPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 116 sfG------------~~~~~~~~~~~~v~~g~~--~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
|.| |...+..++...++.|.. +..|..+.....+|+..-+..||.+|-+|.+-..
T Consensus 199 SiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~ 267 (429)
T KOG0595|consen 199 SIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFD 267 (429)
T ss_pred HHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCchhhhhhHHHhcCccccCchHHhhh
Confidence 999 777788899888877643 4455667777778988889999999988876543
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.33 E-value=4.8e-13 Score=102.52 Aligned_cols=142 Identities=10% Similarity=-0.036 Sum_probs=87.8
Q ss_pred ChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCcee
Q psy1684 7 KRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGLCV 86 (189)
Q Consensus 7 ~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl~~ 86 (189)
.|+|++++.+.+......|||+|++++ |++ .. ++.....+.......+..+.+.|+.+
T Consensus 54 ~hp~Iv~~~~~~~~~~~~~lv~e~~~~-g~L----~~-----------------~~~~~~~l~~~~~~~~~~qi~~~l~~ 111 (329)
T cd05588 54 NHPFLVGLHSCFQTESRLFFVIEFVSG-GDL----MF-----------------HMQRQRKLPEEHARFYSAEISLALNF 111 (329)
T ss_pred CCCCCCceEEEEEcCCEEEEEEeCCCC-CCH----HH-----------------HHHHcCCCCHHHHHHHHHHHHHHHHH
Confidence 355666655544444455666666554 211 00 22223344555566677788888999
Q ss_pred eccCCcccccc-cc---------------cccc---------------------cC-CCCCccc-e-EEEec--------
Q psy1684 87 NLRKPCVQVSC-RI---------------YLVH---------------------GT-NLSGVVV-S-AVDFG-------- 118 (189)
Q Consensus 87 ~~~~~~~~~~~-p~---------------~l~~---------------------~~-~~~~~~~-s-VwsfG-------- 118 (189)
+|..+++|+|+ |+ |+++ |. ....++. + |||||
T Consensus 112 lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~ 191 (329)
T cd05588 112 LHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 191 (329)
T ss_pred HHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHH
Confidence 99999999885 44 2222 11 3456888 9 99999
Q ss_pred ----CCC--------CChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC------HHHHHH
Q psy1684 119 ----SGG--------MTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPT------FETLQW 170 (189)
Q Consensus 119 ----~~~--------~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~------~~~i~~ 170 (189)
|.. ....+.............|..++.++.+++.+|++.||.+||+ +.++++
T Consensus 192 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 192 GRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 321 1112222222223345677889999999999999999999998 566653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=99.33 E-value=9.5e-14 Score=117.63 Aligned_cols=146 Identities=12% Similarity=0.040 Sum_probs=107.1
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..|.|+|+|+.+|+..+.+-.+|.+|++.. | ++.. ...|-++. ...-.--|+.+...|
T Consensus 1289 E~lnHpNlV~YyGVEvHRekv~IFMEyC~~-G----sLa~----ll~~gri~-------------dE~vt~vyt~qll~g 1346 (1509)
T KOG4645|consen 1289 EGLNHPNLVRYYGVEVHREKVYIFMEYCEG-G----SLAS----LLEHGRIE-------------DEMVTRVYTKQLLEG 1346 (1509)
T ss_pred HhccCccccccCceeecHHHHHHHHHHhcc-C----cHHH----HHHhcchh-------------hhhHHHHHHHHHHHH
Confidence 468999999999999988999999999997 4 2222 11111110 011112356677788
Q ss_pred ceeeccCCcccccc-cc----------------------------------------cccccC---C--CCCccce-EEE
Q psy1684 84 LCVNLRKPCVQVSC-RI----------------------------------------YLVHGT---N--LSGVVVS-AVD 116 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~----------------------------------------~l~~~~---~--~~~~~~s-Vws 116 (189)
++++|..+|+|||+ |+ .||+|. . .++...+ |||
T Consensus 1347 la~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWs 1426 (1509)
T KOG4645|consen 1347 LAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWS 1426 (1509)
T ss_pred HHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhc
Confidence 99999999999985 55 333433 1 2223335 999
Q ss_pred ec------------CCCCC-hHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 117 FG------------SGGMT-NAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 117 fG------------~~~~~-~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
+| |..++ .-+|+..|..|..|++|...+.+-.+++.+|+..||+.|.+..||++.
T Consensus 1427 lGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1427 LGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 99 55554 468999999999999999999999999999999999999998877653
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.33 E-value=6e-13 Score=101.59 Aligned_cols=139 Identities=9% Similarity=-0.029 Sum_probs=91.5
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.+.|+|+++++......+..+||+|++.++. + .. ++.....+.......+..+++.|+
T Consensus 52 ~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~-L----~~-----------------~l~~~~~~~~~~~~~~~~qi~~~L 109 (321)
T cd05603 52 NLKHPFLVGLHYSFQTAEKLYFVLDYVNGGE-L----FF-----------------HLQRERCFLEPRARFYAAEVASAI 109 (321)
T ss_pred hCCCCCccceeeEEEcCCEEEEEEcCCCCCC-H----HH-----------------HHHHcCCCCHHHHHHHHHHHHHHH
Confidence 4567777776655555556677777766522 1 01 122222333444455666777888
Q ss_pred eeeccCCcccccc-cc---------------cccc---------------------cC-CCCCccc-e-EEEec------
Q psy1684 85 CVNLRKPCVQVSC-RI---------------YLVH---------------------GT-NLSGVVV-S-AVDFG------ 118 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~---------------~l~~---------------------~~-~~~~~~~-s-VwsfG------ 118 (189)
.++|..+++|+|+ |+ |++. |. ....++. + |||||
T Consensus 110 ~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 189 (321)
T cd05603 110 GYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEM 189 (321)
T ss_pred HHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhh
Confidence 8888888888886 44 2222 11 3456888 9 99999
Q ss_pred ------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH
Q psy1684 119 ------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFE 166 (189)
Q Consensus 119 ------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~ 166 (189)
|.+.+..++...+..+ ....|...+.++.+++.+|++.||.+||+..
T Consensus 190 ~~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 190 LYGLPPFYSRDVSQMYDNILHK-PLQLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred hcCCCCCCCCCHHHHHHHHhcC-CCCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 5555556666666554 3566778899999999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.32 E-value=2e-13 Score=103.07 Aligned_cols=103 Identities=11% Similarity=0.033 Sum_probs=69.7
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cc---------------------cccC-CCCC
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YL---------------------VHGT-NLSG 109 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l---------------------~~~~-~~~~ 109 (189)
+...++..+..+.+.|+.++|..+++|+|+ |. ++ ++|. ....
T Consensus 113 ~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 192 (296)
T cd06654 113 MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 192 (296)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccCcccCCccccCHHHHcCCC
Confidence 345566666777788888888888888886 33 11 1111 2344
Q ss_pred ccc-e-EEEec------------CCCCChHHHHHHH-HcCC-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 110 VVV-S-AVDFG------------SGGMTNAEVLHQV-EHGY-RMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 110 ~~~-s-VwsfG------------~~~~~~~~~~~~v-~~g~-~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
++. + ||||| |.+.++......+ ..+. ..+.|...+..+.+++.+||..||++||++.+|++
T Consensus 193 ~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 778 8 99999 4344343332233 2222 22345678899999999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.32 E-value=4e-13 Score=101.80 Aligned_cols=67 Identities=16% Similarity=0.019 Sum_probs=50.2
Q ss_pred CCCccc-e-EEEec------------CCCCChHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 107 LSGVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYR--MPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 107 ~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~--~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
...++. + ||||| |.+.++.++...+..+.. +..+..+|.++.+|+.+||+.||++||++.++.+
T Consensus 190 ~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ 269 (305)
T cd05609 190 RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFE 269 (305)
T ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHH
Confidence 345788 8 99999 556677777777655532 2233468999999999999999999999766665
Q ss_pred HHH
Q psy1684 171 KLE 173 (189)
Q Consensus 171 ~l~ 173 (189)
.|+
T Consensus 270 ll~ 272 (305)
T cd05609 270 VKQ 272 (305)
T ss_pred HHh
Confidence 554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.8e-13 Score=104.88 Aligned_cols=30 Identities=23% Similarity=0.244 Sum_probs=27.3
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 142 GCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 142 ~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
.+++++.+++.+||+.||++|||++++++.
T Consensus 261 ~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 261 NADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred CCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 467889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.7e-13 Score=102.54 Aligned_cols=102 Identities=10% Similarity=-0.103 Sum_probs=68.6
Q ss_pred CHhHHHHHhhhccCCceeeccCCcccccc-cc---------------ccc--------------------ccC-CCCCcc
Q psy1684 69 HYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLV--------------------HGT-NLSGVV 111 (189)
Q Consensus 69 ~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~--------------------~~~-~~~~~~ 111 (189)
....++.+..+.+.|+.++|..+++|+|+ |. +++ +|. ....++
T Consensus 93 ~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 172 (277)
T cd05607 93 EMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYS 172 (277)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCCccCHHHHccCCCC
Confidence 35556667777888899999999999886 44 111 111 334578
Q ss_pred c-e-EEEec------------CCCCC----hHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 112 V-S-AVDFG------------SGGMT----NAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 112 ~-s-VwsfG------------~~~~~----~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
. + |||+| |.+.. ..++......+.........+.++.+|+..||+.||.+||+++|+++
T Consensus 173 ~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 173 YPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred CchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence 8 9 99999 33321 23343333333322223468899999999999999999999977653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.32 E-value=5.4e-13 Score=98.62 Aligned_cols=105 Identities=19% Similarity=0.196 Sum_probs=73.3
Q ss_pred CcCHhHHHHHhhhccCCceeecc-CCcccccc-cc------------------------------------cccccC-CC
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLR-KPCVQVSC-RI------------------------------------YLVHGT-NL 107 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~-~~~~~~~~-p~------------------------------------~l~~~~-~~ 107 (189)
.+.......+..+.+.++.++|. ..++|+++ |. ++++|. ..
T Consensus 95 ~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~ 174 (264)
T cd06623 95 KIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQG 174 (264)
T ss_pred CCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcccceeecccccCHhhhCC
Confidence 34455555666677778888888 78888775 33 111211 23
Q ss_pred CCccc-e-EEEec------------CCCC---ChHHHHHHHHcCCCCCCCCC-CCHHHHHHHHHhcccCCCCCCCHHHHH
Q psy1684 108 SGVVV-S-AVDFG------------SGGM---TNAEVLHQVEHGYRMPCPPG-CPPRLYDIMLECWLKDPVKRPTFETLQ 169 (189)
Q Consensus 108 ~~~~~-s-VwsfG------------~~~~---~~~~~~~~v~~g~~~~~p~~-~p~~~~~l~~~C~~~~p~~RP~~~~i~ 169 (189)
..++. + ||||| |... ...++...+..+..+..+.. +|..+.+++.+||..+|++||++.+++
T Consensus 175 ~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll 254 (264)
T cd06623 175 ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELL 254 (264)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 45678 8 99999 3333 33455556666656666677 899999999999999999999999998
Q ss_pred HH
Q psy1684 170 WK 171 (189)
Q Consensus 170 ~~ 171 (189)
+.
T Consensus 255 ~~ 256 (264)
T cd06623 255 QH 256 (264)
T ss_pred hC
Confidence 74
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.32 E-value=6.2e-13 Score=100.27 Aligned_cols=145 Identities=12% Similarity=0.005 Sum_probs=93.5
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCC-CcCHhHHHHHhhhccC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRT-TIHYPELVEHYSKDAD 82 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~-~~~l~~li~~~~~~a~ 82 (189)
..++|+|++++++.+...+..++|+|++ . ++ +.. ++.... .+...++..+..+++.
T Consensus 57 ~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~-~~----L~~-----------------~i~~~~~~~~~~~~~~~~~qi~~ 113 (298)
T cd07841 57 QELKHPNIIGLLDVFGHKSNINLVFEFM-E-TD----LEK-----------------VIKDKSIVLTPADIKSYMLMTLR 113 (298)
T ss_pred hhcCCCCChhhhheeecCCEEEEEEccc-C-CC----HHH-----------------HHhccCCCCCHHHHHHHHHHHHH
Confidence 4577889999888777777788899887 3 32 111 222222 3446666777788888
Q ss_pred CceeeccCCcccccc-cc---------------c---------------------ccccC--CCCCccc-e-EEEec---
Q psy1684 83 GLCVNLRKPCVQVSC-RI---------------Y---------------------LVHGT--NLSGVVV-S-AVDFG--- 118 (189)
Q Consensus 83 gl~~~~~~~~~~~~~-p~---------------~---------------------l~~~~--~~~~~~~-s-VwsfG--- 118 (189)
++.++|...++|+|+ |. + +++|. ....++. + |||||
T Consensus 114 al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il 193 (298)
T cd07841 114 GLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIF 193 (298)
T ss_pred HHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHH
Confidence 888999888888875 43 1 11111 1234678 8 99999
Q ss_pred ---------CCCCChHHHHHHHHcCC----------------------CCCC-----CCCCCHHHHHHHHHhcccCCCCC
Q psy1684 119 ---------SGGMTNAEVLHQVEHGY----------------------RMPC-----PPGCPPRLYDIMLECWLKDPVKR 162 (189)
Q Consensus 119 ---------~~~~~~~~~~~~v~~g~----------------------~~~~-----p~~~p~~~~~l~~~C~~~~p~~R 162 (189)
|.+.+..+.+..+.... ..+. ....+.++.+++.+||+.||++|
T Consensus 194 ~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 273 (298)
T cd07841 194 AELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKR 273 (298)
T ss_pred HHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccC
Confidence 33333333333331110 0011 13456889999999999999999
Q ss_pred CCHHHHHHH
Q psy1684 163 PTFETLQWK 171 (189)
Q Consensus 163 P~~~~i~~~ 171 (189)
||+++++..
T Consensus 274 ~s~~e~l~~ 282 (298)
T cd07841 274 ITARQALEH 282 (298)
T ss_pred cCHHHHhhC
Confidence 999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.31 E-value=5e-13 Score=100.20 Aligned_cols=67 Identities=27% Similarity=0.292 Sum_probs=45.9
Q ss_pred CCCCccc-e-EEEec------------CCCCCh--------H---HHHHHHHcCCCCCCCCC-CCHHHHHHHHHhcccCC
Q psy1684 106 NLSGVVV-S-AVDFG------------SGGMTN--------A---EVLHQVEHGYRMPCPPG-CPPRLYDIMLECWLKDP 159 (189)
Q Consensus 106 ~~~~~~~-s-VwsfG------------~~~~~~--------~---~~~~~v~~g~~~~~p~~-~p~~~~~l~~~C~~~~p 159 (189)
....++. + ||||| |..... . +....+.....+..+.. +|.++.+|+.+||+.||
T Consensus 175 ~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp 254 (284)
T cd06620 175 QGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDP 254 (284)
T ss_pred ccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCc
Confidence 3456788 8 99999 332221 1 22233333333334433 88999999999999999
Q ss_pred CCCCCHHHHHHHH
Q psy1684 160 VKRPTFETLQWKL 172 (189)
Q Consensus 160 ~~RP~~~~i~~~l 172 (189)
++|||+.++++..
T Consensus 255 ~~Rpt~~e~~~~~ 267 (284)
T cd06620 255 TERPTPQQLCAMP 267 (284)
T ss_pred ccCcCHHHHhcCc
Confidence 9999999999763
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.31 E-value=4.9e-13 Score=99.43 Aligned_cols=103 Identities=13% Similarity=0.049 Sum_probs=67.7
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cc---------------------cccCC----
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YL---------------------VHGTN---- 106 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l---------------------~~~~~---- 106 (189)
+.......+..+.+.|+.++|..+++|+|+ |. ++ ++|..
T Consensus 108 l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 187 (272)
T cd06637 108 LKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDE 187 (272)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceecccccccCCcccccccccCHhHhcccc
Confidence 333444555667777888888888888765 33 12 22211
Q ss_pred --CCCccc-e-EEEec------------CCCCChHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q psy1684 107 --LSGVVV-S-AVDFG------------SGGMTNAEVLHQVE-HGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQ 169 (189)
Q Consensus 107 --~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~-~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~ 169 (189)
...++. + ||||| |.+.+.......+. ...+...+..++.++.+|+.+||..||++|||+.+|+
T Consensus 188 ~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il 267 (272)
T cd06637 188 NPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLM 267 (272)
T ss_pred CcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 335888 9 99999 33333333333332 2333334567899999999999999999999999987
Q ss_pred H
Q psy1684 170 W 170 (189)
Q Consensus 170 ~ 170 (189)
+
T Consensus 268 ~ 268 (272)
T cd06637 268 K 268 (272)
T ss_pred h
Confidence 5
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.31 E-value=4.3e-13 Score=100.04 Aligned_cols=103 Identities=10% Similarity=0.029 Sum_probs=68.0
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc------------------------------------cccccC-C-CC
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI------------------------------------YLVHGT-N-LS 108 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~------------------------------------~l~~~~-~-~~ 108 (189)
+....+.....+.+.|+.++|..+++|+|+ |. ++++|. . ..
T Consensus 98 l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 177 (277)
T cd06917 98 IAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGK 177 (277)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccccccccCCcceeCHHHhccCC
Confidence 334445556667777888888888888875 33 122222 1 23
Q ss_pred Cccc-e-EEEec------------CCCCChHHHHHHHHcCCCCCCCC-CCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 109 GVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMPCPP-GCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 109 ~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~~p~-~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
.++. + ||||| |.+.+.......+.....+..+. ..+.++.++|.+||..||++||++.++++
T Consensus 178 ~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 178 YYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred ccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 3678 8 99999 44444444333333333333344 37889999999999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.30 E-value=5e-13 Score=98.80 Aligned_cols=103 Identities=16% Similarity=0.003 Sum_probs=70.1
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------c-----------------ccccC-CCCCccc-
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------Y-----------------LVHGT-NLSGVVV- 112 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~-----------------l~~~~-~~~~~~~- 112 (189)
+.......+..+.+.|+.++|..+++|+|+ |. + +++|. ....++.
T Consensus 94 ~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~ 173 (260)
T cd05611 94 LPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPDYLAPETILGVGDDKM 173 (260)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccccccCCCCcCccChhhhcCCCCcch
Confidence 334555566677778888888888888875 33 1 11221 2334688
Q ss_pred e-EEEec------------CCCCChHHHHHHHHcCCC---CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 113 S-AVDFG------------SGGMTNAEVLHQVEHGYR---MPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 113 s-VwsfG------------~~~~~~~~~~~~v~~g~~---~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
+ ||||| |.+.+..++...+..+.. ...+..+|+++.+++.+||+.||++||++.++.+
T Consensus 174 ~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~ 247 (260)
T cd05611 174 SDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQE 247 (260)
T ss_pred hhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence 9 99999 555566666666644422 2234468999999999999999999997755443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.30 E-value=8.1e-13 Score=100.96 Aligned_cols=100 Identities=16% Similarity=0.040 Sum_probs=76.2
Q ss_pred CCCcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cccc---------------------cC-C
Q psy1684 65 RTTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVH---------------------GT-N 106 (189)
Q Consensus 65 ~~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~---------------------~~-~ 106 (189)
...+....+..+..+.+.|+.++|..+++|+|+ |+ |++. |. .
T Consensus 95 ~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 174 (323)
T cd05616 95 VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIA 174 (323)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhc
Confidence 334555666777788888999999999999986 44 2222 11 4
Q ss_pred CCCccc-e-EEEec------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH
Q psy1684 107 LSGVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTF 165 (189)
Q Consensus 107 ~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~ 165 (189)
...++. + ||||| |.+.+..++...+..+. ...|...+.++.+|+.+|++.||++|++.
T Consensus 175 ~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 175 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 456888 9 99999 66667777777776543 45677899999999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.30 E-value=3.4e-12 Score=98.41 Aligned_cols=144 Identities=12% Similarity=0.034 Sum_probs=93.1
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.+.|+|+++++......+..++|+|++..+. +.. ++.....+.......+..+.+.|+
T Consensus 57 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~-----L~~-----------------~l~~~~~l~~~~~~~i~~qi~~aL 114 (350)
T cd05573 57 DADSPWIVKLYYSFQDEEHLYLVMEYMPGGD-----LMN-----------------LLIRKDVFPEETARFYIAELVLAL 114 (350)
T ss_pred hcCCCCccchhhheecCCeEEEEEcCCCCCC-----HHH-----------------HHHHcCCCCHHHHHHHHHHHHHHH
Confidence 4567777777766655566777777776522 111 222222334444455566777788
Q ss_pred eeeccCCcccccc-cc---------------cccc---------------------------------------------
Q psy1684 85 CVNLRKPCVQVSC-RI---------------YLVH--------------------------------------------- 103 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~---------------~l~~--------------------------------------------- 103 (189)
.++|..+++|+|+ |+ +++.
T Consensus 115 ~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 194 (350)
T cd05573 115 DSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTP 194 (350)
T ss_pred HHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCc
Confidence 8888888888875 44 2211
Q ss_pred -----cC-CCCCccc-e-EEEec------------CCCCChHHHHHHHHc---CCCCCCCCCCCHHHHHHHHHhcccCCC
Q psy1684 104 -----GT-NLSGVVV-S-AVDFG------------SGGMTNAEVLHQVEH---GYRMPCPPGCPPRLYDIMLECWLKDPV 160 (189)
Q Consensus 104 -----~~-~~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~---g~~~~~p~~~p~~~~~l~~~C~~~~p~ 160 (189)
|. ....++. + ||||| |.+.+..+....+.. ....+....+|+++.+|+.+|+. ||.
T Consensus 195 ~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~ 273 (350)
T cd05573 195 DYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPE 273 (350)
T ss_pred cccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-Chh
Confidence 11 2345788 9 99999 555555566555543 22333334469999999999997 999
Q ss_pred CCCC-HHHHHHH
Q psy1684 161 KRPT-FETLQWK 171 (189)
Q Consensus 161 ~RP~-~~~i~~~ 171 (189)
+||+ ++++++.
T Consensus 274 ~R~~s~~~ll~h 285 (350)
T cd05573 274 DRLGSFEEIKSH 285 (350)
T ss_pred hcCCCHHHHhcC
Confidence 9999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.30 E-value=5.3e-13 Score=100.64 Aligned_cols=145 Identities=9% Similarity=-0.017 Sum_probs=87.2
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..+.|+|++++.+.+...+..++|+|+..++. +.. ++. ...+...++.....+.+.|
T Consensus 71 ~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~-----L~~-----------------~~~-~~~l~~~~~~~i~~~l~~a 127 (293)
T cd06647 71 RENKHPNIVNYLDSYLVGDELWVVMEYLAGGS-----LTD-----------------VVT-ETCMDEGQIAAVCRECLQA 127 (293)
T ss_pred hhcCCCCeeehhheeeeCCcEEEEEecCCCCc-----HHH-----------------HHh-hcCCCHHHHHHHHHHHHHH
Confidence 35667777777776655666777777766522 111 111 1122233444445555666
Q ss_pred ceeeccCCccccccc-c------------------------------------cccccC-CCCCccc-e-EEEec-----
Q psy1684 84 LCVNLRKPCVQVSCR-I------------------------------------YLVHGT-NLSGVVV-S-AVDFG----- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~p-~------------------------------------~l~~~~-~~~~~~~-s-VwsfG----- 118 (189)
+.++|..+++|+|+. . ++++|. ..+.++. + |||||
T Consensus 128 l~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ 207 (293)
T cd06647 128 LEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIE 207 (293)
T ss_pred HHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHH
Confidence 777777777776642 2 122222 3355788 9 99999
Q ss_pred -------CCCCChHHHHHHHHcCCCCC--CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 119 -------SGGMTNAEVLHQVEHGYRMP--CPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 119 -------~~~~~~~~~~~~v~~g~~~~--~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
|.+.+..+....+..+..+. .+...+..+.+++.+||..+|.+||+|.+++..
T Consensus 208 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 208 MVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred HHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 44443333322232222222 344577899999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.29 E-value=4e-13 Score=102.01 Aligned_cols=30 Identities=20% Similarity=0.390 Sum_probs=27.4
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 142 GCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 142 ~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
.++.++.+|+.+||..||++|||+++|++.
T Consensus 258 ~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 258 AFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 367889999999999999999999999876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.29 E-value=5.3e-13 Score=100.19 Aligned_cols=103 Identities=14% Similarity=-0.038 Sum_probs=71.6
Q ss_pred CcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------ccc--------------------ccC-CCCC
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLV--------------------HGT-NLSG 109 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~--------------------~~~-~~~~ 109 (189)
.+.......+..+.+.|+.++|..+++|+|+ |+ |++ +|. ....
T Consensus 98 ~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 177 (285)
T cd05631 98 GFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEK 177 (285)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcCCC
Confidence 3445556667778888999999999999986 44 222 111 3456
Q ss_pred ccc-e-EEEec------------CCCCCh----HHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HH
Q psy1684 110 VVV-S-AVDFG------------SGGMTN----AEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPT-----FE 166 (189)
Q Consensus 110 ~~~-s-VwsfG------------~~~~~~----~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~-----~~ 166 (189)
++. + ||||| |.+.+. .++...+.. ...+.|...+.++.+|+.+||+.||++||+ ++
T Consensus 178 ~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~ 256 (285)
T cd05631 178 YTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKE-DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAA 256 (285)
T ss_pred CCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhc-ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHH
Confidence 888 9 99999 333322 222222322 234566788999999999999999999997 77
Q ss_pred HHHH
Q psy1684 167 TLQW 170 (189)
Q Consensus 167 ~i~~ 170 (189)
++++
T Consensus 257 ~~~~ 260 (285)
T cd05631 257 GVKQ 260 (285)
T ss_pred HHhc
Confidence 7776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.29 E-value=9.6e-13 Score=98.55 Aligned_cols=145 Identities=11% Similarity=0.066 Sum_probs=89.0
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..++|+|++++++.+......++|+|++.. +.+ .. +......+..........+++.|
T Consensus 55 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~~l----~~-----------------~~~~~~~~~~~~~~~~~~~i~~~ 112 (286)
T cd07846 55 KQLRHENLVNLIEVFRRKKRLYLVFEFVDH-TVL----DD-----------------LEKYPNGLDESRVRKYLFQILRG 112 (286)
T ss_pred HhcCCcchhhHHHhcccCCeEEEEEecCCc-cHH----HH-----------------HHhccCCCCHHHHHHHHHHHHHH
Confidence 357789999999888777778999998775 211 01 01111123355555566677777
Q ss_pred ceeeccCCcccccc-cc---------------c---------------------ccccCC--CCCccc-e-EEEec----
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------Y---------------------LVHGTN--LSGVVV-S-AVDFG---- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~---------------------l~~~~~--~~~~~~-s-VwsfG---- 118 (189)
+.++|..+++|+|+ |. + +++|.. ...++. + |||||
T Consensus 113 l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~ 192 (286)
T cd07846 113 IEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVT 192 (286)
T ss_pred HHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHH
Confidence 77788777777765 33 1 122211 234678 8 99999
Q ss_pred --------CCCCChHHHHHHHH--------------------cCCCCC----------CCCCCCHHHHHHHHHhcccCCC
Q psy1684 119 --------SGGMTNAEVLHQVE--------------------HGYRMP----------CPPGCPPRLYDIMLECWLKDPV 160 (189)
Q Consensus 119 --------~~~~~~~~~~~~v~--------------------~g~~~~----------~p~~~p~~~~~l~~~C~~~~p~ 160 (189)
|.+.+..+....+. .+...+ .++.++..+.+++.+||..||+
T Consensus 193 el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 272 (286)
T cd07846 193 EMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPD 272 (286)
T ss_pred HHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcc
Confidence 33322222211111 010000 1236788999999999999999
Q ss_pred CCCCHHHHHH
Q psy1684 161 KRPTFETLQW 170 (189)
Q Consensus 161 ~RP~~~~i~~ 170 (189)
+||++++|++
T Consensus 273 ~Rp~~~~il~ 282 (286)
T cd07846 273 DRPSSSQLLH 282 (286)
T ss_pred cchhHHHHhc
Confidence 9999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.29 E-value=5.7e-13 Score=98.89 Aligned_cols=104 Identities=14% Similarity=0.125 Sum_probs=65.1
Q ss_pred CcCHhHHHHHhhhccCCceeeccCCcccccc-cc------------------------------------cccccC----
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI------------------------------------YLVHGT---- 105 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~------------------------------------~l~~~~---- 105 (189)
.+....+.....+.+.|+.++|..+++|+|+ |. ++++|.
T Consensus 102 ~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 181 (267)
T cd06645 102 PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVE 181 (267)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccccccCcccccChhhhccc
Confidence 3445555556666677777777777777764 33 122222
Q ss_pred CCCCccc-e-EEEec------------CCCCChHHHHHHHH-cCCCCCC---CCCCCHHHHHHHHHhcccCCCCCCCHHH
Q psy1684 106 NLSGVVV-S-AVDFG------------SGGMTNAEVLHQVE-HGYRMPC---PPGCPPRLYDIMLECWLKDPVKRPTFET 167 (189)
Q Consensus 106 ~~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~-~g~~~~~---p~~~p~~~~~l~~~C~~~~p~~RP~~~~ 167 (189)
..+.++. + ||||| |....+........ ....++. ...+|..+.+++.+||+.||++|||+.+
T Consensus 182 ~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ 261 (267)
T cd06645 182 RKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEK 261 (267)
T ss_pred cCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHH
Confidence 1345788 9 99999 22222323322222 2222221 1257789999999999999999999998
Q ss_pred HHH
Q psy1684 168 LQW 170 (189)
Q Consensus 168 i~~ 170 (189)
|++
T Consensus 262 ll~ 264 (267)
T cd06645 262 LLQ 264 (267)
T ss_pred Hhc
Confidence 875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.29 E-value=7.8e-13 Score=99.48 Aligned_cols=143 Identities=12% Similarity=0.010 Sum_probs=92.3
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.+.|+|++++++........++|+|+.+.+. +.. ++.....+....+..+..+.+.|+
T Consensus 57 ~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~-----L~~-----------------~~~~~~~l~~~~~~~~~~qil~~l 114 (290)
T cd05580 57 SIRHPFLVNLYGSFQDDSNLYLVMEYVPGGE-----LFS-----------------HLRKSGRFPEPVARFYAAQVVLAL 114 (290)
T ss_pred hCCCCCccceeeEEEcCCeEEEEEecCCCCC-----HHH-----------------HHHHcCCCCHHHHHHHHHHHHHHH
Confidence 4567777777666555556677777765422 111 232233344444555566777788
Q ss_pred eeeccCCcccccc-cc---------------------------------cccccC-CCCCccc-e-EEEec---------
Q psy1684 85 CVNLRKPCVQVSC-RI---------------------------------YLVHGT-NLSGVVV-S-AVDFG--------- 118 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~---------------------------------~l~~~~-~~~~~~~-s-VwsfG--------- 118 (189)
.++|..+++|+|+ |. ++++|. ....++. + |||||
T Consensus 115 ~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 194 (290)
T cd05580 115 EYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194 (290)
T ss_pred HHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCCCCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhC
Confidence 8888888888875 33 112221 2345678 8 99999
Q ss_pred ---CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q psy1684 119 ---SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRP-----TFETLQW 170 (189)
Q Consensus 119 ---~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP-----~~~~i~~ 170 (189)
|.+.+..++...+..+ .++.|...+..+++++.+||..||++|| +.+++++
T Consensus 195 ~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 195 YPPFFDDNPIQIYEKILEG-KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred CCCCCCCCHHHHHHHHhcC-CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 4444555555555544 4567788899999999999999999999 6666653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.8e-12 Score=99.27 Aligned_cols=142 Identities=9% Similarity=-0.027 Sum_probs=87.6
Q ss_pred CChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCC-CCcCHhHHHHHhhhccCCc
Q psy1684 6 IKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGR-TTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 6 l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~-~~~~l~~li~~~~~~a~gl 84 (189)
+.|+|+++++......+..+||+|+++++. + .. ++... ..+....+..+..+.+.|+
T Consensus 58 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~-L----~~-----------------~l~~~~~~l~~~~~~~~~~qi~~aL 115 (330)
T cd05601 58 SNSPWIPQLQYAFQDKDNLYLVMEYQPGGD-L----LS-----------------LLNRYEDQFDEDMAQFYLAELVLAI 115 (330)
T ss_pred CCCCCCcceeeEEecCCeEEEEECCCCCCC-H----HH-----------------HHHHhcCCCCHHHHHHHHHHHHHHH
Confidence 455666665554444445566666665421 1 11 22211 2333444444556777788
Q ss_pred eeeccCCcccccc-cc---------------ccc----------------------ccCC-------CCCccc-e-EEEe
Q psy1684 85 CVNLRKPCVQVSC-RI---------------YLV----------------------HGTN-------LSGVVV-S-AVDF 117 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~---------------~l~----------------------~~~~-------~~~~~~-s-Vwsf 117 (189)
.++|..+++|+|+ |+ |++ +|.. ...++. + ||||
T Consensus 116 ~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Diwsl 195 (330)
T cd05601 116 HSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSL 195 (330)
T ss_pred HHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecc
Confidence 8888888888885 44 222 1111 345778 9 9999
Q ss_pred c------------CCCCChHHHHHHHHcCCC-C--CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 118 G------------SGGMTNAEVLHQVEHGYR-M--PCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 118 G------------~~~~~~~~~~~~v~~g~~-~--~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
| |.+.+..+....+....+ + +.+...+.++.+|+..|+. ||++|||+.+++.
T Consensus 196 G~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 196 GVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred cceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 9 445555566666654332 2 2234578999999999997 9999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.28 E-value=1e-12 Score=97.45 Aligned_cols=145 Identities=11% Similarity=0.083 Sum_probs=91.3
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..++|+|++++++.+...+..++|.++... +. +.. ++.....+....+..+..+.+.|
T Consensus 58 ~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~-~~----L~~-----------------~l~~~~~~~~~~~~~~~~ql~~a 115 (268)
T cd06630 58 ARLNHPHIIRMLGATCEDSHFNLFVEWMAG-GS----VSH-----------------LLSKYGAFKEAVIINYTEQLLRG 115 (268)
T ss_pred HHcCCCceehhhceeccCCeEEEEEeccCC-Cc----HHH-----------------HHHHhCCCCHHHHHHHHHHHHHH
Confidence 356788888888877666677888887765 31 111 11112223344455555666677
Q ss_pred ceeeccCCcccccc-cc-----------------------------------------cccccC-CCCCccc-e-EEEec
Q psy1684 84 LCVNLRKPCVQVSC-RI-----------------------------------------YLVHGT-NLSGVVV-S-AVDFG 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~-----------------------------------------~l~~~~-~~~~~~~-s-VwsfG 118 (189)
+.++|..+++|+|+ |. ++++|. ....++. + |||+|
T Consensus 116 l~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG 195 (268)
T cd06630 116 LSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVG 195 (268)
T ss_pred HHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHH
Confidence 77777777777764 32 111111 2245778 8 99999
Q ss_pred ------------CCCCC---hHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 119 ------------SGGMT---NAEVLHQV-EHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 119 ------------~~~~~---~~~~~~~v-~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
|.... ....+..+ .....+..|...++++.+++.+||..||++||++.++++
T Consensus 196 ~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 196 CVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 22211 12233233 233445667788999999999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.28 E-value=9.9e-13 Score=97.63 Aligned_cols=103 Identities=11% Similarity=0.078 Sum_probs=68.3
Q ss_pred CcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------ccc------------------------ccC-
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLV------------------------HGT- 105 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~------------------------~~~- 105 (189)
.+.......+..+.+.|+.++|..+++|+|+ |. +++ +|.
T Consensus 102 ~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 181 (266)
T cd06651 102 ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI 181 (266)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHh
Confidence 3444444556667777888888888888875 33 221 111
Q ss_pred CCCCccc-e-EEEec------------CCCCChHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 106 NLSGVVV-S-AVDFG------------SGGMTNAEVLHQV-EHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 106 ~~~~~~~-s-VwsfG------------~~~~~~~~~~~~v-~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
....++. + ||||| |.+....+.+... ..+..+..|..+++.+..++ +||..+|++||+|++|++
T Consensus 182 ~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 182 SGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 2344688 8 99999 4444333333333 34445666778889999998 788899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.27 E-value=6.2e-13 Score=99.52 Aligned_cols=104 Identities=13% Similarity=0.169 Sum_probs=67.6
Q ss_pred CcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cc---------------------cccC-C-C
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YL---------------------VHGT-N-L 107 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l---------------------~~~~-~-~ 107 (189)
.+....+.....+.+.|+.++|..+++|+|+ |. ++ ++|. . .
T Consensus 96 ~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 175 (286)
T cd07847 96 GVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGD 175 (286)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccCcccccccCCHHHHhCC
Confidence 3445566667777888888999888888875 33 11 1111 1 2
Q ss_pred CCccc-e-EEEec------------CCCCChHHHHHHHHc--------------------CCCCCCC----------CCC
Q psy1684 108 SGVVV-S-AVDFG------------SGGMTNAEVLHQVEH--------------------GYRMPCP----------PGC 143 (189)
Q Consensus 108 ~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~--------------------g~~~~~p----------~~~ 143 (189)
..++. + ||||| |.+.+..+....+.. +...+.| +..
T Consensus 176 ~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (286)
T cd07847 176 TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNI 255 (286)
T ss_pred CCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccC
Confidence 34788 8 99999 455554443333211 1111111 245
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 144 PPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 144 p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
+..+.+|+.+||+.||++||++.+++.
T Consensus 256 ~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 256 SSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred CHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 788999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.4e-12 Score=99.89 Aligned_cols=101 Identities=11% Similarity=-0.051 Sum_probs=70.4
Q ss_pred CCCcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cccc---------------------cC-C
Q psy1684 65 RTTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVH---------------------GT-N 106 (189)
Q Consensus 65 ~~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~---------------------~~-~ 106 (189)
...+.......+..+.+.|+.++|..+++|+|+ |+ |++. |. .
T Consensus 90 ~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 169 (327)
T cd05617 90 QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILR 169 (327)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCcccCCHHHHC
Confidence 334555666667778888999999999999986 44 2222 11 3
Q ss_pred CCCccc-e-EEEec------------CC------CCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH
Q psy1684 107 LSGVVV-S-AVDFG------------SG------GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTF 165 (189)
Q Consensus 107 ~~~~~~-s-VwsfG------------~~------~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~ 165 (189)
...++. + ||||| |. ..+..+.............|...+..+.+++.+|++.||++|+++
T Consensus 170 ~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 170 GEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 456888 9 99999 32 122233333333333455788899999999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.7e-12 Score=101.14 Aligned_cols=106 Identities=8% Similarity=-0.052 Sum_probs=70.9
Q ss_pred CCcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cccc----------------------cC-C
Q psy1684 66 TTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVH----------------------GT-N 106 (189)
Q Consensus 66 ~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~----------------------~~-~ 106 (189)
..+....+..+..+.+.|+.++|..+++|+|+ |+ |++. |. .
T Consensus 98 ~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~ 177 (372)
T cd07853 98 QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILM 177 (372)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHc
Confidence 34555666667778888999999999999986 44 2221 11 1
Q ss_pred C-CCccc-e-EEEec------------CCCCChHHHHHHHHc------------------------CCCC-------CCC
Q psy1684 107 L-SGVVV-S-AVDFG------------SGGMTNAEVLHQVEH------------------------GYRM-------PCP 140 (189)
Q Consensus 107 ~-~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~------------------------g~~~-------~~p 140 (189)
+ ..++. + ||||| |.+.++.+.+..+.+ ...+ ...
T Consensus 178 ~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (372)
T cd07853 178 GSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLS 257 (372)
T ss_pred CCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccC
Confidence 1 34788 8 99999 555544433333211 1111 122
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 141 PGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 141 ~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
...++++.+|+.+|++.||++|||+.+++..
T Consensus 258 ~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 258 SQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred CCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 3567899999999999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.27 E-value=8.4e-13 Score=98.88 Aligned_cols=102 Identities=15% Similarity=0.058 Sum_probs=69.1
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------ccc---------------------ccC-CCCC
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLV---------------------HGT-NLSG 109 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~---------------------~~~-~~~~ 109 (189)
+.......+..+.+.|+.++|..+++|+|+ |. +++ +|. ....
T Consensus 94 l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 173 (280)
T cd05608 94 FPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEE 173 (280)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCCcCccCHHHhcCCC
Confidence 445566667778888999999999999986 43 222 111 3456
Q ss_pred ccc-e-EEEec------------CCCCC----hHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHH
Q psy1684 110 VVV-S-AVDFG------------SGGMT----NAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRP-----TFE 166 (189)
Q Consensus 110 ~~~-s-VwsfG------------~~~~~----~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP-----~~~ 166 (189)
++. + ||||| |.+.. ..++...+..+ ....|..+|.++.+++.+||+.||++|| +++
T Consensus 174 ~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~ 252 (280)
T cd05608 174 YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND-SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCD 252 (280)
T ss_pred CCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc-CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHH
Confidence 788 9 99999 33322 12233333222 2445678999999999999999999999 455
Q ss_pred HHHH
Q psy1684 167 TLQW 170 (189)
Q Consensus 167 ~i~~ 170 (189)
++++
T Consensus 253 ~~l~ 256 (280)
T cd05608 253 GLRT 256 (280)
T ss_pred HHhc
Confidence 6654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.27 E-value=3e-12 Score=98.15 Aligned_cols=109 Identities=17% Similarity=0.007 Sum_probs=73.9
Q ss_pred ccCCCCCcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cccc---------------------
Q psy1684 61 QKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVH--------------------- 103 (189)
Q Consensus 61 yl~~~~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~--------------------- 103 (189)
++.....+...++..+..+.+.|+.++|...++|+|+ |+ |++.
T Consensus 95 ~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~a 174 (332)
T cd05614 95 HLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMA 174 (332)
T ss_pred HHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCCCccccccCCccccC
Confidence 3433444555566667778888999999999999986 44 2222
Q ss_pred -cC-CC-CCccc-e-EEEec------------CCCC----ChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCC
Q psy1684 104 -GT-NL-SGVVV-S-AVDFG------------SGGM----TNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKR 162 (189)
Q Consensus 104 -~~-~~-~~~~~-s-VwsfG------------~~~~----~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~R 162 (189)
|. .. ..++. + ||||| |... ...++...+.. ..++.|...++.+.+++.+||+.||++|
T Consensus 175 PE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~R 253 (332)
T cd05614 175 PEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK-CDPPFPSFIGPEAQDLLHKLLRKDPKKR 253 (332)
T ss_pred HHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc-CCCCCCCCCCHHHHHHHHHHcCCCHHHc
Confidence 11 12 23678 8 99999 3211 12334344433 3456778899999999999999999999
Q ss_pred C-----CHHHHHH
Q psy1684 163 P-----TFETLQW 170 (189)
Q Consensus 163 P-----~~~~i~~ 170 (189)
| +++++++
T Consensus 254 ~~~~~~~~~~~l~ 266 (332)
T cd05614 254 LGAGPQGASEIKE 266 (332)
T ss_pred CCCCCCCHHHHHc
Confidence 9 6677765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.26 E-value=6.5e-13 Score=99.87 Aligned_cols=102 Identities=14% Similarity=0.009 Sum_probs=69.1
Q ss_pred CHhHHHHHhhhccCCceeeccCCcccccc-cc---------------ccc---------------------ccC-C-CCC
Q psy1684 69 HYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLV---------------------HGT-N-LSG 109 (189)
Q Consensus 69 ~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~---------------------~~~-~-~~~ 109 (189)
....+..+..+.+.|+.++|..+++|+|+ |+ |++ +|. . ...
T Consensus 101 ~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 180 (288)
T cd07871 101 SMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTE 180 (288)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccccCceecccccChHHhcCCcc
Confidence 35666667778888999999999999986 44 222 221 1 245
Q ss_pred ccc-e-EEEec------------CCCCChHHHHHHHHcCCCC------------------CC-----------CCCCCHH
Q psy1684 110 VVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRM------------------PC-----------PPGCPPR 146 (189)
Q Consensus 110 ~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~------------------~~-----------p~~~p~~ 146 (189)
++. + |||+| |.+.+..+.+..+...... .. ...++.+
T Consensus 181 ~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (288)
T cd07871 181 YSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTD 260 (288)
T ss_pred cCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHH
Confidence 788 9 99999 5555544444333211000 00 1245778
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 147 LYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 147 ~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
..+|+.+|+..||.+|||++|+++
T Consensus 261 ~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 261 GIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred HHHHHHHhcCcCcccCCCHHHHhc
Confidence 999999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.6e-12 Score=95.55 Aligned_cols=104 Identities=20% Similarity=0.312 Sum_probs=74.2
Q ss_pred CcCHhHHHHHhhhccCCceeeccCCcccccc-cc------------------------------------cccccC-CCC
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI------------------------------------YLVHGT-NLS 108 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~------------------------------------~l~~~~-~~~ 108 (189)
.+....+..+..+...++.++|..+++|+|+ |. ++++|. ...
T Consensus 95 ~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~ 174 (254)
T cd06627 95 PFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMS 174 (254)
T ss_pred CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcccccccccchhhcCHhhhcCC
Confidence 3445555666777788888999999999886 43 111111 223
Q ss_pred Cccc-e-EEEec------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 109 GVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 109 ~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
.++. + |||+| +.+.+.......+..+..++.|..++.++.+++.+||..+|++|||+.+++.
T Consensus 175 ~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 175 GASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 3577 8 99999 3344444444455556666778889999999999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.26 E-value=4.4e-12 Score=95.83 Aligned_cols=145 Identities=8% Similarity=0.032 Sum_probs=94.4
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..+.|+|++++++.+...+..++|.|+.++ +.+ .. ++. ...+....+..+..+...|
T Consensus 73 ~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~-~~L----~~-----------------~~~-~~~~~~~~~~~~~~qi~~~ 129 (297)
T cd06659 73 RDYQHQNVVEMYKSYLVGEELWVLMEFLQG-GAL----TD-----------------IVS-QTRLNEEQIATVCESVLQA 129 (297)
T ss_pred HhCCCCchhhhhhheeeCCeEEEEEecCCC-CCH----HH-----------------HHh-hcCCCHHHHHHHHHHHHHH
Confidence 457899999999877777778888888776 311 11 010 1123344455555666677
Q ss_pred ceeeccCCcccccc-cc---------------c---------------------ccccC-CCCCccc-e-EEEec-----
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------Y---------------------LVHGT-NLSGVVV-S-AVDFG----- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~---------------------l~~~~-~~~~~~~-s-VwsfG----- 118 (189)
+.++|..+++|+|+ |+ + +++|. ....++. + |||||
T Consensus 130 L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e 209 (297)
T cd06659 130 LCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIE 209 (297)
T ss_pred HHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHH
Confidence 77777777777765 33 1 11211 3345788 9 99999
Q ss_pred -------CCCCChHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 119 -------SGGMTNAEVLHQVEHGYR--MPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 119 -------~~~~~~~~~~~~v~~g~~--~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
|...+..+....+..... ...+...+.++.+++.+||+.+|.+||++++|+..
T Consensus 210 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 210 MVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 334444455555543321 22334678899999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.6e-12 Score=97.28 Aligned_cols=63 Identities=17% Similarity=0.177 Sum_probs=44.8
Q ss_pred CCccc-e-EEEec------------CCCCChHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 108 SGVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRM-PCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 108 ~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~-~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
..++. + ||||| |.+..+.+....+.....+ ..+..+|.++.+||.+||+.||.+||++.+|++
T Consensus 201 ~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 201 ATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred cCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 45888 9 99999 3344433333333333222 233468999999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.6e-12 Score=97.36 Aligned_cols=144 Identities=13% Similarity=0.033 Sum_probs=85.9
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC--CCCcCHhHHHHHhhhcc
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG--RTTIHYPELVEHYSKDA 81 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~--~~~~~l~~li~~~~~~a 81 (189)
..++|+|++++++.+......++|+|+... + +.. ++.. ...+.......+..+.+
T Consensus 54 ~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~-~-----l~~-----------------~~~~~~~~~l~~~~~~~~~~~i~ 110 (284)
T cd07860 54 KELNHPNIVKLLDVIHTENKLYLVFEFLHQ-D-----LKK-----------------FMDASPLSGIPLPLIKSYLFQLL 110 (284)
T ss_pred HhcCCCCCcchhhhcccCCcEEEEeecccc-C-----HHH-----------------HHHhCCCCCCCHHHHHHHHHHHH
Confidence 456788888888877767777888887643 2 111 1110 12233445555566666
Q ss_pred CCceeeccCCcccccc-cc------------------------------------cccccC-CC-CCccc-e-EEEec--
Q psy1684 82 DGLCVNLRKPCVQVSC-RI------------------------------------YLVHGT-NL-SGVVV-S-AVDFG-- 118 (189)
Q Consensus 82 ~gl~~~~~~~~~~~~~-p~------------------------------------~l~~~~-~~-~~~~~-s-VwsfG-- 118 (189)
.|+.++|..+++|+|+ |. ++++|. .. ..++. + |||||
T Consensus 111 ~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~i 190 (284)
T cd07860 111 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCI 190 (284)
T ss_pred HHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHH
Confidence 6777777777777664 22 122332 12 23577 8 99999
Q ss_pred ----------CCCCChHHHHHHH-HcCCCC---------------------------CCCCCCCHHHHHHHHHhcccCCC
Q psy1684 119 ----------SGGMTNAEVLHQV-EHGYRM---------------------------PCPPGCPPRLYDIMLECWLKDPV 160 (189)
Q Consensus 119 ----------~~~~~~~~~~~~v-~~g~~~---------------------------~~p~~~p~~~~~l~~~C~~~~p~ 160 (189)
|.+-+..+....+ .....+ ...+.+++++.+++.+||+.||+
T Consensus 191 l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 270 (284)
T cd07860 191 FAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPN 270 (284)
T ss_pred HHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcc
Confidence 3333322222221 111000 01134678899999999999999
Q ss_pred CCCCHHHHHH
Q psy1684 161 KRPTFETLQW 170 (189)
Q Consensus 161 ~RP~~~~i~~ 170 (189)
+|||+++++.
T Consensus 271 ~Rpt~~~~l~ 280 (284)
T cd07860 271 KRISAKAALA 280 (284)
T ss_pred cCCCHHHHhc
Confidence 9999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.25 E-value=2e-12 Score=98.87 Aligned_cols=103 Identities=16% Similarity=0.050 Sum_probs=76.9
Q ss_pred cCCCCCcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cccc---------------------c
Q psy1684 62 KAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVH---------------------G 104 (189)
Q Consensus 62 l~~~~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~---------------------~ 104 (189)
+.....+.......+..+.+.|+.++|..+++|+|+ |+ |++. |
T Consensus 92 ~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE 171 (324)
T cd05587 92 IQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPE 171 (324)
T ss_pred HHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceeeecCCccccChh
Confidence 333344555556667778889999999999999986 54 2222 1
Q ss_pred C-CCCCccc-e-EEEec------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH
Q psy1684 105 T-NLSGVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTF 165 (189)
Q Consensus 105 ~-~~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~ 165 (189)
. ....++. + ||||| |.+.+..++...+..+ .+..|...++++.+++.+||..||.+|++.
T Consensus 172 ~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 172 IIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH-NVSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred hhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 1 3345788 9 99999 6666677777777554 356678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.5e-12 Score=99.64 Aligned_cols=38 Identities=21% Similarity=0.380 Sum_probs=30.8
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHHhh
Q psy1684 141 PGCPPRLYDIMLECWLKDPVKRPTFETLQWK--LEDFFTM 178 (189)
Q Consensus 141 ~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~--l~~~~~~ 178 (189)
..++.++.+|+.+||..||++|||+.++++. ++.+...
T Consensus 278 ~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~ 317 (328)
T cd08226 278 KTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ 317 (328)
T ss_pred hhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence 3466789999999999999999999999753 5555543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.25 E-value=5.9e-13 Score=103.17 Aligned_cols=71 Identities=6% Similarity=-0.055 Sum_probs=47.1
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC-CCCcCHhHHHHHhhhccC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG-RTTIHYPELVEHYSKDAD 82 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~-~~~~~l~~li~~~~~~a~ 82 (189)
..+.|+|++++++.+......++|.++... + +.. ++.. ...+....+..+..+++.
T Consensus 112 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~-----l~~-----------------~l~~~~~~~~~~~~~~i~~qi~~ 168 (357)
T PHA03209 112 QNVNHPSVIRMKDTLVSGAITCMVLPHYSS-D-----LYT-----------------YLTKRSRPLPIDQALIIEKQILE 168 (357)
T ss_pred HhCCCCCCcChhheEEeCCeeEEEEEccCC-c-----HHH-----------------HHHhccCCCCHHHHHHHHHHHHH
Confidence 456788888877766555556677665532 1 111 2211 223456667777888889
Q ss_pred CceeeccCCcccccc
Q psy1684 83 GLCVNLRKPCVQVSC 97 (189)
Q Consensus 83 gl~~~~~~~~~~~~~ 97 (189)
|+.++|..+++|+|+
T Consensus 169 aL~~LH~~~ivHrDl 183 (357)
T PHA03209 169 GLRYLHAQRIIHRDV 183 (357)
T ss_pred HHHHHHHCCeecCCC
Confidence 999999999999986
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.24 E-value=2.7e-12 Score=96.06 Aligned_cols=30 Identities=20% Similarity=0.238 Sum_probs=26.7
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 141 PGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 141 ~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
+..+.++.+++.+||+.||++|||+++++.
T Consensus 250 ~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 250 PNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 356688999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.7e-12 Score=96.41 Aligned_cols=101 Identities=15% Similarity=0.168 Sum_probs=66.4
Q ss_pred HhHHHHHhhhccCCceeeccCCcccccc-cc------------------------------------cccccC------C
Q psy1684 70 YPELVEHYSKDADGLCVNLRKPCVQVSC-RI------------------------------------YLVHGT------N 106 (189)
Q Consensus 70 l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~------------------------------------~l~~~~------~ 106 (189)
...+..+..+.+.++.++|...++|+|+ |. ++++|. .
T Consensus 112 ~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 191 (275)
T cd06608 112 EEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQP 191 (275)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceecccchhhhcCccccccccCHhHhcccccc
Confidence 4444555566667777777777777764 33 122221 1
Q ss_pred CCCccc-e-EEEec------------CCCCChHHHHHHHHcCCCC--CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 107 LSGVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRM--PCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 107 ~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~--~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
...++. + ||||| |.+.+.......+..+... ..+...+.++.+|+.+||..||++|||+.+|++
T Consensus 192 ~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 192 DASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred cCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 234788 9 99999 4444444444445444332 223457889999999999999999999999875
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.24 E-value=5.4e-12 Score=92.57 Aligned_cols=140 Identities=12% Similarity=0.013 Sum_probs=91.6
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.++|+|+.+++.........++|+++... +. +.. ++.....+...++.....+.+.|+
T Consensus 49 ~l~h~~i~~~~~~~~~~~~~~~v~e~~~~-~~----L~~-----------------~l~~~~~l~~~~~~~~~~qi~~~l 106 (250)
T cd05123 49 RINHPFIVKLHYAFQTEEKLYLVLEYAPG-GE----LFS-----------------HLSKEGRFSEERARFYAAEIVLAL 106 (250)
T ss_pred HcCCCcHHHHHHHeecCCeeEEEEecCCC-Cc----HHH-----------------HHHhcCCCCHHHHHHHHHHHHHHH
Confidence 56788888888776666677888887764 31 111 222222233444555555666677
Q ss_pred eeeccCCcccccc-cc------------------------------------cccccC-CCCCccc-e-EEEec------
Q psy1684 85 CVNLRKPCVQVSC-RI------------------------------------YLVHGT-NLSGVVV-S-AVDFG------ 118 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~------------------------------------~l~~~~-~~~~~~~-s-VwsfG------ 118 (189)
.++|...++|.|+ |. ++++|. .....+. + |||||
T Consensus 107 ~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l 186 (250)
T cd05123 107 EYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEM 186 (250)
T ss_pred HHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHH
Confidence 7777777777664 32 111211 2334677 8 99999
Q ss_pred ------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q psy1684 119 ------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFET 167 (189)
Q Consensus 119 ------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~ 167 (189)
|...+..++...+.. ..++.|...|.++.+++.+||..||++||++++
T Consensus 187 ~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 187 LTGKPPFYAEDRKEIYEKILK-DPLRFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHCCCCCCCCCHHHHHHHHhc-CCCCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 444444556666655 456788888999999999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.24 E-value=4.7e-13 Score=101.08 Aligned_cols=101 Identities=9% Similarity=-0.027 Sum_probs=65.9
Q ss_pred HhHHHHHhhhccCCceeeccCCcccccc-cc---------------cc---------------------cccC-CCCCcc
Q psy1684 70 YPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YL---------------------VHGT-NLSGVV 111 (189)
Q Consensus 70 l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l---------------------~~~~-~~~~~~ 111 (189)
..++..+..+.+.|+.++|..+++|+|+ |. ++ ++|. ....++
T Consensus 114 ~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 193 (297)
T cd06656 114 EGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 193 (297)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCcccCCccccCHHHHcCCCCC
Confidence 4445555566667788888888888875 33 11 1111 234577
Q ss_pred c-e-EEEec------------CCCCChHHHHHHHHcCCCC--CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 112 V-S-AVDFG------------SGGMTNAEVLHQVEHGYRM--PCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 112 ~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~--~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
. + ||||| |.+.+..+....+..+..+ ..|...+..+.+++.+||..||++||++++|++
T Consensus 194 ~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 194 PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred cHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 8 8 99999 3333332222223222222 245678899999999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.24 E-value=5e-12 Score=96.68 Aligned_cols=100 Identities=14% Similarity=0.069 Sum_probs=75.0
Q ss_pred CCCcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------ccccc---------------------C-C
Q psy1684 65 RTTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVHG---------------------T-N 106 (189)
Q Consensus 65 ~~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~~---------------------~-~ 106 (189)
...+...+...+..+.+.|+.++|..+++|+|+ |+ |+++. . .
T Consensus 95 ~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 174 (323)
T cd05615 95 VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIA 174 (323)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccCccCCccccCHHHHc
Confidence 334555666677778888999999999999986 44 22221 1 3
Q ss_pred CCCccc-e-EEEec------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH
Q psy1684 107 LSGVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTF 165 (189)
Q Consensus 107 ~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~ 165 (189)
...++. + ||||| |.+.+..++...+..+ ....|..++.++.+++.+|++.||++|++.
T Consensus 175 ~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~-~~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 175 YQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH-NVSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 455788 9 99999 6666677777777554 345678899999999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.4e-12 Score=99.31 Aligned_cols=102 Identities=12% Similarity=0.058 Sum_probs=67.5
Q ss_pred HhHHHHHhhhccCCceeeccCCcccccc-cc--------------------------------cccccC----CCCCccc
Q psy1684 70 YPELVEHYSKDADGLCVNLRKPCVQVSC-RI--------------------------------YLVHGT----NLSGVVV 112 (189)
Q Consensus 70 l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~--------------------------------~l~~~~----~~~~~~~ 112 (189)
..++..+..+.+.++.++|..+++|+|+ |. ++++|. ..+.++.
T Consensus 120 ~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 199 (313)
T cd06633 120 EVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTPYWMAPEVILAMDEGQYDG 199 (313)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCCCCCccccccccChhhccccCCCCCCc
Confidence 4445555666677777778777777765 33 222332 1345788
Q ss_pred -e-EEEec------------CCCCChHHHHHHHHcCCCCCC-CCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 113 -S-AVDFG------------SGGMTNAEVLHQVEHGYRMPC-PPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 113 -s-VwsfG------------~~~~~~~~~~~~v~~g~~~~~-p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
+ ||||| |.+.+.......+..+..+.. ....+..+.+++.+||+.+|.+||++.+++..
T Consensus 200 ~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 200 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 9 99999 334444444444433333322 34577889999999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.23 E-value=9.3e-13 Score=99.96 Aligned_cols=103 Identities=14% Similarity=0.032 Sum_probs=68.8
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------ccc---------------------ccC--CCC
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLV---------------------HGT--NLS 108 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~---------------------~~~--~~~ 108 (189)
+....+..+..+.+.|+.++|..+++|+|+ |+ |++ +|. ...
T Consensus 101 ~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 180 (309)
T cd07872 101 MSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSS 180 (309)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCccccccccccccccCCHHHhCCC
Confidence 335556666778888999999999999986 44 211 111 123
Q ss_pred Cccc-e-EEEec------------CCCCChHHHHHHHHcCCC---------------------C--------CCCCCCCH
Q psy1684 109 GVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYR---------------------M--------PCPPGCPP 145 (189)
Q Consensus 109 ~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~---------------------~--------~~p~~~p~ 145 (189)
.++. + ||||| |.+.+..+....+.+... + .....+++
T Consensus 181 ~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (309)
T cd07872 181 EYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDT 260 (309)
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCH
Confidence 5788 9 99999 555554443333321100 0 01124678
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 146 RLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 146 ~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
++.+|+.+|+..||.+|||+.|+++
T Consensus 261 ~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 261 EGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred HHHHHHHHhccCChhhCCCHHHHhc
Confidence 9999999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.23 E-value=2.2e-12 Score=98.00 Aligned_cols=72 Identities=6% Similarity=-0.117 Sum_probs=45.6
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC--CCCcCHhHHHHHhhhcc
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG--RTTIHYPELVEHYSKDA 81 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~--~~~~~l~~li~~~~~~a 81 (189)
..++|+|++++++.....+..++++|+++.+. +.. ++.. ...+....+..+..+.+
T Consensus 54 ~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~-----l~~-----------------~l~~~~~~~~~~~~~~~~~~~l~ 111 (314)
T cd08216 54 RQLQHPNILPYVTSFIVDSELYVVSPLMAYGS-----CED-----------------LLKTHFPEGLPELAIAFILKDVL 111 (314)
T ss_pred HhcCCcchhhhhheeecCCeEEEEEeccCCCC-----HHH-----------------HHHHhcccCCCHHHHHHHHHHHH
Confidence 35678999998887666667788888877622 111 1111 11223334445556777
Q ss_pred CCceeeccCCcccccc
Q psy1684 82 DGLCVNLRKPCVQVSC 97 (189)
Q Consensus 82 ~gl~~~~~~~~~~~~~ 97 (189)
.|+.++|..+++|+|+
T Consensus 112 ~~L~~LH~~~ivH~dl 127 (314)
T cd08216 112 NALDYIHSKGFIHRSV 127 (314)
T ss_pred HHHHHHHHCCeecCCC
Confidence 7888888888888875
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.23 E-value=5.3e-12 Score=91.73 Aligned_cols=144 Identities=16% Similarity=0.106 Sum_probs=90.8
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.++|++++++++.+......++|+|+...+. +.. ++.....+....+.....+...++
T Consensus 43 ~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~-----L~~-----------------~~~~~~~~~~~~~~~~~~~l~~~l 100 (244)
T smart00220 43 KLKHPNIVRLYDVFEDEDKLYLVMEYCDGGD-----LFD-----------------LLKKRGRLSEDEARFYARQILSAL 100 (244)
T ss_pred hCCCCcHHHHHhheeeCCEEEEEEeCCCCCC-----HHH-----------------HHHhccCCCHHHHHHHHHHHHHHH
Confidence 4678899998888776677888888776622 111 111111123344444445555566
Q ss_pred eeeccCCccccccc-c-----------------------------------cccccC-CCCCccc-e-EEEec-------
Q psy1684 85 CVNLRKPCVQVSCR-I-----------------------------------YLVHGT-NLSGVVV-S-AVDFG------- 118 (189)
Q Consensus 85 ~~~~~~~~~~~~~p-~-----------------------------------~l~~~~-~~~~~~~-s-VwsfG------- 118 (189)
.++|...++|.++. . ++++|. ....++. + |||||
T Consensus 101 ~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~ 180 (244)
T smart00220 101 EYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELL 180 (244)
T ss_pred HHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHH
Confidence 66666666665542 1 122222 2355788 8 99999
Q ss_pred -----CCC-CChHHHHHHHHcCCCCCCCCC--CCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 119 -----SGG-MTNAEVLHQVEHGYRMPCPPG--CPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 119 -----~~~-~~~~~~~~~v~~g~~~~~p~~--~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
|.. .+...+...+..+.....+.. ++.++.+++.+||..+|++||++.++++
T Consensus 181 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 181 TGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred hCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 333 344555555555544433333 8999999999999999999999999985
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.3e-12 Score=98.27 Aligned_cols=61 Identities=16% Similarity=0.171 Sum_probs=44.8
Q ss_pred ccc-e-EEEec------------CCCCChHHHHHHHHcCCCC--CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 110 VVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRM--PCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 110 ~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~--~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
++. + ||||| |...+..+.+..+.++..+ ..|...+.++.+++.+||+.||++||++.+|+.
T Consensus 210 ~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 210 YDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred cCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 678 9 99999 4444444444444444332 235567789999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.8e-12 Score=97.08 Aligned_cols=29 Identities=17% Similarity=0.127 Sum_probs=26.4
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 142 GCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 142 ~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
.+++++.+++.+||+.||.+|||++++++
T Consensus 252 ~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 252 KLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 46788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.9e-12 Score=97.26 Aligned_cols=148 Identities=14% Similarity=-0.010 Sum_probs=84.9
Q ss_pred CCChHHHHHHhcCCCCC--CCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccC
Q psy1684 5 KIKRIEAEKKLLLPEND--HGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDAD 82 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~--~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~ 82 (189)
.++|+|++++++.+... ...+||+|+++++. + .. .+.. .......+....+..+..+.+.
T Consensus 55 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~-L----~~----~l~~---------~~~~~~~l~~~~~~~i~~~i~~ 116 (287)
T cd06621 55 SCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGS-L----DS----IYKK---------VKKRGGRIGEKVLGKIAESVLK 116 (287)
T ss_pred hCCCCCeeeeeeEEEccCCCeEEEEEEecCCCC-H----HH----HHHH---------HHhcCCCCCHHHHHHHHHHHHH
Confidence 46677777776654322 23567777766522 1 11 0000 0000122334445555666777
Q ss_pred CceeeccCCcccccc-cc---------------cc-------------------cccC-CCCCccc-e-EEEec------
Q psy1684 83 GLCVNLRKPCVQVSC-RI---------------YL-------------------VHGT-NLSGVVV-S-AVDFG------ 118 (189)
Q Consensus 83 gl~~~~~~~~~~~~~-p~---------------~l-------------------~~~~-~~~~~~~-s-VwsfG------ 118 (189)
++.++|..+++|+|+ |. ++ ++|. ....++. + |||+|
T Consensus 117 ~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l 196 (287)
T cd06621 117 GLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEV 196 (287)
T ss_pred HHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHH
Confidence 777888777777765 22 11 1221 3456888 9 99999
Q ss_pred ------CCCC-----ChHHHHHHHHcCCCCCCCC------CCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 119 ------SGGM-----TNAEVLHQVEHGYRMPCPP------GCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 119 ------~~~~-----~~~~~~~~v~~g~~~~~p~------~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
|... ...++...+.....+..+. ..++++.+++.+||..||++|||+.||++
T Consensus 197 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 197 AQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred HhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 2221 2234444444333222221 24578999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0790|consensus | Back alignment and domain information |
|---|
Probab=99.21 E-value=5.9e-11 Score=90.74 Aligned_cols=80 Identities=33% Similarity=0.517 Sum_probs=67.0
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEec-------CCCeeeEEEEEeccCC-ccCCCCCcC-Hh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKR-------SSFCLKMTTGRSLFET-QKAGRTTIH-YP 71 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~-------~~~~v~h~~i~~~~~g-yl~~~~~~~-l~ 71 (189)
||||.|+-.+|++||...+ .+|+||||||.+.+|+|+||++.. ...+|.|..|.+..+- -+.+...|. +.
T Consensus 112 WfHG~LsgkeAekLl~ekg-k~gsfLvReSqs~PGdfVlSvrTdd~~~~~~~~~kVtHvmI~~q~~kydVGgge~F~slt 190 (600)
T KOG0790|consen 112 WFHGHLSGKEAEKLLQEKG-KHGSFLVRESQSHPGDFVLSVRTDDKKESNDSKLKVTHVMIRCQEGKYDVGGGERFDSLT 190 (600)
T ss_pred hhccCCCchhHHHHHHhcC-CCccEEEeccccCCCceEEEEEcCCcccCCCCccceEEEEEEecccccccCCccccchHH
Confidence 9999999999999885443 579999999999999999999983 2248999999876644 455667899 99
Q ss_pred HHHHHhhhcc
Q psy1684 72 ELVEHYSKDA 81 (189)
Q Consensus 72 ~li~~~~~~a 81 (189)
+|+++|.++.
T Consensus 191 dLidhykknp 200 (600)
T KOG0790|consen 191 DLVEHYKKNP 200 (600)
T ss_pred HHHHHhccCc
Confidence 9999998874
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.5e-12 Score=97.41 Aligned_cols=30 Identities=17% Similarity=0.135 Sum_probs=27.1
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 141 PGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 141 ~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
..+++++.++|.+||..||++|||+.+|++
T Consensus 252 ~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 252 KNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred CCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 357889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.7e-12 Score=97.56 Aligned_cols=103 Identities=12% Similarity=-0.041 Sum_probs=70.7
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------ccc--------------------ccC-CCCCc
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLV--------------------HGT-NLSGV 110 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~--------------------~~~-~~~~~ 110 (189)
+...++..+..+.+.|+.++|..+++|+|+ |. +++ +|. ....+
T Consensus 99 l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 178 (285)
T cd05630 99 FEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERY 178 (285)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccCCCCCccccChHHHcCCCC
Confidence 445566667778888999999999999885 43 211 111 34558
Q ss_pred cc-e-EEEec------------CCCCCh---HHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHH
Q psy1684 111 VV-S-AVDFG------------SGGMTN---AEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPT-----FETL 168 (189)
Q Consensus 111 ~~-s-VwsfG------------~~~~~~---~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~-----~~~i 168 (189)
+. + ||||| |.+... .+....+........+..+++++.+|+.+||+.||++||| +.++
T Consensus 179 ~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~ 258 (285)
T cd05630 179 TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREV 258 (285)
T ss_pred CCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHH
Confidence 88 9 99999 333221 1222233223334456788999999999999999999999 7788
Q ss_pred HH
Q psy1684 169 QW 170 (189)
Q Consensus 169 ~~ 170 (189)
++
T Consensus 259 ~~ 260 (285)
T cd05630 259 KE 260 (285)
T ss_pred Hc
Confidence 76
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.21 E-value=2.2e-12 Score=95.54 Aligned_cols=62 Identities=24% Similarity=0.254 Sum_probs=44.7
Q ss_pred Cccc-e-EEEec------------CCCCChHHHHHHHHcCCCCCCC-----CCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q psy1684 109 GVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMPCP-----PGCPPRLYDIMLECWLKDPVKRPTFETLQ 169 (189)
Q Consensus 109 ~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~~p-----~~~p~~~~~l~~~C~~~~p~~RP~~~~i~ 169 (189)
.++. + ||||| |.+.+..+....+..+..+..+ ...++++.+++.+||..||++||++++|+
T Consensus 183 ~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll 262 (267)
T cd06610 183 GYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELL 262 (267)
T ss_pred CcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 5788 9 99999 4444444444444333222222 25678999999999999999999999987
Q ss_pred H
Q psy1684 170 W 170 (189)
Q Consensus 170 ~ 170 (189)
+
T Consensus 263 ~ 263 (267)
T cd06610 263 K 263 (267)
T ss_pred h
Confidence 5
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.21 E-value=4.9e-12 Score=94.64 Aligned_cols=99 Identities=14% Similarity=0.109 Sum_probs=62.4
Q ss_pred HHHHhhhccCCceeeccCCcccccc-cc----------------------------------cccccC-CCCCccc-e-E
Q psy1684 73 LVEHYSKDADGLCVNLRKPCVQVSC-RI----------------------------------YLVHGT-NLSGVVV-S-A 114 (189)
Q Consensus 73 li~~~~~~a~gl~~~~~~~~~~~~~-p~----------------------------------~l~~~~-~~~~~~~-s-V 114 (189)
+..+..+.+.|+.++|..+++|+|+ |. ++++|. ....++. + |
T Consensus 97 ~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 176 (279)
T cd06619 97 LGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGIHSDV 176 (279)
T ss_pred HHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccccccCCCCChhhcCceeecCCCCCCcchH
Confidence 3445556666777777777777764 32 222332 3455788 9 9
Q ss_pred EEec------------CCCC-------ChHHHHHHHHcCCCCCC-CCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 115 VDFG------------SGGM-------TNAEVLHQVEHGYRMPC-PPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 115 wsfG------------~~~~-------~~~~~~~~v~~g~~~~~-p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
|||| |... ...+....+.....+.. ....++++.+++.+||+.||++||++.++++.
T Consensus 177 wslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 177 WSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 9999 2111 11223333333322222 23467899999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=99.21 E-value=3.2e-12 Score=91.37 Aligned_cols=155 Identities=15% Similarity=0.156 Sum_probs=98.2
Q ss_pred CCCCChHHHHHHhcCCCCCCC-----cEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHh
Q psy1684 3 FGKIKRIEAEKKLLLPENDHG-----AFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHY 77 (189)
Q Consensus 3 ~g~l~~~n~~~lL~~~~~~~g-----~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~ 77 (189)
|+++.|+|+.+++..+..+.+ .||+.++-.. | |+.+ .+... ..+ +..++-.+.+.++
T Consensus 72 ~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~-G----sl~d----~i~~~----k~k-----g~~~sE~~iL~if 133 (302)
T KOG2345|consen 72 HRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKR-G----SLLD----EIERL----KIK-----GNFVSEAQILWIF 133 (302)
T ss_pred HHhhCCcchHHHHHHHHHhhccCceeEEEEeehhcc-c----cHHH----HHHHH----hhc-----CCccCHHHHHHHH
Confidence 567788888888765544433 5666665554 2 1222 01000 111 2233466778888
Q ss_pred hhccCCceeeccCC--cccccc-cccc--cccC-----------------------------------------------
Q psy1684 78 SKDADGLCVNLRKP--CVQVSC-RIYL--VHGT----------------------------------------------- 105 (189)
Q Consensus 78 ~~~a~gl~~~~~~~--~~~~~~-p~~l--~~~~----------------------------------------------- 105 (189)
..+.+|+.++|... .+|+|+ |..+ +.+.
T Consensus 134 ~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk 213 (302)
T KOG2345|consen 134 LGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVK 213 (302)
T ss_pred HHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecc
Confidence 89999999999875 899996 5511 1101
Q ss_pred CCCCccc-e-EEEec------CCCCChHHHHHH--------HHcCCCCCCC--CCCCHHHHHHHHHhcccCCCCCCCHHH
Q psy1684 106 NLSGVVV-S-AVDFG------SGGMTNAEVLHQ--------VEHGYRMPCP--PGCPPRLYDIMLECWLKDPVKRPTFET 167 (189)
Q Consensus 106 ~~~~~~~-s-VwsfG------~~~~~~~~~~~~--------v~~g~~~~~p--~~~p~~~~~l~~~C~~~~p~~RP~~~~ 167 (189)
.+...++ + |||+| .-+.++.+-... |.++ ...+| ...+..+.+|++.|++.||.+||+..+
T Consensus 214 ~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~-q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ 292 (302)
T KOG2345|consen 214 SHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNA-QISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPE 292 (302)
T ss_pred cCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeecc-ccccCCCCCccHHHHHHHHHHhcCCcccCCCHHH
Confidence 4556788 8 99999 223334332221 2222 23344 347789999999999999999999999
Q ss_pred HHHHHHHHH
Q psy1684 168 LQWKLEDFF 176 (189)
Q Consensus 168 i~~~l~~~~ 176 (189)
++..++.+.
T Consensus 293 ll~~~d~Li 301 (302)
T KOG2345|consen 293 LLSKLDDLI 301 (302)
T ss_pred HHHHHHhhc
Confidence 999987653
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.6e-12 Score=96.21 Aligned_cols=30 Identities=23% Similarity=0.310 Sum_probs=26.9
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 141 PGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 141 ~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
..+|.++.++|.+||..||++|||+++|++
T Consensus 255 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 255 GKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred CccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 346899999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.6e-12 Score=110.17 Aligned_cols=62 Identities=13% Similarity=0.100 Sum_probs=45.9
Q ss_pred CCccc-e-EEEec------------CCCCC-hHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 108 SGVVV-S-AVDFG------------SGGMT-NAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 108 ~~~~~-s-VwsfG------------~~~~~-~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
..++. + ||||| |...+ ..+++..+..+..++. ...+.++.+||..||..+|.+||++.+++.
T Consensus 218 ~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~lpi-~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 218 KSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPDLPI-KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCCCCc-CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 34788 9 99999 33332 3445555555543332 457899999999999999999999999985
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.2e-11 Score=98.38 Aligned_cols=105 Identities=11% Similarity=0.024 Sum_probs=72.3
Q ss_pred CcCHhHHHHHhhhccCCceeeccCCcccccc-cc----------------ccc--------------------ccC-C-C
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI----------------YLV--------------------HGT-N-L 107 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~----------------~l~--------------------~~~-~-~ 107 (189)
.+....+..+..+.+.|+.++|..+++|||+ |+ |++ +|. . .
T Consensus 166 ~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~ 245 (440)
T PTZ00036 166 ALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGA 245 (440)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhccCCCCcccCCCCcCccCHHHhcCC
Confidence 4445566667778889999999999999986 54 222 221 1 2
Q ss_pred CCccc-e-EEEec------------CCCCChHHHHHHHHc--CC--------------------------CCCCCCCCCH
Q psy1684 108 SGVVV-S-AVDFG------------SGGMTNAEVLHQVEH--GY--------------------------RMPCPPGCPP 145 (189)
Q Consensus 108 ~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~--g~--------------------------~~~~p~~~p~ 145 (189)
..|+. + ||||| |.+.+..+.+..+.. |. +...|...|.
T Consensus 246 ~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~ 325 (440)
T PTZ00036 246 TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPD 325 (440)
T ss_pred CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCH
Confidence 35888 9 99999 555544333333211 10 1113456789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 146 RLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 146 ~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
++.+|+.+||..||.+|||+.+++..
T Consensus 326 ~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 326 DAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 99999999999999999999999854
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.20 E-value=6.9e-12 Score=94.16 Aligned_cols=103 Identities=14% Similarity=-0.038 Sum_probs=71.3
Q ss_pred CcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------ccc--------------------ccC-CCCC
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLV--------------------HGT-NLSG 109 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~--------------------~~~-~~~~ 109 (189)
.+....++.+..+.+.|+.++|...++|+|+ |. +++ +|. ....
T Consensus 98 ~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~ 177 (285)
T cd05632 98 GFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQR 177 (285)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccCCCCCcCccChHHhcCCC
Confidence 3556667777788888999999999999886 43 211 111 3455
Q ss_pred ccc-e-EEEec------------CCCCChHHHH----HHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HH
Q psy1684 110 VVV-S-AVDFG------------SGGMTNAEVL----HQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPT-----FE 166 (189)
Q Consensus 110 ~~~-s-VwsfG------------~~~~~~~~~~----~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~-----~~ 166 (189)
++. + ||||| |.+.+..... ..+..+ ....+...+.++.+|+..||+.||++||+ +.
T Consensus 178 ~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~ 256 (285)
T cd05632 178 YTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLET-EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAG 256 (285)
T ss_pred CCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcc-ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChH
Confidence 788 9 99999 4444433222 222222 23456678999999999999999999999 56
Q ss_pred HHHH
Q psy1684 167 TLQW 170 (189)
Q Consensus 167 ~i~~ 170 (189)
+++.
T Consensus 257 ~l~~ 260 (285)
T cd05632 257 EVKR 260 (285)
T ss_pred HHHc
Confidence 6655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.20 E-value=3.5e-12 Score=93.71 Aligned_cols=104 Identities=16% Similarity=0.179 Sum_probs=71.2
Q ss_pred CcCHhHHHHHhhhccCCceeeccCCcccccc-cc--------------------------------------cccccC-C
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI--------------------------------------YLVHGT-N 106 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~--------------------------------------~l~~~~-~ 106 (189)
.++..++..+..+...++.++|...++|+|+ |. ++++|. .
T Consensus 97 ~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~ 176 (260)
T cd06606 97 KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176 (260)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhc
Confidence 4445556666677777888888888888875 33 111111 2
Q ss_pred CCCccc-e-EEEec------------CCCCC-hHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 107 LSGVVV-S-AVDFG------------SGGMT-NAEVLHQVEH-GYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 107 ~~~~~~-s-VwsfG------------~~~~~-~~~~~~~v~~-g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
...++. + ||||| |.... .......+.. +..+..|...|.++.+++.+||+.||++||++.+++.
T Consensus 177 ~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 177 GEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 233677 8 99999 33332 2333344433 4556678889999999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.20 E-value=5.6e-12 Score=95.09 Aligned_cols=143 Identities=17% Similarity=0.091 Sum_probs=84.0
Q ss_pred ChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCcee
Q psy1684 7 KRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGLCV 86 (189)
Q Consensus 7 ~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl~~ 86 (189)
.|+|++++++.+......|+|+|+... ....+ .. .....+..........+.+.|+.+
T Consensus 72 ~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~l--~~-------------------~~~~~l~~~~~~~i~~~i~~~l~~ 129 (296)
T cd06618 72 DCPYIVKCYGYFITDSDVFICMELMST-CLDKL--LK-------------------RIQGPIPEDILGKMTVAIVKALHY 129 (296)
T ss_pred CCCchHhhheeeecCCeEEEEeeccCc-CHHHH--HH-------------------HhcCCCCHHHHHHHHHHHHHHHHH
Confidence 478888888877666677888877542 10000 00 001122223333444555666666
Q ss_pred ecc-CCcccccc-cc-----------------------------------cccccCC-----CCCccc-e-EEEec----
Q psy1684 87 NLR-KPCVQVSC-RI-----------------------------------YLVHGTN-----LSGVVV-S-AVDFG---- 118 (189)
Q Consensus 87 ~~~-~~~~~~~~-p~-----------------------------------~l~~~~~-----~~~~~~-s-VwsfG---- 118 (189)
+|. .+++|+|+ |. ++++|.. .+.++. + |||||
T Consensus 130 lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~ 209 (296)
T cd06618 130 LKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLV 209 (296)
T ss_pred HHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHH
Confidence 665 35666654 32 1222211 134788 9 99999
Q ss_pred --------CCCCC-hHHHHHHHHcCCCCCCC--CCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 119 --------SGGMT-NAEVLHQVEHGYRMPCP--PGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 119 --------~~~~~-~~~~~~~v~~g~~~~~p--~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
|.... ..+++..+..+..+..| ..++.++.+|+.+||+.||.+||++.+|+..
T Consensus 210 el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 210 ELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred HHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 32221 23445455444333333 3478999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.19 E-value=9.9e-12 Score=93.72 Aligned_cols=144 Identities=8% Similarity=-0.012 Sum_probs=92.2
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..++|+|++++++.+...+..++|+|+.+.+. + .. ++. ...+.......+..+...+
T Consensus 72 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~-L----~~-----------------~~~-~~~~~~~~~~~~~~ql~~~ 128 (292)
T cd06657 72 RDYQHENVVEMYNSYLVGDELWVVMEFLEGGA-L----TD-----------------IVT-HTRMNEEQIAAVCLAVLKA 128 (292)
T ss_pred HhcCCcchhheeeEEEeCCEEEEEEecCCCCc-H----HH-----------------HHh-cCCCCHHHHHHHHHHHHHH
Confidence 35678888888877666677888888877622 1 11 110 1122334444555666667
Q ss_pred ceeeccCCcccccc-cc------------------------------------cccccC-CCCCccc-e-EEEec-----
Q psy1684 84 LCVNLRKPCVQVSC-RI------------------------------------YLVHGT-NLSGVVV-S-AVDFG----- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~------------------------------------~l~~~~-~~~~~~~-s-VwsfG----- 118 (189)
+.++|..+++|+|+ |. ++++|. ....++. + |||||
T Consensus 129 l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~e 208 (292)
T cd06657 129 LSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIE 208 (292)
T ss_pred HHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHH
Confidence 77777777777764 33 111111 2345688 8 99999
Q ss_pred -------CCCCChHHHHHHHHcCCCC--CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 119 -------SGGMTNAEVLHQVEHGYRM--PCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 119 -------~~~~~~~~~~~~v~~g~~~--~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
|.+....+....+..+... .....+|+++.+++.+||..||.+||++.+++.
T Consensus 209 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 209 MVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 4444445555555444322 233568899999999999999999999999887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.19 E-value=4.3e-12 Score=92.85 Aligned_cols=104 Identities=15% Similarity=0.125 Sum_probs=68.6
Q ss_pred CcCHhHHHHHhhhccCCceeeccCCcccccc-ccc-----------------------------------ccccC-CCCC
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RIY-----------------------------------LVHGT-NLSG 109 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~~-----------------------------------l~~~~-~~~~ 109 (189)
.+...++.....+.+.++.++|..+++|+|+ |.. +++|. ....
T Consensus 94 ~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~ 173 (253)
T cd05122 94 TLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKP 173 (253)
T ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccccccceecCCcccCHHHHcCCC
Confidence 3445555666677777888888888888875 331 11111 2234
Q ss_pred ccc-e-EEEec------------CCCCChHHHHHHHHcCCCCCCCC--CCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 110 VVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMPCPP--GCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 110 ~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~~p~--~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
++. + ||||| |...+..+..........+..+. .++.++.+++.+||+.||++|||+.++++
T Consensus 174 ~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 174 YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 678 8 99999 34443444444443333333333 34899999999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.7e-11 Score=92.04 Aligned_cols=144 Identities=13% Similarity=-0.001 Sum_probs=87.3
Q ss_pred ChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCcee
Q psy1684 7 KRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGLCV 86 (189)
Q Consensus 7 ~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl~~ 86 (189)
.|+|++.+++........+||+|+..+ +. +.. ++.....+....+..+..+.+.++.+
T Consensus 63 ~~~~i~~~~~~~~~~~~~~lv~e~~~~-~~----L~~-----------------~~~~~~~~~~~~~~~~~~ql~~~l~~ 120 (288)
T cd05583 63 RCPFLVTLHYAFQTDTKLHLILDYVNG-GE----LFT-----------------HLYQREHFTESEVRVYIAEIVLALDH 120 (288)
T ss_pred CCcchhhhheeeecCCEEEEEEecCCC-Cc----HHH-----------------HHhhcCCcCHHHHHHHHHHHHHHHHH
Confidence 467777776655545556677777664 21 111 22222233444455555666777778
Q ss_pred eccCCccccccc-c---------------cc----------------------cccC-CCC--Cccc-e-EEEec-----
Q psy1684 87 NLRKPCVQVSCR-I---------------YL----------------------VHGT-NLS--GVVV-S-AVDFG----- 118 (189)
Q Consensus 87 ~~~~~~~~~~~p-~---------------~l----------------------~~~~-~~~--~~~~-s-VwsfG----- 118 (189)
+|..+++|+|+. . ++ ++|. ... ..+. + |||||
T Consensus 121 lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~e 200 (288)
T cd05583 121 LHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFE 200 (288)
T ss_pred HHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHH
Confidence 887777777753 2 11 1111 111 2567 8 99999
Q ss_pred -------CCCC----ChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q psy1684 119 -------SGGM----TNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLE 173 (189)
Q Consensus 119 -------~~~~----~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~ 173 (189)
|... ...++...+... .++.|..++.++++++.+||+.||++|||+.++...|+
T Consensus 201 l~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 201 LLTGASPFTVDGEQNSQSEISRRILKS-KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred HHhCCCCcccCcccchHHHHHHHHHcc-CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 2111 122333333333 35667788999999999999999999999988876654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.19 E-value=4.2e-12 Score=99.57 Aligned_cols=111 Identities=11% Similarity=0.013 Sum_probs=71.3
Q ss_pred ccCCCCCcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cccc---------------------
Q psy1684 61 QKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVH--------------------- 103 (189)
Q Consensus 61 yl~~~~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~--------------------- 103 (189)
++.....+...++..+..+.+.|+.++|..+++|+|+ |+ |++.
T Consensus 175 ~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~ 254 (392)
T PHA03207 175 YVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETN 254 (392)
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCcc
Confidence 3433344557777888888899999999999999996 44 2221
Q ss_pred --cC-CCCCccc-e-EEEec------------CCCCCh---HHHHHHHH--------------------------cCCCC
Q psy1684 104 --GT-NLSGVVV-S-AVDFG------------SGGMTN---AEVLHQVE--------------------------HGYRM 137 (189)
Q Consensus 104 --~~-~~~~~~~-s-VwsfG------------~~~~~~---~~~~~~v~--------------------------~g~~~ 137 (189)
|. ....|+. + ||||| |.+... ...+..+. ...++
T Consensus 255 aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (392)
T PHA03207 255 SPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRP 334 (392)
T ss_pred CHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccC
Confidence 11 2345788 9 99999 322211 11111111 11111
Q ss_pred CC--C-----CCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 138 PC--P-----PGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 138 ~~--p-----~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
+. | ...+.++.++|.+|+..||.+|||+.+++..
T Consensus 335 ~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 335 PYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred CccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 11 1 1346788899999999999999999999865
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.1e-11 Score=91.15 Aligned_cols=143 Identities=13% Similarity=0.107 Sum_probs=85.1
Q ss_pred CCC-hHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCC--CCcCHhHHHHHhhhcc
Q psy1684 5 KIK-RIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGR--TTIHYPELVEHYSKDA 81 (189)
Q Consensus 5 ~l~-~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~--~~~~l~~li~~~~~~a 81 (189)
.+. |+|++++++.+...+..++|+|+. . +. +.. ++... ..+....++.+..+.+
T Consensus 53 ~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~-~~----l~~-----------------~~~~~~~~~~~~~~~~~~~~~l~ 109 (283)
T cd07830 53 KLNEHPNIVKLKEVFRENDELYFVFEYM-E-GN----LYQ-----------------LMKDRKGKPFSESVIRSIIYQIL 109 (283)
T ss_pred hccCCCCchhHHHHhhcCCcEEEEEecC-C-CC----HHH-----------------HHHhcccccCCHHHHHHHHHHHH
Confidence 455 888888888777777788888887 3 31 111 11111 1233455555666667
Q ss_pred CCceeeccCCccccccc-c-----------------------------------cccccC--CCCCccc-e-EEEec---
Q psy1684 82 DGLCVNLRKPCVQVSCR-I-----------------------------------YLVHGT--NLSGVVV-S-AVDFG--- 118 (189)
Q Consensus 82 ~gl~~~~~~~~~~~~~p-~-----------------------------------~l~~~~--~~~~~~~-s-VwsfG--- 118 (189)
.++.++|...++|+|+. . ++++|. ....++. + |||||
T Consensus 110 ~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l 189 (283)
T cd07830 110 QGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIM 189 (283)
T ss_pred HHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHH
Confidence 77777777777777653 2 112221 1234678 8 99999
Q ss_pred ---------CCCCChHHHHHHHHcC-CCC-----------------C-----------CCCCCCHHHHHHHHHhcccCCC
Q psy1684 119 ---------SGGMTNAEVLHQVEHG-YRM-----------------P-----------CPPGCPPRLYDIMLECWLKDPV 160 (189)
Q Consensus 119 ---------~~~~~~~~~~~~v~~g-~~~-----------------~-----------~p~~~p~~~~~l~~~C~~~~p~ 160 (189)
|++.+..+....+... ..+ . ..+..+.++.+++.+||+.||+
T Consensus 190 ~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~ 269 (283)
T cd07830 190 AELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPK 269 (283)
T ss_pred HHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcc
Confidence 3333322222111110 000 0 0112368899999999999999
Q ss_pred CCCCHHHHHH
Q psy1684 161 KRPTFETLQW 170 (189)
Q Consensus 161 ~RP~~~~i~~ 170 (189)
+|||++||+.
T Consensus 270 ~Rpt~~ei~~ 279 (283)
T cd07830 270 KRPTASQALQ 279 (283)
T ss_pred cCCCHHHHhh
Confidence 9999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.1e-12 Score=103.01 Aligned_cols=105 Identities=8% Similarity=-0.035 Sum_probs=69.2
Q ss_pred CcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cccc-----------------------cC-C
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVH-----------------------GT-N 106 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~-----------------------~~-~ 106 (189)
.+....+..+..+++.|+.++|..+++|+|+ |+ |++. |. .
T Consensus 256 ~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~ 335 (461)
T PHA03211 256 PLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLA 335 (461)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHc
Confidence 3556777778888899999999999999996 44 2221 11 3
Q ss_pred CCCccc-e-EEEec-------------CCC-------CChHHHHHHHHcCCC--CCCCC---------------------
Q psy1684 107 LSGVVV-S-AVDFG-------------SGG-------MTNAEVLHQVEHGYR--MPCPP--------------------- 141 (189)
Q Consensus 107 ~~~~~~-s-VwsfG-------------~~~-------~~~~~~~~~v~~g~~--~~~p~--------------------- 141 (189)
...++. + ||||| |.. ....++...+..+.. ...|.
T Consensus 336 ~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 415 (461)
T PHA03211 336 GDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPA 415 (461)
T ss_pred CCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCc
Confidence 345888 9 99999 111 112334433332210 00110
Q ss_pred ----------CCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 142 ----------GCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 142 ----------~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
..+.++.+|+.+|++.||.+|||+.|+++.
T Consensus 416 ~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 416 YTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 234578899999999999999999999864
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.3e-12 Score=96.68 Aligned_cols=63 Identities=25% Similarity=0.310 Sum_probs=42.9
Q ss_pred Cccc-e-EEEec------------CCCCC-hHHHHHHHHcCCCCCCC----CCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q psy1684 109 GVVV-S-AVDFG------------SGGMT-NAEVLHQVEHGYRMPCP----PGCPPRLYDIMLECWLKDPVKRPTFETLQ 169 (189)
Q Consensus 109 ~~~~-s-VwsfG------------~~~~~-~~~~~~~v~~g~~~~~p----~~~p~~~~~l~~~C~~~~p~~RP~~~~i~ 169 (189)
.++. + ||||| |.... ..+.+..+..+..+..+ ..++.++.+|+.+||+.||++|||+.+|+
T Consensus 186 ~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~ 265 (288)
T cd06616 186 GYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELL 265 (288)
T ss_pred CCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 5888 9 99999 22222 11222223233322222 24789999999999999999999999998
Q ss_pred HH
Q psy1684 170 WK 171 (189)
Q Consensus 170 ~~ 171 (189)
+.
T Consensus 266 ~~ 267 (288)
T cd06616 266 EH 267 (288)
T ss_pred cC
Confidence 64
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.18 E-value=4.8e-12 Score=95.55 Aligned_cols=29 Identities=28% Similarity=0.167 Sum_probs=26.7
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 142 GCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 142 ~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
.+|..+.+++.+||+.||++|||+.+|+.
T Consensus 270 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 270 FIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 46899999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=99.18 E-value=4.7e-12 Score=99.18 Aligned_cols=119 Identities=12% Similarity=0.014 Sum_probs=87.5
Q ss_pred EEEEeccCC----ccCCCCCcCHhHHHHHhhhccCCceeeccCCcccccc-cccccccC---------------------
Q psy1684 52 TTGRSLFET----QKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RIYLVHGT--------------------- 105 (189)
Q Consensus 52 ~~i~~~~~g----yl~~~~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~~l~~~~--------------------- 105 (189)
|.+....+| ||..-..|.....--|..++.+++.|+|+.+|||||+ |+.+..+.
T Consensus 151 FvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~ 230 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKS 230 (604)
T ss_pred EEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhcc
Confidence 334445555 6666566654444446677788999999999999996 77222111
Q ss_pred -----------------------------CCCCccc-e-EEEec------------CCCCChHHHHHHHHcCCCCCCCCC
Q psy1684 106 -----------------------------NLSGVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMPCPPG 142 (189)
Q Consensus 106 -----------------------------~~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~~p~~ 142 (189)
..+..+. + +|+|| |.+.+.--+.++|..- ..++|++
T Consensus 231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l-~y~fp~~ 309 (604)
T KOG0592|consen 231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL-DYEFPEG 309 (604)
T ss_pred ccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh-cccCCCC
Confidence 3445567 8 99999 7777666666676543 3568899
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 143 CPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 143 ~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
.|+.+.+|+.+-+..||++|.|.++|...
T Consensus 310 fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 310 FPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred CCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 99999999999999999999999988764
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.18 E-value=4.2e-12 Score=94.84 Aligned_cols=103 Identities=12% Similarity=0.034 Sum_probs=67.1
Q ss_pred cCHhHHHHHhhhccCCceeeccCCccccccc-c----------------------------------cccccC--CCCCc
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSCR-I----------------------------------YLVHGT--NLSGV 110 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~p-~----------------------------------~l~~~~--~~~~~ 110 (189)
+...++..+..+.+.|+.++|..+++|+|+. . ++++|. ..+.+
T Consensus 97 ~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 176 (282)
T cd07831 97 LPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDDILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYY 176 (282)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcCCCeEEEecccccccccCCCcCCCCCCcccCChhHhhcCCCC
Confidence 4456666677777888888888888888653 2 223332 22346
Q ss_pred cc-e-EEEec------------CCCCChHHHHHHHHc--CC---------------CCCC-----------CCCCCHHHH
Q psy1684 111 VV-S-AVDFG------------SGGMTNAEVLHQVEH--GY---------------RMPC-----------PPGCPPRLY 148 (189)
Q Consensus 111 ~~-s-VwsfG------------~~~~~~~~~~~~v~~--g~---------------~~~~-----------p~~~p~~~~ 148 (189)
+. + ||||| |++.+..+....+.. |. .... ...+|.++.
T Consensus 177 ~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (282)
T cd07831 177 GPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGL 256 (282)
T ss_pred CcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHH
Confidence 78 8 99999 444443333332211 10 0011 125678999
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q psy1684 149 DIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 149 ~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
+|+.+||+.||++||++.++++
T Consensus 257 ~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 257 DLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred HHHHHHhccCcccccCHHHHhh
Confidence 9999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.1e-11 Score=96.52 Aligned_cols=144 Identities=6% Similarity=-0.095 Sum_probs=89.9
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.+.|+|+++++.........|||+|++++ |++ .. ++. +..++......+..+.+.|+
T Consensus 99 ~~~h~~iv~~~~~~~~~~~~~lv~Ey~~g-g~L----~~-----------------~l~-~~~l~~~~~~~~~~qi~~aL 155 (370)
T cd05596 99 HANSEWIVQLHYAFQDDKYLYMVMEYMPG-GDL----VN-----------------LMS-NYDIPEKWARFYTAEVVLAL 155 (370)
T ss_pred hCCCCCcceEEEEEecCCEEEEEEcCCCC-CcH----HH-----------------HHH-hcCCCHHHHHHHHHHHHHHH
Confidence 45566666666555444556677777665 311 11 111 11233333444455667788
Q ss_pred eeeccCCcccccc-cc---------------cc----------------------cccC-----CCCCccc-e-EEEec-
Q psy1684 85 CVNLRKPCVQVSC-RI---------------YL----------------------VHGT-----NLSGVVV-S-AVDFG- 118 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~---------------~l----------------------~~~~-----~~~~~~~-s-VwsfG- 118 (189)
.++|..+++|+|+ |+ |+ |+|. ....++. + |||||
T Consensus 156 ~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGv 235 (370)
T cd05596 156 DAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGV 235 (370)
T ss_pred HHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhH
Confidence 8888888888875 44 22 2221 1224788 9 99999
Q ss_pred -----------CCCCChHHHHHHHHcC-CCCCCCC--CCCHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q psy1684 119 -----------SGGMTNAEVLHQVEHG-YRMPCPP--GCPPRLYDIMLECWLKDPVK--RPTFETLQWK 171 (189)
Q Consensus 119 -----------~~~~~~~~~~~~v~~g-~~~~~p~--~~p~~~~~l~~~C~~~~p~~--RP~~~~i~~~ 171 (189)
|.+.+.......+..+ ..+..|. .++.++.+|+.+|+..+|.+ ||++.++++.
T Consensus 236 ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 236 FLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred HHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 5555555666666543 3344444 57899999999999999987 9999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.17 E-value=5.1e-12 Score=94.49 Aligned_cols=103 Identities=19% Similarity=0.136 Sum_probs=68.5
Q ss_pred cCHhHHHHHhhhccCCceeeccC-Ccccccc-cc---------------cc--------------------cccCC----
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRK-PCVQVSC-RI---------------YL--------------------VHGTN---- 106 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~-~~~~~~~-p~---------------~l--------------------~~~~~---- 106 (189)
+....+..+..+.+.|+.++|.. +++|+|+ |. ++ ++|..
T Consensus 100 ~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 179 (283)
T cd06617 100 IPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPEL 179 (283)
T ss_pred CCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccccccccccCCccccChhhcCCcc
Confidence 34555666777778888888876 7888775 33 11 12211
Q ss_pred -CCCccc-e-EEEec------------CCCC-ChHHHHHHHHcCCCCCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q psy1684 107 -LSGVVV-S-AVDFG------------SGGM-TNAEVLHQVEHGYRMPCP-PGCPPRLYDIMLECWLKDPVKRPTFETLQ 169 (189)
Q Consensus 107 -~~~~~~-s-VwsfG------------~~~~-~~~~~~~~v~~g~~~~~p-~~~p~~~~~l~~~C~~~~p~~RP~~~~i~ 169 (189)
...++. + ||||| |... ...+-+..+..+..+..| ..+|.++.+++.+||..+|++||++.+|+
T Consensus 180 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il 259 (283)
T cd06617 180 NQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELL 259 (283)
T ss_pred cccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 134688 9 99999 2221 122333344445444444 35789999999999999999999999998
Q ss_pred H
Q psy1684 170 W 170 (189)
Q Consensus 170 ~ 170 (189)
.
T Consensus 260 ~ 260 (283)
T cd06617 260 Q 260 (283)
T ss_pred c
Confidence 6
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.17 E-value=5e-12 Score=94.62 Aligned_cols=30 Identities=20% Similarity=0.278 Sum_probs=26.9
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 142 GCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 142 ~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
..+.++.+++.+|+..||.+|||+++++..
T Consensus 253 ~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 253 DASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred CccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 467899999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.5e-11 Score=92.79 Aligned_cols=101 Identities=11% Similarity=0.032 Sum_probs=72.2
Q ss_pred HhHHHHHhhhccCCceeeccCCcccccc-cc---------------cccccC----------------------------
Q psy1684 70 YPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVHGT---------------------------- 105 (189)
Q Consensus 70 l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~~~---------------------------- 105 (189)
...+..+..+.+.|+.++|..+++|||+ |+ |+++..
T Consensus 125 ~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~ 204 (294)
T PHA02882 125 KKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDA 204 (294)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHH
Confidence 3445567778889999999999999996 44 343210
Q ss_pred -CCCCccc-e-EEEec------------CCCCC-hHH--------HHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCC
Q psy1684 106 -NLSGVVV-S-AVDFG------------SGGMT-NAE--------VLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVK 161 (189)
Q Consensus 106 -~~~~~~~-s-VwsfG------------~~~~~-~~~--------~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~ 161 (189)
....++. + ||||| |.+.+ ..+ .+..+..+. . .++.+|+++.+++..||..+|++
T Consensus 205 ~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~ 282 (294)
T PHA02882 205 HNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGK-I-KIKNANKFIYDFIECVTKLSYEE 282 (294)
T ss_pred hCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhhhh-h-ccCCCCHHHHHHHHHHHhCCCCC
Confidence 3345788 9 99999 55542 222 223333332 1 24578999999999999999999
Q ss_pred CCCHHHHHHHH
Q psy1684 162 RPTFETLQWKL 172 (189)
Q Consensus 162 RP~~~~i~~~l 172 (189)
||++.+|.+.|
T Consensus 283 rp~~~~l~~~~ 293 (294)
T PHA02882 283 KPDYDALIKIF 293 (294)
T ss_pred CCCHHHHHHhh
Confidence 99999999876
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.16 E-value=6.3e-12 Score=95.02 Aligned_cols=143 Identities=12% Similarity=0.012 Sum_probs=85.6
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC-CCCcCHhHHHHHhhhccCC
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG-RTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~-~~~~~l~~li~~~~~~a~g 83 (189)
.++|+|++++++........+||+|++.. + +.. ++.. ...+....+..+..+.+.+
T Consensus 60 ~l~h~nI~~~~~~~~~~~~~~lv~e~~~~-~-----l~~-----------------~l~~~~~~~~~~~~~~~~~qi~~a 116 (301)
T cd07873 60 DLKHANIVTLHDIIHTEKSLTLVFEYLDK-D-----LKQ-----------------YLDDCGNSINMHNVKLFLFQLLRG 116 (301)
T ss_pred hcCCCCcceEEEEEecCCeEEEEEecccc-C-----HHH-----------------HHHhcCCCCCHHHHHHHHHHHHHH
Confidence 45666666666655545555666666542 1 111 2221 1223355556666777788
Q ss_pred ceeeccCCcccccc-cc---------------ccc---------------------ccC--CCCCccc-e-EEEec----
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YLV---------------------HGT--NLSGVVV-S-AVDFG---- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l~---------------------~~~--~~~~~~~-s-VwsfG---- 118 (189)
+.++|..+++|+|+ |. +++ +|. ....++. + |||||
T Consensus 117 L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~ 196 (301)
T cd07873 117 LNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFY 196 (301)
T ss_pred HHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHH
Confidence 88888888888875 43 111 111 1234778 8 99999
Q ss_pred --------CCCCChHHHHHHHHcCC------------------CCCC-----------CCCCCHHHHHHHHHhcccCCCC
Q psy1684 119 --------SGGMTNAEVLHQVEHGY------------------RMPC-----------PPGCPPRLYDIMLECWLKDPVK 161 (189)
Q Consensus 119 --------~~~~~~~~~~~~v~~g~------------------~~~~-----------p~~~p~~~~~l~~~C~~~~p~~ 161 (189)
|.+.+..+....+.... .... ...+++++.+|+.+|+..||.+
T Consensus 197 el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~ 276 (301)
T cd07873 197 EMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRK 276 (301)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCccc
Confidence 44444433332221100 0001 1357889999999999999999
Q ss_pred CCCHHHHHH
Q psy1684 162 RPTFETLQW 170 (189)
Q Consensus 162 RP~~~~i~~ 170 (189)
|||+++++.
T Consensus 277 R~t~~eil~ 285 (301)
T cd07873 277 RISAEEAMK 285 (301)
T ss_pred CcCHHHHhc
Confidence 999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.16 E-value=2.3e-11 Score=93.04 Aligned_cols=35 Identities=26% Similarity=0.372 Sum_probs=29.9
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHH
Q psy1684 142 GCPPRLYDIMLECWLKDPVKRPTFETLQWK--LEDFF 176 (189)
Q Consensus 142 ~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~--l~~~~ 176 (189)
..|.++.+++.+||+.||++||++.+++.. |+.+.
T Consensus 260 ~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 260 GASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 468899999999999999999999999874 55443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.2e-11 Score=92.23 Aligned_cols=143 Identities=12% Similarity=0.073 Sum_probs=88.5
Q ss_pred CCC-hHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 5 KIK-RIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 5 ~l~-~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
.+. |+|++++.+........++|+++...+. +.. ++.....+.......+..+.+.|
T Consensus 57 ~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~-----L~~-----------------~l~~~~~l~~~~~~~i~~ql~~~ 114 (280)
T cd05581 57 RLNGHPGIIKLYYTFQDEENLYFVLEYAPNGE-----LLQ-----------------YIRKYGSLDEKCTRFYAAEILLA 114 (280)
T ss_pred hcccCCCchhHHHHhcCCceEEEEEcCCCCCc-----HHH-----------------HHHHcCCCCHHHHHHHHHHHHHH
Confidence 345 8888888877766667788888776522 111 12212233344445555555666
Q ss_pred ceeeccCCcccccc-cc--------------------------------------------------------cccccC-
Q psy1684 84 LCVNLRKPCVQVSC-RI--------------------------------------------------------YLVHGT- 105 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~--------------------------------------------------------~l~~~~- 105 (189)
+.++|..+++|+|+ |. ++++|.
T Consensus 115 l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~ 194 (280)
T cd05581 115 LEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELL 194 (280)
T ss_pred HHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHh
Confidence 66666666666654 22 112221
Q ss_pred CCCCccc-e-EEEec------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH----HH
Q psy1684 106 NLSGVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTF----ET 167 (189)
Q Consensus 106 ~~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~----~~ 167 (189)
....++. + ||||| |...+..+....+..+ ....|...|+.+.+++.+||+.||++||++ .+
T Consensus 195 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 273 (280)
T cd05581 195 NEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL-EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDE 273 (280)
T ss_pred CCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc-CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHH
Confidence 2334677 8 99999 3444444444444433 345677889999999999999999999999 66
Q ss_pred HHH
Q psy1684 168 LQW 170 (189)
Q Consensus 168 i~~ 170 (189)
+++
T Consensus 274 ll~ 276 (280)
T cd05581 274 LKA 276 (280)
T ss_pred Hhc
Confidence 653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.16 E-value=3.2e-12 Score=100.19 Aligned_cols=28 Identities=25% Similarity=0.205 Sum_probs=25.9
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 143 CPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 143 ~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
.|.++.+|+.+|++.||.+|||++|+++
T Consensus 348 ~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 348 LPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 5678999999999999999999999986
|
|
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.6e-12 Score=106.34 Aligned_cols=115 Identities=14% Similarity=0.149 Sum_probs=83.1
Q ss_pred CcCHhHHHHHhhhccCCceeeccC--Ccccccccc-cc--cccC------------------------------------
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRK--PCVQVSCRI-YL--VHGT------------------------------------ 105 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~--~~~~~~~p~-~l--~~~~------------------------------------ 105 (189)
.|+..+++.+..+++++++.+|.. |+||||+.. .+ +...
T Consensus 140 ~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp 219 (738)
T KOG1989|consen 140 RLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTP 219 (738)
T ss_pred cCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCc
Confidence 366788888999999999999986 599999754 11 0000
Q ss_pred -----------CCCCccc-e-EEEec-------CCCCChHHH-HHHHHcC-CCCCCCCCCCHHHHHHHHHhcccCCCCCC
Q psy1684 106 -----------NLSGVVV-S-AVDFG-------SGGMTNAEV-LHQVEHG-YRMPCPPGCPPRLYDIMLECWLKDPVKRP 163 (189)
Q Consensus 106 -----------~~~~~~~-s-VwsfG-------~~~~~~~~~-~~~v~~g-~~~~~p~~~p~~~~~l~~~C~~~~p~~RP 163 (189)
.+...++ + ||++| |....-++- .-+|.+| +..|..+..+..+.+||..|++.||++||
T Consensus 220 ~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RP 299 (738)
T KOG1989|consen 220 QYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERP 299 (738)
T ss_pred cccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCC
Confidence 5666889 9 99999 222211111 1234455 45555567889999999999999999999
Q ss_pred CHHHHHHHHHHHHhhcCC
Q psy1684 164 TFETLQWKLEDFFTMEGS 181 (189)
Q Consensus 164 ~~~~i~~~l~~~~~~~~~ 181 (189)
+.-+++..+-.+....-+
T Consensus 300 nI~Qv~~~~~~l~~~~~~ 317 (738)
T KOG1989|consen 300 NIYQVLEEIFELANKPCP 317 (738)
T ss_pred CHHHHHHHHHHHhcCCCC
Confidence 999999999888765433
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.16 E-value=3e-12 Score=95.30 Aligned_cols=110 Identities=10% Similarity=0.020 Sum_probs=73.6
Q ss_pred ccCCCCCcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------------------------cccccC-
Q psy1684 61 QKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------------------------YLVHGT- 105 (189)
Q Consensus 61 yl~~~~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------------------------~l~~~~- 105 (189)
++.....+...++..+..+.+.|+.++|...++|+|+ |. ++++|.
T Consensus 99 ~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~y~aPE~~ 178 (267)
T PHA03390 99 LLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGTLDYFSPEKI 178 (267)
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCccCCCCCcccChhhh
Confidence 4444445556777777888888999999999999885 33 122222
Q ss_pred CCCCccc-e-EEEec------------CCCCChHHH-HHHH-H-cCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-HHH
Q psy1684 106 NLSGVVV-S-AVDFG------------SGGMTNAEV-LHQV-E-HGYRMPCPPGCPPRLYDIMLECWLKDPVKRPT-FET 167 (189)
Q Consensus 106 ~~~~~~~-s-VwsfG------------~~~~~~~~~-~~~v-~-~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~-~~~ 167 (189)
....++. + ||||| |.+.....+ ...+ . .....+.+..+++.+.+++.+||+.||.+||+ +++
T Consensus 179 ~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~ 258 (267)
T PHA03390 179 KGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNE 258 (267)
T ss_pred cCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHHHHHhccChhhCCchHHH
Confidence 3356788 9 99999 332222211 1111 1 12334556679999999999999999999995 688
Q ss_pred HHH
Q psy1684 168 LQW 170 (189)
Q Consensus 168 i~~ 170 (189)
+++
T Consensus 259 ~l~ 261 (267)
T PHA03390 259 IIK 261 (267)
T ss_pred Hhc
Confidence 874
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.3e-11 Score=92.57 Aligned_cols=103 Identities=16% Similarity=0.027 Sum_probs=68.7
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cc--------------------cccC-CCCCc
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YL--------------------VHGT-NLSGV 110 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l--------------------~~~~-~~~~~ 110 (189)
+....+..+..+.+.|+.++|..+++|+|+ |. ++ ++|. ....+
T Consensus 105 ~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 184 (288)
T cd07863 105 LPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTY 184 (288)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccCcccCCCccccccccCchHhhCCCC
Confidence 445666777788888999999999999986 44 11 1111 24557
Q ss_pred cc-e-EEEec------------CCCCChHHHHHHHHc--CC----------------CC--------CCCCCCCHHHHHH
Q psy1684 111 VV-S-AVDFG------------SGGMTNAEVLHQVEH--GY----------------RM--------PCPPGCPPRLYDI 150 (189)
Q Consensus 111 ~~-s-VwsfG------------~~~~~~~~~~~~v~~--g~----------------~~--------~~p~~~p~~~~~l 150 (189)
+. + |||+| |.+.+..+.+..+.. +. .. ...+.++.++.+|
T Consensus 185 ~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 264 (288)
T cd07863 185 ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQL 264 (288)
T ss_pred CCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHH
Confidence 88 9 99999 333333333333211 00 00 0113567888999
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q psy1684 151 MLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 151 ~~~C~~~~p~~RP~~~~i~~ 170 (189)
+.+|++.||++|||+.+++.
T Consensus 265 i~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 265 LLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred HHHHhccCcccCCCHHHHhc
Confidence 99999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=99.15 E-value=4e-12 Score=99.49 Aligned_cols=144 Identities=12% Similarity=0.105 Sum_probs=102.1
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHH-HHHhhhccC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPEL-VEHYSKDAD 82 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~l-i~~~~~~a~ 82 (189)
.-++|+|+|+|+.+-..+...|||.|.-..+..|-...++ .. -+ -.+| -.|+.|+-.
T Consensus 72 KLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKH-------------e~--------Gl-~E~La~kYF~QI~~ 129 (864)
T KOG4717|consen 72 KLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKH-------------EE--------GL-NEDLAKKYFAQIVH 129 (864)
T ss_pred HHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhh-------------hc--------cc-cHHHHHHHHHHHHH
Confidence 3468999999988877778889998886653312111111 11 11 1222 346777777
Q ss_pred CceeeccCCcccccc-cc--------cccccC-----------------------------CCCCccc-e--EEEec---
Q psy1684 83 GLCVNLRKPCVQVSC-RI--------YLVHGT-----------------------------NLSGVVV-S--AVDFG--- 118 (189)
Q Consensus 83 gl~~~~~~~~~~~~~-p~--------~l~~~~-----------------------------~~~~~~~-s--VwsfG--- 118 (189)
++.|+|...++|||+ |+ ||.+-. .+..|+. + |||+|
T Consensus 130 AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVIL 209 (864)
T KOG4717|consen 130 AISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVIL 209 (864)
T ss_pred HHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHH
Confidence 899999999999995 77 222111 5667888 4 99999
Q ss_pred ---------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 119 ---------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 119 ---------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
|...+..+.+-+|..- ....|..+..+.++||.+++..||.+|.+.++|..
T Consensus 210 yMLVCGq~PFqeANDSETLTmImDC-KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 210 YMLVCGQPPFQEANDSETLTMIMDC-KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred HHHHhCCCccccccchhhhhhhhcc-cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 6666777776666443 34578899999999999999999999999999875
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.1e-12 Score=93.58 Aligned_cols=137 Identities=11% Similarity=-0.003 Sum_probs=84.2
Q ss_pred hHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCceee
Q psy1684 8 RIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGLCVN 87 (189)
Q Consensus 8 ~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl~~~ 87 (189)
|+|++++.+.....+..|||+|++.++. +.. ++.....+...+...+..+.+.|+.++
T Consensus 44 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~-----L~~-----------------~l~~~~~l~~~~~~~~~~ql~~~l~~l 101 (237)
T cd05576 44 VPNMVCLHKYIVSEDSVFLVLQHAEGGK-----LWS-----------------HISKFLNIPEECVKRWAAEMVVALDAL 101 (237)
T ss_pred CCceeehhhheecCCeEEEEEecCCCCC-----HHH-----------------HHHHhcCCCHHHHHHHHHHHHHHHHHH
Confidence 5666666665555556677777666522 111 222222344555666777778888899
Q ss_pred ccCCcccccc-cc---------------------------------cccccC-CCCCccc-e-EEEec------CCCCCh
Q psy1684 88 LRKPCVQVSC-RI---------------------------------YLVHGT-NLSGVVV-S-AVDFG------SGGMTN 124 (189)
Q Consensus 88 ~~~~~~~~~~-p~---------------------------------~l~~~~-~~~~~~~-s-VwsfG------~~~~~~ 124 (189)
|...++|+|+ |+ ++++|. ..+.++. + |||+| ..|..+
T Consensus 102 H~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~ 181 (237)
T cd05576 102 HREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTL 181 (237)
T ss_pred HhCCeeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcch
Confidence 9888999885 44 122222 2345788 8 99999 223221
Q ss_pred HHHH-HHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH
Q psy1684 125 AEVL-HQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFE 166 (189)
Q Consensus 125 ~~~~-~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~ 166 (189)
.... ..+........|..+++++++++.+|++.||++||++.
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 182 VECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred hhcCchhcccccccCCcccCCHHHHHHHHHHccCCHHHhcCCC
Confidence 1110 11122233456778899999999999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.15 E-value=8.1e-12 Score=93.56 Aligned_cols=111 Identities=11% Similarity=-0.007 Sum_probs=75.1
Q ss_pred ccCCCCCcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cc-------------------cccC
Q psy1684 61 QKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YL-------------------VHGT 105 (189)
Q Consensus 61 yl~~~~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l-------------------~~~~ 105 (189)
++.....+....+..+..+.+.|+.++|...++|+|+ |+ ++ ++|.
T Consensus 87 ~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~ 166 (279)
T cd05633 87 HLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEV 166 (279)
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCccCcCCCcCccCHHH
Confidence 4444444556667777788888999999999999986 43 22 2221
Q ss_pred C--CCCccc-e-EEEec------------CCCCCh--HHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCC----
Q psy1684 106 N--LSGVVV-S-AVDFG------------SGGMTN--AEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRP---- 163 (189)
Q Consensus 106 ~--~~~~~~-s-VwsfG------------~~~~~~--~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP---- 163 (189)
. ...++. + ||||| |.+... ...............|..++.++.+++.+||..||++||
T Consensus 167 ~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 246 (279)
T cd05633 167 LQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLG 246 (279)
T ss_pred hcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCC
Confidence 1 234788 9 99999 322211 112222222334556778999999999999999999999
Q ss_pred -CHHHHHHH
Q psy1684 164 -TFETLQWK 171 (189)
Q Consensus 164 -~~~~i~~~ 171 (189)
+++++++.
T Consensus 247 ~~~~~~~~h 255 (279)
T cd05633 247 RGAQEVKEH 255 (279)
T ss_pred CCHHHHHhC
Confidence 58888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.15 E-value=9.8e-12 Score=92.88 Aligned_cols=100 Identities=13% Similarity=-0.010 Sum_probs=66.0
Q ss_pred CcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------c--------------------ccccC-CCCC
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------Y--------------------LVHGT-NLSG 109 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~--------------------l~~~~-~~~~ 109 (189)
.++..++..+..+.+.++.++|..+++|+|+ |. + +++|. ..+.
T Consensus 91 ~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~ 170 (277)
T cd05577 91 GFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEV 170 (277)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCCcCCHHHhcCCC
Confidence 3445666667777888888999988888875 33 1 11111 3345
Q ss_pred ccc-e-EEEec------------CCCCCh----HHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q psy1684 110 VVV-S-AVDFG------------SGGMTN----AEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFET 167 (189)
Q Consensus 110 ~~~-s-VwsfG------------~~~~~~----~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~ 167 (189)
++. + ||||| |.+... .++...+. ....+.|...++++.+++.+||+.||++||++.+
T Consensus 171 ~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 171 YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL-EMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccc-cccccCCccCCHHHHHHHHHHccCChhHccCCCc
Confidence 788 8 99999 322221 22222222 2334566778999999999999999999995544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.2e-11 Score=92.46 Aligned_cols=143 Identities=15% Similarity=0.105 Sum_probs=85.6
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC-CCCcCHhHHHHHhhhccCC
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG-RTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~-~~~~~l~~li~~~~~~a~g 83 (189)
.++|++++++.+.+......++|+|+... + +.. ++.. ...+..........+.+.|
T Consensus 54 ~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~-----l~~-----------------~l~~~~~~~~~~~~~~~~~~i~~~ 110 (283)
T cd05118 54 ELNHPNIIKLLDVFRHKGDLYLVFEFMDT-D-----LYK-----------------LIKDRQRGLPESLIKSYLYQLLQG 110 (283)
T ss_pred HhcCCCcchHHHhhccCCCEEEEEeccCC-C-----HHH-----------------HHHhhcccCCHHHHHHHHHHHHHH
Confidence 45677888877776666677888887653 2 111 1111 1123344455555666667
Q ss_pred ceeeccCCcccccc-cc------------------------------------cccccC-CCC-Cccc-e-EEEec----
Q psy1684 84 LCVNLRKPCVQVSC-RI------------------------------------YLVHGT-NLS-GVVV-S-AVDFG---- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~------------------------------------~l~~~~-~~~-~~~~-s-VwsfG---- 118 (189)
+.++|...++|+|+ |. +.++|. ... .++. + |||+|
T Consensus 111 l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~ 190 (283)
T cd05118 111 LAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFA 190 (283)
T ss_pred HHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHH
Confidence 77777777777764 33 111121 223 5788 8 99999
Q ss_pred --------CCCCChHHHHHHHHcC-CC-------------------------C---CCCCCCCHHHHHHHHHhcccCCCC
Q psy1684 119 --------SGGMTNAEVLHQVEHG-YR-------------------------M---PCPPGCPPRLYDIMLECWLKDPVK 161 (189)
Q Consensus 119 --------~~~~~~~~~~~~v~~g-~~-------------------------~---~~p~~~p~~~~~l~~~C~~~~p~~ 161 (189)
|++.+..+.+..+.+. .. . ...+.++.++.++|.+||+.||.+
T Consensus 191 ~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~ 270 (283)
T cd05118 191 ELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHK 270 (283)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCccc
Confidence 4444443333222111 00 0 011246789999999999999999
Q ss_pred CCCHHHHHH
Q psy1684 162 RPTFETLQW 170 (189)
Q Consensus 162 RP~~~~i~~ 170 (189)
||++.+++.
T Consensus 271 Rp~~~~ll~ 279 (283)
T cd05118 271 RITAEQALA 279 (283)
T ss_pred CcCHHHHhh
Confidence 999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.4e-11 Score=93.69 Aligned_cols=63 Identities=19% Similarity=0.250 Sum_probs=43.8
Q ss_pred CCccc-e-EEEec------------CCCCChHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHhcccCCCCCCC----HHHH
Q psy1684 108 SGVVV-S-AVDFG------------SGGMTNAEVLHQVEH-GYRMPCPPGCPPRLYDIMLECWLKDPVKRPT----FETL 168 (189)
Q Consensus 108 ~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~-g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~----~~~i 168 (189)
..++. + ||||| |.+.+..+....+.. ....+.....|.++.+++.+||..||++||| +.++
T Consensus 207 ~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~l 286 (316)
T cd05574 207 DGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEI 286 (316)
T ss_pred CCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHH
Confidence 34677 8 99999 445555554444432 2222222336899999999999999999999 6666
Q ss_pred HH
Q psy1684 169 QW 170 (189)
Q Consensus 169 ~~ 170 (189)
+.
T Consensus 287 l~ 288 (316)
T cd05574 287 KQ 288 (316)
T ss_pred Hc
Confidence 55
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.4e-11 Score=93.29 Aligned_cols=31 Identities=26% Similarity=0.352 Sum_probs=27.7
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 141 PGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 141 ~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
+..+.++.+++.+||+.+|++||++++++..
T Consensus 264 ~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 264 PKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 3468899999999999999999999998863
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.4e-11 Score=92.11 Aligned_cols=28 Identities=21% Similarity=0.223 Sum_probs=25.8
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 143 CPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 143 ~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
++.++.+++.+||..||.+||+++++++
T Consensus 256 ~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 256 IDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 4889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.3e-11 Score=94.30 Aligned_cols=29 Identities=17% Similarity=0.218 Sum_probs=26.3
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 143 CPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 143 ~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
.+.++.+|+.+||..||++|||++|++..
T Consensus 287 ~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 287 KTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred cchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 45788999999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.8e-11 Score=91.40 Aligned_cols=144 Identities=13% Similarity=0.036 Sum_probs=87.3
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCC-CCcCHhHHHHHhhhccC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGR-TTIHYPELVEHYSKDAD 82 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~-~~~~l~~li~~~~~~a~ 82 (189)
..++|+|++++.+........++|+|+... + +.. ++... ..+....+..+..+.+.
T Consensus 53 ~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~-~-----l~~-----------------~i~~~~~~~~~~~~~~~~~~i~~ 109 (282)
T cd07829 53 KELKHPNIVKLLDVIHTERKLYLVFEYCDM-D-----LKK-----------------YLDKRPGPLSPNLIKSIMYQLLR 109 (282)
T ss_pred HhcCCCCHHHHHhhhhcCCceEEEecCcCc-C-----HHH-----------------HHHhhccCCCHHHHHHHHHHHHH
Confidence 356788888888877666778888887653 2 111 12111 12335555556666677
Q ss_pred CceeeccCCcccccc-cc------------------------------------cccccC-CCC-Cccc-e-EEEec---
Q psy1684 83 GLCVNLRKPCVQVSC-RI------------------------------------YLVHGT-NLS-GVVV-S-AVDFG--- 118 (189)
Q Consensus 83 gl~~~~~~~~~~~~~-p~------------------------------------~l~~~~-~~~-~~~~-s-VwsfG--- 118 (189)
|+.++|..+++|+|+ |. ++++|. ... .++. + |||||
T Consensus 110 ~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l 189 (282)
T cd07829 110 GLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIF 189 (282)
T ss_pred HHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHH
Confidence 777777777777765 33 111221 122 6788 8 99999
Q ss_pred ---------CCCCChHHHHHHHHcCCC--------------------CC--------CCCCCCHHHHHHHHHhcccCCCC
Q psy1684 119 ---------SGGMTNAEVLHQVEHGYR--------------------MP--------CPPGCPPRLYDIMLECWLKDPVK 161 (189)
Q Consensus 119 ---------~~~~~~~~~~~~v~~g~~--------------------~~--------~p~~~p~~~~~l~~~C~~~~p~~ 161 (189)
|.+.+..+.+..+.+... +. .-+..+.++.+++.+||..||++
T Consensus 190 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~ 269 (282)
T cd07829 190 AEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAK 269 (282)
T ss_pred HHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCccc
Confidence 433333222222211000 00 00123678999999999999999
Q ss_pred CCCHHHHHH
Q psy1684 162 RPTFETLQW 170 (189)
Q Consensus 162 RP~~~~i~~ 170 (189)
||++.+++.
T Consensus 270 Rp~~~~~l~ 278 (282)
T cd07829 270 RISAKEALK 278 (282)
T ss_pred CCCHHHHhh
Confidence 999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG4226|consensus | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.8e-10 Score=82.87 Aligned_cols=77 Identities=40% Similarity=0.513 Sum_probs=67.2
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcC-HhHHHHHhhh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIH-YPELVEHYSK 79 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~-l~~li~~~~~ 79 (189)
||.|+|.|..++..|...+ .+|.||||++++++|+|.+|++. .++-+||+++-.++-|.-++.+|+ +.+|++||.+
T Consensus 283 WYyG~itR~qae~~Ln~hG-~eGdFLiRDSEsnpgD~SvSlka--~grNKHFkVq~~d~~ycIGqRkF~tmd~Lv~HY~k 359 (379)
T KOG4226|consen 283 WYYGNITRHQAECALNEHG-HEGDFLIRDSESNPGDFSVSLKA--SGRNKHFKVQLVDNVYCIGQRKFHTMDELVEHYKK 359 (379)
T ss_pred ceeccccHHHHHHHHhccC-ccCceEEecCCCCCcceeEEeec--cCCCcceEEEEecceEEeccceeccHHHHHHhhhc
Confidence 9999999999999884433 46999999999999999999999 999999999765444777788999 9999999986
Q ss_pred c
Q psy1684 80 D 80 (189)
Q Consensus 80 ~ 80 (189)
.
T Consensus 360 a 360 (379)
T KOG4226|consen 360 A 360 (379)
T ss_pred C
Confidence 5
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.12 E-value=8.3e-12 Score=93.39 Aligned_cols=29 Identities=14% Similarity=0.044 Sum_probs=26.3
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 142 GCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 142 ~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
.++.++.+++.+||+.||++||++++|++
T Consensus 252 ~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 252 HADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 46788999999999999999999999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.11 E-value=3.8e-11 Score=93.83 Aligned_cols=65 Identities=15% Similarity=0.167 Sum_probs=45.3
Q ss_pred CCCccc-e-EEEec------------CCCCChHHHHHHHHc-CCCCCCC--CCCCHHHHHHHHH--hcccCCCCCCCHHH
Q psy1684 107 LSGVVV-S-AVDFG------------SGGMTNAEVLHQVEH-GYRMPCP--PGCPPRLYDIMLE--CWLKDPVKRPTFET 167 (189)
Q Consensus 107 ~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~-g~~~~~p--~~~p~~~~~l~~~--C~~~~p~~RP~~~~ 167 (189)
...++. + ||||| |.+.+..+....+.. ...+..| ..++++..+|+.+ |+..+|..||++.+
T Consensus 222 ~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~ 301 (381)
T cd05626 222 RKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADD 301 (381)
T ss_pred CCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHH
Confidence 345888 9 99999 555555555444432 2223333 3678999999987 67777778999999
Q ss_pred HHHH
Q psy1684 168 LQWK 171 (189)
Q Consensus 168 i~~~ 171 (189)
|+..
T Consensus 302 ~l~h 305 (381)
T cd05626 302 IKAH 305 (381)
T ss_pred HhcC
Confidence 9864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.11 E-value=4.3e-12 Score=95.52 Aligned_cols=28 Identities=21% Similarity=0.186 Sum_probs=25.8
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 143 CPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 143 ~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
.++.+.+++.+||+.||++|||++|++.
T Consensus 262 ~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 262 LSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred CChHHHHHHHHHhccCccccCCHHHHhc
Confidence 5788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG4637|consensus | Back alignment and domain information |
|---|
Probab=99.11 E-value=2.2e-10 Score=85.49 Aligned_cols=90 Identities=31% Similarity=0.457 Sum_probs=75.6
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC--ccCCCCCcC-HhHHHHHh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET--QKAGRTTIH-YPELVEHY 77 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g--yl~~~~~~~-l~~li~~~ 77 (189)
||||.++|+++-+.| ..+++|+||||.-.+-.|+|+|+++. .+..+-.+|...++- |. +...|. +.++|+||
T Consensus 25 WYWgdisReev~~~L--~d~PDGsFlVRdAstm~GdYTLtl~k--~g~~KLikI~h~DgKyGF~-d~ltf~SVVelIn~y 99 (464)
T KOG4637|consen 25 WYWGDISREEVNKKL--RDQPDGSFLVRDASTMQGDYTLTLRK--GGNNKLIKIVHRDGKYGFS-DPLTFNSVVELINHY 99 (464)
T ss_pred ccccccCHHHHHHHh--cCCCCCcEEeeccccCCCceEEEEec--CCccceeeeEEecCccCCC-CchhhHHHHHHHHHH
Confidence 999999999999999 56689999999977777999999999 999999999988776 55 566777 99999999
Q ss_pred hhccC-----CceeeccCCcccc
Q psy1684 78 SKDAD-----GLCVNLRKPCVQV 95 (189)
Q Consensus 78 ~~~a~-----gl~~~~~~~~~~~ 95 (189)
+..+. .+...+..|+..+
T Consensus 100 r~~SL~~yN~~LDvrLlyPVs~~ 122 (464)
T KOG4637|consen 100 RNESLAQYNPKLDVRLLYPVSRY 122 (464)
T ss_pred hhhHHHhhCcccceeeechHHHh
Confidence 87753 5666777777654
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=99.11 E-value=3.9e-11 Score=86.66 Aligned_cols=146 Identities=12% Similarity=0.026 Sum_probs=101.4
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..+.|+|+++++.+....++.-||.|+++. + +...+++ ....+.-.+.-.|..+...|
T Consensus 56 qel~h~nIi~LiD~F~~~~~l~lVfEfm~t-d-Le~vIkd--------------------~~i~l~pa~iK~y~~m~LkG 113 (318)
T KOG0659|consen 56 QELKHPNIIELIDVFPHKSNLSLVFEFMPT-D-LEVVIKD--------------------KNIILSPADIKSYMLMTLKG 113 (318)
T ss_pred HHccCcchhhhhhhccCCCceEEEEEeccc-c-HHHHhcc--------------------cccccCHHHHHHHHHHHHHH
Confidence 468899999999988888899999999885 2 2111122 01223356777788888899
Q ss_pred ceeeccCCcccccc-cc---------------cccccC-----------------------CCCCccc-e-EEEec----
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YLVHGT-----------------------NLSGVVV-S-AVDFG---- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l~~~~-----------------------~~~~~~~-s-VwsfG---- 118 (189)
++|+|.+.++|||+ |. |||+.. -...|.. . +||.|
T Consensus 114 l~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~A 193 (318)
T KOG0659|consen 114 LAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFA 193 (318)
T ss_pred HHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHH
Confidence 99999999999996 55 333322 2345889 8 99999
Q ss_pred --------CCCCChHHHHHHHHc--CC--------------------CCCCC-----CCCCHHHHHHHHHhcccCCCCCC
Q psy1684 119 --------SGGMTNAEVLHQVEH--GY--------------------RMPCP-----PGCPPRLYDIMLECWLKDPVKRP 163 (189)
Q Consensus 119 --------~~~~~~~~~~~~v~~--g~--------------------~~~~p-----~~~p~~~~~l~~~C~~~~p~~RP 163 (189)
|+|-+.-+-+..|-+ |. -|..| +.++.+..+|+...|..||.+|.
T Consensus 194 ELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Ri 273 (318)
T KOG0659|consen 194 ELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRI 273 (318)
T ss_pred HHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcc
Confidence 666655333323211 11 01111 24677889999999999999999
Q ss_pred CHHHHHHH
Q psy1684 164 TFETLQWK 171 (189)
Q Consensus 164 ~~~~i~~~ 171 (189)
|++|.++.
T Consensus 274 ta~qaL~~ 281 (318)
T KOG0659|consen 274 TASQALKH 281 (318)
T ss_pred cHHHHhcc
Confidence 99998864
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.11 E-value=3.5e-11 Score=102.16 Aligned_cols=104 Identities=14% Similarity=0.068 Sum_probs=69.0
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc-----------------------------------------------
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI----------------------------------------------- 99 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~----------------------------------------------- 99 (189)
+...+...+..+++.|+.|+|..+|+|||+ |+
T Consensus 77 ~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~ 156 (793)
T PLN00181 77 VDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERR 156 (793)
T ss_pred ccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccc
Confidence 456667778888889999999999999985 54
Q ss_pred ------------------------cccccC-CCCCccc-e-EEEec------CCCCCh----HHHHHHHHcCCCCCCCCC
Q psy1684 100 ------------------------YLVHGT-NLSGVVV-S-AVDFG------SGGMTN----AEVLHQVEHGYRMPCPPG 142 (189)
Q Consensus 100 ------------------------~l~~~~-~~~~~~~-s-VwsfG------~~~~~~----~~~~~~v~~g~~~~~p~~ 142 (189)
++|||. ....|+. + ||||| +.+..+ ...+..+.....++.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (793)
T PLN00181 157 IEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRHRVLPPQILL 236 (793)
T ss_pred hhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHHhhcChhhhh
Confidence 112222 3455888 9 99999 222211 223333333333332223
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 143 CPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 143 ~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
..++...++.+||+.||.+||++.+|++.
T Consensus 237 ~~~~~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 237 NWPKEASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred cCHHHHHHHHHhCCCChhhCcChHHHhhc
Confidence 34567789999999999999999999763
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=99.11 E-value=2.4e-10 Score=91.83 Aligned_cols=143 Identities=12% Similarity=0.089 Sum_probs=98.5
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHH-HHHhhh-cc
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPEL-VEHYSK-DA 81 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~l-i~~~~~-~a 81 (189)
...+|+|++.++|.-...++.+|.+|++..++ +.+ +.|. .. .+.++ +.|... ..
T Consensus 67 ~dc~h~nivay~gsylr~dklwicMEycgggs-----lQd-----iy~~------------Tg--plselqiayvcRetl 122 (829)
T KOG0576|consen 67 RDCRHPNIVAYFGSYLRRDKLWICMEYCGGGS-----LQD-----IYHV------------TG--PLSELQIAYVCRETL 122 (829)
T ss_pred ecCCCcChHHHHhhhhhhcCcEEEEEecCCCc-----ccc-----eeee------------cc--cchhHHHHHHHhhhh
Confidence 35679999999998888889999999988744 222 1110 00 12332 223222 23
Q ss_pred CCceeeccCCcccccccc-------------------------------------cccccC----CCCCccc-e-EEEec
Q psy1684 82 DGLCVNLRKPCVQVSCRI-------------------------------------YLVHGT----NLSGVVV-S-AVDFG 118 (189)
Q Consensus 82 ~gl~~~~~~~~~~~~~p~-------------------------------------~l~~~~----~~~~~~~-s-VwsfG 118 (189)
.|+.|+|+..-+|||+.- |+++|+ +.+.|+. | ||+.|
T Consensus 123 ~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~g 202 (829)
T KOG0576|consen 123 QGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALG 202 (829)
T ss_pred ccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccc
Confidence 466666666666665433 666666 6788999 9 99999
Q ss_pred ------------CCCCChHHHHHHH-HcCCCCCC---CCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 119 ------------SGGMTNAEVLHQV-EHGYRMPC---PPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 119 ------------~~~~~~~~~~~~v-~~g~~~~~---p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
..++++.+++... ..|..+|. +....+.+.++++.|+..||++||+...++.
T Consensus 203 itAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 203 ITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred cchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 4456677777776 55665543 3457789999999999999999999987654
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.11 E-value=5.9e-12 Score=95.32 Aligned_cols=28 Identities=11% Similarity=-0.083 Sum_probs=25.0
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 143 CPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 143 ~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
.+.++.+|+.+|++.||++|||++++++
T Consensus 260 ~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 260 YVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred CChHHHHHHHHHhccCchhccCHHHHhc
Confidence 3467889999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.11 E-value=4.3e-11 Score=92.16 Aligned_cols=105 Identities=12% Similarity=-0.012 Sum_probs=69.5
Q ss_pred CcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------c------------------ccccCC-C-CCc
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------Y------------------LVHGTN-L-SGV 110 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~------------------l~~~~~-~-~~~ 110 (189)
.++...+..+..+.+.|+.++|..+++|+|+ |+ | +|+|.. . ..+
T Consensus 114 ~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 193 (343)
T cd07878 114 KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATRWYRAPEIMLNWMHY 193 (343)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCCCcCCccccccccCchHhcCCccC
Confidence 3555666677788889999999999999996 44 2 222221 2 357
Q ss_pred cc-e-EEEec------------CCCCChHHHHHHHHc--CC--------------------CCCCC--------CCCCHH
Q psy1684 111 VV-S-AVDFG------------SGGMTNAEVLHQVEH--GY--------------------RMPCP--------PGCPPR 146 (189)
Q Consensus 111 ~~-s-VwsfG------------~~~~~~~~~~~~v~~--g~--------------------~~~~p--------~~~p~~ 146 (189)
+. + |||+| |.+.+..+.+..+.. |. .+..| ..+++.
T Consensus 194 ~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (343)
T cd07878 194 NQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPL 273 (343)
T ss_pred CchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHH
Confidence 88 9 99999 444443333322211 10 00011 135667
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 147 LYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 147 ~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
+.+|+.+|+..||++|||+.+++..
T Consensus 274 ~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 274 AIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHHHHHcCCChhhCCCHHHHhcC
Confidence 8899999999999999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.10 E-value=3.3e-11 Score=92.57 Aligned_cols=30 Identities=20% Similarity=0.154 Sum_probs=27.7
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 142 GCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 142 ~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
.++.++.+++.+||+.||++|||+.++++.
T Consensus 266 ~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 266 KASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred CCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 378899999999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.4e-11 Score=91.33 Aligned_cols=102 Identities=10% Similarity=0.054 Sum_probs=66.9
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cc------------------------cccC-C
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YL------------------------VHGT-N 106 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l------------------------~~~~-~ 106 (189)
+.......+..+.+.++.++|..+++|+|+ |. ++ ++|. .
T Consensus 103 ~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 182 (265)
T cd06652 103 LTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 182 (265)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhc
Confidence 334445556667777888888888888775 33 11 1121 2
Q ss_pred CCCccc-e-EEEec------------CCCCChHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 107 LSGVVV-S-AVDFG------------SGGMTNAEVLHQV-EHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 107 ~~~~~~-s-VwsfG------------~~~~~~~~~~~~v-~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
...++. + ||||| |.+.+.......+ .....+..|...+..+.+++.+||. +|++||++++|++
T Consensus 183 ~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 183 GEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred CCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 345778 8 99999 3333333333333 2334455667777889999999995 9999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=99.10 E-value=8.5e-12 Score=90.65 Aligned_cols=124 Identities=17% Similarity=0.182 Sum_probs=85.8
Q ss_pred ccCCCCCcCHhHHHHHhhhccCCceeeccCCcccccc-cc-----------------------------------ccccc
Q psy1684 61 QKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI-----------------------------------YLVHG 104 (189)
Q Consensus 61 yl~~~~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~-----------------------------------~l~~~ 104 (189)
||.+...++-++.-...++..+|.+|+|.+.|+|||+ |+ .||+|
T Consensus 113 yLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~GekLrelCGTPgYLAPE 192 (411)
T KOG0599|consen 113 YLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPGEKLRELCGTPGYLAPE 192 (411)
T ss_pred HhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCCchhHHHhcCCCcccChh
Confidence 6665555554445556667778999999999999995 66 22222
Q ss_pred C-------CCCCccc-e-EEEec------CCC----CChHH--HHHHHHcC-CCCCCC--CCCCHHHHHHHHHhcccCCC
Q psy1684 105 T-------NLSGVVV-S-AVDFG------SGG----MTNAE--VLHQVEHG-YRMPCP--PGCPPRLYDIMLECWLKDPV 160 (189)
Q Consensus 105 ~-------~~~~~~~-s-VwsfG------~~~----~~~~~--~~~~v~~g-~~~~~p--~~~p~~~~~l~~~C~~~~p~ 160 (189)
. ....|+. . .||.| ..| ++..+ ++..|.+| +....| .+.+.+.++||.+|++.||+
T Consensus 193 tikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~ 272 (411)
T KOG0599|consen 193 TIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPT 272 (411)
T ss_pred heeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCch
Confidence 2 4456999 9 99999 222 33333 34556666 333444 35778999999999999999
Q ss_pred CCCCHHHHHHH--HHHHHhhcCCCCC
Q psy1684 161 KRPTFETLQWK--LEDFFTMEGSDYK 184 (189)
Q Consensus 161 ~RP~~~~i~~~--l~~~~~~~~~~~~ 184 (189)
+|-|.+|.+.. +.++..+..+...
T Consensus 273 ~Ritake~LaHpff~q~~~~~~r~ms 298 (411)
T KOG0599|consen 273 KRITAKEALAHPFFIQIAQQQARQMS 298 (411)
T ss_pred hcccHHHHhcChHHHHHHHhcccccC
Confidence 99999999864 6677665554443
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.10 E-value=3.2e-11 Score=90.26 Aligned_cols=108 Identities=11% Similarity=-0.021 Sum_probs=74.9
Q ss_pred cCCCCCcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cc-------------------cccCC
Q psy1684 62 KAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YL-------------------VHGTN 106 (189)
Q Consensus 62 l~~~~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l-------------------~~~~~ 106 (189)
+.....+...++..+..+.+.|+.++|...++|+|+ |. ++ ++|..
T Consensus 88 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~ 167 (278)
T cd05606 88 LSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVL 167 (278)
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCCcCcCCCcCCcCcHHh
Confidence 333344556667777788888999999999999986 43 11 12221
Q ss_pred --CCCccc-e-EEEec------------CCCC---ChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCC----
Q psy1684 107 --LSGVVV-S-AVDFG------------SGGM---TNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRP---- 163 (189)
Q Consensus 107 --~~~~~~-s-VwsfG------------~~~~---~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP---- 163 (189)
...++. + ||||| |.+. ...++. .......++.|..++.++.+++.+|+..||++||
T Consensus 168 ~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~ 246 (278)
T cd05606 168 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-RMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLG 246 (278)
T ss_pred cCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH-HHhhccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCC
Confidence 224788 9 99999 3333 222222 2233445667778899999999999999999999
Q ss_pred -CHHHHHH
Q psy1684 164 -TFETLQW 170 (189)
Q Consensus 164 -~~~~i~~ 170 (189)
++.++++
T Consensus 247 ~~~~~ll~ 254 (278)
T cd05606 247 RGAQEVKE 254 (278)
T ss_pred CCHHHHHh
Confidence 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG4792|consensus | Back alignment and domain information |
|---|
Probab=99.10 E-value=3.5e-10 Score=79.25 Aligned_cols=76 Identities=33% Similarity=0.489 Sum_probs=62.1
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEec---cC-----CccCCCCCcC-Hh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSL---FE-----TQKAGRTTIH-YP 71 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~---~~-----gyl~~~~~~~-l~ 71 (189)
||+|.|+|.+|+.+|+-. ..|.||||++...+|+|+|+++. ...|.||.|..- .. ++--+...|. +.
T Consensus 13 wYfg~mSRqeA~~lL~~~--r~G~FLvRDSst~pGdYvLsV~E--~srVshYiIn~~~p~~~~~~~~~~rIgdQ~Fd~lP 88 (293)
T KOG4792|consen 13 WYFGPMSRQEAVALLQGQ--RHGVFLVRDSSTSPGDYVLSVSE--NSRVSHYIINSSPPSPAQPPPSRLRIGDQEFDSLP 88 (293)
T ss_pred eecCcccHHHHHHHhcCc--ceeeEEEecCCCCCCceEEEEec--CcceeeeeecCCCCCccCCCcceeeeccccccchH
Confidence 999999999999999644 58999999999999999999999 899999999851 11 1333456677 89
Q ss_pred HHHHHhhhc
Q psy1684 72 ELVEHYSKD 80 (189)
Q Consensus 72 ~li~~~~~~ 80 (189)
.|++||.-+
T Consensus 89 aLL~fykih 97 (293)
T KOG4792|consen 89 ALLEFYKIH 97 (293)
T ss_pred HHHhheeEe
Confidence 999987643
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.09 E-value=4.9e-11 Score=92.59 Aligned_cols=63 Identities=11% Similarity=0.102 Sum_probs=45.9
Q ss_pred CCCccc-e-EEEec------------CCCCChHHHHHHHHcC-CCCCCCC--CCCHHHHHHHHHhcccCCCCCCC---HH
Q psy1684 107 LSGVVV-S-AVDFG------------SGGMTNAEVLHQVEHG-YRMPCPP--GCPPRLYDIMLECWLKDPVKRPT---FE 166 (189)
Q Consensus 107 ~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g-~~~~~p~--~~p~~~~~l~~~C~~~~p~~RP~---~~ 166 (189)
...++. + ||||| |.+.+..+....+... ..+..|. .+++++.+|+.+|+. +|.+|++ +.
T Consensus 213 ~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~ 291 (364)
T cd05599 213 QTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVN 291 (364)
T ss_pred CCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHH
Confidence 345788 9 99999 5566666666666443 2334443 468999999999996 9999998 77
Q ss_pred HHHH
Q psy1684 167 TLQW 170 (189)
Q Consensus 167 ~i~~ 170 (189)
+++.
T Consensus 292 ~ll~ 295 (364)
T cd05599 292 EIKS 295 (364)
T ss_pred HHhc
Confidence 7765
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.09 E-value=2e-11 Score=91.31 Aligned_cols=103 Identities=13% Similarity=0.020 Sum_probs=65.5
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc-----------------------------------cccccC-CCCCc
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI-----------------------------------YLVHGT-NLSGV 110 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~-----------------------------------~l~~~~-~~~~~ 110 (189)
+..........+.+.|+.++|..+++|+|+ |. ++++|. ....+
T Consensus 104 l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~ 183 (287)
T cd07838 104 LPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSY 183 (287)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCCcccccccccccccChHHhccCCC
Confidence 445666667777788888888888888875 33 112222 23457
Q ss_pred cc-e-EEEec------------CCCCChHHHHHHHHcCCC------------------CCC--------CCCCCHHHHHH
Q psy1684 111 VV-S-AVDFG------------SGGMTNAEVLHQVEHGYR------------------MPC--------PPGCPPRLYDI 150 (189)
Q Consensus 111 ~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~------------------~~~--------p~~~p~~~~~l 150 (189)
+. + ||||| |.+.+..+.+..+..... +.. .+..+..+.++
T Consensus 184 ~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 263 (287)
T cd07838 184 ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDL 263 (287)
T ss_pred CCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHH
Confidence 88 8 99999 444444333333311000 000 01235677899
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q psy1684 151 MLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 151 ~~~C~~~~p~~RP~~~~i~~ 170 (189)
+.+||+.||++||++.+++.
T Consensus 264 i~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 264 LKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred HHHHhccCCccCCCHHHHhc
Confidence 99999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.09 E-value=3.7e-11 Score=92.97 Aligned_cols=29 Identities=17% Similarity=0.242 Sum_probs=25.9
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 143 CPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 143 ~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
.+.++.+|+.+|+..||++|||+.|+++.
T Consensus 283 ~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 283 KASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred cchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 34678899999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.9e-11 Score=91.58 Aligned_cols=100 Identities=11% Similarity=-0.032 Sum_probs=76.6
Q ss_pred CCCCCcCHhHHHHH-hhhccCCceeeccCCcccccc-cc---------------cccccC--------------------
Q psy1684 63 AGRTTIHYPELVEH-YSKDADGLCVNLRKPCVQVSC-RI---------------YLVHGT-------------------- 105 (189)
Q Consensus 63 ~~~~~~~l~~li~~-~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~~~-------------------- 105 (189)
.....|. .+.+.+ ...++.++.++|.+.|+|||+ |+ ||+++.
T Consensus 117 ~~eg~F~-E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPE 195 (357)
T KOG0598|consen 117 QREGRFS-EDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPE 195 (357)
T ss_pred HhcCCcc-hhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCCccccccCCccccChH
Confidence 3344453 233333 334456899999999999995 77 444433
Q ss_pred --CCCCccc-e-EEEec------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCC
Q psy1684 106 --NLSGVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRP 163 (189)
Q Consensus 106 --~~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP 163 (189)
....|+. + -||.| |.+-+..++.+++.++..+..|...+.+.++|+..-++.||++|-
T Consensus 196 il~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 196 ILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred HHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 5667999 9 99999 777777889999988876777777999999999999999999994
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.09 E-value=2.4e-11 Score=91.42 Aligned_cols=29 Identities=21% Similarity=0.220 Sum_probs=26.5
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 142 GCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 142 ~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
..+.++.+++.+||..||++||++.+++.
T Consensus 262 ~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 262 DLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred ccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 57889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.09 E-value=4.5e-11 Score=92.82 Aligned_cols=28 Identities=14% Similarity=0.184 Sum_probs=25.1
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 144 PPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 144 p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
+.++.+|+.+|+..||++|||+.++++.
T Consensus 291 ~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 291 ASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred cHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 3578899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.08 E-value=4.6e-11 Score=93.17 Aligned_cols=64 Identities=16% Similarity=0.063 Sum_probs=45.0
Q ss_pred CCCccc-e-EEEec------------CCCCChHHHHHHHHcC-CC--CCCCCCCCHHHHHHHHHhcccCCCCCC---CHH
Q psy1684 107 LSGVVV-S-AVDFG------------SGGMTNAEVLHQVEHG-YR--MPCPPGCPPRLYDIMLECWLKDPVKRP---TFE 166 (189)
Q Consensus 107 ~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g-~~--~~~p~~~p~~~~~l~~~C~~~~p~~RP---~~~ 166 (189)
...++. + ||||| |.+.+..+....+... .. .+....+++++.+++.+|+ .+|.+|+ +..
T Consensus 218 ~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ 296 (376)
T cd05598 218 RTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGAD 296 (376)
T ss_pred CCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHH
Confidence 345788 9 99999 5555555655555432 22 2233468899999999987 4999999 888
Q ss_pred HHHHH
Q psy1684 167 TLQWK 171 (189)
Q Consensus 167 ~i~~~ 171 (189)
++++.
T Consensus 297 ell~h 301 (376)
T cd05598 297 EIKAH 301 (376)
T ss_pred HHhCC
Confidence 88754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=99.07 E-value=6.5e-11 Score=91.71 Aligned_cols=146 Identities=12% Similarity=0.065 Sum_probs=99.1
Q ss_pred CCCCChHHHHHHhcCCC--CCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCC-cCHhHHHHHhhh
Q psy1684 3 FGKIKRIEAEKKLLLPE--NDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTT-IHYPELVEHYSK 79 (189)
Q Consensus 3 ~g~l~~~n~~~lL~~~~--~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~-~~l~~li~~~~~ 79 (189)
+.++.|+|+|+|..+-. ..+..|||.|+++.+. +... ..... +...+.-.+.+.
T Consensus 162 lKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~-----v~w~------------------p~d~~els~~~Ar~ylrD 218 (576)
T KOG0585|consen 162 LKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGE-----VKWC------------------PPDKPELSEQQARKYLRD 218 (576)
T ss_pred HHhcCCcCeeEEEEeecCcccCceEEEEEeccCCc-----cccC------------------CCCcccccHHHHHHHHHH
Confidence 35788999999876532 3456799999988632 2220 00111 233445566777
Q ss_pred ccCCceeeccCCcccccc-cccc-----------------------------------------cccC----CCCCccc-
Q psy1684 80 DADGLCVNLRKPCVQVSC-RIYL-----------------------------------------VHGT----NLSGVVV- 112 (189)
Q Consensus 80 ~a~gl~~~~~~~~~~~~~-p~~l-----------------------------------------~~~~----~~~~~~~- 112 (189)
+-.||.|+|..+|+|||+ |..| |+|. ....|+-
T Consensus 219 vv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~ 298 (576)
T KOG0585|consen 219 VVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGF 298 (576)
T ss_pred HHHHHHHHHhcCeeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccch
Confidence 788999999999999996 5511 1111 1234555
Q ss_pred e--EEEec------------CCCCChHHHHHHHHcCCCCCCCC--CCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q psy1684 113 S--AVDFG------------SGGMTNAEVLHQVEHGYRMPCPP--GCPPRLYDIMLECWLKDPVKRPTFETLQWKL 172 (189)
Q Consensus 113 s--VwsfG------------~~~~~~~~~~~~v~~g~~~~~p~--~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l 172 (189)
+ |||.| |.+-...++..+|.+. .+.+|. ...+++++||.+.+.+||++|-+..+|....
T Consensus 299 a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~-pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 299 ALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVND-PLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred hhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcC-cccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 4 99999 4554556777777544 344554 4678999999999999999999999987654
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.9e-11 Score=92.77 Aligned_cols=29 Identities=10% Similarity=0.115 Sum_probs=26.7
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 142 GCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 142 ~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
.++.++.+++.+||+.+|++|||+.+++.
T Consensus 284 ~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 284 NASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred CCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 46788999999999999999999999986
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.07 E-value=6.4e-11 Score=91.03 Aligned_cols=36 Identities=28% Similarity=0.355 Sum_probs=31.2
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHH
Q psy1684 141 PGCPPRLYDIMLECWLKDPVKRPTFETLQWK--LEDFF 176 (189)
Q Consensus 141 ~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~--l~~~~ 176 (189)
+.+++++.+++.+||+.||++|||++++++. |..+.
T Consensus 261 ~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 261 PHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred ccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 4688999999999999999999999999876 65543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.06 E-value=2.4e-11 Score=102.67 Aligned_cols=163 Identities=9% Similarity=-0.034 Sum_probs=100.6
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC-CCCcCHhHHHHHhhhccC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG-RTTIHYPELVEHYSKDAD 82 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~-~~~~~l~~li~~~~~~a~ 82 (189)
..+.|+|++++++.+...+..++|+|+++++. +.-.+.. ... ....-.. .....+..++....+++.
T Consensus 57 s~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGS-L~~lL~s-----~~~------~~~l~e~~~~~lsv~~iL~I~~QIa~ 124 (932)
T PRK13184 57 ADLIHPGIVPVYSICSDGDPVYYTMPYIEGYT-LKSLLKS-----VWQ------KESLSKELAEKTSVGAFLSIFHKICA 124 (932)
T ss_pred HhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCC-HHHHHHH-----hhh------ccccchhhhcccCHHHHHHHHHHHHH
Confidence 35778999998887777777889999887632 2100000 000 0000000 112235666777778888
Q ss_pred CceeeccCCcccccc-cc---------------cccc---------------------------------------cC-C
Q psy1684 83 GLCVNLRKPCVQVSC-RI---------------YLVH---------------------------------------GT-N 106 (189)
Q Consensus 83 gl~~~~~~~~~~~~~-p~---------------~l~~---------------------------------------~~-~ 106 (189)
|+.++|..+++|||+ |+ |++. |. .
T Consensus 125 AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~ 204 (932)
T PRK13184 125 TIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLL 204 (932)
T ss_pred HHHHHHHCCccccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhc
Confidence 999999999999985 54 2221 11 2
Q ss_pred CCCccc-e-EEEec------------CCCCChHHHHHHH--HcCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-CHHHHH
Q psy1684 107 LSGVVV-S-AVDFG------------SGGMTNAEVLHQV--EHGYRMPCPPGCPPRLYDIMLECWLKDPVKRP-TFETLQ 169 (189)
Q Consensus 107 ~~~~~~-s-VwsfG------------~~~~~~~~~~~~v--~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP-~~~~i~ 169 (189)
+..++. + ||||| |.+.+..++.... ...........+|+.+.+++.+|++.||++|| +++++.
T Consensus 205 g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl 284 (932)
T PRK13184 205 GVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK 284 (932)
T ss_pred CCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 345788 8 99999 3333322222221 11111112246889999999999999999995 677888
Q ss_pred HHHHHHHhh
Q psy1684 170 WKLEDFFTM 178 (189)
Q Consensus 170 ~~l~~~~~~ 178 (189)
+.|+.+++.
T Consensus 285 ~~Le~~lq~ 293 (932)
T PRK13184 285 QDLEPHLQG 293 (932)
T ss_pred HHHHHHHhc
Confidence 889888763
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.06 E-value=6.8e-11 Score=91.12 Aligned_cols=36 Identities=19% Similarity=0.159 Sum_probs=30.1
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHHh
Q psy1684 142 GCPPRLYDIMLECWLKDPVKRPTFETLQWK--LEDFFT 177 (189)
Q Consensus 142 ~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~--l~~~~~ 177 (189)
..+.++.+++.+||+.||++||++.+++.. ++.+..
T Consensus 268 ~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 268 KASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 467789999999999999999999999854 655543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.06 E-value=9.3e-11 Score=90.40 Aligned_cols=29 Identities=28% Similarity=0.288 Sum_probs=26.5
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 142 GCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 142 ~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
..++++.+++.+||+.||++|||+.+|+.
T Consensus 269 ~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 269 GANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred cCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 35789999999999999999999999876
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.05 E-value=4.7e-11 Score=91.73 Aligned_cols=36 Identities=25% Similarity=0.349 Sum_probs=30.1
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHHh
Q psy1684 142 GCPPRLYDIMLECWLKDPVKRPTFETLQWK--LEDFFT 177 (189)
Q Consensus 142 ~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~--l~~~~~ 177 (189)
..+.++.++|.+||+.||++|||+.++++. |+....
T Consensus 263 ~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 263 NADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred ccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 456789999999999999999999999886 555443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.05 E-value=3.3e-11 Score=95.99 Aligned_cols=97 Identities=8% Similarity=0.018 Sum_probs=70.1
Q ss_pred hHHHHHhhhccCCceeeccCCcccccc-ccccccc----------------C-------------------CCCCccc-e
Q psy1684 71 PELVEHYSKDADGLCVNLRKPCVQVSC-RIYLVHG----------------T-------------------NLSGVVV-S 113 (189)
Q Consensus 71 ~~li~~~~~~a~gl~~~~~~~~~~~~~-p~~l~~~----------------~-------------------~~~~~~~-s 113 (189)
.+...+..+....+.++|..+++|||+ |+.+--+ . ....||+ |
T Consensus 415 ~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~~tp~~t~~y~APEvl~~~~yt~ac 494 (612)
T KOG0603|consen 415 SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSCDTPALTLQYVAPEVLAIQEYTEAC 494 (612)
T ss_pred HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchhhcccchhhcccChhhhccCCCCcch
Confidence 455556666677888999999999995 5522221 1 5567999 9
Q ss_pred -EEEec------------CCCCChH-HHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 114 -AVDFG------------SGGMTNA-EVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 114 -VwsfG------------~~~~~~~-~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
+||+| |..-... ++...+..| +.....+.+.++|+.+|++.||.+||++.++..
T Consensus 495 D~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~---~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 495 DWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMP---KFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred hhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCC---ccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 99999 3222222 455555433 334788999999999999999999999999865
|
|
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=99.05 E-value=4.1e-12 Score=93.50 Aligned_cols=74 Identities=14% Similarity=0.187 Sum_probs=57.7
Q ss_pred cccccccC-CCCCccc-e-EEEec------------CCCCChHHHHHHHHcCCCCC--CCCCCCHHHHHHHHHhcccCCC
Q psy1684 98 RIYLVHGT-NLSGVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMP--CPPGCPPRLYDIMLECWLKDPV 160 (189)
Q Consensus 98 p~~l~~~~-~~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~--~p~~~p~~~~~l~~~C~~~~p~ 160 (189)
|.|+|+++ ..-.|+. + |||+| |.++++...+..+.....|. .|+.++.++-+++++|+-.+|+
T Consensus 193 PFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE 272 (502)
T KOG0574|consen 193 PFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPE 272 (502)
T ss_pred cccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHH
Confidence 33777766 4456999 9 99999 88898888777775443222 3567788899999999999999
Q ss_pred CCCCHHHHHHH
Q psy1684 161 KRPTFETLQWK 171 (189)
Q Consensus 161 ~RP~~~~i~~~ 171 (189)
+|-|+.++++.
T Consensus 273 ~R~TA~~L~~H 283 (502)
T KOG0574|consen 273 ERKTALRLCEH 283 (502)
T ss_pred HHHHHHHHhhh
Confidence 99999988763
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.3e-11 Score=92.28 Aligned_cols=104 Identities=14% Similarity=0.009 Sum_probs=68.8
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc------------------------------------cccccCC--CC
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI------------------------------------YLVHGTN--LS 108 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~------------------------------------~l~~~~~--~~ 108 (189)
+...++..+..+.+.|+.++|..+++|+|+ |. ++++|.. ..
T Consensus 105 l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 184 (309)
T cd07845 105 FSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCT 184 (309)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccCCCCcccccccccChhhhcCCC
Confidence 445556667777788888888888888875 33 1222221 23
Q ss_pred Cccc-e-EEEec------------CCCCChHHHHHHHHcCCCC------------------C---CC--------CCCCH
Q psy1684 109 GVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRM------------------P---CP--------PGCPP 145 (189)
Q Consensus 109 ~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~------------------~---~p--------~~~p~ 145 (189)
.++. + |||+| |.+.+..+.+..+...... . .+ ...++
T Consensus 185 ~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (309)
T cd07845 185 TYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSE 264 (309)
T ss_pred CcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCH
Confidence 4678 8 99999 5555555555544321100 0 00 12467
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 146 RLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 146 ~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
+..++|.+|+..||++|||+.+++..
T Consensus 265 ~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 265 AGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 88999999999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.04 E-value=9.9e-11 Score=91.36 Aligned_cols=64 Identities=9% Similarity=0.010 Sum_probs=44.9
Q ss_pred CCCccc-e-EEEec------------CCCCChHHHHHHHHcC-CCCCCCC--CCCHHHHHHHHHhcccCCCCC---CCHH
Q psy1684 107 LSGVVV-S-AVDFG------------SGGMTNAEVLHQVEHG-YRMPCPP--GCPPRLYDIMLECWLKDPVKR---PTFE 166 (189)
Q Consensus 107 ~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g-~~~~~p~--~~p~~~~~l~~~C~~~~p~~R---P~~~ 166 (189)
...++. + ||||| |.+.+..+....+... ..+..|. .++.++.+++.+|+. +|.+| +++.
T Consensus 222 ~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~ 300 (377)
T cd05629 222 QQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAH 300 (377)
T ss_pred cCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence 345788 9 99999 4454555666555432 3344444 578999999999997 77765 5888
Q ss_pred HHHHH
Q psy1684 167 TLQWK 171 (189)
Q Consensus 167 ~i~~~ 171 (189)
+++..
T Consensus 301 ~~l~h 305 (377)
T cd05629 301 EIKSH 305 (377)
T ss_pred HHhcC
Confidence 88764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.04 E-value=9.3e-11 Score=91.07 Aligned_cols=65 Identities=18% Similarity=0.242 Sum_probs=45.2
Q ss_pred CCCccc-e-EEEec------------CCCCChHHHHHHHHcC-CCCCCCC--CCCHHHHHHHHH--hcccCCCCCCCHHH
Q psy1684 107 LSGVVV-S-AVDFG------------SGGMTNAEVLHQVEHG-YRMPCPP--GCPPRLYDIMLE--CWLKDPVKRPTFET 167 (189)
Q Consensus 107 ~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g-~~~~~p~--~~p~~~~~l~~~--C~~~~p~~RP~~~~ 167 (189)
...++. + ||||| |.+.+..+....+... ..+..|+ ..+++..+++.+ |...++..||++.+
T Consensus 210 ~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~e 289 (363)
T cd05628 210 QTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEE 289 (363)
T ss_pred CCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHH
Confidence 345788 9 99999 6666677777777543 2333443 467889999887 43345557799999
Q ss_pred HHHH
Q psy1684 168 LQWK 171 (189)
Q Consensus 168 i~~~ 171 (189)
|++.
T Consensus 290 i~~h 293 (363)
T cd05628 290 IKTN 293 (363)
T ss_pred HhCC
Confidence 9875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG4637|consensus | Back alignment and domain information |
|---|
Probab=99.04 E-value=5.1e-10 Score=83.62 Aligned_cols=89 Identities=28% Similarity=0.313 Sum_probs=75.1
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC--ccCCCCCcC-HhHHHHHh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET--QKAGRTTIH-YPELVEHY 77 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g--yl~~~~~~~-l~~li~~~ 77 (189)
|+.+..++.+||.+| .+.++|+||||++.. +|.|.+|+.+ ++.|+|+.|.+++.| |-+....+. +++++.||
T Consensus 334 w~~~~a~r~kAe~ll--rg~~dGtFLIR~ss~-~g~yalSV~~--~~~V~HClIy~tatG~GFa~pyn~y~tlk~lV~hY 408 (464)
T KOG4637|consen 334 WRVRDANRDKAEELL--RGKPDGTFLIRESSK-GGCYALSVVH--DGEVKHCLIYQTATGFGFAEPYNLYSTLKELVLHY 408 (464)
T ss_pred hHHhhhhHHHHHHHh--cCCCCCeEEEeeccC-CCceEEEEEE--CCceeeeEEeeccccccccchhHHHHHHHHHHHHH
Confidence 888999999999998 567899999999655 4999999999 999999999999999 777666777 99999988
Q ss_pred hhc-----cCCceeeccCCccc
Q psy1684 78 SKD-----ADGLCVNLRKPCVQ 94 (189)
Q Consensus 78 ~~~-----a~gl~~~~~~~~~~ 94 (189)
... ++.+...+..|+..
T Consensus 409 ~h~SLe~HnDal~ttLr~Pv~~ 430 (464)
T KOG4637|consen 409 QHTSLEQHNDALTTTLRYPVFA 430 (464)
T ss_pred hhhhHHhhccccccccccceec
Confidence 654 56777777777643
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.04 E-value=9.6e-11 Score=90.62 Aligned_cols=29 Identities=17% Similarity=0.220 Sum_probs=26.1
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 143 CPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 143 ~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
.+.++.+++.+||+.||++|||+.+++..
T Consensus 283 ~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 283 KASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred chhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 46678999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG1264|consensus | Back alignment and domain information |
|---|
Probab=99.02 E-value=7.8e-10 Score=90.24 Aligned_cols=92 Identities=30% Similarity=0.435 Sum_probs=76.1
Q ss_pred CCCCCCC-hHHHHHHhcC----CCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEec-cCC----ccCCCCCcC-
Q psy1684 1 WYFGKIK-RIEAEKKLLL----PENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSL-FET----QKAGRTTIH- 69 (189)
Q Consensus 1 w~~g~l~-~~n~~~lL~~----~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~-~~g----yl~~~~~~~- 69 (189)
||||++. |..|+++|.. .+..+|+|||||+..-.|+|+||+.. .+++.|++|.-. .+| |+.++..|.
T Consensus 536 WFHgkle~R~eAekll~eycke~G~~dGtFlVReS~tFvgDytLSfwr--~grv~HcRIrsk~e~gt~Kyyl~dN~vfds 613 (1267)
T KOG1264|consen 536 WFHGKLEGRTEAEKLLQEYCKETGGKDGTFLVRESETFVGDYTLSFWR--SGRVQHCRIRSKMEGGTLKYYLTDNLVFDS 613 (1267)
T ss_pred hhhcccccchHHHHHHHHHHHHhCCCCccEEEeeccccccceeeeeeE--CCceeeEEEEeeecCCceeEEEecchhHHH
Confidence 9999999 9999998863 23348999999999999999999999 999999999843 444 899898999
Q ss_pred HhHHHHHhhhccC---CceeeccCCccc
Q psy1684 70 YPELVEHYSKDAD---GLCVNLRKPCVQ 94 (189)
Q Consensus 70 l~~li~~~~~~a~---gl~~~~~~~~~~ 94 (189)
+-+||.||.++.. -....++.||+.
T Consensus 614 lY~LI~~Y~~~~Lr~aeF~m~LtePvPq 641 (1267)
T KOG1264|consen 614 LYALIQHYRETHLRCAEFEMRLTEPVPQ 641 (1267)
T ss_pred HHHHHHHHHhccccccceEEEecCCCCC
Confidence 9999999988743 455666666653
|
|
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.02 E-value=4.6e-10 Score=88.79 Aligned_cols=69 Identities=26% Similarity=0.400 Sum_probs=53.8
Q ss_pred ccc-e-EEEec------------C----CCCChHHHHHHHHc-CCCCCCCC-----CCCHHHHHHHHHhcccCCCCCCCH
Q psy1684 110 VVV-S-AVDFG------------S----GGMTNAEVLHQVEH-GYRMPCPP-----GCPPRLYDIMLECWLKDPVKRPTF 165 (189)
Q Consensus 110 ~~~-s-VwsfG------------~----~~~~~~~~~~~v~~-g~~~~~p~-----~~p~~~~~l~~~C~~~~p~~RP~~ 165 (189)
.+. + ||||| | ...++.+++..+.+ +..+..|. ..++++..++.+||..+|..||++
T Consensus 135 ~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~ 214 (484)
T KOG1023|consen 135 LTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSI 214 (484)
T ss_pred ccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccH
Confidence 577 8 99999 2 33345678888877 44444442 467789999999999999999999
Q ss_pred HHHHHHHHHHHhh
Q psy1684 166 ETLQWKLEDFFTM 178 (189)
Q Consensus 166 ~~i~~~l~~~~~~ 178 (189)
++|-..++.+...
T Consensus 215 ~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 215 EQIRSKLLTINKG 227 (484)
T ss_pred HHHHhhhhhhccc
Confidence 9999999887764
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.02 E-value=5e-11 Score=96.34 Aligned_cols=30 Identities=20% Similarity=0.083 Sum_probs=25.9
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 142 GCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 142 ~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
..|.++.+++.+|++.||.+|||+.|++..
T Consensus 425 ~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 425 GLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred CCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 356677888999999999999999999863
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.01 E-value=6.3e-11 Score=89.68 Aligned_cols=27 Identities=26% Similarity=0.313 Sum_probs=24.1
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 144 PPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 144 p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
...+.+|+.+||..||.+|||++++++
T Consensus 280 ~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 280 DPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred CHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 466789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.01 E-value=7.4e-11 Score=88.82 Aligned_cols=29 Identities=24% Similarity=0.147 Sum_probs=26.5
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 142 GCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 142 ~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
..++++.+++.+|++.||++||++.++++
T Consensus 255 ~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 255 TLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred CCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 46788999999999999999999999986
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.00 E-value=2.5e-10 Score=87.98 Aligned_cols=29 Identities=24% Similarity=0.320 Sum_probs=26.6
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 142 GCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 142 ~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
..+.++.+++.+||..||.+|||+.+++.
T Consensus 271 ~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 271 GVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 56788999999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=98.99 E-value=2.5e-10 Score=89.26 Aligned_cols=63 Identities=16% Similarity=0.172 Sum_probs=43.7
Q ss_pred CCCccc-e-EEEec------------CCCCChHHHHHHHHc-CCCCCCC--CCCCHHHHHHHHHhcccCCCCCCC---HH
Q psy1684 107 LSGVVV-S-AVDFG------------SGGMTNAEVLHQVEH-GYRMPCP--PGCPPRLYDIMLECWLKDPVKRPT---FE 166 (189)
Q Consensus 107 ~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~-g~~~~~p--~~~p~~~~~l~~~C~~~~p~~RP~---~~ 166 (189)
...|+. + |||+| |.+.++.+....+.. ...++.| ...+++..+++.+++ .||.+|++ +.
T Consensus 222 ~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ 300 (382)
T cd05625 222 RTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGAD 300 (382)
T ss_pred CCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHH
Confidence 456889 9 99999 666666555555543 2233333 457889999988865 59999997 77
Q ss_pred HHHH
Q psy1684 167 TLQW 170 (189)
Q Consensus 167 ~i~~ 170 (189)
+|+.
T Consensus 301 ei~~ 304 (382)
T cd05625 301 EIKA 304 (382)
T ss_pred HHhc
Confidence 7664
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.7e-10 Score=88.53 Aligned_cols=104 Identities=7% Similarity=-0.119 Sum_probs=68.5
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------ccc----------------------ccCC---
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLV----------------------HGTN--- 106 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~----------------------~~~~--- 106 (189)
+.......+..+.+.++.++|...++|+|+ |+ |++ +|..
T Consensus 99 l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 178 (332)
T cd05623 99 LPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 178 (332)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcceecccccCccccCHHHHhcc
Confidence 334444455667777888888888888885 44 222 2111
Q ss_pred ---CCCccc-e-EEEec------------CCCCChHHHHHHHHcC-CCCCCC---CCCCHHHHHHHHHhcccCCC--CCC
Q psy1684 107 ---LSGVVV-S-AVDFG------------SGGMTNAEVLHQVEHG-YRMPCP---PGCPPRLYDIMLECWLKDPV--KRP 163 (189)
Q Consensus 107 ---~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g-~~~~~p---~~~p~~~~~l~~~C~~~~p~--~RP 163 (189)
.+.++. + ||||| |.+.+..+....+... .+.+.| ..+++++.+|+.+|+..++. .|+
T Consensus 179 ~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~ 258 (332)
T cd05623 179 EDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQN 258 (332)
T ss_pred ccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCC
Confidence 235788 9 99999 5556666666666443 333334 46799999999998755444 478
Q ss_pred CHHHHHHH
Q psy1684 164 TFETLQWK 171 (189)
Q Consensus 164 ~~~~i~~~ 171 (189)
++.++++.
T Consensus 259 ~~~~~~~h 266 (332)
T cd05623 259 GIEDFKQH 266 (332)
T ss_pred CHHHHhCC
Confidence 99988765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.5e-10 Score=87.63 Aligned_cols=28 Identities=25% Similarity=0.164 Sum_probs=24.5
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 143 CPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 143 ~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
..+++.+++.+|++.||++|||+.+++.
T Consensus 280 ~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 280 LGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred CChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 3467889999999999999999998874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.99 E-value=7.1e-11 Score=88.75 Aligned_cols=26 Identities=19% Similarity=0.171 Sum_probs=23.8
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 145 PRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 145 ~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
.+..+++.+|++.||++|||+.+++.
T Consensus 262 ~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 262 PHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhHHHHHHHHhccCcccccCHHHHhc
Confidence 77889999999999999999998874
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.5e-10 Score=85.86 Aligned_cols=102 Identities=11% Similarity=0.040 Sum_probs=69.1
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------ccc------------------------ccC-C
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLV------------------------HGT-N 106 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~------------------------~~~-~ 106 (189)
+.......+..+.+.++.++|...++|+|+ |. +++ +|. .
T Consensus 103 l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 182 (264)
T cd06653 103 LTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVIS 182 (264)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhc
Confidence 344555566677777888888888888764 33 111 111 2
Q ss_pred CCCccc-e-EEEec------------CCCCChHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 107 LSGVVV-S-AVDFG------------SGGMTNAEVLHQV-EHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 107 ~~~~~~-s-VwsfG------------~~~~~~~~~~~~v-~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
...++. + ||||| |.+.+..+.+..+ ..+.++..|...++++.+++.+||. +|..||+..+++.
T Consensus 183 ~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 183 GEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 344678 9 99999 4444433333333 3445566788899999999999999 6799999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=98.98 E-value=4.5e-10 Score=87.56 Aligned_cols=144 Identities=5% Similarity=-0.129 Sum_probs=87.7
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.+.|+|+++++.....+...++|+|+++++. + .. ++. ...+.......+..+.+.|+
T Consensus 99 ~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~-L----~~-----------------~l~-~~~~~~~~~~~~~~qil~aL 155 (370)
T cd05621 99 FANSPWVVQLFCAFQDDKYLYMVMEYMPGGD-L----VN-----------------LMS-NYDVPEKWAKFYTAEVVLAL 155 (370)
T ss_pred hCCCCCEeeEEEEEEcCCEEEEEEcCCCCCc-H----HH-----------------HHH-hcCCCHHHHHHHHHHHHHHH
Confidence 3456666666655544455666666665522 1 11 221 11233344445556777788
Q ss_pred eeeccCCcccccc-cc---------------ccc----------------------ccCC-----CCCccc-e-EEEec-
Q psy1684 85 CVNLRKPCVQVSC-RI---------------YLV----------------------HGTN-----LSGVVV-S-AVDFG- 118 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~---------------~l~----------------------~~~~-----~~~~~~-s-VwsfG- 118 (189)
.++|...++|||+ |+ |++ +|.. .+.++. + |||+|
T Consensus 156 ~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ 235 (370)
T cd05621 156 DAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGV 235 (370)
T ss_pred HHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehH
Confidence 8888888888885 44 222 2211 123778 9 99999
Q ss_pred -----------CCCCChHHHHHHHHcC-CCCCCCC--CCCHHHHHHHHHhcccCCC--CCCCHHHHHHH
Q psy1684 119 -----------SGGMTNAEVLHQVEHG-YRMPCPP--GCPPRLYDIMLECWLKDPV--KRPTFETLQWK 171 (189)
Q Consensus 119 -----------~~~~~~~~~~~~v~~g-~~~~~p~--~~p~~~~~l~~~C~~~~p~--~RP~~~~i~~~ 171 (189)
|.+.+..+....+..+ ..+..|. ..+..+.+++.+|+..++. .||++.++++.
T Consensus 236 ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 236 FLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 5555555666666443 3444554 4688999999999985554 38899998875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=98.97 E-value=5.5e-10 Score=87.09 Aligned_cols=145 Identities=14% Similarity=0.113 Sum_probs=97.4
Q ss_pred CCCCChHHHHHHhcCCCCC--CCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccC-CCCCcCHhHHHHHhhh
Q psy1684 3 FGKIKRIEAEKKLLLPEND--HGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKA-GRTTIHYPELVEHYSK 79 (189)
Q Consensus 3 ~g~l~~~n~~~lL~~~~~~--~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~-~~~~~~l~~li~~~~~ 79 (189)
.+.|.|+||++|.+..... ...|||.|||.. + + .|.+. ....|+..++-.+..|
T Consensus 170 Lr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-D-L---------------------~GLl~~p~vkft~~qIKc~mkQ 226 (560)
T KOG0600|consen 170 LRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-D-L---------------------SGLLSSPGVKFTEPQIKCYMKQ 226 (560)
T ss_pred HHhcCCCcccceeeEEEecCCceEEEEEecccc-h-h---------------------hhhhcCCCcccChHHHHHHHHH
Confidence 3578999999988754333 357889999886 2 1 11111 1335656667777788
Q ss_pred ccCCceeeccCCcccccccc----------------cccccC------------------------CCCCccc-e-EEEe
Q psy1684 80 DADGLCVNLRKPCVQVSCRI----------------YLVHGT------------------------NLSGVVV-S-AVDF 117 (189)
Q Consensus 80 ~a~gl~~~~~~~~~~~~~p~----------------~l~~~~------------------------~~~~~~~-s-Vwsf 117 (189)
...|+.|+|.+.++|||+.. |||+-. -...|+. . +||.
T Consensus 227 Ll~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~ 306 (560)
T KOG0600|consen 227 LLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSV 306 (560)
T ss_pred HHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhh
Confidence 88999999999999999755 555511 2345898 8 9999
Q ss_pred c------------CCCCChHHHHHHH--HcCC-----------------CCCCC---------CCCCHHHHHHHHHhccc
Q psy1684 118 G------------SGGMTNAEVLHQV--EHGY-----------------RMPCP---------PGCPPRLYDIMLECWLK 157 (189)
Q Consensus 118 G------------~~~~~~~~~~~~v--~~g~-----------------~~~~p---------~~~p~~~~~l~~~C~~~ 157 (189)
| |+|-+..+-+.+| .-|. ++..| ...|....+|+...+..
T Consensus 307 GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~l 386 (560)
T KOG0600|consen 307 GCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSL 386 (560)
T ss_pred hHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhcc
Confidence 9 5665543322222 1111 11111 24677888999999999
Q ss_pred CCCCCCCHHHHHH
Q psy1684 158 DPVKRPTFETLQW 170 (189)
Q Consensus 158 ~p~~RP~~~~i~~ 170 (189)
||++|.|+.+.+.
T Consensus 387 dP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 387 DPDKRGTASSALQ 399 (560)
T ss_pred CccccccHHHHhc
Confidence 9999999998764
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=98.95 E-value=3.1e-10 Score=87.11 Aligned_cols=104 Identities=7% Similarity=-0.100 Sum_probs=67.3
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------ccc----------------------ccCCC--
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLV----------------------HGTNL-- 107 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~----------------------~~~~~-- 107 (189)
+.......+..+.+.|+.++|..+++|+|+ |+ |++ +|...
T Consensus 99 l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 178 (331)
T cd05624 99 LPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAM 178 (331)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhcc
Confidence 344444455667778888888888889885 43 222 21111
Q ss_pred ----CCccc-e-EEEec------------CCCCChHHHHHHHHc-CCCCCCCC---CCCHHHHHHHHHhcccCCCC--CC
Q psy1684 108 ----SGVVV-S-AVDFG------------SGGMTNAEVLHQVEH-GYRMPCPP---GCPPRLYDIMLECWLKDPVK--RP 163 (189)
Q Consensus 108 ----~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~-g~~~~~p~---~~p~~~~~l~~~C~~~~p~~--RP 163 (189)
+.++. + ||||| |.+.+..+....+.. ..+++.|. .++.++.+++.+|+..+++. |+
T Consensus 179 ~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~ 258 (331)
T cd05624 179 EDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQN 258 (331)
T ss_pred ccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCC
Confidence 45788 9 99999 455555566666543 34444444 46899999999998865543 46
Q ss_pred CHHHHHHH
Q psy1684 164 TFETLQWK 171 (189)
Q Consensus 164 ~~~~i~~~ 171 (189)
+++++++.
T Consensus 259 ~~~~~~~h 266 (331)
T cd05624 259 GIEDFKKH 266 (331)
T ss_pred CHHHHhcC
Confidence 77777653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=98.95 E-value=4e-10 Score=87.45 Aligned_cols=63 Identities=19% Similarity=0.181 Sum_probs=43.8
Q ss_pred CCCccc-e-EEEec------------CCCCChHHHHHHHHcC-CCCCCCC--CCCHHHHHHHHHhcccCCCCCCC---HH
Q psy1684 107 LSGVVV-S-AVDFG------------SGGMTNAEVLHQVEHG-YRMPCPP--GCPPRLYDIMLECWLKDPVKRPT---FE 166 (189)
Q Consensus 107 ~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g-~~~~~p~--~~p~~~~~l~~~C~~~~p~~RP~---~~ 166 (189)
...++. + ||||| |.+.+..+....+... .....|+ ..+.++.+|+.+++. ||.+|++ +.
T Consensus 210 ~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ 288 (360)
T cd05627 210 QTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVE 288 (360)
T ss_pred CCCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHH
Confidence 345888 9 99999 5566666776666543 2333444 367899999998764 9999985 55
Q ss_pred HHHH
Q psy1684 167 TLQW 170 (189)
Q Consensus 167 ~i~~ 170 (189)
+|+.
T Consensus 289 ei~~ 292 (360)
T cd05627 289 EIKS 292 (360)
T ss_pred HHhc
Confidence 5554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=98.95 E-value=8.9e-10 Score=88.68 Aligned_cols=135 Identities=13% Similarity=0.028 Sum_probs=98.3
Q ss_pred ChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCcee
Q psy1684 7 KRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGLCV 86 (189)
Q Consensus 7 ~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl~~ 86 (189)
+||.++++..+....+..|.|+|+..+ |++ +... + ...|+.....=|...+..||.+
T Consensus 427 ~HPFL~~L~~~fQT~~~l~fvmey~~G-gdm--~~~~------------~--------~~~F~e~rarfyaAev~l~L~f 483 (694)
T KOG0694|consen 427 RHPFLVNLFSCFQTKEHLFFVMEYVAG-GDL--MHHI------------H--------TDVFSEPRARFYAAEVVLGLQF 483 (694)
T ss_pred cCCeEeecccccccCCeEEEEEEecCC-CcE--EEEE------------e--------cccccHHHHHHHHHHHHHHHHH
Confidence 578888877777777888889998876 431 1111 0 2244433333344555667888
Q ss_pred eccCCcccccccc----------------cccccC----------------------CCCCccc-e-EEEec--------
Q psy1684 87 NLRKPCVQVSCRI----------------YLVHGT----------------------NLSGVVV-S-AVDFG-------- 118 (189)
Q Consensus 87 ~~~~~~~~~~~p~----------------~l~~~~----------------------~~~~~~~-s-VwsfG-------- 118 (189)
+|..+||+||+.- ||+++. .+..|+. . =||||
T Consensus 484 LH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~ 563 (694)
T KOG0694|consen 484 LHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLV 563 (694)
T ss_pred HHhcCceeeecchhheEEcccCcEEecccccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHc
Confidence 8888888887543 444444 6677999 8 99999
Q ss_pred ----CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH
Q psy1684 119 ----SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTF 165 (189)
Q Consensus 119 ----~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~ 165 (189)
|+|-+.+++.+.|.... +..|..++.+..+||.+-+..||++|--.
T Consensus 564 Gq~PF~gddEee~FdsI~~d~-~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 564 GESPFPGDDEEEVFDSIVNDE-VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCCCCCCCHHHHHHHHhcCC-CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 99999999999987653 45688999999999999999999999755
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=98.93 E-value=3e-10 Score=85.33 Aligned_cols=102 Identities=16% Similarity=0.031 Sum_probs=64.6
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------ccc----------------------ccCC---
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLV----------------------HGTN--- 106 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~----------------------~~~~--- 106 (189)
+....+..+..+.+.++.++|..+++|+|+ |. +++ +|..
T Consensus 102 l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 181 (290)
T cd05613 102 FKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGG 181 (290)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccccccccccCCcccCChhhccCC
Confidence 334445555556777888888888888875 33 111 1111
Q ss_pred CCCccc-e-EEEec------------CCCC----ChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----
Q psy1684 107 LSGVVV-S-AVDFG------------SGGM----TNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRP----- 163 (189)
Q Consensus 107 ~~~~~~-s-VwsfG------------~~~~----~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP----- 163 (189)
...++. + ||||| |... ...++...+..+ .++.|..+++.+.+++.+||+.||++||
T Consensus 182 ~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~ 260 (290)
T cd05613 182 DGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPS 260 (290)
T ss_pred CCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc-CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCC
Confidence 123567 8 99999 2111 123333333333 3556778999999999999999999997
Q ss_pred CHHHHHH
Q psy1684 164 TFETLQW 170 (189)
Q Consensus 164 ~~~~i~~ 170 (189)
+..+++.
T Consensus 261 ~~~~l~~ 267 (290)
T cd05613 261 DADEIKK 267 (290)
T ss_pred CHHHHHc
Confidence 5565544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=98.93 E-value=4.5e-10 Score=87.59 Aligned_cols=102 Identities=6% Similarity=-0.138 Sum_probs=66.7
Q ss_pred HhHHHHHhhhccCCceeeccCCcccccc-cc---------------ccc----------------------ccCC-----
Q psy1684 70 YPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLV----------------------HGTN----- 106 (189)
Q Consensus 70 l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~----------------------~~~~----- 106 (189)
......+..+.+.|+.++|...++|+|+ |+ |++ +|..
T Consensus 141 ~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~ 220 (371)
T cd05622 141 EKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGG 220 (371)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCC
Confidence 3334445566777888888888888885 43 222 2211
Q ss_pred CCCccc-e-EEEec------------CCCCChHHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHhcccCCCC--CCCHHH
Q psy1684 107 LSGVVV-S-AVDFG------------SGGMTNAEVLHQVEHG-YRMPCP--PGCPPRLYDIMLECWLKDPVK--RPTFET 167 (189)
Q Consensus 107 ~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g-~~~~~p--~~~p~~~~~l~~~C~~~~p~~--RP~~~~ 167 (189)
...++. + ||||| |.+.+.......+... ..++.| ...+.++.+++..|+..++.. ||++.+
T Consensus 221 ~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~e 300 (371)
T cd05622 221 DGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEE 300 (371)
T ss_pred CccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHH
Confidence 123788 9 99999 5555555666666543 233333 468899999999999844432 778888
Q ss_pred HHHH
Q psy1684 168 LQWK 171 (189)
Q Consensus 168 i~~~ 171 (189)
|++.
T Consensus 301 i~~h 304 (371)
T cd05622 301 IKRH 304 (371)
T ss_pred HhcC
Confidence 8875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=98.92 E-value=6.2e-10 Score=86.20 Aligned_cols=152 Identities=16% Similarity=0.178 Sum_probs=101.8
Q ss_pred CCChHHHHHHhcCCCCCC----CcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhc
Q psy1684 5 KIKRIEAEKKLLLPENDH----GAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKD 80 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~----g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~ 80 (189)
.|.|+|++++++.....+ +.+||+++.+++. +.+ ||. .+.+++.++.......
T Consensus 260 ~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGs-----L~d-----------------yL~-~ntisw~~~cria~Sm 316 (534)
T KOG3653|consen 260 GMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGS-----LCD-----------------YLK-ANTISWNSLCRIAESM 316 (534)
T ss_pred CccchhHHHhhchhccCCccccceeEEeeeccCCc-----HHH-----------------HHH-hccccHHHHHHHHHHH
Confidence 688999999997544333 5578888777732 222 444 3345577777777778
Q ss_pred cCCceeeccC---------Ccccccccc---------------------------------------cccccCC-----C
Q psy1684 81 ADGLCVNLRK---------PCVQVSCRI---------------------------------------YLVHGTN-----L 107 (189)
Q Consensus 81 a~gl~~~~~~---------~~~~~~~p~---------------------------------------~l~~~~~-----~ 107 (189)
++|++++|.. +|+|||+.. .||+|+. .
T Consensus 317 arGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl 396 (534)
T KOG3653|consen 317 ARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINL 396 (534)
T ss_pred HHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhccc
Confidence 8888888863 578888765 2233321 1
Q ss_pred C-Ccc-c-e-EEEec------------------------CC---CC--ChHHHHHHH-HcCCCCCCCCC-----CCHHHH
Q psy1684 108 S-GVV-V-S-AVDFG------------------------SG---GM--TNAEVLHQV-EHGYRMPCPPG-----CPPRLY 148 (189)
Q Consensus 108 ~-~~~-~-s-VwsfG------------------------~~---~~--~~~~~~~~v-~~g~~~~~p~~-----~p~~~~ 148 (189)
+ .-. . . |||.| |. |. +.+++...| .+..||.+|+. -...+.
T Consensus 397 ~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~ 476 (534)
T KOG3653|consen 397 QDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLC 476 (534)
T ss_pred ccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHH
Confidence 1 212 2 5 99999 11 11 234555555 56678888863 345778
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q psy1684 149 DIMLECWLKDPVKRPTFETLQWKLEDFFTME 179 (189)
Q Consensus 149 ~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~ 179 (189)
+.+..||..||+.|-|+.=+.+++.++....
T Consensus 477 et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 477 ETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred HHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 9999999999999999999998888776543
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=98.92 E-value=5.6e-10 Score=85.63 Aligned_cols=30 Identities=23% Similarity=0.251 Sum_probs=26.8
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 142 GCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 142 ~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
.++.++.+++.+|++.||++|||+.+++..
T Consensus 263 ~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 263 NANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred CCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 457899999999999999999999998753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.91 E-value=5.6e-10 Score=85.69 Aligned_cols=104 Identities=6% Similarity=-0.120 Sum_probs=66.3
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------ccc----------------------ccCC---
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLV----------------------HGTN--- 106 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~----------------------~~~~--- 106 (189)
+....+..+..+++.|+.++|..+++|+|+ |. |++ +|..
T Consensus 99 ~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 178 (331)
T cd05597 99 LPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAM 178 (331)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhc
Confidence 334445556667788888888888888885 43 222 1111
Q ss_pred ---CCCccc-e-EEEec------------CCCCChHHHHHHHHc-CCCCCCC---CCCCHHHHHHHHHhccc--CCCCCC
Q psy1684 107 ---LSGVVV-S-AVDFG------------SGGMTNAEVLHQVEH-GYRMPCP---PGCPPRLYDIMLECWLK--DPVKRP 163 (189)
Q Consensus 107 ---~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~-g~~~~~p---~~~p~~~~~l~~~C~~~--~p~~RP 163 (189)
.+.++. + ||||| |.+.+..+....+.. ..+.+.| ..+|.++.+++.+|+.. ++..||
T Consensus 179 ~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~ 258 (331)
T cd05597 179 EDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRN 258 (331)
T ss_pred cccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCC
Confidence 134778 8 99999 445555555555533 2233333 35789999999997654 344478
Q ss_pred CHHHHHHH
Q psy1684 164 TFETLQWK 171 (189)
Q Consensus 164 ~~~~i~~~ 171 (189)
++.++++.
T Consensus 259 ~~~~~l~h 266 (331)
T cd05597 259 GLQDFKDH 266 (331)
T ss_pred CHHHHhcC
Confidence 99888765
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.91 E-value=2e-10 Score=87.25 Aligned_cols=29 Identities=24% Similarity=0.164 Sum_probs=25.8
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 142 GCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 142 ~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
..+.++.+++.+|++.||++|||+.+++.
T Consensus 284 ~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 284 KPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred CCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 45678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.5e-10 Score=91.93 Aligned_cols=146 Identities=13% Similarity=0.087 Sum_probs=95.8
Q ss_pred CCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccC
Q psy1684 3 FGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDAD 82 (189)
Q Consensus 3 ~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~ 82 (189)
+..++|||+++++.+-..+.-.+||+|+..++..|. |+.......-...-..+.+...
T Consensus 109 mk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~----------------------yl~~~gr~~e~~ar~~F~q~vs 166 (596)
T KOG0586|consen 109 MKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFD----------------------YLVKHGRMKEKEARAKFRQIVS 166 (596)
T ss_pred HHhcCCcceeeeeeeeeecceeEEEEEeccCchhHH----------------------HHHhcccchhhhhhhhhHHHHH
Confidence 456899999999988777888999999988743221 2221111111111122334445
Q ss_pred CceeeccCCcccccccc------------------------------------cccccC-CCCCccc--e-EEEec----
Q psy1684 83 GLCVNLRKPCVQVSCRI------------------------------------YLVHGT-NLSGVVV--S-AVDFG---- 118 (189)
Q Consensus 83 gl~~~~~~~~~~~~~p~------------------------------------~l~~~~-~~~~~~~--s-VwsfG---- 118 (189)
++.|+|.+.++|||+.. ..++|. .+..|+- + +||.|
T Consensus 167 aveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly 246 (596)
T KOG0586|consen 167 AVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLY 246 (596)
T ss_pred HHHHHhhcceeccccchhhcccccccceeeeccccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhhe
Confidence 56777777777777533 112222 4445765 7 99999
Q ss_pred --------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 119 --------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 119 --------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
|.|-+..++...+..|. ..+|.-+..+..+|+.+.+-.||++|++.++|.+.
T Consensus 247 ~LV~GsLPFDG~~lk~Lr~rvl~gk-~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 247 ALVEGSLPFDGQNLKELRPRVLRGK-YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred eeeecccccCCcccccccchheeee-ecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 77666666666775552 23445566788999999999999999999999864
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=98.89 E-value=2e-10 Score=86.31 Aligned_cols=27 Identities=19% Similarity=0.268 Sum_probs=24.6
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 144 PPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 144 p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
+.++.+++.+|+..||++|||+.+++.
T Consensus 261 ~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 261 PPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 568899999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=98.89 E-value=7.6e-10 Score=84.71 Aligned_cols=145 Identities=13% Similarity=0.142 Sum_probs=107.6
Q ss_pred CCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccC
Q psy1684 3 FGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDAD 82 (189)
Q Consensus 3 ~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~ 82 (189)
+..++|+++.+++.+..+.+...||+|+.+++. +.+ |+.....++-++...|++++..
T Consensus 107 MSsLNHPhII~IyEVFENkdKIvivMEYaS~Ge-----LYD-----------------YiSer~~LsErEaRhfFRQIvS 164 (668)
T KOG0611|consen 107 MSSLNHPHIIQIYEVFENKDKIVIVMEYASGGE-----LYD-----------------YISERGSLSEREARHFFRQIVS 164 (668)
T ss_pred HhhcCCCceeehhhhhcCCceEEEEEEecCCcc-----HHH-----------------HHHHhccccHHHHHHHHHHHHH
Confidence 356789999998888888888888888888733 112 5555556666666777788888
Q ss_pred CceeeccCCccccccc-c---------------cc--------------------cccC-CCCCccc--e-EEEec----
Q psy1684 83 GLCVNLRKPCVQVSCR-I---------------YL--------------------VHGT-NLSGVVV--S-AVDFG---- 118 (189)
Q Consensus 83 gl~~~~~~~~~~~~~p-~---------------~l--------------------~~~~-~~~~~~~--s-VwsfG---- 118 (189)
+..|+|...++|||+. + || ++|. .+.+|.- . -||+|
T Consensus 165 AVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLY 244 (668)
T KOG0611|consen 165 AVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLY 244 (668)
T ss_pred HHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHH
Confidence 8888888888888864 2 11 1111 5566775 6 99999
Q ss_pred --------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 119 --------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 119 --------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
|.|.+...+..+|.+|.-.+ +..|.+..-||...+-.||+.|.|..+|...
T Consensus 245 tLVyGtMPFDG~Dhk~lvrQIs~GaYrE--P~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 245 TLVYGTMPFDGRDHKRLVRQISRGAYRE--PETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred HHhhcccccCCchHHHHHHHhhcccccC--CCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 88888888889998884322 2445677889999999999999999999865
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=98.88 E-value=3.2e-10 Score=86.90 Aligned_cols=30 Identities=20% Similarity=0.232 Sum_probs=27.4
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 142 GCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 142 ~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
.++.++.++|.+||+.+|++|||+.+++..
T Consensus 259 ~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 259 NADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred CCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 577899999999999999999999998765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=98.87 E-value=5.2e-12 Score=93.16 Aligned_cols=110 Identities=15% Similarity=0.049 Sum_probs=72.3
Q ss_pred ccCCCCCcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cccc---------------------
Q psy1684 61 QKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVH--------------------- 103 (189)
Q Consensus 61 yl~~~~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~--------------------- 103 (189)
++.....+....+.....+.+.|+.++|..+++|+|+ |+ +.+.
T Consensus 88 ~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aP 167 (260)
T PF00069_consen 88 YLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAP 167 (260)
T ss_dssp HHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 3432344556777778888889999999999999996 55 2222
Q ss_pred cC-C-CCCccc-e-EEEec------------CCCCCh---HHHHHHHHcCC-C--CCCCCCCCHHHHHHHHHhcccCCCC
Q psy1684 104 GT-N-LSGVVV-S-AVDFG------------SGGMTN---AEVLHQVEHGY-R--MPCPPGCPPRLYDIMLECWLKDPVK 161 (189)
Q Consensus 104 ~~-~-~~~~~~-s-VwsfG------------~~~~~~---~~~~~~v~~g~-~--~~~p~~~p~~~~~l~~~C~~~~p~~ 161 (189)
|. . ...++. + |||+| |.+.+. ...+....... . .......+.++.+++.+||+.||++
T Consensus 168 E~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 247 (260)
T PF00069_consen 168 EVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQ 247 (260)
T ss_dssp HHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGG
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHHHccCChhH
Confidence 11 3 456788 8 99999 444422 22222221110 0 1111223489999999999999999
Q ss_pred CCCHHHHHH
Q psy1684 162 RPTFETLQW 170 (189)
Q Consensus 162 RP~~~~i~~ 170 (189)
|||+.++++
T Consensus 248 R~~~~~l~~ 256 (260)
T PF00069_consen 248 RPSAEELLK 256 (260)
T ss_dssp STTHHHHHT
T ss_pred CcCHHHHhc
Confidence 999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=98.87 E-value=4.1e-10 Score=92.76 Aligned_cols=71 Identities=18% Similarity=0.205 Sum_probs=56.8
Q ss_pred cccccC------CCCCccc-e-EEEec------------CCCCChHHHHHHHHcCCCC--CCCCCCCHHHHHHHHHhccc
Q psy1684 100 YLVHGT------NLSGVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRM--PCPPGCPPRLYDIMLECWLK 157 (189)
Q Consensus 100 ~l~~~~------~~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~--~~p~~~p~~~~~l~~~C~~~ 157 (189)
|||+|. ....|+. + |||+| +.++++...+..|.+..+| ..|.....++.++|..|+..
T Consensus 189 WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~K 268 (953)
T KOG0587|consen 189 WMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVK 268 (953)
T ss_pred cccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhh
Confidence 777766 4455888 9 99999 7788888888777554333 24677889999999999999
Q ss_pred CCCCCCCHHHHHH
Q psy1684 158 DPVKRPTFETLQW 170 (189)
Q Consensus 158 ~p~~RP~~~~i~~ 170 (189)
|-.+||++.++++
T Consensus 269 d~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 269 DYEQRPSTEELLK 281 (953)
T ss_pred ccccCcchhhhcc
Confidence 9999999988764
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=98.86 E-value=2.2e-09 Score=74.78 Aligned_cols=78 Identities=12% Similarity=0.103 Sum_probs=50.5
Q ss_pred cccccccccCCCCCccc-e-EEEec------------CCCCC-hHHHHHHHHcCCCCCC------CCCCCH--HHHHHHH
Q psy1684 96 SCRIYLVHGTNLSGVVV-S-AVDFG------------SGGMT-NAEVLHQVEHGYRMPC------PPGCPP--RLYDIML 152 (189)
Q Consensus 96 ~~p~~l~~~~~~~~~~~-s-VwsfG------------~~~~~-~~~~~~~v~~g~~~~~------p~~~p~--~~~~l~~ 152 (189)
++||.+ ....|+. + ||||| |.+.. ..+.+..+..+..... +...+. ++.+++.
T Consensus 71 ~aPE~~----~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 146 (176)
T smart00750 71 MAPEVI----QGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMR 146 (176)
T ss_pred cChHHh----cCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHH
Confidence 445544 5677999 9 99999 22221 1233333333322221 122223 6899999
Q ss_pred HhcccCCCCCCCHHHHHHHHHHHHh
Q psy1684 153 ECWLKDPVKRPTFETLQWKLEDFFT 177 (189)
Q Consensus 153 ~C~~~~p~~RP~~~~i~~~l~~~~~ 177 (189)
+||..||++||++.++++.+..+..
T Consensus 147 ~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 147 VCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HHHhcccccccCHHHHHHHHHHHHH
Confidence 9999999999999999998876654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=98.85 E-value=5.6e-10 Score=86.84 Aligned_cols=104 Identities=13% Similarity=-0.033 Sum_probs=77.8
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------------------------------cccccCC-
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------------------------------YLVHGTN- 106 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------------------------------~l~~~~~- 106 (189)
++-.+......++..++.++|..+++|||+ |+ .+|+|..
T Consensus 132 ~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~ 211 (382)
T KOG0032|consen 132 YSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLG 211 (382)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhc
Confidence 455555666677788888999999999985 66 2222223
Q ss_pred CCCccc-e-EEEec------------CCCCChHHHHHHHHcCCC-CCCC--CCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q psy1684 107 LSGVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYR-MPCP--PGCPPRLYDIMLECWLKDPVKRPTFETLQ 169 (189)
Q Consensus 107 ~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~-~~~p--~~~p~~~~~l~~~C~~~~p~~RP~~~~i~ 169 (189)
...|+. + |||.| |.+.+..+....|..|.- .+.+ +..+....+++..++..||..|+|..+++
T Consensus 212 ~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L 291 (382)
T KOG0032|consen 212 GRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQAL 291 (382)
T ss_pred CCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHh
Confidence 367999 9 99999 666666677778877732 1212 35688999999999999999999999998
Q ss_pred HH
Q psy1684 170 WK 171 (189)
Q Consensus 170 ~~ 171 (189)
+.
T Consensus 292 ~H 293 (382)
T KOG0032|consen 292 QH 293 (382)
T ss_pred cC
Confidence 84
|
|
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=98.83 E-value=9.6e-10 Score=86.79 Aligned_cols=62 Identities=21% Similarity=0.314 Sum_probs=42.3
Q ss_pred ccc-e-EEEec-------CCCCChHHH---HHH---H-HcCCCCCCCCCCCHH-HHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 110 VVV-S-AVDFG-------SGGMTNAEV---LHQ---V-EHGYRMPCPPGCPPR-LYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 110 ~~~-s-VwsfG-------~~~~~~~~~---~~~---v-~~g~~~~~p~~~p~~-~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
.+. | |||+| |..-.-.++ +.+ | .-+...++|..-+.. +.++|+.|++.||++|||..+++..
T Consensus 549 i~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 549 ISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 677 9 99999 332222222 222 2 234555666654444 9999999999999999999998763
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.3e-09 Score=82.99 Aligned_cols=27 Identities=22% Similarity=0.324 Sum_probs=24.2
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 144 PPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 144 p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
+.++.+|+.+|++.||.+|||++|+++
T Consensus 287 ~~~~~dli~~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 287 DSKAFHLLQKLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred ChHHHHHHHHHhccCcccCCCHHHHhc
Confidence 356789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=98.79 E-value=2e-09 Score=83.06 Aligned_cols=35 Identities=20% Similarity=0.264 Sum_probs=29.5
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHH--HHHHH
Q psy1684 141 PGCPPRLYDIMLECWLKDPVKRPTFETLQW--KLEDF 175 (189)
Q Consensus 141 ~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~--~l~~~ 175 (189)
..+++++.+++.+|++.||++|||+.+++. .++.+
T Consensus 268 ~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 268 PNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred cCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 367788999999999999999999999984 34444
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=98.78 E-value=9.2e-11 Score=87.98 Aligned_cols=150 Identities=13% Similarity=0.076 Sum_probs=92.7
Q ss_pred CCCCChHHHHHHhcCCCCCC-----CcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHh
Q psy1684 3 FGKIKRIEAEKKLLLPENDH-----GAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHY 77 (189)
Q Consensus 3 ~g~l~~~n~~~lL~~~~~~~-----g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~ 77 (189)
++.+.|+|+|+|+-...... -.-||.|+++. . +.. .++| |...+..+++.++--+.
T Consensus 71 m~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-t-----L~~----~~r~---------~~~~~~~mp~~~iKLYt 131 (364)
T KOG0658|consen 71 MRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-T-----LYR----VIRH---------YTRANQRMPLLEIKLYT 131 (364)
T ss_pred HHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-H-----HHH----HHHH---------HhhcCCCCceeeeHHHH
Confidence 45788999998775322111 22446666665 1 111 1111 22224445544444466
Q ss_pred hhccCCceeeccCCcccccc-cccccccC--------------------------------------CCCCccc-e-EEE
Q psy1684 78 SKDADGLCVNLRKPCVQVSC-RIYLVHGT--------------------------------------NLSGVVV-S-AVD 116 (189)
Q Consensus 78 ~~~a~gl~~~~~~~~~~~~~-p~~l~~~~--------------------------------------~~~~~~~-s-Vws 116 (189)
.|...|+.|+|...|.|||+ |..+--+- -...|+. - |||
T Consensus 132 ~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWS 211 (364)
T KOG0658|consen 132 YQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWS 211 (364)
T ss_pred HHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhh
Confidence 68888999999999999996 55221111 3445888 7 999
Q ss_pred ec------------CCCCChHHHHHHHHc--CCC-----------------C-----C----CCCCCCHHHHHHHHHhcc
Q psy1684 117 FG------------SGGMTNAEVLHQVEH--GYR-----------------M-----P----CPPGCPPRLYDIMLECWL 156 (189)
Q Consensus 117 fG------------~~~~~~~~~~~~v~~--g~~-----------------~-----~----~p~~~p~~~~~l~~~C~~ 156 (189)
-| |+|-+..+-+..|.+ |.. + + ....+|++..+|+.+++.
T Consensus 212 aGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~ 291 (364)
T KOG0658|consen 212 AGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQ 291 (364)
T ss_pred hhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhc
Confidence 99 888664332222211 110 0 0 224688999999999999
Q ss_pred cCCCCCCCHHHHHHH
Q psy1684 157 KDPVKRPTFETLQWK 171 (189)
Q Consensus 157 ~~p~~RP~~~~i~~~ 171 (189)
.+|++|-+..|++..
T Consensus 292 Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 292 YSPSKRLSALEALAH 306 (364)
T ss_pred cChhhcCCHHHHhcc
Confidence 999999999998764
|
|
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=98.78 E-value=2.8e-10 Score=88.94 Aligned_cols=75 Identities=11% Similarity=0.145 Sum_probs=63.0
Q ss_pred CCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC--CCCcCHhHHHHHhhhc
Q psy1684 3 FGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG--RTTIHYPELVEHYSKD 80 (189)
Q Consensus 3 ~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~--~~~~~l~~li~~~~~~ 80 (189)
+.+++|+++|+++++|..+.+.+||+|++++ | |++. ||.. +..+.+.+|+++..++
T Consensus 255 Mk~L~H~~lV~l~gV~~~~~piyIVtE~m~~-G----sLl~-----------------yLr~~~~~~l~~~~Ll~~a~qI 312 (468)
T KOG0197|consen 255 MKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK-G----SLLD-----------------YLRTREGGLLNLPQLLDFAAQI 312 (468)
T ss_pred HHhCcccCeEEEEEEEecCCceEEEEEeccc-C----cHHH-----------------HhhhcCCCccchHHHHHHHHHH
Confidence 3578999999999999988899999999999 5 3444 3332 3455589999999999
Q ss_pred cCCceeeccCCcccccccc
Q psy1684 81 ADGLCVNLRKPCVQVSCRI 99 (189)
Q Consensus 81 a~gl~~~~~~~~~~~~~p~ 99 (189)
+.||+|+.++.+||||+.+
T Consensus 313 aeGM~YLes~~~IHRDLAA 331 (468)
T KOG0197|consen 313 AEGMAYLESKNYIHRDLAA 331 (468)
T ss_pred HHHHHHHHhCCccchhhhh
Confidence 9999999999999999765
|
|
| >KOG2996|consensus | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.2e-08 Score=80.68 Aligned_cols=88 Identities=23% Similarity=0.351 Sum_probs=74.8
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC-ccCCCCCcC-HhHHHHHhh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET-QKAGRTTIH-YPELVEHYS 78 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g-yl~~~~~~~-l~~li~~~~ 78 (189)
||.|.|.|..++..|. ...+|+||||.+....+.|.+|++. .+.++|++|...++- +|.+...|. +.+|++||+
T Consensus 687 WyaG~MERaqaes~Lk--~~~ngT~LVR~r~kea~e~AISiky--nnevKHikI~~~dg~~~i~E~k~F~sl~ELVeyYq 762 (865)
T KOG2996|consen 687 WYAGEMERAQAESTLK--NRPNGTYLVRYRTKEAKEFAISIKY--NNEVKHIKIETNDGKVHITEDKKFNSLVELVEYYQ 762 (865)
T ss_pred hhcchHhhhhhhhHhh--cCCCceEEEEecccchhheeEEEEe--ccccceEEEEecCCeEEechhhhhhhHHHHHHHHH
Confidence 9999999999999994 4577999999998888999999999 999999999988555 999999999 999999999
Q ss_pred hccC-----CceeeccCCc
Q psy1684 79 KDAD-----GLCVNLRKPC 92 (189)
Q Consensus 79 ~~a~-----gl~~~~~~~~ 92 (189)
.++. .+...+..|.
T Consensus 763 ~~sLke~Fk~LDTtLk~Py 781 (865)
T KOG2996|consen 763 SHSLKEIFKALDTTLKFPY 781 (865)
T ss_pred hccHHHHHHHhhhhhcCCC
Confidence 8753 4444555443
|
|
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.6e-09 Score=80.59 Aligned_cols=142 Identities=11% Similarity=0.052 Sum_probs=100.9
Q ss_pred CChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCce
Q psy1684 6 IKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGLC 85 (189)
Q Consensus 6 l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl~ 85 (189)
-.|+|+++|+.....++..|||.|.+.++. +.. | |.+..-|+-.+.......++.++.
T Consensus 133 qgh~nilqLiefFEdd~~FYLVfEKm~GGp-----lLs-------h----------I~~~~~F~E~EAs~vvkdia~aLd 190 (463)
T KOG0607|consen 133 QGHKNILQLIEFFEDDTRFYLVFEKMRGGP-----LLS-------H----------IQKRKHFNEREASRVVKDIASALD 190 (463)
T ss_pred cCCccHHHHHHHhcccceEEEEEecccCch-----HHH-------H----------HHHhhhccHHHHHHHHHHHHHHHH
Confidence 468999999998888889999999998743 222 1 222334553333344467788899
Q ss_pred eeccCCcccccc-cc----------------------------------------------cccccC------CCCCccc
Q psy1684 86 VNLRKPCVQVSC-RI----------------------------------------------YLVHGT------NLSGVVV 112 (189)
Q Consensus 86 ~~~~~~~~~~~~-p~----------------------------------------------~l~~~~------~~~~~~~ 112 (189)
++|.++|.|||+ |+ .||+|+ ....|+.
T Consensus 191 FlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDK 270 (463)
T KOG0607|consen 191 FLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDK 270 (463)
T ss_pred HHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccc
Confidence 999999999995 66 122222 4456899
Q ss_pred -e-EEEec------------CC-------CCC--------hHHHHHHHHcCCCCCCCC----CCCHHHHHHHHHhcccCC
Q psy1684 113 -S-AVDFG------------SG-------GMT--------NAEVLHQVEHGYRMPCPP----GCPPRLYDIMLECWLKDP 159 (189)
Q Consensus 113 -s-VwsfG------------~~-------~~~--------~~~~~~~v~~g~~~~~p~----~~p~~~~~l~~~C~~~~p 159 (189)
+ .||+| |. ||+ ...+.+.|.+|. .++|+ +.+.+.++|+..-+..++
T Consensus 271 rCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGk-YeFPdkdWahIS~eakdlisnLlvrda 349 (463)
T KOG0607|consen 271 RCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGK-YEFPDKDWAHISSEAKDLISNLLVRDA 349 (463)
T ss_pred cccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccC-CcCChhhhHHhhHHHHHHHHHHHhccH
Confidence 9 99999 21 222 234566677885 45564 477889999999999999
Q ss_pred CCCCCHHHHHH
Q psy1684 160 VKRPTFETLQW 170 (189)
Q Consensus 160 ~~RP~~~~i~~ 170 (189)
.+|-++.+++.
T Consensus 350 ~~rlsa~~vln 360 (463)
T KOG0607|consen 350 KQRLSAAQVLN 360 (463)
T ss_pred HhhhhhhhccC
Confidence 99999988876
|
|
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=98.75 E-value=2e-09 Score=85.43 Aligned_cols=144 Identities=10% Similarity=0.058 Sum_probs=96.5
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..++|+|++.++.........|+|.|++.+ . ++. +|......+-..+-.+..+.-.+
T Consensus 56 r~lkHpniv~m~esfEt~~~~~vVte~a~g-~-----L~~-----------------il~~d~~lpEe~v~~~a~~LVsa 112 (808)
T KOG0597|consen 56 RSLKHPNIVEMLESFETSAHLWVVTEYAVG-D-----LFT-----------------ILEQDGKLPEEQVRAIAYDLVSA 112 (808)
T ss_pred HhcCCcchhhHHHhhcccceEEEEehhhhh-h-----HHH-----------------HHHhccCCCHHHHHHHHHHHHHH
Confidence 468999999999877777788999999875 2 111 22223333322222233333456
Q ss_pred ceeeccCCcccccc-cc---------------cc---------------------cccC-CCCCccc-e-EEEec-----
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YL---------------------VHGT-NLSGVVV-S-AVDFG----- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l---------------------~~~~-~~~~~~~-s-VwsfG----- 118 (189)
+.|+|+..|+|||. |. |+ |+|. .++.|+. + .||.|
T Consensus 113 L~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE 192 (808)
T KOG0597|consen 113 LYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYE 192 (808)
T ss_pred HHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHH
Confidence 77788888888875 33 22 2322 7788999 9 99999
Q ss_pred -CCCCCh---H---HHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 119 -SGGMTN---A---EVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 119 -~~~~~~---~---~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
|.|-.+ . ++...|... ..+.|......+..++..-+.+||.+|-|-.+++..
T Consensus 193 ~~~G~PPF~a~si~~Lv~~I~~d-~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 193 LYVGQPPFYARSITQLVKSILKD-PVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred HhcCCCCchHHHHHHHHHHHhcC-CCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 444432 3 334444333 344566889999999999999999999999988753
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.74 E-value=6.4e-09 Score=83.49 Aligned_cols=41 Identities=15% Similarity=0.191 Sum_probs=29.9
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHH--HHHHHHhhc--CCCCCC
Q psy1684 145 PRLYDIMLECWLKDPVKRPTFETLQW--KLEDFFTME--GSDYKE 185 (189)
Q Consensus 145 ~~~~~l~~~C~~~~p~~RP~~~~i~~--~l~~~~~~~--~~~~~~ 185 (189)
+.+.+||.+|+..||++|||++|+++ .|....... -|+|.|
T Consensus 412 ~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~~~~~~~~~~ 456 (467)
T PTZ00284 412 DLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYYPECRQHPNYPD 456 (467)
T ss_pred HHHHHHHHHhCCcChhhCCCHHHHhcCccccccCCccccCCCCCC
Confidence 45679999999999999999999987 354433322 355553
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=98.71 E-value=3.2e-09 Score=80.74 Aligned_cols=27 Identities=22% Similarity=0.261 Sum_probs=24.0
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 144 PPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 144 p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
...+.+|+.+|+..||.+|||++|+++
T Consensus 287 ~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 287 DSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred ChHHHHHHHHHhccCcccccCHHHHhc
Confidence 356788999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=98.69 E-value=4.5e-08 Score=71.62 Aligned_cols=79 Identities=22% Similarity=0.295 Sum_probs=60.5
Q ss_pred CcccccccccccccCCCCCccc-e-EEEec------------CCCCC-hHHHHHHHHcCCCCCCCC--CCCHHHHHHHHH
Q psy1684 91 PCVQVSCRIYLVHGTNLSGVVV-S-AVDFG------------SGGMT-NAEVLHQVEHGYRMPCPP--GCPPRLYDIMLE 153 (189)
Q Consensus 91 ~~~~~~~p~~l~~~~~~~~~~~-s-VwsfG------------~~~~~-~~~~~~~v~~g~~~~~p~--~~p~~~~~l~~~ 153 (189)
+|...++||.+-++ ...+|+. + ||||| |++.+ ..+++-+|.+...|..|. ..++++.+++..
T Consensus 253 GC~~YMaPERidp~-~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~ 331 (391)
T KOG0983|consen 253 GCAAYMAPERIDPP-DKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKD 331 (391)
T ss_pred CCccccCccccCCC-CCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHHHHH
Confidence 56666677766444 3567999 9 99999 77743 468888887655444443 368999999999
Q ss_pred hcccCCCCCCCHHHHHH
Q psy1684 154 CWLKDPVKRPTFETLQW 170 (189)
Q Consensus 154 C~~~~p~~RP~~~~i~~ 170 (189)
|+.+|+.+||...++++
T Consensus 332 CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 332 CLTKDHRKRPKYNKLLE 348 (391)
T ss_pred HhhcCcccCcchHHHhc
Confidence 99999999999998875
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=98.69 E-value=2e-09 Score=79.04 Aligned_cols=101 Identities=12% Similarity=-0.014 Sum_probs=77.0
Q ss_pred ccCCCCCcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------------------------cccccC-
Q psy1684 61 QKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------------------------YLVHGT- 105 (189)
Q Consensus 61 yl~~~~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------------------------~l~~~~- 105 (189)
|+....+|+-....=|+.++..++.|+|+..++.||+ || .||+|.
T Consensus 134 ~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~rT~TlCGTPeYLAPEii 213 (355)
T KOG0616|consen 134 YLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGRTWTLCGTPEYLAPEII 213 (355)
T ss_pred HHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCcEEEecCCccccChHHh
Confidence 5665566762222234456667889999999999995 77 333333
Q ss_pred CCCCccc-e-EEEec------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCC
Q psy1684 106 NLSGVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKR 162 (189)
Q Consensus 106 ~~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~R 162 (189)
....|+. + =|||| |-+.++.++.++|.+|. ..+|.....++.+|+..-++.|-++|
T Consensus 214 ~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~-v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 214 QSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGK-VKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred hcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCc-ccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 5666899 8 99999 66677889999998884 56788999999999999999999999
|
|
| >KOG1264|consensus | Back alignment and domain information |
|---|
Probab=98.68 E-value=5.2e-08 Score=79.94 Aligned_cols=78 Identities=28% Similarity=0.337 Sum_probs=65.6
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcC-HhHHHHHhhh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIH-YPELVEHYSK 79 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~-l~~li~~~~~ 79 (189)
|||..+.+..|+.+|.. ...+|+|||| +....+.|++|++. .++++|++|.+...-|..+...|. +.+|++||.+
T Consensus 650 W~~as~treqAE~mL~r-vp~DGaFLiR-~~~~~nsy~iSfr~--~gkikHcRi~rdGr~fvl~t~~FesLv~lv~yY~k 725 (1267)
T KOG1264|consen 650 WYHASLTREQAEDMLMR-VPRDGAFLIR-KREGSNSYAISFRA--RGKIKHCRINRDGRHFVLGTSAFESLVELVSYYEK 725 (1267)
T ss_pred cccccccHHHHHHHHhh-CccCcceEEE-eccCCceEEEEEEE--cCcEeEEEEccCceEEEeccHHHHHHHHHHHHHhc
Confidence 99999999999998864 3578999999 66777999999999 999999999864222777777788 9999999887
Q ss_pred ccC
Q psy1684 80 DAD 82 (189)
Q Consensus 80 ~a~ 82 (189)
+..
T Consensus 726 ~~l 728 (1267)
T KOG1264|consen 726 HPL 728 (1267)
T ss_pred Chh
Confidence 653
|
|
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=98.65 E-value=2.4e-09 Score=80.09 Aligned_cols=99 Identities=16% Similarity=0.134 Sum_probs=68.5
Q ss_pred HHHHhhhccCCceeeccCCcccccc-cc---------------cccccC----------------------CCC-Cccc-
Q psy1684 73 LVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVHGT----------------------NLS-GVVV- 112 (189)
Q Consensus 73 li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~~~----------------------~~~-~~~~- 112 (189)
+-.+..|...|++++|+..|+|||+ |. |+|+.. .+. .|+.
T Consensus 122 ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~ 201 (323)
T KOG0594|consen 122 IKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTS 201 (323)
T ss_pred HHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCC
Confidence 3456678889999999999999996 65 333322 233 4888
Q ss_pred e-EEEec------------CCCCChHHHHHHHHc--CC---------------CCCCCC---------CCC---HHHHHH
Q psy1684 113 S-AVDFG------------SGGMTNAEVLHQVEH--GY---------------RMPCPP---------GCP---PRLYDI 150 (189)
Q Consensus 113 s-VwsfG------------~~~~~~~~~~~~v~~--g~---------------~~~~p~---------~~p---~~~~~l 150 (189)
. +||+| |+|.+..+-+..|-+ |. ..+.|. ..| ++..++
T Consensus 202 vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dl 281 (323)
T KOG0594|consen 202 VDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIEL 281 (323)
T ss_pred cchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHH
Confidence 8 99999 888776554444411 11 111111 112 478899
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q psy1684 151 MLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 151 ~~~C~~~~p~~RP~~~~i~~~ 171 (189)
+..|++.+|.+|.|++..+..
T Consensus 282 l~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 282 LSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred HHHHhccCcccCcCHHHHhcC
Confidence 999999999999999988875
|
|
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=98.62 E-value=5.2e-09 Score=76.08 Aligned_cols=96 Identities=19% Similarity=0.235 Sum_probs=65.2
Q ss_pred eccCCcccccccccccccCCCCCccc-e-EEEec------------CCCCCh-HHHHHHHHcCCCCC--CCCC---CCHH
Q psy1684 87 NLRKPCVQVSCRIYLVHGTNLSGVVV-S-AVDFG------------SGGMTN-AEVLHQVEHGYRMP--CPPG---CPPR 146 (189)
Q Consensus 87 ~~~~~~~~~~~p~~l~~~~~~~~~~~-s-VwsfG------------~~~~~~-~~~~~~v~~g~~~~--~p~~---~p~~ 146 (189)
.+..+|...++||.+.+. ...|+. | |||+| |.+++. .+-+..|..|..|. .+.+ ....
T Consensus 225 T~daGCrpYmAPERi~p~--~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~ 302 (361)
T KOG1006|consen 225 TVDAGCRPYMAPERIDPS--DKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFS 302 (361)
T ss_pred hhccCCccccChhccCCc--cCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHH
Confidence 334466676778877553 236999 9 99999 666653 23333445665432 3333 5678
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH-HHHHHhhcCCCCC
Q psy1684 147 LYDIMLECWLKDPVKRPTFETLQWK-LEDFFTMEGSDYK 184 (189)
Q Consensus 147 ~~~l~~~C~~~~p~~RP~~~~i~~~-l~~~~~~~~~~~~ 184 (189)
+..++..|+.+|-++||++.++.+. +-.+....+++-+
T Consensus 303 ~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~~~~v~ 341 (361)
T KOG1006|consen 303 MVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVEGPDVE 341 (361)
T ss_pred HHHHHHHHhhcccccCcchhhhhcCchhhhhhhcCCcee
Confidence 9999999999999999999998765 4455555555543
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=98.59 E-value=2.8e-08 Score=84.84 Aligned_cols=99 Identities=18% Similarity=0.116 Sum_probs=70.0
Q ss_pred hHHHHHhhhccCCceeeccCCcccccc-cc---------------cccccC-----------------------------
Q psy1684 71 PELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVHGT----------------------------- 105 (189)
Q Consensus 71 ~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~~~----------------------------- 105 (189)
......++++..|+.|+|..++||||+ |- |+|.+.
T Consensus 697 d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~V 776 (1351)
T KOG1035|consen 697 DEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQV 776 (1351)
T ss_pred HHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCccccccc
Confidence 334456778889999999999999996 44 555441
Q ss_pred ------------C--CCCccc-e-EEEec-------CCC---CChHHHHHHHHcCCCCCC---C-CCCCHHHHHHHHHhc
Q psy1684 106 ------------N--LSGVVV-S-AVDFG-------SGG---MTNAEVLHQVEHGYRMPC---P-PGCPPRLYDIMLECW 155 (189)
Q Consensus 106 ------------~--~~~~~~-s-VwsfG-------~~~---~~~~~~~~~v~~g~~~~~---p-~~~p~~~~~l~~~C~ 155 (189)
. ..+|+. . +||.| |+- |.-..++..+++|.-|.. . +.+| .-.++|...+
T Consensus 777 GTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~-~e~slI~~Ll 855 (1351)
T KOG1035|consen 777 GTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLYPFGTSMERASILTNLRKGSIPEPADFFDPEHP-EEASLIRWLL 855 (1351)
T ss_pred ceeeeecHHHhcccccccccchhhhHHHHHHHHHHhccCCchHHHHHHHHhcccCCCCCCcccccccch-HHHHHHHHHh
Confidence 2 237999 9 99999 442 223456666676654433 1 2243 4457899999
Q ss_pred ccCCCCCCCHHHHHH
Q psy1684 156 LKDPVKRPTFETLQW 170 (189)
Q Consensus 156 ~~~p~~RP~~~~i~~ 170 (189)
+.||++|||+.|+++
T Consensus 856 ~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 856 SHDPSKRPTATELLN 870 (1351)
T ss_pred cCCCccCCCHHHHhh
Confidence 999999999999875
|
|
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=98.59 E-value=4e-09 Score=78.80 Aligned_cols=143 Identities=12% Similarity=-0.014 Sum_probs=88.2
Q ss_pred CCChHHHHHHhcC--CCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC-CCCcCHhHHHHHhhhcc
Q psy1684 5 KIKRIEAEKKLLL--PENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG-RTTIHYPELVEHYSKDA 81 (189)
Q Consensus 5 ~l~~~n~~~lL~~--~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~-~~~~~l~~li~~~~~~a 81 (189)
.+.|+|+|.+-.+ ..+-+..|||+|++.. + ++. .++. ...|...+.-....|..
T Consensus 131 ~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-D-----Lks-----------------l~d~m~q~F~~~evK~L~~QlL 187 (419)
T KOG0663|consen 131 KARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-D-----LKS-----------------LMETMKQPFLPGEVKTLMLQLL 187 (419)
T ss_pred hcCCCCeeeeEEEEeccccceeeeeHHHHHh-h-----HHH-----------------HHHhccCCCchHHHHHHHHHHH
Confidence 3557777764332 2233457888887765 2 222 1111 22455444444556777
Q ss_pred CCceeeccCCcccccc-cc---------------cccccC-----------------------CCCCccc-e-EEEec--
Q psy1684 82 DGLCVNLRKPCVQVSC-RI---------------YLVHGT-----------------------NLSGVVV-S-AVDFG-- 118 (189)
Q Consensus 82 ~gl~~~~~~~~~~~~~-p~---------------~l~~~~-----------------------~~~~~~~-s-VwsfG-- 118 (189)
.|+.++|..-++|||+ |. |||++. -...||+ . +||+|
T Consensus 188 ~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI 267 (419)
T KOG0663|consen 188 RGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCI 267 (419)
T ss_pred HHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHH
Confidence 8999999999999996 44 666655 3445899 8 99999
Q ss_pred ----------CCCCChHHHHHHHH--cCC-------------------CCC---------CCCC-CCHHHHHHHHHhccc
Q psy1684 119 ----------SGGMTNAEVLHQVE--HGY-------------------RMP---------CPPG-CPPRLYDIMLECWLK 157 (189)
Q Consensus 119 ----------~~~~~~~~~~~~v~--~g~-------------------~~~---------~p~~-~p~~~~~l~~~C~~~ 157 (189)
|+|-+..+-+.+|- -|. .++ ++.. ....-++|+..-+..
T Consensus 268 ~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~ 347 (419)
T KOG0663|consen 268 FAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTY 347 (419)
T ss_pred HHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhcc
Confidence 55554322222221 111 011 1111 446778999999999
Q ss_pred CCCCCCCHHHHHH
Q psy1684 158 DPVKRPTFETLQW 170 (189)
Q Consensus 158 ~p~~RP~~~~i~~ 170 (189)
||.+|-|+.+.++
T Consensus 348 dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 348 DPGKRITAEDGLK 360 (419)
T ss_pred CccccccHHHhhc
Confidence 9999999998775
|
|
| >KOG1930|consensus | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.5e-07 Score=71.82 Aligned_cols=88 Identities=25% Similarity=0.262 Sum_probs=71.6
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEec-------------CCCeeeEEEEEeccCC-ccCC--
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKR-------------SSFCLKMTTGRSLFET-QKAG-- 64 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~-------------~~~~v~h~~i~~~~~g-yl~~-- 64 (189)
||.-+|+|+.|+.+| ..++.|+||||++.+-.|.|.|.++.. .+..|+||.|+...+| -|.+
T Consensus 214 WYKP~isREQAIalL--rdkePGtFvvRDS~SfrGayGLAlKVstPPPs~~~~~g~~~neLVRHFLIE~spkGVkLKGC~ 291 (483)
T KOG1930|consen 214 WYKPNISREQAIALL--RDKEPGTFVVRDSHSFRGAYGLALKVSTPPPSVQPGDGSDSNELVRHFLIEPSPKGVKLKGCD 291 (483)
T ss_pred ccCCCCCHHHHHHHh--hcCCCCeEEEecCCcCCCccceEEEeccCCCcccCCCCCchhhhhhhheeccCCCceeccCCC
Confidence 999999999999999 456889999999999999999999876 1257999999999998 5544
Q ss_pred -CCCcC-HhHHHHHhhhccCCceeeccC
Q psy1684 65 -RTTIH-YPELVEHYSKDADGLCVNLRK 90 (189)
Q Consensus 65 -~~~~~-l~~li~~~~~~a~gl~~~~~~ 90 (189)
...|. |.+|+--+.-.+.+|.+++.-
T Consensus 292 nEP~FGSLSALV~QHSIt~LALPckL~i 319 (483)
T KOG1930|consen 292 NEPVFGSLSALVYQHSITALALPCKLVI 319 (483)
T ss_pred CCCccchhHHHHhhccchhhhcceeEec
Confidence 45687 999987666666677666653
|
|
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=98.57 E-value=1e-07 Score=71.72 Aligned_cols=94 Identities=20% Similarity=0.096 Sum_probs=67.3
Q ss_pred hhccCCceeeccCCcccccc-cc---------------cccccC-------------------------CCCCccc-e-E
Q psy1684 78 SKDADGLCVNLRKPCVQVSC-RI---------------YLVHGT-------------------------NLSGVVV-S-A 114 (189)
Q Consensus 78 ~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~~~-------------------------~~~~~~~-s-V 114 (189)
.|...|+.|.|+.+++|||+ |. |||+-. ....||. . |
T Consensus 132 YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDi 211 (359)
T KOG0660|consen 132 YQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDI 211 (359)
T ss_pred HHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhh
Confidence 46677999999999999996 55 554422 5677999 8 9
Q ss_pred EEec------------CCCCCh---------------HHHHHHHH----------cCCCCCCC-----CCCCHHHHHHHH
Q psy1684 115 VDFG------------SGGMTN---------------AEVLHQVE----------HGYRMPCP-----PGCPPRLYDIML 152 (189)
Q Consensus 115 wsfG------------~~~~~~---------------~~~~~~v~----------~g~~~~~p-----~~~p~~~~~l~~ 152 (189)
||.| |+|-+. .+.+..+. -+..++.| +++.+...+|+.
T Consensus 212 WSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLle 291 (359)
T KOG0660|consen 212 WSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLE 291 (359)
T ss_pred hhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHH
Confidence 9999 555432 22222221 12233333 367888999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q psy1684 153 ECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 153 ~C~~~~p~~RP~~~~i~~~ 171 (189)
+.+..||.+|+|.+|.+..
T Consensus 292 kmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 292 KMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHhccCccccCCHHHHhcC
Confidence 9999999999999998875
|
|
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=98.54 E-value=7e-08 Score=78.35 Aligned_cols=152 Identities=16% Similarity=0.137 Sum_probs=91.4
Q ss_pred CCCChHHHHHHhcCCCCC------CCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC-CCCcC--HhHHH
Q psy1684 4 GKIKRIEAEKKLLLPEND------HGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG-RTTIH--YPELV 74 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~------~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~-~~~~~--l~~li 74 (189)
++++|+|+|++.+..... ....||+|+++.+. ++. ++.. .+.+. -.+++
T Consensus 66 kKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGs-----L~~-----------------~L~~PEN~~GLpE~e~l 123 (732)
T KOG4250|consen 66 KKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGS-----LRK-----------------VLNSPENAYGLPESEFL 123 (732)
T ss_pred HHcCchhhhhhcccCCccccCcccccceEEEeecCCCc-----HHH-----------------HhcCcccccCCCHHHHH
Confidence 478899999988754322 23467777777632 222 1221 11222 45566
Q ss_pred HHhhhccCCceeeccCCcccccc-cc-------------------cccccC---------------------C-CCCccc
Q psy1684 75 EHYSKDADGLCVNLRKPCVQVSC-RI-------------------YLVHGT---------------------N-LSGVVV 112 (189)
Q Consensus 75 ~~~~~~a~gl~~~~~~~~~~~~~-p~-------------------~l~~~~---------------------~-~~~~~~ 112 (189)
........|+.+++..+|+|||+ |. |.|++. . ...|+.
T Consensus 124 ~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~ 203 (732)
T KOG4250|consen 124 DLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTA 203 (732)
T ss_pred HHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCc
Confidence 66677778999999999999996 55 445554 2 366888
Q ss_pred -e-EEEec---------------CCCC-ChHHHHHHHHc---------------C-----CCCCCCCCCCHHHH----HH
Q psy1684 113 -S-AVDFG---------------SGGM-TNAEVLHQVEH---------------G-----YRMPCPPGCPPRLY----DI 150 (189)
Q Consensus 113 -s-VwsfG---------------~~~~-~~~~~~~~v~~---------------g-----~~~~~p~~~p~~~~----~l 150 (189)
+ -|||| +.+- ++.+++..+.. | ..+|.|....+.+. ..
T Consensus 204 tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kw 283 (732)
T KOG4250|consen 204 TVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKW 283 (732)
T ss_pred eeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHH
Confidence 8 99999 2221 12334433321 1 12555655544433 44
Q ss_pred HHHhcccCCCCCC--CHHHHHHHHHHHHh
Q psy1684 151 MLECWLKDPVKRP--TFETLQWKLEDFFT 177 (189)
Q Consensus 151 ~~~C~~~~p~~RP--~~~~i~~~l~~~~~ 177 (189)
+...+..||.+|- .|.+....+..|++
T Consensus 284 La~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 284 LASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred HHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 4455677777777 77777777666665
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=98.51 E-value=5.8e-08 Score=74.97 Aligned_cols=104 Identities=14% Similarity=-0.009 Sum_probs=66.9
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cc------------------cccC-CC-CCcc
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YL------------------VHGT-NL-SGVV 111 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l------------------~~~~-~~-~~~~ 111 (189)
+.......+..+.+.|+.++|...++|+|+ |. ++ ++|. .. ..++
T Consensus 117 l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 196 (345)
T cd07877 117 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYN 196 (345)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccccccccccCCCccCHHHHhCccCCC
Confidence 444555566778888999999999999986 43 11 1221 11 3477
Q ss_pred c-e-EEEec------------CCCCChHHHHHHHHcCC------------------------CCCC------CCCCCHHH
Q psy1684 112 V-S-AVDFG------------SGGMTNAEVLHQVEHGY------------------------RMPC------PPGCPPRL 147 (189)
Q Consensus 112 ~-s-VwsfG------------~~~~~~~~~~~~v~~g~------------------------~~~~------p~~~p~~~ 147 (189)
. + ||||| |++.+..+....+.... ..+. ....++++
T Consensus 197 ~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (345)
T cd07877 197 QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLA 276 (345)
T ss_pred chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHH
Confidence 8 8 99999 44333333222221110 0000 11357889
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 148 YDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 148 ~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
.++|.+|++.||++||++.+++..
T Consensus 277 ~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 277 VDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHHHHHcCCChhhcCCHHHHhcC
Confidence 999999999999999999998864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.1e-06 Score=69.83 Aligned_cols=89 Identities=27% Similarity=0.312 Sum_probs=68.0
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCc---e-EEEEEecCCCeeeEEEEEeccCC-ccCCCCCcC-HhHHH
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKND---Y-SLSEYKRSSFCLKMTTGRSLFET-QKAGRTTIH-YPELV 74 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~---~-~ls~~~~~~~~v~h~~i~~~~~g-yl~~~~~~~-l~~li 74 (189)
||||.+.+++++.+| ..+|.||||.+....+. + .||+.......++|+.|....++ +......|. +.+++
T Consensus 51 ~yHG~l~red~~~lL----~~~GDfLvR~s~~~~~~~~~~~vlSv~~~~~~~~~h~vi~~~~~~~~~~~~~~F~si~~li 126 (474)
T KOG0194|consen 51 YYHGLLPREDAEKLL----KNDGDFLVRASEPKEGEKREFVVLSVKWSVFKKIKHYVIKRNGNLFFFEGLRKFPTISELV 126 (474)
T ss_pred cccccccHhHHHHHh----CCCCceEEEeecccCCcceeEEEEEEEeecCCceeEEEEEEcCCeeEEeccccCCcHHHHH
Confidence 899999999999999 35799999999887552 3 77777611267889999988888 777778888 99999
Q ss_pred HHhhhccC---CceeeccCCcc
Q psy1684 75 EHYSKDAD---GLCVNLRKPCV 93 (189)
Q Consensus 75 ~~~~~~a~---gl~~~~~~~~~ 93 (189)
.+|..... +....+..|+.
T Consensus 127 ~~~~~~~~~~~~~~~~L~~PI~ 148 (474)
T KOG0194|consen 127 NYYKFSKLEITGKNFFLKRPIP 148 (474)
T ss_pred HHHHhcccceeccceeeccccc
Confidence 99887643 33334455543
|
|
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=98.44 E-value=3.9e-07 Score=67.52 Aligned_cols=105 Identities=11% Similarity=0.043 Sum_probs=77.1
Q ss_pred CCcCHhHHHHHhhhccCCceeeccCCcccccc-cc------------------cccccC---------------------
Q psy1684 66 TTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI------------------YLVHGT--------------------- 105 (189)
Q Consensus 66 ~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~------------------~l~~~~--------------------- 105 (189)
..|.-++......+++.++.|+|+..|.|||+ |+ |+|++.
T Consensus 156 ~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevl 235 (400)
T KOG0604|consen 156 QAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVL 235 (400)
T ss_pred ccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCCccccCCcccccccCHHHh
Confidence 34666667777788888999999999999995 76 555544
Q ss_pred CCCCccc-e-EEEec---------CCCC---C----hHHHHHHHHcCC-CCCCCC--CCCHHHHHHHHHhcccCCCCCCC
Q psy1684 106 NLSGVVV-S-AVDFG---------SGGM---T----NAEVLHQVEHGY-RMPCPP--GCPPRLYDIMLECWLKDPVKRPT 164 (189)
Q Consensus 106 ~~~~~~~-s-VwsfG---------~~~~---~----~~~~~~~v~~g~-~~~~p~--~~p~~~~~l~~~C~~~~p~~RP~ 164 (189)
...+|+. + .||.| |+.. + .-.+..+|..|. -.|-|+ .++++.+++|+..+..+|++|-|
T Consensus 236 g~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlT 315 (400)
T KOG0604|consen 236 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLT 315 (400)
T ss_pred CchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhhee
Confidence 4466999 9 99999 2221 1 123556677774 233332 46788999999999999999999
Q ss_pred HHHHHH
Q psy1684 165 FETLQW 170 (189)
Q Consensus 165 ~~~i~~ 170 (189)
..+++.
T Consensus 316 I~~~m~ 321 (400)
T KOG0604|consen 316 IEEVMD 321 (400)
T ss_pred HHHhhc
Confidence 998875
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=98.42 E-value=4.4e-08 Score=77.12 Aligned_cols=70 Identities=16% Similarity=0.115 Sum_probs=50.9
Q ss_pred cccccC-CCCCccc-e-EEEec------------CCCCChHHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHhcccCCCC
Q psy1684 100 YLVHGT-NLSGVVV-S-AVDFG------------SGGMTNAEVLHQVEHG-YRMPCP--PGCPPRLYDIMLECWLKDPVK 161 (189)
Q Consensus 100 ~l~~~~-~~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g-~~~~~p--~~~p~~~~~l~~~C~~~~p~~ 161 (189)
.+|+|+ .+..|+. + -||+| |.+-++.++..+|.+. ..+..| ..+..+..+||.+|+. ||++
T Consensus 354 YiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~ 432 (550)
T KOG0605|consen 354 YIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPEN 432 (550)
T ss_pred ccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHH
Confidence 333433 4556999 9 99999 6667788998888543 224444 4577999999999998 9999
Q ss_pred CCC---HHHHHH
Q psy1684 162 RPT---FETLQW 170 (189)
Q Consensus 162 RP~---~~~i~~ 170 (189)
|-- +.||.+
T Consensus 433 RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 433 RLGSKGAEEIKK 444 (550)
T ss_pred hcCcccHHHHhc
Confidence 964 555544
|
|
| >KOG0790|consensus | Back alignment and domain information |
|---|
Probab=98.31 E-value=3.3e-06 Score=65.33 Aligned_cols=89 Identities=27% Similarity=0.365 Sum_probs=73.1
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC-ccCCCCCcC-HhHHHHHhh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET-QKAGRTTIH-YPELVEHYS 78 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g-yl~~~~~~~-l~~li~~~~ 78 (189)
|||..++...|+.||.... .+|.||.|.+.+++|+|+++++. .+.+.|.+|....+- -+.++.+|. +.+|+.||+
T Consensus 6 wfh~~~~g~~ae~Ll~~~g-~dgsfl~r~s~sNp~~fsl~~r~--~~~v~hikiq~~~~~~~l~~gekfat~~ELvqyym 82 (600)
T KOG0790|consen 6 WFHPDLSGVEAETLLKERG-VDGSFLARPSESNPGDFSLSVRR--GDKVTHIKIQNSGDFYDLYGGEKFATLAELVQYYM 82 (600)
T ss_pred hcCCCccchhHHHHHHHhc-cccchhhccccCCCcceeEEEEe--CCceEEEEEeecCccccccCCccccchHHHHHHHH
Confidence 9999999999999987543 68999999999999999999999 999999999765443 466677888 999999998
Q ss_pred hcc------CCceeeccCCc
Q psy1684 79 KDA------DGLCVNLRKPC 92 (189)
Q Consensus 79 ~~a------~gl~~~~~~~~ 92 (189)
... +|...-+..|.
T Consensus 83 e~~~~lkekng~~ielK~pl 102 (600)
T KOG0790|consen 83 EHHGQLKEKNGDVIELKYPL 102 (600)
T ss_pred hhhHHHHhcCCCEEEecCCC
Confidence 764 36555555553
|
|
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=98.30 E-value=1.3e-07 Score=78.12 Aligned_cols=94 Identities=16% Similarity=0.142 Sum_probs=61.8
Q ss_pred HHHHhhhccCCceeeccCCcccccc-cc--------------------------------------------cccccCCC
Q psy1684 73 LVEHYSKDADGLCVNLRKPCVQVSC-RI--------------------------------------------YLVHGTNL 107 (189)
Q Consensus 73 li~~~~~~a~gl~~~~~~~~~~~~~-p~--------------------------------------------~l~~~~~~ 107 (189)
.+.-..+.+.|++.+|+..++|||+ |. |.|+|...
T Consensus 608 ~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~ 687 (903)
T KOG1027|consen 608 PISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLR 687 (903)
T ss_pred HHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHh
Confidence 4455567788999999999999996 54 33333322
Q ss_pred CC-ccc-e-EEEec-------------CCCCChHHHHHHHHcCC----CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q psy1684 108 SG-VVV-S-AVDFG-------------SGGMTNAEVLHQVEHGY----RMPCPPGCPPRLYDIMLECWLKDPVKRPTFET 167 (189)
Q Consensus 108 ~~-~~~-s-VwsfG-------------~~~~~~~~~~~~v~~g~----~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~ 167 (189)
+. -+. . ++|+| |.+.-.. -..|.+|. .+..-.+| +..+||.+.++.+|..||++.+
T Consensus 688 ~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~~~~L~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~ 763 (903)
T KOG1027|consen 688 EDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTGNYTLVHLEPLPDC--EAKDLISRMLNPDPQLRPSATD 763 (903)
T ss_pred ccccCcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcCccceeeeccCchH--HHHHHHHHhcCCCcccCCCHHH
Confidence 22 233 5 88888 3222111 12344442 22222344 8889999999999999999999
Q ss_pred HHH
Q psy1684 168 LQW 170 (189)
Q Consensus 168 i~~ 170 (189)
|+.
T Consensus 764 VL~ 766 (903)
T KOG1027|consen 764 VLN 766 (903)
T ss_pred HhC
Confidence 975
|
|
| >KOG3601|consensus | Back alignment and domain information |
|---|
Probab=98.28 E-value=1.4e-07 Score=65.69 Aligned_cols=78 Identities=26% Similarity=0.128 Sum_probs=68.3
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC-ccCCCCCcC-HhHHHHHhh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET-QKAGRTTIH-YPELVEHYS 78 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g-yl~~~~~~~-l~~li~~~~ 78 (189)
||+|.++++-++.++.. +.+|.||+|.+...+|.|.++++. .+.+.|+.+.+.+.| |.....+|. +..+++|+.
T Consensus 60 wve~~i~r~~ae~~l~~--~~~G~fl~r~s~sSPg~fsgsvr~--~d~vqhfkvvrpa~~k~~lw~skfnslnplv~Y~r 135 (222)
T KOG3601|consen 60 WVEGLIPRPLAEDLLSK--KRDGDFLIRLSESSPGDFSGSVRF--PDGVQHFKVVRPAFGKYFLWSSKFNSLNPLVSYHR 135 (222)
T ss_pred ceecccccchhhhhhhc--cCcchhhhhhhhcCcccccccccC--CCCceeccccccCccccccchhhccCCCCCcccCc
Confidence 89999999999998865 688999999999999999999999 999999999998888 766667777 778888877
Q ss_pred hccC
Q psy1684 79 KDAD 82 (189)
Q Consensus 79 ~~a~ 82 (189)
....
T Consensus 136 t~s~ 139 (222)
T KOG3601|consen 136 TASQ 139 (222)
T ss_pred cccc
Confidence 6543
|
|
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=98.26 E-value=7.8e-08 Score=77.63 Aligned_cols=33 Identities=15% Similarity=0.121 Sum_probs=30.4
Q ss_pred CCCCChHHHHHHhcCCCCCCCcEEEecCCCCCC
Q psy1684 3 FGKIKRIEAEKKLLLPENDHGAFLIRDSESRKN 35 (189)
Q Consensus 3 ~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~ 35 (189)
+..|.|+|+|+|||+|..+.+.|||+|+|..++
T Consensus 317 MKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGN 349 (1157)
T KOG4278|consen 317 MKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGN 349 (1157)
T ss_pred HHhhcCccHHHHhhhhccCCCeEEEEecccCcc
Confidence 457899999999999999999999999999865
|
|
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=98.18 E-value=7.5e-07 Score=68.47 Aligned_cols=57 Identities=25% Similarity=0.366 Sum_probs=43.4
Q ss_pred EEEec------------CCCCChHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC----HHHHHH
Q psy1684 114 AVDFG------------SGGMTNAEVLHQVE-HGYRMPCPPGCPPRLYDIMLECWLKDPVKRPT----FETLQW 170 (189)
Q Consensus 114 VwsfG------------~~~~~~~~~~~~v~-~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~----~~~i~~ 170 (189)
=|+|| |.|.++.+.+..|. +..+.|--+..+...++||++-+.+||++|-. ++||.+
T Consensus 318 WWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 318 WWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred HHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence 68888 88888888888874 33333333356789999999999999999988 666644
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=98.11 E-value=2e-06 Score=70.75 Aligned_cols=26 Identities=4% Similarity=-0.077 Sum_probs=23.2
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 146 RLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 146 ~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
...+|+.+|++.||++|||++++++.
T Consensus 425 ~~~dLi~~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 425 AGWELLKSMMRFKGRQRISAKAALAH 450 (566)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhCC
Confidence 45589999999999999999999874
|
|
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=98.10 E-value=5.9e-06 Score=66.72 Aligned_cols=32 Identities=6% Similarity=-0.036 Sum_probs=27.9
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI 99 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~ 99 (189)
+++..+..+..++..+|..++...+||.|+ ||
T Consensus 286 lsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPE 318 (586)
T KOG0667|consen 286 LSLPLVRKFAQQILTALLFLHELGIIHCDLKPE 318 (586)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeeccCChh
Confidence 347777888999999999999999999995 77
|
|
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=98.07 E-value=4.7e-06 Score=63.56 Aligned_cols=39 Identities=0% Similarity=-0.211 Sum_probs=29.1
Q ss_pred ccCCCCC--cCHhHHHHHhhhccCCceeeccCCcccccc-cc
Q psy1684 61 QKAGRTT--IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI 99 (189)
Q Consensus 61 yl~~~~~--~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~ 99 (189)
|+..++. |++..+.....|....+.++|...++|.|+ ||
T Consensus 180 Flk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPE 221 (415)
T KOG0671|consen 180 FLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPE 221 (415)
T ss_pred HhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChh
Confidence 5655544 446666667777788899999999999985 77
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=98.07 E-value=3.3e-06 Score=70.84 Aligned_cols=72 Identities=14% Similarity=0.016 Sum_probs=54.3
Q ss_pred cccccC-CCCCccc-e-EEEec------------CCCCChHHHHHHHHcCC--CCCCCCCCCHHHHHHHHHhcccCCCCC
Q psy1684 100 YLVHGT-NLSGVVV-S-AVDFG------------SGGMTNAEVLHQVEHGY--RMPCPPGCPPRLYDIMLECWLKDPVKR 162 (189)
Q Consensus 100 ~l~~~~-~~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~--~~~~p~~~p~~~~~l~~~C~~~~p~~R 162 (189)
++++|. ....++. + ||||| |.+....+++..+..+. .+..+..++.++.+++..||..||.+|
T Consensus 546 Y~APE~l~~~~~~~~~DiwSlG~il~ElltG~~pf~~~~~~~~~~~il~~~~~~p~~~~~~~~~~~~~l~~lL~~dP~~R 625 (669)
T cd05610 546 YLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWPEGEEKLSVNAQNAIEILLTMDPTKR 625 (669)
T ss_pred ccCHHHcCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccChhHC
Confidence 444443 4556889 9 99999 66777777777764432 222334678899999999999999999
Q ss_pred CCHHHHHHH
Q psy1684 163 PTFETLQWK 171 (189)
Q Consensus 163 P~~~~i~~~ 171 (189)
|++.++++.
T Consensus 626 ~ta~e~l~h 634 (669)
T cd05610 626 AGLKELKQH 634 (669)
T ss_pred cCHHHHHhC
Confidence 999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=98.01 E-value=2.8e-06 Score=66.34 Aligned_cols=64 Identities=13% Similarity=0.208 Sum_probs=41.6
Q ss_pred CCCccc-e-EEEec------------CCC-CChHHHHHH--HHcC--CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q psy1684 107 LSGVVV-S-AVDFG------------SGG-MTNAEVLHQ--VEHG--YRMPCPPGCPPRLYDIMLECWLKDPVKRPTFET 167 (189)
Q Consensus 107 ~~~~~~-s-VwsfG------------~~~-~~~~~~~~~--v~~g--~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~ 167 (189)
.-+.+. . |||.| |.. .+..+|++. |.+. ...|.-+.+..+..++|.+|++.--.+|-...+
T Consensus 658 PPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~q 737 (775)
T KOG1151|consen 658 PPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQ 737 (775)
T ss_pred CCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHH
Confidence 445777 8 99999 211 223344432 2222 223333467889999999999999999988777
Q ss_pred HHH
Q psy1684 168 LQW 170 (189)
Q Consensus 168 i~~ 170 (189)
+..
T Consensus 738 LA~ 740 (775)
T KOG1151|consen 738 LAC 740 (775)
T ss_pred Hcc
Confidence 654
|
|
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=98.00 E-value=6.7e-06 Score=59.86 Aligned_cols=105 Identities=14% Similarity=0.052 Sum_probs=68.9
Q ss_pred CCcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cccccC------------------------
Q psy1684 66 TTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVHGT------------------------ 105 (189)
Q Consensus 66 ~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~~~------------------------ 105 (189)
.+|.+.++-.+....-.|+.++|+..++|||. |+ |+++-.
T Consensus 119 vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppE 198 (376)
T KOG0669|consen 119 VRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPE 198 (376)
T ss_pred ccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHH
Confidence 34556666666666678999999999999996 44 333211
Q ss_pred ---CCCCccc-e-EEEec------------------------------------CCCCChHHHHHHHHc-----CCCCC-
Q psy1684 106 ---NLSGVVV-S-AVDFG------------------------------------SGGMTNAEVLHQVEH-----GYRMP- 138 (189)
Q Consensus 106 ---~~~~~~~-s-VwsfG------------------------------------~~~~~~~~~~~~v~~-----g~~~~- 138 (189)
-...|+. - ||.-| |+++.+..+.+.+.. |..-.
T Consensus 199 llLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv 278 (376)
T KOG0669|consen 199 LLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKV 278 (376)
T ss_pred HhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhh
Confidence 2344777 6 88888 566655555555421 10000
Q ss_pred ----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 139 ----CPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 139 ----~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
.|-.-.++..+||...+..||++|+...+++.
T Consensus 279 ~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 279 KNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred hhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 11122357779999999999999999988765
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=97.98 E-value=4.8e-07 Score=63.88 Aligned_cols=27 Identities=33% Similarity=0.527 Sum_probs=24.5
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 145 PRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 145 ~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
..+.+++..|++.||++||++.++++.
T Consensus 188 ~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 678899999999999999999998864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=97.97 E-value=5.6e-06 Score=64.17 Aligned_cols=89 Identities=17% Similarity=0.091 Sum_probs=67.2
Q ss_pred HHHhhhccCCceeeccCCcccccccc----------------cccccC----------------------CCCCccc-e-
Q psy1684 74 VEHYSKDADGLCVNLRKPCVQVSCRI----------------YLVHGT----------------------NLSGVVV-S- 113 (189)
Q Consensus 74 i~~~~~~a~gl~~~~~~~~~~~~~p~----------------~l~~~~----------------------~~~~~~~-s- 113 (189)
+-|+..+|.||-++|.+.|+.||+.- ||.+|. ..++|.. .
T Consensus 453 vFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvD 532 (683)
T KOG0696|consen 453 VFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVD 532 (683)
T ss_pred hhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCCcceeeecCCCcccccceEEecccccchh
Confidence 33455666777778887777776532 333333 6788999 8
Q ss_pred EEEec------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCC
Q psy1684 114 AVDFG------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRP 163 (189)
Q Consensus 114 VwsfG------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP 163 (189)
=|||| |.|.+..++.+.|.+.. ...|...+.+..+|...-+...|.+|-
T Consensus 533 WWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn-vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 533 WWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN-VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc-CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 99999 88888889988885432 456788999999999999999999984
|
|
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=97.85 E-value=1.8e-06 Score=68.26 Aligned_cols=85 Identities=12% Similarity=0.078 Sum_probs=65.7
Q ss_pred ccCCceeeccCCcccccc-cc---------------cccc--------------------cC-CCCCccc-e-EEEec--
Q psy1684 80 DADGLCVNLRKPCVQVSC-RI---------------YLVH--------------------GT-NLSGVVV-S-AVDFG-- 118 (189)
Q Consensus 80 ~a~gl~~~~~~~~~~~~~-p~---------------~l~~--------------------~~-~~~~~~~-s-VwsfG-- 118 (189)
+..++.|+|++++|.||+ |+ |+|+ |. ....-+. + .||+|
T Consensus 529 v~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIl 608 (732)
T KOG0614|consen 529 VLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGIL 608 (732)
T ss_pred HHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHH
Confidence 345788999999999995 77 2222 11 2233455 6 89999
Q ss_pred ----------CCCCChHHHHHHHHcCC-CCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q psy1684 119 ----------SGGMTNAEVLHQVEHGY-RMPCPPGCPPRLYDIMLECWLKDPVKRPT 164 (189)
Q Consensus 119 ----------~~~~~~~~~~~~v~~g~-~~~~p~~~p~~~~~l~~~C~~~~p~~RP~ 164 (189)
|.+.++......|.+|. .+.+|...+....+||.+-+..+|++|--
T Consensus 609 i~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 609 IYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred HHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 88889988888888884 56789999999999999999999999976
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.77 E-value=1.4e-05 Score=64.79 Aligned_cols=31 Identities=10% Similarity=-0.070 Sum_probs=26.2
Q ss_pred CCCCHHHHHHHHHhcccCC---CCCCCHHHHHHH
Q psy1684 141 PGCPPRLYDIMLECWLKDP---VKRPTFETLQWK 171 (189)
Q Consensus 141 ~~~p~~~~~l~~~C~~~~p---~~RP~~~~i~~~ 171 (189)
..+++...+|+.+++..+| .+|+|++|+++.
T Consensus 467 d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 467 DRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred cccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 4678899999999999766 689999998753
|
|
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=97.58 E-value=8.8e-06 Score=60.90 Aligned_cols=79 Identities=9% Similarity=0.069 Sum_probs=45.2
Q ss_pred CCCCChHHHHHHhcCCCC-CCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhcc
Q psy1684 3 FGKIKRIEAEKKLLLPEN-DHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDA 81 (189)
Q Consensus 3 ~g~l~~~n~~~lL~~~~~-~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a 81 (189)
.+.|+|+|++.|..+..+ +...+|+.++... +.+.+ ++|.+-. . ...++-.-+-+..-++.
T Consensus 81 ~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~I---------I~fHr~~---~-----~~~lp~~mvKsilwQil 142 (438)
T KOG0666|consen 81 LRELKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHI---------IKFHRAS---K-----AKQLPRSMVKSILWQIL 142 (438)
T ss_pred HHHhcCCcchhHHHHHhccCceEEEEehhhhh-hHHHH---------HHHhccc---h-----hccCCHHHHHHHHHHHH
Confidence 356788888877665544 3456778887765 32211 1111100 0 11222111223345778
Q ss_pred CCceeeccCCcccccc-cc
Q psy1684 82 DGLCVNLRKPCVQVSC-RI 99 (189)
Q Consensus 82 ~gl~~~~~~~~~~~~~-p~ 99 (189)
+|+.|+|+.-++|||+ |+
T Consensus 143 ~Gv~YLH~NWvlHRDLKPa 161 (438)
T KOG0666|consen 143 DGVHYLHSNWVLHRDLKPA 161 (438)
T ss_pred hhhHHHhhhheeeccCCcc
Confidence 8999999999999996 55
|
|
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.0002 Score=56.29 Aligned_cols=105 Identities=13% Similarity=-0.041 Sum_probs=72.8
Q ss_pred ccCCCCCcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------ccc--------------------cc
Q psy1684 61 QKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLV--------------------HG 104 (189)
Q Consensus 61 yl~~~~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~--------------------~~ 104 (189)
|-+++..|.....+=|...++-||..+|...|+.||+ |+ ||| +|
T Consensus 277 yn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPE 356 (591)
T KOG0986|consen 277 YNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPE 356 (591)
T ss_pred eccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCCccccccCcccccCHH
Confidence 4445556776667777778888999999999999995 76 333 22
Q ss_pred C-CCCCccc-e-EEEec------------CCC----CChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH
Q psy1684 105 T-NLSGVVV-S-AVDFG------------SGG----MTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTF 165 (189)
Q Consensus 105 ~-~~~~~~~-s-VwsfG------------~~~----~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~ 165 (189)
+ ..+.|+. . =||+| |.. ...++|-..+.+. .-..|+..+++.++|...-++.||++|--.
T Consensus 357 vl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~-~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 357 VLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLED-PEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred HHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcc-hhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 2 4566888 7 99999 211 2233444444322 233567888999999999999999998654
Q ss_pred H
Q psy1684 166 E 166 (189)
Q Consensus 166 ~ 166 (189)
.
T Consensus 436 r 436 (591)
T KOG0986|consen 436 R 436 (591)
T ss_pred C
Confidence 3
|
|
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=97.45 E-value=8.9e-05 Score=57.29 Aligned_cols=29 Identities=31% Similarity=0.392 Sum_probs=25.2
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 143 CPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 143 ~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
-|...++|+.+|+..||.+|-|+++.++.
T Consensus 353 ~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 353 FPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred ccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 34588999999999999999999988763
|
|
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.00058 Score=51.78 Aligned_cols=66 Identities=15% Similarity=0.106 Sum_probs=49.5
Q ss_pred ccccccccC-CCCCccc-e-EEEec------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCC
Q psy1684 97 CRIYLVHGT-NLSGVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVK 161 (189)
Q Consensus 97 ~p~~l~~~~-~~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~ 161 (189)
.|+.||+++ ....|.. . =|..| |-+-+.+.+...|..+ -+.+|....++.+.|+.--+..||++
T Consensus 331 TPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e-d~kFPr~ls~eAktLLsGLL~kdP~k 409 (516)
T KOG0690|consen 331 TPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME-DLKFPRTLSPEAKTLLSGLLKKDPKK 409 (516)
T ss_pred ChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh-hccCCccCCHHHHHHHHHHhhcChHh
Confidence 355666666 4566888 7 99999 4445556666666444 35678899999999999999999999
Q ss_pred CC
Q psy1684 162 RP 163 (189)
Q Consensus 162 RP 163 (189)
|-
T Consensus 410 RL 411 (516)
T KOG0690|consen 410 RL 411 (516)
T ss_pred hc
Confidence 94
|
|
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.00011 Score=51.01 Aligned_cols=27 Identities=7% Similarity=-0.055 Sum_probs=21.3
Q ss_pred HHHHhhhccCCceeeccCCcccccc-cc
Q psy1684 73 LVEHYSKDADGLCVNLRKPCVQVSC-RI 99 (189)
Q Consensus 73 li~~~~~~a~gl~~~~~~~~~~~~~-p~ 99 (189)
..++..+...|+.+.|+..+.|||+ |.
T Consensus 103 ~rsfmlqllrgl~fchshnvlhrdlkpq 130 (292)
T KOG0662|consen 103 VRSFMLQLLRGLGFCHSHNVLHRDLKPQ 130 (292)
T ss_pred HHHHHHHHHhhhhhhhhhhhhhccCCcc
Confidence 3445667778999999999999996 55
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.00016 Score=59.91 Aligned_cols=102 Identities=14% Similarity=-0.019 Sum_probs=64.5
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc----------------------------------------cccccC-
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI----------------------------------------YLVHGT- 105 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~----------------------------------------~l~~~~- 105 (189)
++..+.-.++.+...|+.|+|..++.|||+ ++ ++|+|.
T Consensus 417 ~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~ 496 (601)
T KOG0590|consen 417 LTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVL 496 (601)
T ss_pred cchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccc
Confidence 334445556677778888888888888885 44 233333
Q ss_pred CCCCccc--e-EEEec------------C--CCCChHHHHHHH-------HcCCCCCCCCCCCHHHHHHHHHhcccCCCC
Q psy1684 106 NLSGVVV--S-AVDFG------------S--GGMTNAEVLHQV-------EHGYRMPCPPGCPPRLYDIMLECWLKDPVK 161 (189)
Q Consensus 106 ~~~~~~~--s-VwsfG------------~--~~~~~~~~~~~v-------~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~ 161 (189)
....|+. . |||-| | +.....+..... ..|... +-...|.+.+.+|.+.++.||.+
T Consensus 497 ~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~-~~~~lp~~~~~~~~~~l~~~P~~ 575 (601)
T KOG0590|consen 497 TGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNR-LLSLLPRETRIIIYRMLQLDPTK 575 (601)
T ss_pred cccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHH-HHHhchhhHHHHHHHHccCChhh
Confidence 4556888 5 99999 1 111111001111 111110 11357889999999999999999
Q ss_pred CCCHHHHHH
Q psy1684 162 RPTFETLQW 170 (189)
Q Consensus 162 RP~~~~i~~ 170 (189)
|-|+++|++
T Consensus 576 R~ti~~i~~ 584 (601)
T KOG0590|consen 576 RITIEQILN 584 (601)
T ss_pred eecHHHHhh
Confidence 999999986
|
|
| >KOG3751|consensus | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.00034 Score=55.50 Aligned_cols=78 Identities=27% Similarity=0.320 Sum_probs=63.0
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC---ccCC---CCCcC-HhHH
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET---QKAG---RTTIH-YPEL 73 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g---yl~~---~~~~~-l~~l 73 (189)
|||++|++++.-++++..+.-+|.|++|++.+++..|.+++-+ ..+++|+.|.-.... |... ...|+ +..+
T Consensus 521 ~~~~kis~~es~~~ikq~glv~~~~l~r~sqsnP~~~~~~~~~--~~~v~~~~~~P~~~~~~~~~t~~~g~t~~sd~~ql 598 (622)
T KOG3751|consen 521 WFHGKISRDESQRLIKQQGLVDGLFLVRDSQSNPKIFVLSLCH--PQKVKHFQILPVEDDGCTFFTLDDGPTKFSDLIQL 598 (622)
T ss_pred CcccccCchhhhhHHHhcccceeeeeecccccCcchhhhhccC--CccccceEEecCCCCCceeeccCCCCccccccccc
Confidence 9999999999999999888889999999999999999999998 899999999854333 3322 23455 6777
Q ss_pred HHHhhhc
Q psy1684 74 VEHYSKD 80 (189)
Q Consensus 74 i~~~~~~ 80 (189)
+.++..+
T Consensus 599 ~~~~ql~ 605 (622)
T KOG3751|consen 599 VEFYQLN 605 (622)
T ss_pred cchhhcC
Confidence 7776654
|
|
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.00055 Score=49.47 Aligned_cols=29 Identities=17% Similarity=0.109 Sum_probs=25.5
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 143 CPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 143 ~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
..++..+++..-+..|-.+|+|++|.+..
T Consensus 294 ~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 294 VSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred CChHHHHHHHHHHhhccccccchHHHhcC
Confidence 45788899999999999999999998753
|
|
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.00086 Score=58.20 Aligned_cols=62 Identities=15% Similarity=0.125 Sum_probs=42.1
Q ss_pred CCccc-e-EEEec-------CCC-----CChHHHHHHH-HcCCCCCCC--CCCCHHHHHHHHHhcccCCCCCCC---HHH
Q psy1684 108 SGVVV-S-AVDFG-------SGG-----MTNAEVLHQV-EHGYRMPCP--PGCPPRLYDIMLECWLKDPVKRPT---FET 167 (189)
Q Consensus 108 ~~~~~-s-VwsfG-------~~~-----~~~~~~~~~v-~~g~~~~~p--~~~p~~~~~l~~~C~~~~p~~RP~---~~~ 167 (189)
+.|.. + =||.| |.. -+.-+.+.+| .....+.+| ..++++..+||.+-+. +|+.|-. ..+
T Consensus 256 g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngied 334 (1317)
T KOG0612|consen 256 GEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIED 334 (1317)
T ss_pred cccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHH
Confidence 67999 9 99999 211 1223344444 233456677 5689999999998765 7888877 777
Q ss_pred HHH
Q psy1684 168 LQW 170 (189)
Q Consensus 168 i~~ 170 (189)
|..
T Consensus 335 ik~ 337 (1317)
T KOG0612|consen 335 IKN 337 (1317)
T ss_pred HHh
Confidence 654
|
|
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.00046 Score=51.94 Aligned_cols=27 Identities=19% Similarity=0.235 Sum_probs=24.0
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 145 PRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 145 ~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
....+|+.+.+..||++|-|..++++.
T Consensus 284 ~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 284 SLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHHHHHHhhccChhhcccHHHHhcC
Confidence 457799999999999999999999874
|
|
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.0012 Score=49.02 Aligned_cols=24 Identities=8% Similarity=-0.097 Sum_probs=20.1
Q ss_pred HhhhccCCceeeccCCcccccccc
Q psy1684 76 HYSKDADGLCVNLRKPCVQVSCRI 99 (189)
Q Consensus 76 ~~~~~a~gl~~~~~~~~~~~~~p~ 99 (189)
|..++..|+.|+|+..|+|||+..
T Consensus 161 FlYQILRGLKYLHsA~ILHRDIKP 184 (449)
T KOG0664|consen 161 FVYQILRGLKYLHTANILHRDIKP 184 (449)
T ss_pred hHHHHHhhhHHHhhcchhhccCCC
Confidence 455677899999999999999754
|
|
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.00085 Score=54.45 Aligned_cols=73 Identities=12% Similarity=0.055 Sum_probs=50.8
Q ss_pred CChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCce
Q psy1684 6 IKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGLC 85 (189)
Q Consensus 6 l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl~ 85 (189)
=+|+|++++|......+-.||++|-... | +-+.. ||.-+..+.-.+.--.+.|+..|..
T Consensus 626 ~sH~NIlKlLdfFEddd~yyl~te~hg~-g---IDLFd-----------------~IE~kp~m~E~eAk~IFkQV~agi~ 684 (772)
T KOG1152|consen 626 HSHENILKLLDFFEDDDYYYLETEVHGE-G---IDLFD-----------------FIEFKPRMDEPEAKLIFKQVVAGIK 684 (772)
T ss_pred cCccchhhhhheeecCCeeEEEecCCCC-C---cchhh-----------------hhhccCccchHHHHHHHHHHHhccc
Confidence 3599999999988877778888876443 2 11222 4444444442333334678899999
Q ss_pred eeccCCcccccccc
Q psy1684 86 VNLRKPCVQVSCRI 99 (189)
Q Consensus 86 ~~~~~~~~~~~~p~ 99 (189)
.+|...|+|||+..
T Consensus 685 hlh~~~ivhrdikd 698 (772)
T KOG1152|consen 685 HLHDQGIVHRDIKD 698 (772)
T ss_pred cccccCceeccccc
Confidence 99999999999865
|
|
| >PF14633 SH2_2: SH2 domain; PDB: 3GXX_A 3GXW_B 3PJP_B 2XP1_A | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.0097 Score=42.93 Aligned_cols=72 Identities=17% Similarity=0.151 Sum_probs=50.9
Q ss_pred CCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC--------ccCCCCCcC-HhHH
Q psy1684 3 FGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET--------QKAGRTTIH-YPEL 73 (189)
Q Consensus 3 ~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g--------yl~~~~~~~-l~~l 73 (189)
+.+++...|+++|.. .+.|.+|||.|..+.+.++++++.. ++...|+.|...... +.-++..|. |.++
T Consensus 41 F~n~~~~qAe~~L~~--~~~Ge~iIRPSSkG~dhL~vTwKv~-d~vyqHidV~E~~K~n~~slG~~L~i~~~~yeDLDEi 117 (220)
T PF14633_consen 41 FKNFNYKQAEEYLAD--QDVGEVIIRPSSKGPDHLTVTWKVA-DGVYQHIDVKEEDKENEFSLGKTLKIGGEEYEDLDEI 117 (220)
T ss_dssp EESS-HHHHHHHHCC--S-TT-EEEEE-TTTTTEEEEEEEEE-TTEEEEEEEEEECSSSTTS-SSEEEETTEEESSHHHH
T ss_pred ccCCCHHHHHHHHhc--CCCCCEEEeeCCCCCCeEEEEEEEc-CCcEEEEEEEECCCcCccccCcEEEECCeEECCHHHH
Confidence 448899999999954 4579999999988777789999875 678889999865432 233456677 8887
Q ss_pred HHHh
Q psy1684 74 VEHY 77 (189)
Q Consensus 74 i~~~ 77 (189)
+.-+
T Consensus 118 i~r~ 121 (220)
T PF14633_consen 118 IARH 121 (220)
T ss_dssp HHHC
T ss_pred HHHH
Confidence 7543
|
|
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=96.62 E-value=0.00064 Score=51.74 Aligned_cols=58 Identities=17% Similarity=0.134 Sum_probs=40.2
Q ss_pred CCCCccc-e-EEEec-------------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCC
Q psy1684 106 NLSGVVV-S-AVDFG-------------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRP 163 (189)
Q Consensus 106 ~~~~~~~-s-VwsfG-------------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP 163 (189)
++..|.. . =|++| -++.+.++.+.+|.-.....+|...+.....+++.-+++||++|-
T Consensus 424 rgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 424 RGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred cccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceeehhhHHHHHHhhcCCcHHhc
Confidence 5566888 7 89999 344455666666532223445667777778888999999999984
|
|
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.0049 Score=49.88 Aligned_cols=92 Identities=15% Similarity=0.028 Sum_probs=67.8
Q ss_pred hccCCceeeccCCcccccc-cc--------------------------------------cccccC-CCCCccc-e-EEE
Q psy1684 79 KDADGLCVNLRKPCVQVSC-RI--------------------------------------YLVHGT-NLSGVVV-S-AVD 116 (189)
Q Consensus 79 ~~a~gl~~~~~~~~~~~~~-p~--------------------------------------~l~~~~-~~~~~~~-s-Vws 116 (189)
++.-++.++|.++|+|.|+ |+ .|++|. +...|+. - .||
T Consensus 672 QIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWS 751 (888)
T KOG4236|consen 672 QILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWS 751 (888)
T ss_pred HHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcCCccccCHHHHhhcccccccccee
Confidence 3444688899999999985 66 222222 5566888 6 999
Q ss_pred ec----------CCCCChHHHHHHHHcCCCCCCC---CCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 117 FG----------SGGMTNAEVLHQVEHGYRMPCP---PGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 117 fG----------~~~~~~~~~~~~v~~g~~~~~p---~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
.| |+-...++|-++|.+...+-+| .+..++..+||..-++..-.+|-|..+-+.
T Consensus 752 VGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 752 VGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred eeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 99 5555677888899877655444 357788899999999999999999876543
|
|
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=96.12 E-value=0.0036 Score=48.94 Aligned_cols=42 Identities=19% Similarity=0.273 Sum_probs=34.2
Q ss_pred HcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q psy1684 132 EHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLE 173 (189)
Q Consensus 132 ~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~ 173 (189)
++..-|+.|+.||+.+.+|+..-++.||++||+..-....|+
T Consensus 471 qe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 471 QESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred hhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 344457789999999999999999999999999775555443
|
|
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=95.94 E-value=0.0046 Score=49.86 Aligned_cols=25 Identities=28% Similarity=0.311 Sum_probs=21.1
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 146 RLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 146 ~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
.+.+|+..|+..||++|-|..+.+.
T Consensus 721 ~~rdLLdkml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 721 QLRDLLDKMLILDPEKRITVNQALK 745 (752)
T ss_pred HHHHHHHHHhccChhhcCCHHHHhc
Confidence 4668889999999999999887664
|
|
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=95.63 E-value=0.0095 Score=42.61 Aligned_cols=50 Identities=22% Similarity=0.147 Sum_probs=34.1
Q ss_pred CcccccccccccccCCCCCccc-e-EEEec------------CCCC-ChHHHHHHHHcCCCCCCC
Q psy1684 91 PCVQVSCRIYLVHGTNLSGVVV-S-AVDFG------------SGGM-TNAEVLHQVEHGYRMPCP 140 (189)
Q Consensus 91 ~~~~~~~p~~l~~~~~~~~~~~-s-VwsfG------------~~~~-~~~~~~~~v~~g~~~~~p 140 (189)
+|-..++||.+-++.....|+. | |||+| |+.+ ++.+.+.+|.+...|..|
T Consensus 210 GCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~Lp 274 (282)
T KOG0984|consen 210 GCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQLP 274 (282)
T ss_pred CCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCCCc
Confidence 4666677776666667778999 9 99999 6655 466767777554333333
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=95.45 E-value=0.003 Score=45.09 Aligned_cols=28 Identities=14% Similarity=0.087 Sum_probs=16.8
Q ss_pred CChHHHHHHhcCCCCCCCcEEEecCCCC
Q psy1684 6 IKRIEAEKKLLLPENDHGAFLIRDSESR 33 (189)
Q Consensus 6 l~~~n~~~lL~~~~~~~g~fLvre~~~~ 33 (189)
+.|+|++++++.....+..++|+++...
T Consensus 54 ~~~~~i~~~~~~~~~~~~~~~v~e~~~~ 81 (225)
T smart00221 54 LKHPNIVKLYGVFEDPEPLYLVMEYCEG 81 (225)
T ss_pred CCCCChhhheeeeecCCceEEEEeccCC
Confidence 4566666666655444556666666554
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG3697|consensus | Back alignment and domain information |
|---|
Probab=94.61 E-value=0.098 Score=38.90 Aligned_cols=49 Identities=12% Similarity=-0.022 Sum_probs=37.2
Q ss_pred CCCCCceEEEEEecCCCeeeEEEEEeccCC-ccCCCCCcC-HhHHHHHhhhccC
Q psy1684 31 ESRKNDYSLSEYKRSSFCLKMTTGRSLFET-QKAGRTTIH-YPELVEHYSKDAD 82 (189)
Q Consensus 31 ~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g-yl~~~~~~~-l~~li~~~~~~a~ 82 (189)
...+|.|+|.-.. .+..+|..+. ..+| .-.+...|. +..||+|+..++.
T Consensus 276 ~~~~gqyvltgl~--~~~~khlllv-dpegvvrtkd~~fdsishli~yh~~~~l 326 (345)
T KOG3697|consen 276 TTTPGQYVLTGLQ--SGQPKHLLLV-DPEGVVRTKDRRFDSISHLINYHMDNHL 326 (345)
T ss_pred cCCCccEEEeccc--CCCcceEEEE-CCccceecccchhhHHHHHHHHhhhccC
Confidence 4566888888888 8889998775 4556 555567788 9999999887654
|
|
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=94.54 E-value=0.064 Score=40.10 Aligned_cols=93 Identities=13% Similarity=-0.007 Sum_probs=55.4
Q ss_pred hhhccCCceeeccCCcccccccc------------------cccccC----------------------CCCC--ccc-e
Q psy1684 77 YSKDADGLCVNLRKPCVQVSCRI------------------YLVHGT----------------------NLSG--VVV-S 113 (189)
Q Consensus 77 ~~~~a~gl~~~~~~~~~~~~~p~------------------~l~~~~----------------------~~~~--~~~-s 113 (189)
..+.+.++.++|++.++|||+.. |+++-. ..++ .+. +
T Consensus 127 ~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~ 206 (378)
T KOG1345|consen 127 FAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKYLEYVNNYHAPELCDTVVNEKLVVNPST 206 (378)
T ss_pred HHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCceehhhhhhcccCCcHHHhhccccceEecccc
Confidence 34556788999999999999754 221111 2333 456 7
Q ss_pred -EEEec------CCCCCh-----------HHHHHHHHcCCCCCCCC---CCCHHHHHHHHHhcccCCCCC---CCHHHHH
Q psy1684 114 -AVDFG------SGGMTN-----------AEVLHQVEHGYRMPCPP---GCPPRLYDIMLECWLKDPVKR---PTFETLQ 169 (189)
Q Consensus 114 -VwsfG------~~~~~~-----------~~~~~~v~~g~~~~~p~---~~p~~~~~l~~~C~~~~p~~R---P~~~~i~ 169 (189)
||.|| ..|.-+ .+.. +-..+..+..|. ...+....+.++-+..++++| -+.++..
T Consensus 207 D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~-~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 207 DIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWE-QWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred cchheeeeeeeeecCCCcchhhhccCchHHHHH-HHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 99999 111111 1111 123344444453 355677788889999999999 4554443
Q ss_pred H
Q psy1684 170 W 170 (189)
Q Consensus 170 ~ 170 (189)
+
T Consensus 286 k 286 (378)
T KOG1345|consen 286 K 286 (378)
T ss_pred H
Confidence 3
|
|
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=94.27 E-value=0.014 Score=44.59 Aligned_cols=23 Identities=22% Similarity=0.406 Sum_probs=19.8
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q psy1684 148 YDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 148 ~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
+.++..|++..|..||++.+++.
T Consensus 308 r~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 308 RGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred cCcCcccccCCCCCCcchhhhhc
Confidence 36778999999999999998764
|
|
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=93.88 E-value=0.0038 Score=54.48 Aligned_cols=27 Identities=30% Similarity=0.358 Sum_probs=24.8
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 145 PRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 145 ~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
..+++++..+++.||++|-++.+.++.
T Consensus 265 ~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 265 VSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred ccHHHHHHHHHccCchhccCHHHHHHh
Confidence 378999999999999999999999876
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=93.70 E-value=0.0044 Score=52.38 Aligned_cols=33 Identities=15% Similarity=-0.116 Sum_probs=25.8
Q ss_pred CcCHhHHHHHhhhccCCceeeccCCcccccc-cc
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI 99 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~ 99 (189)
.+.......+..+++.|+.++|...++|+|+ |+
T Consensus 100 ~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~ 133 (669)
T cd05610 100 YFDEEMAVKYISEVALALDYLHRHGIIHRDLKPD 133 (669)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHH
Confidence 3444455667778889999999999999996 55
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=93.05 E-value=0.052 Score=43.60 Aligned_cols=26 Identities=27% Similarity=0.247 Sum_probs=23.2
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 145 PRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 145 ~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
.++.+++.-.++.+|.+|||+++.++
T Consensus 524 ~~fsdFL~PmLef~PeKR~tA~~cl~ 549 (590)
T KOG1290|consen 524 QQFSDFLSPMLEFDPEKRPTAAQCLK 549 (590)
T ss_pred HHHHHHHHHHHhcCccccccHHHHhc
Confidence 46778899999999999999999985
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=90.20 E-value=0.18 Score=44.41 Aligned_cols=57 Identities=21% Similarity=0.111 Sum_probs=43.1
Q ss_pred CCCccc-e-EEEec------------CCCCChHHHHHHHHc--CCCCCCCCCCCHHHHHHHHHhcccCCCCCC
Q psy1684 107 LSGVVV-S-AVDFG------------SGGMTNAEVLHQVEH--GYRMPCPPGCPPRLYDIMLECWLKDPVKRP 163 (189)
Q Consensus 107 ~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~--g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP 163 (189)
...|.. . =|+.| |.|-++++++..+.. ..-++-....|++.++++.+-+..||..|-
T Consensus 232 rqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 232 RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred hhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 344555 5 67877 788889998888743 344444456789999999999999999995
|
|
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=89.87 E-value=0.22 Score=40.26 Aligned_cols=62 Identities=16% Similarity=0.212 Sum_probs=38.9
Q ss_pred CCCCccc-e-EEEec---CCCC----Ch---HHHHHHHHcCCCCCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy1684 106 NLSGVVV-S-AVDFG---SGGM----TN---AEVLHQVEHGYRMPCP-PGCPPRLYDIMLECWLKDPVKRPTFETL 168 (189)
Q Consensus 106 ~~~~~~~-s-VwsfG---~~~~----~~---~~~~~~v~~g~~~~~p-~~~p~~~~~l~~~C~~~~p~~RP~~~~i 168 (189)
.++.|+. + +||+| |+-+ +. ...+.-+++|.-+|.- .+. ++-+.|+.+.+..+|.+||++.+.
T Consensus 435 ~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~~d~r~g~ip~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 435 RGQQYSEKVDIYALGLILAELLIQFSTQFERIATLTDIRDGIIPPEFLQDY-PEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred hhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhhhhhhcCCCChHHhhcC-cHHHHHHHHhcCCCcccCchHHHH
Confidence 6788999 9 99999 1111 11 2223345566544322 233 444689999999999999955543
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=88.56 E-value=1.6 Score=33.52 Aligned_cols=40 Identities=25% Similarity=0.210 Sum_probs=33.3
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q psy1684 140 PPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTME 179 (189)
Q Consensus 140 p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~ 179 (189)
...+|.++.+++..+=..+..++|.-..+...|.......
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 262 GDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred cCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 3456788888888888899999999999999998887764
|
|
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=87.48 E-value=0.4 Score=40.30 Aligned_cols=49 Identities=4% Similarity=-0.135 Sum_probs=26.9
Q ss_pred eEEEEEeccCC----ccCCCCCcCHhHHHHHhhhc-cCCceeeccCCcccccc-cc
Q psy1684 50 KMTTGRSLFET----QKAGRTTIHYPELVEHYSKD-ADGLCVNLRKPCVQVSC-RI 99 (189)
Q Consensus 50 ~h~~i~~~~~g----yl~~~~~~~l~~li~~~~~~-a~gl~~~~~~~~~~~~~-p~ 99 (189)
+-|.+.++.+| .|-....| -.+|..||... .-++.+.|..+.||||+ |.
T Consensus 704 LYFVMdYIPGGDmMSLLIrmgIF-eE~LARFYIAEltcAiesVHkmGFIHRDiKPD 758 (1034)
T KOG0608|consen 704 LYFVMDYIPGGDMMSLLIRMGIF-EEDLARFYIAELTCAIESVHKMGFIHRDIKPD 758 (1034)
T ss_pred eEEEEeccCCccHHHHHHHhccC-HHHHHHHHHHHHHHHHHHHHhccceecccCcc
Confidence 34444455666 22223344 24455554432 23677788889999996 55
|
|
| >KOG4566|consensus | Back alignment and domain information |
|---|
Probab=82.84 E-value=4.5 Score=30.13 Aligned_cols=76 Identities=24% Similarity=0.252 Sum_probs=48.6
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC------ccCCCC--CcC-Hh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET------QKAGRT--TIH-YP 71 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g------yl~~~~--~~~-l~ 71 (189)
||+|.....++...++.+ ..|.|+||++....-.+.|+++. ....+..++..-++. +.+... .+. ..
T Consensus 54 ~~w~~~~~~~~~~~l~~~--p~~~~l~Rdss~~~~~~~I~vk~--~~g~~~~r~~~~~~sfr~ds~~~~~~pl~~~e~~~ 129 (258)
T KOG4566|consen 54 HYWGLETANEAELCLGQE--PRGTFLVRDSSHRPYLFTISVKT--HSGPKNLRIQYQDSSFRLDSSHRHTPPLISFEDVE 129 (258)
T ss_pred cccccccchhHHHhhcCC--CccceeeecCcCccccceeEeee--ccCCCCccccccccceecccccccCCCcccChhHH
Confidence 688888888887777766 67999999998876677888877 444444444433322 122222 333 56
Q ss_pred HHHHHhhhc
Q psy1684 72 ELVEHYSKD 80 (189)
Q Consensus 72 ~li~~~~~~ 80 (189)
.++.++.+.
T Consensus 130 ~~~~~y~~~ 138 (258)
T KOG4566|consen 130 VLIHHYRQS 138 (258)
T ss_pred HHHHhhhhh
Confidence 677766443
|
|
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=82.56 E-value=8.3 Score=28.82 Aligned_cols=39 Identities=15% Similarity=0.189 Sum_probs=32.0
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q psy1684 141 PGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTME 179 (189)
Q Consensus 141 ~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~ 179 (189)
...|.|+.-.+.-|-..-=++-|...-|.+.+..++..-
T Consensus 250 ~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~l 288 (341)
T KOG1163|consen 250 KGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTL 288 (341)
T ss_pred CCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhc
Confidence 467899999999999888889999888877777666653
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 189 | ||||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-18 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-18 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-18 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-18 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-18 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-18 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-18 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-18 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-18 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-18 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-18 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-18 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-18 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-17 | ||
| 2dly_A | 121 | Solution Structure Of The Sh2 Domain Of Murine Fyn- | 4e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 8e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-12 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-12 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-12 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-12 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-12 | ||
| 1blj_A | 114 | Nmr Ensemble Of Blk Sh2 Domain, 20 Structures Lengt | 2e-12 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-12 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-12 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-12 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-12 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-12 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-12 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-12 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-12 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 9e-12 | ||
| 1lck_A | 175 | Sh3-Sh2 Domain Fragment Of Human P56-Lck Tyrosine K | 1e-11 | ||
| 4d8k_A | 175 | Crystal Structure Of A Sh3-Sh2 Domains Of A Lymphoc | 1e-11 | ||
| 1x27_A | 167 | Crystal Structure Of Lck Sh2-Sh3 With Sh2 Binding S | 1e-11 | ||
| 1lcj_A | 109 | Sh2 (Src Homology-2) Domain Of Human P56-Lck Tyrosi | 1e-11 | ||
| 1lkk_A | 105 | Human P56-Lck Tyrosine Kinase Sh2 Domain In Complex | 2e-11 | ||
| 1bhh_B | 103 | Free P56lck Sh2 Domain Length = 103 | 2e-11 | ||
| 1bhf_A | 108 | P56lck Sh2 Domain Inhibitor Complex Length = 108 | 2e-11 | ||
| 1lkl_A | 104 | Human P56-Lck Tyrosine Kinase Sh2 Domain In Complex | 2e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-11 | ||
| 3hck_A | 107 | Nmr Ensemble Of The Uncomplexed Human Hck Sh2 Domai | 4e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-11 | ||
| 3nhn_A | 193 | Crystal Structure Of The Src-Family Kinase Hck Sh3- | 4e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 7e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-11 | ||
| 1ijr_A | 104 | Crystal Structure Of Lck Sh2 Complexed With Nonpept | 7e-11 | ||
| 1fbz_A | 104 | Structure-Based Design Of A Novel, Osteoclast-Selec | 8e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 8e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 8e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-11 | ||
| 3uf4_A | 164 | Crystal Structure Of A Sh3 And Sh2 Domains Of Fyn P | 8e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-11 | ||
| 1kc2_A | 103 | Structure Of The Triple (Lys(Beta)d3ala, Asp(Beta)c | 1e-10 | ||
| 1nzl_A | 103 | Crystal Structure Of Src Sh2 Domain Bound To Doubly | 1e-10 | ||
| 1sha_A | 104 | Crystal Structure Of The Phosphotyrosine Recognitio | 1e-10 | ||
| 1skj_A | 113 | Cocrystal Structure Of Urea-Substituted Phosphopept | 1e-10 | ||
| 1p13_A | 102 | Crystal Structure Of The Src Sh2 Domain Complexed W | 1e-10 | ||
| 1is0_A | 106 | Crystal Structure Of A Complex Of The Src Sh2 Domai | 1e-10 | ||
| 1bkl_A | 113 | Self-Associated Apo Src Sh2 Domain Length = 113 | 2e-10 | ||
| 1bkm_A | 113 | Cocrystal Structure Of D-Amino Acid Substituted Pho | 2e-10 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-10 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-10 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-10 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-10 | ||
| 1a1a_A | 107 | C-Src (Sh2 Domain With C188a Mutation) Complexed Wi | 6e-10 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-10 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-10 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-10 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-10 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 7e-10 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-10 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-10 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-10 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-10 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-10 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 7e-10 | ||
| 1f1w_A | 104 | Src Sh2 Thref1trp Mutant Complexed With The Phospho | 8e-10 | ||
| 4f59_A | 112 | Triple Mutant Src Sh2 Domain Length = 112 | 8e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-09 | ||
| 1shd_A | 107 | Peptide Inhibitors Of Src Sh3-Sh2-Phosphoprotein In | 1e-09 | ||
| 1cwd_L | 98 | Human P56lck Tyrosine Kinase Complexed With Phospho | 2e-09 | ||
| 1o4c_A | 108 | Crystal Structure Of Sh2 In Complex With Phosphate. | 2e-09 | ||
| 1o41_A | 108 | Crystal Structure Of Sh2 In Complex With Ru78300. L | 2e-09 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 6e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-09 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 6e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 7e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 7e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 7e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 8e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 8e-09 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-08 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-08 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-08 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-08 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-08 | ||
| 1g83_A | 165 | Crystal Structure Of Fyn Sh3-Sh2 Length = 165 | 2e-08 | ||
| 1aot_F | 106 | Nmr Structure Of The Fyn Sh2 Domain Complexed With | 3e-08 | ||
| 3eaz_A | 106 | Crystal Structure Of Sh2 Domain Of Human Csk (Carbo | 3e-08 | ||
| 3eac_A | 106 | Crystal Structure Of Sh2 Domain Of Human Csk (Carbo | 3e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-08 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 6e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 6e-08 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-08 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 7e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 8e-08 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-07 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-07 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-07 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-07 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-07 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-07 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-07 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-07 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-07 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-07 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-07 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-07 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-07 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-07 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 9e-07 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-06 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-06 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-06 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-06 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-06 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-06 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-06 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-06 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-06 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-06 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-06 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-06 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-06 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-06 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-06 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-06 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-06 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-06 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-06 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-06 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-06 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-06 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-06 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-06 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-06 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-06 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-06 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-06 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-06 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-06 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-06 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-06 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-06 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-06 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-06 | ||
| 1csy_A | 112 | Syk Tyrosine Kinase C-Terminal Sh2 Domain Complexed | 5e-06 | ||
| 1a81_A | 254 | Crystal Structure Of The Tandem Sh2 Domain Of The S | 5e-06 | ||
| 2ci9_A | 102 | Nck1 Sh2-Domain In Complex With A Dodecaphosphopept | 5e-06 | ||
| 2oq1_A | 254 | Tandem Sh2 Domains Of Zap-70 With 19-Mer Zeta1 Pept | 5e-06 | ||
| 1m61_A | 259 | Crystal Structure Of The Apo Sh2 Domains Of Zap-70 | 6e-06 | ||
| 2ci8_A | 99 | Sh2 Domain Of Human Nck1 Adaptor Protein - Uncomple | 6e-06 | ||
| 2ecd_A | 119 | Solution Structure Of The Human Abl2 Sh2 Domain Len | 1e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-05 | ||
| 1jwo_A | 97 | Crystal Structure Analysis Of The Sh2 Domain Of The | 1e-05 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-05 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-05 | ||
| 3t04_A | 123 | Crystal Structure Of Monobody 7c12ABL1 SH2 DOMAIN C | 2e-05 | ||
| 3k2m_A | 112 | Crystal Structure Of Monobody Ha4ABL1 SH2 DOMAIN CO | 2e-05 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-05 | ||
| 2abl_A | 163 | Sh3-Sh2 Domain Fragment Of Human Bcr-Abl Tyrosine K | 2e-05 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-05 | ||
| 1ab2_A | 109 | Three-Dimensional Solution Structure Of The Src Hom | 2e-05 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-05 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-05 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-05 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-05 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-05 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-05 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-05 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-05 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-05 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-05 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-05 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-05 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-05 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-05 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-05 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-05 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-05 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-05 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-05 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-05 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-05 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-05 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-05 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-05 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-05 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-05 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-05 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-05 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-05 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-05 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-05 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-05 | ||
| 3us4_A | 98 | Crystal Structure Of A Sh2 Domain Of A Megakaryocyt | 3e-05 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-05 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-05 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-05 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-05 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-05 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-05 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-05 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-05 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-05 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-05 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-05 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-05 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-05 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-05 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-05 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-05 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-05 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-05 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-05 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-05 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-05 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-05 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-05 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-05 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-05 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-05 | ||
| 3n84_A | 112 | Crystal Structure Of The Grb2 Sh2 Domain In Complex | 4e-05 | ||
| 1fhs_A | 112 | The Three-Dimensional Solution Structure Of The Src | 4e-05 | ||
| 3ove_A | 117 | Crystal Structure Of The Grb2 Sh2 Domain In Complex | 4e-05 | ||
| 3imd_A | 117 | Crystal Structure Of The Grb2 Sh2 Domain In Complex | 4e-05 | ||
| 2h46_E | 116 | Native Domain-Swapped Dimer Crystal Structure Of Th | 4e-05 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-05 | ||
| 1bm2_A | 117 | Grb2-Sh2 Domain In Complex With Cyclo-[n-Alpha-Acet | 5e-05 | ||
| 1x0n_A | 104 | Nmr Structure Of Growth Factor Receptor Binding Pro | 5e-05 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-05 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-05 | ||
| 1fyr_A | 114 | Dimer Formation Through Domain Swapping In The Crys | 5e-05 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-05 | ||
| 1bmb_A | 123 | Grb2-Sh2 Domain In Complex With KpfyVnvef (Pkf270-9 | 5e-05 | ||
| 1ghu_A | 107 | Nmr Solution Structure Of Growth Factor Receptor-Bo | 5e-05 | ||
| 3mxc_A | 101 | Structures Of Grb2-Sh2 Domain And Aicd Peptide Comp | 6e-05 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-05 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-05 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-05 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-05 | ||
| 2aoa_A | 99 | Crystal Structures Of A High-affinity Macrocyclic P | 6e-05 | ||
| 1tze_E | 98 | Signal Transduction Adaptor Growth Factor, Grb2 Sh2 | 7e-05 | ||
| 1zfp_E | 98 | Growth Factor Receptor Binding Protein Sh2 Domain C | 7e-05 | ||
| 1cj1_A | 96 | Growth Factor Receptor Binding Protein Sh2 Domain ( | 7e-05 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-05 | ||
| 1jyq_A | 96 | Xray Structure Of Grb2 Sh2 Domain Complexed With A | 7e-05 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 7e-05 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 7e-05 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 7e-05 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-05 | ||
| 1gri_A | 217 | Grb2 Length = 217 | 8e-05 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-05 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-05 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-05 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-05 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-05 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-05 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-04 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-04 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-04 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-04 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-04 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-04 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-04 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-04 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-04 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-04 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-04 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-04 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-04 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-04 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-04 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-04 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-04 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-04 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-04 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-04 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-04 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-04 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-04 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-04 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-04 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-04 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-04 | ||
| 2kk6_A | 116 | Solution Structure Of Sh2 Domain Of Proto-Oncogene | 4e-04 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-04 | ||
| 1rja_A | 100 | Solution Structure And Backbone Dynamics Of The Non | 4e-04 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-04 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-04 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-04 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-04 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-04 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-04 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-04 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-04 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-04 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-04 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-04 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-04 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-04 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-04 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-04 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-04 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-04 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-04 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-04 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-04 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-04 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-04 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-04 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-04 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-04 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-04 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-04 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-04 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-04 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-04 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-04 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-04 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-04 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 8e-04 | ||
| 2ge9_A | 125 | Solution Structures Of The Sh2 Domain Of Bruton's T | 8e-04 | ||
| 2cia_A | 102 | Human Nck2 Sh2-Domain In Complex With A Decaphospho | 9e-04 |
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2DLY|A Chain A, Solution Structure Of The Sh2 Domain Of Murine Fyn-Related Kinase Length = 121 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1BLJ|A Chain A, Nmr Ensemble Of Blk Sh2 Domain, 20 Structures Length = 114 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1LCK|A Chain A, Sh3-Sh2 Domain Fragment Of Human P56-Lck Tyrosine Kinase Complexed With The 10 Residue Synthetic Phosphotyrosyl Peptide Tegqpyqpqpa Length = 175 | Back alignment and structure |
|
| >pdb|4D8K|A Chain A, Crystal Structure Of A Sh3-Sh2 Domains Of A Lymphocyte-Specific Protein Tyrosine Kinase (Lck) From Homo Sapiens At 2.36 A Resolution Length = 175 | Back alignment and structure |
|
| >pdb|1X27|A Chain A, Crystal Structure Of Lck Sh2-Sh3 With Sh2 Binding Site Of P130cas Length = 167 | Back alignment and structure |
|
| >pdb|1LCJ|A Chain A, Sh2 (Src Homology-2) Domain Of Human P56-Lck Tyrosine Kinase Complexed With The 11 Residue Phosphotyrosyl Peptide Epqpyeeipiyl Length = 109 | Back alignment and structure |
|
| >pdb|1LKK|A Chain A, Human P56-Lck Tyrosine Kinase Sh2 Domain In Complex With The Phosphotyrosyl Peptide Ac-Ptyr-Glu-Glu-Ile (Pyeei Peptide) Length = 105 | Back alignment and structure |
|
| >pdb|1BHH|B Chain B, Free P56lck Sh2 Domain Length = 103 | Back alignment and structure |
|
| >pdb|1BHF|A Chain A, P56lck Sh2 Domain Inhibitor Complex Length = 108 | Back alignment and structure |
|
| >pdb|1LKL|A Chain A, Human P56-Lck Tyrosine Kinase Sh2 Domain In Complex With The Phosphotyrosyl Peptide Ac-Ptyr-Glu-Glu-Gly (Pyeeg Peptide) Length = 104 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3HCK|A Chain A, Nmr Ensemble Of The Uncomplexed Human Hck Sh2 Domain, 20 Structures Length = 107 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3NHN|A Chain A, Crystal Structure Of The Src-Family Kinase Hck Sh3-Sh2-Linker Regulatory Region Length = 193 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1IJR|A Chain A, Crystal Structure Of Lck Sh2 Complexed With Nonpeptide Phosphotyrosine Mimetic Length = 104 | Back alignment and structure |
|
| >pdb|1FBZ|A Chain A, Structure-Based Design Of A Novel, Osteoclast-Selective, Nonpeptide Src Sh2 Inhibitor With In Vivo Anti-Resorptive Activity Length = 104 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3UF4|A Chain A, Crystal Structure Of A Sh3 And Sh2 Domains Of Fyn Protein (Proto- Concogene Tyrosine-Protein Kinase Fyn) From Mus Musculus At 1.98 A Resolution Length = 164 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1KC2|A Chain A, Structure Of The Triple (Lys(Beta)d3ala, Asp(Beta)c8ala, Aspcd2ala) Mutant Of The Src Sh2 Domain Bound To The Pqpyeeipi Peptide Length = 103 | Back alignment and structure |
|
| >pdb|1NZL|A Chain A, Crystal Structure Of Src Sh2 Domain Bound To Doubly Phosphorylated Peptide Pqpyepyipi Length = 103 | Back alignment and structure |
|
| >pdb|1SHA|A Chain A, Crystal Structure Of The Phosphotyrosine Recognition Domain Sh2 Of V-Src Complexed With Tyrosine-Phosphorylated Peptides Length = 104 | Back alignment and structure |
|
| >pdb|1SKJ|A Chain A, Cocrystal Structure Of Urea-Substituted Phosphopeptide Complex Length = 113 | Back alignment and structure |
|
| >pdb|1P13|A Chain A, Crystal Structure Of The Src Sh2 Domain Complexed With Peptide (Sdpyanfk) Length = 102 | Back alignment and structure |
|
| >pdb|1IS0|A Chain A, Crystal Structure Of A Complex Of The Src Sh2 Domain With Conformationally Constrained Peptide Inhibitor Length = 106 | Back alignment and structure |
|
| >pdb|1BKL|A Chain A, Self-Associated Apo Src Sh2 Domain Length = 113 | Back alignment and structure |
|
| >pdb|1BKM|A Chain A, Cocrystal Structure Of D-Amino Acid Substituted Phosphopeptide Complex Length = 113 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1A1A|A Chain A, C-Src (Sh2 Domain With C188a Mutation) Complexed With Ace-Formyl Phosphotyr-Glu-(N,N-Dipentyl Amine) Length = 107 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1F1W|A Chain A, Src Sh2 Thref1trp Mutant Complexed With The Phosphopeptide S(Ptr)vnvqn Length = 104 | Back alignment and structure |
|
| >pdb|4F59|A Chain A, Triple Mutant Src Sh2 Domain Length = 112 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1SHD|A Chain A, Peptide Inhibitors Of Src Sh3-Sh2-Phosphoprotein Interactions Length = 107 | Back alignment and structure |
|
| >pdb|1CWD|L Chain L, Human P56lck Tyrosine Kinase Complexed With Phosphopeptide Length = 98 | Back alignment and structure |
|
| >pdb|1O4C|A Chain A, Crystal Structure Of Sh2 In Complex With Phosphate. Length = 108 | Back alignment and structure |
|
| >pdb|1O41|A Chain A, Crystal Structure Of Sh2 In Complex With Ru78300. Length = 108 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1G83|A Chain A, Crystal Structure Of Fyn Sh3-Sh2 Length = 165 | Back alignment and structure |
|
| >pdb|1AOT|F Chain F, Nmr Structure Of The Fyn Sh2 Domain Complexed With A Phosphotyrosyl Peptide, Minimized Average Structure Length = 106 | Back alignment and structure |
|
| >pdb|3EAZ|A Chain A, Crystal Structure Of Sh2 Domain Of Human Csk (Carboxyl- Terminal Src Kinase), C122s Mutant Length = 106 | Back alignment and structure |
|
| >pdb|3EAC|A Chain A, Crystal Structure Of Sh2 Domain Of Human Csk (Carboxyl- Terminal Src Kinase), Oxidized Form Length = 106 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1CSY|A Chain A, Syk Tyrosine Kinase C-Terminal Sh2 Domain Complexed With A Phosphopeptidefrom The Gamma Chain Of The High Affinity Immunoglobin G Receptor, Nmr Length = 112 | Back alignment and structure |
|
| >pdb|1A81|A Chain A, Crystal Structure Of The Tandem Sh2 Domain Of The Syk Kinase Bound To A Dually Tyrosine-Phosphorylated Itam Length = 254 | Back alignment and structure |
|
| >pdb|2CI9|A Chain A, Nck1 Sh2-Domain In Complex With A Dodecaphosphopeptide From Epec Protein Tir Length = 102 | Back alignment and structure |
|
| >pdb|2OQ1|A Chain A, Tandem Sh2 Domains Of Zap-70 With 19-Mer Zeta1 Peptide Length = 254 | Back alignment and structure |
|
| >pdb|1M61|A Chain A, Crystal Structure Of The Apo Sh2 Domains Of Zap-70 Length = 259 | Back alignment and structure |
|
| >pdb|2CI8|A Chain A, Sh2 Domain Of Human Nck1 Adaptor Protein - Uncomplexed Length = 99 | Back alignment and structure |
|
| >pdb|2ECD|A Chain A, Solution Structure Of The Human Abl2 Sh2 Domain Length = 119 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1JWO|A Chain A, Crystal Structure Analysis Of The Sh2 Domain Of The Csk Homologous Kinase Chk Length = 97 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3T04|A Chain A, Crystal Structure Of Monobody 7c12ABL1 SH2 DOMAIN COMPLEX Length = 123 | Back alignment and structure |
|
| >pdb|3K2M|A Chain A, Crystal Structure Of Monobody Ha4ABL1 SH2 DOMAIN COMPLEX Length = 112 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2ABL|A Chain A, Sh3-Sh2 Domain Fragment Of Human Bcr-Abl Tyrosine Kinase Length = 163 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1AB2|A Chain A, Three-Dimensional Solution Structure Of The Src Homology 2 Domain Of C-Abl Length = 109 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3US4|A Chain A, Crystal Structure Of A Sh2 Domain Of A Megakaryocyte-Associated Tyrosine Kinase (Matk) From Homo Sapiens At 1.50 A Resolution Length = 98 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3N84|A Chain A, Crystal Structure Of The Grb2 Sh2 Domain In Complex With A 23-Membered Macrocyclic Ligand Having The Sequence Pyvnvp Length = 112 | Back alignment and structure |
|
| >pdb|1FHS|A Chain A, The Three-Dimensional Solution Structure Of The Src Homology Domain-2 Of The Growth Factor Receptor Bound Protein-2, Nmr, 18 Structures Length = 112 | Back alignment and structure |
|
| >pdb|3OVE|A Chain A, Crystal Structure Of The Grb2 Sh2 Domain In Complex With A Pyxn- Derived Tripeptide Length = 117 | Back alignment and structure |
|
| >pdb|3IMD|A Chain A, Crystal Structure Of The Grb2 Sh2 Domain In Complex With A Flexible Ac-Py-Q-N-Nh2 Tripeptide Mimic Length = 117 | Back alignment and structure |
|
| >pdb|2H46|E Chain E, Native Domain-Swapped Dimer Crystal Structure Of The Grb2 Sh2 Domain Length = 116 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1BM2|A Chain A, Grb2-Sh2 Domain In Complex With Cyclo-[n-Alpha-Acetyl-L-Thi Alysyl-O-Phosphotyrosyl-Valyl-Asparagyl-Valyl-Prolyl] (Pkf273-791) Length = 117 | Back alignment and structure |
|
| >pdb|1X0N|A Chain A, Nmr Structure Of Growth Factor Receptor Binding Protein Sh2 Domain Complexed With The Inhibitor Length = 104 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1FYR|A Chain A, Dimer Formation Through Domain Swapping In The Crystal Structure Of The Grb2-Sh2 Ac-Pyvnv Complex Length = 114 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1BMB|A Chain A, Grb2-Sh2 Domain In Complex With KpfyVnvef (Pkf270-974) Length = 123 | Back alignment and structure |
|
| >pdb|1GHU|A Chain A, Nmr Solution Structure Of Growth Factor Receptor-Bound Protein 2 (Grb2) Sh2 Domain, 24 Structures Length = 107 | Back alignment and structure |
|
| >pdb|3MXC|A Chain A, Structures Of Grb2-Sh2 Domain And Aicd Peptide Complexes Reveal A Conformational Switch And Their Functional Implications. Length = 101 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2AOA|A Chain A, Crystal Structures Of A High-affinity Macrocyclic Peptide Mimetic In Complex With The Grb2 Sh2 Domain Length = 99 | Back alignment and structure |
|
| >pdb|1TZE|E Chain E, Signal Transduction Adaptor Growth Factor, Grb2 Sh2 Domain Complexed With Phosphotyrosyl Heptapeptide Lys-Pro-Phe-Ptyr-Val-Asn-Val-Nh2 (Kfppyvnc-Nh2) Length = 98 | Back alignment and structure |
|
| >pdb|1ZFP|E Chain E, Growth Factor Receptor Binding Protein Sh2 Domain Complexed With A Phosphotyrosyl Pentapeptide Length = 98 | Back alignment and structure |
|
| >pdb|1CJ1|A Chain A, Growth Factor Receptor Binding Protein Sh2 Domain (Human) Complexed With A Phosphotyrosyl Derivative Length = 96 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1JYQ|A Chain A, Xray Structure Of Grb2 Sh2 Domain Complexed With A Highly Affine Phospho Peptide Length = 96 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1GRI|A Chain A, Grb2 Length = 217 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2KK6|A Chain A, Solution Structure Of Sh2 Domain Of Proto-Oncogene Tyrosine- Protein Kinase Fer From Homo Sapiens, Northeast Structural Genomics Consortium (Nesg) Target Hr3461d Length = 116 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1RJA|A Chain A, Solution Structure And Backbone Dynamics Of The Nonreceptor Tyrosine Kinase Ptk6BRK SH2 DOMAIN Length = 100 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2GE9|A Chain A, Solution Structures Of The Sh2 Domain Of Bruton's Tyrosine Kinase Length = 125 | Back alignment and structure |
|
| >pdb|2CIA|A Chain A, Human Nck2 Sh2-Domain In Complex With A Decaphosphopeptide From Translocated Intimin Receptor (Tir) Of Epec Length = 102 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 189 | |||
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 1e-34 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 5e-34 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 2e-32 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 7e-25 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 3e-32 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 4e-32 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 5e-32 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 1e-31 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 1e-31 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 2e-31 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 1e-25 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 5e-18 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 2e-31 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 3e-31 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 3e-31 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 4e-31 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 2e-23 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 7e-31 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 2e-24 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 9e-31 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 9e-31 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 1e-30 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 6e-30 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 8e-30 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 3e-21 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 8e-30 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 1e-29 | |
| 2dly_A | 121 | FYN-related kinase; BRK family kinase, structural | 2e-29 | |
| 1nrv_A | 105 | Growth factor receptor-bound protein 10; dimer, si | 4e-29 | |
| 2aug_A | 126 | Growth factor receptor-bound protein 14; phosphory | 4e-29 | |
| 3pqz_A | 117 | Growth factor receptor-bound protein 7; SH2, binds | 5e-29 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 1e-28 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 5e-18 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 1e-28 | |
| 1blj_A | 114 | P55 BLK protein tyrosine kinase; signal transducti | 2e-28 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 2e-28 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 2e-28 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 3e-28 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 3e-28 | |
| 1lkk_A | 105 | Human P56 tyrosine kinase; complex (tyrosine kinas | 3e-28 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 3e-28 | |
| 1rja_A | 100 | Tyrosine-protein kinase 6; human protein tyrosine | 4e-28 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 4e-28 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 4e-28 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 6e-28 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 7e-28 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 8e-28 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 8e-28 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 1e-27 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 1e-27 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 2e-27 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 1e-23 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 2e-27 | |
| 1i3z_A | 103 | EWS/FLI1 activated transcript 2; SH2 domain phosph | 3e-27 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 4e-27 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 4e-27 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 7e-27 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 9e-27 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 1e-26 | |
| 1aot_F | 106 | FYN protein-tyrosine kinase; SH2 domain, signal tr | 1e-26 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 1e-26 | |
| 3eaz_A | 106 | Tyrosine-protein kinase CSK; SH2, disulfide, oxidi | 1e-26 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 2e-26 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 3e-26 | |
| 1d4t_A | 104 | T cell signal transduction molecule SAP; SH2 domai | 5e-26 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 5e-26 | |
| 2ysx_A | 119 | Signaling inositol polyphosphate phosphatase SHIP | 8e-26 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 8e-26 | |
| 1ka6_A | 128 | SH2 domain protein 1A; SH2 domain, protein-peptide | 8e-26 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 1e-25 | |
| 2ecd_A | 119 | Tyrosine-protein kinase ABL2; SH2 domain, phosphot | 1e-25 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 1e-25 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 2e-25 | |
| 3us4_A | 98 | Megakaryocyte-associated tyrosine-protein kinase; | 2e-25 | |
| 3k2m_A | 112 | Proto-oncogene tyrosine-protein kinase ABL1; engin | 6e-25 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 7e-25 | |
| 2dm0_A | 125 | Tyrosine-protein kinase TXK; TEC family kinase, st | 8e-25 | |
| 2gsb_A | 119 | RAS GTPase-activating protein 1; GAP, RAS P21 prot | 9e-25 | |
| 2ekx_A | 110 | Cytoplasmic tyrosine-protein kinase BMX; SH2 domai | 1e-24 | |
| 3ov1_A | 117 | Growth factor receptor-bound protein 2; GRB2 SH2 d | 1e-24 | |
| 3s9k_A | 118 | Tyrosine-protein kinase ITK/TSK; proline isomeriza | 3e-24 | |
| 2eob_A | 124 | 1-phosphatidylinositol-4,5-bisphosphate phosphodie | 5e-24 | |
| 2ge9_A | 125 | Tyrosine-protein kinase BTK; SH2 domain, structure | 7e-24 | |
| 1a81_A | 254 | SYK kinase; complex (transferase-peptide), SYK, ki | 2e-23 | |
| 1a81_A | 254 | SYK kinase; complex (transferase-peptide), SYK, ki | 1e-22 | |
| 3tkz_A | 109 | Tyrosine-protein phosphatase non-receptor type 11; | 3e-23 | |
| 2oq1_A | 254 | Tyrosine-protein kinase ZAP-70; tandem SH2 domains | 8e-23 | |
| 2oq1_A | 254 | Tyrosine-protein kinase ZAP-70; tandem SH2 domains | 1e-22 | |
| 2eo3_A | 111 | CRK-like protein; phosphorylation, repeat, SH2 dom | 1e-22 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 9e-22 | |
| 2cs0_A | 119 | Hematopoietic SH2 domain containing; ALX, FLJ14886 | 2e-21 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 2e-21 | |
| 2dlz_A | 118 | Protein VAV-2; RHO family guanine nucleotide excha | 3e-21 | |
| 1jyr_A | 96 | Growth factor receptor-bound protein 2; receptor b | 4e-21 | |
| 2kk6_A | 116 | Proto-oncogene tyrosine-protein kinase FER; method | 1e-20 | |
| 2crh_A | 138 | VAV proto-oncogene; oncoprotein, structural genomi | 3e-20 | |
| 2cia_A | 102 | Cytoplasmic protein NCK2; SH2-domain, SH3 domain, | 5e-20 | |
| 2kno_A | 131 | Tensin-like C1 domain-containing phosphatase; SH2 | 7e-20 | |
| 2iug_A | 120 | Phosphatidylinositol 3-kinase regulatory alpha sub | 1e-19 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 2e-19 | |
| 1mil_A | 104 | SHC adaptor protein; SH2 domain, phosphorylation, | 3e-19 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 4e-19 | |
| 1ju5_A | 109 | CRK; CRK, SH2, SH3, adaptor protein, phosphopeptid | 9e-19 | |
| 1h9o_A | 112 | Phosphatidylinositol 3-kinase; transferase/recepto | 1e-18 | |
| 2vif_A | 141 | Suppressor of cytokine signalling 6; growth regula | 1e-18 | |
| 3maz_A | 125 | Signal-transducing adaptor protein 1; modular doma | 1e-18 | |
| 3gqi_B | 226 | Phospholipase C-gamma-1; phosphorylated kinase, PY | 3e-18 | |
| 3gqi_B | 226 | Phospholipase C-gamma-1; phosphorylated kinase, PY | 2e-10 | |
| 4d8k_A | 175 | Tyrosine-protein kinase LCK; protein kinases, SH2 | 4e-18 | |
| 2hdv_A | 111 | SH2-B PH domain containing signaling mediator 1 ga | 5e-18 | |
| 2dx0_A | 138 | Phospholipase C, gamma 2; phosphoric diester hydro | 8e-18 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 1e-17 | |
| 2y3a_B | 302 | Phosphatidylinositol 3-kinase regulatory subunit; | 2e-17 | |
| 1r1p_A | 100 | GRB2-related adaptor protein 2; SH2, GADS, phospho | 5e-17 | |
| 2eo6_A | 141 | B-cell linker protein; SH2, cytoplasmic adapter pr | 9e-17 | |
| 3hhm_B | 373 | NISH2 P85alpha; PI3KCA, PI3K, PIK3R1, phosphatidil | 1e-16 | |
| 3hhm_B | 373 | NISH2 P85alpha; PI3KCA, PI3K, PIK3R1, phosphatidil | 1e-09 | |
| 2bbu_A | 164 | Suppressor of cytokine signaling 3; SH2 domain, ex | 1e-16 | |
| 2c9w_A | 169 | Suppressor of cytokine signaling 2; growth regulat | 1e-16 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 3e-16 | |
| 2izv_A | 187 | Suppressor of cytokine signaling 4; signal transdu | 5e-16 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 1e-14 | |
| 1wqu_A | 114 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 2e-13 | |
| 2lqn_A | 303 | CRK-like protein; SH2, SH3, V-CRK sarcoma virus CT | 2e-13 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 3e-13 | |
| 1gri_A | 217 | Growth factor bound protein 2; SH2, SH3, signal tr | 1e-12 | |
| 2hmh_A | 152 | Suppressor of cytokine signaling 3; SOCS3, GP130, | 8e-12 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 9e-12 | |
| 3qwy_A | 308 | Cell death abnormality protein 2; cell engulfment, | 1e-11 | |
| 3qwx_X | 174 | Cell death abnormality protein 2; cell engulfment, | 2e-11 | |
| 2dvj_A | 230 | V-CRK sarcoma virus CT10 oncogene homolog, isoform | 2e-10 | |
| 2el8_A | 118 | Signal-transducing adaptor protein 2; SH2 domain, | 8e-10 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 1e-09 | |
| 2eyz_A | 304 | V-CRK sarcoma virus CT10 oncogene homolog isoform | 1e-08 | |
| 3ps5_A | 595 | Tyrosine-protein phosphatase non-receptor type 6; | 6e-08 | |
| 2b3o_A | 532 | Tyrosine-protein phosphatase, non-receptor type 6; | 1e-07 | |
| 2shp_A | 525 | SHP-2, SYP, SHPTP-2; tyrosine phosphatase, insulin | 2e-07 | |
| 2shp_A | 525 | SHP-2, SYP, SHPTP-2; tyrosine phosphatase, insulin | 8e-04 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 2e-06 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 3e-06 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 3e-05 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 4e-05 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 2e-04 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 6e-04 |
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-34
Identities = 32/65 (49%), Positives = 39/65 (60%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180
GMTN EV+ +E GYRM P CP LY +M CW + P RPTF+ L+ LEDFFT
Sbjct: 213 GMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272
Query: 181 SDYKE 185
Y+
Sbjct: 273 GQYQP 277
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-34
Identities = 26/65 (40%), Positives = 33/65 (50%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180
+ N +V+ +E G R+P P CPP LY +M CW DP RP F L L D + ME
Sbjct: 217 WLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEK 276
Query: 181 SDYKE 185
E
Sbjct: 277 DIAME 281
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-32
Identities = 34/65 (52%), Positives = 44/65 (67%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180
GM+N EV+ +E GYRMP P CP LY+IM+ CW P +RPTFE +Q L+DF+T
Sbjct: 388 GMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATE 447
Query: 181 SDYKE 185
S Y+E
Sbjct: 448 SQYEE 452
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 7e-25
Identities = 36/102 (35%), Positives = 54/102 (52%), Gaps = 10/102 (9%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSS--------FCLKMT 52
W+F I R +AE++LL P N G+F+IRDSE+ K YSLS + ++
Sbjct: 72 WFFKGISRKDAERQLLAPGNMLGSFMIRDSETTKGSYSLSVRDYDPRQGDTVKHYKIRTL 131
Query: 53 TGRSLFETQKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQ 94
+ + ++ +T+ ELV+HY K DGLC L PC+
Sbjct: 132 DNGGFYISPRSTFSTL--QELVDHYKKGNDGLCQKLSVPCMS 171
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-32
Identities = 27/67 (40%), Positives = 37/67 (55%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180
MTN +V+ VE GYR+P P GCP L+ +ML+CW KD +RP F + L+
Sbjct: 257 NMTNRDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316
Query: 181 SDYKEAS 187
S A+
Sbjct: 317 SLRATAT 323
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-32
Identities = 24/61 (39%), Positives = 35/61 (57%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180
+ +V+ +VE GY+M P GCPP +Y++M CW D RP+F L+ +LE T E
Sbjct: 217 RIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHEL 276
Query: 181 S 181
Sbjct: 277 H 277
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 5e-32
Identities = 23/66 (34%), Positives = 34/66 (51%)
Query: 120 GGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTME 179
M EV+ +E G RM CPP CPP LY +M +CW+ RP F T++ ++ +
Sbjct: 215 KKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 274
Query: 180 GSDYKE 185
S +
Sbjct: 275 ASKVEG 280
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-31
Identities = 18/59 (30%), Positives = 27/59 (45%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTME 179
TN+E + G R+ P ++Y IM CW + +RPTF+ L + D E
Sbjct: 224 RFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-31
Identities = 21/59 (35%), Positives = 31/59 (52%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTME 179
TN+EV+ +V G+R+ P +Y IM CW + P KRPTF+ L +E +
Sbjct: 208 LYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-31
Identities = 24/68 (35%), Positives = 35/68 (51%)
Query: 120 GGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTME 179
M EV+ +E G RM CPP CPP LY +M +CW+ RP F T++ ++ +
Sbjct: 541 KKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600
Query: 180 GSDYKEAS 187
S + S
Sbjct: 601 ASKVEGGS 608
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-25
Identities = 32/101 (31%), Positives = 44/101 (43%), Gaps = 5/101 (4%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS---EYKRSSFCLKMTTGRSL 57
+++G I R EAE+ L L G FL+R Y LS + + F ++ +
Sbjct: 10 FFYGSISRAEAEEHLKLAGMADGLFLLRQCLRSLGGYVLSLVHDVRFHHFPIERQLNGTY 69
Query: 58 FETQKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQVSCR 98
EL E YS+D DGL NLRKPC + S
Sbjct: 70 AIAGGKAHCGP--AELCEFYSRDPDGLPCNLRKPCNRPSGL 108
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 80.0 bits (197), Expect = 5e-18
Identities = 26/99 (26%), Positives = 41/99 (41%), Gaps = 6/99 (6%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSS---FCLKMTTGRSL 57
WY + R EAE+KL G FL+R + + Y+LS + + +
Sbjct: 163 WYHSSLTREEAERKLYSGAQTDGKFLLRPRKE-QGTYALSLIYGKTVYHYLISQDKAGKY 221
Query: 58 FETQKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQVS 96
+ T+ +LVE+ ADGL L++ C S
Sbjct: 222 CIPEGTKFDTL--WQLVEYLKLKADGLIYCLKEACPNSS 258
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-31
Identities = 25/61 (40%), Positives = 38/61 (62%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180
G+ N +V+ ++E+G R+P PP CPP LY +M +CW DP +RP F L+ +L E
Sbjct: 220 GVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 279
Query: 181 S 181
+
Sbjct: 280 A 280
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-31
Identities = 23/66 (34%), Positives = 34/66 (51%), Gaps = 1/66 (1%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTM-E 179
G+ ++V +E YRM P GCP ++Y++M CW +P RP+F + E F
Sbjct: 215 GIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 274
Query: 180 GSDYKE 185
SD E
Sbjct: 275 ISDEVE 280
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-31
Identities = 23/58 (39%), Positives = 33/58 (56%)
Query: 120 GGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFT 177
GM +EV +E G RM CP GCP +YD+M CW D RP F ++ +L +++
Sbjct: 222 RGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 4e-31
Identities = 39/67 (58%), Positives = 46/67 (68%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180
GM N EVL QVE GYRMPCPP CP L+D+M +CW K+P +RPTFE LQ LED+FT
Sbjct: 384 GMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443
Query: 181 SDYKEAS 187
Y+
Sbjct: 444 PQYQPGE 450
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 2e-23
Identities = 36/102 (35%), Positives = 51/102 (50%), Gaps = 10/102 (9%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSS--------FCLKMT 52
WYFGKI R E+E+ LL EN G FL+R+SE+ K Y LS + + ++
Sbjct: 67 WYFGKITRRESERLLLNAENPRGTFLVRESETTKGAYCLSVSDFDNAKGLNVKHYKIRKL 126
Query: 53 TGRSLFETQKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQ 94
+ T + ++ +LV +YSK ADGLC L C
Sbjct: 127 DSGGFYITSRTQFNSL--QQLVAYYSKHADGLCHRLTTVCPT 166
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 7e-31
Identities = 39/67 (58%), Positives = 46/67 (68%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180
GM N EVL QVE GYRMPCPP CP L+D+M +CW K+P +RPTFE LQ LED+FT
Sbjct: 467 GMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526
Query: 181 SDYKEAS 187
Y+
Sbjct: 527 PQYQPGE 533
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 2e-24
Identities = 36/101 (35%), Positives = 51/101 (50%), Gaps = 10/101 (9%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSS--------FCLKMT 52
WYFGKI R E+E+ LL EN G FL+R+SE+ K Y LS + + ++
Sbjct: 150 WYFGKITRRESERLLLNAENPRGTFLVRESETTKGAYCLSVSDFDNAKGLNVKHYKIRKL 209
Query: 53 TGRSLFETQKAGRTTIHYPELVEHYSKDADGLCVNLRKPCV 93
+ T + ++ +LV +YSK ADGLC L C
Sbjct: 210 DSGGFYITSRTQFNSL--QQLVAYYSKHADGLCHRLTTVCP 248
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-31
Identities = 19/67 (28%), Positives = 34/67 (50%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180
++N EV+ + G+R+P P CP +Y +M++CW ++ +RP F + L+
Sbjct: 253 ELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312
Query: 181 SDYKEAS 187
S A
Sbjct: 313 SLKTLAD 319
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 9e-31
Identities = 17/57 (29%), Positives = 27/57 (47%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFT 177
+N+EV+ + G+R+ P +Y IM CW + P RP F L +L +
Sbjct: 208 NRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-30
Identities = 26/61 (42%), Positives = 35/61 (57%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180
M+N +V+ V+ GYR+P P CP LY +ML+CW KD RP FE + L+ G
Sbjct: 253 EMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG 312
Query: 181 S 181
S
Sbjct: 313 S 313
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-30
Identities = 21/68 (30%), Positives = 31/68 (45%), Gaps = 1/68 (1%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180
G+ +E+ +E G R+P PP C +Y IM +CW+ D RP F L + +
Sbjct: 222 GIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR-DP 280
Query: 181 SDYKEASG 188
Y G
Sbjct: 281 QRYLVIQG 288
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 8e-30
Identities = 26/61 (42%), Positives = 35/61 (57%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180
+ +V+ +VE GY+M P GCPP +YD+M CW D RPTF L+ +LE T E
Sbjct: 389 RIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHEL 448
Query: 181 S 181
Sbjct: 449 H 449
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-21
Identities = 36/97 (37%), Positives = 51/97 (52%), Gaps = 8/97 (8%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS---EYKRSSFCLKMTTGRSL 57
W+ GKI R +AE+ L PE G FL+R+S + DY+L E K + + + L
Sbjct: 82 WFHGKITREQAERLLYPPET--GLFLVRESTNYPGDYTLCVSCEGKVEHYRIMYHASK-L 138
Query: 58 FETQKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQ 94
++ + +LVEHY+ DADGLC L KP V
Sbjct: 139 SIDEEVYFENL--MQLVEHYTTDADGLCTRLIKPKVM 173
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 8e-30
Identities = 22/66 (33%), Positives = 34/66 (51%), Gaps = 1/66 (1%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFT-ME 179
+ ++ H + G R+P P CP LY +M +CW DP RPTF L ++E + +
Sbjct: 231 HIDPFDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290
Query: 180 GSDYKE 185
G Y +
Sbjct: 291 GDHYVQ 296
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-29
Identities = 19/69 (27%), Positives = 32/69 (46%)
Query: 119 SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTM 178
+ +L +E G R+P PP CP ++++M CW P RP+F L +L+ ++
Sbjct: 245 RDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304
Query: 179 EGSDYKEAS 187
A
Sbjct: 305 SRGCETHAF 313
|
| >2dly_A FYN-related kinase; BRK family kinase, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Mus musculus} Length = 121 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-29
Identities = 42/100 (42%), Positives = 61/100 (61%), Gaps = 5/100 (5%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSS---FCLKMTTGRSL 57
W+FG IKR +AEK+LL EN GAFLIR+SES+K D+SLS + ++
Sbjct: 18 WFFGAIKRADAEKQLLYSENQTGAFLIRESESQKGDFSLSVLDEGVVKHYRIRRLDEGGF 77
Query: 58 FETQKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQVSC 97
F T++ +T+ E V +Y+ +DGLCV L KPC+++
Sbjct: 78 FLTRRKVFSTL--NEFVNYYTTTSDGLCVKLEKPCLKIQV 115
|
| >1nrv_A Growth factor receptor-bound protein 10; dimer, signaling protein; 1.65A {Homo sapiens} SCOP: d.93.1.1 PDB: 3m7f_A Length = 105 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-29
Identities = 23/99 (23%), Positives = 39/99 (39%), Gaps = 5/99 (5%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFC----LKMTTGRS 56
W+ G+I R E+ + + G FL+RDS+S + L+ L
Sbjct: 7 WFHGRISREESHRIIKQQGLVDGLFLLRDSQSNPKAFVLTLCHHQKIKNFQILPCEDDGQ 66
Query: 57 LFETQKAGRTTIHY-PELVEHYSKDADGLCVNLRKPCVQ 94
F + G T +LV+ Y + L L+ C++
Sbjct: 67 TFFSLDDGNTKFSDLIQLVDFYQLNKGVLPCKLKHHCIR 105
|
| >2aug_A Growth factor receptor-bound protein 14; phosphorylation, SH2 domain, signaling protein; 2.30A {Homo sapiens} Length = 126 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-29
Identities = 26/99 (26%), Positives = 41/99 (41%), Gaps = 5/99 (5%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFC----LKMTTGRS 56
W+ KI R EA++ ++ G FL+RDS+S + LS + +
Sbjct: 28 WFHHKISRDEAQRLIIQQGLVDGVFLVRDSQSNPKTFVLSMSHGQKIKHFQIIPVEDDGE 87
Query: 57 LFETQKAGRTTIHY-PELVEHYSKDADGLCVNLRKPCVQ 94
+F T G T +LVE Y + L L+ C +
Sbjct: 88 MFHTLDDGHTRFTDLIQLVEFYQLNKGVLPCKLKHYCAR 126
|
| >3pqz_A Growth factor receptor-bound protein 7; SH2, binds phosphotyrosine, tyrosine kinases, cytoplasmic, P binding; 2.41A {Homo sapiens} PDB: 1mw4_A* 2l4k_A* 2qms_A Length = 117 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-29
Identities = 23/110 (20%), Positives = 41/110 (37%), Gaps = 23/110 (20%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS--------------EYKRSS 46
W+ G+I R E+++ + G FL+R+S+ + LS +
Sbjct: 16 WFHGRISREESQRLIGQQGLVDGLFLVRESQRNPQGFVLSLCHLQKVKHYLILPSEEEGR 75
Query: 47 FCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQVS 96
M G++ F +LVE + + L LR C +V+
Sbjct: 76 LYFSMDDGQTRFTD---------LLQLVEFHQLNRGILPCLLRHCCTRVA 116
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-28
Identities = 19/59 (32%), Positives = 33/59 (55%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTME 179
++N + VE G R+PCP CP ++ +M +CW +P +RP+F T+ +L+
Sbjct: 318 NLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 5e-18
Identities = 23/95 (24%), Positives = 38/95 (40%), Gaps = 8/95 (8%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFC-LKMTTGRSLFE 59
WY G I R E + L+ G FL+R+S+ K +Y LS + + +L+
Sbjct: 15 WYHGAIPRAEVAELLV----HSGDFLVRESQG-KQEYVLSVLWDGLPRHFIIQSLDNLYR 69
Query: 60 TQKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQ 94
+ G +I P L++H L +
Sbjct: 70 LEGEGFPSI--PLLIDHLLSTQQPLTKKSGVVLHR 102
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-28
Identities = 20/62 (32%), Positives = 33/62 (53%), Gaps = 1/62 (1%)
Query: 120 GGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFT-M 178
G M ++ +++ R+P P GCP +Y IM ECW + +RP+F L +++ M
Sbjct: 234 GQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293
Query: 179 EG 180
G
Sbjct: 294 AG 295
|
| >1blj_A P55 BLK protein tyrosine kinase; signal transduction, transferase, phosphotransferase, phosphorylation; NMR {Mus musculus} SCOP: d.93.1.1 PDB: 1blk_A Length = 114 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-28
Identities = 39/109 (35%), Positives = 52/109 (47%), Gaps = 23/109 (21%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMT-------- 52
W+F I R +AE++LL P N G+FLIR+SES K +SLS ++ +
Sbjct: 14 WFFRTISRKDAERQLLAPMNKAGSFLIRESESNKGAFSLSVKDITTQGEVVKHYKIRSLD 73
Query: 53 ------TGRSLFETQKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQV 95
+ R F T LV+HYSK DGLC L PCV +
Sbjct: 74 NGGYYISPRITFPT---------LQALVQHYSKKGDGLCQKLTLPCVNL 113
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-28
Identities = 18/56 (32%), Positives = 33/56 (58%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFF 176
G +N +V+ + + +PCP CP +Y +M+ECW + P +RP F+ + +L +
Sbjct: 233 GYSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 288
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-28
Identities = 20/57 (35%), Positives = 31/57 (54%)
Query: 120 GGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFF 176
G MT +++ ++ G R+PCPP CP +Y +M +CW P R +F+ L E
Sbjct: 245 GQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-28
Identities = 20/60 (33%), Positives = 36/60 (60%), Gaps = 1/60 (1%)
Query: 121 GMTNAEVLHQVE-HGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTME 179
G+ +++LH+++ G R+P P CP +Y++M++CW P RPTF L+ L + +
Sbjct: 227 GLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 286
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 3e-28
Identities = 25/59 (42%), Positives = 37/59 (62%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTME 179
G+ N +V+ ++E+G R+P PP CPP LY +M +CW DP +RP F L+ +L E
Sbjct: 595 GVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653
|
| >1lkk_A Human P56 tyrosine kinase; complex (tyrosine kinase/peptide); HET: PTR; 1.00A {Homo sapiens} SCOP: d.93.1.1 PDB: 1lcj_A* 1bhf_A* 1bhh_A 1lkl_A* 1bhh_B 1fbz_A* 1ijr_A* 1cwd_L* 1cwe_A* Length = 105 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-28
Identities = 35/107 (32%), Positives = 49/107 (45%), Gaps = 24/107 (22%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKM--------- 51
W+F + R +AE++LL P N HG+FLIR+SES +SLS ++
Sbjct: 6 WFFKNLSRKDAERQLLAPGNTHGSFLIRESESTAGSFSLSVRDFDQNQGEVVKHYKIRNL 65
Query: 52 ------TTGRSLFETQKAGRTTIHYPELVEHYSKDADGLCVNLRKPC 92
+ R F ELV HY+ +DGLC L +PC
Sbjct: 66 DNGGFYISPRITFPG---------LHELVRHYTNASDGLCTRLSRPC 103
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-28
Identities = 20/62 (32%), Positives = 33/62 (53%), Gaps = 1/62 (1%)
Query: 120 GGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFT-M 178
G M ++ +++ R+P P GCP +Y IM ECW + +RP+F L +++ M
Sbjct: 265 GQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324
Query: 179 EG 180
G
Sbjct: 325 AG 326
|
| >1rja_A Tyrosine-protein kinase 6; human protein tyrosine kinase-6 (PTK6/BRK), SRC homology 2(S domain, solution structure, backbone dynamics, transferase; NMR {Homo sapiens} SCOP: d.93.1.1 Length = 100 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-28
Identities = 30/107 (28%), Positives = 39/107 (36%), Gaps = 25/107 (23%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS-------------EYKRSSF 47
W+FG I R EA ++L N GAFLIR SE DY LS
Sbjct: 4 WFFGCISRSEAVRRLQAEGNATGAFLIRVSEKPSADYVLSVRDTQAVRHYKIWRRAGGRL 63
Query: 48 CLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQ 94
L F + PELV ++ + + L PC +
Sbjct: 64 HL---NEAVSFLS---------LPELVNYHRAQSLSHGLRLAAPCRK 98
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-28
Identities = 22/68 (32%), Positives = 35/68 (51%), Gaps = 1/68 (1%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTM-E 179
G+ E+ ++ G+RM P C LY +M +CW P +RPTF+ L L+ T+
Sbjct: 262 GIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321
Query: 180 GSDYKEAS 187
+Y + S
Sbjct: 322 NEEYLDLS 329
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-28
Identities = 20/68 (29%), Positives = 31/68 (45%), Gaps = 1/68 (1%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180
G+ AEV +E G R+ P C +Y +M++CW+ D RPTF+ L + +
Sbjct: 220 GLRLAEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR-DP 278
Query: 181 SDYKEASG 188
Y
Sbjct: 279 PRYLVIKR 286
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-28
Identities = 13/59 (22%), Positives = 25/59 (42%), Gaps = 2/59 (3%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTME 179
+ + L E +++P P L +++ C +P RP+F + L FT +
Sbjct: 221 ALDSQRKLQFYEDRHQLPAPKAAE--LANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-28
Identities = 21/58 (36%), Positives = 28/58 (48%)
Query: 120 GGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFT 177
G MT + +E G R+P P CP +Y +M CW + RPTFE L L+
Sbjct: 253 GQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 8e-28
Identities = 20/62 (32%), Positives = 33/62 (53%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180
G+ E+ ++ G+RM P C LY +M +CW P +RPTF+ L L+ T+
Sbjct: 308 GIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 367
Query: 181 SD 182
++
Sbjct: 368 NE 369
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 8e-28
Identities = 19/64 (29%), Positives = 30/64 (46%), Gaps = 1/64 (1%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFF-TME 179
+ ++ + G R+ P CP LY++ML+CW RP+F L ++ F T
Sbjct: 235 DVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294
Query: 180 GSDY 183
G Y
Sbjct: 295 GEHY 298
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-27
Identities = 16/58 (27%), Positives = 28/58 (48%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTM 178
++N EV+ + G + P CP +YD+ML CW ++P +R + + L
Sbjct: 238 QLSNTEVIECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGKA 295
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-27
Identities = 21/68 (30%), Positives = 31/68 (45%), Gaps = 1/68 (1%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180
G+ +E+ +E G R+P PP C +Y IM++CW+ D RP F L +
Sbjct: 222 GIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP- 280
Query: 181 SDYKEASG 188
Y G
Sbjct: 281 QRYLVIQG 288
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-27
Identities = 23/66 (34%), Positives = 34/66 (51%), Gaps = 1/66 (1%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTM-E 179
G+ ++V +E YRM P GCP ++Y++M CW +P RP+F + E F
Sbjct: 422 GIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 481
Query: 180 GSDYKE 185
SD E
Sbjct: 482 ISDEVE 487
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 1e-23
Identities = 30/97 (30%), Positives = 46/97 (47%), Gaps = 7/97 (7%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSS---FCLKMTTGRSL 57
WY G + R AE LL +G+FL+R+SES S+S + + + L
Sbjct: 107 WYHGPVSRNAAEY--LLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKL 164
Query: 58 FETQKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQ 94
+ + ++ T+ ELV H+S ADGL L P +
Sbjct: 165 YVSSESRFNTL--AELVHHHSTVADGLITTLHYPAPK 199
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-27
Identities = 23/69 (33%), Positives = 35/69 (50%), Gaps = 1/69 (1%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180
GMT AE+ ++ GYR+ P C +YD+M +CW + P +RP+F + L E
Sbjct: 244 GMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE-ER 302
Query: 181 SDYKEASGY 189
Y + Y
Sbjct: 303 KTYVNTTLY 311
|
| >1i3z_A EWS/FLI1 activated transcript 2; SH2 domain phosphotyrosine signal transduction lymphocyte, signaling protein; HET: PTR; 2.15A {Mus musculus} SCOP: d.93.1.1 Length = 103 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-27
Identities = 30/100 (30%), Positives = 39/100 (39%), Gaps = 7/100 (7%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFC----LKMTTGR- 55
+Y G + + E E LLL G FLIRDSES L + + G
Sbjct: 5 YYHGCLTKRECEA-LLLKGGVDGNFLIRDSESVPGALCLCVSFKKLVYSYRIFREKHGYY 63
Query: 56 SLFETQKAGRTTIH-YPELVEHYSKDADGLCVNLRKPCVQ 94
+ RT ELV Y K GL V+L P ++
Sbjct: 64 RIETDAHTPRTIFPNLQELVSKYGKPGQGLVVHLSNPIMR 103
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-27
Identities = 22/67 (32%), Positives = 35/67 (52%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180
G+ NAE+ + + G R+ PP C +YD+M +CW DP +RP+F L+ +LE+
Sbjct: 242 GIENAEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301
Query: 181 SDYKEAS 187
Sbjct: 302 VLSTSQD 308
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-27
Identities = 21/69 (30%), Positives = 34/69 (49%), Gaps = 2/69 (2%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180
G+ E+ ++ G+RM P C LY +M +CW P +RPTF+ L L+ +
Sbjct: 296 GVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL-- 353
Query: 181 SDYKEASGY 189
+ +E Y
Sbjct: 354 TSNQEMGYY 362
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 7e-27
Identities = 23/57 (40%), Positives = 32/57 (56%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFT 177
G+ N E+ + HG+R+ P C LY+IM CW DP+ RPTF L+ +LE
Sbjct: 252 GVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 9e-27
Identities = 19/68 (27%), Positives = 31/68 (45%), Gaps = 1/68 (1%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFF-TME 179
+ ++ + G R+ P CP LY++ML+CW RP+F L ++ F T
Sbjct: 299 DVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358
Query: 180 GSDYKEAS 187
G Y +
Sbjct: 359 GEHYVHVN 366
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-26
Identities = 18/57 (31%), Positives = 30/57 (52%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFT 177
G+ + + ++ G+RM P C +Y +ML+CW ++P KRP F + LE
Sbjct: 255 GIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311
|
| >1aot_F FYN protein-tyrosine kinase; SH2 domain, signal transduction, peptide complex, complex (proto-oncogene/early protein); HET: PTR; NMR {Homo sapiens} SCOP: d.93.1.1 PDB: 1aou_F* Length = 106 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-26
Identities = 36/113 (31%), Positives = 45/113 (39%), Gaps = 36/113 (31%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET 60
WYFGK+ R +AE++LL N G FLIR+SE+ K YSLS
Sbjct: 7 WYFGKLGRKDAERQLLSFGNPRGTFLIRESETTKGAYSLS---------------IRDWD 51
Query: 61 QKAGRTTIHY---------------------PELVEHYSKDADGLCVNLRKPC 92
G HY +LV+HYS+ A GL L P
Sbjct: 52 DMKGDHVKHYKIRKLDNGGYYITTRAQFETLQQLVQHYSERAAGLSSRLVVPS 104
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-26
Identities = 17/68 (25%), Positives = 32/68 (47%), Gaps = 1/68 (1%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180
++N E + + G + P CPP +Y IM CW ++P +R + + + +L+
Sbjct: 263 QLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP- 321
Query: 181 SDYKEASG 188
Y + G
Sbjct: 322 PVYLDVLG 329
|
| >3eaz_A Tyrosine-protein kinase CSK; SH2, disulfide, oxidized reduced, ATP-binding, cell membrane, cytoplasm, membrane, nucleotide-binding, phosphoprotein; 1.31A {Homo sapiens} PDB: 3eac_A Length = 106 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 1e-26
Identities = 37/106 (34%), Positives = 47/106 (44%), Gaps = 26/106 (24%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS------------EYKRSSFC 48
W+ GKI R +AE+ L PE G FL+R+S + DY+L Y S
Sbjct: 10 WFHGKITREQAERLLYPPET--GLFLVRESTNYPGDYTLCVSSDGKVEHYRIMYHASKLS 67
Query: 49 LKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQ 94
+ FE +LVEHY+ DADGLC L KP V
Sbjct: 68 I---DEEVYFEN---------LMQLVEHYTSDADGLCTRLIKPKVM 101
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-26
Identities = 21/57 (36%), Positives = 27/57 (47%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFT 177
+N EVL V G RM P CP +Y IM +CW P RP F + ++E
Sbjct: 248 SKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-26
Identities = 19/64 (29%), Positives = 32/64 (50%)
Query: 120 GGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTME 179
G + N++ V+ GY+M P P +Y IM CW +P RPTF+ + L++ +
Sbjct: 269 GILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328
Query: 180 GSDY 183
+
Sbjct: 329 RRER 332
|
| >1d4t_A T cell signal transduction molecule SAP; SH2 domain, tyrosine kinase, signal transduction, peptide recognition, signaling protein; 1.10A {Homo sapiens} SCOP: d.93.1.1 PDB: 1d1z_A 1d4w_A* 1m27_A* Length = 104 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 5e-26
Identities = 27/109 (24%), Positives = 37/109 (33%), Gaps = 25/109 (22%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS---------------EYKRS 45
Y GKI R EK LLL G++L+RDSES Y L E
Sbjct: 6 VYHGKISRETGEK-LLLATGLDGSYLLRDSESVPGVYCLCVLYHGYIYTYRVSQTETGSW 64
Query: 46 SFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQ 94
S + F L+ + K G+ + L+ P +
Sbjct: 65 SAETAPGVHKRYFRK---------IKNLISAFQKPDQGIVIPLQYPVEK 104
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-26
Identities = 22/64 (34%), Positives = 37/64 (57%), Gaps = 2/64 (3%)
Query: 121 GM-TNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTME 179
GM +++ ++ G+RM P P +YDIM CW DP+KRPTF+ + +E + E
Sbjct: 250 GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS-E 308
Query: 180 GSDY 183
+++
Sbjct: 309 STNH 312
|
| >2ysx_A Signaling inositol polyphosphate phosphatase SHIP II; SH2 domain, phosphotyrosine binding domain, protein tyrosine kinase, signal transduction; NMR {Homo sapiens} Length = 119 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 8e-26
Identities = 26/100 (26%), Positives = 41/100 (41%), Gaps = 7/100 (7%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS---EYKRSSFCLKMTTGRSL 57
W G I R +AE+ LL G+FL+R SES Y+L ++ +
Sbjct: 12 WNHGNITRSKAEE-LLSRTGKDGSFLVRASESISRAYALCVLYRNCVYTYRILPNEDDKF 70
Query: 58 FETQKAGRTTIHYP---ELVEHYSKDADGLCVNLRKPCVQ 94
G + + +L+E Y K+ GL +L+ P
Sbjct: 71 TVQASEGVSMRFFTKLDQLIEFYKKENMGLVTHLQYPVPL 110
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 8e-26
Identities = 19/60 (31%), Positives = 29/60 (48%), Gaps = 1/60 (1%)
Query: 121 GMT-NAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTME 179
G+ + E +++ G RM P P +Y ML+CW +P +RPTF L L +
Sbjct: 253 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312
|
| >1ka6_A SH2 domain protein 1A; SH2 domain, protein-peptide complex, immune system; HET: PTR; NMR {Homo sapiens} SCOP: d.93.1.1 PDB: 1ka7_A Length = 128 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 8e-26
Identities = 27/109 (24%), Positives = 37/109 (33%), Gaps = 25/109 (22%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS---------------EYKRS 45
Y GKI R EK LLL G++L+RDSES Y L E
Sbjct: 6 VYHGKISRETGEK-LLLATGLDGSYLLRDSESVPGVYCLCVLYHGYIYTYRVSQTETGSW 64
Query: 46 SFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQ 94
S + F L+ + K G+ + L+ P +
Sbjct: 65 SAETAPGVHKRYFRK---------IKNLISAFQKPDQGIVIPLQYPVEK 104
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 1e-25
Identities = 20/69 (28%), Positives = 35/69 (50%), Gaps = 3/69 (4%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180
G++N +VL V G + P CP L+++M CW +P RP+F + +++
Sbjct: 243 GLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME--- 299
Query: 181 SDYKEASGY 189
++E S Y
Sbjct: 300 PGFREVSFY 308
|
| >2ecd_A Tyrosine-protein kinase ABL2; SH2 domain, phosphotyrosine binding domain, protein tyrosine kinase, signal transduction, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 119 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 1e-25
Identities = 32/110 (29%), Positives = 41/110 (37%), Gaps = 27/110 (24%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS-------------EYKRSSF 47
WY G + R AE L N G+FL+R+SES S+S
Sbjct: 18 WYHGPVSRSAAEYLLSSLIN--GSFLVRESESSPGQLSISLRYEGRVYHYRINTTADGKV 75
Query: 48 CLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQVSC 97
+ T S F T ELV H+S ADGL L P + +
Sbjct: 76 YV---TAESRFST---------LAELVHHHSTVADGLVTTLHYPAPKCNK 113
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-25
Identities = 21/57 (36%), Positives = 27/57 (47%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFT 177
+N EVL V G RM P CP +Y IM +CW P RP F + ++E
Sbjct: 289 SKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-25
Identities = 21/56 (37%), Positives = 31/56 (55%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFF 176
GM + EV++ V G + CP CP LY++M CW K P RP+F ++ L+
Sbjct: 279 GMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 334
|
| >3us4_A Megakaryocyte-associated tyrosine-protein kinase; SH2 domain, signaling protein, structural genomics, joint CE structural genomics, JCSG; 1.50A {Homo sapiens} PDB: 1jwo_A Length = 98 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 2e-25
Identities = 28/104 (26%), Positives = 40/104 (38%), Gaps = 26/104 (25%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS------------EYKRSSFC 48
W+ GKI EA ++L PE G FL+R+S DY L ++
Sbjct: 7 WFHGKISGQEAVQQLQPPE--DGLFLVRESARHPGDYVLCVSFGRDVIHYRVLHRDGHLT 64
Query: 49 LKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGLCVNLRKPC 92
+ F ++VEHYSKD +C L +P
Sbjct: 65 I---DEAVFFCN---------LMDMVEHYSKDKGAICTKLVRPK 96
|
| >3k2m_A Proto-oncogene tyrosine-protein kinase ABL1; engineered binding protein, antibody mimic, protein-protein SH2 domain, ATP-binding, phosphoprotein; 1.75A {Homo sapiens} PDB: 3uyo_A 3t04_A 1ab2_A Length = 112 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 6e-25
Identities = 31/107 (28%), Positives = 41/107 (38%), Gaps = 27/107 (25%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS-------------EYKRSSF 47
WY G + R AE LL +G+FL+R+SES S+S
Sbjct: 7 WYHGPVSRNAAEY--LLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKL 64
Query: 48 CLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQ 94
+ + S F T ELV H+S ADGL L P +
Sbjct: 65 YV---SSESRFNT---------LAELVHHHSTVADGLITTLHYPAPK 99
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 7e-25
Identities = 17/64 (26%), Positives = 28/64 (43%), Gaps = 2/64 (3%)
Query: 121 GM-TNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTME 179
G+ +A +++G++M P +Y IM CW D KRP+F L L +
Sbjct: 277 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA-D 335
Query: 180 GSDY 183
+
Sbjct: 336 AEEA 339
|
| >2dm0_A Tyrosine-protein kinase TXK; TEC family kinase, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 125 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 8e-25
Identities = 28/110 (25%), Positives = 43/110 (39%), Gaps = 27/110 (24%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMT-------- 52
WY I R +AE LL E+ GAF++RDS Y++S + + +
Sbjct: 18 WYHRNITRNQAEH-LLRQESKEGAFIVRDSRH-LGSYTISVFMGARRSTEAAIKHYQIKK 75
Query: 53 --------TGRSLFETQKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQ 94
R F++ PEL+ ++ +A GL LR P
Sbjct: 76 NDSGQWYVAERHAFQS---------IPELIWYHQHNAAGLMTRLRYPVGL 116
|
| >2gsb_A RAS GTPase-activating protein 1; GAP, RAS P21 protein activator, P120GAP, rasgap, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 119 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 9e-25
Identities = 22/98 (22%), Positives = 41/98 (41%), Gaps = 9/98 (9%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFC----LKMTTGRS 56
W+ GKI + EA LL+ +FL+R S++ DYSL + +
Sbjct: 18 WFHGKISKQEAYN-LLMTVGQVCSFLVRPSDNTPGDYSLYFRTNENIQRFKICPTPNNQF 76
Query: 57 LFETQKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQ 94
+ + +I ++++HY K+ L++P
Sbjct: 77 MMGGRYY--NSI--GDIIDHYRKEQIVEGYYLKEPVPM 110
|
| >2ekx_A Cytoplasmic tyrosine-protein kinase BMX; SH2 domain, phosphotyrosine binding domain, protein tyrosine kinase, signal transduction; NMR {Homo sapiens} Length = 110 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-24
Identities = 23/108 (21%), Positives = 45/108 (41%), Gaps = 27/108 (25%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMT-------- 52
W+ G I R ++E+ LL + GAF++R+S Y++S + ++ K T
Sbjct: 13 WFAGNISRSQSEQ-LLRQKGKEGAFMVRNSSQ-VGMYTVSLFSKAVNDKKGTVKHYHVHT 70
Query: 53 --------TGRSLFETQKAGRTTIHYPELVEHYSKDADGLCVNLRKPC 92
F++ P+L+ ++ ++ G+ LR P
Sbjct: 71 NAENKLYLAENYCFDS---------IPKLIHYHQHNSAGMITRLRHPV 109
|
| >3ov1_A Growth factor receptor-bound protein 2; GRB2 SH2 domain, phosphotyrosine binding, signaling protein, signaling protein-antagonist complex; HET: PTR; 1.60A {Homo sapiens} PDB: 3imj_A* 3in7_A* 3imd_A* 3kfj_A* 3n8m_A* 3in8_A* 3s8l_A* 3s8n_A* 3s8o_A* 2huy_A* 2h5k_A* 2huw_A* 2h46_E* 3c7i_A* 3n84_A* 1fhs_A 1bm2_A* 1bmb_A* 3ove_A* 1fyr_A* ... Length = 117 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-24
Identities = 28/107 (26%), Positives = 45/107 (42%), Gaps = 19/107 (17%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS--------EYK-RSSFCLKM 51
W+FGKI R +AE+ +L + GAFLIR+SES D+SLS +K K
Sbjct: 8 WFFGKIPRAKAEE-MLSKQRHDGAFLIRESESAPGDFSLSVKFGNDVQHFKVLRDGAGKY 66
Query: 52 TTGRSLFETQKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQVSCR 98
F + ELV+++ + + ++ +
Sbjct: 67 FLWVVKFNS---------LNELVDYHRSTSVSRNQQIFLRDIEQVPQ 104
|
| >3s9k_A Tyrosine-protein kinase ITK/TSK; proline isomerization, CIS proline, domain swapped dimer, SH transferase; HET: CIT; 2.35A {Mus musculus} PDB: 2etz_A* 2eu0_A* 1lui_A 1luk_A 1lum_A 1lun_A 2k79_B 2k7a_B Length = 118 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-24
Identities = 26/112 (23%), Positives = 44/112 (39%), Gaps = 29/112 (25%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMT-------- 52
WY I R +AEK LLL GAF++RDS + Y++S + ++
Sbjct: 11 WYNKSISRDKAEK-LLLDTGKEGAFMVRDSRT-PGTYTVSVFTKAIISENPCIKHYHIKE 68
Query: 53 ----------TGRSLFETQKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQ 94
+ +F++ P L++++ + GL LR P
Sbjct: 69 TNDSPKRYYVAEKYVFDS---------IPLLIQYHQYNGGGLVTRLRYPVCG 111
|
| >2eob_A 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma 2; SH2, phosphoinositide phospholipase C, PLC-gamma-2, phospholipase C-gamma-2; NMR {Rattus norvegicus} Length = 124 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 5e-24
Identities = 29/96 (30%), Positives = 42/96 (43%), Gaps = 6/96 (6%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSF--CLKMTTGRSLF 58
WY+ ++ R EAE +L+ GAFLIR E + Y+++ R C GR
Sbjct: 21 WYYDRLSRGEAED-MLMRIPRDGAFLIRKREG-TDSYAITFRARGKVKHCRINRDGRHFV 78
Query: 59 ETQKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQ 94
A ++ ELV +Y K A + LR P
Sbjct: 79 LGTSAYFESL--VELVSYYEKHALYRKMRLRYPVTP 112
|
| >2ge9_A Tyrosine-protein kinase BTK; SH2 domain, structure, transferase; NMR {Homo sapiens} Length = 125 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 7e-24
Identities = 28/110 (25%), Positives = 47/110 (42%), Gaps = 27/110 (24%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMT-------- 52
WY + R +AE+ LL E G F++RDS S+ Y++S + +S+ +
Sbjct: 13 WYSKHMTRSQAEQ-LLKQEGKEGGFIVRDS-SKAGKYTVSVFAKSTGDPQGVIRHYVVCS 70
Query: 53 --------TGRSLFETQKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQ 94
+ LF T PEL+ ++ ++ GL L+ P Q
Sbjct: 71 TPQSQYYLAEKHLFST---------IPELINYHQHNSAGLISRLKYPVSQ 111
|
| >1a81_A SYK kinase; complex (transferase-peptide), SYK, kinase, SH2 domain; HET: PTR; 3.00A {Homo sapiens} SCOP: d.93.1.1 d.93.1.1 PDB: 1csy_A* 1csz_A* Length = 254 | Back alignment and structure |
|---|
Score = 92.3 bits (229), Expect = 2e-23
Identities = 25/171 (14%), Positives = 51/171 (29%), Gaps = 7/171 (4%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSS---FCLKMTTGRSL 57
++FG I R EAE L+ G +L+R S + ++LS + ++ +
Sbjct: 7 FFFGNITREEAEDYLVQGGMSDGLYLLRQSRNYLGGFALSVAHGRKAHHYTIERELNGTY 66
Query: 58 FETQKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQVSCRIYLVHGTNLSGVVVSAVDF 117
+ +L ++S+++DGL L+KP + +
Sbjct: 67 AIAGGRTHASP--ADLCHYHSQESDGLVCLLKKPFNRPQGVQPKTGPFEDLKENLIREYV 124
Query: 118 GSGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETL 168
+ + W + R E +
Sbjct: 125 KQTWNLQGQ--ALEQAIISQKPQLEKLIATTAHEKMPWFHGKISREESEQI 173
|
| >1a81_A SYK kinase; complex (transferase-peptide), SYK, kinase, SH2 domain; HET: PTR; 3.00A {Homo sapiens} SCOP: d.93.1.1 d.93.1.1 PDB: 1csy_A* 1csz_A* Length = 254 | Back alignment and structure |
|---|
Score = 90.4 bits (224), Expect = 1e-22
Identities = 30/98 (30%), Positives = 46/98 (46%), Gaps = 6/98 (6%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSS---FCLKMTTGRSL 57
W+ GKI R E+E+ +L+ +G FLIR ++ Y+L + + L
Sbjct: 160 WFHGKISREESEQIVLIGSKTNGKFLIRARDN-NGSYALCLLHEGKVLHYRIDKDKTGKL 218
Query: 58 FETQKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQV 95
+ T+ +LVEHYS ADGL L PC ++
Sbjct: 219 SIPEGKKFDTL--WQLVEHYSYKADGLLRVLTVPCQKI 254
|
| >3tkz_A Tyrosine-protein phosphatase non-receptor type 11; SH2 domain, protein protein interactions, PTR residues, HYDR peptide complex; HET: PTR; 1.80A {Homo sapiens} PDB: 3tl0_A* 1aya_A* 1ayb_A* 1ayc_A* 1ayd_A Length = 109 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-23
Identities = 28/102 (27%), Positives = 43/102 (42%), Gaps = 11/102 (10%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSF--CLKMTTGRSLF 58
W+ I +EAE LLL G+FL R S+S D++LS + + TG
Sbjct: 9 WFHPNITGVEAEN-LLLTRGVDGSFLARPSKSNPGDFTLSVRRNGAVTHIKIQNTGDYYD 67
Query: 59 ETQKAGRTTIHYPELVEHYS------KDADGLCVNLRKPCVQ 94
T+ ELV++Y K+ +G + L+ P
Sbjct: 68 LYGGEKFATL--AELVQYYMEHHGQLKEKNGDVIELKYPLNC 107
|
| >2oq1_A Tyrosine-protein kinase ZAP-70; tandem SH2 domains, ZAP-70, tyrosine kinase, transferase; HET: PTR; 1.90A {Homo sapiens} SCOP: d.93.1.1 d.93.1.1 PDB: 1m61_A Length = 254 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 8e-23
Identities = 25/95 (26%), Positives = 40/95 (42%), Gaps = 6/95 (6%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSS---FCLKMTTGRSL 57
WY + R EAE+KL G FL+R + + Y+LS + + +
Sbjct: 161 WYHSSLTREEAERKLYSGAQTDGKFLLRPRKE-QGTYALSLIYGKTVYHYLISQDKAGKY 219
Query: 58 FETQKAGRTTIHYPELVEHYSKDADGLCVNLRKPC 92
+ T+ +LVE+ ADGL L++ C
Sbjct: 220 CIPEGTKFDTL--WQLVEYLKLKADGLIYCLKEAC 252
|
| >2oq1_A Tyrosine-protein kinase ZAP-70; tandem SH2 domains, ZAP-70, tyrosine kinase, transferase; HET: PTR; 1.90A {Homo sapiens} SCOP: d.93.1.1 d.93.1.1 PDB: 1m61_A Length = 254 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 1e-22
Identities = 37/171 (21%), Positives = 51/171 (29%), Gaps = 7/171 (4%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFC---LKMTTGRSL 57
+++G I R EAE+ L L G FL+R Y LS F ++ +
Sbjct: 8 FFYGSISRAEAEEHLKLAGMADGLFLLRQCLRSLGGYVLSLVHDVRFHHFPIERQLNGTY 67
Query: 58 FETQKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQVSCRIYLVHGTNLSGVVVSAVDF 117
EL E YS+D DGL NLRKPC + S + + V
Sbjct: 68 AIAGGKAHCGP--AELCEFYSRDPDGLPCNLRKPCNRPSGLEPQPGVFDCLRDAM--VRD 123
Query: 118 GSGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETL 168
E + W + R E
Sbjct: 124 YVRQTWKLEGEALEQAIISQAPQVEKLIATTAHERMPWYHSSLTREEAERK 174
|
| >2eo3_A CRK-like protein; phosphorylation, repeat, SH2 domain, SH3 domain, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 111 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-22
Identities = 28/96 (29%), Positives = 39/96 (40%), Gaps = 7/96 (7%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS--EYKRSSFCLKMTTGRSLF 58
WY G + R EA+ L HG FL+RDS + DY LS E R S + + F
Sbjct: 21 WYMGPVSRQEAQT--RLQGQRHGMFLVRDSSTCPGDYVLSVSENSRVSHYIINSLPNRRF 78
Query: 59 ETQKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQ 94
+ + P L+E Y L +P +
Sbjct: 79 KIGDQEFDHL--PALLEFYKIHYLDTTT-LIEPAPR 111
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 9e-22
Identities = 18/57 (31%), Positives = 23/57 (40%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFT 177
+ V CPP CPP + I + C DP KRP+F L+ LE
Sbjct: 226 LPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282
|
| >2cs0_A Hematopoietic SH2 domain containing; ALX, FLJ14886, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: d.93.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-21
Identities = 30/99 (30%), Positives = 44/99 (44%), Gaps = 10/99 (10%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFC----LKMTTGRS 56
W+ G I R +AE LL G+FLIR S S Y+LS +SS C + G
Sbjct: 18 WFHGAISREDAEN--LLESQPLGSFLIRVSHSHV-GYTLSYKAQSSCCHFMVKLLDDGTF 74
Query: 57 LFETQKAGRTTIHYPELVEHYSK-DADGLCVNLRKPCVQ 94
+ +K T++ LV + + + L +PC Q
Sbjct: 75 MIPGEKVAHTSL--DALVTFHQQKPIEPRRELLTQPCRQ 111
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 2e-21
Identities = 18/55 (32%), Positives = 27/55 (49%)
Query: 123 TNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFT 177
+ E +++ G RM P P +Y ML+CW +P +RPTF L L +
Sbjct: 301 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355
|
| >2dlz_A Protein VAV-2; RHO family guanine nucleotide exchange factor, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 118 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 3e-21
Identities = 20/111 (18%), Positives = 38/111 (34%), Gaps = 31/111 (27%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS------------EYKRSSFC 48
W+ G ++R + + L + G +LIR+ + +++S K +
Sbjct: 18 WFAGNMERQQTDNLLKSHAS--GTYLIRERPAEAERFAISIKFNDEVKHIKVVEKDNWIH 75
Query: 49 LKMTTGRSLFETQKAGRTTIHYPELVEHYSK-----DADGLCVNLRKPCVQ 94
+ T F++ ELVE+Y L L+ P
Sbjct: 76 I---TEAKKFDS---------LLELVEYYQCHSLKESFKQLDTTLKYPYSG 114
|
| >1jyr_A Growth factor receptor-bound protein 2; receptor binding, regulatory, inhibitor, signaling protein-I complex; HET: PTR; 1.55A {Homo sapiens} SCOP: d.93.1.1 PDB: 1jyq_A* 1jyu_A 1qg1_E* 1x0n_A* 2aob_A* 2aoa_A* 3n7y_A* 1tze_E* 1zfp_E* 3mxc_A* 3mxy_A* 1cj1_A* Length = 96 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 4e-21
Identities = 28/97 (28%), Positives = 42/97 (43%), Gaps = 19/97 (19%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS--------EYK-RSSFCLKM 51
W+FGKI R +AE+ +L + GAFLIR+SES D+SLS +K K
Sbjct: 5 WFFGKIPRAKAEE-MLSKQRHDGAFLIRESESAPGDFSLSVKFGNDVQHFKVLRDGAGKY 63
Query: 52 TTGRSLFETQKAGRTTIHYPELVEHYSKDADGLCVNL 88
F + ELV+++ + +
Sbjct: 64 FLWVVKFNS---------LNELVDYHRSTSVSRNQQI 91
|
| >2kk6_A Proto-oncogene tyrosine-protein kinase FER; methods development, SH2, NESG, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein; NMR {Homo sapiens} Length = 116 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 1e-20
Identities = 26/99 (26%), Positives = 44/99 (44%), Gaps = 11/99 (11%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFC-LKMTTGRSLFE 59
WY G I RIEA++ L G FL+R+S + +Y LS Y + +++
Sbjct: 19 WYHGAIPRIEAQELL----KKQGDFLVRESHGKPGEYVLSVYSDGQRRHFIIQYVDNMYR 74
Query: 60 TQKAGRTTIHYPELVEHYSKDADGLC----VNLRKPCVQ 94
+ G + I P+L++H+ + V L P +
Sbjct: 75 FEGTGFSNI--PQLIDHHYTTKQVITKKSGVVLLNPIPK 111
|
| >2crh_A VAV proto-oncogene; oncoprotein, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} PDB: 2ror_A* 2lct_A* Length = 138 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 3e-20
Identities = 22/111 (19%), Positives = 38/111 (34%), Gaps = 31/111 (27%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS------------EYKRSSFC 48
WY G ++R AE +L G FL+R ++++S +
Sbjct: 28 WYAGPMERAGAES--ILANRSDGTFLVRQRVKDAAEFAISIKYNVEVKHIKIMTAEGLYR 85
Query: 49 LKMTTGRSLFETQKAGRTTIHYPELVEHYSKDA-----DGLCVNLRKPCVQ 94
+ T + F ELVE Y +++ L L+ P +
Sbjct: 86 I---TEKKAFRG---------LTELVEFYQQNSLKDCFKSLDTTLQFPFKE 124
|
| >2cia_A Cytoplasmic protein NCK2; SH2-domain, SH3 domain, phosphorylation, binding specificity; HET: PTR MPD; 1.45A {Homo sapiens} PDB: 1z3k_A 2ci9_A* 2ci8_A* Length = 102 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 5e-20
Identities = 32/104 (30%), Positives = 42/104 (40%), Gaps = 23/104 (22%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS--------EYKRSSFCLKMT 52
WY+G + R +AE L G FLIRDSES +D+S+S +K
Sbjct: 7 WYYGNVTRHQAEC-ALNERGVEGDFLIRDSESSPSDFSVSLKASGKNKHFKVQLVDNVYC 65
Query: 53 TGRSLFETQKAGRTTIHYPELVEHYSK-----DADGLCVNLRKP 91
G+ F T ELVEHY K G + L +
Sbjct: 66 IGQRRFHT---------MDELVEHYKKAPIFTSEHGEKLYLVRA 100
|
| >2kno_A Tensin-like C1 domain-containing phosphatase; SH2 domain, TENC1, solution structure, cell junctio membrane, hydrolase, membrane, metal-binding; NMR {Homo sapiens} PDB: 2l6k_A Length = 131 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 7e-20
Identities = 28/110 (25%), Positives = 40/110 (36%), Gaps = 20/110 (18%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS-EYKRSSFCLKMTTGRSLFE 59
WY + R +A LL + D GAFLIRDS S + Y L+ + + G + +
Sbjct: 22 WYKPHLSRDQAIA--LLKDKDPGAFLIRDSHSFQGAYGLALKVATPPPSAQPWKGDPVEQ 79
Query: 60 TQK-------------AGRTTIHY----PELVEHYSKDADGLCVNLRKPC 92
+ G + Y LV +S L LR P
Sbjct: 80 LVRHFLIETGPKGVKIKGCPSEPYFGSLSALVSQHSISPISLPCCLRIPS 129
|
| >2iug_A Phosphatidylinositol 3-kinase regulatory alpha subunit; transferase, polymorphism, UBL conjugation, phosphorylation, SH2, PI3K, SH2 domain; 1.89A {Homo sapiens} PDB: 2iuh_A* 2iui_A* 1fu5_A* 1fu6_A 1oo3_A 1oo4_A* 2pna_A 2pnb_A Length = 120 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-19
Identities = 25/112 (22%), Positives = 44/112 (39%), Gaps = 32/112 (28%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKN-DYSLS------------EYKRSSF 47
WY+G I R E +KL + G FL+RD+ ++ + DY+L+ ++ +
Sbjct: 13 WYWGDISREEVNEKLRDTAD--GTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKY 70
Query: 48 CLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDA-----DGLCVNLRKPCVQ 94
+ F + EL+ HY ++ L V L P +
Sbjct: 71 GF---SDPLTFSS---------VVELINHYRNESLAQYNPKLDVKLLYPVSK 110
|
| >1mil_A SHC adaptor protein; SH2 domain, phosphorylation, collagen, growth regulation, transforming protein, alternative initiation; 2.70A {Homo sapiens} SCOP: d.93.1.1 PDB: 1tce_A* Length = 104 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 3e-19
Identities = 21/98 (21%), Positives = 42/98 (42%), Gaps = 12/98 (12%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFC-LKMTTGRSLFE 59
W+ GK+ R EAE L +G FL+R+S + Y L+ + L + +
Sbjct: 9 WFHGKLSRREAEALL----QLNGDFLVRESTTTPGQYVLTGLQSGQPKHLLLVDPEGVVR 64
Query: 60 TQKAGRTTIHYPELVEHYSKD-----ADGLCVNLRKPC 92
T+ ++ L+ ++ + + G + L++P
Sbjct: 65 TKDHRFESV--SHLISYHMDNHLPIISAGSELCLQQPV 100
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 4e-19
Identities = 15/60 (25%), Positives = 27/60 (45%), Gaps = 5/60 (8%)
Query: 121 GMTNAE-VLHQVEHGYRMP----CPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDF 175
+ N + ++ V G P CP R+ +M EC K +RP+F + ++E+
Sbjct: 227 NINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286
|
| >1ju5_A CRK; CRK, SH2, SH3, adaptor protein, phosphopeptide, protein binding/transferase complex; HET: PTR; NMR {Homo sapiens} SCOP: d.93.1.1 Length = 109 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 9e-19
Identities = 28/111 (25%), Positives = 40/111 (36%), Gaps = 20/111 (18%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS---EYKRSSFCLKMTTGRSL 57
WY+G++ R EA LL HG FL+RDS + DY LS + S + + + R
Sbjct: 2 WYWGRLSRQEAVA--LLQGQRHGVFLVRDSSTSPGDYVLSVSENSRVSHYIINSSGPRPP 59
Query: 58 FETQKAGRTTIHY--------------PELVEHYSKDADGLCVNLRKPCVQ 94
A P L+E Y L +P +
Sbjct: 60 VPPSPAQPPPGVSPSRLRIGDQEFDSLPALLEFYKIHY-LDTTTLIEPVSR 109
|
| >1h9o_A Phosphatidylinositol 3-kinase; transferase/receptor, complex (phosphotransferase/receptor), phosphotransferase, SH2 domain; HET: PTR; 1.79A {Homo sapiens} SCOP: d.93.1.1 PDB: 1pic_A* 1bfi_A 1bfj_A 1qad_A Length = 112 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-18
Identities = 27/102 (26%), Positives = 38/102 (37%), Gaps = 13/102 (12%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSS---FCLKMTTGRSL 57
W G R +AE LL G FL+R+S S++ Y+ S + T
Sbjct: 12 WNVGSSNRNKAEN--LLRGKRDGTFLVRES-SKQGCYACSVVVDGEVKHCVINKTATGYG 68
Query: 58 FETQKAGRTTIHYPELVEHYSKDA-----DGLCVNLRKPCVQ 94
F +++ ELV HY + D L V L P
Sbjct: 69 FAEPYNLYSSL--KELVLHYQHTSLVQHNDSLNVTLAYPVYA 108
|
| >2vif_A Suppressor of cytokine signalling 6; growth regulation, signal transduction inhibitor, KIT regula phosphotyrosine, signaling protein; HET: PTR; 1.45A {Homo sapiens} Length = 141 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 1e-18
Identities = 27/117 (23%), Positives = 42/117 (35%), Gaps = 25/117 (21%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS------------EYKRSSFC 48
WY+G I R EAE KL + G+FL+RDS + SLS E+ F
Sbjct: 26 WYWGPITRWEAEGKLANVPD--GSFLVRDSSDDRYLLSLSFRSHGKTLHTRIEHSNGRFS 83
Query: 49 LKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQVS--CRIYLVH 103
+ +L+EH D++ + + S + L +
Sbjct: 84 FYEQPDVEGHTS---------IVDLIEHSIGDSENGAFCYSRSRLPGSATYPVRLTN 131
|
| >3maz_A Signal-transducing adaptor protein 1; modular domain, phosphotyrosine, specificity, cytoplasm, phosphoprotein, SH2 domain, signaling protein; HET: PTR; 1.90A {Homo sapiens} Length = 125 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 1e-18
Identities = 15/98 (15%), Positives = 34/98 (34%), Gaps = 9/98 (9%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSS------FCLKMTTG 54
F + R EA + +L G ++R S +YS++ + + +
Sbjct: 17 ACFYTVSRKEATE-MLQKNPSLGNMILRPG-SDSRNYSITIRQEIDIPRIKHYKVMSVGQ 74
Query: 55 RSLFETQKAGRTTIHYPELVEHYSKDADGLCVNLRKPC 92
E +K T + +++++ K+ G
Sbjct: 75 NYTIELEK-PVTLPNLFSVIDYFVKETRGNLRPFIAST 111
|
| >3gqi_B Phospholipase C-gamma-1; phosphorylated kinase, PY-recognition, tandem SH2 domains, A analog, ATP-binding, craniosynostosis, disease mutation; HET: PTR DVT ACP; 2.50A {Rattus norvegicus} PDB: 2fci_A* 2pld_A* 2ple_A* Length = 226 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 3e-18
Identities = 23/102 (22%), Positives = 39/102 (38%), Gaps = 19/102 (18%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSF--------CLKMT 52
WY + R +AE +L+ GAFL+R + N Y++S +
Sbjct: 124 WYHASLTRAQAEH-MLMRVPRDGAFLVRKR-NEPNSYAISFRAEGKIKHCRVQQEGQTVM 181
Query: 53 TGRSLFETQKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQ 94
G S F++ +L+ +Y K + LR P +
Sbjct: 182 LGNSEFDS---------LVDLISYYEKHPLYRKMKLRYPINE 214
|
| >3gqi_B Phospholipase C-gamma-1; phosphorylated kinase, PY-recognition, tandem SH2 domains, A analog, ATP-binding, craniosynostosis, disease mutation; HET: PTR DVT ACP; 2.50A {Rattus norvegicus} PDB: 2fci_A* 2pld_A* 2ple_A* Length = 226 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 2e-10
Identities = 17/49 (34%), Positives = 26/49 (53%), Gaps = 9/49 (18%)
Query: 1 WYFGKI-----KRIEAEKKL----LLPENDHGAFLIRDSESRKNDYSLS 40
W+ GK+ R AE+ L + G+FL+R+SE+ DY+LS
Sbjct: 6 WFHGKLGAGRDGRHIAERLLTEYCIETGAPDGSFLVRESETFVGDYTLS 54
|
| >4d8k_A Tyrosine-protein kinase LCK; protein kinases, SH2 domain, SH3 domain, structural genomics center for structural genomics, JCSG; 2.36A {Homo sapiens} PDB: 1lck_A* 1x27_A* Length = 175 | Back alignment and structure |
|---|
Score = 76.6 bits (188), Expect = 4e-18
Identities = 33/100 (33%), Positives = 51/100 (51%), Gaps = 10/100 (10%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSS--------FCLKMT 52
W+F + R +AE++LL P N HG+FLIR+SES +SLS + ++
Sbjct: 76 WFFKNLSRKDAERQLLAPGNTHGSFLIRESESTAGSFSLSVRDFDQNQGEVVKHYKIRNL 135
Query: 53 TGRSLFETQKAGRTTIHYPELVEHYSKDADGLCVNLRKPC 92
+ + + + ELV HY+ +DGLC L +PC
Sbjct: 136 DNGGFYISPRITFPGL--HELVRHYTNASDGLCTRLSRPC 173
|
| >2hdv_A SH2-B PH domain containing signaling mediator 1 gamma isoform; adapter protein, signaling protein; 2.00A {Mus musculus} PDB: 2hdx_A* 1rpy_A 1rqq_C* Length = 111 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 5e-18
Identities = 20/101 (19%), Positives = 37/101 (36%), Gaps = 11/101 (10%)
Query: 1 WYFGKIKRIEAEKKLLLPEND-HGAFLIRDSESRKNDYSLSEYKRSSF--CLKMTTGRSL 57
W+ G + R++A + +L HG FL+R SE+R+ + L+ +
Sbjct: 11 WFHGMLSRLKAAQLVLEGGTGSHGVFLVRQSETRRGECVLTFNFQGKAKHLRLSLNAAGQ 70
Query: 58 FETQKAGRTTIHYPELVEHYSK------DADGLCVNLRKPC 92
Q +I +++EH+ V L
Sbjct: 71 CRVQHLHFQSI--FDMLEHFRVHPIPLESGGSSDVVLVSYV 109
|
| >2dx0_A Phospholipase C, gamma 2; phosphoric diester hydrolase, structural genomics, NPPSFA, national project on protein structural and functional analyses; 2.50A {Mus musculus} Length = 138 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 8e-18
Identities = 24/115 (20%), Positives = 40/115 (34%), Gaps = 30/115 (26%)
Query: 1 WYFGKIKRIEAEKKLLL-----PENDHGAFLIRDSESRKNDYSLS------------EYK 43
W+ K++ + +KLL G FL+R+SE+ NDY+LS
Sbjct: 24 WFHKKVESRTSAEKLLQEYCAETGAKDGTFLVRESETFPNDYTLSFWRSGRVQHCRIRST 83
Query: 44 RSSFCLKMT-TGRSLFETQKAGRTTIHYPELVEHYSK---DADGLCVNLRKPCVQ 94
+ +K T F + L++HY + + L P
Sbjct: 84 MENGVMKYYLTDNLTFNS---------IYALIQHYREAHLRCAEFELRLTDPVPN 129
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-17
Identities = 16/55 (29%), Positives = 25/55 (45%), Gaps = 1/55 (1%)
Query: 121 GMTNAEVLHQV-EHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLED 174
G+ V + V + +P P CP +M +CW DP RP+F + +L
Sbjct: 216 GIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270
|
| >2y3a_B Phosphatidylinositol 3-kinase regulatory subunit; transferase, phosphoinositide 3-kinase, RTK; HET: GD9; 3.30A {Mus musculus} Length = 302 | Back alignment and structure |
|---|
Score = 77.0 bits (189), Expect = 2e-17
Identities = 30/102 (29%), Positives = 41/102 (40%), Gaps = 13/102 (12%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSS---FCLKMTTGRSL 57
WY GKI R +AE+ +L G FLIR+S S++ Y+ S + T
Sbjct: 196 WYVGKINRTQAEE--MLSGKRDGTFLIRES-SQRGCYACSVVVDGDTKHCVIYRTATGFG 252
Query: 58 FETQKAGRTTIHYPELVEHYSKDA-----DGLCVNLRKPCVQ 94
F ++ ELV HY + D L V L P
Sbjct: 253 FAEPYNLYGSL--KELVLHYQHASLVQHNDALTVTLAHPVRA 292
|
| >1r1p_A GRB2-related adaptor protein 2; SH2, GADS, phosphopeptide, peptide binding protein; HET: PTR; 1.80A {Mus musculus} SCOP: d.93.1.1 PDB: 1r1q_A* 1r1s_A* Length = 100 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 5e-17
Identities = 23/85 (27%), Positives = 39/85 (45%), Gaps = 10/85 (11%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFC----LKMTTGRS 56
W+ + R +AE LL D G F+IR S+S D+S+S ++ T G
Sbjct: 11 WFHEGLSRHQAEN--LLMGKDIGFFIIRASQSSPGDFSISVRHEDDVQHFKVMRDTKGNY 68
Query: 57 LFETQKAGRTTIHYPELVEHYSKDA 81
T+K ++ +LV++Y +
Sbjct: 69 FLWTEKF--PSL--NKLVDYYRTTS 89
|
| >2eo6_A B-cell linker protein; SH2, cytoplasmic adapter protein, B-cell adapter containing SH2 domain protein; NMR {Mus musculus} Length = 141 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 9e-17
Identities = 20/103 (19%), Positives = 34/103 (33%), Gaps = 9/103 (8%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKND--YSLSEYKRSS---FCLKMTTGR 55
WY G R AE+ L N G+FLIR S + Y+L + ++
Sbjct: 25 WYAGACDRKSAEE-ALHRSNKDGSFLIRKSSGHDSKQPYTLVAFFNKRVYNIPVRFIEAT 83
Query: 56 SLFETQKAGRTTIHY---PELVEHYSKDADGLCVNLRKPCVQV 95
+ K ++ E+V + + L +
Sbjct: 84 KQYALGKKKNGEEYFGSVVEIVNSHQHNPLVLIDSQNNTKDST 126
|
| >3hhm_B NISH2 P85alpha; PI3KCA, PI3K, PIK3R1, phosphatidilynositol 3,4,5- triphosphate, wortmannin, H1047R, ATP-binding, disease mutation, kinase; HET: KWT; 2.80A {Homo sapiens} PDB: 3hiz_B 2rd0_B 4a55_B* 3mtt_A Length = 373 | Back alignment and structure |
|---|
Score = 75.6 bits (185), Expect = 1e-16
Identities = 25/112 (22%), Positives = 43/112 (38%), Gaps = 32/112 (28%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESR-KNDYSLS------------EYKRSSF 47
WY+G I R E +KL + G FL+RD+ ++ DY+L+ ++ +
Sbjct: 12 WYWGDISREEVNEKLRDTAD--GTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKY 69
Query: 48 CLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDA-----DGLCVNLRKPCVQ 94
+ F + EL+ HY ++ L V L P +
Sbjct: 70 GF---SDPLTFSS---------VVELINHYRNESLAQYNPKLDVKLLYPVSK 109
|
| >3hhm_B NISH2 P85alpha; PI3KCA, PI3K, PIK3R1, phosphatidilynositol 3,4,5- triphosphate, wortmannin, H1047R, ATP-binding, disease mutation, kinase; HET: KWT; 2.80A {Homo sapiens} PDB: 3hiz_B 2rd0_B 4a55_B* 3mtt_A Length = 373 | Back alignment and structure |
|---|
Score = 55.6 bits (133), Expect = 1e-09
Identities = 15/40 (37%), Positives = 21/40 (52%), Gaps = 3/40 (7%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS 40
W G R +AE LL G FL+R+S S++ Y+ S
Sbjct: 303 WNVGSSNRNKAEN--LLRGKRDGTFLVRES-SKQGCYACS 339
|
| >2bbu_A Suppressor of cytokine signaling 3; SH2 domain, extended SH2 subdomain, PEST motif, protein complex, cytokine regulator; HET: PTR; NMR {Mus musculus} Length = 164 | Back alignment and structure |
|---|
Score = 72.3 bits (177), Expect = 1e-16
Identities = 21/104 (20%), Positives = 34/104 (32%), Gaps = 19/104 (18%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS------------EYKRSSFC 48
+Y+ + EA L G FLIRDS +++ ++LS + + SF
Sbjct: 25 FYWSAVTGGEANLLLSAEPA--GTFLIRDSSDQRHFFTLSVKTQSGTKNLRIQCEGGSFS 82
Query: 49 LKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGLCVNLRKPC 92
L + +LV HY +L
Sbjct: 83 L---QSDPRSTQPVPRFDCV--LKLVHHYMPPPGTPSFSLPPTE 121
|
| >2c9w_A Suppressor of cytokine signaling 2; growth regulation, SH2 domain, signal transduction inhibitor nuclear protein; 1.9A {Homo sapiens} SCOP: a.271.1.1 d.93.1.1 Length = 169 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 1e-16
Identities = 25/115 (21%), Positives = 43/115 (37%), Gaps = 20/115 (17%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS------------EYKRSSFC 48
WY+G + EA++KL E G FLIRDS ++S EY+ F
Sbjct: 19 WYWGSMTVNEAKEKLK--EAPEGTFLIRDSSHSDYLLTISVKTSAGPTNLRIEYQDGKFR 76
Query: 49 LKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQVSCRIYLVH 103
L +++ ++ L+++Y + P + +YL
Sbjct: 77 L---DSIICVKSKLKQFDSV--VHLIDYYVQMCKDKRTGPEAPR-NGTVHLYLTK 125
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 3e-16
Identities = 15/56 (26%), Positives = 23/56 (41%), Gaps = 1/56 (1%)
Query: 121 GMTNAEVLHQVEHGYRMPCPP-GCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDF 175
++ Q+ G + G + DI+L CW + +RPTF L LE
Sbjct: 245 TQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKL 300
|
| >2izv_A Suppressor of cytokine signaling 4; signal transduction inhibitor, growth regulation, signal transduction, SH2 domain, nuclear protein; 2.55A {Homo sapiens} SCOP: a.271.1.1 d.93.1.1 Length = 187 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 5e-16
Identities = 26/123 (21%), Positives = 43/123 (34%), Gaps = 15/123 (12%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFC---LKMTTGRSL 57
Y+G + + AE L G FL+RDS +S+S + S ++
Sbjct: 36 CYWGVMDKYAAEALLEGKPE--GTFLLRDSAQEDYLFSVSFRRYSRSLHARIEQWNHNFS 93
Query: 58 FETQKAGRTTIH-YPELVEHYSKDADGLC--VNLRKPCV-------QVSCRIYLVHGTNL 107
F+ L+EHY + + L P + Q CR + + T
Sbjct: 94 FDAHDPCVFHSPDITGLLEHYKDPSACMFFEPLLSTPLIRTFPFSLQHICRTVICNCTTY 153
Query: 108 SGV 110
G+
Sbjct: 154 DGI 156
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 1e-14
Identities = 19/56 (33%), Positives = 28/56 (50%), Gaps = 1/56 (1%)
Query: 121 GMTNAEVLHQV-EHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDF 175
++N E+ +V G R PPG P + +M C +DP KRP F+ + LE
Sbjct: 213 DLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268
|
| >1wqu_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; SH2 domain, feline sarcoma oncogene, structural genomics; NMR {Homo sapiens} PDB: 2dcr_A Length = 114 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-13
Identities = 25/97 (25%), Positives = 40/97 (41%), Gaps = 12/97 (12%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFC-LKMTTGRSLFE 59
WY G I R E + L+ G FL+R+S+ K +Y LS + + +L+
Sbjct: 18 WYHGAIPRAEVAELLV----HSGDFLVRESQG-KQEYVLSVLWDGLPRHFIIQSLDNLYR 72
Query: 60 TQKAGRTTIHYPELVEHYSKDADGLC----VNLRKPC 92
+ G +I P L++H L V L +
Sbjct: 73 LEGEGFPSI--PLLIDHLLSTQQPLTKKSGVVLHRAV 107
|
| >2lqn_A CRK-like protein; SH2, SH3, V-CRK sarcoma virus CT10 oncogene homolog (avian)- signaling protein; NMR {Homo sapiens} PDB: 2lqw_A* Length = 303 | Back alignment and structure |
|---|
Score = 66.2 bits (160), Expect = 2e-13
Identities = 26/96 (27%), Positives = 36/96 (37%), Gaps = 6/96 (6%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS--EYKRSSFCLKMTTGRSLF 58
WY G + R EA+ L HG FL+RDS + DY LS E R S + + F
Sbjct: 14 WYMGPVSRQEAQT--RLQGQRHGMFLVRDSSTCPGDYVLSVSENSRVSHYIINSLPNRRF 71
Query: 59 ETQKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQ 94
+ + P L+E Y +
Sbjct: 72 KIGDQEFDHL--PALLEFYKIHYLDTTTLIEPAPRY 105
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 3e-13
Identities = 16/58 (27%), Positives = 26/58 (44%), Gaps = 1/58 (1%)
Query: 121 GMTNAEVLHQV-EHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFT 177
+ A+V+ V R+ P P++ I+ CW +P KRP+F T+ L
Sbjct: 241 NLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298
|
| >1gri_A Growth factor bound protein 2; SH2, SH3, signal transduction adaptor; 3.10A {Homo sapiens} SCOP: b.34.2.1 b.34.2.1 d.93.1.1 PDB: 1aze_A 2a37_A 2azv_A 2a36_A 2azs_A Length = 217 | Back alignment and structure |
|---|
Score = 62.8 bits (152), Expect = 1e-12
Identities = 26/100 (26%), Positives = 46/100 (46%), Gaps = 5/100 (5%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLK--MTTGRSLF 58
W+FGKI R +AE+ +L + GAFLIR+SES D+SLS + + G +
Sbjct: 60 WFFGKIPRAKAEE-MLSKQRHDGAFLIRESESAPGDFSLSVKFGNDVQHFKVLRDGAGKY 118
Query: 59 ETQKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQVSCR 98
++ ELV+++ + + ++ +
Sbjct: 119 FLWVVKFNSL--NELVDYHRSTSVSRNQQIFLRDIEQVPQ 156
|
| >2hmh_A Suppressor of cytokine signaling 3; SOCS3, GP130, PTyr, peptide complex, cytokine regulator; HET: PTR; 2.00A {Mus musculus} Length = 152 | Back alignment and structure |
|---|
Score = 59.2 bits (143), Expect = 8e-12
Identities = 18/86 (20%), Positives = 34/86 (39%), Gaps = 9/86 (10%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS---EYKRSSFCLKMTTGRSL 57
+Y+ + EA L G FLIRDS +++ ++LS + + ++ G
Sbjct: 36 FYWSAVTGGEANLLLS--AEPAGTFLIRDSSDQRHFFTLSVKTQSGTKNLRIQXEGGSFS 93
Query: 58 FETQKAGRTTIH----YPELVEHYSK 79
++ + +LV HY
Sbjct: 94 LQSDPRSTQPVPRFDXVLKLVHHYMP 119
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 9e-12
Identities = 18/58 (31%), Positives = 27/58 (46%), Gaps = 3/58 (5%)
Query: 121 GMTNAEVLHQ---VEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDF 175
+ ++ E G R P CPPRL +++ CW DP KRP F + +L +
Sbjct: 230 EYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3qwy_A Cell death abnormality protein 2; cell engulfment, signaling protein; 2.52A {Caenorhabditis elegans} Length = 308 | Back alignment and structure |
|---|
Score = 61.0 bits (147), Expect = 1e-11
Identities = 19/40 (47%), Positives = 25/40 (62%), Gaps = 1/40 (2%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS 40
+YF + R EA K L P+ G FL+RDS SR +YSL+
Sbjct: 43 FYFPGMSREEAHKLLGEPQVSIGTFLMRDS-SRPGEYSLT 81
|
| >3qwx_X Cell death abnormality protein 2; cell engulfment, signaling protein; 2.01A {Caenorhabditis elegans} Length = 174 | Back alignment and structure |
|---|
Score = 58.6 bits (141), Expect = 2e-11
Identities = 19/42 (45%), Positives = 25/42 (59%), Gaps = 1/42 (2%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEY 42
+YF + R EA K L P+ G FL+RDS SR +YSL+
Sbjct: 14 FYFPGMSREEAHKLLGEPQVSIGTFLMRDS-SRPGEYSLTVR 54
|
| >2dvj_A V-CRK sarcoma virus CT10 oncogene homolog, isoform A; SH3, SH2, signal transduction, adapter molecule, signaling protein; HET: PTR; NMR {Homo sapiens} PDB: 2eyy_A 2eyv_A 2eyw_A Length = 230 | Back alignment and structure |
|---|
Score = 56.8 bits (136), Expect = 2e-10
Identities = 19/40 (47%), Positives = 24/40 (60%), Gaps = 2/40 (5%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS 40
WY+G++ R EA LL HG FL+RDS + DY LS
Sbjct: 15 WYWGRLSRQEAVA--LLQGQRHGVFLVRDSSTSPGDYVLS 52
|
| >2el8_A Signal-transducing adaptor protein 2; SH2 domain, phosphotyrosine binding domain, protein tyrosine kinase, signal transduction, structural genomics; NMR {Homo sapiens} Length = 118 | Back alignment and structure |
|---|
Score = 53.2 bits (127), Expect = 8e-10
Identities = 15/92 (16%), Positives = 32/92 (34%), Gaps = 7/92 (7%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS--EYKRSSFCLK----MTTG 54
F K+ R+EA+ LL + G L+R S + S++ + + ++ G
Sbjct: 23 SCFLKVSRLEAQL-LLERYPECGNLLLRPSGDGADGVSVTTRQMHNGTHVVRHYKVKREG 81
Query: 55 RSLFETQKAGRTTIHYPELVEHYSKDADGLCV 86
+ + +V ++ V
Sbjct: 82 PKYVIDVEQPFSCTSLDAVVNYFVSHTKKALV 113
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 1e-09
Identities = 14/45 (31%), Positives = 21/45 (46%)
Query: 131 VEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDF 175
V +G R P P + +M CW KDP +RP+ E + +
Sbjct: 217 VHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261
|
| >2eyz_A V-CRK sarcoma virus CT10 oncogene homolog isoform A; SH2, SH3, signaling protein; NMR {Homo sapiens} PDB: 2l3s_A 2l3p_A 2l3q_A 2ggr_A Length = 304 | Back alignment and structure |
|---|
Score = 52.7 bits (125), Expect = 1e-08
Identities = 19/40 (47%), Positives = 24/40 (60%), Gaps = 2/40 (5%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS 40
WY+G++ R EA LL HG FL+RDS + DY LS
Sbjct: 13 WYWGRLSRQEAVA--LLQGQRHGVFLVRDSSTSPGDYVLS 50
|
| >3ps5_A Tyrosine-protein phosphatase non-receptor type 6; SH2, PTP, hydrolase, signaling protein; 3.10A {Homo sapiens} Length = 595 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 6e-08
Identities = 27/97 (27%), Positives = 39/97 (40%), Gaps = 7/97 (7%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET 60
W+ + ++AE LL HG+FL R S + D+SLS F
Sbjct: 4 WFHRDLSGLDAET-LLKGRGVHGSFLARPSRKNQGDFSLSVRVGDQVTHIRIQNSGDFYD 62
Query: 61 QKAGRTTIHYPELVEHY------SKDADGLCVNLRKP 91
G ELVE+Y +D DG ++L+ P
Sbjct: 63 LYGGEKFATLTELVEYYTQQQGVLQDRDGTIIHLKYP 99
|
| >2b3o_A Tyrosine-protein phosphatase, non-receptor type 6; protein tyrosine phosphatase, SHP-1, signaling, hydrolase; 2.80A {Homo sapiens} PDB: 1x6c_A 2rmx_A* 2yu7_A* Length = 532 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 1e-07
Identities = 27/97 (27%), Positives = 39/97 (40%), Gaps = 7/97 (7%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET 60
W+ + ++AE LL HG+FL R S + D+SLS F
Sbjct: 4 WFHRDLSGLDAET-LLKGRGVHGSFLARPSRKNQGDFSLSVRVGDQVTHIRIQNSGDFYD 62
Query: 61 QKAGRTTIHYPELVEHY------SKDADGLCVNLRKP 91
G ELVE+Y +D DG ++L+ P
Sbjct: 63 LYGGEKFATLTELVEYYTQQQGVLQDRDGTIIHLKYP 99
|
| >2shp_A SHP-2, SYP, SHPTP-2; tyrosine phosphatase, insulin signaling, SH2 protein; HET: CAT; 2.00A {Homo sapiens} SCOP: c.45.1.2 d.93.1.1 d.93.1.1 Length = 525 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 2e-07
Identities = 26/97 (26%), Positives = 40/97 (41%), Gaps = 7/97 (7%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET 60
W+ I +EAE LLL G+FL R S+S D +LS + + +
Sbjct: 6 WFHPNITGVEAEN-LLLTRGVDGSFLARPSKSNPGDLTLSVRRNGAVTHIKIQNTGDYYD 64
Query: 61 QKAGRTTIHYPELVEHYS------KDADGLCVNLRKP 91
G ELV++Y K+ +G + L+ P
Sbjct: 65 LYGGEKFATLAELVQYYMEHHGQLKEKNGDVIELKYP 101
|
| >2shp_A SHP-2, SYP, SHPTP-2; tyrosine phosphatase, insulin signaling, SH2 protein; HET: CAT; 2.00A {Homo sapiens} SCOP: c.45.1.2 d.93.1.1 d.93.1.1 Length = 525 | Back alignment and structure |
|---|
Score = 38.3 bits (89), Expect = 8e-04
Identities = 18/40 (45%), Positives = 26/40 (65%), Gaps = 1/40 (2%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS 40
W+ G + EAEK LL + HG+FL+R+S+S D+ LS
Sbjct: 112 WFHGHLSGKEAEK-LLTEKGKHGSFLVRESQSHPGDFVLS 150
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 3e-06
Identities = 13/55 (23%), Positives = 17/55 (30%), Gaps = 5/55 (9%)
Query: 131 VEHGYRMPCPPG-----CPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180
E R P + IM ECW + R T ++ L EG
Sbjct: 285 CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 339
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-05
Identities = 11/49 (22%), Positives = 16/49 (32%), Gaps = 5/49 (10%)
Query: 131 VEHGYRMPCPP-----GCPPRLYDIMLECWLKDPVKRPTFETLQWKLED 174
R P L +M ECW ++P R T ++ L
Sbjct: 251 CVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-05
Identities = 11/50 (22%), Positives = 17/50 (34%), Gaps = 5/50 (10%)
Query: 131 VEHGYRMPCPP-----GCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDF 175
R P C ++ +M ECW +P R T ++ L
Sbjct: 280 CIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 39.8 bits (93), Expect = 2e-04
Identities = 8/54 (14%), Positives = 18/54 (33%), Gaps = 6/54 (11%)
Query: 131 VEHGYRMPCPPGC------PPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTM 178
R P L + + +CW +D R T + + ++ + +
Sbjct: 266 SREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 38.5 bits (90), Expect = 6e-04
Identities = 8/49 (16%), Positives = 14/49 (28%), Gaps = 5/49 (10%)
Query: 131 VEHGYRMPCPPGCPP-----RLYDIMLECWLKDPVKRPTFETLQWKLED 174
V R L + + ECW D R + + ++
Sbjct: 267 VHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ 315
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 189 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 99.96 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.96 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 99.96 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.95 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.95 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 99.95 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.95 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.94 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.93 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.93 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 99.93 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.92 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.91 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.85 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 99.85 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 99.83 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.82 | |
| 3k2m_A | 112 | Proto-oncogene tyrosine-protein kinase ABL1; engin | 99.82 | |
| 1lkk_A | 105 | Human P56 tyrosine kinase; complex (tyrosine kinas | 99.81 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 99.81 | |
| 3us4_A | 98 | Megakaryocyte-associated tyrosine-protein kinase; | 99.81 | |
| 1rja_A | 100 | Tyrosine-protein kinase 6; human protein tyrosine | 99.81 | |
| 2dly_A | 121 | FYN-related kinase; BRK family kinase, structural | 99.81 | |
| 3eaz_A | 106 | Tyrosine-protein kinase CSK; SH2, disulfide, oxidi | 99.79 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 99.79 | |
| 1d4t_A | 104 | T cell signal transduction molecule SAP; SH2 domai | 99.78 | |
| 1blj_A | 114 | P55 BLK protein tyrosine kinase; signal transducti | 99.78 | |
| 1nrv_A | 105 | Growth factor receptor-bound protein 10; dimer, si | 99.78 | |
| 2ecd_A | 119 | Tyrosine-protein kinase ABL2; SH2 domain, phosphot | 99.78 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.78 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 99.78 | |
| 3pqz_A | 117 | Growth factor receptor-bound protein 7; SH2, binds | 99.78 | |
| 1i3z_A | 103 | EWS/FLI1 activated transcript 2; SH2 domain phosph | 99.78 | |
| 1aot_F | 106 | FYN protein-tyrosine kinase; SH2 domain, signal tr | 99.77 | |
| 3s9k_A | 118 | Tyrosine-protein kinase ITK/TSK; proline isomeriza | 99.77 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.77 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.76 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.76 | |
| 3maz_A | 125 | Signal-transducing adaptor protein 1; modular doma | 99.76 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 99.76 | |
| 2aug_A | 126 | Growth factor receptor-bound protein 14; phosphory | 99.76 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 99.75 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.75 | |
| 1ka6_A | 128 | SH2 domain protein 1A; SH2 domain, protein-peptide | 99.75 | |
| 2ekx_A | 110 | Cytoplasmic tyrosine-protein kinase BMX; SH2 domai | 99.75 | |
| 1h9o_A | 112 | Phosphatidylinositol 3-kinase; transferase/recepto | 99.75 | |
| 2ysx_A | 119 | Signaling inositol polyphosphate phosphatase SHIP | 99.74 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.74 | |
| 2lnw_A | 122 | VAV-2, guanine nucleotide exchange factor VAV2; si | 99.74 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.74 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.74 | |
| 2gsb_A | 119 | RAS GTPase-activating protein 1; GAP, RAS P21 prot | 99.73 | |
| 2dlz_A | 118 | Protein VAV-2; RHO family guanine nucleotide excha | 99.73 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.73 | |
| 3tkz_A | 109 | Tyrosine-protein phosphatase non-receptor type 11; | 99.73 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.73 | |
| 2ge9_A | 125 | Tyrosine-protein kinase BTK; SH2 domain, structure | 99.73 | |
| 2kno_A | 131 | Tensin-like C1 domain-containing phosphatase; SH2 | 99.73 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.72 | |
| 2dm0_A | 125 | Tyrosine-protein kinase TXK; TEC family kinase, st | 99.72 | |
| 2iug_A | 120 | Phosphatidylinositol 3-kinase regulatory alpha sub | 99.72 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.71 | |
| 4d8k_A | 175 | Tyrosine-protein kinase LCK; protein kinases, SH2 | 99.71 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.71 | |
| 2eo3_A | 111 | CRK-like protein; phosphorylation, repeat, SH2 dom | 99.71 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.71 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.71 | |
| 2crh_A | 138 | VAV proto-oncogene; oncoprotein, structural genomi | 99.71 | |
| 1mil_A | 104 | SHC adaptor protein; SH2 domain, phosphorylation, | 99.71 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.71 | |
| 2oq1_A | 254 | Tyrosine-protein kinase ZAP-70; tandem SH2 domains | 99.7 | |
| 2eob_A | 124 | 1-phosphatidylinositol-4,5-bisphosphate phosphodie | 99.7 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.7 | |
| 2el8_A | 118 | Signal-transducing adaptor protein 2; SH2 domain, | 99.7 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.7 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.7 | |
| 2dx0_A | 138 | Phospholipase C, gamma 2; phosphoric diester hydro | 99.7 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.7 | |
| 2cs0_A | 119 | Hematopoietic SH2 domain containing; ALX, FLJ14886 | 99.7 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.69 | |
| 1jyr_A | 96 | Growth factor receptor-bound protein 2; receptor b | 99.69 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 99.69 | |
| 2oq1_A | 254 | Tyrosine-protein kinase ZAP-70; tandem SH2 domains | 99.69 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.69 | |
| 1a81_A | 254 | SYK kinase; complex (transferase-peptide), SYK, ki | 99.69 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.69 | |
| 2kk6_A | 116 | Proto-oncogene tyrosine-protein kinase FER; method | 99.69 | |
| 1a81_A | 254 | SYK kinase; complex (transferase-peptide), SYK, ki | 99.69 | |
| 1r1p_A | 100 | GRB2-related adaptor protein 2; SH2, GADS, phospho | 99.69 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.69 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.69 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.68 | |
| 3ov1_A | 117 | Growth factor receptor-bound protein 2; GRB2 SH2 d | 99.68 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.68 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.67 | |
| 2vif_A | 141 | Suppressor of cytokine signalling 6; growth regula | 99.67 | |
| 2hdv_A | 111 | SH2-B PH domain containing signaling mediator 1 ga | 99.67 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.67 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.67 | |
| 1ju5_A | 109 | CRK; CRK, SH2, SH3, adaptor protein, phosphopeptid | 99.67 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.67 | |
| 2eo6_A | 141 | B-cell linker protein; SH2, cytoplasmic adapter pr | 99.67 | |
| 2cia_A | 102 | Cytoplasmic protein NCK2; SH2-domain, SH3 domain, | 99.66 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.66 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.66 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.66 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.66 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.66 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.65 | |
| 2c9w_A | 169 | Suppressor of cytokine signaling 2; growth regulat | 99.65 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.64 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.64 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.64 | |
| 1wqu_A | 114 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.64 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.64 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.64 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.63 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 99.63 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.63 | |
| 2bbu_A | 164 | Suppressor of cytokine signaling 3; SH2 domain, ex | 99.63 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.62 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.62 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.62 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.61 | |
| 2hmh_A | 152 | Suppressor of cytokine signaling 3; SOCS3, GP130, | 99.61 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.61 | |
| 2izv_A | 187 | Suppressor of cytokine signaling 4; signal transdu | 99.61 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.6 | |
| 2y3a_B | 302 | Phosphatidylinositol 3-kinase regulatory subunit; | 99.6 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.59 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.59 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.59 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.59 | |
| 4fbn_A | 246 | 1-phosphatidylinositol 4,5-bisphosphate phosphodi | 99.58 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.58 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.58 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.58 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.57 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.57 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.57 | |
| 3hhm_B | 373 | NISH2 P85alpha; PI3KCA, PI3K, PIK3R1, phosphatidil | 99.57 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.56 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.56 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.56 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.56 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.56 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.55 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.55 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.55 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.55 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.55 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.54 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.54 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.54 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.54 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.54 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.54 | |
| 2dvj_A | 230 | V-CRK sarcoma virus CT10 oncogene homolog, isoform | 99.54 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.54 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.54 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.54 | |
| 3qwx_X | 174 | Cell death abnormality protein 2; cell engulfment, | 99.53 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.53 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.53 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.53 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.53 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.53 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.53 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.53 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.53 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.52 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.52 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.51 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 99.51 | |
| 2eyz_A | 304 | V-CRK sarcoma virus CT10 oncogene homolog isoform | 99.51 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.51 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.51 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.5 | |
| 4fbn_A | 246 | 1-phosphatidylinositol 4,5-bisphosphate phosphodi | 99.5 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.5 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.5 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.5 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.5 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.5 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.5 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.49 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.49 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.49 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.49 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.49 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.49 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.49 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.49 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.48 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.48 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.48 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.48 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.48 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.47 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.47 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.47 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.47 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.47 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.47 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.47 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.47 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.47 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.47 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.47 | |
| 2lqn_A | 303 | CRK-like protein; SH2, SH3, V-CRK sarcoma virus CT | 99.2 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.46 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.46 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.46 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.46 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.46 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.45 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.45 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.45 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.45 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.45 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.45 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.45 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.44 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.44 | |
| 3qwy_A | 308 | Cell death abnormality protein 2; cell engulfment, | 99.44 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.44 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.44 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.43 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.43 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.43 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.43 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.43 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.43 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.43 | |
| 2b3o_A | 532 | Tyrosine-protein phosphatase, non-receptor type 6; | 99.43 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.42 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.42 | |
| 3ps5_A | 595 | Tyrosine-protein phosphatase non-receptor type 6; | 99.42 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.42 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.42 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.42 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.42 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.41 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.41 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.41 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.41 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.4 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.4 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.4 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.4 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.4 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.4 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.4 | |
| 2shp_A | 525 | SHP-2, SYP, SHPTP-2; tyrosine phosphatase, insulin | 99.4 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.39 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.39 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.39 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.39 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.39 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.39 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.38 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.38 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.38 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.38 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.38 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.37 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.37 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.36 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.36 | |
| 3ps5_A | 595 | Tyrosine-protein phosphatase non-receptor type 6; | 99.36 | |
| 2cr4_A | 126 | 3BP-2, SH3 domain-binding protein 2; structural ge | 99.36 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.36 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.35 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.35 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.34 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.34 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.34 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.33 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.33 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.32 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.31 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.31 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.3 | |
| 2shp_A | 525 | SHP-2, SYP, SHPTP-2; tyrosine phosphatase, insulin | 99.3 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.28 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.28 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.28 | |
| 2b3o_A | 532 | Tyrosine-protein phosphatase, non-receptor type 6; | 99.28 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.28 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.27 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.27 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.27 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.27 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.26 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 99.26 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.26 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.26 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.25 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.25 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.25 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.24 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.24 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.24 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.23 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.23 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.23 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.22 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.22 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.21 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.21 | |
| 1gri_A | 217 | Growth factor bound protein 2; SH2, SH3, signal tr | 99.18 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.15 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.12 | |
| 3hhm_B | 373 | NISH2 P85alpha; PI3KCA, PI3K, PIK3R1, phosphatidil | 99.1 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.1 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.05 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.04 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.03 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.01 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.01 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 98.96 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 98.94 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 98.85 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 98.82 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 98.53 | |
| 2xp1_A | 178 | SPT6; transcription, IWS1, histone chaperone, mRNA | 98.38 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 97.72 | |
| 3or8_A | 197 | Transcription elongation factor SPT6; SH2, CTD bin | 97.45 | |
| 1uur_A | 473 | Stata protein, STAT protein; transcription activat | 97.32 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 96.66 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 96.54 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 96.29 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 96.18 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 95.9 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 95.89 | |
| 3bux_B | 329 | E3 ubiquitin-protein ligase CBL; TKB, signal trans | 95.79 | |
| 2xp1_A | 178 | SPT6; transcription, IWS1, histone chaperone, mRNA | 95.78 | |
| 3op0_A | 323 | Signal transduction protein CBL-C; structural geno | 95.43 | |
| 1yvl_A | 683 | Signal transducer and activator of transcription 1 | 93.76 | |
| 1y1u_A | 585 | Signal transducer and activator of transcription; | 93.35 | |
| 3or8_A | 197 | Transcription elongation factor SPT6; SH2, CTD bin | 93.23 | |
| 1bf5_A | 575 | Signal transducer and activator of transcription 1 | 91.49 | |
| 1bg1_A | 596 | Protein (transcription factor STAT3B); protein-DNA | 91.22 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 89.18 | |
| 3psi_A | 1219 | Transcription elongation factor SPT6; nucleus; 3.3 | 86.1 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.8e-31 Score=197.78 Aligned_cols=170 Identities=14% Similarity=0.207 Sum_probs=134.5
Q ss_pred CCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC-cc---CCCCCcCHhHHHHHhh
Q psy1684 3 FGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET-QK---AGRTTIHYPELVEHYS 78 (189)
Q Consensus 3 ~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g-yl---~~~~~~~l~~li~~~~ 78 (189)
+..++|+|++++++.+...+..|||+|++++ |++.-.++. .+ ... .. .....++..+++.+..
T Consensus 69 l~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~-G~L~~~l~~--~~----------~~~~~~~~~~~~~~l~~~~~~~i~~ 135 (299)
T 4asz_A 69 LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKH-GDLNKFLRA--HG----------PDAVLMAEGNPPTELTQSQMLHIAQ 135 (299)
T ss_dssp HTTCCCTTBCCEEEEECSSSSEEEEEECCTT-CBHHHHHHH--TS----------HHHHHC----CCCCCCHHHHHHHHH
T ss_pred HHhCCCCCCccEEEEEeeCCEEEEEEEcCCC-CcHHHHHHh--cC----------cccccccccCCCCCCCHHHHHHHHH
Confidence 3578999999999999888889999999998 422111111 00 000 00 1123455778889999
Q ss_pred hccCCceeeccCCcccccc-cc---------------ccc-----------------------ccC-CCCCccc-e-EEE
Q psy1684 79 KDADGLCVNLRKPCVQVSC-RI---------------YLV-----------------------HGT-NLSGVVV-S-AVD 116 (189)
Q Consensus 79 ~~a~gl~~~~~~~~~~~~~-p~---------------~l~-----------------------~~~-~~~~~~~-s-Vws 116 (189)
+++.|+.|+|..+++|||+ |+ |+| ||. ..+.|+. + |||
T Consensus 136 qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS 215 (299)
T 4asz_A 136 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWS 215 (299)
T ss_dssp HHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHH
T ss_pred HHHHHHHHHHhCCcccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHH
Confidence 9999999999999999996 55 333 322 4567999 9 999
Q ss_pred ec-------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcCCCC
Q psy1684 117 FG-------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEGSDY 183 (189)
Q Consensus 117 fG-------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~~~~~ 183 (189)
|| |.+.++.+++..+.+|.+++.|..||+++++||.+||+.||++||||++|...|+++.+ ..|.|
T Consensus 216 ~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~-~~p~~ 294 (299)
T 4asz_A 216 LGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK-ASPVY 294 (299)
T ss_dssp HHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH-HSCCC
T ss_pred HHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh-cCCcc
Confidence 99 77888899999999999999999999999999999999999999999999999999876 56777
Q ss_pred CCC
Q psy1684 184 KEA 186 (189)
Q Consensus 184 ~~~ 186 (189)
.|.
T Consensus 295 ldi 297 (299)
T 4asz_A 295 LDI 297 (299)
T ss_dssp SCC
T ss_pred ccC
Confidence 764
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-28 Score=193.40 Aligned_cols=187 Identities=44% Similarity=0.724 Sum_probs=155.1
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEec---CCCeeeEEEEEeccCC--ccCCCCCcC-HhHHH
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKR---SSFCLKMTTGRSLFET--QKAGRTTIH-YPELV 74 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~---~~~~v~h~~i~~~~~g--yl~~~~~~~-l~~li 74 (189)
||||.|+|.+|+++|....+.+|+||||++...+|.|+||++.. ..+.++||+|.+..+| |+.....|. +.+++
T Consensus 67 w~~g~~~r~~ae~~L~~~~~~~G~FLvR~s~~~~g~y~lsv~~~~~~~~~~v~h~~I~~~~~g~~~~~~~~~F~Sl~~Li 146 (452)
T 1fmk_A 67 WYFGKITRRESERLLLNAENPRGTFLVRESETTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSRTQFNSLQQLV 146 (452)
T ss_dssp TEEETCCHHHHHHHHTCTTSCTTEEEEEECSSSTTCEEEEEEEEETTTEEEEEEEEEEECTTSCEESSTTSEESSHHHHH
T ss_pred cccCCccHHHHHHHhccCCCCCceEEEEeCCCCCCceEEEEEeeccCCCCcEEEEEEEEcCCCCEEEecCcccCCHHHHH
Confidence 99999999999999987777889999999998889999999852 2458999999987766 787777888 99999
Q ss_pred HHhhhccCCceeeccCCcccccccc--cccccC-----------------------------------------------
Q psy1684 75 EHYSKDADGLCVNLRKPCVQVSCRI--YLVHGT----------------------------------------------- 105 (189)
Q Consensus 75 ~~~~~~a~gl~~~~~~~~~~~~~p~--~l~~~~----------------------------------------------- 105 (189)
.++...++|++..+..+|... .|. +++++.
T Consensus 147 ~~y~~~~~~l~~~l~~~~~~~-~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~ 225 (452)
T 1fmk_A 147 AYYSKHADGLCHRLTTVCPTS-KPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA 225 (452)
T ss_dssp HHHTTCCTTSSSCCCEECCCC-CCCCSSSSTTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHH
T ss_pred HHhhhccccchhhcccccccc-ccccCCCCccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHH
Confidence 999988888876555443211 000 000000
Q ss_pred --------------------------------------------------------------------------------
Q psy1684 106 -------------------------------------------------------------------------------- 105 (189)
Q Consensus 106 -------------------------------------------------------------------------------- 105 (189)
T Consensus 226 ~~~E~~~l~~l~hp~iv~~~~~~~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrD 305 (452)
T 1fmk_A 226 FLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 305 (452)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEcCCceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCC
Confidence
Q ss_pred ------------------------------------------------CCCCccc-e-EEEec-------------CCCC
Q psy1684 106 ------------------------------------------------NLSGVVV-S-AVDFG-------------SGGM 122 (189)
Q Consensus 106 ------------------------------------------------~~~~~~~-s-VwsfG-------------~~~~ 122 (189)
..+.++. + ||||| |.+.
T Consensus 306 lkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~ 385 (452)
T 1fmk_A 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 385 (452)
T ss_dssp CSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred CChhhEEECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCC
Confidence 2355788 9 99999 6778
Q ss_pred ChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcCCCCCCCCC
Q psy1684 123 TNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEGSDYKEASG 188 (189)
Q Consensus 123 ~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~~ 188 (189)
+..++...+..|.+++.|..||+++.+||.+||+.||++||||++|++.|+.++.+.+++|++.+.
T Consensus 386 ~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~~~~~~ 451 (452)
T 1fmk_A 386 VNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 451 (452)
T ss_dssp CHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCCSCC
T ss_pred CHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCcccccccC
Confidence 888999999999999999999999999999999999999999999999999999999999998875
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-30 Score=196.87 Aligned_cols=176 Identities=14% Similarity=0.198 Sum_probs=130.4
Q ss_pred CCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccC
Q psy1684 3 FGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDAD 82 (189)
Q Consensus 3 ~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~ 82 (189)
+..++|+|++++++.|...+..|||+|++++ |++.-.+.. ....... . ..+-......++..+++.+..+++.
T Consensus 97 l~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~-G~L~~~l~~--~~~~~~~-~---~~~~~~~~~~l~~~~~~~i~~qia~ 169 (329)
T 4aoj_A 97 LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRH-GDLNRFLRS--HGPDAKL-L---AGGEDVAPGPLGLGQLLAVASQVAA 169 (329)
T ss_dssp HTTCCCTTBCCEEEEECSSSSEEEEEECCTT-CBHHHHHHT--SSCC---------------CCSCCHHHHHHHHHHHHH
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEEcCCC-CcHHHHHHh--cCccccc-c---cccccccCCCCCHHHHHHHHHHHHH
Confidence 4578999999999999888889999999998 432111111 0000000 0 0000011234568888999999999
Q ss_pred CceeeccCCcccccc-cc---------------cccc-----------------------cC-CCCCccc-e-EEEec--
Q psy1684 83 GLCVNLRKPCVQVSC-RI---------------YLVH-----------------------GT-NLSGVVV-S-AVDFG-- 118 (189)
Q Consensus 83 gl~~~~~~~~~~~~~-p~---------------~l~~-----------------------~~-~~~~~~~-s-VwsfG-- 118 (189)
|+.|+|..+++|||+ |+ |+|+ |. ....|+. + |||||
T Consensus 170 gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvv 249 (329)
T 4aoj_A 170 GMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVV 249 (329)
T ss_dssp HHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHH
T ss_pred HHHHHhcCCeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHH
Confidence 999999999999996 55 4433 22 5667999 9 99999
Q ss_pred -----------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcCCCCCCC
Q psy1684 119 -----------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEGSDYKEA 186 (189)
Q Consensus 119 -----------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~ 186 (189)
|.+.+..+++..+.+|.+++.|..||+++++||.+||+.||++||||+||++.|+.+.+ ..|.|.|.
T Consensus 250 l~Ellt~G~~Pf~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~-~pp~~ld~ 327 (329)
T 4aoj_A 250 LWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ-APPVYLDV 327 (329)
T ss_dssp HHHHHTTSCCTTCSSCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH-SCC-----
T ss_pred HHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh-CCcccccC
Confidence 77888899999999999999999999999999999999999999999999999999887 45666553
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=4e-28 Score=195.36 Aligned_cols=188 Identities=44% Similarity=0.720 Sum_probs=151.6
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEec---CCCeeeEEEEEeccCC--ccCCCCCcC-HhHHH
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKR---SSFCLKMTTGRSLFET--QKAGRTTIH-YPELV 74 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~---~~~~v~h~~i~~~~~g--yl~~~~~~~-l~~li 74 (189)
||||.|+|.+|+++|....+.+|.||||++...+|.|+|+++.. ..+.++||+|....+| |+.....|. +.+|+
T Consensus 150 wy~g~i~r~~ae~~L~~~~~~~G~FLvR~S~~~~g~y~lsv~~~~~~~~~~v~h~~I~~~~~g~~~i~~~~~F~SL~eLv 229 (535)
T 2h8h_A 150 WYFGKITRRESERLLLNAENPRGTFLVRESETTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSRTQFNSLQQLV 229 (535)
T ss_dssp TBCCSCCHHHHHHHHTCTTCCTTEEEEEECSSSTTCEEEEEEEEETTTEEEEEEEEEBC-CCSCEEEETTEEESSHHHHH
T ss_pred eeccccCHHHHHHHhccCCCCCCeEEEEecCCCCCcEEEEEEeeccCCCCceEEEEEEEcCCCcEEeeccccccChHHhh
Confidence 99999999999999987777889999999998889999999852 2458999999987766 777777788 99999
Q ss_pred HHhhhccCCceeeccCCcccc------------cccc-----------------cccccC--------------------
Q psy1684 75 EHYSKDADGLCVNLRKPCVQV------------SCRI-----------------YLVHGT-------------------- 105 (189)
Q Consensus 75 ~~~~~~a~gl~~~~~~~~~~~------------~~p~-----------------~l~~~~-------------------- 105 (189)
.++...++|++..+..+|... .++. +.+...
T Consensus 230 ~~y~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~ 309 (535)
T 2h8h_A 230 AYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAF 309 (535)
T ss_dssp HHHHHCCTTSSSCCCEECCCCCCCCSSSSTTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHH
T ss_pred eeeccccCccccccccccccccccccccCccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHH
Confidence 999998888776554443211 0000 000000
Q ss_pred --------------------------------------------------------------------------------
Q psy1684 106 -------------------------------------------------------------------------------- 105 (189)
Q Consensus 106 -------------------------------------------------------------------------------- 105 (189)
T Consensus 310 ~~E~~~l~~l~hpniv~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDl 389 (535)
T 2h8h_A 310 LQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 389 (535)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred HHHHHHHHhCCCCCEeeEEEEEeeccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCC
Confidence
Q ss_pred -----------------------------------------------CCCCccc-e-EEEec-------------CCCCC
Q psy1684 106 -----------------------------------------------NLSGVVV-S-AVDFG-------------SGGMT 123 (189)
Q Consensus 106 -----------------------------------------------~~~~~~~-s-VwsfG-------------~~~~~ 123 (189)
..+.|+. + ||||| |.+.+
T Consensus 390 kp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~ 469 (535)
T 2h8h_A 390 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 469 (535)
T ss_dssp SGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC
T ss_pred CHhhEEEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 2345788 9 99999 67778
Q ss_pred hHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcCCCCCCCCC
Q psy1684 124 NAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEGSDYKEASG 188 (189)
Q Consensus 124 ~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~~ 188 (189)
..+++..+..+.+++.|..||.++++||.+||+.||++||||.+|++.|+.++...+++|++.+.
T Consensus 470 ~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~~~~~~ 534 (535)
T 2h8h_A 470 NREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 534 (535)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSCSSCC---
T ss_pred HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCcccCcccc
Confidence 88999999999999999999999999999999999999999999999999999999999998875
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=189.19 Aligned_cols=186 Identities=42% Similarity=0.750 Sum_probs=151.8
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEec---CCCeeeEEEEEeccCC--ccCCCCCcC-HhHHH
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKR---SSFCLKMTTGRSLFET--QKAGRTTIH-YPELV 74 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~---~~~~v~h~~i~~~~~g--yl~~~~~~~-l~~li 74 (189)
||||.|+|.+|+++|......+|+||||++...+|.|+||++.. ..+.++||+|....+| |+.....|. +.+++
T Consensus 72 W~~g~i~r~~ae~~L~~~~~~~G~FLvR~s~~~~g~y~lsv~~~~~~~~~~v~H~~I~~~~~g~~~i~~~~~F~sl~eLv 151 (454)
T 1qcf_A 72 WFFKGISRKDAERQLLAPGNMLGSFMIRDSETTKGSYSLSVRDYDPRQGDTVKHYKIRTLDNGGFYISPRSTFSTLQELV 151 (454)
T ss_dssp TEETTCCHHHHHHHHHSTTCCTTCEEEEECSSSTTSEEEEEEEEETTTEEEEEEEEEEECTTSCEESSSSSCBSSHHHHH
T ss_pred ccccccchhhhhhhhhcCCCCCceEEEEECcCCCCeEEEEEEecccCCCCceEEEEEEEcCCCcEEEeCccccCCHHHHH
Confidence 99999999999999987777899999999998889999999863 2458999999987766 777677788 99999
Q ss_pred HHhhhccCCceeeccCCccccc-----------ccc-----------------cccccC---------------------
Q psy1684 75 EHYSKDADGLCVNLRKPCVQVS-----------CRI-----------------YLVHGT--------------------- 105 (189)
Q Consensus 75 ~~~~~~a~gl~~~~~~~~~~~~-----------~p~-----------------~l~~~~--------------------- 105 (189)
.++....+|++..+..++.... ++. +.+...
T Consensus 152 ~~y~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~ 231 (454)
T 1qcf_A 152 DHYKKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFL 231 (454)
T ss_dssp HHHTSSCTTSSSCCCSBCCCCCCCCCCCTTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHH
T ss_pred HHHHhccCCccccccccccccCccccccccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHH
Confidence 9888877777655544432210 000 000000
Q ss_pred --------------------------------------------------------------------------------
Q psy1684 106 -------------------------------------------------------------------------------- 105 (189)
Q Consensus 106 -------------------------------------------------------------------------------- 105 (189)
T Consensus 232 ~E~~~l~~l~h~~iv~l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlk 311 (454)
T 1qcf_A 232 AEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLR 311 (454)
T ss_dssp HHHHHHTTCCCTTBCCEEEEECSSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCS
T ss_pred HHHHHHhhCCCCCEeeEEEEEeCCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCC
Confidence
Q ss_pred ----------------------------------------------CCCCccc-e-EEEec-------------CCCCCh
Q psy1684 106 ----------------------------------------------NLSGVVV-S-AVDFG-------------SGGMTN 124 (189)
Q Consensus 106 ----------------------------------------------~~~~~~~-s-VwsfG-------------~~~~~~ 124 (189)
..+.++. + ||||| |.+.+.
T Consensus 312 p~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~ 391 (454)
T 1qcf_A 312 AANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 391 (454)
T ss_dssp GGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred HHHEEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH
Confidence 2356888 9 99999 777888
Q ss_pred HHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcCCCCCCC
Q psy1684 125 AEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEGSDYKEA 186 (189)
Q Consensus 125 ~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~ 186 (189)
.++...+..+.+++.|..||+++++||.+||+.||++||||.+|++.|+.++++.+++|++.
T Consensus 392 ~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~~~~~~ 453 (454)
T 1qcf_A 392 PEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQYEEI 453 (454)
T ss_dssp HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCCSSBCC
T ss_pred HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhccccccccC
Confidence 89999999999999999999999999999999999999999999999999999999999875
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=99.95 E-value=4.9e-30 Score=193.02 Aligned_cols=163 Identities=19% Similarity=0.300 Sum_probs=126.7
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC-c---cCCCCCcCHhHHHHHhhh
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET-Q---KAGRTTIHYPELVEHYSK 79 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g-y---l~~~~~~~l~~li~~~~~ 79 (189)
..++|+|+++++|+|...+..+||+|++++ |++.-.+.. .... ...+ . ......+...+++.+..+
T Consensus 84 ~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~-G~L~~~L~~--~~~~-------~~~~~~~~~~~~~~~l~~~~~~~i~~q 153 (308)
T 4gt4_A 84 ARLQHPNVVCLLGVVTKDQPLSMIFSYCSH-GDLHEFLVM--RSPH-------SDVGSTDDDRTVKSALEPPDFVHLVAQ 153 (308)
T ss_dssp HHCCCTTBCCEEEEECSSSSCEEEEECCSS-CBHHHHHHT--TCSS-------CCCC-----CCEECCCCHHHHHHHHHH
T ss_pred HhCCCCCCCCcceEEEECCEEEEEEEcCCC-CcHHHHHHh--hCcc-------ccccccccccccccCCCHHHHHHHHHH
Confidence 468999999999999888889999999998 432111111 0000 0000 0 000123447788889999
Q ss_pred ccCCceeeccCCcccccc-cc---------------cccccC------------------------CCCCccc-e-EEEe
Q psy1684 80 DADGLCVNLRKPCVQVSC-RI---------------YLVHGT------------------------NLSGVVV-S-AVDF 117 (189)
Q Consensus 80 ~a~gl~~~~~~~~~~~~~-p~---------------~l~~~~------------------------~~~~~~~-s-Vwsf 117 (189)
++.|+.|+|+.+++|||+ |+ |+|+.. ..+.||. + ||||
T Consensus 154 ia~gl~yLH~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSf 233 (308)
T 4gt4_A 154 IAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSY 233 (308)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhH
Confidence 999999999999999996 44 444322 4577999 9 9999
Q ss_pred c-------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q psy1684 118 G-------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFF 176 (189)
Q Consensus 118 G-------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~ 176 (189)
| |.+.+..+++..+.+|.+++.|+.||+++++||.+||+.||++||||+||++.|+.+.
T Consensus 234 Gvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 234 GVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp HHHHHHHHTTTCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 9 7888899999999999999999999999999999999999999999999999997653
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.2e-27 Score=191.53 Aligned_cols=91 Identities=27% Similarity=0.342 Sum_probs=80.6
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC--ccCCCCCcC-HhHHHHHh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET--QKAGRTTIH-YPELVEHY 77 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g--yl~~~~~~~-l~~li~~~ 77 (189)
||||.|+|.+|+++|......+|+||||++ +.+|.|+||++. .+.++||+|.+..+| ++.....|. +.+||+||
T Consensus 163 wyhg~i~r~~ae~~L~~~~~~~G~FLvR~s-~~~~~~~lsv~~--~~~v~h~~I~~~~~g~~~~~~~~~F~sl~~Lv~~y 239 (613)
T 2ozo_A 163 WYHSSLTREEAERKLYSGAQTDGKFLLRPR-KEQGTYALSLIY--GKTVYHYLISQDKAGKYCIPEGTKFDTLWQLVEYL 239 (613)
T ss_dssp TBCTTCCHHHHHHHHSSSCCCTTCEEEEEC-SSTTEEEEEEEE--TTEEEEEEEEECTTCCEECTTSCEESSHHHHHHHH
T ss_pred ccccCCCHHHHHHHHhhcCCCCceEEEEec-CCCCCEEEEEEE--CCeEEEEEEEECCCCCEEECCCCCcCCHHHHHHHH
Confidence 999999999999999766668999999999 667999999999 999999999987777 677677898 99999999
Q ss_pred hhccCCceeeccCCccc
Q psy1684 78 SKDADGLCVNLRKPCVQ 94 (189)
Q Consensus 78 ~~~a~gl~~~~~~~~~~ 94 (189)
...++|+.+.+..+|..
T Consensus 240 ~~~~~~l~~~L~~pC~~ 256 (613)
T 2ozo_A 240 KLKADGLIYCLKEACPN 256 (613)
T ss_dssp HHCCTTCSSCCCSBCCC
T ss_pred hhCCCCceecccccccc
Confidence 99999998888777643
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-26 Score=188.39 Aligned_cols=91 Identities=31% Similarity=0.439 Sum_probs=82.5
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC--ccCCCCCcC-HhHHHHHh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET--QKAGRTTIH-YPELVEHY 77 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g--yl~~~~~~~-l~~li~~~ 77 (189)
||||.|+|.+|+++|......+|+||||++ +.+|.|+||++. .+.++||+|.+..+| ++.+...|. +.+||+||
T Consensus 168 Wy~g~isr~~ae~~L~~~~~~~G~FLvR~s-~~~g~y~lsv~~--~~~v~h~~i~~~~~g~~~~~~~~~F~sl~~Lv~~y 244 (635)
T 4fl3_A 168 WFHGKISREESEQIVLIGSKTNGKFLIRAR-DNNGSYALCLLH--EGKVLHYRIDKDKTGKLSIPEGKKFDTLWQLVEHY 244 (635)
T ss_dssp TBCCSCCHHHHHHHHHSSSCCTTCEEEEES-SSSSCEEEEEEE--TTEEEEEEEEECTTSCEESTTCCCBSSHHHHHHHH
T ss_pred ceeccCCHHHHHHHHHcCCCCCceEEEEec-CCCCCEEEEEEE--CCEEEEEEEEECCCCCEEeCCCCccCCHHHHHHHh
Confidence 999999999999999877777899999999 566999999999 999999999887777 777778899 99999999
Q ss_pred hhccCCceeeccCCccc
Q psy1684 78 SKDADGLCVNLRKPCVQ 94 (189)
Q Consensus 78 ~~~a~gl~~~~~~~~~~ 94 (189)
...++|+...+..||..
T Consensus 245 ~~~~~~l~~~L~~p~~~ 261 (635)
T 4fl3_A 245 SYKADGLLRVLTVPCQK 261 (635)
T ss_dssp TTCCTTSSSCCCSBCCC
T ss_pred hhCCCCCccccCccCcC
Confidence 99999999999888764
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2.1e-26 Score=183.85 Aligned_cols=173 Identities=29% Similarity=0.479 Sum_probs=141.2
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC--ccCCCCCcC-HhHHHHHh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET--QKAGRTTIH-YPELVEHY 77 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g--yl~~~~~~~-l~~li~~~ 77 (189)
||||.|+|..|+++|.. ..+|+||||++...+|.|+||++. .+.++||+|....+| |+.....|. +.+++.++
T Consensus 107 wyhg~i~r~~ae~ll~~--~~~G~fLvR~s~~~~~~~~lsv~~--~~~v~h~~I~~~~~g~~~~~~~~~F~sl~eLv~~~ 182 (495)
T 1opk_A 107 WYHGPVSRNAAEYLLSS--GINGSFLVRESESSPGQRSISLRY--EGRVYHYRINTASDGKLYVSSESRFNTLAELVHHH 182 (495)
T ss_dssp TEEEECCHHHHHHHGGG--CCTTEEEEEECSSSTTCEEEEEEE--TTEEEEEECEECTTSCEESSTTSCBSSHHHHHHHH
T ss_pred hhccCCCHHHHHHHhhC--CCCceEEEEeCCCCCCceEEEEee--CCeEEEEEEEecCCCceEeccCccchhHHHHhhhh
Confidence 99999999999999853 467999999999888999999999 999999999987777 777777888 99999999
Q ss_pred hhccCCceeeccCCcccccccc--------------------------------cccccC--------------------
Q psy1684 78 SKDADGLCVNLRKPCVQVSCRI--------------------------------YLVHGT-------------------- 105 (189)
Q Consensus 78 ~~~a~gl~~~~~~~~~~~~~p~--------------------------------~l~~~~-------------------- 105 (189)
...++|+...+..++.....|. +.+...
T Consensus 183 ~~~~~g~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~ 262 (495)
T 1opk_A 183 STVADGLITTLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE 262 (495)
T ss_dssp TTCCTTSSSCCCEECCCCSCCCCSSSCSSSSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHH
T ss_pred cccccccchhccccccccccccccccCccccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHH
Confidence 9888887765543332211110 000000
Q ss_pred --------------------------------------------------------------------------------
Q psy1684 106 -------------------------------------------------------------------------------- 105 (189)
Q Consensus 106 -------------------------------------------------------------------------------- 105 (189)
T Consensus 263 ~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHr 342 (495)
T 1opk_A 263 FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 342 (495)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred HHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence
Q ss_pred -------------------------------------------------CCCCccc-e-EEEec-------------CCC
Q psy1684 106 -------------------------------------------------NLSGVVV-S-AVDFG-------------SGG 121 (189)
Q Consensus 106 -------------------------------------------------~~~~~~~-s-VwsfG-------------~~~ 121 (189)
..+.|+. + ||||| |.+
T Consensus 343 Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~ 422 (495)
T 1opk_A 343 NLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 422 (495)
T ss_dssp CCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCChhhEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCC
Confidence 1245788 9 99999 677
Q ss_pred CChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q psy1684 122 MTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFT 177 (189)
Q Consensus 122 ~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~ 177 (189)
.+..++...+..+.+++.|..||+++++||.+||+.||++||||.+|++.|+.+++
T Consensus 423 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 423 IDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp CCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred CCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 77788888889999999999999999999999999999999999999999988765
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.93 E-value=8.7e-26 Score=178.33 Aligned_cols=174 Identities=34% Similarity=0.550 Sum_probs=140.6
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC-ccCCCCCcC-HhHHHHHhh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET-QKAGRTTIH-YPELVEHYS 78 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g-yl~~~~~~~-l~~li~~~~ 78 (189)
||||.|+|.+|+++|.. ..+|.||||++.+..|.|+|+++. .+.++|++|....++ ++.....|. +.+++.++.
T Consensus 82 wyhg~i~r~~ae~~L~~--~~~G~FlvR~S~~~~g~~~Lsv~~--~~~v~H~~I~~~~~~~~i~~~~~F~sl~eLv~~y~ 157 (450)
T 1k9a_A 82 WFHGKITREQAERLLYP--PETGLFLVRESTNYPGDYTLCVSC--EGKVEHYRIMYHASKLSIDEEVYFENLMQLVEHYT 157 (450)
T ss_dssp TBCTTCCHHHHHHHTCS--CCTTEEEEEECSSSTTSEEEEEEC--SSSEEEEEEEEETTEEESSSSSCBSSHHHHHHHHH
T ss_pred ccccCcCHHHhhhhhcc--CCCceEEEEecCCCCCceEEEEEe--CCeeeEEEEEecCCceEeccccccccHHHHHhhhc
Confidence 99999999999999943 356999999999988999999999 899999999776666 888777888 999999988
Q ss_pred hccCCceeeccCCccccccc--------------c-----------------cccccC----------------------
Q psy1684 79 KDADGLCVNLRKPCVQVSCR--------------I-----------------YLVHGT---------------------- 105 (189)
Q Consensus 79 ~~a~gl~~~~~~~~~~~~~p--------------~-----------------~l~~~~---------------------- 105 (189)
..++|++..+..++...... . +.+...
T Consensus 158 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~E~ 237 (450)
T 1k9a_A 158 TDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEA 237 (450)
T ss_dssp HCCTTSSSCCCEECCCTTCEEHHHHHHHTTCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCTTSHHHHHHH
T ss_pred ccccchhhhccccccccCcccchhhhcccccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCchHHHHHHHHH
Confidence 87777665444332211000 0 000000
Q ss_pred --------------------------------------------------------------------------------
Q psy1684 106 -------------------------------------------------------------------------------- 105 (189)
Q Consensus 106 -------------------------------------------------------------------------------- 105 (189)
T Consensus 238 ~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp 317 (450)
T 1k9a_A 238 SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAA 317 (450)
T ss_dssp HHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCG
T ss_pred HHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCH
Confidence
Q ss_pred -----------------------------------------CCCCccc-e-EEEec-------------CCCCChHHHHH
Q psy1684 106 -----------------------------------------NLSGVVV-S-AVDFG-------------SGGMTNAEVLH 129 (189)
Q Consensus 106 -----------------------------------------~~~~~~~-s-VwsfG-------------~~~~~~~~~~~ 129 (189)
....++. + ||||| |++.+..++..
T Consensus 318 ~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~ 397 (450)
T 1k9a_A 318 RNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP 397 (450)
T ss_dssp GGEEECTTSCEEECCCTTCEECC------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHH
T ss_pred hhEEECCCCCEEEeeCCCcccccccccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 2456889 9 99999 66777788888
Q ss_pred HHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q psy1684 130 QVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTM 178 (189)
Q Consensus 130 ~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~ 178 (189)
.+..|.+++.|..||+++++||.+||+.||++||||.+|++.|+.+.+.
T Consensus 398 ~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 398 RVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 9999999999999999999999999999999999999999999998864
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.9e-28 Score=184.74 Aligned_cols=169 Identities=18% Similarity=0.236 Sum_probs=123.3
Q ss_pred CCh-HHHHHHhcCCCCC-CCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 6 IKR-IEAEKKLLLPEND-HGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 6 l~~-~n~~~lL~~~~~~-~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
+.| +|++++++.|..+ ...+||+|++++ |++.-.++.. ......+..... -.....++..+++.+..+++.|
T Consensus 124 l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~-G~L~~~L~~~-~~~~~~~~~~~~----~~~~~~l~~~~~~~~~~qia~g 197 (353)
T 4ase_A 124 IGHHLNVVNLLGACTKPGGPLMVIVEFCKF-GNLSTYLRSK-RNEFVPYKVAPE----DLYKDFLTLEHLICYSFQVAKG 197 (353)
T ss_dssp HCCCTTBCCEEEEECCTTSCCEEEEECCTT-EEHHHHHHHT-GGGBCCC-----------CTTCBCHHHHHHHHHHHHHH
T ss_pred cCCCCcEEEEEEEEEecCCEEEEEEEcCCC-CCHHHHHHhc-ccccccccccch----hhccccCCHHHHHHHHHHHHHH
Confidence 444 8999999988654 457999999998 4221111110 000000000000 0012234578889999999999
Q ss_pred ceeeccCCcccccc-cc---------------cccccC------------------------CCCCccc-e-EEEec---
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YLVHGT------------------------NLSGVVV-S-AVDFG--- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l~~~~------------------------~~~~~~~-s-VwsfG--- 118 (189)
+.|+|..+++|||+ |+ |+|+.. ..+.||. + |||||
T Consensus 198 l~yLH~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l 277 (353)
T 4ase_A 198 MEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 277 (353)
T ss_dssp HHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HHhHhhCCeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHH
Confidence 99999999999996 44 555432 4567999 9 99999
Q ss_pred ----------CCCCC-hHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcC
Q psy1684 119 ----------SGGMT-NAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180 (189)
Q Consensus 119 ----------~~~~~-~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~~ 180 (189)
|++.+ ..++...+.+|.+++.|+.||+++++||.+||+.||++||||++|++.|+.++++..
T Consensus 278 ~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~ 350 (353)
T 4ase_A 278 WEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 350 (353)
T ss_dssp HHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhh
Confidence 66665 356667788999999999999999999999999999999999999999999998643
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=7e-25 Score=169.52 Aligned_cols=71 Identities=31% Similarity=0.651 Sum_probs=64.5
Q ss_pred CCccc-e-EEEec-------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q psy1684 108 SGVVV-S-AVDFG-------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKL 172 (189)
Q Consensus 108 ~~~~~-s-VwsfG-------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l 172 (189)
+.++. + ||||| |.+.+..++...+..+.+++.|..||+++++||.+||+.||++||||++|++.|
T Consensus 290 ~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L 369 (377)
T 3cbl_A 290 GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQEL 369 (377)
T ss_dssp CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 45788 9 99999 677788888888999999999999999999999999999999999999999999
Q ss_pred HHHHhh
Q psy1684 173 EDFFTM 178 (189)
Q Consensus 173 ~~~~~~ 178 (189)
+.+.+.
T Consensus 370 ~~i~~~ 375 (377)
T 3cbl_A 370 QSIRKR 375 (377)
T ss_dssp HHHHHH
T ss_pred HHHHhh
Confidence 988753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=6.6e-26 Score=170.17 Aligned_cols=152 Identities=16% Similarity=0.215 Sum_probs=117.8
Q ss_pred CCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC-CCCcCHhHHHHHhhhcc
Q psy1684 3 FGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG-RTTIHYPELVEHYSKDA 81 (189)
Q Consensus 3 ~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~-~~~~~l~~li~~~~~~a 81 (189)
+..++|+|++++++++. ++..+||+|+++++. +.. +|.. ...++..+++.+..+++
T Consensus 86 l~~l~HpNIV~l~g~~~-~~~~~iVmEy~~gGs-----L~~-----------------~l~~~~~~l~~~~~~~i~~qia 142 (307)
T 3omv_A 86 LRKTRHVNILLFMGYMT-KDNLAIVTQWCEGSS-----LYK-----------------HLHVQETKFQMFQLIDIARQTA 142 (307)
T ss_dssp HTTCCCTTBCCEEEEEC-SSSCEEEEECCSSCB-----HHH-----------------HHHTSCCCCCHHHHHHHHHHHH
T ss_pred HHhCCCCCEeeEEEEEE-CCeEEEEEEcCCCCC-----HHH-----------------HHhhcCCCCCHHHHHHHHHHHH
Confidence 45789999999999875 456899999999832 222 3322 23466788888999999
Q ss_pred CCceeeccCCcccccc-cc---------------cccc-----------------------cC----CCCCccc-e-EEE
Q psy1684 82 DGLCVNLRKPCVQVSC-RI---------------YLVH-----------------------GT----NLSGVVV-S-AVD 116 (189)
Q Consensus 82 ~gl~~~~~~~~~~~~~-p~---------------~l~~-----------------------~~----~~~~~~~-s-Vws 116 (189)
.|+.|+|..+++|||+ |+ |+|+ |. ..+.||. + |||
T Consensus 143 ~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS 222 (307)
T 3omv_A 143 QGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYS 222 (307)
T ss_dssp HHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHH
T ss_pred HHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHh
Confidence 9999999999999996 55 4443 22 2456999 9 999
Q ss_pred ec------------CCCCChH-HHHHHHHcCCCCC----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q psy1684 117 FG------------SGGMTNA-EVLHQVEHGYRMP----CPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFT 177 (189)
Q Consensus 117 fG------------~~~~~~~-~~~~~v~~g~~~~----~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~ 177 (189)
|| |.+.++. .+...+..+.+.| .|..||+++++||.+||+.||++||||++|++.|+.+..
T Consensus 223 ~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 223 YGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp HHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 99 7777654 4445556665543 456899999999999999999999999999999987654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=4.5e-24 Score=160.48 Aligned_cols=152 Identities=16% Similarity=0.149 Sum_probs=108.9
Q ss_pred CCCChHHHHHHhcCCCCCCC----cEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhh
Q psy1684 4 GKIKRIEAEKKLLLPENDHG----AFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSK 79 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g----~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~ 79 (189)
..++|+|++++++.+...++ .|||+|+++++. +.. ++. ...+.....+.+..+
T Consensus 52 ~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gs-----L~~-----------------~l~-~~~l~~~~~~~i~~~ 108 (303)
T 3hmm_A 52 VMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGS-----LFD-----------------YLN-RYTVTVEGMIKLALS 108 (303)
T ss_dssp TTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCB-----HHH-----------------HHH-HCCBCHHHHHHHHHH
T ss_pred hcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCc-----HHH-----------------HHH-hCCCCHHHHHHHHHH
Confidence 46889999999998765433 489999999732 222 222 123446677788888
Q ss_pred ccCCceeeccC--------Ccccccc-cc---------------ccc-------------------------ccCC----
Q psy1684 80 DADGLCVNLRK--------PCVQVSC-RI---------------YLV-------------------------HGTN---- 106 (189)
Q Consensus 80 ~a~gl~~~~~~--------~~~~~~~-p~---------------~l~-------------------------~~~~---- 106 (189)
++.|+.|+|.. +++|||+ |+ |+| ||..
T Consensus 109 ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~ 188 (303)
T 3hmm_A 109 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSI 188 (303)
T ss_dssp HHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCS
T ss_pred HHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccc
Confidence 99999999976 8999996 55 333 2221
Q ss_pred ---CCCccc-e-EEEec----------------------CCCC-----ChHHHHHHH-HcCCCCCCCCC-----CCHHHH
Q psy1684 107 ---LSGVVV-S-AVDFG----------------------SGGM-----TNAEVLHQV-EHGYRMPCPPG-----CPPRLY 148 (189)
Q Consensus 107 ---~~~~~~-s-VwsfG----------------------~~~~-----~~~~~~~~v-~~g~~~~~p~~-----~p~~~~ 148 (189)
...|+. + ||||| |.++ ...++...+ ..+.+|+.|.. ++..+.
T Consensus 189 ~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~ 268 (303)
T 3hmm_A 189 NMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMA 268 (303)
T ss_dssp CTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHH
T ss_pred cccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHH
Confidence 124788 9 99999 1111 234455555 45677777653 446889
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q psy1684 149 DIMLECWLKDPVKRPTFETLQWKLEDFFTM 178 (189)
Q Consensus 149 ~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~ 178 (189)
+||.+||+.||++||||++|++.|+++.+.
T Consensus 269 ~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 269 KIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 999999999999999999999999998774
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.1e-23 Score=159.65 Aligned_cols=155 Identities=8% Similarity=-0.058 Sum_probs=121.9
Q ss_pred CCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccC
Q psy1684 3 FGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDAD 82 (189)
Q Consensus 3 ~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~ 82 (189)
+..++|+|++++++.....+..|||+|+++++. +.. +|.....++..+...+..+++.
T Consensus 104 l~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~-----L~~-----------------~l~~~~~l~e~~~~~~~~qi~~ 161 (336)
T 4g3f_A 104 CAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS-----LGQ-----------------LIKQMGCLPEDRALYYLGQALE 161 (336)
T ss_dssp TTTCCCTTBCCEEEEEEETTEEEEEECCCTTCB-----HHH-----------------HHHHHSSCCHHHHHHHHHHHHH
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEeccCCCc-----HHH-----------------HHHHcCCCCHHHHHHHHHHHHH
Confidence 467899999999988777777899999998732 222 2332345666777788889999
Q ss_pred CceeeccCCcccccc-cc----------------cccc--------------------------cC-CCCCccc-e-EEE
Q psy1684 83 GLCVNLRKPCVQVSC-RI----------------YLVH--------------------------GT-NLSGVVV-S-AVD 116 (189)
Q Consensus 83 gl~~~~~~~~~~~~~-p~----------------~l~~--------------------------~~-~~~~~~~-s-Vws 116 (189)
|+.|+|...++|||+ |+ |+|+ |. .+..|+. + |||
T Consensus 162 aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwS 241 (336)
T 4g3f_A 162 GLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWS 241 (336)
T ss_dssp HHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHH
T ss_pred HHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHH
Confidence 999999999999996 66 3332 11 5567999 9 999
Q ss_pred ec------------CCCCChHHHHHHHHcCCCC--CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q psy1684 117 FG------------SGGMTNAEVLHQVEHGYRM--PCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTME 179 (189)
Q Consensus 117 fG------------~~~~~~~~~~~~v~~g~~~--~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~ 179 (189)
+| |.+.+..+++..+..+..+ ..|+.+|+++.+|+.+||+.||++|||+.||++.|..+++..
T Consensus 242 lGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~ 318 (336)
T 4g3f_A 242 SCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318 (336)
T ss_dssp HHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence 99 7776666777777665432 367899999999999999999999999999999999888753
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=1.4e-22 Score=154.33 Aligned_cols=145 Identities=9% Similarity=0.070 Sum_probs=116.5
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC--CCCcCHhHHHHHhhhcc
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG--RTTIHYPELVEHYSKDA 81 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~--~~~~~l~~li~~~~~~a 81 (189)
..++|+|++++++.....+..|||+|+++++. +.. +|.. ...+...+...+..+++
T Consensus 78 ~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~-----L~~-----------------~i~~~~~~~~~e~~~~~~~~qi~ 135 (350)
T 4b9d_A 78 ANMKHPNIVQYRESFEENGSLYIVMDYCEGGD-----LFK-----------------RINAQKGVLFQEDQILDWFVQIC 135 (350)
T ss_dssp HHCCCTTBCCEEEEEEETTEEEEEEECCTTCB-----HHH-----------------HHHHTTTCCCCHHHHHHHHHHHH
T ss_pred HHCCCCCCCcEEEEEEECCEEEEEEeCCCCCc-----HHH-----------------HHHHcCCCCCCHHHHHHHHHHHH
Confidence 35789999999887776677899999988732 222 2221 22344566777888999
Q ss_pred CCceeeccCCcccccc-cc---------------ccccc---------------------C-CCCCccc-e-EEEec---
Q psy1684 82 DGLCVNLRKPCVQVSC-RI---------------YLVHG---------------------T-NLSGVVV-S-AVDFG--- 118 (189)
Q Consensus 82 ~gl~~~~~~~~~~~~~-p~---------------~l~~~---------------------~-~~~~~~~-s-VwsfG--- 118 (189)
.|+.|+|..+|+|||+ |+ |+|+. . .+..|+. + |||+|
T Consensus 136 ~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvil 215 (350)
T 4b9d_A 136 LALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVL 215 (350)
T ss_dssp HHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred HHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHH
Confidence 9999999999999996 66 33332 2 5667999 9 99999
Q ss_pred ---------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 119 ---------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 119 ---------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
|.+.+..+++.++.++..++.|..+|+++.+||.+||+.||++|||++|+++
T Consensus 216 yemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 216 YELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 8888889999999888888888999999999999999999999999999976
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.82 E-value=1e-22 Score=151.74 Aligned_cols=145 Identities=10% Similarity=0.048 Sum_probs=108.5
Q ss_pred CCCChHHHHHHhcCCCC----CCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhh
Q psy1684 4 GKIKRIEAEKKLLLPEN----DHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSK 79 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~----~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~ 79 (189)
..++|+|++++++.+.. +...|||+|+++++. +.. ++.....++...+..+..+
T Consensus 80 ~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~-----L~~-----------------~l~~~~~l~~~~~~~~~~q 137 (290)
T 3fpq_A 80 KGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGT-----LKT-----------------YLKRFKVMKIKVLRSWCRQ 137 (290)
T ss_dssp HTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCB-----HHH-----------------HHHHHSSCCHHHHHHHHHH
T ss_pred HhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCC-----HHH-----------------HHHhcCCCCHHHHHHHHHH
Confidence 46789999998875422 233688889888732 222 3333345556777788889
Q ss_pred ccCCceeeccCC--cccccc-cc-----------------------------------cccccCCCCCccc-e-EEEec-
Q psy1684 80 DADGLCVNLRKP--CVQVSC-RI-----------------------------------YLVHGTNLSGVVV-S-AVDFG- 118 (189)
Q Consensus 80 ~a~gl~~~~~~~--~~~~~~-p~-----------------------------------~l~~~~~~~~~~~-s-VwsfG- 118 (189)
++.|+.|+|... ++|||+ |+ ++|||...+.|+. + |||||
T Consensus 138 i~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGv 217 (290)
T 3fpq_A 138 ILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGM 217 (290)
T ss_dssp HHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHH
T ss_pred HHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCCccCCcccCccccCHHHcCCCCCcHHHHHHHHH
Confidence 999999999987 999996 66 4444445667999 9 99999
Q ss_pred -----------CCCCC-hHHHHHHHHcCCCCC-CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 119 -----------SGGMT-NAEVLHQVEHGYRMP-CPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 119 -----------~~~~~-~~~~~~~v~~g~~~~-~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
|.+.+ ..++...+..+.+++ .|..+++++.+|+.+||+.||++|||++|+++
T Consensus 218 ilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 218 CMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 65544 456667777776553 46678999999999999999999999999875
|
| >3k2m_A Proto-oncogene tyrosine-protein kinase ABL1; engineered binding protein, antibody mimic, protein-protein SH2 domain, ATP-binding, phosphoprotein; 1.75A {Homo sapiens} PDB: 3uyo_A 3t04_A 1ab2_A | Back alignment and structure |
|---|
Probab=99.82 E-value=8.6e-20 Score=117.50 Aligned_cols=95 Identities=28% Similarity=0.331 Sum_probs=82.7
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC--ccCCCCCcC-HhHHHHHh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET--QKAGRTTIH-YPELVEHY 77 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g--yl~~~~~~~-l~~li~~~ 77 (189)
||||.|+|.+|+++|. ...+|+||||++.+.+|.|+||++. .+.++|++|....+| ++.+...|. +.+||+||
T Consensus 7 Wyhg~isR~~Ae~lL~--~~~~G~FLVR~S~~~~g~y~LSv~~--~~~v~H~~I~~~~~g~~~~~~~~~F~sl~~LV~~y 82 (112)
T 3k2m_A 7 WYHGPVSRNAAEYLLS--SGINGSFLVRESESSPGQRSISLRY--EGRVYHYRINTASDGKLYVSSESRFNTLAELVHHH 82 (112)
T ss_dssp TEEESCCHHHHHHHTT--TCCTTEEEEEECSSSTTCEEEEEEE--TTEEEEEEEEECTTSCEESSTTCCBSSHHHHHHHH
T ss_pred ceeeCCCHHHHHHHhc--cCCCceEEEEeCCCCCCCEEEEEEe--CCcEEEEEEEECCCCcEEECCCCeECCHHHHHHHH
Confidence 9999999999999985 3478999999999888999999999 999999999987777 677777898 99999999
Q ss_pred hhccCCceeeccCCcccccccc
Q psy1684 78 SKDADGLCVNLRKPCVQVSCRI 99 (189)
Q Consensus 78 ~~~a~gl~~~~~~~~~~~~~p~ 99 (189)
...++|+...+..||.....|.
T Consensus 83 ~~~~~~l~~~L~~P~~~~~~p~ 104 (112)
T 3k2m_A 83 STVADGLITTLHYPAPKRNKPT 104 (112)
T ss_dssp HHCCTTSSSCCCEECCCC----
T ss_pred hhCCCCCccCCCCCCCCCCCCC
Confidence 9999999999999987744443
|
| >1lkk_A Human P56 tyrosine kinase; complex (tyrosine kinase/peptide); HET: PTR; 1.00A {Homo sapiens} SCOP: d.93.1.1 PDB: 1lcj_A* 1bhf_A* 1bhh_A 1lkl_A* 1bhh_B 1fbz_A* 1ijr_A* 1cwd_L* 1cwe_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=2.5e-19 Score=114.11 Aligned_cols=93 Identities=41% Similarity=0.692 Sum_probs=81.7
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEec---CCCeeeEEEEEeccCC--ccCCCCCcC-HhHHH
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKR---SSFCLKMTTGRSLFET--QKAGRTTIH-YPELV 74 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~---~~~~v~h~~i~~~~~g--yl~~~~~~~-l~~li 74 (189)
||||.|+|.+|+++|......+|+||||++.+.+|.|+||++.. ..+.++||+|....+| ++.+...|. +.+||
T Consensus 6 Wyhg~isR~~Ae~lL~~~~~~~G~FLVR~S~~~~g~~~LSv~~~~~~~~~~v~H~~I~~~~~g~~~l~~~~~F~sl~~LI 85 (105)
T 1lkk_A 6 WFFKNLSRKDAERQLLAPGNTHGSFLIRESESTAGSFSLSVRDFDQNQGEVVKHYKIRNLDNGGFYISPRITFPGLHELV 85 (105)
T ss_dssp TBCTTCCHHHHHHHHTSTTCCTTCEEEEECSSSTTCEEEEEEEEETTTEEEEEEEEEEECTTSCEESSTTSCBSSHHHHH
T ss_pred eecCCCCHHHHHHHHHhcCCCCceEEEEECCCCCCcEEEEEEEcccCCCCcEEEEEEEECCCCCEEECCCceeCCHHHHH
Confidence 99999999999999976666899999999998889999999872 1368999999987666 777777898 99999
Q ss_pred HHhhhccCCceeeccCCcc
Q psy1684 75 EHYSKDADGLCVNLRKPCV 93 (189)
Q Consensus 75 ~~~~~~a~gl~~~~~~~~~ 93 (189)
+||....+|+.+.+..||.
T Consensus 86 ~~y~~~~~~l~~~L~~P~~ 104 (105)
T 1lkk_A 86 RHYTNASDGLCTRLSRPCQ 104 (105)
T ss_dssp HHHHHCCTTSSSCCCSBCC
T ss_pred HHHhhCCCCCccCCcCcCC
Confidence 9999999999999988875
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=6.3e-22 Score=148.31 Aligned_cols=145 Identities=12% Similarity=0.053 Sum_probs=115.1
Q ss_pred CCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccC
Q psy1684 3 FGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDAD 82 (189)
Q Consensus 3 ~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~ 82 (189)
+..++|+|++++++....++..|||+|++++ | ++.. ++.....++..+...+..+++.
T Consensus 80 l~~l~HpnIv~l~~~~~~~~~~~ivmEy~~g-g----~L~~-----------------~l~~~~~l~e~~~~~~~~qi~~ 137 (304)
T 3ubd_A 80 LVEVNHPFIVKLHYAFQTEGKLYLILDFLRG-G----DLFT-----------------RLSKEVMFTEEDVKFYLAELAL 137 (304)
T ss_dssp CCCCCCTTEECEEEEEEETTEEEEEECCCTT-C----EEHH-----------------HHHHHCCCCHHHHHHHHHHHHH
T ss_pred HHHCCCCCCCeEEEEEEECCEEEEEEEcCCC-C----CHHH-----------------HHHhcCCCCHHHHHHHHHHHHH
Confidence 4678899999999877777778999999987 4 2333 2333345566677778889999
Q ss_pred CceeeccCCcccccc-cc---------------ccccc---------------------C-CCCCccc-e-EEEec----
Q psy1684 83 GLCVNLRKPCVQVSC-RI---------------YLVHG---------------------T-NLSGVVV-S-AVDFG---- 118 (189)
Q Consensus 83 gl~~~~~~~~~~~~~-p~---------------~l~~~---------------------~-~~~~~~~-s-VwsfG---- 118 (189)
|+.|+|..+++|||+ |+ |+|+. . ....|+. + |||+|
T Consensus 138 aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvily 217 (304)
T 3ubd_A 138 ALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMF 217 (304)
T ss_dssp HHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHH
T ss_pred HHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHH
Confidence 999999999999996 66 34332 2 4567999 9 99999
Q ss_pred --------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q psy1684 119 --------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTF-----ETLQW 170 (189)
Q Consensus 119 --------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~-----~~i~~ 170 (189)
|.+.+..+++..+.++. ++.|..+|+++.+|+.+||+.||++|||+ +||++
T Consensus 218 emltG~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 218 EMLTGTLPFQGKDRKETMTMILKAK-LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred HHHhCCCCCCCcCHHHHHHHHHcCC-CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 88888889998887764 56788999999999999999999999984 56654
|
| >3us4_A Megakaryocyte-associated tyrosine-protein kinase; SH2 domain, signaling protein, structural genomics, joint CE structural genomics, JCSG; 1.50A {Homo sapiens} SCOP: d.93.1.1 PDB: 1jwo_A | Back alignment and structure |
|---|
Probab=99.81 E-value=2.4e-19 Score=112.68 Aligned_cols=89 Identities=28% Similarity=0.400 Sum_probs=80.5
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC-ccCCCCCcC-HhHHHHHhh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET-QKAGRTTIH-YPELVEHYS 78 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g-yl~~~~~~~-l~~li~~~~ 78 (189)
||||.|+|.+|+++|. ...+|+||||++.+.+|.|+||++. .+.++|++|....++ ++.+...|. +.+||+||.
T Consensus 7 Wyhg~isr~~Ae~lL~--~~~~G~FLVR~S~~~~g~y~LSv~~--~~~v~H~~I~~~~~~~~~~~~~~F~sl~~Lv~~y~ 82 (98)
T 3us4_A 7 WFHGKISGQEAVQQLQ--PPEDGLFLVRESARHPGDYVLCVSF--GRDVIHYRVLHRDGHLTIDEAVFFCNLMDMVEHYS 82 (98)
T ss_dssp TBCCSCCHHHHHHHTC--SCCTTCEEEEECSSSTTCEEEEEEE--TTEEEEEEEEEETTEEESSSSSEESSHHHHHHHHH
T ss_pred ccCCCCCHHHHHHHcc--CCCCcEEEEEeCCCCCCcEEEEEEE--CCceEEEEEEEeCCEEEECCCCccCCHHHHHHHhh
Confidence 9999999999999995 3478999999999888999999999 999999999986555 787777888 999999999
Q ss_pred hccCCceeeccCCcc
Q psy1684 79 KDADGLCVNLRKPCV 93 (189)
Q Consensus 79 ~~a~gl~~~~~~~~~ 93 (189)
...+|+...+..||.
T Consensus 83 ~~~~~l~~~L~~P~p 97 (98)
T 3us4_A 83 KDKGAICTKLVRPKR 97 (98)
T ss_dssp HCCTTSSSCCCSBCC
T ss_pred hCCCCCeEcCCccCC
Confidence 999999999998875
|
| >1rja_A Tyrosine-protein kinase 6; human protein tyrosine kinase-6 (PTK6/BRK), SRC homology 2(S domain, solution structure, backbone dynamics, transferase; NMR {Homo sapiens} SCOP: d.93.1.1 | Back alignment and structure |
|---|
Probab=99.81 E-value=1.5e-19 Score=114.05 Aligned_cols=92 Identities=30% Similarity=0.413 Sum_probs=82.7
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC--ccCCCCCcC-HhHHHHHh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET--QKAGRTTIH-YPELVEHY 77 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g--yl~~~~~~~-l~~li~~~ 77 (189)
||||.|+|.+|+++|......+|+||||++.+.+|.|+||++. .+.++|++|....+| ++.+...|. +.+||+||
T Consensus 4 Wyhg~isR~~Ae~lL~~~g~~~G~FLVR~S~~~~g~~~LSv~~--~~~v~H~~I~~~~~g~~~l~~~~~F~sl~~LV~~y 81 (100)
T 1rja_A 4 WFFGCISRSEAVRRLQAEGNATGAFLIRVSEKPSADYVLSVRD--TQAVRHYKIWRRAGGRLHLNEAVSFLSLPELVNYH 81 (100)
T ss_dssp CBCTTCCHHHHHHHHSSTTCSSCCEEEEECSSSSSCEEEEECT--TSSCEEEEEEECSSSCEEEETTEEESSHHHHHHHH
T ss_pred cccCCCCHHHHHHHHhccCCCCCEEEEEeCCCCCCCEEEEEEE--CCEEEEEEEEEcCCCcEEECCCCccCCHHHHHHHH
Confidence 9999999999999997655679999999999888999999999 999999999987667 677677888 99999999
Q ss_pred hhccCCceeeccCCccc
Q psy1684 78 SKDADGLCVNLRKPCVQ 94 (189)
Q Consensus 78 ~~~a~gl~~~~~~~~~~ 94 (189)
.....|+...+..||..
T Consensus 82 ~~~~~~l~~~L~~p~~~ 98 (100)
T 1rja_A 82 RAQSLSHGLRLAAPCRK 98 (100)
T ss_dssp HHCCTTSSSCCCSBCCC
T ss_pred hhCCCCCCCCCCccCCC
Confidence 99999998888888754
|
| >2dly_A FYN-related kinase; BRK family kinase, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=99.81 E-value=2.7e-19 Score=116.55 Aligned_cols=93 Identities=47% Similarity=0.771 Sum_probs=83.9
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC--ccCCCCCcC-HhHHHHHh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET--QKAGRTTIH-YPELVEHY 77 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g--yl~~~~~~~-l~~li~~~ 77 (189)
||||.|+|.+|+++|......+|+||||++.+.+|.|+||++. .+.++||+|....+| ++.+...|. +.+||+||
T Consensus 18 WyhG~isR~eAe~lL~~~~~~~G~FLVR~S~~~~g~y~LSv~~--~~~v~H~~I~~~~~g~~~l~~~~~F~sl~eLV~~y 95 (121)
T 2dly_A 18 WFFGAIKRADAEKQLLYSENQTGAFLIRESESQKGDFSLSVLD--EGVVKHYRIRRLDEGGFFLTRRKVFSTLNEFVNYY 95 (121)
T ss_dssp SBCSSCCHHHHHHHHTSSSCCTTCEEEEECSSSSSCEEEEEES--SSCEEEEEEEECSSSCEEEETTEEESSHHHHHHHH
T ss_pred ccccCCCHHHHHHHHhcCCCCCCEEEEEcCCCCCCceEEEEEE--CCeEEEEEEEEcCCCCEEECCCCccCCHHHHHHHH
Confidence 9999999999999997666688999999999888999999999 999999999986666 777777898 99999999
Q ss_pred hhccCCceeeccCCcccc
Q psy1684 78 SKDADGLCVNLRKPCVQV 95 (189)
Q Consensus 78 ~~~a~gl~~~~~~~~~~~ 95 (189)
....+|+...+..||...
T Consensus 96 ~~~~~~l~~~L~~P~~~~ 113 (121)
T 2dly_A 96 TTTSDGLCVKLEKPCLKI 113 (121)
T ss_dssp TTCCSSSSSCCCSBCCCC
T ss_pred hhCCCCCceeCCeecCCC
Confidence 999999999999998764
|
| >3eaz_A Tyrosine-protein kinase CSK; SH2, disulfide, oxidized reduced, ATP-binding, cell membrane, cytoplasm, membrane, nucleotide-binding, phosphoprotein; 1.31A {Homo sapiens} PDB: 3eac_A | Back alignment and structure |
|---|
Probab=99.79 E-value=5.6e-19 Score=112.58 Aligned_cols=91 Identities=34% Similarity=0.505 Sum_probs=81.2
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC-ccCCCCCcC-HhHHHHHhh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET-QKAGRTTIH-YPELVEHYS 78 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g-yl~~~~~~~-l~~li~~~~ 78 (189)
||||.|+|.+|+++|. ...+|+||||++.+.+|.|+||++. .+.++|++|....++ ++.+...|. +.+|++||.
T Consensus 10 Wyhg~isr~~Ae~lL~--~~~~G~FLVR~S~~~~g~~~LSv~~--~~~v~H~~I~~~~g~~~l~~~~~F~sl~~Lv~~y~ 85 (106)
T 3eaz_A 10 WFHGKITREQAERLLY--PPETGLFLVRESTNYPGDYTLCVSS--DGKVEHYRIMYHASKLSIDEEVYFENLMQLVEHYT 85 (106)
T ss_dssp TBCCSCCHHHHHHHTC--SCCTTEEEEEECTTSTTCEEEEEEE--TTEEEEEECEEETTEEESSSSSCBSSHHHHHHHHH
T ss_pred CcCCCCCHHHHHHHhC--CCCCCEEEEEECCCCCCcEEEEEEe--CCceEEEEEEecCCEEEECCCCccCCHHHHHHHHh
Confidence 9999999999999995 3478999999999888999999999 999999999876444 777677898 999999999
Q ss_pred hccCCceeeccCCcccc
Q psy1684 79 KDADGLCVNLRKPCVQV 95 (189)
Q Consensus 79 ~~a~gl~~~~~~~~~~~ 95 (189)
..++|+...+..||...
T Consensus 86 ~~~~gl~~~L~~P~~~~ 102 (106)
T 3eaz_A 86 SDADGLCTRLIKPKVME 102 (106)
T ss_dssp HCCTTSSSCCCEECCCC
T ss_pred hCCCCCCeecCCcCCCC
Confidence 99999999999998764
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=99.79 E-value=3.9e-21 Score=142.20 Aligned_cols=153 Identities=10% Similarity=0.116 Sum_probs=115.1
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.++|+|+++++.....++..|||+|++. |+ +.. ++.....++..+...+..+.+.|+
T Consensus 69 ~l~HpnIv~~~~~~~~~~~~~ivmEy~~--g~----L~~-----------------~l~~~~~l~e~~~~~~~~qi~~al 125 (275)
T 3hyh_A 69 LLRHPHIIKLYDVIKSKDEIIMVIEYAG--NE----LFD-----------------YIVQRDKMSEQEARRFFQQIISAV 125 (275)
T ss_dssp HCCCTTBCCEEEEEECSSEEEEEEECCC--EE----HHH-----------------HHHHSCSCCHHHHHHHHHHHHHHH
T ss_pred HCCCCCCCeEEEEEEECCEEEEEEeCCC--CC----HHH-----------------HHHHcCCCCHHHHHHHHHHHHHHH
Confidence 4678888888877666667788888763 31 112 333344566677778888999999
Q ss_pred eeeccCCcccccc-cc---------------ccc--------------------ccC-CCCCc-cc-e-EEEec------
Q psy1684 85 CVNLRKPCVQVSC-RI---------------YLV--------------------HGT-NLSGV-VV-S-AVDFG------ 118 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~---------------~l~--------------------~~~-~~~~~-~~-s-VwsfG------ 118 (189)
.|+|+.+++|||+ |+ |+| ||. .+..| +. + |||+|
T Consensus 126 ~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~l 205 (275)
T 3hyh_A 126 EYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVM 205 (275)
T ss_dssp HHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHH
T ss_pred HHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHH
Confidence 9999999999996 66 333 222 44555 57 8 99999
Q ss_pred ------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcCCCC
Q psy1684 119 ------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEGSDY 183 (189)
Q Consensus 119 ------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~~~~~ 183 (189)
|.+.+..++...+.++. ++.|..+++++.+|+.+|++.||++|||++|+++. .+++..-|+|
T Consensus 206 ltg~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h--pw~k~~~p~~ 273 (275)
T 3hyh_A 206 LCRRLPFDDESIPVLFKNISNGV-YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD--DWFKVDLPEY 273 (275)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHTC-CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC--HHHHTTCCGG
T ss_pred HHCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC--cccccCCChh
Confidence 77777888888887774 56788999999999999999999999999999873 4555555555
|
| >1d4t_A T cell signal transduction molecule SAP; SH2 domain, tyrosine kinase, signal transduction, peptide recognition, signaling protein; 1.10A {Homo sapiens} SCOP: d.93.1.1 PDB: 1d1z_A 1d4w_A* 1m27_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=6.7e-19 Score=111.81 Aligned_cols=90 Identities=26% Similarity=0.324 Sum_probs=78.6
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC--ccCC-----CCCcC-HhH
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET--QKAG-----RTTIH-YPE 72 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g--yl~~-----~~~~~-l~~ 72 (189)
||||.|+|.+|+++|.... .+|+||||++.+.+|.|+||++. .+.++|++|....+| ++.. ...|. +.+
T Consensus 6 Wyhg~isR~~Ae~lL~~~~-~~G~FLVR~S~~~~g~~~LSv~~--~~~v~H~~I~~~~~g~~~l~~~~g~~~~~F~sl~~ 82 (104)
T 1d4t_A 6 VYHGKISRETGEKLLLATG-LDGSYLLRDSESVPGVYCLCVLY--HGYIYTYRVSQTETGSWSAETAPGVHKRYFRKIKN 82 (104)
T ss_dssp TBCCSCCHHHHHHHHHHHC-CTTEEEEEECSSSTTCEEEEEEE--TTEEEEEEEEECTTSCEEECBCTTSCCCCBSSHHH
T ss_pred eEccCCCHHHHHHHHHhcC-CCCEEEEeeCCCCCCCEEEEEEE--CCeEEEEEEEECCCCeEEEeccCCCCCcccCCHHH
Confidence 9999999999999996433 67999999999888999999999 999999999987777 5552 56788 999
Q ss_pred HHHHhhhccCCceeeccCCcc
Q psy1684 73 LVEHYSKDADGLCVNLRKPCV 93 (189)
Q Consensus 73 li~~~~~~a~gl~~~~~~~~~ 93 (189)
||+||....+|+...+..||.
T Consensus 83 LV~~y~~~~~~l~~~L~~P~~ 103 (104)
T 1d4t_A 83 LISAFQKPDQGIVIPLQYPVE 103 (104)
T ss_dssp HHHHHTSSSSSSSSCCCEECC
T ss_pred HHHHHhhCCCCCeEECCCcCC
Confidence 999999999999888887764
|
| >1blj_A P55 BLK protein tyrosine kinase; signal transduction, transferase, phosphotransferase, phosphorylation; NMR {Mus musculus} SCOP: d.93.1.1 PDB: 1blk_A | Back alignment and structure |
|---|
Probab=99.78 E-value=6.1e-19 Score=113.91 Aligned_cols=94 Identities=45% Similarity=0.684 Sum_probs=82.5
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEec--CCCeeeEEEEEeccCC--ccCCCCCcC-HhHHHH
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKR--SSFCLKMTTGRSLFET--QKAGRTTIH-YPELVE 75 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~--~~~~v~h~~i~~~~~g--yl~~~~~~~-l~~li~ 75 (189)
||||.|+|.+|+++|......+|+||||++.+.+|.|+||++.. ..+.++|++|....+| ++.+...|. +.+||+
T Consensus 14 Wyhg~isR~~Ae~lL~~~g~~~G~FLVR~S~~~~g~y~LSv~~~~~~~~~v~H~~I~~~~~g~~~l~~~~~F~sl~~LV~ 93 (114)
T 1blj_A 14 WFFRTISRKDAERQLLAPMNKAGSFLIRESESNKGAFSLSVKDITTQGEVVKHYKIRSLDNGGYYISPRITFPTLQALVQ 93 (114)
T ss_dssp SBCCSCCHHHHHHHHSSTTCCTTCEEBCBCTTCSSCEEEEECBCCTTTCBCCCEEEEEETTTEEEEETTEEESSHHHHHH
T ss_pred ccCCCCCHHHHHHHHhhCCCCCceEEEEeCCCCCCCEEEEEEEecCCCCcEEEEEEEEcCCCCEEECCCcccCCHHHHHH
Confidence 99999999999999976666899999999998889999999972 1368999999987666 777777888 999999
Q ss_pred HhhhccCCceeeccCCccc
Q psy1684 76 HYSKDADGLCVNLRKPCVQ 94 (189)
Q Consensus 76 ~~~~~a~gl~~~~~~~~~~ 94 (189)
||...++|+.+.+..||..
T Consensus 94 ~y~~~~~~l~~~L~~p~~~ 112 (114)
T 1blj_A 94 HYSKKGDGLCQKLTLPCVN 112 (114)
T ss_dssp HHHHCCSSSSSCCCCCSCC
T ss_pred HhhhCCCCCceecCccCCC
Confidence 9999999999999998864
|
| >1nrv_A Growth factor receptor-bound protein 10; dimer, signaling protein; 1.65A {Homo sapiens} SCOP: d.93.1.1 PDB: 3m7f_A | Back alignment and structure |
|---|
Probab=99.78 E-value=1.3e-18 Score=110.68 Aligned_cols=91 Identities=23% Similarity=0.351 Sum_probs=78.0
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEecc-CC---c-cCC-CCCcC-HhHH
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLF-ET---Q-KAG-RTTIH-YPEL 73 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~-~g---y-l~~-~~~~~-l~~l 73 (189)
||||.|+|.+|+++|......+|+||||++.+.+|.|+||++. .+.++|++|.... +| | +.+ ...|. +.+|
T Consensus 7 Wyhg~isR~~Ae~lL~~~g~~~G~FLVR~S~~~~g~~~LSv~~--~~~v~H~~I~~~~~~g~~~~~~~~~~~~F~sl~~L 84 (105)
T 1nrv_A 7 WFHGRISREESHRIIKQQGLVDGLFLLRDSQSNPKAFVLTLCH--HQKIKNFQILPCEDDGQTFFSLDDGNTKFSDLIQL 84 (105)
T ss_dssp TBCTTCCHHHHHHHHHHTTCCTTEEEEEECSSCTTCEEEEEEE--TTEEEEEEEEEC-----CCEESSTTSSCBSSHHHH
T ss_pred ccCCCCCHHHHHHHHHhcCCCCceEEEEeCCCCCCCEEEEEEe--CCEEEEEEEEEEcCCCCEEEEEcCCCcccCCHHHH
Confidence 9999999999999997666678999999999888999999999 9999999998754 44 4 443 46788 9999
Q ss_pred HHHhhhccCCceeeccCCcc
Q psy1684 74 VEHYSKDADGLCVNLRKPCV 93 (189)
Q Consensus 74 i~~~~~~a~gl~~~~~~~~~ 93 (189)
|++|....+|+.+.+..||.
T Consensus 85 V~~y~~~~~~l~~~L~~p~~ 104 (105)
T 1nrv_A 85 VDFYQLNKGVLPCKLKHHCI 104 (105)
T ss_dssp HHHHTTCCTTSSSCCCEECC
T ss_pred HHHhhhCCCCCcEeCCCcCC
Confidence 99999999999888888875
|
| >2ecd_A Tyrosine-protein kinase ABL2; SH2 domain, phosphotyrosine binding domain, protein tyrosine kinase, signal transduction, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=4.7e-19 Score=115.03 Aligned_cols=94 Identities=29% Similarity=0.343 Sum_probs=83.5
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC--ccCCCCCcC-HhHHHHHh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET--QKAGRTTIH-YPELVEHY 77 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g--yl~~~~~~~-l~~li~~~ 77 (189)
||||.|+|.+|+++|. ...+|+||||++...+|.|+||++. .+.++||+|....+| |+.....|. +.+||+||
T Consensus 18 WyhG~isR~~Ae~lL~--~~~~G~FLVR~S~~~~g~y~LSv~~--~~~v~H~~I~~~~~g~~~l~~~~~F~sl~~LV~~y 93 (119)
T 2ecd_A 18 WYHGPVSRSAAEYLLS--SLINGSFLVRESESSPGQLSISLRY--EGRVYHYRINTTADGKVYVTAESRFSTLAELVHHH 93 (119)
T ss_dssp SEEEECCHHHHHHHHH--TSCTTBEEEEEESSSTTEEEEEEEC--SSCEEEECCCCCSSSCCCCCSSCCCSSHHHHHHHH
T ss_pred cccCCCCHHHHHHHhc--CCCCCeEEEEeCCCCCCCEEEEEEE--CCeEEEEEEEEcCCCCEEEcCCCcCCCHHHHHHHH
Confidence 9999999999999995 3468999999999888999999999 999999999987777 676677888 99999999
Q ss_pred hhccCCceeeccCCccccccc
Q psy1684 78 SKDADGLCVNLRKPCVQVSCR 98 (189)
Q Consensus 78 ~~~a~gl~~~~~~~~~~~~~p 98 (189)
...++|+...+..||.....|
T Consensus 94 ~~~~~gl~~~L~~P~~~~~~p 114 (119)
T 2ecd_A 94 STVADGLVTTLHYPAPKCNKS 114 (119)
T ss_dssp HHCCTTSSSCCCBCCSSCCSS
T ss_pred hhCCCCCceECCCccCCCCCC
Confidence 999999999999998775444
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.78 E-value=1.2e-20 Score=145.41 Aligned_cols=167 Identities=21% Similarity=0.267 Sum_probs=122.5
Q ss_pred ChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEec-CCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCce
Q psy1684 7 KRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKR-SSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGLC 85 (189)
Q Consensus 7 ~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~-~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl~ 85 (189)
.|+|++++++.+......|||+|++.+ |.+.-.+... ..+....+.+.. .....+...+++.+..+++.|+.
T Consensus 145 ~hpnIv~~~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~i~~qi~~aL~ 217 (370)
T 2psq_A 145 KHKNIINLLGACTQDGPLYVIVEYASK-GNLREYLRARRPPGMEYSYDINR------VPEEQMTFKDLVSCTYQLARGME 217 (370)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTT-CBHHHHHHHTCCC-----------------CCCCCCHHHHHHHHHHHHHHHH
T ss_pred CCCCEeeEEEEEccCCCEEEEEEcCCC-CCHHHHHHhhCCccccccccccc------cccccCCHHHHHHHHHHHHHHHH
Confidence 799999999988877889999999887 4221111110 000000011100 01223457778888889999999
Q ss_pred eeccCCcccccc-cc---------------cccccC------------------------CCCCccc-e-EEEec-----
Q psy1684 86 VNLRKPCVQVSC-RI---------------YLVHGT------------------------NLSGVVV-S-AVDFG----- 118 (189)
Q Consensus 86 ~~~~~~~~~~~~-p~---------------~l~~~~------------------------~~~~~~~-s-VwsfG----- 118 (189)
++|..+++|+|+ |+ |+++.. ....|+. + |||||
T Consensus 218 ~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~e 297 (370)
T 2psq_A 218 YLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE 297 (370)
T ss_dssp HHHHTTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHH
T ss_pred HHHhCCeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHH
Confidence 999999999996 55 322211 2455888 9 99999
Q ss_pred --------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcC
Q psy1684 119 --------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180 (189)
Q Consensus 119 --------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~~ 180 (189)
|.+.+..++...+..+.+++.|..+|.++.+||.+||+.||++|||+.+|++.|+.+++...
T Consensus 298 llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~ 367 (370)
T 2psq_A 298 IFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 367 (370)
T ss_dssp HHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 66777788888888999999999999999999999999999999999999999999987654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=5.7e-21 Score=145.29 Aligned_cols=144 Identities=8% Similarity=-0.034 Sum_probs=112.7
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..++|+|++++++.....+..|||+|++++ |+ +.. ++. ...+...+...+..+++.|
T Consensus 126 ~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g-g~----L~~-----------------~l~-~~~l~e~~~~~~~~qi~~a 182 (346)
T 4fih_A 126 RDYQHENVVEMYNSYLVGDELWVVMEFLEG-GA----LTD-----------------IVT-HTRMNEEQIAAVCLAVLQA 182 (346)
T ss_dssp HHCCCTTBCCEEEEEEETTEEEEEECCCTT-EE----HHH-----------------HHH-HSCCCHHHHHHHHHHHHHH
T ss_pred HhCCCCCCCcEEEEEEECCEEEEEEeCCCC-Cc----HHH-----------------HHH-cCCCCHHHHHHHHHHHHHH
Confidence 357899999999887777788999999987 42 212 121 2235566677788899999
Q ss_pred ceeeccCCcccccc-cc---------------cccc---------------------cC-CCCCccc-e-EEEec-----
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YLVH---------------------GT-NLSGVVV-S-AVDFG----- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l~~---------------------~~-~~~~~~~-s-VwsfG----- 118 (189)
+.|+|..+|+|||+ |+ |+|+ |. ....|+. + |||+|
T Consensus 183 L~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilye 262 (346)
T 4fih_A 183 LSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIE 262 (346)
T ss_dssp HHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHH
T ss_pred HHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHH
Confidence 99999999999996 66 3332 22 5567999 9 99999
Q ss_pred -------CCCCChHHHHHHHHcCCCC--CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 119 -------SGGMTNAEVLHQVEHGYRM--PCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 119 -------~~~~~~~~~~~~v~~g~~~--~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
|.+.+..+++..+..+..+ +.+..+++++.+|+.+||..||++|||++|+++
T Consensus 263 ml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 263 MVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp HHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 7888888888888776543 334578999999999999999999999999876
|
| >3pqz_A Growth factor receptor-bound protein 7; SH2, binds phosphotyrosine, tyrosine kinases, cytoplasmic, P binding; 2.41A {Homo sapiens} PDB: 1mw4_A* 2l4k_A* 2qms_A | Back alignment and structure |
|---|
Probab=99.78 E-value=1.3e-18 Score=112.92 Aligned_cols=92 Identities=25% Similarity=0.297 Sum_probs=79.5
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEec-cCC--ccC---CCCCcC-HhHH
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSL-FET--QKA---GRTTIH-YPEL 73 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~-~~g--yl~---~~~~~~-l~~l 73 (189)
||||.|+|.+|+++|......+|+||||++.+.+|.|+||++. .+.++|++|... .+| |+. +...|. +.+|
T Consensus 16 Wyhg~isR~~Ae~lL~~~g~~~G~FLVR~S~~~~g~y~LSv~~--~~~v~H~~I~~~~~~g~~~~~~~~~~~~F~sl~~L 93 (117)
T 3pqz_A 16 WFHGRISREESQRLIGQQGLVDGLFLVRESQRNPQGFVLSLCH--LQKVKHYLILPSEEEGRLYFSMDDGQTRFTDLLQL 93 (117)
T ss_dssp TBCCSCCHHHHHHHHHHTTCCTTEEEEEECCC-CCCEEEEEEE--TTEEEEEEEEEECCTTCCEEESSTTSSCBSSHHHH
T ss_pred cccCCCCHHHHHHHHhcCCCCCCEEEEEecCCCCCcEEEEEEe--CCeeEEEEEEEecCCCCEEEEECCCCcccCCHHHH
Confidence 9999999999999997666678999999999988999999999 999999999985 455 333 246788 9999
Q ss_pred HHHhhhccCCceeeccCCccc
Q psy1684 74 VEHYSKDADGLCVNLRKPCVQ 94 (189)
Q Consensus 74 i~~~~~~a~gl~~~~~~~~~~ 94 (189)
|+||....+|+.+.+..||..
T Consensus 94 V~~y~~~~~~l~~~L~~P~~~ 114 (117)
T 3pqz_A 94 VEFHQLNRGILPCLLRHCCTR 114 (117)
T ss_dssp HHHHHHCCTTSSSCCCEECC-
T ss_pred HHHHhhCCCCCcEECCCcCcc
Confidence 999999999999999988865
|
| >1i3z_A EWS/FLI1 activated transcript 2; SH2 domain phosphotyrosine signal transduction lymphocyte, signaling protein; HET: PTR; 2.15A {Mus musculus} SCOP: d.93.1.1 | Back alignment and structure |
|---|
Probab=99.78 E-value=9.4e-19 Score=110.98 Aligned_cols=90 Identities=31% Similarity=0.340 Sum_probs=78.6
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC--ccCC-----CCCcC-HhH
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET--QKAG-----RTTIH-YPE 72 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g--yl~~-----~~~~~-l~~ 72 (189)
||||.|++.+|+++|.... .+|+||||++.+.+|.|+||++. .+.++|++|....+| ++.. ...|. +.+
T Consensus 5 Wyhg~isR~~Ae~lL~~~~-~~G~FLVR~S~~~~g~~~LSv~~--~~~v~H~~I~~~~~g~~~l~~~~g~~~~~F~sl~~ 81 (103)
T 1i3z_A 5 YYHGCLTKRECEALLLKGG-VDGNFLIRDSESVPGALCLCVSF--KKLVYSYRIFREKHGYYRIETDAHTPRTIFPNLQE 81 (103)
T ss_dssp TEESSCCHHHHHHHHHTTC-STTEEEEEECSSSTTCEEEEEEC--SSSEEEEEEEECTTSCEEECBCTTSCCCEESSSHH
T ss_pred cccCCCCHHHHHHHHhhcC-CCceEEEEeCCCCCCCEEEEEEE--CCEEEEEEEEECCCCeEEEeccCCCCCcccCCHHH
Confidence 9999999999999996533 68999999999888999999999 999999999987777 5652 56788 999
Q ss_pred HHHHhhhccCCceeeccCCcc
Q psy1684 73 LVEHYSKDADGLCVNLRKPCV 93 (189)
Q Consensus 73 li~~~~~~a~gl~~~~~~~~~ 93 (189)
||+||....+|+...+..||.
T Consensus 82 LV~~y~~~~~~l~~~L~~P~~ 102 (103)
T 1i3z_A 82 LVSKYGKPGQGLVVHLSNPIM 102 (103)
T ss_dssp HHHHTTSSSSSSSSCCCEECC
T ss_pred HHHHHhhCCCCCeEEcCCccC
Confidence 999999999999888887764
|
| >1aot_F FYN protein-tyrosine kinase; SH2 domain, signal transduction, peptide complex, complex (proto-oncogene/early protein); HET: PTR; NMR {Homo sapiens} SCOP: d.93.1.1 PDB: 1aou_F* | Back alignment and structure |
|---|
Probab=99.77 E-value=2.6e-19 Score=114.18 Aligned_cols=93 Identities=40% Similarity=0.559 Sum_probs=81.6
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEec---CCCeeeEEEEEeccCC--ccCCCCCcC-HhHHH
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKR---SSFCLKMTTGRSLFET--QKAGRTTIH-YPELV 74 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~---~~~~v~h~~i~~~~~g--yl~~~~~~~-l~~li 74 (189)
||||.|+|.+|+++|......+|+||||++.+.+|.|+||++.. ..+.++|++|....+| ++.+...|. +.+||
T Consensus 7 Wyhg~isR~~Ae~lL~~~g~~~G~FLVR~S~~~~g~~~LSv~~~~~~~~~~v~H~~I~~~~~g~~~l~~~~~F~sl~~LV 86 (106)
T 1aot_F 7 WYFGKLGRKDAERQLLSFGNPRGTFLIRESETTKGAYSLSIRDWDDMKGDHVKHYKIRKLDNGGYYITTRAQFETLQQLV 86 (106)
T ss_dssp SCCBSCCHHHHHHHHHTTTCCTTEECCBCBSSSSSBBCCEEECCBTTTBCCEEECCBEEETTTEEEEETTEEESSHHHHH
T ss_pred cCCCCCCHHHHHHHHhhCCCCCcEEEEEeCCCCCCCEEEEEEecccCCCCcEEEEEEEEeCCCCEEECCCCccCCHHHHH
Confidence 99999999999999976666889999999998889999999852 1568999999987666 777777898 99999
Q ss_pred HHhhhccCCceeeccCCcc
Q psy1684 75 EHYSKDADGLCVNLRKPCV 93 (189)
Q Consensus 75 ~~~~~~a~gl~~~~~~~~~ 93 (189)
+||....+|+.+.+..||.
T Consensus 87 ~~y~~~~~~l~~~L~~p~~ 105 (106)
T 1aot_F 87 QHYSERAAGLSSRLVVPSH 105 (106)
T ss_dssp HHHTTCCTTSSSCSCSSCC
T ss_pred HHhccCCCCCcEeecccCC
Confidence 9999999999999998875
|
| >3s9k_A Tyrosine-protein kinase ITK/TSK; proline isomerization, CIS proline, domain swapped dimer, SH transferase; HET: CIT; 2.35A {Mus musculus} PDB: 2etz_A* 2eu0_A* 1lui_A 1luk_A 1lum_A 1lun_A 2k79_B 2k7a_B | Back alignment and structure |
|---|
Probab=99.77 E-value=1.8e-18 Score=112.44 Aligned_cols=90 Identities=30% Similarity=0.449 Sum_probs=78.4
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCC------CeeeEEEEE--eccCC--ccCCCCCcC-
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSS------FCLKMTTGR--SLFET--QKAGRTTIH- 69 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~------~~v~h~~i~--~~~~g--yl~~~~~~~- 69 (189)
||||.|+|.+|+++|.... .+|+||||++ +.++.|+||++. . +.++||+|. ...+| ++.+...|.
T Consensus 11 Wyhg~isR~~Ae~lL~~~~-~~G~FLVR~S-~~~g~y~LSv~~--~~~~~~~~~v~H~~I~~~~~~~g~~~~~~~~~F~s 86 (118)
T 3s9k_A 11 WYNKSISRDKAEKLLLDTG-KEGAFMVRDS-RTPGTYTVSVFT--KAIISENPCIKHYHIKETNDSPKRYYVAEKYVFDS 86 (118)
T ss_dssp TBCTTCCHHHHHHHHHHHC-CTTCEEEEEC-SSTTCEEEEEEE--CCSCSSSCEEEEEEEEECSCSSCCEEEECSCCCSC
T ss_pred eecCCCCHHHHHHHHHhcC-CCCeEEEEee-CCCCCEEEEEEe--cccccCCCceEEEEEeEEECCCCCEEECCCcccCC
Confidence 9999999999999996432 5899999999 778999999998 5 899999994 45566 777777888
Q ss_pred HhHHHHHhhhccCCceeeccCCccc
Q psy1684 70 YPELVEHYSKDADGLCVNLRKPCVQ 94 (189)
Q Consensus 70 l~~li~~~~~~a~gl~~~~~~~~~~ 94 (189)
+.+||+||...++|+.+.+..||..
T Consensus 87 l~~LV~~y~~~~~~l~~~L~~Pv~~ 111 (118)
T 3s9k_A 87 IPLLIQYHQYNGGGLVTRLRYPVCG 111 (118)
T ss_dssp HHHHHHHHHHCCTTSSSCCCCCCCC
T ss_pred HHHHHHHheeCCCCCccCCCCcCCC
Confidence 9999999999999999999988864
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.77 E-value=1.6e-20 Score=144.99 Aligned_cols=153 Identities=22% Similarity=0.318 Sum_probs=120.4
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCC-CCcCHhHHHHHhhhccC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGR-TTIHYPELVEHYSKDAD 82 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~-~~~~l~~li~~~~~~a~ 82 (189)
..++|+|++++++.+......+||+|++.++. +.. ++... ..+...++..+..+++.
T Consensus 101 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s-----L~~-----------------~l~~~~~~~~~~~~~~i~~qi~~ 158 (373)
T 2qol_A 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGS-----LDS-----------------FLRKHDAQFTVIQLVGMLRGIAS 158 (373)
T ss_dssp TTCCCTTBCCEEEEECSSSSCEEEEECCTTCB-----HHH-----------------HHHTTTTCSCHHHHHHHHHHHHH
T ss_pred HhCCCCCCCeEEEEEeeCCceEEEEeCCCCCc-----HHH-----------------HHHhCCCCCCHHHHHHHHHHHHH
Confidence 56789999999988877777899999887632 222 23222 24557778888889999
Q ss_pred CceeeccCCcccccc-cc---------------cccccC-------------------------CCCCccc-e-EEEec-
Q psy1684 83 GLCVNLRKPCVQVSC-RI---------------YLVHGT-------------------------NLSGVVV-S-AVDFG- 118 (189)
Q Consensus 83 gl~~~~~~~~~~~~~-p~---------------~l~~~~-------------------------~~~~~~~-s-VwsfG- 118 (189)
|+.++|..+++|+|+ |+ |+++.. ....++. + |||||
T Consensus 159 aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~ 238 (373)
T 2qol_A 159 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGI 238 (373)
T ss_dssp HHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHH
T ss_pred HHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHH
Confidence 999999999999996 54 222111 2345788 9 99999
Q ss_pred ------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q psy1684 119 ------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTM 178 (189)
Q Consensus 119 ------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~ 178 (189)
|.+.+..++...+..+.+++.|..+|.++.+||.+||+.||++||+|.+|++.|+.+++.
T Consensus 239 il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 239 VLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp HHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 566677888888888888888999999999999999999999999999999999999864
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.76 E-value=4.7e-20 Score=142.34 Aligned_cols=155 Identities=17% Similarity=0.235 Sum_probs=117.1
Q ss_pred CCCCChHHHHHHhcCCCC-CCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCC-CCcCHhHHHHHhhhc
Q psy1684 3 FGKIKRIEAEKKLLLPEN-DHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGR-TTIHYPELVEHYSKD 80 (189)
Q Consensus 3 ~g~l~~~n~~~lL~~~~~-~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~-~~~~l~~li~~~~~~ 80 (189)
+..++|+|++++++.+.. ....++|+|++..+. +.. ++... ..+...++..+..++
T Consensus 144 l~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~-----L~~-----------------~l~~~~~~~~~~~~~~i~~qi 201 (373)
T 3c1x_A 144 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGD-----LRN-----------------FIRNETHNPTVKDLIGFGLQV 201 (373)
T ss_dssp STTCCCTTBCCCCEEECCCSSCCEEEEECCTTCB-----HHH-----------------HHHCTTCCCBHHHHHHHHHHH
T ss_pred HHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCC-----HHH-----------------HHhhcccCCCHHHHHHHHHHH
Confidence 457789999998886543 345688888887622 222 23222 223467778888899
Q ss_pred cCCceeeccCCcccccc-cc---------------cccccC--------------------------CCCCccc-e-EEE
Q psy1684 81 ADGLCVNLRKPCVQVSC-RI---------------YLVHGT--------------------------NLSGVVV-S-AVD 116 (189)
Q Consensus 81 a~gl~~~~~~~~~~~~~-p~---------------~l~~~~--------------------------~~~~~~~-s-Vws 116 (189)
+.|+.++|..+++|+|+ |+ |+++.. ....++. + |||
T Consensus 202 ~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS 281 (373)
T 3c1x_A 202 AKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWS 281 (373)
T ss_dssp HHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHH
T ss_pred HHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHH
Confidence 99999999999999996 55 332211 2356788 9 999
Q ss_pred ec-------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q psy1684 117 FG-------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTME 179 (189)
Q Consensus 117 fG-------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~ 179 (189)
|| |.+.+..++...+..+.++..|..+|.++.+||.+||+.||++|||+++|++.|+.++.+.
T Consensus 282 lG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~ 357 (373)
T 3c1x_A 282 FGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357 (373)
T ss_dssp HHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred HHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 99 5555666677778888888889999999999999999999999999999999999998764
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.76 E-value=3.2e-20 Score=140.73 Aligned_cols=155 Identities=23% Similarity=0.312 Sum_probs=120.8
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC-CCCcCHhHHHHHhhhccC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG-RTTIHYPELVEHYSKDAD 82 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~-~~~~~l~~li~~~~~~a~ 82 (189)
..++|+|++++++.+......+||+|++.++. +.. ++.. ...+...++..+..+.+.
T Consensus 105 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~-----L~~-----------------~l~~~~~~~~~~~~~~i~~qi~~ 162 (325)
T 3kul_A 105 GQFDHPNIIRLEGVVTRGRLAMIVTEYMENGS-----LDT-----------------FLRTHDGQFTIMQLVGMLRGVGA 162 (325)
T ss_dssp TTCCCTTBCCEEEEECGGGCCEEEEECCTTCB-----HHH-----------------HHHTTTTCSCHHHHHHHHHHHHH
T ss_pred HhCCCCCCCcEEEEEEeCCccEEEeeCCCCCc-----HHH-----------------HHHhcccCCCHHHHHHHHHHHHH
Confidence 45678888888887766667788888877622 111 2221 234557777888888999
Q ss_pred CceeeccCCcccccc-cc---------------cccccC-------------------------CCCCccc-e-EEEec-
Q psy1684 83 GLCVNLRKPCVQVSC-RI---------------YLVHGT-------------------------NLSGVVV-S-AVDFG- 118 (189)
Q Consensus 83 gl~~~~~~~~~~~~~-p~---------------~l~~~~-------------------------~~~~~~~-s-VwsfG- 118 (189)
|+.++|..+++|+|+ |+ |++... ....++. + |||||
T Consensus 163 ~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~ 242 (325)
T 3kul_A 163 GMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGV 242 (325)
T ss_dssp HHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHH
T ss_pred HHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHH
Confidence 999999999999996 55 222111 1245788 9 99999
Q ss_pred ------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcC
Q psy1684 119 ------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180 (189)
Q Consensus 119 ------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~~ 180 (189)
|.+.+..++...+..+.+++.|..+|+++.+||.+||+.||++|||+.+|++.|+.+++..+
T Consensus 243 il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 243 VMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp HHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred HHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 56677888888899998999999999999999999999999999999999999999988643
|
| >3maz_A Signal-transducing adaptor protein 1; modular domain, phosphotyrosine, specificity, cytoplasm, phosphoprotein, SH2 domain, signaling protein; HET: PTR; 1.90A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.9e-18 Score=110.82 Aligned_cols=90 Identities=16% Similarity=0.162 Sum_probs=74.5
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEec-CCCeeeEEEEEeccCC-ccCC--CCCcC-HhHHHH
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKR-SSFCLKMTTGRSLFET-QKAG--RTTIH-YPELVE 75 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~-~~~~v~h~~i~~~~~g-yl~~--~~~~~-l~~li~ 75 (189)
||+++|+|.+|+++|.. ...+|+||||++.+.+ .|+||+++. ..+.|+||+|.+..++ ||.. ...|. |.+||+
T Consensus 17 Wff~~isR~eAE~lL~~-~~~~GaFLVR~Se~~~-~ySLSVR~~~~~~~VKHYkI~~~~G~y~I~~~~~~~F~SL~eLV~ 94 (125)
T 3maz_A 17 ACFYTVSRKEATEMLQK-NPSLGNMILRPGSDSR-NYSITIRQEIDIPRIKHYKVMSVGQNYTIELEKPVTLPNLFSVID 94 (125)
T ss_dssp TTBCCCCHHHHHHHHHH-CGGGCSEEEEECTTSS-SEEEEEEECSSSCEEEEEEEEEETTEEEECSSSCEEESSHHHHHH
T ss_pred CCcCCCCHHHHHHHHhc-cCCCCcEEEEeCCCCC-CEEEEEEecCCCCCEeeeEEEEeCCEEEEecCCCcCcCCHHHHHH
Confidence 99999999999998853 4568999999998764 899999983 2368999999988434 7763 44688 999999
Q ss_pred HhhhccCCceeeccCCc
Q psy1684 76 HYSKDADGLCVNLRKPC 92 (189)
Q Consensus 76 ~~~~~a~gl~~~~~~~~ 92 (189)
||...++|++..+..+|
T Consensus 95 yY~~~adGl~~~L~~~c 111 (125)
T 3maz_A 95 YFVKETRGNLRPFIAST 111 (125)
T ss_dssp HHHHHTTTCCCBCCC--
T ss_pred HHHhCCCcCcccccccc
Confidence 99999999999999887
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.76 E-value=2.1e-20 Score=145.52 Aligned_cols=144 Identities=8% Similarity=-0.022 Sum_probs=112.5
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..++|+|++++++.....+..|||+|++.+ |+ +.. ++. ...+...++..+..+++.|
T Consensus 203 ~~l~HpnIV~l~~~~~~~~~~~iVmEy~~g-G~----L~~-----------------~i~-~~~l~e~~~~~~~~qil~a 259 (423)
T 4fie_A 203 RDYQHENVVEMYNSYLVGDELWVVMEFLEG-GA----LTD-----------------IVT-HTRMNEEQIAAVCLAVLQA 259 (423)
T ss_dssp HHCCCTTBCCEEEEEEETTEEEEEEECCTT-EE----HHH-----------------HHH-HSCCCHHHHHHHHHHHHHH
T ss_pred HhCCCCCCCceEEEEEECCEEEEEEeCCCC-Cc----HHH-----------------HHh-ccCCCHHHHHHHHHHHHHH
Confidence 357899999999887777788999999987 42 212 121 1235566677788889999
Q ss_pred ceeeccCCcccccc-cc---------------cccc---------------------cC-CCCCccc-e-EEEec-----
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YLVH---------------------GT-NLSGVVV-S-AVDFG----- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l~~---------------------~~-~~~~~~~-s-VwsfG----- 118 (189)
+.|+|..+|+|||+ |+ |+|+ |. ....|+. + |||+|
T Consensus 260 L~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilye 339 (423)
T 4fie_A 260 LSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIE 339 (423)
T ss_dssp HHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHH
T ss_pred HHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHH
Confidence 99999999999996 55 3332 22 4567999 9 99999
Q ss_pred -------CCCCChHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 119 -------SGGMTNAEVLHQVEHGYR--MPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 119 -------~~~~~~~~~~~~v~~g~~--~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
|.+.+..+++..+..+.. ++.+..+++++.+|+.+||..||++|||++|+++
T Consensus 340 ml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 340 MVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp HHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 788888888888876643 3445679999999999999999999999999986
|
| >2aug_A Growth factor receptor-bound protein 14; phosphorylation, SH2 domain, signaling protein; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.76 E-value=3.9e-18 Score=111.56 Aligned_cols=91 Identities=27% Similarity=0.389 Sum_probs=79.7
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEecc-CC--cc--C-CCCCcC-HhHH
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLF-ET--QK--A-GRTTIH-YPEL 73 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~-~g--yl--~-~~~~~~-l~~l 73 (189)
||||.|+|.+|+++|......+|+||||++.+.+|.|+||++. .+.++||+|.... +| |+ . +...|. +.+|
T Consensus 28 WyhG~isR~eAe~lL~~~g~~~G~FLVR~S~~~~g~y~LSv~~--~~~v~H~~I~~~~~~G~~~~~l~~~~~~F~SL~eL 105 (126)
T 2aug_A 28 WFHHKISRDEAQRLIIQQGLVDGVFLVRDSQSNPKTFVLSMSH--GQKIKHFQIIPVEDDGEMFHTLDDGHTRFTDLIQL 105 (126)
T ss_dssp TEETTCCHHHHHHHHHTTTCCTTEEEEEECSSSSCCEEEEEEE--TTEEEEEEEEEEEETTEEEEESSTTSSCBSSHHHH
T ss_pred cccCCCCHHHHHHHHhccCCCCCEEEEeecCCCCCCEEEEEEc--CCeEEEEEEEEECCCCeEEEEeCCCCCccCCHHHH
Confidence 9999999999999998766678999999999888999999999 9999999998763 56 33 3 356788 9999
Q ss_pred HHHhhhccCCceeeccCCcc
Q psy1684 74 VEHYSKDADGLCVNLRKPCV 93 (189)
Q Consensus 74 i~~~~~~a~gl~~~~~~~~~ 93 (189)
|++|....+|+.+.+..||.
T Consensus 106 V~~y~~~~~~l~~~L~~P~~ 125 (126)
T 2aug_A 106 VEFYQLNKGVLPCKLKHYCA 125 (126)
T ss_dssp HHHHTTCCTTSSSCCCEECC
T ss_pred HHHHhhCCCCCceecCCCcC
Confidence 99999999999888888875
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=99.75 E-value=8e-21 Score=142.52 Aligned_cols=144 Identities=10% Similarity=-0.023 Sum_probs=113.4
Q ss_pred CCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccC
Q psy1684 3 FGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDAD 82 (189)
Q Consensus 3 ~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~ 82 (189)
+..++|+|+++++.....++..|||+|++++ |+ +.. ++.....++..+...+..++..
T Consensus 86 l~~l~HpnIv~l~~~~~~~~~~yivmEy~~g-G~----L~~-----------------~i~~~~~l~e~~~~~~~~qi~~ 143 (311)
T 4aw0_A 86 MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN-GE----LLK-----------------YIRKIGSFDETCTRFYTAEIVS 143 (311)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEECCCTT-EE----HHH-----------------HHHHHSSCCHHHHHHHHHHHHH
T ss_pred HHhCCCCCCCeEEEEEEeCCEEEEEEecCCC-CC----HHH-----------------HHHHcCCCCHHHHHHHHHHHHH
Confidence 3568899999988877667778999999887 41 222 2333345556666778889999
Q ss_pred CceeeccCCcccccc-cc---------------cccccC------------------------CCCCccc-e-EEEec--
Q psy1684 83 GLCVNLRKPCVQVSC-RI---------------YLVHGT------------------------NLSGVVV-S-AVDFG-- 118 (189)
Q Consensus 83 gl~~~~~~~~~~~~~-p~---------------~l~~~~------------------------~~~~~~~-s-VwsfG-- 118 (189)
|+.|+|...++|||+ |+ |+|+.. ....|+. + |||+|
T Consensus 144 al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvi 223 (311)
T 4aw0_A 144 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCI 223 (311)
T ss_dssp HHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHH
T ss_pred HHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHH
Confidence 999999999999996 66 444321 3456899 9 99999
Q ss_pred ----------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q psy1684 119 ----------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQ 169 (189)
Q Consensus 119 ----------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~ 169 (189)
|.+.+..+++..+.++. +.+|..+++++.+|+.+|+..||++|||++|++
T Consensus 224 lyeml~G~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 224 IYQLVAGLPPFRAGNEGLIFAKIIKLE-YDFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHTC-CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 78888888998887774 567889999999999999999999999999874
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=1.2e-19 Score=136.74 Aligned_cols=156 Identities=17% Similarity=0.196 Sum_probs=114.7
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCC---CcCHhHHHHHhhhcc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRT---TIHYPELVEHYSKDA 81 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~---~~~l~~li~~~~~~a 81 (189)
.++|+|++++++.+......+||+|++.++. +.. ++.... .+....+..+..+.+
T Consensus 90 ~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~-----L~~-----------------~l~~~~~~~~~~~~~~~~i~~qi~ 147 (309)
T 3p86_A 90 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS-----LYR-----------------LLHKSGAREQLDERRRLSMAYDVA 147 (309)
T ss_dssp HCCCTTBCCEEEEECSTTCCEEEEECCTTCB-----HHH-----------------HHHSTTHHHHSCHHHHHHHHHHHH
T ss_pred hCCCCCEeeEEEEEEECCceEEEEecCCCCc-----HHH-----------------HHhhcCCCCCCCHHHHHHHHHHHH
Confidence 4678888888877766667788888877622 111 222221 244666777888889
Q ss_pred CCceeeccCC--cccccc-cc---------------ccc---------------------ccC-CCCCccc-e-EEEec-
Q psy1684 82 DGLCVNLRKP--CVQVSC-RI---------------YLV---------------------HGT-NLSGVVV-S-AVDFG- 118 (189)
Q Consensus 82 ~gl~~~~~~~--~~~~~~-p~---------------~l~---------------------~~~-~~~~~~~-s-VwsfG- 118 (189)
.|+.++|... ++|+|+ |+ |++ +|. ....++. + |||||
T Consensus 148 ~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 227 (309)
T 3p86_A 148 KGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGV 227 (309)
T ss_dssp HHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHH
T ss_pred HHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHH
Confidence 9999999998 999996 55 222 111 3455788 9 99999
Q ss_pred -----------CCCCChHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcCCC
Q psy1684 119 -----------SGGMTNAEVLHQVE-HGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEGSD 182 (189)
Q Consensus 119 -----------~~~~~~~~~~~~v~-~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~~~~ 182 (189)
|.+.+..++...+. ...+++.|..+|+++.+|+.+||+.||++|||+++|++.|+.+++...|.
T Consensus 228 il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~ 303 (309)
T 3p86_A 228 ILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303 (309)
T ss_dssp HHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence 77778877777764 56677889999999999999999999999999999999999999865554
|
| >1ka6_A SH2 domain protein 1A; SH2 domain, protein-peptide complex, immune system; HET: PTR; NMR {Homo sapiens} SCOP: d.93.1.1 PDB: 1ka7_A | Back alignment and structure |
|---|
Probab=99.75 E-value=4.5e-18 Score=111.80 Aligned_cols=92 Identities=25% Similarity=0.316 Sum_probs=80.4
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC--ccCC-----CCCcC-HhH
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET--QKAG-----RTTIH-YPE 72 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g--yl~~-----~~~~~-l~~ 72 (189)
||||.|+|.+|+++|.... .+|+||||++.+.+|.|+||++. .+.++||+|....+| ++.. ...|. +.+
T Consensus 6 WyhG~isR~eAe~lL~~~~-~~G~FLVR~S~~~~g~y~LSv~~--~~~v~H~~I~~~~~g~~~l~~~~g~~~~~F~sl~~ 82 (128)
T 1ka6_A 6 VYHGKISRETGEKLLLATG-LDGSYLLRDSESVPGVYCLCVLY--HGYIYTYRVSQTETGSWSAETAPGVHKRYFRKIKN 82 (128)
T ss_dssp SBCCSCCHHHHHHHHHHHC-CTTCEEEEECSSSTTCEEEEEES--SSCEEEEEEEECTTSCEEEECSTTSCCCEESSHHH
T ss_pred ccCCCCCHHHHHHHHhcCC-CCCEEEEeecCCCCCCEEEEEEe--CCEEEEEEEEECCCCeEEEeecCCCCCCccCCHHH
Confidence 9999999999999995433 67999999999888999999999 999999999987777 5552 56788 999
Q ss_pred HHHHhhhccCCceeeccCCcccc
Q psy1684 73 LVEHYSKDADGLCVNLRKPCVQV 95 (189)
Q Consensus 73 li~~~~~~a~gl~~~~~~~~~~~ 95 (189)
||+||....+|+...+..||...
T Consensus 83 LV~~y~~~~~gl~~~L~~P~~~~ 105 (128)
T 1ka6_A 83 LISAFQKPDQGIVIPLQYPVEKK 105 (128)
T ss_dssp HHHHTTSSCSSSSSCCCSBCCSS
T ss_pred HHHHHhhCCCCCcEEcCCcCCCC
Confidence 99999999999999999888653
|
| >2ekx_A Cytoplasmic tyrosine-protein kinase BMX; SH2 domain, phosphotyrosine binding domain, protein tyrosine kinase, signal transduction; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.75 E-value=4.1e-18 Score=109.22 Aligned_cols=90 Identities=26% Similarity=0.434 Sum_probs=77.1
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEec----CCCeeeEEEEEeccCC--ccCCCCCcC-HhHH
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKR----SSFCLKMTTGRSLFET--QKAGRTTIH-YPEL 73 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~----~~~~v~h~~i~~~~~g--yl~~~~~~~-l~~l 73 (189)
||||.|+|.+|+++|.... .+|+||||++ +.++.|+||++.. ..+.++||+|....+| ++.+...|. +.+|
T Consensus 13 Wyhg~isR~~Ae~lL~~~~-~~G~FLVR~S-~~~g~y~LSv~~~~~~~~~~~v~H~~I~~~~~g~~~l~~~~~F~sl~~L 90 (110)
T 2ekx_A 13 WFAGNISRSQSEQLLRQKG-KEGAFMVRNS-SQVGMYTVSLFSKAVNDKKGTVKHYHVHTNAENKLYLAENYCFDSIPKL 90 (110)
T ss_dssp SBCCSCCHHHHHHHHHHTC-CTTEEEEEEC-SSTTCEEEEECCCCSSCSSCCCEEEECEECTTCCEESSTTCCCSCHHHH
T ss_pred eecCCCCHHHHHHHHhccC-CCceEEEEec-CCCCCEEEEEEeccccCCCCcEEEEEEEECCCCCEEECCCCccCCHHHH
Confidence 9999999999999996553 7799999999 5679999999862 1368999999988766 777677888 9999
Q ss_pred HHHhhhccCCceeeccCCc
Q psy1684 74 VEHYSKDADGLCVNLRKPC 92 (189)
Q Consensus 74 i~~~~~~a~gl~~~~~~~~ 92 (189)
|+||....+|+.+.+..||
T Consensus 91 V~~y~~~~~~l~~~L~~Pv 109 (110)
T 2ekx_A 91 IHYHQHNSAGMITRLRHPV 109 (110)
T ss_dssp HHHHHHSCCSSSCCCCEEC
T ss_pred HHHHeeCCCCCceecCccC
Confidence 9999999999988887775
|
| >1h9o_A Phosphatidylinositol 3-kinase; transferase/receptor, complex (phosphotransferase/receptor), phosphotransferase, SH2 domain; HET: PTR; 1.79A {Homo sapiens} SCOP: d.93.1.1 PDB: 1pic_A* 1bfi_A 1bfj_A 1qad_A | Back alignment and structure |
|---|
Probab=99.75 E-value=1.5e-17 Score=106.89 Aligned_cols=89 Identities=29% Similarity=0.334 Sum_probs=76.9
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC-ccCC-CCCcC-HhHHHHHh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET-QKAG-RTTIH-YPELVEHY 77 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g-yl~~-~~~~~-l~~li~~~ 77 (189)
||||.|+|.+|+++|. ...+|+||||++ +.++.|+||++. .+.++|++|....+| ++.+ ...|. +.+||+||
T Consensus 12 Wyhg~isR~~Ae~lL~--~~~~G~FLVR~S-~~~g~y~LSv~~--~~~v~H~~I~~~~~g~~~~~~~~~F~sl~~LV~~y 86 (112)
T 1h9o_A 12 WNVGSSNRNKAENLLR--GKRDGTFLVRES-SKQGCYACSVVV--DGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHY 86 (112)
T ss_dssp TBCCSCCHHHHHHHHT--TCCTTEEEEEEC-SSTTCEEEEEEE--TTEEEEEEEEEETTEEESSTTCCCBSSHHHHHHHH
T ss_pred cccCCCCHHHHHHHhc--CCCCceEEEeec-CCCCCEEEEEEE--CCEEEEEEEEEcCCceEEeCCCCCcCCHHHHHHHH
Confidence 9999999999999995 458899999999 778999999999 999999999988888 5543 56788 99999999
Q ss_pred hhc-----cCCceeeccCCccc
Q psy1684 78 SKD-----ADGLCVNLRKPCVQ 94 (189)
Q Consensus 78 ~~~-----a~gl~~~~~~~~~~ 94 (189)
... .+|+...+..||..
T Consensus 87 ~~~~l~~~~~gl~~~L~~P~~~ 108 (112)
T 1h9o_A 87 QHTSLVQHNDSLNVTLAYPVYA 108 (112)
T ss_dssp HHSCGGGTCTTCCCCCCEETTC
T ss_pred hhCcccccCCCcCeeCCCCcCC
Confidence 874 46888888888754
|
| >2ysx_A Signaling inositol polyphosphate phosphatase SHIP II; SH2 domain, phosphotyrosine binding domain, protein tyrosine kinase, signal transduction; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.74 E-value=4.8e-18 Score=110.37 Aligned_cols=91 Identities=27% Similarity=0.392 Sum_probs=79.8
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC--ccCC-----CCCcC-HhH
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET--QKAG-----RTTIH-YPE 72 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g--yl~~-----~~~~~-l~~ 72 (189)
||||.|+|.+|+++|... ..+|+||||++.+.+|.|+||++. .+.++||+|....+| +|.. ...|. +.+
T Consensus 12 WyhG~isR~eAe~lL~~~-~~~G~FLVR~S~~~~g~y~LSv~~--~~~v~H~~I~~~~~g~~~l~~~~g~~~~~F~sl~e 88 (119)
T 2ysx_A 12 WNHGNITRSKAEELLSRT-GKDGSFLVRASESISRAYALCVLY--RNCVYTYRILPNEDDKFTVQASEGVSMRFFTKLDQ 88 (119)
T ss_dssp SEEESCCHHHHHHHHHHH-CCTTEEEEEECSSCTTSEEEEEEC--SSCEEEEEEEECTTSCEEECCSCSSSCCCBSSHHH
T ss_pred cccCCCCHHHHHHHHhhc-CCCCEEEEEeCCCCCCCEEEEEEE--CCEEEEEEEEEcCCCCEEEeccCCcCCcccCCHHH
Confidence 999999999999999642 268999999999888999999999 999999999987777 5654 35788 999
Q ss_pred HHHHhhhccCCceeeccCCccc
Q psy1684 73 LVEHYSKDADGLCVNLRKPCVQ 94 (189)
Q Consensus 73 li~~~~~~a~gl~~~~~~~~~~ 94 (189)
||+||.....|+...+..||..
T Consensus 89 LV~~y~~~~~~l~~~L~~P~~~ 110 (119)
T 2ysx_A 89 LIEFYKKENMGLVTHLQYPVPL 110 (119)
T ss_dssp HHHHTTSSSSSSSSCCCEECCC
T ss_pred HHHHHhhCCCCCCeECCCcCCC
Confidence 9999999999999888888865
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.74 E-value=7.7e-20 Score=140.83 Aligned_cols=159 Identities=19% Similarity=0.242 Sum_probs=119.8
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.++|+|++++++.+......|||+|++.+ |+ +... + . ...........+...++..+..+++.|+
T Consensus 130 ~l~hpnIv~~~~~~~~~~~~~lv~e~~~~-g~----L~~~----l-----~-~~~~~~~~~~~~~~~~~~~i~~qi~~aL 194 (367)
T 3l9p_A 130 KFNHQNIVRCIGVSLQSLPRFILLELMAG-GD----LKSF----L-----R-ETRPRPSQPSSLAMLDLLHVARDIACGC 194 (367)
T ss_dssp HCCCTTBCCEEEEECSSSSCEEEEECCTT-EE----HHHH----H-----H-HHSCCSSSCCCCCHHHHHHHHHHHHHHH
T ss_pred hCCCCCCCeEEEEEecCCCCEEEEEeCCC-CC----HHHH----H-----H-hhccccCccccccHHHHHHHHHHHHHHH
Confidence 46789999988887777778999998876 31 2210 0 0 0000011122355777888888999999
Q ss_pred eeeccCCcccccc-cccccc-----------------------------------------cC-CCCCccc-e-EEEec-
Q psy1684 85 CVNLRKPCVQVSC-RIYLVH-----------------------------------------GT-NLSGVVV-S-AVDFG- 118 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~~l~~-----------------------------------------~~-~~~~~~~-s-VwsfG- 118 (189)
.++|..+++|+|+ |+.+.- |. ....++. + |||||
T Consensus 195 ~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~ 274 (367)
T 3l9p_A 195 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGV 274 (367)
T ss_dssp HHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred HHHHhCCeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHH
Confidence 9999999999996 552111 10 2455888 9 99999
Q ss_pred ------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q psy1684 119 ------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTM 178 (189)
Q Consensus 119 ------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~ 178 (189)
|.+.+..++...+..+.+++.|..+|.++.+||.+||+.||++|||+.+|++.|+.+.+.
T Consensus 275 il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 275 LLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp HHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 666777888888988988888999999999999999999999999999999999888764
|
| >2lnw_A VAV-2, guanine nucleotide exchange factor VAV2; signaling protein; HET: PTR; NMR {Homo sapiens} PDB: 2lnx_A | Back alignment and structure |
|---|
Probab=99.74 E-value=1.3e-17 Score=108.50 Aligned_cols=90 Identities=20% Similarity=0.274 Sum_probs=79.3
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC-ccCCCCCcC-HhHHHHHhh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET-QKAGRTTIH-YPELVEHYS 78 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g-yl~~~~~~~-l~~li~~~~ 78 (189)
||||.|+|.+|+++|.. ..+|+||||++.+.+|.|+||++. .+.++|++|....++ ++.+...|. +.+||++|.
T Consensus 24 WyhG~isR~eAe~lL~~--~~~G~FLVR~S~~~~g~y~LSv~~--~~~v~H~~I~~~~~~~~l~~~~~F~sl~eLV~~y~ 99 (122)
T 2lnw_A 24 WFAGNMERQQTDNLLKS--HASGTYLIRERPAEAERFAISIKF--NDEVKHIKVVEKDNWIHITEAKKFDSLLELVEYYQ 99 (122)
T ss_dssp TBCCSCCHHHHHHHHHH--SCTTBEEEEECCCSSEEEEEEEEC--SSCEEEEEEEEETTEEESSSSCCBSSHHHHHHHHH
T ss_pred CCCcCCCHHHHHHHhcC--CCCCeEEEEeCCCCCCcEEEEEEe--CCcEEEEEEEEcCCEEEECCCCeECCHHHHHHHHh
Confidence 99999999999999964 368999999999888999999999 999999999987666 787778898 999999999
Q ss_pred hc-----cCCceeeccCCccc
Q psy1684 79 KD-----ADGLCVNLRKPCVQ 94 (189)
Q Consensus 79 ~~-----a~gl~~~~~~~~~~ 94 (189)
.. .+|+...+..||..
T Consensus 100 ~~~l~~~~~~l~~~L~~P~~~ 120 (122)
T 2lnw_A 100 CHSLKESFKQLDTTLKYPYKS 120 (122)
T ss_dssp HSCGGGTCTTCCCCCCBCSSS
T ss_pred hCcCcccCCCcCeeeCCcCCC
Confidence 88 67888788877643
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.74 E-value=2.6e-19 Score=138.54 Aligned_cols=160 Identities=21% Similarity=0.269 Sum_probs=121.9
Q ss_pred ChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC----c---cCCCCCcCHhHHHHHhhh
Q psy1684 7 KRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET----Q---KAGRTTIHYPELVEHYSK 79 (189)
Q Consensus 7 ~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g----y---l~~~~~~~l~~li~~~~~ 79 (189)
+|+|++++++.+......+||+|++.+ +++.-.+.. . ...+ + ......++...+..+..+
T Consensus 133 ~hpnIv~~~~~~~~~~~~~lv~e~~~~-g~L~~~l~~--~----------~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q 199 (382)
T 3tt0_A 133 KHKNIINLLGACTQDGPLYVIVEYASK-GNLREYLQA--R----------RPPGLEYSYNPSHNPEEQLSSKDLVSCAYQ 199 (382)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTT-CBHHHHHHH--T----------CCSSSSSCCCCCSSCCCCCCHHHHHHHHHH
T ss_pred CCchhhhheeeeccCCceEEEEEecCC-CcHHHHHHH--h----------cccccccccccccccccccCHHHHHHHHHH
Confidence 789999999888777788999999887 322111111 0 0000 0 111234557778888889
Q ss_pred ccCCceeeccCCcccccc-cc---------------cccccC------------------------CCCCccc-e-EEEe
Q psy1684 80 DADGLCVNLRKPCVQVSC-RI---------------YLVHGT------------------------NLSGVVV-S-AVDF 117 (189)
Q Consensus 80 ~a~gl~~~~~~~~~~~~~-p~---------------~l~~~~------------------------~~~~~~~-s-Vwsf 117 (189)
.+.|+.++|..+++|+|+ |+ |++... ....++. + ||||
T Consensus 200 i~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Diwsl 279 (382)
T 3tt0_A 200 VARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 279 (382)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHH
T ss_pred HHHHHHHHHhCCEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHH
Confidence 999999999999999996 55 222211 2445788 9 9999
Q ss_pred c-------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q psy1684 118 G-------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTME 179 (189)
Q Consensus 118 G-------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~ 179 (189)
| |.+.+..++...+..+.+++.|..+++++.+|+.+||+.||++|||+++|++.|+.++...
T Consensus 280 G~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 354 (382)
T 3tt0_A 280 GVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 354 (382)
T ss_dssp HHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred HHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 9 6677788888888999889999999999999999999999999999999999999998764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.74 E-value=9.4e-20 Score=138.66 Aligned_cols=175 Identities=20% Similarity=0.259 Sum_probs=120.5
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCC---eeeEEEEEeccCCccCCCCCcCHhHHHHHhhhc
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSF---CLKMTTGRSLFETQKAGRTTIHYPELVEHYSKD 80 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~---~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~ 80 (189)
..++|+|++++++.+...+..+||+|++.. +++.-.+...... ...+..+.......-.....+...++..+..+.
T Consensus 105 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 183 (343)
T 1luf_A 105 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAY-GDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQV 183 (343)
T ss_dssp HTCCCTTBCCEEEEECSSSSCEEEEECCTT-CBHHHHHHHTCC----------------------CCCCHHHHHHHHHHH
T ss_pred HhCCCCCEEEEEEEEccCCceEEEEecCCC-CcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHH
Confidence 357899999999988777889999999887 4321111110000 000000000000001112345577788888899
Q ss_pred cCCceeeccCCcccccc-cc---------------ccc-----------------------ccC-CCCCccc-e-EEEec
Q psy1684 81 ADGLCVNLRKPCVQVSC-RI---------------YLV-----------------------HGT-NLSGVVV-S-AVDFG 118 (189)
Q Consensus 81 a~gl~~~~~~~~~~~~~-p~---------------~l~-----------------------~~~-~~~~~~~-s-VwsfG 118 (189)
+.|+.++|..+++|+|+ |+ +++ +|. ....++. + |||||
T Consensus 184 ~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG 263 (343)
T 1luf_A 184 AAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYG 263 (343)
T ss_dssp HHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred HHHHHHHHhCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHH
Confidence 99999999999999996 55 111 111 2356788 9 99999
Q ss_pred -------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q psy1684 119 -------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTME 179 (189)
Q Consensus 119 -------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~ 179 (189)
|.+.+..++...+..+..++.|..+|+++.+|+.+||+.||++|||+.+|++.|+++.+..
T Consensus 264 ~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 264 VVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp HHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred HHHHHHHhcCCCcCCCCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 5566778888888888888889999999999999999999999999999999999887643
|
| >2gsb_A RAS GTPase-activating protein 1; GAP, RAS P21 protein activator, P120GAP, rasgap, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.73 E-value=8.1e-18 Score=109.13 Aligned_cols=92 Identities=23% Similarity=0.297 Sum_probs=79.8
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC-ccCCCCCcC-HhHHHHHhh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET-QKAGRTTIH-YPELVEHYS 78 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g-yl~~~~~~~-l~~li~~~~ 78 (189)
||||.|+|.+|+++|.... .+|+||||++...+|.|+||++. .+.++||+|....+| |..+...|. +.+||+||.
T Consensus 18 WyhG~isR~~Ae~lL~~~g-~~G~FLVR~S~~~~g~y~LSv~~--~~~v~H~~I~~~~~g~~~l~~~~F~sl~~LI~~y~ 94 (119)
T 2gsb_A 18 WFHGKISKQEAYNLLMTVG-QVCSFLVRPSDNTPGDYSLYFRT--NENIQRFKICPTPNNQFMMGGRYYNSIGDIIDHYR 94 (119)
T ss_dssp SBCCSSCHHHHHHHHHHTC-CSSEEEEEECSSSTTCEEEEEEC--SSCBCCCCEEEETTTEEEESSCCBSCHHHHHHHHT
T ss_pred cccCCCCHHHHHHHHhhcC-CCCeEEEEeCCCCCCceEEEEEE--CCEEEEEEEEEcCCCCEEECCcccCCHHHHHHHHh
Confidence 9999999999999996543 56999999999888999999999 899999999987777 444456788 999999999
Q ss_pred hccCCceeeccCCcccc
Q psy1684 79 KDADGLCVNLRKPCVQV 95 (189)
Q Consensus 79 ~~a~gl~~~~~~~~~~~ 95 (189)
....+....+..||...
T Consensus 95 ~~~l~~~~~L~~Pv~~~ 111 (119)
T 2gsb_A 95 KEQIVEGYYLKEPVPMQ 111 (119)
T ss_dssp TSCSBTTBCCCCCCCCC
T ss_pred hCccCCCCEeCCccCCC
Confidence 98888878888888763
|
| >2dlz_A Protein VAV-2; RHO family guanine nucleotide exchange factor, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.73 E-value=1.5e-17 Score=107.72 Aligned_cols=90 Identities=20% Similarity=0.259 Sum_probs=77.9
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC-ccCCCCCcC-HhHHHHHhh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET-QKAGRTTIH-YPELVEHYS 78 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g-yl~~~~~~~-l~~li~~~~ 78 (189)
||||.|+|.+|+++|... .+|+||||++...++.|+||++. .+.++||+|....++ ++.+...|. +.+||+||.
T Consensus 18 WyhG~isR~~Ae~lL~~~--~~G~FLVR~S~~~~g~y~LSv~~--~~~v~H~~I~~~~g~~~l~~~~~F~sl~~LV~~y~ 93 (118)
T 2dlz_A 18 WFAGNMERQQTDNLLKSH--ASGTYLIRERPAEAERFAISIKF--NDEVKHIKVVEKDNWIHITEAKKFDSLLELVEYYQ 93 (118)
T ss_dssp TEEESCCHHHHHHHHHHS--CTTBEEEECCSCSSCCEEEEEEC--SSSEEEEEEEEETTEEESTTSCCBSSHHHHHHHHT
T ss_pred ceecCCCHHHHHHHhcCC--CCCEEEEEeCCCCCCCEEEEEEE--CCcEEEEEEEEcCCEEEEeCCcccCCHHHHHHHHh
Confidence 999999999999999653 78999999999888999999999 999999999986555 777677898 999999999
Q ss_pred hccC-----CceeeccCCccc
Q psy1684 79 KDAD-----GLCVNLRKPCVQ 94 (189)
Q Consensus 79 ~~a~-----gl~~~~~~~~~~ 94 (189)
.... |+...+..||..
T Consensus 94 ~~~l~~~~~gl~~~L~~Pv~~ 114 (118)
T 2dlz_A 94 CHSLKESFKQLDTTLKYPYSG 114 (118)
T ss_dssp TSCTTTTCTTCCCCCCBCCSC
T ss_pred hCcccccCCCcccEeCCcCCC
Confidence 8765 777777777644
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=2.7e-19 Score=131.67 Aligned_cols=153 Identities=18% Similarity=0.185 Sum_probs=113.2
Q ss_pred CCCCChHHHHHHhcCCCCC--CCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCC--CcCHhHHHHHhh
Q psy1684 3 FGKIKRIEAEKKLLLPEND--HGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRT--TIHYPELVEHYS 78 (189)
Q Consensus 3 ~g~l~~~n~~~lL~~~~~~--~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~--~~~l~~li~~~~ 78 (189)
...++|+|++++++.+... ...++|+|++.++. +.. ++.... .++...+..+..
T Consensus 61 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~-----L~~-----------------~l~~~~~~~~~~~~~~~i~~ 118 (271)
T 3kmu_A 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGS-----LYN-----------------VLHEGTNFVVDQSQAVKFAL 118 (271)
T ss_dssp GCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCB-----HHH-----------------HHHSCSSCCCCHHHHHHHHH
T ss_pred HHhcCCCchhheEEEEccCCCCCeEeeecccCCCc-----HHH-----------------HHhhcccCCCCHHHHHHHHH
Confidence 3466788888888766554 45678888877522 222 233222 345777788888
Q ss_pred hccCCceeeccCC--cccccc-cc-------------------------------cccccC----CCCCccc-e-EEEec
Q psy1684 79 KDADGLCVNLRKP--CVQVSC-RI-------------------------------YLVHGT----NLSGVVV-S-AVDFG 118 (189)
Q Consensus 79 ~~a~gl~~~~~~~--~~~~~~-p~-------------------------------~l~~~~----~~~~~~~-s-VwsfG 118 (189)
+.+.|+.++|... ++|+|+ |+ ++|+|. ....++. + |||||
T Consensus 119 qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG 198 (271)
T 3kmu_A 119 DMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFA 198 (271)
T ss_dssp HHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHH
T ss_pred HHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecccCccCCccccChhhhccCCCCCCCchhhHHHHH
Confidence 9999999999988 999996 54 112221 1234567 8 99999
Q ss_pred ------------CCCCChHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q psy1684 119 ------------SGGMTNAEVLHQV-EHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFT 177 (189)
Q Consensus 119 ------------~~~~~~~~~~~~v-~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~ 177 (189)
|.+.+..++...+ ..+.+++.|..+|+++.+++.+||+.||++|||++++++.|+.+.+
T Consensus 199 ~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 199 VLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred HHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 6777777766565 5677888899999999999999999999999999999999988753
|
| >3tkz_A Tyrosine-protein phosphatase non-receptor type 11; SH2 domain, protein protein interactions, PTR residues, HYDR peptide complex; HET: PTR; 1.80A {Homo sapiens} PDB: 3tl0_A* 1aya_A* 1ayb_A* 1ayc_A* 1ayd_A | Back alignment and structure |
|---|
Probab=99.73 E-value=2.3e-17 Score=105.61 Aligned_cols=90 Identities=27% Similarity=0.383 Sum_probs=74.9
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCc-cCCCCCcC-HhHHHHHhh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQ-KAGRTTIH-YPELVEHYS 78 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gy-l~~~~~~~-l~~li~~~~ 78 (189)
||||.|+|.+|+++|.... .+|+||||++.+.+|.|+||++. .+.++|++|....+.| +.+...|. +.+||+||.
T Consensus 9 Wyhg~isr~~Ae~lL~~~~-~~G~FLVR~S~~~~g~y~LSv~~--~~~v~H~~I~~~~~~~~~~~~~~F~sl~~LV~~y~ 85 (109)
T 3tkz_A 9 WFHPNITGVEAENLLLTRG-VDGSFLARPSKSNPGDFTLSVRR--NGAVTHIKIQNTGDYYDLYGGEKFATLAELVQYYM 85 (109)
T ss_dssp SBCTTCCHHHHHHHHHHHC-CTTEEEEEECSSSTTCEEEEEEE--TTEEEEEEEEECSSCEESSSSCCBSSHHHHHHHHH
T ss_pred ceecCCCHHHHHHHHhcCC-CCCEEEEEecCCCCCCEEEEEEE--CCEEEEEEEEeCCCEEEecCCcccCCHHHHHHHHH
Confidence 9999999999999996433 68999999999888999999999 9999999998753324 66677898 999999999
Q ss_pred hcc------CCceeeccCCcc
Q psy1684 79 KDA------DGLCVNLRKPCV 93 (189)
Q Consensus 79 ~~a------~gl~~~~~~~~~ 93 (189)
..+ +|+...+..||.
T Consensus 86 ~~~~~l~~~~gl~~~L~~Pv~ 106 (109)
T 3tkz_A 86 EHHGQLKEKNGDVIELKYPLN 106 (109)
T ss_dssp HSTTSEEETTSCBCCCCEECC
T ss_pred hCcCccccCCCceEECCCccc
Confidence 876 455566666654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.73 E-value=4.1e-19 Score=135.02 Aligned_cols=153 Identities=18% Similarity=0.307 Sum_probs=116.5
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC-CCCcCHhHHHHHhhhccCC
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG-RTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~-~~~~~l~~li~~~~~~a~g 83 (189)
.++|+|++++++.+......+||+|++.+ + ++.. ++.. ...+...++..+..+.+.|
T Consensus 102 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~----~L~~-----------------~l~~~~~~~~~~~~~~i~~qi~~a 159 (333)
T 1mqb_A 102 QFSHHNIIRLEGVISKYKPMMIITEYMEN-G----ALDK-----------------FLREKDGEFSVLQLVGMLRGIAAG 159 (333)
T ss_dssp TCCCTTBCCEEEEECSSSSEEEEEECCTT-E----EHHH-----------------HHHHTTTCSCHHHHHHHHHHHHHH
T ss_pred hCCCCCCCcEEEEEecCCCcEEEEeCCCC-C----cHHH-----------------HHHhCCCCCCHHHHHHHHHHHHHH
Confidence 46777888877776666667778877765 2 1211 2221 2345567778888888999
Q ss_pred ceeeccCCcccccc-cc---------------cccc------------------------cC-CCCCccc-e-EEEec--
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YLVH------------------------GT-NLSGVVV-S-AVDFG-- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l~~------------------------~~-~~~~~~~-s-VwsfG-- 118 (189)
+.++|..+++|+|+ |+ +++. |. ....++. + |||||
T Consensus 160 L~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 239 (333)
T 1mqb_A 160 MKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIV 239 (333)
T ss_dssp HHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHH
T ss_pred HHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHH
Confidence 99999999999996 54 1111 11 2356788 9 99999
Q ss_pred -----------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q psy1684 119 -----------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTME 179 (189)
Q Consensus 119 -----------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~ 179 (189)
|.+.+..++...+..+.+++.|..+|.++.+|+.+||+.||++||++.+|++.|+.+++..
T Consensus 240 l~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 240 MWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp HHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred HHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 5566778888888889888889999999999999999999999999999999999988753
|
| >2ge9_A Tyrosine-protein kinase BTK; SH2 domain, structure, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.73 E-value=1.1e-17 Score=109.53 Aligned_cols=92 Identities=26% Similarity=0.435 Sum_probs=79.5
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEec----CCCeeeEEEEEeccCC--ccCCCCCcC-HhHH
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKR----SSFCLKMTTGRSLFET--QKAGRTTIH-YPEL 73 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~----~~~~v~h~~i~~~~~g--yl~~~~~~~-l~~l 73 (189)
||||.|+|.+|+++|.... .+|+||||++ +.+|.|+||++.. ..+.++||+|....+| ++.+...|. +.+|
T Consensus 13 WyhG~isR~eAe~lL~~~g-~~G~FLVR~S-s~~g~y~LSv~~~~~~~~~~~v~H~~I~~~~~g~~~l~~~~~F~sl~eL 90 (125)
T 2ge9_A 13 WYSKHMTRSQAEQLLKQEG-KEGGFIVRDS-SKAGKYTVSVFAKSTGDPQGVIRHYVVCSTPQSQYYLAEKHLFSTIPEL 90 (125)
T ss_dssp SEETTCCHHHHHHHHHHHT-CTTEEEEEEC-SSSCCEEEEEEESSSSSTTCEEEEEECEEETTTEEESSTTSCBSSHHHH
T ss_pred ccccCCCHHHHHHHHhhcC-CCceEEEEec-CCCCCEEEEEEeccccCCCCeEEEEEEEEcCCCCEEECCCCcCCCHHHH
Confidence 9999999999999996543 6799999999 5679999999962 1368999999988777 777777898 9999
Q ss_pred HHHhhhccCCceeeccCCccc
Q psy1684 74 VEHYSKDADGLCVNLRKPCVQ 94 (189)
Q Consensus 74 i~~~~~~a~gl~~~~~~~~~~ 94 (189)
|++|....+|+...+..||..
T Consensus 91 V~~y~~~~~~l~~~L~~P~~~ 111 (125)
T 2ge9_A 91 INYHQHNSAGLISRLKYPVSQ 111 (125)
T ss_dssp HHHHHCCCTTCSCCSSEECCS
T ss_pred HHHhhhCCCCCceeCCCccCC
Confidence 999999999999999888865
|
| >2kno_A Tensin-like C1 domain-containing phosphatase; SH2 domain, TENC1, solution structure, cell junctio membrane, hydrolase, membrane, metal-binding; NMR {Homo sapiens} PDB: 2l6k_A | Back alignment and structure |
|---|
Probab=99.73 E-value=2.7e-17 Score=108.35 Aligned_cols=88 Identities=27% Similarity=0.260 Sum_probs=78.3
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCC---------------CeeeEEEEEeccCC-cc--
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSS---------------FCLKMTTGRSLFET-QK-- 62 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~---------------~~v~h~~i~~~~~g-yl-- 62 (189)
||||.|+|.+|+++|.. ..+|+||||++.+.+|.|+||++. . +.++||+|....+| +|
T Consensus 22 Wyhg~isR~eAe~lL~~--~~~G~FLVR~S~s~~g~y~LSv~~--~~~~~~~~~~~g~~~~~~v~H~~I~~~~~g~~l~g 97 (131)
T 2kno_A 22 WYKPHLSRDQAIALLKD--KDPGAFLIRDSHSFQGAYGLALKV--ATPPPSAQPWKGDPVEQLVRHFLIETGPKGVKIKG 97 (131)
T ss_dssp HBCTTCCHHHHHHHHTT--SCTTBEEEEECSSSTTEEEEEEEC--SCCSSSSSSCCSCHHHHHEEEEEEECCSSCCCEET
T ss_pred ceecCCCHHHHHHHhcC--CCCCeEEEecCCCCCCCEEEEEEe--CCCCcccccccccccCCceEEEEEEECCCCCEEec
Confidence 99999999999999953 478999999999888999999998 4 38999999988888 77
Q ss_pred -CCCCCcC-HhHHHHHhhhccCCceeeccCCc
Q psy1684 63 -AGRTTIH-YPELVEHYSKDADGLCVNLRKPC 92 (189)
Q Consensus 63 -~~~~~~~-l~~li~~~~~~a~gl~~~~~~~~ 92 (189)
.....|. +.+||++|.....|+.+.+..|+
T Consensus 98 ~~~~~~F~SL~eLV~~y~~~~~~L~~~L~~P~ 129 (131)
T 2kno_A 98 CPSEPYFGSLSALVSQHSISPISLPCCLRIPS 129 (131)
T ss_dssp CSSCCCCCSHHHHHHTTTTCCSSCSSCCBCSS
T ss_pred CCCCCccCCHHHHHHHHhhCCCCCCeECCCcC
Confidence 4566788 99999999999999998888776
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=1.6e-19 Score=133.93 Aligned_cols=152 Identities=24% Similarity=0.394 Sum_probs=111.8
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCC-CCcCHhHHHHHhhhccCC
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGR-TTIHYPELVEHYSKDADG 83 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~-~~~~l~~li~~~~~~a~g 83 (189)
.++|+|++++++... .+..|+|+|++.. + ++.. ++... ..++...+..+..+.+.|
T Consensus 72 ~l~h~~iv~~~~~~~-~~~~~lv~e~~~~-~----~L~~-----------------~l~~~~~~~~~~~~~~~~~qi~~~ 128 (281)
T 1mp8_A 72 QFDHPHIVKLIGVIT-ENPVWIIMELCTL-G----ELRS-----------------FLQVRKYSLDLASLILYAYQLSTA 128 (281)
T ss_dssp TCCCTTBCCEEEEEC-SSSCEEEEECCTT-E----EHHH-----------------HHHHTTTTSCHHHHHHHHHHHHHH
T ss_pred hCCCCccceEEEEEc-cCccEEEEecCCC-C----CHHH-----------------HHHhcCCCCCHHHHHHHHHHHHHH
Confidence 456777777776542 3456777776654 2 1111 23222 235567777788889999
Q ss_pred ceeeccCCcccccc-cc---------------ccccc----------------------C-CCCCccc-e-EEEec----
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YLVHG----------------------T-NLSGVVV-S-AVDFG---- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l~~~----------------------~-~~~~~~~-s-VwsfG---- 118 (189)
+.++|..+++|+|+ |+ +++.. . ....++. + |||||
T Consensus 129 l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 208 (281)
T 1mp8_A 129 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMW 208 (281)
T ss_dssp HHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHH
T ss_pred HHHHHhCCeecccccHHHEEECCCCCEEECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHH
Confidence 99999999999996 55 22211 1 2356788 9 99999
Q ss_pred ---------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q psy1684 119 ---------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTME 179 (189)
Q Consensus 119 ---------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~ 179 (189)
|.+.+..++...+..+.+++.|..+|+++.+|+.+||+.||++|||+.+|++.|+.+++..
T Consensus 209 ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 209 EILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp HHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 5556667788888888888899999999999999999999999999999999999998753
|
| >2dm0_A Tyrosine-protein kinase TXK; TEC family kinase, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.72 E-value=1.2e-17 Score=109.34 Aligned_cols=93 Identities=29% Similarity=0.413 Sum_probs=79.8
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecC----CCeeeEEEEEeccCC--ccCCCCCcC-HhHH
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRS----SFCLKMTTGRSLFET--QKAGRTTIH-YPEL 73 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~----~~~v~h~~i~~~~~g--yl~~~~~~~-l~~l 73 (189)
||||.|+|.+|+++|.... .+|+||||++ +.++.|+||++... .+.++||+|....+| ++.+...|. +.+|
T Consensus 18 WyhG~isR~eAe~lL~~~~-~~G~FLVR~S-~~~g~y~LSv~~~~~~~~~~~v~H~~I~~~~~g~~~l~~~~~F~sl~eL 95 (125)
T 2dm0_A 18 WYHRNITRNQAEHLLRQES-KEGAFIVRDS-RHLGSYTISVFMGARRSTEAAIKHYQIKKNDSGQWYVAERHAFQSIPEL 95 (125)
T ss_dssp SBCCSCCHHHHHHHHHHHC-STTCBCEEEE-TTEEEEEEEEECCCSSSSSCCEEEEEEEECTTCCEESSSSCCCSSHHHH
T ss_pred cccCCCCHHHHHHHHhhcC-CCCEEEEEec-CCCCCEEEEEEeccccCCCCcEEEEEEEEcCCCCEEECCCCccCCHHHH
Confidence 9999999999999996443 6799999999 56799999999721 358999999988777 777677888 9999
Q ss_pred HHHhhhccCCceeeccCCcccc
Q psy1684 74 VEHYSKDADGLCVNLRKPCVQV 95 (189)
Q Consensus 74 i~~~~~~a~gl~~~~~~~~~~~ 95 (189)
|+||....+|+...+..||...
T Consensus 96 V~~y~~~~~~l~~~L~~P~~~~ 117 (125)
T 2dm0_A 96 IWYHQHNAAGLMTRLRYPVGLM 117 (125)
T ss_dssp HHHHTTCCCSSSCCCCSBCCSS
T ss_pred HHHhhhCCCCCccCCCCccCCC
Confidence 9999999999999999988764
|
| >2iug_A Phosphatidylinositol 3-kinase regulatory alpha subunit; transferase, polymorphism, UBL conjugation, phosphorylation, SH2, PI3K, SH2 domain; 1.89A {Homo sapiens} PDB: 2iuh_A* 2iui_A* 1fu5_A* 1fu6_A 1oo3_A 1oo4_A* 2pna_A 2pnb_A | Back alignment and structure |
|---|
Probab=99.72 E-value=4.2e-17 Score=106.02 Aligned_cols=90 Identities=30% Similarity=0.426 Sum_probs=77.6
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCC-CCceEEEEEecCCCeeeEEEEEeccCC-ccCCCCCcC-HhHHHHHh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESR-KNDYSLSEYKRSSFCLKMTTGRSLFET-QKAGRTTIH-YPELVEHY 77 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~-~~~~~ls~~~~~~~~v~h~~i~~~~~g-yl~~~~~~~-l~~li~~~ 77 (189)
||||.|+|.+|+++|.. ..+|+||||++.+. ++.|+||++. .+.++|++|....++ ++.+...|. +.+||+||
T Consensus 13 WyhG~isR~eAe~lL~~--~~~G~FLVR~S~~~~~g~y~LSv~~--~~~v~H~~I~~~~g~~~l~~~~~F~sl~~LI~~y 88 (120)
T 2iug_A 13 WYWGDISREEVNEKLRD--TADGTFLVRDASTKMHGDYTLTLRK--GGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHY 88 (120)
T ss_dssp TBCCSCCHHHHHHHHTT--CCTTEEEEEECSSGGGCSEEEEEEE--TTEEEEEEEEEETTEEESSSSCCBSSHHHHHHHH
T ss_pred ccccCCCHHHHHHHhcC--CCCcEEEEECCCCCCCCcEEEEEEE--CCEEEEEEEEEcCCEEEECCCCccCCHHHHHHHH
Confidence 99999999999999953 57899999999987 7999999999 999999999987444 677777888 99999999
Q ss_pred hhccC-----CceeeccCCccc
Q psy1684 78 SKDAD-----GLCVNLRKPCVQ 94 (189)
Q Consensus 78 ~~~a~-----gl~~~~~~~~~~ 94 (189)
..... |+...+..||.+
T Consensus 89 ~~~~~~~~~~~l~~~L~~Pv~r 110 (120)
T 2iug_A 89 RNESLAQYNPKLDVKLLYPVSK 110 (120)
T ss_dssp HHSCGGGTCGGGCCCCCEECCT
T ss_pred HhCccccccCCcceeeCCcCCc
Confidence 98864 577778878765
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=4.1e-19 Score=132.41 Aligned_cols=118 Identities=26% Similarity=0.453 Sum_probs=95.3
Q ss_pred ccCCCCCcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cccccC-------------------
Q psy1684 61 QKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVHGT------------------- 105 (189)
Q Consensus 61 yl~~~~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~~~------------------- 105 (189)
++.....++...+..+..+.+.|+.++|..+++|+|+ |+ +++...
T Consensus 107 ~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y 186 (291)
T 1xbb_A 107 YLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 186 (291)
T ss_dssp HHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGG
T ss_pred HHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCcee
Confidence 4443444566777788888999999999999999996 55 221110
Q ss_pred ------CCCCccc-e-EEEec-------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q psy1684 106 ------NLSGVVV-S-AVDFG-------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPT 164 (189)
Q Consensus 106 ------~~~~~~~-s-VwsfG-------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~ 164 (189)
....++. + ||||| |.+.+..++...+..+.+++.|..+|+++.+|+.+||+.||++|||
T Consensus 187 ~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps 266 (291)
T 1xbb_A 187 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPG 266 (291)
T ss_dssp CCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCC
T ss_pred eChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcC
Confidence 1234678 8 99999 5666778888888888888899999999999999999999999999
Q ss_pred HHHHHHHHHHHHhh
Q psy1684 165 FETLQWKLEDFFTM 178 (189)
Q Consensus 165 ~~~i~~~l~~~~~~ 178 (189)
+.+|++.|++++..
T Consensus 267 ~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 267 FAAVELRLRNYYYD 280 (291)
T ss_dssp HHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHH
Confidence 99999999999875
|
| >4d8k_A Tyrosine-protein kinase LCK; protein kinases, SH2 domain, SH3 domain, structural genomics center for structural genomics, JCSG; 2.36A {Homo sapiens} PDB: 1lck_A* 1x27_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=7e-17 Score=111.91 Aligned_cols=93 Identities=41% Similarity=0.692 Sum_probs=82.3
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEec---CCCeeeEEEEEeccCC--ccCCCCCcC-HhHHH
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKR---SSFCLKMTTGRSLFET--QKAGRTTIH-YPELV 74 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~---~~~~v~h~~i~~~~~g--yl~~~~~~~-l~~li 74 (189)
||||.|+|.+|+++|......+|+||||++.+..|.|+||++.. ..+.++||+|....+| |+.....|. +.+||
T Consensus 76 w~~g~isr~~ae~lL~~~~~~~G~FLVR~S~~~~g~y~LSv~~~~~~~~~~v~H~~I~~~~~g~~~~~~~~~F~sl~~LV 155 (175)
T 4d8k_A 76 WFFKNLSRKDAERQLLAPGNTHGSFLIRESESTAGSFSLSVRDFDQNQGEVVKHYKIRNLDNGGFYISPRITFPGLHELV 155 (175)
T ss_dssp TBCSSCCHHHHHHHHHSTTCCTTCEEEEECSSSTTCEEEEEEEECTTSCEEEEEEEEEECSSSCEESSTTSEESSHHHHH
T ss_pred eecCcccHHHHHHHHhcCCCCCCEEEEEECCCCCCeEEEEEEeCcccCCCceEEEEEEECCCCCEEECCCCccCCHHHHH
Confidence 99999999999999977666799999999998889999999862 2468999999987777 777777898 99999
Q ss_pred HHhhhccCCceeeccCCcc
Q psy1684 75 EHYSKDADGLCVNLRKPCV 93 (189)
Q Consensus 75 ~~~~~~a~gl~~~~~~~~~ 93 (189)
+||...++|+.+.+..||.
T Consensus 156 ~~y~~~~~gl~~~L~~Pc~ 174 (175)
T 4d8k_A 156 RHYTNASDGLCTRLSRPCQ 174 (175)
T ss_dssp HHHHHCCTTSSSCCCSBCC
T ss_pred HHHhhCCCCCcccCCCcCC
Confidence 9999999999999999885
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.71 E-value=1.5e-18 Score=129.56 Aligned_cols=153 Identities=19% Similarity=0.277 Sum_probs=115.0
Q ss_pred CCChHHHHHHhcCCCCCCCc-EEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC-CCCcCHhHHHHHhhhccC
Q psy1684 5 KIKRIEAEKKLLLPENDHGA-FLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG-RTTIHYPELVEHYSKDAD 82 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~-fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~-~~~~~l~~li~~~~~~a~ 82 (189)
.++|+|++++++.+...++. ++|.++...+. +.. ++.. ...+....+..+..+.+.
T Consensus 78 ~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~-----L~~-----------------~~~~~~~~~~~~~~~~i~~qi~~ 135 (298)
T 3pls_A 78 GLNHPNVLALIGIMLPPEGLPHVLLPYMCHGD-----LLQ-----------------FIRSPQRNPTVKDLISFGLQVAR 135 (298)
T ss_dssp TCCCTTBCCCCEEECCSSSCCEEEECCCTTCB-----HHH-----------------HHHCTTCCCBHHHHHHHHHHHHH
T ss_pred hCCCCCeeeEEEEEecCCCCcEEEEecccCCC-----HHH-----------------HHhccccCCCHHHHHHHHHHHHH
Confidence 46677777777766555454 77777766522 111 2322 223446777788888999
Q ss_pred CceeeccCCcccccc-cc---------------cccccC--------------------------CCCCccc-e-EEEec
Q psy1684 83 GLCVNLRKPCVQVSC-RI---------------YLVHGT--------------------------NLSGVVV-S-AVDFG 118 (189)
Q Consensus 83 gl~~~~~~~~~~~~~-p~---------------~l~~~~--------------------------~~~~~~~-s-VwsfG 118 (189)
|+.++|..+++|+|+ |+ +++... ....++. + |||||
T Consensus 136 ~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 215 (298)
T 3pls_A 136 GMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFG 215 (298)
T ss_dssp HHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHH
T ss_pred HHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHH
Confidence 999999999999996 54 222211 3446788 9 99999
Q ss_pred -------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q psy1684 119 -------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTME 179 (189)
Q Consensus 119 -------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~ 179 (189)
|.+.+..++...+..+.+++.|..+|+++.+|+.+||+.||.+|||++++++.|+++++..
T Consensus 216 ~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 216 VLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp HHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 5566677788888888888889999999999999999999999999999999999998864
|
| >2eo3_A CRK-like protein; phosphorylation, repeat, SH2 domain, SH3 domain, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=4.4e-17 Score=104.48 Aligned_cols=86 Identities=31% Similarity=0.497 Sum_probs=73.4
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC--ccCCCCCcC-HhHHHHHh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET--QKAGRTTIH-YPELVEHY 77 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g--yl~~~~~~~-l~~li~~~ 77 (189)
||||.|+|.+|+++|. ...+|+||||++.+.+|.|+||++. .+.++|++|....+| ++ +...|. +.+||+||
T Consensus 21 Wyhg~isR~~Ae~lL~--~~~~G~FLVR~S~~~~g~y~LSv~~--~~~v~H~~I~~~~~g~~~l-~~~~F~sl~~LV~~y 95 (111)
T 2eo3_A 21 WYMGPVSRQEAQTRLQ--GQRHGMFLVRDSSTCPGDYVLSVSE--NSRVSHYIINSLPNRRFKI-GDQEFDHLPALLEFY 95 (111)
T ss_dssp HEEESCCHHHHHHHHS--SCCTTCEEEEECSSSSSCEEEEEEE--TTEEEEEEEEEETTTEEEE-TTCCBSSHHHHHHHH
T ss_pred cccCCCCHHHHHHHhc--CCCCceEEEEeecCCCCCEEEEEEe--CCeEEEEEEEEcCCCCEEE-CCcccCCHHHHHHHH
Confidence 9999999999999994 4578999999999888999999999 999999999986667 55 467888 99999999
Q ss_pred hhccCCceeeccCCc
Q psy1684 78 SKDADGLCVNLRKPC 92 (189)
Q Consensus 78 ~~~a~gl~~~~~~~~ 92 (189)
.....+ ...+..||
T Consensus 96 ~~~~l~-~~~L~~Pv 109 (111)
T 2eo3_A 96 KIHYLD-TTTLIEPA 109 (111)
T ss_dssp TTSCSS-SSCCCCBC
T ss_pred hhCCCC-CccCCCcC
Confidence 988765 34555555
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=2.8e-19 Score=134.43 Aligned_cols=173 Identities=17% Similarity=0.215 Sum_probs=119.6
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEE-eccCC-cc--CCCCCcCHhHHHHHhhh
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGR-SLFET-QK--AGRTTIHYPELVEHYSK 79 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~-~~~~g-yl--~~~~~~~l~~li~~~~~ 79 (189)
..++|+|++++++.+......++|+|++.+ +.+.-.+... ...-..+.-. ..... .+ .....+...++..+..+
T Consensus 81 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~q 158 (314)
T 2ivs_A 81 KQVNHPHVIKLYGACSQDGPLLLIVEYAKY-GSLRGFLRES-RKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQ 158 (314)
T ss_dssp TTCCCTTBCCEEEEECSSSSCEEEEECCTT-CBHHHHHHHT-TTSTTEEC----------------CEECHHHHHHHHHH
T ss_pred hhCCCCceeeEEEEEecCCceEEEEeecCC-CCHHHHHHHH-hhccCCcccccccccccccccccccCcCHHHHHHHHHH
Confidence 467899999999888777788999999886 3221001110 0000000000 00000 00 01223446777888889
Q ss_pred ccCCceeeccCCcccccc-cc---------------cccccC------------------------CCCCccc-e-EEEe
Q psy1684 80 DADGLCVNLRKPCVQVSC-RI---------------YLVHGT------------------------NLSGVVV-S-AVDF 117 (189)
Q Consensus 80 ~a~gl~~~~~~~~~~~~~-p~---------------~l~~~~------------------------~~~~~~~-s-Vwsf 117 (189)
.+.|+.++|..+++|+|+ |+ +++... ....++. + |||+
T Consensus 159 i~~~l~~lH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 238 (314)
T 2ivs_A 159 ISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSF 238 (314)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHH
T ss_pred HHHHHHHHHHCCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHH
Confidence 999999999999999996 55 222111 1234688 8 9999
Q ss_pred c-------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q psy1684 118 G-------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTM 178 (189)
Q Consensus 118 G-------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~ 178 (189)
| |.+.+..++...+..+.+++.|..+|+++.+|+.+||+.||++|||+.+|++.|+.++..
T Consensus 239 G~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 239 GVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp HHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHHHHhCCCCCCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 9 556667778888888888888999999999999999999999999999999999998863
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.71 E-value=6e-19 Score=130.66 Aligned_cols=120 Identities=33% Similarity=0.600 Sum_probs=93.9
Q ss_pred CcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cccccC-----------------------CC
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVHGT-----------------------NL 107 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~~~-----------------------~~ 107 (189)
.++...+..+..+.+.|+.++|..+++|+|+ |+ +++... ..
T Consensus 105 ~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 184 (279)
T 1qpc_A 105 KLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184 (279)
T ss_dssp TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccCCCCccCccChhhhcc
Confidence 3456777888888999999999999999996 55 111110 12
Q ss_pred CCccc-e-EEEec-------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q psy1684 108 SGVVV-S-AVDFG-------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKL 172 (189)
Q Consensus 108 ~~~~~-s-VwsfG-------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l 172 (189)
+.++. + ||||| |.+.+..++...+..+.++..|..+|.++.+|+.+||+.||++|||+.+|++.|
T Consensus 185 ~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 264 (279)
T 1qpc_A 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264 (279)
T ss_dssp CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 45788 8 99999 566677888888888888888999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCC
Q psy1684 173 EDFFTMEGSDYKEA 186 (189)
Q Consensus 173 ~~~~~~~~~~~~~~ 186 (189)
+.++......|++.
T Consensus 265 ~~~~~~~~~~~~~~ 278 (279)
T 1qpc_A 265 EDFFTATEGQYQPQ 278 (279)
T ss_dssp HHHHHHC-------
T ss_pred HHHHHhccCCCCCC
Confidence 99999887777653
|
| >2crh_A VAV proto-oncogene; oncoprotein, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} PDB: 2ror_A* 2lct_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=8.3e-17 Score=106.94 Aligned_cols=90 Identities=24% Similarity=0.384 Sum_probs=78.0
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC--ccCCCCCcC-HhHHHHHh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET--QKAGRTTIH-YPELVEHY 77 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g--yl~~~~~~~-l~~li~~~ 77 (189)
||||.|+|.+|+++|.. ..+|+||||++...++.|+||++. .+.++||+|. ..+| +|.+...|. +.+||+||
T Consensus 28 WyhG~isR~eAe~lL~~--~~~G~FLVR~S~~~~g~y~LSv~~--~~~v~H~~I~-~~~g~~~l~~~~~F~sl~eLV~~y 102 (138)
T 2crh_A 28 WYAGPMERAGAESILAN--RSDGTFLVRQRVKDAAEFAISIKY--NVEVKHIKIM-TAEGLYRITEKKAFRGLTELVEFY 102 (138)
T ss_dssp SBCCSCCHHHHHHHTTT--SCTTEEEEECCSSTTCCCEEEEEE--TTEEEEEECE-EETTEEESSTTCCBSSHHHHHHHH
T ss_pred cccCCCCHHHHHHHhcC--CCCCEEEEEECCCCCCCEEEEEEE--CCeEEEEEEE-eCCCEEEECCCCccCCHHHHHHHH
Confidence 99999999999999954 478999999999888999999999 9999999996 5556 677677898 99999999
Q ss_pred hhcc-----CCceeeccCCcccc
Q psy1684 78 SKDA-----DGLCVNLRKPCVQV 95 (189)
Q Consensus 78 ~~~a-----~gl~~~~~~~~~~~ 95 (189)
.... +|+...+..||...
T Consensus 103 ~~~~l~~~~~~l~~~L~~Pv~~~ 125 (138)
T 2crh_A 103 QQNSLKDCFKSLDTTLQFPFKEP 125 (138)
T ss_dssp TTSCGGGTCTTCCCCCCEESSCC
T ss_pred HhCccccccCCcCcccCCccCCC
Confidence 9887 57888888887653
|
| >1mil_A SHC adaptor protein; SH2 domain, phosphorylation, collagen, growth regulation, transforming protein, alternative initiation; 2.70A {Homo sapiens} SCOP: d.93.1.1 PDB: 1tce_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=4.9e-17 Score=103.08 Aligned_cols=87 Identities=25% Similarity=0.315 Sum_probs=73.7
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC-ccCCCCCcC-HhHHHHHhh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET-QKAGRTTIH-YPELVEHYS 78 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g-yl~~~~~~~-l~~li~~~~ 78 (189)
||||.|+|.+|+++|. .+|+||||++.+.+|.|+||++. .+.++|++|. ..+| |..+...|. +.+||+||.
T Consensus 9 Wyhg~isR~~Ae~lL~----~~G~FLVR~S~~~~g~~~LSv~~--~~~v~H~~I~-~~~g~~~~~~~~F~sl~~LI~~y~ 81 (104)
T 1mil_A 9 WFHGKLSRREAEALLQ----LNGDFLVRESTTTPGQYVLTGLQ--SGQPKHLLLV-DPEGVVRTKDHRFESVSHLISYHM 81 (104)
T ss_dssp TBCSSCCHHHHHTTCC----STTEEEEEECCSSCSSEEEEEEE--TTEEEEEEEB-CTTSSEECSSCEESSHHHHHHHHH
T ss_pred cCCCCCCHHHHHHHhc----cCCcEEEEeCCCCCCCEEEEEEE--CCEEEEEEEE-eCCCEEEECCceeCCHHHHHHHHh
Confidence 9999999999999984 58999999999888999999999 9999999996 4556 555567888 999999999
Q ss_pred hccC-----CceeeccCCccc
Q psy1684 79 KDAD-----GLCVNLRKPCVQ 94 (189)
Q Consensus 79 ~~a~-----gl~~~~~~~~~~ 94 (189)
.... |+...+..||..
T Consensus 82 ~~~~p~~~~g~~~~L~~Pv~r 102 (104)
T 1mil_A 82 DNHLPIISAGSELCLQQPVER 102 (104)
T ss_dssp HHTCCEEETTEEECCCEECCC
T ss_pred hCCCccccCCceEEeCccCCC
Confidence 8753 666677777643
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=1.2e-18 Score=128.42 Aligned_cols=152 Identities=17% Similarity=0.211 Sum_probs=114.9
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC-CCCcCHhHHHHHhhhccCC
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG-RTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~-~~~~~l~~li~~~~~~a~g 83 (189)
.++|+|++++++.+......++|+|+++.+. +.. ++.. ...++...+..+..+.+.|
T Consensus 61 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~-----L~~-----------------~l~~~~~~~~~~~~~~i~~~i~~~ 118 (269)
T 4hcu_A 61 KLSHPKLVQLYGVCLEQAPICLVFEFMEHGC-----LSD-----------------YLRTQRGLFAAETLLGMCLDVCEG 118 (269)
T ss_dssp TCCCTTBCCEEEEECSSSSEEEEEECCTTCB-----HHH-----------------HHHTTTTCCCHHHHHHHHHHHHHH
T ss_pred hCCCCCEeeEEEEEecCCceEEEEEeCCCCc-----HHH-----------------HHHhcCcccCHHHHHHHHHHHHHH
Confidence 4667777777776666666677777766521 111 2322 2235567777778888899
Q ss_pred ceeeccCCcccccc-cc---------------ccccc----------------------C-CCCCccc-e-EEEec----
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YLVHG----------------------T-NLSGVVV-S-AVDFG---- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l~~~----------------------~-~~~~~~~-s-VwsfG---- 118 (189)
+.++|..+++|+|+ |+ +++.. . ....++. + |||+|
T Consensus 119 l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 198 (269)
T 4hcu_A 119 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMW 198 (269)
T ss_dssp HHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred HHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHH
Confidence 99999999999996 54 22211 1 2356788 9 99999
Q ss_pred ---------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q psy1684 119 ---------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTM 178 (189)
Q Consensus 119 ---------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~ 178 (189)
|.+.+..++...+..+.++..|..+++++.+|+.+||+.||++|||++++++.|+.+.++
T Consensus 199 ~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 199 EVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp HHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 566677888888888888888999999999999999999999999999999999998763
|
| >2oq1_A Tyrosine-protein kinase ZAP-70; tandem SH2 domains, ZAP-70, tyrosine kinase, transferase; HET: PTR; 1.90A {Homo sapiens} SCOP: d.93.1.1 d.93.1.1 PDB: 1m61_A | Back alignment and structure |
|---|
Probab=99.70 E-value=9.8e-17 Score=117.41 Aligned_cols=90 Identities=28% Similarity=0.344 Sum_probs=82.1
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC--ccCCCCCcC-HhHHHHHh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET--QKAGRTTIH-YPELVEHY 77 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g--yl~~~~~~~-l~~li~~~ 77 (189)
||||.|+|.+|+++|......+|+||||++ +.+|.|+||++. .+.++|++|....+| ++.+...|. +.+||+||
T Consensus 161 Wyhg~isR~~Ae~lL~~~g~~~G~FLVR~S-~~~g~~~LSv~~--~~~v~H~~I~~~~~g~~~~~~~~~F~sl~~LV~~y 237 (254)
T 2oq1_A 161 WYHSSLTREEAERKLYSGAQTDGKFLLRPR-KEQGTYALSLIY--GKTVYHYLISQDKAGKYCIPEGTKFDTLWQLVEYL 237 (254)
T ss_dssp TBCSSCCHHHHHHHHHSSCCCTTEEEEEEC-SSTTEEEEEEEE--TTEEEEEEEEECTTSCEESTTSCCBSSHHHHHHHH
T ss_pred ccccCCCHHHHHHHHHhcCCCCceEEEEec-CCCCCEEEEEEE--CCeEEEEEEEEcCCCCEEECCCceECCHHHHHHHH
Confidence 999999999999999776668999999999 778999999999 999999999987777 676678898 99999999
Q ss_pred hhccCCceeeccCCcc
Q psy1684 78 SKDADGLCVNLRKPCV 93 (189)
Q Consensus 78 ~~~a~gl~~~~~~~~~ 93 (189)
....+|+.+.+..||.
T Consensus 238 ~~~~~~l~~~L~~p~~ 253 (254)
T 2oq1_A 238 KLKADGLIYCLKEACP 253 (254)
T ss_dssp HHCCTTSSSCCCSBCC
T ss_pred HhCCCCCCeeCCccCc
Confidence 9999999999888875
|
| >2eob_A 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma 2; SH2, phosphoinositide phospholipase C, PLC-gamma-2, phospholipase C-gamma-2; NMR {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.70 E-value=6.6e-17 Score=105.59 Aligned_cols=90 Identities=28% Similarity=0.315 Sum_probs=75.9
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCc-cCCCCCcC-HhHHHHHhh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQ-KAGRTTIH-YPELVEHYS 78 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gy-l~~~~~~~-l~~li~~~~ 78 (189)
||||.|+|.+|+++|.... .+|+||||++. .++.|+||++. .+.++|++|....+.| +.....|. +.+||+||.
T Consensus 21 WyhG~isR~eAe~lL~~~~-~~G~FLVR~S~-~~g~y~LSv~~--~~~v~H~~I~~~~~~~~~~~~~~F~sl~~LV~~y~ 96 (124)
T 2eob_A 21 WYYDRLSRGEAEDMLMRIP-RDGAFLIRKRE-GTDSYAITFRA--RGKVKHCRINRDGRHFVLGTSAYFESLVELVSYYE 96 (124)
T ss_dssp TEESSCCHHHHHHHHHHCC-SSSEEEEECCT-TSSCEEEEEEE--TTEEEEEEEEESSSCEESSSSCCBSSHHHHHHHHT
T ss_pred CeecCCCHHHHHHHHhcCC-CCCEEEEEecC-CCCCEEEEEEe--CCeEEEEEEEECCCEEEECCCCcCCCHHHHHHHHh
Confidence 9999999999999996442 57999999999 77999999999 9999999998753334 55455588 999999999
Q ss_pred hccCCceeeccCCccc
Q psy1684 79 KDADGLCVNLRKPCVQ 94 (189)
Q Consensus 79 ~~a~gl~~~~~~~~~~ 94 (189)
....++...+..||..
T Consensus 97 ~~~~~~~~~L~~P~~~ 112 (124)
T 2eob_A 97 KHALYRKMRLRYPVTP 112 (124)
T ss_dssp TSCSSSSCCSCEECCH
T ss_pred hCCCCCCcCCCCcCCc
Confidence 9988888888877754
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.70 E-value=9.5e-19 Score=132.92 Aligned_cols=166 Identities=21% Similarity=0.271 Sum_probs=117.6
Q ss_pred ChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEec-CCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCce
Q psy1684 7 KRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKR-SSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGLC 85 (189)
Q Consensus 7 ~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~-~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl~ 85 (189)
.|+|++++++.+......+||+|+..+ +.+.-.+... ..+....+.+.. .....+...++..+..+.+.|+.
T Consensus 99 ~hp~iv~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~i~~qi~~aL~ 171 (334)
T 2pvf_A 99 KHKNIINLLGACTQDGPLYVIVEYASK-GNLREYLRARRPPGMEYSYDINR------VPEEQMTFKDLVSCTYQLARGME 171 (334)
T ss_dssp CCTTBCCEEEEECSSSCCEEEEECCTT-CBHHHHHHTTSCTTCCSCC--------------CCCHHHHHHHHHHHHHHHH
T ss_pred cCCCEeeEEEEEccCCceEEEEECCCC-CcHHHHHHHhccccccccccccc------cccccCCHHHHHHHHHHHHHHHH
Confidence 688888888887777788999998876 3221001000 000000000000 00123446777888889999999
Q ss_pred eeccCCcccccc-cc---------------cccccC------------------------CCCCccc-e-EEEec-----
Q psy1684 86 VNLRKPCVQVSC-RI---------------YLVHGT------------------------NLSGVVV-S-AVDFG----- 118 (189)
Q Consensus 86 ~~~~~~~~~~~~-p~---------------~l~~~~------------------------~~~~~~~-s-VwsfG----- 118 (189)
++|..+++|+|+ |+ +++... ....++. + |||||
T Consensus 172 ~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 251 (334)
T 2pvf_A 172 YLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE 251 (334)
T ss_dssp HHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHH
T ss_pred HHHhCCeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHH
Confidence 999999999996 54 222111 1244788 8 99999
Q ss_pred --------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q psy1684 119 --------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTME 179 (189)
Q Consensus 119 --------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~ 179 (189)
|.+.+..++...+..+.+++.|..+|.++.+|+.+||+.||++|||+.+|++.|+.+++..
T Consensus 252 llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 252 IFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320 (334)
T ss_dssp HHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHhCCCCCcCcCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 5667778888888888888889999999999999999999999999999999999998864
|
| >2el8_A Signal-transducing adaptor protein 2; SH2 domain, phosphotyrosine binding domain, protein tyrosine kinase, signal transduction, structural genomics; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.70 E-value=3.7e-17 Score=105.80 Aligned_cols=88 Identities=15% Similarity=0.126 Sum_probs=74.2
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEec--CCCeeeEEEEEeccCC-ccCCCCCc--C-HhHHH
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKR--SSFCLKMTTGRSLFET-QKAGRTTI--H-YPELV 74 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~--~~~~v~h~~i~~~~~g-yl~~~~~~--~-l~~li 74 (189)
||||.|+|.+|+++|.... .+|+||||++.+.+|.|+||++.. ..+.++||+|....++ ++.....| . +.+||
T Consensus 23 WyhG~isR~eAe~lL~~~~-~~G~FLVR~S~~~~g~y~LSv~~~~~~~~~v~H~~I~~~~g~~~i~~~~~F~~~sL~eLV 101 (118)
T 2el8_A 23 SCFLKVSRLEAQLLLERYP-ECGNLLLRPSGDGADGVSVTTRQMHNGTHVVRHYKVKREGPKYVIDVEQPFSCTSLDAVV 101 (118)
T ss_dssp TTCCCCCHHHHHHHHHHSS-TTCSBEEEECCSSSSSEEEEECCCBTTBCCCEEECBCCBTTBCCBSSSSCCCCSSHHHHH
T ss_pred ceecCCCHHHHHHHHhhCC-CCcEEEEeeCCCCCCceEEEEEEecCCCCcEEEEEEEEcCCEEEEeCCCeECCCCHHHHH
Confidence 9999999999999996544 789999999998889999999873 1368999999884434 77767788 7 99999
Q ss_pred HHhhhccCCceeecc
Q psy1684 75 EHYSKDADGLCVNLR 89 (189)
Q Consensus 75 ~~~~~~a~gl~~~~~ 89 (189)
+||...+.|++..+.
T Consensus 102 ~~y~~~~~gl~~~L~ 116 (118)
T 2el8_A 102 NYFVSHTKKALVPFL 116 (118)
T ss_dssp HHHHHHSSSCCCBCC
T ss_pred HHHhhCCCCCeEeee
Confidence 999999999886553
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.70 E-value=2.4e-19 Score=135.91 Aligned_cols=111 Identities=24% Similarity=0.378 Sum_probs=91.9
Q ss_pred CcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cccc-----------------------cC-C
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVH-----------------------GT-N 106 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~-----------------------~~-~ 106 (189)
.+....+..+..+.+.|+.++|..+++|+|+ |+ |+++ |. .
T Consensus 113 ~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 192 (327)
T 3poz_A 113 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192 (327)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhc
Confidence 4556777788889999999999999999996 55 2111 11 2
Q ss_pred CCCccc-e-EEEec-------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 107 LSGVVV-S-AVDFG-------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 107 ~~~~~~-s-VwsfG-------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
...++. + ||||| |.+.+..++...+..+.+++.|..++.++.+|+.+||+.||++|||+.+|++.
T Consensus 193 ~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred cCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 355788 9 99999 56666777888888888888999999999999999999999999999999999
Q ss_pred HHHHHh
Q psy1684 172 LEDFFT 177 (189)
Q Consensus 172 l~~~~~ 177 (189)
|+.+..
T Consensus 273 l~~~~~ 278 (327)
T 3poz_A 273 FSKMAR 278 (327)
T ss_dssp HHHHHT
T ss_pred HHHHHh
Confidence 998875
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=1.1e-18 Score=143.44 Aligned_cols=151 Identities=23% Similarity=0.384 Sum_probs=117.3
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC-CCCcCHhHHHHHhhhccCC
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG-RTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~-~~~~~l~~li~~~~~~a~g 83 (189)
.++|+|++++++.+. .+..|||+|++.. |+ +.. ++.. ...+....++.+..+.+.|
T Consensus 447 ~l~HpnIv~l~~~~~-~~~~~lv~E~~~~-g~----L~~-----------------~l~~~~~~l~~~~~~~i~~qi~~a 503 (656)
T 2j0j_A 447 QFDHPHIVKLIGVIT-ENPVWIIMELCTL-GE----LRS-----------------FLQVRKFSLDLASLILYAYQLSTA 503 (656)
T ss_dssp HCCCTTBCCEEEEEC-SSSCEEEEECCTT-CB----HHH-----------------HHHHTTTTCCHHHHHHHHHHHHHH
T ss_pred hCCCCCCCeEEEEEe-cCceEEEEEcCCC-Cc----HHH-----------------HHHhccCCCCHHHHHHHHHHHHHH
Confidence 467888888887763 4567888888775 31 111 2221 1234467777888899999
Q ss_pred ceeeccCCcccccc-cc---------------cccccC-----------------------CCCCccc-e-EEEec----
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YLVHGT-----------------------NLSGVVV-S-AVDFG---- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l~~~~-----------------------~~~~~~~-s-VwsfG---- 118 (189)
+.++|..+++|+|+ |+ |+++.. ....++. + |||||
T Consensus 504 L~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ 583 (656)
T 2j0j_A 504 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMW 583 (656)
T ss_dssp HHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred HHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHH
Confidence 99999999999996 55 322211 2345888 9 99999
Q ss_pred ---------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q psy1684 119 ---------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTM 178 (189)
Q Consensus 119 ---------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~ 178 (189)
|.+.+..++...+..+.+++.|..+|+++.+||.+||+.||++|||+.+|++.|+.+++.
T Consensus 584 ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 584 EILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp HHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 666777888888989999999999999999999999999999999999999999999864
|
| >2dx0_A Phospholipase C, gamma 2; phosphoric diester hydrolase, structural genomics, NPPSFA, national project on protein structural and functional analyses; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.70 E-value=7.1e-17 Score=107.38 Aligned_cols=92 Identities=29% Similarity=0.436 Sum_probs=78.4
Q ss_pred CCCCCC-ChHHHHHHhcCC----CCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEecc-CC----ccCCCCCcC-
Q psy1684 1 WYFGKI-KRIEAEKKLLLP----ENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLF-ET----QKAGRTTIH- 69 (189)
Q Consensus 1 w~~g~l-~~~n~~~lL~~~----~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~-~g----yl~~~~~~~- 69 (189)
||||.| +|.+|+++|... ...+|+||||++...+|.|+||++. .+.++||+|.... +| |+.+...|.
T Consensus 24 WyhG~i~sR~eAe~lL~~~c~~~g~~~G~FLVR~S~~~~g~y~LSv~~--~~~v~H~~I~~~~~gg~~~~~l~~~~~F~s 101 (138)
T 2dx0_A 24 WFHKKVESRTSAEKLLQEYCAETGAKDGTFLVRESETFPNDYTLSFWR--SGRVQHCRIRSTMENGVMKYYLTDNLTFNS 101 (138)
T ss_dssp TBCTTCCCHHHHHHHHHHHHTTTTCCTTCEEEEECSSSTTCEEEEEEE--TTEEEEEEEEEEEETTEEEEESSTTSCBSS
T ss_pred cccCCCCCHHHHHHHHHhhccccCCCCCEEEEEeCCCCCCCeEEEEEE--CCeEEEEEEEEecCCCceEEEeCCCCcCCC
Confidence 999999 899999999642 4578999999999888999999999 9999999998764 33 777778899
Q ss_pred HhHHHHHhhhcc---CCceeeccCCccc
Q psy1684 70 YPELVEHYSKDA---DGLCVNLRKPCVQ 94 (189)
Q Consensus 70 l~~li~~~~~~a---~gl~~~~~~~~~~ 94 (189)
+.+||+||.... .|+...+..||.+
T Consensus 102 l~eLI~~y~~~~l~~~gl~~~L~~Pv~~ 129 (138)
T 2dx0_A 102 IYALIQHYREAHLRCAEFELRLTDPVPN 129 (138)
T ss_dssp HHHHHHHTTTSCCCCGGGSSCCCCBCC-
T ss_pred HHHHHHHHhhCCCCCCCcccccCccCCC
Confidence 999999999886 4778888888754
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.70 E-value=1.4e-18 Score=128.90 Aligned_cols=152 Identities=18% Similarity=0.239 Sum_probs=115.1
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC-CCCcCHhHHHHHhhhccCC
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG-RTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~-~~~~~l~~li~~~~~~a~g 83 (189)
.++|+|++++++.+......++|+|++..+. +.. ++.. ...+....+..+..+.+.|
T Consensus 75 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~-----L~~-----------------~l~~~~~~~~~~~~~~i~~qi~~~ 132 (283)
T 3gen_A 75 NLSHEKLVQLYGVCTKQRPIFIITEYMANGC-----LLN-----------------YLREMRHRFQTQQLLEMCKDVCEA 132 (283)
T ss_dssp TCCCTTBCCEEEEECSSSSEEEEECCCTTCB-----HHH-----------------HHHCGGGCCCHHHHHHHHHHHHHH
T ss_pred cCCCCCEeeEEEEEecCCCeEEEEeccCCCc-----HHH-----------------HHHHhccCCCHHHHHHHHHHHHHH
Confidence 4567777777776666666777777776521 111 2222 2335567777788888999
Q ss_pred ceeeccCCcccccc-cc---------------cccc----------------------cC-CCCCccc-e-EEEec----
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YLVH----------------------GT-NLSGVVV-S-AVDFG---- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l~~----------------------~~-~~~~~~~-s-VwsfG---- 118 (189)
+.++|..+++|+|+ |+ +++. |. ....++. + |||+|
T Consensus 133 l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ 212 (283)
T 3gen_A 133 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMW 212 (283)
T ss_dssp HHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHH
T ss_pred HHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHH
Confidence 99999999999996 54 2221 11 2355788 9 99999
Q ss_pred ---------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q psy1684 119 ---------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTM 178 (189)
Q Consensus 119 ---------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~ 178 (189)
|.+.+..+....+..+.+...|..+|+++.+|+.+||+.||++|||++++++.|+.++..
T Consensus 213 ~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 213 EIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp HHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 556677788888888888888999999999999999999999999999999999998864
|
| >2cs0_A Hematopoietic SH2 domain containing; ALX, FLJ14886, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: d.93.1.1 | Back alignment and structure |
|---|
Probab=99.70 E-value=1.5e-16 Score=103.14 Aligned_cols=89 Identities=28% Similarity=0.329 Sum_probs=75.6
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC--ccCC-CCCcC-HhHHHHH
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET--QKAG-RTTIH-YPELVEH 76 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g--yl~~-~~~~~-l~~li~~ 76 (189)
||||.|+|.+|+++|. ...+|+||||++...++ |+||++. .+.++|++|....+| ++.+ ...|. +.+||+|
T Consensus 18 WyhG~isR~~Ae~lL~--~~~~G~FLVR~S~~~~~-y~LSv~~--~~~v~H~~I~~~~~g~~~l~~~~~~F~sl~eLV~~ 92 (119)
T 2cs0_A 18 WFHGAISREDAENLLE--SQPLGSFLIRVSHSHVG-YTLSYKA--QSSCCHFMVKLLDDGTFMIPGEKVAHTSLDALVTF 92 (119)
T ss_dssp SBCSSCCHHHHHHHHH--TSCTTCEEEEECSSSSS-EEEEECC--SSSCEEEEEEECTTSCEECTTCSCCBSSHHHHHHH
T ss_pred ccccCCCHHHHHHHhc--CCCCCEEEEEecCCCCC-EEEEEEE--CCEEEEEEEEEcCCCcEEEecCCCcCCCHHHHHHH
Confidence 9999999999999994 45789999999998877 9999999 899999999988776 5653 56788 9999999
Q ss_pred hhhccCC-ceeeccCCccc
Q psy1684 77 YSKDADG-LCVNLRKPCVQ 94 (189)
Q Consensus 77 ~~~~a~g-l~~~~~~~~~~ 94 (189)
|.....+ ....+..||..
T Consensus 93 y~~~~l~~~~~~L~~P~~~ 111 (119)
T 2cs0_A 93 HQQKPIEPRRELLTQPCRQ 111 (119)
T ss_dssp HTTSCCSSCCCCCCSBCCC
T ss_pred HhhCcCCCCCCEeCccCCC
Confidence 9988754 34667777765
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.69 E-value=1.1e-18 Score=129.78 Aligned_cols=119 Identities=27% Similarity=0.460 Sum_probs=97.6
Q ss_pred CcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cccccC-------------------------
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVHGT------------------------- 105 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~~~------------------------- 105 (189)
.++...+..+..+.+.|+.++|..+++|+|+ |+ +++...
T Consensus 106 ~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 185 (287)
T 1u59_A 106 EIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 185 (287)
T ss_dssp TSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHH
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHh
Confidence 4557777888889999999999999999996 55 222111
Q ss_pred CCCCccc-e-EEEec-------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 106 NLSGVVV-S-AVDFG-------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 106 ~~~~~~~-s-VwsfG-------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
....++. + ||||| |.+.+..++...+..+.+++.|..+|+++.+|+.+||+.||++||++.++++
T Consensus 186 ~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 265 (287)
T 1u59_A 186 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 265 (287)
T ss_dssp HHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred ccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1245788 8 99999 5556677888888889889999999999999999999999999999999999
Q ss_pred HHHHHHhhcCCCCCC
Q psy1684 171 KLEDFFTMEGSDYKE 185 (189)
Q Consensus 171 ~l~~~~~~~~~~~~~ 185 (189)
.|+.++.+....+..
T Consensus 266 ~l~~~~~~~~~~~~~ 280 (287)
T 1u59_A 266 RMRACYYSLASKVEG 280 (287)
T ss_dssp HHHHHHHHHHTTCSS
T ss_pred HHHHHHHhcCCcccC
Confidence 999999987666554
|
| >1jyr_A Growth factor receptor-bound protein 2; receptor binding, regulatory, inhibitor, signaling protein-I complex; HET: PTR; 1.55A {Homo sapiens} SCOP: d.93.1.1 PDB: 1jyq_A* 1jyu_A 1qg1_E* 1x0n_A* 2aob_A* 2aoa_A* 3n7y_A* 1tze_E* 1zfp_E* 3mxc_A* 3mxy_A* 1cj1_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=1.3e-16 Score=99.62 Aligned_cols=78 Identities=32% Similarity=0.331 Sum_probs=68.5
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC--ccCCCCCcC-HhHHHHHh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET--QKAGRTTIH-YPELVEHY 77 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g--yl~~~~~~~-l~~li~~~ 77 (189)
||||.|+|.+|+++|.... .+|+||||++.+.+|.|+||++. .+.++|++|....+| ++. ...|. +.+||+||
T Consensus 5 Wyhg~isR~~Ae~lL~~~~-~~G~FLVR~S~~~~g~~~LSv~~--~~~v~H~~I~~~~~g~~~l~-~~~F~sl~~LV~~y 80 (96)
T 1jyr_A 5 WFFGKIPRAKAEEMLSKQR-HDGAFLIRESESAPGDFSLSVKF--GNDVQHFKVLRDGAGKYFLW-VVKFNSLNELVDYH 80 (96)
T ss_dssp TBCCSCCHHHHHHHHHTCC-STTBEEEEECSSSTTCEEEEEEE--TTEEEEEECEECTTSCEESS-SCEESSHHHHHHHT
T ss_pred eeccCCCHHHHHHHHhcCC-CCcEEEEEecCCCCCCEEEEEEe--CCeEEEEEEEEcCCCCEEEC-CcccCCHHHHHHHH
Confidence 9999999999999997654 38999999999888999999999 999999999987667 555 47788 99999999
Q ss_pred hhccC
Q psy1684 78 SKDAD 82 (189)
Q Consensus 78 ~~~a~ 82 (189)
.....
T Consensus 81 ~~~~l 85 (96)
T 1jyr_A 81 RSTSV 85 (96)
T ss_dssp TSSCS
T ss_pred hhCCC
Confidence 87753
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=5.2e-20 Score=137.99 Aligned_cols=99 Identities=14% Similarity=0.028 Sum_probs=72.4
Q ss_pred HHHHHhhhccCCceeeccCCcccccc-cc---------------cccccC------------------------------
Q psy1684 72 ELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVHGT------------------------------ 105 (189)
Q Consensus 72 ~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~~~------------------------------ 105 (189)
....+..+++.|+.|+|+.+++|||+ |+ |+|+..
T Consensus 119 ~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmA 198 (299)
T 4g31_A 119 VCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMS 198 (299)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSC
T ss_pred HHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccC
Confidence 35567789999999999999999996 66 444321
Q ss_pred ----CCCCccc-e-EEEec-------CCCCChH---HHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q psy1684 106 ----NLSGVVV-S-AVDFG-------SGGMTNA---EVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQ 169 (189)
Q Consensus 106 ----~~~~~~~-s-VwsfG-------~~~~~~~---~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~ 169 (189)
.+..|+. + |||+| ++-.+.. ..+..+.++..++.+...+++..+|+.+||+.||++|||+.||+
T Consensus 199 PE~~~~~~y~~~~DiwSlGvilyell~Pf~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil 278 (299)
T 4g31_A 199 PEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINII 278 (299)
T ss_dssp HHHHTTCCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHcCCCCCCHHHHHHHHHHHHHHccCCCCccHHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 4567999 9 99999 4333332 33344455554444455667888999999999999999999998
Q ss_pred H
Q psy1684 170 W 170 (189)
Q Consensus 170 ~ 170 (189)
+
T Consensus 279 ~ 279 (299)
T 4g31_A 279 E 279 (299)
T ss_dssp T
T ss_pred c
Confidence 6
|
| >2oq1_A Tyrosine-protein kinase ZAP-70; tandem SH2 domains, ZAP-70, tyrosine kinase, transferase; HET: PTR; 1.90A {Homo sapiens} SCOP: d.93.1.1 d.93.1.1 PDB: 1m61_A | Back alignment and structure |
|---|
Probab=99.69 E-value=1.3e-16 Score=116.82 Aligned_cols=93 Identities=34% Similarity=0.502 Sum_probs=84.4
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC--ccCCCCCcC-HhHHHHHh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET--QKAGRTTIH-YPELVEHY 77 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g--yl~~~~~~~-l~~li~~~ 77 (189)
||||.|++.+|+++|......+|+||||++.+.+|.|+||++. .+.++||+|....+| ++.+...|. +.+||+||
T Consensus 8 Wyhg~isR~~Ae~lL~~~~~~~G~FLVR~S~~~~g~y~LSv~~--~~~v~H~~I~~~~~g~~~l~~~~~F~sl~~LV~~y 85 (254)
T 2oq1_A 8 FFYGSISRAEAEEHLKLAGMADGLFLLRQCLRSLGGYVLSLVH--DVRFHHFPIERQLNGTYAIAGGKAHCGPAELCEFY 85 (254)
T ss_dssp TBCBSCCHHHHHHHHHHTTCCTTCEEEEECSSSTTCEEEEEEE--TTEEEEEEEEECTTSCEEETTSCCBSSHHHHHHHH
T ss_pred ccCCCCCHHHHHHHHhccCCCCcEEEEEeCCCCCCCEEEEEEE--CCeEEEEEEEEeCCCCEEeCCCCccCCHHHHHHHH
Confidence 9999999999999997656688999999999988999999999 999999999986666 777778899 99999999
Q ss_pred hhccCCceeeccCCcccc
Q psy1684 78 SKDADGLCVNLRKPCVQV 95 (189)
Q Consensus 78 ~~~a~gl~~~~~~~~~~~ 95 (189)
....+|+...+..||...
T Consensus 86 ~~~~~~l~~~L~~p~~~~ 103 (254)
T 2oq1_A 86 SRDPDGLPCNLRKPCNRP 103 (254)
T ss_dssp HHCCTTSSSCCCSBCCCC
T ss_pred HhCCCCcccccccccCCC
Confidence 999999999999998764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=2.4e-18 Score=131.69 Aligned_cols=111 Identities=24% Similarity=0.433 Sum_probs=89.9
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cccccC------------------------CC
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVHGT------------------------NL 107 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~~~------------------------~~ 107 (189)
++...+..+..+.+.|+.++|..+++|+|+ |+ |++... ..
T Consensus 190 l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 269 (359)
T 3vhe_A 190 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 269 (359)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcC
Confidence 446677788889999999999999999996 54 332211 24
Q ss_pred CCccc-e-EEEec-------------CCCCC-hHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 108 SGVVV-S-AVDFG-------------SGGMT-NAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 108 ~~~~~-s-VwsfG-------------~~~~~-~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
..++. + ||||| |.+.+ ...+...+..+.+++.|..+++++.+|+.+||+.||++|||+++|++.
T Consensus 270 ~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 270 RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 56788 9 99999 33333 345666677888888899999999999999999999999999999999
Q ss_pred HHHHHhh
Q psy1684 172 LEDFFTM 178 (189)
Q Consensus 172 l~~~~~~ 178 (189)
|+.++++
T Consensus 350 L~~~~~~ 356 (359)
T 3vhe_A 350 LGNLLQA 356 (359)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999875
|
| >1a81_A SYK kinase; complex (transferase-peptide), SYK, kinase, SH2 domain; HET: PTR; 3.00A {Homo sapiens} SCOP: d.93.1.1 d.93.1.1 PDB: 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=1.1e-16 Score=117.06 Aligned_cols=91 Identities=31% Similarity=0.439 Sum_probs=82.5
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC--ccCCCCCcC-HhHHHHHh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET--QKAGRTTIH-YPELVEHY 77 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g--yl~~~~~~~-l~~li~~~ 77 (189)
||||.|+|.+|+++|......+|+||||++ +.+|.|+||++. .+.++|++|....+| ++.+...|. +.+||+||
T Consensus 160 Wyhg~isR~~Ae~lL~~~g~~~G~FLVR~S-~~~g~~~LSv~~--~~~v~H~~I~~~~~g~~~l~~~~~F~sl~~LV~~y 236 (254)
T 1a81_A 160 WFHGKISREESEQIVLIGSKTNGKFLIRAR-DNNGSYALCLLH--EGKVLHYRIDKDKTGKLSIPEGKKFDTLWQLVEHY 236 (254)
T ss_dssp TEEEECCHHHHHHHHHSSCCCTTCEEEEEC-SSSSCEEEEEEE--TTEEEEEEEEECTTSCEECTTSCCBSCHHHHHHHH
T ss_pred ccccCCCHHHHHHHHHhcCCCCceEEEEec-CCCCCEEEEEEE--CCEEEEEEEEEcCCCCEEecCCcccCCHHHHHHHH
Confidence 999999999999999776668999999999 778999999999 999999999987777 676678898 99999999
Q ss_pred hhccCCceeeccCCccc
Q psy1684 78 SKDADGLCVNLRKPCVQ 94 (189)
Q Consensus 78 ~~~a~gl~~~~~~~~~~ 94 (189)
....+|+...+..||.+
T Consensus 237 ~~~~~~l~~~L~~p~~r 253 (254)
T 1a81_A 237 SYKADGLLRVLTVPCQK 253 (254)
T ss_dssp TTCCTTSSSCCCCBCCC
T ss_pred HHCCCCCCeecCCcCCC
Confidence 99999999999888864
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.69 E-value=3.2e-18 Score=127.84 Aligned_cols=154 Identities=17% Similarity=0.221 Sum_probs=113.9
Q ss_pred CCChHHHHHHhcCCCC-CCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC-CCCcCHhHHHHHhhhccC
Q psy1684 5 KIKRIEAEKKLLLPEN-DHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG-RTTIHYPELVEHYSKDAD 82 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~-~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~-~~~~~l~~li~~~~~~a~ 82 (189)
.++|+|++++++.+.. ....++|+|++.++. +.. ++.. ...+...++..+..+.+.
T Consensus 82 ~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~-----L~~-----------------~l~~~~~~~~~~~~~~i~~ql~~ 139 (298)
T 3f66_A 82 DFSHPNVLSLLGICLRSEGSPLVVLPYMKHGD-----LRN-----------------FIRNETHNPTVKDLIGFGLQVAK 139 (298)
T ss_dssp TCCCTTBCCCCEEECCSSSCCEEEEECCTTCB-----HHH-----------------HHHCTTCCCCHHHHHHHHHHHHH
T ss_pred hCCCCCEeeeeeEEEcCCCceEEEEeCCCCCC-----HHH-----------------HHHhcccCCCHHHHHHHHHHHHH
Confidence 4677788777775332 334577777776522 111 2322 223446777788888999
Q ss_pred CceeeccCCcccccc-cc---------------cccccC--------------------------CCCCccc-e-EEEec
Q psy1684 83 GLCVNLRKPCVQVSC-RI---------------YLVHGT--------------------------NLSGVVV-S-AVDFG 118 (189)
Q Consensus 83 gl~~~~~~~~~~~~~-p~---------------~l~~~~--------------------------~~~~~~~-s-VwsfG 118 (189)
|+.++|..+++|+|+ |+ |++... ....++. + |||+|
T Consensus 140 ~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 219 (298)
T 3f66_A 140 GMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFG 219 (298)
T ss_dssp HHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHH
T ss_pred HHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHH
Confidence 999999999999996 55 222211 2345788 9 99999
Q ss_pred -------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcC
Q psy1684 119 -------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180 (189)
Q Consensus 119 -------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~~ 180 (189)
|.+.+..++...+..+.+...|..+|.++.+++.+||+.||++|||++++++.|+.+++.-.
T Consensus 220 ~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 220 VLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp HHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred HHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 55566667777788888888899999999999999999999999999999999999988543
|
| >2kk6_A Proto-oncogene tyrosine-protein kinase FER; methods development, SH2, NESG, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.69 E-value=1.2e-16 Score=102.97 Aligned_cols=87 Identities=29% Similarity=0.453 Sum_probs=73.3
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC-ccCCCCCcC-HhHHHHHhh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET-QKAGRTTIH-YPELVEHYS 78 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g-yl~~~~~~~-l~~li~~~~ 78 (189)
||||.|+|.+|+++|. .+|+||||++.+.+|.|+||++. .+.++||+|.. .+| |..+...|. +.+||++|.
T Consensus 19 WyhG~isR~eAe~lL~----~~G~FLVR~S~~~~g~y~LSv~~--~~~v~H~~I~~-~~g~y~~~~~~F~sl~eLV~~y~ 91 (116)
T 2kk6_A 19 WYHGAIPRIEAQELLK----KQGDFLVRESHGKPGEYVLSVYS--DGQRRHFIIQY-VDNMYRFEGTGFSNIPQLIDHHY 91 (116)
T ss_dssp TEEESCCHHHHHHTCC----STTCEEEEECTTCTTCEEEEEEE--TTEEEEEEEEE-ETTEEESSSCEESCHHHHHHHHH
T ss_pred CccCCCCHHHHHHHhc----cCCcEEEEECCCCCCcEEEEEEE--CCeEEEEEEEe-cCCEEEECCCEeCCHHHHHHHHh
Confidence 9999999999999984 57999999999888999999999 99999999996 455 544567888 999999999
Q ss_pred hccC----CceeeccCCccc
Q psy1684 79 KDAD----GLCVNLRKPCVQ 94 (189)
Q Consensus 79 ~~a~----gl~~~~~~~~~~ 94 (189)
.... +....+..||.+
T Consensus 92 ~~~~~i~~~~~~~L~~Pv~r 111 (116)
T 2kk6_A 92 TTKQVITKKSGVVLLNPIPK 111 (116)
T ss_dssp HTTCCSCTTTTCCCCSCCCC
T ss_pred hCCCCccCCCCCeECcccCC
Confidence 8765 345566677654
|
| >1a81_A SYK kinase; complex (transferase-peptide), SYK, kinase, SH2 domain; HET: PTR; 3.00A {Homo sapiens} SCOP: d.93.1.1 d.93.1.1 PDB: 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=1.4e-16 Score=116.58 Aligned_cols=93 Identities=28% Similarity=0.346 Sum_probs=84.3
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC--ccCCCCCcC-HhHHHHHh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET--QKAGRTTIH-YPELVEHY 77 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g--yl~~~~~~~-l~~li~~~ 77 (189)
||||.|++.+|+++|......+|+||||++.+.+|.|+||++. .+.++|++|....+| ++.+...|. +.+||+||
T Consensus 7 Wy~g~isR~~Ae~lL~~~g~~~G~FLVR~S~~~~g~y~LSv~~--~~~v~H~~I~~~~~g~~~l~~~~~F~sl~eLv~~y 84 (254)
T 1a81_A 7 FFFGNITREEAEDYLVQGGMSDGLYLLRQSRNYLGGFALSVAH--GRKAHHYTIERELNGTYAIAGGRTHASPADLCHYH 84 (254)
T ss_dssp TBCSSCCHHHHHHHHHHTTCCTTEEEEEECSSSTTCEEEEEEE--TTEEEEEEEEECTTSCEEETTSCCBSSHHHHHHHH
T ss_pred cccCCCCHHHHHHHHhcCCCCCcEEEEEecCCCCCCEEEEEEE--CCeeEEEEEEEcCCCCEEeCCCCCcCCHHHHHHHH
Confidence 9999999999999997666688999999999988999999999 999999999986666 777778898 99999999
Q ss_pred hhccCCceeeccCCcccc
Q psy1684 78 SKDADGLCVNLRKPCVQV 95 (189)
Q Consensus 78 ~~~a~gl~~~~~~~~~~~ 95 (189)
....+|+...+..||...
T Consensus 85 ~~~~~~l~~~L~~p~~~~ 102 (254)
T 1a81_A 85 SQESDGLVCLLKKPFNRP 102 (254)
T ss_dssp TTCCTTSSSCCCEECCCC
T ss_pred HhCCCCceECCccccCCC
Confidence 999999999999888764
|
| >1r1p_A GRB2-related adaptor protein 2; SH2, GADS, phosphopeptide, peptide binding protein; HET: PTR; 1.80A {Mus musculus} SCOP: d.93.1.1 PDB: 1r1q_A* 1r1s_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=1.8e-16 Score=99.70 Aligned_cols=78 Identities=23% Similarity=0.265 Sum_probs=68.9
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC--ccCCCCCcC-HhHHHHHh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET--QKAGRTTIH-YPELVEHY 77 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g--yl~~~~~~~-l~~li~~~ 77 (189)
||||.|+|.+|+++|... .+|+||||++.+.+|.|+||++. .+.++|++|....+| ++. ...|. +.+|+++|
T Consensus 11 Wyhg~isR~~Ae~lL~~~--~~G~FLVR~S~~~~g~~~LSv~~--~~~v~H~~I~~~~~g~~~l~-~~~F~sl~~LV~~y 85 (100)
T 1r1p_A 11 WFHEGLSRHQAENLLMGK--DIGFFIIRASQSSPGDFSISVRH--EDDVQHFKVMRDTKGNYFLW-TEKFPSLNKLVDYY 85 (100)
T ss_dssp TSCTTCCHHHHHHHHHTS--CTTBEEEEECSSSTTCEEEEEEC--SSSEEEEECEECTTCCEESS-SCEESSHHHHHHHH
T ss_pred ccccCCCHHHHHHHhcCC--CCCEEEEEecCCCCCCEEEEEEE--CCEEEEEEEEEcCCCCEEEe-CCEeCCHHHHHHHH
Confidence 999999999999999654 68999999999888999999999 999999999987667 555 46888 99999999
Q ss_pred hhccCC
Q psy1684 78 SKDADG 83 (189)
Q Consensus 78 ~~~a~g 83 (189)
.....+
T Consensus 86 ~~~~l~ 91 (100)
T 1r1p_A 86 RTTSIS 91 (100)
T ss_dssp TTSCSS
T ss_pred HhCCCC
Confidence 987653
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=4.1e-19 Score=134.51 Aligned_cols=151 Identities=19% Similarity=0.227 Sum_probs=112.0
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC-CCCcCHhHHHHHhhhccCC
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG-RTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~-~~~~~l~~li~~~~~~a~g 83 (189)
.++|+|++++++.+. ....++|++++..+. +.. ++.. ...+....+..+..+.+.|
T Consensus 71 ~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~-----L~~-----------------~l~~~~~~~~~~~~~~~~~qi~~~ 127 (325)
T 3kex_A 71 SLDHAHIVRLLGLCP-GSSLQLVTQYLPLGS-----LLD-----------------HVRQHRGALGPQLLLNWGVQIAKG 127 (325)
T ss_dssp TCCCTTBCCEEEEEC-BSSEEEEEECCTTCB-----SHH-----------------HHHSSGGGSCTTHHHHHHHHHHHH
T ss_pred cCCCCCcCeEEEEEc-CCccEEEEEeCCCCC-----HHH-----------------HHHHccccCCHHHHHHHHHHHHHH
Confidence 456777777776553 345667777766522 111 2222 1234456677777888999
Q ss_pred ceeeccCCcccccc-cc---------------cccccC------------------------CCCCccc-e-EEEec---
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YLVHGT------------------------NLSGVVV-S-AVDFG--- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l~~~~------------------------~~~~~~~-s-VwsfG--- 118 (189)
+.++|..+++|+|+ |+ |+++.. ..+.++. + |||||
T Consensus 128 l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l 207 (325)
T 3kex_A 128 MYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTV 207 (325)
T ss_dssp HHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHH
Confidence 99999999999996 55 333211 2256788 9 99999
Q ss_pred ----------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q psy1684 119 ----------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTM 178 (189)
Q Consensus 119 ----------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~ 178 (189)
|.+.+..++...+..+.+++.|..++.++.+|+.+||+.||++|||++++++.|+.+...
T Consensus 208 ~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 208 WELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp HHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred HHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 556666788888888888889999999999999999999999999999999999988753
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=2.5e-18 Score=129.39 Aligned_cols=113 Identities=27% Similarity=0.427 Sum_probs=92.8
Q ss_pred CCcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cccccC------------------------
Q psy1684 66 TTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVHGT------------------------ 105 (189)
Q Consensus 66 ~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~~~------------------------ 105 (189)
..++...+..+..+.+.|+.++|..+++|+|+ |+ +++...
T Consensus 142 ~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 221 (313)
T 3brb_A 142 KHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESL 221 (313)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHH
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhh
Confidence 34557778888889999999999999999996 55 222111
Q ss_pred CCCCccc-e-EEEec-------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 106 NLSGVVV-S-AVDFG-------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 106 ~~~~~~~-s-VwsfG-------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
....++. + ||||| |.+.+..++...+..+.+++.|..+|+++.+|+.+||+.||++|||+.+|++
T Consensus 222 ~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 301 (313)
T 3brb_A 222 ADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRL 301 (313)
T ss_dssp HSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred cCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 2345788 9 99999 5556667777888888888889999999999999999999999999999999
Q ss_pred HHHHHHhh
Q psy1684 171 KLEDFFTM 178 (189)
Q Consensus 171 ~l~~~~~~ 178 (189)
.|+.+++.
T Consensus 302 ~L~~l~~~ 309 (313)
T 3brb_A 302 QLEKLLES 309 (313)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHh
Confidence 99999874
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=2.8e-18 Score=126.15 Aligned_cols=152 Identities=17% Similarity=0.217 Sum_probs=114.9
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC-CCCcCHhHHHHHhhhccCC
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG-RTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~-~~~~~l~~li~~~~~~a~g 83 (189)
.++|+|++++++.+......++|+|+.+.+. +.. ++.. ...++...+..+..+.+.|
T Consensus 59 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~-----L~~-----------------~~~~~~~~~~~~~~~~~~~~i~~~ 116 (267)
T 3t9t_A 59 KLSHPKLVQLYGVCLEQAPICLVTEFMEHGC-----LSD-----------------YLRTQRGLFAAETLLGMCLDVCEG 116 (267)
T ss_dssp TCCCTTBCCEEEEECSSSSCEEEECCCTTCB-----HHH-----------------HHHHTTTCCCHHHHHHHHHHHHHH
T ss_pred hCCCCCEeeEEEEEccCCCeEEEEeCCCCCc-----HHH-----------------HHhhCcccCCHHHHHHHHHHHHHH
Confidence 4678888888777766667788888776522 111 2221 1234566677778888899
Q ss_pred ceeeccCCcccccc-cc---------------cccccC-----------------------CCCCccc-e-EEEec----
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YLVHGT-----------------------NLSGVVV-S-AVDFG---- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l~~~~-----------------------~~~~~~~-s-VwsfG---- 118 (189)
+.++|..+++|+|+ |+ +++... ....++. + |||+|
T Consensus 117 l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 196 (267)
T 3t9t_A 117 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMW 196 (267)
T ss_dssp HHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred HHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHH
Confidence 99999999999996 54 222111 2255788 9 99999
Q ss_pred ---------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q psy1684 119 ---------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTM 178 (189)
Q Consensus 119 ---------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~ 178 (189)
|.+.+..++...+..+.++..|..+|.++.+|+.+||+.||++|||++++++.|+.+.++
T Consensus 197 ~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 197 EVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp HHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 555667788888888888888899999999999999999999999999999999998763
|
| >3ov1_A Growth factor receptor-bound protein 2; GRB2 SH2 domain, phosphotyrosine binding, signaling protein, signaling protein-antagonist complex; HET: PTR; 1.60A {Homo sapiens} SCOP: d.93.1.1 PDB: 3imj_A* 3in7_A* 3imd_A* 3kfj_A* 3n8m_A* 3in8_A* 3s8l_A* 3s8n_A* 3s8o_A* 2huy_A* 2h5k_A* 2huw_A* 2h46_E* 3c7i_A* 3n84_A* 1fhs_A 1bm2_A* 1bmb_A* 3ove_A* 1fyr_A* ... | Back alignment and structure |
|---|
Probab=99.68 E-value=3.1e-16 Score=101.29 Aligned_cols=78 Identities=32% Similarity=0.339 Sum_probs=68.8
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC--ccCCCCCcC-HhHHHHHh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET--QKAGRTTIH-YPELVEHY 77 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g--yl~~~~~~~-l~~li~~~ 77 (189)
||||.|+|.+|+++|.. ...+|+||||++.+.+|.|+||++. .+.++|++|.+..+| ++. ...|. +.+||++|
T Consensus 8 WyhG~isR~eAe~lL~~-~~~~G~FLVR~S~~~~g~y~LSv~~--~~~v~H~~I~~~~~g~~~l~-~~~F~sl~eLV~~y 83 (117)
T 3ov1_A 8 WFFGKIPRAKAEEMLSK-QRHDGAFLIRESESAPGDFSLSVKF--GNDVQHFKVLRDGAGKYFLW-VVKFNSLNELVDYH 83 (117)
T ss_dssp TBCCSCCHHHHHHHHHT-CCSTTBEEEEECSSSTTCEEEEEEE--TTEEEEEECEECTTSCEESS-SCEESSHHHHHHHT
T ss_pred cccCCCCHHHHHHHHhC-CCCCCcEEEEeCCCCCCCEEEEEec--CCceEEEEEEECCCCeEEEC-CCCcCCHHHHHHHH
Confidence 99999999999999976 3468999999999888999999999 999999999987777 555 47888 99999999
Q ss_pred hhccC
Q psy1684 78 SKDAD 82 (189)
Q Consensus 78 ~~~a~ 82 (189)
.....
T Consensus 84 ~~~~l 88 (117)
T 3ov1_A 84 RSTSV 88 (117)
T ss_dssp TTSCS
T ss_pred hhCCC
Confidence 98754
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.68 E-value=4.3e-19 Score=132.47 Aligned_cols=152 Identities=20% Similarity=0.237 Sum_probs=106.2
Q ss_pred CCChHHHHHHhcCCCCC--CCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCC-CCcCHhHHHHHhhhcc
Q psy1684 5 KIKRIEAEKKLLLPEND--HGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGR-TTIHYPELVEHYSKDA 81 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~--~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~-~~~~l~~li~~~~~~a 81 (189)
.++|+|++++++.+... ...+||+|++..+. +.. ++... ..++...+..+..+.+
T Consensus 67 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~-----L~~-----------------~l~~~~~~~~~~~~~~~~~qi~ 124 (295)
T 3ugc_A 67 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGS-----LRD-----------------YLQKHKERIDHIKLLQYTSQIC 124 (295)
T ss_dssp TCCCTTBCCEEEEECHHHHTSCEEEEECCTTCB-----HHH-----------------HHHHCGGGCCHHHHHHHHHHHH
T ss_pred hCCCCCEeeEEEEEecCCCCceEEEEEeCCCCC-----HHH-----------------HHHhcccccCHHHHHHHHHHHH
Confidence 45677777776654322 23577777766522 111 22222 2355667777888899
Q ss_pred CCceeeccCCcccccc-cc---------------cccc------------------------cC-CCCCccc-e-EEEec
Q psy1684 82 DGLCVNLRKPCVQVSC-RI---------------YLVH------------------------GT-NLSGVVV-S-AVDFG 118 (189)
Q Consensus 82 ~gl~~~~~~~~~~~~~-p~---------------~l~~------------------------~~-~~~~~~~-s-VwsfG 118 (189)
.|+.++|..+++|+|+ |+ +++. |. ....++. + |||||
T Consensus 125 ~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 204 (295)
T 3ugc_A 125 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFG 204 (295)
T ss_dssp HHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred HHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHH
Confidence 9999999999999996 54 2221 11 2355788 9 99999
Q ss_pred ------CCC----CC------------------hHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 119 ------SGG----MT------------------NAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 119 ------~~~----~~------------------~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
+.+ .. ...+...+..+.+++.|..+|+++.+||.+||+.||++|||+++|++
T Consensus 205 ~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 205 VVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 111 00 11345556778888899999999999999999999999999999999
Q ss_pred HHHHHHhh
Q psy1684 171 KLEDFFTM 178 (189)
Q Consensus 171 ~l~~~~~~ 178 (189)
.|+.+.+.
T Consensus 285 ~L~~l~~~ 292 (295)
T 3ugc_A 285 RVDQIRDN 292 (295)
T ss_dssp HHHHHHHC
T ss_pred HHHHHHHh
Confidence 99998764
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=1.1e-17 Score=125.76 Aligned_cols=150 Identities=15% Similarity=0.196 Sum_probs=110.1
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCC---CcCHhHHHHHhhhcc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRT---TIHYPELVEHYSKDA 81 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~---~~~l~~li~~~~~~a 81 (189)
.++|+|++++++.+. +..+||+|++.++. +.. ++.... .+....++.+..+.+
T Consensus 57 ~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~-----L~~-----------------~l~~~~~~~~~~~~~~~~~~~qi~ 112 (307)
T 2eva_A 57 RVNHPNIVKLYGACL--NPVCLVMEYAEGGS-----LYN-----------------VLHGAEPLPYYTAAHAMSWCLQCS 112 (307)
T ss_dssp HCCCTTBCCEEEBCT--TTTEEEEECCTTCB-----HHH-----------------HHHCSSSEECCCHHHHHHHHHHHH
T ss_pred cCCCCCcCeEEEEEc--CCcEEEEEcCCCCC-----HHH-----------------HHhccCCCCccCHHHHHHHHHHHH
Confidence 467899999888765 35789999887632 111 122111 233566677778888
Q ss_pred CCceeecc---CCcccccc-cc----------------ccc------------------ccC-CCCCccc-e-EEEec--
Q psy1684 82 DGLCVNLR---KPCVQVSC-RI----------------YLV------------------HGT-NLSGVVV-S-AVDFG-- 118 (189)
Q Consensus 82 ~gl~~~~~---~~~~~~~~-p~----------------~l~------------------~~~-~~~~~~~-s-VwsfG-- 118 (189)
.|+.++|. .+++|+|+ |+ +++ +|. ....++. + |||||
T Consensus 113 ~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~i 192 (307)
T 2eva_A 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGII 192 (307)
T ss_dssp HHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------------CCTTSSCHHHHTCCCCCTHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccccccCCCCCceEChhhhCCCCCCcHHHHHHHHHH
Confidence 89999998 78999986 54 111 111 3456888 9 99999
Q ss_pred ----------CCCC--ChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q psy1684 119 ----------SGGM--TNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTM 178 (189)
Q Consensus 119 ----------~~~~--~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~ 178 (189)
|.+. ...++...+..+.+++.+..+|.++.+|+.+||+.||++|||+.+|++.|+.+.+.
T Consensus 193 l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 264 (307)
T 2eva_A 193 LWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264 (307)
T ss_dssp HHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred HHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 4433 23455566777888888899999999999999999999999999999999988764
|
| >2vif_A Suppressor of cytokine signalling 6; growth regulation, signal transduction inhibitor, KIT regula phosphotyrosine, signaling protein; HET: PTR; 1.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=3.5e-16 Score=104.45 Aligned_cols=86 Identities=30% Similarity=0.294 Sum_probs=73.8
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC-ccC---CCCCcC-HhHHHH
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET-QKA---GRTTIH-YPELVE 75 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g-yl~---~~~~~~-l~~li~ 75 (189)
||||.|+|.+|+++|.. ..+|+||||++...++.|+||++. .+.++|++|....++ ++. ....|. +.+||+
T Consensus 26 WyhG~isR~eAe~lL~~--~~~G~FLVR~S~~~~~~~~LSv~~--~~~v~H~~I~~~~g~~~l~~~~~~~~F~sl~eLI~ 101 (141)
T 2vif_A 26 WYWGPITRWEAEGKLAN--VPDGSFLVRDSSDDRYLLSLSFRS--HGKTLHTRIEHSNGRFSFYEQPDVEGHTSIVDLIE 101 (141)
T ss_dssp CBCCSCCHHHHHHHTTT--SCTTCEEEEECSSTTCSEEEEEEE--TTEEEEEEEEEETTEEEETTCCSCCCBSSHHHHHH
T ss_pred CcccCCCHHHHHHHhcC--CCCceEEEEecCCCCCCEEEEEEE--CCEEEEEEEEEECCEEEEeecCCCCccCCHHHHHH
Confidence 99999999999999954 468999999999888999999999 999999999987444 676 477888 999999
Q ss_pred Hhhhcc-CCceeeccC
Q psy1684 76 HYSKDA-DGLCVNLRK 90 (189)
Q Consensus 76 ~~~~~a-~gl~~~~~~ 90 (189)
||.... +|+.+.+..
T Consensus 102 ~y~~~~~~gl~c~l~~ 117 (141)
T 2vif_A 102 HSIGDSENGAFCYSRS 117 (141)
T ss_dssp HHHHHHHHTCCEEESC
T ss_pred HHhhCCCCCcceeccc
Confidence 999888 587655443
|
| >2hdv_A SH2-B PH domain containing signaling mediator 1 gamma isoform; adapter protein, signaling protein; 2.00A {Mus musculus} PDB: 2hdx_A* 1rpy_A 1rqq_C* | Back alignment and structure |
|---|
Probab=99.67 E-value=1.1e-16 Score=102.59 Aligned_cols=82 Identities=22% Similarity=0.321 Sum_probs=70.7
Q ss_pred CCCCCCChHHHHHHhcCCC-CCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC-ccCCCCCcC-HhHHHHHh
Q psy1684 1 WYFGKIKRIEAEKKLLLPE-NDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET-QKAGRTTIH-YPELVEHY 77 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~-~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g-yl~~~~~~~-l~~li~~~ 77 (189)
||||.|+|.+|+++|.... ..+|+||||++.+.+|.|+||++. .+.++|++|....+| |..+...|. +.+||+||
T Consensus 11 WyhG~isR~~Ae~lL~~~g~~~~G~FLVR~S~~~~g~y~LSv~~--~~~v~H~~I~~~~~g~~~l~~~~F~sl~~LV~~y 88 (111)
T 2hdv_A 11 WFHGMLSRLKAAQLVLEGGTGSHGVFLVRQSETRRGECVLTFNF--QGKAKHLRLSLNAAGQCRVQHLHFQSIFDMLEHF 88 (111)
T ss_dssp TEEEECCHHHHHHHHHTTGGGGTTEEEEEECSSCTTEEEEEEEE--TTEEEEEEEEECTTCCEEETTEEESSHHHHHHHH
T ss_pred CcCCCCCHHHHHHHHHHcCCCCCCeEEEEecCCCCCCEEEEEEe--CCeEEEEEEEEcCCCCEEeCCceeCCHHHHHHHH
Confidence 9999999999999997654 278999999999888999999999 999999999987777 433467788 99999999
Q ss_pred hhccCCc
Q psy1684 78 SKDADGL 84 (189)
Q Consensus 78 ~~~a~gl 84 (189)
......+
T Consensus 89 ~~~~l~~ 95 (111)
T 2hdv_A 89 RVHPIPL 95 (111)
T ss_dssp TTSCCC-
T ss_pred hhCCccc
Confidence 9877654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.67 E-value=1.5e-18 Score=131.17 Aligned_cols=112 Identities=28% Similarity=0.451 Sum_probs=91.6
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cccccC------------------------CC
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVHGT------------------------NL 107 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~~~------------------------~~ 107 (189)
++...+..+..+.+.|+.++|..+++|+|+ |+ |++... ..
T Consensus 134 ~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 213 (323)
T 3qup_A 134 LPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD 213 (323)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcC
Confidence 446777788889999999999999999996 55 222111 23
Q ss_pred CCccc-e-EEEec-------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q psy1684 108 SGVVV-S-AVDFG-------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKL 172 (189)
Q Consensus 108 ~~~~~-s-VwsfG-------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l 172 (189)
..++. + ||||| |.+.+..++...+..+.+++.|..+|+++.+|+.+||+.||++|||+.++++.|
T Consensus 214 ~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 293 (323)
T 3qup_A 214 NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMEL 293 (323)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 45788 9 99999 566677788888888888888999999999999999999999999999999999
Q ss_pred HHHHhhc
Q psy1684 173 EDFFTME 179 (189)
Q Consensus 173 ~~~~~~~ 179 (189)
++++...
T Consensus 294 ~~~l~~~ 300 (323)
T 3qup_A 294 ENILGHL 300 (323)
T ss_dssp HHHHHC-
T ss_pred HHHHHHh
Confidence 9998753
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=4.7e-18 Score=128.71 Aligned_cols=159 Identities=19% Similarity=0.234 Sum_probs=116.1
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.+.|+|++++++.+......|||+|++.+ + ++... + . ...........+...++..+..+.+.|+
T Consensus 89 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~----~L~~~----l-----~-~~~~~~~~~~~~~~~~~~~i~~qi~~al 153 (327)
T 2yfx_A 89 KFNHQNIVRCIGVSLQSLPRFILMELMAG-G----DLKSF----L-----R-ETRPRPSQPSSLAMLDLLHVARDIACGC 153 (327)
T ss_dssp HCCCTTBCCEEEEECSSSSCEEEEECCTT-E----EHHHH----H-----H-HTSCCSSSTTSCCHHHHHHHHHHHHHHH
T ss_pred hCCCCCCCeEEEEEcCCCCcEEEEecCCC-C----cHHHH----H-----H-hhcccccccccccHHHHHHHHHHHHHHH
Confidence 45788888888877766777888888765 3 12220 0 0 0000001112344677788888999999
Q ss_pred eeeccCCcccccc-ccccccc-----------------------------------------C-CCCCccc-e-EEEec-
Q psy1684 85 CVNLRKPCVQVSC-RIYLVHG-----------------------------------------T-NLSGVVV-S-AVDFG- 118 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~~l~~~-----------------------------------------~-~~~~~~~-s-VwsfG- 118 (189)
.++|..+++|+|+ |+.+.-. . ....++. + |||||
T Consensus 154 ~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 233 (327)
T 2yfx_A 154 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGV 233 (327)
T ss_dssp HHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred HHHhhCCeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHH
Confidence 9999999999996 5511110 0 2355788 9 99999
Q ss_pred ------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q psy1684 119 ------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTM 178 (189)
Q Consensus 119 ------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~ 178 (189)
|.+.+..++...+..+.++..|..+|.++.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus 234 il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 234 LLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp HHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 555667788888888888888999999999999999999999999999999999887663
|
| >1ju5_A CRK; CRK, SH2, SH3, adaptor protein, phosphopeptide, protein binding/transferase complex; HET: PTR; NMR {Homo sapiens} SCOP: d.93.1.1 | Back alignment and structure |
|---|
Probab=99.67 E-value=2.5e-16 Score=100.63 Aligned_cols=87 Identities=30% Similarity=0.458 Sum_probs=71.0
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccC-----------------C-cc
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFE-----------------T-QK 62 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~-----------------g-yl 62 (189)
||||.|++.+|+++|. ...+|+||||++.+.+|.|+||++. .+.++|++|..... + |.
T Consensus 2 Wyhg~isr~~Ae~lL~--~~~~G~FLVR~S~~~~g~y~LSv~~--~~~v~H~~I~~~~~~g~~~~~~~~~~~g~~~~~~~ 77 (109)
T 1ju5_A 2 WYWGRLSRQEAVALLQ--GQRHGVFLVRDSSTSPGDYVLSVSE--NSRVSHYIINSSGPRPPVPPSPAQPPPGVSPSRLR 77 (109)
T ss_dssp CEETTCCHHHHHHHHT--TCCTTEEEEEECSSSTTEEEEEEEC--SSCEEEEEEECCSSSSCCCCCCSSCCTTCCCCCEE
T ss_pred ccccCCCHHHHHHHhc--CCCCCEEEEEecCCCCCCEEEEEEE--CCeEEEEEEEECCCCcccccccccccccccccEEE
Confidence 9999999999999994 3578999999999888999999999 99999999987653 4 43
Q ss_pred CCCCCcC-HhHHHHHhhhccCCceeeccCCc
Q psy1684 63 AGRTTIH-YPELVEHYSKDADGLCVNLRKPC 92 (189)
Q Consensus 63 ~~~~~~~-l~~li~~~~~~a~gl~~~~~~~~ 92 (189)
.+...|. +.+||+||.....+. ..+..||
T Consensus 78 l~~~~F~sl~~LV~~y~~~~l~~-~~L~~Pv 107 (109)
T 1ju5_A 78 IGDQEFDSLPALLEFYKIHYLDT-TTLIEPV 107 (109)
T ss_dssp ETTEEESSHHHHHHHHHHSCSSS-SCCCEES
T ss_pred eCCcccCCHHHHHHHHhhCCCCC-eecCccC
Confidence 3566788 999999999876542 2344444
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=2.9e-18 Score=129.84 Aligned_cols=150 Identities=23% Similarity=0.347 Sum_probs=112.6
Q ss_pred ChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC----------------CCCcCH
Q psy1684 7 KRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG----------------RTTIHY 70 (189)
Q Consensus 7 ~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~----------------~~~~~l 70 (189)
.|+|++++++.+......|||+|+++.+. +.. ++.. ...+..
T Consensus 84 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~-----L~~-----------------~l~~~~~~~~~~~~~~~~~~~~~~~~ 141 (327)
T 1fvr_A 84 HHPNIINLLGACEHRGYLYLAIEYAPHGN-----LLD-----------------FLRKSRVLETDPAFAIANSTASTLSS 141 (327)
T ss_dssp CCTTBCCEEEEEEETTEEEEEECCCTTCB-----HHH-----------------HHHTTCHHHHCHHHHHHTTBSCSSCH
T ss_pred CCCchhhhceeeeeCCceEEEEecCCCCC-----HHH-----------------HHHhcccccccccccccccccccCCH
Confidence 57777777766555555677777766522 111 2211 123556
Q ss_pred hHHHHHhhhccCCceeeccCCcccccc-cc---------------cccccC---------------------CCCCccc-
Q psy1684 71 PELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVHGT---------------------NLSGVVV- 112 (189)
Q Consensus 71 ~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~~~---------------------~~~~~~~- 112 (189)
..+..+..+.+.|+.++|..+++|+|+ |+ +++... ....++.
T Consensus 142 ~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 221 (327)
T 1fvr_A 142 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN 221 (327)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHH
T ss_pred HHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCch
Confidence 777888889999999999999999996 55 222111 2234688
Q ss_pred e-EEEec-------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q psy1684 113 S-AVDFG-------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTM 178 (189)
Q Consensus 113 s-VwsfG-------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~ 178 (189)
+ |||+| |.+.+..++...+..+.+++.|..+|+++.+|+.+||+.||++|||+.++++.|+.+++.
T Consensus 222 ~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 222 SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred hcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 8 99999 556667788888888888888999999999999999999999999999999999999874
|
| >2eo6_A B-cell linker protein; SH2, cytoplasmic adapter protein, B-cell adapter containing SH2 domain protein; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=99.67 E-value=1.5e-16 Score=106.12 Aligned_cols=83 Identities=28% Similarity=0.334 Sum_probs=70.0
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCC--CCCceEEEEEecCCCeeeEEEEEeccCC--ccCC-----CCCcC-H
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSES--RKNDYSLSEYKRSSFCLKMTTGRSLFET--QKAG-----RTTIH-Y 70 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~--~~~~~~ls~~~~~~~~v~h~~i~~~~~g--yl~~-----~~~~~-l 70 (189)
||||.|+|.+|+++|... ..+|+||||++.. .++.|+||++. .+.++|++|.+..+| |..+ ...|. +
T Consensus 25 WyhG~isR~eAe~lL~~~-~~~G~FLVR~S~~~~~~g~y~LSv~~--~~~v~H~~I~~~~~g~~~~l~~~~~~~~~F~sl 101 (141)
T 2eo6_A 25 WYAGACDRKSAEEALHRS-NKDGSFLIRKSSGHDSKQPYTLVAFF--NKRVYNIPVRFIEATKQYALGKKKNGEEYFGSV 101 (141)
T ss_dssp SEEESCCHHHHHHHHHHH-CCTTCBCEEECSTTCSSCSEEEEEEE--TTEEEEEEECEETTTTEECSSSCCTTCCCBSSH
T ss_pred eEecCCCHHHHHHHhhcc-CCCceEEEEECCCCCCCCCEEEEEEE--CCEEEEEEEEEeCCCCEEEEccccCCCCccCCH
Confidence 999999999999999532 2589999999986 67999999999 999999999875555 4433 46788 9
Q ss_pred hHHHHHhhhccCCcee
Q psy1684 71 PELVEHYSKDADGLCV 86 (189)
Q Consensus 71 ~~li~~~~~~a~gl~~ 86 (189)
.+||+||.....+++.
T Consensus 102 ~eLV~~y~~~~~~l~~ 117 (141)
T 2eo6_A 102 VEIVNSHQHNPLVLID 117 (141)
T ss_dssp HHHHHHHHHSCCCCCC
T ss_pred HHHHHHHhhCCcccee
Confidence 9999999999988843
|
| >2cia_A Cytoplasmic protein NCK2; SH2-domain, SH3 domain, phosphorylation, binding specificity; HET: PTR MPD; 1.45A {Homo sapiens} PDB: 1z3k_A 2ci9_A* 2ci8_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=1.4e-16 Score=100.60 Aligned_cols=77 Identities=38% Similarity=0.470 Sum_probs=65.5
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC-ccCCCCCcC-HhHHHHHhh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET-QKAGRTTIH-YPELVEHYS 78 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g-yl~~~~~~~-l~~li~~~~ 78 (189)
||||.|+|.+|+++|.... .+|+||||++.+.+|.|+||++. .+.++|++|....++ ++. ...|. +.+||+||.
T Consensus 7 Wyhg~isR~~Ae~lL~~~~-~~G~FLVR~S~~~~g~~~LSv~~--~~~v~H~~I~~~~g~~~l~-~~~F~sl~~LV~~y~ 82 (102)
T 2cia_A 7 WYYGNVTRHQAECALNERG-VEGDFLIRDSESSPSDFSVSLKA--SGKNKHFKVQLVDNVYCIG-QRRFHTMDELVEHYK 82 (102)
T ss_dssp TBCCSCCHHHHHHHHHHHC-CTTEEEEEECSSSTTCEEEEECC--SSSCEEEEEEEETTEEEET-TEEESSHHHHHHHHH
T ss_pred cccCCCCHHHHHHHHhhCC-CCcEEEEEECCCCCCCEEEEEEe--CCeeEEEEEEecCCEEEEC-CcCcCCHHHHHHHHh
Confidence 9999999999999994332 67999999999888999999999 999999999954333 555 46788 999999998
Q ss_pred hcc
Q psy1684 79 KDA 81 (189)
Q Consensus 79 ~~a 81 (189)
...
T Consensus 83 ~~~ 85 (102)
T 2cia_A 83 KAP 85 (102)
T ss_dssp HSC
T ss_pred hCc
Confidence 764
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=1.7e-18 Score=128.19 Aligned_cols=153 Identities=22% Similarity=0.347 Sum_probs=109.9
Q ss_pred CCCChHHHHHHhcCCCCC-CCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCC--CcCHhHHHHHhhhc
Q psy1684 4 GKIKRIEAEKKLLLPEND-HGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRT--TIHYPELVEHYSKD 80 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~-~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~--~~~l~~li~~~~~~ 80 (189)
..++|+|++++++.+... ...++|+|+... + ++.. ++.... .++...+..+..+.
T Consensus 69 ~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~-~----~L~~-----------------~l~~~~~~~~~~~~~~~~~~~i 126 (278)
T 1byg_A 69 TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK-G----SLVD-----------------YLRSRGRSVLGGDCLLKFSLDV 126 (278)
T ss_dssp TTCCCTTBCCEEEEECCC--CCEEEECCCTT-E----EHHH-----------------HHHHHHHHHCCHHHHHHHHHHH
T ss_pred HhCCCCCEeeEEEEEEcCCCceEEEEecCCC-C----CHHH-----------------HHHhcccccCCHHHHHHHHHHH
Confidence 356777877777754333 356777777665 2 1211 221111 13355667777888
Q ss_pred cCCceeeccCCcccccc-cc---------------cccc------------------cC-CCCCccc-e-EEEec-----
Q psy1684 81 ADGLCVNLRKPCVQVSC-RI---------------YLVH------------------GT-NLSGVVV-S-AVDFG----- 118 (189)
Q Consensus 81 a~gl~~~~~~~~~~~~~-p~---------------~l~~------------------~~-~~~~~~~-s-VwsfG----- 118 (189)
+.|+.++|..+++|+|+ |+ +++. |. ....++. + |||||
T Consensus 127 ~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 206 (278)
T 1byg_A 127 CEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWE 206 (278)
T ss_dssp HHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccccccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHH
Confidence 89999999999999996 55 1111 11 2345788 9 99999
Q ss_pred --------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q psy1684 119 --------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTM 178 (189)
Q Consensus 119 --------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~ 178 (189)
|.+.+..++...+..+.+++.|..+|+++.+|+.+||+.||++|||+.++++.|+.+...
T Consensus 207 l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 207 IYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp HHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 455556777788888888888999999999999999999999999999999999998763
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.66 E-value=4.4e-18 Score=129.61 Aligned_cols=172 Identities=17% Similarity=0.157 Sum_probs=112.7
Q ss_pred ChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC---ccCCCCCcCHhHHHHHhhhccCC
Q psy1684 7 KRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET---QKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 7 ~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g---yl~~~~~~~l~~li~~~~~~a~g 83 (189)
.|+|++++++.+...+..|||+|++.. +++.-.+... ......-.+...... --.....++...+..+..+.+.|
T Consensus 107 ~hp~iv~~~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a 184 (344)
T 1rjb_A 107 SHENIVNLLGACTLSGPIYLIFEYCCY-GDLLNYLRSK-REKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKG 184 (344)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTT-CBHHHHHHTT-TTCC---------------------CCHHHHHHHHHHHHHH
T ss_pred CCCCeeeEEEEEeeCCccEEEEecCCC-CcHHHHHhhc-cccccccccchhhhcccccccccccCCHHHHHHHHHHHHHH
Confidence 789999999888777788999999876 3221111110 000000000000000 00011234467778888899999
Q ss_pred ceeeccCCcccccc-cc---------------cccc-----------------------cC-CCCCccc-e-EEEec---
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YLVH-----------------------GT-NLSGVVV-S-AVDFG--- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l~~-----------------------~~-~~~~~~~-s-VwsfG--- 118 (189)
+.++|..+++|+|+ |+ |++. |. ....++. + |||||
T Consensus 185 L~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il 264 (344)
T 1rjb_A 185 MEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILL 264 (344)
T ss_dssp HHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HHHHHhCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHH
Confidence 99999999999996 55 2221 11 2356888 9 99999
Q ss_pred ----------CCCCCh-HHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcC
Q psy1684 119 ----------SGGMTN-AEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180 (189)
Q Consensus 119 ----------~~~~~~-~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~~ 180 (189)
|.+.+. ..+...+..+.+++.|..+|+++.+|+.+||+.||++|||+.+|++.|+.++....
T Consensus 265 ~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 265 WEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp HHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred HHHHcCCCCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 334433 34555567788888899999999999999999999999999999999999887643
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.66 E-value=2.5e-18 Score=130.44 Aligned_cols=112 Identities=24% Similarity=0.335 Sum_probs=91.9
Q ss_pred CcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cccccC------------------------C
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVHGT------------------------N 106 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~~~------------------------~ 106 (189)
.+....+..+..+.+.|+.++|..+++|+|+ |+ |++... .
T Consensus 113 ~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 192 (327)
T 3lzb_A 113 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192 (327)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHc
Confidence 4556777788889999999999999999996 55 222111 2
Q ss_pred CCCccc-e-EEEec-------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 107 LSGVVV-S-AVDFG-------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 107 ~~~~~~-s-VwsfG-------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
...++. + ||||| |.+.+..++...+..+.+++.|..+|.++.+|+.+||+.||.+|||+.+|++.
T Consensus 193 ~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 345788 9 99999 56666777888888888889999999999999999999999999999999999
Q ss_pred HHHHHhh
Q psy1684 172 LEDFFTM 178 (189)
Q Consensus 172 l~~~~~~ 178 (189)
|+.+...
T Consensus 273 L~~~~~~ 279 (327)
T 3lzb_A 273 FSKMARD 279 (327)
T ss_dssp HHHHHTS
T ss_pred HHHHHhC
Confidence 9988753
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=1.3e-18 Score=128.11 Aligned_cols=151 Identities=20% Similarity=0.250 Sum_probs=111.8
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC-CCCcCHhHHHHHhhhccCC
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG-RTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~-~~~~~l~~li~~~~~~a~g 83 (189)
.++|+|++++++.+......++|+|+++++. +.. ++.. ...++...+..+..+.+.|
T Consensus 59 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~-----L~~-----------------~l~~~~~~~~~~~~~~i~~qi~~~ 116 (268)
T 3sxs_A 59 KLSHPKLVKFYGVCSKEYPIYIVTEYISNGC-----LLN-----------------YLRSHGKGLEPSQLLEMCYDVCEG 116 (268)
T ss_dssp HCCCTTBCCEEEEECSSSSEEEEEECCTTCB-----HHH-----------------HHHHHGGGCCHHHHHHHHHHHHHH
T ss_pred hCCCCCEeeEEEEEccCCceEEEEEccCCCc-----HHH-----------------HHHHcCCCCCHHHHHHHHHHHHHH
Confidence 3567777777777666666777777776521 111 2221 1234566777778888899
Q ss_pred ceeeccCCcccccc-cc---------------cccc----------------------cC-CCCCccc-e-EEEec----
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YLVH----------------------GT-NLSGVVV-S-AVDFG---- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l~~----------------------~~-~~~~~~~-s-VwsfG---- 118 (189)
+.++|..+++|+|+ |+ +++. |. ....++. + |||+|
T Consensus 117 l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 196 (268)
T 3sxs_A 117 MAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMW 196 (268)
T ss_dssp HHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHH
T ss_pred HHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHH
Confidence 99999999999996 55 1111 10 1235688 8 99999
Q ss_pred ---------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q psy1684 119 ---------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFT 177 (189)
Q Consensus 119 ---------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~ 177 (189)
|.+.+..++...+..+.++..|..+|+++.+|+.+||+.||++|||++++++.|+.+.+
T Consensus 197 ~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 197 EVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp HHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred HHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 55566777888888888888889999999999999999999999999999999987754
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.66 E-value=1.8e-18 Score=130.59 Aligned_cols=160 Identities=19% Similarity=0.281 Sum_probs=115.0
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC--ccCCCCCcCHhHHHHHhhhcc
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET--QKAGRTTIHYPELVEHYSKDA 81 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g--yl~~~~~~~l~~li~~~~~~a 81 (189)
..+.|+|++++++.+......+||+|++.++. +... + ...... .-.....+....++.+..+.+
T Consensus 83 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~-----L~~~----l-----~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 148 (322)
T 1p4o_A 83 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGD-----LKSY----L-----RSLRPAMANNPVLAPPSLSKMIQMAGEIA 148 (322)
T ss_dssp GGCCCTTBCCEEEEECSSSSCEEEEECCTTCB-----HHHH----H-----HHHHHHHHHCTTCCCCCHHHHHHHHHHHH
T ss_pred HhcCCCCEeeeEEEEccCCccEEEEEeCCCCc-----HHHH----H-----HHhchhhccCCCCCCcCHHHHHHHHHHHH
Confidence 35678888888887766677788888877622 1110 0 000000 000012234677778888899
Q ss_pred CCceeeccCCcccccc-cc---------------cccccC------------------------CCCCccc-e-EEEec-
Q psy1684 82 DGLCVNLRKPCVQVSC-RI---------------YLVHGT------------------------NLSGVVV-S-AVDFG- 118 (189)
Q Consensus 82 ~gl~~~~~~~~~~~~~-p~---------------~l~~~~------------------------~~~~~~~-s-VwsfG- 118 (189)
.|+.++|..+++|+|+ |+ +++... ....++. + |||+|
T Consensus 149 ~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 228 (322)
T 1p4o_A 149 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 228 (322)
T ss_dssp HHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred HHHHHHHHCCCccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHH
Confidence 9999999999999996 55 222111 2355788 9 99999
Q ss_pred ------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q psy1684 119 ------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFT 177 (189)
Q Consensus 119 ------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~ 177 (189)
|.+.+..++...+..+..++.|..+|.++.+|+.+||+.||++|||+.++++.|+.++.
T Consensus 229 il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 229 VLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHHHhcCCCccccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 56667788888888888888889999999999999999999999999999999987644
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.65 E-value=6.9e-18 Score=125.41 Aligned_cols=152 Identities=20% Similarity=0.343 Sum_probs=112.8
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC--CCCcCHhHHHHHhhhccC
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG--RTTIHYPELVEHYSKDAD 82 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~--~~~~~l~~li~~~~~~a~ 82 (189)
.++|+|++++++.+......++|+|++.+ + ++.. ++.. ...+....+..+..+.+.
T Consensus 65 ~l~h~~i~~~~~~~~~~~~~~~v~e~~~~-~----~L~~-----------------~~~~~~~~~~~~~~~~~i~~~i~~ 122 (288)
T 3kfa_A 65 EIKHPNLVQLLGVCTREPPFYIITEFMTY-G----NLLD-----------------YLRECNRQEVSAVVLLYMATQISS 122 (288)
T ss_dssp HCCCTTBCCEEEEECSSSSEEEEEECCTT-E----EHHH-----------------HHHHCCTTTSCHHHHHHHHHHHHH
T ss_pred hCCCCCEeeEEEEEccCCCEEEEEEcCCC-C----cHHH-----------------HHHhcccCCccHhHHHHHHHHHHH
Confidence 35677777777766666666777777664 2 1211 2221 223456667777788889
Q ss_pred CceeeccCCcccccc-cc---------------ccccc----------------------C-CCCCccc-e-EEEec---
Q psy1684 83 GLCVNLRKPCVQVSC-RI---------------YLVHG----------------------T-NLSGVVV-S-AVDFG--- 118 (189)
Q Consensus 83 gl~~~~~~~~~~~~~-p~---------------~l~~~----------------------~-~~~~~~~-s-VwsfG--- 118 (189)
|+.++|..+++|+|+ |+ +++.. . ....++. + |||+|
T Consensus 123 ~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 202 (288)
T 3kfa_A 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLL 202 (288)
T ss_dssp HHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHH
Confidence 999999999999996 55 11111 0 2356788 9 99999
Q ss_pred ----------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q psy1684 119 ----------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTM 178 (189)
Q Consensus 119 ----------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~ 178 (189)
|.+.+..++...+..+.+++.|..+|+++.+|+.+||+.||++|||+.++++.|+.++..
T Consensus 203 ~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 203 WEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp HHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 556666778888888888888999999999999999999999999999999999988874
|
| >2c9w_A Suppressor of cytokine signaling 2; growth regulation, SH2 domain, signal transduction inhibitor nuclear protein; 1.9A {Homo sapiens} SCOP: a.271.1.1 d.93.1.1 | Back alignment and structure |
|---|
Probab=99.65 E-value=1.4e-15 Score=104.57 Aligned_cols=79 Identities=24% Similarity=0.285 Sum_probs=68.2
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC-ccCCC-------CCcC-Hh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET-QKAGR-------TTIH-YP 71 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g-yl~~~-------~~~~-l~ 71 (189)
||||.|+|.+|+++|. ...+|+||||++.+..+.|+||++. .+.++|++|....++ ++.+. ..|. +.
T Consensus 19 WyhG~isR~eAe~lL~--~~~~G~FLVR~S~~~~~~~~LSv~~--~~~v~H~rI~~~~g~~~l~~~~~~~~~~~~F~sl~ 94 (169)
T 2c9w_A 19 WYWGSMTVNEAKEKLK--EAPEGTFLIRDSSHSDYLLTISVKT--SAGPTNLRIEYQDGKFRLDSIICVKSKLKQFDSVV 94 (169)
T ss_dssp CBCTTCCHHHHHHHHT--TSCTTCEEEEECCSTTCSEEEEEEE--TTEEEEEEEEEETTEEEECTTTTTGGGCCCBSCHH
T ss_pred ccccCCCHHHHHHHcC--CCCCcEEEEecCCCCCCeEEEEEEE--CCeeEEEEEEEeCCEEEEccccCccccCCCCCCHH
Confidence 9999999999999994 4578999999999888999999999 999999999986444 66653 6788 99
Q ss_pred HHHHHhhhccCC
Q psy1684 72 ELVEHYSKDADG 83 (189)
Q Consensus 72 ~li~~~~~~a~g 83 (189)
+||+||...+.+
T Consensus 95 eLI~~y~~~~~~ 106 (169)
T 2c9w_A 95 HLIDYYVQMCKD 106 (169)
T ss_dssp HHHHHHHHHTC-
T ss_pred HHHHHHHhCcCC
Confidence 999999987654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.64 E-value=1.6e-17 Score=124.85 Aligned_cols=168 Identities=18% Similarity=0.253 Sum_probs=111.0
Q ss_pred ChHHHHHHhcCCCCCCC-cEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCce
Q psy1684 7 KRIEAEKKLLLPENDHG-AFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGLC 85 (189)
Q Consensus 7 ~~~n~~~lL~~~~~~~g-~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl~ 85 (189)
.|+|++++++.+...++ .++|+|++.+ +.+.-.+.. .........+.. .-.....++...+..+..+.+.|+.
T Consensus 89 ~hp~iv~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~-~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~qi~~al~ 162 (316)
T 2xir_A 89 HHLNVVNLLGACTKPGGPLMVIVEFCKF-GNLSTYLRS-KRNEFVPYKVAP----EDLYKDFLTLEHLICYSFQVAKGME 162 (316)
T ss_dssp CCTTBCCEEEEECCTTSCCEEEEECCTT-EEHHHHHHT-CTTSEECC-----------CTTCEEHHHHHHHHHHHHHHHH
T ss_pred cCCCeeeEEEEEecCCCceEEEEEcCCC-CcHHHHHHh-cccccccccccc----hhhhccccCHHHHHHHHHHHHHHHH
Confidence 46788887776554433 7888888775 311100000 000000000000 0000112446677778888899999
Q ss_pred eeccCCcccccc-cc---------------cccccC------------------------CCCCccc-e-EEEec-----
Q psy1684 86 VNLRKPCVQVSC-RI---------------YLVHGT------------------------NLSGVVV-S-AVDFG----- 118 (189)
Q Consensus 86 ~~~~~~~~~~~~-p~---------------~l~~~~------------------------~~~~~~~-s-VwsfG----- 118 (189)
++|..+++|+|+ |+ +++... ....++. + |||||
T Consensus 163 ~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~ 242 (316)
T 2xir_A 163 FLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE 242 (316)
T ss_dssp HHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred HHHhCCcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHH
Confidence 999999999996 54 222211 2345788 9 99999
Q ss_pred --------CCCCC-hHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcC
Q psy1684 119 --------SGGMT-NAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180 (189)
Q Consensus 119 --------~~~~~-~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~~ 180 (189)
|.+.+ ...+...+..+.+++.|..+++++.+++.+||+.||++|||+.+|++.|+.+++...
T Consensus 243 l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 243 IFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp HHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHhCCCCCCcccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 33333 345666677888888889999999999999999999999999999999999998643
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=1.3e-17 Score=125.24 Aligned_cols=169 Identities=19% Similarity=0.269 Sum_probs=114.2
Q ss_pred ChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccC-CCCCcCHhHHHHHhhhccCCce
Q psy1684 7 KRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKA-GRTTIHYPELVEHYSKDADGLC 85 (189)
Q Consensus 7 ~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~-~~~~~~l~~li~~~~~~a~gl~ 85 (189)
.|+|++++++.+......+||+|++.. +++.-.+.. .......-. .....+. ....+...++..+..+.+.|+.
T Consensus 85 ~h~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~-~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~ 159 (313)
T 1t46_A 85 NHMNIVNLLGACTIGGPTLVITEYCCY-GDLLNFLRR-KRDSFICSK---TSPAIMEDDELALDLEDLLSFSYQVAKGMA 159 (313)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTT-EEHHHHHHH-TTTTC-----------------CCCCHHHHHHHHHHHHHHHH
T ss_pred cCCCeeeEEEEEecCCCcEEEEecCCC-CCHHHHHHh-ccccccccc---ccccccccccccCCHHHHHHHHHHHHHHHH
Confidence 688999988887777788999998876 321100100 000000000 0000111 1223457778888889999999
Q ss_pred eeccCCcccccc-cc---------------cccccC------------------------CCCCccc-e-EEEec-----
Q psy1684 86 VNLRKPCVQVSC-RI---------------YLVHGT------------------------NLSGVVV-S-AVDFG----- 118 (189)
Q Consensus 86 ~~~~~~~~~~~~-p~---------------~l~~~~------------------------~~~~~~~-s-VwsfG----- 118 (189)
++|..+++|+|+ |+ +++... ....++. + |||||
T Consensus 160 ~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 239 (313)
T 1t46_A 160 FLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWE 239 (313)
T ss_dssp HHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred HHHHCCeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHH
Confidence 999999999996 55 222111 2345788 9 99999
Q ss_pred --------CCCCCh-HHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcC
Q psy1684 119 --------SGGMTN-AEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180 (189)
Q Consensus 119 --------~~~~~~-~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~~ 180 (189)
|.+.+. ..+...+..+.++..|..+|.++.+|+.+||+.||++|||+.+|++.|+.+++...
T Consensus 240 llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 240 LFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp HHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred HHhCCCCCCCcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 334332 44555567777788888999999999999999999999999999999999987543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.64 E-value=1.4e-17 Score=122.75 Aligned_cols=148 Identities=18% Similarity=0.230 Sum_probs=105.4
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.++|+|++++++.+......+||+|++.+ + ++.. ++. ...++...+..+..+.+.|+
T Consensus 62 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~----~L~~-----------------~~~-~~~~~~~~~~~i~~~l~~~l 118 (271)
T 3dtc_A 62 MLKHPNIIALRGVCLKEPNLCLVMEFARG-G----PLNR-----------------VLS-GKRIPPDILVNWAVQIARGM 118 (271)
T ss_dssp HCCCTTBCCEEEEECCC--CEEEEECCTT-E----EHHH-----------------HHT-SSCCCHHHHHHHHHHHHHHH
T ss_pred hcCCCCEeeEEEEEecCCceEEEEEcCCC-C----CHHH-----------------Hhh-cCCCCHHHHHHHHHHHHHHH
Confidence 35677777777766666667777777665 2 1111 222 33455666777788888999
Q ss_pred eeeccCC---cccccc-cccccc----------cC---------------------------------CCCCccc-e-EE
Q psy1684 85 CVNLRKP---CVQVSC-RIYLVH----------GT---------------------------------NLSGVVV-S-AV 115 (189)
Q Consensus 85 ~~~~~~~---~~~~~~-p~~l~~----------~~---------------------------------~~~~~~~-s-Vw 115 (189)
.++|... ++|+|+ |+.+.- .. ....++. + ||
T Consensus 119 ~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 198 (271)
T 3dtc_A 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVW 198 (271)
T ss_dssp HHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-------------CCGGGSCHHHHHHCCCSHHHHHH
T ss_pred HHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccccccccccCCCCccceeCHHHhccCCCCchhhHH
Confidence 9999987 889996 552211 00 2345788 9 99
Q ss_pred Eec------------CCCCChHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q psy1684 116 DFG------------SGGMTNAEVLHQVE-HGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDF 175 (189)
Q Consensus 116 sfG------------~~~~~~~~~~~~v~-~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~ 175 (189)
||| |.+.+..+....+. .....+.|..+|+++.+|+.+||+.||++|||+.++++.|+++
T Consensus 199 slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 199 SYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 999 67777766666664 4556778889999999999999999999999999999999753
|
| >1wqu_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; SH2 domain, feline sarcoma oncogene, structural genomics; NMR {Homo sapiens} PDB: 2dcr_A | Back alignment and structure |
|---|
Probab=99.64 E-value=5.6e-16 Score=99.69 Aligned_cols=87 Identities=26% Similarity=0.392 Sum_probs=72.3
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcC-HhHHHHHhhh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIH-YPELVEHYSK 79 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~-l~~li~~~~~ 79 (189)
||||.|+|.+|+++|. .+|+||||++...+ .|+||++. .+.++|++|....+.|..+...|. +.+||+||..
T Consensus 18 WyhG~isR~eAe~lL~----~~G~FLVR~S~~~~-~y~LSv~~--~~~v~H~~I~~~~g~~~~~~~~F~sl~~LV~~y~~ 90 (114)
T 1wqu_A 18 WYHGAIPRAEVAELLV----HSGDFLVRESQGKQ-EYVLSVLW--DGLPRHFIIQSLDNLYRLEGEGFPSIPLLIDHLLS 90 (114)
T ss_dssp TEEESCCHHHHHTTCC----STTEEEEEECSSSC-CEEEEEEE--TTEEEEEECEECSSSEESSSCCBSSHHHHHHHHHH
T ss_pred cEeeCCCHHHHHHHhc----cCCeEEEEEcCCCC-CEEEEEEE--CCEEEEEEEEecCCEEEECCCCCCCHHHHHHHHHH
Confidence 9999999999999884 47999999999886 99999999 999999999876433555677888 9999999998
Q ss_pred ccCCc----eeeccCCccc
Q psy1684 80 DADGL----CVNLRKPCVQ 94 (189)
Q Consensus 80 ~a~gl----~~~~~~~~~~ 94 (189)
...++ ...+..||.+
T Consensus 91 ~~~~~~~~~~~~L~~Pv~r 109 (114)
T 1wqu_A 91 TQQPLTKKSGVVLHRAVPS 109 (114)
T ss_dssp HCCCSCTTTCCCCCEECCS
T ss_pred CCCCcCCCCCcEECcccCC
Confidence 76643 5556666654
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=3.7e-18 Score=126.95 Aligned_cols=156 Identities=13% Similarity=0.107 Sum_probs=106.8
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCC-CcCHhHHHHHhhhccC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRT-TIHYPELVEHYSKDAD 82 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~-~~~l~~li~~~~~~a~ 82 (189)
..++|+|++++++.+...+..+||+|++.++. +.. ++.... .++......+..+.+.
T Consensus 67 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~-----L~~-----------------~l~~~~~~~~~~~~~~i~~qi~~ 124 (289)
T 4fvq_A 67 SKLSHKHLVLNYGVCVCGDENILVQEFVKFGS-----LDT-----------------YLKKNKNCINILWKLEVAKQLAA 124 (289)
T ss_dssp HTSCCTTBCCEEEEECCTTCCEEEEECCTTCB-----HHH-----------------HHHHTGGGCCHHHHHHHHHHHHH
T ss_pred HhCCCCCEeEEEEEEEeCCCCEEEEECCCCCC-----HHH-----------------HHHhCCCCCCHHHHHHHHHHHHH
Confidence 35678888888887777777788888887522 211 222222 2456667778888899
Q ss_pred CceeeccCCcccccc-cccc----------------------------------------cccC-CC-CCccc-e-EEEe
Q psy1684 83 GLCVNLRKPCVQVSC-RIYL----------------------------------------VHGT-NL-SGVVV-S-AVDF 117 (189)
Q Consensus 83 gl~~~~~~~~~~~~~-p~~l----------------------------------------~~~~-~~-~~~~~-s-Vwsf 117 (189)
|+.++|..+++|+|+ |+.+ |+|. .. ..++. + ||||
T Consensus 125 ~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl 204 (289)
T 4fvq_A 125 AMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSF 204 (289)
T ss_dssp HHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHH
T ss_pred HHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCcccccccCccccCCcCcccCHHHhCCCCCCCchhHHHHH
Confidence 999999999999996 5511 1111 12 45888 9 9999
Q ss_pred c-------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcCCCC
Q psy1684 118 G-------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEGSDY 183 (189)
Q Consensus 118 G-------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~~~~~ 183 (189)
| +.+.+.......... +...|..+++++.+|+.+||+.||++|||+.++++.|+++++...+..
T Consensus 205 G~il~el~~g~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~~ 281 (289)
T 4fvq_A 205 GTTLWEICSGGDKPLSALDSQRKLQFYED--RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPR 281 (289)
T ss_dssp HHHHHHHHTTTCCTTTTSCHHHHHHHHHT--TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-------
T ss_pred HHHHHHHHcCCCCCccccchHHHHHHhhc--cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCCC
Confidence 9 344444444444433 344566778999999999999999999999999999999988655443
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=6.9e-18 Score=125.08 Aligned_cols=151 Identities=24% Similarity=0.328 Sum_probs=108.1
Q ss_pred CChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC-CCCcCHhHHHHHhhhccCCc
Q psy1684 6 IKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG-RTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 6 l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~-~~~~~l~~li~~~~~~a~gl 84 (189)
++|+|++++++... .+..|+|+|+...+. +.. ++.. ...++...+..+..+.+.|+
T Consensus 70 l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~-----L~~-----------------~l~~~~~~~~~~~~~~~~~~i~~~l 126 (281)
T 3cc6_A 70 LDHPHIVKLIGIIE-EEPTWIIMELYPYGE-----LGH-----------------YLERNKNSLKVLTLVLYSLQICKAM 126 (281)
T ss_dssp HCCTTBCCEEEEEC-SSSCEEEEECCTTCB-----HHH-----------------HHHHHTTTCCHHHHHHHHHHHHHHH
T ss_pred CCCCCcceEEEEEc-CCCCEEEEecCCCCC-----HHH-----------------HHHhccccCCHHHHHHHHHHHHHHH
Confidence 45666666665543 334566666655421 111 2221 22345666777788889999
Q ss_pred eeeccCCcccccc-cc---------------cccccC-----------------------CCCCccc-e-EEEec-----
Q psy1684 85 CVNLRKPCVQVSC-RI---------------YLVHGT-----------------------NLSGVVV-S-AVDFG----- 118 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~---------------~l~~~~-----------------------~~~~~~~-s-VwsfG----- 118 (189)
.++|..+++|+|+ |+ +++... ....++. + |||||
T Consensus 127 ~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 206 (281)
T 3cc6_A 127 AYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWE 206 (281)
T ss_dssp HHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred HHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHH
Confidence 9999999999996 54 222111 2356788 9 99999
Q ss_pred --------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q psy1684 119 --------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTME 179 (189)
Q Consensus 119 --------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~ 179 (189)
|.+.+..++...+..+.+++.|..+|+++.+|+.+||+.||++|||+.++++.|+.+++..
T Consensus 207 llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 275 (281)
T 3cc6_A 207 ILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275 (281)
T ss_dssp HHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence 3344556777778888888889999999999999999999999999999999999988753
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=1.1e-17 Score=126.77 Aligned_cols=165 Identities=19% Similarity=0.243 Sum_probs=113.0
Q ss_pred ChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCcee
Q psy1684 7 KRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGLCV 86 (189)
Q Consensus 7 ~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl~~ 86 (189)
.|+|++++++.+......+||+|++.. |++.-.+.. ..... .....+......++...+..+..+.+.|+.+
T Consensus 108 ~h~~iv~~~~~~~~~~~~~lv~e~~~~-g~L~~~l~~--~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~ 179 (333)
T 2i1m_A 108 QHENIVNLLGACTHGGPVLVITEYCCY-GDLLNFLRR--KSRVL-----ETDPAFAIANSTASTRDLLHFSSQVAQGMAF 179 (333)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTT-EEHHHHHHH--HHHHH-----SCC-------CCCCHHHHHHHHHHHHHHHHH
T ss_pred CCCCeeeEEEEEecCCceEEEEecCCC-CcHHHHHHH--hcccc-----cccccccccccccCHHHHHHHHHHHHHHHHH
Confidence 688999988888777788999998876 321100000 00000 0000011112334567778888899999999
Q ss_pred eccCCcccccc-cc---------------cccccC------------------------CCCCccc-e-EEEec------
Q psy1684 87 NLRKPCVQVSC-RI---------------YLVHGT------------------------NLSGVVV-S-AVDFG------ 118 (189)
Q Consensus 87 ~~~~~~~~~~~-p~---------------~l~~~~------------------------~~~~~~~-s-VwsfG------ 118 (189)
+|..+++|+|+ |+ +++... ....++. + |||||
T Consensus 180 lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 259 (333)
T 2i1m_A 180 LASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 259 (333)
T ss_dssp HHHTTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred HhcCCcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHH
Confidence 99999999996 54 222211 2345788 9 99999
Q ss_pred -------CCCCCh-HHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q psy1684 119 -------SGGMTN-AEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTME 179 (189)
Q Consensus 119 -------~~~~~~-~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~ 179 (189)
|.+... ..+...+..+.+++.|..+|+++.+|+.+||+.||++|||+.+|++.|+.+....
T Consensus 260 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 260 FSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp TTTSCCSSTTCCSSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HcCCCCCCcccchhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 333332 3444555777788888999999999999999999999999999999999887653
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.63 E-value=1.8e-17 Score=128.66 Aligned_cols=144 Identities=10% Similarity=0.016 Sum_probs=102.2
Q ss_pred CCChHHHHHHhcCCCC------CCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhh
Q psy1684 5 KIKRIEAEKKLLLPEN------DHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYS 78 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~------~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~ 78 (189)
.++|+|+++++++... ....|||+|++.+ + +.. ++.....++..+...+..
T Consensus 109 ~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~g-~-----L~~-----------------~i~~~~~l~~~~~~~~~~ 165 (398)
T 4b99_A 109 HFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMES-D-----LHQ-----------------IIHSSQPLTLEHVRYFLY 165 (398)
T ss_dssp HCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCSE-E-----HHH-----------------HHTSSSCCCHHHHHHHHH
T ss_pred hcCCCCcceEeeeeecccccccCCEEEEEEeCCCC-C-----HHH-----------------HHHhcCCCCHHHHHHHHH
Confidence 5678888888875432 1345788888742 2 112 344455666777778889
Q ss_pred hccCCceeeccCCcccccc-cc---------------cccccC--------------------------CC-CCccc-e-
Q psy1684 79 KDADGLCVNLRKPCVQVSC-RI---------------YLVHGT--------------------------NL-SGVVV-S- 113 (189)
Q Consensus 79 ~~a~gl~~~~~~~~~~~~~-p~---------------~l~~~~--------------------------~~-~~~~~-s- 113 (189)
++..|+.|+|..+++|||+ |+ |+|+.. .+ ..|+. +
T Consensus 166 qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~D 245 (398)
T 4b99_A 166 QLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAID 245 (398)
T ss_dssp HHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHH
T ss_pred HHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhh
Confidence 9999999999999999996 66 444321 33 34688 9
Q ss_pred EEEec------------CCCCChHHHHHHHHc--CCCC-----------------------CC-----CCCCCHHHHHHH
Q psy1684 114 AVDFG------------SGGMTNAEVLHQVEH--GYRM-----------------------PC-----PPGCPPRLYDIM 151 (189)
Q Consensus 114 VwsfG------------~~~~~~~~~~~~v~~--g~~~-----------------------~~-----p~~~p~~~~~l~ 151 (189)
|||+| |.+.+..+.+..+.. |... +. .+.+++++.+|+
T Consensus 246 iWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl 325 (398)
T 4b99_A 246 LWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLL 325 (398)
T ss_dssp HHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHH
T ss_pred eehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHH
Confidence 99999 888877777666632 2110 00 124678999999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q psy1684 152 LECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 152 ~~C~~~~p~~RP~~~~i~~~ 171 (189)
.+|+..||++|||++|+++.
T Consensus 326 ~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 326 GRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp HHHSCSSTTTSCCHHHHTTS
T ss_pred HHHCcCChhHCcCHHHHhcC
Confidence 99999999999999998863
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.63 E-value=2.3e-17 Score=124.25 Aligned_cols=153 Identities=14% Similarity=0.100 Sum_probs=109.9
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCC-CcCHhHHHHHhhhccC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRT-TIHYPELVEHYSKDAD 82 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~-~~~l~~li~~~~~~a~ 82 (189)
..++|+|++++++.+......++|+|++.+ + ++.. ++.... .++...+..+..+.+.
T Consensus 84 ~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~-~----~L~~-----------------~l~~~~~~~~~~~~~~i~~qi~~ 141 (319)
T 2y4i_B 84 RQTRHENVVLFMGACMSPPHLAIITSLCKG-R----TLYS-----------------VVRDAKIVLDVNKTRQIAQEIVK 141 (319)
T ss_dssp TTCCCTTBCCCCEEEECSSCEEEECBCCCS-E----EHHH-----------------HTTSSCCCCCSHHHHHHHHHHHH
T ss_pred hcCCCCCEeEEEEEEecCCceEEEeecccC-C----cHHH-----------------HHHhcCCCCCHHHHHHHHHHHHH
Confidence 456777777777766666666777777654 2 1111 333322 3456677778888899
Q ss_pred CceeeccCCcccccc-cc--------------cc--------------------------cccC-C---------CCCcc
Q psy1684 83 GLCVNLRKPCVQVSC-RI--------------YL--------------------------VHGT-N---------LSGVV 111 (189)
Q Consensus 83 gl~~~~~~~~~~~~~-p~--------------~l--------------------------~~~~-~---------~~~~~ 111 (189)
|+.++|..+++|+|+ |+ ++ ++|. . ...++
T Consensus 142 al~~lH~~~i~H~dlkp~NIl~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~ 221 (319)
T 2y4i_B 142 GMGYLHAKGILHKDLKSKNVFYDNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFS 221 (319)
T ss_dssp HHHHHHHTTCCCCCCCSTTEEEC--CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCC
T ss_pred HHHHHHhCCccccCCChhhEEEeCCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCC
Confidence 999999999999986 44 22 1111 1 23478
Q ss_pred c-e-EEEec------------CCCCChHHHHHHHHcCCCCCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q psy1684 112 V-S-AVDFG------------SGGMTNAEVLHQVEHGYRMPCP-PGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFF 176 (189)
Q Consensus 112 ~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~~p-~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~ 176 (189)
. + ||||| |.+.+..++...+..+.++..+ ..+|.++.+|+.+||+.||++|||+.++++.|+.+.
T Consensus 222 ~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~ 301 (319)
T 2y4i_B 222 KHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP 301 (319)
T ss_dssp HHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-
T ss_pred chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 8 9 99999 7777778888888777666544 468999999999999999999999999999998876
Q ss_pred hh
Q psy1684 177 TM 178 (189)
Q Consensus 177 ~~ 178 (189)
+.
T Consensus 302 ~~ 303 (319)
T 2y4i_B 302 KR 303 (319)
T ss_dssp --
T ss_pred Hh
Confidence 54
|
| >2bbu_A Suppressor of cytokine signaling 3; SH2 domain, extended SH2 subdomain, PEST motif, protein complex, cytokine regulator; HET: PTR; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=99.63 E-value=1.1e-15 Score=104.03 Aligned_cols=89 Identities=21% Similarity=0.258 Sum_probs=74.8
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC-ccCCC-------CCcC-Hh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET-QKAGR-------TTIH-YP 71 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g-yl~~~-------~~~~-l~ 71 (189)
||||.|+|.+|+++|.. ..+|+||||++.+..+.|+||++. .+.++|++|....++ ++... ..|. +.
T Consensus 25 WyhG~IsR~eAe~lL~~--~~~GtFLVR~S~s~~g~y~LSvr~--~~~v~H~rI~~~~g~f~l~~~~~~~~~~~~F~SL~ 100 (164)
T 2bbu_A 25 FYWSAVTGGEANLLLSA--EPAGTFLIRDSSDQRHFFTLSVKT--QSGTKNLRIQCEGGSFSLQSDPRSTQPVPRFDCVL 100 (164)
T ss_dssp CCCTTSCHHHHHHHHHH--SSTTCCEEEECSTTSCCEEEEECC--TTCCEEEECEEETTEEESSSCCCCCSSCTTCCHHH
T ss_pred ccCCCCCHHHHHHHhcC--CCCCCEEEEECCCCCCCEEEEEEE--CCceEEEEEEeCCCeEEEecCcccccCCCccCCHH
Confidence 99999999999999943 578999999999888999999999 999999999974444 66654 6788 99
Q ss_pred HHHHHhhhccC--CceeeccCCcc
Q psy1684 72 ELVEHYSKDAD--GLCVNLRKPCV 93 (189)
Q Consensus 72 ~li~~~~~~a~--gl~~~~~~~~~ 93 (189)
+||+||..... |++..+..|+.
T Consensus 101 eLV~~Y~~~~~~~~~~~~l~ep~~ 124 (164)
T 2bbu_A 101 KLVHHYMPPPGTPSFSLPPTEPSS 124 (164)
T ss_dssp HHHHHHSCCCSCSCCSSSCSSCCS
T ss_pred HHHHHHhhCCCCCCccccccCCCc
Confidence 99999998765 67766666643
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=7.3e-18 Score=126.08 Aligned_cols=111 Identities=24% Similarity=0.455 Sum_probs=86.1
Q ss_pred CcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cccccC-------------------------
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVHGT------------------------- 105 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~~~------------------------- 105 (189)
.++...+..+..+.+.|+.++|..+++|+|+ |+ +++...
T Consensus 122 ~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 201 (302)
T 4e5w_A 122 KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECL 201 (302)
T ss_dssp TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHH
T ss_pred cCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeee
Confidence 4556777778888899999999999999996 55 222110
Q ss_pred CCCCccc-e-EEEec------CCC---------------------CChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcc
Q psy1684 106 NLSGVVV-S-AVDFG------SGG---------------------MTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWL 156 (189)
Q Consensus 106 ~~~~~~~-s-VwsfG------~~~---------------------~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~ 156 (189)
....++. + |||+| +.+ ....++...+..+.+++.|..+|+++.+|+.+||+
T Consensus 202 ~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 281 (302)
T 4e5w_A 202 MQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWE 281 (302)
T ss_dssp HHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTC
T ss_pred cCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcC
Confidence 2345778 8 99999 111 12234556667788888999999999999999999
Q ss_pred cCCCCCCCHHHHHHHHHHHHh
Q psy1684 157 KDPVKRPTFETLQWKLEDFFT 177 (189)
Q Consensus 157 ~~p~~RP~~~~i~~~l~~~~~ 177 (189)
.||++|||+.++++.|+.+++
T Consensus 282 ~dp~~Rps~~~ll~~L~~ll~ 302 (302)
T 4e5w_A 282 FQPSNRTSFQNLIEGFEALLK 302 (302)
T ss_dssp SSGGGSCCHHHHHHHHHHHHC
T ss_pred CCCCCCCCHHHHHHHHHHHhC
Confidence 999999999999999998863
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=2e-15 Score=123.28 Aligned_cols=92 Identities=35% Similarity=0.514 Sum_probs=85.0
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC--ccCCCCCcC-HhHHHHHh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET--QKAGRTTIH-YPELVEHY 77 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g--yl~~~~~~~-l~~li~~~ 77 (189)
||||.|+|.+|+++|......+|+||||+|.+.+|.|+||++. .+.++||+|.+..+| |+.+...|. +.+||+||
T Consensus 10 W~~g~i~r~~ae~~L~~~~~~~G~fLvR~s~~~~g~~~ls~~~--~~~~~h~~i~~~~~g~~~~~~~~~f~sl~~Lv~~y 87 (613)
T 2ozo_A 10 FFYGSISRAEAEEHLKLAGMADGLFLLRQCLRSLGGYVLSLVH--DVRFHHFPIERQLNGTYAIAGGKAHCGPAELCEFY 87 (613)
T ss_dssp TBCBSCCHHHHHHHHHTTTCCTTEEEEEECTTBTTCEEEEEEE--TTEEEEEEEEECTTSCEEETTSCCBSSHHHHHHHH
T ss_pred CcCccCCHHHHHHHHhccCCCCCeEEEEecCCCCCCEEEEEEE--CCeEEEEEEEECCCCcEEECCCCCcCCHHHHHHHH
Confidence 9999999999999998777789999999999999999999999 999999999987677 777788899 99999999
Q ss_pred hhccCCceeeccCCccc
Q psy1684 78 SKDADGLCVNLRKPCVQ 94 (189)
Q Consensus 78 ~~~a~gl~~~~~~~~~~ 94 (189)
....+|+...+..||..
T Consensus 88 ~~~~~~l~~~L~~p~~~ 104 (613)
T 2ozo_A 88 SRDPDGLPCNLRKPCNR 104 (613)
T ss_dssp TSCCTTSSSCCCSBCCC
T ss_pred hhCCCCCCccCCccCCC
Confidence 99999999999998865
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=2.2e-17 Score=122.71 Aligned_cols=147 Identities=18% Similarity=0.276 Sum_probs=101.1
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccC-CCCCcCHhHHHHHhhhccCC
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKA-GRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~-~~~~~~l~~li~~~~~~a~g 83 (189)
.++|+|++++++... +..+||+|++..+. +.. ++. ....+.......+..+.+.|
T Consensus 79 ~l~h~~i~~~~~~~~--~~~~lv~e~~~~~~-----L~~-----------------~l~~~~~~~~~~~~~~~~~~l~~~ 134 (287)
T 4f0f_A 79 NLNHPNIVKLYGLMH--NPPRMVMEFVPCGD-----LYH-----------------RLLDKAHPIKWSVKLRLMLDIALG 134 (287)
T ss_dssp TCCCTTBCCEEEEET--TTTEEEEECCTTCB-----HHH-----------------HHHCTTSCCCHHHHHHHHHHHHHH
T ss_pred hCCCCCchhhheeec--CCCeEEEEecCCCC-----HHH-----------------HHhcccCCccHHHHHHHHHHHHHH
Confidence 456777777766543 23467777766521 111 121 12345566677777888889
Q ss_pred ceeeccCC--cccccc-ccc--------------------------------------ccccCC---CCCccc-e-EEEe
Q psy1684 84 LCVNLRKP--CVQVSC-RIY--------------------------------------LVHGTN---LSGVVV-S-AVDF 117 (189)
Q Consensus 84 l~~~~~~~--~~~~~~-p~~--------------------------------------l~~~~~---~~~~~~-s-Vwsf 117 (189)
+.++|... ++|+|+ |+. +++|.. ...++. + |||+
T Consensus 135 l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~sl 214 (287)
T 4f0f_A 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSF 214 (287)
T ss_dssp HHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHH
T ss_pred HHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCccccccccccccCCCccccCchhhccCCCCcCchhhHHHH
Confidence 99999988 999986 541 222222 334788 9 9999
Q ss_pred c------------CCCCChH--HHHHHH-HcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q psy1684 118 G------------SGGMTNA--EVLHQV-EHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDF 175 (189)
Q Consensus 118 G------------~~~~~~~--~~~~~v-~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~ 175 (189)
| |.+.+.. .....+ ..+.++..|..+|+++.+|+.+||+.||++|||+++|++.|+++
T Consensus 215 G~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 215 AMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred HHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 9 4444332 223444 56677888999999999999999999999999999999999753
|
| >2hmh_A Suppressor of cytokine signaling 3; SOCS3, GP130, PTyr, peptide complex, cytokine regulator; HET: PTR; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.61 E-value=2.2e-15 Score=101.62 Aligned_cols=77 Identities=23% Similarity=0.259 Sum_probs=67.3
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC-ccCCC-------CCcC-Hh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET-QKAGR-------TTIH-YP 71 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g-yl~~~-------~~~~-l~ 71 (189)
||||.|+|.+|+++|.. ..+|+||||++...++.|+||++. .+.++|++|....++ ++... ..|. +.
T Consensus 36 WyhG~isR~eAe~lL~~--~~~G~FLVR~S~~~~g~y~LSv~~--~~~v~H~rI~~~~g~f~l~~~~~~~~~~~~F~SL~ 111 (152)
T 2hmh_A 36 FYWSAVTGGEANLLLSA--EPAGTFLIRDSSDQRHFFTLSVKT--QSGTKNLRIQXEGGSFSLQSDPRSTQPVPRFDXVL 111 (152)
T ss_dssp SEETTCCHHHHHHHHHT--SCTTEEEEEECCSTTCSEEEEEEE--TTEEEEEEEECGGGCBEECBCTTCSSCCCCBSSHH
T ss_pred CcCCCCCHHHHHHHhcC--CCCCcEEEEeCCCCCCcEEEEEEc--CCceEEEEEEecCCEEEEecccccccccCccCCHH
Confidence 99999999999999953 578999999999888999999999 999999999984444 66654 6788 99
Q ss_pred HHHHHhhhcc
Q psy1684 72 ELVEHYSKDA 81 (189)
Q Consensus 72 ~li~~~~~~a 81 (189)
+||+||....
T Consensus 112 eLV~~Y~~~~ 121 (152)
T 2hmh_A 112 KLVHHYMPPQ 121 (152)
T ss_dssp HHHHHTCCCC
T ss_pred HHHHHHhhCc
Confidence 9999998875
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.61 E-value=8.9e-18 Score=136.02 Aligned_cols=144 Identities=19% Similarity=0.159 Sum_probs=108.5
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC-CCCcCHhHHHHHhhhccCC
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG-RTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~-~~~~~l~~li~~~~~~a~g 83 (189)
.++|+|+++++.........|||+|+++++. + .. +|.. ...+...+...+..++..|
T Consensus 210 ~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~-L----~~-----------------~i~~~~~~l~e~~~~~~~~qi~~a 267 (573)
T 3uto_A 210 VLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE-L----FE-----------------KVADEHNKMSEDEAVEYMRQVCKG 267 (573)
T ss_dssp HTCCTTBCCEEEEEECSSEEEEEEECCCCCB-H----HH-----------------HHTCTTSCEEHHHHHHHHHHHHHH
T ss_pred hCCCCCCCeEEEEEEECCEEEEEEeecCCCc-H----HH-----------------HHHHhCCCCCHHHHHHHHHHHHHH
Confidence 4678888888877666677788888887632 1 11 2322 2345566677788899999
Q ss_pred ceeeccCCcccccc-cc-----------------cccc--------------------cC-CCCCccc-e-EEEec----
Q psy1684 84 LCVNLRKPCVQVSC-RI-----------------YLVH--------------------GT-NLSGVVV-S-AVDFG---- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~-----------------~l~~--------------------~~-~~~~~~~-s-VwsfG---- 118 (189)
+.|+|...++|||+ |+ |+|+ |. .+..|+. + |||+|
T Consensus 268 l~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvily 347 (573)
T 3uto_A 268 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSY 347 (573)
T ss_dssp HHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHH
T ss_pred HHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHH
Confidence 99999999999996 66 2222 11 4566999 9 99999
Q ss_pred --------CCCCChHHHHHHHHcCC-CCC--CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 119 --------SGGMTNAEVLHQVEHGY-RMP--CPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 119 --------~~~~~~~~~~~~v~~g~-~~~--~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
|.+.+..+++..+..+. .++ .+..+++++.+||.+||..||++|||+.|+++
T Consensus 348 eml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 348 ILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp HHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 78888888888887663 222 23578999999999999999999999999986
|
| >2izv_A Suppressor of cytokine signaling 4; signal transduction inhibitor, growth regulation, signal transduction, SH2 domain, nuclear protein; 2.55A {Homo sapiens} SCOP: a.271.1.1 d.93.1.1 | Back alignment and structure |
|---|
Probab=99.61 E-value=1.5e-15 Score=105.35 Aligned_cols=90 Identities=21% Similarity=0.250 Sum_probs=74.3
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC-ccCCC----CCcC-HhHHH
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET-QKAGR----TTIH-YPELV 74 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g-yl~~~----~~~~-l~~li 74 (189)
||||.|+|.+|+++|. ...+|+||||+|.+..+.|+||++. .+.++|++|...+++ ++... ..|. +.+||
T Consensus 36 WYhG~isR~eAE~lL~--~~~dGtFLVR~S~~~~~~lsLSvr~--~~~v~H~rI~~~~g~f~l~~~~~~~~~F~SL~eLV 111 (187)
T 2izv_A 36 CYWGVMDKYAAEALLE--GKPEGTFLLRDSAQEDYLFSVSFRR--YSRSLHARIEQWNHNFSFDAHDPCVFHSPDITGLL 111 (187)
T ss_dssp TEEEECCHHHHHHHHT--TCCTTEEEEEECSSTTCSEEEEEEE--TTEEEEEECEEETTEEESCTTCTTSCCBSSHHHHH
T ss_pred ccccCCCHHHHHHHhc--CCCCCcEEEEECCCCCceEEEEEee--CCeEEEEEEEECCCEEEEeccCCCccccCCHHHHH
Confidence 9999999999999994 3478999999999877789999999 899999999987555 66543 2688 99999
Q ss_pred HHhhhccCCce--eeccCCccc
Q psy1684 75 EHYSKDADGLC--VNLRKPCVQ 94 (189)
Q Consensus 75 ~~~~~~a~gl~--~~~~~~~~~ 94 (189)
+||...+.++. ..+..|+..
T Consensus 112 ~hY~~~~~~~~~~~~L~~Pv~r 133 (187)
T 2izv_A 112 EHYKDPSACMFFEPLLSTPLIR 133 (187)
T ss_dssp HHTCCGGGCCTTSCCCCEECCC
T ss_pred HHHHhccccccccccccccccc
Confidence 99999888763 455566544
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=2.4e-15 Score=123.25 Aligned_cols=92 Identities=28% Similarity=0.357 Sum_probs=84.5
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC--ccCCCCCcC-HhHHHHHh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET--QKAGRTTIH-YPELVEHY 77 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g--yl~~~~~~~-l~~li~~~ 77 (189)
||||.|+|.+|+++|......+|+||||+|.+.+|.|+||++. .+.++||+|.+..+| ++.+...|. +.+|++||
T Consensus 15 Wy~g~isr~~Ae~~L~~~~~~~G~FLvR~S~~~~g~y~lsv~~--~~~v~h~~i~~~~~g~~~~~~~~~f~sl~~Lv~~y 92 (635)
T 4fl3_A 15 FFFGNITREEAEDYLVQGGMSDGLYLLRQSRNYLGGFALSVAH--GRKAHHYTIERELNGTYAIAGGRTHASPADLCHYH 92 (635)
T ss_dssp TBCBSCCHHHHHHHHHHTTCCTTEEEEEECTTSSSCEEEEEEE--TTEEEEEEEEECTTSCEESTTCCCBSSHHHHHHHH
T ss_pred ccCCCCCHHHHHHHHhcCCCCCceEEEeecccCCCCEEEEEEe--CCEEEeEEEEEcCCCCEEeCCCCccCCHHHHHHHH
Confidence 9999999999999997766678999999999988999999999 999999999988777 777788899 99999999
Q ss_pred hhccCCceeeccCCccc
Q psy1684 78 SKDADGLCVNLRKPCVQ 94 (189)
Q Consensus 78 ~~~a~gl~~~~~~~~~~ 94 (189)
...++|+...+..||..
T Consensus 93 ~~~~~~l~~~L~~p~~~ 109 (635)
T 4fl3_A 93 SQESDGLVCLLKKPFNR 109 (635)
T ss_dssp TTCCTTSSSCCCEECCC
T ss_pred hhCCCCCeeccCCcCCC
Confidence 99999999999988864
|
| >2y3a_B Phosphatidylinositol 3-kinase regulatory subunit; transferase, phosphoinositide 3-kinase, RTK; HET: GD9; 3.30A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.60 E-value=3.8e-15 Score=110.29 Aligned_cols=90 Identities=33% Similarity=0.393 Sum_probs=78.2
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC-ccCC-CCCcC-HhHHHHHh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET-QKAG-RTTIH-YPELVEHY 77 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g-yl~~-~~~~~-l~~li~~~ 77 (189)
||||.|+|..|+++|. ...+|+||||+| +.+|.|+||++. .+.++||+|....+| ++.. ...|. +.+||+||
T Consensus 196 WyhG~IsR~eAE~lL~--~~~~GtFLVR~S-s~~g~y~LSv~~--~~~V~H~rI~~~~~g~~~~~~~~~F~SL~eLV~~Y 270 (302)
T 2y3a_B 196 WYVGKINRTQAEEMLS--GKRDGTFLIRES-SQRGCYACSVVV--DGDTKHCVIYRTATGFGFAEPYNLYGSLKELVLHY 270 (302)
T ss_dssp TBCCSCCHHHHHHHHT--TSCTTBEEBCCC-SSTTCEEEEEEC--SSSEEEEEEEEETTEEESBTTBCCCSSHHHHHHTT
T ss_pred ccCCCCCHHHHHHHhc--CCCCCcEEEEec-cCCCceEEEEEe--CCeeEEEEEEECCCceEEeCCCCCCCCHHHHHHHH
Confidence 9999999999999994 468899999999 778999999999 999999999998888 5554 36788 99999999
Q ss_pred hhc-----cCCceeeccCCcccc
Q psy1684 78 SKD-----ADGLCVNLRKPCVQV 95 (189)
Q Consensus 78 ~~~-----a~gl~~~~~~~~~~~ 95 (189)
... .+|+.+.+..||...
T Consensus 271 ~~~~L~~~~~gl~~~L~~Pv~~~ 293 (302)
T 2y3a_B 271 QHASLVQHNDALTVTLAHPVRAP 293 (302)
T ss_dssp SSSCSTTTCSSCCCCCSBCSCCC
T ss_pred HhCCccccCCCCceeeCCccCCC
Confidence 874 468888899888663
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.59 E-value=1.9e-17 Score=125.37 Aligned_cols=152 Identities=20% Similarity=0.233 Sum_probs=102.7
Q ss_pred CCChHHHHHHhcCCCCC--CCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCC-CCcCHhHHHHHhhhcc
Q psy1684 5 KIKRIEAEKKLLLPEND--HGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGR-TTIHYPELVEHYSKDA 81 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~--~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~-~~~~l~~li~~~~~~a 81 (189)
.++|+|++++++.+... ...+||+|+.+.+. +.. ++... ..+....+..+..+.+
T Consensus 98 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~-----L~~-----------------~l~~~~~~~~~~~~~~i~~qi~ 155 (326)
T 2w1i_A 98 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGS-----LRD-----------------YLQKHKERIDHIKLLQYTSQIC 155 (326)
T ss_dssp TCCCTTBCCEEEEECC----CCEEEECCCTTCB-----HHH-----------------HHHHSTTSSCHHHHHHHHHHHH
T ss_pred hCCCCCeeeEEEEEEecCCCceEEEEECCCCCC-----HHH-----------------HHHhcccCCCHHHHHHHHHHHH
Confidence 45666666666544322 24566776665421 111 22222 2355667777888889
Q ss_pred CCceeeccCCcccccc-cc---------------cccccC-------------------------CCCCccc-e-EEEec
Q psy1684 82 DGLCVNLRKPCVQVSC-RI---------------YLVHGT-------------------------NLSGVVV-S-AVDFG 118 (189)
Q Consensus 82 ~gl~~~~~~~~~~~~~-p~---------------~l~~~~-------------------------~~~~~~~-s-VwsfG 118 (189)
.|+.++|..+++|+|+ |+ +++... ....++. + |||||
T Consensus 156 ~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 235 (326)
T 2w1i_A 156 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFG 235 (326)
T ss_dssp HHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHH
T ss_pred HHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHH
Confidence 9999999999999996 55 221110 1234678 8 99999
Q ss_pred ------CCCCC----------------------hHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 119 ------SGGMT----------------------NAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 119 ------~~~~~----------------------~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
+.+.. ...+...+..+.+++.|..+|+++.+||.+||+.||++|||+.+|++
T Consensus 236 ~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 236 VVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11110 11334455667788889999999999999999999999999999999
Q ss_pred HHHHHHhh
Q psy1684 171 KLEDFFTM 178 (189)
Q Consensus 171 ~l~~~~~~ 178 (189)
.|+.+.+.
T Consensus 316 ~L~~l~~~ 323 (326)
T 2w1i_A 316 RVDQIRDQ 323 (326)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 99988764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.59 E-value=5e-17 Score=123.38 Aligned_cols=144 Identities=13% Similarity=0.094 Sum_probs=104.9
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.++|+|++++++.+......|||+|+++++. +.. ++.....++..+...+..+.+.|+
T Consensus 70 ~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~-----L~~-----------------~l~~~~~l~~~~~~~~~~qi~~al 127 (328)
T 3fe3_A 70 ILNHPNIVKLFEVIETEKTLYLIMEYASGGE-----VFD-----------------YLVAHGRMKEKEARSKFRQIVSAV 127 (328)
T ss_dssp HCCCTTBCCEEEEEECSSEEEEEECCCTTCB-----HHH-----------------HHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred hCCCCCEeeEEEEEEECCEEEEEEECCCCCc-----HHH-----------------HHHHcCCCCHHHHHHHHHHHHHHH
Confidence 3567777777776655666777777776522 111 232233455566677778888999
Q ss_pred eeeccCCcccccc-cc---------------cccccC---------------------CCCCcc-c-e-EEEec------
Q psy1684 85 CVNLRKPCVQVSC-RI---------------YLVHGT---------------------NLSGVV-V-S-AVDFG------ 118 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~---------------~l~~~~---------------------~~~~~~-~-s-VwsfG------ 118 (189)
.++|..+++|+|+ |+ |++... ....++ . + |||+|
T Consensus 128 ~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el 207 (328)
T 3fe3_A 128 QYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTL 207 (328)
T ss_dssp HHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHH
T ss_pred HHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHH
Confidence 9999999999996 55 222211 234444 6 8 99999
Q ss_pred ------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 119 ------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 119 ------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
|.+.+..++...+..+. ...|..+++++.+|+.+||..||++|||++++++.
T Consensus 208 l~g~~pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 208 VSGSLPFDGQNLKELRERVLRGK-YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred HhCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 78888888888887764 45678899999999999999999999999999863
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=3.5e-17 Score=122.89 Aligned_cols=113 Identities=16% Similarity=0.115 Sum_probs=84.2
Q ss_pred CcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------ccc---------------------ccC-CCC
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLV---------------------HGT-NLS 108 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~---------------------~~~-~~~ 108 (189)
.+....+..+..+.+.|+.++|..+++|+|+ |. +++ +|. ...
T Consensus 132 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 211 (310)
T 2wqm_A 132 LIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN 211 (310)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC------------------CCSSCCHHHHTTC
T ss_pred CCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCCC
Confidence 3446667777888889999999999999986 44 111 111 345
Q ss_pred Cccc-e-EEEec------------CCC--CChHHHHHHHHcCCCCCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 109 GVVV-S-AVDFG------------SGG--MTNAEVLHQVEHGYRMPCP-PGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 109 ~~~~-s-VwsfG------------~~~--~~~~~~~~~v~~g~~~~~p-~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
.++. + ||||| |.+ .+..++...+..+..++.+ ..+|.++.+|+.+||+.||++|||+.+|++.
T Consensus 212 ~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 212 GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 6788 9 99999 322 2344566666666555444 6789999999999999999999999999999
Q ss_pred HHHHHhhc
Q psy1684 172 LEDFFTME 179 (189)
Q Consensus 172 l~~~~~~~ 179 (189)
|+++....
T Consensus 292 l~~l~~~~ 299 (310)
T 2wqm_A 292 AKRMHACT 299 (310)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHhh
Confidence 99987753
|
| >4fbn_A 1-phosphatidylinositol 4,5-bisphosphate phosphodi gamma-1; SH2 domain, plcgamma specific array, interaction domain, FIB growth factor receptor 1; 2.40A {Homo sapiens} PDB: 4ey0_A* 3gqi_B* 2fci_A* 2pld_A* 2ple_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=4.9e-15 Score=107.63 Aligned_cols=92 Identities=26% Similarity=0.412 Sum_probs=75.7
Q ss_pred CCCCCC-----ChHHHHHHhcC----CCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC-----ccCCCC
Q psy1684 1 WYFGKI-----KRIEAEKKLLL----PENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET-----QKAGRT 66 (189)
Q Consensus 1 w~~g~l-----~~~n~~~lL~~----~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g-----yl~~~~ 66 (189)
||||.| +|..|+++|.. ....+|+||||+|.+.+|+|+||++. .+.++||+|....++ |+.+..
T Consensus 6 WfhG~i~~~~~sR~~AE~lL~~~~~~~~~~dG~FLVR~S~s~~G~y~LSv~~--~~~v~H~~I~~~~~~g~~~~~~~~~~ 83 (246)
T 4fbn_A 6 WFHGKLGAGRDGRHIAERLLTEYCIETGAPDGSFLVRESETFVGDYTLSFWR--NGKVQHCRIHSRQDAGTPKFFLTDNL 83 (246)
T ss_dssp TBCCCCSCC-CHHHHHHHHHHHHHHHHTCCTTCEEEEECSSSTTCEEEEEEE--TTEEEEEEEEEECGGGCCEEEEETTE
T ss_pred CcCCccccccCCHHHHHHHHHHhhhccCCCCCEEEEEcCCCCCCCEEEEEEE--CCEEEEEEEEEECCCCceeEEecCCc
Confidence 999999 79999999942 24578999999999999999999999 999999999876543 677777
Q ss_pred CcC-HhHHHHHhhhcc---CCceeeccCCccc
Q psy1684 67 TIH-YPELVEHYSKDA---DGLCVNLRKPCVQ 94 (189)
Q Consensus 67 ~~~-l~~li~~~~~~a---~gl~~~~~~~~~~ 94 (189)
.|. +.+||.||+++. +++...+..++..
T Consensus 84 ~F~sl~~LV~~y~~~~l~~~~~~~~l~~p~p~ 115 (246)
T 4fbn_A 84 VFDSLYDLITHYQQVPLRCNEFEMRLSEPVPQ 115 (246)
T ss_dssp EESSHHHHHHHHHHSCEECSSCEECCCCBCCC
T ss_pred ccCCHHHHHHhHhhcccccccccccccccccc
Confidence 898 999999998864 4666555555544
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.58 E-value=1.6e-17 Score=127.59 Aligned_cols=118 Identities=15% Similarity=0.046 Sum_probs=84.0
Q ss_pred CCcCHhHHHHHhhhccCCceeeccCCcccccc-cc-----------------ccccc-----------------------
Q psy1684 66 TTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI-----------------YLVHG----------------------- 104 (189)
Q Consensus 66 ~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~-----------------~l~~~----------------------- 104 (189)
..++...+..+..+++.|+.++|..+++|+|+ |+ |+++.
T Consensus 147 ~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~ 226 (364)
T 3op5_A 147 KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIE 226 (364)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTT
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCC
Confidence 45667788888899999999999999999996 55 22211
Q ss_pred -----C-CCCCccc-e-EEEec------------CCCC-ChHHHHHHHHcCCCCC---------CCCCCCHHHHHHHHHh
Q psy1684 105 -----T-NLSGVVV-S-AVDFG------------SGGM-TNAEVLHQVEHGYRMP---------CPPGCPPRLYDIMLEC 154 (189)
Q Consensus 105 -----~-~~~~~~~-s-VwsfG------------~~~~-~~~~~~~~v~~g~~~~---------~p~~~p~~~~~l~~~C 154 (189)
. ....++. + ||||| |.+. ...........+.+.. .+..+|.++.+||..|
T Consensus 227 y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 306 (364)
T 3op5_A 227 FTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETV 306 (364)
T ss_dssp TCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHH
T ss_pred ccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHH
Confidence 0 3345888 9 99999 4432 1222221111111111 1367899999999999
Q ss_pred cccCCCCCCCHHHHHHHHHHHHhhcCCCC
Q psy1684 155 WLKDPVKRPTFETLQWKLEDFFTMEGSDY 183 (189)
Q Consensus 155 ~~~~p~~RP~~~~i~~~l~~~~~~~~~~~ 183 (189)
|+.||++||++.+|++.|+.+++..+..+
T Consensus 307 l~~~p~~RP~~~~l~~~l~~~~~~~~~~~ 335 (364)
T 3op5_A 307 KLLDYTEKPLYENLRDILLQGLKAIGSKD 335 (364)
T ss_dssp HTCCTTCCCCHHHHHHHHHHHHHHTTCCC
T ss_pred hcCCCCCCCCHHHHHHHHHHHHHHcCCCc
Confidence 99999999999999999999998765444
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=2.3e-17 Score=124.55 Aligned_cols=155 Identities=15% Similarity=0.173 Sum_probs=105.4
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC----CCCcCHhHHHHHhhh
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG----RTTIHYPELVEHYSK 79 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~----~~~~~l~~li~~~~~ 79 (189)
..++|+|++++++.+......++|+|++.++. +.. ++.. ...+....+..+..+
T Consensus 90 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~-----L~~-----------------~l~~~~~~~~~~~~~~~~~i~~~ 147 (321)
T 2qkw_B 90 SFCRHPHLVSLIGFCDERNEMILIYKYMENGN-----LKR-----------------HLYGSDLPTMSMSWEQRLEICIG 147 (321)
T ss_dssp GSCCCTTBCCEEEECCCTTCCEEEEECCTTCB-----TGG-----------------GSSSSCCCSCCCCHHHHHHHHHH
T ss_pred HhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCc-----HHH-----------------HHhccCCCccccCHHHHHHHHHH
Confidence 46789999999988877778899999887632 111 2211 123446777788888
Q ss_pred ccCCceeeccCCcccccc-cc---------------ccccc-----------------------C-CCCCccc-e-EEEe
Q psy1684 80 DADGLCVNLRKPCVQVSC-RI---------------YLVHG-----------------------T-NLSGVVV-S-AVDF 117 (189)
Q Consensus 80 ~a~gl~~~~~~~~~~~~~-p~---------------~l~~~-----------------------~-~~~~~~~-s-Vwsf 117 (189)
.+.|+.++|..+++|+|+ |+ +++.. . ....++. + ||||
T Consensus 148 i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 227 (321)
T 2qkw_B 148 AARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSF 227 (321)
T ss_dssp HHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHH
T ss_pred HHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhH
Confidence 999999999999999996 54 22211 0 2356788 9 9999
Q ss_pred c------------CCCCCh------HHH-HHHHHcC---------CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q psy1684 118 G------------SGGMTN------AEV-LHQVEHG---------YRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQ 169 (189)
Q Consensus 118 G------------~~~~~~------~~~-~~~v~~g---------~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~ 169 (189)
| |.+..+ .+. ......+ .....+..++.++.+++.+||+.||++|||+.+++
T Consensus 228 G~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 307 (321)
T 2qkw_B 228 GVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307 (321)
T ss_dssp HHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHH
Confidence 9 222111 111 1111111 11122344667899999999999999999999999
Q ss_pred HHHHHHHhhcC
Q psy1684 170 WKLEDFFTMEG 180 (189)
Q Consensus 170 ~~l~~~~~~~~ 180 (189)
+.|+.+++..+
T Consensus 308 ~~L~~~l~~~~ 318 (321)
T 2qkw_B 308 WKLEYALRLQE 318 (321)
T ss_dssp HHHHHHHHSSC
T ss_pred HHHHHHhhccc
Confidence 99999987543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=2.5e-17 Score=124.36 Aligned_cols=113 Identities=23% Similarity=0.349 Sum_probs=86.3
Q ss_pred CcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------ccccc------------------------C-
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVHG------------------------T- 105 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~~------------------------~- 105 (189)
.++...+..+..+.+.|+.++|..+++|+|+ |+ +++.. .
T Consensus 130 ~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 209 (318)
T 3lxp_A 130 SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 209 (318)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHh
Confidence 3556777778888899999999999999996 54 22211 1
Q ss_pred CCCCccc-e-EEEec------CCCC---------------------ChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcc
Q psy1684 106 NLSGVVV-S-AVDFG------SGGM---------------------TNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWL 156 (189)
Q Consensus 106 ~~~~~~~-s-VwsfG------~~~~---------------------~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~ 156 (189)
....++. + |||+| ..+. ...++...+..+.+++.|..+|+++.+||.+||+
T Consensus 210 ~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 289 (318)
T 3lxp_A 210 KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWE 289 (318)
T ss_dssp HHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred cCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcC
Confidence 2235778 8 99999 1211 1123445567788888999999999999999999
Q ss_pred cCCCCCCCHHHHHHHHHHHHhhc
Q psy1684 157 KDPVKRPTFETLQWKLEDFFTME 179 (189)
Q Consensus 157 ~~p~~RP~~~~i~~~l~~~~~~~ 179 (189)
.||++|||+.++++.|+.+.+..
T Consensus 290 ~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 290 TEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp SSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCcccCcCHHHHHHHHHHHHHhh
Confidence 99999999999999999987753
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.57 E-value=5.5e-17 Score=121.98 Aligned_cols=116 Identities=12% Similarity=0.088 Sum_probs=80.5
Q ss_pred CCcCHhHHHHHhhhccCCceeeccCCcccccc-cc-------------------------------------cccccC-C
Q psy1684 66 TTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI-------------------------------------YLVHGT-N 106 (189)
Q Consensus 66 ~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~-------------------------------------~l~~~~-~ 106 (189)
..+...++..+..+.+.|+.++|..+++|+|+ |+ ++++|. .
T Consensus 129 ~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 208 (309)
T 2h34_A 129 GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFS 208 (309)
T ss_dssp CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----------------CCGGGCCGGGTC
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccccccccCCCcCccCHHHHc
Confidence 34556677778888889999999999999986 44 112222 2
Q ss_pred CCCccc-e-EEEec------------CCCCChHHHHHHHHcCCCC--CCCCCCCHHHHHHHHHhcccCCCCCC-CHHHHH
Q psy1684 107 LSGVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRM--PCPPGCPPRLYDIMLECWLKDPVKRP-TFETLQ 169 (189)
Q Consensus 107 ~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~--~~p~~~p~~~~~l~~~C~~~~p~~RP-~~~~i~ 169 (189)
...++. + ||||| |.+.+...+...+...... ..+..+|+++.+|+.+||+.||++|| ++.+++
T Consensus 209 ~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~ 288 (309)
T 2h34_A 209 ESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLS 288 (309)
T ss_dssp C----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred CCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHH
Confidence 455788 9 99999 5555444444444433322 24578999999999999999999999 999999
Q ss_pred HHHHHHHhhcCC
Q psy1684 170 WKLEDFFTMEGS 181 (189)
Q Consensus 170 ~~l~~~~~~~~~ 181 (189)
+.|+.++.....
T Consensus 289 ~~l~~~l~~~~~ 300 (309)
T 2h34_A 289 AAAHAALATADQ 300 (309)
T ss_dssp HHHHHTCC----
T ss_pred HHHHHHHHhhcc
Confidence 999988876543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.57 E-value=9.7e-17 Score=119.87 Aligned_cols=154 Identities=11% Similarity=0.080 Sum_probs=108.0
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..++|+|++++++.+...+..|||+|+++++. +.. ++.....++...+..+..+.+.|
T Consensus 66 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~-----L~~-----------------~l~~~~~~~~~~~~~~~~qi~~~ 123 (294)
T 4eqm_A 66 SQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPT-----LSE-----------------YIESHGPLSVDTAINFTNQILDG 123 (294)
T ss_dssp TTCCBTTBCCEEEEEECSSEEEEEEECCCSCB-----HHH-----------------HHHHHCSCCHHHHHHHHHHHHHH
T ss_pred hcCCCCCCceEEEeeeeCCeEEEEEeCCCCCC-----HHH-----------------HHHhcCCCCHHHHHHHHHHHHHH
Confidence 35667777777766655555677777766521 111 33323345567777788888999
Q ss_pred ceeeccCCcccccc-cc---------------ccccc----------------------C-CCCCccc-e-EEEec----
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YLVHG----------------------T-NLSGVVV-S-AVDFG---- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l~~~----------------------~-~~~~~~~-s-VwsfG---- 118 (189)
+.++|..+++|+|+ |+ +++.. . ....++. + |||+|
T Consensus 124 l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~ 203 (294)
T 4eqm_A 124 IKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLY 203 (294)
T ss_dssp HHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHH
T ss_pred HHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHH
Confidence 99999999999996 55 22211 1 3345788 9 99999
Q ss_pred --------CCCCChHHHHHHHHcCCCCC----CCCCCCHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHHHhhc
Q psy1684 119 --------SGGMTNAEVLHQVEHGYRMP----CPPGCPPRLYDIMLECWLKDPVKRP-TFETLQWKLEDFFTME 179 (189)
Q Consensus 119 --------~~~~~~~~~~~~v~~g~~~~----~p~~~p~~~~~l~~~C~~~~p~~RP-~~~~i~~~l~~~~~~~ 179 (189)
|.+.+..+.......+..+. .+..+|+.+.+++.+||+.||++|| +++++.+.|+.++...
T Consensus 204 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 204 EMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp HHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred HHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 67766665554544443332 3567999999999999999999998 9999999998887643
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.57 E-value=6.7e-18 Score=126.90 Aligned_cols=153 Identities=18% Similarity=0.189 Sum_probs=100.9
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC-CCCcCHhHHHHHhhhccC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG-RTTIHYPELVEHYSKDAD 82 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~-~~~~~l~~li~~~~~~a~ 82 (189)
..++|+|++++++.+......++|+|++.++. +.. ++.. ...++..++..+..+.+.
T Consensus 62 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~-----L~~-----------------~l~~~~~~~~~~~~~~i~~qi~~ 119 (310)
T 3s95_A 62 RCLEHPNVLKFIGVLYKDKRLNFITEYIKGGT-----LRG-----------------IIKSMDSQYPWSQRVSFAKDIAS 119 (310)
T ss_dssp TTCCCTTBCCEEEEEEETTEEEEEEECCTTCB-----HHH-----------------HHHHCCTTSCHHHHHHHHHHHHH
T ss_pred HhCCCcCcccEEEEEecCCeeEEEEEecCCCc-----HHH-----------------HHHhccCCCCHHHHHHHHHHHHH
Confidence 45677777777776665556677777766521 111 2222 234556777788889999
Q ss_pred CceeeccCCcccccc-cc---------------cccc-----------------------------------cC-CCCCc
Q psy1684 83 GLCVNLRKPCVQVSC-RI---------------YLVH-----------------------------------GT-NLSGV 110 (189)
Q Consensus 83 gl~~~~~~~~~~~~~-p~---------------~l~~-----------------------------------~~-~~~~~ 110 (189)
|+.++|..+++|+|+ |+ +++. |. ....+
T Consensus 120 al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 199 (310)
T 3s95_A 120 GMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSY 199 (310)
T ss_dssp HHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCC
T ss_pred HHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCC
Confidence 999999999999996 54 2221 11 33457
Q ss_pred cc-e-EEEec------------CCCCChHH--HHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q psy1684 111 VV-S-AVDFG------------SGGMTNAE--VLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLED 174 (189)
Q Consensus 111 ~~-s-VwsfG------------~~~~~~~~--~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~ 174 (189)
+. + ||||| +.+..... ....+........|..+|+++.+|+.+||+.||++|||+.+|++.|+.
T Consensus 200 ~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~ 279 (310)
T 3s95_A 200 DEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLET 279 (310)
T ss_dssp CTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 88 9 99999 22111000 000000011123467899999999999999999999999999999988
Q ss_pred HHhh
Q psy1684 175 FFTM 178 (189)
Q Consensus 175 ~~~~ 178 (189)
+...
T Consensus 280 l~~~ 283 (310)
T 3s95_A 280 LRMH 283 (310)
T ss_dssp HHHH
T ss_pred HHHh
Confidence 8654
|
| >3hhm_B NISH2 P85alpha; PI3KCA, PI3K, PIK3R1, phosphatidilynositol 3,4,5- triphosphate, wortmannin, H1047R, ATP-binding, disease mutation, kinase; HET: KWT; 2.80A {Homo sapiens} PDB: 3hiz_B 2rd0_B 4a55_B* 3mtt_A | Back alignment and structure |
|---|
Probab=99.57 E-value=9.2e-15 Score=111.43 Aligned_cols=90 Identities=30% Similarity=0.463 Sum_probs=79.2
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCC-CCceEEEEEecCCCeeeEEEEEeccCC-ccCCCCCcC-HhHHHHHh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESR-KNDYSLSEYKRSSFCLKMTTGRSLFET-QKAGRTTIH-YPELVEHY 77 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~-~~~~~ls~~~~~~~~v~h~~i~~~~~g-yl~~~~~~~-l~~li~~~ 77 (189)
||||.|+|.+|+++|. ...+|+||||++.+. +|.|+||++. .+.++|++|....++ ++.....|. +.+||.||
T Consensus 12 WYhG~IsR~eAE~lL~--~~~dG~FLVR~S~s~~~g~y~LSvr~--~~~v~H~rI~~~~g~y~l~~~~~F~SL~eLV~~Y 87 (373)
T 3hhm_B 12 WYWGDISREEVNEKLR--DTADGTFLVRDASTKMHGDYTLTLRK--GGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHY 87 (373)
T ss_dssp TEEESCCHHHHHHHTT--TCCTTEEEEEECSCC--CCEEEEEEE--TTEEEEEEECCSSSCBCSSSSCCBSSSHHHHHHH
T ss_pred ccCCCCCHHHHHHHhc--CCCCCCEEEeccCCCCCCCEEEEEEE--CCeeEEEEEEecCCeEEeCCCCCcCCHHHHHHHH
Confidence 9999999999999995 347899999999987 8999999999 999999999977655 777667898 99999999
Q ss_pred hhcc-----CCceeeccCCccc
Q psy1684 78 SKDA-----DGLCVNLRKPCVQ 94 (189)
Q Consensus 78 ~~~a-----~gl~~~~~~~~~~ 94 (189)
...+ .|+...+..||..
T Consensus 88 ~~~~l~~~~~gl~~~L~~Pv~r 109 (373)
T 3hhm_B 88 RNESLAQYNPKLDVKLLYPVSK 109 (373)
T ss_dssp HHSCGGGSCTTCCCCCCEECCS
T ss_pred hhCCccccCCCCCcccCCCCCC
Confidence 9987 7888888888865
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.56 E-value=2.9e-16 Score=123.73 Aligned_cols=145 Identities=12% Similarity=0.043 Sum_probs=105.3
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.++|+|++++++........|||+|++.++. +.. ++.....++..++..+..+.+.|+
T Consensus 66 ~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~-----L~~-----------------~i~~~~~~~e~~~~~i~~qil~aL 123 (444)
T 3soa_A 66 LLKHPNIVRLHDSISEEGHHYLIFDLVTGGE-----LFE-----------------DIVAREYYSEADASHCIQQILEAV 123 (444)
T ss_dssp HCCBTTBCCEEEEEECSSEEEEEECCCBCCB-----HHH-----------------HHHHCSCCCHHHHHHHHHHHHHHH
T ss_pred hCCCcCCCeEEEEEEECCEEEEEEEeCCCCC-----HHH-----------------HHHHcCCCCHHHHHHHHHHHHHHH
Confidence 4577888887776666666777887776522 111 222234455667777788888999
Q ss_pred eeeccCCcccccc-cc------------------cccc---------------------cC-CCCCccc-e-EEEec---
Q psy1684 85 CVNLRKPCVQVSC-RI------------------YLVH---------------------GT-NLSGVVV-S-AVDFG--- 118 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~------------------~l~~---------------------~~-~~~~~~~-s-VwsfG--- 118 (189)
.++|..+++|+|+ |+ |++. |. ....|+. + |||+|
T Consensus 124 ~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvil 203 (444)
T 3soa_A 124 LHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203 (444)
T ss_dssp HHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHH
T ss_pred HHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHH
Confidence 9999999999996 55 1111 11 3446899 9 99999
Q ss_pred ---------CCCCChHHHHHHHHcCCC-CCCC--CCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 119 ---------SGGMTNAEVLHQVEHGYR-MPCP--PGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 119 ---------~~~~~~~~~~~~v~~g~~-~~~p--~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
|.+.+..++...+..+.. .+.| ..+++++.+|+.+||+.||++|||+.|+++.
T Consensus 204 yell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 204 YILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 667777888888876643 3333 4789999999999999999999999999873
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.56 E-value=1.1e-16 Score=118.40 Aligned_cols=144 Identities=10% Similarity=0.046 Sum_probs=101.3
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.++|+|++++++.+......++|+|++.. + ++.. ++.....+.......+..+.+.|+
T Consensus 65 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~----~l~~-----------------~l~~~~~~~~~~~~~~~~qi~~~l 122 (279)
T 3fdn_A 65 HLRHPNILRLYGYFHDATRVYLILEYAPL-G----TVYR-----------------ELQKLSKFDEQRTATYITELANAL 122 (279)
T ss_dssp TCCCTTBCCEEEEEECSSEEEEEECCCTT-E----EHHH-----------------HHHHHSSCCHHHHHHHHHHHHHHH
T ss_pred cCCCCCCcchhheEecCCEEEEEEecCCC-C----cHHH-----------------HHHhcCCCCHHHHHHHHHHHHHHH
Confidence 45666776666665555556666666554 2 1111 222223455666777778888999
Q ss_pred eeeccCCcccccc-cc---------------ccc-------------------ccC-CCCCccc-e-EEEec--------
Q psy1684 85 CVNLRKPCVQVSC-RI---------------YLV-------------------HGT-NLSGVVV-S-AVDFG-------- 118 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~---------------~l~-------------------~~~-~~~~~~~-s-VwsfG-------- 118 (189)
.++|..+++|+|+ |+ +++ +|. ....++. + |||+|
T Consensus 123 ~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 202 (279)
T 3fdn_A 123 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV 202 (279)
T ss_dssp HHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC--------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred HHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHH
Confidence 9999999999996 54 111 111 3455788 8 99999
Q ss_pred ----CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 119 ----SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 119 ----~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
|.+.+..+....+..+ ....|..+++++.+|+.+||+.||++|||+.+|++.
T Consensus 203 g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 203 GKPPFEANTYQETYKRISRV-EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp SSCTTCCSSHHHHHHHHHHT-CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CCCCCCCCcHHHHHHHHHhC-CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 6666777777666554 355678899999999999999999999999999975
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=1.6e-17 Score=122.85 Aligned_cols=105 Identities=13% Similarity=0.078 Sum_probs=84.0
Q ss_pred cCHhHHHHHhhhccCCceeeccCC-----cccccc-ccc---------------c---------------------cccC
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKP-----CVQVSC-RIY---------------L---------------------VHGT 105 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~-----~~~~~~-p~~---------------l---------------------~~~~ 105 (189)
++...+..+..+.+.|+.++|... ++|+|+ |+. + ++|.
T Consensus 108 ~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~ 187 (279)
T 2w5a_A 108 LDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQ 187 (279)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeeccccccccccCCCccccChHH
Confidence 456677778888889999999988 999996 541 1 1111
Q ss_pred -CCCCccc-e-EEEec------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 106 -NLSGVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 106 -~~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
....++. + ||||| |.+.+..++...+..+..++.|..+|.++.+|+.+||+.||++|||+.+|++
T Consensus 188 ~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 267 (279)
T 2w5a_A 188 MNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267 (279)
T ss_dssp HHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 2345788 9 99999 6777778888888888888888999999999999999999999999999987
Q ss_pred HH
Q psy1684 171 KL 172 (189)
Q Consensus 171 ~l 172 (189)
.+
T Consensus 268 ~~ 269 (279)
T 2w5a_A 268 NP 269 (279)
T ss_dssp ST
T ss_pred Ch
Confidence 65
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.56 E-value=4.1e-16 Score=123.76 Aligned_cols=144 Identities=12% Similarity=0.059 Sum_probs=105.2
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..++|+|++++++.+......|||+|++.+ + ++.. ++.....++..+...+..+.+.|
T Consensus 71 ~~l~HpnIv~l~~~~~~~~~~~lv~E~~~g-g----~L~~-----------------~l~~~~~l~~~~~~~i~~qi~~a 128 (476)
T 2y94_A 71 KLFRHPHIIKLYQVISTPSDIFMVMEYVSG-G----ELFD-----------------YICKNGRLDEKESRRLFQQILSG 128 (476)
T ss_dssp TTCCCTTBCCEEEEEECSSEEEEEEECCSS-E----EHHH-----------------HTTSSSSCCHHHHHHHHHHHHHH
T ss_pred HhCCCCCCCcEEEEEEECCEEEEEEeCCCC-C----cHHH-----------------HHHhcCCCCHHHHHHHHHHHHHH
Confidence 345677777776665555566677776654 2 1111 45545556677777888899999
Q ss_pred ceeeccCCcccccc-cc---------------ccccc--------------------C-CCCCc-cc-e-EEEec-----
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YLVHG--------------------T-NLSGV-VV-S-AVDFG----- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l~~~--------------------~-~~~~~-~~-s-VwsfG----- 118 (189)
+.++|..+++|+|+ |+ |++.. . ....+ +. + |||+|
T Consensus 129 L~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~e 208 (476)
T 2y94_A 129 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYA 208 (476)
T ss_dssp HHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHH
T ss_pred HHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHH
Confidence 99999999999996 55 22211 1 23334 57 8 99999
Q ss_pred -------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 119 -------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 119 -------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
|.+.+..++...+..+. ...|..+++++.+|+.+||+.||++|||+.+|++
T Consensus 209 lltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 209 LLCGTLPFDDDHVPTLFKKICDGI-FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp HHHSSCSSCCSSSHHHHHHHHTTC-CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HhhCCCCCCCCCHHHHHHHHhcCC-cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 66767777888887764 4567889999999999999999999999999987
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=1.1e-16 Score=127.63 Aligned_cols=150 Identities=13% Similarity=0.108 Sum_probs=107.3
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..++|+|++++++.+......+||+|++.++. +.. ++.....++..+...+..+++.|
T Consensus 91 ~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~-----L~~-----------------~~~~~~~~~~~~~~~i~~qi~~~ 148 (494)
T 3lij_A 91 KLLDHPNIMKLYDFFEDKRNYYLVMECYKGGE-----LFD-----------------EIIHRMKFNEVDAAVIIKQVLSG 148 (494)
T ss_dssp TTCCCTTBCCEEEEEECSSEEEEEEECCCSCB-----HHH-----------------HHHHHSSCCHHHHHHHHHHHHHH
T ss_pred HhCCCCCCCeEEEEEEeCCEEEEEEecCCCCc-----HHH-----------------HHHHcCCCCHHHHHHHHHHHHHH
Confidence 45678888888877766666778888776522 111 12222345555666677888889
Q ss_pred ceeeccCCcccccc-cc------------------c--------------------ccccCCCCCccc-e-EEEec----
Q psy1684 84 LCVNLRKPCVQVSC-RI------------------Y--------------------LVHGTNLSGVVV-S-AVDFG---- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~------------------~--------------------l~~~~~~~~~~~-s-VwsfG---- 118 (189)
+.++|..+++|+|+ |+ | +|||...+.|+. + |||+|
T Consensus 149 l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~ 228 (494)
T 3lij_A 149 VTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILF 228 (494)
T ss_dssp HHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHH
T ss_pred HHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHH
Confidence 99999999999996 55 1 112223356889 9 99999
Q ss_pred --------CCCCChHHHHHHHHcCCCC-CCC--CCCCHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHH
Q psy1684 119 --------SGGMTNAEVLHQVEHGYRM-PCP--PGCPPRLYDIMLECWLKDPVKRPTFETLQWK--LEDF 175 (189)
Q Consensus 119 --------~~~~~~~~~~~~v~~g~~~-~~p--~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~--l~~~ 175 (189)
|.+.+..++...+..+... +.| ..+++++.+|+.+||+.||++|||+.++++. |..+
T Consensus 229 ~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 229 ILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 7788888888888766432 222 4689999999999999999999999999863 4444
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=7e-17 Score=128.43 Aligned_cols=146 Identities=12% Similarity=0.069 Sum_probs=104.8
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..++|+|++++++.+......+||+|++.++. +.. ++.....++..++..+..+.+.|
T Consensus 81 ~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~-----L~~-----------------~~~~~~~~~~~~~~~i~~qi~~~ 138 (484)
T 3nyv_A 81 KQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGE-----LFD-----------------EIISRKRFSEVDAARIIRQVLSG 138 (484)
T ss_dssp TTCCCTTBCCEEEEEECSSEEEEEECCCCSCB-----HHH-----------------HHHTCSCCBHHHHHHHHHHHHHH
T ss_pred HhCCCCCCCcEEEEEEeCCEEEEEEecCCCCC-----HHH-----------------HHHhcCCCCHHHHHHHHHHHHHH
Confidence 35567777777766555555666776665421 111 33334455566777788888999
Q ss_pred ceeeccCCcccccc-cccc--------------------------------------cccCCCCCccc-e-EEEec----
Q psy1684 84 LCVNLRKPCVQVSC-RIYL--------------------------------------VHGTNLSGVVV-S-AVDFG---- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~~l--------------------------------------~~~~~~~~~~~-s-VwsfG---- 118 (189)
+.++|..+++|+|+ |+.+ |||...+.|+. + |||+|
T Consensus 139 l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~ 218 (484)
T 3nyv_A 139 ITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILY 218 (484)
T ss_dssp HHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHH
T ss_pred HHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccccccCCCCccccCceeecCCCCCcceeHHHHHHHH
Confidence 99999999999996 5521 11113346889 9 99999
Q ss_pred --------CCCCChHHHHHHHHcCC-CCCCC--CCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 119 --------SGGMTNAEVLHQVEHGY-RMPCP--PGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 119 --------~~~~~~~~~~~~v~~g~-~~~~p--~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
|.+.+..+++..+..+. ..+.| ..+++++.+|+.+||+.||++|||+.++++.
T Consensus 219 ~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 219 ILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 77888888888887664 33333 4689999999999999999999999999863
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.55 E-value=8.5e-17 Score=119.60 Aligned_cols=110 Identities=25% Similarity=0.448 Sum_probs=85.8
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cccccC-------------------------C
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVHGT-------------------------N 106 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~~~-------------------------~ 106 (189)
+....+..+..+.+.|+.++|..+++|+|+ |+ +++... .
T Consensus 118 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 197 (291)
T 1u46_A 118 FLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 197 (291)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhc
Confidence 446667777888889999999999999996 55 211110 1
Q ss_pred CCCccc-e-EEEec-------------CCCCChHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 107 LSGVVV-S-AVDFG-------------SGGMTNAEVLHQVE-HGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 107 ~~~~~~-s-VwsfG-------------~~~~~~~~~~~~v~-~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
...++. + ||||| |.+.+..++...+. .+.+++.|..+|.++.+++.+||+.||++|||+.++++
T Consensus 198 ~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 198 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp HCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 234688 8 99999 55566677777774 45667778899999999999999999999999999999
Q ss_pred HHHHHHh
Q psy1684 171 KLEDFFT 177 (189)
Q Consensus 171 ~l~~~~~ 177 (189)
.|+.+..
T Consensus 278 ~l~~~~~ 284 (291)
T 1u46_A 278 FLLEAQP 284 (291)
T ss_dssp HHHHHC-
T ss_pred HHHHhCc
Confidence 9987765
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=8.5e-17 Score=121.75 Aligned_cols=113 Identities=24% Similarity=0.386 Sum_probs=84.8
Q ss_pred CcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cccccC-------------------------
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVHGT------------------------- 105 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~~~------------------------- 105 (189)
.+....+..+..+.+.|+.++|..+++|+|+ |+ +++...
T Consensus 123 ~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 202 (327)
T 3lxl_A 123 RLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL 202 (327)
T ss_dssp GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHh
Confidence 3556777778888999999999999999996 55 222111
Q ss_pred CCCCccc-e-EEEec------CCCC--------------------C-hHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcc
Q psy1684 106 NLSGVVV-S-AVDFG------SGGM--------------------T-NAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWL 156 (189)
Q Consensus 106 ~~~~~~~-s-VwsfG------~~~~--------------------~-~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~ 156 (189)
....++. + |||+| +.+. . ..++...+..+.+++.|..+|+++.+|+.+||+
T Consensus 203 ~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 282 (327)
T 3lxl_A 203 SDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWA 282 (327)
T ss_dssp HHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred ccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcC
Confidence 1234678 8 99999 1111 1 134556667888888999999999999999999
Q ss_pred cCCCCCCCHHHHHHHHHHHHhhc
Q psy1684 157 KDPVKRPTFETLQWKLEDFFTME 179 (189)
Q Consensus 157 ~~p~~RP~~~~i~~~l~~~~~~~ 179 (189)
.||++|||+.++++.|+.+....
T Consensus 283 ~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 283 PSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp SSGGGSCCHHHHHHHHHHC----
T ss_pred CChhhCcCHHHHHHHHHHHHhhh
Confidence 99999999999999999887643
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=4.8e-17 Score=124.40 Aligned_cols=144 Identities=13% Similarity=0.046 Sum_probs=100.5
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccC-CCCCcCHhHHHHHhhhccCC
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKA-GRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~-~~~~~~l~~li~~~~~~a~g 83 (189)
.++|+|++++++.+...+..+||+|++.+ + +.. ++. ....+....+..+..+.+.|
T Consensus 110 ~l~hpniv~~~~~~~~~~~~~lv~e~~~g-~-----l~~-----------------~l~~~~~~l~~~~~~~i~~qi~~a 166 (348)
T 1u5q_A 110 KLRHPNTIQYRGCYLREHTAWLVMEYCLG-S-----ASD-----------------LLEVHKKPLQEVEIAAVTHGALQG 166 (348)
T ss_dssp HCCCTTBCCEEEEEEETTEEEEEEECCSE-E-----HHH-----------------HHHHHTSCCCHHHHHHHHHHHHHH
T ss_pred hCCCCCEeeEEEEEEECCeEEEEEecCCC-C-----HHH-----------------HHHHhcCCCCHHHHHHHHHHHHHH
Confidence 45677777777666555566777777642 1 111 111 12334566667777888899
Q ss_pred ceeeccCCcccccc-cc---------------c-----------------ccccC----CCCCccc-e-EEEec------
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------Y-----------------LVHGT----NLSGVVV-S-AVDFG------ 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~-----------------l~~~~----~~~~~~~-s-VwsfG------ 118 (189)
+.++|..+++|+|+ |+ | +|+|. ..+.++. + |||||
T Consensus 167 L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~el 246 (348)
T 1u5q_A 167 LAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 246 (348)
T ss_dssp HHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHH
T ss_pred HHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCCCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHH
Confidence 99999999999996 54 2 22222 2466899 9 99999
Q ss_pred ------CCCCChHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 119 ------SGGMTNAEVLHQVEHGYRM-PCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 119 ------~~~~~~~~~~~~v~~g~~~-~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
|.+.+..+.+..+..+..+ ..+..+|+++.+||.+||+.||++|||+.++++.
T Consensus 247 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 247 AERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp HHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred HhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 5666666666666555444 3456799999999999999999999999999764
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=1.7e-16 Score=118.86 Aligned_cols=106 Identities=13% Similarity=0.107 Sum_probs=85.0
Q ss_pred CCcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------ccc---------------------ccC-CC
Q psy1684 66 TTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLV---------------------HGT-NL 107 (189)
Q Consensus 66 ~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~---------------------~~~-~~ 107 (189)
..++...+..+..+.+.|+.++|..+++|+|+ |. +++ +|. ..
T Consensus 114 ~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 193 (303)
T 3a7i_A 114 GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ 193 (303)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTT
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccccCccCCCcCccCHHHHhc
Confidence 34556777778888889999999999999986 44 111 111 34
Q ss_pred CCccc-e-EEEec------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 108 SGVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 108 ~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
..++. + ||||| |.+.+..++...+..+..+..+..+|.++.+|+.+||+.||++|||+.+|++.
T Consensus 194 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 194 SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 56788 9 99999 66677777777777777777888999999999999999999999999999874
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.54 E-value=1e-15 Score=114.37 Aligned_cols=104 Identities=9% Similarity=0.016 Sum_probs=77.6
Q ss_pred CcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cc---------------------cccCCC-C
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YL---------------------VHGTNL-S 108 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l---------------------~~~~~~-~ 108 (189)
.++..++..+..+.+.|+.++|..+++|+|+ |+ |+ |+|... .
T Consensus 133 ~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 212 (298)
T 2zv2_A 133 PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSET 212 (298)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTT
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccC
Confidence 4556677778888899999999999999996 55 22 222211 1
Q ss_pred C---ccc-e-EEEec------------CCCCChHHHHHHHHcC-CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 109 G---VVV-S-AVDFG------------SGGMTNAEVLHQVEHG-YRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 109 ~---~~~-s-VwsfG------------~~~~~~~~~~~~v~~g-~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
. ++. + ||||| |.+.+...+...+..+ ...+.+..+|+++.+|+.+||+.||++|||+.+|++
T Consensus 213 ~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 213 RKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp CCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 1 367 8 99999 6666666666666544 334445689999999999999999999999999875
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=1.7e-16 Score=126.30 Aligned_cols=145 Identities=12% Similarity=0.090 Sum_probs=104.7
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.++|+|++++++.+......+||+|++.++. +.. ++.....++...+..+..+.+.|+
T Consensus 77 ~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~-----L~~-----------------~~~~~~~~~~~~~~~i~~qi~~al 134 (486)
T 3mwu_A 77 KLDHPNIMKLFEILEDSSSFYIVGELYTGGE-----LFD-----------------EIIKRKRFSEHDAARIIKQVFSGI 134 (486)
T ss_dssp HCCCTTBCCEEEEEECSSEEEEEECCCCSCB-----HHH-----------------HHHHHSSCCHHHHHHHHHHHHHHH
T ss_pred hCCCCCcCeEEEEEEcCCEEEEEEEcCCCCc-----HHH-----------------HHHhcCCCCHHHHHHHHHHHHHHH
Confidence 4567777777776666666677777766522 111 222233455666777778888899
Q ss_pred eeeccCCcccccc-cc--------------------------------------cccccCCCCCccc-e-EEEec-----
Q psy1684 85 CVNLRKPCVQVSC-RI--------------------------------------YLVHGTNLSGVVV-S-AVDFG----- 118 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~--------------------------------------~l~~~~~~~~~~~-s-VwsfG----- 118 (189)
.++|..+++|+|+ |+ ++|||...+.|+. + |||+|
T Consensus 135 ~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ 214 (486)
T 3mwu_A 135 TYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYI 214 (486)
T ss_dssp HHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHH
T ss_pred HHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHH
Confidence 9999999999986 55 2223334456889 9 99999
Q ss_pred -------CCCCChHHHHHHHHcCCC-CCCC--CCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 119 -------SGGMTNAEVLHQVEHGYR-MPCP--PGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 119 -------~~~~~~~~~~~~v~~g~~-~~~p--~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
|.+.+..+++..+..+.. .+.| ..+++++.+|+.+||+.||++|||+.++++.
T Consensus 215 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 215 LLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 777788888888876643 2222 4689999999999999999999999999874
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=6.5e-17 Score=122.28 Aligned_cols=153 Identities=12% Similarity=0.096 Sum_probs=98.2
Q ss_pred CCCCChHHHHHHhcCCCCCCC----cEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhh
Q psy1684 3 FGKIKRIEAEKKLLLPENDHG----AFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYS 78 (189)
Q Consensus 3 ~g~l~~~n~~~lL~~~~~~~g----~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~ 78 (189)
...++|+|++++++.+..... .+||+|++.++. +.. ++. ...++...+..+..
T Consensus 72 l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~-----L~~-----------------~l~-~~~~~~~~~~~i~~ 128 (322)
T 3soc_A 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGS-----LSD-----------------FLK-ANVVSWNELCHIAE 128 (322)
T ss_dssp STTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCB-----HHH-----------------HHH-HCCBCHHHHHHHHH
T ss_pred HhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCC-----HHH-----------------HHH-hcCCCHHHHHHHHH
Confidence 346678888877765543222 367777766522 111 222 12355666777777
Q ss_pred hccCCceeeccC----------Ccccccc-cc---------------ccc-----------------------ccC-CC-
Q psy1684 79 KDADGLCVNLRK----------PCVQVSC-RI---------------YLV-----------------------HGT-NL- 107 (189)
Q Consensus 79 ~~a~gl~~~~~~----------~~~~~~~-p~---------------~l~-----------------------~~~-~~- 107 (189)
+.+.|+.++|.. +++|+|+ |+ |++ +|. ..
T Consensus 129 qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 208 (322)
T 3soc_A 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGA 208 (322)
T ss_dssp HHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTC
T ss_pred HHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccc
Confidence 888888888888 9999996 54 222 111 11
Q ss_pred ----CCccc-e-EEEec------------CCCC----------------ChHHHHHHHH-cCCCCCCCC-----CCCHHH
Q psy1684 108 ----SGVVV-S-AVDFG------------SGGM----------------TNAEVLHQVE-HGYRMPCPP-----GCPPRL 147 (189)
Q Consensus 108 ----~~~~~-s-VwsfG------------~~~~----------------~~~~~~~~v~-~g~~~~~p~-----~~p~~~ 147 (189)
..++. + ||||| |.+. ...++...+. .+.++..+. .+++++
T Consensus 209 ~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (322)
T 3soc_A 209 INFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAML 288 (322)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHH
T ss_pred cccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHH
Confidence 35678 8 99999 2211 2334444443 333443332 245679
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q psy1684 148 YDIMLECWLKDPVKRPTFETLQWKLEDFFTM 178 (189)
Q Consensus 148 ~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~ 178 (189)
.+||.+||+.||++|||+.+|++.|+.+.+.
T Consensus 289 ~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 289 CETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 9999999999999999999999999988764
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.54 E-value=3.5e-16 Score=120.20 Aligned_cols=145 Identities=11% Similarity=0.038 Sum_probs=103.2
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.++|+|++++++.+......|||+|++.++. +.. ++.....+...++..+..+++.|+
T Consensus 84 ~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~-----L~~-----------------~l~~~~~~~~~~~~~~~~qi~~al 141 (362)
T 2bdw_A 84 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGE-----LFE-----------------DIVAREFYSEADASHCIQQILESI 141 (362)
T ss_dssp HCCCTTBCCEEEEEECSSEEEEEECCCCSCB-----HHH-----------------HHTTCSCCCHHHHHHHHHHHHHHH
T ss_pred hCCCCCCCeEEEEEEeCCEEEEEEecCCCCC-----HHH-----------------HHHHcCCCCHHHHHHHHHHHHHHH
Confidence 3567777777766655556677777766521 111 333344555677777888889999
Q ss_pred eeeccCCcccccc-cc------------------ccccc--------------------C-CCCCccc-e-EEEec----
Q psy1684 85 CVNLRKPCVQVSC-RI------------------YLVHG--------------------T-NLSGVVV-S-AVDFG---- 118 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~------------------~l~~~--------------------~-~~~~~~~-s-VwsfG---- 118 (189)
.++|..+++|+|+ |+ |++.. . ....|+. + |||+|
T Consensus 142 ~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 221 (362)
T 2bdw_A 142 AYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILY 221 (362)
T ss_dssp HHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred HHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHH
Confidence 9999999999996 55 11111 1 3346889 9 99999
Q ss_pred --------CCCCChHHHHHHHHcCCC-CCCC--CCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 119 --------SGGMTNAEVLHQVEHGYR-MPCP--PGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 119 --------~~~~~~~~~~~~v~~g~~-~~~p--~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
|.+.+..++...+..+.. .+.+ ..+|+++.+|+.+||+.||++|||+.++++.
T Consensus 222 ~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 222 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 667777788888876643 2322 3689999999999999999999999998764
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=3.5e-16 Score=118.26 Aligned_cols=145 Identities=8% Similarity=0.000 Sum_probs=101.7
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..++|+|++++++.+...+..+||+|++.++. +.. ++. ...+....+..+..+.+.|
T Consensus 97 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~-----L~~-----------------~l~-~~~l~~~~~~~i~~qi~~~ 153 (321)
T 2c30_A 97 RDYQHFNVVEMYKSYLVGEELWVLMEFLQGGA-----LTD-----------------IVS-QVRLNEEQIATVCEAVLQA 153 (321)
T ss_dssp TTCCCTTBCCEEEEEEETTEEEEEECCCCSCB-----HHH-----------------HHT-TCCCCHHHHHHHHHHHHHH
T ss_pred HhCCCCCcceEEEEEEECCEEEEEEecCCCCC-----HHH-----------------HHH-hcCCCHHHHHHHHHHHHHH
Confidence 35567777777666555556677777666521 111 222 2245566777778888899
Q ss_pred ceeeccCCcccccc-cc---------------cccc---------------------cC-CCCCccc-e-EEEec-----
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YLVH---------------------GT-NLSGVVV-S-AVDFG----- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l~~---------------------~~-~~~~~~~-s-VwsfG----- 118 (189)
+.++|..+++|+|+ |+ |++. |. ....++. + |||||
T Consensus 154 L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~e 233 (321)
T 2c30_A 154 LAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIE 233 (321)
T ss_dssp HHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHH
T ss_pred HHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHH
Confidence 99999999999996 55 2211 11 3455888 9 99999
Q ss_pred -------CCCCChHHHHHHHHcCCCCC--CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 119 -------SGGMTNAEVLHQVEHGYRMP--CPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 119 -------~~~~~~~~~~~~v~~g~~~~--~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
|.+.+..+....+..+..+. .+..+|+++.+++.+||+.||++|||+.++++.
T Consensus 234 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 234 MVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 66666777777776654433 334689999999999999999999999999863
|
| >2dvj_A V-CRK sarcoma virus CT10 oncogene homolog, isoform A; SH3, SH2, signal transduction, adapter molecule, signaling protein; HET: PTR; NMR {Homo sapiens} PDB: 2eyy_A 2eyv_A 2eyw_A | Back alignment and structure |
|---|
Probab=99.54 E-value=6e-15 Score=106.39 Aligned_cols=89 Identities=29% Similarity=0.452 Sum_probs=73.7
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccC-----------------C-cc
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFE-----------------T-QK 62 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~-----------------g-yl 62 (189)
||||.|+|.+|+++|. ...+|+||||++....|.|+||++. .+.++||+|....+ + |.
T Consensus 15 WyhG~isR~eAe~lL~--~~~~G~FLVR~S~~~~g~y~LSv~~--~~~v~H~~I~~~~~~~~~~~~~~~~~~g~~~~~~~ 90 (230)
T 2dvj_A 15 WYWGRLSRQEAVALLQ--GQRHGVFLVRDSSTSPGDYVLSVSE--NSRVSHYIINSSGPRPPVPPSPAQPPPGVSPSRLR 90 (230)
T ss_dssp SCCSSCCTTHHHHHHT--TSSSSCBEEECCSSCTTSCEEECCC--SSSCCCEECBCCCSCCSSSSSSSSTTTSCCCCCEE
T ss_pred cccCCCCHHHHHHHhc--CCCCceEEEEeCCCCCCCEEEEEEE--CCEEEEEEEEeCCCCcccccccccccccccceEEE
Confidence 9999999999999994 3568999999999888999999999 99999999987653 4 44
Q ss_pred CCCCCcC-HhHHHHHhhhccCCceeeccCCccc
Q psy1684 63 AGRTTIH-YPELVEHYSKDADGLCVNLRKPCVQ 94 (189)
Q Consensus 63 ~~~~~~~-l~~li~~~~~~a~gl~~~~~~~~~~ 94 (189)
.+...|. +.+||+||.....+ ...+..||..
T Consensus 91 ~~~~~F~sl~~LV~~y~~~~l~-~~~L~~Pv~~ 122 (230)
T 2dvj_A 91 IGDQEFDSLPALLEFYKIHYLD-TTTLIEPVSR 122 (230)
T ss_dssp SSSCEESSHHHHHTTSTTTCSS-SSCCCCBCCS
T ss_pred eCCceeCCHHHHHHHHhhCccc-cccccccccc
Confidence 4567788 99999999987765 3455556543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=1.3e-16 Score=119.30 Aligned_cols=143 Identities=10% Similarity=-0.013 Sum_probs=98.6
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.++|+|++++++.+...+..+||+|++.++. +.. ++. ...+....+..+..+.+.|+
T Consensus 73 ~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~-----L~~-----------------~~~-~~~~~~~~~~~~~~qi~~~l 129 (297)
T 3fxz_A 73 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGS-----LTD-----------------VVT-ETCMDEGQIAAVCRECLQAL 129 (297)
T ss_dssp HCCCTTBCCEEEEEEETTEEEEEEECCTTCB-----HHH-----------------HHH-HSCCCHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCeEeEEEEECCEEEEEEECCCCCC-----HHH-----------------HHh-hcCCCHHHHHHHHHHHHHHH
Confidence 3567777776665555555667777665521 111 222 12344566677778888999
Q ss_pred eeeccCCcccccc-cc---------------cccc---------------------cC-CCCCccc-e-EEEec------
Q psy1684 85 CVNLRKPCVQVSC-RI---------------YLVH---------------------GT-NLSGVVV-S-AVDFG------ 118 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~---------------~l~~---------------------~~-~~~~~~~-s-VwsfG------ 118 (189)
.++|..+++|+|+ |+ |++. |. ....++. + |||+|
T Consensus 130 ~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 209 (297)
T 3fxz_A 130 EFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEM 209 (297)
T ss_dssp HHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHH
T ss_pred HHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHH
Confidence 9999999999996 55 2211 11 3456888 9 99999
Q ss_pred ------CCCCChHHHHHHHHc-C-CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 119 ------SGGMTNAEVLHQVEH-G-YRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 119 ------~~~~~~~~~~~~v~~-g-~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
|.+.+..+....+.. + ..+..|..++..+.+|+.+||+.||++|||++++++
T Consensus 210 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 210 IEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp HHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 666666665555533 3 344567789999999999999999999999999986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.54 E-value=6.6e-16 Score=114.93 Aligned_cols=111 Identities=21% Similarity=0.351 Sum_probs=82.5
Q ss_pred CcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cccc-----------------------cC--
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVH-----------------------GT-- 105 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~-----------------------~~-- 105 (189)
.+....+..+..+.+.|+.++|..+++|+|+ |+ +++. |.
T Consensus 116 ~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 195 (289)
T 3og7_A 116 KFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195 (289)
T ss_dssp -CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhc
Confidence 4557777888888999999999999999996 54 2221 11
Q ss_pred --CCCCccc-e-EEEec------------CCCCCh-HHHHHHHHcCCCCC----CCCCCCHHHHHHHHHhcccCCCCCCC
Q psy1684 106 --NLSGVVV-S-AVDFG------------SGGMTN-AEVLHQVEHGYRMP----CPPGCPPRLYDIMLECWLKDPVKRPT 164 (189)
Q Consensus 106 --~~~~~~~-s-VwsfG------------~~~~~~-~~~~~~v~~g~~~~----~p~~~p~~~~~l~~~C~~~~p~~RP~ 164 (189)
....++. + |||+| |.+.+. .++...+..+...+ .+..+|+++.+|+.+||+.||++|||
T Consensus 196 ~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps 275 (289)
T 3og7_A 196 MQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPS 275 (289)
T ss_dssp ----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred ccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCC
Confidence 1456888 9 99999 555443 45555566554433 23579999999999999999999999
Q ss_pred HHHHHHHHHHHHh
Q psy1684 165 FETLQWKLEDFFT 177 (189)
Q Consensus 165 ~~~i~~~l~~~~~ 177 (189)
+.+|++.|+.+.+
T Consensus 276 ~~ell~~L~~l~~ 288 (289)
T 3og7_A 276 FPRILAEIEELAR 288 (289)
T ss_dssp HHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHhh
Confidence 9999999998764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.54 E-value=3.1e-16 Score=118.84 Aligned_cols=143 Identities=17% Similarity=0.097 Sum_probs=97.7
Q ss_pred CChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCce
Q psy1684 6 IKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGLC 85 (189)
Q Consensus 6 l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl~ 85 (189)
++|+|++++++.+......+||+|++..+. +.. ++.....++..++..+..+.+.|+.
T Consensus 71 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~-----L~~-----------------~l~~~~~~~~~~~~~i~~qi~~al~ 128 (326)
T 2y0a_A 71 IQHPNVITLHEVYENKTDVILILELVAGGE-----LFD-----------------FLAEKESLTEEEATEFLKQILNGVY 128 (326)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCCSCB-----HHH-----------------HHTTSSCCBHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCcEEEEEEeCCEEEEEEEcCCCCC-----HHH-----------------HHHhcCCcCHHHHHHHHHHHHHHHH
Confidence 445555555554444444555555554411 111 4444445566777788888899999
Q ss_pred eeccCCcccccc-cccc-------------------cc--------------------cC-CCCCccc-e-EEEec----
Q psy1684 86 VNLRKPCVQVSC-RIYL-------------------VH--------------------GT-NLSGVVV-S-AVDFG---- 118 (189)
Q Consensus 86 ~~~~~~~~~~~~-p~~l-------------------~~--------------------~~-~~~~~~~-s-VwsfG---- 118 (189)
++|..+++|+|+ |+.+ +. |. ....++. + |||+|
T Consensus 129 ~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 208 (326)
T 2y0a_A 129 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 208 (326)
T ss_dssp HHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred HHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHH
Confidence 999999999996 5511 11 10 3356888 9 99999
Q ss_pred --------CCCCChHHHHHHHHcCCCC-C--CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 119 --------SGGMTNAEVLHQVEHGYRM-P--CPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 119 --------~~~~~~~~~~~~v~~g~~~-~--~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
|.+.+..+++..+..+... + .+..+|.++.+|+.+||+.||++|||+.++++
T Consensus 209 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 209 ILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 6666677777777554322 1 12578999999999999999999999999986
|
| >3qwx_X Cell death abnormality protein 2; cell engulfment, signaling protein; 2.01A {Caenorhabditis elegans} | Back alignment and structure |
|---|
Probab=99.53 E-value=1.8e-14 Score=99.62 Aligned_cols=88 Identities=27% Similarity=0.312 Sum_probs=71.4
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCe---eeEEEEEe---c-cC---C-ccCCCCCcC
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFC---LKMTTGRS---L-FE---T-QKAGRTTIH 69 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~---v~h~~i~~---~-~~---g-yl~~~~~~~ 69 (189)
||||.|+|.+|+++|......+|+||||++ +.+|.|+||++. .+. ++||+|.. . .+ | |..+...|.
T Consensus 14 Wyhg~isR~~Ae~lL~~~~~~~G~FLVR~S-~~~g~y~LSv~~--~~~~~~v~H~~I~~~~~~~~g~~~~~~~~~~~~F~ 90 (174)
T 3qwx_X 14 FYFPGMSREEAHKLLGEPQVSIGTFLMRDS-SRPGEYSLTVRE--ADEGNAVCHYLIERGEPKEDGTAAAGVKIANQSFP 90 (174)
T ss_dssp GEETTCCHHHHHHHHHSTTCCTTEEEEEEC-SSTTCEEEEEEC--CSSSSCEEEEEEEECCCCTTSSSCCCEEETTEEES
T ss_pred CccCCCCHHHHHHHHhccCCCCCeEEEEec-CCCCCEEEEEEE--CCCCCceEEEEEEeccCCCCCcccceEEECCeecC
Confidence 999999999999999765667899999999 888999999999 888 99999987 3 33 5 444577888
Q ss_pred -HhHHHHHhhhccCCceeeccCCc
Q psy1684 70 -YPELVEHYSKDADGLCVNLRKPC 92 (189)
Q Consensus 70 -l~~li~~~~~~a~gl~~~~~~~~ 92 (189)
+.+|++++..... +...+..|+
T Consensus 91 sl~eLv~~y~~~~~-~~~~L~~P~ 113 (174)
T 3qwx_X 91 DIPALLNHFKMRVL-TEASLLAAY 113 (174)
T ss_dssp SHHHHHHHTTSSCS-SSCCCCEEC
T ss_pred cHHHHhhhhhcCcc-ccccccccc
Confidence 9999999987764 444444444
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.53 E-value=4.7e-16 Score=118.44 Aligned_cols=144 Identities=7% Similarity=-0.041 Sum_probs=100.8
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.+.|+|++++++.....+..|||+|++++ |++ .. ++.....+.......+..+++.|+
T Consensus 61 ~l~hp~iv~l~~~~~~~~~~~lv~E~~~g-g~L----~~-----------------~l~~~~~~~~~~~~~~~~qi~~aL 118 (337)
T 1o6l_A 61 NTRHPFLTALKYAFQTHDRLCFVMEYANG-GEL----FF-----------------HLSRERVFTEERARFYGAEIVSAL 118 (337)
T ss_dssp SCCCTTBCCEEEEEECSSEEEEEEECCTT-CBH----HH-----------------HHHHHSCCCHHHHHHHHHHHHHHH
T ss_pred hCCCCcCcceEEEEEeCCEEEEEEeCCCC-CcH----HH-----------------HHHhcCCCCHHHHHHHHHHHHHHH
Confidence 34566666666555555556666666654 211 11 232233455566666777888899
Q ss_pred eeeccCCcccccc-cc---------------cccc---------------------cC-CCCCccc-e-EEEec------
Q psy1684 85 CVNLRKPCVQVSC-RI---------------YLVH---------------------GT-NLSGVVV-S-AVDFG------ 118 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~---------------~l~~---------------------~~-~~~~~~~-s-VwsfG------ 118 (189)
.++|..+++|||+ |+ |+++ |. ....|+. + |||+|
T Consensus 119 ~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 198 (337)
T 1o6l_A 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 198 (337)
T ss_dssp HHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHH
T ss_pred HHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHH
Confidence 9999999999996 55 3332 22 3456888 9 99999
Q ss_pred ------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q psy1684 119 ------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRP-----TFETLQWK 171 (189)
Q Consensus 119 ------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP-----~~~~i~~~ 171 (189)
|.+.+..++...+..+ .+..|..+++++.+|+.+||+.||++|| ++++|++.
T Consensus 199 l~g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 199 MCGRLPFYNQDHERLFELILME-EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHC-CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred hcCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 6666777777777655 3556788999999999999999999999 89988763
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=1e-16 Score=118.43 Aligned_cols=151 Identities=9% Similarity=0.014 Sum_probs=102.4
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.++|+|++++++.+......++|+|++..+. +.. ++.....++..++..+..+.+.|+
T Consensus 62 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~-----L~~-----------------~~~~~~~~~~~~~~~i~~~i~~~l 119 (277)
T 3f3z_A 62 SLDHPNIIRLYETFEDNTDIYLVMELCTGGE-----LFE-----------------RVVHKRVFRESDAARIMKDVLSAV 119 (277)
T ss_dssp TCCCTTBCCEEEEEECSSEEEEEEECCCSCB-----HHH-----------------HHHHHCSCCHHHHHHHHHHHHHHH
T ss_pred hCCCCCEeeEEEEEecCCeEEEEEeccCCCc-----HHH-----------------HHHHcCCCCHHHHHHHHHHHHHHH
Confidence 4566666666665555555566666655411 111 222233455666777778888899
Q ss_pred eeeccCCcccccc-ccccc--------------------------------------ccCCCCCccc-e-EEEec-----
Q psy1684 85 CVNLRKPCVQVSC-RIYLV--------------------------------------HGTNLSGVVV-S-AVDFG----- 118 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~~l~--------------------------------------~~~~~~~~~~-s-VwsfG----- 118 (189)
.++|..+++|+|+ |+.+. +|...+.++. + |||+|
T Consensus 120 ~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~ 199 (277)
T 3f3z_A 120 AYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYV 199 (277)
T ss_dssp HHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHH
T ss_pred HHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccchhccCCCCCccChHHhcccCCchhhehhHHHHHHH
Confidence 9999999999986 54221 1112344788 9 99999
Q ss_pred -------CCCCChHHHHHHHHcCCCCCCC---CCCCHHHHHHHHHhcccCCCCCCCHHHHHH--HHHHHHh
Q psy1684 119 -------SGGMTNAEVLHQVEHGYRMPCP---PGCPPRLYDIMLECWLKDPVKRPTFETLQW--KLEDFFT 177 (189)
Q Consensus 119 -------~~~~~~~~~~~~v~~g~~~~~p---~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~--~l~~~~~ 177 (189)
|.+.+..++...+..+.....+ ..+|+++.+|+.+||+.||++|||+.++++ .++..+.
T Consensus 200 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~ 270 (277)
T 3f3z_A 200 LLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLS 270 (277)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHC
T ss_pred HHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcccc
Confidence 7777778888888776433222 278999999999999999999999999986 3554443
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=5.7e-16 Score=119.01 Aligned_cols=144 Identities=15% Similarity=0.053 Sum_probs=101.0
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.+.|+|++++++........+||+|+++++. +.. ++.....++..++..+..+++.|+
T Consensus 71 ~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~-----L~~-----------------~l~~~~~l~~~~~~~i~~qi~~aL 128 (361)
T 2yab_A 71 QVLHPNIITLHDVYENRTDVVLILELVSGGE-----LFD-----------------FLAQKESLSEEEATSFIKQILDGV 128 (361)
T ss_dssp TCCCTTBCCEEEEEECSSEEEEEEECCCSCB-----HHH-----------------HHTTCSCCBHHHHHHHHHHHHHHH
T ss_pred hCCCcCCCcEEEEEEeCCEEEEEEEcCCCCc-----HHH-----------------HHHhcCCCCHHHHHHHHHHHHHHH
Confidence 4556666666655544445566666655421 111 444444566777778888899999
Q ss_pred eeeccCCcccccc-cccc-------------------cc--------------------cC-CCCCccc-e-EEEec---
Q psy1684 85 CVNLRKPCVQVSC-RIYL-------------------VH--------------------GT-NLSGVVV-S-AVDFG--- 118 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~~l-------------------~~--------------------~~-~~~~~~~-s-VwsfG--- 118 (189)
.++|..+++|+|+ |+.+ +. |. ....|+. + |||+|
T Consensus 129 ~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil 208 (361)
T 2yab_A 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208 (361)
T ss_dssp HHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred HHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHH
Confidence 9999999999996 5521 11 00 3456889 9 99999
Q ss_pred ---------CCCCChHHHHHHHHcCCCCC---CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 119 ---------SGGMTNAEVLHQVEHGYRMP---CPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 119 ---------~~~~~~~~~~~~v~~g~~~~---~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
|.+.+..+++..+..+.... .+..+++++.+|+.+||..||++|||+.++++
T Consensus 209 ~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 209 YILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 67777788888886664221 22578999999999999999999999999985
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.53 E-value=3e-16 Score=120.09 Aligned_cols=104 Identities=10% Similarity=-0.054 Sum_probs=82.9
Q ss_pred CCcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------ccc------------------ccC-CCCCc
Q psy1684 66 TTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLV------------------HGT-NLSGV 110 (189)
Q Consensus 66 ~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~------------------~~~-~~~~~ 110 (189)
..++...+..+..+++.|+.++|..+++|+|+ |+ |++ +|. ....+
T Consensus 136 ~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~ 215 (350)
T 1rdq_E 136 GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGY 215 (350)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBCCCEECGGGCCHHHHTTCCB
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCCcccccCCccccCHHHhcCCCC
Confidence 34556666777788889999999999999996 55 222 221 44568
Q ss_pred cc-e-EEEec------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q psy1684 111 VV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPT-----FETLQW 170 (189)
Q Consensus 111 ~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~-----~~~i~~ 170 (189)
+. + |||+| |.+.+..++...+..+. +..|..+++++.+|+.+||+.||++||+ +++|++
T Consensus 216 ~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 89 9 99999 66777788888887773 5678899999999999999999999998 788765
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=3.8e-16 Score=123.05 Aligned_cols=144 Identities=8% Similarity=-0.059 Sum_probs=102.7
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..+.|+|++++++.+...+..+||+|++.+ +.+ .. ++.....++...+..+..+++.|
T Consensus 203 ~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~-~~L----~~-----------------~l~~~~~~~~~~~~~~~~qi~~a 260 (446)
T 4ejn_A 203 QNSRHPFLTALKYSFQTHDRLCFVMEYANG-GEL----FF-----------------HLSRERVFSEDRARFYGAEIVSA 260 (446)
T ss_dssp CCCSCTTSCCEEEEEEETTEEEEEECCCSS-CBH----HH-----------------HHHHHSCCCHHHHHHHHHHHHHH
T ss_pred HhCCCCeEeeEEEEEeeCCEEEEEEeeCCC-CcH----HH-----------------HHHhcCCCCHHHHHHHHHHHHHH
Confidence 345666666666655555556666666655 211 11 23223345566677777888999
Q ss_pred ceeecc-CCcccccc-cc---------------cccccC----------------------CCCCccc-e-EEEec----
Q psy1684 84 LCVNLR-KPCVQVSC-RI---------------YLVHGT----------------------NLSGVVV-S-AVDFG---- 118 (189)
Q Consensus 84 l~~~~~-~~~~~~~~-p~---------------~l~~~~----------------------~~~~~~~-s-VwsfG---- 118 (189)
+.++|. .+++|+|+ |+ |+++.. ....|+. + |||||
T Consensus 261 L~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 340 (446)
T 4ejn_A 261 LDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 340 (446)
T ss_dssp HHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHH
T ss_pred HHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHH
Confidence 999998 89999996 55 333221 3456889 9 99999
Q ss_pred --------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q psy1684 119 --------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRP-----TFETLQW 170 (189)
Q Consensus 119 --------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP-----~~~~i~~ 170 (189)
|.+.+..++...+..+. +..|..+++++.+|+.+||+.||++|| +++++++
T Consensus 341 ell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 341 EMMCGRLPFYNQDHEKLFELILMEE-IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHhhCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 67777777777775543 456788999999999999999999999 9999876
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=2.6e-17 Score=123.38 Aligned_cols=151 Identities=12% Similarity=0.141 Sum_probs=98.8
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccC---CCCCcCHhHHHHHhhhcc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKA---GRTTIHYPELVEHYSKDA 81 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~---~~~~~~l~~li~~~~~~a 81 (189)
.++|+|++++++.+...+..+||++++.++. +.. ++. ....+....+..+..+.+
T Consensus 86 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~-----L~~-----------------~l~~~~~~~~~~~~~~~~i~~~i~ 143 (307)
T 2nru_A 86 KCQHENLVELLGFSSDGDDLCLVYVYMPNGS-----LLD-----------------RLSCLDGTPPLSWHMRCKIAQGAA 143 (307)
T ss_dssp HCCCTTBCCEEEEECSSSSCEEEEECCTTCB-----HHH-----------------HHHTGGGCCCCCHHHHHHHHHHHH
T ss_pred hcCCCCeEEEEEEEecCCceEEEEEecCCCc-----HHH-----------------HHHhccCCCCCCHHHHHHHHHHHH
Confidence 4567888887777766667788888776522 111 111 122344666777778888
Q ss_pred CCceeeccCCcccccc-cc---------------ccc-----------------------ccCCCCCccc-e-EEEec--
Q psy1684 82 DGLCVNLRKPCVQVSC-RI---------------YLV-----------------------HGTNLSGVVV-S-AVDFG-- 118 (189)
Q Consensus 82 ~gl~~~~~~~~~~~~~-p~---------------~l~-----------------------~~~~~~~~~~-s-VwsfG-- 118 (189)
.|+.++|..+++|+|+ |+ +++ +|...+.++. + |||||
T Consensus 144 ~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~i 223 (307)
T 2nru_A 144 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVV 223 (307)
T ss_dssp HHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHH
T ss_pred HHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcCCCCccchhHHHHHH
Confidence 9999999999999986 54 111 1112334788 8 99999
Q ss_pred ----------CCCCCh----HHHHHHHHcC----------CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q psy1684 119 ----------SGGMTN----AEVLHQVEHG----------YRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLED 174 (189)
Q Consensus 119 ----------~~~~~~----~~~~~~v~~g----------~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~ 174 (189)
|.+.+. ..+...+... .....+..++..+.+++.+||+.||++|||+.+|++.|++
T Consensus 224 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~ 303 (307)
T 2nru_A 224 LLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303 (307)
T ss_dssp HHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred HHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 333221 1222222211 1122344566789999999999999999999999999998
Q ss_pred HHh
Q psy1684 175 FFT 177 (189)
Q Consensus 175 ~~~ 177 (189)
+.+
T Consensus 304 l~~ 306 (307)
T 2nru_A 304 MTA 306 (307)
T ss_dssp HC-
T ss_pred Hhc
Confidence 754
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.53 E-value=2.1e-16 Score=126.33 Aligned_cols=145 Identities=13% Similarity=0.080 Sum_probs=103.3
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.++|+|++++++.+......+||+|++.++. +.. ++.....++......+..+.+.|+
T Consensus 102 ~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~-----L~~-----------------~l~~~~~~~~~~~~~i~~qi~~~l 159 (504)
T 3q5i_A 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGE-----LFE-----------------QIINRHKFDECDAANIMKQILSGI 159 (504)
T ss_dssp TCCCTTBCCEEEEEECSSEEEEEEECCTTCB-----HHH-----------------HHHHHSCCCHHHHHHHHHHHHHHH
T ss_pred hCCCCCCCeEEEEEEcCCEEEEEEecCCCCc-----HHH-----------------HHHHcCCCCHHHHHHHHHHHHHHH
Confidence 4567777777766655555677777766521 111 222233455666777788888999
Q ss_pred eeeccCCcccccc-ccc--------------------------------------ccccCCCCCccc-e-EEEec-----
Q psy1684 85 CVNLRKPCVQVSC-RIY--------------------------------------LVHGTNLSGVVV-S-AVDFG----- 118 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~~--------------------------------------l~~~~~~~~~~~-s-VwsfG----- 118 (189)
.++|..+++|+|+ |+. +|||...+.|+. + |||+|
T Consensus 160 ~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ 239 (504)
T 3q5i_A 160 CYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYI 239 (504)
T ss_dssp HHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHH
T ss_pred HHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHH
Confidence 9999999999986 551 111113356889 9 99999
Q ss_pred -------CCCCChHHHHHHHHcCCCC-CC--CCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 119 -------SGGMTNAEVLHQVEHGYRM-PC--PPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 119 -------~~~~~~~~~~~~v~~g~~~-~~--p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
|.+.+..+++..+..+... +. ...+++++.+|+.+||+.||++|||+.++++.
T Consensus 240 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 240 LLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 7788888898888777432 21 15789999999999999999999999999863
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.53 E-value=4e-16 Score=120.88 Aligned_cols=146 Identities=15% Similarity=0.108 Sum_probs=104.4
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCC-CCcCHhHHHHHhhhccC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGR-TTIHYPELVEHYSKDAD 82 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~-~~~~l~~li~~~~~~a~ 82 (189)
..++|+|++++++.+......+||+|++.++. +.. ++... ..++..++..+..+++.
T Consensus 103 ~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~-----L~~-----------------~l~~~~~~l~~~~~~~i~~qi~~ 160 (387)
T 1kob_A 103 NQLHHPKLINLHDAFEDKYEMVLILEFLSGGE-----LFD-----------------RIAAEDYKMSEAEVINYMRQACE 160 (387)
T ss_dssp TTCCSTTBCCEEEEEECSSEEEEEEECCCCCB-----HHH-----------------HTTCTTCCBCHHHHHHHHHHHHH
T ss_pred HhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCc-----HHH-----------------HHHhhcCCCCHHHHHHHHHHHHH
Confidence 45677777777776665666777777776522 111 23322 24557777888889999
Q ss_pred CceeeccCCcccccc-cccc-----------------cc--------------------cC-CCCCccc-e-EEEec---
Q psy1684 83 GLCVNLRKPCVQVSC-RIYL-----------------VH--------------------GT-NLSGVVV-S-AVDFG--- 118 (189)
Q Consensus 83 gl~~~~~~~~~~~~~-p~~l-----------------~~--------------------~~-~~~~~~~-s-VwsfG--- 118 (189)
|+.++|..+++|+|+ |+.+ +. |. ....++. + |||+|
T Consensus 161 aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 240 (387)
T 1kob_A 161 GLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240 (387)
T ss_dssp HHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHH
T ss_pred HHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHH
Confidence 999999999999996 5521 11 11 3456888 9 99999
Q ss_pred ---------CCCCChHHHHHHHHcCCC---CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 119 ---------SGGMTNAEVLHQVEHGYR---MPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 119 ---------~~~~~~~~~~~~v~~g~~---~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
|.+.+..+.+..+..+.. .+.+..+|+++.+|+.+||+.||++|||+.++++.
T Consensus 241 ~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 241 YVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp HHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 677777777777765532 22335789999999999999999999999999863
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.52 E-value=2.4e-16 Score=119.25 Aligned_cols=145 Identities=10% Similarity=-0.041 Sum_probs=103.5
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCC-CCcCHhHHHHHhhhccCC
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGR-TTIHYPELVEHYSKDADG 83 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~-~~~~l~~li~~~~~~a~g 83 (189)
.++|+|++++++.+...+..+||+|++++ ++ +.. ++... ..++..++..+..+.+.|
T Consensus 57 ~l~hpnIv~~~~~~~~~~~~~lv~e~~~g-~~----L~~-----------------~l~~~~~~~~~~~~~~i~~qi~~a 114 (321)
T 1tki_A 57 IARHRNILHLHESFESMEELVMIFEFISG-LD----IFE-----------------RINTSAFELNEREIVSYVHQVCEA 114 (321)
T ss_dssp HSCCTTBCCEEEEEEETTEEEEEECCCCC-CB----HHH-----------------HHTSSSCCCCHHHHHHHHHHHHHH
T ss_pred hCCCCCCCeEeEEEecCCEEEEEEEeCCC-CC----HHH-----------------HHHhcCCCCCHHHHHHHHHHHHHH
Confidence 35677777777766555667777777665 21 111 23222 245567777888899999
Q ss_pred ceeeccCCcccccc-cccc-----------------c--------------------ccC-CCCCccc-e-EEEec----
Q psy1684 84 LCVNLRKPCVQVSC-RIYL-----------------V--------------------HGT-NLSGVVV-S-AVDFG---- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~~l-----------------~--------------------~~~-~~~~~~~-s-VwsfG---- 118 (189)
+.++|..+++|+|+ |+.+ + +|. ....++. + |||+|
T Consensus 115 l~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 194 (321)
T 1tki_A 115 LQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVY 194 (321)
T ss_dssp HHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHH
T ss_pred HHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHH
Confidence 99999999999996 5521 1 111 3344788 9 99999
Q ss_pred --------CCCCChHHHHHHHHcCCCCCC---CCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 119 --------SGGMTNAEVLHQVEHGYRMPC---PPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 119 --------~~~~~~~~~~~~v~~g~~~~~---p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
|.+.+..++...+..+..... ...+|.++.+|+.+||..||++|||+.|+++.
T Consensus 195 ~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 195 VLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 667777888888876643322 24789999999999999999999999999873
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.52 E-value=3.7e-15 Score=113.94 Aligned_cols=116 Identities=11% Similarity=0.036 Sum_probs=83.1
Q ss_pred CCcCHhHHHHHhhhccCCceeeccCCcccccc-cc-----------------cccccC----------------------
Q psy1684 66 TTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI-----------------YLVHGT---------------------- 105 (189)
Q Consensus 66 ~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~-----------------~l~~~~---------------------- 105 (189)
..++..++..+..+.+.|+.++|..+++|+|+ |+ +++...
T Consensus 154 ~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~ 233 (352)
T 2jii_A 154 HVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLE 233 (352)
T ss_dssp GCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTT
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCcc
Confidence 34567778888899999999999999999996 54 222110
Q ss_pred -------CCCCccc-e-EEEec------------CCCC--ChHHHHHHHH--cCCCCCCC------CCCCHHHHHHHHHh
Q psy1684 106 -------NLSGVVV-S-AVDFG------------SGGM--TNAEVLHQVE--HGYRMPCP------PGCPPRLYDIMLEC 154 (189)
Q Consensus 106 -------~~~~~~~-s-VwsfG------------~~~~--~~~~~~~~v~--~g~~~~~p------~~~p~~~~~l~~~C 154 (189)
....++. + ||||| |.+. +...+..... .....+.+ ..+|+++.+|+.+|
T Consensus 234 y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 313 (352)
T 2jii_A 234 FISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVV 313 (352)
T ss_dssp TCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHH
T ss_pred ccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHH
Confidence 3346788 9 99999 4333 2333333322 11222222 24689999999999
Q ss_pred cccCCCCCCCHHHHHHHHHHHHhhcCC
Q psy1684 155 WLKDPVKRPTFETLQWKLEDFFTMEGS 181 (189)
Q Consensus 155 ~~~~p~~RP~~~~i~~~l~~~~~~~~~ 181 (189)
|+.||++|||+++|++.|+.+++..+.
T Consensus 314 l~~dp~~Rps~~~l~~~L~~~~~~~~~ 340 (352)
T 2jii_A 314 MALTYEEKPPYAMLRNNLEALLQDLRV 340 (352)
T ss_dssp HTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HhCChhhCCCHHHHHHHHHHHHHhcCC
Confidence 999999999999999999999986543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=4.5e-16 Score=115.36 Aligned_cols=144 Identities=10% Similarity=0.040 Sum_probs=97.1
Q ss_pred CChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCce
Q psy1684 6 IKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGLC 85 (189)
Q Consensus 6 l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl~ 85 (189)
++|+|++++++.+......++|+|++..+. +.. ++.....++..++..+..+.+.|+.
T Consensus 62 l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~-----l~~-----------------~~~~~~~~~~~~~~~~~~~i~~~l~ 119 (284)
T 3kk8_A 62 LQHPNIVRLHDSIQEESFHYLVFDLVTGGE-----LFE-----------------DIVAREFYSEADASHCIQQILESIA 119 (284)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCCSCB-----HHH-----------------HHHHHSSCCHHHHHHHHHHHHHHHH
T ss_pred cCCCCcCeEEEEEEcCCEEEEEEecCCCCC-----HHH-----------------HHHhcCCCCHHHHHHHHHHHHHHHH
Confidence 456666666555544444566666555411 101 2222334556666777788888999
Q ss_pred eeccCCcccccc-cccc--------------------------------------cccC-CCCCccc-e-EEEec-----
Q psy1684 86 VNLRKPCVQVSC-RIYL--------------------------------------VHGT-NLSGVVV-S-AVDFG----- 118 (189)
Q Consensus 86 ~~~~~~~~~~~~-p~~l--------------------------------------~~~~-~~~~~~~-s-VwsfG----- 118 (189)
++|..+++|+|+ |+.+ ++|. ....++. + |||+|
T Consensus 120 ~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ 199 (284)
T 3kk8_A 120 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYI 199 (284)
T ss_dssp HHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHH
T ss_pred HHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHH
Confidence 999999999986 4411 1111 3445788 9 99999
Q ss_pred -------CCCCChHHHHHHHHcCC-CCCCC--CCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 119 -------SGGMTNAEVLHQVEHGY-RMPCP--PGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 119 -------~~~~~~~~~~~~v~~g~-~~~~p--~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
|.+.+..++...+..+. ..+.| ..+|+++.+|+.+||+.||++|||+.++++.
T Consensus 200 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 200 LLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 66777777777776553 23322 4789999999999999999999999999873
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=99.51 E-value=4.7e-16 Score=126.84 Aligned_cols=143 Identities=10% Similarity=-0.082 Sum_probs=102.2
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.+.|+|+++++......+..|||+|++++ |++ .. +|.....++......+..++..|+
T Consensus 248 ~~~HP~IV~l~~~f~~~~~lylVmEy~~G-GdL----~~-----------------~l~~~~~l~E~~a~~y~~qIl~aL 305 (689)
T 3v5w_A 248 TGDCPFIVCMSYAFHTPDKLSFILDLMNG-GDL----HY-----------------HLSQHGVFSEADMRFYAAEIILGL 305 (689)
T ss_dssp SSCCTTBCCEEEEEECSSEEEEEECCCCS-CBH----HH-----------------HHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred hCCCCCEeEEEEEEEECCEEEEEEecCCC-CcH----HH-----------------HHHhcCCCCHHHHHHHHHHHHHHH
Confidence 45678888877766666677888888776 321 11 233234566566667788889999
Q ss_pred eeeccCCcccccc-cc---------------cc-------------------cccC-C-CCCccc-e-EEEec-------
Q psy1684 85 CVNLRKPCVQVSC-RI---------------YL-------------------VHGT-N-LSGVVV-S-AVDFG------- 118 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~---------------~l-------------------~~~~-~-~~~~~~-s-VwsfG------- 118 (189)
.|+|..+|+|||+ |+ |+ |||. . ...|+. + |||+|
T Consensus 306 ~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmL 385 (689)
T 3v5w_A 306 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385 (689)
T ss_dssp HHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHH
T ss_pred HHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence 9999999999996 66 33 3332 3 346999 9 99999
Q ss_pred -----CCCC---ChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q psy1684 119 -----SGGM---TNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPT-----FETLQW 170 (189)
Q Consensus 119 -----~~~~---~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~-----~~~i~~ 170 (189)
|.+. +..++...+..+ .+..|..+++++.+|+.+|+..||++|++ ++||++
T Consensus 386 tG~~PF~~~~~~~~~~i~~~i~~~-~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 386 RGHSPFRQHKTKDKHEIDRMTLTM-AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp HSSCTTCGGGCCCHHHHHHHHHHC-CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred hCCCCCCCCChHHHHHHHHhhcCC-CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 4332 234555555444 45678899999999999999999999998 577765
|
| >2eyz_A V-CRK sarcoma virus CT10 oncogene homolog isoform A; SH2, SH3, signaling protein; NMR {Homo sapiens} PDB: 2l3s_A 2l3p_A 2l3q_A 2ggr_A | Back alignment and structure |
|---|
Probab=99.51 E-value=2e-14 Score=107.75 Aligned_cols=89 Identities=29% Similarity=0.461 Sum_probs=74.7
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEec-----------------cCC-cc
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSL-----------------FET-QK 62 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~-----------------~~g-yl 62 (189)
||||.|+|.+|+++|. ...+|+||||++.+..|.|+||++. .+.++||+|.+. .+| |.
T Consensus 13 WyhG~isR~eAe~lL~--~~~~G~FLVR~S~~~~g~y~LSv~~--~~~v~H~~I~~~~~~~~~~~~~~~~~~~~~~~~~~ 88 (304)
T 2eyz_A 13 WYWGRLSRQEAVALLQ--GQRHGVFLVRDSSTSPGDYVLSVSE--NSRVSHYIINSSGPRPPVPPSPAQPPPGVSPSRLR 88 (304)
T ss_dssp SCCCCCCSSHHHHTTT--TCCSSCEECCSCCSSSSCCEEEECS--SSSCEEEECCCCSSCCSSCCCCCCCSSSSSCCCCC
T ss_pred CccCCCCHHHHHHHhc--CCCCCEEEEEeCCCCCCCEEEEEEE--CCEEEEEEEeeccccccccccccccccccCCCeEE
Confidence 9999999999999984 4578999999999888999999999 999999999873 455 66
Q ss_pred CCCCCcC-HhHHHHHhhhccCCceeeccCCccc
Q psy1684 63 AGRTTIH-YPELVEHYSKDADGLCVNLRKPCVQ 94 (189)
Q Consensus 63 ~~~~~~~-l~~li~~~~~~a~gl~~~~~~~~~~ 94 (189)
.+...|. +.+||+||..+..+ ...+..||..
T Consensus 89 ~~~~~F~sl~~LV~~y~~~~l~-~~~L~~P~~~ 120 (304)
T 2eyz_A 89 IGDQEFDSLPALLEFYKIHYLD-TTTLIEPVSR 120 (304)
T ss_dssp BTTBCCSCHHHHHTTTTTSCCS-SSSSCCBCCS
T ss_pred eCCcEECCHHHHHHHhhhCccc-cceecccccc
Confidence 6677888 99999999988765 4455566544
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.51 E-value=5.2e-17 Score=123.95 Aligned_cols=116 Identities=9% Similarity=-0.024 Sum_probs=80.7
Q ss_pred ccCCCCCcCHhHHHHHhhhccCCceeeccCCcccccc-cc-----------------ccccc------------------
Q psy1684 61 QKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI-----------------YLVHG------------------ 104 (189)
Q Consensus 61 yl~~~~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~-----------------~l~~~------------------ 104 (189)
++.....++..++..+..+.+.|+.++|..+++|+|+ |+ |+++.
T Consensus 141 ~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~ 220 (345)
T 2v62_A 141 ISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGH 220 (345)
T ss_dssp HCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCS
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhcccccc
Confidence 5554445667888888899999999999999999996 54 22210
Q ss_pred ----------C-CCCCccc-e-EEEec------------CCCC-ChHHHHHHHHcCCCCCCC---------CCCCHHHHH
Q psy1684 105 ----------T-NLSGVVV-S-AVDFG------------SGGM-TNAEVLHQVEHGYRMPCP---------PGCPPRLYD 149 (189)
Q Consensus 105 ----------~-~~~~~~~-s-VwsfG------------~~~~-~~~~~~~~v~~g~~~~~p---------~~~p~~~~~ 149 (189)
. ....++. + ||||| |.+. ...........+.....| ..+|+++.+
T Consensus 221 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 300 (345)
T 2v62_A 221 NGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQ 300 (345)
T ss_dssp CSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHH
T ss_pred CCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHH
Confidence 0 2335788 9 99999 4221 122222222222112222 279999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHH
Q psy1684 150 IMLECWLKDPVKRPTFETLQWKLEDFF 176 (189)
Q Consensus 150 l~~~C~~~~p~~RP~~~~i~~~l~~~~ 176 (189)
|+.+||+.||++|||+.+|++.|+.+.
T Consensus 301 li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 301 FLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 999999999999999999999997654
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.50 E-value=1e-15 Score=116.11 Aligned_cols=47 Identities=17% Similarity=0.299 Sum_probs=39.2
Q ss_pred cCCCCCCCCCCC------HHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q psy1684 133 HGYRMPCPPGCP------PRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTME 179 (189)
Q Consensus 133 ~g~~~~~p~~~p------~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~ 179 (189)
.+.++..|..++ +++.+||.+||+.||++|||++++++.|+.++..-
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~ 320 (336)
T 3g2f_A 268 EKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW 320 (336)
T ss_dssp SCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred cccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence 445666666544 48999999999999999999999999999998753
|
| >4fbn_A 1-phosphatidylinositol 4,5-bisphosphate phosphodi gamma-1; SH2 domain, plcgamma specific array, interaction domain, FIB growth factor receptor 1; 2.40A {Homo sapiens} PDB: 4ey0_A* 3gqi_B* 2fci_A* 2pld_A* 2ple_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=4.1e-14 Score=102.76 Aligned_cols=90 Identities=26% Similarity=0.356 Sum_probs=76.5
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcC-HhHHHHHhhh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIH-YPELVEHYSK 79 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~-l~~li~~~~~ 79 (189)
||||.|++.+|+++|.... .+|+||||++. .+|.|+||++. .+.++|++|...++.|+.+...|. +.+||+||.+
T Consensus 124 Wyhg~isr~~Ae~lL~~~~-~~G~FLVR~s~-~~g~y~Lsv~~--~~~v~H~~I~~~~~~~~~~~~~F~sL~~Lv~~y~~ 199 (246)
T 4fbn_A 124 WYHASLTRAQAEHMLMRVP-RDGAFLVRKRN-EPNSYAISFRA--EGKIKHCRVQQEGQTVMLGNSEFDSLVDLISYYEK 199 (246)
T ss_dssp TEESSCCHHHHHHHHHTSC-CTTEEEEEECS-STTEEEEEEEE--TTEEEEEEEEEETTEEEETTEEESCHHHHHHHHHH
T ss_pred eeecCccHHHHHHHHhhCC-CCCeEEEEecC-CCCCEEEEEEe--CCCeEEEEEEeCCCEEEeCCCccCCHHHHHHHhCc
Confidence 9999999999999995443 47999999984 46899999999 999999999865333777777898 9999999999
Q ss_pred ccCCceeeccCCccc
Q psy1684 80 DADGLCVNLRKPCVQ 94 (189)
Q Consensus 80 ~a~gl~~~~~~~~~~ 94 (189)
...++...+..||..
T Consensus 200 ~p~~~~~~L~~Pv~~ 214 (246)
T 4fbn_A 200 HPLYRKMKLRYPINE 214 (246)
T ss_dssp SCSBTTBCCCEECSH
T ss_pred CCCCCCcCCCCcCCC
Confidence 999888888877743
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.50 E-value=1.1e-15 Score=114.50 Aligned_cols=143 Identities=14% Similarity=0.039 Sum_probs=96.4
Q ss_pred CChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCce
Q psy1684 6 IKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGLC 85 (189)
Q Consensus 6 l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl~ 85 (189)
++|+|++++++.+......++|+|++.++. +.. ++.....+....+..+..+.+.|+.
T Consensus 63 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~-----L~~-----------------~l~~~~~~~~~~~~~~~~qi~~~l~ 120 (304)
T 2jam_A 63 IKHENIVTLEDIYESTTHYYLVMQLVSGGE-----LFD-----------------RILERGVYTEKDASLVIQQVLSAVK 120 (304)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCCSCB-----HHH-----------------HHHHHSCCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCeeehhhhcccCCEEEEEEEcCCCcc-----HHH-----------------HHHHcCCCCHHHHHHHHHHHHHHHH
Confidence 455666665555444445566666554411 111 2222334455666667778888999
Q ss_pred eeccCCcccccc-cccc-------------------------------------cccC-CCCCccc-e-EEEec------
Q psy1684 86 VNLRKPCVQVSC-RIYL-------------------------------------VHGT-NLSGVVV-S-AVDFG------ 118 (189)
Q Consensus 86 ~~~~~~~~~~~~-p~~l-------------------------------------~~~~-~~~~~~~-s-VwsfG------ 118 (189)
++|..+++|+|+ |+.+ ++|. ....++. + |||+|
T Consensus 121 ~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 200 (304)
T 2jam_A 121 YLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYIL 200 (304)
T ss_dssp HHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHH
T ss_pred HHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHH
Confidence 999999999885 5421 1111 3455888 9 99999
Q ss_pred ------CCCCChHHHHHHHHcCCCC---CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 119 ------SGGMTNAEVLHQVEHGYRM---PCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 119 ------~~~~~~~~~~~~v~~g~~~---~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
|.+.+..++...+.++... +.+..+|+++.+|+.+||+.||++|||+.++++
T Consensus 201 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 201 LCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp HHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred HHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 6666777787788766422 234678999999999999999999999999986
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.50 E-value=1.4e-15 Score=116.34 Aligned_cols=144 Identities=9% Similarity=-0.045 Sum_probs=98.4
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.++|+|++++++.+......+||+|++.++. +.. ++.....++..++..+..+.+.|+
T Consensus 104 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~-----L~~-----------------~l~~~~~~~~~~~~~i~~qi~~~L 161 (349)
T 2w4o_A 104 RLSHPNIIKLKEIFETPTEISLVLELVTGGE-----LFD-----------------RIVEKGYYSERDAADAVKQILEAV 161 (349)
T ss_dssp HCCCTTBCCEEEEEECSSEEEEEECCCCSCB-----HHH-----------------HHTTCSSCCHHHHHHHHHHHHHHH
T ss_pred hCCCCCCcceeeeEecCCeEEEEEEeCCCCC-----HHH-----------------HHHhcCCCCHHHHHHHHHHHHHHH
Confidence 3567777777666655555677777665421 111 344344556677777888889999
Q ss_pred eeeccCCcccccc-cccccc--------------------------------------cC-CCCCccc-e-EEEec----
Q psy1684 85 CVNLRKPCVQVSC-RIYLVH--------------------------------------GT-NLSGVVV-S-AVDFG---- 118 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~~l~~--------------------------------------~~-~~~~~~~-s-VwsfG---- 118 (189)
.++|..+++|+|+ |+.+.- |. ....++. + |||||
T Consensus 162 ~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 241 (349)
T 2w4o_A 162 AYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITY 241 (349)
T ss_dssp HHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred HHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHH
Confidence 9999999999996 552111 11 3446888 9 99999
Q ss_pred --------CCCCCh-HHHHHHHHcCCCC---CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 119 --------SGGMTN-AEVLHQVEHGYRM---PCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 119 --------~~~~~~-~~~~~~v~~g~~~---~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
|.+... ..+...+..+... +....+|.++.+|+.+||+.||++|||+.++++
T Consensus 242 ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 242 ILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp HHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 444443 3355566554322 223578999999999999999999999999886
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.50 E-value=6.3e-16 Score=114.66 Aligned_cols=144 Identities=10% Similarity=0.031 Sum_probs=98.3
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.+.|+|++++++.+......++|+|+... + ++.. ++.....++...+..+..+.+.|+
T Consensus 70 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~----~L~~-----------------~l~~~~~~~~~~~~~~~~qi~~~l 127 (284)
T 2vgo_A 70 HLRHPNILRMYNYFHDRKRIYLMLEFAPR-G----ELYK-----------------ELQKHGRFDEQRSATFMEELADAL 127 (284)
T ss_dssp TCCCTTBCCEEEEEECSSEEEEEECCCTT-E----EHHH-----------------HHHHHSSCCHHHHHHHHHHHHHHH
T ss_pred cCCCCCEeeEEEEEEcCCEEEEEEEeCCC-C----cHHH-----------------HHHhcCCCCHHHHHHHHHHHHHHH
Confidence 34566666655554444455566665543 1 1111 233233455666777778888999
Q ss_pred eeeccCCcccccc-cc---------------ccc-------------------ccC-CCCCccc-e-EEEec--------
Q psy1684 85 CVNLRKPCVQVSC-RI---------------YLV-------------------HGT-NLSGVVV-S-AVDFG-------- 118 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~---------------~l~-------------------~~~-~~~~~~~-s-VwsfG-------- 118 (189)
.++|..+++|+|+ |+ +++ +|. ....++. + |||||
T Consensus 128 ~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 207 (284)
T 2vgo_A 128 HYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLV 207 (284)
T ss_dssp HHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHH
T ss_pred HHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcccccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHH
Confidence 9999999999986 54 111 111 3455788 9 99999
Q ss_pred ----CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 119 ----SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 119 ----~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
|.+.+..+....+..+ ....|..++.++.+|+.+||+.||++|||+.++++.
T Consensus 208 g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 208 GMPPFDSPSHTETHRRIVNV-DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp SSCTTCCSSHHHHHHHHHTT-CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred CCCCCCCCCHhHHHHHHhcc-ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 6666666666666554 355778899999999999999999999999999873
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.50 E-value=1.2e-15 Score=115.26 Aligned_cols=143 Identities=10% Similarity=-0.030 Sum_probs=101.8
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.+.|+|++++++........|||+|++.++. +.. ++.....++......+..+++.|+
T Consensus 62 ~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~-----L~~-----------------~l~~~~~~~~~~~~~~~~qi~~aL 119 (318)
T 1fot_A 62 IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGE-----LFS-----------------LLRKSQRFPNPVAKFYAAEVCLAL 119 (318)
T ss_dssp SCCBTTBCCEEEEEECSSEEEEEECCCCSCB-----HHH-----------------HHHHTSSCCHHHHHHHHHHHHHHH
T ss_pred hCCCCCCceEeEEEEeCCEEEEEEeCCCCCC-----HHH-----------------HHHHcCCCCHHHHHHHHHHHHHHH
Confidence 4566777776665555555667777666521 111 333334455556666778888999
Q ss_pred eeeccCCcccccc-cc---------------cccc------------------cC-CCCCccc-e-EEEec---------
Q psy1684 85 CVNLRKPCVQVSC-RI---------------YLVH------------------GT-NLSGVVV-S-AVDFG--------- 118 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~---------------~l~~------------------~~-~~~~~~~-s-VwsfG--------- 118 (189)
.++|..+++|+|+ |+ |++. |. ....|+. + |||+|
T Consensus 120 ~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 199 (318)
T 1fot_A 120 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199 (318)
T ss_dssp HHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHS
T ss_pred HHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhC
Confidence 9999999999996 55 2221 11 3456888 9 99999
Q ss_pred ---CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q psy1684 119 ---SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRP-----TFETLQW 170 (189)
Q Consensus 119 ---~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP-----~~~~i~~ 170 (189)
|.+.+..++...+..+. +..|..+++++.+|+.+|+..||++|| ++.+|++
T Consensus 200 ~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 200 YTPFYDSNTMKTYEKILNAE-LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp SCTTCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 66667777777776653 556788999999999999999999999 8888875
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=6.3e-16 Score=114.87 Aligned_cols=106 Identities=12% Similarity=0.021 Sum_probs=80.4
Q ss_pred CCcCHhHHHHHhhhccCCceeeccCCcccccc-cccc--------------------------------------cccCC
Q psy1684 66 TTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RIYL--------------------------------------VHGTN 106 (189)
Q Consensus 66 ~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~~l--------------------------------------~~~~~ 106 (189)
..++..++..+..+.+.|+.++|..+++|+|+ |..+ ++|..
T Consensus 116 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~ 195 (287)
T 2wei_A 116 KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL 195 (287)
T ss_dssp SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCccccccCcccccChHHh
Confidence 34556667777888889999999999999986 4411 11112
Q ss_pred CCCccc-e-EEEec------------CCCCChHHHHHHHHcCCCC-CCC--CCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q psy1684 107 LSGVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRM-PCP--PGCPPRLYDIMLECWLKDPVKRPTFETLQ 169 (189)
Q Consensus 107 ~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~-~~p--~~~p~~~~~l~~~C~~~~p~~RP~~~~i~ 169 (189)
.+.++. + ||||| |.+.+..++...+..+... +.| ..+|+++.+++.+||+.||++|||+.+++
T Consensus 196 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell 275 (287)
T 2wei_A 196 RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCL 275 (287)
T ss_dssp TTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred cCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHh
Confidence 345788 9 99999 6777777888888766432 222 57899999999999999999999999998
Q ss_pred HH
Q psy1684 170 WK 171 (189)
Q Consensus 170 ~~ 171 (189)
+.
T Consensus 276 ~h 277 (287)
T 2wei_A 276 EH 277 (287)
T ss_dssp HS
T ss_pred cC
Confidence 73
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=5.6e-16 Score=115.81 Aligned_cols=143 Identities=11% Similarity=0.011 Sum_probs=97.9
Q ss_pred CChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC-CCCcCHhHHHHHhhhccCCc
Q psy1684 6 IKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG-RTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 6 l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~-~~~~~l~~li~~~~~~a~gl 84 (189)
+.|+|++++++.+......++|+|++.. + ++.. ++.. ...++...+..+..+.+.|+
T Consensus 73 l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~----~l~~-----------------~~~~~~~~~~~~~~~~~~~~i~~~l 130 (302)
T 2j7t_A 73 CDHPYIVKLLGAYYHDGKLWIMIEFCPG-G----AVDA-----------------IMLELDRGLTEPQIQVVCRQMLEAL 130 (302)
T ss_dssp CCCTTBCCEEEEEECC-CEEEEEECCTT-E----EHHH-----------------HHHHHTSCCCHHHHHHHHHHHHHHH
T ss_pred CCCCCEeeeeeeeeeCCeEEEEEEeCCC-C----cHHH-----------------HHHhhccCCCHHHHHHHHHHHHHHH
Confidence 4566666666655555556666666554 2 1111 2211 23355667777788889999
Q ss_pred eeeccCCcccccc-cc---------------c---------------------ccccC------CCCCccc-e-EEEec-
Q psy1684 85 CVNLRKPCVQVSC-RI---------------Y---------------------LVHGT------NLSGVVV-S-AVDFG- 118 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~---------------~---------------------l~~~~------~~~~~~~-s-VwsfG- 118 (189)
.++|..+++|+|+ |+ + +++|. ....++. + |||||
T Consensus 131 ~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~ 210 (302)
T 2j7t_A 131 NFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGI 210 (302)
T ss_dssp HHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHH
T ss_pred HHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHH
Confidence 9999999999986 54 1 12221 2456888 9 99999
Q ss_pred -----------CCCCChHHHHHHHHcCCCC--CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 119 -----------SGGMTNAEVLHQVEHGYRM--PCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 119 -----------~~~~~~~~~~~~v~~g~~~--~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
|.+.+..+....+..+..+ ..|..+|.++.+|+.+||+.||++|||+.++++
T Consensus 211 il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 211 TLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp HHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred HHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 6666666666666555433 346678999999999999999999999999875
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.49 E-value=4.1e-16 Score=115.86 Aligned_cols=144 Identities=13% Similarity=0.084 Sum_probs=98.0
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccC----CCCCcCHhHHHHHhhhc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKA----GRTTIHYPELVEHYSKD 80 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~----~~~~~~l~~li~~~~~~ 80 (189)
.++|+|++++++.+......++|+|++..+. +.. ++. ....+....+..+..+.
T Consensus 76 ~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~-----L~~-----------------~l~~~~~~~~~~~~~~~~~i~~qi 133 (285)
T 3is5_A 76 SLDHPNIIKIFEVFEDYHNMYIVMETCEGGE-----LLE-----------------RIVSAQARGKALSEGYVAELMKQM 133 (285)
T ss_dssp TCCCTTBCCEEEEEECSSEEEEEECCCSCCB-----HHH-----------------HHHHHHHHTCCCCHHHHHHHHHHH
T ss_pred hCCCchHHhHHHheecCCeEEEEEEeCCCCc-----HHH-----------------HHHhhhhcccCCCHHHHHHHHHHH
Confidence 4567777777766655556677777766522 111 111 12334466677777888
Q ss_pred cCCceeeccCCcccccc-cccc--------------------------------------cccCCCCCccc-e-EEEec-
Q psy1684 81 ADGLCVNLRKPCVQVSC-RIYL--------------------------------------VHGTNLSGVVV-S-AVDFG- 118 (189)
Q Consensus 81 a~gl~~~~~~~~~~~~~-p~~l--------------------------------------~~~~~~~~~~~-s-VwsfG- 118 (189)
+.|+.++|..+++|+|+ |+.+ ++|...+.++. + |||+|
T Consensus 134 ~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~ 213 (285)
T 3is5_A 134 MNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGV 213 (285)
T ss_dssp HHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----------CTTGGGCCHHHHTTCCCHHHHHHHHHH
T ss_pred HHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcccCcCcccccCcCChHHhccCCCcccCeehHHH
Confidence 89999999999999986 5411 11113355788 9 99999
Q ss_pred -----------CCCCChHHHHHHHHcCCCCC--CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 119 -----------SGGMTNAEVLHQVEHGYRMP--CPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 119 -----------~~~~~~~~~~~~v~~g~~~~--~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
|.+.+..++...+..+.... .....++++.+|+.+||+.||++|||+.|+++
T Consensus 214 il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 214 VMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred HHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 77777777776665443221 22347899999999999999999999999875
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.49 E-value=3.8e-16 Score=115.65 Aligned_cols=142 Identities=11% Similarity=0.094 Sum_probs=96.3
Q ss_pred ChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCC----CCcCHhHHHHHhhhccC
Q psy1684 7 KRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGR----TTIHYPELVEHYSKDAD 82 (189)
Q Consensus 7 ~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~----~~~~l~~li~~~~~~a~ 82 (189)
.|+|++++++.+...+..+||+|+++.+. +.. ++... ..++...+..+..+.+.
T Consensus 69 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~-----L~~-----------------~l~~~~~~~~~~~~~~~~~i~~qi~~ 126 (289)
T 1x8b_A 69 QHSHVVRYFSAWAEDDHMLIQNEYCNGGS-----LAD-----------------AISENYRIMSYFKEAELKDLLLQVGR 126 (289)
T ss_dssp SCTTBCCEEEEEEETTEEEEEEECCTTCB-----HHH-----------------HHHHHHHHTCCCCHHHHHHHHHHHHH
T ss_pred CCCCeeeeeeeeecCCeEEEEEEecCCCc-----HHH-----------------HHHhhcccccCCCHHHHHHHHHHHHH
Confidence 56666666665544555566666655421 111 22211 23456667778888899
Q ss_pred CceeeccCCcccccc-cccccc---------------------------------------------------cC-CCC-
Q psy1684 83 GLCVNLRKPCVQVSC-RIYLVH---------------------------------------------------GT-NLS- 108 (189)
Q Consensus 83 gl~~~~~~~~~~~~~-p~~l~~---------------------------------------------------~~-~~~- 108 (189)
|+.++|..+++|+|+ |+.+.- |. ...
T Consensus 127 al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~~ 206 (289)
T 1x8b_A 127 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENY 206 (289)
T ss_dssp HHHHHHHTTEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCSCCCCCCGGGCCHHHHTTCC
T ss_pred HHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCccccCCCccccChhHhcCCC
Confidence 999999999999996 552211 00 122
Q ss_pred Cccc-e-EEEec------CCC---CChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 109 GVVV-S-AVDFG------SGG---MTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 109 ~~~~-s-VwsfG------~~~---~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
.++. + ||||| ..+ ....+....+..+..+..|..+|+++.+|+.+||+.||++|||+.++++
T Consensus 207 ~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 207 THLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp TTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCchhhHHHHHHHHHHHhcCCCCCcchhHHHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 5667 8 99999 111 1123445567778778888999999999999999999999999999875
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.49 E-value=7.5e-16 Score=113.68 Aligned_cols=104 Identities=11% Similarity=0.034 Sum_probs=79.0
Q ss_pred CcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------c--------------------ccccC-CCCC
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------Y--------------------LVHGT-NLSG 109 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~--------------------l~~~~-~~~~ 109 (189)
.+...++..+..+.+.|+.++|..+++|+|+ |. + +++|. ....
T Consensus 107 ~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 186 (276)
T 2h6d_A 107 RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRL 186 (276)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-------------CCTGGGTTSC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCcceecccCCccccCHHHHcCCC
Confidence 4455666777788888999999999999986 44 1 12222 2223
Q ss_pred c-cc-e-EEEec------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 110 V-VV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 110 ~-~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
+ +. + |||+| |.+.+..++...+..+. ...|..++.++.+++.+||+.||++|||+.++++.
T Consensus 187 ~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 187 YAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV-FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp CCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred CCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 3 57 8 99999 66666777777776664 45678899999999999999999999999999873
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.49 E-value=9.2e-16 Score=114.35 Aligned_cols=117 Identities=14% Similarity=0.061 Sum_probs=85.5
Q ss_pred CcCHhHHHHHhhhccCCceeeccCCcccccc-cccc--------------------cc----------------------
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RIYL--------------------VH---------------------- 103 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~~l--------------------~~---------------------- 103 (189)
.++..++..+..+.+.|+.++|..+++|+|+ |+.+ +.
T Consensus 102 ~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt 181 (298)
T 1csn_A 102 KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 181 (298)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCC
Confidence 4667778888899999999999999999996 5511 11
Q ss_pred ------cC-CCCCccc-e-EEEec------------CCCC---ChHHHHHHHHcC-CCCC---CCCCCCHHHHHHHHHhc
Q psy1684 104 ------GT-NLSGVVV-S-AVDFG------------SGGM---TNAEVLHQVEHG-YRMP---CPPGCPPRLYDIMLECW 155 (189)
Q Consensus 104 ------~~-~~~~~~~-s-VwsfG------------~~~~---~~~~~~~~v~~g-~~~~---~p~~~p~~~~~l~~~C~ 155 (189)
|. ....++. + ||||| |.+. ...+....+..+ ...+ .+..+|+++.+|+.+||
T Consensus 182 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 261 (298)
T 1csn_A 182 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYAR 261 (298)
T ss_dssp TTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHH
T ss_pred cccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHh
Confidence 00 2345788 9 99999 4443 344444444322 1122 23578999999999999
Q ss_pred ccCCCCCCCHHHHHHHHHHHHhhcCCCC
Q psy1684 156 LKDPVKRPTFETLQWKLEDFFTMEGSDY 183 (189)
Q Consensus 156 ~~~p~~RP~~~~i~~~l~~~~~~~~~~~ 183 (189)
+.||++|||+++|++.|+++++......
T Consensus 262 ~~dp~~RP~~~~l~~~l~~~~~~~~~~~ 289 (298)
T 1csn_A 262 NLAFDATPDYDYLQGLFSKVLERLNTTE 289 (298)
T ss_dssp HCCTTCCCCHHHHHHHHHHHHHHTTCCS
T ss_pred cCCcccCCCHHHHHHHHHHHHHhcCCCC
Confidence 9999999999999999999998755433
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.49 E-value=1.1e-15 Score=115.46 Aligned_cols=110 Identities=15% Similarity=0.036 Sum_probs=81.5
Q ss_pred ccCCCCCcCHhHHHHHhhhccCCceeeccCCcccccc-cccc-------------------c------------------
Q psy1684 61 QKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RIYL-------------------V------------------ 102 (189)
Q Consensus 61 yl~~~~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~~l-------------------~------------------ 102 (189)
++.....++...+..+..+.+.|+.++|..+++|+|+ |+.+ +
T Consensus 105 ~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y 184 (321)
T 2a2a_A 105 FLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEF 184 (321)
T ss_dssp HHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCCCCCCCSCGGG
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCccccccccCCCCCc
Confidence 4443444556677777888889999999999999986 5511 1
Q ss_pred --ccC-CCCCccc-e-EEEec------------CCCCChHHHHHHHHcCCCCC---CCCCCCHHHHHHHHHhcccCCCCC
Q psy1684 103 --HGT-NLSGVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMP---CPPGCPPRLYDIMLECWLKDPVKR 162 (189)
Q Consensus 103 --~~~-~~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~---~p~~~p~~~~~l~~~C~~~~p~~R 162 (189)
+|. ....++. + ||||| |.+.+..+....+..+.... .+..+|.++.+|+.+||+.||++|
T Consensus 185 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 264 (321)
T 2a2a_A 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKR 264 (321)
T ss_dssp CCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTS
T ss_pred cCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhC
Confidence 110 3356888 9 99999 66667777777776653222 125789999999999999999999
Q ss_pred CCHHHHHH
Q psy1684 163 PTFETLQW 170 (189)
Q Consensus 163 P~~~~i~~ 170 (189)
||+.++++
T Consensus 265 ps~~e~l~ 272 (321)
T 2a2a_A 265 LTIQEALR 272 (321)
T ss_dssp CCHHHHHH
T ss_pred cCHHHHhc
Confidence 99999986
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.49 E-value=1e-15 Score=118.11 Aligned_cols=145 Identities=8% Similarity=0.016 Sum_probs=104.4
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC-CCCcCHhHHHHHhhhccC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG-RTTIHYPELVEHYSKDAD 82 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~-~~~~~l~~li~~~~~~a~ 82 (189)
..++|+|++++++.+......+||+|++.+ + ++.. ++.. ...+...+...+..+++.
T Consensus 141 ~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~-~----~L~~-----------------~l~~~~~~l~~~~~~~i~~qi~~ 198 (373)
T 2x4f_A 141 NQLDHANLIQLYDAFESKNDIVLVMEYVDG-G----ELFD-----------------RIIDESYNLTELDTILFMKQICE 198 (373)
T ss_dssp TTCCCTTBCCEEEEEECSSEEEEEEECCTT-C----EEHH-----------------HHHHTGGGCCHHHHHHHHHHHHH
T ss_pred HhCCCCCCCeEEEEEEECCEEEEEEeCCCC-C----cHHH-----------------HHHhcCCCCCHHHHHHHHHHHHH
Confidence 467888998888877766778888888876 3 2222 1111 123445566667788889
Q ss_pred CceeeccCCcccccc-cccc-----------------cc--------------------cC-CCCCccc-e-EEEec---
Q psy1684 83 GLCVNLRKPCVQVSC-RIYL-----------------VH--------------------GT-NLSGVVV-S-AVDFG--- 118 (189)
Q Consensus 83 gl~~~~~~~~~~~~~-p~~l-----------------~~--------------------~~-~~~~~~~-s-VwsfG--- 118 (189)
|+.++|..+++|+|+ |+.+ +. |. ....++. + |||||
T Consensus 199 aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 278 (373)
T 2x4f_A 199 GIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278 (373)
T ss_dssp HHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHH
T ss_pred HHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHH
Confidence 999999999999996 5521 11 10 3355788 9 99999
Q ss_pred ---------CCCCChHHHHHHHHcCCC-CC--CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 119 ---------SGGMTNAEVLHQVEHGYR-MP--CPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 119 ---------~~~~~~~~~~~~v~~g~~-~~--~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
|.+.+..+.+..+..+.. ++ ....+++++.+|+.+||+.||.+|||+.++++
T Consensus 279 ~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 279 YMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp HHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 677777777777755432 22 12578999999999999999999999999987
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.49 E-value=2.1e-16 Score=122.35 Aligned_cols=145 Identities=13% Similarity=0.070 Sum_probs=92.8
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC--CCCcCHhHHHHHhhhccC
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG--RTTIHYPELVEHYSKDAD 82 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~--~~~~~l~~li~~~~~~a~ 82 (189)
.++|+|++++++.+......+||+|++..+. +.. ++.. ...+....+..+..+.+.
T Consensus 82 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~-----L~~-----------------~l~~~~~~~~~~~~~~~~~~qi~~ 139 (389)
T 3gni_B 82 LFNHPNIVPYRATFIADNELWVVTSFMAYGS-----AKD-----------------LICTHFMDGMNELAIAYILQGVLK 139 (389)
T ss_dssp HCCCTTBCCEEEEEEETTEEEEEEECCTTCB-----HHH-----------------HHHHTCTTCCCHHHHHHHHHHHHH
T ss_pred hCCCCCCCcEeEEEEECCEEEEEEEccCCCC-----HHH-----------------HHhhhcccCCCHHHHHHHHHHHHH
Confidence 4567777777776665566777777776522 111 2211 123456667777888899
Q ss_pred CceeeccCCcccccc-cc---------------c----------------------------ccccC-CC--CCccc-e-
Q psy1684 83 GLCVNLRKPCVQVSC-RI---------------Y----------------------------LVHGT-NL--SGVVV-S- 113 (189)
Q Consensus 83 gl~~~~~~~~~~~~~-p~---------------~----------------------------l~~~~-~~--~~~~~-s- 113 (189)
|+.++|..+++|+|+ |+ + +|+|. .. ..|+. +
T Consensus 140 ~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 219 (389)
T 3gni_B 140 ALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSD 219 (389)
T ss_dssp HHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHH
T ss_pred HHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhH
Confidence 999999999999996 55 1 12222 22 46889 9
Q ss_pred EEEec------------CCCCChHHHHHHHHcCC---------------------------------------------C
Q psy1684 114 AVDFG------------SGGMTNAEVLHQVEHGY---------------------------------------------R 136 (189)
Q Consensus 114 VwsfG------------~~~~~~~~~~~~v~~g~---------------------------------------------~ 136 (189)
|||+| |.+.+..+.+..+..+. .
T Consensus 220 iwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (389)
T 3gni_B 220 IYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPS 299 (389)
T ss_dssp HHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------------------------------------------------
T ss_pred HHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCC
Confidence 99999 55544433332222111 1
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 137 MPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 137 ~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
.+.+..+++++.+|+.+||+.||++|||+.|+++.
T Consensus 300 ~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 300 HPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 12345688999999999999999999999999854
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.49 E-value=5.4e-16 Score=115.77 Aligned_cols=110 Identities=18% Similarity=0.170 Sum_probs=76.3
Q ss_pred CCcCHhHHHHHhhhccCCceeec--------cCCcccccc-cc---------------ccc-------------------
Q psy1684 66 TTIHYPELVEHYSKDADGLCVNL--------RKPCVQVSC-RI---------------YLV------------------- 102 (189)
Q Consensus 66 ~~~~l~~li~~~~~~a~gl~~~~--------~~~~~~~~~-p~---------------~l~------------------- 102 (189)
..+.......+..+.+.|+.++| ..+++|+|+ |+ |++
T Consensus 100 ~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g 179 (301)
T 3q4u_A 100 TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVG 179 (301)
T ss_dssp CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCC
T ss_pred cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeeccccccccccccccccc
Confidence 34556677778888999999999 889999996 55 222
Q ss_pred ------ccC-CCC------Cccc-e-EEEec------CCC---------------------CChHHHHHHH-HcCCCCCC
Q psy1684 103 ------HGT-NLS------GVVV-S-AVDFG------SGG---------------------MTNAEVLHQV-EHGYRMPC 139 (189)
Q Consensus 103 ------~~~-~~~------~~~~-s-VwsfG------~~~---------------------~~~~~~~~~v-~~g~~~~~ 139 (189)
+|. ... .++. + ||||| ..+ .....+...+ ..+.++..
T Consensus 180 t~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (301)
T 3q4u_A 180 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNI 259 (301)
T ss_dssp CGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCC
T ss_pred ccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCC
Confidence 111 111 4568 8 99999 211 1112333333 33444544
Q ss_pred CC-----CCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q psy1684 140 PP-----GCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDF 175 (189)
Q Consensus 140 p~-----~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~ 175 (189)
|. .+++++.+||.+||+.||++|||+++|++.|+.+
T Consensus 260 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 260 PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 43 3667899999999999999999999999999875
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=1.5e-15 Score=115.16 Aligned_cols=142 Identities=12% Similarity=0.017 Sum_probs=97.0
Q ss_pred CChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCce
Q psy1684 6 IKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGLC 85 (189)
Q Consensus 6 l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl~ 85 (189)
+.|+|++++++.+......|||+|++.+ + ++.. ++.....+....+..+..+.+.|+.
T Consensus 78 l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~----~L~~-----------------~l~~~~~~~~~~~~~~~~qi~~al~ 135 (327)
T 3a62_A 78 VKHPFIVDLIYAFQTGGKLYLILEYLSG-G----ELFM-----------------QLEREGIFMEDTACFYLAEISMALG 135 (327)
T ss_dssp CCCTTBCCEEEEEECSSCEEEEEECCTT-E----EHHH-----------------HHHHHSSCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCccceeEEEEcCCEEEEEEeCCCC-C----cHHH-----------------HHHhCCCCCHHHHHHHHHHHHHHHH
Confidence 4556666655555444455666665554 2 1111 2322334445556667778888999
Q ss_pred eeccCCcccccc-cc---------------ccccc---------------------C-CCCCccc-e-EEEec-------
Q psy1684 86 VNLRKPCVQVSC-RI---------------YLVHG---------------------T-NLSGVVV-S-AVDFG------- 118 (189)
Q Consensus 86 ~~~~~~~~~~~~-p~---------------~l~~~---------------------~-~~~~~~~-s-VwsfG------- 118 (189)
++|..+++|+|+ |+ |++.. . ....++. + |||+|
T Consensus 136 ~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 215 (327)
T 3a62_A 136 HLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDML 215 (327)
T ss_dssp HHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHH
T ss_pred HHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHH
Confidence 999999999996 55 22221 1 3455788 9 99999
Q ss_pred -----CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q psy1684 119 -----SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRP-----TFETLQW 170 (189)
Q Consensus 119 -----~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP-----~~~~i~~ 170 (189)
|.+.+..++...+.++ .+..|..+++++.+|+.+||..||++|| ++.++++
T Consensus 216 ~g~~pf~~~~~~~~~~~i~~~-~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 216 TGAPPFTGENRKKTIDKILKC-KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp HSSCSCCCSSHHHHHHHHHHT-CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred HCCCCCCCCCHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 7777777777777665 3556788999999999999999999999 6777765
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.48 E-value=3.5e-16 Score=117.74 Aligned_cols=113 Identities=15% Similarity=0.089 Sum_probs=81.1
Q ss_pred CCcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------c-----------------------------
Q psy1684 66 TTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------Y----------------------------- 100 (189)
Q Consensus 66 ~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~----------------------------- 100 (189)
..++...+..+..+.+.|+.++|..+++|+|+ |+ +
T Consensus 129 ~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 208 (317)
T 2buj_A 129 NFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208 (317)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGG
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcc
Confidence 34556777778888999999999999999986 54 1
Q ss_pred -ccccCCC----CCccc-e-EEEec------CCCCCh--------HHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCC
Q psy1684 101 -LVHGTNL----SGVVV-S-AVDFG------SGGMTN--------AEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDP 159 (189)
Q Consensus 101 -l~~~~~~----~~~~~-s-VwsfG------~~~~~~--------~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p 159 (189)
+++|... ..++. + ||||| +.+..+ ..+...+....+.+.+..+|.++.+|+.+||+.||
T Consensus 209 y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 288 (317)
T 2buj_A 209 YRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDP 288 (317)
T ss_dssp GCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSG
T ss_pred cCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccCCCCccccCCHHHHHHHHHHhhcCh
Confidence 1222211 12688 8 99999 112111 12333445555666677899999999999999999
Q ss_pred CCCCCHHHHHHHHHHHHhh
Q psy1684 160 VKRPTFETLQWKLEDFFTM 178 (189)
Q Consensus 160 ~~RP~~~~i~~~l~~~~~~ 178 (189)
++|||+.++++.|+.+...
T Consensus 289 ~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 289 HQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp GGSCCHHHHHHHHHHTCCC
T ss_pred hhCCCHHHHHHHhhhcCCC
Confidence 9999999999999887653
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=5.2e-16 Score=115.66 Aligned_cols=144 Identities=14% Similarity=0.095 Sum_probs=99.5
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.+.|+|++++++.+...+..++|+|++..+. +.. ++.....++..++..+..+.+.|+
T Consensus 71 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~-----L~~-----------------~~~~~~~~~~~~~~~i~~qi~~~l 128 (294)
T 2rku_A 71 SLAHQHVVGFHGFFEDNDFVFVVLELCRRRS-----LLE-----------------LHKRRKALTEPEARYYLRQIVLGC 128 (294)
T ss_dssp TCCCTTBCCEEEEEECSSEEEEEEECCTTCB-----HHH-----------------HHHHHCSCCHHHHHHHHHHHHHHH
T ss_pred hCCCCCEeeeeeeeccCCEEEEEEecCCCCC-----HHH-----------------HHHhcCCCCHHHHHHHHHHHHHHH
Confidence 4566777776666555555666666665421 111 222223455666777778888999
Q ss_pred eeeccCCcccccc-cc---------------cccc---------------------cC-CCCCccc-e-EEEec------
Q psy1684 85 CVNLRKPCVQVSC-RI---------------YLVH---------------------GT-NLSGVVV-S-AVDFG------ 118 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~---------------~l~~---------------------~~-~~~~~~~-s-VwsfG------ 118 (189)
.++|..+++|+|+ |+ +++. |. ....++. + |||+|
T Consensus 129 ~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l 208 (294)
T 2rku_A 129 QYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTL 208 (294)
T ss_dssp HHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHH
T ss_pred HHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHH
Confidence 9999999999986 44 1111 11 2345788 8 99999
Q ss_pred ------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 119 ------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 119 ------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
|.+.+..+....+..+ ..+.|..+++++.+|+.+||+.||++|||+.++++.
T Consensus 209 ~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 209 LVGKPPFETSCLKETYLRIKKN-EYSIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp HHSSCTTCCSSHHHHHHHHHTT-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred HhCCCCCCCCCHHHHHHHHhhc-cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 6666666666666554 355678899999999999999999999999999874
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.48 E-value=5.9e-16 Score=118.41 Aligned_cols=147 Identities=11% Similarity=0.009 Sum_probs=96.8
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.++|+|++++++.+......|||+|++.+ +++.-.+.. . ......+.......+..+++.|+
T Consensus 82 ~l~hpnIv~~~~~~~~~~~~~lv~e~~~g-~~L~~~l~~------------~-----~~~~~~~~~~~~~~i~~qi~~al 143 (351)
T 3c0i_A 82 MLKHPHIVELLETYSSDGMLYMVFEFMDG-ADLCFEIVK------------R-----ADAGFVYSEAVASHYMRQILEAL 143 (351)
T ss_dssp HCCCTTBCCEEEEEEETTEEEEEEECCSS-CBHHHHHHH------------H-----HHTTCCCCHHHHHHHHHHHHHHH
T ss_pred hCCCCCCCcEEEEEEeCCEEEEEEeCCCC-CCHHHHHHH------------h-----cccCCCCCHHHHHHHHHHHHHHH
Confidence 35677777777666555566777777765 211000000 0 00112344556667778888999
Q ss_pred eeeccCCcccccc-cccc------------------cc---------------------cC-CCCCccc-e-EEEec---
Q psy1684 85 CVNLRKPCVQVSC-RIYL------------------VH---------------------GT-NLSGVVV-S-AVDFG--- 118 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~~l------------------~~---------------------~~-~~~~~~~-s-VwsfG--- 118 (189)
.++|..+++|+|+ |+.+ +. |. ....|+. + |||+|
T Consensus 144 ~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 223 (351)
T 3c0i_A 144 RYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223 (351)
T ss_dssp HHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHH
T ss_pred HHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHH
Confidence 9999999999996 5511 11 11 3456888 9 99999
Q ss_pred ---------CCCCChHHHHHHHHcCCCCCCC---CCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 119 ---------SGGMTNAEVLHQVEHGYRMPCP---PGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 119 ---------~~~~~~~~~~~~v~~g~~~~~p---~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
|.+ ...++...+..+.....| ..+++++.+|+.+||+.||++|||+.++++
T Consensus 224 ~~ll~g~~pf~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 224 FILLSGCLPFYG-TKERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHHHHSSCSSCS-SHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHCCCCCCC-cHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 444 345666666665433222 578999999999999999999999999986
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.48 E-value=6.9e-17 Score=122.98 Aligned_cols=144 Identities=10% Similarity=0.022 Sum_probs=97.7
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..++|+|++++++.+......+||+|++. | ++.. ++.....++..+...+..+.+.|
T Consensus 64 ~~l~hpnIv~l~~~~~~~~~~~lv~E~~~--g----~l~~-----------------~l~~~~~l~~~~~~~i~~qi~~a 120 (336)
T 3h4j_B 64 KLLRHPHIIKLYDVITTPTDIVMVIEYAG--G----ELFD-----------------YIVEKKRMTEDEGRRFFQQIICA 120 (336)
T ss_dssp TTCCCTTBCCEEEEEECSSEEEEEECCCC--E----EHHH-----------------HHHHHCSCCHHHHHHHHHHHHHH
T ss_pred HhCCCCCCCeEEEEEEeCCEEEEEEECCC--C----cHHH-----------------HHHHcCCCCHHHHHHHHHHHHHH
Confidence 45667777777776665666677777762 2 1111 33333445566777788888999
Q ss_pred ceeeccCCcccccc-cc---------------cc--------------------cccC-CCCCc-cc-e-EEEec-----
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YL--------------------VHGT-NLSGV-VV-S-AVDFG----- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l--------------------~~~~-~~~~~-~~-s-VwsfG----- 118 (189)
+.++|..+++|+|+ |+ |+ |+|. ....+ +. + |||+|
T Consensus 121 L~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ 200 (336)
T 3h4j_B 121 IEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYV 200 (336)
T ss_dssp HHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHH
T ss_pred HHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHH
Confidence 99999999999996 55 22 2222 22334 57 8 99999
Q ss_pred -------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 119 -------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 119 -------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
|.+....++...+..+ ....|..+++++.+|+.+||+.||.+|||++||++.
T Consensus 201 ll~g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 201 MLVGRLPFDDEFIPNLFKKVNSC-VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp HHHSSCSSBCSSSTTCBCCCCSS-CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred HHhCCCCCCCccHHHHHHHHHcC-CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 4443333333333333 345678899999999999999999999999999864
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=2.2e-15 Score=113.98 Aligned_cols=144 Identities=8% Similarity=-0.015 Sum_probs=95.9
Q ss_pred CChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCce
Q psy1684 6 IKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGLC 85 (189)
Q Consensus 6 l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl~ 85 (189)
++|+|++++++.+......|||+|++.+ + ++.. ++.....++..++..+..+.+.|+.
T Consensus 62 l~hpnIv~~~~~~~~~~~~~lv~e~~~~-~----~L~~-----------------~l~~~~~~~~~~~~~i~~qi~~aL~ 119 (323)
T 3tki_A 62 LNHENVVKFYGHRREGNIQYLFLEYCSG-G----ELFD-----------------RIEPDIGMPEPDAQRFFHQLMAGVV 119 (323)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCTT-E----EGGG-----------------GSBTTTBCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCeEEEEEecCCeEEEEEEcCCC-C----cHHH-----------------HHhhcCCCCHHHHHHHHHHHHHHHH
Confidence 5566777766665555556666666654 2 1111 4444445667777888889999999
Q ss_pred eeccCCcccccc-cc---------------cccc-----------------------cC-CCCC-ccc-e-EEEec----
Q psy1684 86 VNLRKPCVQVSC-RI---------------YLVH-----------------------GT-NLSG-VVV-S-AVDFG---- 118 (189)
Q Consensus 86 ~~~~~~~~~~~~-p~---------------~l~~-----------------------~~-~~~~-~~~-s-VwsfG---- 118 (189)
++|..+++|+|+ |+ |++. |. .... ++. + |||+|
T Consensus 120 ~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ 199 (323)
T 3tki_A 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 199 (323)
T ss_dssp HHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHH
T ss_pred HHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHH
Confidence 999999999996 55 2221 11 1233 377 8 99999
Q ss_pred --------CCCCCh--HHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 119 --------SGGMTN--AEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 119 --------~~~~~~--~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
|.+.+. .............+....++.++.+|+.+||+.||++|||+.|+++.
T Consensus 200 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 200 AMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp HHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 444333 22222223333344446789999999999999999999999999763
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.47 E-value=8.4e-16 Score=116.46 Aligned_cols=114 Identities=17% Similarity=0.278 Sum_probs=78.5
Q ss_pred CcCHhHHHHHhhhccCCceeeccC--------Ccccccc-cc---------------cccc-------------------
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRK--------PCVQVSC-RI---------------YLVH------------------- 103 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~--------~~~~~~~-p~---------------~l~~------------------- 103 (189)
.+....+..+..+.+.|+.++|.. +++|+|+ |+ |++.
T Consensus 130 ~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt 209 (337)
T 3mdy_A 130 TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGT 209 (337)
T ss_dssp CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccC
Confidence 345666777778888999999988 8999996 54 2221
Q ss_pred ------cC-C----CC--Cccc-e-EEEec------CCC----------------C-----ChHHHHHHH-HcCCCCCCC
Q psy1684 104 ------GT-N----LS--GVVV-S-AVDFG------SGG----------------M-----TNAEVLHQV-EHGYRMPCP 140 (189)
Q Consensus 104 ------~~-~----~~--~~~~-s-VwsfG------~~~----------------~-----~~~~~~~~v-~~g~~~~~p 140 (189)
|. . .. .++. + ||||| ..+ . ...++...+ ..+.++..|
T Consensus 210 ~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (337)
T 3mdy_A 210 KRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFP 289 (337)
T ss_dssp GGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCC
T ss_pred cceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCcccc
Confidence 11 0 11 1235 8 99999 111 1 122333333 334455555
Q ss_pred C-----CCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcC
Q psy1684 141 P-----GCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180 (189)
Q Consensus 141 ~-----~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~~ 180 (189)
. .|++++.+||.+||+.||++|||+.+|++.|+.+.++.+
T Consensus 290 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 290 NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 3 677889999999999999999999999999999988643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=6.5e-16 Score=118.01 Aligned_cols=103 Identities=14% Similarity=0.067 Sum_probs=82.2
Q ss_pred CCcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cccccC----------------------CC
Q psy1684 66 TTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVHGT----------------------NL 107 (189)
Q Consensus 66 ~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~~~----------------------~~ 107 (189)
..++......+..+.+.|+.++|..+++|||+ |+ |+++.. ..
T Consensus 113 ~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~ 192 (345)
T 1xjd_A 113 HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG 192 (345)
T ss_dssp SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTT
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcC
Confidence 44556667777888889999999999999996 55 333321 34
Q ss_pred CCccc-e-EEEec------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH-HHH
Q psy1684 108 SGVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFE-TLQ 169 (189)
Q Consensus 108 ~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~-~i~ 169 (189)
..|+. + |||+| |.+.+..++...+..+. +..|..+++++.+|+.+||..||++||++. +|+
T Consensus 193 ~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 193 QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC-CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 56889 9 99999 77777788888887663 556788999999999999999999999997 665
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.47 E-value=3.7e-16 Score=117.60 Aligned_cols=104 Identities=15% Similarity=0.134 Sum_probs=76.9
Q ss_pred CcCHhHHHHHhhhccCCceeeccCCcccccc-cc-----------------------------------cccccCCCCCc
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI-----------------------------------YLVHGTNLSGV 110 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~-----------------------------------~l~~~~~~~~~ 110 (189)
.++...+..+..+.+.|+.++|..+++|+|+ |+ ++|+|...+.+
T Consensus 153 ~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 232 (311)
T 3p1a_A 153 SLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSY 232 (311)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------CCCCCGGGCCGGGGGTCC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCCCcccCCCccccCHhHhcCCC
Confidence 3556777778888999999999999999996 44 23344344578
Q ss_pred cc-e-EEEec------C---CCCChHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 111 VV-S-AVDFG------S---GGMTNAEVLHQVEHGYRM-PCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 111 ~~-s-VwsfG------~---~~~~~~~~~~~v~~g~~~-~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
+. + ||||| . .-....+....+..+..+ ..+..+++++.+|+.+||+.||++|||++++++
T Consensus 233 ~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 233 GTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp STHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCccHHHHHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 89 9 99999 1 111223344455555332 345789999999999999999999999999885
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=1.1e-15 Score=118.52 Aligned_cols=111 Identities=14% Similarity=0.105 Sum_probs=79.8
Q ss_pred ccCCCCCcCHhHHHHHhhhccCCceeeccCCcccccc-cc--------------ccccc---------------------
Q psy1684 61 QKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI--------------YLVHG--------------------- 104 (189)
Q Consensus 61 yl~~~~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~--------------~l~~~--------------------- 104 (189)
++.....+...+...+..+++.|+.++|..+++|||+ |+ |++..
T Consensus 145 ~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~a 224 (390)
T 2zmd_A 145 WLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMP 224 (390)
T ss_dssp HHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESSSCEEECCCSSSCCC---------CCSCCCGGGCC
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEECCeEEEEecCccccccCCCccccCCCCCcCCCccC
Confidence 4444445555667777888899999999999999996 55 22221
Q ss_pred --CC------------CCCccc-e-EEEec------------CCCCC-hHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHh
Q psy1684 105 --TN------------LSGVVV-S-AVDFG------------SGGMT-NAEVLHQVE-HGYRMPCPPGCPPRLYDIMLEC 154 (189)
Q Consensus 105 --~~------------~~~~~~-s-VwsfG------------~~~~~-~~~~~~~v~-~g~~~~~p~~~p~~~~~l~~~C 154 (189)
.. ...|+. + ||||| |.+.. ....+..+. .....+.|..++.++.+|+.+|
T Consensus 225 PE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 304 (390)
T 2zmd_A 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCC 304 (390)
T ss_dssp HHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHH
T ss_pred hHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCccchHHHHHHHHHH
Confidence 11 135888 9 99999 44433 233444443 3456677888899999999999
Q ss_pred cccCCCCCCCHHHHHHH
Q psy1684 155 WLKDPVKRPTFETLQWK 171 (189)
Q Consensus 155 ~~~~p~~RP~~~~i~~~ 171 (189)
|+.||++|||+.++++.
T Consensus 305 L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 305 LKRDPKQRISIPELLAH 321 (390)
T ss_dssp TCSSTTTSCCHHHHHTS
T ss_pred cccChhhCCCHHHHhhC
Confidence 99999999999999864
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=7.4e-16 Score=117.07 Aligned_cols=144 Identities=14% Similarity=0.087 Sum_probs=100.5
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.+.|+|++++++.+...+..|||+|++..+. +.. ++.....+...++..+..+.+.|+
T Consensus 97 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~-----L~~-----------------~~~~~~~l~~~~~~~i~~qi~~aL 154 (335)
T 2owb_A 97 SLAHQHVVGFHGFFEDNDFVFVVLELCRRRS-----LLE-----------------LHKRRKALTEPEARYYLRQIVLGC 154 (335)
T ss_dssp TCCCTTBCCEEEEEECSSEEEEEECCCTTCB-----HHH-----------------HHHHHCSCCHHHHHHHHHHHHHHH
T ss_pred hCCCCCCCeEEEEEecCCeEEEEEecCCCCC-----HHH-----------------HHhccCCCCHHHHHHHHHHHHHHH
Confidence 4567777777666555555667777665421 111 222223455666777788888999
Q ss_pred eeeccCCcccccc-cc---------------ccccc---------------------C-CCCCccc-e-EEEec------
Q psy1684 85 CVNLRKPCVQVSC-RI---------------YLVHG---------------------T-NLSGVVV-S-AVDFG------ 118 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~---------------~l~~~---------------------~-~~~~~~~-s-VwsfG------ 118 (189)
.++|..+++|+|+ |+ +++.. . ....++. + |||||
T Consensus 155 ~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l 234 (335)
T 2owb_A 155 QYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTL 234 (335)
T ss_dssp HHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHH
T ss_pred HHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHH
Confidence 9999999999996 54 22111 0 2344788 8 99999
Q ss_pred ------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 119 ------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 119 ------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
|.+....+....+..+. ...|..+++++.+|+.+||+.||++|||+.++++.
T Consensus 235 ~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 235 LVGKPPFETSCLKETYLRIKKNE-YSIPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp HHSSCTTCCSSHHHHHHHHHHTC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred HHCcCCCCCCCHHHHHHHHhcCC-CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 66666666666665543 45678899999999999999999999999999873
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.47 E-value=1.2e-15 Score=113.56 Aligned_cols=110 Identities=12% Similarity=0.092 Sum_probs=80.0
Q ss_pred ccCCCCCcCHhHHHHHhhhccCCceeeccCC--cccccc-cc-----------------------------------ccc
Q psy1684 61 QKAGRTTIHYPELVEHYSKDADGLCVNLRKP--CVQVSC-RI-----------------------------------YLV 102 (189)
Q Consensus 61 yl~~~~~~~l~~li~~~~~~a~gl~~~~~~~--~~~~~~-p~-----------------------------------~l~ 102 (189)
++.....+....+..+..+.+.|+.++|... ++|+|+ |+ +++
T Consensus 119 ~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~a 198 (290)
T 1t4h_A 119 YLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMA 198 (290)
T ss_dssp HHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTSBEESCSSCCCCC
T ss_pred HHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccccccccccCCcCcCC
Confidence 3433334556667777888889999999988 999986 54 122
Q ss_pred ccCCCCCccc-e-EEEec------------CCCC-ChHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHhcccCCCCCCCHH
Q psy1684 103 HGTNLSGVVV-S-AVDFG------------SGGM-TNAEVLHQVEHGYRM-PCPPGCPPRLYDIMLECWLKDPVKRPTFE 166 (189)
Q Consensus 103 ~~~~~~~~~~-s-VwsfG------------~~~~-~~~~~~~~v~~g~~~-~~p~~~p~~~~~l~~~C~~~~p~~RP~~~ 166 (189)
+|...+.++. + |||+| |.+. +..++...+..+..+ ..+..+++++.+|+.+||+.||++|||+.
T Consensus 199 PE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 278 (290)
T 1t4h_A 199 PEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIK 278 (290)
T ss_dssp GGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred HHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHH
Confidence 2223456888 9 99999 5443 345566666666444 34567889999999999999999999999
Q ss_pred HHHH
Q psy1684 167 TLQW 170 (189)
Q Consensus 167 ~i~~ 170 (189)
++++
T Consensus 279 ell~ 282 (290)
T 1t4h_A 279 DLLN 282 (290)
T ss_dssp HHHT
T ss_pred HHhh
Confidence 9886
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=1.4e-15 Score=117.30 Aligned_cols=101 Identities=13% Similarity=-0.048 Sum_probs=78.4
Q ss_pred CCcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cccccC----------------------CC
Q psy1684 66 TTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVHGT----------------------NL 107 (189)
Q Consensus 66 ~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~~~----------------------~~ 107 (189)
..+.......+..+++.|+.++|..+++|||+ |+ |+++.. ..
T Consensus 134 ~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~ 213 (373)
T 2r5t_A 134 RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHK 213 (373)
T ss_dssp SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTT
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCCCccccccCCccccCHHHhCC
Confidence 34555555667778889999999999999996 55 333321 34
Q ss_pred CCccc-e-EEEec------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q psy1684 108 SGVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFET 167 (189)
Q Consensus 108 ~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~ 167 (189)
..|+. + |||+| |.+.+..++...+..+ .+..|..++.++.+|+.+||+.||++||++.+
T Consensus 214 ~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 214 QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK-PLQLKPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS-CCCCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 56889 9 99999 6677777888887665 34567789999999999999999999999854
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=6.4e-16 Score=117.15 Aligned_cols=110 Identities=11% Similarity=0.036 Sum_probs=77.0
Q ss_pred ccCCCCCcCHhHHHHHhhhccCCceeeccCCcccccc-cccccc------------------------------------
Q psy1684 61 QKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RIYLVH------------------------------------ 103 (189)
Q Consensus 61 yl~~~~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~~l~~------------------------------------ 103 (189)
++.....+....+..+..+.+.|+.++|..+++|+|+ |+.+.-
T Consensus 122 ~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~ 201 (329)
T 3gbz_A 122 YMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITL 201 (329)
T ss_dssp HHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-----------CC
T ss_pred HHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCc
Confidence 4443445566777778888899999999999999996 552111
Q ss_pred -----cC-CC-CCccc-e-EEEec------------CCCCChHHHHHHHHcCCCCCCC----------------------
Q psy1684 104 -----GT-NL-SGVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMPCP---------------------- 140 (189)
Q Consensus 104 -----~~-~~-~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~~p---------------------- 140 (189)
|. .. ..++. + |||+| |.+.+..+.+..+......+.+
T Consensus 202 ~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (329)
T 3gbz_A 202 WYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGK 281 (329)
T ss_dssp TTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCC
T ss_pred cccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccc
Confidence 11 22 34788 9 99999 6666666655555322111111
Q ss_pred -------CCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 141 -------PGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 141 -------~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
..+++++.+|+.+||+.||++|||++|+++
T Consensus 282 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 282 TLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp CHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 116789999999999999999999999876
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.47 E-value=1.2e-15 Score=114.24 Aligned_cols=104 Identities=15% Similarity=0.116 Sum_probs=80.6
Q ss_pred CcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------ccc-----------------------ccC-C
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLV-----------------------HGT-N 106 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~-----------------------~~~-~ 106 (189)
.++...+..+..+.+.|+.++|..+++|+|+ |+ +++ +|. .
T Consensus 105 ~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 184 (305)
T 2wtk_C 105 RFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIAN 184 (305)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHT
T ss_pred ccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhcc
Confidence 4556677778888899999999999999996 54 111 111 1
Q ss_pred C--CCccc-e-EEEec------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 107 L--SGVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 107 ~--~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
. ..++. + |||+| |.+.+..++...+..+. .+.|..+++++.+|+.+||+.||++|||+.++++
T Consensus 185 ~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 185 GLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS-YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp CCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC-CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC-CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1 22467 8 99999 66767777777776663 4567899999999999999999999999999986
Q ss_pred H
Q psy1684 171 K 171 (189)
Q Consensus 171 ~ 171 (189)
.
T Consensus 264 ~ 264 (305)
T 2wtk_C 264 H 264 (305)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=7.5e-17 Score=121.90 Aligned_cols=150 Identities=12% Similarity=0.077 Sum_probs=97.5
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccC----CCCCcCHhHHHHHhhh
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKA----GRTTIHYPELVEHYSK 79 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~----~~~~~~l~~li~~~~~ 79 (189)
..+.|+|++++++.+......+||+|++.++. +.. ++. ....+.......+..+
T Consensus 82 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~-----L~~-----------------~l~~~~~~~~~~~~~~~~~i~~~ 139 (326)
T 3uim_A 82 SMAVHRNLLRLRGFCMTPTERLLVYPYMANGS-----VAS-----------------CLRERPESQPPLDWPKRQRIALG 139 (326)
T ss_dssp GTCCCTTBCCCCEEECCSSCCEEEEECCTTCB-----HHH-----------------HHHCCSTTCCCCCHHHHHHHHHH
T ss_pred HhccCCCccceEEEEecCCceEEEEEeccCCC-----HHH-----------------HHHhccccCCCCCHHHHHHHHHH
Confidence 45778999998888877777889998887632 111 111 1223446667777888
Q ss_pred ccCCceeeccC---Ccccccc-cc---------------cccc----------------------cC-CCCCccc-e-EE
Q psy1684 80 DADGLCVNLRK---PCVQVSC-RI---------------YLVH----------------------GT-NLSGVVV-S-AV 115 (189)
Q Consensus 80 ~a~gl~~~~~~---~~~~~~~-p~---------------~l~~----------------------~~-~~~~~~~-s-Vw 115 (189)
.+.|+.++|.. +++|+|+ |+ |++. |. ....++. + ||
T Consensus 140 i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~ 219 (326)
T 3uim_A 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVF 219 (326)
T ss_dssp HHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHH
T ss_pred HHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccch
Confidence 88999999999 9999996 54 2221 11 2345788 8 99
Q ss_pred Eec------CCCCCh-----------HHHHHHHH---cCC----------CCCCCCCCCHHHHHHHHHhcccCCCCCCCH
Q psy1684 116 DFG------SGGMTN-----------AEVLHQVE---HGY----------RMPCPPGCPPRLYDIMLECWLKDPVKRPTF 165 (189)
Q Consensus 116 sfG------~~~~~~-----------~~~~~~v~---~g~----------~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~ 165 (189)
||| ..+..+ ..+...+. ... ....+..++.++.+++.+||+.||++|||+
T Consensus 220 slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 299 (326)
T 3uim_A 220 GYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKM 299 (326)
T ss_dssp HHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCH
T ss_pred hHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCH
Confidence 999 111111 00111111 111 111222344789999999999999999999
Q ss_pred HHHHHHHHHH
Q psy1684 166 ETLQWKLEDF 175 (189)
Q Consensus 166 ~~i~~~l~~~ 175 (189)
++|++.|+..
T Consensus 300 ~ell~~L~~~ 309 (326)
T 3uim_A 300 SEVVRMLEGD 309 (326)
T ss_dssp HHHHHHHHTS
T ss_pred HHHHHHhcCc
Confidence 9999999753
|
| >2lqn_A CRK-like protein; SH2, SH3, V-CRK sarcoma virus CT10 oncogene homolog (avian)- signaling protein; NMR {Homo sapiens} PDB: 2lqw_A* | Back alignment and structure |
|---|
Probab=99.20 E-value=4.4e-15 Score=111.30 Aligned_cols=89 Identities=31% Similarity=0.448 Sum_probs=76.4
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC-ccCCCCCcC-HhHHHHHhh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET-QKAGRTTIH-YPELVEHYS 78 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g-yl~~~~~~~-l~~li~~~~ 78 (189)
||||.|+|.+|+++|... .+|+||||++.+..|.|+||++. .+.++||+|.+..+| |..+...|. +.+||+||.
T Consensus 14 Wyhg~isR~~Ae~lL~~~--~~G~FLvR~S~~~~g~~~LSv~~--~~~v~H~~I~~~~~g~~~~~~~~F~sl~~Lv~~y~ 89 (303)
T 2lqn_A 14 WYMGPVSRQEAQTRLQGQ--RHGMFLVRDSSTCPGDYVLSVSE--NSRVSHYIINSLPNRRFKIGDQEFDHLPALLEFYK 89 (303)
Confidence 999999999999999643 78999999998888999999999 899999999987777 666667888 999999999
Q ss_pred hccCCceeeccCCccc
Q psy1684 79 KDADGLCVNLRKPCVQ 94 (189)
Q Consensus 79 ~~a~gl~~~~~~~~~~ 94 (189)
.... ....+..||.+
T Consensus 90 ~~~~-~~~~L~~P~~r 104 (303)
T 2lqn_A 90 IHYL-DTTTLIEPAPR 104 (303)
Confidence 8776 35566666654
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.46 E-value=6.4e-15 Score=112.20 Aligned_cols=150 Identities=10% Similarity=-0.042 Sum_probs=103.4
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC--CCCcCHhHHHHHhhhcc
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG--RTTIHYPELVEHYSKDA 81 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~--~~~~~l~~li~~~~~~a 81 (189)
..++|+|++++++.+...+..+||+|++.. +++.-.+.. .. .+.. ...++...+..+..+.+
T Consensus 98 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~~~~--------~~-------~l~~~~~~~~~~~~~~~i~~qi~ 161 (348)
T 2pml_X 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMEN-DSILKFDEY--------FF-------VLDKNYTCFIPIQVIKCIIKSVL 161 (348)
T ss_dssp TTCCCTTBCCCSEEEESSSEEEEEEECCTT-CBSSEESSS--------EE-------SSCSSSCCCCCHHHHHHHHHHHH
T ss_pred HhCCCCCcceEEEEEeeCCeEEEEEeccCC-CcHHHHHHH--------hh-------hhhhccccCCCHHHHHHHHHHHH
Confidence 457788888888877777778899998876 321110000 00 0222 23445677777888889
Q ss_pred CCceeecc-CCcccccc-cc----------------------------------cccccC-CCC-Cccc--e-EEEec--
Q psy1684 82 DGLCVNLR-KPCVQVSC-RI----------------------------------YLVHGT-NLS-GVVV--S-AVDFG-- 118 (189)
Q Consensus 82 ~gl~~~~~-~~~~~~~~-p~----------------------------------~l~~~~-~~~-~~~~--s-VwsfG-- 118 (189)
.|+.++|. .+++|+|+ |+ ++++|. ... .++. + |||||
T Consensus 162 ~~l~~lH~~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~i 241 (348)
T 2pml_X 162 NSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGIC 241 (348)
T ss_dssp HHHHHHHHTSCEECCCCCGGGEEECTTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHH
T ss_pred HHHHHHhccCCEeecCCChHhEEEcCCCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHH
Confidence 99999998 99999996 54 122222 222 4554 7 99999
Q ss_pred ----------CCCCCh-HHHHHHHHcCCCCCCC-------------------CCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy1684 119 ----------SGGMTN-AEVLHQVEHGYRMPCP-------------------PGCPPRLYDIMLECWLKDPVKRPTFETL 168 (189)
Q Consensus 119 ----------~~~~~~-~~~~~~v~~g~~~~~p-------------------~~~p~~~~~l~~~C~~~~p~~RP~~~~i 168 (189)
|.+.+. .++...+..+. ++.| ..+|.++.+|+.+||+.||++|||+.++
T Consensus 242 l~~l~~g~~pf~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~ 320 (348)
T 2pml_X 242 LYVMFYNVVPFSLKISLVELFNNIRTKN-IEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDA 320 (348)
T ss_dssp HHHHHHSSCSSCCSSCSHHHHHHHTSCC-CCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred HHHHHhCCCCCCCCCcHHHHHHHHhccC-cCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHH
Confidence 555544 67777776553 3334 6789999999999999999999999999
Q ss_pred HH
Q psy1684 169 QW 170 (189)
Q Consensus 169 ~~ 170 (189)
++
T Consensus 321 l~ 322 (348)
T 2pml_X 321 LK 322 (348)
T ss_dssp HT
T ss_pred hc
Confidence 86
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=1.9e-15 Score=113.58 Aligned_cols=118 Identities=14% Similarity=0.080 Sum_probs=83.1
Q ss_pred ccCCCCCcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cccc---------------------
Q psy1684 61 QKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVH--------------------- 103 (189)
Q Consensus 61 yl~~~~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~--------------------- 103 (189)
++.....+...++..+..+.+.|+.++|..+++|+|+ |+ +++.
T Consensus 106 ~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y 185 (311)
T 3ork_A 106 IVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185 (311)
T ss_dssp HHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC------------------CCTT
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCccc
Confidence 3333344556777778888899999999999999996 55 2221
Q ss_pred ---cC-CCCCccc-e-EEEec------------CCCCChHHHHHHHHcCCCCC---CCCCCCHHHHHHHHHhcccCCCCC
Q psy1684 104 ---GT-NLSGVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMP---CPPGCPPRLYDIMLECWLKDPVKR 162 (189)
Q Consensus 104 ---~~-~~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~---~p~~~p~~~~~l~~~C~~~~p~~R 162 (189)
|. ....++. + ||||| |.+.+..++......+...+ .+..+|.++.+|+.+||+.||.+|
T Consensus 186 ~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 265 (311)
T 3ork_A 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENR 265 (311)
T ss_dssp CCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGS
T ss_pred CCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhC
Confidence 11 2346788 9 99999 67777767666654443332 235799999999999999999999
Q ss_pred CCHHHHH-HHHHHHHhh
Q psy1684 163 PTFETLQ-WKLEDFFTM 178 (189)
Q Consensus 163 P~~~~i~-~~l~~~~~~ 178 (189)
|+..+++ ..|..+...
T Consensus 266 ~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 266 YQTAAEMRADLVRVHNG 282 (311)
T ss_dssp CSSHHHHHHHHHHHHTT
T ss_pred hhhHHHHHHHHHHHhcC
Confidence 9766554 456665543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.46 E-value=6e-16 Score=114.40 Aligned_cols=144 Identities=12% Similarity=0.036 Sum_probs=88.8
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCC-CCcCHhHHHHHhhhccC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGR-TTIHYPELVEHYSKDAD 82 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~-~~~~l~~li~~~~~~a~ 82 (189)
..++|+|++++++.+......+||+|++.. + ++.. ++... ..++..++..+..+.+.
T Consensus 66 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~----~L~~-----------------~l~~~~~~~~~~~~~~~~~qi~~ 123 (278)
T 3cok_A 66 CQLKHPSILELYNYFEDSNYVYLVLEMCHN-G----EMNR-----------------YLKNRVKPFSENEARHFMHQIIT 123 (278)
T ss_dssp TTBCCTTBCCEEEEEECSSEEEEEEECCTT-E----EHHH-----------------HHHTCSSCCCHHHHHHHHHHHHH
T ss_pred HhCCCCCeEeEEEEEccCCeEEEEEecCCC-C----cHHH-----------------HHhhccCCCCHHHHHHHHHHHHH
Confidence 345666666666655555555666666554 2 1111 33322 34556777778888899
Q ss_pred CceeeccCCcccccc-cc---------------cc---------------------cccC-CCCCccc-e-EEEec----
Q psy1684 83 GLCVNLRKPCVQVSC-RI---------------YL---------------------VHGT-NLSGVVV-S-AVDFG---- 118 (189)
Q Consensus 83 gl~~~~~~~~~~~~~-p~---------------~l---------------------~~~~-~~~~~~~-s-VwsfG---- 118 (189)
|+.++|..+++|+|+ |+ ++ ++|. ....++. + |||||
T Consensus 124 ~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 203 (278)
T 3cok_A 124 GMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFY 203 (278)
T ss_dssp HHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC----------------------------CTHHHHHHHHHH
T ss_pred HHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHH
Confidence 999999999999996 54 11 1111 2345778 8 99999
Q ss_pred --------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 119 --------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 119 --------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
|.+.+..+....+... ....|..++.++.+|+.+||+.||++|||++++++
T Consensus 204 ~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 204 TLLIGRPPFDTDTVKNTLNKVVLA-DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp HHHHSSCSSCCCSCC-----CCSS-CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHhCCCCCCChhHHHHHHHHhhc-ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 4444433444333222 23467789999999999999999999999999886
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.46 E-value=2.3e-15 Score=111.97 Aligned_cols=144 Identities=11% Similarity=0.009 Sum_probs=93.9
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC-CCCcCHhHHHHHhhhccC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG-RTTIHYPELVEHYSKDAD 82 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~-~~~~~l~~li~~~~~~a~ 82 (189)
..++|+|++++++.....+..+||+|++.. + +.. ++.. ...+.......+..+.+.
T Consensus 55 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~-----l~~-----------------~~~~~~~~~~~~~~~~~~~qi~~ 111 (288)
T 1ob3_A 55 KELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-D-----LKK-----------------LLDVCEGGLESVTAKSFLLQLLN 111 (288)
T ss_dssp GGCCCTTBCCEEEEEECSSCEEEEEECCSE-E-----HHH-----------------HHHTSTTCCCHHHHHHHHHHHHH
T ss_pred HhcCCCCEeeeeeEEccCCeEEEEEEecCC-C-----HHH-----------------HHHhcccCCCHHHHHHHHHHHHH
Confidence 345677777776665555556666666542 1 111 2221 223445566677788899
Q ss_pred CceeeccCCcccccc-cc---------------c---------------------ccccC-C-CCCccc-e-EEEec---
Q psy1684 83 GLCVNLRKPCVQVSC-RI---------------Y---------------------LVHGT-N-LSGVVV-S-AVDFG--- 118 (189)
Q Consensus 83 gl~~~~~~~~~~~~~-p~---------------~---------------------l~~~~-~-~~~~~~-s-VwsfG--- 118 (189)
|+.++|..+++|+|+ |+ | +|+|. . ...++. + |||+|
T Consensus 112 ~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 191 (288)
T 1ob3_A 112 GIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIF 191 (288)
T ss_dssp HHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHH
T ss_pred HHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHH
Confidence 999999999999996 55 1 11221 1 235888 9 99999
Q ss_pred ---------CCCCChHHHHHHHHc--CCCC--------------------------CCCCCCCHHHHHHHHHhcccCCCC
Q psy1684 119 ---------SGGMTNAEVLHQVEH--GYRM--------------------------PCPPGCPPRLYDIMLECWLKDPVK 161 (189)
Q Consensus 119 ---------~~~~~~~~~~~~v~~--g~~~--------------------------~~p~~~p~~~~~l~~~C~~~~p~~ 161 (189)
|.+.+..+.+..+.+ +... ..+..+++++.+|+.+||+.||++
T Consensus 192 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 271 (288)
T 1ob3_A 192 AEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQ 271 (288)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTT
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCccc
Confidence 666666555544422 1100 012357899999999999999999
Q ss_pred CCCHHHHHH
Q psy1684 162 RPTFETLQW 170 (189)
Q Consensus 162 RP~~~~i~~ 170 (189)
|||++++++
T Consensus 272 Rpt~~e~l~ 280 (288)
T 1ob3_A 272 RITAKQALE 280 (288)
T ss_dssp SCCHHHHHT
T ss_pred CCCHHHHhc
Confidence 999999875
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.45 E-value=1.4e-15 Score=112.70 Aligned_cols=116 Identities=15% Similarity=0.055 Sum_probs=83.5
Q ss_pred ccCCCCCcCHhHHHHHhhhccCCceeeccCCcccccc-cccc-------------------c------------------
Q psy1684 61 QKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RIYL-------------------V------------------ 102 (189)
Q Consensus 61 yl~~~~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~~l-------------------~------------------ 102 (189)
++.....++..++..+..+.+.|+.++|..+++|+|+ |+.+ +
T Consensus 98 ~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y 177 (283)
T 3bhy_A 98 FLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEF 177 (283)
T ss_dssp HHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC--------CCCGGG
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccCCCcccccCCCcCc
Confidence 3333344556677777888889999999999999986 5411 1
Q ss_pred --ccC-CCCCccc-e-EEEec------------CCCCChHHHHHHHHcCCCCC---CCCCCCHHHHHHHHHhcccCCCCC
Q psy1684 103 --HGT-NLSGVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMP---CPPGCPPRLYDIMLECWLKDPVKR 162 (189)
Q Consensus 103 --~~~-~~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~---~p~~~p~~~~~l~~~C~~~~p~~R 162 (189)
+|. ....++. + ||||| |.+.+..+....+..+.... .+..+|.++.+|+.+||+.||++|
T Consensus 178 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 257 (283)
T 3bhy_A 178 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRR 257 (283)
T ss_dssp CCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGS
T ss_pred cCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHC
Confidence 110 3456888 9 99999 66666777777665543221 235789999999999999999999
Q ss_pred CCHHHHHH--HHHHHH
Q psy1684 163 PTFETLQW--KLEDFF 176 (189)
Q Consensus 163 P~~~~i~~--~l~~~~ 176 (189)
||+.++++ .++.+.
T Consensus 258 ps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 258 MTIAQSLEHSWIKAIR 273 (283)
T ss_dssp CCHHHHHHCHHHHHHH
T ss_pred cCHHHHHhCHHHHHHH
Confidence 99999987 355543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.45 E-value=5.6e-16 Score=115.09 Aligned_cols=147 Identities=16% Similarity=0.054 Sum_probs=93.8
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.+.|+|++++++.+......+||+|++.. + +.. ... . .......++...+..+..+.+.|+
T Consensus 62 ~~~h~~iv~~~~~~~~~~~~~lv~e~~~~-~-----l~~----~l~-----~----~~~~~~~~~~~~~~~i~~qi~~~l 122 (290)
T 3fme_A 62 TVDCPFTVTFYGALFREGDVWICMELMDT-S-----LDK----FYK-----Q----VIDKGQTIPEDILGKIAVSIVKAL 122 (290)
T ss_dssp TCCCTTBCCEEEEEECSSSEEEEEECCSE-E-----HHH----HHH-----H----HHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred hCCCCeEEEEeeeeeccCCEEEEEehhcc-c-----hHH----HHH-----H----HHhcCCCCCHHHHHHHHHHHHHHH
Confidence 45666666666655555556666666542 1 111 000 0 111233455667777888889999
Q ss_pred eeeccC-Ccccccc-cc---------------cc--------------------cccC-----CCCCccc-e-EEEec--
Q psy1684 85 CVNLRK-PCVQVSC-RI---------------YL--------------------VHGT-----NLSGVVV-S-AVDFG-- 118 (189)
Q Consensus 85 ~~~~~~-~~~~~~~-p~---------------~l--------------------~~~~-----~~~~~~~-s-VwsfG-- 118 (189)
.++|.. +++|+|+ |+ ++ ++|. ....++. + |||+|
T Consensus 123 ~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~i 202 (290)
T 3fme_A 123 EHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGIT 202 (290)
T ss_dssp HHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHH
T ss_pred HHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHH
Confidence 999998 9999996 54 11 2221 2345788 9 99999
Q ss_pred ----------CCCC-ChHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 119 ----------SGGM-TNAEVLHQV-EHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 119 ----------~~~~-~~~~~~~~v-~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
|.+. ...+.+..+ ........+..+|+++.+|+.+||+.||++|||+.++++
T Consensus 203 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 203 MIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp HHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 4432 233333344 444333344679999999999999999999999999987
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.45 E-value=9.3e-16 Score=116.50 Aligned_cols=151 Identities=17% Similarity=0.186 Sum_probs=96.7
Q ss_pred CChHHHHHHhcCCCCCC----CcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhcc
Q psy1684 6 IKRIEAEKKLLLPENDH----GAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDA 81 (189)
Q Consensus 6 l~~~n~~~lL~~~~~~~----g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a 81 (189)
+.|+|++++++.+.... ..+||+|++..+. +.. ++. ...+...++..+..+.+
T Consensus 93 l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~-----L~~-----------------~l~-~~~~~~~~~~~i~~~i~ 149 (342)
T 1b6c_B 93 LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGS-----LFD-----------------YLN-RYTVTVEGMIKLALSTA 149 (342)
T ss_dssp CCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCB-----HHH-----------------HHH-HCCBCHHHHHHHHHHHH
T ss_pred cCCCcEEEEEeeecccCCccceeEEEEeecCCCc-----HHH-----------------HHh-ccCccHHHHHHHHHHHH
Confidence 56666666665543333 3466666665421 111 232 12345667777788888
Q ss_pred CCceeec--------cCCcccccc-cc---------------ccc-------------------------ccC-CCC---
Q psy1684 82 DGLCVNL--------RKPCVQVSC-RI---------------YLV-------------------------HGT-NLS--- 108 (189)
Q Consensus 82 ~gl~~~~--------~~~~~~~~~-p~---------------~l~-------------------------~~~-~~~--- 108 (189)
.|+.++| ..+++|+|+ |+ +++ +|. ...
T Consensus 150 ~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 229 (342)
T 1b6c_B 150 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 229 (342)
T ss_dssp HHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCT
T ss_pred HHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccc
Confidence 9999999 788999996 55 111 111 111
Q ss_pred ---Cccc-e-EEEec------CCC----------------C-----ChHHHHHHH-HcCCCCCCCC-----CCCHHHHHH
Q psy1684 109 ---GVVV-S-AVDFG------SGG----------------M-----TNAEVLHQV-EHGYRMPCPP-----GCPPRLYDI 150 (189)
Q Consensus 109 ---~~~~-s-VwsfG------~~~----------------~-----~~~~~~~~v-~~g~~~~~p~-----~~p~~~~~l 150 (189)
.++. + ||||| ..+ . ...++...+ ..+.++..|. .++..+.+|
T Consensus 230 ~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 309 (342)
T 1b6c_B 230 KHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKI 309 (342)
T ss_dssp TCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHH
T ss_pred cccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHH
Confidence 3447 8 99999 221 1 123444444 3445555553 455789999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q psy1684 151 MLECWLKDPVKRPTFETLQWKLEDFFTME 179 (189)
Q Consensus 151 ~~~C~~~~p~~RP~~~~i~~~l~~~~~~~ 179 (189)
|.+||+.||++|||+.+|++.|+.+.+..
T Consensus 310 i~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 310 MRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp HHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred HHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 99999999999999999999999998753
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.45 E-value=2.2e-15 Score=116.64 Aligned_cols=143 Identities=9% Similarity=0.038 Sum_probs=97.6
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.++|+|++++++.+......|+|+|++.+ | ++.. ++.....+....+..+..+.+.|+
T Consensus 71 ~l~hp~Iv~l~~~~~~~~~~~lv~e~~~g-g----~L~~-----------------~l~~~~~l~~~~~~~~~~qi~~aL 128 (384)
T 4fr4_A 71 GLEHPFLVNLWYSFQDEEDMFMVVDLLLG-G----DLRY-----------------HLQQNVHFKEETVKLFICELVMAL 128 (384)
T ss_dssp TCCCTTBCCEEEEEECSSEEEEEECCCTT-E----EHHH-----------------HHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred hCCCCCCCcEEEEEEeCCEEEEEEecCCC-C----cHHH-----------------HHHhcCCCCHHHHHHHHHHHHHHH
Confidence 45667777766655555566666666654 2 1111 344344566666777778889999
Q ss_pred eeeccCCcccccc-cc-----------------------------------cccccCC----CCCccc-e-EEEec----
Q psy1684 85 CVNLRKPCVQVSC-RI-----------------------------------YLVHGTN----LSGVVV-S-AVDFG---- 118 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~-----------------------------------~l~~~~~----~~~~~~-s-VwsfG---- 118 (189)
.++|..+++|+|+ |+ ++|+|.. ...|+. + |||+|
T Consensus 129 ~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~ 208 (384)
T 4fr4_A 129 DYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAY 208 (384)
T ss_dssp HHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHH
T ss_pred HHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHH
Confidence 9999999999996 55 2223322 345888 9 99999
Q ss_pred --------CCC---CChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-HHHHHH
Q psy1684 119 --------SGG---MTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPT-FETLQW 170 (189)
Q Consensus 119 --------~~~---~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~-~~~i~~ 170 (189)
|.+ ....++...+... ..+.|..+++++.+|+.+||+.||++||+ +.+|.+
T Consensus 209 elltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 209 ELLRGRRPYHIRSSTSSKEIVHTFETT-VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HHHHSSCSSCCCTTSCHHHHHHHHHHC-CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred HHHhCCCCCCCCCCccHHHHHHHHhhc-ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 432 2334555544443 45678899999999999999999999998 666654
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.45 E-value=8.3e-16 Score=113.76 Aligned_cols=112 Identities=11% Similarity=0.050 Sum_probs=79.2
Q ss_pred CcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cccc--------------------cC-CCCC
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVH--------------------GT-NLSG 109 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~--------------------~~-~~~~ 109 (189)
.++...+..+..+.+.|+.++|..+++|+|+ |+ +++. |. ....
T Consensus 118 ~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 197 (284)
T 2a19_B 118 KLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQD 197 (284)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhheeccccccccccCCcccccChhhhccCC
Confidence 3445666777888899999999999999996 55 1111 11 2345
Q ss_pred ccc-e-EEEec------CCCCC----hHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q psy1684 110 VVV-S-AVDFG------SGGMT----NAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFT 177 (189)
Q Consensus 110 ~~~-s-VwsfG------~~~~~----~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~ 177 (189)
++. + ||||| +.+.. ..+....+..+ ..+..+|.++.+|+.+||+.||.+|||+.++++.|..+..
T Consensus 198 ~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 198 YGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDG---IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp CCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHHHHHTT---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred CcchhhhHHHHHHHHHHHhcCCcchhHHHHHHHhhcc---cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 788 9 99999 22222 22333334433 3457789999999999999999999999999999998877
Q ss_pred hcCC
Q psy1684 178 MEGS 181 (189)
Q Consensus 178 ~~~~ 181 (189)
..+.
T Consensus 275 ~~~~ 278 (284)
T 2a19_B 275 SPEK 278 (284)
T ss_dssp ----
T ss_pred CCCc
Confidence 6543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.45 E-value=3e-15 Score=114.92 Aligned_cols=145 Identities=8% Similarity=0.046 Sum_probs=95.7
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.++|+|++++++.+......+||+|++.+ +. +.. ++.....++...+..+..+.+.|+
T Consensus 72 ~l~hpniv~~~~~~~~~~~~~lv~e~~~~-~~----L~~-----------------~l~~~~~~~~~~~~~i~~ql~~~L 129 (361)
T 3uc3_A 72 SLRHPNIVRFKEVILTPTHLAIIMEYASG-GE----LYE-----------------RICNAGRFSEDEARFFFQQLLSGV 129 (361)
T ss_dssp HCCCTTBCCEEEEEECSSEEEEEEECCCS-CB----HHH-----------------HHHHHSSCCHHHHHHHHHHHHHHH
T ss_pred hCCCCCCCcEEEEEeeCCEEEEEEEeCCC-CC----HHH-----------------HHHhcCCCCHHHHHHHHHHHHHHH
Confidence 45677777777666555566777777665 21 111 222233455667777888889999
Q ss_pred eeeccCCcccccc-cc-----------------cccc--------------------cC-CCCCc-cc-e-EEEec----
Q psy1684 85 CVNLRKPCVQVSC-RI-----------------YLVH--------------------GT-NLSGV-VV-S-AVDFG---- 118 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~-----------------~l~~--------------------~~-~~~~~-~~-s-VwsfG---- 118 (189)
.++|..+++|+|+ |+ |+++ |. ....+ +. + |||+|
T Consensus 130 ~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ 209 (361)
T 3uc3_A 130 SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLY 209 (361)
T ss_dssp HHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHH
T ss_pred HHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHH
Confidence 9999999999996 55 1111 11 23344 45 8 99999
Q ss_pred --------CCCCC----hHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 119 --------SGGMT----NAEVLHQVEH-GYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 119 --------~~~~~----~~~~~~~v~~-g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
|.+.+ ..+++..+.. ....+.+..+++++.+|+.+||+.||++|||+.++++.
T Consensus 210 ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 210 VMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp HHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 44322 2344444433 33444445789999999999999999999999999874
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.45 E-value=1e-15 Score=117.26 Aligned_cols=105 Identities=8% Similarity=-0.087 Sum_probs=82.8
Q ss_pred CCCcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cccccC----------------------C
Q psy1684 65 RTTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVHGT----------------------N 106 (189)
Q Consensus 65 ~~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~~~----------------------~ 106 (189)
...++......+..+.+.|+.++|..+++|||+ |+ |+++.. .
T Consensus 118 ~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~ 197 (353)
T 3txo_A 118 SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQ 197 (353)
T ss_dssp HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---------CCGGGCCHHHHH
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCCccccccCCCcCeEChhhcC
Confidence 345666667777888889999999999999996 55 333321 2
Q ss_pred CCCccc-e-EEEec------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH------H
Q psy1684 107 LSGVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTF------E 166 (189)
Q Consensus 107 ~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~------~ 166 (189)
...|+. + |||+| |.+.+..++...+..+. +..|..+++++.+|+.+|++.||++||++ .
T Consensus 198 ~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~ 276 (353)
T 3txo_A 198 EMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE-VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEH 276 (353)
T ss_dssp HHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTH
T ss_pred CCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHH
Confidence 234788 9 99999 77888888888887764 45678899999999999999999999998 6
Q ss_pred HHHH
Q psy1684 167 TLQW 170 (189)
Q Consensus 167 ~i~~ 170 (189)
+|++
T Consensus 277 ~il~ 280 (353)
T 3txo_A 277 AILR 280 (353)
T ss_dssp HHHT
T ss_pred HHhh
Confidence 6654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.44 E-value=7.5e-16 Score=114.73 Aligned_cols=108 Identities=9% Similarity=-0.062 Sum_probs=76.1
Q ss_pred HhHHHHHhhhccCCceeeccCCcccccc-cccccccC----------CCCCccc-e-EEEec------------CCCCCh
Q psy1684 70 YPELVEHYSKDADGLCVNLRKPCVQVSC-RIYLVHGT----------NLSGVVV-S-AVDFG------------SGGMTN 124 (189)
Q Consensus 70 l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~~l~~~~----------~~~~~~~-s-VwsfG------------~~~~~~ 124 (189)
..+.+.+..+.+.|+.++|..+++|+|+ |+.+.-.. ....++. + ||||| |.+.+.
T Consensus 128 ~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~~~~~~~~~Di~slG~il~elltg~~Pf~~~~~ 207 (286)
T 3uqc_A 128 PVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATMPDANPQDDIRGIGASLYALLVNRWPLPEAGV 207 (286)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCCCTTCCHHHHHHHHHHHHHHHHHSEECSCCCSB
T ss_pred hHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccccCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 3456667788899999999999999996 66221111 3345788 9 99999 555443
Q ss_pred HHHHH---HHHcCCCCC---CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q psy1684 125 AEVLH---QVEHGYRMP---CPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTM 178 (189)
Q Consensus 125 ~~~~~---~v~~g~~~~---~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~ 178 (189)
.+.+. ....+...+ .+..+|+++.+|+.+||+.||++| |+.++++.|+.+...
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 208 RSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp CCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred chhhHHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 22111 111121111 235799999999999999999999 999999999987764
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.44 E-value=4.4e-15 Score=112.95 Aligned_cols=165 Identities=10% Similarity=-0.057 Sum_probs=105.8
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCce---EEEEEecCCCeeeEEEEEeccC------------CccCC---CC
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDY---SLSEYKRSSFCLKMTTGRSLFE------------TQKAG---RT 66 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~---~ls~~~~~~~~v~h~~i~~~~~------------gyl~~---~~ 66 (189)
.++|+|++++++.+......+||+|++.+ +++ .-..... .............. +.+.. ..
T Consensus 84 ~l~hpniv~~~~~~~~~~~~~lv~e~~~g-g~L~~~l~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (345)
T 3hko_A 84 KLHHPNIARLYEVYEDEQYICLVMELCHG-GHLLDKLNVFIDD-STGKCAMDVVKTQICPCPECNEEAINGSIHGFRESL 161 (345)
T ss_dssp HCCCTTBCCEEEEEECSSEEEEEEECCCS-CBHHHHEEEEEET-TTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEEC
T ss_pred hCCCCCcceeehhhccCCeEEEEEeCCCC-CcHHHHHHHhhcc-cccccccccccccccccccccccccccccccccccc
Confidence 46799999999988777778999999987 432 1111110 11111111111000 00000 00
Q ss_pred C--cCHhHHHHHhhhccCCceeeccCCcccccc-cc-----------------cccc-----------------------
Q psy1684 67 T--IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI-----------------YLVH----------------------- 103 (189)
Q Consensus 67 ~--~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~-----------------~l~~----------------------- 103 (189)
. +....+..+..+.+.|+.++|..+++|+|+ |+ +++.
T Consensus 162 ~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~ 241 (345)
T 3hko_A 162 DFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFV 241 (345)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGC
T ss_pred cccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCcccc
Confidence 1 113345567778889999999999999986 54 1111
Q ss_pred --cC---CCCCccc-e-EEEec------------CCCCChHHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHhcccCCCC
Q psy1684 104 --GT---NLSGVVV-S-AVDFG------------SGGMTNAEVLHQVEHG-YRMPCP--PGCPPRLYDIMLECWLKDPVK 161 (189)
Q Consensus 104 --~~---~~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g-~~~~~p--~~~p~~~~~l~~~C~~~~p~~ 161 (189)
|. ....++. + ||||| |.+.+..+....+..+ ...+.| ..+++++.+|+.+||+.||++
T Consensus 242 aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 321 (345)
T 3hko_A 242 APEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDE 321 (345)
T ss_dssp CHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTT
T ss_pred CchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhH
Confidence 11 1256888 9 99999 7777777777777544 333333 248999999999999999999
Q ss_pred CCCHHHHHHH
Q psy1684 162 RPTFETLQWK 171 (189)
Q Consensus 162 RP~~~~i~~~ 171 (189)
|||+.++++.
T Consensus 322 Rps~~~~l~h 331 (345)
T 3hko_A 322 RFDAMRALQH 331 (345)
T ss_dssp SCCHHHHHHS
T ss_pred CCCHHHHhcC
Confidence 9999999873
|
| >3qwy_A Cell death abnormality protein 2; cell engulfment, signaling protein; 2.52A {Caenorhabditis elegans} | Back alignment and structure |
|---|
Probab=99.44 E-value=2.2e-13 Score=102.32 Aligned_cols=79 Identities=29% Similarity=0.364 Sum_probs=67.5
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCe---eeEEEEEe-ccC------C-ccCCCCCcC
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFC---LKMTTGRS-LFE------T-QKAGRTTIH 69 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~---v~h~~i~~-~~~------g-yl~~~~~~~ 69 (189)
||||.|+|.+|+++|......+|+||||++ +.+|.|+||++. .+. ++||+|.. ... | |..+...|.
T Consensus 43 Wyhg~i~R~~Ae~lL~~~~~~~G~FLVR~S-~~~g~y~LSv~~--~~~~~~v~H~~I~~~~~~~~g~~~g~~~~~~~~F~ 119 (308)
T 3qwy_A 43 FYFPGMSREEAHKLLGEPQVSIGTFLMRDS-SRPGEYSLTVRE--ADEGNAVCHYLIERGEPKEDGTAAAGVKIANQSFP 119 (308)
T ss_dssp GEETTCCHHHHHHHHHSTTCCTTEEEEEEC-SSTTCEEEEEEC--CSSSSCEEEEEEEECCCCTTTTCCCCEEETTEEES
T ss_pred cccCCCCHHHHHHHHhccCCCCceEEEEcc-CCCCCEEEEEEe--CCCCCceEEEEEeeccCCCcCcccceEEEeCeeeC
Confidence 999999999999999764567899999999 888999999999 888 99999987 543 6 444457888
Q ss_pred -HhHHHHHhhhccC
Q psy1684 70 -YPELVEHYSKDAD 82 (189)
Q Consensus 70 -l~~li~~~~~~a~ 82 (189)
+.+|+.++.....
T Consensus 120 Sl~eLv~~y~~~~~ 133 (308)
T 3qwy_A 120 DIPALLNHFKMRVL 133 (308)
T ss_dssp SHHHHHHHHHHSCS
T ss_pred CHHHHHHHHhhccc
Confidence 9999999987765
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.44 E-value=1.7e-15 Score=115.44 Aligned_cols=111 Identities=14% Similarity=0.121 Sum_probs=80.0
Q ss_pred ccCCCCCcCHhHHHHHhhhccCCceeeccCCcccccc-cc--------------ccccc---------------------
Q psy1684 61 QKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI--------------YLVHG--------------------- 104 (189)
Q Consensus 61 yl~~~~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~--------------~l~~~--------------------- 104 (189)
++.....+...+...+..+.+.|+.++|..+++|+|+ |+ |++..
T Consensus 98 ~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~a 177 (343)
T 3dbq_A 98 WLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177 (343)
T ss_dssp HHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTEEEECCCSSSCCC------------CCCCSSCC
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEECCcEEEeecccccccCcccccccCCCCcCCcCcCC
Confidence 4544455666677778888999999999999999996 55 22221
Q ss_pred --CC------------CCCccc-e-EEEec------------CCCCC-hHHHHHH-HHcCCCCCCCCCCCHHHHHHHHHh
Q psy1684 105 --TN------------LSGVVV-S-AVDFG------------SGGMT-NAEVLHQ-VEHGYRMPCPPGCPPRLYDIMLEC 154 (189)
Q Consensus 105 --~~------------~~~~~~-s-VwsfG------------~~~~~-~~~~~~~-v~~g~~~~~p~~~p~~~~~l~~~C 154 (189)
.. ...++. + ||||| |.+.. ....+.. +........|..++.++.+|+.+|
T Consensus 178 PE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 257 (343)
T 3dbq_A 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCC 257 (343)
T ss_dssp HHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHH
T ss_pred HHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCcccCCHHHHHHHHHH
Confidence 10 156888 9 99999 44432 2233333 344556677888999999999999
Q ss_pred cccCCCCCCCHHHHHHH
Q psy1684 155 WLKDPVKRPTFETLQWK 171 (189)
Q Consensus 155 ~~~~p~~RP~~~~i~~~ 171 (189)
|+.||.+|||+.++++.
T Consensus 258 L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 258 LKRDPKQRISIPELLAH 274 (343)
T ss_dssp TCSSTTTSCCHHHHHTS
T ss_pred cCCChhHCCCHHHHHhC
Confidence 99999999999999864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.44 E-value=2.5e-15 Score=114.25 Aligned_cols=145 Identities=12% Similarity=-0.033 Sum_probs=91.5
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.++|+|++++++.+......+||+|+...+.+ +.. ++.....+....+..+..+.+.|+
T Consensus 85 ~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~----l~~-----------------~~~~~~~l~~~~~~~i~~qi~~~L 143 (335)
T 3dls_A 85 RVEHANIIKVLDIFENQGFFQLVMEKHGSGLD----LFA-----------------FIDRHPRLDEPLASYIFRQLVSAV 143 (335)
T ss_dssp TCCCTTBCCEEEEEECSSEEEEEEECCTTSCB----HHH-----------------HHHTCCCCCHHHHHHHHHHHHHHH
T ss_pred hCCCCCEeeEEEEEeeCCEEEEEEEeCCCCcc----HHH-----------------HHHhcCCCCHHHHHHHHHHHHHHH
Confidence 45666666666655544555666665544221 111 343344556666777788889999
Q ss_pred eeeccCCcccccc-cc---------------ccc--------------------ccC-CCCCc-cc-e-EEEec------
Q psy1684 85 CVNLRKPCVQVSC-RI---------------YLV--------------------HGT-NLSGV-VV-S-AVDFG------ 118 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~---------------~l~--------------------~~~-~~~~~-~~-s-VwsfG------ 118 (189)
.++|..+++|+|+ |+ +++ +|. ....+ +. + |||||
T Consensus 144 ~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el 223 (335)
T 3dls_A 144 GYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTL 223 (335)
T ss_dssp HHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHH
T ss_pred HHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHH
Confidence 9999999999996 55 111 111 33444 67 8 99999
Q ss_pred CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 119 SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 119 ~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
..+..+..-.... .......|..+++++.+|+.+||+.||++|||+.++++.
T Consensus 224 ~~g~~pf~~~~~~-~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 224 VFEENPFCELEET-VEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp HHSSCSCSSGGGG-TTTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred HhCCCchhhHHHH-HhhccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111100000011 112344567899999999999999999999999999874
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.43 E-value=9.5e-16 Score=114.65 Aligned_cols=105 Identities=8% Similarity=-0.034 Sum_probs=73.3
Q ss_pred CcCHhHHHHHhhhccCCceeeccCCcccccc-cc------------------cccccCCCCCccc-e-EEEec-------
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI------------------YLVHGTNLSGVVV-S-AVDFG------- 118 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~------------------~l~~~~~~~~~~~-s-VwsfG------- 118 (189)
.++...+..+..+.+.|+.++|..+++|+|+ |+ |++.......++. + |||+|
T Consensus 113 ~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~DiwslG~il~el~ 192 (299)
T 3m2w_A 113 AFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEKYDKSCDMWSLGVIMYILL 192 (299)
T ss_dssp CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTTCGGGGHHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccccccCCchhhHHHHHHHHHHHH
Confidence 3556777888889999999999999999996 55 2233325567899 9 99999
Q ss_pred -----CCCCChHHHHHHHHcC---CCCCCC----CCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 119 -----SGGMTNAEVLHQVEHG---YRMPCP----PGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 119 -----~~~~~~~~~~~~v~~g---~~~~~p----~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
|.+.+..++...+... ...+.| ..+|+++.+|+.+||+.||++|||+.++++.
T Consensus 193 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 193 CGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp HSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 4443333322211111 112223 5789999999999999999999999999873
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.43 E-value=1.6e-15 Score=114.81 Aligned_cols=141 Identities=12% Similarity=0.066 Sum_probs=95.0
Q ss_pred hHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCceee
Q psy1684 8 RIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGLCVN 87 (189)
Q Consensus 8 ~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl~~~ 87 (189)
|+|++++++.+......|||+|++.+ ++ +.. ++.....++..++..+..+.+.|+.++
T Consensus 65 h~niv~~~~~~~~~~~~~lv~e~~~~-~~----L~~-----------------~l~~~~~~~~~~~~~i~~qi~~~l~~L 122 (325)
T 3kn6_A 65 HPNIVKLHEVFHDQLHTFLVMELLNG-GE----LFE-----------------RIKKKKHFSETEASYIMRKLVSAVSHM 122 (325)
T ss_dssp CTTBCCEEEEEECSSEEEEEECCCCS-CB----HHH-----------------HHHHCSCCCHHHHHHHHHHHHHHHHHH
T ss_pred CCCeeEEEEEEEcCCEEEEEEEccCC-Cc----HHH-----------------HHHhcCCCCHHHHHHHHHHHHHHHHHH
Confidence 67777777666555566777777665 21 111 333344556667777888888999999
Q ss_pred ccCCcccccc-cc------------------ccc---------------------ccC-CCCCccc-e-EEEec------
Q psy1684 88 LRKPCVQVSC-RI------------------YLV---------------------HGT-NLSGVVV-S-AVDFG------ 118 (189)
Q Consensus 88 ~~~~~~~~~~-p~------------------~l~---------------------~~~-~~~~~~~-s-VwsfG------ 118 (189)
|..+++|+|+ |+ |++ +|. ....|+. + |||+|
T Consensus 123 H~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~l 202 (325)
T 3kn6_A 123 HDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTM 202 (325)
T ss_dssp HHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----------------------CCCCHHHHHHHHHHHHHHH
T ss_pred HHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHH
Confidence 9999999996 54 111 111 3455888 9 99999
Q ss_pred ------CCCC-------ChHHHHHHHHcCCCCCCC---CCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 119 ------SGGM-------TNAEVLHQVEHGYRMPCP---PGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 119 ------~~~~-------~~~~~~~~v~~g~~~~~p---~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
|.+. ...+++..+..+.....+ ..+++++.+|+.+||+.||++|||++++++
T Consensus 203 l~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 203 LSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred HhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 3332 235667777666432222 368999999999999999999999999874
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.43 E-value=4.7e-15 Score=111.57 Aligned_cols=143 Identities=13% Similarity=0.062 Sum_probs=94.7
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC-CCCcCHhHHHHHhhhccCC
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG-RTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~-~~~~~l~~li~~~~~~a~g 83 (189)
.++|+|++++++.+......+||+|++.. + +.. ++.. ...+....+..+..+.+.|
T Consensus 75 ~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~-----l~~-----------------~~~~~~~~~~~~~~~~~~~qi~~~ 131 (311)
T 3niz_A 75 ELHHPNIVSLIDVIHSERCLTLVFEFMEK-D-----LKK-----------------VLDENKTGLQDSQIKIYLYQLLRG 131 (311)
T ss_dssp HCCCTTBCCEEEEECCSSCEEEEEECCSE-E-----HHH-----------------HHHTCTTCCCHHHHHHHHHHHHHH
T ss_pred HcCCCCEeeeeeEEccCCEEEEEEcCCCC-C-----HHH-----------------HHHhccCCCCHHHHHHHHHHHHHH
Confidence 45677777777766656666777777653 1 111 1221 2235566667777888899
Q ss_pred ceeeccCCcccccc-cc---------------ccc---------------------ccC-C-CCCccc-e-EEEec----
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YLV---------------------HGT-N-LSGVVV-S-AVDFG---- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l~---------------------~~~-~-~~~~~~-s-VwsfG---- 118 (189)
+.++|..+++|+|+ |+ |++ +|. . ...++. + |||+|
T Consensus 132 l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 211 (311)
T 3niz_A 132 VAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFA 211 (311)
T ss_dssp HHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHH
T ss_pred HHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHH
Confidence 99999999999996 55 222 111 2 245888 9 99999
Q ss_pred --------CCCCChHHHHHHHHc--CCCCC---------------------------CCCCCCHHHHHHHHHhcccCCCC
Q psy1684 119 --------SGGMTNAEVLHQVEH--GYRMP---------------------------CPPGCPPRLYDIMLECWLKDPVK 161 (189)
Q Consensus 119 --------~~~~~~~~~~~~v~~--g~~~~---------------------------~p~~~p~~~~~l~~~C~~~~p~~ 161 (189)
|.+.+..+.+..+.. |...+ .++.+++++.+|+.+||+.||++
T Consensus 212 ~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 291 (311)
T 3niz_A 212 EMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNK 291 (311)
T ss_dssp HHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTT
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhH
Confidence 666555444444422 11100 12346789999999999999999
Q ss_pred CCCHHHHHH
Q psy1684 162 RPTFETLQW 170 (189)
Q Consensus 162 RP~~~~i~~ 170 (189)
|||++|+++
T Consensus 292 Rpt~~ell~ 300 (311)
T 3niz_A 292 RISARDAMN 300 (311)
T ss_dssp SCCHHHHHT
T ss_pred CCCHHHHhc
Confidence 999999986
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.43 E-value=6.1e-15 Score=108.72 Aligned_cols=110 Identities=6% Similarity=-0.022 Sum_probs=75.4
Q ss_pred ccCCCCCcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cc-----------------------
Q psy1684 61 QKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YL----------------------- 101 (189)
Q Consensus 61 yl~~~~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l----------------------- 101 (189)
++.....++..++..+..+.+.|+.++|..+++|+|+ |+ ++
T Consensus 95 ~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 174 (276)
T 2yex_A 95 RIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174 (276)
T ss_dssp GSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGC
T ss_pred HHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCcc
Confidence 4444445666777778888899999999999999986 44 11
Q ss_pred cccC-CCCCc-cc-e-EEEec------------CCCCChH-HHHHHHHc-CCCCCCCCCCCHHHHHHHHHhcccCCCCCC
Q psy1684 102 VHGT-NLSGV-VV-S-AVDFG------------SGGMTNA-EVLHQVEH-GYRMPCPPGCPPRLYDIMLECWLKDPVKRP 163 (189)
Q Consensus 102 ~~~~-~~~~~-~~-s-VwsfG------------~~~~~~~-~~~~~v~~-g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP 163 (189)
++|. ....+ +. + ||||| |.+.+.. .....+.. ....+.+..+|+++.+|+.+||+.||++||
T Consensus 175 aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 254 (276)
T 2yex_A 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARI 254 (276)
T ss_dssp CGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSC
T ss_pred ChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHHHHCCCCchhCC
Confidence 1221 22343 67 8 99999 4443321 22333332 233333457899999999999999999999
Q ss_pred CHHHHHH
Q psy1684 164 TFETLQW 170 (189)
Q Consensus 164 ~~~~i~~ 170 (189)
|+++|++
T Consensus 255 s~~~il~ 261 (276)
T 2yex_A 255 TIPDIKK 261 (276)
T ss_dssp CHHHHTT
T ss_pred CHHHHhc
Confidence 9999876
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.43 E-value=2.4e-15 Score=114.72 Aligned_cols=143 Identities=9% Similarity=-0.011 Sum_probs=96.8
Q ss_pred ChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCcee
Q psy1684 7 KRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGLCV 86 (189)
Q Consensus 7 ~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl~~ 86 (189)
.|+|++++++........|||+|++.++. +.. ++.....++..+...+..+++.|+.+
T Consensus 74 ~hp~iv~~~~~~~~~~~~~lv~E~~~gg~-----L~~-----------------~i~~~~~~~~~~~~~~~~qi~~al~~ 131 (342)
T 2qr7_A 74 QHPNIITLKDVYDDGKYVYVVTELMKGGE-----LLD-----------------KILRQKFFSEREASAVLFTITKTVEY 131 (342)
T ss_dssp TSTTBCCEEEEEECSSEEEEEECCCCSCB-----HHH-----------------HHHTCTTCCHHHHHHHHHHHHHHHHH
T ss_pred CCCCcCeEEEEEEcCCEEEEEEeCCCCCc-----HHH-----------------HHHHcCCCCHHHHHHHHHHHHHHHHH
Confidence 45666665555544444566666655411 111 33334456667777788888999999
Q ss_pred eccCCcccccc-ccccc-------------------ccC----------------------CCCCccc-e-EEEec----
Q psy1684 87 NLRKPCVQVSC-RIYLV-------------------HGT----------------------NLSGVVV-S-AVDFG---- 118 (189)
Q Consensus 87 ~~~~~~~~~~~-p~~l~-------------------~~~----------------------~~~~~~~-s-VwsfG---- 118 (189)
+|..+++|+|+ |+.+. ... ....|+. + |||+|
T Consensus 132 lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 211 (342)
T 2qr7_A 132 LHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLY 211 (342)
T ss_dssp HHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHH
Confidence 99999999996 55221 100 1123778 8 99999
Q ss_pred --------CCC---CChHHHHHHHHcCCCCC---CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 119 --------SGG---MTNAEVLHQVEHGYRMP---CPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 119 --------~~~---~~~~~~~~~v~~g~~~~---~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
|.+ .+..++...+..+.... .+..+++++.+|+.+||..||++|||+.++++.
T Consensus 212 ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 212 TMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp HHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 433 35677888887764332 235789999999999999999999999999863
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.43 E-value=2.9e-15 Score=112.57 Aligned_cols=104 Identities=13% Similarity=0.107 Sum_probs=77.4
Q ss_pred CcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------ccc---------------------ccC-CCC
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLV---------------------HGT-NLS 108 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~---------------------~~~-~~~ 108 (189)
.++...+..+..+.+.|+.++|..+++|+|+ |. +++ +|. ...
T Consensus 121 ~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 200 (314)
T 3com_A 121 TLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI 200 (314)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSS
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCCC
Confidence 4556667777888889999999999999986 54 111 111 344
Q ss_pred Cccc-e-EEEec------------CCCCChHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 109 GVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYR--MPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 109 ~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~--~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
.++. + ||||| |.+.+..+....+..+.. ...|..+|.++.+|+.+||+.||.+|||+.++++
T Consensus 201 ~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 201 GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 5788 9 99999 666666665555544432 2345678999999999999999999999999976
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.43 E-value=1e-14 Score=111.28 Aligned_cols=144 Identities=13% Similarity=-0.018 Sum_probs=94.9
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC-CCCcCHhHHHHHhhhccCC
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG-RTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~-~~~~~l~~li~~~~~~a~g 83 (189)
.++|+|++++++.+......+||+|++.. + +.. ++.. ...++..++..+..+.+.|
T Consensus 68 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~-----l~~-----------------~~~~~~~~~~~~~~~~~~~qi~~~ 124 (346)
T 1ua2_A 68 ELSHPNIIGLLDAFGHKSNISLVFDFMET-D-----LEV-----------------IIKDNSLVLTPSHIKAYMLMTLQG 124 (346)
T ss_dssp HCCCTTBCCEEEEECCTTCCEEEEECCSE-E-----HHH-----------------HHTTCCSSCCSSHHHHHHHHHHHH
T ss_pred hCCCCCCCeEEEEEeeCCceEEEEEcCCC-C-----HHH-----------------HHHhcCcCCCHHHHHHHHHHHHHH
Confidence 35677777777666555666777776653 1 111 2222 2234455666777788889
Q ss_pred ceeeccCCcccccc-cc---------------cccc---------------------cC-CC-CCccc-e-EEEec----
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YLVH---------------------GT-NL-SGVVV-S-AVDFG---- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l~~---------------------~~-~~-~~~~~-s-VwsfG---- 118 (189)
+.++|..+++|+|+ |+ |++. |. .. ..++. + |||+|
T Consensus 125 l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 204 (346)
T 1ua2_A 125 LEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILA 204 (346)
T ss_dssp HHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHH
T ss_pred HHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHH
Confidence 99999999999996 55 2222 11 12 34788 9 99999
Q ss_pred --------CCCCChHHHHHHHHc--CCC--------------------CCCC-----CCCCHHHHHHHHHhcccCCCCCC
Q psy1684 119 --------SGGMTNAEVLHQVEH--GYR--------------------MPCP-----PGCPPRLYDIMLECWLKDPVKRP 163 (189)
Q Consensus 119 --------~~~~~~~~~~~~v~~--g~~--------------------~~~p-----~~~p~~~~~l~~~C~~~~p~~RP 163 (189)
|.+.+..+.+..+.. |.. +..| ..++.++.+|+.+||+.||++||
T Consensus 205 ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 284 (346)
T 1ua2_A 205 ELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI 284 (346)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSC
T ss_pred HHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCC
Confidence 666666665555532 110 0011 45678999999999999999999
Q ss_pred CHHHHHHH
Q psy1684 164 TFETLQWK 171 (189)
Q Consensus 164 ~~~~i~~~ 171 (189)
|++|+++.
T Consensus 285 t~~ell~h 292 (346)
T 1ua2_A 285 TATQALKM 292 (346)
T ss_dssp CHHHHHTS
T ss_pred CHHHHhcC
Confidence 99999864
|
| >2b3o_A Tyrosine-protein phosphatase, non-receptor type 6; protein tyrosine phosphatase, SHP-1, signaling, hydrolase; 2.80A {Homo sapiens} PDB: 1x6c_A 2rmx_A* 2yu7_A* | Back alignment and structure |
|---|
Probab=99.43 E-value=3.5e-13 Score=108.36 Aligned_cols=90 Identities=27% Similarity=0.369 Sum_probs=76.6
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC-c-cCCCCCcC-HhHHHHHh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET-Q-KAGRTTIH-YPELVEHY 77 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g-y-l~~~~~~~-l~~li~~~ 77 (189)
||||.|+|.+|+++|.... .+|+||||++.+.+|.|+||++. .+.++|++|.. .+| | +.+...|. +.+|++||
T Consensus 4 Wyhg~i~r~~Ae~lL~~~~-~~G~FLvR~S~~~~g~~~Lsv~~--~~~v~H~~I~~-~~~~~~~~~~~~F~sl~~Lv~~y 79 (532)
T 2b3o_A 4 WFHRDLSGLDAETLLKGRG-VHGSFLARPSRKNQGDFSLSVRV--GDQVTHIRIQN-SGDFYDLYGGEKFATLTELVEYY 79 (532)
T ss_dssp TBCSSCCHHHHHHHHHHHC-CTTEEEEEECSSSSSEEEEEEEE--TTEEEEEEEEC-SSSCEEETTSCEESCHHHHHHHH
T ss_pred ceeCCCCHHHHHHHHHhcC-CCCCEEEecCCCCCCceEEEEEE--CCEEEEEEEEe-cCCEEEECCCcccCCHHHHHHHH
Confidence 9999999999999996443 67999999999888999999999 99999999986 444 4 76677888 99999999
Q ss_pred hhcc------CCceeeccCCccc
Q psy1684 78 SKDA------DGLCVNLRKPCVQ 94 (189)
Q Consensus 78 ~~~a------~gl~~~~~~~~~~ 94 (189)
.... +|+...+..|+..
T Consensus 80 ~~~~~~l~~~~g~~~~L~~P~~~ 102 (532)
T 2b3o_A 80 TQQQGVLQDRDGTIIHLKYPLNC 102 (532)
T ss_dssp HTTCSCBCCSSSCCBCCCEECCC
T ss_pred HhcccccccccCchhhccccccc
Confidence 9876 6777777776654
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.42 E-value=2.2e-15 Score=113.05 Aligned_cols=107 Identities=14% Similarity=0.180 Sum_probs=75.5
Q ss_pred CCCcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------ccc---------------------ccC--
Q psy1684 65 RTTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLV---------------------HGT-- 105 (189)
Q Consensus 65 ~~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~---------------------~~~-- 105 (189)
...++...+..+..+.+.|+.++|..+++|+|+ |+ |++ +|.
T Consensus 96 ~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 175 (311)
T 4agu_A 96 QRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLV 175 (311)
T ss_dssp SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC------------GGGCCHHHHH
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHh
Confidence 334556666777778889999999999999996 54 221 111
Q ss_pred CCCCccc-e-EEEec------------CCCCChHHHHHHHHc--------------------CCCCCCC----------C
Q psy1684 106 NLSGVVV-S-AVDFG------------SGGMTNAEVLHQVEH--------------------GYRMPCP----------P 141 (189)
Q Consensus 106 ~~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~--------------------g~~~~~p----------~ 141 (189)
....++. + |||+| |.+.+..+....+.+ +...+.| +
T Consensus 176 ~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (311)
T 4agu_A 176 GDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFP 255 (311)
T ss_dssp TCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCT
T ss_pred cCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcc
Confidence 1355788 9 99999 666665555444321 1222222 3
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 142 GCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 142 ~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
.++.++.+|+.+||+.||++|||++++++.
T Consensus 256 ~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 256 NISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp TCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 678899999999999999999999999863
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.42 E-value=6.9e-15 Score=112.66 Aligned_cols=109 Identities=15% Similarity=0.036 Sum_probs=84.0
Q ss_pred ccCCCCCcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cccccC-------------------
Q psy1684 61 QKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVHGT------------------- 105 (189)
Q Consensus 61 yl~~~~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~~~------------------- 105 (189)
++.....+.......+..+++.|+.++|..+++|||+ |+ |+++..
T Consensus 111 ~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aP 190 (353)
T 2i0e_A 111 HIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAP 190 (353)
T ss_dssp HHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCH
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCcccccccCCccccCh
Confidence 3433345666667778888899999999999999996 55 333321
Q ss_pred ---CCCCccc-e-EEEec------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH---
Q psy1684 106 ---NLSGVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTF--- 165 (189)
Q Consensus 106 ---~~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~--- 165 (189)
....|+. + |||+| |.+.+..++...+..+. +..|..+++++.+|+.+||..||++||++
T Consensus 191 E~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~ 269 (353)
T 2i0e_A 191 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPE 269 (353)
T ss_dssp HHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTT
T ss_pred hhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCC
Confidence 3456889 9 99999 77777888888886653 55778999999999999999999999964
Q ss_pred --HHHHH
Q psy1684 166 --ETLQW 170 (189)
Q Consensus 166 --~~i~~ 170 (189)
.+|++
T Consensus 270 ~~~~i~~ 276 (353)
T 2i0e_A 270 GERDIKE 276 (353)
T ss_dssp HHHHHHT
T ss_pred CHHHHhc
Confidence 66654
|
| >3ps5_A Tyrosine-protein phosphatase non-receptor type 6; SH2, PTP, hydrolase, signaling protein; 3.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.42 E-value=6.8e-13 Score=107.89 Aligned_cols=90 Identities=27% Similarity=0.376 Sum_probs=75.7
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC-ccCCCCCcC-HhHHHHHhh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET-QKAGRTTIH-YPELVEHYS 78 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g-yl~~~~~~~-l~~li~~~~ 78 (189)
||||.|+|.+|+++|.... .+|+||||++.+.+|.|+||++. .+.++|++|....++ ++.+...|. +.+|++||.
T Consensus 4 Wy~g~isr~~Ae~lL~~~~-~~G~FLvR~S~~~~g~y~LSv~~--~~~v~H~~I~~~~~~~~~~~~~~F~sl~eLv~~y~ 80 (595)
T 3ps5_A 4 WFHRDLSGLDAETLLKGRG-VHGSFLARPSRKNQGDFSLSVRV--GDQVTHIRIQNSGDFYDLYGGEKFATLTELVEYYT 80 (595)
T ss_dssp CCCSSCCHHHHHHHHHHHC-CTTCEEEEECSSSTTSEEEEEEE--TTEEEEEEEEECSSCEESSSSCCBSSHHHHHHHHH
T ss_pred ccCCCCCHHHHHHHHhhCC-CCCEEEEeecCCCCCceEEEEEE--CCEEEEEEEEeCCCcEEEecCccccchhhhhhhhc
Confidence 9999999999999996443 58999999999999999999999 999999999876555 688888899 999999999
Q ss_pred hcc------CCceeeccCCcc
Q psy1684 79 KDA------DGLCVNLRKPCV 93 (189)
Q Consensus 79 ~~a------~gl~~~~~~~~~ 93 (189)
... +|+...+..|+.
T Consensus 81 ~~~~~l~~~~g~~i~L~~P~~ 101 (595)
T 3ps5_A 81 QQQGVLQDRDGTIIHLKYPLN 101 (595)
T ss_dssp TTSSCCBCSSCCBCCCCCBCC
T ss_pred cCccccccccccccccccccc
Confidence 863 355555555543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.42 E-value=3.5e-15 Score=114.32 Aligned_cols=145 Identities=12% Similarity=-0.006 Sum_probs=94.2
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.++|+|++++++.+......+||+|++.+ ++ +.. ++.....++...+..+..+.+.|+
T Consensus 87 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~~----L~~-----------------~l~~~~~~~~~~~~~i~~~i~~~l 144 (360)
T 3eqc_A 87 ECNSPYIVGFYGAFYSDGEISICMEHMDG-GS----LDQ-----------------VLKKAGRIPEQILGKVSIAVIKGL 144 (360)
T ss_dssp GCCCTTBCCEEEEEEETTEEEEEECCCTT-CB----HHH-----------------HHHHHSSCCHHHHHHHHHHHHHHH
T ss_pred HCCCCCEEEEeEEEEECCEEEEEEECCCC-CC----HHH-----------------HHHHcCCCCHHHHHHHHHHHHHHH
Confidence 45677777766655555556677776654 21 111 222223444556666777888899
Q ss_pred eeeccC-Ccccccc-cc---------------ccc-------------------ccC-CCCCccc-e-EEEec-------
Q psy1684 85 CVNLRK-PCVQVSC-RI---------------YLV-------------------HGT-NLSGVVV-S-AVDFG------- 118 (189)
Q Consensus 85 ~~~~~~-~~~~~~~-p~---------------~l~-------------------~~~-~~~~~~~-s-VwsfG------- 118 (189)
.++|.. +++|+|+ |+ +++ +|. ....++. + |||||
T Consensus 145 ~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 224 (360)
T 3eqc_A 145 TYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMA 224 (360)
T ss_dssp HHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHH
T ss_pred HHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHH
Confidence 999986 8999996 54 111 111 3456889 9 99999
Q ss_pred -----CCCCChHH------------------------------------------HHHHHHcCCCCCCC-CCCCHHHHHH
Q psy1684 119 -----SGGMTNAE------------------------------------------VLHQVEHGYRMPCP-PGCPPRLYDI 150 (189)
Q Consensus 119 -----~~~~~~~~------------------------------------------~~~~v~~g~~~~~p-~~~p~~~~~l 150 (189)
|.+.+..+ +...+..+..+..| ..++.++.+|
T Consensus 225 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 304 (360)
T 3eqc_A 225 VGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDF 304 (360)
T ss_dssp HTSCCSSCCCHHHHHHHHC------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHH
T ss_pred hCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHH
Confidence 44433332 23333344334333 3578999999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q psy1684 151 MLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 151 ~~~C~~~~p~~RP~~~~i~~~ 171 (189)
+.+||+.||++|||++++++.
T Consensus 305 i~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 305 VNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp HHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHHhhcChhhCCCHHHHhhC
Confidence 999999999999999999874
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.42 E-value=1e-14 Score=114.08 Aligned_cols=142 Identities=11% Similarity=0.053 Sum_probs=94.2
Q ss_pred CChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCce
Q psy1684 6 IKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGLC 85 (189)
Q Consensus 6 l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl~ 85 (189)
++|+|++++++.+. .+..|||+|++.++. +.. ++.....+.......+..+.+.|+.
T Consensus 197 l~hpniv~l~~~~~-~~~~~lv~e~~~~g~-----L~~-----------------~l~~~~~~~~~~~~~i~~qi~~~l~ 253 (419)
T 3i6u_A 197 LNHPCIIKIKNFFD-AEDYYIVLELMEGGE-----LFD-----------------KVVGNKRLKEATCKLYFYQMLLAVQ 253 (419)
T ss_dssp CCCTTBCCCCEEEE-SSEEEEEEECCTTCB-----GGG-----------------GTSSSCCCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCEeeEEEEEe-cCceEEEEEcCCCCc-----HHH-----------------HHhccCCCCHHHHHHHHHHHHHHHH
Confidence 45666666555432 233566666665421 111 3444455666777777888899999
Q ss_pred eeccCCcccccc-cc--------------------------------------cccccCC----CCCccc-e-EEEec--
Q psy1684 86 VNLRKPCVQVSC-RI--------------------------------------YLVHGTN----LSGVVV-S-AVDFG-- 118 (189)
Q Consensus 86 ~~~~~~~~~~~~-p~--------------------------------------~l~~~~~----~~~~~~-s-VwsfG-- 118 (189)
++|..+++|+|+ |+ ++|+|.. ...|+. + |||||
T Consensus 254 ~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~i 333 (419)
T 3i6u_A 254 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 333 (419)
T ss_dssp HHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHH
T ss_pred HHHHCCccccCCChHhEEEecCCCcceEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHH
Confidence 999999999996 55 1122221 356888 9 99999
Q ss_pred ----------CCCCCh-HHHHHHHHcCCCCCCC---CCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 119 ----------SGGMTN-AEVLHQVEHGYRMPCP---PGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 119 ----------~~~~~~-~~~~~~v~~g~~~~~p---~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
|.+... ..+...+..+.....| ..+++++.+|+.+||+.||++|||++++++
T Consensus 334 l~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 334 LFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 444322 2344555555433333 578999999999999999999999999986
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.42 E-value=2.5e-15 Score=113.66 Aligned_cols=143 Identities=13% Similarity=0.018 Sum_probs=94.6
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC-CCCcCHhHHHHHhhhccCC
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG-RTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~-~~~~~l~~li~~~~~~a~g 83 (189)
.++|+|++++++.+......+||+|++.. + +.. ++.. ...+....+..+..+.+.|
T Consensus 56 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~-----l~~-----------------~~~~~~~~~~~~~~~~~~~qi~~a 112 (324)
T 3mtl_A 56 DLKHANIVTLHDIIHTEKSLTLVFEYLDK-D-----LKQ-----------------YLDDCGNIINMHNVKLFLFQLLRG 112 (324)
T ss_dssp CCCCTTBCCEEEEEECSSCEEEEEECCSE-E-----HHH-----------------HHHHTTTCCCHHHHHHHHHHHHHH
T ss_pred hcCCCCCCeeeeEEeeCCEEEEEeccccc-C-----HHH-----------------HHHhcCCCCCHHHHHHHHHHHHHH
Confidence 45666666666655555555666666542 1 111 2222 2234466677777888899
Q ss_pred ceeeccCCcccccc-cc---------------ccc---------------------ccC-C-CCCccc-e-EEEec----
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YLV---------------------HGT-N-LSGVVV-S-AVDFG---- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l~---------------------~~~-~-~~~~~~-s-VwsfG---- 118 (189)
+.++|..+++|+|+ |+ |++ +|. . ...++. + |||+|
T Consensus 113 L~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 192 (324)
T 3mtl_A 113 LAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFY 192 (324)
T ss_dssp HHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHH
T ss_pred HHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHH
Confidence 99999999999996 55 211 111 2 245888 9 99999
Q ss_pred --------CCCCChHHHHHHHHcCCCCC-----------------------------CCCCCCHHHHHHHHHhcccCCCC
Q psy1684 119 --------SGGMTNAEVLHQVEHGYRMP-----------------------------CPPGCPPRLYDIMLECWLKDPVK 161 (189)
Q Consensus 119 --------~~~~~~~~~~~~v~~g~~~~-----------------------------~p~~~p~~~~~l~~~C~~~~p~~ 161 (189)
|.+.+..+.+..+.+....+ .++.+++++.+|+.+|++.||++
T Consensus 193 ~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 272 (324)
T 3mtl_A 193 EMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRN 272 (324)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGG
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCccc
Confidence 77777766665553321111 11356789999999999999999
Q ss_pred CCCHHHHHH
Q psy1684 162 RPTFETLQW 170 (189)
Q Consensus 162 RP~~~~i~~ 170 (189)
|||++|+++
T Consensus 273 R~t~~e~l~ 281 (324)
T 3mtl_A 273 RISAEDAMK 281 (324)
T ss_dssp SCCHHHHTT
T ss_pred CCCHHHHhc
Confidence 999999987
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.42 E-value=1e-14 Score=110.37 Aligned_cols=112 Identities=8% Similarity=0.047 Sum_probs=78.7
Q ss_pred CCcCHhHHHHHhhhccCCceeeccCC--cccccc-cc---------------ccc-------------------------
Q psy1684 66 TTIHYPELVEHYSKDADGLCVNLRKP--CVQVSC-RI---------------YLV------------------------- 102 (189)
Q Consensus 66 ~~~~l~~li~~~~~~a~gl~~~~~~~--~~~~~~-p~---------------~l~------------------------- 102 (189)
..+....+..+..+.+.|+.++|... ++|+|+ |+ +++
T Consensus 131 ~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (337)
T 3ll6_A 131 GPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210 (337)
T ss_dssp CSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC------------------
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccc
Confidence 34557777788889999999999988 999996 54 222
Q ss_pred --------ccC----CCCCccc-e-EEEec------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcc
Q psy1684 103 --------HGT----NLSGVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWL 156 (189)
Q Consensus 103 --------~~~----~~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~ 156 (189)
+|. ....++. + ||||| |.+... ...+......+.+..++..+.+|+.+||+
T Consensus 211 ~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 287 (337)
T 3ll6_A 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK---LRIVNGKYSIPPHDTQYTVFHSLIRAMLQ 287 (337)
T ss_dssp -------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------------CCCCTTCCSSGGGHHHHHHHSC
T ss_pred cCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH---HHhhcCcccCCcccccchHHHHHHHHHcc
Confidence 111 2334788 8 99999 333222 22233444556667889999999999999
Q ss_pred cCCCCCCCHHHHHHHHHHHHhhcC
Q psy1684 157 KDPVKRPTFETLQWKLEDFFTMEG 180 (189)
Q Consensus 157 ~~p~~RP~~~~i~~~l~~~~~~~~ 180 (189)
.||++|||+.++++.|+.+.....
T Consensus 288 ~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 288 VNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp SSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred CChhhCcCHHHHHHHHHHHHhccC
Confidence 999999999999999999887543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.41 E-value=7.1e-15 Score=109.72 Aligned_cols=153 Identities=12% Similarity=0.037 Sum_probs=94.4
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..+.|+|++++++.+...+..++|+|+..++. +.. .+.+ .... -......++...+..+..+.+.|
T Consensus 68 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~-----L~~----~l~~----~~~~-~~~~~~~~~~~~~~~i~~qi~~~ 133 (303)
T 2vwi_A 68 SQCHHPNIVSYYTSFVVKDELWLVMKLLSGGS-----VLD----IIKH----IVAK-GEHKSGVLDESTIATILREVLEG 133 (303)
T ss_dssp CCCCCTTBCCEEEEEESSSCEEEEEECCTTCB-----HHH----HHHH----HHHT-TTTTTCSSCHHHHHHHHHHHHHH
T ss_pred hhcCCCCEeeEEEEEeecCCcEEEehhccCCc-----hHH----HHHH----Hhhc-cccccCCCCHHHHHHHHHHHHHH
Confidence 45566666666665555555666666665421 111 0000 0000 00012335566777788888999
Q ss_pred ceeeccCCcccccc-cc---------------ccc--------------------------ccCC-C-CCccc-e-EEEe
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YLV--------------------------HGTN-L-SGVVV-S-AVDF 117 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l~--------------------------~~~~-~-~~~~~-s-Vwsf 117 (189)
+.++|..+++|+|+ |+ +++ +|.. . ..++. + ||||
T Consensus 134 l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 213 (303)
T 2vwi_A 134 LEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSF 213 (303)
T ss_dssp HHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHH
T ss_pred HHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHH
Confidence 99999999999996 54 111 1100 1 34788 8 9999
Q ss_pred c------------CCCCChHHHHHHHHcCCCC---------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 118 G------------SGGMTNAEVLHQVEHGYRM---------PCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 118 G------------~~~~~~~~~~~~v~~g~~~---------~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
| |.+.+..+.......+..+ ..+..+|.++.+|+.+||+.||++|||+.++++
T Consensus 214 G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 214 GITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp HHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 9 5555554444443333222 123568899999999999999999999999986
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.41 E-value=1e-14 Score=113.24 Aligned_cols=136 Identities=7% Similarity=-0.061 Sum_probs=90.9
Q ss_pred ChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCcee
Q psy1684 7 KRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGLCV 86 (189)
Q Consensus 7 ~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl~~ 86 (189)
.|+|++++++........|||+|++.+ |++ .. ++.....+.......+..+++.|+.+
T Consensus 111 ~hp~Iv~l~~~~~~~~~~~lV~E~~~g-g~L----~~-----------------~l~~~~~l~~~~~~~~~~qi~~aL~~ 168 (396)
T 4dc2_A 111 NHPFLVGLHSCFQTESRLFFVIEYVNG-GDL----MF-----------------HMQRQRKLPEEHARFYSAEISLALNY 168 (396)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCTT-CBH----HH-----------------HHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred CCCCcCeeEEEEEECCEEEEEEEcCCC-CcH----HH-----------------HHHHcCCCCHHHHHHHHHHHHHHHHH
Confidence 456666655554444555666666654 211 11 23323445566667777888899999
Q ss_pred eccCCcccccc-cc---------------cccccC----------------------CCCCccc-e-EEEec--------
Q psy1684 87 NLRKPCVQVSC-RI---------------YLVHGT----------------------NLSGVVV-S-AVDFG-------- 118 (189)
Q Consensus 87 ~~~~~~~~~~~-p~---------------~l~~~~----------------------~~~~~~~-s-VwsfG-------- 118 (189)
+|..+++|||+ |+ |+++.. ....|+. + |||+|
T Consensus 169 LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~ 248 (396)
T 4dc2_A 169 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 248 (396)
T ss_dssp HHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH
T ss_pred HHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHh
Confidence 99999999996 55 333321 4456889 9 99999
Q ss_pred ----CCCC---------ChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH
Q psy1684 119 ----SGGM---------TNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTF 165 (189)
Q Consensus 119 ----~~~~---------~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~ 165 (189)
|.+. ....+...+..+ .+..|..+++++.+|+.+||+.||++||++
T Consensus 249 G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 249 GRSPFDIVGSSDNPDQNTEDYLFQVILEK-QIRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp SSCSSTTTTC------CCHHHHHHHHHHC-CCCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred CCCCCcccccccccchhhHHHHHHHHhcc-ccCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 4321 122344444443 466788999999999999999999999995
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.41 E-value=2.6e-15 Score=113.23 Aligned_cols=150 Identities=11% Similarity=-0.015 Sum_probs=99.2
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..++|+|++++++.+...+..+||+|++.+ + +... + .... .......+....+..+..+.+.|
T Consensus 58 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~-----L~~~----l-----~~~~--~~~~~~~~~~~~~~~~~~qi~~a 120 (317)
T 2pmi_A 58 KELKHENIVRLYDVIHTENKLTLVFEFMDN-D-----LKKY----M-----DSRT--VGNTPRGLELNLVKYFQWQLLQG 120 (317)
T ss_dssp TTCCBTTBCCEEEEECCTTEEEEEEECCCC-B-----HHHH----H-----HHHH--SSSCCCCCCHHHHHHHHHHHHHH
T ss_pred HhcCCCCcceEEEEEEECCeEEEEEEecCC-C-----HHHH----H-----Hhcc--ccccccCCCHHHHHHHHHHHHHH
Confidence 467888888888877766777888888763 2 1110 0 0000 00111234456666677788899
Q ss_pred ceeeccCCcccccc-cc---------------cccc---------------------cC-C-CCCccc-e-EEEec----
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YLVH---------------------GT-N-LSGVVV-S-AVDFG---- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l~~---------------------~~-~-~~~~~~-s-VwsfG---- 118 (189)
+.++|..+++|+|+ |+ |++. |. . ...++. + |||+|
T Consensus 121 L~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 200 (317)
T 2pmi_A 121 LAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILA 200 (317)
T ss_dssp HHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHH
T ss_pred HHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHH
Confidence 99999999999996 55 2221 11 1 235888 9 99999
Q ss_pred --------CCCCChHHHHHHHHc--CCC-------------------------------CCCCCCCCHHHHHHHHHhccc
Q psy1684 119 --------SGGMTNAEVLHQVEH--GYR-------------------------------MPCPPGCPPRLYDIMLECWLK 157 (189)
Q Consensus 119 --------~~~~~~~~~~~~v~~--g~~-------------------------------~~~p~~~p~~~~~l~~~C~~~ 157 (189)
|.+.+..+.+..+.+ |.. +..+..++.++.+|+.+||+.
T Consensus 201 el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 280 (317)
T 2pmi_A 201 EMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQL 280 (317)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCS
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCC
Confidence 777776666555522 110 011235788999999999999
Q ss_pred CCCCCCCHHHHHH
Q psy1684 158 DPVKRPTFETLQW 170 (189)
Q Consensus 158 ~p~~RP~~~~i~~ 170 (189)
||++|||++++++
T Consensus 281 dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 281 NPDMRLSAKQALH 293 (317)
T ss_dssp SGGGSCCHHHHTT
T ss_pred CcccCCCHHHHhC
Confidence 9999999999976
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.41 E-value=7.1e-15 Score=110.23 Aligned_cols=103 Identities=16% Similarity=0.039 Sum_probs=76.1
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cccc--------------------cC-CCCCc
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVH--------------------GT-NLSGV 110 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~--------------------~~-~~~~~ 110 (189)
++...+..+..+.+.|+.++|...++|+|+ |+ +++. |. ....+
T Consensus 117 ~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 196 (308)
T 3g33_A 117 LPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTY 196 (308)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccccccCCCcccCCccccccccCchHHcCCCC
Confidence 557777788889999999999999999996 55 2221 11 35568
Q ss_pred cc-e-EEEec------------CCCCChHHHHHHHHcCCCCC--------------------------CCCCCCHHHHHH
Q psy1684 111 VV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMP--------------------------CPPGCPPRLYDI 150 (189)
Q Consensus 111 ~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~--------------------------~p~~~p~~~~~l 150 (189)
+. + |||+| |.+.+..+.+..+.+....+ .++.+++++.+|
T Consensus 197 ~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 276 (308)
T 3g33_A 197 ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQL 276 (308)
T ss_dssp CSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHH
T ss_pred CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHH
Confidence 88 9 99999 66666666665553211111 113578899999
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q psy1684 151 MLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 151 ~~~C~~~~p~~RP~~~~i~~ 170 (189)
+.+||+.||++|||+.++++
T Consensus 277 i~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 277 LLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHhcCCCccCCCHHHHhc
Confidence 99999999999999999886
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.40 E-value=1.5e-14 Score=119.24 Aligned_cols=109 Identities=15% Similarity=0.036 Sum_probs=86.2
Q ss_pred ccCCCCCcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cccccC-------------------
Q psy1684 61 QKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVHGT------------------- 105 (189)
Q Consensus 61 yl~~~~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~~~------------------- 105 (189)
++.....+.......+..+++.|+.++|..+++|||+ |+ |+++..
T Consensus 432 ~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~AP 511 (674)
T 3pfq_A 432 HIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAP 511 (674)
T ss_dssp HHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCH
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCCcccccccCCCcccCH
Confidence 3333345666667778888999999999999999996 55 333321
Q ss_pred ---CCCCccc-e-EEEec------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH---
Q psy1684 106 ---NLSGVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTF--- 165 (189)
Q Consensus 106 ---~~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~--- 165 (189)
....|+. + ||||| |.+.+..++...+..+. +..|..+++++.+|+.+||+.||++||++
T Consensus 512 E~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~ 590 (674)
T 3pfq_A 512 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPE 590 (674)
T ss_dssp HHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSC-CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTT
T ss_pred hhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHHHHHHccCCHHHCCCCCCC
Confidence 4567899 9 99999 78888888888887653 56788999999999999999999999998
Q ss_pred --HHHHH
Q psy1684 166 --ETLQW 170 (189)
Q Consensus 166 --~~i~~ 170 (189)
++|++
T Consensus 591 ~~~ei~~ 597 (674)
T 3pfq_A 591 GERDIKE 597 (674)
T ss_dssp HHHHHHS
T ss_pred cHHHHhc
Confidence 66654
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=8e-15 Score=110.21 Aligned_cols=111 Identities=14% Similarity=0.114 Sum_probs=79.7
Q ss_pred ccCCCCCcCHhHHHHHhhhccCCceeeccCCcccccc-cc--------------ccc-----------------------
Q psy1684 61 QKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI--------------YLV----------------------- 102 (189)
Q Consensus 61 yl~~~~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~--------------~l~----------------------- 102 (189)
++.....+...+...+..+.+.|+.++|..+++|+|+ |+ +++
T Consensus 117 ~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~a 196 (313)
T 3cek_A 117 WLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 196 (313)
T ss_dssp HHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTEEEECCCSSSCC--------------CCGGGCC
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEECCeEEEeeccccccccCccccccccCCCCCCCcCC
Confidence 4444445556667777888899999999999999996 54 222
Q ss_pred ccCC------------CCCccc-e-EEEec------------CCCCC-hHHHHHH-HHcCCCCCCCCCCCHHHHHHHHHh
Q psy1684 103 HGTN------------LSGVVV-S-AVDFG------------SGGMT-NAEVLHQ-VEHGYRMPCPPGCPPRLYDIMLEC 154 (189)
Q Consensus 103 ~~~~------------~~~~~~-s-VwsfG------------~~~~~-~~~~~~~-v~~g~~~~~p~~~p~~~~~l~~~C 154 (189)
+|.. ...++. + ||||| |.+.. ....... +..+.+.+.|..++.++.+|+.+|
T Consensus 197 PE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 276 (313)
T 3cek_A 197 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCC 276 (313)
T ss_dssp HHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHH
T ss_pred HHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCcccchHHHHHHHHHH
Confidence 1111 136888 9 99999 44432 2233333 344556677888999999999999
Q ss_pred cccCCCCCCCHHHHHHH
Q psy1684 155 WLKDPVKRPTFETLQWK 171 (189)
Q Consensus 155 ~~~~p~~RP~~~~i~~~ 171 (189)
|+.||++|||+.++++.
T Consensus 277 l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 277 LKRDPKQRISIPELLAH 293 (313)
T ss_dssp TCSSTTTSCCHHHHHTS
T ss_pred ccCCcccCcCHHHHhcC
Confidence 99999999999999874
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=3.9e-15 Score=110.97 Aligned_cols=110 Identities=15% Similarity=0.057 Sum_probs=80.0
Q ss_pred ccCCCCCcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cccc--------------------c
Q psy1684 61 QKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVH--------------------G 104 (189)
Q Consensus 61 yl~~~~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~--------------------~ 104 (189)
++.....++...+..+..+.+.|+.++|..+++|+|+ |. +++. |
T Consensus 114 ~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE 193 (298)
T 1phk_A 114 YLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 193 (298)
T ss_dssp HHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHH
T ss_pred HHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhcCCCcccccccCCccccCHH
Confidence 3333334556667777888889999999999999986 44 1111 1
Q ss_pred C-------CCCCccc-e-EEEec------------CCCCChHHHHHHHHcCC-CCCCC--CCCCHHHHHHHHHhcccCCC
Q psy1684 105 T-------NLSGVVV-S-AVDFG------------SGGMTNAEVLHQVEHGY-RMPCP--PGCPPRLYDIMLECWLKDPV 160 (189)
Q Consensus 105 ~-------~~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~-~~~~p--~~~p~~~~~l~~~C~~~~p~ 160 (189)
. ....++. + ||||| |.+.+..++...+..+. ..+.| ..+|.++.+|+.+||+.||+
T Consensus 194 ~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 273 (298)
T 1phk_A 194 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQ 273 (298)
T ss_dssp HHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGG
T ss_pred HhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcc
Confidence 1 1345788 9 99999 66666677777776553 23323 46899999999999999999
Q ss_pred CCCCHHHHHH
Q psy1684 161 KRPTFETLQW 170 (189)
Q Consensus 161 ~RP~~~~i~~ 170 (189)
+|||+.++++
T Consensus 274 ~Rps~~~ll~ 283 (298)
T 1phk_A 274 KRYTAEEALA 283 (298)
T ss_dssp GSCCHHHHTT
T ss_pred cCCCHHHHHh
Confidence 9999999875
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=1.7e-14 Score=110.73 Aligned_cols=68 Identities=6% Similarity=-0.113 Sum_probs=45.8
Q ss_pred ChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCcee
Q psy1684 7 KRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGLCV 86 (189)
Q Consensus 7 ~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl~~ 86 (189)
+|+|+++++.+....+..|||+|+++++. +.. ++ ..++..+...+..+...|+.|
T Consensus 78 ~h~nIv~l~~~~~~~~~~~lvmE~~~g~~-----L~~-----------------~~---~~l~~~~~~~~~~qll~al~y 132 (361)
T 4f9c_A 78 GQDNVMGVKYCFRKNDHVVIAMPYLEHES-----FLD-----------------IL---NSLSFQEVREYMLNLFKALKR 132 (361)
T ss_dssp SBTTBCCCSEEEEETTEEEEEEECCCCCC-----HHH-----------------HH---TTCCHHHHHHHHHHHHHHHHH
T ss_pred CCCCCceEEEEEEECCEEEEEEeCCCccc-----HHH-----------------HH---cCCCHHHHHHHHHHHHHHHHH
Confidence 46677766655545555677777766522 111 22 134566677778888999999
Q ss_pred eccCCcccccc-cc
Q psy1684 87 NLRKPCVQVSC-RI 99 (189)
Q Consensus 87 ~~~~~~~~~~~-p~ 99 (189)
+|..+++|||+ |+
T Consensus 133 lH~~gIiHRDiKPe 146 (361)
T 4f9c_A 133 IHQFGIVHRDVKPS 146 (361)
T ss_dssp HHHTTEECSCCSGG
T ss_pred HHHCCeEeCcCCHH
Confidence 99999999996 66
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.40 E-value=8.9e-16 Score=115.95 Aligned_cols=99 Identities=10% Similarity=0.001 Sum_probs=70.7
Q ss_pred HHHHHhhhccCCceeeccCCcccccc-cc---------------cccccC------------------------------
Q psy1684 72 ELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVHGT------------------------------ 105 (189)
Q Consensus 72 ~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~~~------------------------------ 105 (189)
.+..+..+.+.|+.++|..+++|+|+ |+ |++...
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 45677788899999999999999996 55 222110
Q ss_pred ----CCCCccc-e-EEEec------CCCCC----hHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q psy1684 106 ----NLSGVVV-S-AVDFG------SGGMT----NAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQ 169 (189)
Q Consensus 106 ----~~~~~~~-s-VwsfG------~~~~~----~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~ 169 (189)
....++. + |||+| ..+.. ..++...+..+..+..+...++++.+|+.+||+.||++|||+++++
T Consensus 245 PE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 324 (332)
T 3qd2_B 245 PEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDII 324 (332)
T ss_dssp HHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHH
T ss_pred hHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCHHHHh
Confidence 2346788 9 99999 22222 2233344445544434456778899999999999999999999988
Q ss_pred H
Q psy1684 170 W 170 (189)
Q Consensus 170 ~ 170 (189)
+
T Consensus 325 ~ 325 (332)
T 3qd2_B 325 E 325 (332)
T ss_dssp H
T ss_pred h
Confidence 5
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.40 E-value=2.8e-15 Score=111.68 Aligned_cols=105 Identities=11% Similarity=-0.006 Sum_probs=74.1
Q ss_pred CCcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cccc---------------------cC-CC
Q psy1684 66 TTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVH---------------------GT-NL 107 (189)
Q Consensus 66 ~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~---------------------~~-~~ 107 (189)
..++...+..+..+.+.|+.++|..+++|+|+ |+ |++. |. ..
T Consensus 96 ~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 175 (292)
T 3o0g_A 96 GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175 (292)
T ss_dssp TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTT
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccCCccccCCcChHHHcC
Confidence 34556667777888899999999999999996 55 2221 11 23
Q ss_pred CC-ccc-e-EEEec-------------CCCCChHHHHHHHHcCCC----------------------------CCCCCCC
Q psy1684 108 SG-VVV-S-AVDFG-------------SGGMTNAEVLHQVEHGYR----------------------------MPCPPGC 143 (189)
Q Consensus 108 ~~-~~~-s-VwsfG-------------~~~~~~~~~~~~v~~g~~----------------------------~~~p~~~ 143 (189)
.. ++. + |||+| |.+.+..+.+..+.+... ...++.+
T Consensus 176 ~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (292)
T 3o0g_A 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKL 255 (292)
T ss_dssp CSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTC
T ss_pred CCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhccccc
Confidence 33 788 9 99999 445555555555422100 0112357
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 144 PPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 144 p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
++++.+|+.+|++.||++|||++|+++
T Consensus 256 ~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 256 NATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 889999999999999999999999886
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.40 E-value=9.5e-15 Score=112.29 Aligned_cols=105 Identities=12% Similarity=-0.002 Sum_probs=78.8
Q ss_pred CCcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cccc--------------------cC----
Q psy1684 66 TTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVH--------------------GT---- 105 (189)
Q Consensus 66 ~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~--------------------~~---- 105 (189)
..+....+..+..+++.|+.++|..+++|+|+ |. |++. |.
T Consensus 195 ~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 274 (365)
T 2y7j_A 195 VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCS 274 (365)
T ss_dssp SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHT
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCCcccccCCCCCCccChhhcccc
Confidence 34556667778888899999999999999996 55 2221 11
Q ss_pred ---CCCCccc-e-EEEec------------CCCCChHHHHHHHHcCCCC-CCC--CCCCHHHHHHHHHhcccCCCCCCCH
Q psy1684 106 ---NLSGVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRM-PCP--PGCPPRLYDIMLECWLKDPVKRPTF 165 (189)
Q Consensus 106 ---~~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~-~~p--~~~p~~~~~l~~~C~~~~p~~RP~~ 165 (189)
....++. + ||||| |.+.+..++...+..+... +.| ..+|.++.+|+.+||+.||++|||+
T Consensus 275 ~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~ 354 (365)
T 2y7j_A 275 MDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTA 354 (365)
T ss_dssp TCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred ccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCH
Confidence 1235888 9 99999 6666667777777665432 222 5789999999999999999999999
Q ss_pred HHHHH
Q psy1684 166 ETLQW 170 (189)
Q Consensus 166 ~~i~~ 170 (189)
.++++
T Consensus 355 ~ell~ 359 (365)
T 2y7j_A 355 EQALQ 359 (365)
T ss_dssp HHHHH
T ss_pred HHHhc
Confidence 99986
|
| >2shp_A SHP-2, SYP, SHPTP-2; tyrosine phosphatase, insulin signaling, SH2 protein; HET: CAT; 2.00A {Homo sapiens} SCOP: c.45.1.2 d.93.1.1 d.93.1.1 | Back alignment and structure |
|---|
Probab=99.40 E-value=7.1e-13 Score=106.40 Aligned_cols=91 Identities=26% Similarity=0.361 Sum_probs=74.8
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC-ccCCCCCcC-HhHHHHHhh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET-QKAGRTTIH-YPELVEHYS 78 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g-yl~~~~~~~-l~~li~~~~ 78 (189)
||||.|+|..|+++|.... .+|+||||++.+.+|.|+||++. .+.++|++|....++ ++.+...|. +.+|++||.
T Consensus 6 Wyhg~i~r~~Ae~lL~~~~-~~G~FLvR~S~~~~g~~~Lsv~~--~~~v~H~~I~~~~~~~~l~~~~~F~sl~eLv~~y~ 82 (525)
T 2shp_A 6 WFHPNITGVEAENLLLTRG-VDGSFLARPSKSNPGDLTLSVRR--NGAVTHIKIQNTGDYYDLYGGEKFATLAELVQYYM 82 (525)
T ss_dssp TBCSSCCHHHHHHHHHHHC-CTTEEEEEECSSSTTCEEEEEEE--TTEEEEEEEECSSSCEEETTSCEESSHHHHHHHHH
T ss_pred cccCCCCHHHHHHHHHhCC-CCCcEEeeccCCCCCcEEEEEEE--CCEEEEEEEEecCCeEEECCCCeECCHHHHHHHHH
Confidence 9999999999999996443 67999999999888999999999 999999999865444 577778898 999999998
Q ss_pred hcc------CCceeeccCCccc
Q psy1684 79 KDA------DGLCVNLRKPCVQ 94 (189)
Q Consensus 79 ~~a------~gl~~~~~~~~~~ 94 (189)
... +|....+..|+..
T Consensus 83 ~~~~~l~~~~g~~i~L~~Pv~~ 104 (525)
T 2shp_A 83 EHHGQLKEKNGDVIELKYPLNC 104 (525)
T ss_dssp TCTTCSBSSSSCBCCCCEECCC
T ss_pred hCCccccccccccccccccccc
Confidence 775 3545555555543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=7.5e-15 Score=111.22 Aligned_cols=113 Identities=12% Similarity=0.045 Sum_probs=81.4
Q ss_pred CCcCHhHHHHHhhhccCCceeeccCCcccccc-cc--------------------cccccC-------------------
Q psy1684 66 TTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI--------------------YLVHGT------------------- 105 (189)
Q Consensus 66 ~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~--------------------~l~~~~------------------- 105 (189)
..++...+..+..+.+.|+.++|..+++|+|+ |+ |++...
T Consensus 100 ~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~g 179 (330)
T 2izr_A 100 RTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTG 179 (330)
T ss_dssp TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCS
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCC
Confidence 45667778888889999999999999999996 55 111100
Q ss_pred ----------CCCCccc-e-EEEec------------CCCCC---hHHHHHHHHcCCCCCC----CCCCCHHHHHHHHHh
Q psy1684 106 ----------NLSGVVV-S-AVDFG------------SGGMT---NAEVLHQVEHGYRMPC----PPGCPPRLYDIMLEC 154 (189)
Q Consensus 106 ----------~~~~~~~-s-VwsfG------------~~~~~---~~~~~~~v~~g~~~~~----p~~~p~~~~~l~~~C 154 (189)
....++. + ||||| |.+.+ ..+.+..+..+..... ...+| ++.+|+..|
T Consensus 180 t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~ 258 (330)
T 2izr_A 180 TARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYV 258 (330)
T ss_dssp CTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHH
T ss_pred CccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHH
Confidence 2345788 9 99999 55543 3344444433322111 23466 999999999
Q ss_pred cccCCCCCCCHHHHHHHHHHHHhhc
Q psy1684 155 WLKDPVKRPTFETLQWKLEDFFTME 179 (189)
Q Consensus 155 ~~~~p~~RP~~~~i~~~l~~~~~~~ 179 (189)
|+.||.+||++.+|.+.|+.+++..
T Consensus 259 l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 259 RRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp HHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 9999999999999999999988754
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=2.7e-14 Score=108.07 Aligned_cols=105 Identities=14% Similarity=0.140 Sum_probs=79.6
Q ss_pred CcCHhHHHHHhhhccCCceeeccCCcccccc-cccc------------------c--------------------ccC-C
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RIYL------------------V--------------------HGT-N 106 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~~l------------------~--------------------~~~-~ 106 (189)
.+....+..+..+.+.|+.++|..+++|+|+ |+.+ + +|. .
T Consensus 127 ~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 206 (327)
T 3lm5_A 127 MVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILN 206 (327)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---------CCCGGGCCHHHHT
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCccccccccCCcCccCCeeec
Confidence 4556777788888999999999999999996 5511 1 111 3
Q ss_pred CCCccc-e-EEEec------------CCCCChHHHHHHHHcCC---CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q psy1684 107 LSGVVV-S-AVDFG------------SGGMTNAEVLHQVEHGY---RMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQ 169 (189)
Q Consensus 107 ~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~---~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~ 169 (189)
...++. + |||+| |.+.+..+....+.... ..+.+..+++++.+|+.+||+.||++|||+++++
T Consensus 207 ~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll 286 (327)
T 3lm5_A 207 YDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICL 286 (327)
T ss_dssp TCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 456888 9 99999 66777777666664432 2334467999999999999999999999999997
Q ss_pred HH
Q psy1684 170 WK 171 (189)
Q Consensus 170 ~~ 171 (189)
+.
T Consensus 287 ~h 288 (327)
T 3lm5_A 287 SH 288 (327)
T ss_dssp TC
T ss_pred CC
Confidence 63
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=9.5e-15 Score=110.25 Aligned_cols=110 Identities=10% Similarity=0.008 Sum_probs=77.9
Q ss_pred ccCCCCCcCHhHHHHHhhhccCCceeeccCCcccccc-cccc--------------------------------------
Q psy1684 61 QKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RIYL-------------------------------------- 101 (189)
Q Consensus 61 yl~~~~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~~l-------------------------------------- 101 (189)
++.....+.......+..+.+.|+.++|..+++|+|+ |+.+
T Consensus 104 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~ 183 (322)
T 2ycf_A 104 KVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 183 (322)
T ss_dssp HHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHHHHHHHSCCTTC
T ss_pred HHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecccccccccccCCcCcc
Confidence 3444455666667777788899999999999999996 5411
Q ss_pred cccC----CCCCccc-e-EEEec------------CCCCCh-HHHHHHHHcCCCCCC---CCCCCHHHHHHHHHhcccCC
Q psy1684 102 VHGT----NLSGVVV-S-AVDFG------------SGGMTN-AEVLHQVEHGYRMPC---PPGCPPRLYDIMLECWLKDP 159 (189)
Q Consensus 102 ~~~~----~~~~~~~-s-VwsfG------------~~~~~~-~~~~~~v~~g~~~~~---p~~~p~~~~~l~~~C~~~~p 159 (189)
++|. ....++. + ||||| |.+... ..+...+..+..... +..++.++.+|+.+||+.||
T Consensus 184 aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP 263 (322)
T 2ycf_A 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDP 263 (322)
T ss_dssp CHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSST
T ss_pred CchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCH
Confidence 1111 1456888 9 99999 433322 234455555543332 25789999999999999999
Q ss_pred CCCCCHHHHHH
Q psy1684 160 VKRPTFETLQW 170 (189)
Q Consensus 160 ~~RP~~~~i~~ 170 (189)
++|||+.++++
T Consensus 264 ~~Rps~~~~l~ 274 (322)
T 2ycf_A 264 KARFTTEEALR 274 (322)
T ss_dssp TTSCCHHHHHT
T ss_pred hhCCCHHHHhh
Confidence 99999999984
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=1.3e-14 Score=110.81 Aligned_cols=136 Identities=7% Similarity=-0.061 Sum_probs=90.6
Q ss_pred ChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCcee
Q psy1684 7 KRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGLCV 86 (189)
Q Consensus 7 ~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl~~ 86 (189)
.|+|++++++........|||+|++.+ |++ .. ++.....++......+..+++.|+.+
T Consensus 68 ~hp~iv~l~~~~~~~~~~~lv~e~~~g-g~L----~~-----------------~l~~~~~l~~~~~~~~~~qi~~aL~~ 125 (345)
T 3a8x_A 68 NHPFLVGLHSCFQTESRLFFVIEYVNG-GDL----MF-----------------HMQRQRKLPEEHARFYSAEISLALNY 125 (345)
T ss_dssp TCTTBCCEEEEEECSSEEEEEECCCCS-CBH----HH-----------------HHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred CCCccCeEEEEEEeCCEEEEEEeCCCC-CcH----HH-----------------HHHHcCCCCHHHHHHHHHHHHHHHHH
Confidence 456666655555444555666666554 211 11 23323345566667777888899999
Q ss_pred eccCCcccccc-cc---------------cccccC----------------------CCCCccc-e-EEEec--------
Q psy1684 87 NLRKPCVQVSC-RI---------------YLVHGT----------------------NLSGVVV-S-AVDFG-------- 118 (189)
Q Consensus 87 ~~~~~~~~~~~-p~---------------~l~~~~----------------------~~~~~~~-s-VwsfG-------- 118 (189)
+|..+++|||+ |+ |+++.. ....|+. + |||+|
T Consensus 126 LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 205 (345)
T 3a8x_A 126 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 205 (345)
T ss_dssp HHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH
T ss_pred HHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHh
Confidence 99999999996 55 333321 3456888 9 99999
Q ss_pred ----CCCC---------ChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH
Q psy1684 119 ----SGGM---------TNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTF 165 (189)
Q Consensus 119 ----~~~~---------~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~ 165 (189)
|.+. ....+...+..+ .+..|..++.++.+|+.+||+.||++||++
T Consensus 206 g~~pf~~~~~~~~~~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 206 GRSPFDIVGSSDNPDQNTEDYLFQVILEK-QIRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp SSCTTTTTTC-------CHHHHHHHHHHC-CCCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred CCCCcCCcccccccccccHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 4321 223344445444 456788999999999999999999999995
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.39 E-value=2.6e-13 Score=100.84 Aligned_cols=118 Identities=10% Similarity=0.108 Sum_probs=84.4
Q ss_pred CCcCHhHHHHHhhhccCCceeeccCCcccccc-cccccc----cC-----------------------------------
Q psy1684 66 TTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RIYLVH----GT----------------------------------- 105 (189)
Q Consensus 66 ~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~~l~~----~~----------------------------------- 105 (189)
..++..++..+..+.+.|+.++|..+++|+|+ |+.+.- +.
T Consensus 100 ~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~ 179 (296)
T 4hgt_A 100 RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 179 (296)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCG
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCc
Confidence 34567778888889999999999999999996 552111 00
Q ss_pred --------CCCCccc-e-EEEec------------CCCCCh---HHHHHHHHcC-CCCC---CCCCCCHHHHHHHHHhcc
Q psy1684 106 --------NLSGVVV-S-AVDFG------------SGGMTN---AEVLHQVEHG-YRMP---CPPGCPPRLYDIMLECWL 156 (189)
Q Consensus 106 --------~~~~~~~-s-VwsfG------------~~~~~~---~~~~~~v~~g-~~~~---~p~~~p~~~~~l~~~C~~ 156 (189)
....++. + ||||| |.+.+. .+.+..+..+ ...+ .+..+|+++.+|+.+||+
T Consensus 180 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 259 (296)
T 4hgt_A 180 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRS 259 (296)
T ss_dssp GGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHT
T ss_pred cccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHh
Confidence 3345788 9 99999 444322 1222222211 1111 226789999999999999
Q ss_pred cCCCCCCCHHHHHHHHHHHHhhcCCCC
Q psy1684 157 KDPVKRPTFETLQWKLEDFFTMEGSDY 183 (189)
Q Consensus 157 ~~p~~RP~~~~i~~~l~~~~~~~~~~~ 183 (189)
.||++|||+++|++.|+.+++..+..+
T Consensus 260 ~~p~~Rpt~~~l~~~l~~~~~~~~~~~ 286 (296)
T 4hgt_A 260 LRFDDKPDYSYLRQLFRNLFHRQGFSY 286 (296)
T ss_dssp SCTTCCCCHHHHHHHHHHHHHHHTCCT
T ss_pred cCCCCCCCHHHHHHHHHHHHHHhCCCc
Confidence 999999999999999999999766544
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.39 E-value=3.8e-15 Score=112.00 Aligned_cols=142 Identities=11% Similarity=0.029 Sum_probs=90.9
Q ss_pred ChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCcee
Q psy1684 7 KRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGLCV 86 (189)
Q Consensus 7 ~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl~~ 86 (189)
.|+|++++++.....+..|||+|++.++. +.. ++.....++..++..+..+.+.|+.+
T Consensus 69 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~-----L~~-----------------~l~~~~~~~~~~~~~i~~qi~~~l~~ 126 (316)
T 2ac3_A 69 GHRNVLELIEFFEEEDRFYLVFEKMRGGS-----ILS-----------------HIHKRRHFNELEASVVVQDVASALDF 126 (316)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCTTCB-----HHH-----------------HHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred CCCCeeeEEEEEeeCCEEEEEEEcCCCCc-----HHH-----------------HHhccCCCCHHHHHHHHHHHHHHHHH
Confidence 45555555554444444555555555411 111 33333345566666777888899999
Q ss_pred eccCCcccccc-cccc------------------ccc----------------------------CC------CCCccc-
Q psy1684 87 NLRKPCVQVSC-RIYL------------------VHG----------------------------TN------LSGVVV- 112 (189)
Q Consensus 87 ~~~~~~~~~~~-p~~l------------------~~~----------------------------~~------~~~~~~- 112 (189)
+|..+++|+|+ |+.+ +.. .. ...++.
T Consensus 127 lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~ 206 (316)
T 2ac3_A 127 LHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKR 206 (316)
T ss_dssp HHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTT
T ss_pred HHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcc
Confidence 99999999996 5511 110 00 033678
Q ss_pred e-EEEec------------CCCCC---------------hHHHHHHHHcCCCCCCC----CCCCHHHHHHHHHhcccCCC
Q psy1684 113 S-AVDFG------------SGGMT---------------NAEVLHQVEHGYRMPCP----PGCPPRLYDIMLECWLKDPV 160 (189)
Q Consensus 113 s-VwsfG------------~~~~~---------------~~~~~~~v~~g~~~~~p----~~~p~~~~~l~~~C~~~~p~ 160 (189)
+ |||+| |.+.+ ...+...+..+.. ..| ..+|+++.+|+.+||+.||+
T Consensus 207 ~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~ 285 (316)
T 2ac3_A 207 CDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKY-EFPDKDWAHISCAAKDLISKLLVRDAK 285 (316)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCC-CCCHHHHTTSCHHHHHHHHHHSCSSTT
T ss_pred cccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCc-ccCchhcccCCHHHHHHHHHHhhCChh
Confidence 8 99999 43332 2345556655532 233 46899999999999999999
Q ss_pred CCCCHHHHHHH
Q psy1684 161 KRPTFETLQWK 171 (189)
Q Consensus 161 ~RP~~~~i~~~ 171 (189)
+|||+.++++.
T Consensus 286 ~Rps~~e~l~h 296 (316)
T 2ac3_A 286 QRLSAAQVLQH 296 (316)
T ss_dssp TSCCHHHHHHS
T ss_pred hCCCHHHHhcC
Confidence 99999999873
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.38 E-value=5.8e-15 Score=114.84 Aligned_cols=105 Identities=10% Similarity=0.056 Sum_probs=75.6
Q ss_pred CcCHhHHHHHhhhccCCceeeccCCcccccc-ccc------------------c--------------------cccC-C
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RIY------------------L--------------------VHGT-N 106 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~~------------------l--------------------~~~~-~ 106 (189)
.+....+..+..+++.|+.++|..+++|+|+ |+. + ++|. .
T Consensus 157 ~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~ 236 (400)
T 1nxk_A 157 AFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG 236 (400)
T ss_dssp CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----------CTTCCGGGSC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCCCccccCCCCCCccCHhhcC
Confidence 3556777788889999999999999999996 541 1 1111 3
Q ss_pred CCCccc-e-EEEec------------CCCCChH----HHHHHHHcC-CCCCCC--CCCCHHHHHHHHHhcccCCCCCCCH
Q psy1684 107 LSGVVV-S-AVDFG------------SGGMTNA----EVLHQVEHG-YRMPCP--PGCPPRLYDIMLECWLKDPVKRPTF 165 (189)
Q Consensus 107 ~~~~~~-s-VwsfG------------~~~~~~~----~~~~~v~~g-~~~~~p--~~~p~~~~~l~~~C~~~~p~~RP~~ 165 (189)
...|+. + ||||| |.+.+.. .+...+..+ ...+.| ..++.++.+||.+||+.||++|||+
T Consensus 237 ~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 316 (400)
T 1nxk_A 237 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTI 316 (400)
T ss_dssp CCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCH
T ss_pred CCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCH
Confidence 456899 9 99999 4333211 234445444 233332 4689999999999999999999999
Q ss_pred HHHHHH
Q psy1684 166 ETLQWK 171 (189)
Q Consensus 166 ~~i~~~ 171 (189)
.+|++.
T Consensus 317 ~eil~h 322 (400)
T 1nxk_A 317 TEFMNH 322 (400)
T ss_dssp HHHHHS
T ss_pred HHHhcC
Confidence 999874
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.38 E-value=5.9e-15 Score=110.94 Aligned_cols=104 Identities=18% Similarity=0.135 Sum_probs=74.8
Q ss_pred CcCHhHHHHHhhhccCCceeeccC-Ccccccc-cc---------------ccc--------------------ccC----
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRK-PCVQVSC-RI---------------YLV--------------------HGT---- 105 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~-~~~~~~~-p~---------------~l~--------------------~~~---- 105 (189)
.++...+..+..+.+.|+.++|.. +++|+|+ |+ +++ +|.
T Consensus 120 ~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 199 (318)
T 2dyl_A 120 PIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPP 199 (318)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--------------CCTTCCHHHHC--
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCccccccCCCccccChhhcccc
Confidence 344566677778888999999985 8999986 54 111 111
Q ss_pred --CCCCccc-e-EEEec------------CCC-CChHHHHHHHHcCCCCCCC--CCCCHHHHHHHHHhcccCCCCCCCHH
Q psy1684 106 --NLSGVVV-S-AVDFG------------SGG-MTNAEVLHQVEHGYRMPCP--PGCPPRLYDIMLECWLKDPVKRPTFE 166 (189)
Q Consensus 106 --~~~~~~~-s-VwsfG------------~~~-~~~~~~~~~v~~g~~~~~p--~~~p~~~~~l~~~C~~~~p~~RP~~~ 166 (189)
....++. + ||||| |.+ .+..+++..+..+..+..| ..+|+++.+|+.+||+.||.+|||+.
T Consensus 200 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 279 (318)
T 2dyl_A 200 DPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYN 279 (318)
T ss_dssp ------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHH
T ss_pred cccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHH
Confidence 1345788 9 99999 444 2345666666666554444 46899999999999999999999999
Q ss_pred HHHH
Q psy1684 167 TLQW 170 (189)
Q Consensus 167 ~i~~ 170 (189)
+|++
T Consensus 280 ~ll~ 283 (318)
T 2dyl_A 280 KLLE 283 (318)
T ss_dssp HHTT
T ss_pred HHhh
Confidence 9986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.38 E-value=1.4e-14 Score=111.66 Aligned_cols=95 Identities=6% Similarity=-0.193 Sum_probs=66.7
Q ss_pred hHHHHHhhhccCCceeeccCCcccccc-cc---------------cccccC------------------CCC--------
Q psy1684 71 PELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVHGT------------------NLS-------- 108 (189)
Q Consensus 71 ~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~~~------------------~~~-------- 108 (189)
..+..+..+++.|+.++|..+++|+|+ |+ |++... ...
T Consensus 206 ~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g~~y~aPE~~~~~~~~~~~~~ 285 (377)
T 3byv_A 206 HARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVSRGFEPPELEARRATISYHRD 285 (377)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTCEEECCCCTTCCCHHHHHHHTSTHHHHC
T ss_pred HHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEechhheecCCcccCCCCcCccChhhhccccccccccc
Confidence 445567889999999999999999996 55 332211 112
Q ss_pred ---Cccc-e-EEEec------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 109 ---GVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 109 ---~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
.|+. + ||||| |.+.+..+....+. ..+..+|+++.+||.+||+.||++|||+.++++
T Consensus 286 ~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 286 RRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIF-----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp CEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGG-----SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred ccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhh-----hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 6888 9 99999 33322222222221 224678999999999999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.38 E-value=5.4e-15 Score=114.27 Aligned_cols=106 Identities=11% Similarity=-0.043 Sum_probs=76.9
Q ss_pred CCCcCHhHHHHHhhhccCCceeeccCCcccccc-cc----------------cccc--------------------cC-C
Q psy1684 65 RTTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI----------------YLVH--------------------GT-N 106 (189)
Q Consensus 65 ~~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~----------------~l~~--------------------~~-~ 106 (189)
+..++...+..+..+.+.|+.++|..+++|+|+ |+ |++. |. .
T Consensus 135 ~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~ 214 (383)
T 3eb0_A 135 GRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELML 214 (383)
T ss_dssp TCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHT
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhc
Confidence 345556667777888899999999999999996 55 2221 11 2
Q ss_pred C-CCccc-e-EEEec------------CCCCChHHHHHHHHc--CCC--------------------------CCCCCCC
Q psy1684 107 L-SGVVV-S-AVDFG------------SGGMTNAEVLHQVEH--GYR--------------------------MPCPPGC 143 (189)
Q Consensus 107 ~-~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~--g~~--------------------------~~~p~~~ 143 (189)
. ..++. + |||+| |.+.+..+.+..+.+ |.. ...|..+
T Consensus 215 ~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (383)
T 3eb0_A 215 GATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGT 294 (383)
T ss_dssp TCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTC
T ss_pred CCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCC
Confidence 2 34888 9 99999 777666555544421 110 0135678
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 144 PPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 144 p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
|+++.+|+.+||+.||++|||+.|+++
T Consensus 295 ~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 295 PSLAIDLLEQILRYEPDLRINPYEAMA 321 (383)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 999999999999999999999999985
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.38 E-value=3.2e-13 Score=100.41 Aligned_cols=118 Identities=10% Similarity=0.111 Sum_probs=84.0
Q ss_pred CCcCHhHHHHHhhhccCCceeeccCCcccccc-cccccc----cC-----------------------------------
Q psy1684 66 TTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RIYLVH----GT----------------------------------- 105 (189)
Q Consensus 66 ~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~~l~~----~~----------------------------------- 105 (189)
..++...+..+..+.+.|+.++|..+++|+|+ |+.+.- ..
T Consensus 100 ~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~ 179 (296)
T 3uzp_A 100 RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 179 (296)
T ss_dssp TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCT
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccccccccccccccccccc
Confidence 34557777788889999999999999999996 552111 00
Q ss_pred --------CCCCccc-e-EEEec------------CCCCC---hHHHHHHHHcC-CCCC---CCCCCCHHHHHHHHHhcc
Q psy1684 106 --------NLSGVVV-S-AVDFG------------SGGMT---NAEVLHQVEHG-YRMP---CPPGCPPRLYDIMLECWL 156 (189)
Q Consensus 106 --------~~~~~~~-s-VwsfG------------~~~~~---~~~~~~~v~~g-~~~~---~p~~~p~~~~~l~~~C~~ 156 (189)
....++. + ||||| |.+.+ ..+.+..+..+ ...+ .+..+|+++.+|+.+||+
T Consensus 180 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 259 (296)
T 3uzp_A 180 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRS 259 (296)
T ss_dssp TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHT
T ss_pred ccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHh
Confidence 2345788 9 99999 44432 12233333221 1111 236789999999999999
Q ss_pred cCCCCCCCHHHHHHHHHHHHhhcCCCC
Q psy1684 157 KDPVKRPTFETLQWKLEDFFTMEGSDY 183 (189)
Q Consensus 157 ~~p~~RP~~~~i~~~l~~~~~~~~~~~ 183 (189)
.||++|||+.+|++.|+.++.......
T Consensus 260 ~dp~~Rps~~~l~~~l~~~~~~~~~~~ 286 (296)
T 3uzp_A 260 LRFDDKPDYSYLRQLFRNLFHRQGFSY 286 (296)
T ss_dssp SCTTCCCCHHHHHHHHHHHHHHTTCCS
T ss_pred cCcCcCCCHHHHHHHHHHHHHhcCCcc
Confidence 999999999999999999998765543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.37 E-value=5.8e-15 Score=114.62 Aligned_cols=152 Identities=14% Similarity=0.076 Sum_probs=99.7
Q ss_pred CCChHHHHHHhcCCCCCC--CcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCC---CcCHhHHHHHhhh
Q psy1684 5 KIKRIEAEKKLLLPENDH--GAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRT---TIHYPELVEHYSK 79 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~--g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~---~~~l~~li~~~~~ 79 (189)
.++|+|++++++.+.... ..+||+|++.+ + ++.. ++.... .++...+..+..+
T Consensus 63 ~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~-g----~L~~-----------------~l~~~~~~~~l~~~~~~~i~~q 120 (396)
T 4eut_A 63 KLNHKNIVKLFAIEEETTTRHKVLIMEFCPC-G----SLYT-----------------VLEEPSNAYGLPESEFLIVLRD 120 (396)
T ss_dssp HCCCTTBCCEEEEEECTTTCCEEEEECCCTT-E----EHHH-----------------HTTSGGGTTCCCHHHHHHHHHH
T ss_pred hcCCCCCCeEEEeeccCCCCeeEEEEecCCC-C----CHHH-----------------HHHhhhcccCCCHHHHHHHHHH
Confidence 356777777766543332 34677777665 2 1211 232211 2557777888889
Q ss_pred ccCCceeeccCCcccccc-cccc-------------------cccC---------------------C--------CCCc
Q psy1684 80 DADGLCVNLRKPCVQVSC-RIYL-------------------VHGT---------------------N--------LSGV 110 (189)
Q Consensus 80 ~a~gl~~~~~~~~~~~~~-p~~l-------------------~~~~---------------------~--------~~~~ 110 (189)
.+.|+.++|..+++|+|+ |+.+ +... . ...+
T Consensus 121 i~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~ 200 (396)
T 4eut_A 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY 200 (396)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHH
T ss_pred HHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCC
Confidence 999999999999999996 5522 1110 0 1356
Q ss_pred cc-e-EEEec------------CCC----CChHHHHHHHHcCCCC--------------------CCC----CCCCHHHH
Q psy1684 111 VV-S-AVDFG------------SGG----MTNAEVLHQVEHGYRM--------------------PCP----PGCPPRLY 148 (189)
Q Consensus 111 ~~-s-VwsfG------------~~~----~~~~~~~~~v~~g~~~--------------------~~p----~~~p~~~~ 148 (189)
+. + ||||| |.+ ....+++..+..+... +.+ ..++..+.
T Consensus 201 ~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 280 (396)
T 4eut_A 201 GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLT 280 (396)
T ss_dssp HHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHH
T ss_pred CcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhch
Confidence 78 8 99999 322 2345666666555322 111 22446788
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q psy1684 149 DIMLECWLKDPVKRPTFETLQWKLEDFFTM 178 (189)
Q Consensus 149 ~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~ 178 (189)
+++.+||+.||++||++.++++.++.+++.
T Consensus 281 ~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 281 PVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred HHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 999999999999999999999999998874
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.37 E-value=4.5e-15 Score=112.19 Aligned_cols=143 Identities=15% Similarity=0.047 Sum_probs=87.5
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccC-----CCCCcCHhHHHHHhhh
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKA-----GRTTIHYPELVEHYSK 79 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~-----~~~~~~l~~li~~~~~ 79 (189)
.+.|+|++++++.+...+..+||+|++.. + +.. ++. ....+....+..+..+
T Consensus 77 ~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~-----l~~-----------------~~~~~~~~~~~~~~~~~~~~i~~~ 133 (327)
T 3aln_A 77 SSDCPYIVQFYGALFREGDCWICMELMST-S-----FDK-----------------FYKYVYSVLDDVIPEEILGKITLA 133 (327)
T ss_dssp SCCCTTBCCEEEEEECSSEEEEEECCCSE-E-----HHH-----------------HHHHHHHTTCCCCCHHHHHHHHHH
T ss_pred cCCCCcEeeeeeEEEeCCceEEEEeecCC-C-----hHH-----------------HHHHHHhhhcccCcHHHHHHHHHH
Confidence 45677777777665555556677766653 1 111 111 1233445556667778
Q ss_pred ccCCceeeccC-Ccccccc-cc-----------------------------------cccccCC-----CCCccc-e-EE
Q psy1684 80 DADGLCVNLRK-PCVQVSC-RI-----------------------------------YLVHGTN-----LSGVVV-S-AV 115 (189)
Q Consensus 80 ~a~gl~~~~~~-~~~~~~~-p~-----------------------------------~l~~~~~-----~~~~~~-s-Vw 115 (189)
.+.|+.++|.. +++|+|+ |. ++++|.. ...++. + ||
T Consensus 134 i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~ 213 (327)
T 3aln_A 134 TVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVW 213 (327)
T ss_dssp HHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC------------------------------CCSHHHHH
T ss_pred HHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHH
Confidence 88899999998 9999986 44 1222221 344788 9 99
Q ss_pred Eec------------CCCCCh-HHHHHHHHcCCCCCCC----CCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 116 DFG------------SGGMTN-AEVLHQVEHGYRMPCP----PGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 116 sfG------------~~~~~~-~~~~~~v~~g~~~~~p----~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
||| |.+.+. .+.+..+..+..+..+ ..+++++.+|+.+||+.||++|||+.+|++
T Consensus 214 slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 214 SLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp HHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 999 444332 2222233344433333 468999999999999999999999999976
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=2.5e-15 Score=113.94 Aligned_cols=105 Identities=16% Similarity=0.157 Sum_probs=74.1
Q ss_pred CCcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------ccc---------------------ccC-CC
Q psy1684 66 TTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLV---------------------HGT-NL 107 (189)
Q Consensus 66 ~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~---------------------~~~-~~ 107 (189)
..+....+..+..+.+.|+.++|..+++|+|+ |+ +++ +|. ..
T Consensus 119 ~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 198 (331)
T 4aaa_A 119 NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVG 198 (331)
T ss_dssp TCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC------------CCCCCTTCCHHHHTT
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccC
Confidence 34556777778888899999999999999996 55 221 111 22
Q ss_pred -CCccc-e-EEEec------------CCCCChHHHHHHHHc--------------------CCCCCC----------CCC
Q psy1684 108 -SGVVV-S-AVDFG------------SGGMTNAEVLHQVEH--------------------GYRMPC----------PPG 142 (189)
Q Consensus 108 -~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~--------------------g~~~~~----------p~~ 142 (189)
..++. + |||+| |.+.+..+.+..+.. +.+.+. .+.
T Consensus 199 ~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (331)
T 4aaa_A 199 DVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPK 278 (331)
T ss_dssp CTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTT
T ss_pred CCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccc
Confidence 35788 9 99999 666655544433311 111111 136
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 143 CPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 143 ~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
+++++.+|+.+||+.||++|||++|+++
T Consensus 279 ~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 279 LSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 7899999999999999999999999986
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.36 E-value=8.4e-15 Score=108.96 Aligned_cols=101 Identities=13% Similarity=0.035 Sum_probs=71.6
Q ss_pred HhHHHHHhhhccCCceeeccCCcccccc-cc----------------ccccc---------------------C-CC--C
Q psy1684 70 YPELVEHYSKDADGLCVNLRKPCVQVSC-RI----------------YLVHG---------------------T-NL--S 108 (189)
Q Consensus 70 l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~----------------~l~~~---------------------~-~~--~ 108 (189)
...+..+..+.+.|+.++|..+++|+|+ |. +++.. . .. .
T Consensus 121 ~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 200 (295)
T 2clq_A 121 EQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPR 200 (295)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGG
T ss_pred HHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCC
Confidence 4555566778888999999999999986 44 11110 0 01 2
Q ss_pred Cccc-e-EEEec------------CCCCC-hHHHH-HHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 109 GVVV-S-AVDFG------------SGGMT-NAEVL-HQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 109 ~~~~-s-VwsfG------------~~~~~-~~~~~-~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
.++. + ||||| |.+.. ..... ........+..|..+|+++.+|+.+||+.||++|||+.++++
T Consensus 201 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 201 GYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp GCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 2778 8 99999 33322 22222 222345667788899999999999999999999999999975
|
| >3ps5_A Tyrosine-protein phosphatase non-receptor type 6; SH2, PTP, hydrolase, signaling protein; 3.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.36 E-value=1.1e-12 Score=106.68 Aligned_cols=90 Identities=30% Similarity=0.410 Sum_probs=76.5
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCC---------eeeEEEEEeccCC-ccCCCCCcC-
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSF---------CLKMTTGRSLFET-QKAGRTTIH- 69 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~---------~v~h~~i~~~~~g-yl~~~~~~~- 69 (189)
||||.++|.+|+++|.... .+|+||||+|.+.+|.|+||++. .+ .++|++|....++ ++.+...|.
T Consensus 110 Wy~g~~~r~eAe~lL~~~~-~~G~FLVR~S~~~~g~y~LSv~~--~~~~~~~~~~~~v~H~~I~~~~~~~~~~~~~~F~s 186 (595)
T 3ps5_A 110 WYHGHMSGGQAETLLQAKG-EPWTFLVRESLSQPGDFVLSVLS--DQPKAGPGSPLRVTHIKVMCEGGRYTVGGLETFDS 186 (595)
T ss_dssp TEEESCCHHHHHHHHHHHC-CTTEEEEEECSSSTTCEEEEEEE--EEESSSTTSCEEEEEEEEBCGGGCBBSSSSCCBSS
T ss_pred cccccCCHHHHHHHHhccC-CCceEEEEecCCCCCcEEEEEEE--CCccccccCCCceEEEEEEEeCCEEEEcCCcCCCC
Confidence 9999999999999985443 67999999999999999999999 66 8999999876555 787777899
Q ss_pred HhHHHHHhhhc----cCCceeeccCCcc
Q psy1684 70 YPELVEHYSKD----ADGLCVNLRKPCV 93 (189)
Q Consensus 70 l~~li~~~~~~----a~gl~~~~~~~~~ 93 (189)
+.+||+||... ..|+...+..|+.
T Consensus 187 l~~LV~~y~~~~l~~~~g~~~~L~~p~~ 214 (595)
T 3ps5_A 187 LTDLVEHFKKTGIEEASGAFVYLRQPYY 214 (595)
T ss_dssp HHHHHHHHHHSCBCCTTSCCBCCCEECC
T ss_pred HHHHHHHHhcCCccccCCcEEEeecccc
Confidence 99999999873 5677777777764
|
| >2cr4_A 3BP-2, SH3 domain-binding protein 2; structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.36 E-value=1.4e-12 Score=84.96 Aligned_cols=70 Identities=20% Similarity=0.183 Sum_probs=57.5
Q ss_pred CCCcEEEecCCCCCCceEEEEEecCC--CeeeEEEEEeccCC-ccCCCCCcC-HhHHHHHhhhccCC--ceeeccCCcc
Q psy1684 21 DHGAFLIRDSESRKNDYSLSEYKRSS--FCLKMTTGRSLFET-QKAGRTTIH-YPELVEHYSKDADG--LCVNLRKPCV 93 (189)
Q Consensus 21 ~~g~fLvre~~~~~~~~~ls~~~~~~--~~v~h~~i~~~~~g-yl~~~~~~~-l~~li~~~~~~a~g--l~~~~~~~~~ 93 (189)
.+|+||||++. .+|.|+||++. . +.++||+|....++ |+.+...|. +.+||+||+..+.. ....+..|+-
T Consensus 43 ~dG~FLVR~S~-~~g~y~LSv~~--~~~~~vkH~rI~~~~~~~~i~~~~~F~sL~eLV~hY~~~~l~~~~~~~L~~P~~ 118 (126)
T 2cr4_A 43 QDGLYCIRNSS-TKSGKVLVVWD--ETSNKVRNYRIFEKDSKFYLEGEVLFVSVGSMVEHYHTHVLPSHQSLLLRHPYG 118 (126)
T ss_dssp CTTCEEEEECS-STTCEEEEEEE--TTTTEECCEECEEETTEEESSSSCEESSHHHHHHHHTTSCCSSSSSCCCCSBSS
T ss_pred CCCeEEEEecC-CCCCEEEEEEe--CCCCCEEEEEEEECCCeEEEcCCccCCCHHHHHHHHhhCCcCCCCCEEeCCcCC
Confidence 35999999999 77999999999 8 89999999987777 888778899 99999999987653 2334445543
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.36 E-value=2.9e-13 Score=107.66 Aligned_cols=118 Identities=10% Similarity=0.093 Sum_probs=85.8
Q ss_pred CCcCHhHHHHHhhhccCCceeeccCCcccccc-cccccc------------------cC---------------------
Q psy1684 66 TTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RIYLVH------------------GT--------------------- 105 (189)
Q Consensus 66 ~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~~l~~------------------~~--------------------- 105 (189)
..+....+..+..+++.|+.++|..+++|+|+ |+.+.- ..
T Consensus 98 ~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~ 177 (483)
T 3sv0_A 98 RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTA 177 (483)
T ss_dssp TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCT
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCc
Confidence 34667778888889999999999999999996 552211 00
Q ss_pred --------CCCCccc-e-EEEec------------CCCCCh---HHHHHHHHc----CCCCCCCCCCCHHHHHHHHHhcc
Q psy1684 106 --------NLSGVVV-S-AVDFG------------SGGMTN---AEVLHQVEH----GYRMPCPPGCPPRLYDIMLECWL 156 (189)
Q Consensus 106 --------~~~~~~~-s-VwsfG------------~~~~~~---~~~~~~v~~----g~~~~~p~~~p~~~~~l~~~C~~ 156 (189)
....++. + ||||| |.+... .+.+..+.. ......+..+|.++.+||..||+
T Consensus 178 ~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~ 257 (483)
T 3sv0_A 178 RYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRS 257 (483)
T ss_dssp TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHT
T ss_pred cccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhc
Confidence 3345788 9 99999 555432 333333321 11112336889999999999999
Q ss_pred cCCCCCCCHHHHHHHHHHHHhhcCCCC
Q psy1684 157 KDPVKRPTFETLQWKLEDFFTMEGSDY 183 (189)
Q Consensus 157 ~~p~~RP~~~~i~~~l~~~~~~~~~~~ 183 (189)
.||++||++.+|++.|+.++...+..+
T Consensus 258 ~dP~~RPs~~el~~~L~~l~~~~~~~~ 284 (483)
T 3sv0_A 258 LRFDDKPDYSYLKRLFRDLFIREGFQF 284 (483)
T ss_dssp CCTTCCCCHHHHHHHHHHHHHHTTCCC
T ss_pred CChhhCcCHHHHHHHHHHHHHHcCCCc
Confidence 999999999999999999988655443
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.35 E-value=2.5e-14 Score=107.90 Aligned_cols=103 Identities=14% Similarity=0.064 Sum_probs=75.5
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cccc--------------------cC-CCCCc
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVH--------------------GT-NLSGV 110 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~--------------------~~-~~~~~ 110 (189)
++...+..+..+.+.|+.++|..+++|+|+ |+ +++. |. ....+
T Consensus 117 ~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 196 (326)
T 1blx_A 117 VPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSY 196 (326)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccccccCCCCccccccccceeCHHHHhcCCC
Confidence 556677778888899999999999999996 54 2211 11 34568
Q ss_pred cc-e-EEEec------------CCCCChHHHHHHHHcCCCC--------------------------CCCCCCCHHHHHH
Q psy1684 111 VV-S-AVDFG------------SGGMTNAEVLHQVEHGYRM--------------------------PCPPGCPPRLYDI 150 (189)
Q Consensus 111 ~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~--------------------------~~p~~~p~~~~~l 150 (189)
+. + ||||| |.+.+..+.+..+...... ..+..+|.++.+|
T Consensus 197 ~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 276 (326)
T 1blx_A 197 ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDL 276 (326)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHH
T ss_pred CcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHH
Confidence 88 9 99999 6666665555554321100 1235688999999
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q psy1684 151 MLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 151 ~~~C~~~~p~~RP~~~~i~~ 170 (189)
+.+||+.||++|||+.++++
T Consensus 277 i~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 277 LLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp HHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHcCCCcccCCCHHHHhc
Confidence 99999999999999999985
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.35 E-value=1.7e-14 Score=108.82 Aligned_cols=104 Identities=13% Similarity=0.056 Sum_probs=75.9
Q ss_pred CcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------ccc---------------------ccC-C--
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLV---------------------HGT-N-- 106 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~---------------------~~~-~-- 106 (189)
.+....+..+..+.+.|+.++|..+++|+|+ |. +++ +|. .
T Consensus 125 ~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 204 (326)
T 2x7f_A 125 TLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACD 204 (326)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC-------------CCGGGCCHHHHC--
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecCcCccccccccCCccccChhhhccc
Confidence 3445556677788889999999999999986 44 111 111 1
Q ss_pred ---CCCccc-e-EEEec------------CCCCChHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy1684 107 ---LSGVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRM-PCPPGCPPRLYDIMLECWLKDPVKRPTFETL 168 (189)
Q Consensus 107 ---~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~-~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i 168 (189)
...++. + ||||| |.+.+..+....+..+..+ ..+..+|.++.+|+.+||..||++|||+.++
T Consensus 205 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 284 (326)
T 2x7f_A 205 ENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQL 284 (326)
T ss_dssp ------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred cccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHH
Confidence 355888 9 99999 6666666666666444333 3456789999999999999999999999999
Q ss_pred HH
Q psy1684 169 QW 170 (189)
Q Consensus 169 ~~ 170 (189)
++
T Consensus 285 l~ 286 (326)
T 2x7f_A 285 MK 286 (326)
T ss_dssp HT
T ss_pred hh
Confidence 87
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=2e-14 Score=113.80 Aligned_cols=104 Identities=13% Similarity=0.078 Sum_probs=72.6
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------ccccc--------------------C-CCCCc
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVHG--------------------T-NLSGV 110 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~~--------------------~-~~~~~ 110 (189)
+....+..+..+.+.|+.++|..+++|||+ |+ |+++. . ....|
T Consensus 161 l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 240 (464)
T 3ttj_A 161 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 240 (464)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----CCCC----CCCTTCCHHHHTTCCC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCcccCCCcccccccCHHHHcCCCC
Confidence 445566667788889999999999999996 55 22221 1 44568
Q ss_pred cc-e-EEEec------------CCCCChHHHHHHHHcCCCCCCC--------------------------CC--------
Q psy1684 111 VV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMPCP--------------------------PG-------- 142 (189)
Q Consensus 111 ~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~~p--------------------------~~-------- 142 (189)
+. + |||+| |.+.+..+.+..+.+....+.| ..
T Consensus 241 ~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (464)
T 3ttj_A 241 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPA 320 (464)
T ss_dssp CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCC
T ss_pred CHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCccccccc
Confidence 99 9 99999 7777765555554321111100 00
Q ss_pred -------CCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 143 -------CPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 143 -------~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
.++++.+|+.+|+..||++|||++|+++.
T Consensus 321 ~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 321 DSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp SSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 04578999999999999999999999874
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.34 E-value=1.2e-14 Score=109.57 Aligned_cols=109 Identities=14% Similarity=0.086 Sum_probs=76.3
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cccccc----cC-------------------------------------
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RIYLVH----GT------------------------------------- 105 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~~l~~----~~------------------------------------- 105 (189)
++...+..+..+.+.|+.++|..+++|+|+ |+.+.- +.
T Consensus 109 ~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 188 (319)
T 4euu_A 109 LPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE 188 (319)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCceeecccCCCccCHHHhh
Confidence 556777788888999999999999999996 552211 00
Q ss_pred -------CCCCccc-e-EEEec------------CCCC----ChHHHHHHHHcCCCC--------------------CCC
Q psy1684 106 -------NLSGVVV-S-AVDFG------------SGGM----TNAEVLHQVEHGYRM--------------------PCP 140 (189)
Q Consensus 106 -------~~~~~~~-s-VwsfG------------~~~~----~~~~~~~~v~~g~~~--------------------~~p 140 (189)
....++. + ||||| |.+. ...+++..+..+... +.+
T Consensus 189 ~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 268 (319)
T 4euu_A 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVS 268 (319)
T ss_dssp HHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTT
T ss_pred hccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcc
Confidence 0366888 9 99999 3322 234555555444321 111
Q ss_pred ----CCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q psy1684 141 ----PGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFF 176 (189)
Q Consensus 141 ----~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~ 176 (189)
..++..+.+|+.+||+.||++|||++|+++..++..
T Consensus 269 ~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 269 CSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp CSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred cccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 234457889999999999999999999999887543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=9.4e-15 Score=114.63 Aligned_cols=103 Identities=14% Similarity=0.029 Sum_probs=74.2
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc-----------------cc------------------cccC-CCCCc
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI-----------------YL------------------VHGT-NLSGV 110 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~-----------------~l------------------~~~~-~~~~~ 110 (189)
+....+..+..+++.|+.++|..+++|+|+ |+ |+ |+|. ....|
T Consensus 197 ~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~ 276 (429)
T 3kvw_A 197 FSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVILGARY 276 (429)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTCCCCSSCSCGGGCCHHHHHTBCC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecCCcccccCCCCCccChHHHhCCCC
Confidence 556777778889999999999999999996 55 11 1111 34458
Q ss_pred cc-e-EEEec------------CCCCChHHHHHHHHcCCCCC--------------------------------------
Q psy1684 111 VV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMP-------------------------------------- 138 (189)
Q Consensus 111 ~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~-------------------------------------- 138 (189)
+. + ||||| |.+.+..+.+..+.....++
T Consensus 277 ~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (429)
T 3kvw_A 277 GMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNG 356 (429)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECC
T ss_pred CchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccc
Confidence 89 9 99999 66666655554442211000
Q ss_pred --------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 139 --------------------CPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 139 --------------------~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
.+...++++.+|+.+||+.||++|||++|+++
T Consensus 357 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~ 408 (429)
T 3kvw_A 357 GRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALR 408 (429)
T ss_dssp EECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhC
Confidence 11234788999999999999999999999987
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.33 E-value=6e-14 Score=108.00 Aligned_cols=104 Identities=14% Similarity=-0.031 Sum_probs=75.0
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------c------------------ccccC-CC-CCcc
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------Y------------------LVHGT-NL-SGVV 111 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~------------------l~~~~-~~-~~~~ 111 (189)
++...+..+..+.+.|+.++|..+++|+|+ |+ | +|+|. .. ..++
T Consensus 141 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 220 (371)
T 4exu_A 141 FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYN 220 (371)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC--------CTTCCCTTSCHHHHSCCSCCC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccccCcCCcccCccccCHHHhcCCCCCC
Confidence 556667777888899999999999999996 55 1 12221 22 5688
Q ss_pred c-e-EEEec------------CCCCChHHHHHHHHc--CCC----------------------C------CCCCCCCHHH
Q psy1684 112 V-S-AVDFG------------SGGMTNAEVLHQVEH--GYR----------------------M------PCPPGCPPRL 147 (189)
Q Consensus 112 ~-s-VwsfG------------~~~~~~~~~~~~v~~--g~~----------------------~------~~p~~~p~~~ 147 (189)
. + |||+| |.+.+..+.+..+.. |.. . ..++.+++++
T Consensus 221 ~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (371)
T 4exu_A 221 QTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQA 300 (371)
T ss_dssp TTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHH
T ss_pred cHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHH
Confidence 8 9 99999 666665555544422 110 0 0124678999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 148 YDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 148 ~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
.+|+.+||+.||++|||++++++.
T Consensus 301 ~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 301 ADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHCCCChhhcCCHHHHhcC
Confidence 999999999999999999999864
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.32 E-value=3.2e-14 Score=108.91 Aligned_cols=143 Identities=16% Similarity=0.015 Sum_probs=93.1
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCC--CCcCHhHHHHHhhhccC
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGR--TTIHYPELVEHYSKDAD 82 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~--~~~~l~~li~~~~~~a~ 82 (189)
.+.|+|++++++.+...+..+||+|++ . +. +.. ++... ..++..++..+..+.+.
T Consensus 92 ~~~h~~iv~~~~~~~~~~~~~lv~e~~-~-~~----L~~-----------------~~~~~~~~~~~~~~~~~i~~qi~~ 148 (360)
T 3llt_A 92 DINNNNIVKYHGKFMYYDHMCLIFEPL-G-PS----LYE-----------------IITRNNYNGFHIEDIKLYCIEILK 148 (360)
T ss_dssp STTGGGBCCEEEEEEETTEEEEEECCC-C-CB----HHH-----------------HHHHTTTCCCCHHHHHHHHHHHHH
T ss_pred CCCCCCeecccceeeECCeeEEEEcCC-C-CC----HHH-----------------HHHhcCCCCCCHHHHHHHHHHHHH
Confidence 345777777776655555566777766 2 21 111 22211 23556777778888999
Q ss_pred CceeeccCCcccccc-cccccc---------------------------cC-----------------------------
Q psy1684 83 GLCVNLRKPCVQVSC-RIYLVH---------------------------GT----------------------------- 105 (189)
Q Consensus 83 gl~~~~~~~~~~~~~-p~~l~~---------------------------~~----------------------------- 105 (189)
|+.++|..+++|+|+ |+.+.- ..
T Consensus 149 aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aP 228 (360)
T 3llt_A 149 ALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAP 228 (360)
T ss_dssp HHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCH
T ss_pred HHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCCCcCccCcccccCc
Confidence 999999999999996 552211 11
Q ss_pred ---CCCCccc-e-EEEec------------CCCCChHHHHHHHHcCCCCC-------------------------CCC--
Q psy1684 106 ---NLSGVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMP-------------------------CPP-- 141 (189)
Q Consensus 106 ---~~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~-------------------------~p~-- 141 (189)
....++. + |||+| |.+.+..+.+..+.....+. .|.
T Consensus 229 E~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 308 (360)
T 3llt_A 229 EVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENA 308 (360)
T ss_dssp HHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTC
T ss_pred HHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccc
Confidence 4556889 9 99999 66666656555543321111 111
Q ss_pred ------------------CCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 142 ------------------GCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 142 ------------------~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
..++++.+|+.+||+.||++|||++|+++
T Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 309 SSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp SCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 12367889999999999999999999875
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.31 E-value=3.4e-14 Score=108.79 Aligned_cols=105 Identities=15% Similarity=0.041 Sum_probs=75.0
Q ss_pred CCcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------ccccc----------------------C-C
Q psy1684 66 TTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVHG----------------------T-N 106 (189)
Q Consensus 66 ~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~~----------------------~-~ 106 (189)
..+....+..+..+++.|+.++|..+++|+|+ |+ |++.. . .
T Consensus 154 ~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~ 233 (355)
T 1vzo_A 154 ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 233 (355)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHT
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhc
Confidence 34556667777788899999999999999996 55 22221 1 1
Q ss_pred --CCCccc-e-EEEec------------CCC----CChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCC---
Q psy1684 107 --LSGVVV-S-AVDFG------------SGG----MTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRP--- 163 (189)
Q Consensus 107 --~~~~~~-s-VwsfG------------~~~----~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP--- 163 (189)
...++. + ||||| |.. ....++...+..+ .++.|..++..+.+|+.+||..||++||
T Consensus 234 ~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~ 312 (355)
T 1vzo_A 234 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-EPPYPQEMSALAKDLIQRLLMKDPKKRLGCG 312 (355)
T ss_dssp TCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSS
T ss_pred CCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc-CCCCCcccCHHHHHHHHHHhhhCHHHhcCCC
Confidence 234778 9 99999 322 1234455444443 4567888999999999999999999999
Q ss_pred --CHHHHHHH
Q psy1684 164 --TFETLQWK 171 (189)
Q Consensus 164 --~~~~i~~~ 171 (189)
+++++++.
T Consensus 313 ~~s~~ell~h 322 (355)
T 1vzo_A 313 PRDADEIKEH 322 (355)
T ss_dssp TTTHHHHHTS
T ss_pred CCCHHHHHcC
Confidence 88988764
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.31 E-value=5e-13 Score=102.08 Aligned_cols=104 Identities=16% Similarity=0.001 Sum_probs=74.7
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cc------------------cccC-CC-CCcc
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YL------------------VHGT-NL-SGVV 111 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l------------------~~~~-~~-~~~~ 111 (189)
++...+..+..+.+.|+.++|..+++|+|+ |+ |+ ++|. .. ..++
T Consensus 123 ~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 202 (353)
T 3coi_A 123 FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYN 202 (353)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC--------CCSBCCSCHHHHSCCSCCC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCCccccccCcCcCCHHHHhCcCCCC
Confidence 556777778888899999999999999996 55 11 1111 22 4688
Q ss_pred c-e-EEEec------------CCCCChHHHHHHHHc--C-------------------------CC---CCCCCCCCHHH
Q psy1684 112 V-S-AVDFG------------SGGMTNAEVLHQVEH--G-------------------------YR---MPCPPGCPPRL 147 (189)
Q Consensus 112 ~-s-VwsfG------------~~~~~~~~~~~~v~~--g-------------------------~~---~~~p~~~p~~~ 147 (189)
. + |||+| |.+.+..+.+..+.+ | .+ ...++.+++++
T Consensus 203 ~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (353)
T 3coi_A 203 QTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQA 282 (353)
T ss_dssp TTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHH
T ss_pred chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHH
Confidence 8 9 99999 666555544444321 1 01 11234688999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 148 YDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 148 ~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
.+|+.+||+.||++|||++++++.
T Consensus 283 ~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 283 ADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHcCCCcccCCCHHHHhcC
Confidence 999999999999999999999863
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.30 E-value=4.9e-14 Score=108.50 Aligned_cols=104 Identities=13% Similarity=0.061 Sum_probs=73.9
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------ccc--------------------ccC-CCCCc
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLV--------------------HGT-NLSGV 110 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~--------------------~~~-~~~~~ 110 (189)
+....+..+..+.+.|+.++|..+++|+|+ |+ |++ +|. ....|
T Consensus 124 ~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 203 (371)
T 2xrw_A 124 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 203 (371)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC----------------CTTCCHHHHTTCCC
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccccccccCCceecCCccCHHHhcCCCC
Confidence 445666677788889999999999999996 55 222 111 34568
Q ss_pred cc-e-EEEec------------CCCCChHHHHHHHHcCCCCCCC-----------------------------------C
Q psy1684 111 VV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMPCP-----------------------------------P 141 (189)
Q Consensus 111 ~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~~p-----------------------------------~ 141 (189)
+. + |||+| |.+.+..+.+..+.+....+.| .
T Consensus 204 ~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (371)
T 2xrw_A 204 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPA 283 (371)
T ss_dssp CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCC
T ss_pred CchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcc
Confidence 89 9 99999 7777766666665443222211 0
Q ss_pred ------CCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 142 ------GCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 142 ------~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
..+.++.+|+.+||..||++|||++++++.
T Consensus 284 ~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 284 DSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp SSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred cccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 014678999999999999999999999874
|
| >2shp_A SHP-2, SYP, SHPTP-2; tyrosine phosphatase, insulin signaling, SH2 protein; HET: CAT; 2.00A {Homo sapiens} SCOP: c.45.1.2 d.93.1.1 d.93.1.1 | Back alignment and structure |
|---|
Probab=99.30 E-value=1.2e-11 Score=99.33 Aligned_cols=91 Identities=31% Similarity=0.477 Sum_probs=76.1
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCC----------eeeEEEEEeccCC-ccCCCCCcC
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSF----------CLKMTTGRSLFET-QKAGRTTIH 69 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~----------~v~h~~i~~~~~g-yl~~~~~~~ 69 (189)
||||.+++.+|+++|.... .+|+||||+|.+.+|.|+||++. .+ .++|++|....++ ++.....|.
T Consensus 112 w~~g~~~r~~Ae~lL~~~~-~~G~FLVR~S~~~~g~y~LSv~~--~~~~~~~~~~~~~v~H~~I~~~~g~~~l~~~~~F~ 188 (525)
T 2shp_A 112 WFHGHLSGKEAEKLLTEKG-KHGSFLVRESQSHPGDFVLSVRT--GDDKGESNDGKSKVTHVMIRCQELKYDVGGGERFD 188 (525)
T ss_dssp TBCCSCCHHHHHHHHHHTC-CTTEEEEEECSSSTTCEEEEEEE--CC-----CCCCCEEEEEEEEEETTEEESSSSCCBS
T ss_pred eecccCCHHHHHHHHhccC-CCceEEEEecCCCCCCEEEEEEE--CCccccccccccceEEEEEEecCCeEEECCCceeC
Confidence 9999999999999996443 67999999999888999999999 66 8999999887555 677677888
Q ss_pred -HhHHHHHhhhcc----CCceeeccCCccc
Q psy1684 70 -YPELVEHYSKDA----DGLCVNLRKPCVQ 94 (189)
Q Consensus 70 -l~~li~~~~~~a----~gl~~~~~~~~~~ 94 (189)
+.+|++||.... .|+...+..|+..
T Consensus 189 sL~eLV~~y~~~~l~~~~g~~~~L~~P~~~ 218 (525)
T 2shp_A 189 SLTDLVEHYKKNPMVETLGTVLQLKQPLNT 218 (525)
T ss_dssp SHHHHHHHHHHSCCBCTTSCBCCCCEECCC
T ss_pred cHHHHHHhhhccCccccCCeEEEeeccccc
Confidence 999999998875 4666667766544
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.28 E-value=1.4e-13 Score=110.82 Aligned_cols=137 Identities=15% Similarity=0.030 Sum_probs=92.9
Q ss_pred CChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC----CCCcCHhHHHHHhhhcc
Q psy1684 6 IKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG----RTTIHYPELVEHYSKDA 81 (189)
Q Consensus 6 l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~----~~~~~l~~li~~~~~~a 81 (189)
+.|+|+++++.........|||+|++.+ |++ .. ++.. ...+.......+..+++
T Consensus 242 l~hp~Iv~l~~~~~~~~~l~lVmE~~~g-g~L----~~-----------------~l~~~~~~~~~l~e~~~~~~~~qi~ 299 (543)
T 3c4z_A 242 VHSRFIVSLAYAFETKTDLCLVMTIMNG-GDI----RY-----------------HIYNVDEDNPGFQEPRAIFYTAQIV 299 (543)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCTT-CBH----HH-----------------HHHTSSTTSCSCCHHHHHHHHHHHH
T ss_pred cCCCCEeeEEEEEeeCCEEEEEEEeccC-CCH----HH-----------------HHHHhhcccccccHHHHHHHHHHHH
Confidence 4566666655554444556666666655 211 11 1211 22355666677788889
Q ss_pred CCceeeccCCcccccc-cc---------------ccccc---------------------C-CCCCccc-e-EEEec---
Q psy1684 82 DGLCVNLRKPCVQVSC-RI---------------YLVHG---------------------T-NLSGVVV-S-AVDFG--- 118 (189)
Q Consensus 82 ~gl~~~~~~~~~~~~~-p~---------------~l~~~---------------------~-~~~~~~~-s-VwsfG--- 118 (189)
.|+.++|..+++|||+ |+ |++.. . ....|+. + |||+|
T Consensus 300 ~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvil 379 (543)
T 3c4z_A 300 SGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTL 379 (543)
T ss_dssp HHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHH
T ss_pred HHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHH
Confidence 9999999999999996 55 22221 1 3456899 9 99999
Q ss_pred ---------CCCC----ChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH
Q psy1684 119 ---------SGGM----TNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTF 165 (189)
Q Consensus 119 ---------~~~~----~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~ 165 (189)
|.+. ...++...+..+ ....|..+++++.+|+.+||+.||++||++
T Consensus 380 yelltG~~PF~~~~~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 380 YEMIAARGPFRARGEKVENKELKQRVLEQ-AVTYPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp HHHHHSSCSSCCTTCCCCHHHHHHHHHHC-CCCCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred HHHHhCCCCCCCCccchhHHHHHHHHhhc-ccCCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 4443 345666666554 355678999999999999999999999976
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.28 E-value=1.4e-13 Score=103.32 Aligned_cols=105 Identities=12% Similarity=-0.002 Sum_probs=75.3
Q ss_pred CcCHhHHHHHhhhccCCceeeccCCcccccc-cc----------------cccccC------------------------
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI----------------YLVHGT------------------------ 105 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~----------------~l~~~~------------------------ 105 (189)
.+....+..+..+.+.|+.++|..+++|+|+ |+ +++...
T Consensus 116 ~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 195 (320)
T 2i6l_A 116 PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRL 195 (320)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHH
T ss_pred CccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHH
Confidence 4556666777888899999999999999996 55 211110
Q ss_pred --CCCCccc-e-EEEec------------CCCCChHHHHHHHHcCCC------------------------CC-----CC
Q psy1684 106 --NLSGVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYR------------------------MP-----CP 140 (189)
Q Consensus 106 --~~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~------------------------~~-----~p 140 (189)
....++. + ||||| |.+.+..+.+..+..+.. +. .+
T Consensus 196 ~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (320)
T 2i6l_A 196 LLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLL 275 (320)
T ss_dssp HHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHS
T ss_pred hcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhc
Confidence 2256888 9 99999 666665555544432211 11 12
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 141 PGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 141 ~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
+.+|.++.+|+.+||+.||++|||++++++.
T Consensus 276 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 276 PGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp TTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred chhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 4689999999999999999999999999863
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=8.8e-14 Score=112.42 Aligned_cols=142 Identities=13% Similarity=-0.030 Sum_probs=96.6
Q ss_pred CChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC--CCCcCHhHHHHHhhhccCC
Q psy1684 6 IKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG--RTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 6 l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~--~~~~~l~~li~~~~~~a~g 83 (189)
++|+|++++++.....+..|||+|++.+ |++ .. ++.. ...+.......+..+++.|
T Consensus 241 l~hp~Iv~l~~~~~~~~~l~lVmEy~~g-g~L----~~-----------------~l~~~~~~~l~e~~~~~i~~qIl~a 298 (576)
T 2acx_A 241 VNSRFVVSLAYAYETKDALCLVLTLMNG-GDL----KF-----------------HIYHMGQAGFPEARAVFYAAEICCG 298 (576)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCCS-CBH----HH-----------------HHHSSSSCCCCHHHHHHHHHHHHHH
T ss_pred cCCCCEeeEEEEEeeCCEEEEEEEcCCC-CcH----HH-----------------HHHhcCCCCCCHHHHHHHHHHHHHH
Confidence 4566666666555555556667766655 211 11 2221 1235566677778888999
Q ss_pred ceeeccCCcccccc-cc---------------cccc--------------------cC-CCCCccc-e-EEEec------
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YLVH--------------------GT-NLSGVVV-S-AVDFG------ 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l~~--------------------~~-~~~~~~~-s-VwsfG------ 118 (189)
+.++|..+++|||+ |+ |++. |. ....|+. + |||+|
T Consensus 299 L~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeL 378 (576)
T 2acx_A 299 LEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEM 378 (576)
T ss_dssp HHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHH
T ss_pred HHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHH
Confidence 99999999999996 55 2222 11 3456889 9 99999
Q ss_pred ------CCCC----ChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q psy1684 119 ------SGGM----TNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRP-----TFETLQW 170 (189)
Q Consensus 119 ------~~~~----~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP-----~~~~i~~ 170 (189)
|.+. ...++...+... ....|..+++++.+|+.+||+.||++|| +++||++
T Consensus 379 ltG~~PF~~~~~~~~~~~i~~~i~~~-~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 379 IAGQSPFQQRKKKIKREEVERLVKEV-PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp HHSSCSSSCSSSCCCHHHHHHHHHHC-CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred HhCCCCCcccccchhHHHHHHHhhcc-cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 4443 234555555544 3556788999999999999999999999 6788875
|
| >2b3o_A Tyrosine-protein phosphatase, non-receptor type 6; protein tyrosine phosphatase, SHP-1, signaling, hydrolase; 2.80A {Homo sapiens} PDB: 1x6c_A 2rmx_A* 2yu7_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=9.3e-12 Score=100.07 Aligned_cols=91 Identities=30% Similarity=0.404 Sum_probs=75.5
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCC---------eeeEEEEEeccCC-ccCCCCCcC-
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSF---------CLKMTTGRSLFET-QKAGRTTIH- 69 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~---------~v~h~~i~~~~~g-yl~~~~~~~- 69 (189)
||||.|++.+|+++|.... .+|+||||++.+.+|.|+||++. .+ .++|++|....++ ++.....|.
T Consensus 110 w~~g~i~r~~Ae~lL~~~~-~~G~FLVR~S~~~~g~y~Lsv~~--~~~~~~~~~~~~v~h~~I~~~~g~~~l~~~~~F~s 186 (532)
T 2b3o_A 110 WYHGHMSGGQAETLLQAKG-EPWTFLVRESLSQPGDFVLSVLS--DQPKAGPGSPLRVTHIKVMCEGGRYTVGGLETFDS 186 (532)
T ss_dssp TBCTTCCHHHHHHHHHHHC-CTTEEEEEECSSSTTCEEEEEEE--EEEC----CCEEEEEEEEBCCTTSBBSSSSCCBSS
T ss_pred ccccccchHHHHHHHhcCC-CCceEEEecCCCCCCceEEEEEe--cCccccccCCCceEEEEEEEcCCceeeCCCcccCc
Confidence 9999999999999986433 56999999999888999999998 66 8999999887555 676677888
Q ss_pred HhHHHHHhhhc----cCCceeeccCCccc
Q psy1684 70 YPELVEHYSKD----ADGLCVNLRKPCVQ 94 (189)
Q Consensus 70 l~~li~~~~~~----a~gl~~~~~~~~~~ 94 (189)
+.+|++||... ..|+...+..|+..
T Consensus 187 l~eLV~~y~~~~l~~~~g~~~~L~~P~~~ 215 (532)
T 2b3o_A 187 LTDLVEHFKKTGIEEASGAFVYLRQPYYA 215 (532)
T ss_dssp HHHHHHHHHHHCEECSSSCEECCCEECCC
T ss_pred HHHHHhhccccCccccCCeeEeccccccc
Confidence 99999999876 46777777766643
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=3e-14 Score=108.29 Aligned_cols=104 Identities=12% Similarity=0.023 Sum_probs=67.5
Q ss_pred CcCHhHHHHHhhhccCCceeeccCCcccccc-cccc-------------------------------------cccC-CC
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RIYL-------------------------------------VHGT-NL 107 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~~l-------------------------------------~~~~-~~ 107 (189)
.++..++..+..+.+.|+.++|..+++|+|+ |+.+ ++|. ..
T Consensus 124 ~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~ 203 (336)
T 3fhr_A 124 AFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGP 203 (336)
T ss_dssp CCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC----------------------
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceeccccccccCCCCcCccChhhhCC
Confidence 4557777888889999999999999999996 5511 1111 24
Q ss_pred CCccc-e-EEEec------------CCCCChHHH----HHHHHcC-CC--CCCCCCCCHHHHHHHHHhcccCCCCCCCHH
Q psy1684 108 SGVVV-S-AVDFG------------SGGMTNAEV----LHQVEHG-YR--MPCPPGCPPRLYDIMLECWLKDPVKRPTFE 166 (189)
Q Consensus 108 ~~~~~-s-VwsfG------------~~~~~~~~~----~~~v~~g-~~--~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~ 166 (189)
..++. + ||||| |.+.+...+ ...+..+ .. .+....+++++.+|+.+||+.||++|||+.
T Consensus 204 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 283 (336)
T 3fhr_A 204 EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTIT 283 (336)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHH
Confidence 45788 8 99999 333332222 2222222 11 222357899999999999999999999999
Q ss_pred HHHH
Q psy1684 167 TLQW 170 (189)
Q Consensus 167 ~i~~ 170 (189)
++++
T Consensus 284 ell~ 287 (336)
T 3fhr_A 284 QFMN 287 (336)
T ss_dssp HHHH
T ss_pred HHhc
Confidence 9997
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.27 E-value=3.8e-14 Score=110.02 Aligned_cols=106 Identities=12% Similarity=0.002 Sum_probs=75.3
Q ss_pred CCcCHhHHHHHhhhccCCceeeccCCcccccc-cc----------------cccc--------------------cC-CC
Q psy1684 66 TTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI----------------YLVH--------------------GT-NL 107 (189)
Q Consensus 66 ~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~----------------~l~~--------------------~~-~~ 107 (189)
..++...+..+..+.+.|+.++|..+++|+|+ |+ |+++ |. ..
T Consensus 136 ~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~ 215 (394)
T 4e7w_A 136 QTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFG 215 (394)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTT
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcC
Confidence 34555666677788899999999999999996 55 2221 11 22
Q ss_pred -CCccc-e-EEEec------------CCCCChHHHHHHHHc--CC----------------CC----------CCCCCCC
Q psy1684 108 -SGVVV-S-AVDFG------------SGGMTNAEVLHQVEH--GY----------------RM----------PCPPGCP 144 (189)
Q Consensus 108 -~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~--g~----------------~~----------~~p~~~p 144 (189)
..|+. + |||+| |.+.+..+.+..+.+ |. .. ..+..++
T Consensus 216 ~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (394)
T 4e7w_A 216 ATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTP 295 (394)
T ss_dssp CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCC
T ss_pred CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCC
Confidence 34888 9 99999 777665554444322 10 00 0234588
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 145 PRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 145 ~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
+++.+|+.+||+.||++|||+.++++.
T Consensus 296 ~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 296 PDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 999999999999999999999999863
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.27 E-value=9.9e-14 Score=104.12 Aligned_cols=105 Identities=10% Similarity=0.167 Sum_probs=72.1
Q ss_pred ccCCCCCcCHhHHHHHhhhccCCceeeccCCcccccc-ccccccc---C-------------------------------
Q psy1684 61 QKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RIYLVHG---T------------------------------- 105 (189)
Q Consensus 61 yl~~~~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~~l~~~---~------------------------------- 105 (189)
++.....+....+..+..+.+.|+.++|..+++|+|+ |+.+.-. .
T Consensus 129 ~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE 208 (312)
T 2iwi_A 129 YITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPE 208 (312)
T ss_dssp HHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEECCSSCBCCCCSCTTTSCHH
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhhcccCcccccCCcccccCce
Confidence 3333334556667778888899999999999999996 5411111 0
Q ss_pred --CCCCc-cc-e-EEEec------CCCC----ChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 106 --NLSGV-VV-S-AVDFG------SGGM----TNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 106 --~~~~~-~~-s-VwsfG------~~~~----~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
....+ +. + |||+| +.+. ...++ ..+ ....|..++.++.+|+.+||+.||++|||+.++++
T Consensus 209 ~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 209 WISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI----LEA-ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp HHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH----HHT-CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred eeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHH----hhh-ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 12233 55 8 99999 1111 12222 222 34567889999999999999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.27 E-value=6.6e-14 Score=104.30 Aligned_cols=103 Identities=15% Similarity=0.058 Sum_probs=72.4
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------ccccc---------------------------
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVHG--------------------------- 104 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~~--------------------------- 104 (189)
+...++..+..+.+.|+.++|..+++|+|+ |+ +++..
T Consensus 113 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (303)
T 1zy4_A 113 QQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIG 192 (303)
T ss_dssp GCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC------------------------
T ss_pred cchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCC
Confidence 335666777788899999999999999986 54 22211
Q ss_pred --------C-C-CCCccc-e-EEEec-------CC---CCChHHHHHHHHcCC---CCCCCCCCCHHHHHHHHHhcccCC
Q psy1684 105 --------T-N-LSGVVV-S-AVDFG-------SG---GMTNAEVLHQVEHGY---RMPCPPGCPPRLYDIMLECWLKDP 159 (189)
Q Consensus 105 --------~-~-~~~~~~-s-VwsfG-------~~---~~~~~~~~~~v~~g~---~~~~p~~~p~~~~~l~~~C~~~~p 159 (189)
. . .+.++. + ||||| .+ +.+..++...+..+. ....+..+|..+.+|+.+||+.||
T Consensus 193 ~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp 272 (303)
T 1zy4_A 193 TAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDP 272 (303)
T ss_dssp -CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSG
T ss_pred cccccCcccccCCCCCcchhhHHHHHHHHHHHHhccCCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCc
Confidence 0 1 235888 9 99999 21 222344555554432 222445678889999999999999
Q ss_pred CCCCCHHHHHH
Q psy1684 160 VKRPTFETLQW 170 (189)
Q Consensus 160 ~~RP~~~~i~~ 170 (189)
++|||+.++++
T Consensus 273 ~~Rps~~~ll~ 283 (303)
T 1zy4_A 273 NKRPGARTLLN 283 (303)
T ss_dssp GGSCCHHHHHH
T ss_pred ccCcCHHHHhC
Confidence 99999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.27 E-value=2.2e-13 Score=104.30 Aligned_cols=105 Identities=17% Similarity=0.093 Sum_probs=75.3
Q ss_pred CcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cc--------------------cccC-CC-C
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YL--------------------VHGT-NL-S 108 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l--------------------~~~~-~~-~ 108 (189)
.++...+..+..+.+.|+.++|..+++|+|+ |+ ++ ++|. .. .
T Consensus 130 ~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 209 (362)
T 3pg1_A 130 VISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFK 209 (362)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTTC---------------CGGGCCHHHHTTCT
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecCcccccccccccceecccceecCcHHhcCCC
Confidence 4556777788889999999999999999996 55 22 2221 22 5
Q ss_pred Cccc-e-EEEec------------CCCCChHHHHHHHHc--CC----------------------C-C------CCCCCC
Q psy1684 109 GVVV-S-AVDFG------------SGGMTNAEVLHQVEH--GY----------------------R-M------PCPPGC 143 (189)
Q Consensus 109 ~~~~-s-VwsfG------------~~~~~~~~~~~~v~~--g~----------------------~-~------~~p~~~ 143 (189)
.++. + |||+| |.+.+..+.+..+.. |. . . ..++.+
T Consensus 210 ~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (362)
T 3pg1_A 210 GFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTA 289 (362)
T ss_dssp TCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTS
T ss_pred CCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCC
Confidence 6888 9 99999 666555555444421 10 0 0 012467
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 144 PPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 144 p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
++++.+|+.+||+.||++|||+.++++.
T Consensus 290 ~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 290 DPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 8899999999999999999999999863
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.26 E-value=2.6e-13 Score=104.33 Aligned_cols=105 Identities=11% Similarity=0.012 Sum_probs=74.6
Q ss_pred CcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------ccc------------------ccC--CCCCc
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLV------------------HGT--NLSGV 110 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~------------------~~~--~~~~~ 110 (189)
.++...+..+..+.+.|+.++|..+++|+|+ |+ |++ +|. ....+
T Consensus 124 ~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 203 (367)
T 1cm8_A 124 KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRY 203 (367)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSSCCSSCSCGGGCCTHHHHTTTCC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccccccCcCcCCCCcCCHHHHhCCCCC
Confidence 3445556667778889999999999999996 55 222 221 22568
Q ss_pred cc-e-EEEec------------CCCCChHHHHHHHHc--CCC----------------------------CCCCCCCCHH
Q psy1684 111 VV-S-AVDFG------------SGGMTNAEVLHQVEH--GYR----------------------------MPCPPGCPPR 146 (189)
Q Consensus 111 ~~-s-VwsfG------------~~~~~~~~~~~~v~~--g~~----------------------------~~~p~~~p~~ 146 (189)
+. + |||+| |.+.+..+.+..+.+ |.. ...++.++++
T Consensus 204 ~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (367)
T 1cm8_A 204 TQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPL 283 (367)
T ss_dssp CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHH
T ss_pred ChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHH
Confidence 88 9 99999 666665554444321 110 0123467899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 147 LYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 147 ~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
+.+|+.+|+..||++|||+.++++.
T Consensus 284 ~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 284 AVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHccCChhHCCCHHHHhcC
Confidence 9999999999999999999999873
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=99.26 E-value=1.7e-11 Score=96.95 Aligned_cols=68 Identities=21% Similarity=0.226 Sum_probs=59.0
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC-ccCCCCCcC-HhHHHH
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET-QKAGRTTIH-YPELVE 75 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g-yl~~~~~~~-l~~li~ 75 (189)
||||.|+|.+|+++|. ..+|+||||+|.+.+|.|+||++. .+.++||+|.. +++ |+. ...|. +.+|++
T Consensus 53 w~hg~i~r~~ae~lL~---~~~G~FLvR~S~~~~g~~~Lsv~~--~~~v~H~~I~~-~g~~~~~-~~~F~sl~~Lv~ 122 (463)
T 3cxl_A 53 EFHGMISREAADQLLI---VAEGSYLIRESQRQPGTYTLALRF--GSQTRNFRLYY-DGKHFVG-EKRFESIHDLVT 122 (463)
T ss_dssp TBCCSCCHHHHHHHHT---TSTTEEEEEECSSSTTCEEEEEEC--SSSEEEEECEE-SSSEESS-SCCBSCHHHHHH
T ss_pred ccccCCCHHHHHHHHc---CCCCeEEEeccCCCCCCEEEEEEE--CCEEEEEEEec-CCeEEEC-CCccCCHHHHHH
Confidence 6799999999999994 257999999999998999999999 99999999987 333 554 57888 999998
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.26 E-value=1.3e-13 Score=107.54 Aligned_cols=143 Identities=6% Similarity=-0.094 Sum_probs=98.9
Q ss_pred CChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCce
Q psy1684 6 IKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGLC 85 (189)
Q Consensus 6 l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl~ 85 (189)
+.|+|++++++.+......|||+|++++ |+ +.. ++. ...+.......+..+++.|+.
T Consensus 126 l~hp~Iv~l~~~~~~~~~~~lV~E~~~g-g~----L~~-----------------~l~-~~~~~e~~~~~~~~qi~~aL~ 182 (410)
T 3v8s_A 126 ANSPWVVQLFYAFQDDRYLYMVMEYMPG-GD----LVN-----------------LMS-NYDVPEKWARFYTAEVVLALD 182 (410)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCTT-EE----HHH-----------------HHH-HCCCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCeEEEEEEECCEEEEEEeCCCC-Cc----HHH-----------------HHH-cCCCCHHHHHHHHHHHHHHHH
Confidence 5677777777666655666777777765 31 111 222 123445555666778888999
Q ss_pred eeccCCcccccc-cc---------------ccccc----------------------C-CC----CCccc-e-EEEec--
Q psy1684 86 VNLRKPCVQVSC-RI---------------YLVHG----------------------T-NL----SGVVV-S-AVDFG-- 118 (189)
Q Consensus 86 ~~~~~~~~~~~~-p~---------------~l~~~----------------------~-~~----~~~~~-s-VwsfG-- 118 (189)
++|..+++|||+ |+ |+++. . .. ..|+. + |||||
T Consensus 183 ~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvi 262 (410)
T 3v8s_A 183 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 262 (410)
T ss_dssp HHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHH
T ss_pred HHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHH
Confidence 999999999996 55 33221 1 11 12788 9 99999
Q ss_pred ----------CCCCChHHHHHHHHcC---CCCCCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q psy1684 119 ----------SGGMTNAEVLHQVEHG---YRMPCPPGCPPRLYDIMLECWLKDPVK--RPTFETLQWK 171 (189)
Q Consensus 119 ----------~~~~~~~~~~~~v~~g---~~~~~p~~~p~~~~~l~~~C~~~~p~~--RP~~~~i~~~ 171 (189)
|.+.+..++...+..+ ...|.+..+++++.+|+.+|+..+|.+ ||+++||++.
T Consensus 263 lyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 263 LYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred HHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 6677777777777543 234444579999999999999988888 9999999864
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.26 E-value=4.7e-13 Score=102.98 Aligned_cols=105 Identities=13% Similarity=-0.022 Sum_probs=74.4
Q ss_pred CcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cc------------------cccC-CC-CCc
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YL------------------VHGT-NL-SGV 110 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l------------------~~~~-~~-~~~ 110 (189)
.++...+..+..+.+.|+.++|..+++|+|+ |+ |+ |+|. .. ..+
T Consensus 128 ~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 207 (367)
T 2fst_X 128 KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHY 207 (367)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---------------CCCTTCCHHHHTTCCSC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccccCCCcCcCcCccChHHHcCCcCC
Confidence 3556666777788899999999999999996 55 22 2221 22 568
Q ss_pred cc-e-EEEec------------CCCCChHHHHHHHHc--CCC-----------------------CC-----CCCCCCHH
Q psy1684 111 VV-S-AVDFG------------SGGMTNAEVLHQVEH--GYR-----------------------MP-----CPPGCPPR 146 (189)
Q Consensus 111 ~~-s-VwsfG------------~~~~~~~~~~~~v~~--g~~-----------------------~~-----~p~~~p~~ 146 (189)
+. + |||+| |++.+..+.+..+.+ |.. +. ....++++
T Consensus 208 ~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (367)
T 2fst_X 208 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPL 287 (367)
T ss_dssp CTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHH
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHH
Confidence 88 9 99999 777666554444422 110 00 01357889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 147 LYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 147 ~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
+.+|+.+||..||++|||+.++++.
T Consensus 288 ~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 288 AVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHhCCCCcccCcCHHHHhcC
Confidence 9999999999999999999999864
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.25 E-value=7.1e-14 Score=108.14 Aligned_cols=30 Identities=17% Similarity=0.192 Sum_probs=28.2
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 142 GCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 142 ~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
.+++++.+|+.+||..||++|||++|+++.
T Consensus 300 ~~~~~~~dll~~~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 300 DCNEEALDLLDKLLQFNPNKRISANDALKH 329 (388)
T ss_dssp CCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred cCCHHHHHHHHHhhccCcccCCCHHHHhCC
Confidence 788999999999999999999999999875
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.25 E-value=2.6e-13 Score=103.42 Aligned_cols=104 Identities=14% Similarity=0.052 Sum_probs=73.0
Q ss_pred CcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------ccc----------------------------
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLV---------------------------- 102 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~---------------------------- 102 (189)
.++...+..+..+.+.|+.++|..+++|+|+ |+ |++
T Consensus 108 ~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 187 (353)
T 2b9h_A 108 MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRW 187 (353)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGG
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhcccccc
Confidence 3456667777888889999999999999986 44 222
Q ss_pred ---ccC--CCCCccc-e-EEEec------------CCCCChHHHHHHHHc--CCC-----------------------CC
Q psy1684 103 ---HGT--NLSGVVV-S-AVDFG------------SGGMTNAEVLHQVEH--GYR-----------------------MP 138 (189)
Q Consensus 103 ---~~~--~~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~--g~~-----------------------~~ 138 (189)
+|. ....++. + ||||| |.+.+..+.+..+.. |.. .+
T Consensus 188 y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (353)
T 2b9h_A 188 YRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYP 267 (353)
T ss_dssp GCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCC
T ss_pred ccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCC
Confidence 111 2356888 9 99999 666654443333211 100 00
Q ss_pred ------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 139 ------CPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 139 ------~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
.++.+|+++.+|+.+||+.||++|||++++++
T Consensus 268 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 268 AAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 12468899999999999999999999999987
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.25 E-value=2.5e-13 Score=103.66 Aligned_cols=106 Identities=14% Similarity=0.054 Sum_probs=75.4
Q ss_pred CCcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cccc-------------------------c
Q psy1684 66 TTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVH-------------------------G 104 (189)
Q Consensus 66 ~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~-------------------------~ 104 (189)
..++..++..+..+.+.|+.++|..+++|+|+ |+ |++. |
T Consensus 119 ~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE 198 (351)
T 3mi9_A 119 VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 198 (351)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCch
Confidence 34567777888889999999999999999996 55 2221 1
Q ss_pred C-C-CCCccc-e-EEEec------------CCCCChHHHHHHHHcCCCCCCCC---C-----------------------
Q psy1684 105 T-N-LSGVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMPCPP---G----------------------- 142 (189)
Q Consensus 105 ~-~-~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~~p~---~----------------------- 142 (189)
. . ...++. + ||||| |.+.+..+....+........+. .
T Consensus 199 ~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (351)
T 3mi9_A 199 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDR 278 (351)
T ss_dssp HHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHH
T ss_pred hhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHH
Confidence 1 1 244788 9 99999 66666666655553321111111 1
Q ss_pred -----CCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 143 -----CPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 143 -----~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
.++++.+|+.+||+.||++|||++|+++.
T Consensus 279 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 279 LKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp HHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 26779999999999999999999999873
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=1.1e-13 Score=108.72 Aligned_cols=144 Identities=7% Similarity=-0.090 Sum_probs=99.8
Q ss_pred CChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC-CCCcCHhHHHHHhhhccCCc
Q psy1684 6 IKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG-RTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 6 l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~-~~~~~l~~li~~~~~~a~gl 84 (189)
+.|+|++++++.+......|||+|++.++. +.. ++.. ...++......+..+.+.|+
T Consensus 131 ~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~-----L~~-----------------~l~~~~~~l~e~~~~~~~~qi~~aL 188 (437)
T 4aw2_A 131 GDSKWITTLHYAFQDDNNLYLVMDYYVGGD-----LLT-----------------LLSKFEDRLPEEMARFYLAEMVIAI 188 (437)
T ss_dssp SCTTTBCCEEEEEECSSEEEEEECCCTTCB-----HHH-----------------HHHTTTTCCCHHHHHHHHHHHHHHH
T ss_pred CCCCCEEEEEEEEeeCCEEEEEEecCCCCc-----HHH-----------------HHHHccCCCCHHHHHHHHHHHHHHH
Confidence 456777776666655566677777776522 111 3332 23455666667778888999
Q ss_pred eeeccCCcccccc-cc---------------cccccC-----------------------C-----CCCccc-e-EEEec
Q psy1684 85 CVNLRKPCVQVSC-RI---------------YLVHGT-----------------------N-----LSGVVV-S-AVDFG 118 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~---------------~l~~~~-----------------------~-----~~~~~~-s-VwsfG 118 (189)
.++|..+++|||+ |+ |+++.. . .+.|+. + |||||
T Consensus 189 ~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlG 268 (437)
T 4aw2_A 189 DSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLG 268 (437)
T ss_dssp HHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHH
T ss_pred HHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHH
Confidence 9999999999996 55 333211 1 345889 9 99999
Q ss_pred ------------CCCCChHHHHHHHHcC-CCCCCC---CCCCHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q psy1684 119 ------------SGGMTNAEVLHQVEHG-YRMPCP---PGCPPRLYDIMLECWLKDPVK--RPTFETLQWK 171 (189)
Q Consensus 119 ------------~~~~~~~~~~~~v~~g-~~~~~p---~~~p~~~~~l~~~C~~~~p~~--RP~~~~i~~~ 171 (189)
|.+.+..++...+..+ .+++.| ..+++++.+||.+|+..+|+. ||+++||++.
T Consensus 269 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 269 VCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred HHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 7777777777777432 233333 458999999999999888877 9999998763
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.24 E-value=1.8e-14 Score=108.74 Aligned_cols=109 Identities=12% Similarity=0.053 Sum_probs=72.5
Q ss_pred ccCCCCCcCHhHHHHHhhhccCCceeeccCCcccccc-cccc----------------cc-------------------c
Q psy1684 61 QKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RIYL----------------VH-------------------G 104 (189)
Q Consensus 61 yl~~~~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~~l----------------~~-------------------~ 104 (189)
++.....+....+..+..+.+.|+.++|..+++|+|+ |+.+ +. |
T Consensus 139 ~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~~~~~~gt~~y~aPE 218 (320)
T 3a99_A 139 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE 218 (320)
T ss_dssp HHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCSSCBCCCCSCGGGSCHH
T ss_pred HHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccccccccccccCCCCCccCCChH
Confidence 3433344556666777788899999999999999996 5511 11 1
Q ss_pred C-CCCCc-cc-e-EEEec------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 105 T-NLSGV-VV-S-AVDFG------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 105 ~-~~~~~-~~-s-VwsfG------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
. ....+ +. + ||||| +.+..+.+-...+..+ ....+..+|+++.+||.+||+.||++|||+++|++
T Consensus 219 ~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 219 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG-QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp HHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHC-CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhhcc-cccccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 12233 67 8 99999 1111110001122223 23456789999999999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=3.8e-14 Score=109.04 Aligned_cols=96 Identities=10% Similarity=-0.145 Sum_probs=65.8
Q ss_pred HHhhhccCCceeeccCCcccccc-cc---------------cc------------------cccC-CC--CCccc-e-EE
Q psy1684 75 EHYSKDADGLCVNLRKPCVQVSC-RI---------------YL------------------VHGT-NL--SGVVV-S-AV 115 (189)
Q Consensus 75 ~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l------------------~~~~-~~--~~~~~-s-Vw 115 (189)
.+..+++.|+.++|..+++|||+ |+ |+ |||. .. ..|+. + ||
T Consensus 198 ~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~Diw 277 (371)
T 3q60_A 198 ILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAW 277 (371)
T ss_dssp HHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHH
T ss_pred HHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHH
Confidence 44478889999999999999996 55 22 2222 22 45888 9 99
Q ss_pred Eec------------CCCCChHH--HHHH---H---HcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 116 DFG------------SGGMTNAE--VLHQ---V---EHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 116 sfG------------~~~~~~~~--~~~~---v---~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
||| |.+..... .... . ......+.+..+|+++.+||.+||+.||++|||+.++++
T Consensus 278 SlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 278 QLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp HHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred HHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 999 33332110 0000 0 112223344689999999999999999999999999975
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.23 E-value=2.4e-13 Score=104.35 Aligned_cols=105 Identities=14% Similarity=0.077 Sum_probs=73.7
Q ss_pred CcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cc------------------------cccC-
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YL------------------------VHGT- 105 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l------------------------~~~~- 105 (189)
.++...+..+..+.+.|+.++|..+++|+|+ |+ |+ ++|.
T Consensus 124 ~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 203 (364)
T 3qyz_A 124 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203 (364)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHh
Confidence 3556667777888889999999999999996 54 11 1111
Q ss_pred -CCCCccc-e-EEEec------------CCCCChHHHHHHHHc--CC-----------------------CCC-----CC
Q psy1684 106 -NLSGVVV-S-AVDFG------------SGGMTNAEVLHQVEH--GY-----------------------RMP-----CP 140 (189)
Q Consensus 106 -~~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~--g~-----------------------~~~-----~p 140 (189)
....++. + |||+| |.+.+..+.+..+.. |. ... .+
T Consensus 204 ~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (364)
T 3qyz_A 204 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLF 283 (364)
T ss_dssp HTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHC
T ss_pred cCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhC
Confidence 2344788 9 99999 666655444444321 10 000 12
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 141 PGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 141 ~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
+.+++++.+|+.+||+.||++|||+.++++.
T Consensus 284 ~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 284 PNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 4678999999999999999999999999863
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.23 E-value=8.2e-14 Score=109.39 Aligned_cols=98 Identities=10% Similarity=-0.020 Sum_probs=61.5
Q ss_pred HHHHhhhccCCceeeccCCcccccc-cccc--------------------------------------------cccCC-
Q psy1684 73 LVEHYSKDADGLCVNLRKPCVQVSC-RIYL--------------------------------------------VHGTN- 106 (189)
Q Consensus 73 li~~~~~~a~gl~~~~~~~~~~~~~-p~~l--------------------------------------------~~~~~- 106 (189)
...+..+++.|+.++|..+++|||+ |+.+ |+|..
T Consensus 120 ~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~ 199 (432)
T 3p23_A 120 PITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLS 199 (432)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTS
T ss_pred HHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhh
Confidence 3455667788899999999999985 4411 22211
Q ss_pred ---CCCccc-e-EEEec-------------CCCCChHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHhcccCCCCCCCHH
Q psy1684 107 ---LSGVVV-S-AVDFG-------------SGGMTNAEVLHQVEHGYR--MPCPPGCPPRLYDIMLECWLKDPVKRPTFE 166 (189)
Q Consensus 107 ---~~~~~~-s-VwsfG-------------~~~~~~~~~~~~v~~g~~--~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~ 166 (189)
...++. + ||||| |.+....+....+..... ...+...+..+.+|+.+||+.||++|||+.
T Consensus 200 ~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ 279 (432)
T 3p23_A 200 EDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAK 279 (432)
T ss_dssp CC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHH
T ss_pred cccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHH
Confidence 345778 8 99999 222222232222221111 111223456688999999999999999999
Q ss_pred HHHH
Q psy1684 167 TLQW 170 (189)
Q Consensus 167 ~i~~ 170 (189)
+|++
T Consensus 280 evl~ 283 (432)
T 3p23_A 280 HVLK 283 (432)
T ss_dssp HHHT
T ss_pred HHHh
Confidence 9984
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.23 E-value=9.1e-14 Score=108.49 Aligned_cols=142 Identities=10% Similarity=-0.073 Sum_probs=92.8
Q ss_pred CChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC-CCCcCHhHHHHHhhhccCCc
Q psy1684 6 IKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG-RTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 6 l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~-~~~~~l~~li~~~~~~a~gl 84 (189)
+.|+|++++++.+...+..|||+|++.++. +.. ++.. ...+.......+..+++.|+
T Consensus 118 ~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~-----L~~-----------------~l~~~~~~l~~~~~~~~~~qi~~aL 175 (412)
T 2vd5_A 118 GDRRWITQLHFAFQDENYLYLVMEYYVGGD-----LLT-----------------LLSKFGERIPAEMARFYLAEIVMAI 175 (412)
T ss_dssp SCTTTBCCEEEEEECSSEEEEEECCCCSCB-----HHH-----------------HHHHHSSCCCHHHHHHHHHHHHHHH
T ss_pred cCCCCeeeEEEEEeeCCEEEEEEcCCCCCc-----HHH-----------------HHHhcCCCCCHHHHHHHHHHHHHHH
Confidence 456666666555544455666666665521 111 2222 12455555666777888899
Q ss_pred eeeccCCcccccc-cc---------------cccccC-----------------------C-------CCCccc-e-EEE
Q psy1684 85 CVNLRKPCVQVSC-RI---------------YLVHGT-----------------------N-------LSGVVV-S-AVD 116 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~---------------~l~~~~-----------------------~-------~~~~~~-s-Vws 116 (189)
.++|..+++|||+ |+ |+++.. . ...|+. + |||
T Consensus 176 ~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwS 255 (412)
T 2vd5_A 176 DSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWA 255 (412)
T ss_dssp HHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHH
T ss_pred HHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhH
Confidence 9999999999996 55 222211 1 245888 9 999
Q ss_pred ec------------CCCCChHHHHHHHHcC---CC-CCCCCCCCHHHHHHHHHhcccCCCCC---CCHHHHHH
Q psy1684 117 FG------------SGGMTNAEVLHQVEHG---YR-MPCPPGCPPRLYDIMLECWLKDPVKR---PTFETLQW 170 (189)
Q Consensus 117 fG------------~~~~~~~~~~~~v~~g---~~-~~~p~~~p~~~~~l~~~C~~~~p~~R---P~~~~i~~ 170 (189)
|| |.+.+..++...+..+ .. +..+..+|+++.+||.+||. +|.+| |++++|++
T Consensus 256 lGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 256 LGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred HhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 99 6777777777776432 12 22346899999999999999 99998 68888865
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.22 E-value=1.1e-13 Score=105.77 Aligned_cols=106 Identities=8% Similarity=-0.120 Sum_probs=72.7
Q ss_pred CCcCHhHHHHHhhhccCCceeec--cCCcccccc-cc----------------cccc--------------------cC-
Q psy1684 66 TTIHYPELVEHYSKDADGLCVNL--RKPCVQVSC-RI----------------YLVH--------------------GT- 105 (189)
Q Consensus 66 ~~~~l~~li~~~~~~a~gl~~~~--~~~~~~~~~-p~----------------~l~~--------------------~~- 105 (189)
..+....+..+..+.+.|+.++| ..+++|+|+ |+ |++. |.
T Consensus 124 ~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~ 203 (360)
T 3e3p_A 124 VAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELI 203 (360)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHH
T ss_pred cCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHH
Confidence 34445555666777888899999 899999996 55 2221 11
Q ss_pred CC-CCccc-e-EEEec------------CCCCChHHHHHHHHcCCC-------------------------------CCC
Q psy1684 106 NL-SGVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYR-------------------------------MPC 139 (189)
Q Consensus 106 ~~-~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~-------------------------------~~~ 139 (189)
.. ..++. + ||||| |.+.+..+.+..+.+... ...
T Consensus 204 ~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (360)
T 3e3p_A 204 FGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDH 283 (360)
T ss_dssp TTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTC
T ss_pred cCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchh
Confidence 12 33788 9 99999 666666555555432100 112
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 140 PPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 140 p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
+..+++++.+|+.+||+.||.+|||+.|+++.
T Consensus 284 ~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 284 SLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp CCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred hccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 23367899999999999999999999999874
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.22 E-value=1.1e-12 Score=102.88 Aligned_cols=31 Identities=16% Similarity=0.122 Sum_probs=28.3
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 141 PGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 141 ~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
+.+++++.+|+.+||..||++|||++|+++.
T Consensus 332 ~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 362 (432)
T 3n9x_A 332 PSISDDGINLLESMLKFNPNKRITIDQALDH 362 (432)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTC
T ss_pred CCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 4688999999999999999999999999873
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.21 E-value=1.1e-13 Score=106.89 Aligned_cols=26 Identities=19% Similarity=0.078 Sum_probs=23.9
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 145 PRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 145 ~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
+++.+|+.+||+.||++|||++|+++
T Consensus 347 ~~~~dli~~mL~~dP~~Rpta~e~L~ 372 (382)
T 2vx3_A 347 LKFKDLILRMLDYDPKTRIQPYYALQ 372 (382)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHHHHHhcCCChhhCCCHHHHhc
Confidence 37889999999999999999999875
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.21 E-value=1.3e-12 Score=103.24 Aligned_cols=31 Identities=16% Similarity=0.206 Sum_probs=28.1
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 141 PGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 141 ~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
+.+++++.+|+.+||..||++|||++|+++.
T Consensus 367 ~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 367 PASSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 3568999999999999999999999999874
|
| >1gri_A Growth factor bound protein 2; SH2, SH3, signal transduction adaptor; 3.10A {Homo sapiens} SCOP: b.34.2.1 b.34.2.1 d.93.1.1 PDB: 1aze_A 2a37_A 2azv_A 2a36_A 2azs_A | Back alignment and structure |
|---|
Probab=99.18 E-value=1.6e-10 Score=82.58 Aligned_cols=80 Identities=31% Similarity=0.330 Sum_probs=68.7
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC-ccCCCCCcC-HhHHHHHhh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET-QKAGRTTIH-YPELVEHYS 78 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g-yl~~~~~~~-l~~li~~~~ 78 (189)
||||.|++..++++|. ....+|.||||++.+.+|.|+||++. .+.++|++|....+| |......|. +.+|++++.
T Consensus 60 w~~g~isr~~ae~lL~-~~~~~G~fLvR~S~~~~g~~~LSv~~--~~~v~h~~I~~~~~g~~~~~~~~f~sl~eLv~~~~ 136 (217)
T 1gri_A 60 WFFGKIPRAKAEEMLS-KQRHDGAFLIRESESAPGDFSLSVKF--GNDVQHFKVLRDGAGKYFLWVVKFNSLNELVDYHR 136 (217)
T ss_dssp SBCTTCCHHHHHHHHH-TCSSTTCEEEEECSSSTTCEEEEEEE--TTEEEEEEEEECSSSCEESSSCEESSHHHHHHHHH
T ss_pred hhcccCCHHHHHHHHh-ccCCCceEEEEccCCCCCCEEEEEEE--CCEEEEEEEEEcCCCCEEEeeeEcCCHHHHHHhhh
Confidence 9999999999999884 34578999999999989999999999 999999999988888 433366788 999999998
Q ss_pred hccCC
Q psy1684 79 KDADG 83 (189)
Q Consensus 79 ~~a~g 83 (189)
....+
T Consensus 137 ~~~~~ 141 (217)
T 1gri_A 137 STSVS 141 (217)
T ss_dssp HSCSS
T ss_pred ccccc
Confidence 76543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.15 E-value=1.3e-12 Score=101.65 Aligned_cols=28 Identities=21% Similarity=0.318 Sum_probs=25.7
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 144 PPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 144 p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
+.++.+|+.+||..||++|||++|+++.
T Consensus 307 ~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 307 DSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp TSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 6788999999999999999999999873
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.12 E-value=2.3e-12 Score=97.32 Aligned_cols=103 Identities=11% Similarity=-0.091 Sum_probs=69.0
Q ss_pred cCHhHHHHHhhhccCCceeeccCCcccccc-cc----------------cccc--------------------cC-CC-C
Q psy1684 68 IHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI----------------YLVH--------------------GT-NL-S 108 (189)
Q Consensus 68 ~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~----------------~l~~--------------------~~-~~-~ 108 (189)
+...++..+..+.+.|+.++|..+++|+|+ |+ |++. |. .. .
T Consensus 127 ~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 206 (330)
T 3nsz_A 127 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206 (330)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCC
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCccccccccccccChhhhcCCC
Confidence 445566677788889999999999999996 55 2221 11 22 5
Q ss_pred Cccc-e-EEEec------------C-CCCChHHHHHH-------------HHcCC-----------------------CC
Q psy1684 109 GVVV-S-AVDFG------------S-GGMTNAEVLHQ-------------VEHGY-----------------------RM 137 (189)
Q Consensus 109 ~~~~-s-VwsfG------------~-~~~~~~~~~~~-------------v~~g~-----------------------~~ 137 (189)
.++. + |||+| | .+.+..+.+.. +.... ..
T Consensus 207 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (330)
T 3nsz_A 207 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS 286 (330)
T ss_dssp CCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCT
T ss_pred cCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccc
Confidence 5888 9 99999 2 33333222221 11110 01
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 138 PCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 138 ~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
..+..+++++.+|+.+||+.||++|||++|+++
T Consensus 287 ~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 287 ENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp TTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 112237899999999999999999999999986
|
| >3hhm_B NISH2 P85alpha; PI3KCA, PI3K, PIK3R1, phosphatidilynositol 3,4,5- triphosphate, wortmannin, H1047R, ATP-binding, disease mutation, kinase; HET: KWT; 2.80A {Homo sapiens} PDB: 3hiz_B 2rd0_B 4a55_B* 3mtt_A | Back alignment and structure |
|---|
Probab=99.10 E-value=7.8e-12 Score=95.37 Aligned_cols=67 Identities=24% Similarity=0.246 Sum_probs=0.0
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC--ccCCCCCcC-HhH
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET--QKAGRTTIH-YPE 72 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g--yl~~~~~~~-l~~ 72 (189)
||||.|+|..|+++|. ...+|+||||+| +.+|.|+||++. .+.++||+|....+| ++.....|. +.+
T Consensus 303 WyhG~isR~~AE~LL~--~~~~G~FLVR~S-s~~g~y~LSv~~--~~~v~H~~I~~~~~g~~~~~~~~~F~SL~e 372 (373)
T 3hhm_B 303 WNVGSSNRNKAENLLR--GKRDGTFLVRES-SKQGCYACSVVV--DGEVKHCVINKTATGYGFAEPYNLYSSLKE 372 (373)
T ss_dssp ---------------------------------------------------------------------------
T ss_pred CcCCCCCHHHHHHHhc--cCCCCcEEEEec-CCCCCEEEEEEE--CCeEEEEEEEEcCCCcEEeCCCCCCCChhh
Confidence 9999999999999884 337899999999 888999999999 999999999988888 444446676 554
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.10 E-value=1.9e-13 Score=112.95 Aligned_cols=149 Identities=11% Similarity=0.022 Sum_probs=89.8
Q ss_pred CCCCChHHHHHHhcCCCCCCC-----cEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHh
Q psy1684 3 FGKIKRIEAEKKLLLPENDHG-----AFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHY 77 (189)
Q Consensus 3 ~g~l~~~n~~~lL~~~~~~~g-----~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~ 77 (189)
...++|+|++++++.+...+. .|||+|++.+ + ++.. ++. ..++..+.+.+.
T Consensus 133 l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g-~----~L~~-----------------~~~--~~l~~~~~~~~~ 188 (681)
T 2pzi_A 133 LAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGG-Q----SLKR-----------------SKG--QKLPVAEAIAYL 188 (681)
T ss_dssp GGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCC-E----ECC-----------------------CCCCHHHHHHHH
T ss_pred HHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCC-C----cHHH-----------------HHh--CCCCHHHHHHHH
Confidence 346778888888776543332 4788887765 2 1111 111 135577788888
Q ss_pred hhccCCceeeccCCcccccc-cc--------------c-----------------ccccCCCCCccc-e-EEEec-----
Q psy1684 78 SKDADGLCVNLRKPCVQVSC-RI--------------Y-----------------LVHGTNLSGVVV-S-AVDFG----- 118 (189)
Q Consensus 78 ~~~a~gl~~~~~~~~~~~~~-p~--------------~-----------------l~~~~~~~~~~~-s-VwsfG----- 118 (189)
.+++.|+.++|..+++|+|+ |+ | +++|...+.++. + |||||
T Consensus 189 ~qi~~aL~~lH~~giiHrDlkp~NIll~~~~~kl~DFG~a~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~ 268 (681)
T 2pzi_A 189 LEILPALSYLHSIGLVYNDLKPENIMLTEEQLKLIDLGAVSRINSFGYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAA 268 (681)
T ss_dssp HHHHHHHHHHHHTTEECCCCSGGGEEECSSCEEECCCTTCEETTCCSCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHCCCeecccChHHeEEeCCcEEEEecccchhcccCCccCCCccccCHHHHcCCCCCceehhhhHHHHHH
Confidence 89999999999999999996 55 1 222222223477 8 99999
Q ss_pred -CCCCChHHHHHHHHcCCCCCC-CCCCCHHHHHHHHHhcccCCCCCCC-HHHHHHHHHHHHh
Q psy1684 119 -SGGMTNAEVLHQVEHGYRMPC-PPGCPPRLYDIMLECWLKDPVKRPT-FETLQWKLEDFFT 177 (189)
Q Consensus 119 -~~~~~~~~~~~~v~~g~~~~~-p~~~p~~~~~l~~~C~~~~p~~RP~-~~~i~~~l~~~~~ 177 (189)
..+..+..- ....+..... ...+++.+.+|+.+||+.||++||+ ++++...|..++.
T Consensus 269 l~~g~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 269 LTLDLPTRNG--RYVDGLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp HHSCCCEETT--EECSSCCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred HHhCCCCCcc--cccccccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 111111000 0000100000 0124578999999999999999995 6666666766553
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.05 E-value=1.1e-10 Score=91.38 Aligned_cols=106 Identities=12% Similarity=0.002 Sum_probs=75.0
Q ss_pred CCcCHhHHHHHhhhccCCceeeccCCcccccc-cc----------------cccc--------------------cC-CC
Q psy1684 66 TTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI----------------YLVH--------------------GT-NL 107 (189)
Q Consensus 66 ~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~----------------~l~~--------------------~~-~~ 107 (189)
..+....+..+..+++.|+.++|..+++|||+ |+ |+++ |. ..
T Consensus 151 ~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~ 230 (420)
T 1j1b_A 151 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 230 (420)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTT
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcC
Confidence 34455666777788899999999999999996 55 2222 11 22
Q ss_pred -CCccc-e-EEEec------------CCCCChHHHHHHHHc--C----------------CCCC----------CCCCCC
Q psy1684 108 -SGVVV-S-AVDFG------------SGGMTNAEVLHQVEH--G----------------YRMP----------CPPGCP 144 (189)
Q Consensus 108 -~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~--g----------------~~~~----------~p~~~p 144 (189)
..|+. + ||||| |.+.+..+.+..+.+ | ...+ .+..+|
T Consensus 231 ~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 310 (420)
T 1j1b_A 231 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTP 310 (420)
T ss_dssp CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSC
T ss_pred CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCC
Confidence 35888 9 99999 777665444433321 1 0111 234678
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 145 PRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 145 ~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
+++.+|+.+||..||++|||+.|+++.
T Consensus 311 ~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 311 PEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 999999999999999999999999863
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.04 E-value=8.2e-12 Score=98.07 Aligned_cols=28 Identities=25% Similarity=0.281 Sum_probs=25.7
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 143 CPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 143 ~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
+++++.+|+.+||+.||++|||+.+|++
T Consensus 268 ~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 268 LIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred chHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 4578999999999999999999999975
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.03 E-value=3.3e-12 Score=104.69 Aligned_cols=151 Identities=13% Similarity=0.020 Sum_probs=88.4
Q ss_pred CCChHHHHHHhcCCCC------CCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC---CCCcCHhHHHH
Q psy1684 5 KIKRIEAEKKLLLPEN------DHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG---RTTIHYPELVE 75 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~------~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~---~~~~~l~~li~ 75 (189)
.++|+|++++++.+.. ....+||+|++.++. +.. ++.. ...++...+..
T Consensus 68 ~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggs-----L~~-----------------~L~~~~~~~~lse~~i~~ 125 (676)
T 3qa8_A 68 KLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGD-----LRK-----------------YLNQFENCCGLKEGPIRT 125 (676)
T ss_dssp HCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCB-----HHH-----------------HHHSSSCTTCCCSSHHHH
T ss_pred hCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCC-----HHH-----------------HHHhcccCCCCCHHHHHH
Confidence 4578888877765433 445677888776522 111 1211 11244555666
Q ss_pred HhhhccCCceeeccCCcccccc-cc--------------------------------------cccccC-CCCCccc-e-
Q psy1684 76 HYSKDADGLCVNLRKPCVQVSC-RI--------------------------------------YLVHGT-NLSGVVV-S- 113 (189)
Q Consensus 76 ~~~~~a~gl~~~~~~~~~~~~~-p~--------------------------------------~l~~~~-~~~~~~~-s- 113 (189)
+..+.+.|+.++|..+++|+|+ |+ ++++|. ....++. +
T Consensus 126 I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksD 205 (676)
T 3qa8_A 126 LLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVD 205 (676)
T ss_dssp HHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHH
T ss_pred HHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccccccccccccccccCCcccCChHHhccCCCCchhH
Confidence 7778888999999999999986 44 122222 3456888 9
Q ss_pred EEEec------------CCCCC-hHHHH--------HH-H----HcC-----CCCCCCC----CCCHHHHHHHHHhcccC
Q psy1684 114 AVDFG------------SGGMT-NAEVL--------HQ-V----EHG-----YRMPCPP----GCPPRLYDIMLECWLKD 158 (189)
Q Consensus 114 VwsfG------------~~~~~-~~~~~--------~~-v----~~g-----~~~~~p~----~~p~~~~~l~~~C~~~~ 158 (189)
||||| |.+.. +.+.. .. . ..| ..++.|. .+|+++.+|+.+||..|
T Consensus 206 IwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~D 285 (676)
T 3qa8_A 206 YWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWH 285 (676)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSS
T ss_pred HHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCC
Confidence 99999 22211 11100 00 0 011 1122232 35678999999999999
Q ss_pred CCCCCCHHH-----HHHHHHHHHh
Q psy1684 159 PVKRPTFET-----LQWKLEDFFT 177 (189)
Q Consensus 159 p~~RP~~~~-----i~~~l~~~~~ 177 (189)
|++|||+++ ..+.++.+++
T Consensus 286 P~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 286 QRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp CC---CCTTCCCCTTHHHHHHHHC
T ss_pred HhhCcCHHHHhcCHHHHHHHHHHh
Confidence 999999988 4566666665
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.01 E-value=5.5e-11 Score=89.75 Aligned_cols=105 Identities=14% Similarity=0.077 Sum_probs=73.7
Q ss_pred CcCHhHHHHHhhhccCCceeeccCCcccccc-ccccc--c----------------------------------------
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RIYLV--H---------------------------------------- 103 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~~l~--~---------------------------------------- 103 (189)
.++...+..+..+.+.|+.++|..+++|+|+ |+.+. .
T Consensus 114 ~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 193 (339)
T 1z57_A 114 PFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHST 193 (339)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSCCCS
T ss_pred CCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCcccccc
Confidence 3456777788889999999999999999996 55221 1
Q ss_pred ----------cC-CCCCccc-e-EEEec------------CCCCChHHHHHHHHc--CCC--------------------
Q psy1684 104 ----------GT-NLSGVVV-S-AVDFG------------SGGMTNAEVLHQVEH--GYR-------------------- 136 (189)
Q Consensus 104 ----------~~-~~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~--g~~-------------------- 136 (189)
|. ....++. + ||||| |.+.+..+....+.. +..
T Consensus 194 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 273 (339)
T 1z57_A 194 LVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLD 273 (339)
T ss_dssp SCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEEC
T ss_pred ccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhcccc
Confidence 00 3456889 9 99999 666665554444322 110
Q ss_pred ---------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 137 ---------------------MPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 137 ---------------------~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
...+..+++++.+|+.+||+.||++|||++|+++.
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 274 WDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKH 329 (339)
T ss_dssp CCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcC
Confidence 01122346789999999999999999999999753
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.01 E-value=6.3e-11 Score=90.04 Aligned_cols=104 Identities=15% Similarity=0.048 Sum_probs=72.9
Q ss_pred CcCHhHHHHHhhhccCCceeeccCCcccccc-cccccc------------------------------------------
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RIYLVH------------------------------------------ 103 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~~l~~------------------------------------------ 103 (189)
.++...+..+..+.+.|+.++|..+++|+|+ |+.+.-
T Consensus 119 ~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 198 (355)
T 2eu9_A 119 PYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTT 198 (355)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCCCS
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCccccccccccC
Confidence 4557777888889999999999999999996 552211
Q ss_pred ----------cC-CCCCccc-e-EEEec------------CCCCChHHHHHHHHc--CCCC-------------------
Q psy1684 104 ----------GT-NLSGVVV-S-AVDFG------------SGGMTNAEVLHQVEH--GYRM------------------- 137 (189)
Q Consensus 104 ----------~~-~~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~--g~~~------------------- 137 (189)
|. ....++. + |||+| |.+.+..+.+..+.. +..+
T Consensus 199 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 278 (355)
T 2eu9_A 199 IVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLV 278 (355)
T ss_dssp SCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEEC
T ss_pred CcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccc
Confidence 00 3556889 9 99999 666555554444322 1100
Q ss_pred ----------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 138 ----------------------PCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 138 ----------------------~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
..+...+.++.+|+.+||+.||++|||+.++++
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 279 WDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp CCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 001122458889999999999999999999975
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=98.96 E-value=3.8e-11 Score=93.71 Aligned_cols=93 Identities=6% Similarity=-0.141 Sum_probs=64.0
Q ss_pred HHHHHhhhccCCceeeccCCcccccc-cc---------------ccc-----------------ccCC----------C-
Q psy1684 72 ELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLV-----------------HGTN----------L- 107 (189)
Q Consensus 72 ~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~-----------------~~~~----------~- 107 (189)
..+.+..+++.|+.++|..+++|||+ |+ |++ +|.. .
T Consensus 212 ~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g~~y~aPE~~~~~~~~~~~~~~ 291 (413)
T 3dzo_A 212 ARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHP 291 (413)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEEECCCCCTTTCCHHHHHHHTSTTGGGCC
T ss_pred HHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCeEEEEeccceeecCCccccCCCCceeCchhhhccccccccccC
Confidence 34445578889999999999999996 55 222 2211 2
Q ss_pred CCccc-e-EEEec------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q psy1684 108 SGVVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQ 169 (189)
Q Consensus 108 ~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~ 169 (189)
..|+. + ||||| |.+.+..++...+.. ....+|+++.+||.+||+.||++|||+.+++
T Consensus 292 ~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 292 TLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFR-----SCKNIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp EEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGGS-----SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred cCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHHHh-----hcccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 23788 8 99999 444333322222211 2246889999999999999999999976663
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=98.94 E-value=4.6e-11 Score=91.55 Aligned_cols=31 Identities=19% Similarity=0.128 Sum_probs=27.6
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 140 PPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 140 p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
|..++.++.+|+.+||+.||++|||++++++
T Consensus 303 ~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 303 SKDEAKEISDFLSPMLQLDPRKRADAGGLVN 333 (373)
T ss_dssp CHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred CcchHHHHHHHHHHHhccCccccCCHHHHhh
Confidence 4456678999999999999999999999987
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.85 E-value=6.1e-10 Score=85.33 Aligned_cols=144 Identities=8% Similarity=-0.091 Sum_probs=95.7
Q ss_pred ChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccC-----CCCCcCHhHHHHHhhhcc
Q psy1684 7 KRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKA-----GRTTIHYPELVEHYSKDA 81 (189)
Q Consensus 7 ~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~-----~~~~~~l~~li~~~~~~a 81 (189)
.|+|++.+++.+...+..+||+|++.++. +.. ++. ....++...+..+..+++
T Consensus 125 ~~~~iv~~~~~~~~~~~~~lv~e~~~~g~-----L~~-----------------~l~~~~~~~~~~l~~~~~~~i~~qi~ 182 (365)
T 3e7e_A 125 MQHMFMKFYSAHLFQNGSVLVGELYSYGT-----LLN-----------------AINLYKNTPEKVMPQGLVISFAMRML 182 (365)
T ss_dssp GGGGBCCEEEEEECSSCEEEEECCCCSCB-----HHH-----------------HHHHHHTSTTCSCCHHHHHHHHHHHH
T ss_pred hhhhhhhhheeeecCCCcEEEEeccCCCc-----HHH-----------------HHHHhhcccccCCCHHHHHHHHHHHH
Confidence 36777777776666677788888877622 111 121 133455777888888999
Q ss_pred CCceeeccCCcccccc-cccc--cc-----------cC-------------------------------------CCCCc
Q psy1684 82 DGLCVNLRKPCVQVSC-RIYL--VH-----------GT-------------------------------------NLSGV 110 (189)
Q Consensus 82 ~gl~~~~~~~~~~~~~-p~~l--~~-----------~~-------------------------------------~~~~~ 110 (189)
.|+.++|..+++|||+ |+.+ .. .. ....|
T Consensus 183 ~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 262 (365)
T 3e7e_A 183 YMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPW 262 (365)
T ss_dssp HHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCB
T ss_pred HHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCC
Confidence 9999999999999996 5511 11 01 44558
Q ss_pred cc-e-EEEecCCCCChHHHHHHHHcCCCC--------------CCCCCCCHHHHHHHHHhcccCCCCC-CCHHHHHHHHH
Q psy1684 111 VV-S-AVDFGSGGMTNAEVLHQVEHGYRM--------------PCPPGCPPRLYDIMLECWLKDPVKR-PTFETLQWKLE 173 (189)
Q Consensus 111 ~~-s-VwsfG~~~~~~~~~~~~v~~g~~~--------------~~p~~~p~~~~~l~~~C~~~~p~~R-P~~~~i~~~l~ 173 (189)
+. + ||||| -++..+..|..| -.....++.+.+++..|++.+|.+| |+++++.+.|+
T Consensus 263 ~~~~DiwslG-------~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~ 335 (365)
T 3e7e_A 263 NYQIDYFGVA-------ATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLK 335 (365)
T ss_dssp STHHHHHHHH-------HHHHHHHHSSCCCEEEETTEEEECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHH
T ss_pred CccccHHHHH-------HHHHHHHhCCCccccCCCCceeechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHH
Confidence 88 8 99998 011111111111 0111345788899999999999998 68899999999
Q ss_pred HHHhhc
Q psy1684 174 DFFTME 179 (189)
Q Consensus 174 ~~~~~~ 179 (189)
.++...
T Consensus 336 ~~l~~~ 341 (365)
T 3e7e_A 336 KVFQQH 341 (365)
T ss_dssp HHHHHH
T ss_pred HHHHHh
Confidence 888754
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=98.82 E-value=5.6e-10 Score=86.07 Aligned_cols=33 Identities=12% Similarity=0.049 Sum_probs=27.5
Q ss_pred CcCHhHHHHHhhhccCCceeeccC-Ccccccc-cc
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRK-PCVQVSC-RI 99 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~-~~~~~~~-p~ 99 (189)
.++...+..+..+.+.|+.++|.. +++|+|+ |+
T Consensus 142 ~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~ 176 (397)
T 1wak_A 142 GLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPE 176 (397)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGG
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHH
Confidence 355677778888999999999998 9999996 55
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=98.53 E-value=1.9e-08 Score=76.06 Aligned_cols=134 Identities=7% Similarity=-0.118 Sum_probs=85.7
Q ss_pred hHHHHHHhcCCCC-------------CCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHH
Q psy1684 8 RIEAEKKLLLPEN-------------DHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELV 74 (189)
Q Consensus 8 ~~n~~~lL~~~~~-------------~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li 74 (189)
|+|++++++.... ....|||+|++..+. ... .+. +..++...+.
T Consensus 108 hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~-----ll~-----------------~~~-~~~~~~~~~~ 164 (336)
T 2vuw_A 108 PPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGI-----DLE-----------------QMR-TKLSSLATAK 164 (336)
T ss_dssp CHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCE-----ETG-----------------GGT-TTCCCHHHHH
T ss_pred cHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCc-----cHH-----------------HHH-hcCCCHHHHH
Confidence 8999998875432 456788888877632 111 121 1234567777
Q ss_pred HHhhhccCCceeec-cCCcccccc-cc-------c--------------------------------------------c
Q psy1684 75 EHYSKDADGLCVNL-RKPCVQVSC-RI-------Y--------------------------------------------L 101 (189)
Q Consensus 75 ~~~~~~a~gl~~~~-~~~~~~~~~-p~-------~--------------------------------------------l 101 (189)
.+..+++.|+.++| ..+++|||+ |+ + +
T Consensus 165 ~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~~~~gt~~y~ 244 (336)
T 2vuw_A 165 SILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSM 244 (336)
T ss_dssp HHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETTEEECCCCTT
T ss_pred HHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCCcEEEeeccc
Confidence 88889999999999 899999996 55 1 1
Q ss_pred cccCCCCCccc-e-EEEec-------CCCCChHH-------HHHHHHcCCCCC------CCCCCCHHHHHHHHHhcccCC
Q psy1684 102 VHGTNLSGVVV-S-AVDFG-------SGGMTNAE-------VLHQVEHGYRMP------CPPGCPPRLYDIMLECWLKDP 159 (189)
Q Consensus 102 ~~~~~~~~~~~-s-VwsfG-------~~~~~~~~-------~~~~v~~g~~~~------~p~~~p~~~~~l~~~C~~~~p 159 (189)
|+|...+..+. + |||+| +.+..+.. +...+......+ .+..+++++.+|+.+||+.|
T Consensus 245 aPE~~~g~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d- 323 (336)
T 2vuw_A 245 DEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS- 323 (336)
T ss_dssp CSGGGCCCSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-
T ss_pred ChhhhcCCCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-
Confidence 12212334477 8 99987 44554432 223333221111 12357789999999999976
Q ss_pred CCCCCHHHHH
Q psy1684 160 VKRPTFETLQ 169 (189)
Q Consensus 160 ~~RP~~~~i~ 169 (189)
|++|++
T Consensus 324 ----sa~e~l 329 (336)
T 2vuw_A 324 ----SATDLL 329 (336)
T ss_dssp ----SHHHHH
T ss_pred ----CHHHHH
Confidence 888877
|
| >2xp1_A SPT6; transcription, IWS1, histone chaperone, mRNA export; 2.20A {Antonospora locustae} | Back alignment and structure |
|---|
Probab=98.38 E-value=9.8e-07 Score=60.46 Aligned_cols=72 Identities=17% Similarity=0.125 Sum_probs=57.5
Q ss_pred CCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcC-HhHHHHHhhh
Q psy1684 2 YFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIH-YPELVEHYSK 79 (189)
Q Consensus 2 ~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~-l~~li~~~~~ 79 (189)
|+ +++..+|+++|.. .+|.||||+|.. ++.++++++.. ++.++|++|.....-|+-++..|. |.+++..+.+
T Consensus 17 F~-n~s~~qAe~~L~~---~~G~~liRPSsk-~~~ltit~Kv~-d~~~~Hi~I~E~~k~l~ig~~~fedLDElI~~yv~ 89 (178)
T 2xp1_A 17 FK-NFNVTESENYLRS---STDDFLIRKGSR-HGYCVLVIKFA-SDVFVHMKIEEHSEHYTCSNKHFEDIDEVISVYVR 89 (178)
T ss_dssp EE-CCCHHHHHHHHHH---SSCCEEEEECSS-TTEEEEEEEEE-TTEEEEEEEEECSSCEEETTEEESSHHHHHHHTHH
T ss_pred cC-CCCHHHHHHHHhc---CCCCEEEeecCC-CCcEEEEEEEC-CCcEEEEEEEECCCEEEECCcEECCHHHHHHHHHH
Confidence 44 7999999999975 359999999987 68899999942 778999999764433555566898 9999988765
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=97.72 E-value=4.5e-07 Score=73.54 Aligned_cols=68 Identities=12% Similarity=0.013 Sum_probs=44.2
Q ss_pred ChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCcee
Q psy1684 7 KRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGLCV 86 (189)
Q Consensus 7 ~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl~~ 86 (189)
.|+|+++++.....+...|||+|++++ + ++.. +|.....+...+ +..+++.|+.+
T Consensus 300 ~~~~i~~~~~~~ed~~~~yLVMEyv~G-~----~L~d-----------------~i~~~~~l~~~~---I~~QIl~AL~y 354 (569)
T 4azs_A 300 AGFDAPAVLAHGENAQSGWLVMEKLPG-R----LLSD-----------------MLAAGEEIDREK---ILGSLLRSLAA 354 (569)
T ss_dssp TTCCCCCEEEEEECSSEEEEEEECCCS-E----EHHH-----------------HHHTTCCCCHHH---HHHHHHHHHHH
T ss_pred CCCCeeEEEEEEEECCEEEEEEecCCC-C----cHHH-----------------HHHhCCCCCHHH---HHHHHHHHHHH
Confidence 456666666655555567777777765 3 2222 333344444333 34688899999
Q ss_pred eccCCcccccc-cc
Q psy1684 87 NLRKPCVQVSC-RI 99 (189)
Q Consensus 87 ~~~~~~~~~~~-p~ 99 (189)
+|..+|+|||+ |+
T Consensus 355 lH~~GIIHRDIKPe 368 (569)
T 4azs_A 355 LEKQGFWHDDVRPW 368 (569)
T ss_dssp HHHTTCEESCCCGG
T ss_pred HHHCCceeccCchH
Confidence 99999999996 66
|
| >1uur_A Stata protein, STAT protein; transcription activator, SH2, signal transduction, transducer, transcription factor; HET: PTR; 2.7A {Dictyostelium discoideum} SCOP: a.47.1.1 b.2.5.5 d.93.1.1 PDB: 1uus_A* | Back alignment and structure |
|---|
Probab=97.32 E-value=0.00048 Score=53.73 Aligned_cols=54 Identities=22% Similarity=0.279 Sum_probs=45.6
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEec-CCCeeeEEEEEe
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKR-SSFCLKMTTGRS 56 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~-~~~~v~h~~i~~ 56 (189)
|+||.|++.+++.+|.. ...|+||+|-|.+..|.+++++... ..+.++|+.+..
T Consensus 353 ~I~GFIsk~ea~~lL~~--~~~GTFLLRFSeS~~GgitIsyV~~d~~~~~kh~~v~p 407 (473)
T 1uur_A 353 IIYGYMGRQEVNDALQN--QDPGTFIIRFSERNPGQFGIAYIGVEMPARIKHYLVQP 407 (473)
T ss_dssp SSCBSCCHHHHHHTTSS--CCTTCEEEEECSSSTTCEEEEEECSSSSCCEEEEECCG
T ss_pred cEEEEecHHHHHHHhhC--CCCCeEEEEeccCCCceEEEEEEeecCCCceeEEEecC
Confidence 89999999999999954 5789999999999889999999873 236888887764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=96.66 E-value=2.1e-05 Score=60.40 Aligned_cols=74 Identities=7% Similarity=0.046 Sum_probs=56.3
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC-CCCcCHhHHHHHhhhccC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG-RTTIHYPELVEHYSKDAD 82 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~-~~~~~l~~li~~~~~~a~ 82 (189)
..++|+|++++++.+...+..+||+|+++++. +.. ++.. ...+....+..+..+++.
T Consensus 167 ~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~-----L~~-----------------~l~~~~~~~~~~~~~~~~~qi~~ 224 (377)
T 3cbl_A 167 KQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD-----FLT-----------------FLRTEGARLRVKTLLQMVGDAAA 224 (377)
T ss_dssp TTCCCTTBCCEEEEECSSSSCEEEEECCTTCB-----HHH-----------------HHHHHGGGCCHHHHHHHHHHHHH
T ss_pred HhCCCCCEEEEEEEEecCCCcEEEEEcCCCCC-----HHH-----------------HHHhcCCCCCHHHHHHHHHHHHH
Confidence 46789999999998887778899999988632 211 2221 123457778888889999
Q ss_pred CceeeccCCcccccc-cc
Q psy1684 83 GLCVNLRKPCVQVSC-RI 99 (189)
Q Consensus 83 gl~~~~~~~~~~~~~-p~ 99 (189)
|+.++|..+++|+|+ |+
T Consensus 225 ~l~~LH~~~ivHrDlkp~ 242 (377)
T 3cbl_A 225 GMEYLESKCCIHRDLAAR 242 (377)
T ss_dssp HHHHHHHTTEECSCCSGG
T ss_pred HHHHHHHCCcCCcccCHH
Confidence 999999999999996 55
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=96.54 E-value=6e-05 Score=60.01 Aligned_cols=72 Identities=11% Similarity=0.026 Sum_probs=54.6
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC--CCCcCHhHHHHHhhhccC
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG--RTTIHYPELVEHYSKDAD 82 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~--~~~~~l~~li~~~~~~a~ 82 (189)
.++|+|++++++.+......+||+|++.++. +.. ++.. ...+....++.+..+++.
T Consensus 272 ~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~-----L~~-----------------~l~~~~~~~~~~~~~~~i~~qi~~ 329 (495)
T 1opk_A 272 EIKHPNLVQLLGVCTREPPFYIITEFMTYGN-----LLD-----------------YLRECNRQEVSAVVLLYMATQISS 329 (495)
T ss_dssp HCCCTTBCCEEEEECSSSSCEEEEECCTTCB-----HHH-----------------HHHHSCTTTSCHHHHHHHHHHHHH
T ss_pred hcCCCCEeeEEEEEecCCcEEEEEEccCCCC-----HHH-----------------HHHhcCcCCCCHHHHHHHHHHHHH
Confidence 5789999999998888888899999988632 222 2221 223456777788889999
Q ss_pred CceeeccCCccccccc
Q psy1684 83 GLCVNLRKPCVQVSCR 98 (189)
Q Consensus 83 gl~~~~~~~~~~~~~p 98 (189)
|+.++|..+++|+|+.
T Consensus 330 ~L~~LH~~~ivHrDlk 345 (495)
T 1opk_A 330 AMEYLEKKNFIHRNLA 345 (495)
T ss_dssp HHHHHHHTTEECSCCS
T ss_pred HHHHHHhCCcccCCCC
Confidence 9999999999999963
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=96.29 E-value=5.9e-05 Score=59.33 Aligned_cols=73 Identities=8% Similarity=0.124 Sum_probs=53.4
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCC--CCcCHhHHHHHhhhcc
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGR--TTIHYPELVEHYSKDA 81 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~--~~~~l~~li~~~~~~a 81 (189)
..++|+|++++++.+. .+..+||+|++.++. +.. ++... ..+....++.+..+++
T Consensus 238 ~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~-----L~~-----------------~l~~~~~~~~~~~~~~~~~~qi~ 294 (454)
T 1qcf_A 238 KTLQHDKLVKLHAVVT-KEPIYIITEFMAKGS-----LLD-----------------FLKSDEGSKQPLPKLIDFSAQIA 294 (454)
T ss_dssp TTCCCTTBCCEEEEEC-SSSCEEEECCCTTCB-----HHH-----------------HHHSHHHHTCCHHHHHHHHHHHH
T ss_pred hhCCCCCEeeEEEEEe-CCccEEEEeecCCCc-----HHH-----------------HHHhccCCCCCHHHHHHHHHHHH
Confidence 4678999999888775 566889999888732 222 22211 1344677888889999
Q ss_pred CCceeeccCCcccccc-cc
Q psy1684 82 DGLCVNLRKPCVQVSC-RI 99 (189)
Q Consensus 82 ~gl~~~~~~~~~~~~~-p~ 99 (189)
.|+.++|..+++|+|+ |+
T Consensus 295 ~~l~~LH~~~ivHrDlkp~ 313 (454)
T 1qcf_A 295 EGMAFIEQRNYIHRDLRAA 313 (454)
T ss_dssp HHHHHHHHTTCCCSSCSGG
T ss_pred HHHHHHHhCCccCCCCCHH
Confidence 9999999999999996 44
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=96.18 E-value=7.8e-05 Score=58.61 Aligned_cols=72 Identities=7% Similarity=0.053 Sum_probs=50.9
Q ss_pred CCCChHHHHHHhcCCCCCC-CcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC--CCCcCHhHHHHHhhhc
Q psy1684 4 GKIKRIEAEKKLLLPENDH-GAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG--RTTIHYPELVEHYSKD 80 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~-g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~--~~~~~l~~li~~~~~~ 80 (189)
..++|+|++++++.+...+ ..+||+|++.++. +.. ++.. ...+....++.+..++
T Consensus 241 ~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~-----L~~-----------------~l~~~~~~~~~~~~~~~~~~qi 298 (450)
T 1k9a_A 241 TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS-----LVD-----------------YLRSRGRSVLGGDCLLKFSLDV 298 (450)
T ss_dssp HTCCCTTBCCEEEEEECTTSCEEEEEECCTTCB-----HHH-----------------HHHHHCTTTCCHHHHHHHHHHH
T ss_pred HhccCCCEEEEEEEEEcCCCceEEEEEecCCCc-----HHH-----------------HHHhcCCCCCCHHHHHHHHHHH
Confidence 3578999999888765444 5789999888632 222 2221 1124466777888888
Q ss_pred cCCceeeccCCcccccc
Q psy1684 81 ADGLCVNLRKPCVQVSC 97 (189)
Q Consensus 81 a~gl~~~~~~~~~~~~~ 97 (189)
+.|+.++|..+++|+|+
T Consensus 299 ~~~l~~LH~~~ivHrDl 315 (450)
T 1k9a_A 299 CEAMEYLEGNNFVHRDL 315 (450)
T ss_dssp HHHHHHHHHTTEECSCC
T ss_pred HHHHHHHHhCCeeCCCC
Confidence 99999999999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=95.90 E-value=0.0002 Score=56.31 Aligned_cols=72 Identities=14% Similarity=0.185 Sum_probs=52.4
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC--CCCcCHhHHHHHhhhccC
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG--RTTIHYPELVEHYSKDAD 82 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~--~~~~~l~~li~~~~~~a~ 82 (189)
.++|+|++++++.+.. ...+||+|++.++. +.. ++.. ...+...+++.+..+++.
T Consensus 235 ~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gs-----L~~-----------------~l~~~~~~~~~~~~~~~i~~qi~~ 291 (452)
T 1fmk_A 235 KLRHEKLVQLYAVVSE-EPIYIVTEYMSKGS-----LLD-----------------FLKGETGKYLRLPQLVDMAAQIAS 291 (452)
T ss_dssp HCCCTTBCCEEEEECS-SSCEEEECCCTTCB-----HHH-----------------HHSHHHHTTCCHHHHHHHHHHHHH
T ss_pred hCCCCCEeeEEEEEcC-CceEEEehhhcCCC-----HHH-----------------HHHhcCCCCCCHHHHHHHHHHHHH
Confidence 4678899988887754 66889999887632 222 2221 123457778888899999
Q ss_pred CceeeccCCcccccc-cc
Q psy1684 83 GLCVNLRKPCVQVSC-RI 99 (189)
Q Consensus 83 gl~~~~~~~~~~~~~-p~ 99 (189)
|+.++|..+++|+|+ |+
T Consensus 292 ~l~~LH~~~ivHrDlkp~ 309 (452)
T 1fmk_A 292 GMAYVERMNYVHRDLRAA 309 (452)
T ss_dssp HHHHHHHTTCCCSCCSGG
T ss_pred HHHHHHhCCeeCCCCChh
Confidence 999999999999996 44
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=95.89 E-value=0.00021 Score=57.51 Aligned_cols=71 Identities=17% Similarity=0.229 Sum_probs=51.9
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC--CCCcCHhHHHHHhhhccC
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG--RTTIHYPELVEHYSKDAD 82 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~--~~~~~l~~li~~~~~~a~ 82 (189)
.++|+|++++++.+.. ...+||+|++.+ | ++.. ++.. ...+...+++.+..+++.
T Consensus 318 ~l~hpniv~~~~~~~~-~~~~lv~e~~~~-g----sL~~-----------------~l~~~~~~~l~~~~~~~i~~qi~~ 374 (535)
T 2h8h_A 318 KLRHEKLVQLYAVVSE-EPIYIVTEYMSK-G----SLLD-----------------FLKGETGKYLRLPQLVDMAAQIAS 374 (535)
T ss_dssp HCCCTTBCCEEEEECS-SSCEEEECCCTT-E----EHHH-----------------HHSHHHHTTCCHHHHHHHHHHHHH
T ss_pred hCCCCCEeeEEEEEee-ccceEeeehhcC-C----cHHH-----------------HHhhcCCCCCCHHHHHHHHHHHHH
Confidence 4678888888887754 567888888876 3 2222 2321 123457778888899999
Q ss_pred CceeeccCCccccccc
Q psy1684 83 GLCVNLRKPCVQVSCR 98 (189)
Q Consensus 83 gl~~~~~~~~~~~~~p 98 (189)
|+.++|..+++|+|+.
T Consensus 375 ~L~~LH~~~ivHrDlk 390 (535)
T 2h8h_A 375 GMAYVERMNYVHRDLR 390 (535)
T ss_dssp HHHHHHHTTCCCSCCS
T ss_pred HHHHHHhCCeeCCCCC
Confidence 9999999999999963
|
| >3bux_B E3 ubiquitin-protein ligase CBL; TKB, signal transduction, proto-oncogene, complex, ATP-binding, glycoprotein, kinase, membrane, nucleotide-binding; HET: PTR; 1.35A {Homo sapiens} SCOP: a.39.1.7 a.48.1.1 d.93.1.1 PDB: 1yvh_A* 3bun_B* 3buo_B* 3bum_B* 3buw_B* 3ob1_B* 3ob2_B* 3plf_B* 2cbl_A* 1b47_A 3pfv_A* | Back alignment and structure |
|---|
Probab=95.79 E-value=0.023 Score=41.88 Aligned_cols=49 Identities=14% Similarity=0.170 Sum_probs=41.8
Q ss_pred CCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeE
Q psy1684 2 YFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKM 51 (189)
Q Consensus 2 ~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h 51 (189)
|++.++-.||.++|..+.+..|+||+|-|++..|.+.++.... ++.+.|
T Consensus 246 y~aFlTydEv~~~L~~~~~kpGsYIfR~ScTrlGqwAIgyV~~-~~~I~q 294 (329)
T 3bux_B 246 YMAFLTYDEVKARLQKFIHKPGSYIFRLSCTRLGQWAIGYVTA-DGNILQ 294 (329)
T ss_dssp BCTTCCHHHHHHHHGGGTTSTTEEEEEECSSSTTSEEEEEECT-TSCEEE
T ss_pred hhheeeHHHHHHHHHHhcCCCCcEEEEeccCccCceEEEEECC-CCceee
Confidence 6778999999999987778999999999999999999988773 455544
|
| >2xp1_A SPT6; transcription, IWS1, histone chaperone, mRNA export; 2.20A {Antonospora locustae} | Back alignment and structure |
|---|
Probab=95.78 E-value=0.035 Score=37.90 Aligned_cols=73 Identities=12% Similarity=0.033 Sum_probs=51.0
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcC-HhHHHHHhhh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIH-YPELVEHYSK 79 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~-l~~li~~~~~ 79 (189)
||++ +.++++++|.......-.|.++++...+|.|.+++.. +.+.|.-|... .||--.+..|. +.+|++++.+
T Consensus 103 kf~~--s~~~~e~~L~~~~p~~~~Y~f~~s~~~PG~f~l~~~~---~~~~~e~i~V~-~g~~~~~~~f~sl~~L~~~fK~ 176 (178)
T 2xp1_A 103 KYFN--SPEDAEKLLSSFDGSKVVYAFYFSRKYPGKLTFAYNN---GSILEEYIGVS-DMLTYNNSTFKDIDSFVAYRKR 176 (178)
T ss_dssp TBCS--CTTTSHHHHHTCCSSSCEEEEEECSSSTTEEEEEEES---SSEEEEEEEES-SSEEETTEEESSHHHHHHHHHC
T ss_pred ccCC--CHHHHHHHHHHhCCCCceEEEEecCCCCCeEEEEEcC---CCCceeeEEEc-cCCEEcCcCCcCHHHHHHHHhh
Confidence 6776 7788999886441111238888998899999998854 35666556555 45222677888 9999999875
|
| >3op0_A Signal transduction protein CBL-C; structural genomics, structural genomics consortium, SGC, SI transduction protein, SH3-binding protein; HET: PTR; 2.52A {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.43 E-value=0.027 Score=41.25 Aligned_cols=49 Identities=14% Similarity=0.261 Sum_probs=41.8
Q ss_pred CCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeE
Q psy1684 2 YFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKM 51 (189)
Q Consensus 2 ~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h 51 (189)
|+|.|+-.||.+.|..+.+..|+||+|-|++..|.+.++.... ++.+.+
T Consensus 231 y~aFlTydEV~~~L~~~~~KpGsYIfR~ScTrlGqwAIgYV~s-~g~I~q 279 (323)
T 3op0_A 231 YMAFLTYDEVQERLQACRDKPGSYIFRPSCTRLGQWAIGYVSS-DGSILQ 279 (323)
T ss_dssp BCTTCCHHHHHHHTTGGGGSTTEEEEEECSSSTTCEEEEEECT-TSCEEE
T ss_pred eeeeeeHHHHHHHHHHhccCCCcEEEEeccCccCceEEEEEcC-CCceee
Confidence 6789999999999987788999999999999999999988873 444444
|
| >1yvl_A Signal transducer and activator of transcription 1-alpha/beta; signaling protein; HET: PTR; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.76 E-value=0.14 Score=42.02 Aligned_cols=42 Identities=29% Similarity=0.404 Sum_probs=35.8
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCC-CCCceEEEEEec
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSES-RKNDYSLSEYKR 44 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~-~~~~~~ls~~~~ 44 (189)
|.+|.|++..++.+|. ...+|+||+|-|.+ ..|.+++++...
T Consensus 577 ~I~GFIsK~~a~~lL~--~~~~GTFLLRFSdS~~~Ggitia~V~~ 619 (683)
T 1yvl_A 577 CIMGFISKERERALLK--DQQPGTFLLRFSESSREGAITFTWVER 619 (683)
T ss_dssp CCCBCCCHHHHHHHHS--SSCSSCEEEEECSSCSSCEEEEEEEEC
T ss_pred ceEEeecHHHHHHHHh--CCCCCeEEEecCCCCCCCceEEEEEec
Confidence 5689999999999995 45889999999988 889888888763
|
| >1y1u_A Signal transducer and activator of transcription; STAT, DNA-binding, SH2 domain, transcription REGU signaling protein; 3.21A {Mus musculus} | Back alignment and structure |
|---|
Probab=93.35 E-value=0.083 Score=42.69 Aligned_cols=41 Identities=22% Similarity=0.286 Sum_probs=36.0
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEe
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYK 43 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~ 43 (189)
|.+|.|++..++.+|.. ...|+||+|-|.+..|.+++++..
T Consensus 466 ~I~Gfisk~~a~~~L~~--~~~GtFLlRFSds~~G~~tisyv~ 506 (585)
T 1y1u_A 466 AILGFVNKQQAHDLLIN--KPDGTFLLRFSDSEIGGITIAWKF 506 (585)
T ss_dssp CCCBSCCHHHHHHHHHT--SCTTCEEEEEETTSTTEEEEEECC
T ss_pred ceEEeccHHHHHHHHhC--CCCCceEEEeccCCcCcEEEEEEe
Confidence 57899999999999964 578999999999888989998877
|
| >1bf5_A Signal transducer and activator of transcription 1-alpha/beta; complex (SH2 domain/DNA), SH2 domain, transcription factor; HET: DNA PTR; 2.90A {Homo sapiens} SCOP: a.47.1.1 b.2.5.5 d.93.1.1 | Back alignment and structure |
|---|
Probab=91.49 E-value=0.24 Score=39.82 Aligned_cols=41 Identities=27% Similarity=0.375 Sum_probs=34.8
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCC-CCCceEEEEEe
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSES-RKNDYSLSEYK 43 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~-~~~~~~ls~~~ 43 (189)
|.+|.|++..++.+|. ....|+||+|-|.+ ..|.+++++..
T Consensus 442 ~I~GFIsK~~a~~lL~--~~~~GTFLLRFSdS~~~GgITia~V~ 483 (575)
T 1bf5_A 442 CIMGFISKERERALLK--DQQPGTFLLRFSESSREGAITFTWVE 483 (575)
T ss_dssp CCCCCCCHHHHHHHTT--TCCSCCCCEEECSSCSSCCEEEEECC
T ss_pred ceEEeecHHHHHHHHh--CCCCCeEEEecCCCCCCCcEEEEEEe
Confidence 5689999999999884 45789999999888 88888888866
|
| >1bg1_A Protein (transcription factor STAT3B); protein-DNA complex, cytokine activation, complex (transcription factor/DNA), transcription/DNA complex; HET: DNA PTR; 2.25A {Mus musculus} SCOP: a.47.1.1 b.2.5.5 d.93.1.1 PDB: 3cwg_A | Back alignment and structure |
|---|
Probab=91.22 E-value=0.035 Score=44.75 Aligned_cols=41 Identities=24% Similarity=0.366 Sum_probs=34.5
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCC-CCCceEEEEEe
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSES-RKNDYSLSEYK 43 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~-~~~~~~ls~~~ 43 (189)
|.+|.|++..++.+|. ....|+||+|-|.+ ..|.+++++..
T Consensus 458 ~I~Gfisk~~a~~lL~--~~~~GTFLlRFSes~~~Ggitis~v~ 499 (596)
T 1bg1_A 458 YIMGFISKERERAILS--TKPPGTFLLRFSESSKEGGVTFTWVE 499 (596)
T ss_dssp CCCBCCCTTGGGTTTT--TSCTTCBCEEECSSCSSCCEEECCCC
T ss_pred CeEEEecHHHHHHHHh--CCCCCeeEEeecCCCCCCcEEEEEEe
Confidence 5689999999999885 45789999999888 77888887766
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=89.18 E-value=0.0057 Score=49.25 Aligned_cols=27 Identities=4% Similarity=-0.118 Sum_probs=21.5
Q ss_pred HHhhhccCCceeeccCCcccccc-cccc
Q psy1684 75 EHYSKDADGLCVNLRKPCVQVSC-RIYL 101 (189)
Q Consensus 75 ~~~~~~a~gl~~~~~~~~~~~~~-p~~l 101 (189)
.+..+.+.|+.++|...++|||+ |+.+
T Consensus 435 ~i~~qi~~aL~~LH~~gIiHrDiKp~NI 462 (540)
T 3en9_A 435 DIAYKIGEIVGKLHKNDVIHNDLTTSNF 462 (540)
T ss_dssp HHHHHHHHHHHHHHHTTEECTTCCTTSE
T ss_pred HHHHHHHHHHHHHHHCcCccCCCCHHHE
Confidence 44566778999999999999996 6644
|
| >3psi_A Transcription elongation factor SPT6; nucleus; 3.30A {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=86.10 E-value=0.14 Score=44.97 Aligned_cols=72 Identities=14% Similarity=0.142 Sum_probs=0.0
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccC------C--ccCCCCCcC-HhHHH
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFE------T--QKAGRTTIH-YPELV 74 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~------g--yl~~~~~~~-l~~li 74 (189)
.+++...|+++|. ....|.++||.|..+.+.++++++.. .+...|+.|..... | +.-++..|. |.+++
T Consensus 1028 ~n~~~~qAe~~L~--~~~~Gd~vIRPSSkG~dhLtvTwKv~-d~vyqHidV~E~~K~n~~slG~~L~I~~~~y~DLDEli 1104 (1219)
T 3psi_A 1028 FPFNGRQAEDYLR--SKERGEFVIRQSSRGDDHLVITWKLD-KDLFQHIDIQELEKENPLALGKVLIVDNQKYNDLDQII 1104 (1219)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred CCCCHHHHHHHHh--cCCCCCEEEeecCCCCCceEEEEEEc-CCcEEEEEEEecCCccccccCceEEECCceECCHHHHH
Confidence 4677788999994 45679999999988777788888875 67889998875332 2 333445787 88887
Q ss_pred HHhh
Q psy1684 75 EHYS 78 (189)
Q Consensus 75 ~~~~ 78 (189)
.-|.
T Consensus 1105 ~r~V 1108 (1219)
T 3psi_A 1105 VEYL 1108 (1219)
T ss_dssp ----
T ss_pred HHHH
Confidence 5443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 189 | ||||
| d1lkka_ | 105 | d.93.1.1 (A:) p56-lck tyrosine kinase {Human (Homo | 1e-22 | |
| d1blja_ | 114 | d.93.1.1 (A:) P55 Blk protein tyrosine kinase {Mou | 4e-22 | |
| d1qcfa2 | 103 | d.93.1.1 (A:146-248) Hemopoetic cell kinase Hck {H | 8e-22 | |
| d1o48a_ | 106 | d.93.1.1 (A:) c-src tyrosine kinase {Human (Homo s | 8e-22 | |
| d1nrva_ | 105 | d.93.1.1 (A:) Growth factor receptor-bound protein | 2e-21 | |
| d1a81a1 | 129 | d.93.1.1 (A:9-137) Syk tyrosine kinase {Human (Hom | 2e-21 | |
| d2oq1a1 | 130 | d.93.1.1 (A:5-134) Tyrosine-protein kinase zap-70 | 3e-21 | |
| d1a81a2 | 125 | d.93.1.1 (A:138-262) Syk tyrosine kinase {Human (H | 4e-21 | |
| d1rjaa_ | 100 | d.93.1.1 (A:) Tyrosine-protein kinase 6 (Breast tu | 1e-20 | |
| d2qmsa1 | 113 | d.93.1.1 (A:420-532) Growth factor receptor-bound | 2e-20 | |
| d1g83a2 | 104 | d.93.1.1 (A:142-245) Tyrosine kinase Fyn {Human (H | 3e-20 | |
| d1i3za_ | 103 | d.93.1.1 (A:) Ews/fli1 activated transcript 2, Eat | 6e-20 | |
| d1opka2 | 101 | d.93.1.1 (A:140-240) Abl tyrosine kinase {Mouse (M | 1e-19 | |
| d1d4ta_ | 104 | d.93.1.1 (A:) The Xlp protein Sap {Human (Homo sap | 2e-19 | |
| d2oq1a2 | 124 | d.93.1.1 (A:135-258) Tyrosine-protein kinase zap-7 | 2e-19 | |
| d1k9aa2 | 101 | d.93.1.1 (A:77-177) Carboxyl-terminal src kinase ( | 3e-18 | |
| d1jwoa_ | 97 | d.93.1.1 (A:) Csk homologous kinase Chk {Human (Ho | 7e-18 | |
| d1luia_ | 108 | d.93.1.1 (A:) Itk/tsk protein tyrosine kinase {Mou | 9e-18 | |
| d2shpa2 | 109 | d.93.1.1 (A:2-110) Tyrosine phoshatase shp-2 {Huma | 2e-17 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-17 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-16 | |
| d2shpa3 | 108 | d.93.1.1 (A:111-218) Tyrosine phoshatase shp-2 {Hu | 1e-15 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-15 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-15 | |
| d2fcia1 | 105 | d.93.1.1 (A:1-105) Phospholipase C-gamma-1 {Cow (B | 9e-15 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-14 | |
| d2cs0a1 | 106 | d.93.1.1 (A:8-113) Hematopoietic SH2 domain contai | 4e-14 | |
| d1mila_ | 104 | d.93.1.1 (A:) Shc adaptor protein {Human (Homo sap | 4e-14 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-13 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-13 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-13 | |
| d1jyra_ | 96 | d.93.1.1 (A:) Growth factor receptor-bound protein | 3e-13 | |
| d1fu6a_ | 111 | d.93.1.1 (A:) Phosphatidylinositol 3-kinase, p85-a | 4e-13 | |
| d2izva2 | 112 | d.93.1.1 (A:274-385) Suppressor of cytokine signal | 8e-13 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-13 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-12 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-12 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-12 | |
| d2eyva1 | 109 | d.93.1.1 (A:12-120) Crk proto-oncogen {Human (Homo | 2e-12 | |
| d1r1qa_ | 97 | d.93.1.1 (A:) GRB2-related adaptor protein 2 (MONA | 4e-12 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-12 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-12 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-11 | |
| d1qada_ | 107 | d.93.1.1 (A:) Phosphatidylinositol 3-kinase, p85-a | 1e-11 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-11 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-11 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-11 | |
| d1rpya_ | 86 | d.93.1.1 (A:) Adaptor protein Aps {Rat (Rattus nor | 4e-11 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-10 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-10 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-10 | |
| d1uura3 | 131 | d.93.1.1 (A:577-707) STAT homologue {Dictyostelium | 2e-09 | |
| d2c9wa2 | 103 | d.93.1.1 (A:32-134) Suppressor of cytokine signali | 2e-09 | |
| d1xa6a2 | 141 | d.93.1.1 (A:21-161) Beta-chimaerin, N-terminal dom | 2e-09 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 7e-09 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-08 | |
| d1bg1a3 | 141 | d.93.1.1 (A:576-716) STAT3b {Mouse (Mus musculus) | 2e-08 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-08 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-07 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-07 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-06 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-06 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-06 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-06 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-05 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-05 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-05 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-05 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-05 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-05 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-05 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-05 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-05 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-04 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-04 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-04 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-04 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-04 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 8e-04 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 0.003 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 0.004 |
| >d1lkka_ d.93.1.1 (A:) p56-lck tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 105 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: p56-lck tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.5 bits (211), Expect = 1e-22
Identities = 35/98 (35%), Positives = 48/98 (48%), Gaps = 6/98 (6%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSS------FCLKMTTG 54
W+F + R +AE++LL P N HG+FLIR+SES +SLS K+
Sbjct: 6 WFFKNLSRKDAERQLLAPGNTHGSFLIRESESTAGSFSLSVRDFDQNQGEVVKHYKIRNL 65
Query: 55 RSLFETQKAGRTTIHYPELVEHYSKDADGLCVNLRKPC 92
+ T ELV HY+ +DGLC L +PC
Sbjct: 66 DNGGFYISPRITFPGLHELVRHYTNASDGLCTRLSRPC 103
|
| >d1blja_ d.93.1.1 (A:) P55 Blk protein tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 114 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: P55 Blk protein tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 84.4 bits (208), Expect = 4e-22
Identities = 37/103 (35%), Positives = 54/103 (52%), Gaps = 9/103 (8%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS-------EYKRSSFCLKMTT 53
W+F I R +AE++LL P N G+FLIR+SES K +SLS + ++
Sbjct: 14 WFFRTISRKDAERQLLAPMNKAGSFLIRESESNKGAFSLSVKDITTQGEVVKHYKIRSLD 73
Query: 54 GRSLFETQKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQVS 96
+ + + T+ LV+HYSK DGLC L PCV ++
Sbjct: 74 NGGYYISPRITFPTLQ--ALVQHYSKKGDGLCQKLTLPCVNLA 114
|
| >d1qcfa2 d.93.1.1 (A:146-248) Hemopoetic cell kinase Hck {Human (Homo sapiens) [TaxId: 9606]} Length = 103 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Hemopoetic cell kinase Hck species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.2 bits (205), Expect = 8e-22
Identities = 39/101 (38%), Positives = 49/101 (48%), Gaps = 8/101 (7%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET 60
W+F I R +AE++LL P N G+F+IRDSE+ K YSLS + T T
Sbjct: 3 WFFKGISRKDAERQLLAPGNMLGSFMIRDSETTKGSYSLS-VRDYDPRQGDTVKHYKIRT 61
Query: 61 QKAGRTTI-------HYPELVEHYSKDADGLCVNLRKPCVQ 94
G I ELV+HY K DGLC L PC+
Sbjct: 62 LDNGGFYISPRSTFSTLQELVDHYKKGNDGLCQKLSVPCMS 102
|
| >d1o48a_ d.93.1.1 (A:) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 106 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.2 bits (205), Expect = 8e-22
Identities = 36/98 (36%), Positives = 46/98 (46%), Gaps = 6/98 (6%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET 60
WYFGKI R E+E+ LL EN G FL+R+SE+ K Y LS + + +
Sbjct: 7 WYFGKITRRESERLLLNAENPRGTFLVRESETTKGAYCLSVSDFDNAKGLNVKHYKIRKL 66
Query: 61 QKAGRTTIHY------PELVEHYSKDADGLCVNLRKPC 92
G +LV +YSK ADGLC L C
Sbjct: 67 DSGGFYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVC 104
|
| >d1nrva_ d.93.1.1 (A:) Growth factor receptor-bound protein 10, GRB10 {Human (Homo sapiens) [TaxId: 9606]} Length = 105 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Growth factor receptor-bound protein 10, GRB10 species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.3 bits (203), Expect = 2e-21
Identities = 22/99 (22%), Positives = 40/99 (40%), Gaps = 5/99 (5%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS-----EYKRSSFCLKMTTGR 55
W+ G+I R E+ + + G FL+RDS+S + L+ + K G+
Sbjct: 7 WFHGRISREESHRIIKQQGLVDGLFLLRDSQSNPKAFVLTLCHHQKIKNFQILPCEDDGQ 66
Query: 56 SLFETQKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQ 94
+ F +LV+ Y + L L+ C++
Sbjct: 67 TFFSLDDGNTKFSDLIQLVDFYQLNKGVLPCKLKHHCIR 105
|
| >d1a81a1 d.93.1.1 (A:9-137) Syk tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 129 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Syk tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.8 bits (204), Expect = 2e-21
Identities = 25/93 (26%), Positives = 40/93 (43%), Gaps = 1/93 (1%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET 60
++FG I R EAE L+ G +L+R S + ++LS
Sbjct: 7 FFFGNITREEAEDYLVQGGMSDGLYLLRQSRNYLGGFALSVAHGRKAHHYTIERELNGTY 66
Query: 61 QKAGRTTIH-YPELVEHYSKDADGLCVNLRKPC 92
AG T +L ++S+++DGL L+KP
Sbjct: 67 AIAGGRTHASPADLCHYHSQESDGLVCLLKKPF 99
|
| >d2oq1a1 d.93.1.1 (A:5-134) Tyrosine-protein kinase zap-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 130 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine-protein kinase zap-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.4 bits (203), Expect = 3e-21
Identities = 31/95 (32%), Positives = 42/95 (44%), Gaps = 1/95 (1%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS-EYKRSSFCLKMTTGRSLFE 59
+++G I R EAE+ L L G FL+R Y LS + + +
Sbjct: 8 FFYGSISRAEAEEHLKLAGMADGLFLLRQCLRSLGGYVLSLVHDVRFHHFPIERQLNGTY 67
Query: 60 TQKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQ 94
G+ EL E YS+D DGL NLRKPC +
Sbjct: 68 AIAGGKAHCGPAELCEFYSRDPDGLPCNLRKPCNR 102
|
| >d1a81a2 d.93.1.1 (A:138-262) Syk tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 125 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Syk tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.1 bits (202), Expect = 4e-21
Identities = 27/95 (28%), Positives = 47/95 (49%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET 60
W+ GKI R E+E+ +L+ +G FLIR ++ + ++ ++ ++ +
Sbjct: 31 WFHGKISREESEQIVLIGSKTNGKFLIRARDNNGSYALCLLHEGKVLHYRIDKDKTGKLS 90
Query: 61 QKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQV 95
G+ +LVEHYS ADGL L PC ++
Sbjct: 91 IPEGKKFDTLWQLVEHYSYKADGLLRVLTVPCQKI 125
|
| >d1rjaa_ d.93.1.1 (A:) Tyrosine-protein kinase 6 (Breast tumor kinase, Brk) {Human (Homo sapiens) [TaxId: 9606]} Length = 100 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine-protein kinase 6 (Breast tumor kinase, Brk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.1 bits (197), Expect = 1e-20
Identities = 30/97 (30%), Positives = 43/97 (44%), Gaps = 5/97 (5%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS---EYKRSSFCLKMTTGRSL 57
W+FG I R EA ++L N GAFLIR SE DY LS + + G L
Sbjct: 4 WFFGCISRSEAVRRLQAEGNATGAFLIRVSEKPSADYVLSVRDTQAVRHYKIWRRAGGRL 63
Query: 58 FETQKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQ 94
+ ++ PELV ++ + + L PC +
Sbjct: 64 HLNEAVSFLSL--PELVNYHRAQSLSHGLRLAAPCRK 98
|
| >d2qmsa1 d.93.1.1 (A:420-532) Growth factor receptor-bound protein 7 {Human (Homo sapiens) [TaxId: 9606]} Length = 113 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Growth factor receptor-bound protein 7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.6 bits (196), Expect = 2e-20
Identities = 23/101 (22%), Positives = 38/101 (37%), Gaps = 5/101 (4%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSF-----CLKMTTGR 55
W+ G+I R E+++ + G FL+R+S+ + LS GR
Sbjct: 12 WFHGRISREESQRLIGQQGLVDGLFLVRESQRNPQGFVLSLCHLQKVKHYLILPSEEEGR 71
Query: 56 SLFETQKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQVS 96
F +LVE + + L LR C +V+
Sbjct: 72 LYFSMDDGQTRFTDLLQLVEFHQLNRGILPCLLRHCCTRVA 112
|
| >d1g83a2 d.93.1.1 (A:142-245) Tyrosine kinase Fyn {Human (Homo sapiens) [TaxId: 9606]} Length = 104 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine kinase Fyn species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.0 bits (194), Expect = 3e-20
Identities = 34/97 (35%), Positives = 45/97 (46%), Gaps = 6/97 (6%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFC------LKMTTG 54
WYFGK+ R +AE++LL N G FLIR+SE+ K YSLS K+
Sbjct: 8 WYFGKLGRKDAERQLLSFGNPRGTFLIRESETTKGAYSLSIRDWDDMKGDHVKHYKIRKL 67
Query: 55 RSLFETQKAGRTTIHYPELVEHYSKDADGLCVNLRKP 91
+ +LV+HYS+ A GL L P
Sbjct: 68 DNGGYYITTRAQFETLQQLVQHYSERAAGLSSRLVVP 104
|
| >d1i3za_ d.93.1.1 (A:) Ews/fli1 activated transcript 2, Eat2 {Mouse (Mus musculus) [TaxId: 10090]} Length = 103 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Ews/fli1 activated transcript 2, Eat2 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 78.2 bits (192), Expect = 6e-20
Identities = 32/98 (32%), Positives = 38/98 (38%), Gaps = 7/98 (7%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFC----LKMTTGRS 56
+Y G + + E E LLL G FLIRDSES L + + G
Sbjct: 5 YYHGCLTKRECEA-LLLKGGVDGNFLIRDSESVPGALCLCVSFKKLVYSYRIFREKHGYY 63
Query: 57 LFETQKAGRTTIH--YPELVEHYSKDADGLCVNLRKPC 92
ET TI ELV Y K GL V+L P
Sbjct: 64 RIETDAHTPRTIFPNLQELVSKYGKPGQGLVVHLSNPI 101
|
| >d1opka2 d.93.1.1 (A:140-240) Abl tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 101 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Abl tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 77.4 bits (190), Expect = 1e-19
Identities = 30/95 (31%), Positives = 43/95 (45%), Gaps = 3/95 (3%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS-EYKRSSFCLKMTTGRSLFE 59
WY G + R AE LL +G+FL+R+SES S+S Y+ + ++ T
Sbjct: 7 WYHGPVSRNAAEY--LLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKL 64
Query: 60 TQKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQ 94
+ ELV H+S ADGL L P +
Sbjct: 65 YVSSESRFNTLAELVHHHSTVADGLITTLHYPAPK 99
|
| >d1d4ta_ d.93.1.1 (A:) The Xlp protein Sap {Human (Homo sapiens) [TaxId: 9606]} Length = 104 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: The Xlp protein Sap species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.0 bits (189), Expect = 2e-19
Identities = 29/98 (29%), Positives = 38/98 (38%), Gaps = 7/98 (7%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFC----LKMTTGRS 56
Y GKI R EK LLL G++L+RDSES Y L + TG
Sbjct: 6 VYHGKISRETGEK-LLLATGLDGSYLLRDSESVPGVYCLCVLYHGYIYTYRVSQTETGSW 64
Query: 57 LFETQKA--GRTTIHYPELVEHYSKDADGLCVNLRKPC 92
ET R L+ + K G+ + L+ P
Sbjct: 65 SAETAPGVHKRYFRKIKNLISAFQKPDQGIVIPLQYPV 102
|
| >d2oq1a2 d.93.1.1 (A:135-258) Tyrosine-protein kinase zap-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine-protein kinase zap-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.4 bits (190), Expect = 2e-19
Identities = 25/95 (26%), Positives = 40/95 (42%), Gaps = 6/95 (6%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSS---FCLKMTTGRSL 57
WY + R EAE+KL G FL+R + + Y+LS + + +
Sbjct: 31 WYHSSLTREEAERKLYSGAQTDGKFLLRPRKEQ-GTYALSLIYGKTVYHYLISQDKAGKY 89
Query: 58 FETQKAGRTTIHYPELVEHYSKDADGLCVNLRKPC 92
+ T+ +LVE+ ADGL L++ C
Sbjct: 90 CIPEGTKFDTL--WQLVEYLKLKADGLIYCLKEAC 122
|
| >d1k9aa2 d.93.1.1 (A:77-177) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 101 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.9 bits (181), Expect = 3e-18
Identities = 33/94 (35%), Positives = 45/94 (47%), Gaps = 2/94 (2%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET 60
W+ GKI R +AE+ L PE G FL+R+S + DY+L + +
Sbjct: 6 WFHGKITREQAERLLYPPET--GLFLVRESTNYPGDYTLCVSCEGKVEHYRIMYHASKLS 63
Query: 61 QKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQ 94
+ +LVEHY+ DADGLC L KP V
Sbjct: 64 IDEEVYFENLMQLVEHYTTDADGLCTRLIKPKVM 97
|
| >d1jwoa_ d.93.1.1 (A:) Csk homologous kinase Chk {Human (Homo sapiens) [TaxId: 9606]} Length = 97 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Csk homologous kinase Chk species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.7 bits (178), Expect = 7e-18
Identities = 29/92 (31%), Positives = 40/92 (43%), Gaps = 2/92 (2%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET 60
W+ GKI EA ++L PE+ G FL+R+S DY L R T
Sbjct: 6 WFHGKISGQEAVQQLQPPED--GLFLVRESARHPGDYVLCVSFGRDVIHYRVLHRDGHLT 63
Query: 61 QKAGRTTIHYPELVEHYSKDADGLCVNLRKPC 92
+ ++VEHYSKD +C L +P
Sbjct: 64 IDEAVFFCNLMDMVEHYSKDKGAICTKLVRPK 95
|
| >d1luia_ d.93.1.1 (A:) Itk/tsk protein tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 108 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Itk/tsk protein tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 72.8 bits (178), Expect = 9e-18
Identities = 27/101 (26%), Positives = 40/101 (39%), Gaps = 11/101 (10%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS--EYKRSSFCLKMTTGRSLF 58
WY I R +AEK LLL GAF++RDS + Y++S S +
Sbjct: 8 WYNKSISRDKAEK-LLLDTGKEGAFMVRDSRTP-GTYTVSVFTKAIISENPCIKHYHIKE 65
Query: 59 ETQKAGRTTI-------HYPELVEHYSKDADGLCVNLRKPC 92
R + P L++++ + GL LR P
Sbjct: 66 TNDSPKRYYVAEKYVFDSIPLLIQYHQYNGGGLVTRLRYPV 106
|
| >d2shpa2 d.93.1.1 (A:2-110) Tyrosine phoshatase shp-2 {Human (Homo sapiens) [TaxId: 9606]} Length = 109 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine phoshatase shp-2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.0 bits (176), Expect = 2e-17
Identities = 28/100 (28%), Positives = 41/100 (41%), Gaps = 11/100 (11%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS--EYKRSSFCLKMTTGRSLF 58
W+ I +EAE LLL G+FL R S+S D +LS + TG
Sbjct: 5 WFHPNITGVEAEN-LLLTRGVDGSFLARPSKSNPGDLTLSVRRNGAVTHIKIQNTGDYYD 63
Query: 59 ETQKAGRTTIHYPELVEHYS------KDADGLCVNLRKPC 92
T+ ELV++Y K+ +G + L+ P
Sbjct: 64 LYGGEKFATL--AELVQYYMEHHGQLKEKNGDVIELKYPL 101
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.7 bits (183), Expect = 4e-17
Identities = 39/64 (60%), Positives = 46/64 (71%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180
GM N EVL QVE GYRMPCPP CP L+D+M +CW K+P +RPTFE LQ LED+FT
Sbjct: 217 GMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276
Query: 181 SDYK 184
Y+
Sbjct: 277 PQYQ 280
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.4 bits (177), Expect = 2e-16
Identities = 31/58 (53%), Positives = 37/58 (63%)
Query: 120 GGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFT 177
GMTN EV+ +E GYRM P CP LY +M CW + P RPTF+ L+ LEDFFT
Sbjct: 212 PGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269
|
| >d2shpa3 d.93.1.1 (A:111-218) Tyrosine phoshatase shp-2 {Human (Homo sapiens) [TaxId: 9606]} Length = 108 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine phoshatase shp-2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.5 bits (164), Expect = 1e-15
Identities = 30/106 (28%), Positives = 44/106 (41%), Gaps = 15/106 (14%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS--------EYKRSSFCLKMT 52
W+ G + EAEK LL + HG+FL+R+S+S D+ LS E +
Sbjct: 2 WFHGHLSGKEAEK-LLTEKGKHGSFLVRESQSHPGDFVLSVRTGDDKGESNDGKSKVTHV 60
Query: 53 TGRSLFETQKAGRTTIHY--PELVEHYSKD----ADGLCVNLRKPC 92
R G +LVEHY K+ G + L++P
Sbjct: 61 MIRCQELKYDVGGGERFDSLTDLVEHYKKNPMVETLGTVLQLKQPL 106
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.8 bits (170), Expect = 2e-15
Identities = 23/56 (41%), Positives = 33/56 (58%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFF 176
GM +EV +E G RM CP GCP +YD+M CW D RP F ++ +L +++
Sbjct: 213 GMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.7 bits (170), Expect = 3e-15
Identities = 22/56 (39%), Positives = 32/56 (57%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFF 176
M EV+ +E G RM CPP CPP LY +M +CW+ RP F T++ ++ +
Sbjct: 215 KMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270
|
| >d2fcia1 d.93.1.1 (A:1-105) Phospholipase C-gamma-1 {Cow (Bos taurus) [TaxId: 9913]} Length = 105 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Phospholipase C-gamma-1 species: Cow (Bos taurus) [TaxId: 9913]
Score = 64.7 bits (157), Expect = 9e-15
Identities = 17/94 (18%), Positives = 34/94 (36%), Gaps = 3/94 (3%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET 60
WY + R +AE +L+ GAFL+R + + ++
Sbjct: 11 WYHASLTRAQAEH-MLMRVPRDGAFLVRKRNEPNSYAISFRAEGKIKHCRVQQEGQTVML 69
Query: 61 QKAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQ 94
+ ++ +L+ +Y K + LR P +
Sbjct: 70 GNSEFDSL--VDLISYYEKHPLYRKMKLRYPINE 101
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.0 bits (163), Expect = 2e-14
Identities = 24/60 (40%), Positives = 35/60 (58%)
Query: 120 GGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTME 179
+ +V+ +VE GY+M P GCPP +Y++M CW D RP+F L+ +LE T E
Sbjct: 202 PRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 261
|
| >d2cs0a1 d.93.1.1 (A:8-113) Hematopoietic SH2 domain containing protein HSH2D {Human (Homo sapiens) [TaxId: 9606]} Length = 106 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Hematopoietic SH2 domain containing protein HSH2D species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.2 bits (153), Expect = 4e-14
Identities = 25/98 (25%), Positives = 39/98 (39%), Gaps = 8/98 (8%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTT---GRSL 57
W+ G I R +AE LL G+FLIR S S + + S + G +
Sbjct: 11 WFHGAISREDAEN--LLESQPLGSFLIRVSHSHVGYTLSYKAQSSCCHFMVKLLDDGTFM 68
Query: 58 FETQKAGRTTIHYPELVEHYSKDA-DGLCVNLRKPCVQ 94
+K T++ LV + + + L +PC Q
Sbjct: 69 IPGEKVAHTSL--DALVTFHQQKPIEPRRELLTQPCRQ 104
|
| >d1mila_ d.93.1.1 (A:) Shc adaptor protein {Human (Homo sapiens) [TaxId: 9606]} Length = 104 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Shc adaptor protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.1 bits (153), Expect = 4e-14
Identities = 21/98 (21%), Positives = 40/98 (40%), Gaps = 12/98 (12%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS-EYKRSSFCLKMTTGRSLFE 59
W+ GK+ R EAE L +G FL+R+S + Y L+ L + +
Sbjct: 9 WFHGKLSRREAEALL----QLNGDFLVRESTTTPGQYVLTGLQSGQPKHLLLVDPEGVVR 64
Query: 60 TQKAGRTTIHYPELVEHYSKDA-----DGLCVNLRKPC 92
T+ ++ L+ ++ + G + L++P
Sbjct: 65 TKDHRFESV--SHLISYHMDNHLPIISAGSELCLQQPV 100
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.8 bits (157), Expect = 2e-13
Identities = 19/55 (34%), Positives = 29/55 (52%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDF 175
G+ +E+ +E G R+P PP C +Y IM++CW+ D RP F L +
Sbjct: 216 GIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.3 bits (156), Expect = 2e-13
Identities = 17/54 (31%), Positives = 26/54 (48%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLED 174
TN+E + G R+ P ++Y IM CW + +RPTF+ L + D
Sbjct: 204 RFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 64.0 bits (155), Expect = 3e-13
Identities = 20/57 (35%), Positives = 31/57 (54%)
Query: 120 GGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFF 176
G+ ++V +E YRM P GCP ++Y++M CW +P RP+F + E F
Sbjct: 218 PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274
|
| >d1jyra_ d.93.1.1 (A:) Growth factor receptor-bound protein 2 (GRB2) {Human (Homo sapiens) [TaxId: 9606]} Length = 96 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Growth factor receptor-bound protein 2 (GRB2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.3 bits (146), Expect = 3e-13
Identities = 26/81 (32%), Positives = 40/81 (49%), Gaps = 5/81 (6%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS--EYKRSSFCLKMTTGRSLF 58
W+FGKI R +AE+ +L + GAFLIR+SES D+SLS + G +
Sbjct: 5 WFFGKIPRAKAEE-MLSKQRHDGAFLIRESESAPGDFSLSVKFGNDVQHFKVLRDGAGKY 63
Query: 59 ETQKAGRTTIHYPELVEHYSK 79
++ ELV+++
Sbjct: 64 FLWVVKFNSL--NELVDYHRS 82
|
| >d1fu6a_ d.93.1.1 (A:) Phosphatidylinositol 3-kinase, p85-alpha subunit {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 111 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Phosphatidylinositol 3-kinase, p85-alpha subunit species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 60.4 bits (146), Expect = 4e-13
Identities = 24/100 (24%), Positives = 40/100 (40%), Gaps = 12/100 (12%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESR-KNDYSLSEYKRSSFC--LKMTTGRSL 57
WY+G I R E + L + G FL+RD+ ++ DY+L+ K +
Sbjct: 13 WYWGDISREEVNE--KLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKSIKIFHRDGKY 70
Query: 58 FETQKAGRTTIHYPELVEHYSKDA-----DGLCVNLRKPC 92
+ ++ EL+ HY ++ L V L P
Sbjct: 71 GFSDPLTFNSV--VELINHYRNESLAQYNPKLDVKLLYPV 108
|
| >d2izva2 d.93.1.1 (A:274-385) Suppressor of cytokine signaling 4, SOCS-4 {Human (Homo sapiens) [TaxId: 9606]} Length = 112 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Suppressor of cytokine signaling 4, SOCS-4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.1 bits (145), Expect = 8e-13
Identities = 21/100 (21%), Positives = 36/100 (36%), Gaps = 8/100 (8%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS---EYKRSSFCLKMTTGRSL 57
Y+G + + AE LL G FL+RDS +S+S + ++
Sbjct: 13 CYWGVMDKYAAEA--LLEGKPEGTFLLRDSAQEDYLFSVSFRRYSRSLHARIEQWNHNFS 70
Query: 58 FETQKAGRTTIH-YPELVEHYSKDADGLCVN--LRKPCVQ 94
F+ L+EHY + + L P ++
Sbjct: 71 FDAHDPCVFHSPDITGLLEHYKDPSACMFFEPLLSTPLIR 110
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 62.9 bits (152), Expect = 8e-13
Identities = 21/53 (39%), Positives = 31/53 (58%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLE 173
GM + EV++ V G + CP CP LY++M CW K P RP+F ++ L+
Sbjct: 245 GMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 297
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 62.5 bits (151), Expect = 1e-12
Identities = 22/55 (40%), Positives = 32/55 (58%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDF 175
MTN +V++ +E YR+P P CP L+ +ML+CW KD RP F + L+
Sbjct: 236 DMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.5 bits (151), Expect = 1e-12
Identities = 25/59 (42%), Positives = 37/59 (62%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTME 179
G+ N +V+ ++E+G R+P PP CPP LY +M +CW DP +RP F L+ +L E
Sbjct: 212 GVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.5 bits (151), Expect = 1e-12
Identities = 19/65 (29%), Positives = 30/65 (46%), Gaps = 1/65 (1%)
Query: 120 GGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFF-TM 178
+ ++ + G R+ P CP LY++ML+CW RP+F L ++ F T
Sbjct: 236 PDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295
Query: 179 EGSDY 183
G Y
Sbjct: 296 IGEHY 300
|
| >d2eyva1 d.93.1.1 (A:12-120) Crk proto-oncogen {Human (Homo sapiens) [TaxId: 9606]} Length = 109 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Crk proto-oncogen species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.6 bits (141), Expect = 2e-12
Identities = 27/109 (24%), Positives = 37/109 (33%), Gaps = 20/109 (18%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS-----------------EYK 43
WY+G++ R EA LL HG FL+RDS + DY LS
Sbjct: 2 WYWGRLSRQEAVA--LLQGQRHGVFLVRDSSTSPGDYVLSVSENSRVSHYIINSSGPRPP 59
Query: 44 RSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGLCVNLRKPC 92
+ G S + + P L+E Y L +P
Sbjct: 60 VPPSPAQPPPGVSPSRLRIGDQEFDSLPALLEFYKIH-YLDTTTLIEPV 107
|
| >d1r1qa_ d.93.1.1 (A:) GRB2-related adaptor protein 2 (MONA, GRID) {Mouse (Mus musculus) [TaxId: 10090]} Length = 97 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: GRB2-related adaptor protein 2 (MONA, GRID) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 57.6 bits (139), Expect = 4e-12
Identities = 20/81 (24%), Positives = 34/81 (41%), Gaps = 6/81 (7%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS--EYKRSSFCLKMTTGRSLF 58
W+ + R +AE LL D G F+IR S+S D+S+S M + +
Sbjct: 8 WFHEGLSRHQAEN--LLMGKDIGFFIIRASQSSPGDFSISVRHEDDVQHFKVMRDTKGNY 65
Query: 59 ETQKAGRTTIHYPELVEHYSK 79
++ +LV++Y
Sbjct: 66 FLWTEKFPSL--NKLVDYYRT 84
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.6 bits (146), Expect = 6e-12
Identities = 19/58 (32%), Positives = 30/58 (51%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTM 178
G+ E+ ++ G+RM P C LY +M +CW P +RPTF+ L L+ +
Sbjct: 240 GVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.2 bits (145), Expect = 6e-12
Identities = 17/56 (30%), Positives = 32/56 (57%)
Query: 120 GGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDF 175
++N EV+ + G+R+P P CP +Y +M++CW ++ +RP F + L+
Sbjct: 215 WELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.8 bits (144), Expect = 1e-11
Identities = 20/53 (37%), Positives = 31/53 (58%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLE 173
GMT AE+ ++ GYR+ P C +YD+M +CW + P +RP+F + L
Sbjct: 229 GMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281
|
| >d1qada_ d.93.1.1 (A:) Phosphatidylinositol 3-kinase, p85-alpha subunit {Cow (Bos taurus) [TaxId: 9913]} Length = 107 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Phosphatidylinositol 3-kinase, p85-alpha subunit species: Cow (Bos taurus) [TaxId: 9913]
Score = 56.6 bits (136), Expect = 1e-11
Identities = 25/98 (25%), Positives = 35/98 (35%), Gaps = 9/98 (9%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS-EYKRSSFCLKMTTGRSLFE 59
W G R +AE LL G FL+R+S S++ Y+ S + + +
Sbjct: 11 WNVGSSNRNKAEN--LLRGKRDGTFLVRES-SKQGCYACSVVVDGEVKHCVINKTATGYG 67
Query: 60 TQKAGRTTIHYPELVEHYSK-----DADGLCVNLRKPC 92
+ ELV HY D L V L P
Sbjct: 68 FAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPV 105
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.0 bits (142), Expect = 2e-11
Identities = 20/55 (36%), Positives = 35/55 (63%), Gaps = 1/55 (1%)
Query: 121 GMTNAEVLHQVEH-GYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLED 174
G+ +++LH+++ G R+P P CP +Y++M++CW P RPTF L+ L +
Sbjct: 217 GLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.9 bits (142), Expect = 2e-11
Identities = 17/55 (30%), Positives = 27/55 (49%)
Query: 120 GGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLED 174
+N+EV+ + G+R+ P +Y IM CW + P RP F L +L +
Sbjct: 204 ENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAE 258
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.1 bits (142), Expect = 2e-11
Identities = 21/69 (30%), Positives = 35/69 (50%), Gaps = 4/69 (5%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTF----ETLQWKLEDFF 176
G++N +VL V G + P CP L+++M CW +P RP+F +++ ++E F
Sbjct: 238 GLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 297
Query: 177 TMEGSDYKE 185
Y E
Sbjct: 298 REVSFYYSE 306
|
| >d1rpya_ d.93.1.1 (A:) Adaptor protein Aps {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 86 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Adaptor protein Aps species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 55.0 bits (132), Expect = 4e-11
Identities = 17/80 (21%), Positives = 35/80 (43%), Gaps = 5/80 (6%)
Query: 1 WYFGKIKRIEAEKKLLL-PENDHGAFLIRDSESRKNDYSLS--EYKRSSFCLKMTTGRSL 57
W+ G + R++A + +L HG F+IR SE+R + L+ ++ G
Sbjct: 7 WFHGTLSRVKAAQLVLAGGPRSHGLFVIRQSETRPGECVLTFNFQGKAKHLRLSLNGHGQ 66
Query: 58 FETQKAGRTTIHYPELVEHY 77
Q ++ +++ H+
Sbjct: 67 CHVQHLWFQSV--FDMLRHF 84
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.4 bits (135), Expect = 1e-10
Identities = 19/57 (33%), Positives = 28/57 (49%)
Query: 119 SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDF 175
G + E +++ G RM P P +Y ML+CW +P +RPTF L L +
Sbjct: 238 PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.6 bits (133), Expect = 4e-10
Identities = 17/55 (30%), Positives = 25/55 (45%)
Query: 119 SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLE 173
G +A +++G++M P +Y IM CW D KRP+F L L
Sbjct: 268 PGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.4 bits (130), Expect = 8e-10
Identities = 20/55 (36%), Positives = 31/55 (56%)
Query: 119 SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLE 173
G +++ ++ G+RM P P +YDIM CW DP+KRPTF+ + +E
Sbjct: 249 PGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303
|
| >d1uura3 d.93.1.1 (A:577-707) STAT homologue {Dictyostelium discoideum [TaxId: 44689]} Length = 131 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: STAT homologue species: Dictyostelium discoideum [TaxId: 44689]
Score = 51.5 bits (123), Expect = 2e-09
Identities = 11/40 (27%), Positives = 17/40 (42%), Gaps = 2/40 (5%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLS 40
+G + R E L D G F+IR SE + ++
Sbjct: 11 IIYGYMGRQEVND--ALQNQDPGTFIIRFSERNPGQFGIA 48
|
| >d2c9wa2 d.93.1.1 (A:32-134) Suppressor of cytokine signaling 2, SOCS-2 {Human (Homo sapiens) [TaxId: 9606]} Length = 103 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Suppressor of cytokine signaling 2, SOCS-2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.8 bits (121), Expect = 2e-09
Identities = 18/86 (20%), Positives = 37/86 (43%), Gaps = 9/86 (10%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSS---FCLKMTTGRSL 57
WY+G + EA++ L E G FLIRDS ++S + ++ G+
Sbjct: 17 WYWGSMTVNEAKE--KLKEAPEGTFLIRDSSHSDYLLTISVKTSAGPTNLRIEYQDGKFR 74
Query: 58 FETQKAGRTTIHY----PELVEHYSK 79
++ ++ + L+++Y +
Sbjct: 75 LDSIICVKSKLKQFDSVVHLIDYYVQ 100
|
| >d1xa6a2 d.93.1.1 (A:21-161) Beta-chimaerin, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 141 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Beta-chimaerin, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.5 bits (123), Expect = 2e-09
Identities = 16/92 (17%), Positives = 34/92 (36%), Gaps = 11/92 (11%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET 60
+ G I R +A++ L GA+++R+S+ + Y+L+ L+ +
Sbjct: 37 EFHGIISREQADELL---GGVEGAYILRESQRQPGCYTLA--------LRFGNQTLNYRL 85
Query: 61 QKAGRTTIHYPELVEHYSKDADGLCVNLRKPC 92
G+ + + DGL +
Sbjct: 86 FHDGKHFVGEKRFESIHDLVTDGLITLYIETK 117
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.5 bits (123), Expect = 7e-09
Identities = 8/48 (16%), Positives = 16/48 (33%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETL 168
+ E+ ++ G P L +I+ RP+ E +
Sbjct: 216 AFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEI 263
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.7 bits (121), Expect = 1e-08
Identities = 15/58 (25%), Positives = 23/58 (39%), Gaps = 5/58 (8%)
Query: 121 GMTNAEVLHQ-VEHGYRMP----CPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLE 173
+ N + + V GY P CP + +M EC K +RP F + +E
Sbjct: 211 NINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1bg1a3 d.93.1.1 (A:576-716) STAT3b {Mouse (Mus musculus) [TaxId: 10090]} Length = 141 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: STAT3b species: Mouse (Mus musculus) [TaxId: 10090]
Score = 49.1 bits (117), Expect = 2e-08
Identities = 16/94 (17%), Positives = 32/94 (34%), Gaps = 6/94 (6%)
Query: 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKN-DYSLSEYKRSSFCLKMTTGRSLFE 59
+ G I + +L G FL+R SES K + + ++ +
Sbjct: 9 YIMGFISKERERA--ILSTKPPGTFLLRFSESSKEGGVTFTWVEKDISGSTQIQSVEPYT 66
Query: 60 TQKAGRTTIHYPELVEHYSKDADGLCVNLRKPCV 93
Q+ + + E++ Y K D + +
Sbjct: 67 KQQ--LNNMSFAEIIMGY-KIMDATNILVSPLVY 97
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 49.5 bits (117), Expect = 4e-08
Identities = 8/46 (17%), Positives = 14/46 (30%)
Query: 138 PCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEGSDY 183
G P + C +P + L+ + F +G Y
Sbjct: 239 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 284
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 46.7 bits (110), Expect = 4e-07
Identities = 11/72 (15%), Positives = 18/72 (25%), Gaps = 4/72 (5%)
Query: 118 GSGGMTNAEVLHQVEHGYRMP----CPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLE 173
G TN + ++ + G P Y M P ++ LQ
Sbjct: 215 GLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 274
Query: 174 DFFTMEGSDYKE 185
+ E
Sbjct: 275 KVLERLNTTEDE 286
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.6 bits (107), Expect = 9e-07
Identities = 13/55 (23%), Positives = 17/55 (30%), Gaps = 5/55 (9%)
Query: 131 VEHGYRMPCP-----PGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180
E R P + IM ECW + R T ++ L EG
Sbjct: 246 CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (107), Expect = 1e-06
Identities = 12/64 (18%), Positives = 23/64 (35%), Gaps = 6/64 (9%)
Query: 121 GMTNAEVLHQVEHG--YRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLED-FFT 177
+ VL ++ + P D + +C K+ R T L L+ F T
Sbjct: 217 ELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL---LQHPFVT 273
Query: 178 MEGS 181
++ +
Sbjct: 274 VDSN 277
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.4 bits (107), Expect = 1e-06
Identities = 10/49 (20%), Positives = 16/49 (32%), Gaps = 1/49 (2%)
Query: 121 GMTNAEVLHQV-EHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETL 168
M L+ + ++ + + C K P RPT E L
Sbjct: 216 NMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVL 264
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (103), Expect = 4e-06
Identities = 8/50 (16%), Positives = 14/50 (28%), Gaps = 2/50 (4%)
Query: 121 GMTNAEVLHQVEHG--YRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETL 168
L+ + + P D + C D KR + + L
Sbjct: 218 NENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (101), Expect = 5e-06
Identities = 7/48 (14%), Positives = 14/48 (29%), Gaps = 1/48 (2%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETL 168
T E ++ P D++ +P +RP +
Sbjct: 206 ANTYQETYKRISRV-EFTFPDFVTEGARDLISRLLKHNPSQRPMLREV 252
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.3 bits (99), Expect = 1e-05
Identities = 9/51 (17%), Positives = 21/51 (41%), Gaps = 1/51 (1%)
Query: 119 SGGMTNAEVLHQVEHGYRMP-CPPGCPPRLYDIMLECWLKDPVKRPTFETL 168
S A++ +V G + P + +I+ C ++ +R + + L
Sbjct: 213 SECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL 263
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.6 bits (97), Expect = 2e-05
Identities = 8/46 (17%), Positives = 18/46 (39%), Gaps = 1/46 (2%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFE 166
G E+ H + P D++++ ++++P KR
Sbjct: 205 GQDEEELFHSIRMD-NPFYPRWLEKEAKDLLVKLFVREPEKRLGVR 249
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 41.6 bits (97), Expect = 2e-05
Identities = 11/51 (21%), Positives = 16/51 (31%), Gaps = 3/51 (5%)
Query: 121 GMTNAEVLHQVEHG---YRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETL 168
G + E L V+ + P D + K+P KR T
Sbjct: 230 GEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 280
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 41.2 bits (96), Expect = 3e-05
Identities = 12/52 (23%), Positives = 16/52 (30%), Gaps = 3/52 (5%)
Query: 120 GGMTNAEVLHQVEHG---YRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETL 168
GG + E L V+ G D + + L DP R T
Sbjct: 226 GGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQA 277
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.5 bits (94), Expect = 4e-05
Identities = 12/51 (23%), Positives = 16/51 (31%), Gaps = 3/51 (5%)
Query: 121 GMTNAEVLHQVEHG---YRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETL 168
G T E L V + D + +KDP KR T +
Sbjct: 218 GDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.4 bits (94), Expect = 5e-05
Identities = 11/51 (21%), Positives = 17/51 (33%), Gaps = 3/51 (5%)
Query: 121 GMTNAEVLHQVEHG---YRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETL 168
+A++ Q+ + P D + KDP KR T E
Sbjct: 211 DENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQA 261
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.4 bits (94), Expect = 5e-05
Identities = 6/51 (11%), Positives = 15/51 (29%), Gaps = 3/51 (5%)
Query: 121 GMTNAEVLHQVEHG---YRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETL 168
TN +++ + + + D + +K+ R T
Sbjct: 205 AETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA 255
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (93), Expect = 7e-05
Identities = 5/52 (9%), Positives = 15/52 (28%)
Query: 117 FGSGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETL 168
+ + E E + ++ + +++P R T +
Sbjct: 206 WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDI 257
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (92), Expect = 9e-05
Identities = 7/49 (14%), Positives = 17/49 (34%), Gaps = 1/49 (2%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQ 169
+ ++ P P+ D++ + + D KR E ++
Sbjct: 212 AGNEYLIFQKIIKL-EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEME 259
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 38.2 bits (88), Expect = 3e-04
Identities = 10/47 (21%), Positives = 17/47 (36%), Gaps = 3/47 (6%)
Query: 121 GMTNAEVLHQVEHGYRMP---CPPGCPPRLYDIMLECWLKDPVKRPT 164
G + V +Q +P G L ++L+ K+P R
Sbjct: 216 GDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQ 262
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 38.1 bits (88), Expect = 3e-04
Identities = 9/51 (17%), Positives = 16/51 (31%), Gaps = 3/51 (5%)
Query: 121 GMTNAEVLHQVEHG---YRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETL 168
+L + G + P + D++ + P KR T E
Sbjct: 217 HRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 38.2 bits (88), Expect = 3e-04
Identities = 5/44 (11%), Positives = 15/44 (34%), Gaps = 1/44 (2%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPT 164
+ ++ + + PP + D++ +D +R
Sbjct: 203 DSNTMKTYEKILNA-ELRFPPFFNEDVKDLLSRLITRDLSQRLG 245
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.8 bits (87), Expect = 4e-04
Identities = 6/44 (13%), Positives = 13/44 (29%), Gaps = 1/44 (2%)
Query: 121 GMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPT 164
+ + + + P P ++ KDP +R
Sbjct: 207 NQDHERLFELILME-EIRFPRTLSPEAKSLLAGLLKKDPKQRLG 249
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 37.4 bits (86), Expect = 6e-04
Identities = 6/48 (12%), Positives = 15/48 (31%)
Query: 117 FGSGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPT 164
F + + ++ + P P L ++ +D +R
Sbjct: 206 FRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLG 253
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.6 bits (84), Expect = 8e-04
Identities = 7/33 (21%), Positives = 12/33 (36%)
Query: 136 RMPCPPGCPPRLYDIMLECWLKDPVKRPTFETL 168
++ ++ C P RPTFE +
Sbjct: 220 QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 252
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 35.1 bits (80), Expect = 0.003
Identities = 4/31 (12%), Positives = 9/31 (29%)
Query: 138 PCPPGCPPRLYDIMLECWLKDPVKRPTFETL 168
P + ++ +P +R T
Sbjct: 239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 269
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 34.8 bits (79), Expect = 0.004
Identities = 9/47 (19%), Positives = 15/47 (31%)
Query: 118 GSGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPT 164
G + + + P P D++ +KDP KR
Sbjct: 234 VDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLG 280
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 189 | |||
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 99.93 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 99.93 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.92 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 99.91 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 99.91 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 99.91 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.91 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 99.9 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.9 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.9 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.9 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.9 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.9 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.9 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.89 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.89 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.89 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 99.89 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.88 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.87 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.86 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.85 | |
| d1rjaa_ | 100 | Tyrosine-protein kinase 6 (Breast tumor kinase, Br | 99.83 | |
| d1jwoa_ | 97 | Csk homologous kinase Chk {Human (Homo sapiens) [T | 99.83 | |
| d1qcfa2 | 103 | Hemopoetic cell kinase Hck {Human (Homo sapiens) [ | 99.82 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 99.82 | |
| d1k9aa2 | 101 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.82 | |
| d1a81a1 | 129 | Syk tyrosine kinase {Human (Homo sapiens) [TaxId: | 99.82 | |
| d2oq1a2 | 124 | Tyrosine-protein kinase zap-70 {Human (Homo sapien | 99.82 | |
| d2oq1a1 | 130 | Tyrosine-protein kinase zap-70 {Human (Homo sapien | 99.82 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 99.81 | |
| d1opka2 | 101 | Abl tyrosine kinase {Mouse (Mus musculus) [TaxId: | 99.8 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 99.8 | |
| d1lkka_ | 105 | p56-lck tyrosine kinase {Human (Homo sapiens) [Tax | 99.8 | |
| d1o48a_ | 106 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.8 | |
| d1blja_ | 114 | P55 Blk protein tyrosine kinase {Mouse (Mus muscul | 99.8 | |
| d1a81a2 | 125 | Syk tyrosine kinase {Human (Homo sapiens) [TaxId: | 99.79 | |
| d1nrva_ | 105 | Growth factor receptor-bound protein 10, GRB10 {Hu | 99.79 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 99.78 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 99.78 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 99.78 | |
| d1g83a2 | 104 | Tyrosine kinase Fyn {Human (Homo sapiens) [TaxId: | 99.78 | |
| d1i3za_ | 103 | Ews/fli1 activated transcript 2, Eat2 {Mouse (Mus | 99.77 | |
| d2qmsa1 | 113 | Growth factor receptor-bound protein 7 {Human (Hom | 99.77 | |
| d1d4ta_ | 104 | The Xlp protein Sap {Human (Homo sapiens) [TaxId: | 99.76 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 99.75 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 99.75 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 99.75 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 99.74 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.74 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.73 | |
| d1jyra_ | 96 | Growth factor receptor-bound protein 2 (GRB2) {Hum | 99.73 | |
| d2fcia1 | 105 | Phospholipase C-gamma-1 {Cow (Bos taurus) [TaxId: | 99.73 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 99.72 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.72 | |
| d2shpa2 | 109 | Tyrosine phoshatase shp-2 {Human (Homo sapiens) [T | 99.72 | |
| d1luia_ | 108 | Itk/tsk protein tyrosine kinase {Mouse (Mus muscul | 99.71 | |
| d1r1qa_ | 97 | GRB2-related adaptor protein 2 (MONA, GRID) {Mouse | 99.71 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 99.7 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.7 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 99.69 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 99.69 | |
| d1mila_ | 104 | Shc adaptor protein {Human (Homo sapiens) [TaxId: | 99.69 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 99.69 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 99.68 | |
| d1qada_ | 107 | Phosphatidylinositol 3-kinase, p85-alpha subunit { | 99.67 | |
| d2izva2 | 112 | Suppressor of cytokine signaling 4, SOCS-4 {Human | 99.67 | |
| d2shpa3 | 108 | Tyrosine phoshatase shp-2 {Human (Homo sapiens) [T | 99.66 | |
| d1rpya_ | 86 | Adaptor protein Aps {Rat (Rattus norvegicus) [TaxI | 99.66 | |
| d2cs0a1 | 106 | Hematopoietic SH2 domain containing protein HSH2D | 99.66 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.65 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.65 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.64 | |
| d2eyva1 | 109 | Crk proto-oncogen {Human (Homo sapiens) [TaxId: 96 | 99.62 | |
| d1fu6a_ | 111 | Phosphatidylinositol 3-kinase, p85-alpha subunit { | 99.62 | |
| d2c9wa2 | 103 | Suppressor of cytokine signaling 2, SOCS-2 {Human | 99.61 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.58 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.56 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.55 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.54 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.54 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.54 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.45 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.44 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.43 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.43 | |
| d1xa6a2 | 141 | Beta-chimaerin, N-terminal domain {Human (Homo sap | 99.42 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.37 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.32 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.31 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.27 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.22 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.11 | |
| d1uura3 | 131 | STAT homologue {Dictyostelium discoideum [TaxId: 4 | 99.09 | |
| d1bg1a3 | 141 | STAT3b {Mouse (Mus musculus) [TaxId: 10090]} | 98.86 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 98.71 | |
| d1bf5a3 | 142 | STAT-1 {Human (Homo sapiens) [TaxId: 9606]} | 95.32 | |
| d3buxb3 | 88 | Cbl {Human (Homo sapiens) [TaxId: 9606]} | 81.19 |
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.93 E-value=5.9e-28 Score=179.54 Aligned_cols=155 Identities=21% Similarity=0.288 Sum_probs=127.3
Q ss_pred CCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC-CCCcCHhHHHHHhhhcc
Q psy1684 3 FGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG-RTTIHYPELVEHYSKDA 81 (189)
Q Consensus 3 ~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~-~~~~~l~~li~~~~~~a 81 (189)
+..++|+|++++++.+...+..+||+|++++ | ++.. ++.. ...++..++..+..+++
T Consensus 81 l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~-g----~L~~-----------------~~~~~~~~l~~~~~~~i~~qia 138 (299)
T d1jpaa_ 81 MGQFDHPNVIHLEGVVTKSTPVMIITEFMEN-G----SLDS-----------------FLRQNDGQFTVIQLVGMLRGIA 138 (299)
T ss_dssp HTTCCCTTBCCEEEEECSSSSCEEEEECCTT-E----EHHH-----------------HHHTTTTCSCHHHHHHHHHHHH
T ss_pred HHhCCCCCCccEEEEEeeCCEEEEEEEecCC-C----ccee-----------------eeccccCCCCHHHHHHHHHHHH
Confidence 4578999999999999888889999999987 3 1211 2222 23456777888899999
Q ss_pred CCceeeccCCcccccc-cc---------------ccccc--------------------------C-CCCCccc-e-EEE
Q psy1684 82 DGLCVNLRKPCVQVSC-RI---------------YLVHG--------------------------T-NLSGVVV-S-AVD 116 (189)
Q Consensus 82 ~gl~~~~~~~~~~~~~-p~---------------~l~~~--------------------------~-~~~~~~~-s-Vws 116 (189)
.|+.|+|..+++|||+ |+ |+++. . ..+.|+. + |||
T Consensus 139 ~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS 218 (299)
T d1jpaa_ 139 AGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWS 218 (299)
T ss_dssp HHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHH
T ss_pred HHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCccccccc
Confidence 9999999999999996 55 33321 1 4567899 9 999
Q ss_pred ec-------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q psy1684 117 FG-------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTME 179 (189)
Q Consensus 117 fG-------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~ 179 (189)
|| |.+.+..+++..+.++.+++.|..||+++.+||.+||+.||++||||++|++.|+.+++.+
T Consensus 219 ~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p 294 (299)
T d1jpaa_ 219 YGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294 (299)
T ss_dssp HHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred chHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcCh
Confidence 99 6777888999999999999999999999999999999999999999999999999998753
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=9.5e-28 Score=175.44 Aligned_cols=153 Identities=17% Similarity=0.208 Sum_probs=125.8
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC-CCCcCHhHHHHHhhhccC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG-RTTIHYPELVEHYSKDAD 82 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~-~~~~~l~~li~~~~~~a~ 82 (189)
..++|+|++++++.+..++..+||+|+++++. +.. ++.. ...+....++.+..+++.
T Consensus 55 ~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~-----L~~-----------------~l~~~~~~~~~~~~~~i~~qia~ 112 (263)
T d1sm2a_ 55 MKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC-----LSD-----------------YLRTQRGLFAAETLLGMCLDVCE 112 (263)
T ss_dssp HHCCCTTBCCEEEEECSSSSCEEEEECCTTCB-----HHH-----------------HHHTTTTCCCHHHHHHHHHHHHH
T ss_pred HhcCCCCcccccceeccCCceEEEEEecCCCc-----HHH-----------------HhhccccCCCHHHHHHHHHHHHH
Confidence 46789999999999988888999999998732 222 2222 233446777888999999
Q ss_pred CceeeccCCcccccc-cc---------------ccc----------------------ccC-CCCCccc-e-EEEec---
Q psy1684 83 GLCVNLRKPCVQVSC-RI---------------YLV----------------------HGT-NLSGVVV-S-AVDFG--- 118 (189)
Q Consensus 83 gl~~~~~~~~~~~~~-p~---------------~l~----------------------~~~-~~~~~~~-s-VwsfG--- 118 (189)
|+.++|..+++|||+ |+ |++ ||. ..+.|+. + |||||
T Consensus 113 gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil 192 (263)
T d1sm2a_ 113 GMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLM 192 (263)
T ss_dssp HHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred HHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHH
Confidence 999999999999996 55 222 222 5577999 9 99999
Q ss_pred ----------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q psy1684 119 ----------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTM 178 (189)
Q Consensus 119 ----------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~ 178 (189)
|.+.+..++...+.+|.+++.|..||+++.+||.+||+.||++||||++|++.|+++.++
T Consensus 193 ~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 193 WEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp HHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 566677889999999999999999999999999999999999999999999999998764
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1.1e-27 Score=176.21 Aligned_cols=151 Identities=23% Similarity=0.364 Sum_probs=124.1
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..++|+|++++++.+. .++.+||+|++++ | ++.. ++.....++...++.+..+++.|
T Consensus 63 ~~l~HpnIv~~~g~~~-~~~~~lvmE~~~~-g----~L~~-----------------~l~~~~~l~~~~~~~i~~qi~~g 119 (277)
T d1xbba_ 63 QQLDNPYIVRMIGICE-AESWMLVMEMAEL-G----PLNK-----------------YLQQNRHVKDKNIIELVHQVSMG 119 (277)
T ss_dssp HTCCCTTBCCEEEEEE-SSSEEEEEECCTT-E----EHHH-----------------HHHHCTTCCHHHHHHHHHHHHHH
T ss_pred HhCCCCCCceEEEEec-cCCEEEEEEcCCC-C----cHHH-----------------HHhhccCCCHHHHHHHHHHHHHH
Confidence 4688999999999874 4567999999887 3 1222 33334456677888899999999
Q ss_pred ceeeccCCcccccc-cc---------------cccc------------------------cC-CCCCccc-e-EEEec--
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YLVH------------------------GT-NLSGVVV-S-AVDFG-- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l~~------------------------~~-~~~~~~~-s-VwsfG-- 118 (189)
+.++|..+++|||+ |+ |+++ |. ..+.|+. + |||||
T Consensus 120 l~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~ 199 (277)
T d1xbba_ 120 MKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVL 199 (277)
T ss_dssp HHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHH
T ss_pred HhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhh
Confidence 99999999999996 55 3333 21 4566899 9 99999
Q ss_pred -----------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q psy1684 119 -----------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFT 177 (189)
Q Consensus 119 -----------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~ 177 (189)
|.+.+..++...+.+|.+++.|..||+++++||.+||+.||++||||++|.+.|+.++.
T Consensus 200 l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 200 MWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp HHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred hhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 77888889999999999999999999999999999999999999999999999987764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=5.7e-27 Score=172.98 Aligned_cols=152 Identities=23% Similarity=0.378 Sum_probs=123.5
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC-CCCcCHhHHHHHhhhccC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG-RTTIHYPELVEHYSKDAD 82 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~-~~~~~l~~li~~~~~~a~ 82 (189)
..++|+|++++++++. .++.|||+|++++ | ++.. ++.. +..++...+..+..+++.
T Consensus 64 ~~l~HpnIv~l~g~~~-~~~~~lvmE~~~~-g----~L~~-----------------~l~~~~~~l~~~~~~~i~~qi~~ 120 (285)
T d1u59a_ 64 HQLDNPYIVRLIGVCQ-AEALMLVMEMAGG-G----PLHK-----------------FLVGKREEIPVSNVAELLHQVSM 120 (285)
T ss_dssp HHCCCTTBCCEEEEEE-SSSEEEEEECCTT-E----EHHH-----------------HHTTCTTTSCHHHHHHHHHHHHH
T ss_pred HhCCCCCEeeEeeeec-cCeEEEEEEeCCC-C----cHHH-----------------HhhccccCCCHHHHHHHHHHHHH
Confidence 3578999999999875 4578999999987 3 1222 2222 334667778888999999
Q ss_pred CceeeccCCcccccc-cc---------------cccccC-------------------------CCCCccc-e-EEEec-
Q psy1684 83 GLCVNLRKPCVQVSC-RI---------------YLVHGT-------------------------NLSGVVV-S-AVDFG- 118 (189)
Q Consensus 83 gl~~~~~~~~~~~~~-p~---------------~l~~~~-------------------------~~~~~~~-s-VwsfG- 118 (189)
|+.++|..+++|||+ |+ |+++.. ..+.|+. + |||||
T Consensus 121 gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv 200 (285)
T d1u59a_ 121 GMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGV 200 (285)
T ss_dssp HHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHH
T ss_pred HHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchH
Confidence 999999999999996 55 333221 3466899 9 99999
Q ss_pred ------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q psy1684 119 ------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTM 178 (189)
Q Consensus 119 ------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~ 178 (189)
|.+.+..++...+.+|.+++.|+.||+++++||.+||+.||++||||.+|.+.|+.++.+
T Consensus 201 ~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 201 TMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp HHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 777788899999999999999999999999999999999999999999999999877653
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=9.4e-27 Score=171.79 Aligned_cols=155 Identities=19% Similarity=0.328 Sum_probs=125.2
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..++|+|++++++.+...+..++|.|++..+. +.. . .......+...+++.+..+++.|
T Consensus 64 ~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~-----l~~-----~-----------~~~~~~~~~~~~~~~i~~~i~~g 122 (283)
T d1mqba_ 64 GQFSHHNIIRLEGVISKYKPMMIITEYMENGA-----LDK-----F-----------LREKDGEFSVLQLVGMLRGIAAG 122 (283)
T ss_dssp HTCCCTTBCCEEEEECSSSSEEEEEECCTTEE-----HHH-----H-----------HHHTTTCSCHHHHHHHHHHHHHH
T ss_pred HhcCCCCEeeeeEEEecCCceEEEEEecccCc-----chh-----h-----------hhcccccccHHHHHHHHHHHHHh
Confidence 46789999999998887788899999887622 111 0 11123345577888899999999
Q ss_pred ceeeccCCcccccc-cc---------------cccc------------------------cC-CCCCccc-e-EEEec--
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YLVH------------------------GT-NLSGVVV-S-AVDFG-- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l~~------------------------~~-~~~~~~~-s-VwsfG-- 118 (189)
+.++|..+++|||+ |+ |+++ |. ..+.|+. + |||||
T Consensus 123 l~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvi 202 (283)
T d1mqba_ 123 MKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIV 202 (283)
T ss_dssp HHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHH
T ss_pred hhhccccccccCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHH
Confidence 99999999999996 55 3332 21 4567899 9 99999
Q ss_pred -----------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q psy1684 119 -----------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTME 179 (189)
Q Consensus 119 -----------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~ 179 (189)
+.+.+..++...+..|.+++.|..+|.++.+||.+||+.||++||||.+|++.|+.+++.+
T Consensus 203 l~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p 274 (283)
T d1mqba_ 203 MWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274 (283)
T ss_dssp HHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred HHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence 5666788899999999999999999999999999999999999999999999999998754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=1.3e-26 Score=170.14 Aligned_cols=153 Identities=26% Similarity=0.448 Sum_probs=123.9
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC--CCCcCHhHHHHHhhhcc
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG--RTTIHYPELVEHYSKDA 81 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~--~~~~~l~~li~~~~~~a 81 (189)
..++|+|++++++.+. +++.+||+|+++++. +.. ++.. ...++..+++.+..+++
T Consensus 63 ~~l~HpnIv~~~g~~~-~~~~~iv~Ey~~~g~-----L~~-----------------~~~~~~~~~l~~~~~~~i~~qi~ 119 (272)
T d1qpca_ 63 KQLQHQRLVRLYAVVT-QEPIYIITEYMENGS-----LVD-----------------FLKTPSGIKLTINKLLDMAAQIA 119 (272)
T ss_dssp HHCCCTTBCCEEEEEC-SSSCEEEEECCTTCB-----HHH-----------------HTTSHHHHTCCHHHHHHHHHHHH
T ss_pred HhCCCCCEeEEEeeec-cCCeEEEEEeCCCCc-----HHH-----------------HHhhcCCCCCCHHHHHHHHHHHH
Confidence 4578999999999775 466899999998733 111 1111 12345777888899999
Q ss_pred CCceeeccCCcccccc-cc---------------cccccC-----------------------CCCCccc-e-EEEec--
Q psy1684 82 DGLCVNLRKPCVQVSC-RI---------------YLVHGT-----------------------NLSGVVV-S-AVDFG-- 118 (189)
Q Consensus 82 ~gl~~~~~~~~~~~~~-p~---------------~l~~~~-----------------------~~~~~~~-s-VwsfG-- 118 (189)
.|+.++|..+++|||+ |+ |+|+.. ..+.|+. + |||||
T Consensus 120 ~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvv 199 (272)
T d1qpca_ 120 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 199 (272)
T ss_dssp HHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHH
T ss_pred HHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHH
Confidence 9999999999999996 55 333211 4467899 9 99999
Q ss_pred -----------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q psy1684 119 -----------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTME 179 (189)
Q Consensus 119 -----------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~ 179 (189)
+.+.+..+++..+..|.+++.|..+|+++.+||.+||+.||++||||++|++.|+.+++++
T Consensus 200 l~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ftst 271 (272)
T d1qpca_ 200 LTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (272)
T ss_dssp HHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhcC
Confidence 5666778899999999999999999999999999999999999999999999999999865
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=4.8e-27 Score=171.10 Aligned_cols=150 Identities=19% Similarity=0.233 Sum_probs=121.7
Q ss_pred CCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccC-CCCCcCHhHHHHHhhhcc
Q psy1684 3 FGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKA-GRTTIHYPELVEHYSKDA 81 (189)
Q Consensus 3 ~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~-~~~~~~l~~li~~~~~~a 81 (189)
+..++|+|++++++.+..+.+.++|+|++.++. +.. ++. ....+....+..+..+.+
T Consensus 53 ~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~-----l~~-----------------~~~~~~~~~~~~~~~~i~~qi~ 110 (258)
T d1k2pa_ 53 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC-----LLN-----------------YLREMRHRFQTQQLLEMCKDVC 110 (258)
T ss_dssp HHTCCCTTBCCEEEEECCSSSEEEEEECCTTEE-----HHH-----------------HHHSGGGCCCHHHHHHHHHHHH
T ss_pred HHhcCCCceeeEEEEEeeCCceEEEEEccCCCc-----HHH-----------------hhhccccCCcHHHHHHHHHHHH
Confidence 356899999999999888888999999998732 111 111 122344666777888999
Q ss_pred CCceeeccCCcccccc-cc---------------cccc----------------------cC-CCCCccc-e-EEEec--
Q psy1684 82 DGLCVNLRKPCVQVSC-RI---------------YLVH----------------------GT-NLSGVVV-S-AVDFG-- 118 (189)
Q Consensus 82 ~gl~~~~~~~~~~~~~-p~---------------~l~~----------------------~~-~~~~~~~-s-VwsfG-- 118 (189)
.|+.++|..+++|+|+ |. |+++ |. ....|+. + |||||
T Consensus 111 ~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~ 190 (258)
T d1k2pa_ 111 EAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVL 190 (258)
T ss_dssp HHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred HHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchh
Confidence 9999999999999996 44 3332 22 4567899 9 99999
Q ss_pred -----------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q psy1684 119 -----------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLED 174 (189)
Q Consensus 119 -----------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~ 174 (189)
|.+.+..++...+.+|.+++.|..+|+++.+||.+||+.||++||||++|++.|.+
T Consensus 191 l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 191 MWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp HHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred hHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 77888899999999999999999999999999999999999999999999998854
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.90 E-value=6.2e-26 Score=167.62 Aligned_cols=153 Identities=21% Similarity=0.349 Sum_probs=124.6
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC--CCCcCHhHHHHHhhhcc
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG--RTTIHYPELVEHYSKDA 81 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~--~~~~~l~~li~~~~~~a 81 (189)
..++|+|++++++.+...+..+||+|+++++. +.. ++.. ...++...++.+..+++
T Consensus 68 ~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~-----l~~-----------------~l~~~~~~~~~~~~~~~i~~qi~ 125 (287)
T d1opja_ 68 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGN-----LLD-----------------YLRECNRQEVSAVVLLYMATQIS 125 (287)
T ss_dssp HHCCCTTBCCEEEEECSSSSCEEEEECCTTCB-----HHH-----------------HHHHSCTTTSCHHHHHHHHHHHH
T ss_pred HhCCCCCEecCCccEeeCCeeEEEeecccCcc-----hHH-----------------HhhhccccchHHHHHHHHHHHHH
Confidence 45789999999999888888999999998733 111 1211 22344667788888999
Q ss_pred CCceeeccCCcccccc-cc---------------cccc----------------------cC-CCCCccc-e-EEEec--
Q psy1684 82 DGLCVNLRKPCVQVSC-RI---------------YLVH----------------------GT-NLSGVVV-S-AVDFG-- 118 (189)
Q Consensus 82 ~gl~~~~~~~~~~~~~-p~---------------~l~~----------------------~~-~~~~~~~-s-VwsfG-- 118 (189)
.|+.|+|..+++|||+ |+ |+|+ |. ..+.|+. + |||||
T Consensus 126 ~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~ 205 (287)
T d1opja_ 126 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 205 (287)
T ss_dssp HHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHH
T ss_pred HHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHH
Confidence 9999999999999996 55 3332 21 5677999 9 99999
Q ss_pred -----------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q psy1684 119 -----------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTM 178 (189)
Q Consensus 119 -----------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~ 178 (189)
+.+.+..++...+..+.+++.|..+|+++.+||.+||+.||++||||++|++.|+.+++.
T Consensus 206 l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 206 LWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp HHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred HHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 566777888888889999999999999999999999999999999999999999988753
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=5e-26 Score=169.81 Aligned_cols=166 Identities=23% Similarity=0.330 Sum_probs=126.6
Q ss_pred CCC-ChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC---ccCCCCCcCHhHHHHHhhh
Q psy1684 4 GKI-KRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET---QKAGRTTIHYPELVEHYSK 79 (189)
Q Consensus 4 g~l-~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g---yl~~~~~~~l~~li~~~~~ 79 (189)
..+ +|+|++++++.+...+..+||+|++++++...+ +.. .... ..... .......++......+..+
T Consensus 65 ~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~-l~~--~~~~------~~~~~~~~~~~~~~~l~~~~~~~~~~q 135 (309)
T d1fvra_ 65 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDF-LRK--SRVL------ETDPAFAIANSTASTLSSQQLLHFAAD 135 (309)
T ss_dssp TTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHH-HHT--TCHH------HHCHHHHHHTTBSCSSCHHHHHHHHHH
T ss_pred HhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHH-Hhh--cccc------ccchhhhccccccCCCCHHHHHHHHHH
Confidence 355 699999999998888889999999987431111 111 0000 00000 0111234556778888999
Q ss_pred ccCCceeeccCCcccccc-cc---------------cccccC---------------------CCCCccc-e-EEEec--
Q psy1684 80 DADGLCVNLRKPCVQVSC-RI---------------YLVHGT---------------------NLSGVVV-S-AVDFG-- 118 (189)
Q Consensus 80 ~a~gl~~~~~~~~~~~~~-p~---------------~l~~~~---------------------~~~~~~~-s-VwsfG-- 118 (189)
++.|+.++|..+++|||+ |+ |+++.. ..+.|+. + |||||
T Consensus 136 ia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvi 215 (309)
T d1fvra_ 136 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVL 215 (309)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHH
T ss_pred HHHHHHhhhcCCccccccccceEEEcCCCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHH
Confidence 999999999999999996 55 333211 4567899 9 99999
Q ss_pred -----------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q psy1684 119 -----------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTM 178 (189)
Q Consensus 119 -----------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~ 178 (189)
|.+.+..++...+.+|.+++.|..+|+++.+||.+||+.||++||||++|++.|+.+++.
T Consensus 216 l~ell~~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 216 LWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp HHHHHTTSCCTTTTCCHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 677788899999999999999999999999999999999999999999999999999874
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=1.1e-25 Score=165.95 Aligned_cols=162 Identities=33% Similarity=0.554 Sum_probs=132.1
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC--CCCcCHhHHHHHhhhcc
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG--RTTIHYPELVEHYSKDA 81 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~--~~~~~l~~li~~~~~~a 81 (189)
..++|+|++++++.+. ++..|||+|++.++. + .. ++.. ...++..+++.+..+++
T Consensus 67 ~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~g~-l----~~-----------------~~~~~~~~~l~~~~~~~i~~~i~ 123 (285)
T d1fmka3 67 KKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGS-L----LD-----------------FLKGETGKYLRLPQLVDMAAQIA 123 (285)
T ss_dssp HHCCCTTBCCEEEEEC-SSSCEEEECCCTTCB-H----HH-----------------HHSHHHHTTCCHHHHHHHHHHHH
T ss_pred HhcccCCEeEEEEEEe-cCCeEEEEEecCCCc-h----hh-----------------hhhhcccccchHHHHHHHHHHHH
Confidence 3578999999999874 567899999998732 1 11 1111 22355778888999999
Q ss_pred CCceeeccCCcccccc-cc---------------cccccC-----------------------CCCCccc-e-EEEec--
Q psy1684 82 DGLCVNLRKPCVQVSC-RI---------------YLVHGT-----------------------NLSGVVV-S-AVDFG-- 118 (189)
Q Consensus 82 ~gl~~~~~~~~~~~~~-p~---------------~l~~~~-----------------------~~~~~~~-s-VwsfG-- 118 (189)
.|+.++|..+++|+|+ |+ |+++.. ..+.++. + |||||
T Consensus 124 ~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Gii 203 (285)
T d1fmka3 124 SGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 203 (285)
T ss_dssp HHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHH
T ss_pred HHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHH
Confidence 9999999999999996 55 333321 4567899 9 99999
Q ss_pred -----------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcCCCCCCCC
Q psy1684 119 -----------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEGSDYKEAS 187 (189)
Q Consensus 119 -----------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~ 187 (189)
+.+.+..+++..+.++.+++.|..||+++.+||.+||+.||++||||++|++.|+.+++...|.|.+.+
T Consensus 204 l~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~p~~ 283 (285)
T d1fmka3 204 LTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGE 283 (285)
T ss_dssp HHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCCSC
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCCCCC
Confidence 556677888999999999999999999999999999999999999999999999999999999999877
Q ss_pred C
Q psy1684 188 G 188 (189)
Q Consensus 188 ~ 188 (189)
+
T Consensus 284 ~ 284 (285)
T d1fmka3 284 N 284 (285)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=3.8e-26 Score=167.73 Aligned_cols=153 Identities=24% Similarity=0.384 Sum_probs=122.4
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCcc-CCCCCcCHhHHHHHhhhccC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQK-AGRTTIHYPELVEHYSKDAD 82 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl-~~~~~~~l~~li~~~~~~a~ 82 (189)
..++|+|++++++.+. ++..|||+|+++.+. +.. ++ .....++..++..+..+++.
T Consensus 63 ~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~-----l~~-----------------~~~~~~~~l~~~~~~~~~~qi~~ 119 (273)
T d1mp8a_ 63 RQFDHPHIVKLIGVIT-ENPVWIIMELCTLGE-----LRS-----------------FLQVRKYSLDLASLILYAYQLST 119 (273)
T ss_dssp HTCCCTTBCCEEEEEC-SSSCEEEEECCTTEE-----HHH-----------------HHHHTTTTSCHHHHHHHHHHHHH
T ss_pred HhCCCCCEeeEEEEEe-cCeEEEEEEeccCCc-----HHh-----------------hhhccCCCCCHHHHHHHHHHHHH
Confidence 4688999999999875 466899999988632 111 11 11234557788888999999
Q ss_pred CceeeccCCcccccc-cc---------------cccccC-----------------------CCCCccc-e-EEEec---
Q psy1684 83 GLCVNLRKPCVQVSC-RI---------------YLVHGT-----------------------NLSGVVV-S-AVDFG--- 118 (189)
Q Consensus 83 gl~~~~~~~~~~~~~-p~---------------~l~~~~-----------------------~~~~~~~-s-VwsfG--- 118 (189)
|+.++|..+++|||+ |+ |+|+.. ..+.|+. + |||||
T Consensus 120 gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil 199 (273)
T d1mp8a_ 120 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCM 199 (273)
T ss_dssp HHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHH
T ss_pred HhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHH
Confidence 999999999999996 55 333221 4567899 9 99999
Q ss_pred ----------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q psy1684 119 ----------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTME 179 (189)
Q Consensus 119 ----------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~ 179 (189)
|.+.+..++...+.+|.+++.|+.+|+++.+||.+||+.||++||||.+|++.|+.+++..
T Consensus 200 ~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 200 WEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp HHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 6667788899999999999999999999999999999999999999999999999998753
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=2.9e-26 Score=167.30 Aligned_cols=154 Identities=21% Similarity=0.345 Sum_probs=122.5
Q ss_pred CCCCChHHHHHHhcCCCCC-CCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCC--CCcCHhHHHHHhhh
Q psy1684 3 FGKIKRIEAEKKLLLPEND-HGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGR--TTIHYPELVEHYSK 79 (189)
Q Consensus 3 ~g~l~~~n~~~lL~~~~~~-~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~--~~~~l~~li~~~~~ 79 (189)
+..++|+|++++++.+... +..+||+|+++++. +.. |+... ..++...++.+..+
T Consensus 54 l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~-----L~~-----------------~l~~~~~~~l~~~~~~~i~~~ 111 (262)
T d1byga_ 54 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS-----LVD-----------------YLRSRGRSVLGGDCLLKFSLD 111 (262)
T ss_dssp HTTCCCTTBCCEEEEECCC--CCEEEECCCTTEE-----HHH-----------------HHHHHHHHHCCHHHHHHHHHH
T ss_pred HHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCC-----HHH-----------------HHHhcCCCCCCHHHHHHHHHH
Confidence 4678999999999977543 45789999998832 222 22211 12446667788889
Q ss_pred ccCCceeeccCCcccccc-cc---------------cc------------------cccC-CCCCccc-e-EEEec----
Q psy1684 80 DADGLCVNLRKPCVQVSC-RI---------------YL------------------VHGT-NLSGVVV-S-AVDFG---- 118 (189)
Q Consensus 80 ~a~gl~~~~~~~~~~~~~-p~---------------~l------------------~~~~-~~~~~~~-s-VwsfG---- 118 (189)
++.|+.|+|+.+++|+|+ |. ++ |||. ..+.||. + |||||
T Consensus 112 i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~ 191 (262)
T d1byga_ 112 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLW 191 (262)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred HHhhccccccCceeccccchHhheecCCCCEeecccccceecCCCCccccccccCCChHHHhCCCCChHHHHHhHHHHHH
Confidence 999999999999999996 54 22 2221 4567999 9 99999
Q ss_pred ---------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q psy1684 119 ---------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTM 178 (189)
Q Consensus 119 ---------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~ 178 (189)
|.+.+..++...+.+|.+++.|..+|+++++|+.+||+.||++||||++|++.|+++.+.
T Consensus 192 el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 192 EIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp HHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 566677889999999999999999999999999999999999999999999999988653
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.90 E-value=4.5e-26 Score=169.49 Aligned_cols=171 Identities=20% Similarity=0.256 Sum_probs=124.7
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCe----eeEEEEEeccCCccCCCCCcCHhHHHHHhhh
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFC----LKMTTGRSLFETQKAGRTTIHYPELVEHYSK 79 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~----v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~ 79 (189)
..++|+|++++++.+......++|+|++.+++...+ +... ... ..+................++..+.+.+..+
T Consensus 71 ~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~-l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q 148 (301)
T d1lufa_ 71 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEF-LRSM-SPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQ 148 (301)
T ss_dssp HTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHH-HHHT-CC----------------------CCCCHHHHHHHHHH
T ss_pred HhcCCCCcccceeeeccCCceEEEEEecCCCcHHHH-HHhc-CccccccccccccchhhhccccCCCCCCHHHHHHHHHH
Confidence 467899999999999888899999999988432111 1110 000 0000000000001111233557778888999
Q ss_pred ccCCceeeccCCcccccc-cc---------------cccc-----------------------cC-CCCCccc-e-EEEe
Q psy1684 80 DADGLCVNLRKPCVQVSC-RI---------------YLVH-----------------------GT-NLSGVVV-S-AVDF 117 (189)
Q Consensus 80 ~a~gl~~~~~~~~~~~~~-p~---------------~l~~-----------------------~~-~~~~~~~-s-Vwsf 117 (189)
.+.|+.|+|..+++|||+ |+ |+|+ |. ....||. + ||||
T Consensus 149 i~~gl~ylH~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~ 228 (301)
T d1lufa_ 149 VAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAY 228 (301)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHhhhcccCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccc
Confidence 999999999999999996 55 3332 11 4557899 9 9999
Q ss_pred c-------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q psy1684 118 G-------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFF 176 (189)
Q Consensus 118 G-------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~ 176 (189)
| |.+.+..+++..+.+|.+++.|..+|+++++||.+||+.||++||||.||++.|++|+
T Consensus 229 Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 229 GVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred hhhHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 9 6777888999999999999999999999999999999999999999999999999876
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=9e-26 Score=167.71 Aligned_cols=167 Identities=21% Similarity=0.243 Sum_probs=125.8
Q ss_pred ChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCcee
Q psy1684 7 KRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGLCV 86 (189)
Q Consensus 7 ~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl~~ 86 (189)
+|+|++++++.+..+...|+|+|++.++. +.-.++.. ........... .-.....++...+..+..+.+.|+.|
T Consensus 77 ~HpnIv~~~~~~~~~~~~~~v~e~~~~g~-l~~~i~~~-~~~~~~~~~~~----~~~~~~~l~~~~~~~~~~qi~~al~y 150 (299)
T d1fgka_ 77 KHKNIINLLGACTQDGPLYVIVEYASKGN-LREYLQAR-RPPGLEYSYNP----SHNPEEQLSSKDLVSCAYQVARGMEY 150 (299)
T ss_dssp CCTTBCCEEEEECSSSSCEEEECCCTTCB-HHHHHHTT-SCC----------------CCCCCHHHHHHHHHHHHHHHHH
T ss_pred CCCeEEecccccccCCeEEEEEEccCCCc-HHHHHHhh-cCCcccccccc----ccCccccCCHHHHHHHHHHHHHHHHH
Confidence 69999999999988888999999999843 21111110 00000000000 01113345677788899999999999
Q ss_pred eccCCcccccc-cc---------------c-----------------------ccccC-CCCCccc-e-EEEec------
Q psy1684 87 NLRKPCVQVSC-RI---------------Y-----------------------LVHGT-NLSGVVV-S-AVDFG------ 118 (189)
Q Consensus 87 ~~~~~~~~~~~-p~---------------~-----------------------l~~~~-~~~~~~~-s-VwsfG------ 118 (189)
+|..+++|||+ |+ + +|+|. ..+.|+. + |||||
T Consensus 151 lH~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~el 230 (299)
T d1fgka_ 151 LASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 230 (299)
T ss_dssp HHHTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHh
Confidence 99999999996 55 1 11111 4578999 9 99999
Q ss_pred -------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q psy1684 119 -------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTME 179 (189)
Q Consensus 119 -------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~ 179 (189)
|.+.+..++...+..|.+++.|..+|+++.+||.+||+.||++||||.||++.|+++++.+
T Consensus 231 l~~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~~ 298 (299)
T d1fgka_ 231 FTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 298 (299)
T ss_dssp HTTSCCSSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ccCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhcC
Confidence 6778888898889999999999999999999999999999999999999999999998753
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=1.5e-25 Score=167.32 Aligned_cols=157 Identities=17% Similarity=0.230 Sum_probs=118.6
Q ss_pred CCCChHHHHHHhcCCCCCC-CcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCC-CcCHhHHHHHhhhcc
Q psy1684 4 GKIKRIEAEKKLLLPENDH-GAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRT-TIHYPELVEHYSKDA 81 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~-g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~-~~~l~~li~~~~~~a 81 (189)
..++|+|++++++.+...+ ..++|+|++.++. +.. ++.... ......++.+..+.+
T Consensus 83 ~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~-----l~~-----------------~~~~~~~~~~~~~~~~i~~qia 140 (311)
T d1r0pa_ 83 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGD-----LRN-----------------FIRNETHNPTVKDLIGFGLQVA 140 (311)
T ss_dssp HTCCCTTBCCCCEEEEETTTEEEEEEECCTTCB-----HHH-----------------HHHCTTCCCBHHHHHHHHHHHH
T ss_pred HhCCCCCEeEEeEEEEecCCceEEEEEEeecCc-----hhh-----------------hhccccccchHHHHHHHHHHHH
Confidence 4688999999998875444 4688999988732 111 222222 223667788889999
Q ss_pred CCceeeccCCcccccc-cc---------------cccccC--------------------------CCCCccc-e-EEEe
Q psy1684 82 DGLCVNLRKPCVQVSC-RI---------------YLVHGT--------------------------NLSGVVV-S-AVDF 117 (189)
Q Consensus 82 ~gl~~~~~~~~~~~~~-p~---------------~l~~~~--------------------------~~~~~~~-s-Vwsf 117 (189)
.|+.++|..+++|||+ |+ |+++.. ..+.++. + ||||
T Consensus 141 ~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~Sf 220 (311)
T d1r0pa_ 141 KGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF 220 (311)
T ss_dssp HHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred HhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhh
Confidence 9999999999999996 54 443322 4567899 9 9999
Q ss_pred c-------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhcCCC
Q psy1684 118 G-------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTMEGSD 182 (189)
Q Consensus 118 G-------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~~~~ 182 (189)
| +.+.+..++...+.+|.+++.|..||+++++||.+||+.||++||||.||++.|++++++-..+
T Consensus 221 Givl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~ 298 (311)
T d1r0pa_ 221 GVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 298 (311)
T ss_dssp HHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred HHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhh
Confidence 9 3344556777888899999999999999999999999999999999999999999999864443
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=4.3e-26 Score=170.12 Aligned_cols=161 Identities=17% Similarity=0.246 Sum_probs=125.1
Q ss_pred CCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC--ccCCCCCcCHhHHHHHhhhc
Q psy1684 3 FGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET--QKAGRTTIHYPELVEHYSKD 80 (189)
Q Consensus 3 ~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g--yl~~~~~~~l~~li~~~~~~ 80 (189)
+..+.|+|++++++.+..+++.+||+|++.++....+.... ..+ ............++.+..+.
T Consensus 77 l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~i~~~i 142 (308)
T d1p4oa_ 77 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL--------------RPAMANNPVLAPPSLSKMIQMAGEI 142 (308)
T ss_dssp GGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHH--------------HHHHHHCTTCCCCCHHHHHHHHHHH
T ss_pred HHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhc--------------ccccccccccCCCCHHHHHHHHHHH
Confidence 34688999999999998888999999999984311110000 000 01111123367778888899
Q ss_pred cCCceeeccCCcccccc-cc---------------cccccC------------------------CCCCccc-e-EEEec
Q psy1684 81 ADGLCVNLRKPCVQVSC-RI---------------YLVHGT------------------------NLSGVVV-S-AVDFG 118 (189)
Q Consensus 81 a~gl~~~~~~~~~~~~~-p~---------------~l~~~~------------------------~~~~~~~-s-VwsfG 118 (189)
+.|+.++|..+++|||+ |. |+|+.. ..+.++. + |||||
T Consensus 143 a~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G 222 (308)
T d1p4oa_ 143 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFG 222 (308)
T ss_dssp HHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred HHHHHHHhhCCeeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHH
Confidence 99999999999999996 44 443322 4567888 9 99999
Q ss_pred -------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q psy1684 119 -------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFT 177 (189)
Q Consensus 119 -------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~ 177 (189)
|.+.+..+++..+.+|.+++.|..||+++++||.+||+.||++||||++|++.|+..++
T Consensus 223 ~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 223 VVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 78888999999999999999999999999999999999999999999999999876654
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=4.6e-25 Score=162.02 Aligned_cols=152 Identities=18% Similarity=0.231 Sum_probs=116.3
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC-CCCcCHhHHHHHhhhccC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG-RTTIHYPELVEHYSKDAD 82 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~-~~~~~l~~li~~~~~~a~ 82 (189)
..++|+|++++++.+. ++..+||+|++++ | ++.. ++.. +..++...++.+..+++.
T Consensus 59 ~~l~HpnIv~~~~~~~-~~~~~lv~Ey~~~-g----~L~~-----------------~l~~~~~~~~~~~~~~i~~qi~~ 115 (276)
T d1uwha_ 59 RKTRHVNILLFMGYST-APQLAIVTQWCEG-S----SLYH-----------------HLHIIETKFEMIKLIDIARQTAQ 115 (276)
T ss_dssp TTCCCTTBCCEEEEEC-SSSCEEEEECCCE-E----EHHH-----------------HHHTSCCCCCHHHHHHHHHHHHH
T ss_pred HhCCCCCEeeeeEEEe-ccEEEEEEecCCC-C----CHHH-----------------HHhhccCCCCHHHHHHHHHHHHH
Confidence 5688999999998775 3457899999886 3 1222 3322 234667788889999999
Q ss_pred CceeeccCCcccccc-cc---------------cc-----------------------cccC----CCCCccc-e-EEEe
Q psy1684 83 GLCVNLRKPCVQVSC-RI---------------YL-----------------------VHGT----NLSGVVV-S-AVDF 117 (189)
Q Consensus 83 gl~~~~~~~~~~~~~-p~---------------~l-----------------------~~~~----~~~~~~~-s-Vwsf 117 (189)
|+.|+|+.+++|||+ |+ |+ |||. ..+.|+. + ||||
T Consensus 116 gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~ 195 (276)
T d1uwha_ 116 GMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAF 195 (276)
T ss_dssp HHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHH
T ss_pred HHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhh
Confidence 999999999999996 55 33 2322 2345899 9 9999
Q ss_pred c------------CCCCChH-HHHHHHHcCCCCC----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q psy1684 118 G------------SGGMTNA-EVLHQVEHGYRMP----CPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTM 178 (189)
Q Consensus 118 G------------~~~~~~~-~~~~~v~~g~~~~----~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~ 178 (189)
| |.+.+.. .+...+.++...| .+..||+++.+||.+||+.||++||||++|++.|+.+.++
T Consensus 196 Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 196 GIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp HHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 9 7776654 4455556676544 4678999999999999999999999999999999988764
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=1.4e-25 Score=168.44 Aligned_cols=165 Identities=17% Similarity=0.162 Sum_probs=115.8
Q ss_pred ChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC---ccCCCCCcCHhHHHHHhhhccCC
Q psy1684 7 KRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET---QKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 7 ~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g---yl~~~~~~~l~~li~~~~~~a~g 83 (189)
+|+|++++++.+...+..|||+|+++++. +.-.++.. ............... .......++..++..+..+++.|
T Consensus 99 ~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~-L~~~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~g 176 (325)
T d1rjba_ 99 SHENIVNLLGACTLSGPIYLIFEYCCYGD-LLNYLRSK-REKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKG 176 (325)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTCB-HHHHHHTT-TTCC---------------------CCHHHHHHHHHHHHHH
T ss_pred CCCcEeEEEEEEeeCCeEEEEEEcCCCCc-HHHHHHhc-cCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHH
Confidence 79999999999888888999999999843 21111110 111100000000000 01112234467788899999999
Q ss_pred ceeeccCCcccccc-cc---------------cccccC------------------------CCCCccc-e-EEEec---
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YLVHGT------------------------NLSGVVV-S-AVDFG--- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l~~~~------------------------~~~~~~~-s-VwsfG--- 118 (189)
+.++|..+++|||+ |+ |+|+.. ..+.|+. + |||||
T Consensus 177 l~yLH~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil 256 (325)
T d1rjba_ 177 MEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILL 256 (325)
T ss_dssp HHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HHHHHhCCeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHH
Confidence 99999999999996 55 333222 4577899 9 99999
Q ss_pred ----------CCCCChH-HHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q psy1684 119 ----------SGGMTNA-EVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLE 173 (189)
Q Consensus 119 ----------~~~~~~~-~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~ 173 (189)
|.+.+.. .+...+..+.+++.|..||+++.+||.+||+.||++||||+||++.|.
T Consensus 257 ~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 257 WEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 5555544 444556788999999999999999999999999999999999999985
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=2.1e-25 Score=166.95 Aligned_cols=152 Identities=20% Similarity=0.250 Sum_probs=118.2
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..++|+|++++++.+.. +..++|.+.+..++ +.. + .......++...+..+..+++.|
T Consensus 66 ~~l~HpnIv~l~g~~~~-~~~~~v~e~~~~~~-----l~~--------~--------~~~~~~~~~~~~~~~i~~qi~~g 123 (317)
T d1xkka_ 66 ASVDNPHVCRLLGICLT-STVQLITQLMPFGC-----LLD--------Y--------VREHKDNIGSQYLLNWCVQIAKG 123 (317)
T ss_dssp HHCCCTTBCCEEEEEES-SSEEEEEECCTTCB-----HHH--------H--------HHHTSSSCCHHHHHHHHHHHHHH
T ss_pred HhCCCCCEeeEEEEEec-CCeeEEEEeccCCc-----ccc--------c--------ccccccCCCHHHHHHHHHHHHHH
Confidence 35788999998887754 44566667666532 111 0 11113345567788888999999
Q ss_pred ceeeccCCcccccc-cc---------------cc-----------------------cccC-CCCCccc-e-EEEec---
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YL-----------------------VHGT-NLSGVVV-S-AVDFG--- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l-----------------------~~~~-~~~~~~~-s-VwsfG--- 118 (189)
+.|+|..+++|||+ |+ |+ |+|. ..+.|+. + |||||
T Consensus 124 l~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil 203 (317)
T d1xkka_ 124 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 203 (317)
T ss_dssp HHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHH
Confidence 99999999999996 55 22 2222 4567899 9 99999
Q ss_pred ----------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q psy1684 119 ----------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFT 177 (189)
Q Consensus 119 ----------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~ 177 (189)
|.+.+..++...+.+|.+++.|+.||+++++||.+||+.||++||||++|+..|+.+.+
T Consensus 204 ~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 204 WELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp HHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 67777888888899999999999999999999999999999999999999999988765
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=1.3e-24 Score=159.37 Aligned_cols=148 Identities=19% Similarity=0.305 Sum_probs=116.7
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccC-CCCCcCHhHHHHHhhhccC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKA-GRTTIHYPELVEHYSKDAD 82 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~-~~~~~~l~~li~~~~~~a~ 82 (189)
..++|+|++++++.+.+ +..+||+|++..++ +.. ++. ....+....++.+..+.+.
T Consensus 66 ~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~-----l~~-----------------~~~~~~~~l~~~~~~~~~~qi~~ 122 (273)
T d1u46a_ 66 HSLDHRNLIRLYGVVLT-PPMKMVTELAPLGS-----LLD-----------------RLRKHQGHFLLGTLSRYAVQVAE 122 (273)
T ss_dssp HHCCCTTBCCEEEEECS-SSCEEEEECCTTCB-----HHH-----------------HHHHHGGGSCHHHHHHHHHHHHH
T ss_pred HhCCCCCEEEEEEEEee-cchheeeeeecCcc-----hhh-----------------hhhcccCCCCHHHHHHHHHHHHH
Confidence 35789999999998854 56889999988733 111 111 1234557788889999999
Q ss_pred CceeeccCCcccccc-cc---------------cccccC-------------------------CCCCccc-e-EEEec-
Q psy1684 83 GLCVNLRKPCVQVSC-RI---------------YLVHGT-------------------------NLSGVVV-S-AVDFG- 118 (189)
Q Consensus 83 gl~~~~~~~~~~~~~-p~---------------~l~~~~-------------------------~~~~~~~-s-VwsfG- 118 (189)
|+.|+|..+++|||+ |+ |+++.. ....++. + |||||
T Consensus 123 gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gv 202 (273)
T d1u46a_ 123 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGV 202 (273)
T ss_dssp HHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHH
T ss_pred HHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHH
Confidence 999999999999996 55 222211 3456888 9 99999
Q ss_pred ------------CCCCChHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q psy1684 119 ------------SGGMTNAEVLHQV-EHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLED 174 (189)
Q Consensus 119 ------------~~~~~~~~~~~~v-~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~ 174 (189)
|.+.+..++...+ ..+.+++.|+.+|+++.+||.+||+.||++||||++|.+.|++
T Consensus 203 il~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 203 TLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp HHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 6778888888887 5678899999999999999999999999999999999988865
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.86 E-value=3.3e-24 Score=160.03 Aligned_cols=167 Identities=19% Similarity=0.288 Sum_probs=119.6
Q ss_pred ChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC-ccCCCCCcCHhHHHHHhhhccCCce
Q psy1684 7 KRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET-QKAGRTTIHYPELVEHYSKDADGLC 85 (189)
Q Consensus 7 ~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g-yl~~~~~~~l~~li~~~~~~a~gl~ 85 (189)
+|+|++++++.+...+..+||+|++++ |++.-.++.. ......... ..+ .......++..++..+..+++.|+.
T Consensus 85 ~HpnIv~~~g~~~~~~~~~lvmE~~~~-g~l~~~l~~~-~~~~~~~~~---~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ 159 (311)
T d1t46a_ 85 NHMNIVNLLGACTIGGPTLVITEYCCY-GDLLNFLRRK-RDSFICSKT---SPAIMEDDELALDLEDLLSFSYQVAKGMA 159 (311)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTT-EEHHHHHHHT-TTTC-----------------CCCCHHHHHHHHHHHHHHHH
T ss_pred CCCCEEEEEEEEeeCCEEEEEEEcCCC-CCHHHHHHhc-ccccccccc---ccccccccccCCCHHHHHHHHHHHHHHHH
Confidence 699999999999888889999999997 4221111110 000000000 000 1122334557788889999999999
Q ss_pred eeccCCcccccc-cc---------------cccc-----------------------cC-CCCCccc-e-EEEec-----
Q psy1684 86 VNLRKPCVQVSC-RI---------------YLVH-----------------------GT-NLSGVVV-S-AVDFG----- 118 (189)
Q Consensus 86 ~~~~~~~~~~~~-p~---------------~l~~-----------------------~~-~~~~~~~-s-VwsfG----- 118 (189)
++|..+++|||+ |+ |+++ |. ..+.++. + |||||
T Consensus 160 ~LH~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~e 239 (311)
T d1t46a_ 160 FLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWE 239 (311)
T ss_dssp HHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred HHHhCCeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHH
Confidence 999999999996 65 2222 11 4567899 9 99999
Q ss_pred --------CCCCCh-HHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q psy1684 119 --------SGGMTN-AEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTM 178 (189)
Q Consensus 119 --------~~~~~~-~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~ 178 (189)
+.+.+. ..+...+..|.++..|..+|+++.+||.+||+.||++||||++|++.|+++++.
T Consensus 240 llt~g~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 240 LFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 444444 345555688999999999999999999999999999999999999999988775
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.85 E-value=9.7e-24 Score=156.64 Aligned_cols=166 Identities=19% Similarity=0.242 Sum_probs=113.1
Q ss_pred ChHHHHHHhcCCCCC-CCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCce
Q psy1684 7 KRIEAEKKLLLPEND-HGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGLC 85 (189)
Q Consensus 7 ~~~n~~~lL~~~~~~-~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl~ 85 (189)
.|+|++.+++.+... ...++|+|+++++. +.-.+... ........... .......++..++..+..+++.|+.
T Consensus 75 ~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~-L~~~l~~~-~~~~~~~~~~~----~~~~~~~l~~~~~~~~~~qi~~gl~ 148 (299)
T d1ywna1 75 HHLNVVNLLGACTKPGGPLMVIVEFCKFGN-LSTYLRSK-RNEFVPYKVAP----EDLYKDFLTLEHLICYSFQVAKGME 148 (299)
T ss_dssp CCTTBCCEEEEECSTTSCCEEEEECCTTCB-HHHHHHHT-GGGBCC---------------CBCHHHHHHHHHHHHHHHH
T ss_pred CCCeEEEeeeeeccCCCeEEEEEEecCCCc-HHHHHHhc-cccccccccch----hhhhcccCCHHHHHHHHHHHHHHHH
Confidence 467777777655443 34688888888733 21111110 00000000000 0001223457778889999999999
Q ss_pred eeccCCcccccc-cc---------------cccccC------------------------CCCCccc-e-EEEec-----
Q psy1684 86 VNLRKPCVQVSC-RI---------------YLVHGT------------------------NLSGVVV-S-AVDFG----- 118 (189)
Q Consensus 86 ~~~~~~~~~~~~-p~---------------~l~~~~------------------------~~~~~~~-s-VwsfG----- 118 (189)
|+|..+++|||+ |+ |+|+.. ..+.|+. + |||||
T Consensus 149 ylH~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~e 228 (299)
T d1ywna1 149 FLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE 228 (299)
T ss_dssp HHHHTTCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred HHHhCCCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHH
Confidence 999999999996 55 444321 4566899 9 99999
Q ss_pred --------CCCCC-hHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q psy1684 119 --------SGGMT-NAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTM 178 (189)
Q Consensus 119 --------~~~~~-~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~ 178 (189)
|.+.+ ..++...+..|.+++.|..+|+++.+||.+||+.||++||||+||++.|++++++
T Consensus 229 llt~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 229 IFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp HHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 55554 3556667789999999999999999999999999999999999999999999875
|
| >d1rjaa_ d.93.1.1 (A:) Tyrosine-protein kinase 6 (Breast tumor kinase, Brk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine-protein kinase 6 (Breast tumor kinase, Brk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.83 E-value=9.3e-21 Score=117.74 Aligned_cols=92 Identities=30% Similarity=0.413 Sum_probs=83.8
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC--ccCCCCCcC-HhHHHHHh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET--QKAGRTTIH-YPELVEHY 77 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g--yl~~~~~~~-l~~li~~~ 77 (189)
||||.|+|..|+++|......+|+||||++.+.+|.|+||++. .+.++|++|.+..+| ++.+...|. +.+||+||
T Consensus 4 Wy~g~isR~~Ae~~L~~~~~~~G~FLvR~S~~~~g~y~LSv~~--~~~v~H~~I~~~~~g~~~l~~~~~F~sl~~LV~~y 81 (100)
T d1rjaa_ 4 WFFGCISRSEAVRRLQAEGNATGAFLIRVSEKPSADYVLSVRD--TQAVRHYKIWRRAGGRLHLNEAVSFLSLPELVNYH 81 (100)
T ss_dssp CBCTTCCHHHHHHHHSSTTCSSCCEEEEECSSSSSCEEEEECT--TSSCEEEEEEECSSSCEEEETTEEESSHHHHHHHH
T ss_pred CcCCCCCHHHHHHHHhccCCCCCeEEeecCCCCCCCEEEEEEc--CCCceEEEEEECCCCCEEecCCCccCCHHHHHHHH
Confidence 9999999999999997777789999999999888999999999 999999999988777 677777899 99999999
Q ss_pred hhccCCceeeccCCccc
Q psy1684 78 SKDADGLCVNLRKPCVQ 94 (189)
Q Consensus 78 ~~~a~gl~~~~~~~~~~ 94 (189)
.....|+...+..||.+
T Consensus 82 ~~~~~~~~~~L~~Pc~~ 98 (100)
T d1rjaa_ 82 RAQSLSHGLRLAAPCRK 98 (100)
T ss_dssp HHCCTTSSSCCCSBCCC
T ss_pred hhCCCCCccCcCeecCC
Confidence 99999999888888854
|
| >d1jwoa_ d.93.1.1 (A:) Csk homologous kinase Chk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Csk homologous kinase Chk species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.83 E-value=2.8e-20 Score=114.88 Aligned_cols=89 Identities=28% Similarity=0.400 Sum_probs=80.5
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC-ccCCCCCcC-HhHHHHHhh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET-QKAGRTTIH-YPELVEHYS 78 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g-yl~~~~~~~-l~~li~~~~ 78 (189)
||||.|+|.+|+++|. ...+|+||||++.+.+|.|+||++. .+.++|++|....++ ++.+...|. +.+||+||.
T Consensus 6 Wy~g~isR~eAe~~L~--~~~~G~FLVR~S~~~~g~~vLSv~~--~~~v~H~~I~~~~~~~~~~~~~~F~sl~~LI~~y~ 81 (97)
T d1jwoa_ 6 WFHGKISGQEAVQQLQ--PPEDGLFLVRESARHPGDYVLCVSF--GRDVIHYRVLHRDGHLTIDEAVFFCNLMDMVEHYS 81 (97)
T ss_dssp TEEESCCHHHHHHHTC--SCCTTCEEEEECSSSTTCEEEEEEE--TTEEEEEEEEESSSEESSTTSCCBSCHHHHHHHHH
T ss_pred ccCCCCCHHHHHHHhc--CCCCCeEEEEecCCCCccEEEEEEe--cCceEEEEEEEcCCcEEecCCcccCCHHHHHHHHh
Confidence 9999999999999994 3468999999999888999999999 999999999887766 888778898 999999999
Q ss_pred hccCCceeeccCCcc
Q psy1684 79 KDADGLCVNLRKPCV 93 (189)
Q Consensus 79 ~~a~gl~~~~~~~~~ 93 (189)
+..+|+.+.+..||.
T Consensus 82 ~~~~~L~~~L~~P~~ 96 (97)
T d1jwoa_ 82 KDKGAICTKLVRPKR 96 (97)
T ss_dssp HCCTTSSSCCCCBCC
T ss_pred hCCCCCCccCCccCc
Confidence 999999988888874
|
| >d1qcfa2 d.93.1.1 (A:146-248) Hemopoetic cell kinase Hck {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Hemopoetic cell kinase Hck species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.82 E-value=4e-20 Score=115.69 Aligned_cols=94 Identities=43% Similarity=0.683 Sum_probs=83.5
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEec---CCCeeeEEEEEeccCC--ccCCCCCcC-HhHHH
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKR---SSFCLKMTTGRSLFET--QKAGRTTIH-YPELV 74 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~---~~~~v~h~~i~~~~~g--yl~~~~~~~-l~~li 74 (189)
||||.|+|.+|+++|......+|+||||++.+.+|.|+|+++.. .++.+.|+.|....+| |+.+...|. +.+||
T Consensus 3 Wy~g~isR~eAe~~L~~~~~~~G~FLVR~S~~~~g~~~Lsv~~~~~~~~~~v~H~~i~~~~~g~~~~~~~~~F~sl~~LV 82 (103)
T d1qcfa2 3 WFFKGISRKDAERQLLAPGNMLGSFMIRDSETTKGSYSLSVRDYDPRQGDTVKHYKIRTLDNGGFYISPRSTFSTLQELV 82 (103)
T ss_dssp TEETTCCHHHHHHHHHSTTCCTTCEEEEECSSSTTSEEEEEEEEETTTEEEEEEEEEEECTTSCEESSSSSCBSSHHHHH
T ss_pred ccCCCCCHHHHHHHHhhcCCCCCcEEEEccCCCCCCeEEEEEecCCCcCceEEEEEEEEcCCCceeecCCcccCCHHHHH
Confidence 99999999999999876767899999999999989999999752 2568999999988777 777777899 99999
Q ss_pred HHhhhccCCceeeccCCccc
Q psy1684 75 EHYSKDADGLCVNLRKPCVQ 94 (189)
Q Consensus 75 ~~~~~~a~gl~~~~~~~~~~ 94 (189)
+||.+.++|+.+.+..||+.
T Consensus 83 ~~y~~~~~gL~~~L~~PC~~ 102 (103)
T d1qcfa2 83 DHYKKGNDGLCQKLSVPCMS 102 (103)
T ss_dssp HHHTSSCTTSSSCCCSBCCC
T ss_pred HHHhhCCCCCCccCCccCCC
Confidence 99999999999999999864
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.82 E-value=1.6e-22 Score=147.36 Aligned_cols=144 Identities=10% Similarity=0.035 Sum_probs=114.1
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..++|+|++++++....++..|||+|++++ |+ +.. ++.....+...+...+..+.+.|
T Consensus 61 ~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~-g~----L~~-----------------~l~~~~~l~e~~~~~i~~qi~~a 118 (263)
T d2j4za1 61 SHLRHPNILRLYGYFHDATRVYLILEYAPL-GT----VYR-----------------ELQKLSKFDEQRTATYITELANA 118 (263)
T ss_dssp HTCCCTTBCCEEEEEECSSEEEEEEECCTT-CB----HHH-----------------HHHHHSSCCHHHHHHHHHHHHHH
T ss_pred HhcCCCCCCeEEEEEEECCEEEEEEeecCC-Cc----HHH-----------------HHhhcCCCCHHHHHHHHHHHHHH
Confidence 367899999999887777778899999886 31 111 23323345567777888899999
Q ss_pred ceeeccCCcccccc-cc---------------ccc-------------------ccC-CCCCccc-e-EEEec-------
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YLV-------------------HGT-NLSGVVV-S-AVDFG------- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l~-------------------~~~-~~~~~~~-s-VwsfG------- 118 (189)
+.++|..+++|||+ |+ |+| ||. .+..|+. + |||||
T Consensus 119 l~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell 198 (263)
T d2j4za1 119 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL 198 (263)
T ss_dssp HHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred HHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHh
Confidence 99999999999996 66 222 222 5566899 9 99999
Q ss_pred -----CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 119 -----SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 119 -----~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
|.+.+..++...+.++. ++.|+.+|+++.+|+.+||+.||++|||++|+++
T Consensus 199 ~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 199 VGKPPFEANTYQETYKRISRVE-FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp HSSCTTCCSSHHHHHHHHHTTC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cCCCCCCCCCHHHHHHHHHcCC-CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 77888888888887664 5678899999999999999999999999999986
|
| >d1k9aa2 d.93.1.1 (A:77-177) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.82 E-value=4.7e-20 Score=114.65 Aligned_cols=90 Identities=34% Similarity=0.499 Sum_probs=81.6
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC-ccCCCCCcC-HhHHHHHhh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET-QKAGRTTIH-YPELVEHYS 78 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g-yl~~~~~~~-l~~li~~~~ 78 (189)
||||.|+|.+|+++|.. .++|+||||++.+.+|.|+||++. .+.++|++|....++ ++.+...|. +.+||+||+
T Consensus 6 Wy~g~isR~~Ae~lL~~--~~~G~FLVR~S~~~~g~y~LSv~~--~~~v~H~~I~~~~~~~~~~~~~~F~sl~~LV~~y~ 81 (101)
T d1k9aa2 6 WFHGKITREQAERLLYP--PETGLFLVRESTNYPGDYTLCVSC--EGKVEHYRIMYHASKLSIDEEVYFENLMQLVEHYT 81 (101)
T ss_dssp TBCTTCCHHHHHHHTCS--CCTTEEEEEECSSSTTSEEEEEEC--SSSEEEEEEEEETTEEESSSSSCBSSHHHHHHHHH
T ss_pred ccCCCCCHHHHHHHHcC--CCCCCEEEeccCCCCCCEEEEEEe--CCccEEEEEEEcCCCceecCCcccCCHHHHHHHHh
Confidence 99999999999999853 468999999998888999999999 999999999988777 887777899 999999999
Q ss_pred hccCCceeeccCCccc
Q psy1684 79 KDADGLCVNLRKPCVQ 94 (189)
Q Consensus 79 ~~a~gl~~~~~~~~~~ 94 (189)
+..+|+.+.+..||..
T Consensus 82 ~~~~gl~~~L~~P~~~ 97 (101)
T d1k9aa2 82 TDADGLCTRLIKPKVM 97 (101)
T ss_dssp HCCTTSSSCCCEECCC
T ss_pred hCCCCCceeCCccccC
Confidence 9999999999888754
|
| >d1a81a1 d.93.1.1 (A:9-137) Syk tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Syk tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.82 E-value=4.1e-20 Score=119.40 Aligned_cols=92 Identities=28% Similarity=0.357 Sum_probs=83.5
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC--ccCCCCCcC-HhHHHHHh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET--QKAGRTTIH-YPELVEHY 77 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g--yl~~~~~~~-l~~li~~~ 77 (189)
||||.|+|..|+++|......+|+||||+|.+..|.|+||++. .+.++|++|.+..+| ++.....|. +.+||+||
T Consensus 7 Wyhg~isR~~Ae~lL~~~g~~dG~FLVR~S~~~~g~y~LSv~~--~~~v~H~~I~~~~~g~~~i~~~~~F~sl~eLV~~Y 84 (129)
T d1a81a1 7 FFFGNITREEAEDYLVQGGMSDGLYLLRQSRNYLGGFALSVAH--GRKAHHYTIERELNGTYAIAGGRTHASPADLCHYH 84 (129)
T ss_dssp TBCSSCCHHHHHHHHHHTTCCTTEEEEEECSSSTTCEEEEEEE--TTEEEEEEEEECTTSCEEETTSCCBSSHHHHHHHH
T ss_pred cccCCCCHHHHHHHHHhcCCCCccEEEEccCCCCcceEEEeee--cccceEEEEEEcCCCCeeecCCcccCCHHHHHHHH
Confidence 9999999999999997666688999999999988999999999 999999999988887 677677899 99999999
Q ss_pred hhccCCceeeccCCccc
Q psy1684 78 SKDADGLCVNLRKPCVQ 94 (189)
Q Consensus 78 ~~~a~gl~~~~~~~~~~ 94 (189)
++..+|+.+.+..||..
T Consensus 85 ~~~~~gl~~~L~~P~~~ 101 (129)
T d1a81a1 85 SQESDGLVCLLKKPFNR 101 (129)
T ss_dssp TTCCTTSSSCCCEECCC
T ss_pred hhCCCCCcccCCCCCCC
Confidence 99999999999988743
|
| >d2oq1a2 d.93.1.1 (A:135-258) Tyrosine-protein kinase zap-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine-protein kinase zap-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.82 E-value=8e-20 Score=117.50 Aligned_cols=90 Identities=28% Similarity=0.347 Sum_probs=81.7
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC--ccCCCCCcC-HhHHHHHh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET--QKAGRTTIH-YPELVEHY 77 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g--yl~~~~~~~-l~~li~~~ 77 (189)
||||.|+|..|+++|..+...+|+||||.+.. .+.|+||++. .+.++|++|.+..+| ++.....|. +.+||+||
T Consensus 31 Wyhg~isR~eAe~lL~~~~~~dGtFLVR~S~~-~g~yvLSv~~--~~~v~H~~I~~~~~g~~~l~~~~~F~sl~~LV~~y 107 (124)
T d2oq1a2 31 WYHSSLTREEAERKLYSGAQTDGKFLLRPRKE-QGTYALSLIY--GKTVYHYLISQDKAGKYCIPEGTKFDTLWQLVEYL 107 (124)
T ss_dssp TBCSSCCHHHHHHHHHSSCCCTTEEEEEECSS-TTEEEEEEEE--TTEEEEEEEEECTTSCEESTTSCCBSSHHHHHHHH
T ss_pred CccCCCCHHHHHHHHhhcCCCCceEEeEecCC-CCCEEEEeec--CCceEEEEEEECCCCCEEeCCCcccCCHHHHHHHH
Confidence 99999999999999987777899999999966 5889999999 999999999988777 666667888 99999999
Q ss_pred hhccCCceeeccCCcc
Q psy1684 78 SKDADGLCVNLRKPCV 93 (189)
Q Consensus 78 ~~~a~gl~~~~~~~~~ 93 (189)
++..+|+.+.+..||+
T Consensus 108 ~~~~~gL~~~L~~PcP 123 (124)
T d2oq1a2 108 KLKADGLIYCLKEACP 123 (124)
T ss_dssp HHCCTTSSSCCCSBCC
T ss_pred hhCCCCCcccCCCcCc
Confidence 9999999999998875
|
| >d2oq1a1 d.93.1.1 (A:5-134) Tyrosine-protein kinase zap-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine-protein kinase zap-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.82 E-value=5.9e-20 Score=119.00 Aligned_cols=92 Identities=35% Similarity=0.514 Sum_probs=84.0
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC--ccCCCCCcC-HhHHHHHh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET--QKAGRTTIH-YPELVEHY 77 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g--yl~~~~~~~-l~~li~~~ 77 (189)
||||.|+|..|+++|......+|+||||+|.+..|.|+||++. .+.++||+|....+| ++.+...|. +.+||+||
T Consensus 8 Wy~g~i~R~~Ae~~L~~~g~~~G~FLVR~S~~~~g~yvLSv~~--~~~v~H~~I~~~~~g~~~l~~~~~F~sl~~Lv~~Y 85 (130)
T d2oq1a1 8 FFYGSISRAEAEEHLKLAGMADGLFLLRQCLRSLGGYVLSLVH--DVRFHHFPIERQLNGTYAIAGGKAHCGPAELCEFY 85 (130)
T ss_dssp TBCBSCCHHHHHHHHHHTTCCTTCEEEEECSSSTTCEEEEEEE--TTEEEEEEEEECTTSCEEETTSCCBSSHHHHHHHH
T ss_pred CccCCCCHHHHHHHHHhcCCCCceEEEEecCCCCccEEEEEee--CCceEEEEEEEcCCCceeccCCCCcCCHHHHHHHH
Confidence 9999999999999997666788999999999998999999999 999999999988777 676667799 99999999
Q ss_pred hhccCCceeeccCCccc
Q psy1684 78 SKDADGLCVNLRKPCVQ 94 (189)
Q Consensus 78 ~~~a~gl~~~~~~~~~~ 94 (189)
+...+|+.+.+..||..
T Consensus 86 ~~~~~gL~~~L~~P~~r 102 (130)
T d2oq1a1 86 SRDPDGLPCNLRKPCNR 102 (130)
T ss_dssp HHCCTTSSSCCCSBCCC
T ss_pred hhCCCCCCccCCccCCC
Confidence 99999999999999865
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.81 E-value=6.1e-23 Score=150.05 Aligned_cols=146 Identities=12% Similarity=0.080 Sum_probs=107.0
Q ss_pred CCCCChHHHHHHhcCCCC--CCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccC----CCCCcCHhHHHHH
Q psy1684 3 FGKIKRIEAEKKLLLPEN--DHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKA----GRTTIHYPELVEH 76 (189)
Q Consensus 3 ~g~l~~~n~~~lL~~~~~--~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~----~~~~~~l~~li~~ 76 (189)
+..++|+|++++++.+.. ....|||+|++++ |+ +.. ++. .+..++...+..+
T Consensus 57 l~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~-g~----L~~-----------------~i~~~~~~~~~l~e~~~~~i 114 (269)
T d2java1 57 LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEG-GD----LAS-----------------VITKGTKERQYLDEEFVLRV 114 (269)
T ss_dssp TTSCCCTTBCCEEEEEEC----CEEEEEECCTT-EE----HHH-----------------HHHHHHHHTCCCCHHHHHHH
T ss_pred HHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCC-Cc----HHH-----------------HHHhccccCCCCCHHHHHHH
Confidence 457889999998876533 2346889998876 31 221 111 1234556677778
Q ss_pred hhhccCCceeeccCC-----cccccc-cc------------------------------------cccccC-CCCCccc-
Q psy1684 77 YSKDADGLCVNLRKP-----CVQVSC-RI------------------------------------YLVHGT-NLSGVVV- 112 (189)
Q Consensus 77 ~~~~a~gl~~~~~~~-----~~~~~~-p~------------------------------------~l~~~~-~~~~~~~- 112 (189)
..+.+.|+.|+|..+ ++|||+ |+ ++|||. ....|+.
T Consensus 115 ~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~ 194 (269)
T d2java1 115 MTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEK 194 (269)
T ss_dssp HHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHH
T ss_pred HHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChH
Confidence 889999999999864 999996 65 223332 5667999
Q ss_pred e-EEEec------------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 113 S-AVDFG------------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 113 s-VwsfG------------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
+ ||||| |.+.+..++...+.++..++.|..+|+++.+||.+||+.||++|||++||++
T Consensus 195 ~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 195 SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 9 99999 7888889999999888888889999999999999999999999999999875
|
| >d1opka2 d.93.1.1 (A:140-240) Abl tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Abl tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.80 E-value=6.3e-20 Score=114.30 Aligned_cols=91 Identities=30% Similarity=0.342 Sum_probs=81.6
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC--ccCCCCCcC-HhHHHHHh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET--QKAGRTTIH-YPELVEHY 77 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g--yl~~~~~~~-l~~li~~~ 77 (189)
||||.|+|.+|+++|..+ .+|+||||++.+.+|.|+||++. .+.+.|++|....+| ++.+...|. +.+||+||
T Consensus 7 Wy~g~isR~eAe~lL~~~--~~G~FLVR~S~~~~~~~~LSv~~--~~~v~H~~I~~~~~g~~~~~~~~~F~sl~~LI~~y 82 (101)
T d1opka2 7 WYHGPVSRNAAEYLLSSG--INGSFLVRESESSPGQRSISLRY--EGRVYHYRINTASDGKLYVSSESRFNTLAELVHHH 82 (101)
T ss_dssp TEEEECCHHHHHHHGGGC--CTTEEEEEECSSSTTCEEEEEEE--TTEEEEEECEECTTSCEESSTTSCBSSHHHHHHHH
T ss_pred ccCCCCCHHHHHHHhcCC--CCCeEEEEecCCCCCCEEEEEEc--CcceEEEEeEECCCCCEEeCCCcccCCHHHHHHHH
Confidence 999999999999999643 68999999999888999999999 999999999988888 566677788 99999999
Q ss_pred hhccCCceeeccCCcccc
Q psy1684 78 SKDADGLCVNLRKPCVQV 95 (189)
Q Consensus 78 ~~~a~gl~~~~~~~~~~~ 95 (189)
....+|+.+.+..||..+
T Consensus 83 ~~~~~~l~~~L~~P~pr~ 100 (101)
T d1opka2 83 STVADGLITTLHYPAPKR 100 (101)
T ss_dssp TTCCTTSSSCCCEECCCC
T ss_pred hhCCCCCceECCCccCCC
Confidence 999999999888888654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.80 E-value=1.3e-22 Score=151.03 Aligned_cols=146 Identities=12% Similarity=0.073 Sum_probs=112.4
Q ss_pred CCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccC
Q psy1684 3 FGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDAD 82 (189)
Q Consensus 3 ~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~ 82 (189)
+..++|+|++++++.+...+..|||+|++.+ |.+. . ++..+..++..++..+..+++.
T Consensus 69 l~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~-g~l~----~-----------------~~~~~~~l~e~~~~~i~~qi~~ 126 (309)
T d1u5ra_ 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYCLG-SASD----L-----------------LEVHKKPLQEVEIAAVTHGALQ 126 (309)
T ss_dssp HTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHH----H-----------------HHHHTSCCCHHHHHHHHHHHHH
T ss_pred HHHCCCCCEeeEEEEEEECCEEEEEEEecCC-CchH----H-----------------HHHhCCCCCHHHHHHHHHHHHH
Confidence 3578899999999887767778899998875 3110 0 1222344566777888899999
Q ss_pred CceeeccCCcccccc-cc--------------------------------cccccC----CCCCccc-e-EEEec-----
Q psy1684 83 GLCVNLRKPCVQVSC-RI--------------------------------YLVHGT----NLSGVVV-S-AVDFG----- 118 (189)
Q Consensus 83 gl~~~~~~~~~~~~~-p~--------------------------------~l~~~~----~~~~~~~-s-VwsfG----- 118 (189)
|+.|+|..+++|||+ |+ ++|||. ..+.|+. + |||||
T Consensus 127 aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilye 206 (309)
T d1u5ra_ 127 GLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 206 (309)
T ss_dssp HHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHH
T ss_pred HHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCCCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHH
Confidence 999999999999996 65 334443 2456999 9 99999
Q ss_pred -------CCCCChHHHHHHHHcCCCCC-CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 119 -------SGGMTNAEVLHQVEHGYRMP-CPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 119 -------~~~~~~~~~~~~v~~g~~~~-~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
|.+.+..+.+..+..+..++ .+..+|+++.+||.+||+.||++|||++|+++
T Consensus 207 l~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 207 LAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 77777778887876665544 45678999999999999999999999999975
|
| >d1lkka_ d.93.1.1 (A:) p56-lck tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: p56-lck tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.80 E-value=2.8e-19 Score=112.16 Aligned_cols=93 Identities=41% Similarity=0.692 Sum_probs=81.0
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEec---CCCeeeEEEEEeccCC--ccCCCCCcC-HhHHH
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKR---SSFCLKMTTGRSLFET--QKAGRTTIH-YPELV 74 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~---~~~~v~h~~i~~~~~g--yl~~~~~~~-l~~li 74 (189)
||||.|+|.+|+++|......+|+||||.+.+.+|.|+||++.. ....+.|+.|....+| ++.+...|. +.+||
T Consensus 6 Wy~g~isR~eAe~~L~~~~~~~GtFLVR~S~~~~g~~~lsv~~~~~~~~~~v~h~~i~~~~~~~~~~~~~~~F~sl~~LV 85 (105)
T d1lkka_ 6 WFFKNLSRKDAERQLLAPGNTHGSFLIRESESTAGSFSLSVRDFDQNQGEVVKHYKIRNLDNGGFYISPRITFPGLHELV 85 (105)
T ss_dssp TBCTTCCHHHHHHHHTSTTCCTTCEEEEECSSSTTCEEEEEEEEETTTEEEEEEEEEEECTTSCEESSTTSCBSSHHHHH
T ss_pred ccCCCCCHHHHHHHHHhcCCCCCcEEEEccCCCCCCEEEEEEEcccCCCccEEEEEEEEcCCCCEEecCCcccCCHHHHH
Confidence 99999999999999977777899999999998889999999863 2235899999887777 777777799 99999
Q ss_pred HHhhhccCCceeeccCCcc
Q psy1684 75 EHYSKDADGLCVNLRKPCV 93 (189)
Q Consensus 75 ~~~~~~a~gl~~~~~~~~~ 93 (189)
+||+.+++|+.+.+..||.
T Consensus 86 ~~y~~~~~gL~~~L~~Pcp 104 (105)
T d1lkka_ 86 RHYTNASDGLCTRLSRPCQ 104 (105)
T ss_dssp HHHHHCCTTSSSCCCSBCC
T ss_pred HHHhhCCCCCCccCCCcCC
Confidence 9999999999999988874
|
| >d1o48a_ d.93.1.1 (A:) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.80 E-value=1.8e-19 Score=113.18 Aligned_cols=93 Identities=43% Similarity=0.649 Sum_probs=81.2
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEec---CCCeeeEEEEEeccCC--ccCCCCCcC-HhHHH
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKR---SSFCLKMTTGRSLFET--QKAGRTTIH-YPELV 74 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~---~~~~v~h~~i~~~~~g--yl~~~~~~~-l~~li 74 (189)
||||.|+|.+|+++|.....++|+||||++.+..|.|+||++.. ....+.|+.+....+| ++.+...|. +.+||
T Consensus 7 Wy~g~i~R~eAe~lL~~~~~~~G~FLVR~S~~~~g~y~LSv~~~~~~~~~~i~h~~i~~~~~g~~~~~~~~~F~sl~eLV 86 (106)
T d1o48a_ 7 WYFGKITRRESERLLLNAENPRGTFLVRESETTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSRTQFNSLQQLV 86 (106)
T ss_dssp TEEESCCHHHHHHHHCCTTCCTTCEEEEECSSSTTCEEEEEEEEETTTEEEEEEEEEEECTTSCEESSTTSEESSHHHHH
T ss_pred ccCCCCCHHHHHHHHHhcCCCCCcEEEEcccCCCCCEEEEEEecccCcccceEEEEEEEecCCCEEEcCCeeECCHHHHH
Confidence 99999999999999977777899999999998889999999863 2346889999887777 777777899 99999
Q ss_pred HHhhhccCCceeeccCCcc
Q psy1684 75 EHYSKDADGLCVNLRKPCV 93 (189)
Q Consensus 75 ~~~~~~a~gl~~~~~~~~~ 93 (189)
+||.++++|+.+.+..||+
T Consensus 87 ~~y~~~~~gL~~~L~~pcP 105 (106)
T d1o48a_ 87 AYYSKHADGLCHRLTTVCP 105 (106)
T ss_dssp HHHTTCCTTSSSCCCSBCC
T ss_pred HHHhhCCCCCCccCCCcCC
Confidence 9999999999999888874
|
| >d1blja_ d.93.1.1 (A:) P55 Blk protein tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: P55 Blk protein tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.80 E-value=1.2e-19 Score=115.48 Aligned_cols=94 Identities=45% Similarity=0.684 Sum_probs=83.1
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEec--CCCeeeEEEEEeccCC--ccCCCCCcC-HhHHHH
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKR--SSFCLKMTTGRSLFET--QKAGRTTIH-YPELVE 75 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~--~~~~v~h~~i~~~~~g--yl~~~~~~~-l~~li~ 75 (189)
||||.|+|.+|+++|......+|+||||++.+.+|.|+|+++.. ..+.++|++|....+| ++.+...|. +.+||+
T Consensus 14 Wy~g~isR~eAe~~L~~~~~~~G~FLVR~S~~~~g~~~Lsv~~~~~~~~~v~H~~i~~~~~g~~~l~~~~~F~sl~eLV~ 93 (114)
T d1blja_ 14 WFFRTISRKDAERQLLAPMNKAGSFLIRESESNKGAFSLSVKDITTQGEVVKHYKIRSLDNGGYYISPRITFPTLQALVQ 93 (114)
T ss_dssp SBCCSCCHHHHHHHHSSTTCCTTCEEBCBCTTCSSCEEEEECBCCTTTCBCCCEEEEEETTTEEEEETTEEESSHHHHHH
T ss_pred CcCCCCCHHHHHHHHHhcCCCCceEEEeccCCCCCCeEEEEEeeccCCCEEEEEEEEEcCCCCEEecCCceECCHHHHHH
Confidence 99999999999998877667899999999998889999999853 2456899999988777 777677799 999999
Q ss_pred HhhhccCCceeeccCCccc
Q psy1684 76 HYSKDADGLCVNLRKPCVQ 94 (189)
Q Consensus 76 ~~~~~a~gl~~~~~~~~~~ 94 (189)
||.++++|+...+..||+.
T Consensus 94 ~y~~~~~gL~~~L~~PC~~ 112 (114)
T d1blja_ 94 HYSKKGDGLCQKLTLPCVN 112 (114)
T ss_dssp HHHHCCSSSSSCCCCCSCC
T ss_pred HHhhCCCCCCccCCccCcC
Confidence 9999999999999999875
|
| >d1a81a2 d.93.1.1 (A:138-262) Syk tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Syk tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=3e-19 Score=115.03 Aligned_cols=91 Identities=31% Similarity=0.449 Sum_probs=81.0
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC--ccCCCCCcC-HhHHHHHh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET--QKAGRTTIH-YPELVEHY 77 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g--yl~~~~~~~-l~~li~~~ 77 (189)
||||.|+|.+|+++|......+|+||||++.. .+.|+||++. .+.++|++|....+| ++.+...|. +.+||+||
T Consensus 31 Wyhg~isR~~Ae~lL~~~g~~~G~FLVR~S~~-~~~yvLSv~~--~~~v~H~~I~~~~~g~~~~~~~~~F~sL~~LI~~y 107 (125)
T d1a81a2 31 WFHGKISREESEQIVLIGSKTNGKFLIRARDN-NGSYALCLLH--EGKVLHYRIDKDKTGKLSIPEGKKFDTLWQLVEHY 107 (125)
T ss_dssp TEEEECCHHHHHHHHHSSCCCTTCEEEEECSS-SSCEEEEEEE--TTEEEEEEEEECTTSCEECTTSCCBSCHHHHHHHH
T ss_pred ccCCCCCHHHHHHHHHhcCCCCceEEEEecCC-CCCEEEEeec--cccceeEeeeEcCCCcEeccCCcccCCHHHHHHHH
Confidence 99999999999999977777889999999865 4889999999 999999999988887 566666788 99999999
Q ss_pred hhccCCceeeccCCccc
Q psy1684 78 SKDADGLCVNLRKPCVQ 94 (189)
Q Consensus 78 ~~~a~gl~~~~~~~~~~ 94 (189)
....+|+.+.+..||.+
T Consensus 108 ~~~~~gL~~~L~~P~~k 124 (125)
T d1a81a2 108 SYKADGLLRVLTVPCQK 124 (125)
T ss_dssp TTCCTTSSSCCCCBCCC
T ss_pred hhCCCCCCccCCeeCCC
Confidence 99999999999998854
|
| >d1nrva_ d.93.1.1 (A:) Growth factor receptor-bound protein 10, GRB10 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Growth factor receptor-bound protein 10, GRB10 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=4.1e-19 Score=111.34 Aligned_cols=91 Identities=23% Similarity=0.365 Sum_probs=77.7
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC-----ccCC-CCCcC-HhHH
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET-----QKAG-RTTIH-YPEL 73 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g-----yl~~-~~~~~-l~~l 73 (189)
||||.|+|..|+++|.....++|+||||++.+.+|.|+||++. .+.+.|++|....++ ++.+ ...|. +.+|
T Consensus 7 Wyhg~isR~~Ae~lL~~~g~~dG~FLVR~S~~~~g~y~LSv~~--~~~v~H~~I~~~~~~~~~~~~~~~~~~~F~sl~~L 84 (105)
T d1nrva_ 7 WFHGRISREESHRIIKQQGLVDGLFLLRDSQSNPKAFVLTLCH--HQKIKNFQILPCEDDGQTFFSLDDGNTKFSDLIQL 84 (105)
T ss_dssp TBCTTCCHHHHHHHHHHTTCCTTEEEEEECSSCTTCEEEEEEE--TTEEEEEEEEEC-----CCEESSTTSSCBSSHHHH
T ss_pred ccCCCCCHHHHHHHHhhcCCCCceEEEEeCCCCCCCEEEEEEE--CCceeEEEEEEecCCCeEEEEECCCCcccCCHHHH
Confidence 9999999999999997666688999999999988999999999 999999999876543 2333 34688 9999
Q ss_pred HHHhhhccCCceeeccCCcc
Q psy1684 74 VEHYSKDADGLCVNLRKPCV 93 (189)
Q Consensus 74 i~~~~~~a~gl~~~~~~~~~ 93 (189)
|+||....+|+.+.+..||+
T Consensus 85 V~~y~~~~~~L~~~L~~Pc~ 104 (105)
T d1nrva_ 85 VDFYQLNKGVLPCKLKHHCI 104 (105)
T ss_dssp HHHHTTCCTTSSSCCCEECC
T ss_pred HHHhccCcCCCCccCCcCCC
Confidence 99999999999998888875
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.78 E-value=3.6e-21 Score=143.06 Aligned_cols=145 Identities=15% Similarity=0.007 Sum_probs=111.0
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..++|+|++++++........|||+|++++ |+ +.. ++.....++..+...+..+.+.|
T Consensus 62 ~~l~HpnIv~l~~~~~~~~~~~lvmE~~~g-g~----L~~-----------------~l~~~~~l~e~~~~~~~~qi~~a 119 (307)
T d1a06a_ 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSG-GE----LFD-----------------RIVEKGFYTERDASRLIFQVLDA 119 (307)
T ss_dssp HTCCCTTBCCEEEEEECSSEEEEEECCCCS-CB----HHH-----------------HHHTCSCCCHHHHHHHHHHHHHH
T ss_pred HhCCCCCCCcEEEEEEECCEEEEEEeccCC-Cc----HHH-----------------hhhcccCCCHHHHHHHHHHHHHH
Confidence 357888888888877666677888888876 31 222 34444556677778888899999
Q ss_pred ceeeccCCcccccc-cc------------------cc--------------------cccC-CCCCccc-e-EEEec---
Q psy1684 84 LCVNLRKPCVQVSC-RI------------------YL--------------------VHGT-NLSGVVV-S-AVDFG--- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~------------------~l--------------------~~~~-~~~~~~~-s-VwsfG--- 118 (189)
+.++|..+++|||+ |+ |+ |||. ..+.|+. + |||+|
T Consensus 120 l~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvil 199 (307)
T d1a06a_ 120 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIA 199 (307)
T ss_dssp HHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------------------CTTSCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred HHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHH
Confidence 99999999999996 55 11 2221 5567999 9 99999
Q ss_pred ---------CCCCChHHHHHHHHcCCC-C--CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 119 ---------SGGMTNAEVLHQVEHGYR-M--PCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 119 ---------~~~~~~~~~~~~v~~g~~-~--~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
|.+.+..++...+.++.. + +.++.+|+++.+|+.+||+.||++|||++|+++
T Consensus 200 yell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 200 YILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 777778888888866543 2 234679999999999999999999999999987
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.78 E-value=5.7e-22 Score=146.20 Aligned_cols=145 Identities=10% Similarity=0.015 Sum_probs=111.9
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCC-CCCcCHhHHHHHhhhccC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAG-RTTIHYPELVEHYSKDAD 82 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~-~~~~~l~~li~~~~~~a~ 82 (189)
..++|+|++++++.+..++..+||+|++++ |+ +.. ++.. ...++..+...+..+.+.
T Consensus 64 ~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~-g~----L~~-----------------~~~~~~~~l~e~~~~~i~~qi~~ 121 (288)
T d2jfla1 64 ASCDHPNIVKLLDAFYYENNLWILIEFCAG-GA----VDA-----------------VMLELERPLTESQIQVVCKQTLD 121 (288)
T ss_dssp HHCCCTTBCCEEEEEEETTEEEEEEECCTT-EE----HHH-----------------HHHHHTSCCCHHHHHHHHHHHHH
T ss_pred HhCCCCCCCeEEEEEeeCCeEEEEEecCCC-Cc----HHH-----------------HHHhcCCCCCHHHHHHHHHHHHH
Confidence 357899999999887777788999999887 31 111 2211 234556677778889999
Q ss_pred CceeeccCCcccccc-cc---------------cc---------------------cccC------CCCCccc-e-EEEe
Q psy1684 83 GLCVNLRKPCVQVSC-RI---------------YL---------------------VHGT------NLSGVVV-S-AVDF 117 (189)
Q Consensus 83 gl~~~~~~~~~~~~~-p~---------------~l---------------------~~~~------~~~~~~~-s-Vwsf 117 (189)
|+.|+|..+++|||+ |+ |+ |||. ....|+. + ||||
T Consensus 122 gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSl 201 (288)
T d2jfla1 122 ALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSL 201 (288)
T ss_dssp HHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHH
T ss_pred HHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHH
Confidence 999999999999996 65 22 2222 2455899 9 9999
Q ss_pred c------------CCCCChHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 118 G------------SGGMTNAEVLHQVEHGYR--MPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 118 G------------~~~~~~~~~~~~v~~g~~--~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
| |.+.+..+++..+.++.. ++.|..+|+++.+||.+||+.||++|||++|+++
T Consensus 202 Gvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 202 GITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp HHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 9 777788888888876653 3456789999999999999999999999999976
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.78 E-value=1.2e-21 Score=143.22 Aligned_cols=145 Identities=10% Similarity=0.048 Sum_probs=106.1
Q ss_pred CCCChHHHHHHhcCCCC----CCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhh
Q psy1684 4 GKIKRIEAEKKLLLPEN----DHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSK 79 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~----~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~ 79 (189)
..++|+|++++++.+.. ....|||+|+++++. +.. ++.....++...+..+..+
T Consensus 63 ~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~-----L~~-----------------~l~~~~~~~~~~~~~~~~q 120 (270)
T d1t4ha_ 63 KGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGT-----LKT-----------------YLKRFKVMKIKVLRSWCRQ 120 (270)
T ss_dssp TTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCB-----HHH-----------------HHHHHSSCCHHHHHHHHHH
T ss_pred HhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCc-----HHH-----------------HHhccccccHHHHHHHHHH
Confidence 46788888888765321 223577888777622 111 3333345556777788889
Q ss_pred ccCCceeeccCC--cccccc-cc-----------------------------------cccccCCCCCccc-e-EEEec-
Q psy1684 80 DADGLCVNLRKP--CVQVSC-RI-----------------------------------YLVHGTNLSGVVV-S-AVDFG- 118 (189)
Q Consensus 80 ~a~gl~~~~~~~--~~~~~~-p~-----------------------------------~l~~~~~~~~~~~-s-VwsfG- 118 (189)
++.|+.|+|... ++|||+ |+ ++|||...+.|+. + |||||
T Consensus 121 i~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGv 200 (270)
T d1t4ha_ 121 ILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGM 200 (270)
T ss_dssp HHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHH
T ss_pred HHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCccCCcccCccccCHHHhCCCCCCcCchhhHHH
Confidence 999999999987 999996 55 3444445667999 9 99999
Q ss_pred -----------CCCCC-hHHHHHHHHcCCCCC-CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 119 -----------SGGMT-NAEVLHQVEHGYRMP-CPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 119 -----------~~~~~-~~~~~~~v~~g~~~~-~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
|.+.+ ..++...+..+.+++ .+..+++++.+||.+||+.||++|||++||++
T Consensus 201 ilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 201 CMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp HHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 55544 456667777776543 46678999999999999999999999999875
|
| >d1g83a2 d.93.1.1 (A:142-245) Tyrosine kinase Fyn {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine kinase Fyn species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.78 E-value=9.6e-19 Score=109.50 Aligned_cols=91 Identities=41% Similarity=0.578 Sum_probs=79.0
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEec---CCCeeeEEEEEeccCC--ccCCCCCcC-HhHHH
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKR---SSFCLKMTTGRSLFET--QKAGRTTIH-YPELV 74 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~---~~~~v~h~~i~~~~~g--yl~~~~~~~-l~~li 74 (189)
||||.|+|.+|+++|......+|+||||++.+.+|.|+||++.. ..+.+.|++|....+| ++.+...|. +.+||
T Consensus 8 Wy~g~i~R~eAe~~L~~~g~~~G~FLVR~S~~~~g~~~Lsv~~~~~~~~~~v~h~~i~~~~~g~~~~~~~~~F~sl~~LV 87 (104)
T d1g83a2 8 WYFGKLGRKDAERQLLSFGNPRGTFLIRESETTKGAYSLSIRDWDDMKGDHVKHYKIRKLDNGGYYITTRAQFETLQQLV 87 (104)
T ss_dssp SBCTTCCHHHHHHHHHSTTCCTTCEEEEECSSSTTCEEEEEEEECSSSCEEEEEEEEEECTTSCEEETTTEEESSHHHHH
T ss_pred CcCCCCCHHHHHHHHHhcCCCCCcEEEeccCCCCCCeEEEEEEeecCcCCeEEEEEEEEcCCCCEEecCCcccCCHHHHH
Confidence 99999999999999987777899999999999889999999863 2467999999987777 677777788 99999
Q ss_pred HHhhhccCCceeeccCC
Q psy1684 75 EHYSKDADGLCVNLRKP 91 (189)
Q Consensus 75 ~~~~~~a~gl~~~~~~~ 91 (189)
+||.++..|+.+.+..|
T Consensus 88 ~~y~~~~~gL~~~L~~P 104 (104)
T d1g83a2 88 QHYSERAAGLSSRLVVP 104 (104)
T ss_dssp HHHHHCCTTSSSCCCCC
T ss_pred HHHhhCCCCCceeCCCC
Confidence 99999999988776654
|
| >d1i3za_ d.93.1.1 (A:) Ews/fli1 activated transcript 2, Eat2 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Ews/fli1 activated transcript 2, Eat2 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.77 E-value=5.2e-19 Score=110.36 Aligned_cols=90 Identities=31% Similarity=0.345 Sum_probs=77.1
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC--ccCC-----CCCcC-HhH
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET--QKAG-----RTTIH-YPE 72 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g--yl~~-----~~~~~-l~~ 72 (189)
||||.|+|..|+++|... ..+|+||||+|.+.+|.|+||++. .+.+.|++|.+..+| ++.. ...|. +.+
T Consensus 5 Wy~g~isR~~AE~lL~~~-~~~G~FLVR~S~~~~g~~~LSv~~--~~~v~H~~I~~~~~g~~~~~~~~~~~~~~F~sl~~ 81 (103)
T d1i3za_ 5 YYHGCLTKRECEALLLKG-GVDGNFLIRDSESVPGALCLCVSF--KKLVYSYRIFREKHGYYRIETDAHTPRTIFPNLQE 81 (103)
T ss_dssp TEESSCCHHHHHHHHHTT-CSTTEEEEEECSSSTTCEEEEEEC--SSSEEEEEEEECTTSCEEECBCTTSCCCEESSSHH
T ss_pred cccCCCCHHHHHHHHHhC-CCCCeEEEEecCCCCCCEEEEEEe--CCeEEEEEeEEcCCCcEEEeccCCcCccccCCHHH
Confidence 999999999999988544 368999999999988999999999 999999999887777 4432 23577 999
Q ss_pred HHHHhhhccCCceeeccCCcc
Q psy1684 73 LVEHYSKDADGLCVNLRKPCV 93 (189)
Q Consensus 73 li~~~~~~a~gl~~~~~~~~~ 93 (189)
||+||.+..+|+.+.+..||.
T Consensus 82 LV~~y~~~~~gl~~~L~~P~~ 102 (103)
T d1i3za_ 82 LVSKYGKPGQGLVVHLSNPIM 102 (103)
T ss_dssp HHHHTTSSSSSSSSCCCEECC
T ss_pred HHHHhhhCCCCCeEeCCcccc
Confidence 999999999999888877764
|
| >d2qmsa1 d.93.1.1 (A:420-532) Growth factor receptor-bound protein 7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Growth factor receptor-bound protein 7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=6.5e-19 Score=111.70 Aligned_cols=92 Identities=24% Similarity=0.286 Sum_probs=79.6
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC-----ccCC-CCCcC-HhHH
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET-----QKAG-RTTIH-YPEL 73 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g-----yl~~-~~~~~-l~~l 73 (189)
||||.|+|.+|+++|.....++|+||||++.+.+|.|+||++. .+.+.|++|....++ .+.+ ...|. +.+|
T Consensus 12 Wy~g~isR~~Ae~lL~~~g~~dG~FLvR~S~~~~g~y~LSv~~--~~~v~H~~I~~~~~~~~~~~~~~~~~~~F~sl~~L 89 (113)
T d2qmsa1 12 WFHGRISREESQRLIGQQGLVDGLFLVRESQRNPQGFVLSLCH--LQKVKHYLILPSEEEGRLYFSMDDGQTRFTDLLQL 89 (113)
T ss_dssp TEEEEBCHHHHHHHHHHTTCCTTEEEEEECSSCTTCEEEEEEE--TTEEEEEEEEEEESSSCEEEESSTTSSCBSSHHHH
T ss_pred ccCCCCCHHHHHHHHhccCCCCccEEEEeccCCCCCEEEEEEe--CCeEEEEEEEEeCCCCeEEEEecCCCcccCCHHHH
Confidence 9999999999999997666688999999999888999999999 999999999865443 2333 34588 9999
Q ss_pred HHHhhhccCCceeeccCCccc
Q psy1684 74 VEHYSKDADGLCVNLRKPCVQ 94 (189)
Q Consensus 74 i~~~~~~a~gl~~~~~~~~~~ 94 (189)
|+||++..+|+.+.+..||.+
T Consensus 90 I~~y~~~~~~L~~~L~~pc~r 110 (113)
T d2qmsa1 90 VEFHQLNRGILPCLLRHCCTR 110 (113)
T ss_dssp HHHHTTCCTTSSSCCCEECCS
T ss_pred HHHhccCCCCCccccCCCCcC
Confidence 999999999999999988865
|
| >d1d4ta_ d.93.1.1 (A:) The Xlp protein Sap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: The Xlp protein Sap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=2.4e-18 Score=107.79 Aligned_cols=90 Identities=26% Similarity=0.312 Sum_probs=77.3
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC-c-c-----CCCCCcC-HhH
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET-Q-K-----AGRTTIH-YPE 72 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g-y-l-----~~~~~~~-l~~ 72 (189)
||||.|+|.+|+++|..+. .+|+||||++.+.+|.|+||++. .+.+.|++|.+..+| + + .....|. +.+
T Consensus 6 wyhG~isR~eAe~lL~~~~-~~G~FLVR~S~~~~g~~~Lsv~~--~~~v~H~~I~~~~~~~~~~~~~~~~~~~~F~sl~~ 82 (104)
T d1d4ta_ 6 VYHGKISRETGEKLLLATG-LDGSYLLRDSESVPGVYCLCVLY--HGYIYTYRVSQTETGSWSAETAPGVHKRYFRKIKN 82 (104)
T ss_dssp TBCCSCCHHHHHHHHHHHC-CTTEEEEEECSSSTTCEEEEEEE--TTEEEEEEEEECTTSCEEECBCTTSCCCCBSSHHH
T ss_pred ccccCCCHHHHHHHHhhCC-CCCeEEEEecCCCCCCEEEEEec--CCCceEEEEEEcCCCcEEEeeccCCCCcccCCHHH
Confidence 9999999999999996443 57999999999988999999999 999999999988777 3 2 2245688 999
Q ss_pred HHHHhhhccCCceeeccCCcc
Q psy1684 73 LVEHYSKDADGLCVNLRKPCV 93 (189)
Q Consensus 73 li~~~~~~a~gl~~~~~~~~~ 93 (189)
|+++|.+...|+.+.+..||.
T Consensus 83 Li~~y~~~~~gl~~~L~~P~~ 103 (104)
T d1d4ta_ 83 LISAFQKPDQGIVIPLQYPVE 103 (104)
T ss_dssp HHHHHTSSSSSSSSCCCEECC
T ss_pred HHHHHhhCCCCCcEeCCcccc
Confidence 999999999999888877764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=6e-21 Score=141.06 Aligned_cols=144 Identities=16% Similarity=0.082 Sum_probs=110.0
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.++|+|++++++........|||+|++++ |+ +.. ++.....+....+..+..+.+.|+
T Consensus 69 ~l~HpnIv~~~~~~~~~~~~~iv~E~~~g-g~----L~~-----------------~i~~~~~l~~~~~~~~~~qi~~al 126 (293)
T d1jksa_ 69 EIQHPNVITLHEVYENKTDVILILELVAG-GE----LFD-----------------FLAEKESLTEEEATEFLKQILNGV 126 (293)
T ss_dssp HCCCTTBCCEEEEEECSSEEEEEEECCCS-CB----HHH-----------------HHHHHSSCCHHHHHHHHHHHHHHH
T ss_pred hCCCCCCCcEEEEEEECCEEEEEEEcCCC-cc----ccc-----------------hhccccccchhHHHHHHHHHHHHH
Confidence 56889999988887777778899998876 31 111 222233455666777888889999
Q ss_pred eeeccCCcccccc-cc-------------------c--------------------ccccC-CCCCccc-e-EEEec---
Q psy1684 85 CVNLRKPCVQVSC-RI-------------------Y--------------------LVHGT-NLSGVVV-S-AVDFG--- 118 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~-------------------~--------------------l~~~~-~~~~~~~-s-VwsfG--- 118 (189)
.++|..+++|||+ |+ | +|||. ....|+. + |||||
T Consensus 127 ~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvil 206 (293)
T d1jksa_ 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 206 (293)
T ss_dssp HHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHH
T ss_pred HhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHH
Confidence 9999999999996 55 1 11111 4567899 9 99999
Q ss_pred ---------CCCCChHHHHHHHHcCCCC-C--CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 119 ---------SGGMTNAEVLHQVEHGYRM-P--CPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 119 ---------~~~~~~~~~~~~v~~g~~~-~--~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
|.+.+..+++..+..+... + .++.+|+++.+||.+||+.||++|||++|+++
T Consensus 207 yell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 207 YILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 7788888888888766432 2 24689999999999999999999999999986
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=6.2e-21 Score=140.53 Aligned_cols=144 Identities=10% Similarity=-0.037 Sum_probs=111.6
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..++|+|++++++.....+..|||+|++++ |+ +.. ++.....+...+...+..+.+.|
T Consensus 63 ~~l~HpnIv~l~~~~~~~~~~~ivmEy~~g-g~----L~~-----------------~~~~~~~l~e~~~~~~~~qi~~a 120 (288)
T d1uu3a_ 63 SRLDHPFFVKLYFTFQDDEKLYFGLSYAKN-GE----LLK-----------------YIRKIGSFDETCTRFYTAEIVSA 120 (288)
T ss_dssp HHCCSTTBCCEEEEEECSSEEEEEECCCTT-EE----HHH-----------------HHHHHSSCCHHHHHHHHHHHHHH
T ss_pred HHcCCCCeeEEEEEEEECCEEEEEEEccCC-CC----HHH-----------------hhhccCCCCHHHHHHHHHHHHHH
Confidence 357889999988877667778899998876 31 211 22323455666677788888999
Q ss_pred ceeeccCCcccccc-cc---------------ccccc-----------------------C-CCCCccc-e-EEEec---
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YLVHG-----------------------T-NLSGVVV-S-AVDFG--- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l~~~-----------------------~-~~~~~~~-s-VwsfG--- 118 (189)
+.++|..+++|||+ |+ |+|+. . .+..|+. + |||+|
T Consensus 121 l~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvil 200 (288)
T d1uu3a_ 121 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCII 200 (288)
T ss_dssp HHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHH
T ss_pred HHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHH
Confidence 99999999999996 66 33321 1 4566899 9 99999
Q ss_pred ---------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 119 ---------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 119 ---------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
|.+.+..++...+.++. +..|..+++++.+||.+||+.||++|||++|++.
T Consensus 201 yell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 201 YQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHTTC-CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred HHHhhCCCCCCCcCHHHHHHHHHcCC-CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 77778888888887764 5678899999999999999999999999999754
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=1.2e-20 Score=139.21 Aligned_cols=144 Identities=9% Similarity=-0.026 Sum_probs=109.4
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..++|+|++++++....++..|||+|++++ |++ .. ++. ...++..+...+..+.+.|
T Consensus 72 ~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g-g~L----~~-----------------~~~-~~~l~~~~~~~i~~qi~~a 128 (293)
T d1yhwa1 72 RENKNPNIVNYLDSYLVGDELWVVMEYLAG-GSL----TD-----------------VVT-ETCMDEGQIAAVCRECLQA 128 (293)
T ss_dssp HHCCCTTBCCEEEEEEETTEEEEEEECCTT-CBH----HH-----------------HHH-HSCCCHHHHHHHHHHHHHH
T ss_pred HhCCCCCEeeEeEEEEECCEEEEEEEecCC-CcH----HH-----------------Hhh-ccCCCHHHHHHHHHHHHHH
Confidence 357899999999877777788999999887 421 11 111 2235566777788899999
Q ss_pred ceeeccCCcccccc-cc---------------cccc---------------------cC-CCCCccc-e-EEEec-----
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YLVH---------------------GT-NLSGVVV-S-AVDFG----- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l~~---------------------~~-~~~~~~~-s-VwsfG----- 118 (189)
+.|+|..+++|||+ |+ |+|+ |. ..+.|+. + |||+|
T Consensus 129 L~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilye 208 (293)
T d1yhwa1 129 LEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIE 208 (293)
T ss_dssp HHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHH
T ss_pred HHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHH
Confidence 99999999999996 66 3332 22 5567999 9 99999
Q ss_pred -------CCCCChHHHHHHHHcCC--CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 119 -------SGGMTNAEVLHQVEHGY--RMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 119 -------~~~~~~~~~~~~v~~g~--~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
|.+.+..+.+..+..+. .++.|..+++++.+||.+||+.||++|||++|+++
T Consensus 209 mltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 209 MIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp HHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 67777777666664332 34556789999999999999999999999999975
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=2.1e-20 Score=136.50 Aligned_cols=145 Identities=8% Similarity=-0.014 Sum_probs=103.2
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..++|+|++++++....+...|||+|++++ | ++.. ++.....++..+...+..+.+.|
T Consensus 58 ~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g-g----~L~~-----------------~l~~~~~l~e~~~~~i~~qi~~a 115 (271)
T d1nvra_ 58 KMLNHENVVKFYGHRREGNIQYLFLEYCSG-G----ELFD-----------------RIEPDIGMPEPDAQRFFHQLMAG 115 (271)
T ss_dssp HTCCCTTBCCEEEEEEETTEEEEEEECCTT-E----EGGG-----------------GSBTTTBCCHHHHHHHHHHHHHH
T ss_pred HhCCCCCEeeEeeeeccCceeEEEEeccCC-C----cHHH-----------------HHhcCCCCCHHHHHHHHHHHHHH
Confidence 457888888888877666677888888776 3 1222 45445566677778888999999
Q ss_pred ceeeccCCcccccc-cc---------------ccc-----------------------ccC-CCCCc-cc-e-EEEec--
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YLV-----------------------HGT-NLSGV-VV-S-AVDFG-- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l~-----------------------~~~-~~~~~-~~-s-VwsfG-- 118 (189)
+.++|..+++|||+ |+ |+| ||. ....+ +. + |||+|
T Consensus 116 l~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvi 195 (271)
T d1nvra_ 116 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIV 195 (271)
T ss_dssp HHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHH
T ss_pred HHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHH
Confidence 99999999999996 66 333 222 34444 67 8 99999
Q ss_pred ----------CCCCCh-HHHHHHH-HcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 119 ----------SGGMTN-AEVLHQV-EHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 119 ----------~~~~~~-~~~~~~v-~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
|.+.+. ......+ ......+.+..+++++.+|+.+||+.||++|||++|+++
T Consensus 196 lyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 196 LTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp HHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 433332 2222233 333334444678999999999999999999999999875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.74 E-value=2e-20 Score=137.17 Aligned_cols=112 Identities=17% Similarity=0.149 Sum_probs=88.0
Q ss_pred CCCcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------------------------------ccccc
Q psy1684 65 RTTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------------------------------YLVHG 104 (189)
Q Consensus 65 ~~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------------------------------~l~~~ 104 (189)
...+...+...+..+.+.|+.++|..+++|||+ |+ ++|||
T Consensus 105 ~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE 184 (277)
T d1o6ya_ 105 EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184 (277)
T ss_dssp HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHH
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHH
Confidence 445567778888899999999999999999996 66 11222
Q ss_pred C-CCCCccc-e-EEEec------------CCCCChHHHHHHHHcC-CCCC--CCCCCCHHHHHHHHHhcccCCCCCC-CH
Q psy1684 105 T-NLSGVVV-S-AVDFG------------SGGMTNAEVLHQVEHG-YRMP--CPPGCPPRLYDIMLECWLKDPVKRP-TF 165 (189)
Q Consensus 105 ~-~~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~g-~~~~--~p~~~p~~~~~l~~~C~~~~p~~RP-~~ 165 (189)
. ....|+. + |||+| |.+.+..++...+.++ ..++ .++.+|+++.+|+.+||+.||++|| |+
T Consensus 185 ~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa 264 (277)
T d1o6ya_ 185 QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTA 264 (277)
T ss_dssp HHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSH
T ss_pred HHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHH
Confidence 1 5567999 9 99999 7777777777766444 3332 3467999999999999999999999 89
Q ss_pred HHHHHHHHHHH
Q psy1684 166 ETLQWKLEDFF 176 (189)
Q Consensus 166 ~~i~~~l~~~~ 176 (189)
+++...|.++.
T Consensus 265 ~~l~~~l~r~~ 275 (277)
T d1o6ya_ 265 AEMRADLVRVH 275 (277)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHh
Confidence 99999887764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.73 E-value=1.9e-20 Score=139.87 Aligned_cols=143 Identities=11% Similarity=0.026 Sum_probs=112.0
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCc
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGL 84 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl 84 (189)
.+.|+|++++++........|||+|++++ |+ +.. ++.....++..++..+..+++.|+
T Consensus 59 ~~~hp~Iv~~~~~~~~~~~~yivmEy~~~-g~----L~~-----------------~i~~~~~~~e~~~~~~~~qi~~al 116 (320)
T d1xjda_ 59 AWEHPFLTHMFCTFQTKENLFFVMEYLNG-GD----LMY-----------------HIQSCHKFDLSRATFYAAEIILGL 116 (320)
T ss_dssp HTTCTTBCCEEEEEECSSEEEEEEECCTT-CB----HHH-----------------HHHHHSSCCHHHHHHHHHHHHHHH
T ss_pred hCCCCcEEEEEEEEccCCceeEEEeecCC-Cc----HHH-----------------HhhccCCCCHHHHHHHHHHHHHHH
Confidence 46788888888877777778888888876 31 111 333334555667778888999999
Q ss_pred eeeccCCcccccc-cc---------------cccc---------------------cC-CCCCccc-e-EEEec------
Q psy1684 85 CVNLRKPCVQVSC-RI---------------YLVH---------------------GT-NLSGVVV-S-AVDFG------ 118 (189)
Q Consensus 85 ~~~~~~~~~~~~~-p~---------------~l~~---------------------~~-~~~~~~~-s-VwsfG------ 118 (189)
.|+|...++|||+ |+ |+++ |. ....|+. + |||+|
T Consensus 117 ~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyem 196 (320)
T d1xjda_ 117 QFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEM 196 (320)
T ss_dssp HHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHH
T ss_pred HHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHH
Confidence 9999999999996 55 2222 21 6667999 9 99999
Q ss_pred ------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH-HHHH
Q psy1684 119 ------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFE-TLQW 170 (189)
Q Consensus 119 ------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~-~i~~ 170 (189)
|.+.+..++...+..+. +..|..+|+++.+|+.+||..||++|||+. +|++
T Consensus 197 ltG~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 197 LIGQSPFHGQDEEELFHSIRMDN-PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred HhCCCCCCCCCHHHHHHHHHcCC-CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 88888889988887764 677889999999999999999999999995 6753
|
| >d1jyra_ d.93.1.1 (A:) Growth factor receptor-bound protein 2 (GRB2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Growth factor receptor-bound protein 2 (GRB2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.73 E-value=1.1e-17 Score=102.73 Aligned_cols=79 Identities=32% Similarity=0.319 Sum_probs=70.7
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC-ccCCCCCcC-HhHHHHHhh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET-QKAGRTTIH-YPELVEHYS 78 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g-yl~~~~~~~-l~~li~~~~ 78 (189)
||||.|+|.+|+++|..+. ++|+||||++.+.+|.|+||++. .+.++|++|.+..+| |..+...|. +.+||+||.
T Consensus 5 Wy~g~isR~~Ae~lL~~~~-~~G~FLvR~S~~~~g~~~LSv~~--~~~v~H~~I~~~~~g~~~~~~~~F~sl~~LV~~y~ 81 (96)
T d1jyra_ 5 WFFGKIPRAKAEEMLSKQR-HDGAFLIRESESAPGDFSLSVKF--GNDVQHFKVLRDGAGKYFLWVVKFNSLNELVDYHR 81 (96)
T ss_dssp TBCCSCCHHHHHHHHHTCC-STTBEEEEECSSSTTCEEEEEEE--TTEEEEEECEECTTSCEESSSCEESSHHHHHHHTT
T ss_pred ccCCCCCHHHHHHHHhhCC-CCCeEEEEecCCCCCCEEEEEEe--CCceEEEEEEECCCCeEEeCCccCCCHHHHHHHHh
Confidence 9999999999999995543 68999999999888999999999 999999999998888 777777899 999999998
Q ss_pred hccC
Q psy1684 79 KDAD 82 (189)
Q Consensus 79 ~~a~ 82 (189)
++..
T Consensus 82 ~~~l 85 (96)
T d1jyra_ 82 STSV 85 (96)
T ss_dssp SSCS
T ss_pred hCCC
Confidence 7754
|
| >d2fcia1 d.93.1.1 (A:1-105) Phospholipase C-gamma-1 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Phospholipase C-gamma-1 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.73 E-value=5.6e-18 Score=105.68 Aligned_cols=90 Identities=26% Similarity=0.356 Sum_probs=76.6
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcC-HhHHHHHhhh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIH-YPELVEHYSK 79 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~-l~~li~~~~~ 79 (189)
||||.|+|.+|+++|..+. .+|+||||++. ..+.|+||++. .+.++|++|.+..+.|+.+...|. +.+||+||.+
T Consensus 11 Wy~g~i~R~eAe~lL~~~~-~~G~FLVR~S~-~~~~yvLSv~~--~~~v~H~~I~~~~~~~~~~~~~F~sl~~LV~~y~~ 86 (105)
T d2fcia1 11 WYHASLTRAQAEHMLMRVP-RDGAFLVRKRN-EPNSYAISFRA--EGKIKHCRVQQEGQTVMLGNSEFDSLVDLISYYEK 86 (105)
T ss_dssp CCCSSSCSHHHHHHHHHSS-SSCCEEEEECS-STTCEEEEEEE--TTEECCCEEBCCSSCEECSSSEESTTHHHHHHHHH
T ss_pred CccCCCCHHHHHHHHHhCC-CCCeEEEEecC-CCCCEEEEEEe--ccccEEEEEEecCCeEecCCcccCCHHHHHHHHhh
Confidence 9999999999999996543 47999999994 56899999999 999999999765333666677898 9999999999
Q ss_pred ccCCceeeccCCccc
Q psy1684 80 DADGLCVNLRKPCVQ 94 (189)
Q Consensus 80 ~a~gl~~~~~~~~~~ 94 (189)
...++...+..||..
T Consensus 87 ~~~~~~~~L~~P~~~ 101 (105)
T d2fcia1 87 HPLYRKMKLRYPINE 101 (105)
T ss_dssp SCCSTTCSSCCCCCC
T ss_pred CCCCCccCCCCCCCC
Confidence 999988888888755
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=99.72 E-value=4.2e-20 Score=139.61 Aligned_cols=146 Identities=16% Similarity=0.108 Sum_probs=112.4
Q ss_pred CCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccC-CCCCcCHhHHHHHhhhcc
Q psy1684 3 FGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKA-GRTTIHYPELVEHYSKDA 81 (189)
Q Consensus 3 ~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~-~~~~~~l~~li~~~~~~a 81 (189)
+..++|+|++++++....++..|||+|+++++. + .. ++. ....++..++..+..+++
T Consensus 80 l~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~-L----~~-----------------~~~~~~~~l~e~~~~~i~~qi~ 137 (352)
T d1koba_ 80 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGE-L----FD-----------------RIAAEDYKMSEAEVINYMRQAC 137 (352)
T ss_dssp HTTCCSTTBCCEEEEEECSSEEEEEEECCCCCB-H----HH-----------------HTTCTTCCBCHHHHHHHHHHHH
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCh-H----HH-----------------HHHhcCCCCCHHHHHHHHHHHH
Confidence 356889999999887777777889999888632 1 11 122 133466777888889999
Q ss_pred CCceeeccCCcccccc-cc-----------------ccccc--------------------C-CCCCccc-e-EEEec--
Q psy1684 82 DGLCVNLRKPCVQVSC-RI-----------------YLVHG--------------------T-NLSGVVV-S-AVDFG-- 118 (189)
Q Consensus 82 ~gl~~~~~~~~~~~~~-p~-----------------~l~~~--------------------~-~~~~~~~-s-VwsfG-- 118 (189)
.|+.++|..+++|||+ |+ |+|.. . ....|+. + |||+|
T Consensus 138 ~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 217 (352)
T d1koba_ 138 EGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVL 217 (352)
T ss_dssp HHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHH
T ss_pred HHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHH
Confidence 9999999999999996 66 22211 1 5567999 9 99999
Q ss_pred ----------CCCCChHHHHHHHHcCCCC-C--CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 119 ----------SGGMTNAEVLHQVEHGYRM-P--CPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 119 ----------~~~~~~~~~~~~v~~g~~~-~--~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
|.+.+..+++..+.++... + .+..+|+++.+||.+||+.||++|||++|+++
T Consensus 218 lyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 218 GYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp HHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 8888888888888766432 2 33578999999999999999999999999976
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=2.2e-20 Score=138.60 Aligned_cols=154 Identities=16% Similarity=0.144 Sum_probs=102.9
Q ss_pred CCCChHHHHHHhcCCCCCCC----cEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhh
Q psy1684 4 GKIKRIEAEKKLLLPENDHG----AFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSK 79 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g----~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~ 79 (189)
..++|+|++++++.+..+++ .|||+|+++. |+ +.. ++.. ..+...+.+.+..+
T Consensus 52 ~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~-g~----L~~-----------------~l~~-~~l~~~~~~~~~~~ 108 (303)
T d1vjya_ 52 VMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH-GS----LFD-----------------YLNR-YTVTVEGMIKLALS 108 (303)
T ss_dssp TTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT-CB----HHH-----------------HHHH-CCBCHHHHHHHHHH
T ss_pred hhCCCCcCcceEEEEEeCCCcceEEEEEEecccC-CC----HHH-----------------HHhc-CCCCHHHHHHHHHH
Confidence 46789999999988764433 4788888887 42 212 2321 23446666677777
Q ss_pred ccCCceeecc--------CCcccccc-cc---------------ccc-------------------------ccCC----
Q psy1684 80 DADGLCVNLR--------KPCVQVSC-RI---------------YLV-------------------------HGTN---- 106 (189)
Q Consensus 80 ~a~gl~~~~~--------~~~~~~~~-p~---------------~l~-------------------------~~~~---- 106 (189)
.+.|+.++|. .+++|||+ |+ |++ ||..
T Consensus 109 ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 188 (303)
T d1vjya_ 109 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSI 188 (303)
T ss_dssp HHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCS
T ss_pred HHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccc
Confidence 7777777775 58999996 55 222 2211
Q ss_pred ---CCCccc-e-EEEec----------------------CC-----CCChHHHHHHH-HcCCCCCCCCC-----CCHHHH
Q psy1684 107 ---LSGVVV-S-AVDFG----------------------SG-----GMTNAEVLHQV-EHGYRMPCPPG-----CPPRLY 148 (189)
Q Consensus 107 ---~~~~~~-s-VwsfG----------------------~~-----~~~~~~~~~~v-~~g~~~~~p~~-----~p~~~~ 148 (189)
...++. + ||||| +. ..+..++...+ ..+.++++|.. ++.++.
T Consensus 189 ~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~ 268 (303)
T d1vjya_ 189 NMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMA 268 (303)
T ss_dssp CTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHH
T ss_pred cccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHH
Confidence 113688 8 99999 11 11234444444 44566666543 345689
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHHHHhhcC
Q psy1684 149 DIMLECWLKDPVKRPTFETLQWKLEDFFTMEG 180 (189)
Q Consensus 149 ~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~~ 180 (189)
+||.+||+.||++||||.||++.|+++.+..+
T Consensus 269 ~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~ 300 (303)
T d1vjya_ 269 KIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp HHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHHHHcccCHhHCcCHHHHHHHHHHHHHhcC
Confidence 99999999999999999999999999987654
|
| >d2shpa2 d.93.1.1 (A:2-110) Tyrosine phoshatase shp-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine phoshatase shp-2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=1.3e-17 Score=104.97 Aligned_cols=90 Identities=27% Similarity=0.366 Sum_probs=75.4
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC-ccCCCCCcC-HhHHHHHhh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET-QKAGRTTIH-YPELVEHYS 78 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g-yl~~~~~~~-l~~li~~~~ 78 (189)
||||.|+|..|+++|.... .+|+||||++.+..|.|+||++. .+.+.|++|....++ ++.+...|. +.+||+||.
T Consensus 5 Wy~g~isR~~Ae~lL~~~~-~~G~FLvR~S~~~~g~y~LSv~~--~~~v~H~~I~~~~~~~~~~~~~~F~sl~~LV~~y~ 81 (109)
T d2shpa2 5 WFHPNITGVEAENLLLTRG-VDGSFLARPSKSNPGDLTLSVRR--NGAVTHIKIQNTGDYYDLYGGEKFATLAELVQYYM 81 (109)
T ss_dssp TBCSSCCHHHHHHHHHHHC-CTTEEEEEECSSSTTCEEEEEEE--TTEEEEEEEECSSSCEEETTSCEESSHHHHHHHHH
T ss_pred cccCCCCHHHHHHHHhhCC-CCCeEEEEecCCCCCCEEEEEEe--CCcEEEEEEEEcCCeEEEcCCcccCCHHHHHHHHH
Confidence 9999999999999985443 47999999999888999999999 999999999987777 777778899 999999998
Q ss_pred hccC------CceeeccCCcc
Q psy1684 79 KDAD------GLCVNLRKPCV 93 (189)
Q Consensus 79 ~~a~------gl~~~~~~~~~ 93 (189)
+... |+...+..|+.
T Consensus 82 ~~~~~~~~~~~~~~~L~~P~~ 102 (109)
T d2shpa2 82 EHHGQLKEKNGDVIELKYPLN 102 (109)
T ss_dssp TCTTCSBSSSSCBCCCCEECC
T ss_pred HCCCCcccCCCCeeeccccCC
Confidence 7543 44455555654
|
| >d1luia_ d.93.1.1 (A:) Itk/tsk protein tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Itk/tsk protein tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.71 E-value=1.4e-17 Score=104.61 Aligned_cols=91 Identities=30% Similarity=0.493 Sum_probs=75.9
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEec----CCCeeeEEEEEeccCC----ccCCCCCcC-Hh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKR----SSFCLKMTTGRSLFET----QKAGRTTIH-YP 71 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~----~~~~v~h~~i~~~~~g----yl~~~~~~~-l~ 71 (189)
||||.|+|.+|+++|.... .+|+||||++.+ +|.|+||++.. ....++|++|....+| ++.....|. +.
T Consensus 8 Wy~g~isR~eAe~lL~~~~-~~G~FLVR~S~~-~g~y~LSv~~~~~~~~~~~i~h~~I~~~~~~~~~~~~~~~~~F~sl~ 85 (108)
T d1luia_ 8 WYNKSISRDKAEKLLLDTG-KEGAFMVRDSRT-PGTYTVSVFTKAIISENPCIKHYHIKETNDSPKRYYVAEKYVFDSIP 85 (108)
T ss_dssp TBCTTCCHHHHHHHHHHHC-CTTEEEEEECCT-TTCEEEEEECSCCTTTCSCEEEEECEECCCSSCCEESSSSCCBSSHH
T ss_pred CcCCCCCHHHHHHHHHhcC-CCCeEEEEecCC-CCCEEEEEEecCCcccCCceeEEEEEEecCCCceeecCCCcccCCHH
Confidence 9999999999999995332 579999999965 58999999863 3457899999887666 566677888 99
Q ss_pred HHHHHhhhccCCceeeccCCcc
Q psy1684 72 ELVEHYSKDADGLCVNLRKPCV 93 (189)
Q Consensus 72 ~li~~~~~~a~gl~~~~~~~~~ 93 (189)
+|++||++.++|+.+.+..||.
T Consensus 86 ~LV~~y~~~~~~L~~~L~~Pv~ 107 (108)
T d1luia_ 86 LLIQYHQYNGGGLVTRLRYPVC 107 (108)
T ss_dssp HHHHHHHTTCCSSSSSSSEECC
T ss_pred HHHHHHhhCCCCCccCCCCcCC
Confidence 9999999999999888887763
|
| >d1r1qa_ d.93.1.1 (A:) GRB2-related adaptor protein 2 (MONA, GRID) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: GRB2-related adaptor protein 2 (MONA, GRID) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.71 E-value=2.2e-17 Score=101.61 Aligned_cols=77 Identities=23% Similarity=0.281 Sum_probs=69.6
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC-ccCCCCCcC-HhHHHHHhh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET-QKAGRTTIH-YPELVEHYS 78 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g-yl~~~~~~~-l~~li~~~~ 78 (189)
||||.|+|..|+++|.. .++|+||||++...+|.|+||++. .+.+.|++|....+| |+.+...|. +.+||+||+
T Consensus 8 Wy~g~isR~~Ae~lL~~--~~~G~FLVR~S~~~~g~~~LSv~~--~~~v~H~~I~~~~~g~~~~~~~~F~sl~~LV~~y~ 83 (97)
T d1r1qa_ 8 WFHEGLSRHQAENLLMG--KDIGFFIIRASQSSPGDFSISVRH--EDDVQHFKVMRDTKGNYFLWTEKFPSLNKLVDYYR 83 (97)
T ss_dssp TBCTTCCHHHHHHHHHT--SCTTCEEEEECSSSTTCEEEEEEC--SSSEEEEECEECTTCCEESSSCCBSSHHHHHHHTT
T ss_pred ccCCCCCHHHHHHHHhc--CCCCCEEEeecCCCCCCEEEEEEe--cCCeEEEEEEEcCCCeEEeCCCCcCCHHHHHHHHc
Confidence 99999999999999963 578999999998888999999999 999999999999888 666677898 999999998
Q ss_pred hcc
Q psy1684 79 KDA 81 (189)
Q Consensus 79 ~~a 81 (189)
++.
T Consensus 84 ~~~ 86 (97)
T d1r1qa_ 84 TTS 86 (97)
T ss_dssp TSC
T ss_pred cCC
Confidence 764
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=99.70 E-value=2.1e-19 Score=135.67 Aligned_cols=146 Identities=19% Similarity=0.145 Sum_probs=111.1
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccC-CCCCcCHhHHHHHhhhccC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKA-GRTTIHYPELVEHYSKDAD 82 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~-~~~~~~l~~li~~~~~~a~ 82 (189)
..++|+|++++++....+...|||+|+++++. +.. ++. ....++..+...+..+++.
T Consensus 78 ~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~-----L~~-----------------~l~~~~~~l~e~~~~~i~~qi~~ 135 (350)
T d1koaa2 78 SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE-----LFE-----------------KVADEHNKMSEDEAVEYMRQVCK 135 (350)
T ss_dssp HHTCCTTBCCEEEEEEETTEEEEEECCCCSCB-----HHH-----------------HHTCTTSCBCHHHHHHHHHHHHH
T ss_pred HhCCCCCCCcEEEEEEECCEEEEEEEcCCCCC-----HHH-----------------HHHhhcCCCCHHHHHHHHHHHHH
Confidence 35789999999988777778899999988732 111 222 1334667777888899999
Q ss_pred CceeeccCCcccccc-cc-----------------ccccc--------------------C-CCCCccc-e-EEEec---
Q psy1684 83 GLCVNLRKPCVQVSC-RI-----------------YLVHG--------------------T-NLSGVVV-S-AVDFG--- 118 (189)
Q Consensus 83 gl~~~~~~~~~~~~~-p~-----------------~l~~~--------------------~-~~~~~~~-s-VwsfG--- 118 (189)
|+.++|..+++|||+ |+ |++.. . .+..|+. + |||+|
T Consensus 136 aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvil 215 (350)
T d1koaa2 136 GLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 215 (350)
T ss_dssp HHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHH
T ss_pred HHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHH
Confidence 999999999999996 66 22211 1 4566899 9 99999
Q ss_pred ---------CCCCChHHHHHHHHcCCC-CC--CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 119 ---------SGGMTNAEVLHQVEHGYR-MP--CPPGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 119 ---------~~~~~~~~~~~~v~~g~~-~~--~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
|.+.+..+++..+..+.. ++ .+..+++++.+|+.+||+.||++|||++|+++.
T Consensus 216 yell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 216 YILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 778888888888866542 22 224689999999999999999999999999873
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.70 E-value=1.8e-19 Score=134.57 Aligned_cols=144 Identities=10% Similarity=-0.040 Sum_probs=108.9
Q ss_pred CCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCC-CCcCHhHHHHHhhhccCC
Q psy1684 5 KIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGR-TTIHYPELVEHYSKDADG 83 (189)
Q Consensus 5 ~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~-~~~~l~~li~~~~~~a~g 83 (189)
.++|+|++++++....+...|||+|+++++. +.. ++... ..++..++..+..+.+.|
T Consensus 57 ~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~-----L~~-----------------~i~~~~~~l~e~~~~~i~~qi~~a 114 (321)
T d1tkia_ 57 IARHRNILHLHESFESMEELVMIFEFISGLD-----IFE-----------------RINTSAFELNEREIVSYVHQVCEA 114 (321)
T ss_dssp HSCCTTBCCEEEEEEETTEEEEEECCCCCCB-----HHH-----------------HHTSSSCCCCHHHHHHHHHHHHHH
T ss_pred hCCCCCCCeEEEEEEECCEEEEEEecCCCCc-----HHH-----------------HHHhcCCCCCHHHHHHHHHHHHHH
Confidence 4678888888877666667888888887622 111 23322 245677778888899999
Q ss_pred ceeeccCCcccccc-ccc-----------------ccccC---------------------CCCCccc-e-EEEec----
Q psy1684 84 LCVNLRKPCVQVSC-RIY-----------------LVHGT---------------------NLSGVVV-S-AVDFG---- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~~-----------------l~~~~---------------------~~~~~~~-s-VwsfG---- 118 (189)
+.|+|..+++|||+ |+. ++... ....|+. + |||+|
T Consensus 115 l~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily 194 (321)
T d1tkia_ 115 LQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVY 194 (321)
T ss_dssp HHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCcccccccccccccchhccCCCCCchhhcccHHHHHH
Confidence 99999999999996 662 11111 5566899 9 99999
Q ss_pred --------CCCCChHHHHHHHHcCCCC-C--CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 119 --------SGGMTNAEVLHQVEHGYRM-P--CPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 119 --------~~~~~~~~~~~~v~~g~~~-~--~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
|.+.+..+++..+.++... + .++.+++++.+|+.+|+..||++|||++|+++
T Consensus 195 ~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 195 VLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 7777888888888766422 2 12478999999999999999999999999986
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.69 E-value=5.1e-19 Score=132.83 Aligned_cols=144 Identities=7% Similarity=-0.058 Sum_probs=109.1
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..++|+|+++++......+..|||+|++++ |++ .. ++.....++......+..+...|
T Consensus 60 ~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~g-g~L----~~-----------------~~~~~~~~~e~~~~~~~~qil~a 117 (337)
T d1o6la_ 60 QNTRHPFLTALKYAFQTHDRLCFVMEYANG-GEL----FF-----------------HLSRERVFTEERARFYGAEIVSA 117 (337)
T ss_dssp HSCCCTTBCCEEEEEECSSEEEEEEECCTT-CBH----HH-----------------HHHHHSCCCHHHHHHHHHHHHHH
T ss_pred HhCCCCCEEEEEeeeccccccccceeccCC-Cch----hh-----------------hhhcccCCcHHHHHHHHHHHhhh
Confidence 356788888888777667777888888876 321 11 23323345555566677788899
Q ss_pred ceeeccCCcccccc-cc---------------ccc---------------------ccC-CCCCccc-e-EEEec-----
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YLV---------------------HGT-NLSGVVV-S-AVDFG----- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l~---------------------~~~-~~~~~~~-s-VwsfG----- 118 (189)
+.|+|..+++|||+ |+ |+| +|. .+..|+. + |||+|
T Consensus 118 l~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilye 197 (337)
T d1o6la_ 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 197 (337)
T ss_dssp HHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHH
T ss_pred hhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHH
Confidence 99999999999996 66 333 332 5667999 9 99999
Q ss_pred -------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q psy1684 119 -------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPT-----FETLQW 170 (189)
Q Consensus 119 -------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~-----~~~i~~ 170 (189)
|.+.+..++...+..+. ++.|..+++++.+||.+||+.||++||+ +++|++
T Consensus 198 ml~G~~pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 198 MMCGRLPFYNQDHERLFELILMEE-IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHCCCCCCCcCHHHHHHHHhcCC-CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 77778888888887764 6778899999999999999999999995 777765
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=99.69 E-value=2.1e-19 Score=131.56 Aligned_cols=141 Identities=13% Similarity=0.020 Sum_probs=106.4
Q ss_pred hHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCCceee
Q psy1684 8 RIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADGLCVN 87 (189)
Q Consensus 8 ~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~gl~~~ 87 (189)
|+|++++++........|||+|++++ |+ +.. ++.....++..+...+..++..|+.++
T Consensus 69 hpnIv~~~~~~~~~~~~~ivmE~~~~-g~----L~~-----------------~l~~~~~l~e~~~~~~~~qi~~al~~l 126 (277)
T d1phka_ 69 HPNIIQLKDTYETNTFFFLVFDLMKK-GE----LFD-----------------YLTEKVTLSEKETRKIMRALLEVICAL 126 (277)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCTT-CB----HHH-----------------HHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred CCCeEEEEeecccCcceEEEEEcCCC-ch----HHH-----------------HHHhcCCCCHHHHHHHHHHHHHHHHHH
Confidence 78888888877777777888888876 32 211 233234455777778888999999999
Q ss_pred ccCCcccccc-cc---------------cccccC---------------------------CCCCccc-e-EEEec----
Q psy1684 88 LRKPCVQVSC-RI---------------YLVHGT---------------------------NLSGVVV-S-AVDFG---- 118 (189)
Q Consensus 88 ~~~~~~~~~~-p~---------------~l~~~~---------------------------~~~~~~~-s-VwsfG---- 118 (189)
|..+++|||+ |+ |++... ....++. + |||+|
T Consensus 127 H~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvily 206 (277)
T d1phka_ 127 HKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMY 206 (277)
T ss_dssp HHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHH
T ss_pred HHcCCcccccccceEEEcCCCCeEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhh
Confidence 9999999996 66 222111 3445888 9 99999
Q ss_pred --------CCCCChHHHHHHHHcCC-CCCC--CCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 119 --------SGGMTNAEVLHQVEHGY-RMPC--PPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 119 --------~~~~~~~~~~~~v~~g~-~~~~--p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
|.+.+..++...+.++. .++. +..+|+++.+|+.+||+.||++|||++||++
T Consensus 207 eml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 207 TLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred hhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 78888888888886664 3333 3479999999999999999999999999865
|
| >d1mila_ d.93.1.1 (A:) Shc adaptor protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Shc adaptor protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.69 E-value=5.4e-17 Score=101.05 Aligned_cols=78 Identities=23% Similarity=0.294 Sum_probs=66.8
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcC-HhHHHHHhhh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIH-YPELVEHYSK 79 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~-l~~li~~~~~ 79 (189)
||||.|+|.+|+++| ..+|+||||++.+.+|.|+||++. .+.+.|++|....++|..+...|. +.+||+||.+
T Consensus 9 WyhG~i~R~~Ae~lL----~~~G~FLVR~S~~~~g~~vLSv~~--~~~v~H~~I~~~~~~~~~~~~~F~sl~~LV~~y~~ 82 (104)
T d1mila_ 9 WFHGKLSRREAEALL----QLNGDFLVRESTTTPGQYVLTGLQ--SGQPKHLLLVDPEGVVRTKDHRFESVSHLISYHMD 82 (104)
T ss_dssp TBCSSCCHHHHHTTC----CSTTEEEEEECCSSCSSEEEEEEE--TTEEEEEEEBCTTSSEECSSCEESSHHHHHHHHHH
T ss_pred CcCCCCCHHHHHHHH----hcCCcEEEEecCCCCCCEEEEEEE--ccccceEEEEeCCCEEEeCCeeECCHHHHHHHHhh
Confidence 999999999999988 357999999999888999999999 999999999765444555567888 9999999988
Q ss_pred ccCCc
Q psy1684 80 DADGL 84 (189)
Q Consensus 80 ~a~gl 84 (189)
...++
T Consensus 83 ~~~~~ 87 (104)
T d1mila_ 83 NHLPI 87 (104)
T ss_dssp HTCCE
T ss_pred CCCCc
Confidence 65443
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.69 E-value=6.3e-19 Score=131.33 Aligned_cols=144 Identities=10% Similarity=0.010 Sum_probs=110.6
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..++|+|++++++.....+..|+|+|++.+ |.+ .. ++.....+.......+..+++.|
T Consensus 59 ~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g-g~l----~~-----------------~~~~~~~~~~~~~~~~~~qi~~a 116 (316)
T d1fota_ 59 SIVTHPFIIRMWGTFQDAQQIFMIMDYIEG-GEL----FS-----------------LLRKSQRFPNPVAKFYAAEVCLA 116 (316)
T ss_dssp HSCCBTTBCCEEEEEECSSEEEEEECCCCS-CBH----HH-----------------HHHHTSSCCHHHHHHHHHHHHHH
T ss_pred HhccCcChhheeeeEeeCCeeeeEeeecCC-ccc----cc-----------------cccccccccccHHHHHHHHHHHh
Confidence 457899999998887777788999998876 311 11 12223334445555677788999
Q ss_pred ceeeccCCcccccc-cc---------------------------------cccccC-CCCCccc-e-EEEec--------
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------------------------YLVHGT-NLSGVVV-S-AVDFG-------- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------------------------~l~~~~-~~~~~~~-s-VwsfG-------- 118 (189)
+.++|..+++|||+ |+ ++|||. .+..|+. + |||+|
T Consensus 117 l~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemlt 196 (316)
T d1fota_ 117 LEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLA 196 (316)
T ss_dssp HHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHH
T ss_pred hhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHh
Confidence 99999999999996 66 223333 5567999 9 99999
Q ss_pred ----CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q psy1684 119 ----SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRP-----TFETLQW 170 (189)
Q Consensus 119 ----~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP-----~~~~i~~ 170 (189)
|.+.+..++...+.++. .+.|+.+|+++.+++.+||..||.+|+ |+++|++
T Consensus 197 G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 197 GYTPFYDSNTMKTYEKILNAE-LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp SSCTTCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCCCcCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 78888888988887774 457788999999999999999999996 8888876
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.68 E-value=3.2e-19 Score=133.31 Aligned_cols=147 Identities=12% Similarity=0.000 Sum_probs=101.4
Q ss_pred CCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccC
Q psy1684 3 FGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDAD 82 (189)
Q Consensus 3 ~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~ 82 (189)
+..++|+|++++++.+......+||+|++.+ |+ +.. ++.....+....+..+..+.+.
T Consensus 58 l~~l~HpnIv~l~~~~~~~~~~~iVmEy~~g-g~----L~~-----------------~l~~~~~l~~~~~~~~~~qil~ 115 (322)
T d1s9ja_ 58 LHECNSPYIVGFYGAFYSDGEISICMEHMDG-GS----LDQ-----------------VLKKAGRIPEQILGKVSIAVIK 115 (322)
T ss_dssp GGGCCCTTBCCEEEEEECSSEEEEEEECCTT-EE----HHH-----------------HHHHHSSCCHHHHHHHHHHHHH
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEEcCCC-Cc----HHH-----------------HHhhcCCCCHHHHHHHHHHHHH
Confidence 4568899999999888777778999998876 31 222 2322334556667778889999
Q ss_pred CceeeccC-Ccccccc-cc---------------ccc-------------------ccC-CCCCccc-e-EEEec-----
Q psy1684 83 GLCVNLRK-PCVQVSC-RI---------------YLV-------------------HGT-NLSGVVV-S-AVDFG----- 118 (189)
Q Consensus 83 gl~~~~~~-~~~~~~~-p~---------------~l~-------------------~~~-~~~~~~~-s-VwsfG----- 118 (189)
|+.|+|.+ +++|||+ |+ |+| ||. .+..|+. + |||+|
T Consensus 116 aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~e 195 (322)
T d1s9ja_ 116 GLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 195 (322)
T ss_dssp HHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHH
T ss_pred HHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHH
Confidence 99999975 8999996 66 222 222 4567999 9 99999
Q ss_pred -------CCCCChHH------------------------------------------HHHHHHcCCCCCCCC-CCCHHHH
Q psy1684 119 -------SGGMTNAE------------------------------------------VLHQVEHGYRMPCPP-GCPPRLY 148 (189)
Q Consensus 119 -------~~~~~~~~------------------------------------------~~~~v~~g~~~~~p~-~~p~~~~ 148 (189)
|.+.+..+ ....+.....+..|. ..+.++.
T Consensus 196 ll~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 275 (322)
T d1s9ja_ 196 MAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQ 275 (322)
T ss_dssp HHHSSCCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHH
T ss_pred HHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHH
Confidence 43322111 111122222222332 3578999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q psy1684 149 DIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 149 ~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
+|+.+||..||++|||++|+++.
T Consensus 276 dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 276 DFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHcCCChhHCcCHHHHhhC
Confidence 99999999999999999999873
|
| >d1qada_ d.93.1.1 (A:) Phosphatidylinositol 3-kinase, p85-alpha subunit {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Phosphatidylinositol 3-kinase, p85-alpha subunit species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.67 E-value=1.4e-16 Score=99.89 Aligned_cols=87 Identities=28% Similarity=0.332 Sum_probs=69.7
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC-cc-CCCCCcC-HhHHHHHh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET-QK-AGRTTIH-YPELVEHY 77 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g-yl-~~~~~~~-l~~li~~~ 77 (189)
||||.|+|.+|+++|. ...+|+||||.+. ..+.|+||++. .+.+.|++|....+| |+ .....|. +.+||+||
T Consensus 11 Wy~g~isR~eAe~lL~--~~~~G~FLVR~S~-~~~~y~Lsv~~--~~~v~H~~I~~~~~g~~~~~~~~~F~sl~~LI~~Y 85 (107)
T d1qada_ 11 WNVGSSNRNKAENLLR--GKRDGTFLVRESS-KQGCYACSVVV--DGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHY 85 (107)
T ss_dssp TEEEECCHHHHHHHHT--TCCTTEEEEEEC----CCEEEEEEE--TTEEEEEEEEEETTEEESSTTCCCBSSHHHHHHHH
T ss_pred ccCCCCCHHHHHHHHc--CCCCCcEEEEecC-CCCCEEEEEEe--cCCeEEEEEEECCCCeEEcCCCCccCCHHHHHHHH
Confidence 9999999999999994 4578999999995 46889999999 999999999998888 44 4456688 99999999
Q ss_pred hhcc-----CCceeeccCCc
Q psy1684 78 SKDA-----DGLCVNLRKPC 92 (189)
Q Consensus 78 ~~~a-----~gl~~~~~~~~ 92 (189)
.++. .++...+..|+
T Consensus 86 ~~~~l~~~~~~l~~~L~~Pv 105 (107)
T d1qada_ 86 QHTSLVQHNDSLNVTLAYPV 105 (107)
T ss_dssp HHSCGGGTCTTCCCCCCEET
T ss_pred HhCccccccCCCceEccccc
Confidence 8764 35555554443
|
| >d2izva2 d.93.1.1 (A:274-385) Suppressor of cytokine signaling 4, SOCS-4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Suppressor of cytokine signaling 4, SOCS-4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.67 E-value=9.2e-17 Score=101.51 Aligned_cols=89 Identities=21% Similarity=0.239 Sum_probs=72.4
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC-ccCCC----CCcC-HhHHH
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET-QKAGR----TTIH-YPELV 74 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g-yl~~~----~~~~-l~~li 74 (189)
||||.|+|.+|+++|. ...+|+||||++.+..+.|+||++. .+.++|++|.+.+++ ++... ..|. +.+||
T Consensus 13 Wy~g~isR~~Ae~lL~--~~~~GtFLVR~S~~~~~~~~LSv~~--~~~v~H~~I~~~~~~~~l~~~~~~~~~F~sl~~LV 88 (112)
T d2izva2 13 CYWGVMDKYAAEALLE--GKPEGTFLLRDSAQEDYLFSVSFRR--YSRSLHARIEQWNHNFSFDAHDPCVFHSPDITGLL 88 (112)
T ss_dssp TEEEECCHHHHHHHHT--TCCTTEEEEEECSSTTCSEEEEEEE--TTEEEEEECEEETTEEESCTTCTTSCCBSSHHHHH
T ss_pred CcCCCCCHHHHHHHHc--cCCCCcEEEeecCCCCCCeEEEEEe--cCCceEEEEEEeCCeEEEeecccCcccCCCHHHHH
Confidence 9999999999999995 3468999999999888999999999 999999999987766 55432 2577 99999
Q ss_pred HHhhhccCCc--eeeccCCcc
Q psy1684 75 EHYSKDADGL--CVNLRKPCV 93 (189)
Q Consensus 75 ~~~~~~a~gl--~~~~~~~~~ 93 (189)
+||++...++ ..+++.||+
T Consensus 89 ~~Y~~~~~~~~~~~llt~P~~ 109 (112)
T d2izva2 89 EHYKDPSACMFFEPLLSTPLI 109 (112)
T ss_dssp HHTCCGGGCCTTSCCCCEECC
T ss_pred HHHhcccccccCccccCCCCC
Confidence 9998876543 344566654
|
| >d2shpa3 d.93.1.1 (A:111-218) Tyrosine phoshatase shp-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine phoshatase shp-2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.66 E-value=2.8e-16 Score=98.87 Aligned_cols=91 Identities=31% Similarity=0.489 Sum_probs=73.4
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEec--------CCCeeeEEEEEeccCC-ccCCCCCcC-H
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKR--------SSFCLKMTTGRSLFET-QKAGRTTIH-Y 70 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~--------~~~~v~h~~i~~~~~g-yl~~~~~~~-l 70 (189)
||||.|+|.+|+++|..+. .+|+||||++.+.+|.|+||++.. ..+.+.|+.|...+++ ++.+...|. +
T Consensus 2 WyhG~i~R~~Ae~lL~~~~-~~G~FLVR~S~~~~g~~~LSv~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~F~sl 80 (108)
T d2shpa3 2 WFHGHLSGKEAEKLLTEKG-KHGSFLVRESQSHPGDFVLSVRTGDDKGESNDGKSKVTHVMIRCQELKYDVGGGERFDSL 80 (108)
T ss_dssp TBCCSCCHHHHHHHHHHTC-CTTEEEEEECSSSTTCEEEEEEECC-----CCCCCEEEEEEEEEETTEEESSSSCCBSSH
T ss_pred CCcCCCCHHHHHHHHhhcC-CCCeEEEEecCCCCCCeEEEEEecCccccccccccceeeEEEEeCCCceEeCCCcccCCH
Confidence 9999999999999995432 579999999998889999999973 2356889999877777 787788899 9
Q ss_pred hHHHHHhhhc----cCCceeeccCCc
Q psy1684 71 PELVEHYSKD----ADGLCVNLRKPC 92 (189)
Q Consensus 71 ~~li~~~~~~----a~gl~~~~~~~~ 92 (189)
.+|++||+++ .+|+...+..||
T Consensus 81 ~~LV~~y~~~~l~~~~g~~~~L~~Pv 106 (108)
T d2shpa3 81 TDLVEHYKKNPMVETLGTVLQLKQPL 106 (108)
T ss_dssp HHHHHHHHHSCCBCTTSCBCCCCEEC
T ss_pred HHHHHHHhhCCCCCCCCceEEcCCCC
Confidence 9999999876 345555555443
|
| >d1rpya_ d.93.1.1 (A:) Adaptor protein Aps {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Adaptor protein Aps species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.66 E-value=1.9e-17 Score=99.81 Aligned_cols=76 Identities=21% Similarity=0.296 Sum_probs=63.3
Q ss_pred CCCCCCChHHHHHHhcCCC-CCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC-ccCCCCCcC-HhHHHHHh
Q psy1684 1 WYFGKIKRIEAEKKLLLPE-NDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET-QKAGRTTIH-YPELVEHY 77 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~-~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g-yl~~~~~~~-l~~li~~~ 77 (189)
||||.|+|..|+++|.... ..+|+||||++.+..|.|+||++. .+.++|++|.+..+| ++.+...|. +.+||+||
T Consensus 7 Wyhg~isR~~Ae~lL~~~~~~~dG~FLvR~S~~~~g~~~Lsv~~--~~~v~h~~I~~~~~~~~~~~~~~F~sl~~LV~~y 84 (86)
T d1rpya_ 7 WFHGTLSRVKAAQLVLAGGPRSHGLFVIRQSETRPGECVLTFNF--QGKAKHLRLSLNGHGQCHVQHLWFQSVFDMLRHF 84 (86)
T ss_dssp TBCTTCCHHHHHHHHHTTGGGGTTCEEEEECSSSTTCEEEEEEE--TTEEEEEEC----CCCHHHHHHHHHHHHHHHHHH
T ss_pred ccCCCCCHHHHHHHHHhCCCCCCceEEEEecCCCCCcEEEEEEE--CCceEEEEEEEcCCceEEeCCCeeCCHHHHHHhh
Confidence 9999999999999996543 467999999998888999999999 999999999998888 655566788 99999988
Q ss_pred h
Q psy1684 78 S 78 (189)
Q Consensus 78 ~ 78 (189)
.
T Consensus 85 ~ 85 (86)
T d1rpya_ 85 H 85 (86)
T ss_dssp T
T ss_pred c
Confidence 5
|
| >d2cs0a1 d.93.1.1 (A:8-113) Hematopoietic SH2 domain containing protein HSH2D {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Hematopoietic SH2 domain containing protein HSH2D species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.66 E-value=4.9e-16 Score=97.23 Aligned_cols=90 Identities=28% Similarity=0.307 Sum_probs=75.0
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC--ccCC-CCCcC-HhHHHHH
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET--QKAG-RTTIH-YPELVEH 76 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g--yl~~-~~~~~-l~~li~~ 76 (189)
||||.|+|.+|+++|.. ..+|+||||.+....+ |+|+++. .+.++|+.|....+| ++.+ ...|. +.+||+|
T Consensus 11 Wy~g~isR~eAe~lL~~--~~~G~FLvR~S~~~~~-y~Lsv~~--~~~~~h~~I~~~~~g~~~~~~~~~~F~sl~eLV~~ 85 (106)
T d2cs0a1 11 WFHGAISREDAENLLES--QPLGSFLIRVSHSHVG-YTLSYKA--QSSCCHFMVKLLDDGTFMIPGEKVAHTSLDALVTF 85 (106)
T ss_dssp SBCSSCCHHHHHHHHHT--SCTTCEEEEECSSSSS-EEEEECC--SSSCEEEEEEECTTSCEECTTCSCCBSSHHHHHHH
T ss_pred CccCCCCHHHHHHHHcC--CCCCcEEEEecCCCCC-EEEEEEe--cCCceeEEEEEcCCCCEEEecCCccCCCHHHHHHH
Confidence 99999999999999964 4689999999987655 9999999 999999999988888 4543 34678 9999999
Q ss_pred hhhccC-CceeeccCCcccc
Q psy1684 77 YSKDAD-GLCVNLRKPCVQV 95 (189)
Q Consensus 77 ~~~~a~-gl~~~~~~~~~~~ 95 (189)
|++... ++...+..||...
T Consensus 86 y~~~~~~~~~~~L~~P~~~~ 105 (106)
T d2cs0a1 86 HQQKPIEPRRELLTQPCRQK 105 (106)
T ss_dssp HTTSCCSSCCCCCCSBCCCS
T ss_pred HHHCCCCCccCcccCcCCCC
Confidence 998754 7777777787653
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.65 E-value=1.2e-18 Score=132.09 Aligned_cols=144 Identities=9% Similarity=-0.088 Sum_probs=100.9
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..+.|+|++++++.....+..|||+|++.++. +.. ++.....+...+...+..+++.|
T Consensus 62 ~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~-----L~~-----------------~l~~~~~~~e~~~~~~~~qi~~a 119 (364)
T d1omwa3 62 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGD-----LHY-----------------HLSQHGVFSEADMRFYAAEIILG 119 (364)
T ss_dssp SSSCCTTBCCEEEEEECSSEEEEEECCCCSCB-----HHH-----------------HHHHHCSCCHHHHHHHHHHHHHH
T ss_pred hcCCCCcEEEEEEEEEECCEEEEEEEecCCCc-----HHH-----------------HHHhcccccHHHHHHHHHHHHHH
Confidence 34568888888777666667788888877632 111 23223344456677788889999
Q ss_pred ceeeccCCcccccc-cc---------------ccc-------------------ccC-C-CCCccc-e-EEEec------
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YLV-------------------HGT-N-LSGVVV-S-AVDFG------ 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l~-------------------~~~-~-~~~~~~-s-VwsfG------ 118 (189)
+.++|..+++|||+ |+ |+| ||. . ...|+. + |||+|
T Consensus 120 L~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyem 199 (364)
T d1omwa3 120 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKL 199 (364)
T ss_dssp HHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHH
T ss_pred HHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHH
Confidence 99999999999996 66 333 222 3 345899 9 99999
Q ss_pred ------CCCCChH---HHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q psy1684 119 ------SGGMTNA---EVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPT-----FETLQW 170 (189)
Q Consensus 119 ------~~~~~~~---~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~-----~~~i~~ 170 (189)
|.+.+.. ++...+ ....++.|..+++++.+||.+||+.||++||| +++|++
T Consensus 200 ltG~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 200 LRGHSPFRQHKTKDKHEIDRMT-LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp HHSSCSSCSSCSSCHHHHHHHS-SSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred HhCCCCCCCCCHHHHHHHHHhc-ccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 5544332 232222 23345667889999999999999999999999 577765
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.65 E-value=2.2e-18 Score=130.01 Aligned_cols=144 Identities=8% Similarity=-0.035 Sum_probs=105.3
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..++|+|++++++........++|++++.++. + .. ++.....++...+..+..+.+.|
T Consensus 96 ~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~-l----~~-----------------~l~~~~~l~e~~~~~i~~qi~~a 153 (350)
T d1rdqe_ 96 QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE-M----FS-----------------HLRRIGRFSEPHARFYAAQIVLT 153 (350)
T ss_dssp TTCCCTTBCCEEEEEECSSEEEEEEECCTTCB-H----HH-----------------HHHHHCCCCHHHHHHHHHHHHHH
T ss_pred HHcCCCcEeecccccccccccccccccccccc-h----hh-----------------hHhhcCCCCHHHHHHHHHHHHHH
Confidence 34566666666655554555566666655422 0 01 33333445566777788899999
Q ss_pred ceeeccCCcccccc-cc---------------cccc------------------cC-CCCCccc-e-EEEec--------
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YLVH------------------GT-NLSGVVV-S-AVDFG-------- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l~~------------------~~-~~~~~~~-s-VwsfG-------- 118 (189)
+.++|..+++|||+ |+ |+|+ |. .+..|+. + |||+|
T Consensus 154 L~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemlt 233 (350)
T d1rdqe_ 154 FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA 233 (350)
T ss_dssp HHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH
T ss_pred HHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHh
Confidence 99999999999996 66 3322 22 5667999 9 99999
Q ss_pred ----CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCC-----CCHHHHHH
Q psy1684 119 ----SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKR-----PTFETLQW 170 (189)
Q Consensus 119 ----~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~R-----P~~~~i~~ 170 (189)
|.+.+..+++..+..+. +..|..+++++.+|+.+||..||++| ||+++|++
T Consensus 234 G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 234 GYPPFFADQPIQIYEKIVSGK-VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp SSCSSCCSSHHHHHHHHHHCC-CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCCCcCHHHHHHHHhcCC-CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 77888888888887774 55678999999999999999999999 48999876
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.64 E-value=3.9e-18 Score=126.11 Aligned_cols=145 Identities=12% Similarity=-0.034 Sum_probs=102.4
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..++|+|++++++....++..+||+|++.. +.+ .. ....+..++..++..+..+++.|
T Consensus 55 ~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~-~~~----~~-----------------~~~~~~~l~~~~~~~~~~qil~a 112 (299)
T d1ua2a_ 55 QELSHPNIIGLLDAFGHKSNISLVFDFMET-DLE----VI-----------------IKDNSLVLTPSHIKAYMLMTLQG 112 (299)
T ss_dssp HHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHH----HH-----------------HTTCCSSCCSSHHHHHHHHHHHH
T ss_pred HhCCCCCEeEEEeeeccCCceeehhhhhcc-hHH----hh-----------------hhhcccCCCHHHHHHHHHHHHHH
Confidence 356788999988888777788888888765 210 00 12223345556667778888999
Q ss_pred ceeeccCCcccccc-cc---------------cccccC-----------------------CCCCccc-e-EEEec----
Q psy1684 84 LCVNLRKPCVQVSC-RI---------------YLVHGT-----------------------NLSGVVV-S-AVDFG---- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~---------------~l~~~~-----------------------~~~~~~~-s-VwsfG---- 118 (189)
+.++|...++|||+ |+ |++... ....|+. + |||+|
T Consensus 113 L~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ 192 (299)
T d1ua2a_ 113 LEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILA 192 (299)
T ss_dssp HHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHH
T ss_pred HHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHH
Confidence 99999999999996 66 333221 2345788 9 99999
Q ss_pred --------CCCCChHHHHHHHHcCCC----------------------CCC-----CCCCCHHHHHHHHHhcccCCCCCC
Q psy1684 119 --------SGGMTNAEVLHQVEHGYR----------------------MPC-----PPGCPPRLYDIMLECWLKDPVKRP 163 (189)
Q Consensus 119 --------~~~~~~~~~~~~v~~g~~----------------------~~~-----p~~~p~~~~~l~~~C~~~~p~~RP 163 (189)
|.+.+..+.+..+.+... +.. .+..++++.+|+.+|++.||++||
T Consensus 193 el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~ 272 (299)
T d1ua2a_ 193 ELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI 272 (299)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSC
T ss_pred HHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCc
Confidence 777777776666532110 000 125678999999999999999999
Q ss_pred CHHHHHH
Q psy1684 164 TFETLQW 170 (189)
Q Consensus 164 ~~~~i~~ 170 (189)
|++|+++
T Consensus 273 sa~e~L~ 279 (299)
T d1ua2a_ 273 TATQALK 279 (299)
T ss_dssp CHHHHHT
T ss_pred CHHHHhC
Confidence 9999986
|
| >d2eyva1 d.93.1.1 (A:12-120) Crk proto-oncogen {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Crk proto-oncogen species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.62 E-value=2.4e-15 Score=94.63 Aligned_cols=87 Identities=30% Similarity=0.444 Sum_probs=69.1
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC-ccC----------------
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET-QKA---------------- 63 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g-yl~---------------- 63 (189)
||||.|+|++|+++|. ...+|+||||++....+.|+||++. .+.+.|++|....++ ++.
T Consensus 2 Wy~g~isR~~Ae~lL~--~~~~G~FLVR~S~~~~~~~~LS~~~--~~~v~H~~I~~~~~~~~~~~~~~~~~~~~~~~~~~ 77 (109)
T d2eyva1 2 WYWGRLSRQEAVALLQ--GQRHGVFLVRDSSTSPGDYVLSVSE--NSRVSHYIINSSGPRPPVPPSPAQPPPGVSPSRLR 77 (109)
T ss_dssp SCCBCCCHHHHHHHCS--SCSTTCEEEECCCSSSSCEEEEEEE--TTEEEEEEEECCCCSSCCCSSSSCCCCSCCCCCEE
T ss_pred CCCCCCCHHHHHHHhc--CCCCCeEEeeecCCCCCCEEEEEEE--CCEEEEEEEEEcCCcceeeccccccccccccceEE
Confidence 9999999999999884 3468999999998888999999999 999999999987766 221
Q ss_pred -CCCCcC-HhHHHHHhhhccCCceeeccCCc
Q psy1684 64 -GRTTIH-YPELVEHYSKDADGLCVNLRKPC 92 (189)
Q Consensus 64 -~~~~~~-l~~li~~~~~~a~gl~~~~~~~~ 92 (189)
+...|. +.+||+||+.+..+. ..+..||
T Consensus 78 ~~~~~F~sl~~LV~~y~~~~l~~-~~L~~P~ 107 (109)
T d2eyva1 78 IGDQEFDSLPALLEFYKIHYLDT-TTLIEPV 107 (109)
T ss_dssp ETTEEESSHHHHHHHSSSSCSSS-SCCCSBC
T ss_pred eCCeeeCCHHHHHHHHhhCcCCC-CccCCcC
Confidence 123577 999999998765432 2344454
|
| >d1fu6a_ d.93.1.1 (A:) Phosphatidylinositol 3-kinase, p85-alpha subunit {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Phosphatidylinositol 3-kinase, p85-alpha subunit species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.62 E-value=3.9e-16 Score=98.58 Aligned_cols=89 Identities=30% Similarity=0.427 Sum_probs=73.6
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCC-CCceEEEEEecCCCeeeEEEEEeccCC-ccCCCCCcC-HhHHHHHh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESR-KNDYSLSEYKRSSFCLKMTTGRSLFET-QKAGRTTIH-YPELVEHY 77 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~-~~~~~ls~~~~~~~~v~h~~i~~~~~g-yl~~~~~~~-l~~li~~~ 77 (189)
||||.|+|.+|+++|.. ..+|+||||++.+. ++.|++++.. .+.+.|++|...+++ ++.+...|. +.+||++|
T Consensus 13 WyhG~isR~eAe~lL~~--~~~G~FLVR~S~~~~~~~~~ls~~~--~~~~~H~~I~~~~~~~~~~~~~~F~sl~~LV~~y 88 (111)
T d1fu6a_ 13 WYWGDISREEVNEKLRD--TADGTFLVRDASTKMHGDYTLTLRK--GGNNKSIKIFHRDGKYGFSDPLTFNSVVELINHY 88 (111)
T ss_dssp SCCSSCCSHHHHHHSSS--CSSCCCCCBSSCCSSSCCSBCEEEE--TTEEEECCCCCTTTCCCTTTTSCCCCTTHHHHHH
T ss_pred CCCCCCCHHHHHHHhCc--CCCCEEEEEeccCCCCccEEEEEec--CCceEEEEEEEcCCeEEECCCcccCCHHHHHHHH
Confidence 99999999999999954 35899999998765 4679999999 999999999877666 777777888 99999999
Q ss_pred hhcc-----CCceeeccCCcc
Q psy1684 78 SKDA-----DGLCVNLRKPCV 93 (189)
Q Consensus 78 ~~~a-----~gl~~~~~~~~~ 93 (189)
.+.. .++...+..||.
T Consensus 89 ~~~~l~~~~~~l~~~L~~Pv~ 109 (111)
T d1fu6a_ 89 RNESLAQYNPKLDVKLLYPVS 109 (111)
T ss_dssp HTTCSTTTCSSCCCCSCCCCC
T ss_pred hhCcCCccCCCCccccCcccc
Confidence 8764 355666666664
|
| >d2c9wa2 d.93.1.1 (A:32-134) Suppressor of cytokine signaling 2, SOCS-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Suppressor of cytokine signaling 2, SOCS-2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.61 E-value=2.4e-15 Score=93.61 Aligned_cols=77 Identities=25% Similarity=0.290 Sum_probs=65.0
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC-cc-------CCCCCcC-Hh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET-QK-------AGRTTIH-YP 71 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g-yl-------~~~~~~~-l~ 71 (189)
||||.|+|..|+++|. ..++|+||||++...++.|+||++. .+.++|++|....++ .+ .....|. +.
T Consensus 17 Wy~g~i~R~~Ae~~L~--~~~~GtFLVR~S~~~~~~~~LSv~~--~~~v~H~~I~~~~~~~~~~~~~~~~~~~~~F~sl~ 92 (103)
T d2c9wa2 17 WYWGSMTVNEAKEKLK--EAPEGTFLIRDSSHSDYLLTISVKT--SAGPTNLRIEYQDGKFRLDSIICVKSKLKQFDSVV 92 (103)
T ss_dssp CBCTTCCHHHHHHHHT--TSCTTCEEEEECCSTTCSEEEEEEE--TTEEEEEEEEEETTEEEECTTTTTGGGCCCBSCHH
T ss_pred CcCCCCCHHHHHHHhc--CCCCCceEEeccCCCCCCEEEEEEE--CCEEEEEEEEEcCCeEeeCCccccccCCCccCCHH
Confidence 9999999999999995 4478999999999988999999999 999999999876654 22 2234688 99
Q ss_pred HHHHHhhhcc
Q psy1684 72 ELVEHYSKDA 81 (189)
Q Consensus 72 ~li~~~~~~a 81 (189)
+||+||.+.+
T Consensus 93 ~LI~~y~~~s 102 (103)
T d2c9wa2 93 HLIDYYVQMC 102 (103)
T ss_dssp HHHHHHHHHT
T ss_pred HHHHHHHhhC
Confidence 9999998653
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.58 E-value=3.5e-16 Score=115.43 Aligned_cols=119 Identities=13% Similarity=0.108 Sum_probs=84.5
Q ss_pred CCCcCHhHHHHHhhhccCCceeeccCCcccccc-ccc------------------ccccC--------------------
Q psy1684 65 RTTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RIY------------------LVHGT-------------------- 105 (189)
Q Consensus 65 ~~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~~------------------l~~~~-------------------- 105 (189)
...++...+..+..+.+.|+.++|...++|||+ |+. +|+..
T Consensus 97 ~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt 176 (299)
T d1ckia_ 97 SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176 (299)
T ss_dssp TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCC
T ss_pred cCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCC
Confidence 445667778888899999999999999999996 662 22110
Q ss_pred ---------CCCCccc-e-EEEec------------CCCCChHHHHHHH----HcCCCCC---CCCCCCHHHHHHHHHhc
Q psy1684 106 ---------NLSGVVV-S-AVDFG------------SGGMTNAEVLHQV----EHGYRMP---CPPGCPPRLYDIMLECW 155 (189)
Q Consensus 106 ---------~~~~~~~-s-VwsfG------------~~~~~~~~~~~~v----~~g~~~~---~p~~~p~~~~~l~~~C~ 155 (189)
.+..|+. + ||||| |.+....+....+ ......+ .+..+|+++.+||..||
T Consensus 177 ~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl 256 (299)
T d1ckia_ 177 ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCR 256 (299)
T ss_dssp SSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHH
T ss_pred ccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHc
Confidence 3445899 9 99999 5555443332222 1111122 34689999999999999
Q ss_pred ccCCCCCCCHHHHHHHHHHHHhhcCCCC
Q psy1684 156 LKDPVKRPTFETLQWKLEDFFTMEGSDY 183 (189)
Q Consensus 156 ~~~p~~RP~~~~i~~~l~~~~~~~~~~~ 183 (189)
+.||++||+|++|.+.|+.++....-.+
T Consensus 257 ~~~p~~RP~~~~i~~~l~~~~~~~~~~~ 284 (299)
T d1ckia_ 257 SLRFDDKPDYSYLRQLFRNLFHRQGFSY 284 (299)
T ss_dssp HSCTTCCCCHHHHHHHHHHHHHHHTCCC
T ss_pred cCChhHCcCHHHHHHHHHHHHHHcCCCC
Confidence 9999999999999999999877654444
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.56 E-value=1.1e-17 Score=125.42 Aligned_cols=104 Identities=10% Similarity=0.050 Sum_probs=72.7
Q ss_pred CcCHhHHHHHhhhccCCceeeccCCcccccc-cc--------------------------------------cccccC-C
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI--------------------------------------YLVHGT-N 106 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~--------------------------------------~l~~~~-~ 106 (189)
.++..+...+..+.+.|+.|+|..+++|||+ |+ ++|||. .
T Consensus 107 ~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~ 186 (335)
T d2ozaa1 107 AFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG 186 (335)
T ss_dssp CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCC
T ss_pred CcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCCCccccccCCcccCCcHHHc
Confidence 4556677788889999999999999999996 66 222222 3
Q ss_pred CCCccc-e-EEEec------------CCCCChHHHHHH----HHcCC-CCCCC--CCCCHHHHHHHHHhcccCCCCCCCH
Q psy1684 107 LSGVVV-S-AVDFG------------SGGMTNAEVLHQ----VEHGY-RMPCP--PGCPPRLYDIMLECWLKDPVKRPTF 165 (189)
Q Consensus 107 ~~~~~~-s-VwsfG------------~~~~~~~~~~~~----v~~g~-~~~~p--~~~p~~~~~l~~~C~~~~p~~RP~~ 165 (189)
...|+. + |||+| |.+.+..++... +..+. ..+.| ..+++++.+|+.+|++.||++|||+
T Consensus 187 ~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~ 266 (335)
T d2ozaa1 187 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTI 266 (335)
T ss_dssp GGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred CCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCH
Confidence 445899 9 99999 444333333332 22222 12222 3588999999999999999999999
Q ss_pred HHHHH
Q psy1684 166 ETLQW 170 (189)
Q Consensus 166 ~~i~~ 170 (189)
.|+++
T Consensus 267 ~eil~ 271 (335)
T d2ozaa1 267 TEFMN 271 (335)
T ss_dssp HHHHH
T ss_pred HHHHc
Confidence 99976
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.55 E-value=7.1e-17 Score=118.49 Aligned_cols=106 Identities=12% Similarity=0.058 Sum_probs=77.4
Q ss_pred CCCcCHhHHHHHhhhccCCceeeccCCcccccc-ccccc--ccC------------------------------------
Q psy1684 65 RTTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RIYLV--HGT------------------------------------ 105 (189)
Q Consensus 65 ~~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~~l~--~~~------------------------------------ 105 (189)
...++......+..+++.|+.++|..+++|||+ |+.+. .+.
T Consensus 94 ~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~ 173 (286)
T d1ob3a_ 94 EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM 173 (286)
T ss_dssp TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHT
T ss_pred cCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccccceecccchhhhHHHHh
Confidence 445667777788899999999999999999996 66221 111
Q ss_pred CCCCccc-e-EEEec------------CCCCChHHHHHHHHc--CCC--------------------------CCCCCCC
Q psy1684 106 NLSGVVV-S-AVDFG------------SGGMTNAEVLHQVEH--GYR--------------------------MPCPPGC 143 (189)
Q Consensus 106 ~~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~--g~~--------------------------~~~p~~~ 143 (189)
....++. + |||+| |.+.+..+.+..+.. |.. ...+..+
T Consensus 174 ~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (286)
T d1ob3a_ 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGL 253 (286)
T ss_dssp TCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSC
T ss_pred CCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccC
Confidence 2345788 9 99999 777776666555421 110 0123467
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 144 PPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 144 p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
++++.+|+.+|++.||++|||++|+++
T Consensus 254 s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 254 DESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 889999999999999999999999874
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.54 E-value=3.7e-17 Score=121.02 Aligned_cols=104 Identities=14% Similarity=0.091 Sum_probs=78.7
Q ss_pred CcCHhHHHHHhhhccCCceeeccCCcccccc-cc-----------------------------------cccccC-CCCC
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI-----------------------------------YLVHGT-NLSG 109 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~-----------------------------------~l~~~~-~~~~ 109 (189)
.++...+..+..+.+.|+.++|..+++|||+ |+ ++|||. ....
T Consensus 112 ~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~ 191 (305)
T d1blxa_ 112 GVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS 191 (305)
T ss_dssp CSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhhcccccCCCcccChhhcCcchhcCCC
Confidence 3445666678889999999999999999996 66 223332 5677
Q ss_pred ccc-e-EEEec------------CCCCChHHHHHHHHc--CCC------------------------CCCCCCCCHHHHH
Q psy1684 110 VVV-S-AVDFG------------SGGMTNAEVLHQVEH--GYR------------------------MPCPPGCPPRLYD 149 (189)
Q Consensus 110 ~~~-s-VwsfG------------~~~~~~~~~~~~v~~--g~~------------------------~~~p~~~p~~~~~ 149 (189)
|+. + |||+| |.+.+..+.+..+.+ |.. ...+...++++.+
T Consensus 192 y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 271 (305)
T d1blxa_ 192 YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKD 271 (305)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHH
T ss_pred CChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHH
Confidence 999 9 99999 777777766655522 110 0123467889999
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q psy1684 150 IMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 150 l~~~C~~~~p~~RP~~~~i~~ 170 (189)
|+.+||+.||++|||++|+++
T Consensus 272 li~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 272 LLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp HHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHCcCChhHCcCHHHHhc
Confidence 999999999999999999876
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.54 E-value=3.6e-17 Score=120.80 Aligned_cols=147 Identities=13% Similarity=0.075 Sum_probs=95.0
Q ss_pred CCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcCHhHHHHHhhhccCC
Q psy1684 4 GKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIHYPELVEHYSKDADG 83 (189)
Q Consensus 4 g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~l~~li~~~~~~a~g 83 (189)
..++|+|++++++.....+..+||+|++.. +.+.+. .......+...++..+..+.+.|
T Consensus 56 ~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~-~~~~~~--------------------~~~~~~~l~e~~~~~~~~qil~~ 114 (298)
T d1gz8a_ 56 KELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--------------------DASALTGIPLPLIKSYLFQLLQG 114 (298)
T ss_dssp TTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHH--------------------HHTTTTCCCHHHHHHHHHHHHHH
T ss_pred HhCCCCcEEEeccccccccceeEEEeecCC-chhhhh--------------------hhhcccCCCHHHHHHHHHHHHHH
Confidence 456677777766655555555666666543 100000 11123345567778888999999
Q ss_pred ceeeccCCcccccc-ccc---------------cc---------------------ccC-CC-CCccc-e-EEEec----
Q psy1684 84 LCVNLRKPCVQVSC-RIY---------------LV---------------------HGT-NL-SGVVV-S-AVDFG---- 118 (189)
Q Consensus 84 l~~~~~~~~~~~~~-p~~---------------l~---------------------~~~-~~-~~~~~-s-VwsfG---- 118 (189)
+.++|..+++|||+ |+. +| +|. .. ..++. + |||+|
T Consensus 115 L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily 194 (298)
T d1gz8a_ 115 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFA 194 (298)
T ss_dssp HHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred HHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhh
Confidence 99999999999996 661 11 111 23 33577 8 99999
Q ss_pred --------CCCCChHHHHHHHHc--CC---------------CCCCC-----------CCCCHHHHHHHHHhcccCCCCC
Q psy1684 119 --------SGGMTNAEVLHQVEH--GY---------------RMPCP-----------PGCPPRLYDIMLECWLKDPVKR 162 (189)
Q Consensus 119 --------~~~~~~~~~~~~v~~--g~---------------~~~~p-----------~~~p~~~~~l~~~C~~~~p~~R 162 (189)
|.+.+..+.+..+.+ |. ....| ..+++++.+|+.+|+..||++|
T Consensus 195 ~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R 274 (298)
T d1gz8a_ 195 EMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKR 274 (298)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTS
T ss_pred HHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHC
Confidence 677776666555421 11 00011 2456889999999999999999
Q ss_pred CCHHHHHHH
Q psy1684 163 PTFETLQWK 171 (189)
Q Consensus 163 P~~~~i~~~ 171 (189)
||++|+++.
T Consensus 275 ~t~~ell~H 283 (298)
T d1gz8a_ 275 ISAKAALAH 283 (298)
T ss_dssp CCHHHHHTS
T ss_pred cCHHHHhCC
Confidence 999999874
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.54 E-value=2.5e-17 Score=120.25 Aligned_cols=101 Identities=12% Similarity=0.039 Sum_probs=73.8
Q ss_pred CCCcCHhHHHHHhhhccCCceeeccCCcccccc-cc----------------ccc-------------------ccC-CC
Q psy1684 65 RTTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI----------------YLV-------------------HGT-NL 107 (189)
Q Consensus 65 ~~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~----------------~l~-------------------~~~-~~ 107 (189)
...+...+...+..+.+.|+.++|..+++|||+ |+ |+| +|. ..
T Consensus 104 ~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~~~~~~~GT~~y~aPE~~~~ 183 (273)
T d1xwsa_ 104 RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRY 183 (273)
T ss_dssp HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHH
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecccccccccccCCCcCCHHHHcC
Confidence 345556667778889999999999999999996 66 222 111 23
Q ss_pred CC-ccc-e-EEEec----------CCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 108 SG-VVV-S-AVDFG----------SGGMTNAEVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 108 ~~-~~~-s-VwsfG----------~~~~~~~~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
.. ++. + |||+| .+-....+ +.++ ....|..+|+++.+|+.+||+.||++|||++|+++
T Consensus 184 ~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~----i~~~-~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----IIRG-QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp SCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----HHHC-CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCcccccccceeeehhHhhCCCCCCCchH----Hhhc-ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 34 467 8 99999 11112222 3334 34567889999999999999999999999999976
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.45 E-value=8.1e-16 Score=112.93 Aligned_cols=109 Identities=12% Similarity=0.003 Sum_probs=76.1
Q ss_pred cCCCCCcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cccccC--------------------
Q psy1684 62 KAGRTTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVHGT-------------------- 105 (189)
Q Consensus 62 l~~~~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~~~-------------------- 105 (189)
+.....+...++..+..+.+.|+.++|..+++|||+ |+ |++...
T Consensus 92 ~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe 171 (292)
T d1unla_ 92 DSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPD 171 (292)
T ss_dssp HHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHH
T ss_pred cccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCccceeeccccchhhhh
Confidence 333445556777788889999999999999999996 66 222211
Q ss_pred --CCC-Cccc-e-EEEec-------------CCCCChHHHHHHHHc--CC--------------------------CCCC
Q psy1684 106 --NLS-GVVV-S-AVDFG-------------SGGMTNAEVLHQVEH--GY--------------------------RMPC 139 (189)
Q Consensus 106 --~~~-~~~~-s-VwsfG-------------~~~~~~~~~~~~v~~--g~--------------------------~~~~ 139 (189)
... .++. + |||+| |.+.+..+.+..+.. +. ....
T Consensus 172 ~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (292)
T d1unla_ 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNV 251 (292)
T ss_dssp HHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTT
T ss_pred HhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhc
Confidence 233 3688 9 99999 344444555554421 11 1112
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 140 PPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 140 p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
+...++++.+|+.+|++.||++|||++|+++
T Consensus 252 ~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 252 VPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp STTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 3456789999999999999999999999875
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.44 E-value=3.5e-15 Score=112.13 Aligned_cols=105 Identities=10% Similarity=0.004 Sum_probs=75.3
Q ss_pred CcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------c------------------ccccC--CCCCc
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------Y------------------LVHGT--NLSGV 110 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~------------------l~~~~--~~~~~ 110 (189)
.++...+..+..+.+.|+.++|..+++|||+ |+ | +|+|. ....+
T Consensus 117 ~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 196 (346)
T d1cm8a_ 117 KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRY 196 (346)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSSCCSSCSCGGGCCTHHHHTTTCC
T ss_pred cccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCCccccccccccccCHHHHcCCCCC
Confidence 4566677778889999999999999999996 66 2 22222 23456
Q ss_pred cc-e-EEEec------------CCCCChHHHHHHHHc--CC-------------------------C---CCCCCCCCHH
Q psy1684 111 VV-S-AVDFG------------SGGMTNAEVLHQVEH--GY-------------------------R---MPCPPGCPPR 146 (189)
Q Consensus 111 ~~-s-VwsfG------------~~~~~~~~~~~~v~~--g~-------------------------~---~~~p~~~p~~ 146 (189)
+. + |||+| |.+.+..+.+..+.. +. . ...+..++++
T Consensus 197 ~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 276 (346)
T d1cm8a_ 197 TQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPL 276 (346)
T ss_dssp CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHH
T ss_pred CccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHH
Confidence 88 8 99999 555555444433311 11 0 0123467889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 147 LYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 147 ~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
+.+|+.+|+..||++|||++|+++.
T Consensus 277 ~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 277 AVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHCcCChhHCcCHHHHhcC
Confidence 9999999999999999999999874
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.43 E-value=8.8e-16 Score=115.65 Aligned_cols=107 Identities=12% Similarity=0.009 Sum_probs=76.8
Q ss_pred CCCcCHhHHHHHhhhccCCceeeccCCcccccc-cc----------------cccccC----------------------
Q psy1684 65 RTTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI----------------YLVHGT---------------------- 105 (189)
Q Consensus 65 ~~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~----------------~l~~~~---------------------- 105 (189)
...++..++..+..+++.|+.++|..+++|||+ |+ |++...
T Consensus 116 ~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~ 195 (350)
T d1q5ka_ 116 KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF 195 (350)
T ss_dssp TCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHT
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCCcccccccccccccChHHhh
Confidence 344556777778889999999999999999996 66 222111
Q ss_pred CCCCccc-e-EEEec------------CCCCChHHHHHHHHc--CC----------------CCC----------CCCCC
Q psy1684 106 NLSGVVV-S-AVDFG------------SGGMTNAEVLHQVEH--GY----------------RMP----------CPPGC 143 (189)
Q Consensus 106 ~~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~--g~----------------~~~----------~p~~~ 143 (189)
....|+. + |||+| |.+.+..+.+..+.+ |. ..+ ....+
T Consensus 196 ~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (350)
T d1q5ka_ 196 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRT 275 (350)
T ss_dssp TCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTS
T ss_pred cccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCC
Confidence 2345888 9 99999 666665555444321 10 000 12357
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 144 PPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 144 p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
++++.+|+.+|+..||++|||++|+++.
T Consensus 276 s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 276 PPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 8899999999999999999999999863
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.43 E-value=4e-16 Score=116.31 Aligned_cols=105 Identities=15% Similarity=0.020 Sum_probs=73.3
Q ss_pred CCCcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cccccC-----------------------
Q psy1684 65 RTTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVHGT----------------------- 105 (189)
Q Consensus 65 ~~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~~~----------------------- 105 (189)
...+.......+..+.+.|+.++|+.+++|||+ |+ |+++..
T Consensus 123 ~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~ 202 (322)
T d1vzoa_ 123 RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202 (322)
T ss_dssp HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHH
T ss_pred cccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcccccccccccccccccchhHHh
Confidence 334445556667778889999999999999996 55 333221
Q ss_pred C--CCCccc-e-EEEec------------CCCCChH----HHHHHHHcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-
Q psy1684 106 N--LSGVVV-S-AVDFG------------SGGMTNA----EVLHQVEHGYRMPCPPGCPPRLYDIMLECWLKDPVKRPT- 164 (189)
Q Consensus 106 ~--~~~~~~-s-VwsfG------------~~~~~~~----~~~~~v~~g~~~~~p~~~p~~~~~l~~~C~~~~p~~RP~- 164 (189)
. ...++. + |||+| |.+.+.. ++...... ..++.|..+++++.+|+.+||+.||++|||
T Consensus 203 ~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~-~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~ 281 (322)
T d1vzoa_ 203 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK-SEPPYPQEMSALAKDLIQRLLMKDPKKRLGC 281 (322)
T ss_dssp TTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH-CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred hcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhccc-CCCCCcccCCHHHHHHHHHHcccCHHHcCCC
Confidence 2 234788 9 99999 5554332 33333223 356778899999999999999999999995
Q ss_pred ----HHHHHH
Q psy1684 165 ----FETLQW 170 (189)
Q Consensus 165 ----~~~i~~ 170 (189)
++|+++
T Consensus 282 ~~~t~~eil~ 291 (322)
T d1vzoa_ 282 GPRDADEIKE 291 (322)
T ss_dssp STTTHHHHHT
T ss_pred CcccHHHHHc
Confidence 677765
|
| >d1xa6a2 d.93.1.1 (A:21-161) Beta-chimaerin, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Beta-chimaerin, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.42 E-value=1.1e-13 Score=90.02 Aligned_cols=68 Identities=19% Similarity=0.154 Sum_probs=56.8
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEecCCCeeeEEEEEeccCC-ccCCCCCcC-HhHHHH
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKRSSFCLKMTTGRSLFET-QKAGRTTIH-YPELVE 75 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~~~~~v~h~~i~~~~~g-yl~~~~~~~-l~~li~ 75 (189)
||||.|+|.+|+++|. ..+|+||||+|.+..|.|+||++. .+.++|++|.+. ++ |+. ...|. +.+|+.
T Consensus 37 wyhG~isR~eAe~lL~---~~dGsFLVR~S~~~~g~y~LSv~~--~~~v~H~~I~~~-g~~~~~-~~~F~sl~eLV~ 106 (141)
T d1xa6a2 37 EFHGIISREQADELLG---GVEGAYILRESQRQPGCYTLALRF--GNQTLNYRLFHD-GKHFVG-EKRFESIHDLVT 106 (141)
T ss_dssp SEEEECCHHHHHHHHC---SCTTBEEEEECSSSTTCEEEEEEE--TTEEEECCCEES-SSEECS-SSCCCCSSHHHH
T ss_pred eeeccCCHHHHHHHHc---CCCCeEEEEecCCCCCCEEEEEEE--CCEEEEEEEEEC-CCEEEC-CCeECCHHHHHh
Confidence 9999999999999984 247999999998888999999999 999999999863 44 654 44687 777663
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.37 E-value=2.3e-13 Score=99.89 Aligned_cols=129 Identities=11% Similarity=-0.034 Sum_probs=90.0
Q ss_pred EEEEEeccCC----ccCC-CCCcCHhHHHHHhhhccCCceeeccCCcccccc-cc--------------------ccccc
Q psy1684 51 MTTGRSLFET----QKAG-RTTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI--------------------YLVHG 104 (189)
Q Consensus 51 h~~i~~~~~g----yl~~-~~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~--------------------~l~~~ 104 (189)
.+.+....+| ++.. ...++......+..+.+.|+.++|..+++|||+ |+ |+|+.
T Consensus 76 ~~~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 76 NVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp EEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred cEEEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 3445555544 3332 334667777788888899999999999999996 66 22211
Q ss_pred C-----------------------------CCCCccc-e-EEEec------------CCCCC---hHHHHHHHHcCC-CC
Q psy1684 105 T-----------------------------NLSGVVV-S-AVDFG------------SGGMT---NAEVLHQVEHGY-RM 137 (189)
Q Consensus 105 ~-----------------------------~~~~~~~-s-VwsfG------------~~~~~---~~~~~~~v~~g~-~~ 137 (189)
. .+..++. + ||||| |.+.+ ..+....+.... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 0 4556899 9 99999 54433 333333332211 11
Q ss_pred ---CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhc
Q psy1684 138 ---PCPPGCPPRLYDIMLECWLKDPVKRPTFETLQWKLEDFFTME 179 (189)
Q Consensus 138 ---~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~l~~~~~~~ 179 (189)
..+..+|+++.+||..||+.+|++||+++.|.+.|+++++..
T Consensus 236 ~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 236 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 134679999999999999999999999999999999988754
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.32 E-value=9e-15 Score=110.26 Aligned_cols=105 Identities=12% Similarity=0.052 Sum_probs=72.9
Q ss_pred CcCHhHHHHHhhhccCCceeeccCCcccccc-cc-----------------------------------cccccC-CCCC
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI-----------------------------------YLVHGT-NLSG 109 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~-----------------------------------~l~~~~-~~~~ 109 (189)
.++..++..+..++..|+.++|..+++|||+ |+ +.|+|. .+..
T Consensus 115 ~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~ 194 (355)
T d2b1pa1 115 ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 194 (355)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---------------CCTTCCHHHHTTCC
T ss_pred CCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccccccccccccccccChhhhcCCC
Confidence 3456667778889999999999999999996 65 112222 5567
Q ss_pred ccc-e-EEEec------------CCCCChHHHHHHHHcCCCCC---------------------C--------------C
Q psy1684 110 VVV-S-AVDFG------------SGGMTNAEVLHQVEHGYRMP---------------------C--------------P 140 (189)
Q Consensus 110 ~~~-s-VwsfG------------~~~~~~~~~~~~v~~g~~~~---------------------~--------------p 140 (189)
++. + |||+| |.+.+.......+......+ . +
T Consensus 195 ~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (355)
T d2b1pa1 195 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFP 274 (355)
T ss_dssp CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSC
T ss_pred CCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCcccccccccccccccccc
Confidence 889 9 99999 66665544444332110000 0 0
Q ss_pred ------CCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 141 ------PGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 141 ------~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
...++++.+|+.+|+..||++|||++|+++.
T Consensus 275 ~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 275 ADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp CSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0124577899999999999999999999864
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.31 E-value=1.3e-13 Score=102.76 Aligned_cols=105 Identities=11% Similarity=-0.082 Sum_probs=70.8
Q ss_pred CCcCHhHHHHHhhhccCCceeeccCCcccccc-cc----------------cccccC----------------------C
Q psy1684 66 TTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI----------------YLVHGT----------------------N 106 (189)
Q Consensus 66 ~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~----------------~l~~~~----------------------~ 106 (189)
..++..++..+..++..|+.++|..+++|||+ |+ |+|... .
T Consensus 124 ~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~ 203 (328)
T d3bqca1 124 QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 203 (328)
T ss_dssp TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTT
T ss_pred cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCCcccccccCccccCcccccC
Confidence 35666777788899999999999999999996 66 222111 2
Q ss_pred CCCccc-e-EEEec------------CCC-CChHHHHHHHHc--C----------------------------------C
Q psy1684 107 LSGVVV-S-AVDFG------------SGG-MTNAEVLHQVEH--G----------------------------------Y 135 (189)
Q Consensus 107 ~~~~~~-s-VwsfG------------~~~-~~~~~~~~~v~~--g----------------------------------~ 135 (189)
...++. + |||+| |.. .+..+....+.. | .
T Consensus 204 ~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (328)
T d3bqca1 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFV 283 (328)
T ss_dssp CCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGC
T ss_pred CCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcc
Confidence 344788 9 99999 222 222221111100 0 0
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 136 RMPCPPGCPPRLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 136 ~~~~p~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
..+.+..+++++.+||.+|+..||++|||++|+++
T Consensus 284 ~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 284 HSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00111347789999999999999999999999876
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.27 E-value=1.6e-12 Score=96.24 Aligned_cols=107 Identities=16% Similarity=0.074 Sum_probs=75.1
Q ss_pred CCCcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cccccC-----------------------
Q psy1684 65 RTTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YLVHGT----------------------- 105 (189)
Q Consensus 65 ~~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l~~~~----------------------- 105 (189)
...+.......+..+++.|+.++|..+++|||+ |+ |++...
T Consensus 111 ~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aP 190 (318)
T d3blha1 111 LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 190 (318)
T ss_dssp TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCH
T ss_pred ccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhH
Confidence 445556677778889999999999999999996 66 222211
Q ss_pred ---C-CCCccc-e-EEEec------------CCCCChHHHHHHHHc--CCCCCC-CC-----------------------
Q psy1684 106 ---N-LSGVVV-S-AVDFG------------SGGMTNAEVLHQVEH--GYRMPC-PP----------------------- 141 (189)
Q Consensus 106 ---~-~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~--g~~~~~-p~----------------------- 141 (189)
. ...|+. + |||+| |.+.+..+....+.+ +...+. ..
T Consensus 191 E~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (318)
T d3blha1 191 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKD 270 (318)
T ss_dssp HHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHH
T ss_pred HHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchh
Confidence 2 335889 9 99999 667676665555432 111100 00
Q ss_pred -----CCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 142 -----GCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 142 -----~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
...+++.+||.+|++.||++|||++|+++.
T Consensus 271 ~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 271 RLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp HHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 135677899999999999999999999853
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.22 E-value=1.6e-12 Score=97.42 Aligned_cols=105 Identities=14% Similarity=0.004 Sum_probs=75.4
Q ss_pred CCcCHhHHHHHhhhccCCceeeccCCcccccc-cccc---------------------------------cccC-CC-CC
Q psy1684 66 TTIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RIYL---------------------------------VHGT-NL-SG 109 (189)
Q Consensus 66 ~~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~~l---------------------------------~~~~-~~-~~ 109 (189)
..++..++..+..+++.|+.++|..+++|||+ |+.+ ++|. .. ..
T Consensus 116 ~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~~~~~~g~~~y~apE~~~~~~~ 195 (348)
T d2gfsa1 116 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMH 195 (348)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTGGGSSSCHHHHTSCHHHHTTCSC
T ss_pred ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCcccccccccccccCchhhcCCcc
Confidence 35666777778889999999999999999996 6611 1111 33 34
Q ss_pred ccc-e-EEEec------------CCCCChHHHHHHHHcC--C----------------------CCC------CCCCCCH
Q psy1684 110 VVV-S-AVDFG------------SGGMTNAEVLHQVEHG--Y----------------------RMP------CPPGCPP 145 (189)
Q Consensus 110 ~~~-s-VwsfG------------~~~~~~~~~~~~v~~g--~----------------------~~~------~p~~~p~ 145 (189)
++. + |||+| |.+.+.......+... . +.+ ....+++
T Consensus 196 ~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 275 (348)
T d2gfsa1 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 275 (348)
T ss_dssp CCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCH
T ss_pred CCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCH
Confidence 677 8 99999 6666655554444221 1 000 0135788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHH
Q psy1684 146 RLYDIMLECWLKDPVKRPTFETLQW 170 (189)
Q Consensus 146 ~~~~l~~~C~~~~p~~RP~~~~i~~ 170 (189)
++.+||.+|+..||++|||++|+++
T Consensus 276 ~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 276 LAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHCcCChhhCcCHHHHhc
Confidence 9999999999999999999999987
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.11 E-value=9.3e-12 Score=93.14 Aligned_cols=105 Identities=14% Similarity=0.088 Sum_probs=73.6
Q ss_pred CcCHhHHHHHhhhccCCceeeccCCcccccc-cc---------------cc------------------------cccC-
Q psy1684 67 TIHYPELVEHYSKDADGLCVNLRKPCVQVSC-RI---------------YL------------------------VHGT- 105 (189)
Q Consensus 67 ~~~l~~li~~~~~~a~gl~~~~~~~~~~~~~-p~---------------~l------------------------~~~~- 105 (189)
.++..++..+..+...|+.++|..+++|||+ |+ |+ |+|.
T Consensus 105 ~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l 184 (345)
T d1pmea_ 105 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184 (345)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGT
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHh
Confidence 4556777888899999999999999999996 66 22 2221
Q ss_pred -CCCCccc-e-EEEec------------CCCCChHHHHHHHHc-------------------------CCC--CC---CC
Q psy1684 106 -NLSGVVV-S-AVDFG------------SGGMTNAEVLHQVEH-------------------------GYR--MP---CP 140 (189)
Q Consensus 106 -~~~~~~~-s-VwsfG------------~~~~~~~~~~~~v~~-------------------------g~~--~~---~p 140 (189)
....++. + |||+| |.+.+..+....... ... .+ ..
T Consensus 185 ~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (345)
T d1pmea_ 185 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLF 264 (345)
T ss_dssp TTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHC
T ss_pred hcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhC
Confidence 3345788 8 99999 555554333322211 000 00 12
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 141 PGCPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 141 ~~~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
+..++++.+|+.+|+..||++|||++|+++.
T Consensus 265 ~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 265 PNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 3567889999999999999999999999874
|
| >d1uura3 d.93.1.1 (A:577-707) STAT homologue {Dictyostelium discoideum [TaxId: 44689]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: STAT homologue species: Dictyostelium discoideum [TaxId: 44689]
Probab=99.09 E-value=1.2e-10 Score=74.85 Aligned_cols=58 Identities=21% Similarity=0.220 Sum_probs=49.3
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEec-CCCeeeEEEEEeccCC
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYKR-SSFCLKMTTGRSLFET 60 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~~-~~~~v~h~~i~~~~~g 60 (189)
||||.|+|..|+++|.. .++|+||||.|.+.+|.|+|+++.. ..+.++|+.|....++
T Consensus 11 ~~~G~isr~~ae~~L~~--~~~GtFLvR~S~s~~g~~~ls~~~~~~~~~v~h~~i~~~~~~ 69 (131)
T d1uura3 11 IIYGYMGRQEVNDALQN--QDPGTFIIRFSERNPGQFGIAYIGVEMPARIKHYLVQPNDTA 69 (131)
T ss_dssp SSCBSCCHHHHHHTTSS--CCTTCEEEEECSSSTTCEEEEEECSSSSCCEEEEECCGGGSB
T ss_pred cEEccCCHHHHHHHHhc--CCCCeEEEEecCCCCCcEEEEEEEecCCCcEEEEEEeecCCC
Confidence 89999999999999953 4689999999998889999999974 3468999999866543
|
| >d1bg1a3 d.93.1.1 (A:576-716) STAT3b {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: STAT3b species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.86 E-value=1.4e-10 Score=74.72 Aligned_cols=78 Identities=18% Similarity=0.170 Sum_probs=58.5
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCC-CCCCceEEEEEecCCCeeeEEEEEeccCCccCCCCCcC-HhHHHHHhh
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSE-SRKNDYSLSEYKRSSFCLKMTTGRSLFETQKAGRTTIH-YPELVEHYS 78 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~-~~~~~~~ls~~~~~~~~v~h~~i~~~~~gyl~~~~~~~-l~~li~~~~ 78 (189)
||||.|++..|+++|.. ..+|+||||+|. +..|.++++++. .+...|++|.... .|..+...+. +.++|.++.
T Consensus 9 w~~G~isr~~a~~~L~~--~~~GtFLvR~S~~s~~G~~tis~~~--~~~~~~~~i~~~~-p~t~~dl~~~sL~dlI~~y~ 83 (141)
T d1bg1a3 9 YIMGFISKERERAILST--KPPGTFLLRFSESSKEGGVTFTWVE--KDISGSTQIQSVE-PYTKQQLNNMSFAEIIMGYK 83 (141)
T ss_dssp CCCBCCCTTGGGTTTTT--SCTTCBCEEECSSCSSCCEEECCCC--SSSCSSCCCCCCC-CBCGGGGTSSCHHHHTTSCC
T ss_pred eEEEeCCHHHHHHHhhC--CCCCeEEEEecCCccCCCEEEEEEe--cCcCCceEEeecC-CeecCccccCCHHHHHHhhh
Confidence 99999999999999853 478999999997 457889999988 6777777665332 2444344455 999998887
Q ss_pred hccCC
Q psy1684 79 KDADG 83 (189)
Q Consensus 79 ~~a~g 83 (189)
..+.+
T Consensus 84 ~~~~~ 88 (141)
T d1bg1a3 84 IMDAT 88 (141)
T ss_dssp CBCTT
T ss_pred hhccc
Confidence 65543
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=98.71 E-value=3.4e-10 Score=84.83 Aligned_cols=29 Identities=21% Similarity=0.145 Sum_probs=25.8
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q psy1684 143 CPPRLYDIMLECWLKDPVKRPTFETLQWK 171 (189)
Q Consensus 143 ~p~~~~~l~~~C~~~~p~~RP~~~~i~~~ 171 (189)
.++++.+|+.+|+..||.+|||++|+++.
T Consensus 300 ~~~~~~dll~~mL~~dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 300 EAKEISDFLSPMLQLDPRKRADAGGLVNH 328 (362)
T ss_dssp HHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred cCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 45678899999999999999999999863
|
| >d1bf5a3 d.93.1.1 (A:569-710) STAT-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: STAT-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.32 E-value=0.013 Score=36.55 Aligned_cols=41 Identities=24% Similarity=0.274 Sum_probs=33.1
Q ss_pred CCCCCCChHHHHHHhcCCCCCCCcEEEecCCCC-CCceEEEEEe
Q psy1684 1 WYFGKIKRIEAEKKLLLPENDHGAFLIRDSESR-KNDYSLSEYK 43 (189)
Q Consensus 1 w~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~-~~~~~ls~~~ 43 (189)
|..|.|++..+..+|..+ ..|+||+|=|.+. .|..++++..
T Consensus 9 ~I~GFIsK~~a~~~L~~~--~~GTFLLRFSdS~~~GgitiawV~ 50 (142)
T d1bf5a3 9 CIMGFISKERERALLKDQ--QPGTFLLRFSESSREGAITFTWVE 50 (142)
T ss_dssp CCCCCCCHHHHHHHTTTC--CSCCCCEEECSSCSSCCEEEEECC
T ss_pred EEEEEecHHHHHHHhhCC--CCceEEEEeccCccCCceEEEEEE
Confidence 468999999999999554 6799999998865 4777777765
|
| >d3buxb3 d.93.1.1 (B:264-351) Cbl {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Cbl species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.19 E-value=2.7 Score=22.68 Aligned_cols=42 Identities=17% Similarity=0.256 Sum_probs=33.5
Q ss_pred CCCCCChHHHHHHhcCCCCCCCcEEEecCCCCCCceEEEEEe
Q psy1684 2 YFGKIKRIEAEKKLLLPENDHGAFLIRDSESRKNDYSLSEYK 43 (189)
Q Consensus 2 ~~g~l~~~n~~~lL~~~~~~~g~fLvre~~~~~~~~~ls~~~ 43 (189)
|+..|.=.++...|....+..|+||.|-|+..-|.+.+-...
T Consensus 5 Y~AFlTYDevk~rL~~~~~kPGSYiFRlSCTrlGQWAIGyvt 46 (88)
T d3buxb3 5 YMAFLTYDEVKARLQKFIHKPGSYIFRLSCTRLGQWAIGYVT 46 (88)
T ss_dssp BCTTCCHHHHHHHHGGGTTSTTEEEEEECSSSTTSEEEEEEC
T ss_pred eeEEEeHHHHHHHHHHHhcCCCceEEeeccccccceeeeeec
Confidence 345666777877787777889999999999999988776655
|